PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Chen, X; Zhang, B; Chai, Y; Dong, B; Lei, P; Jiang, RC; Zhang, JN				Chen, Xin; Zhang, Bin; Chai, Yan; Dong, Bo; Lei, Ping; Jiang, Rongcai; Zhang, Jianning			Methylprednisolone exacerbates acute critical illness-related corticosteroid insufficiency associated with traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Corticosteroid insufficiency; Apoptosis; Methylprednisolone	CELL-DEATH; HYPOTHALAMOPITUITARY DYSFUNCTION; POSTTRAUMATIC HYPOPITUITARISM; ADRENAL-RESPONSE; PITUITARY-GLAND; SEPTIC SHOCK; HEAD-INJURY; GLUCOCORTICOIDS; APOPTOSIS; DEFICITS	Emerging evidence demonstrates that severe illness could induce critical illness-related corticosteroid insufficiency (CIRCI) and cause poor prognosis. The purpose of this study was to test the hypothesis that methylprednisolone (MP), a synthetic glucocorticoid, promotes post-traumatic apoptosis in both the hypothalamus and pituitary, resulting in acute CIRCI and increased mortality in the acute phase of traumatic brain injury (TBI). We tested this hypothesis by measuring acute CIRCI in rats subjected to fluid percussion injury (FPI) and treated with MP (5-30 mg/kg). The corticosteroid response to TBI was evaluated using the corticosterone increase index (CII), where values less than 2.5 were considered indicative of acute CIRCI. The CII of MP treated rats was comparable to that of saline treated control rats before injury but was significantly decreased in injured rats receiving high-dose MP on post-injury day 7. Similarly, the incidence of acute CIRCI was significantly higher in the high-dose MP group on post-injury day 7. Furthermore, the CH of rats that did not survive post-injury was significantly lower compared to that of survival and was indicative of acute CIRCI. We also examined apoptosis in the paraventricular nucleus (PVN) of the hypothalamus and the adenohypophysis of the pituitary, using a TUNEL assay and transmission electron microscopy (TEM). The number of TUNEL-positive cells was significantly higher in injured rats treated with high-dose MP. No TUNEL-positive cells were detected in the adenohypophysis across experimental groups at either 7 or 14 days after TBI. However, autopsies performed on rats that did not survive post-injury revealed obvious apoptotic cells in the adenohypophysis. Moreover, TEM revealed morphological changes characteristic of apoptosis in both the PVN and adenohypophysis of high-dose MP treated rats. These data suggest that MP therapy for TBI could increase neuronal apoptosis in both the hypothalamus and pituitary and consequently exacerbate acute CIRCI and mortality induced by TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Dong, Bo] Tianjin Chest Hosp, Dept Cardiol, Tianjin 300051, Peoples R China		Zhang, JN (corresponding author), Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	woshichenxin@sina.com; victorbin922@163.com; chaiyankelly@yahoo.cn; dongbo121@yahoo.com.cn; leiping1974@163.com; jianghope@gmail.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533]; National Key Basic Research Program in ChinaNational Basic Research Program of China [2005CB522600]; Tianjin Medical University	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81000533), National Key Basic Research Program in China (grant no. 2005CB522600), and "211 Project" Graduate Innovation Grant of Tianjin Medical University. The authors sincerely thank Dr. Jing-fei Dong from Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, for his suggestion and edit during paper revision; the authors also thank Dr. Chrissandra Zagami, from Center for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, for her advice and help for publication, and appreciate Li Liu, Weiyun Cui, Fanglian Chen, and Lei Zhou, from Tianjin Neurological Institute, for their assistance in technical support.	Allen TC, 1992, LAB METHODS HISTOTEC, P53; Annane D, 2008, EUR RESPIR J, V31, P1150, DOI 10.1183/09031936.00040908; Bendel S, 2008, ANESTH ANALG, V106, P1813, DOI 10.1213/ane.0b013e318172fdba; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fombonne J, 2004, MOL BIOL CELL, V15, P4938, DOI 10.1091/mbc.E04-07-0601; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Llompart-Pou JA, 2008, NEUROCRIT CARE, V9, P230, DOI 10.1007/s12028-008-9115-6; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mesotten D, 2008, NAT CLIN PRACT ENDOC, V4, P496, DOI 10.1038/ncpendmet0921; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; Peyton JL, 2009, J VET EMERG CRIT CAR, V19, P262, DOI 10.1111/j.1476-4431.2009.00407.x; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5185; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schuetz Philipp, 2008, BMC Pulm Med, V8, P1, DOI 10.1186/1471-2466-8-1; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794	34	12	14	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 25	2011	1382						298	307		10.1016/j.brainres.2011.01.045			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	745AF	WOS:000289135600034	21262204				2022-02-06	
J	Grossman, KJ; Goss, CW; Stein, DG				Grossman, Kimberly J.; Goss, Cynthia W.; Stein, Donald G.			Sickness behaviors following medial frontal cortical contusions in male rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Sickness behavior; Traumatic brain injury; Progesterone; Weight maintenance; Food consumption; Grooming; Exploratory activity; Lesion size	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; PROGESTERONE TREATMENT; METABOLIC-RESPONSE; PREFRONTAL CORTEX; NEURONAL LOSS; HEAD-INJURY; EDEMA; ALLOPREGNANOLONE; PROTECTS	Behaviors associated with sickness (food consumption, weight maintenance, exploratory activity and grooming frequency) were examined on post-surgical days 1, 3, 5, 7 and 9 in male rats treated with progesterone (4 mg/kg) and/or vehicle. Rats with medial frontal cortex contusions showed reduced food consumption on days 1 and 3 (p < 0.01), reduced weight maintenance on days 1, 3, 5, 7 and 9 (p < 0.01), reduced grooming frequency on day 1 (p < .01), and reduced exploratory activity on day 1 (p < 0.01), after injury compared to sham rats. Contusion induced behaviors were not attenuated with 5 days of progesterone treatment (p > 0.05). Progesterone did reduce lesion size at 9 days after injury (p < 0.05). Our results suggest sickness behaviors occur after traumatic brain injury and that they might not respond to some neurosteroidal agents. (C) 2010 Elsevier B.V. All rights reserved.	[Grossman, Kimberly J.; Goss, Cynthia W.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA		Grossman, KJ (corresponding author), Emory Univ, Dept Psychol, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	kgrossm@gmail.com	Stein, Donald/AAJ-5139-2020		General Cologne Reinsurance Corporation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-38664]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038664] Funding Source: NIH RePORTER	Aamir Dam for his assistance with behavioral testing preparations. Research supported by General Cologne Reinsurance Corporation and NIH R01 NS-38664.	Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Cavalli R, 1999, INT J PHARM, V182, P59, DOI 10.1016/S0378-5173(99)00066-6; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DICKERSON JWT, 1992, ADV EXP MED BIOL, V325, P23; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; GIPSEN WH, 1975, LIFE SCI, V17, P645; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Inui A, 2000, PHARMACOL REV, V52, P35; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Kelley KW, 1997, ANN NY ACAD SCI, V823, P234, DOI 10.1111/j.1749-6632.1997.tb48395.x; KEPPEL G, 1991, ANAL RES HDB; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Paxinos G., 1982, RAT BRAIN; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Roe SY, 1997, J NEUROTRAUM, V14, P399, DOI 10.1089/neu.1997.14.399; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	36	12	12	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	FEB 2	2011	217	1					202	208		10.1016/j.bbr.2010.09.029			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	710TK	WOS:000286539700029	20933021	Green Accepted			2022-02-06	
J	Frye, CA; Walf, A				Frye, Cheryl A.; Walf, Alicia			Progesterone, Administered Before Kainic Acid, Prevents Decrements in Cognitive Performance in the Morris Water Maze	DEVELOPMENTAL NEUROBIOLOGY			English	Article						dihydroprogesterone; allopregnanolone; neurosteroid; learning; ictal activity; hippocampus; neuroprotection	TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; 4-DAY ESTROUS-CYCLE; FEMALE RAT-BRAIN; CELL-DEATH; MEDROXYPROGESTERONE ACETATE; OBJECT RECOGNITION; INDUCED NEUROPROTECTION; NEUROACTIVE STEROIDS; PREFRONTAL CORTEX	The nature of progesterone (P-4)'s neuroprotective effects is of interest. We investigated effects of P-4 when administered before, or after, kainic acid, which produces ictal activity and damage to the hippocampus, to mediate effects on spatial performance. The hypothesis was that P-4, compared with vehicle, would reduce decrements in Morris Water Maze performance induced by kainic acid. Experiment 1: We examined the effects of kainic acid on plasma stress hormone, corticosterone, and progestogen (P-4 and its metabolites) levels in plasma and the hippocampus after subcutaneous (s.c.) P-4 administration to ovariectomized rats. Rats administered kainic acid had the highest corticosterone levels immediately following injection. P-4 is 5 alpha-reduced to dihydroprogesterone (DHP) and subsequently metabolized to 5 alpha-pregnan-3 alpha-ol-20-one (3 alpha,5 alpha-THP) by 3 alpha-hydroxysteroid dehydrogenase. The regimen of P-4 used produced circulating and hippocampal levels of P-4, DHP, and 3 alpha,5 alpha-THP within a physiological range, which declined at 14 hours postinjection and were not altered by kainic acid. Experiment 2: The physiological P-4 regimen was administered to rats before, or after, kainic acid-induced seizures, and later effects on water maze performance were compared with that of rats administered vehicle. Rats administered kainic acid had significantly poorer performance in the water maze (i.e., increased latencies and distances to the hidden platform) than did rats administered vehicle. Administration of P-4 before, but not after, kainic acid prevented these performance deficits. Thus, these data suggest that a physiological regimen of P-4 can prevent some of the deficits in water maze performance produced by kainic acid. (C) 2010 Wiley Periodicals, Inc. Develop Neurobiol 71: 142-152, 2011	[Frye, Cheryl A.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Frye, Cheryl A.] SUNY Albany, Dept Biol, Albany, NY 12222 USA; [Frye, Cheryl A.; Walf, Alicia] SUNY Albany, Ctr Life Sci, Albany, NY 12222 USA		Frye, CA (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	cafrye@albany.edu			National Institutes of Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Science FoundationNational Science Foundation (NSF); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R56MH067698, R01MH067698] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health (NIMH) and National Science Foundation.	Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Balasubramanian B, 2008, ENDOCRINOLOGY, V149, P5509, DOI 10.1210/en.2008-0712; BELANGER A, 1981, BIOL REPROD, V24, P591, DOI 10.1095/biolreprod24.3.591; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; BUTCHER RL, 1974, ENDOCRINOLOGY, V94, P1704, DOI 10.1210/endo-94-6-1704; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carroll JC, 2008, NEUROSCI LETT, V445, P229, DOI 10.1016/j.neulet.2008.09.010; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Foy MR, 2008, LEARN MEMORY, V15, P820, DOI 10.1101/lm.1124708; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Frye CA, 1999, J NEUROENDOCRINOL, V11, P839; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; FRYE CA, 1995, PHYSIOL BEHAV, V57, P5, DOI 10.1016/0031-9384(94)00197-D; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; Frye CA, 2008, INT REV NEUROBIOL, V83, P27, DOI 10.1016/S0074-7742(08)00003-2; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2008, NEUROSCI LETT, V437, P116, DOI 10.1016/j.neulet.2008.04.004; Frye CA, 2008, NEUROBIOL LEARN MEM, V89, P17, DOI 10.1016/j.nlm.2007.09.008; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2010, NEUROREPORT, V21, P590, DOI 10.1097/WNR.0b013e32833a7e14; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Harburger LL, 2007, NEUROBIOL AGING, V28, P602, DOI 10.1016/j.neurobiolaging.2006.02.019; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Herzog AG, 2003, ANN NEUROL, V53, P390, DOI 10.1002/ana.10508; Herzog AG, 2009, NEUROTHERAPEUTICS, V6, P383, DOI 10.1016/j.nurt.2009.01.009; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; HORIKOSHI H, 1974, ENDOCRINOL JAPON, V21, P69; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Li XD, 1997, J STEROID BIOCHEM, V60, P311, DOI 10.1016/S0960-0760(96)00195-1; Littleton-Kearney MT, 2005, J CEREBR BLOOD F MET, V25, P421, DOI 10.1038/sj.jcbfm.9600052; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Melcangi RC, 1999, J NEUROBIOL, V40, P471, DOI 10.1002/(SICI)1097-4695(19990915)40:4<471::AID-NEU5>3.3.CO;2-G; Melcangi RC, 2001, INT REV NEUROBIOL, V46, P145; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nilsen J, 2002, NEUROREPORT, V13, P825, DOI 10.1097/00001756-200205070-00018; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Palumbo MA, 1995, J ENDOCRINOL INVEST, V18, P853, DOI 10.1007/BF03349832; Paris JJ, 2008, REPRODUCTION, V136, P105, DOI 10.1530/REP-07-0512; PURDY RH, 1990, STEROIDS, V55, P290, DOI 10.1016/0039-128X(90)90031-6; Reyna-Neyra A, 2002, BRAIN RES BULL, V58, P607, DOI 10.1016/S0361-9230(02)00829-8; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P140, DOI 10.1016/j.yebeh.2004.11.019; Rhodes ME, 2004, EPILEPSIA, V45, P1531, DOI 10.1111/j.0013-9580.2004.16504.x; Rhodes ME, 2004, PHARMACOL BIOCHEM BE, V78, P505, DOI 10.1016/j.pbb.2004.04.021; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; RODBARD D, 1974, CLIN CHEM, V20, P1255; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosario ER, 2006, BRAIN RES, V1099, P206, DOI 10.1016/j.brainres.2006.03.127; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; SHAIKH AA, 1975, ENDOCRINOLOGY, V96, P37, DOI 10.1210/endo-96-1-37; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Sugino N, 1996, ENDOCRINOLOGY, V137, P749, DOI 10.1210/en.137.2.749; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1288, DOI 10.1038/sj.npp.1300708; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	87	12	13	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1932-8451			DEV NEUROBIOL	Dev. Neurobiol.	FEB	2011	71	2					142	152		10.1002/dneu.20832			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	718ED	WOS:000287102700002	20715152	Green Accepted			2022-02-06	
J	Merten, T				Merten, T.			Symptom Validity Assessment and Forensic Evaluation of Cognitive and Mental Disorders	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article						symptom validity assessment; malingering; forensic assessment; symptom exaggeration; neuropsychological assessment; questionnaires	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; MUNCHAUSEN-BY-PROXY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; POSTTRAUMATIC-STRESS-DISORDER; NEGATIVE RESPONSE BIAS; TEST-PERFORMANCE; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; SUBOPTIMAL EFFORT	Continuing from two previous reviews in this journal (Fortchr Neurol Psychiatr 2002; 70: 126 - 138; 2007; 75: 140 - 154), modern methods and research on symptom validity assessment are presented, with special emphasis on civil forensic examinations. In spite of continuing resistance from many professionals, symptom validity assessment is gradually gaining ground in German-speaking countries, but there is a developmental lag in European countries as a whole, as compared to developments in North America. Major research lines are presented, and questionnaire measures for the detection of a negative response bias are illustrated in more detail.	Vivantes Klinikum Friedrichshain, Neurol Klin, D-10249 Berlin, Germany		Merten, T (corresponding author), Vivantes Klinikum Friedrichshain, Neurol Klin, Landsberger Allee 49, D-10249 Berlin, Germany.	thomas.merten@vivantes.de					Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; Allen L., 1997, CARB 97 MANUAL COMPU; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; BAGBY RM, 2006, MMPI 2 PRACTITIONERS, P39, DOI DOI 10.1037/11287-003; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Blaskewitz N, 2007, FORTSCHR NEUROL PSYC, V75, P140, DOI 10.1055/s-2006-932204; BLASKEWITZ N, 2009, THESIS HUMBOLDT U BE; Blaskewitz N., 2006, Z NEUROPSYCHOL, V17, P35, DOI DOI 10.1024/1016-264X.17.1.35; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boccaccini MT, 2006, J FORENSIC PSYCHOL P, V6, P51, DOI 10.1300/J158v06n03_03; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Brickenkamp R., 2002, TEST D2 AUFMERKSAMKE; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; BROCKMEYER M, 2009, DIAGNOSTIK BESCHWERD, P280; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; BUSH SS, 2007, PRAXIS RECHTSPSYCHOL, V17, P155; BUSH SS, 2006, ETHICAL PRACTICE FOR; BUSH SS, 2009, DIAGNOSTIK BESCHWERD, P79; Busichio K, 2004, J INT NEUROPSYCH SOC, V10, P278, DOI 10.1017/S1355617704102178; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Chesterman LP, 2008, J FORENSIC PSYCHI PS, V19, P275, DOI 10.1080/14789940701841129; CHRISTIANSON SA, 2007, OFFENDERS MEMORIES V; Cima M, 2003, NERVENARZT, V74, P977, DOI 10.1007/s00115-002-1438-5; Cima M, 2003, CLIN NEUROPSYCHOL, V17, P235, DOI 10.1076/clin.17.2.235.16507; CIMA M, 2007, PRAXIS RECHTSPSYCHOL, V17, P47; Cima M, 2008, J FORENSIC SCI, V53, P975, DOI 10.1111/j.1556-4029.2008.00740.x; Colwell K., 2005, AM J FORENS PSYCHOL, V23, P83; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Day DO, 2010, J FORENSIC PSYCHOL P, V10, P13, DOI 10.1080/15228930903172981; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DETTENBORN H, 2009, DIAGNOSTIK BESCHWERD, P70; DIEDERICH C, 2009, EINSATZ SELBSTBEURTE; DIEDERICH C, 2009, 1 EUR S SYMPT VAL WU; Dohrenbusch R, 2009, SCHMERZ, V23, P241, DOI 10.1007/s00482-009-0789-2; Dohrenbusch R, 2009, SCHMERZ, V23, P231, DOI 10.1007/s00482-009-0788-3; DOHRENBUSCH R., 2007, BEGUTACHTUNG SOMATOF; Drob SL, 2009, J AM ACAD PSYCHIATRY, V37, P98; *DTSCH RENT, 2010, LEITL SOZ BEURT BEI; *DTSCH RENT BUND, SOZ BEG GES IN PRESS; EBERT A, 2007, AGGRAVATIONS SIMULAT; ENGEL R, VEI VERHALT IN PRESS; Engel R, 2000, MMPI 2 MINNESOTA MUL; ETTINGER AB, 2007, PSYCHIAT ISSUES EPIL; Everington C, 2007, BEHAV SCI LAW, V25, P545, DOI 10.1002/bsl.735; Fabra M, 2009, Versicherungsmedizin, V61, P111; FABRA M, 2003, KOMPENDIUM MED BEGUT; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Feldman MD, 2004, PSYCHOSOMATICS, V45, P365, DOI 10.1176/appi.psy.45.4.365; Flaro L., 2007, PRAXIS RECHTSPSYCHOL, V17, P125; Franke, 2002, SCL 90 R SYMPTOM CHE; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Gast J, 2010, J FORENSIC PSYCHOL P, V10, P53, DOI 10.1080/15228930903173062; GERAERTS E, 2007, NEUROPRAXIS, V1, P8; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GIGER P, 2009, DIAGNOSTIK BESCHWERD, P101; GIGER P, J FORENS PS IN PRESS; Giger P, 2010, PRAXIS RECHTSPSYCHOL, V20, P131; GIGER P, 2008, DIAGNOSTIK BESCHWERD; Gill David, 2007, Med Leg J, V75, P64; Gorny I., 2005, J FORENSIC NEUROPSYC, V4, P71, DOI DOI 10.1300/J151V04N04_05; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; Granhag ParAnders., 2004, DETECTION DECEPTION; Graue LO, 2007, CLIN NEUROPSYCHOL, V21, P929, DOI 10.1080/13854040600932137; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; GREEN P, APPL NEUROL IN PRESS; Green P., 2008, GREENS NONVERBAL MED; Green P, 2004, GREENS MED SYMPTOM V; Green P, 2004, REPORT PSYCHOL, V29, P303; GREENE RL, 2008, CLIN ASSESSMENT MALI, P00159; Greiffenstein MF, 2010, CLIN NEUROPSYCHOL, V24, P305, DOI 10.1080/13854040903456222; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; GUBBAY J, GUIDELINES 1 I UNPUB; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; HALL HV, 2000, DETECTING MALINGERIN; Hanlon RE, 2010, ARCH CLIN NEUROPSYCH, V25, P1, DOI 10.1093/arclin/acp099; Harrison AG, 2007, ARCH CLIN NEUROPSYCH, V22, P577, DOI 10.1016/j.acn.2007.03.008; Harrison AG, 2010, ARCH CLIN NEUROPSYCH, V25, P89, DOI 10.1093/arclin/acp104; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HAUSOTTER W, 1995, MED SACH, V91, P10; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Helmstaedter C., 2001, VLMT VERBALER LERN M; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P158, DOI 10.1080/13825580601025916; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Henry GK, 2009, CLIN NEUROPSYCHOL, V23, P153, DOI 10.1080/13854040801969524; HENRY M, 2009, DIAGNOSTIK BESCHWERD, P118; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Heubrock D., 2000, TESTBATTERIE FORENSI; Hilsabeck RC, 2001, ARCH CLIN NEUROPSYCH, V16, P669, DOI 10.1016/S0887-6177(00)00077-9; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Iverson G. L., 2010, HDB FORENSIC NEUROPS, P91; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; Jones AB., 1917, MALINGERING SIMULATI; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P385, DOI 10.1136/jnnp.57.3.385; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KLUMBIES G, 1980, PSYCHOTHERAPIE INNER; KOOL J, 2008, 408 BUND SOZ; KOPELMAN MD, 1995, HDB MEMORY DISORDERS, P427; KUBINGER K, PSYCHOL DIA IN PRESS; Lamberty G. J., 2008, UNDERSTANDING SOMATI; LANG CJG, 2010, MED SACH, V106, P128; Lange RT, 2006, ARCH CLIN NEUROPSYCH, V21, P552; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P335; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Leiguarda R., 2005, HIGHER ORDER MOTOR D; Lindstrom WA, 2009, ARCH CLIN NEUROPSYCH, V24, P659, DOI 10.1093/arclin/acp071; Lorenz J, 1998, NEUROREPORT, V9, P187, DOI 10.1097/00001756-199801260-00003; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Maercker A, 1998, DIAGNOSTICA, V44, P130; MCCANN JT, 1998, MALINGERING DECEPTIO; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; McKinzey RK, 2003, BRIT J CLIN PSYCHOL, V42, P95, DOI 10.1348/014466503762842048; MCNABB AW, 1988, J NEUROL NEUROSUR PS, V51, P218, DOI 10.1136/jnnp.51.2.218; MEINS W, 2010, MED SACH, V106, P153; MERCKELBACH H, J CLIN EXP IN PRESS; MERCKELBACH H, 2007, PRAXIS RECHTSPSYCHOL, V17, P29; MERCKELBACH H, 2009, 1 EUR S SYMPT VAL AS; MERCKELBACH H, 2007, OFFENDERS MEMORIES V, P165, DOI DOI 10.1002/9780470713082.CH7; Merten T, 2008, AKTUEL NEUROL, V35, P8, DOI 10.1055/s-2007-986232; Merten T, 2007, NERVENARZT, V78, P511, DOI 10.1007/s00115-006-2101-3; Merten T, 2007, AKTUEL NEUROL, V34, P134, DOI 10.1055/s-2006-951966; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2010, Versicherungsmedizin, V62, P126; Merten T, 2010, ORTHOPADE, V39, P329, DOI 10.1007/s00132-009-1550-3; Merten T, 2001, Z KLIN PSYCH PSYCHIA, V49, P417; Merten T, 2002, FORTSCHR NEUROL PSYC, V70, P126, DOI 10.1055/s-2002-20531; Merten T., 2007, PRAXIS RECHTSPSYCHOL, V17, P140; MERTEN T, 2009, DIAGNOSTIK BESCHWERD; MERTEN T, 2006, FORUM MED BEGUTACHTU, V2, P11; MERTEN T, 2009, MED SACH, V105, P228; MERTEN T, 2006, MED SACH, V102, P58; Merten T., 2010, GERMAN J PSYCHIAT, V13, P140; MERTEN T, 2004, Z NEUROPSYCHOL, V15, P81; Merten Th, 2004, Versicherungsmedizin, V56, P67; Merten Th, 2006, Versicherungsmedizin, V58, P19; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Meyers JE., 1995, REY COMPLEX FIGURE T; Miller H.A., 2001, MILLER FORENSIC ASSE; Miller L, 2001, NEUROREHABILITATION, V16, P109; MILLER LS, 2006, J INT NEUROPSYCH SOC, V12, P159; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Morel KR, 2008, J ANXIETY DISORD, V22, P1542, DOI 10.1016/j.janxdis.2008.03.008; Morel KR, 2008, CLIN NEUROPSYCHOL, V22, P350, DOI 10.1080/13854040701300531; Morel KR, 2009, ARCH CLIN NEUROPSYCH, V24, P635, DOI 10.1093/arclin/acp062; Morgan J. E., 2009, NEUROPSYCHOLOGY MALI; MULLERFRANK C, 2006, BUZAKTUELL, V1, P21; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; OSTENDORF GM, 2010, VERSMED, V62, P45; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1988, Z KLIN PSYCHOL PSYCH, V36, P130; Peebles R, 2005, CLIN PEDIATR, V44, P237, DOI 10.1177/000992280504400307; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Quinn CA, 2003, ARCH CLIN NEUROPSYCH, V18, P379, DOI 10.1016/S0887-6177(02)00150-6; Reinhard MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P533, DOI 10.1016/j.acn.2007.03.006; Rey A, 1958, LEXAMEN CLINIQUE PSY; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Rogers R, 2004, CHILD ABUSE NEGLECT, V28, P225, DOI 10.1016/j.chiabu.2003.08.004; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 2008, CLIN ASSESSMENT MALI; Rosen G. M., 2004, POSTTRAUMATIC STRESS, P85, DOI 10.1002/9780470713570.ch5.; RUBENZER S, 2005, FOR DEFENSE, V4, P4; RUBENZER S, 2006, FEDERATION DEFENSE C, V56, P499; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Ruchsow M, 2010, NERVENARZT, V81, P1085, DOI 10.1007/s00115-009-2921-z; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Salekin KL, 2009, APPL NEUROPSYCHOL, V16, P105, DOI 10.1080/09084280902864485; Samuel R.Z., 2005, PRIMARY PSYCHIAT, V12, P60; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHMAND B, 2005, AMSTERDAM SHORT TERM; Schmidt-Atzert L, 2004, DIAGNOSTICA, V50, P124, DOI 10.1026/0012-1924.50.3.124; Schmidt-Atzert L, 1998, DIAGNOSTICA, V44, P142; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Simon RI, 2010, AM PSYCHIAT PUBLISHI; SINGH J, 2007, GER J PSYCHIAT, V0010, P00126; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spence SA, 2000, LANCET, V355, P1243, DOI 10.1016/S0140-6736(00)02096-1; Spitzer C, 2005, FRAGEBOGEN DISSOZIAT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Steffan JS, 2003, ASSESSMENT, V10, P382, DOI 10.1177/1073191103259548; STETTLER TJ, 2009, THESIS PACIFIC U HIL; STEVENS A, 2009, MED SACH, V105, P100; STEVENS A, 2006, MED SACH, V102, P139; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Streppel M, 2007, HNO, V55 Suppl 1, pE7, DOI 10.1007/s00106-006-1433-4; Streppel M, 2010, HNO, V58, P126, DOI 10.1007/s00106-009-2064-3; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Svitak M, 2007, Versicherungsmedizin, V59, P170; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; THOMANN KD, 2009, HDB ORTHOPADISCH UNF; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turner M, 1997, BRIT J PSYCHIAT, V171, P409, DOI 10.1192/bjp.171.5.409; TYDECKS S, 2006, INT J FORENSIC PSYCH, V0001, P00029; VAGNINI VL, 2008, J CLIN EXP NEUROPSYC, V26, P1; van Hooff JC, 2008, AM J BIOETHICS, V8, P25, DOI 10.1080/15265160701828501; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Verschuere B, 2008, PSYCHOL CRIME LAW, V14, P523, DOI 10.1080/10683160801955183; Walters GD, 2009, J CLIN EXP NEUROPSYC, V31, P584, DOI 10.1080/13803390802363728; WIDDER B, BEGUTACHTUN IN PRESS; WIDDER B, 2010, MED SACH, V106, P34; WILBOURN AJ, 1995, NEUROL CLIN, V13, P385, DOI 10.1016/S0733-8619(18)30052-5; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wurzer W, 1992, POSTTRAUMATISCHE ORG; Ylioja SG, 2009, ARCH CLIN NEUROPSYCH, V24, P729, DOI 10.1093/arclin/acp078; ZIBERI M, 2009, 1 EUR S SYMPT VAL AS; [No title captured]; [No title captured]; [No title captured]	255	12	12	0	11	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	FEB	2011	79	2					102	116		10.1055/s-0029-1245731			15	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	724HB	WOS:000287565600007	21117012				2022-02-06	
J	Ono, MY; Ownsworth, T; Walters, B				Ono, Miyuki; Ownsworth, Tamara; Walters, Benjamin			Preliminary investigation of misconceptions and expectations of the effects of traumatic brain injury and symptom reporting	BRAIN INJURY			English	Article						Brain injury; TBI; misconceptions; expectations; symptom reporting	PERSISTENT POSTCONCUSSION SYNDROME; HEAD-INJURY; SUBJECTIVE COMPLAINTS; EMOTIONAL ADJUSTMENT; SELF-AWARENESS; ETIOLOGY; DEFICITS	Objective: This study aimed, first, to introduce a new measure for examining misconceptions of the effects of traumatic brain injury (TBI) and, secondly, to conduct a preliminary investigation of the impact of misconceptions and expectations on level of symptom reporting. Methods: The Head Injury Knowledge Scale (HIKS) was piloted for its utility in this study using a sample (n = 13) of individuals with brain injury. A sample of 99 uninjured participants was randomly allocated into either TBI simulation (n = 59) or control (n = 40) groups using a 3:2 allocation ratio. All participants initially completed the HIKS and then controls completed the Symptom Expectancy Checklist (SEC). The TBI simulation group was presented with a simulation scenario concerning severe TBI and then completed the SEC. Retrospective data on the SEC for individuals with a severe TBI (n = 38) were used for comparison purposes. Results: The HIKS was deemed suitable for use in the present study based on pilot data and internal consistency analysis of the two sub-scales (alpha > 0.60). The uninjured participants displayed a greater tendency to over-generalize than minimize the effects of TBI (p < 0.001). The TBI simulation group reported a higher level of symptoms on the SEC than controls and those with severe TBI (p < 0.001). However, level of symptom reporting on the SEC in the simulation group was not significantly related to misconceptions of the effects of TBI (p > 0.05). Conclusions: Based on these preliminary findings, the HIKS may provide a useful measure of the relative tendency to over-generalize or minimize the effects of TBI. However, further research is needed to investigate the reliability and validity of the HIKS prior to clinical use.	Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Griffith Inst Hlth & Med Res, Brisbane, Qld 4111, Australia		Ono, MY (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt Campus, Nathan, Qld 4111, Australia.	m.ono@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094			Babin PR, 2002, J REHABIL, V68, P4; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CULLUM CM, 1990, TRAUMATIC BRAIN INJU, P129; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gallois, 1993, ASSERTION ITS SOCIAL; Gouvier D. W., 1988, ARCH CLIN NEUROPSYCH, V3, P331; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KIRMAYER LJ, 1997, ADULT PSYCHOPATHOLOG, P00333; KOLB B, 1996, FUNDAMENTALS HUMAN N; KOLB B, 2003, FUNDAMENTALS HUMAN N; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1998, ORGANIC PSYCHIAT CON; Mitchell ML, 2004, RES DESIGN EXPLAINED; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nunnally J., 1994, PSYCHOMETRIC THEORY; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P299; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M, 2004, AWARENESS QUESTIONNA; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010; [No title captured]	45	12	12	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2011	25	2					237	249		10.3109/02699052.2010.541893			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800010	21219094				2022-02-06	
J	Piebes, SK; Snyder, AR; Bay, RC; McLeod, TCV				Piebes, Sarah K.; Snyder, Alison R.; Bay, R. Curtis; McLeod, Tamara C. Valovich			Measurement Properties of Headache-Specific Outcomes Scales in Adolescent Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; patient report; reliability	QUALITY-OF-LIFE; SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; IMPACT; QUESTIONNAIRE; DISABILITY; COLLEGIATE; CHILDREN; IDENTIFICATION; MANAGEMENT	Context: Recurrent headaches significantly affect health-related quality of life (HRQOL) in adults; the impact of headache on HRQOL among adolescents is unknown, and the psychometric properties of headache-specific outcomes instruments have not been adequately studied in this population. Objective: To evaluate the psychometric properties of the Headache Impact Test (HIT-6) and Pediatric Migraine Disability Assessment (PedMIDAS) in healthy adolescent athletes. Design: Descriptive survey. Setting: High school athletic training facilities during the fall sports season. Participants: 177 high school athletes (89 males and 88 females). Interventions: A survey consisting of a demographic and concussion-history questionnaire, a graded symptom scale, the HIT-6, and the PedMIDAS. Internal consistency (alpha), test retest reliability (r(s)), Bland-Altman analyses, and the Mann-Whitney U test were used to evaluate psychometric properties and age and gender differences. Main Outcome Measures: The HIT-6 and PedMIDAS item and total scores. Results: Test-retest reliability for the HIT-6 total score was r(s)=.72, and reliability of individual items ranged from r(s)=.52 to .67. The test-retest reliability for the PedMIDAS total score was r(s)=.61, and reliability of individual items ranged from r(s)=.23 to .62. Both scales demonstrated acceptable internal consistency: HIT-6 alpha=.89-.90 and PedMIDAS alpha=.71-.75. Conclusions: The authors found moderate test-retest reliability for the HIT-6 and the PedMIDAS in a healthy adolescent athlete population. Research on the applicability and utility of the HIT-6 and PedMIDAS in concussed adolescents is warranted.	[Piebes, Sarah K.; Snyder, Alison R.; Bay, R. Curtis; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA		Piebes, SK (corresponding author), AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA.		Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Bay, Ralph/0000-0003-3525-9269			Aliprandi A, 2004, NEUROL SCI, V25, pS274, DOI 10.1007/s10072-004-0307-3; Bayliss M., 2002, HIT 6 USERS GUIDE; Bjorner JB, 2003, QUAL LIFE RES, V12, P981, DOI 10.1023/A:1026123400242; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; D'Amico D, 2003, NEUROL SCI, V24, pS97; Egger HL, 1998, J AM ACAD CHILD PSY, V37, P951, DOI 10.1097/00004583-199809000-00015; Evans RW, 2004, NEUROL CLIN, V22, pXI, DOI 10.1016/S0733-8619(03)00103-8; Fichtel A, 2002, HEADACHE, V42, P766, DOI 10.1046/j.1526-4610.2002.02178.x; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hershey AD, 2004, CEPHALALGIA, V24, P844, DOI 10.1111/j.1468-2982.2004.00757.x; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; LANGLOIS J, 2007, PHYS TOOL KIT; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; Patrick DL, 2002, J ADOLESCENCE, V25, P287, DOI 10.1006/jado.2002.0471; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rhee Hyekyun, 2005, Pediatr Nurs, V31, P314; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Snyder A, 2007, ATHL TRAIN ED J, V2, P31; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vitulano LA, 2003, CHILD ADOL PSYCH CL, V12, pXIII, DOI 10.1016/S1056-4993(03)00032-4; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd	35	12	12	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716			J SPORT REHABIL	J. Sport Rehabil.	FEB	2011	20	1			SI		129	142		10.1123/jsr.20.1.129			14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	719AX	WOS:000287172700012	21411828				2022-02-06	
B	Badr, H; Barker, TM; Milbury, K		Wadsworth, SM; Riggs, D		Badr, Hoda; Barker, Trina M.; Milbury, Kathrin			Couples' Psychosocial Adaptation to Combat Wounds and Injuries	RISK AND RESILIENCE IN U S MILITARY FAMILIES			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MALE VIETNAM VETERANS; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; MAINTENANCE STRATEGIES; FEMALE PARTNERS; CANCER-PATIENTS; BREAST-CANCER	Almost half of all service members are married at the time of their deployment, and spouses play a key role in their rehabilitation after being wounded in combat. This chapter reviews the literature on couples' psychosocial adaptation to combat wounds and injuries and is divided into three parts. First, we review studies on the impact of physical and psychological wounds on service members' spousal relationships. Next, given the relative paucity of research in this area, we review the major theoretical frameworks that have guided an understanding of how spousal relationships promote adaptation to health-related stress in the civilian population and discuss how these frameworks can be used to help military couples cope with the unique challenges and implications of combat wounds and injuries. Finally, we discuss some of the challenges of doing research in this area and propose directions for future research.	[Badr, Hoda] Mt Sinai Sch Med, Dept Oncol Sci, Unit 1130, New York, NY 10029 USA; [Barker, Trina M.; Milbury, Kathrin] Univ Texas MD Anderson Canc Ctr, Houston, TX USA		Badr, H (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, Unit 1130, 1 Gustave L Levy Pl, New York, NY 10029 USA.	hoda.badr@mssm.edu					Acitelli LK, 2002, COMMUN THEOR, V12, P92, DOI 10.1111/j.1468-2885.2002.tb00261.x; Acitelli LK, 1999, J SOC PERS RELAT, V16, P591, DOI 10.1177/0265407599165003; Adler AB, 1996, MIL PSYCHOL, V8, P1, DOI 10.1207/s15327876mp0801_1; AKESODE FA, 1981, TROP GEOGR MED, V33, P71; Alessi MW, 2001, J CLIN PSYCHOL, V57, P1535, DOI 10.1002/jclp.1115; Althof SE, 2002, UROLOGY, V59, P803, DOI 10.1016/S0090-4295(02)01606-0; Andersen B. L., 2001, PSYCHOSOC INTERV, P99, DOI [10.1037/10402-006, DOI 10.1037/10402-006]; ANDREASEN NJ, 1971, ANN SURG, V174, P785, DOI 10.1097/00000658-197111000-00009; Badr H, 2005, J FAM PSYCHOL, V19, P465, DOI 10.1037/0893-3200.19.3.465; Badr Hoda, 2008, J Cancer Surviv, V2, P53, DOI 10.1007/s11764-008-0044-3; Badr H, 2007, PSYCHOL HEALTH, V22, P211, DOI 10.1080/14768320600843077; Badr H, 2006, PSYCHO-ONCOL, V15, P673, DOI 10.1002/pon.996; Badr H, 2009, PSYCHO-ONCOL, V18, P735, DOI 10.1002/pon.1449; Beckham JC, 1996, J CONSULT CLIN PSYCH, V64, P1068, DOI 10.1037/0022-006X.64.5.1068; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bodenmann, 2005, COUPLES COPING STRES, P33, DOI DOI 10.1037/11031-002; Bodenmann G, 1997, EUR REV APPL PSYCHOL, V47, P137; BODENMANN G, 2000, Z FAMILIENFORSCH, V12, P5; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Canary DJ, 2002, J MARRIAGE FAM, V64, P395, DOI 10.1111/j.1741-3737.2002.00395.x; CARLOCK D, 2007, GUIDE RESOURCES SEVE; CARROLL EM, 1985, J ABNORM PSYCHOL, V94, P329, DOI 10.1037/0021-843X.94.3.329; CHANG FC, 1976, ANN SURG, V183, P34, DOI 10.1097/00000658-197601000-00007; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Couper J, 2006, PSYCHO-ONCOLOGY, V15, P937, DOI 10.1002/pon.1031; Cowan G, 2004, SEX ROLES, V51, P67, DOI 10.1023/B:SERS.0000032310.16273.da; de Riesthal M, 2009, PERSPECTIVES NEUROPH, V19, P58; DEVIVO MJ, 1985, ARCH PHYS MED REHAB, V66, P501; DINDIA K, 1987, J SOC PERS RELAT, V4, P143, DOI 10.1177/0265407587042003; DUCK S, 1995, J SOC PERS RELAT, V12, P535, DOI 10.1177/0265407595124006; Egendorf A., 1981, LEGACIES VIETNAM COM; ELGHATIT AZ, 1975, J CHRON DIS, V28, P383, DOI 10.1016/0021-9681(75)90034-X; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; Faber AJ, 2008, J FAM PSYCHOL, V22, P222, DOI 10.1037/0893-3200.22.2.222; Fang CY, 2001, HEALTH PSYCHOL, V20, P452, DOI 10.1037//0278-6133.20.6.452; FLETCHER GJO, 1987, J PERS SOC PSYCHOL, V53, P481, DOI 10.1037/0022-3514.53.3.481; Folkman S., 1984, STRESS; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Garrido EF, 1999, J SOC PERS RELAT, V16, P619, DOI 10.1177/0265407599165004; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gilboa Dalia, 1994, Journal of Burn Care and Rehabilitation, V15, P86, DOI 10.1097/00004630-199401000-00017; Gosling J, 1999, BRAIN INJURY, V13, P785; GUERRERO LK, 1993, J SOC PERS RELAT, V10, P273, DOI 10.1177/026540759301000207; HARRIS MJ, 1985, J SPECIALISTS GROUP, V0010, P00044, DOI DOI 10.1080/01933928508411797; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Jensen MP, 2002, PAIN, V95, P133, DOI 10.1016/S0304-3959(01)00390-6; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; KASHANI JH, 1983, J CLIN PSYCHIAT, V44, P256; Kauvar DS, 2006, BURNS, V32, P853, DOI 10.1016/j.burns.2006.03.008; Kayser K, 2002, SOC WORK HEALTH CARE, V35, P391, DOI 10.1300/J010v35n01_04; Kenny DA., 2006, DYADIC DATA ANAL; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kramer U, 2005, SWISS J PSYCHOL, V64, P241, DOI 10.1024/1421-0185.64.4.241; Kreuter M, 1996, ARCH PHYS MED REHAB, V77, P541, DOI 10.1016/S0003-9993(96)90292-0; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Laurenceau JP, 1998, J PERS SOC PSYCHOL, V74, P1238, DOI 10.1037/0022-3514.74.5.1238; Lyons R.F., 1995, RELATIONSHIPS CHRONI; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Manne S, 2004, J FAM PSYCHOL, V18, P589, DOI 10.1037/0893-3200.18.4.589; Manne S, 2004, J CONSULT CLIN PSYCH, V72, P660, DOI 10.1037/0022-006X.72.4.660; Manne S, 2003, J CONSULT CLIN PSYCH, V71, P1076, DOI 10.1037/0022-006X.71.6.1076; MANNE S, 2009, PSYCHOONCOLOGY; MANNE S, 1999, CANC RES THERAPY CON, V8, P175, DOI DOI 10.1002/P0N; Manne S, 2008, CANCER-AM CANCER SOC, V112, P2541, DOI 10.1002/cncr.23450; Manne SL, 2007, J FAM PSYCHOL, V21, P380, DOI 10.1037/0893-3200.21.3.380; Manne SL, 1997, J BEHAV MED, V20, P101, DOI 10.1023/A:1025574626454; MARCHIONE M, 2007, US TODAY; MIKULINCER M, 1995, ANXIETY STRESS COPIN, V8, P203, DOI 10.1080/10615809508249373; Neese LE, 2003, PSYCHO-ONCOL, V12, P463, DOI 10.1002/pon.657; Nelson BS, 1996, J MARITAL FAM THER, V22, P455, DOI 10.1111/j.1752-0606.1996.tb00220.x; North NT, 1999, SPINAL CORD, V37, P671, DOI 10.1038/sj.sc.3100913; Northouse L, 2001, J BEHAV MED, V24, P115, DOI 10.1023/A:1010772913717; O'Hanlon Michael E., 2007, IRAQ INDEX TRACKING; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; PISTRANG N, 1995, SOC SCI MED, V40, P789, DOI 10.1016/0277-9536(94)00136-H; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; PTACEK JT, 1994, J PSYCHOSOC ONCOL, V12, P47, DOI 10.1300/J077V12N03_04; REINSTEIN L, 1978, ARCH PHYS MED REHAB, V59, P501; Reis H.T., 1988, HDB PERSONAL RELATIO, P367; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; RYBARCZYK BD, 1992, ARCH PHYS MED REHAB, V73, P1169; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Schwartz CE, 2000, PSYCHOL HEALTH, V15, P651, DOI 10.1080/08870440008405477; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; SHUKLA GD, 1982, BRIT J PSYCHIAT, V141, P50, DOI 10.1192/bjp.141.1.50; Silverstein R, 1996, J GENET PSYCHOL, V157, P169, DOI 10.1080/00221325.1996.9914855; Solomon Z, 1991, ANXIETY RES, V4, P213, DOI [10.1080/08917779108248775, DOI 10.1080/08917779108248775]; Spanier G. B., 1989, DYADIC ADJUSTMENT SC; STAFFORD L, 1991, J SOC PERS RELAT, V8, P217, DOI 10.1177/0265407591082004; Taylor CLC, 2008, ANN BEHAV MED, V36, P129, DOI 10.1007/s12160-008-9062-7; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; Thompson D M, 1983, Int Rehabil Med, V5, P165; Unger DG, 1996, J SOC PERS RELAT, V13, P123, DOI 10.1177/0265407596131007; UREY JR, 1987, ARCH PHYS MED REHAB, V68, P69; Verbosky S J, 1988, Issues Ment Health Nurs, V9, P95, DOI 10.3109/01612848809140912; Waysman M., 1993, J FAMILY PSYCHOL, V7, P104, DOI [10.1037/0893-3200.7.1.104, DOI 10.1037/0893-3200.7.1.104]; WILLIAMS C, 1987, HDB CLIN, P221	103	12	12	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-7063-3				2011							213	234		10.1007/978-1-4419-7064-0_11	10.1007/978-1-4419-7064-0		22	Psychology, Clinical; Psychology, Developmental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BSJ70	WOS:000284727200011					2022-02-06	
J	Clark, IA; Atwood, CS				Clark, Ian A.; Atwood, Craig S.			Is TNF a Link between Aging-Related Reproductive Endocrine Dyscrasia and Alzheimer's Disease?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; anxiety; cell cycle; dyotic signaling; endocrine dyscrasia; etanercept; inflammation; oxytocin; sex hormones; tumor necrosis factor (TNF)	TUMOR-NECROSIS-FACTOR; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; FOLLICLE-STIMULATING-HORMONE; FACTOR-ALPHA; LUTEINIZING-HORMONE; RHEUMATOID-ARTHRITIS; POSTMENOPAUSAL WOMEN; CELL-PROLIFERATION; COGNITIVE DECLINE	This commentary addresses a novel mechanism by which aging-related changes in reproductive hormones could mediate their action in the brain. It presents the evidence that dyotic endocrine signals modulate the expression of tumor necrosis factor (TNF) and related cytokines, and that these cytokines are a functionally important downstream link mediating neurodegeneration and dysfunction. This convergence of dyotic signaling on TNF-mediated degeneration and dysfunction has important implications for understanding the pathophysiology of AD, stroke, and traumatic brain disease, and also for the treatment of these diseases.	[Clark, Ian A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Atwood, Craig S.] Vet Adm Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Atwood, Craig S.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA, Australia		Clark, IA (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia.	ian.clark@anu.edu.au; csa@medicine.wisc.edu	, Craig/AAB-3963-2022; Clark, Ian A./K-2069-2012		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG033514] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG033514] Funding Source: NIH RePORTER		Akiyama H, 1996, NEUROSCI LETT, V219, P115, DOI 10.1016/S0304-3940(96)13197-9; ANDREWS H, 1987, GUT, V28, P1600, DOI 10.1136/gut.28.12.1600; Arendt T, 1998, J NEURAL TRANSM-SUPP, P147; Asthana S, 1999, PSYCHONEUROENDOCRINO, V24, P657, DOI 10.1016/S0306-4530(99)00020-7; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; Atwood CS, 2011, EXP GERONTOL, V46, P100, DOI 10.1016/j.exger.2010.09.007; Atwood CS, 2005, J NEUROPATH EXP NEUR, V64, P93, DOI 10.1093/jnen/64.2.93; Atwood CS, 2010, FUNCTIONAL AMYLOID A, P115; Barron AM, 2010, ENDOCRINOLOGY, V151, P5380, DOI 10.1210/en.2009-1168; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Berry A, 2008, HORM BEHAV, V54, P143, DOI 10.1016/j.yhbeh.2008.02.006; Bishop GM, 2002, NATURE, V416, P677, DOI 10.1038/416677d; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bowen RL, 2004, GERONTOLOGY, V50, P265, DOI 10.1159/000079125; Bowen RL, 2000, J NEUROENDOCRINOL, V12, P351; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; BOWEN RL, 2004, 9 INT C ALZH DIS 17; BRENNAN FM, 1989, LANCET, V2, P244; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Buchhave P, 2009, NEUROSCI LETT, V450, P56, DOI 10.1016/j.neulet.2008.10.091; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carter CJ, 2008, NEUROCHEM INT, V52, P920, DOI 10.1016/j.neuint.2007.11.003; Casadesus G, 2006, BBA-MOL BASIS DIS, V1762, P447, DOI 10.1016/j.bbadis.2006.01.008; Casadesus G, 2007, MOL CELL ENDOCRINOL, V269, P107, DOI 10.1016/j.mce.2006.06.013; Chang D, 1997, ADV EXP MED BIOL, V429, P261; Charles P, 1999, J IMMUNOL, V163, P1521; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clodi M, 2008, AM J PHYSIOL-ENDOC M, V295, pE686, DOI 10.1152/ajpendo.90263.2008; D'Amico AV, 2010, ALZ DIS ASSOC DIS, V24, P85, DOI 10.1097/WAD.0b013e31819cb8f4; Di Bona D, 2009, BRAIN RES REV, V61, P60, DOI 10.1016/j.brainresrev.2009.05.001; Dinomais M, 2009, J REHABIL MED, V41, P286, DOI 10.2340/16501977-0329; Ferreira RA, 2010, CONTRACEPTION, V81, P117, DOI 10.1016/j.contraception.2009.08.003; Ficicioglu C, 2010, GYNECOL ENDOCRINOL, V26, P181, DOI [10.1080/09513590903215557, 10.3109/09513590903215557]; FILLIT H, 1986, PSYCHONEUROENDOCRINO, V11, P337, DOI 10.1016/0306-4530(86)90019-3; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Gouras GK, 2000, P NATL ACAD SCI USA, V97, P1202, DOI 10.1073/pnas.97.3.1202; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; HARDARDOTTIR I, 1994, J CLIN INVEST, V94, P1304, DOI 10.1172/JCI117449; Hawken PAR, 2009, BIOL REPROD, V80, P1146, DOI 10.1095/biolreprod.108.075341; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsu SM, 2000, BIOCHEM BIOPH RES CO, V279, P47, DOI 10.1006/bbrc.2000.3891; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; JAFFE K, 1994, PHARMACOL BIOCHEM BE, V47, P493, DOI 10.1016/0091-3057(94)90149-X; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Karelina K, 2009, P NATL ACAD SCI USA, V106, P5895, DOI 10.1073/pnas.0810737106; Kass AS, 2010, SCAND J RHEUMATOL, V39, P109, DOI 10.3109/03009740903270607; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; Kipp M, 2007, J NEUROENDOCRINOL, V19, P819, DOI 10.1111/j.1365-2826.2007.01588.x; Laurin D, 2009, NEUROBIOL AGING, V30, P1724, DOI 10.1016/j.neurobiolaging.2008.01.008; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee R, 2009, PSYCHONEUROENDOCRINO, V34, P1567, DOI 10.1016/j.psyneuen.2009.06.002; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lin J, 2010, J NEUROPATH EXP NEUR, V69, P253, DOI 10.1097/NEN.0b013e3181d072cf; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Manly JJ, 2000, NEUROLOGY, V54, P833, DOI 10.1212/WNL.54.4.833; Manthey D, 2001, EUR J BIOCHEM, V268, P4285, DOI 10.1046/j.1432-1327.2001.02346.x; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040; Meethal SV, 2005, ENDOCRINE, V26, P317, DOI 10.1385/ENDO:26:3:317; Meresman GF, 2003, HUM REPROD, V18, P1767, DOI 10.1093/humrep/deg356; Missig G, 2010, NEUROPSYCHOPHARMACOL, V35, P2607, DOI 10.1038/npp.2010.155; Mueller L, 2010, BIOCHEM BIOPH RES CO, V397, P586, DOI 10.1016/j.bbrc.2010.05.163; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Norman GJ, 2010, PSYCHOSOM MED, V72, P519, DOI 10.1097/PSY.0b013e3181de8678; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Patel A, 2010, BRAIN BEHAV IMMUN, V24, P1276, DOI 10.1016/j.bbi.2010.05.005; Petanceska SS, 2000, EXP GERONTOL, V35, P1317, DOI 10.1016/S0531-5565(00)00157-1; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.3.CO;2-8; Raina AK, 1999, INT J EXP PATHOL, V80, P71, DOI 10.1046/j.1365-2613.1999.00106.x; RALSTON SH, 1990, J BONE MINER RES, V5, P983; REDL H, 1996, AM J PHYSIOL, V40, pR1193; RODRIGUEZSIERRA JF, 1986, LIFE SCI, V38, P1841, DOI 10.1016/0024-3205(86)90139-6; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; SHALABY MR, 1989, CLIN IMMUNOL IMMUNOP, V53, P488, DOI 10.1016/0090-1229(89)90010-X; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Short RA, 2001, MAYO CLIN PROC, V76, P906; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Smith MA, 2002, LANCET, V359, P1864, DOI 10.1016/S0140-6736(02)08695-6; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Uguz F, 2009, PSYCHIAT CLIN NEUROS, V63, P50, DOI 10.1111/j.1440-1819.2008.01905.x; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vieira MMM, 2010, J NEUROIMMUNOL, V229, P212, DOI 10.1016/j.jneuroim.2010.07.018; WHARTON W, 2011, J ALZHEIMERS DIS; Wilson AC, 2008, BBA-MOL BASIS DIS, V1782, P401, DOI 10.1016/j.bbadis.2008.02.011; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yi KD, 2011, BRAIN RES, V1379, P61, DOI 10.1016/j.brainres.2010.11.058; Zheng H, 2002, J NEUROCHEM, V80, P191, DOI 10.1046/j.0022-3042.2001.00690.x	127	12	14	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2011	27	4					691	699		10.3233/JAD-2011-110887			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866GI	WOS:000298368100002	21891866	Green Accepted			2022-02-06	
J	Lah, S; Epps, A; Levick, W; Parry, L				Lah, Suncica; Epps, Adrienne; Levick, Wayne; Parry, Louise			Implicit and explicit memory outcome in children who have sustained severe traumatic brain injury: Impact of age at injury (preliminary findings)	BRAIN INJURY			English	Article						Traumatic brain injury; children; memory	CHILDHOOD HEAD-INJURY; DEVELOPMENTAL-CHANGES; COGNITIVE-DEVELOPMENT; VISUAL COMPLEXITY; NAME AGREEMENT; RECOVERY; PLASTICITY; FAMILIARITY; PICTURES; LANGUAGE	Primary objective: To examine implicit and explicit memory outcome in children who had sustained severe traumatic brain injury (TBI) through childhood. Opposite patterns of impairments were expected: (i) impaired implicit memory in children with early TBI (TBI-EC, <6 years) and (ii) impaired explicit memory in children with late TBI (TBI-LC, >= 6 years). Research design: Children who had sustained severe TBI more then 1 year ago were assessed. Methods and procedure: Fourteen children who had sustained severe TBI (TBI-EC, n=10 and TBI-LC, n=4) between 8 months and 13 years 7 months of age and 13 non-injured control subjects (NC) participated. Implicit (repetition priming and skill learning) and explicit verbal memory were examined. Results: The TBI group performed worse on implicit (repetition priming) and explicit memory tasks compared to the NC group. Moreover, impairments were found in implicit and explicit memory in the TBI-EC, but not in the TBI-LC group. Conclusions: This study has shown, for the first time, that severe childhood TBI may compromise not only explicit, but also implicit memory. Nevertheless, instead of a selective implicit memory impairment, it was found that children who sustained injuries in early childhood present with impairments in both memory systems.	[Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Epps, Adrienne; Parry, Louise] Sydney Childrens Hosp Randwick, Sydney, NSW, Australia; [Levick, Wayne] John Hunter Childrens Hosp, Newcastle, NSW, Australia; [Levick, Wayne] Univ Newcastle, Newcastle, NSW 2308, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Mungo Mac Callum Bldg, Sydney, NSW 2006, Australia.	sunnyl@psych.usyd.edu.au		Lah, Suncica/0000-0003-2282-4812	University of SydneyUniversity of Sydney	This research was supported by the research grant awarded to the first author by The University of Sydney. We wish to thank Drs Lisa Azizi and Ilana Hapner for assistance with recruitment and data collection.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; BERMAN S, 1989, BEHAV RES METH INSTR, V21, P371, DOI 10.3758/BF03202800; Billingsley RL, 2002, J EXP CHILD PSYCHOL, V82, P251, DOI 10.1016/S0022-0965(02)00007-3; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cycowicz YM, 2000, MEMORY, V8, P19, DOI 10.1080/096582100387687; Delis DC., 1994, CALIFORNIA VERBAL LE; DeMarie D, 2003, J EXP CHILD PSYCHOL, V84, P167, DOI 10.1016/S0022-0965(03)00004-3; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; DIGIULIO DV, 1994, BRAIN COGNITION, V25, P79, DOI 10.1006/brcg.1994.1024; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIRKS J, 1977, J EXP CHILD PSYCHOL, V23, P315, DOI 10.1016/0022-0965(77)90108-4; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Gleissner U, 2005, BRAIN, V128, P2822, DOI 10.1093/brain/awh597; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GREENBAUM JL, 1989, B PSYCHONOMIC SOC, V27, P417; Hebb DO, 1947, AM PSYCHOL, V2, P737; HEINDEL WC, 1989, J NEUROSCI, V9, P582; HEYWOOD C, 1987, LANGUAGE DEV DISORDE, P146; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kolb B., 1995, BRAIN PLASTICITY BEH; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LORSBACH TC, 1989, CONTEMP EDUC PSYCHOL, V14, P67, DOI 10.1016/0361-476X(89)90006-4; Luciana M, 2003, DEV PSYCHOPATHOL, V15, P1017, DOI 10.1017/S095457940300049X; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MEYER E, 1952, AMA AM J DIS CHILD, V84, P543, DOI 10.1001/archpedi.1952.02050050017001; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; NEWCOMBE N, 1977, DEV PSYCHOL, V13, P337, DOI 10.1037/0012-1649.13.4.337; Pavlovic J, 2006, NEUROPEDIATRICS, V37, P13, DOI 10.1055/s-2006-923932; Piaget J, 1963, ORIGINS INTELLIGENCE; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; Sattler JM, 2004, ASSESSMENT CHILDRE S; SCHACHTER DL, 1984, INFANTS AMNESICS DIS; SCHWARTZ BL, 1991, J EXP PSYCHOL LEARN, V17, P1177, DOI 10.1037/0278-7393.17.6.1177; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; SNODGRASS JG, 1987, BEHAV RES METH INSTR, V19, P270, DOI 10.3758/BF03203798; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Squire LR., 1987, MEMORY BRAIN; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEUBER ML, 1975, CIBA F SYMP, V34, P159; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Wechsler D, 2003, WECHSLER INTELLIGENC, V4; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	68	12	12	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					44	52		10.3109/02699052.2010.531693			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700006	21117914				2022-02-06	
J	Laxe, S; Zasler, N; Tschiesner, U; Lopez-Blazquez, R; Tormos, JM; Bernabeu, M				Laxe, Sara; Zasler, Nathan; Tschiesner, Uta; Lopez-Blazquez, Raquel; Tormos, Jose M.; Bernabeu, Montserrat			ICF use to identify common problems on a TBI neurorehabilitation unit in Spain	NEUROREHABILITATION			English	Article						Traumatic brain injury; disability; International Classification of Functioning; Disability and Health (ICF); multi-centre study	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; HEALTH ICF; CORE SETS; PRACTICAL SCALE; DISABILITY; REHABILITATION; SATISFACTION; MODEL	Objective: To describe functioning and health of individuals with traumatic brain injury (TBI) based on the International Classification of Functioning, Disability and Health (ICF). Methods: A cross-sectional, prospective study was conducted in a neurorehabilitation hospital. Data collection included sociodemographic factors, single interviews based on the extended ICF Checklist 2.1 for TBI, patient ratings on general health and functioning status, WHOQoL, EQ5D and the Comorbidity Questionnaire. Results: 103 patients (81% males) were included in the study. The mean of age was 34 yrs. 24% were inpatients whereas 76% were outpatients. 130 out of 150 categories (87%) of the extended checklist were relevant in > 10% of patients. Differences in functioning and disability between patients in the shorter versus long term situation were noted to be predominantly in the ICF domains of Activities and Participation as well as in Body Functions. Correlations between EQ5D and ICF-based data collections were all p < 0.01. Conclusions: This study identified the most common problems in patients with TBI receiving Neurorehabilitation services based on the ICF. Results emphasize the need to describe disability and rehabilitation standards from a comprehensive perspective that not only includes Body Functions and Structures but also the ICF domains of Activities and Participation and Environmental factors.	[Laxe, Sara] Univ Autonoma Barcelona, Guttmann Inst Hosp Neurorehabil, Brain Injury Unit, Badalona, Spain; [Zasler, Nathan] Concuss Care Ctr Virginia, Richmond, VA USA; [Tschiesner, Uta] Univ Munich, Dept Otorhinolaryngol, Munich, Germany; [Tschiesner, Uta] Univ Munich, ICF Res Branch, Dept Biopsychosocial Hlth, Munich, Germany		Laxe, S (corresponding author), Univ Autonoma Barcelona, Guttmann Inst Hosp Neurorehabil, Brain Injury Unit, Badalona, Spain.	slaxe@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			AIACHINI B, EUR J PHYS REHABIL M, V46, P27; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Boldt C, 2005, DISABIL REHABIL, V27, P375, DOI 10.1080/09638280400013982; Brach M, 2004, J REHABIL MED, V36, P121, DOI 10.1080/16501960410016811; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P128, DOI 10.1080/16501960410016055; Cieza A, 2004, J REHABIL MED, V36, P94, DOI 10.1080/16501960410016785; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; DEWALL J, JEMS, V35, P54; DEWALL J, JEMS, V35, P63; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Grill E, 2005, DISABIL REHABIL, V27, P361, DOI 10.1080/09638280400013974; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Ruof J, 2001, J REHABIL MED S, V44, P100; Sandberg MA, 2009, CLIN NEUROPSYCHOL, V23, P1416, DOI 10.1080/13854040903369425; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Schwarzkopf SR, 2008, CLIN RHEUMATOL, V27, P1355, DOI 10.1007/s10067-008-0916-y; TEASDALE G, 1974, LANCET, V2, P81; TSCHIESNER U, 2009, HEAD NECK       0701; Tschiesner U, 2009, LARYNGOSCOPE, V119, P915, DOI 10.1002/lary.20211; van Echteld I, 2006, J RHEUMATOL, V33, P2475; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; World Health Organization, 2001, ICF INT CLASS FUNCT	39	12	13	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2011	29	1					99	110		10.3233/NRE-2011-0683			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814JR	WOS:000294447000013	21876302				2022-02-06	
J	Narevic, E; Giles, GM; Rajadhyax, R; Managuelod, E; Monis, F; Diamond, F				Narevic, Egle; Giles, Gordon M.; Rajadhyax, Rashmi; Managuelod, Eva; Monis, Florencia; Diamond, Franco			The effects of enhanced program review and staff training on the management of aggression among clients in a long-term neurobehavioral rehabilitation program	AGING & MENTAL HEALTH			English	Article						mental disorder; quality assurance; non-aversive approach; support groups; geriatric patients	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-INPATIENTS; MEDICAL COMORBIDITY; BEHAVIOR; CARE; ASSAULTS; SCHIZOPHRENIA; MORTALITY; INTERVENTION; DISABILITY	Objective: This article examined the effects of staff training, staff support groups, and increased client behavior monitoring on the rate of physical aggression toward peers and objects in an older neurobehavioral population treated in a long-term neurorehabilitation program. Methods: During the 15 months of data collection, programmatic enhancements were introduced including: Staff training and support groups, comprehensive assessment and individualized program development, and client-centered weekly and systemic monthly behavior management review. Incidents of physical aggression were assessed using staff report. Data were corroborated using multiple sources including, medical records, written incident reports, and Overt Aggression Scale-Modified for Neurorehabilitation - Extended (OAS-MNR-E). Results: A total of 267 clients were present in the facility during the reporting period. The clients had neurobehavioral disability of various origins, 73% had a psychiatric diagnosis in addition to one or more medical diagnoses, and 58% had a dementia diagnosis. An already low rate of incidents of physical aggression per client month (0.02) was reduced by 77% following the implementation of programmatic enhancements. Conclusion: Enhanced systematic behavioral review of clients provided concurrently with staff training in non-aversive principles and ongoing staff support groups reduced the incidents of behavioral disregulation in older persons with psychiatric diagnoses, medical comorbidities, and neurobehavioral disabilities.	[Narevic, Egle; Giles, Gordon M.; Rajadhyax, Rashmi; Managuelod, Eva; Monis, Florencia; Diamond, Franco] Idylwood Care Ctr, Sunnyvale, CA USA; [Giles, Gordon M.] Samuel Merritt Univ, Fac Occupat Therapy, Oakland, CA USA		Narevic, E (corresponding author), Idylwood Care Ctr, 1002 W Fremont Ave, Sunnyvale, CA USA.	narevic_e@comcast.net					Ackerman SJ, 2003, CLIN PSYCHOL REV, V23, P1, DOI 10.1016/S0272-7358(02)00146-0; AIKEN GJM, 1984, MED SCI LAW, V24, P199, DOI 10.1177/002580248402400309; Bisconer SW, 2006, J PSYCHIATR MENT HLT, V13, P515, DOI 10.1111/j.1365-2850.2006.00973.x; Bowers L, 1999, J Psychiatr Ment Health Nurs, V6, P199, DOI 10.1046/j.1365-2850.1999.630199.x; Bowers L., 1999, J MENT HEALTH, V8, P339; BRAILSFORD DS, 1973, NURSING TIMES S, V69, P9; BROMLEY J, 1995, J INTELL DISABIL RES, V39, P341, DOI 10.1111/j.1365-2788.1995.tb00526.x; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Cassidy EL, 2002, AGING MENT HEALTH, V6, P166, DOI 10.1080/13607860220126727; CHOU K, 1996, J GERONTOLOGICAL NUR, V22, P31; Conn L, 1983, ASSAULTS PSYCHIAT FA, P61; Dixon L, 1999, J NERV MENT DIS, V187, P496, DOI 10.1097/00005053-199908000-00006; Druss BG, 2002, MED CARE, V40, P129, DOI 10.1097/00005650-200202000-00007; Edberg AK, 2001, INT J NURS STUD, V38, P271, DOI 10.1016/S0020-7489(00)00076-6; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feldt K S, 1992, J Gerontol Nurs, V18, P3; FLEMINGER S, 2003, COCHRANE LIB; FOTTRELL E, 1980, BRIT J PSYCHIAT, V136, P216, DOI 10.1192/bjp.136.3.216; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 2007, BRAIN INJURY, V21, P505, DOI 10.1080/02699050701311729; Green CA, 2008, PSYCHIATR REHABIL J, V32, P9, DOI 10.2975/32.1.2008.9.22; HALLER RM, 1988, BRIT J PSYCHIAT, V152, P174, DOI 10.1192/bjp.152.2.174; Heflin L. J., 2001, FOCUS AUTISM OTHER D, V16, P93, DOI DOI 10.1177/108835760101600205; HODGKINSON PE, 1985, MED SCI LAW, V25, P288, DOI 10.1177/002580248502500411; HUSSIAN RA, 1981, GERIATRIC PSYCHOL BE; Kelly G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Kisely S, 2005, BRIT J PSYCHIAT, V187, P552, DOI 10.1192/bjp.187.6.552; Kunik ME, 2000, J GERIATR PSYCH NEUR, V13, P49, DOI 10.1177/089198870001300108; Landreville P, 1998, Int Psychogeriatr, V10, P397, DOI 10.1017/S1041610298005481; LION JR, 1981, HOSP COMMUNITY PSYCH, V32, P487; Lyketsos CG, 2002, PSYCHOSOMATICS, V43, P24, DOI 10.1176/appi.psy.43.1.24; MADDEN DJ, 1976, AM J PSYCHIAT, V133, P422; Moniz-Cook E, 1998, INT J GERIATR PSYCH, V13, P149, DOI 10.1002/(SICI)1099-1166(199803)13:3<149::AID-GPS746>3.0.CO;2-Q; Morgan JC, 2008, GERONTOLOGIST, V48, P71, DOI 10.1093/geront/48.Supplement_1.71; NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401; RUBEN I, 1980, J NERV MENT DIS, V168, P243, DOI 10.1097/00005053-198004000-00010; Scully R, 1981, J Nurs Adm, V11, P48, DOI 10.1097/00005110-198103000-00008; TERESI J, 1993, GERONTOLOGIST, V33, P667, DOI 10.1093/geront/33.5.667; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037/0022-3514.81.6.1058; Visser SM, 2008, AGING MENT HEALTH, V12, P47, DOI 10.1080/13607860701366012; Waddington L, 2002, BEHAV COGN PSYCHOTH, V30, P179, DOI 10.1017/S1352465802002059; Whittington R, 1996, BRIT J CLIN PSYCHOL, V35, P11, DOI 10.1111/j.2044-8260.1996.tb01158.x; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	44	12	12	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1360-7863			AGING MENT HEALTH	Aging Ment. Health		2011	15	1					103	112	PII 927578304	10.1080/13607863.2010.501070			10	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	714SH	WOS:000286828800013	20924812				2022-02-06	
J	Pastore, V; Colombo, K; Liscio, M; Galbiati, S; Adduci, A; Villa, F; Strazzer, S				Pastore, Valentina; Colombo, Katia; Liscio, Mariarosaria; Galbiati, Susanna; Adduci, Anna; Villa, Federica; Strazzer, Sandra			Efficacy of cognitive behavioural therapy for children and adolescents with traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; cognitive behavioural therapy; psychological intervention	PSYCHIATRIC-DISORDERS; PRACTICAL SCALE; SEQUELAE; INDIVIDUALS; CHILDHOOD; ANXIETY; OUTCOMES; TBI; AGE	Purpose. Behavioural and psychological disorders after traumatic brain injury (TBI) are very common. The purposes of this study were to estimate the frequency of these problems in our sample, to evaluate the effectiveness of cognitive behavioural therapy (CBT) and to assess the predictive value of important clinical variables for the treatment outcome. Method. Forty patients aged 4-18 years were included in this study. Twenty-eight patients received CBT at our Institute (clinical group), while 12 patients did not receive any treatment at all (control group). The CBCL/4-18 and the VABS were administered to parents at the beginning of the study and after 12 months. Results. A high frequency of psychological and behavioural problems was found in both groups of patients. After CBT, the clinical group showed a significant advantage on several CBCL scales and a greater increase in adaptive behaviour on the VABS Socialisation domain. The Glasgow Coma Scale score, days of unconsciousness and age at injury were not predictors of the severity of psychological problems at the follow-up for the patients of the clinical group. Conclusions. Our results suggest that CBT is an effective intervention for young patients with psychological problems after TBI.	[Pastore, Valentina; Colombo, Katia; Liscio, Mariarosaria; Galbiati, Susanna; Adduci, Anna; Villa, Federica; Strazzer, Sandra] IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy		Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	valentina.pastore@bp.lnf.it	Colombo, Katia/ABE-5754-2020; Galbiati, Susanna/AAH-6883-2019; Strazzer, Sandra/AAH-5712-2019; Pastore, Valentina/AAH-6831-2019	Colombo, Katia/0000-0002-5390-106X; Galbiati, Susanna/0000-0001-7209-4251; Strazzer, Sandra/0000-0001-8414-6565; Pastore, Valentina/0000-0002-3170-3070			Achenbach T. M., 1983, CHILD BEHAV CHECKLIS; Balboni G, 2001, AM J MENT RETARD, V106, P162, DOI 10.1352/0895-8017(2001)106<0162:DVOTVS>2.0.CO;2; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burns B J, 1999, Clin Child Fam Psychol Rev, V2, P199, DOI 10.1023/A:1021826216025; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Compton SN, 2004, J AM ACAD CHILD PSY, V43, P930, DOI 10.1097/01.chi.0000127589.57468.bf; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gualtieri CT, 1999, NEUROREHABILITATION, V13, P103; JENNETT B, 1975, LANCET, V1, P480; Kazdin AE, 1998, J CONSULT CLIN PSYCH, V66, P19, DOI 10.1037/0022-006X.66.1.19; Kendall PC, 1998, J CONSULT CLIN PSYCH, V66, P3, DOI 10.1037/0022-006X.66.1.3; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Monga S, 2009, DEPRESS ANXIETY, V26, P243, DOI 10.1002/da.20551; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nybo T, 1999, BRAIN INJURY, V13, P759; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Suveg C, 2009, J ANXIETY DISORD, V23, P341, DOI 10.1016/j.janxdis.2009.01.003; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; TEASDALE G, 1974, LANCET, V2, P81; Warner CM, 2009, J CLIN PSYCHOL MED S, V16, P169, DOI 10.1007/s10880-008-9143-6; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Ylvisaker M, 2007, PHYS MED REH CLIN N, V18, pvii; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	37	12	12	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	8					675	683		10.3109/09638288.2010.506239			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	746UG	WOS:000289272600006	20695794				2022-02-06	
J	Perry, JC; Oblak, J; Jung, JH; Cikajlo, I; Veneman, JF; Goljar, N; Bizovicar, N; Matjacic, Z; Keller, T				Perry, Joel C.; Oblak, Jakob; Jung, Je H.; Cikajlo, Imre; Veneman, Jan F.; Goljar, Nika; Bizovicar, Natasa; Matjacic, Zlatko; Keller, Thierry			Variable structure pantograph mechanism with spring suspension system for comprehensive upper-limb haptic movement training	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						arm therapy; haptic device; haptic training; pantograph mechanism; rehabilitation; rehabilitation robotics; series elastic actuation; stroke; stroke therapy; upper limb; wrist therapy	ROBOT; ARM; STROKE	Numerous haptic devices have been developed for upper-limb neurorehabilitation, but their widespread use has been largely impeded because of complexity and cost. Here, we describe a variable structure pantograph mechanism combined with a spring suspension system that produces a versatile rehabilitation robot, called Universal Haptic Pantograph, for movement training of the shoulder, elbow, and wrist. The variable structure is a 5-degree-of-freedom (DOF) mechanism composed of 7 joints, 11 joint axes, and 3 configurable joint locks that reduce the number of system DOFs to between 0 and 3. The resulting device has eight operational modes: Arm, Wrist, ISO (isometric) 1, ISO 2, Reach, Lift 1, Lift 2, and Steer. The combination of available work spaces (reachable areas) shows a high suitability for movement training of most upper-limb activities of daily living. The mechanism, driven by series elastic actuators, performs similarly in all operational modes, with a single control scheme and set of gains. Thus, a single device with minimal setup changes can be used to treat a variety of upper-limb impairments that commonly afflict veterans with stroke, traumatic brain injury, or other direct trauma to the arm. With appropriately selected design parameters, the developed multimode haptic device significantly reduces the costs of robotic hardware for full-arm rehabilitation while performing similarly to that of single-mode haptic devices. We conducted case studies with three patients with stroke who underwent clinical training using the developed mechanism in Arm, Wrist, and/or Reach operational modes. We assessed outcomes using Fugl-Meyer Motor Assessment and Wolf Motor Function Test scores showing that upper-limb ability improved significantly following training sessions.	[Perry, Joel C.; Jung, Je H.; Veneman, Jan F.; Keller, Thierry] Tecnalia Res & Innovat, Hlth & Qual Life Div, E-20009 Donostia San Sebastian, Spain; [Oblak, Jakob; Cikajlo, Imre; Goljar, Nika; Bizovicar, Natasa; Matjacic, Zlatko] Univ Rehabil Inst, Ljubljana, Slovenia		Keller, T (corresponding author), Tecnalia Res & Innovat, Hlth & Qual Life Div, Mikeletegi Pasealekua 1, E-20009 Donostia San Sebastian, Spain.	thierry.keller@tecnalia.com	Cikajlo, Imre/A-8951-2012; Veneman, Jan/V-3570-2019; Cikajlo, Imre/AAD-5189-2019; Matjacic, Zlatko/AAY-5906-2021; Keller, Thierry/H-4262-2012	Veneman, Jan/0000-0002-6408-6558; Cikajlo, Imre/0000-0002-8428-7621; Keller, Thierry/0000-0003-4000-958X; Jung, Dr Je Hyung/0000-0002-2525-8337	FIK; Spanish Ministry of Science and InnovationSpanish Government [PID-020100-2009-21]	This material was based on work supported in part by FIK and the Spanish Ministry of Science and Innovation, project PID-020100-2009-21.	Burgar CG, 2000, J REHABIL RES DEV, V37, P663; Che Fai Yeong, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P46, DOI 10.1109/ICORR.2009.5209475; Coote S., 2003, P 8 INT C REH ROB, P59; CRAIG JJ, 1989, INTRO ROBOTICS MECH, P277; Ellis MD, 2009, NEUROREHAB NEURAL RE, V23, P862, DOI 10.1177/1545968309332927; Fanin C., 2003, P 8 INT C REH ROB SE, P23; Gupta A, 2006, IEEE-ASME T MECH, V11, P280, DOI 10.1109/TMECH.2006.875558; Harwin WS, 2006, P IEEE, V94, P1717, DOI 10.1109/JPROC.2006.880671; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Hidler Joseph, 2005, Top Stroke Rehabil, V12, P22, DOI 10.1310/RYT5-62N4-CTVX-8JTE; Kahn LE, 2006, J REHABIL RES DEV, V43, P619, DOI 10.1682/JRRD.2005.03.0056; Kayyali Ruba, 2007, HAVE 2007 - IEEE International Workshop on Haptic Audio Visual Environments and their Applications, P118; KOENEMAN EJ, 2004, P IEEE ENG MED BIOL, V4, P2711; Krebs H I, 1999, Technol Health Care, V7, P419; Krebs HI, 2007, IEEE T NEUR SYS REH, V15, P327, DOI 10.1109/TNSRE.2007.903899; Krebs HI, 2003, AUTON ROBOT, V15, P7, DOI 10.1023/A:1024494031121; *MOT MED INC, 2008, REOTHERAPY; Nef T, 2007, INT C REHAB ROBOT, P68, DOI 10.1109/ICORR.2007.4428408; Oblak J, 2010, IEEE T NEUR SYS REH, V18, P293, DOI 10.1109/TNSRE.2009.2034162; Perry Joel C, 2009, Applied Bionics and Biomechanics, V6, P175, DOI 10.1080/11762320902920575; Sanchez RJ, 2005, INT C REHAB ROBOT, P500; Sanchez RJ, 2006, IEEE T NEUR SYS REH, V14, P378, DOI 10.1109/TNSRE.2006.881553; Spencer S. J., 2008, 2008 2 IEEE RAS EMBS, P869; Stienen AHA, 2007, INT C REHAB ROBOT, P820, DOI 10.1109/ICORR.2007.4428519; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; Takahashi CD, 2005, INT C REHAB ROBOT, P17; Toth A, 2005, INT C REHAB ROBOT, P127; van der Linde RQ, 2003, IND ROBOT, V30, P515, DOI 10.1108/01439910310506783	28	12	12	1	15	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	4					317	333		10.1682/JRRD.2010.03.0043			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	774GB	WOS:000291372200004	21674386	Bronze			2022-02-06	
J	Russell, KC; Arenth, PM; Scanlon, JM; Kessler, LJ; Ricker, JH				Russell, Kathryn C.; Arenth, Patricia M.; Scanlon, Joelle M.; Kessler, Lauren J.; Ricker, Joseph H.			A functional magnetic resonance imaging investigation of episodic memory after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Episodic memory; Traumatic brain injury; Encoding; Recognition; Functional magnetic resonance imaging	VERBAL-LEARNING TEST; EVENT-RELATED FMRI; EDITION CVLT-II; POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; WORKING; ACTIVATION; RETRIEVAL; REHABILITATION; PERFORMANCE	Traumatic brain injury often negatively impacts episodic memory; however, studies of the neural substrates of this impairment have been limited. In this study, both encoding and recognition of visually presented stimuli were examined with functional magnetic resonance imaging. Twelve adults with chronic complicated mild, moderate, and severe injuries were compared with a matched group of 12 controls. Behavioral task performance did not differentiate the groups. During neuroimaging, however, the group of individuals with traumatic brain injury exhibited increased activation, as well as increased bilaterality and dispersion as compared to controls. Findings are discussed in terms of increased resource recruitment.	[Ricker, Joseph H.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Russell, Kathryn C.; Arenth, Patricia M.; Ricker, Joseph H.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA		Ricker, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Kaufmann Med Bldg,Suite 201,3471 5th Ave, Pittsburgh, PA 15213 USA.	ricker@pitt.edu		Ricker, Joseph/0000-0003-3415-991X	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178] Funding Source: NIH RePORTER	This study was supported in part by a grant (NIH-NINDS R01NS048178-01) awarded to J. H. Ricker. The first two authors contributed equally to this manuscript. First authorship was determined randomly.	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P296; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1027, DOI 10.1017/S1355617703970068; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Duverne S, 2008, NEUROBIOL AGING, V29, P1902, DOI 10.1016/j.neurobiolaging.2007.04.022; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; LANCASTER J, 2007, TALAIRACH CLIENT COM; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDermott KB, 1999, MEMORY, V7, P661; Miller MB, 2009, NEUROIMAGE, V48, P625, DOI 10.1016/j.neuroimage.2009.06.033; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MOZES S, 2009, ARTIFACT DETECTION T; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Primus EA, 1997, BRAIN INJURY, V11, P577; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Raye CL, 2000, PSYCHOBIOLOGY, V28, P197; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spreen O., 1969, NEUROSENSORY CTR COM; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; WechslerD, 2001, WECHSLER TEST ADULT; Whyte J, 2005, PHYS MED REHABILITAT, P1677; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010; 2009, SPM8 COMPUTER SOFTWA	58	12	13	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	5					538	547	PII 933037939	10.1080/13803395.2010.537253			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	773AQ	WOS:000291279800005	21294021	Green Accepted			2022-02-06	
J	Sahin, B; Albayrak, BS; Ismailoglu, O; Gorgulu, A				Sahin, Berkant; Albayrak, Baki S.; Ismailoglu, Ozgur; Gorgulu, Askin			The effects of medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the spinal cord injury	NEUROLOGICAL RESEARCH			English	Article						Medroxy progesterone acetate; TNF-alpha; IL-1beta; Spinal cord injury	TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; NERVOUS-SYSTEM; BLOOD-FLOW; METHYLPREDNISOLONE; EXPRESSION; RATS; INTERLEUKIN-1-BETA; RECEPTORS; RECOVERY	Objectives: Spinal cord injuries (SCIs) have high morbidity and mortality rates and currently the definitive treatment of complete SCIs are still not possible. We investigated the effects of the medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the SCI. Methods: Forty-eight Wistar albino male rats were divided equally into four groups each consisting of 12 rats. All animals underwent T10-T12 laminectomy. We administered placebo, and 8 mg/kg medroxy progesterone acetate (MPA) intra-peritoneally into control and progesterone group at 30 minutes after the clip-compression trauma in spinal cord. We performed only T10-T12 laminectomy and clip-compression trauma in laminectomy and trauma group, respectively. Half of the rats from each group were killed at 1 hour and the other half were killed at 6 hours after the trauma. Spinal cord segments were then removed and stored at -80 degrees C in phosphate buffer. TNF-alpha and IL-1beta levels were determined using ELISA kit. Results: We have found that there was an increase only in the TNF-alpha level at 6 hours after the trauma comparing to control group. MPA appeared to lower the TNF-alpha level significantly in the trauma group. Discussion: This experimentally proven anti-inflammatory effect of MPA via acting upon TNF-alpha may offer new therapeutic options in human subjects with SCIs.	[Sahin, Berkant; Albayrak, Baki S.; Ismailoglu, Ozgur; Gorgulu, Askin] Suleyman Demirel Univ, Dept Neurosurg, TR-32200 Isparta, Turkey		Albayrak, BS (corresponding author), Suleyman Demirel Univ, Dept Neurosurg, TR-32200 Isparta, Turkey.	serdarbaki@gmail.com					ALOISI F, 1992, J IMMUNOL, V149, P2358; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Banik N L, 1985, Cent Nerv Syst Trauma, V2, P99; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; Braughler RW, 1985, CENT NERV SYST TRAUM, V2, P269; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; DELATORRE JC, 1981, SPINE, V6, P315, DOI 10.1097/00007632-198107000-00001; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; Dohrmann GJ, 1972, ARCH NEUROL-CHICAGO, V7, P468; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; FADEN AI, 1985, NEUROLOGY, V35, P1331, DOI 10.1212/WNL.35.9.1331; Hall E D, 1987, Cent Nerv Syst Trauma, V4, P15; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Katoh S, 1997, INJURY, V28, P215, DOI 10.1016/S0020-1383(96)00184-2; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Koyanagi I, 1997, NEUROL RES, V19, P289, DOI 10.1080/01616412.1997.11740815; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Marketos SG, 1999, SPINE, V24, P2358, DOI 10.1097/00007632-199911150-00012; MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154; Naderi S, 2002, SPINE SPINAL CORD SU, P1; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sanon A, 1996, NEUROSURGERY, V39, P657; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; SMITH SS, 1989, BRAIN RES, V476, P307, DOI 10.1016/0006-8993(89)91251-1; TATOR CH, 1984, CAN J SURG, V27, P289; Thind KK, 1997, NEUROENDOCRINOLOGY, V65, P314, DOI 10.1159/000127190; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004	40	12	15	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2011	33	1					63	67		10.1179/016164110X12807570510095			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	704JN	WOS:000286048500009	21208533				2022-02-06	
J	Donaldson, CJ; Hoffer, ME; Balough, BJ; Gottshall, KR				Donaldson, Chadwick J.; Hoffer, Michael E.; Balough, Ben J.; Gottshall, Kim R.			Prognostic assessments of medical therapy and vestibular testing in post-traumatic migraine-associated dizziness patients	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article							BRAIN-INJURY; HISTORY; PROPHYLAXIS; DYSFUNCTION	OBJECTIVE: The aim of this study was to characterize our clinical population of patients suffering with post-traumatic migraine-associated dizziness (PTMAD) and determine any associations with medical interventions and vestibular testing metrics to help predict response to treatments. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary referral center. SUBJECTS AND METHODS: The electronic medical records of 83 patients presenting to a tertiary referral center who were given a diagnosis of PTMAD and who had been treated were retrospectively reviewed. General characteristics, clinical treatment, pre- and post-vestibular therapy testing metrics, and success and failure outcomes were assessed. Patients were assigned into responder and nonresponder groups related to their headaches and evaluated at two specific time points. Medication failures and vestibular test metrics were compared to identify and predict clinical outcomes. RESULTS: Seventy-two of 82 patients (88%) were analyzed at two time points. Use of verapamil, topiramate, gabapentin, amitryptiline, and valproic acid showed no comparative treatment benefit in responders compared to nonresponders (P = 0.294). Findings associated with successful treatments include response to initial medication (P = 0.001), final dynamic gait index (DGI) scores (P = 0.029), final vertical dynamic visual acuity test (DVAT) scores (up, 0.007; down, 0.006), and both final and change in computerized dynamic posturography-sensory organization test (CDP-SOT) scores (P = 0.001, P = 0.032). The antipsychotic quetiapine was specifically associated with outcome failures (P = 0.003). CONCLUSION: Specific prophylactic antimigraine medications were not associated with improved outcomes in PTMAD patients. Initial clinical responses and vestibular test metrics may guide physicians to predict successful outcomes. Copyright (C) 2010. Published by Mosby, Inc.	[Donaldson, Chadwick J.; Hoffer, Michael E.; Balough, Ben J.; Gottshall, Kim R.] USN, Spatial Orientat Ctr, Dept Otolaryngol, San Diego Med Ctr, San Diego, CA 92134 USA		Donaldson, CJ (corresponding author), USN, Spatial Orientat Ctr, Dept Otolaryngol, San Diego Med Ctr, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Benedek K, 2002, CEPHALALGIA, V22, P142, DOI 10.1046/j.1468-2982.2002.00351.x; Bikhazi P, 1997, AM J OTOL, V18, P350; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Eggers Scott D Z, 2007, Curr Pain Headache Rep, V11, P217, DOI 10.1007/s11916-007-0193-5; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Lempert T, 1997, BRAIN, V120, P1005, DOI 10.1093/brain/120.6.1005; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Lewis D, 2007, HEADACHE, V47, P1409, DOI 10.1111/j.1526-4610.2007.00867.x; Maione A, 2006, LARYNGOSCOPE, V116, P1782, DOI 10.1097/01.mlg.0000231302.77922.c5; Neuhauser H, 2009, NEUROL CLIN, V27, P379, DOI 10.1016/j.ncl.2008.11.004; Ramadan NM, 2007, HEADACHE, V47, pS52, DOI 10.1111/j.1526-4610.2007.00677.x; Vitkovic J, 2008, AUDIOL NEURO-OTOL, V13, P113, DOI 10.1159/000111783; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wrisley DM, 2002, OTOL NEUROTOL, V23, P483, DOI 10.1097/00129492-200207000-00016	20	12	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0194-5998			OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	DEC	2010	143	6					820	825		10.1016/j.otohns.2010.09.024			6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	690BF	WOS:000284974400015	21109084				2022-02-06	
J	Gobbel, GT; Kondziolka, D; Fellows-Mayle, W; Uram, M				Gobbel, Glenn T.; Kondziolka, Douglas; Fellows-Mayle, Wendy; Uram, Martin			Manual Vs Automated Delivery of Cells for Transplantation: Accuracy, Reproducibility, and Impact on Viability	NEUROSURGERY			English	Article						Brain; Cell transplantation; Parkinson disease; Stroke	MARROW STROMAL CELLS; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; FUNCTIONAL RECOVERY; DOPAMINE NEURONS; SPINAL-CORD; RAT MODEL	BACKGROUND: Cellular transplantation holds promise for the management of a variety of neurological disorders. However, there is great variability in cell type, preparation methods, and implantation technique, which are crucial to clinical outcomes. OBJECTIVE: We compared manual injection with automated injection using a prototype device to determine the possible value of a mechanized delivery system. METHODS: Neural progenitor cells and bone marrow stromal cells were injected using manual or automated methods. Consistency of injection volumes and cell number and viability were evaluated immediately or 1 day after injection. RESULTS: When cells were delivered as a series of 3 manual injections from the same syringe, the variation in fluid volume was greater than for single manual injections. Automated delivery of a series of 3 injections resulted in a lower variability in the amount of delivery than manual injection for both cell lines (1.2%-2.6% coefficient of variability for automated delivery vs 4.3%-24.0% for manual delivery). The amount delivered from injection 1 to injection 3 increased significantly with manual injections, whereas the amount injected did not vary over the 3 injections for the automated unit. Cell viability 1 day after injection was typically 30% to 40% of the value immediately after injection for the bone marrow stromal cells and 30% to 70% for the neural progenitor cells. There were no significant differences in viability attributed to the method of injection. CONCLUSION: The automated delivery device led to enhanced consistency of volumetric cell delivery but did not improve cell viability in the methods tested. Automated techniques could be useful in standardizing reproducible procedures for cell transplantation and improve both preclinical and clinical research.	[Kondziolka, Douglas] Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Uram, Martin] MEDRAD Inc, Corp Innovat Dept, Indianola, PA USA		Kondziolka, D (corresponding author), Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, McGowan Inst Regenerat Med, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	kondziolkads@upmc.edu			Pittsburgh Tissue Engineering Initiative (PTEI); MEDRAD, Inc; NASANational Aeronautics & Space Administration (NASA) [NNJ06HE87G]	This study was supported by a grant from Pittsburgh Tissue Engineering Initiative (PTEI) and MEDRAD, Inc, based on work supported by NASA under award no. NNJ06HE87G. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; MADRAZO I, 1995, NEUROL RES, V17, P312, DOI 10.1080/01616412.1995.11740334; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ott HC, 2005, EUR J CARDIO-THORAC, V27, P1017, DOI 10.1016/j.ejcts.2005.01.065; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Pillarisetti A, 2007, IEEE T AUTOM SCI ENG, V4, P322, DOI 10.1109/TASE.2006.888051; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Stilley CS, 2004, NEUROLOGY, V63, P1320, DOI 10.1212/01.WNL.0000140700.44904.53; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	30	12	12	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2010	67	6					1662	1668		10.1227/NEU.0b013e3181f9b1e2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	685DF	WOS:000284606500047	21107197				2022-02-06	
J	Ni, H; Gong, Y; Yan, JZ; Zhang, LL				Ni, Hong; Gong, Yong; Yan, Jian-Zhen; Zhang, Le-Ling			Autophagy inhibitor 3-methyladenine regulates the expression of LC3, Beclin-1 and ZnTs in rat cerebral cortex following recurrent neonatal seizures	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Zinc transporter 1; Zinc transporter 3; LC3; Beclin-1; Seizure	UP-REGULATION; ZINC; BRAIN; HIPPOCAMPUS; HOMEOSTASIS; MECHANISM; TRANSPORT; MEMBRANES; RECEPTOR; NEURONS	BACKGROUND: Autophagy is a homeostatic process for intracellular recycling of bulk proteins and aging organelles. Increased autophagy has now been reported in experimental models of traumatic brain injury, stroke and excitotoxicity, and in patients with Alzheimer's disease and critical illness. The role of autophagy in developmental epilepsy, however, is unknown. The present study was to investigate the effects of recurrent neonatal seizure, in the presence and absence of autophagy inhibitor 3-methyladenine (3-MA), on the acute phase gene expression of ZnTs, LC3 and Beclin-1 in rat cerebral cortex and the interaction among them. METHODS: Thirty-six Sprague-Dawley neonatal rats at postnatal day 6(P6) were randomly divided into three groups: a recurrent-seizures group (RS, n=12), a 3-MA treated- seizure group (3-MA group, each rat pretreated with 3-methyladenine before seizures, 100nmol/mu l/day, i.p., n=12) and a control group (n=12). At 1.5 and 6 hours after the last seizures, the mRNA levels of ZnT1-ZnT3, microtubule-associated protein 1A/1B light chain 3 (LC3) and beclin-1 were detected using the real-time RT-PCR method. The LC3 protein level was examined by Western blotting. RESULTS: The levels of LC3, beclin-1 and ZnT-2 transcripts in the RS group elevated significantly at 1.5 and 6 hours after the last seizures compared with those in the control and 3-MA groups. At the interval of 1.5 hours, the mRNA level of ZnT-1 increased significantly after the last seizure compared with that in the control group. There was no significant difference in the transcript levels of ZnT-3 among the three groups. Linear correlation analysis showed that the expression of the five genes in the control group exhibited a significant inter-relationship. In the 3-MA group, however, the inter-relationship was only found between beclin-1 and ZnT-1. In the RS group, the inter-relationship was not observed. CONCLUSIONS: The autophagy/lysosomal pathway is immediately activated along with the elevated expression of ZnT1 and ZnT2 in the cerebral cortex after recurrent seizures. 3-MA is involved in the regulation of the autophagy/lysosomal pathway and ZnTs by down-regulating the expression of LC3 and beclin-1.	[Ni, Hong; Gong, Yong; Yan, Jian-Zhen; Zhang, Le-Ling] Soochow Univ, Affiliated Childrens Hosp, Lab Aging & Nervous Dis, Neurol Lab, Suzhou 215003, Peoples R China		Ni, H (corresponding author), Soochow Univ, Affiliated Childrens Hosp, Lab Aging & Nervous Dis, Neurol Lab, Suzhou 215003, Peoples R China.	nyr2000@yeah.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30470555, 30870808]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK2007509, BK2010233]	This work was supported by grants from the National Natural Science Foundation of China (30470555, 30870808), the Natural Science Foundation of Jiangsu Province of China (BK2007509, BK2010233).	Au AK, 2010, BBA-MOL BASIS DIS, V1802, P918, DOI 10.1016/j.bbadis.2009.10.010; Beharier O, 2007, CELL CALCIUM, V42, P71, DOI 10.1016/j.ceca.2006.11.007; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Danzer SC, 2010, HIPPOCAMPUS, V20, P113, DOI 10.1002/hipo.20589; Devirgiliis C, 2007, MUTAT RES-FUND MOL M, V622, P84, DOI 10.1016/j.mrfmmm.2007.01.013; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Hirosako K, 2004, BIOCHEM BIOPH RES CO, V316, P845, DOI 10.1016/j.bbrc.2004.02.119; Holmes GL, 2005, PEDIATR NEUROL, V33, P1, DOI 10.1016/j.pediatrneurol.2004.12.003; Holopainen IE, 2008, NEUROCHEM INT, V52, P935, DOI 10.1016/j.neuint.2007.10.021; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Landrot ID, 2001, DEV BRAIN RES, V129, P27; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; McAuliffe JJ, 2010, HIPPOCAMPUS; Missuya K, 2009, EPILEPSIA, V50, P1979; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Ni H, 2006, TOXICO LETT, V188, P161; Ni H, 2010, TOXICOL LETT, V194, P86, DOI 10.1016/j.toxlet.2010.02.008; Ni H, 2009, TOXICOL LETT, V184, P145, DOI 10.1016/j.toxlet.2008.11.003; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Siddiqui AH, 2005, BRAIN RES, V1066, P129, DOI 10.1016/j.brainres.2005.10.066; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Williams BL, 2006, BRAIN PATHOL, V16, P1, DOI 10.1111/j.1750-3639.2006.tb00556.x; Yan L, 2006, CELL CYCLE, V5, P1175, DOI 10.4161/cc.5.11.2787	34	12	13	0	1	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.	DEC	2010	1	3					216	223					8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V4W4O	WOS:000219325300012	25214972				2022-02-06	
J	Patanwala, AE; Amini, A; Erstad, BL				Patanwala, Asad E.; Amini, Albert; Erstad, Brian L.			Use of hypertonic saline injection in trauma	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						Brain injuries; Electrolytes; Mannitol; Osmotic agents; Protocols; Sodium chloride; Tonicity; Toxicity; Wounds and injuries	7.5-PERCENT SODIUM-CHLORIDE; ELEVATED INTRACRANIAL-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LACTATED RINGERS SOLUTION; SEVERELY BURNED CHILDREN; HEAD-INJURED PATIENTS; HEMORRHAGIC-SHOCK; BRAIN-INJURY; FLUID RESUSCITATION; NEUTROPHIL ACTIVATION	The use of hypertonic saline injection in trauma patients is discussed. Summary. Patients with hemorrhage, burns, and traumatic brain injury (TBI) may develop hypovolemic shock and require resuscitation. Compared with conventional isotonic crystalloids, hypertonic saline has several advantages, including hemodynamic, immune-modulating, and antiinflammatory effects, for use in trauma patients for resuscitation. In addition, hypertonic saline is also used in patients with TBI to reduce intracranial pressure (ICP). Overall, studies have not shown a difference in mortality or other clinically important outcomes with the use of hypertonic saline for resuscitation in trauma patients; however, most of these studies were not adequately powered to show significant differences. A recent Cochrane review concluded that there is no evidence that hypertonic crystalloids are better than isotonic or near-isotonic crystalloids for fluid resuscitation in trauma patients. Two recent trials that were adequately powered to investigate a mortality endpoint were halted for futility. A few small randomized controlled studies found that hypertonic saline was more effective than mannitol as a hyperosmolar agent for ICP reduction. Recent guidelines from the American Burn Association have suggested that hypertonic saline may be used for burn shock resuscitation by experienced providers with close monitoring to avoid excessive hypernatremia. One of the main concerns with the use of hypertonic saline is its potential to cause central pontine myelinolysis due to a rapid increase in serum sodium levels. Conclusion. There is no evidence that hypertonic saline provides any additional benefit over isotonic crystalloid solutions for trauma resuscitation. Hypertonic saline may be more effective than mannitol at reducing ICP in patients with TBI.	[Patanwala, Asad E.; Erstad, Brian L.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Amini, Albert] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85721 USA		Patanwala, AE (corresponding author), Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, 1295 N Martin,POB 210202, Tucson, AZ 85721 USA.	patanwala@pharmacy.arizona.edu					Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2004, RESUSCITATION, V60, P91, DOI 10.1016/j.resuscitation.2003.08.006; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bortolani A, 1996, Acta Chir Plast, V38, P132; BOWSERWALLACE BH, 1986, BURNS, V12, P402, DOI 10.1016/0305-4179(86)90035-5; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bunn F, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/146151858.CD002045.PUB2; CALDWELL FT, 1979, ANN SURG, V189, P546, DOI 10.1097/00000658-197905000-00002; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GUNN ML, 1989, J TRAUMA, V29, P1261, DOI 10.1097/00005373-198909000-00013; Hartl R, 1997, ZBL CHIR, V122, P181; Hartl R, 1997, ACT NEUR S, V70, P126; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Jarvela K, 2003, ANAESTHESIA, V58, P878, DOI 10.1046/j.1365-2044.2003.03332.x; JELENKO C, 1979, CRIT CARE MED, V7, P157, DOI 10.1097/00003246-197904000-00003; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Laureno R, 1997, ANN INTERN MED, V126, P57, DOI 10.7326/0003-4819-126-1-199701010-00008; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MONAFO WW, 1970, J TRAUM, V10, P575, DOI 10.1097/00005373-197007000-00006; MOYLAN JA, 1973, AM J SURG, V125, P580, DOI 10.1016/0002-9610(73)90141-4; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murao Y, 2003, SHOCK, V20, P23, DOI 10.1097/01.shk.0000078832.57685.6c; Murao Y, 2003, SHOCK, V20, P29, DOI 10.1097/01.shk.0000071060.78689.f1; Murphy JT, 1999, ARCH SURG-CHICAGO, V134, P1091, DOI 10.1001/archsurg.134.10.1091; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Oda J, 2006, J TRAUMA, V60, P64, DOI 10.1097/01.ta.0000199431.66938.99; Papia G, 2008, SURGERY, V144, P814, DOI 10.1016/j.surg.2008.07.008; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rhee P, 1998, J TRAUMA, V44, P313, DOI 10.1097/00005373-199802000-00014; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Schatzmann C, 1998, ACT NEUR S, V71, P31; SHACKFORD SR, 1987, SURG GYNECOL OBSTET, V164, P127; SHIMAZAKI S, 1977, J TRAUMA, V17, P38, DOI 10.1097/00005373-197701000-00005; SILVA MR, 1990, CRIT CARE MED, V18, P203, DOI 10.1097/00003246-199002000-00015; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade C, 1997, Acta Anaesthesiol Scand Suppl, V110, P77; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001; YOUNES RN, 1992, SURGERY, V111, P380	75	12	15	0	11	AMER SOC HEALTH-SYSTEM PHARMACISTS	BETHESDA	7272 WISCONSIN AVE, BETHESDA, MD 20814 USA	1079-2082			AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	NOV 15	2010	67	22					1920	1928		10.2146/ajhp090523			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	858BW	WOS:000297771900008	21048208				2022-02-06	
J	Hoskins, LL; Binder, LM; Chaytor, NS; Williamson, DJ; Drane, DL				Hoskins, Laura L.; Binder, Laurence M.; Chaytor, Naomi S.; Williamson, David J.; Drane, Daniel L.			Comparison of Oral and Computerized Versions of the Word Memory Test(dagger)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Word Memory Test (WMT); Symptom validity testing; Computerized assessments; Neuropsychological assessment	PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; CATEGORY TEST; TESTS; PERFORMANCE; EPILEPSY; EQUIVALENCE; EXAMINER; STANDARD; OBSERVER	A computer-administered version of the Word Memory Test (WMT) was compared with the orally administered version in two clinical samples to assess equivalency of the two versions. The two samples included inpatients at an epilepsy center (n = 67) and forensic and clinical referrals to a private practice (n = 58). A randomized procedure was used to assign participants to either version of the WMT. Only the results of the WMT primary effort measures were analyzed. Between-group comparisons of the WMT effort measures were conducted using Mann-Whitney nonparametric analysis. No significant differences were found between versions for several diagnostic subgroups. The data generally support equivalency of the orally administered version and the computerized version of the WMT effort measures in a mixed outpatient sample.	[Hoskins, Laura L.] N Shore Long Isl Jewish Hlth Syst, Dept Psychiat, Manhasset, NY 11030 USA; [Binder, Laurence M.] Independent Practice, Beaverton, OR 97005 USA; [Chaytor, Naomi S.] Univ Washington Reg Epilepsy Ctr, Harborview Med Ctr, Seattle, WA 98104 USA; [Chaytor, Naomi S.; Drane, Daniel L.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Williamson, David J.] Ortho McNeil Janssen Sci Affairs LLC, Raritan, NJ 08869 USA; [Williamson, David J.] Univ S Alabama, Dept Neurol, Mobile, AL 36688 USA; [Drane, Daniel L.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA		Hoskins, LL (corresponding author), N Shore Univ Hosp, Dept Psychiat, 400 Community Dr, Manhasset, NY 11030 USA.	lhoskins@nshs.edu	Chaytor, Naomi/L-4315-2019	Chaytor, Naomi/0000-0001-8821-289X			AGNEW J, 1991, J OCCUP ENVIRON MED, V33, P1156, DOI 10.1097/00043764-199111000-00012; Allen LM, 2000, ARCH CLIN NEUROPSYCH, V15, P840, DOI 10.1016/S0887-6177(00)80345-5; ALLEN LM, 2002, WEBPSYCHEMPIRICIST; Berger S. G., 1994, ASSESSMENT, V1, P255; Campbell KA, 1999, ASSESSMENT, V6, P21, DOI 10.1177/107319119900600103; Choca J., 1992, CLIN NEUROPSYCHOL, V6, P9, DOI [10.1080/13854049208404112, DOI 10.1080/13854049208404112]; Constantinou M, 2002, CLIN NEUROPSYCHOL, V16, P407, DOI 10.1076/clin.16.3.407.13853; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Fortuny LA, 1996, CLIN NEUROPSYCHOL, V10, P419, DOI 10.1080/13854049608406702; FRENCH CC, 1990, J CLIN PSYCHOL, V46, P129, DOI 10.1002/1097-4679(199003)46:2<129::AID-JCLP2270460203>3.0.CO;2-Y; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1995, MANUAL WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HOFER PJ, 1985, COMPUT HUM BEHAV, V1, P305; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; LETZ R, 1986, OCCUPATIONAL MED */*, V1, P197; Lichtenberger EO, 2006, J CLIN PSYCHOL, V62, P19, DOI 10.1002/jclp.20197; MEAD AD, 1993, PSYCHOL BULL, V114, P449, DOI 10.1037/0033-2909.114.3.449; Mercer WN, 1997, CLIN NEUROPSYCHOL, V11, P174, DOI 10.1080/13854049708407047; RUSSELL EW, 2000, CLIN GUIDE NEUROPSYC, P483; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Williamson DJ, 2005, EPILEPSIA, V46, P74; Williamson DJ, 2004, EPILEPSIA, V45, P179; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C, P346; Yantz CL, 2007, CLIN NEUROPSYCHOL, V21, P663, DOI 10.1080/13854040600788158; Yantz CL, 2009, CLIN NEUROPSYCHOL, V23, P118, DOI 10.1080/13854040801894722; [No title captured]; [No title captured]	38	12	13	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2010	25	7					591	600		10.1093/arclin/acq060			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	673KK	WOS:000283658500001	20719808	Bronze			2022-02-06	
J	Xiao, FR; Liao, CC; Huang, KC; Chiang, IJ; Wong, JM				Xiao, Furen; Liao, Chun-Chih; Huang, Ke-Chun; Chiang, I. -Jen; Wong, Jau-Min			Automated assessment of midline shift in head injury patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CT scanning; Head trauma; Midline shift; Computer-aided assessment; Outcome; Other tools of modern imaging	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; OUTCOME PREDICTION; TOMOGRAPHY; CLASSIFICATION; CT	Objectives: Midline shift (MLS) is an important quantitative feature for evaluating severity of brain compression by various pathologies, including traumatic intracranial hematomas. In this study, we sought to determine the accuracy and the prognostic value of our computer algorithm that automatically measures the MLS of the brain on computed tomography (CT) images in patients with head injury. Patients and methods: Modelling the deformed midline into three segments, we had designed an algorithm to estimate the MLS automatically. We retrospectively applied our algorithm to the initial CT images of 53 patients with head injury to determine the automated MLS (aMLS) and validated it against that measured by human (hMLS). Both measurements were separately used to predict the neurological outcome of the patients. Results: The hMLS ranged from 0 to 30 mm. It was greater than 5 mm in images of 17 patients (32%). In 49 images (92%), the difference between hMLS and aMLS was <1 mm. To detect MLS >5 mm, our algorithm achieved sensitivity of 94% and specificity of 100%. For mortality prediction, aMLS was no worse than hMLS. Conclusion: In summary. automated MLS was accurate and predicted outcome as well as that measured manually. This approach might be useful in constructing a fully automated computer-assisted diagnosis system. (C) 2010 Elsevier B.V. All rights reserved.	[Xiao, Furen; Liao, Chun-Chih; Huang, Ke-Chun; Chiang, I. -Jen; Wong, Jau-Min] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Xiao, Furen] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Liao, Chun-Chih] Taipei Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, I. -Jen] Taipei Med Univ, Grad Inst Med Informat, Taipei, Taiwan		Liao, CC (corresponding author), Dept Neurosurg, 127 Su Yuan Rd, Hsinchuang 242, Taipei County, Taiwan.	d95548001@ntu.edu.tw		Liao, Chun-Chih/0000-0001-9398-8617; Xiao, Furen/0000-0001-9683-3979			Bardera A, 2009, COMPUT MED IMAG GRAP, V33, P304, DOI 10.1016/j.compmedimag.2009.02.001; Bullock RM, 2000, J NEUROTRAUM, V17, P449; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Development Core Team R, 2008, R LANG ENV STAT COMP; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LIAO CC, 2006, 6 IEEE INT C DAT MIN, P463; Liao CC, 2010, COMPUT BIOL MED, V40, P331, DOI 10.1016/j.compbiomed.2010.01.004; Liu BQ, 2008, IEEE ENG MED BIO, P1214, DOI 10.1109/IEMBS.2008.4649381; Lu W, 2005, ULTRASOUND MED BIOL, V31, P929, DOI 10.1016/j.ultrasmedbio.2005.04.002; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590	20	12	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2010	112	9					785	790		10.1016/j.clineuro.2010.06.020			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	676MR	WOS:000283916500009	20663606				2022-02-06	
J	Birthi, P; Walters, C; Karandikar, N				Birthi, Pravardhan; Walters, Chadwick; Karandikar, Ninad			A Rare Case of Tardive Dyskinesia and Akathisia Induced by Citalopram	PM&R			English	Article								Depression is one of the most commonly encountered problems in clinical practice. It also is a very common condition in patients with traumatic brain injury (TBI). Citalopram is one of the most commonly used antidepressants agents, and as is true for all selective serotonin reuptake inhibitors (SSRIs), it exerts its antidepressant effect by blocking the reuptake of serotonin, thereby increasing extrasynaptic serotonin levels [1]. Tardive dyskinesia is a movement disorder characterized by involuntary movements of the tongue, lips, face, trunk, and extremities that has been shown to occur in patients treated long term with dopaminergic antagonist medications. The medications most commonly associated with this disorder are older anti psychotic agents such as haloperidol, fluphenazine, and trifluoperazine. Other nonantipsychotic medications associated with this syndrome include cinnarizine, flunarizine, and metoclopramide. Tardive dyskinesia is most common in patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have undergone long-term treatment with antipsychotic medication. However, patients with fetal alcohol syndrome, other developmental deficits, and various brain disorders are vulnerable to the development of tardive dyskinesia, even after receiving a single close of the causative agent [2]. Extrapyramidal symptoms (EPS), such as akathisia, are commonly reported side effects of SSRIs. Tardive dyskinesias also have been reported in the literature in conjunction with the use of some SSRIs such as paroxetine, fluoxetine, and sertraline but not with citalopram. These side effects are thought to be a consequence of serotonergically mediated inhibition of the dopaminergic system. Here, we report a case of tardive dyskinesia and akathisia that occurred after the use of citalopram to treat depression in a patient with history of head injury.	[Birthi, Pravardhan; Walters, Chadwick; Karandikar, Ninad] Univ Kentucky, Lexington, KY 40506 USA		Birthi, P (corresponding author), Univ Kentucky, Lexington, KY 40506 USA.						Bezchlibnyk-Butler K, 2000, J PSYCHIATR NEUROSCI, V25, P241; Brasic JR, 2010, TARDIVE DYSKINESIA; de Lago E, 2007, LIFE SCI, V80, P979, DOI 10.1016/j.lfs.2006.11.029; Groenendijk C, SSRI SSNRI ANTIDEPRE; Han P, 2002, CASE MONTH COMPREHEN, V2; Lavalaye J, 2001, PSYCHOPHARMACOLOGY, V155, P107, DOI 10.1007/s002130000670; Leo RJ, 1996, J CLIN PSYCHIAT, V57, P449, DOI 10.4088/JCP.v57n1002; Lozsadi DA, 2004, MOVEMENT DISORD, V19, P708, DOI 10.1002/mds.10696	8	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	OCT	2010	2	10					973	975		10.1016/j.pmrj.2010.05.007			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V23SE	WOS:000208361700021	20970768				2022-02-06	
J	Davenport, A				Davenport, Andrew			Management of acute kidney injury in neurotrauma	HEMODIALYSIS INTERNATIONAL			English	Article						Hemodialysis; cerebral edema; dialyzer membranes; acute kidney injury; hemofiltration	ACUTE-RENAL-FAILURE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PERITONEAL-DIALYSIS; REPLACEMENT THERAPY; ILL PATIENTS; HEAD-INJURY; HEMODIALYSIS; COMPLICATIONS; PATIENT	Fortunately, the incidence of acute kidney injury (AKI) in neurotrauma is low and decreasing. Whereas the majority of AKI occurs in older patients with pre-existing chronic kidney disease, neurotrauma typically occurs in children and young adults with normal renal function. The development of outreach trauma teams has improved initial resuscitation, reducing both volume responsive and volume unresponsive cases of AKI. Most cases occur in the setting of multiple organ trauma with muscle injury, or patients who subsequently develop multiple organ failure. Once AKI has developed and renal replacement therapy is required, continuous modalities of renal replacement therapy offer an advantage to the patient with compromised cerebral perfusion and intracranial hypertension, by reducing the rate of change in serum urea, compared with standard intermittent therapies of hemodialysis and hemofiltration, thus minimizing abrupt changes in serum osmolality. Continuous hemodialysis and hemofiltration are better suited to maintain a normal or high serum sodium and thermal losses through the extracorporeal circuit, than peritoneal dialysis. Dialyzers should preferably be minimally bioincompatible and of a small surface area. In patients at risk of intracranial hemorrhage and those with invasive intracranial monitoring, systemic anticoagulants should either be avoided or regional anticoagulants should be used.	UCL, Sch Med, UCL Ctr Nephrol, London NW3 2PF, England		Davenport, A (corresponding author), UCL, Sch Med, UCL Ctr Nephrol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; Basile C, 2009, G Ital Nefrol, V26, P22; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P561; DAVENPORT A, 1989, AM J KIDNEY DIS, V14, P516, DOI 10.1016/S0272-6386(89)80153-2; Davenport A, 2008, PERITON DIALYSIS INT, V28, P423; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; DAVENPORT A, 1989, INT J ARTIF ORGANS, V12, P703, DOI 10.1177/039139888901201107; DAVENPORT A, 1991, NEPHRON, V59, P449, DOI 10.1159/000186607; DAVENPORT A, 2008, NEPHROL DIAL TRANSPL, V1, P41; Davenport A, 2008, HEMODIAL INT, V12, P307, DOI 10.1111/j.1542-4758.2008.00271.x; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Davenport Andrew, 2006, Hemodial Int, V10, P162; Davenport A, 2009, CLIN KIDNEY J, V2, P439, DOI 10.1093/ndtplus/sfp136; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Gabriel DP, 2009, PERITON DIALYSIS INT, V29, pS62; Gondo G, 1989, Neurol Med Chir (Tokyo), V29, P1125, DOI 10.2176/nmc.29.1125; Iunovidov I M, 1977, Zh Nevropatol Psikhiatr Im S S Korsakova, V77, P1656; Ivarsen P, 2007, NEPHROL DIAL TRANSPL, V22, P2999, DOI 10.1093/ndt/gfm284; JONES JG, 1992, NEPHROL DIAL TRANSPL, V7, P110, DOI 10.1093/oxfordjournals.ndt.a092078; Kielar ML, 2002, CURR OPIN NEPHROL HY, V11, P451, DOI 10.1097/00041552-200207000-00013; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Sabsovich I, 2007, AM J CRIT CARE, V16, P82, DOI 10.4037/ajcc2007.16.1.82; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Stoves J, 2001, ARTIF ORGANS, V25, P1009, DOI 10.1046/j.1525-1594.2001.06703.x; TAYLOR WH, 1957, LANCET, V2, P703; TAYLOR WH, 1958, BRIT J SURG, V46, P136, DOI 10.1002/bjs.18004619611; Trinh-Trang-Tan MM, 2005, NEPHROL DIAL TRANSPL, V20, P1984, DOI 10.1093/ndt/gfh877	35	12	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2010	14			1			S27	S31		10.1111/j.1542-4758.2010.00487.x			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	660IW	WOS:000282634800006	21040416				2022-02-06	
J	De Wolf, A; Lane-Brown, A; Tate, RL; Middleton, J; Cameron, ID				De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.			Measuring community integration after spinal cord injury: validation of the Sydney psychosocial reintegration scale and community integration measure	QUALITY OF LIFE RESEARCH			English	Article						Sydney psychosocial reintegration scale-SPRS; Community integration measure-CIM; Outcomes measurement; Community integration; Participation	PSYCHOMETRIC PROPERTIES; OUTCOMES RESEARCH; BRAIN-INJURY; HANDICAP; DIFFERENCE; RECOVERY; HEALTH	To evaluate the reliability, validity, sensitivity to change, and clinical usefulness of the Sydney Psychosocial Reintegration Scale (SPRS) and Community Integration Measure (CIM) for people with spinal cord injury (SCI). A sample of 58 people with recent traumatic SCI was followed up at 12 months post-discharge from inpatient rehabilitation. The SPRS, CIM, Craig Handicap Assessment and Reporting Technique (CHART) and SF-6D Health Utility Scale (SF-6D) were administered. The SPRS and CIM were internally consistent (alpha = .80 and .78, respectively). The SPRS showed greatest sensitivity to change as measured by percentage of participants meeting minimum difference in score change over time (21%). CIM and CHART had comparable sensitivity to change (14% minimum difference). SPRS correlated significantly with CHART (r = .72, P < .001), unlike CIM. Neither SPRS nor CIM discriminated between high and low impairment, unlike CHART. Correlations with CHART and SF-6D domains supported convergent and divergent validity of the SPRS domains. Research should continue to develop conceptually and psychometrically valid instruments to capture the multidimensionality of community integration. The SPRS and CIM show potential to extend measurement of community reintegration following SCI.	[De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.] Univ Sydney, Rehabil Studies Unit, Ryde, NSW 2112, Australia; [De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.] Royal Rehabil Ctr Sydney, Ryde, NSW 2112, Australia		De Wolf, A (corresponding author), Univ Sydney, Rehabil Studies Unit, 59 Charles St, Ryde, NSW 2112, Australia.	anneliesd@med.usyd.edu.au		Middleton, James/0000-0002-2777-8619			Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Betz N., 2000, PSYCHOL RES HDB GUID, P239; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; CARR AJ, 1994, BRIT J RHEUMATOL, V33, P378; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; De Wolf A., 2008, J REHABILITATION S47, V40, P106; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers M., 1998, TOP SPINAL CORD INJ, V4, P1, DOI DOI 10.1310/BJJA-2018-45KL-0VTL; Dijkers M., 1991, J AM PARAPLEGIA SOC, V14, P85; Dijkers M. P., 2000, ARCH PHYS MED REH S2, V81, P63; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lee BB, 2008, VALUE HEALTH, V11, P680, DOI 10.1111/j.1524-4733.2007.00311.x; Ley P., 1972, QUANTITATIVE ASPECTS; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Noreau Luc, 2005, J Neurol Phys Ther, V29, P147; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; Streiner DL, 2003, J PERS ASSESS, V80, P99, DOI 10.1207/S15327752JPA8001_18; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1998, CLIN NEUROPSYCHOL, V12, P348, DOI 10.1076/clin.12.3.348.1988; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Whiteneck G, 1999, ARCH PHYS MED REHAB, V80, P1485, DOI 10.1016/S0003-9993(99)90262-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS	35	12	12	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343			QUAL LIFE RES	Qual. Life Res.	OCT	2010	19	8					1185	1193		10.1007/s11136-010-9685-6			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	651CS	WOS:000281902800012	20582722				2022-02-06	
J	Nakao, K; Kibayashi, K; Taki, T; Koyama, H				Nakao, Ken-ichiro; Kibayashi, Kazuhiko; Taki, Takashi; Koyama, Hiroyoshi			Changes in the Brain after Intracerebral Implantation of a Lead Pellet in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						bullet; firearm; gunshot wound; lead; penetrating brain injury	TRAUMATIC BRAIN; CELL-DEATH; INJURY; METALLOTHIONEIN; EXPRESSION; HIPPOCAMPUS; ASTROCYTES; EXPOSURE; NEURONS; BULLET	In gunshot wounds to the head, the bullet containing neurotoxic lead may remain in the brain after trauma, and brain damage is therefore anticipated. We developed an animal model incorporating a lead ball implanted in the brain, or a glass ball as a control, and analyzed histological and biochemical changes in the brain for 28 days after surgery. The concentration of lead in the brain increased with time after implantation of the lead ball, while lead was not detected in brains implanted with a glass ball. A number of changes were noted following implantation of the lead ball. The number of neutrophils increased significantly at 7-28 days, while the number of macrophages also increased significantly with time. The number of neurons was significantly decreased by 28 days, and apoptotic cells were identified at 14-28 days. Expression of genes encoding N-methyl-D-aspartate receptors, which are related to cognitive function and help regulate apoptosis, was significantly suppressed at 7-21 days after implantation. Expression of metallothionein protein increased significantly with time. Metallothionein detoxifies lead and its overexpression is a known method of protection against lead neurotoxicity. These findings indicate that intracerebral lead induces neuronal degeneration that is attributable in part to the inflammation and apoptosis caused by leached lead. Although the severity of the brain damage primarily depends on the destructive effect of the moving bullet, the results of this study indicate that lead leaching from the residual bullet also damages the brain.	[Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Nakao, Ken-ichiro; Koyama, Hiroyoshi] Saga Univ, Dept Forens Med, Fac Med, Saga 840, Japan		Kibayashi, K (corresponding author), Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kibayash@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215; Taki, Takashi/0000-0002-7350-538X	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19390186, 21659177]	This work was supported by grants to K.K. from the Japan Society for the Promotion of Science (no. 19390186 and 21659177).	Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BELLINGER D, 1991, PEDIATRICS, V87, P219; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Chao CC, 1996, GLIA, V16, P276, DOI 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; DIMAIO VJM, 1985, GUNSHOT WOUNDS PRACT, P1; El-Neweshy MS, 2011, EXP TOXICOL PATHOL, V63, P221, DOI 10.1016/j.etp.2009.12.003; Farrell SE, 1999, ACAD EMERG MED, V6, P208, DOI 10.1111/j.1553-2712.1999.tb00157.x; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; KANE AB, 1999, ROBBINS COTRAN PATHO, V7, P415; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lau WK, 2002, BRAIN RES, V932, P10, DOI 10.1016/S0006-8993(01)03395-9; LINDENBERG R, 1993, SPITZ FISHERS MEDICO, P585; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Mizuno T, 2005, BRAIN RES, V1066, P78, DOI 10.1016/j.brainres.2005.10.050; NAIDOO SR, 2005, ENCY FORENSIC LEGAL, P271; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Neal JW, 1996, NEUROPATH APPL NEURO, V22, P243; Nihei MK, 1999, MOL BRAIN RES, V66, P42, DOI 10.1016/S0169-328X(99)00005-4; Ozkan U, 2002, NEUROSURG REV, V25, P231, DOI 10.1007/s101430100173; Ozkan U, 2006, CLIN NEUROL NEUROSUR, V108, P573, DOI 10.1016/j.clineuro.2005.03.002; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 1999, J NEUROSCI, V19, P2535; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; RENGACHARY SS, 1992, NEUROSURGERY, V30, P291, DOI 10.1227/00006123-199202000-00029; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Sharifi AM, 2002, NEUROSCI LETT, V329, P45, DOI 10.1016/S0304-3940(02)00576-1; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003; Vikman P, 2007, J NEUROSURG, V107, P1015, DOI 10.3171/JNS-07/11/1015; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Wunnapuk K, 2007, BIOL TRACE ELEM RES, V120, P74, DOI 10.1007/s12011-007-8014-6; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YAMAMOTO I, 1985, SURG NEUROL, V23, P396, DOI 10.1016/0090-3019(85)90215-0; Zhang J, 2004, FREE RADICAL BIO MED, V37, P1037, DOI 10.1016/j.freeradbiomed.2004.06.037; [No title captured]	42	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2010	27	10					1925	1934		10.1089/neu.2010.1379			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	665OZ	WOS:000283046600016	20698761				2022-02-06	
J	Xie, JR; Qian, ZY; Yang, TM; Li, WT; Hu, GX				Xie, Jieru; Qian, Zhiyu; Yang, Tianming; Li, Weitao; Hu, Guangxia			Minimally invasive assessment of the effect of mannitol and hypertonic saline therapy on traumatic brain edema using measurements of reduced scattering coefficient (mu '(s))	APPLIED OPTICS			English	Article							CEREBRAL EDEMA; INTRACRANIAL-PRESSURE; HEMORRHAGIC-SHOCK; INJURY; SURVIVAL	Minimally invasive functional near infrared spectroscopy (fNIRs) technology was utilized to assess the effects of mannitol and hypertonic saline (HS) in treating traumatic brain edema (TBE). Rats with TBE models were given mannitol or HS in different dosages for different groups. The reduced scattering coefficient (mu'(s)) of the local cortex of rats was simultaneously monitored and recorded in vivo and real time by the minimally invasive fNIRs system. Brain water content (BWC) was measured by the wet and dry weight method at 1, 6, 24, 72, and 120 h after injury and treatment. Effects of treating TBE with different dehydration agents were then assessed by recording mu'(s) and BWC before and after administration of dehydration. In this study, the dynamic changes of brain edema and the effects of dehydration therapy were continuously monitored. Results implied that mu'(s) of the local cortex in rats is a good indicator for assessing effects of treatment of TBE. By recording changes in the value of mu'(s), the following conclusions were obtained: HS is more effective than mannitol in reducing cerebral edema. The effect of dehydration of HS is only related to osmotic gradient and has no correlation with concentration. (C) 2010 Optical Society of America	[Xie, Jieru; Qian, Zhiyu; Li, Weitao; Hu, Guangxia] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing 210016, Peoples R China; [Yang, Tianming] Southeast Univ, Sch Clin Med, Nanjing 210009, Peoples R China		Qian, ZY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, 29 Yudao St, Nanjing 210016, Peoples R China.	zhiyu@nuaa.edu.cn			National High Technology Research and Development Program ("863" Program) of ChinaNational High Technology Research and Development Program of China [2008AA02Z438]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK2009371]	This work was carried out in the Biophotonics Laboratory in the University of Aeronautics and Astronautics and was financially supported by the National High Technology Research and Development Program ("863" Program) of China (2008AA02Z438) and the Natural Science Foundation of Jiangsu Province of China (BK2009371).	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Ashman TA, 2006, MT SINAI J MED, V73, P999; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; BULLOCK MR, 2006, NEUROSURG QUART, V58, P306; Dai LJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2957974; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; DONATO T, 1994, ANESTH ANALG, V78, P58; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; FANTINI S, 1995, OPT ENG, V34, P32, DOI 10.1117/12.183988; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GOLDWASSER P, 1984, ARCH INTERN MED, V144, P2214, DOI 10.1001/archinte.144.11.2214; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Hirsh M, 2002, CRIT CARE MED, V30, P861, DOI 10.1097/00003246-200204000-00025; James HE, 2006, ACT NEUR S, V96, P125; JIA W, 2001, J CAPITAL U MED SCI, V22, P216; Junger H, 2003, J MOL NEUROSCI, V21, P111, DOI 10.1385/JMN:21:2:111; KOBAYASHI H, 1995, SURG NEUROL, V44, P55, DOI 10.1016/0090-3019(95)00065-8; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Oi Y, 2000, CRIT CARE MED, V28, P2843, DOI 10.1097/00003246-200008000-00027; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Prough DS, 1998, CRIT CARE MED, V26, P997, DOI 10.1097/00003246-199806000-00013; QIAN Z, 2005, J MED PHYS, V22, P463; Qian Zhi-yu, 2004, Journal of Nanjing University of Aeronautics & Astronautics, V36, P369; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Todd MM, 2006, ANESTHESIOLOGY, V105, P1176, DOI 10.1097/00000542-200612000-00017; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WANG G, 2000, NEW CHIN MED, V31, P413; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; WHELAN TV, 1984, ARCH INTERN MED, V144, P2053, DOI 10.1001/archinte.144.10.2053; Xie JR, 2009, SPECTROSC SPECT ANAL, V29, P3254, DOI 10.3964/j.issn.1000-0593(2009)12-3254-05; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684, DOI 10.1177/153537020422900713; ZENG H, 2002, CHIN J EMER MED, V11, P176; ZHU G, 1997, CHIN J NERV MENT DIS, V23, P286	40	12	12	0	4	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 1	2010	49	28					5407	5414		10.1364/AO.49.005407			8	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	657WO	WOS:000282449800028	20885479				2022-02-06	
J	Kozminski, M				Kozminski, Matthew			Combat-Related Posttraumatic Headache: Diagnosis, Mechanisms of Injury, and Challenges to Treatment	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY	Context: Studies have revealed the rates of posttraumatic stress disorder (PTSD) and concussion among US soldiers returning from combat, but only one study has focused on the subpopulation of soldiers with headache. Objectives: To determine the rate of PTSD among US soldiers with comorbid chronic posttraumatic headache attributed to head injury, to identify common mechanisms of head injury, and to identify the common challenges a health-care provider must face when treating US soldiers with chronic posttraumatic headache attributed to head injury. Methods: Between July 2007 and December 2008, the author examined 42 US Army soldiers with complaint of chronic headache. In March 2009, the author retrospectively reviewed the outpatient records for diagnoses, mechanisms of injury, and challenges to treatment. Results: The rate of concussion, defined by the Defense and Veterans Brain Injury Center Working Group on the Acute Management of Mild Traumatic Brain Injury in Military Operational Settings, was 95%. The rate of PTSD, as determined either with the PTSD Checklist or by confirming a prior diagnosis by another healthcare provider, was 97.9%. Both rates are remarkably higher than rates reported in the literature. The most common mechanisms of injury were proximity to blast (18 [45.2%]) and direct target of blast (15 [35.7%]). The most common treatment challenges were overuse of headache-abortive medications (10 [23.8%]) and poor patient follow-up (7 [16.7%]). Conclusion: Physicians should be aware that the rates of PTSD and concussion for US soldiers, most often linked to involvement in or proximity to a blast, are higher for soldiers complaining of chronic headache. Physicians should also be aware of the potential for overuse of medications in this patient population.	[Kozminski, Matthew] Madigan Army Med Ctr, Tacoma, WA 98431 USA		Kozminski, M (corresponding author), Darnall Army Med Ctr, Neurol Clin, 36000 Darnall Loop, Ft Hood, TX 76544 USA.	mpkst17@yahoo.com					Anderson RE, 2006, HEADACHE, V46, P1273, DOI 10.1111/j.1526-4610.2006.00535.x; Batchelor K, 2008, AM ACAD OSTEOPATH J, V18, P30; Bernhardi EF, 1995, CRANIAL LETT, V48, P4; Biondi DM, 2005, J AM OSTEOPATH ASSOC, V105, pS16; Biondi DM, 2005, HEADACHE, V45, P738, DOI 10.1111/j.1526-4610.2005.05141.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kozminski M., 2009, AM ACAD OSTEOPAT J, V19, P23; Kuchera ML, 2007, J AM OSTEOPATH ASSOC, V107, pES28; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Weathers F.W., 1993, 9 ANN C ISTSS	15	12	12	0	1	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	SEP	2010	110	9					514	519					6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V04QO	WOS:000213819700005	20876836				2022-02-06	
J	Hilbert, P; Lefering, R; Stuttmann, R				Hilbert, P.; Lefering, R.; Stuttmann, R.			Different case fatality rates at German trauma centres	ANAESTHESIST			German	Article						Multiple trauma; Revised injury severity classification; Case fatality rate; Standardized mortality ratio; Injury severity score	EMERGENCY-ROOM MANAGEMENT; COMPUTED-TOMOGRAPHY; INJURED PATIENTS; MULTIPLE TRAUMA; RESUSCITATION; ALGORITHM	The level of trauma care in Germany belongs to one of the best worldwide. Nevertheless, previous studies have shown significant differences in the case fatality rates of multiple trauma patients in German trauma centres. The objective of this study was to indentify the reasons for the different outcomes based on data of the trauma registry of the German Society of Orthopaedic Surgery and Traumatology. Due to the inadequacy of comparing only the case fataltiy rates in the different trauma centres, the data recorded in the trauma registry were analyzed in a retrospective, multicentre study to calculate the probability of survival, revised injury severity classification (RISC) and, additionally, the standardized mortality ratio (SMR) for ranking of the participating trauma centres. As a criterion for inclusion in the study, a minimum of 100 trauma patients admitted directly from the scene within a 4 year period was set. The ranking was carried out using the SMR (observed mortality divided by probability of survival). With the help of data from the trauma registry an attempt was made to find the differences in trauma management between the top 10 centres (lowest SMR), the 10 middle and the last 10 centres (highest SMR) in the ranking. The data of 6,522 patients were included in the study. There were significant differences in the pre-hospital time, the time spent in the emergency room (ER) and time until a CT scan had been performed. Pre-hospital time was longer in patients admitted to the top centres, whereas time in the ER was longer in the last centres of the ranking. Comparing the sum of pre-hospital time and time in the ER, there were no differences between the top and the last centres. At the scene of accident overall intubation rate and intubation rate in patients with traumatic brain injury were higher in patients admitted to the top centres. Regarding the transport modality, significantly more patients were transported by helicopter in the group of the top centres. In top centres CT scans, in particular whole-body CTs, were initiated sooner and used much more frequently so that the rate of missed injuries was much lower. The amount of fluid given at the scene of accident did not differ between the centres but the amount of fluid given in ER and the operating room until admission to the intensive care unit was significantly higher in the top centres. There are significant differences in the pre-hospital and clinical care of patients admitted to German trauma centres. Under clinical conditions a tight time management, an immediate and complete diagnostic approach, particularly by means of whole-body CT and a liberal fluid resuscitation seem to be favorable factors.	[Hilbert, P.; Stuttmann, R.] BG Kliniken Bergmannstrost, Klin Anaesthesiol Intens & Notfallmed, D-06112 Halle, Saale, Germany; [Lefering, R.] Univ Witten Herdecke, IFOM, Cologne, Germany		Hilbert, P (corresponding author), BG Kliniken Bergmannstrost, Klin Anaesthesiol Intens & Notfallmed, Merseburgerstr 165, D-06112 Halle, Saale, Germany.	Peter.Hilbert@bergmannstrost.com		Hilbert-Carius, Peter/0000-0002-4704-2377			Bogner V, 2009, UNFALLCHIRURG, V112, P838, DOI 10.1007/s00113-009-1606-1; Boldt J, 2004, CAN J ANAESTH, V51, P500, DOI 10.1007/BF03018316; Chiara O, 2008, MINERVA ANESTESIOL, V74, P303; COWLEY RA, 1976, CLIN MED/US, V83, P16; Exadaktylos AK, 2008, INJURY, V39, P525, DOI 10.1016/j.injury.2007.10.019; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Hilbert P, 2005, ANASTH INTENSIV NOTF, V40, P720, DOI 10.1055/s-2005-921036; Hoffstetter P, 2008, ROFO-FORTSCHR RONTG, V180, P120, DOI 10.1055/s-2007-963594; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kanz KG, 2004, UNFALLCHIRURG, V107, P937, DOI 10.1007/s00113-004-0845-4; Maury P, 2007, EUROPACE, V9, P212, DOI 10.1093/europace/eum016; Nast-Kolb D, 2005, UNFALLCHIRURG, V108, P804, DOI 10.1007/s00113-005-1004-2; Nast-Kolb D, 2005, UNFALLCHIRURG, V108, P792, DOI 10.1007/s00113-005-1022-0	13	12	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	AUG	2010	59	8					700	+		10.1007/s00101-010-1742-6			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	640HI	WOS:000281040100003	20532470				2022-02-06	
J	Jones, J; Curtin, M				Jones, Jennifer; Curtin, Michael			Traumatic Brain Injury, Participation, and Rural Identity	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; participation, social; quality of life; research, rural; social identity; stigma	HEALTH; AUSTRALIA; COUNTRYSIDE; EXCLUSION; RESIDENTS; OUTCOMES; SEEKING; ENGLISH; STIGMA; PLACE	In this article we focus on participation following traumatic brain injury (TBI) in rural and regional Australian contexts, asking how aspects of rurality, such as place identity and rural belonging, impact on participation for the individual living with TBI. We found a preference for country living, despite disadvantages including distance from services and lack of anonymity. A rural identity provides access to an enabling narrative, the "rural idyll," which allows people with TBI to inhabit the realm of social normality. A rural identity is enabling in this regard, because it cooperates with TBI-based preferences for social isolation and a relaxed pace that accommodates fatigue. Thus, people living in rural areas report satisfaction with their quality of life despite restricted access to resources and reduced social participation.	[Jones, Jennifer] Univ Melbourne, Sch Hist Studies, Australian Ctr, Melbourne, Vic, Australia; [Curtin, Michael] Charles Sturt Univ, Albury, NSW, Australia		Jones, J (corresponding author), Univ Melbourne, Australian Ctr, Parkville, Vic 3010, Australia.	ja.jones@unimelb.edu.au	Curtin, Michael/G-2650-2014; Jones, Jennifer/N-1940-2015	Curtin, Michael/0000-0002-2152-7501; Jones, Jennifer/0000-0003-1855-2674			Alston M, 2007, HEALTH SOC CARE COMM, V15, P195, DOI 10.1111/j.1365-2524.2007.00696.x; Argent N, 2002, AUST GEOGR, V33, P97, DOI 10.1080/00049180220125033; Argent N, 2007, GEOGR RES, V45, P217, DOI 10.1111/j.1745-5871.2007.00456.x; Baum FE, 2000, J EPIDEMIOL COMMUN H, V54, P414, DOI 10.1136/jech.54.6.414; Bell D., 2006, HDB RURAL STUDIES, P149, DOI DOI 10.4135/9781848608016.N10; Bolam B, 2006, PSYCHOL HEALTH, V21, P399, DOI 10.1080/14768320500286526; Charmaz K., 2014, BROKERAGE CLOSURE IN; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; CURTIS S, 1998, SOCIOLOGY HLTH INEQU, P85; DAVIES A, 2006, GEOGRAPHICAL RES, V46, P162; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Finlay L, 2006, QUALITATIVE RES ALLI; Gwynn R., 2003, DISCOURSE BODY IDENT, P209; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; HUGO G, 1998, MIGRATION RURAL AREA; Judd F, 2006, AUST NZ J PSYCHIAT, V40, P769, DOI 10.1111/j.1440-1614.2006.01882.x; KELLY M, 1996, EXPLORING DIVIDE ILL; Lupton D, 2003, DISCOURSE BODY IDENT, P246; Moorin RE, 2006, HEALTH PLACE, V12, P131, DOI 10.1016/j.healthplace.2004.10.013; Murphy P., 2006, CHANGING NATURE AUST, P26; Neuman W, 2004, BASICS SOCIAL RES QU; Phillips A, 2009, AUST J RURAL HEALTH, V17, P2, DOI 10.1111/j.1440-1584.2008.01029.x; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Punch K., 2005, INTRO SOCIAL RES QUA, Vsecond; Quine S, 2008, AUST J RURAL HEALTH, V16, P115, DOI 10.1111/j.1440-1584.2008.00960.x; Raphael D., 2009, QUALITATIVE HLTH RES, V19, P297; Reidpath DD, 2005, SOCIOL HEALTH ILL, V27, P468, DOI 10.1111/j.1467-9566.2005.00452.x; Shildrick M, 2005, CRIT QUART, V47, P30, DOI 10.1111/j.1467-8705.2005.00648.x; Shin KR, 2009, QUAL HEALTH RES, V19, P850, DOI 10.1177/1049732309335857; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Wainer J, 2000, Aust J Rural Health, V8, P141, DOI 10.1046/j.1440-1584.2000.00304.x; Watkins F, 2007, HEALTH PLACE, V13, P851, DOI 10.1016/j.healthplace.2007.02.002	34	12	12	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323			QUAL HEALTH RES	Qual. Health Res.	JUL	2010	20	7					942	951		10.1177/1049732310365501			10	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	610SV	WOS:000278757400007	20360567				2022-02-06	
J	Quinlan, JD; Gauron, MR; Deschere, BR; Stephens, MB				Quinlan, Jeffrey D.; Gauron, Michael R.; Deschere, Bruce R.; Stephens, Mark B.			Care of the Returning Veteran	AMERICAN FAMILY PHYSICIAN			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; VIETNAM VETERANS; US VETERANS; RISK; ARMY; AFGHANISTAN; DEPRESSION; SOLDIERS	Of the 23.8 million military veterans living in the United States, approximately 3 million have served in Operation Enduring Freedom or Operation Iraqi Freedom. The injuries and illnesses that affect veterans returning from combat are predictable. Blast injuries are common and most often present as mild traumatic brain injury, which is synonymous with concussion. Family physicians caring for returning veterans will also encounter conditions such as posttraumatic stress disorder at rates higher than those in the general population. The symptoms associated with posttraumatic stress disorder and mild traumatic brain injury often overlap and can present concurrently. Treatment of traumatic brain injury should be based on symptoms and guided by clinical practice guidelines from the U.S. Department of Veterans Affairs and Department of Defense. Family physicians should understand the range of post-war health concerns and screen returning service members for posttraumatic stress disorder, substance abuse, suicidality, and clinical depression. Family physicians are well positioned to offer continuity of care for issues affecting returning service members and to coordinate the delivery of specialized care when needed. (Am Fam Physician. 2010;82(1):43-49. Copyright (C) 2010 American Academy of Family Physicians.)	[Stephens, Mark B.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Quinlan, Jeffrey D.] USN, Med Support Command, Jacksonville, FL USA; [Gauron, Michael R.] Mike OCallaghan Fed Hosp, Family Med Residency Program, Nellis AFB, NV USA; [Deschere, Bruce R.] USN, Hosp Pensacola, Family Med Residency Program, Pensacola, FL USA		Stephens, MB (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mstephens@usuhs.mil	Stephens, Mark/A-2679-2015				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P467; Ballenger JC, 2004, J CLIN PSYCHIAT, V65, P55; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Bullman TA, 1996, AM J PUBLIC HEALTH, V86, P662, DOI 10.2105/AJPH.86.5.662; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Keane T.M., 1991, PCL M DSM 4; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; ROTHBERG JM, 1990, JAMA-J AM MED ASSOC, V264, P2241, DOI 10.1001/jama.264.17.2241; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *US DEP VET AFF, MAN TRAUM STRESS DIS; *US DEP VET AFF, REP BLUE RIBB WORK G; US Department of Veterans Affairs/Department of Defense, CLIN PRACT GUID MAN; *USA HOOAH 4 HLTH, DEPL GUID FAM DEPL S; Wessely S, 2005, BRIT J PSYCHIAT, V186, P459, DOI 10.1192/bjp.186.6.459; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801	25	12	12	0	8	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	JUL 1	2010	82	1					43	49					7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621PV	WOS:000279594300008	20590069				2022-02-06	
J	Schneiders, AG; Sullivan, SJ; Kvarnstrom, J; Olsson, M; Yden, T; Marshall, S				Schneiders, Anthony G.; Sullivan, S. John; Kvarnstrom, Johan; Olsson, Maria; Yden, Tobias; Marshall, Stephen			The effect of footwear and sports-surface on dynamic neurological screening for sport-related concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Footwear; Performance; Tandem Gait; Measurement	RUGBY-UNION; ASSOCIATION; INJURIES; EPIDEMIOLOGY; PERFORMANCE; MANAGEMENT; PLAYERS; BALANCE; SYSTEM	The Sport Concussion Assessment Tool (SCAT) is a standardised global assessment for the identification of sport-related concussion (SRC). An integral component of the SCAT is the neurological screen, which contains the assessment of motor performance including gait evaluation. However, it is not known how performance of gait is affected by the surface/footwear interactions encountered in various sporting environments. The purpose of this study was to investigate the effect of footwear and sporting surface on the time to perform a standardised Tandem Gait (TG) task. One hundred and eight amateur athletes were recruited, and three common sports-surfaces (grass, hardwood court, artificial turf) were compared. All groups were tested barefoot and with sports-surface specific footwear. Mixed model ANOVA, controlling for covariates and including a post hoc Bonferroni procedure, was used to investigate the influence of footwear and sports-surface on TG time. The study demonstrated that times for a defined TG task in healthy athletes depended on footwear, sports-surface, and the specific athletic population. The study demonstrated a significant interaction (F-2.104 = 3.35, p = 0.039) between groups (grass, hardwood court and artificial turf), and times were faster wearing footwear compared to barefoot (F-2.138 = 26.31, p = 0.001). In contrast to the footwear conditions, there was no statistical difference between the barefoot conditions on any of the sport-surfaces. These findings suggest that clinicians should standardise footwear and the testing surface at baseline in order to accurately assess motor performance tests when SRC is suspected. (C) 2010 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Schneiders, Anthony G.; Sullivan, S. John] Univ Otago, Ctr Physiotherapy Res, Dunedin, New Zealand; [Kvarnstrom, Johan; Olsson, Maria; Yden, Tobias] Umea Univ, Dept Community Med & Rehabil, S-90187 Umea, Sweden; [Marshall, Stephen] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA		Schneiders, AG (corresponding author), Univ Otago, Ctr Physiotherapy Res, Dunedin, New Zealand.	tony.schneiders@otago.ac.nz	; Schneiders, Anthony/F-4212-2015	Marshall, Stephen/0000-0002-2664-9233; Schneiders, Anthony/0000-0002-1583-3879	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NHS	We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organisation with which we are associated and, if applicable, we certify that all financial and material support for this research (e.g. NIH or NHS grants) and work are clearly identified in the title page of the manuscript.	Bloom GA, 2008, EUR J SPORT SCI, V8, P295, DOI 10.1080/17461390802251836; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Davids K, 2004, BRIT J SPORT MED, V38, P601, DOI 10.1136/bjsm.2003.007427; Dick R, 2007, J ATHL TRAINING, V42, P211; DOBBS RJ, 1993, AGE AGEING, V22, P27, DOI 10.1093/ageing/22.1.27; Finlay O, 2007, PHYSIOTHERAPY, V93, P144, DOI 10.1016/j.physio.2006.11.014; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Onate JA, 2007, J ATHL TRAINING, V42, P446; ROBBINS S, 1994, BRIT J SPORT MED, V28, P117, DOI 10.1136/bjsm.28.2.117; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; SCHNEIDERS AG, SPORTS CONCUSS UNPUB; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Takemura M, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.035568	19	12	12	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2010	13	4					382	386		10.1016/j.jsams.2010.01.003			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	623JZ	WOS:000279737100003	20227916				2022-02-06	
J	Jones, KD; Young, T; Leppma, M				Jones, Karyn Dayle; Young, Tabitha; Leppma, Monica			Mild Traumatic Brain Injury and Posttraumatic Stress Disorder in Returning Iraq and Afghanistan War Veterans: Implications for Assessment and Diagnosis	JOURNAL OF COUNSELING AND DEVELOPMENT			English	Article								Mild traumatic brain injury (MTBI) and posttraumatic stress disorder (PTSD) are considered the "signature injuries" of combat soldiers returning from Iraq and Afghanistan. Both disorders can greatly affect the functioning of soldiers, yet the disorders often go undetected or are misdiagnosed by both military and civilian health care providers. This article provides information about MTBI and PTSD in returning combat soldiers along with implications for assessment and diagnosis.	[Jones, Karyn Dayle; Young, Tabitha; Leppma, Monica] Univ Cent Florida, Dept Child Family & Community Sci, Orlando, FL 32816 USA		Jones, KD (corresponding author), Univ Cent Florida, Dept Child Family & Community Sci, POB 161250, Orlando, FL 32816 USA.	kjones@mail.ucf.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carlat DJ, 2005, PSYCHIAT INTERVIEW P; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; COLARUSSO LM, 2007, BOSTON GLOBE    0610; *DEP VET AFF, 2004, TRAUM BRAIN INJ; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs, 2007, SCREEN EV POSS TRAUM; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keltner NL, 2007, PERSPECT PSYCHIATR C, V43, P223, DOI 10.1111/j.1744-6163.2007.00138.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koch L, 1995, J REHABIL, V61, P50; Levin A., 2007, PSYCHIAT NEWS, V42, P15; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; LUNG DS, 2007, THESIS; MATEO MA, 2003, J AM PSYCHIAT NURSES, V9, P129; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Schwab KA, 2006, NEUROLOGY, V66, pA235; TEASDALE G, 1974, LANCET, V2, P81; *TRAUM BRAIN INJ T, 2008, REP SURG GEN; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WHYTE J, 1988, REHABILITATION MED P, P585	30	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-9633	1556-6676		J COUNS DEV	J. Couns. Dev.	SUM	2010	88	3					372	376		10.1002/j.1556-6678.2010.tb00036.x			5	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	610CJ	WOS:000278707000015					2022-02-06	
J	Koenigkam-Santos, M; de Castro, M; Versiani, BR; Diniz, PRB; Santos, AC				Koenigkam-Santos, Marcel; de Castro, Margaret; Versiani, Beatriz R.; Diniz, Paula Rejane B.; Santos, Antonio Carlos			Kallmann syndrome and mirror movements: White matter quantitative evaluation with magnetic resonance imaging	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Kallmann syndrome; Synkinesis; Magnetic resonance imaging; Quantitative evaluation	TRAUMATIC BRAIN-INJURY; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; PROTON MR SPECTROSCOPY; MULTIPLE-SCLEROSIS; TRANSFER RATIO; CLINICAL-ASSESSMENT; T2; DEFICIENCY; GLIOSIS; LESIONS	Kallmann syndrome (KS), characterized by the association of hypogonadotropic hypogonadism and anosmia, may present many other phenotypic abnormalities, including neurologic features as involuntary movements, called mirror movements (MM). MM etiology probably involves a complex mechanism comprising corticospinal tract abnormal development associated with deficient contralateral motor cortex inhibitory system. In this study, in order to address previous hypotheses concerning MM etiology, we identified and quantified white matter (WM) alterations in 21 KS patients, comparing subjects with and without MM and 16 control subjects, using magnetization transfer ratio (MTR) and T2 relaxometry (R2). Magnetization transfer and 12 double-echo images were acquired in a 1.5 T system. MTR and R2 were calculated pixel by pixel to initially create individual maps, and then, group average maps, co-registered with MNI305 stereotaxic coordinate system. After analysis of selected regions of interest, we demonstrated areas with higher 12 relaxation time and lower MTR values in KS patients, with and without MM, differently involving corticospinal tract projection, frontal lobes and corpus callosum. Higher MTR was observed only in pyramidal decussation when compared in both groups of patients with controls. In conclusion, we demonstrated that patients with KS have altered WM areas, presenting in a different manner in patients with and without MM. These data suggest axonal loss or disorganization involving abnormal pyramidal tracts and other associative/connective areas, relating to the presence or absence of MM. We also found a different pattern of alteration in pyramidal decussation, which can represent the primary area of neuronal disarrangement. (C) 2010 Elsevier B.V. All rights reserved.	[Koenigkam-Santos, Marcel] Univ Sao Paulo, Dept Radiol, Sch Med Ribeirao Preto, Div Radiol, BR-14048900 Ribeirao Preto, SP, Brazil; [de Castro, Margaret; Versiani, Beatriz R.] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Div Endocrinol & Metab, BR-14048900 Ribeirao Preto, SP, Brazil		Koenigkam-Santos, M (corresponding author), Univ Sao Paulo, Dept Radiol, Sch Med Ribeirao Preto, Div Radiol, Av Bandeirantes 3900,Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.	marcelk46@yahoo.com.br	Santos, Marcel Koenigkam/B-8177-2013; de Castro, Margaret/A-4918-2009; Santos, Antonio/F-5419-2012	Santos, Marcel Koenigkam/0000-0002-7160-4691; de Castro, Margaret/0000-0003-4932-4623; 			Bagley LJ, 1999, AM J NEURORADIOL, V20, P977; BARNES D, 1988, BRAIN, V111, P83, DOI 10.1093/brain/111.1.83; Bernasconi A, 2000, NEUROIMAGE, V12, P739, DOI 10.1006/nimg.2000.0724; Berry I, 1999, J MAGN RESON IMAGING, V9, P441, DOI 10.1002/(SICI)1522-2586(199903)9:3<441::AID-JMRI12>3.0.CO;2-R; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; KALTWASSER JP, 1990, BRIT J HAEMATOL, V74, P360, DOI 10.1111/j.1365-2141.1990.tb02596.x; Kimura H, 1996, AM J NEURORADIOL, V17, P1539; Koenigkam-Santos M, 2008, AM J NEURORADIOL, V29, P1799, DOI 10.3174/ajnr.A1202; Krams M, 1997, BRAIN, V120, P1217, DOI 10.1093/brain/120.7.1217; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Leinsinger GL, 1997, RADIOLOGY, V203, P545, DOI 10.1148/radiology.203.2.9114119; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mayer M, 1999, BRAIN TOPOGR, V12, P49, DOI 10.1023/A:1022281607426; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; McGowan JC, 1999, NEUROLOGY, V53, pS3; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; NASS R, 1985, NEUROLOGY, V35, P1059, DOI 10.1212/WNL.35.7.1059; Papanikolaou N, 2004, EUR RADIOL, V14, P115, DOI 10.1007/s00330-003-1946-0; Quinton R, 1996, J CLIN ENDOCR METAB, V81, P3010, DOI 10.1210/jc.81.8.3010; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Trarbach EB, 2006, J CLIN ENDOCR METAB, V91, P4006, DOI 10.1210/jc.2005-2793; Versiani BR, 2007, CLIN ENDOCRINOL, V66, P173, DOI 10.1111/j.1365-2265.2006.02702.x; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	29	12	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	MAY 15	2010	292	1-2					40	44		10.1016/j.jns.2010.02.010			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	584WJ	WOS:000276784100008	20211475				2022-02-06	
J	Tu, J; Liao, JX; Stoodley, MA; Cunningham, AM				Tu, Jian; Liao, Jinxin; Stoodley, Marcus A.; Cunningham, Anne M.			Differentiation of Endogenous Progenitors in an Animal Model of Post-Traumatic Syringomyelia	SPINE			English	Article						adult progenitor/stem cell; astrocyte; differentiation; macrophage; rat; spinal cord injury; syringomyelia; trauma	SPINAL-CORD-INJURY; NEURAL STEM-CELLS; ADULT-MOUSE BRAIN; AMINO-ACIDS; ASTROGLIAL PROLIFERATION; QUISQUALIC ACID; FLUID-FLOW; RAT; MICROGLIA; MACROPHAGES	Study Design. An in vivo study to examine the differentiation of endogenous neural progenitor cells in an adult rat model of post-traumatic syringomyelia. Objective. To quantitatively evaluate the phenotypic fate of endogenous neural progenitor cells in post-traumatic syringomyelia. Summary of Background Data. Although neural progenitors have been identified in the central nervous system, their differentiation in experimental post-traumatic syringomyelia and possible role in the pathophysiology of this condition have not been investigated. Methods. Bromodeoxyuridine was used to label proliferating cells in a time-dependent rat model of posttraumatic syringomyelia. Eight neural markers were quantitatively analyzed to phenotype the cellular fate of these cells by double labeling immunohistochemistry. Results. Following syrinx induction, cell proliferation rate increased to 25-115 times that of cells in the intact and sham-operated controls with a peak at day 14 post-injury. In the earliest time points post-syrinx induction, ED1-expressing inflammatory cells formed a significant proportion of the proliferating population. Proliferating neural progenitor cells predominantly differentiated into NG2-expressing immature oligodendrocytes at all stages post-syrinx induction, except the final time point of 56 days. At this time, there was a peak in the number of newly generated astrocytes identified to have developed from labeled proliferating precursor cells. Conclusions. Endogenous neural progenitors proliferate markedly following induction of post-traumatic syringomyelia which consists of two stages, initial cyst formation and progressive cyst enlargement. During the former stage, macrophages proliferate in situ and contribute to the inflammatory process. The predominant cell type formed from progeny of the induced neural progenitors was characterized to be immature oliggodendrocytes. However, during the latter stage of cyst development, there was an increase in astrocytic progeny which may represent an environment more conductive to glial scar formation acting to limit further cyst enlargement.	[Tu, Jian; Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Tu, Jian; Liao, Jinxin; Stoodley, Marcus A.] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW, Australia; [Cunningham, Anne M.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia		Stoodley, MA (corresponding author), Macquarie Univ, Australian Sch Adv Med, Level 1,Dow Corning Bldg,3 Innovat Rd, Sydney, NSW 2109, Australia.	marcus@teamneuro.com	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Stoodley, Marcus/0000-0002-4207-8493	Australian Brain Foundation; Westfield Research Laboratory, Sydney Children's Hospital	Supported by a project grant from Australian Brain Foundation. This work was performed, in part, in the Westfield Research Laboratory, Sydney Children's Hospital.	AIHARA N, 1995, J NEUROTRAUM, V38, P654; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9; Brodbelt AR, 2003, J NEUROTRAUM, V20, P883, DOI 10.1089/089771503322385818; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fedoroff S, 1997, J NEUROSCI RES, V50, P477; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GIULIAN D, 1985, J CELL BIOL, V101, P2411, DOI 10.1083/jcb.101.6.2411; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; HINTZE JL, 2007, NCSS STAT SOFTWARE 2; Hirji NS, 1999, INT ARCH ALLERGY IMM, V118, P180, DOI 10.1159/000024060; Horner PJ, 2000, J NEUROSCI, V20, P2218; HURLEY SD, 1996, TOPICAL ISSUES MICRO, P1; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kurz H, 1998, GLIA, V22, P98, DOI 10.1002/(SICI)1098-1136(199801)22:1<98::AID-GLIA10>3.3.CO;2-R; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lee TT, 2000, J NEUROSURG, V92, P149, DOI 10.3171/spi.2000.92.2.0149; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Louro J, 2008, NEUROL RES, V30, P5, DOI 10.1179/174313208X284070; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Pedersen EB, 1997, J NEUROIMMUNOL, V76, P117, DOI 10.1016/S0165-5728(97)00038-6; PISHARODI M, 1985, APPL NEUROPHYSIOL, V48, P226; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Schaller B, 1999, J SPINAL DISORD, V12, P485; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SQUIER MV, 1994, J NEUROL NEUROSUR PS, V57, P1095, DOI 10.1136/jnnp.57.9.1095; Stoodley MA, 1999, NEUROSURGERY, V44, P1065, DOI 10.1097/00006123-199905000-00068; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Tokumine J, 2003, J NEUROSCI RES, V74, P552, DOI 10.1002/jnr.10760; Urushitani M, 1998, ANN NEUROL, V44, P796, DOI 10.1002/ana.410440514; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yang LQ, 2001, SPINE, V26, P1842, DOI 10.1097/00007632-200109010-00004; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	37	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 15	2010	35	11					1116	1121		10.1097/BRS.0b013e3181ba6ce4			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	601PG	WOS:000278074000003	20421862				2022-02-06	
J	Mauer, UM; Kunz, U				Mauer, Uwe Max; Kunz, Ulrich			Management of neurotrauma by surgeons and orthopedists in a military operational setting	NEUROSURGICAL FOCUS			English	Article						neurosurgery course; craniotomy; trauma surgeon; orthopedist	TRAUMA; NEUROSURGERY; INJURIES; PROTOCOL; HEAD	There is a considerable discrepancy between the potential demand for neurosurgeons and the actual availability of such specialists not only in civilian settings but even more so in military operational environments. For this reason, the Department of Neurosurgery at the German Armed Forces Hospital in Ulm conducts courses for surgeons and orthopedists on the management of patients with neurotrauma. Twelve such courses have already taken place. Each course lasts 1 week. Participants can expect to gain the theoretical knowledge and practical skills they need to provide initial surgical care for patients with traumatic brain injuries and/or spinal trauma. Surgical techniques are practiced above all in pig and human cadavers. At the end of the course, participants with previous surgical knowledge should be able to independently perform a craniotomy, from the planning of the procedure to the closure of the wound. Former course participants have successfully used their neurosurgical knowledge in countries of deployment where they managed patients during teleconsultation sessions and helped repatriate, or even provided surgical treatment to, patients with traumatic brain injuries. In these situations, it was particularly helpful when the physician deployed abroad and the neurosurgeon in Germany knew each other personally. In the future, efforts will be made to combine telemedicine and neuronavigation in an attempt to further improve direct support for physicians under military deployment conditions. (DOI: 10.3171/2010.1.FOCUS09328)	[Mauer, Uwe Max; Kunz, Ulrich] German Armed Forces Hosp, Dept Neurosurg, D-89070 Ulm, Germany		Mauer, UM (corresponding author), German Armed Forces Hosp, Dept Neurosurg, Oberer Eselsberg 40, D-89070 Ulm, Germany.	UweMaxMauer@bundeswehr.org					Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Kossmann T, 2004, INJURY, V35, P661, DOI 10.1016/j.injury.2004.03.005; Mauer U, 1995, WEHRMED MSCHR, V39, P160; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Treacy PJ, 2005, ANZ J SURG, V75, P852, DOI 10.1111/j.1445-2197.2005.03549.x; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66	8	12	16	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E10	10.3171/2010.1.FOCUS09328			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600010	20568926				2022-02-06	
J	Peterson, MD				Peterson, Michelle D.			A Case-Oriented Approach Exploring the Relationship Between Visual and Vestibular Disturbances and Problems of Higher-Level Mobility in Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance problems; higher-level mobility impairments; traumatic brain injury; vestibular dysfunction; visual disturbances	PAROXYSMAL POSITIONAL VERTIGO; ASSESSMENT-TOOL HIMAT; FUNCTIONAL GAIT ASSESSMENT; HUMAN POSTURAL CONTROL; BERG BALANCE SCALE; SENSORIMOTOR INTEGRATION; INTERNAL CONSISTENCY; HEAD-INJURY; RELIABILITY; REHABILITATION	Dizziness and impaired balance are common complaints after traumatic brain injury as a result of injuries to many systems. Ambient visual and vestibular system impairments are strong contributors to imbalance and dizziness, often leading to problems with spatial orientation and gaze stability during movement. The purpose of this review is to provide an overview of visual-vestibular impairments common to traumatic brain injury and summarize the contribution impairments in these systems will have on higher-level mobility. Standard visual and vestibular tests and measures are described and summarized, followed by several case presentations discussing the examination and evaluation processes and interventions chosen for visual-vestibular difficulties and their relationship to higher-level mobility.	Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA		Peterson, MD (corresponding author), Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA.	MPeterson9533@msn.com					[Anonymous], 2008, BAL MAN SYST CLIN IN; Bent LR, 2002, EXP BRAIN RES, V146, P490, DOI 10.1007/s00221-002-1204-8; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bhattacharyya N, 2008, OTOLARYNGOL HEAD S4, V139, P547; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; COHEN H, 1995, OTOLARYNG HEAD NECK, V112, P526, DOI 10.1016/S0194-5998(95)70206-7; Cohen HS, 2008, J VESTIBUL RES-EQUIL, V18, P295; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dieterich M, 2000, CURR OPIN NEUROL, V13, P13, DOI 10.1097/00019052-200002000-00004; DIFABIO RP, 1995, PHYS THER, V75, P209; El-Kashlan HK, 1998, LARYNGOSCOPE, V108, P311, DOI 10.1097/00005537-199803000-00002; GIBSON WPR, 1984, VERTIGO, P373; GIZZI M, 1995, J HEAD TRAUMA REHAB, V10, P60, DOI 10.1097/00001199-199512000-00009; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; GROSSMAN GE, 1990, ANN NEUROL, V27, P528, DOI 10.1002/ana.410270512; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Hain TC, 2007, VESTIBULAR REHABILIT, P2; Halker RB, 2008, NEUROLOGIST, V14, P201, DOI 10.1097/NRL.0b013e31816f2820; HARRO CC, 2006, ORL FL ANN C EXP APT, P21; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Herdman SJ, 1998, AM J OTOL, V19, P790; Hughes CA, 1997, LARYNGOSCOPE, V107, P607, DOI 10.1097/00005537-199705000-00010; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; KNAPIK J, 1989, MIL MED, V154, P326; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Loughran S, 2005, CLIN OTOLARYNGOL, V30, P255, DOI 10.1111/j.1365-2273.2005.00988.x; Maeda N, 2009, J INT MED RES, V37, P697, DOI 10.1177/147323000903700313; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mishra A, 2009, AM J AUDIOL, V18, P53, DOI 10.1044/1059-0889(2009/06-0024); Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; *NEUROCOM INT INC, 1991, BAL MAN SYST CLIN IN; NORRE ME, 1995, AM J OTOL, V16, P806; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rosen S. A., 2001, VISUAL VESTIBULAR CO, P174; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; SHUMWAYCOOK A, 1992, PHYS MED REHABIL CLI, V3, P355; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; WEISS LM, 2002, J OPTOM VIS DEV, V33, P33; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Zee DS, 2007, VESTIBULAR REHABILIT, P19	55	12	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2010	25	3					193	205		10.1097/HTR.0b013e3181dc82fa			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	606KG	WOS:000278423300006	20473093				2022-02-06	
J	Fluckiger, C; Bechir, M; Brenni, M; Ludwig, S; Sommerfeld, J; Cottini, SR; Keel, M; Stocker, R; Stover, JF				Flueckiger, Carole; Bechir, Markus; Brenni, Mirko; Ludwig, Silke; Sommerfeld, Jutta; Cottini, Silvia R.; Keel, Marius; Stocker, Reto; Stover, John F.			Increasing hematocrit above 28% during early resuscitative phase is not associated with decreased mortality following severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Critical care; Emergency room; Intracranial pressure; Transfusion; Secondary brain injury	BLOOD-CELL TRANSFUSION; ACUTE NORMOVOLEMIC HEMODILUTION; CEREBRAL OXYGENATION; TISSUE OXYGENATION; CRITICALLY-ILL; TEMPORAL PROFILE; PROGNOSTIC VALUE; ANEMIA; PERFUSION; FLOW	To prevent iatrogenic damage, transfusions of red blood cells should be avoided. For this, specific and reliable transfusion triggers must be defined. To date, the optimal hematocrit during the initial operating room (OR) phase is still unclear in patients with severe traumatic brain injury (TBI). We hypothesized that hematocrit values exceeding 28%, the local hematocrit target reached by the end of the initial OR phase, resulted in more complications, increased mortality, and impaired recovery compared to patients in whom hematocrit levels did not exceed 28%. Impact of hematocrit (independent variable) reached by the end of the OR phase on mortality and morbidity determined by the extended Glasgow outcome scale (eGOS; dependent variables) was investigated retrospectively in 139 TBI patients. In addition, multiple logistic regression analysis was performed to identify additional important variables. Following severe TBI, mortality and morbidity were neither aggravated by hematocrit above 28% reached by the end of the OR phase nor worsened by the required transfusions. Upon multiple logistic regression analysis, eGOS was significantly influenced by the highest intracranial pressure and the lowest cerebral perfusion pressure values during the initial OR phase. Based on this retrospective observational analysis, increasing hematocrit above 28% during the initial OR phase following severe TBI was not associated with improved or worsened outcome. This questions the need for aggressive transfusion management. Prospective analysis is required to determine the lowest acceptable hematocrit value during the OR phase which neither increases mortality nor impairs recovery. For this, a larger caseload and early monitoring of cerebral metabolism and oxygenation are indispensable.	[Brenni, Mirko; Stover, John F.] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Keel, Marius] Univ Zurich Hosp, Div Trauma Surg, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, Raemistr 100, CH-8091 Zurich, Switzerland.	john.stover@access.unizh.ch	Christoph, Fluckiger/H-8169-2014	Christoph, Fluckiger/0000-0003-3058-5815	SUVA	This study was supported in part by grants from the SUVA funds to JFS and RS.	Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Cherry T, 2008, AM J CLIN PATHOL, V129, P287, DOI 10.1309/D3F7BXH466AE3G0P; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Frietsch T, 2004, EUR J ANAESTH, V21, P53, DOI 10.1017/S0265021504001097; Ge YL, 2007, ACTA ANAESTH SCAND, V51, P1331, DOI 10.1111/j.1399-6576.2007.01448.x; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Gonzalez AM, 2007, SURGERY, V141, P630, DOI 10.1016/j.surg.2006.09.015; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Han SH, 2004, INT J CLIN PRACT, V58, P903, DOI 10.1111/j.1742-1241.2004.00120.x; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Madjdpour C, 2006, CRIT CARE MED, V34, pS102, DOI 10.1097/01.CCM.0000214317.26717.73; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre L, 2004, J TRAUMA, V57, P563, DOI 10.1097/01.TA.0000136158.93864.54; McIntyre LA, 2006, CURR OPIN CRIT CARE, V12, P575, DOI 10.1097/MCC.0b013e32801067f0; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Tomiyama Y, 1999, AM J PHYSIOL-HEART C, V276, pH1190, DOI 10.1152/ajpheart.1999.276.4.H1190; Tomiyama Y, 2000, AM J PHYSIOL-HEART C, V279, pH1949, DOI 10.1152/ajpheart.2000.279.4.H1949; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x; Tschuor C, 2008, CRIT CARE, V12, DOI 10.1186/cc6931; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Bommel J, 2002, ANESTHESIOLOGY, V97, P660, DOI 10.1097/00000542-200209000-00021; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; Weiskopf RB, 2005, CLIN NEUROPHYSIOL, V116, P1028, DOI 10.1016/j.clinph.2004.12.009; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	46	12	13	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2010	152	4					627	636		10.1007/s00701-009-0579-8			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	573WI	WOS:000275945600008	20033233	Green Submitted, Green Published, Green Accepted			2022-02-06	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Buonocunto, F; Sacco, V; Colonna, F; Navarro, J; Lanzilotti, C; Megna, G				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa; Megna, Gianfranco			Post-coma Persons with Minimal Consciousness and Motor Disabilities Learn to Use Assistive Communication Technology to Seek Environmental Stimulation	JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES			English	Article						Post-coma; Assistive technology; Microswitches; Minimally conscious state; Motor disabilities	PROFOUND MULTIPLE DISABILITIES; PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; RECOVERY SCALE; REHABILITATION; DISORDERS; MICROSWITCH; CONSENSUS; PEOPLE; ADULTS	This study assessed whether two post-coma persons with minimally conscious state and extensive motor disabilities would learn to use assistive communication technology, namely microswitches, to gain access to preferred environmental stimuli. Each of the participants (adults) was provided with two microswitches that could be activated with small motor responses (e.g., finger movements and eyelid raising). The microswitches were introduced in succession according to a multiple probe design across microswitches/responses and allowed access to different sets of stimuli (i.e., recordings of songs and video-clips). Eventually, the use of the two microswitches was alternated within and across days. Each participant learned to use both microswitches successfully and maintained high levels of responding when the microswitches were alternated. The importance of assistive communication technology within programs for post-coma persons with disorders of consciousness and extensive motor disabilities is discussed.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] ONE Res Inst, Midlothian, VA USA; [Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa] S Raffaele Rehabil Ctr, Ceglie Messapica, BR, Italy; [Megna, Gianfranco] Univ Bari, Dept Neurorehabil, I-70100 Bari, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Navarro solano, Jorge/0000-0003-1508-6727; Lancioni, Giulio/0000-0002-6515-5690			Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Catania A.C., 2007, LEARNING; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coleman MR, 2005, NEUROPSYCHOL REHABIL, V15, P161, DOI 10.1080/09602010443000669; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; Holburn S, 2004, BEHAV INTERVENT, V19, P25, DOI 10.1002/bin.147; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kazdin A. E., 2001, BEHAV MODIFICATION A; Kennedy K, 2005, SINGLE CASE DESIGNS; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; Lancioni G E, 2006, Pediatr Rehabil, V9, P137, DOI 10.1080/13638490500235466; Lancioni GE, 2005, BEHAV INTERVENT, V20, P147, DOI 10.1002/bin.185; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P379, DOI 10.1007/s10882-008-9104-x; Lancioni GE, 2008, PERCEPT MOTOR SKILL, V106, P355, DOI 10.2466/PMS.106.2.355-370; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P209, DOI 10.1007/s10882-008-9105-9; Lancioni GE, 2009, DISABIL REHABIL-ASSI, V4, P367, DOI 10.1080/17483100903038584; Lancioni GE, 2009, DEV NEUROREHABIL, V12, P24, DOI 10.1080/17518420902776995; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Mcnaughton D, 2007, AUGMENT ALTERN COMM, V23, P217, DOI 10.1080/07434610701573856; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Petry K, 2005, J APPL RES INTELLECT, V18, P35, DOI 10.1111/j.1468-3148.2004.00209.x; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Siegel S., 1988, NONPARAMETRIC STAT; SIMPSON DM, 2009, NEUROSURGERY PSYCHIA, V80, P380; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Wales L., 2005, BRIT J OCCUPATIONAL, V68, P486; Wilson FC, 2007, DISABIL REHABIL, V29, P1751, DOI 10.1080/09638280601118432	41	12	12	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1056-263X			J DEV PHYS DISABIL	J. Dev. Phys. Disabil.	APR	2010	22	2					119	129		10.1007/s10882-009-9163-7			11	Education, Special; Psychology, Developmental; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	568RM	WOS:000275540200003					2022-02-06	
J	Castaneda, MM; Cubilla, MA; Lopez-Vicchi, MM; Suburo, AM				Castaneda, Mauricio M.; Cubilla, Marisa A.; Lopez-Vicchi, Martin M.; Suburo, Angela M.			Endothelinergic cells in the subependymal region of mice	BRAIN RESEARCH			English	Article						Endothelin; Astrocyte; Subventricular zone; Subependymal zone; Cingulum; Adult neurogenesis; Granulocyte-colony stimulating factor; Neural stem cell; Stroke; Traumatic brain injury	NEURAL STEM-CELLS; ROSTRAL MIGRATORY STREAM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; MARKER PROMININ-1; ISCHEMIC-STROKE; RAT-BRAIN; ASTROCYTES; RECEPTORS; NEUROGENESIS	Endothelin (ET) is a small peptide that activates astrocyte proliferation, regulates proliferation and migration of embryonic neural precursor cells and stimulates glioblastoma growth. We found that in mouse brain, ET and its receptor B (ETRB) were highly expressed in the subependymal zone (SEZ), an adult neurogenic niche. Cells with ET immunoreactivity (ET+ cells) selectively appeared along the lateral and dorsal walls of the lateral ventricle. They also appeared in the cingular region of the corpus callosum. Subependymal ET+ cells also displayed prominin (PRO), glial fibrillary acidic protein (GFAP) and ETRB immunoreactivities. ET+ processes traversed the ependymal epithelium and approached the ventricular lumen. Ependymal cells only showed ETRB-ir. A small but consistent number of ET+ cells displayed proliferation markers: 5-bromo-2'-deoxyuridine (BrdU) incorporation, and minichromosome maintenance protein 2 (Mcm2). Cortical injury and G-CSF increased subependymal endothelinergic cells and their proliferation markers. Our findings suggest that ET and ETRB might be associated with regulation of adult neural stem cells and their migration through neurogenic and gliogenic pathways. (C) 2010 Elsevier B.V. All rights reserved.	[Castaneda, Mauricio M.; Cubilla, Marisa A.; Lopez-Vicchi, Martin M.; Suburo, Angela M.] Univ Austral, Fac Ciencias Biomed, Buenos Aires, DF, Argentina		Suburo, AM (corresponding author), Univ Austral, Fac Ciencias Biomed, B1629AHJ, Buenos Aires, DF, Argentina.	amsuburo@cas.austral.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); ANPCyTANPCyT [21399/2004]; MINCYT, Argentina; Universidad Austral	MMC and MAC are research fellows from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and ANPCyT, MINCYT, Argentina, respectively. MML-V was a training fellow from the Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (GC), and AMS is Principal Researcher from CONICET. Studies reported here were funded by grants from Universidad Austral, 2006 and 2007, and ANPCyT (21399/2004). We are very grateful to Guillermo Gaston and Soledad Arregui for their skilful technical assistance.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404; Bartnik BL, 2001, BRAIN RES, V915, P133, DOI 10.1016/S0006-8993(01)02805-0; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davenport A. P., 2006, V176, P295; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; EHRENREICH H, 1991, NEW BIOL, V3, P135; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kam M, 2009, J CHEM NEUROANAT, V37, P196, DOI 10.1016/j.jchemneu.2008.12.009; Koyama Y, 2005, J NEUROSCI RES, V80, P809, DOI 10.1002/jnr.20512; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; KREIPKE CW, 2009, NEUROL RES; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mizuno N, 2005, P NATL ACAD SCI USA, V102, P12365, DOI 10.1073/pnas.0506101102; Morishita R, 2007, NEUROSCI RES, V59, P205, DOI 10.1016/j.neures.2007.06.1478; Naidoo V, 2005, CANCER-AM CANCER SOC, V104, P1049, DOI 10.1002/cncr.21277; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Paolillo M, 2006, J NEURO-ONCOL, V79, P1, DOI 10.1007/s11060-005-9111-z; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Riechers CC, 2004, NEUROSCIENCE, V124, P719, DOI 10.1016/j.neuroscience.2003.10.023; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Stenman E, 2007, EUR J PHARMACOL, V570, P142, DOI 10.1016/j.ejphar.2007.05.049; SUBURO AM, 1992, NEUROSCIENCE, V46, P881, DOI 10.1016/0306-4522(92)90191-4; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Torbidoni V, 2005, EXP EYE RES, V81, P265, DOI 10.1016/j.exer.2004.12.024; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430	56	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 19	2010	1321						20	30		10.1016/j.brainres.2010.01.056			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576CH	WOS:000276120800003	20116370				2022-02-06	
J	McCauley, SR; Pedroza, C; Chapman, SB; Cook, LG; Hotz, G; Vasquez, AC; Levin, HS				McCauley, Stephen R.; Pedroza, Claudia; Chapman, Sandra B.; Cook, Lori G.; Hotz, Gillian; Vasquez, Ana C.; Levin, Harvey S.			Event-based prospective memory performance during subacute recovery following moderate to severe traumatic brain injury in children: Effects of monetary incentives	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Event-based prospective memory; Traumatic brain injury; Incentive; Motivation; Memory rehabilitation; Pediatrics	AGE; IMPAIRMENT; SENSITIVITY; INTENTIONS; REMEMBER; OUTCOMES; ADULTS; TERM	There are very few Studies investigating remediation of event-based prospective memory (EB-PM) impairments following traumatic brain injury (TBI). To address this, we used 2 levels of motivational enhancement (dollars vs. pennies) to improve EB-PM in children with moderate to severe TBI in the subacute recovery phase. Children with orthopedic injuries (OI; n = 61), moderate (n = 28), or severe (n = 30) TBI were compared. Significant effects included Group X Motivation Condition (F(2, 115) = 3.73, p < .03). The OI (p<.002) and moderate TBI (p<.03) groups performed significantly better under the high- versus low-incentive condition; however, the severe TBI group failed to demonstrate improvement (p = .38). EB-PM performance was better in adolescents compared to Younger children (p < .02). These results suggest that EB-PM can be significantly improved in the subacute phase with this level of monetary incentives in children with moderate, but not severe, TBI. Other strategies to improve EB-PM in these children at a similar point in recovery remain to be identified and evaluated. (JINS, 2010, 16, 335-341)	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Vasquez, Ana C.; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Chapman, Sandra B.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Inst Biomed Sci & Technol, Dallas, TX 75230 USA; [Hotz, Gillian] Univ Miami, Sch Med, Miami, FL USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD040896, K23 HD-40896] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, R01 NS021889] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Baddeley A., 1990, HUMAN MEMORY; Best D. L., 1992, MEMORY IMPROVEMENT I, P122; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; *COMM INJ SCAL, 1990, ABBR INJ SCAL; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; GENTRY M, 1990, PERS SOC PSYCHOL B, V16, P241, DOI 10.1177/0146167290162005; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KVAVILASHVILI L, 1992, APPL COGNITIVE PSYCH, V6, P507, DOI 10.1002/acp.2350060605; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Louda J., 2007, Z NEUROPSYCHOL, V18, P91, DOI [10.1080/09602010600831004, DOI 10.1080/09602010600831004]; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; MCCAULEY SR, CHILD NEURO IN PRESS; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; MEACHAM JA, 1976, CATALOG SELECTED DOC; Neisser U., 1982, MEMORY OBSERVED REME, P327; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUTHER NM, 1993, M SE PSYCH ASS ATL G; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; WILKINS AJ, 1978, PRACTICAL ASPECTS ME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON B, 1987, REHABILITATION MEMOR; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; [No title captured]	60	12	12	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2010	16	2					335	341		10.1017/S135561770999138X			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	562DZ	WOS:000275030900014	20109242				2022-02-06	
J	Ryu, WHA; Cullen, NK; Bayley, MT				Ryu, Won Hyung A.; Cullen, Nora K.; Bayley, Mark T.			Early neuropsychological tests as correlates of productivity 1 year after traumatic brain injury: a preliminary matched case-control study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						employment; neuropsychological assessment; productivity; rehabilitation outcome; traumatic brain injury	FUNCTIONAL INDEPENDENCE; HEAD-INJURY; PERFORMANCE; COMMUNITY; SCALE; MODEL	This study explored the relative strength of five neuropsychological tests in correlating with productivity 1 year after traumatic brain injury (TBI). Six moderate-to-severe TBI patients who returned to work at 1-year post-injury were matched with six controls who were unemployed after 1 year based on age, severity of injury, and Functional Independence Measure scores. Five neuropsychological tests were administered to patients during inpatient rehabilitation. Two of the five tests (Symbol Digit and Block Design) discriminated TBI patients based on employment outcome. Symbol Digit and Rey Auditory Verbal Learning Test were significantly correlated with follow-up Functional Independence Measure scores. Results indicate that neuropsychological measures of visual perception (Block Design), and attention and mental speed (Symbol Digit) may be useful predictors of employment productivity after TBI; whereas attention and mental speed, learning and memory ability (Symbol Digit and Rey Auditory Verbal Learning Test) may predict functional outcomes. International Journal of Rehabilitation Research 33: 84-87 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Cullen, Nora K.; Bayley, Mark T.] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Ryu, Won Hyung A.; Cullen, Nora K.; Bayley, Mark T.] Univ Toronto, Toronto, ON M5S 1A1, Canada		Cullen, NK (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontorehab.on.ca	Ryu, Won H/AAU-6774-2020	Cullen, Nora/0000-0001-6359-9418; Bayley, Mark/0000-0001-7860-9463			Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Millis S R, 1994, Int J Neurosci, V79, P165; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roberts CB, 2004, INT J REHABIL RES, V27, P145, DOI 10.1097/01.mrr.0000127142.43208.3b; Rosenthal M, 1999, REHABILITATION ADULT; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; [No title captured]	17	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2010	33	1					84	87		10.1097/MRR.0b013e32832e6b4b			4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	562OS	WOS:000275062600013	19620876				2022-02-06	
J	Zweckberger, K; Simunovic, F; Kiening, KL; Unterberg, AW; Sakowitz, OW				Zweckberger, Klaus; Simunovic, Filip; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.			Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Lisuride; Controlled cortical impact injury (CCII); Post-traumatic epileptic seizures; Secondary brain damage; Hypotension	CONTROLLED CORTICAL IMPACT; MAGNOCELLULAR NUCLEUS BASALIS; PROLACTIN-INDUCED EXPRESSION; CEREBRAL PERFUSION-PRESSURE; VOLUME-TARGETED THERAPY; NECROSIS-FACTOR-ALPHA; POSTTRAUMATIC EPILEPSY; PARKINSONS-DISEASE; RAT; MECHANISMS	Traumatic brain injury is a heterogeneous disease, encompassing a wide range of pathologies. The dopamine agonist lisuride is well established in the therapy of Parkinson's disease. Additionally to its dopaminergic effects it decreases prolactine release, reducing the amount of inflammatory mediators such as TNF-alpha or II-6. Lisuride has strong binding affinity to serotonergic and histaminergic receptors on neuronal and glial cells leading to scavenging of highly reactive free radicals. Due to its interaction with dopaminergic D2 and D4 receptors as well as 5-HT-1A receptors, NMDA-receptor signaling and glutamate-mediated excitotoxicity can be modulated beneficially. Despite of these promising neuroprotective effects, experimental data scrutinizing the effects of lisuride after acute brain injury are sparse. We therefore investigated the effect of lisuride after controlled cortical impact injury (CCII) in rats. 70 male Sprague-Dawley rats were randomized to lisuride or to placebo treatment by an initial s.c. loading dose (0.3 mglkg BW) and following continuous application (0.5 mg/kg/d) by s.c. implanted osmotic pumps. In three experimental groups we determined (sub)acute neuro-physiological changes after trauma. Mean arterial blood pressure, intracranial pressure, and electrical brain activity were monitored acutely for up to 3 h after trauma. Brain edema formation was assessed 24 h after CCII. Furthermore, contusion volumes were quantified by magnetic resonance tomography and neurological testing was performed for up to 7 days after injury. Associated with the administration of lisuride there was a significant reduction in duration and number of post-traumatic seizures. Despite of a sustained arterial hypotension following the initial bolus administration in the treatment group, contusion volumes and neurological function tests did not differ significantly in comparison to the control group. Overall, lisuride seems to have significant anticonvulsive effects but seems not to influence secondary brain damage in this experimental model. (C) 2010 Published by Elsevier Ireland Ltd.	[Zweckberger, Klaus; Simunovic, Filip; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany		Zweckberger, K (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	klaus.zweckberger@med.uni-heidelberg.de	Simunovic, Filip/ABE-8802-2021	Simunovic, Filip/0000-0003-1755-5734; Sakowitz, Oliver/0000-0003-3248-6335			BARONTI F, 1992, ANN NEUROL, V32, P776, DOI 10.1002/ana.410320611; CARDWELL M, 1996, NEUROPHYSIOBIOLOGY, V34, P117; CARDWELL M, 1997, BRAIN RES, V771; CARRUBA MO, 1980, PSYCHOPHARMACOLOGY, V70, P223, DOI 10.1007/BF00427878; Chase T.N., 1989, NEUROLOGY S2, V39, P19; CHASE TN, 1989, NEUROLOGY, V39, P7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; DEVITO WJ, 1995, J CELL BIOCHEM, V57, P290, DOI 10.1002/jcb.240570213; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Double KL, 2003, EXP NEUROL, V184, P530, DOI 10.1016/j.expneurol.2003.08.006; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; FARJO IB, 1979, BRIT J PHARMACOL, V67, P353, DOI 10.1111/j.1476-5381.1979.tb08687.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fricker AD, 2005, MOL BRAIN RES, V138, P228, DOI 10.1016/j.molbrainres.2005.04.016; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gille G, 2002, J NEURAL TRANSM, V109, P157, DOI 10.1007/s007020200011; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Harkany T, 2001, NEUROSCIENCE, V108, P629, DOI 10.1016/S0306-4522(01)00444-4; Horowski R, 1988, J Neural Transm Suppl, V27, P249; HOROWSKI R, 1979, N-S ARCH PHARMACOL, V306, P147, DOI 10.1007/BF00498984; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; ITIL TM, 1975, INT J CLIN PHARM BI, V12, P221; Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005; Johnson KW, 2003, CEPHALALGIA, V23, P117, DOI 10.1046/j.1468-2982.2003.00464.x; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Micieli G, 1996, FUNCT NEUROL, V11, P317; MIYAZAWA T, 1991, FOLIA PHARMACOL JPN, V98, P449, DOI 10.1254/fpj.98.6_449; Nobuhara K, 1993, Seishin Shinkeigaku Zasshi, V95, P392; Nordstrom C H, 2005, Acta Neurochir Suppl, V95, P475; Nordstrom CH, 2005, ANESTH ANALG, V101, P299, DOI 10.1213/01.ANE.0000156702.60474.2E; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ACTA NEUROCHIR SUPPL, V86, P355; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; Oosterink BJ, 1998, EUR J PHARMACOL, V358, P147, DOI 10.1016/S0014-2999(98)00614-1; Sakowitz OW, 2002, ACT NEUR S, V81, P221; STRACKE H, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1834; Wang X, 2003, J NEUROSCI, V23, P9852; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	43	12	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 12	2010	470	2					150	154		10.1016/j.neulet.2009.12.075			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	561AJ	WOS:000274946900013	20056133				2022-02-06	
J	Charalambides, C; Sgouros, S; Sakas, D				Charalambides, Constantinos; Sgouros, Spyros; Sakas, Damianos			Intracerebral microdialysis in children	CHILDS NERVOUS SYSTEM			English	Article						Microdialysis; Traumatic brain injury; Intracranial pressure	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURIES; EXTRACELLULAR GLUTAMATE; NEUROINTENSIVE CARE; MITOCHONDRIAL GLUTAMINASE; DIABETIC-KETOACIDOSIS; ENERGY-METABOLISM; ISCHEMIA	Cerebral microdialysis is a relatively new, minimally invasive technique that permits sampling and analyzing the chemical constituents of the extracellular fluid. Although mainly used as a research tool, it is also used in the neurointensive care, in combination with other monitoring methods, in patients with severe traumatic brain injury and subarachnoid hemorrhage. Its main clinical utility is the identification of markers of ischemia and cell damage with the ultimate goal of preventing any secondary insults to the brain by instituting early appropriate treatment measures. With few exceptions, all the available data on intracerebral microdialysis in humans comes from studies performed in adults. The purpose of this report is to provide a brief review of the intracerebral microdialysis studies performed in children. Differences in trends of concentrations of structural and excitatory amino acids have been identified in children, in comparison to those observed in adults, the significance of which remains unknown at present.	[Charalambides, Constantinos; Sgouros, Spyros] Attikon Univ Hosp, Dept Neurosurg, Div Pediat Neurosurg, Athens 12462, Greece; [Sakas, Damianos] Evangelismos Univ Hosp, Dept Neurosurg, Athens, Greece		Sgouros, S (corresponding author), Attikon Univ Hosp, Dept Neurosurg, Div Pediat Neurosurg, Rimini 1, Athens 12462, Greece.	sgouros@med.uoa.gr	Sgouros, Spyridon/AAH-1361-2020	Sgouros, Spyridon/0000-0003-4615-0808			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Ahlsson Fredrik, 2004, Pediatr Crit Care Med, V5, P89, DOI 10.1097/01.PCC.0000102396.02043.22; Alessandri B, 1999, ACT NEUR S, V75, P21; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; DUCK SC, 1988, J PEDIATR-US, V113, P10, DOI 10.1016/S0022-3476(88)80521-3; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 1999, ACT NEUR S, V75, P3; HLATKY R, 2004, J NEUROTRAUM, V21, P984; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Mahoney CP, 1999, PEDIATR NEUROL, V21, P721, DOI 10.1016/S0887-8994(99)00079-X; Maurer MH, 2007, J CEREBR BLOOD F MET, V27, P1675, DOI 10.1038/sj.jcbfm.9600466; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Newcomb R, 1997, J BIOL CHEM, V272, P11276; Newcomb R, 1998, BRAIN RES, V813, P103, DOI 10.1016/S0006-8993(98)01006-3; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; RASMUSSEN JS, 2004, J NEUROSURG, V100, P8; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Tolias CM, 2002, CHILD NERV SYST, V18, P368, DOI 10.1007/s00381-002-0623-y; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd	35	12	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2010	26	2					215	220		10.1007/s00381-009-1031-3			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	539GK	WOS:000273241700012	19940995				2022-02-06	
J	Martin, CA; Care, M; Rangel, EL; Brown, RL; Garcia, VF; Falcone, RA				Martin, Colin A.; Care, Marguerite; Rangel, Erika L.; Brown, Rebeccah L.; Garcia, Victor F.; Falcone, Richard A., Jr.			Severity of head computed tomography scan findings fail to explain racial differences in mortality following child abuse	AMERICAN JOURNAL OF SURGERY			English	Article						Non-accidental trauma; Traumatic brain injury; Computed tomography; Outcomes disparities	TRAUMATIC BRAIN-INJURY; HEALTH-INSURANCE PROGRAM; GLASGOW COMA SCALE; EMERGENCY-DEPARTMENT; PEDIATRIC TRAUMA; DIRECT TRANSPORT; CARE; DISPARITIES; SYSTEM; PREDICTORS	INTRODUCTION: Differences in head injury severity may not be fully appreciated in child abuse victims. The purpose of this study was to determine if differential findings on initial head computed tomography (CT) scan could explain observed differential outcome by race. METHODS: We identified 164 abuse patients from our trauma registry with an Injury Severity Score (ISS) >= 15. Their initial head CT scan was graded from I to 4 (normal to severe). Statistical analysis was performed to asses the correlation between race, head CT grade, Glascow Coma Scale (GCS) score, and mortality. RESULTS: Overall mortality was 17%: 11% for white children, 32% for African-American children (P < .05). In review of the head CT scans there was no difference by race in types of injuries or head CT grade. Using a multivariate regression model, African-American race remained an independent risk factor for mortality with an odd ratio of 4.3 (95% confidence interval [CI] 1.6-11.5). CONCLUSION: African-American children had a significantly higher mortality rate despite similar findings on initial head CT scans. Factors other than injury severity may explain these disparate outcomes. (C) 2010 Elsevier Inc. All rights reserved.	[Martin, Colin A.; Rangel, Erika L.; Brown, Rebeccah L.; Garcia, Victor F.; Falcone, Richard A., Jr.] Univ Cincinnati, Div Pediat & Thorac Surg, Dept Surg, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA; [Care, Marguerite] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA		Falcone, RA (corresponding author), Univ Cincinnati, Div Pediat & Thorac Surg, Dept Surg, Cincinnati Childrens Hosp,Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Richard.Falcone@cchmc.org	Martin, COlin/AAU-6821-2021				Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Byck GR, 2000, PEDIATRICS, V106, P14, DOI 10.1542/peds.106.1.14; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Epstein AM, 2001, NEW ENGL J MED, V344, P1471, DOI 10.1056/NEJM200105103441911; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Federico SG, 2007, PEDIATRICS, V120, pe1009, DOI 10.1542/peds.2006-3094; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hannan EL, 2005, J TRAUMA, V58, P244, DOI 10.1097/01.TA.0000141995.44721.44; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; JENNETT B, 1976, LANCET, V1, P1031; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; KRIEGER N, 1962, AM J PUBLIC HEALTH, V98, pS20; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; RANGEL E, PEDIATRICS IN PRESS; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Shone LP, 2003, PEDIATRICS, V112, pE521; Smedley BD, 2008, HEALTH AFFAIR, V27, P447, DOI 10.1377/hlthaff.27.2.447; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zimmerman R A, 1994, Neuroimaging Clin N Am, V4, P349; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P39, DOI 10.1007/BF00395197; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	48	12	12	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	FEB	2010	199	2					210	215		10.1016/j.amjsurg.2009.05.001			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	587AU	WOS:000276959700012	19892316				2022-02-06	
J	Smith, KD; Zhu, L				Smith, Katisha D.; Zhu, Liang			Theoretical evaluation of a simple cooling pad for inducing hypothermia in the spinal cord following traumatic injury	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Spinal cord injury; Cerebrospinal fluid; Hypothermia; Temperature; Heat transfer	CEREBROSPINAL-FLUID CIRCULATION; HEAT-TRANSFER ENHANCEMENT; OSCILLATING-FLOW; BLOOD-FLOW; SYSTEMIC HYPOTHERMIA; LOCAL HYPOTHERMIA; BRAIN; ISCHEMIA; RAT; PATHOPHYSIOLOGY	The Pennes bioheat equation and finite element method (FEM) are used to solve for the temperature distributions in the spinal cord and cerebrospinal fluid (CSF) during 30 min of cooling for spinal cord injury (SCI) patients. The average CSF and spinal cord temperatures are reduced by 3.48 and 2.72A degrees C, respectively. The 100-mm wide pad provides the desired cooling and uses the least amount of material. The presence of zero-average CSF oscillation under normal conditions decreases the cooling extent in the spinal cord due to the introduction of warm CSF surrounding the spinal cord. The temperature decrease in the spinal cord is more than doubled when the temperature at the back of the torso is lowered from 20 to 0A degrees C. Spinal cord ischemia, often observed after traumatic spinal cord injury, promotes cooling penetration. The proposed technique can reduce the spinal cord temperature by 2A degrees C within 30 min and may be a feasible treatment for traumatic SCI.	[Smith, Katisha D.; Zhu, Liang] Univ Maryland, Dept Mech Engn, Baltimore, MD 21250 USA		Zhu, L (corresponding author), Univ Maryland, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	zliang@umbc.edu			State of Maryland TEDCO fund; LSAMP Bridge to the Doctorate Program; NIGMS Initiative for Minority Student DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25-GM55036]; Procter and GambleProcter & Gamble; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM055036] Funding Source: NIH RePORTER	This research was supported in part by the State of Maryland TEDCO fund, the LSAMP Bridge to the Doctorate Program, an NIGMS Initiative for Minority Student Development Grant (R25-GM55036), and Procter and Gamble. This research was performed by Katisha D. Smith in partial fulfillment of the requirements for the Ph.D. degree from the University of Maryland, Baltimore County.	Acosta-Rua G J, 1970, J Iowa Med Soc, V60, P326; ALBIN M, 1968, J NEUROSURG, V28, P113; Albin M S, 1968, Surg Forum, V19, P423; Albin M S, 1965, Surg Forum, V16, P423; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Belegundu, 2002, INTRO FINITE ELEMENT; BLACK PR, 1976, J SURG RES, V20, P49, DOI 10.1016/0022-4804(76)90083-4; Bricolo A, 1976, Surg Neurol, V6, P101; Casas CE, 2005, J NEUROSURG-SPINE, V2, P308, DOI 10.3171/spi.2005.2.3.0308; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; FEINBERG DA, 1987, RADIOLOGY, V163, P793, DOI 10.1148/radiology.163.3.3575734; GOETZ T, 1988, Journal of Neurotrauma, V5, P139, DOI 10.1089/neu.1988.5.139; GRAY H, 2001, GRAYS ANATOMY FACSIM; Gul H, 2007, EXP HEAT TRANSFER, V20, P73, DOI 10.1080/08916150600977523; Hansebout R R, 1975, Surg Neurol, V4, P531; HANSEBOUT RR, 1984, SPINE, V9, P508, DOI 10.1097/00007632-198407000-00020; HANSEBOUT RR, 1985, CAN J NEUROL SCI, V12, P83, DOI 10.1017/S0317167100046758; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hemida HN, 2002, INT J HEAT MASS TRAN, V45, P1767, DOI 10.1016/S0017-9310(01)00274-5; Hirsch C, 1988, NUMERICAL COMPUTATIO; Huang PC, 2005, J THERMOPHYS HEAT TR, V19, P460, DOI 10.2514/1.10348; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Incropera F.P., 1996, FUNDAMENTALS HEAT MA, V6; Isaka M, 2006, J VASC SURG, V43, P1257, DOI 10.1016/j.jvs.2006.02.017; Iwai H, 2004, INT J HEAT MASS TRAN, V47, P4659, DOI 10.1016/j.ijheatmasstransfer.2003.08.03; Kwun BD, 1995, J SURG RES, V59, P780, DOI 10.1006/jsre.1995.1239; Leong KC, 2005, INT J HEAT MASS TRAN, V48, P243, DOI 10.1016/j.ijheatmasstransfer.2004.08.025; Li P, 2000, INT J HEAT MASS TRAN, V43, P3551, DOI 10.1016/S0017-9310(99)00390-7; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; MAGANAES B, 1989, BRIT J NEUROSURG, V3, P659; Marsala M, 1997, J NEUROSCI METH, V74, P97, DOI 10.1016/S0165-0270(97)02270-X; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; MINKOWYCZ W, 1997, ADV NUMERICAL HEAT T; Mori A, 2005, ANN THORAC SURG, V80, P1829, DOI 10.1016/j.athoracsur.2005.04.031; O'Connell JEA, 1943, BRAIN, V66, P204, DOI 10.1093/brain/66.3.204; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; PRYTHERCH DR, 1979, PHYS MED BIOL, V24, P1196, DOI 10.1088/0031-9155/24/6/010; Reyes Onix, 2003, P R Health Sci J, V22, P277; RUBINI L, 1981, SPINE, V6, P417, DOI 10.1097/00007632-198107000-00013; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; SCHELLINGER D, 1992, AM J NEURORADIOL, V13, P1393; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; TATOR CH, 1972, CAN MED ASSOC J, V107, P143; THIENPRASIT P, 1975, J NEUROSURG, V42, P150, DOI 10.3171/jns.1975.42.2.0150; Tsutsumi Koji, 2004, Jpn J Thorac Cardiovasc Surg, V52, P411; Wang LM, 2005, CELL RES, V15, P387, DOI 10.1038/sj.cr.7290306; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; WELLS JD, 1978, SURG NEUROL, V10, P200; Westergren H, 2001, SPINAL CORD, V39, P74, DOI 10.1038/sj.sc.3101127; Xian HZ, 2007, DRY TECHNOL, V25, P723, DOI 10.1080/07373930701291173; Xu XJ, 1999, J APPL PHYSIOL, V86, P265, DOI 10.1152/jappl.1999.86.1.265; YASHON D, 1973, J NEUROSURG, V39, P742, DOI 10.3171/jns.1973.39.6.0742; Zhang XR, 2004, INT J HEAT MASS TRAN, V47, P4439, DOI 10.1016/j.ijheatmasstransfer.2004.03.030; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; ZHU L, 2002, STANDARD HDB BIOMEDI, pCH2	58	12	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	FEB	2010	48	2					167	175		10.1007/s11517-009-0543-z			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	544UL	WOS:000273684700008	19890670				2022-02-06	
J	Anderson, TM; Knight, RG				Anderson, Tracy M.; Knight, Robert G.			The long-term effects of traumatic brain injury on the coordinative function of the central executive	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Dual task; Dual-task test; Divided attention; Traumatic brain injury; Dysexecutive syndrome; Digit span; Tracing task	DUAL-TASK COORDINATION; WORKING-MEMORY; DIVIDED ATTENTION; DEFICIT; SCALE	The objective of this study was to compare the coordinative function of the central executive of working memory in matched groups of controls and persons with traumatic brain injury (TBI) with long-term impairments in functioning, using a dual-task paradigm. The dual-task procedure required participants to complete digit span and tracing tasks separately and then together to produce a change index that reflects loss of productivity on the dual trial. A TBI group and a matched group of controls were compared on this task and on ratings of social competency and neuropsychological tests. The two groups were found to differ in social competence, in the number of dysexecutive symptoms, and on dual-task performance, but not on any other measures of cognitive ability. Poor performance on the dual task was found only in persons with initial very severe TBI. There was no evidence that the group difference on the dual task was the consequence of increased task difficulty level, distribution of attention, or other within-task biases. Performance on the dual task was correlated with dysexecutive symptoms and social competency (in particular interpersonal and cognitive competence), but not with other tests of executive functioning. The findings suggest that deficits in the coordinative function persist in long-term survivors of TBI after other deficits in executive functioning may have resolved and are associated with lower ratings of current interpersonal competence.	[Knight, Robert G.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Anderson, Tracy M.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Anderson, Tracy M.] St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW 2010, Australia		Knight, RG (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz			Neurological Foundation of New Zealand	The authors are grateful to Alan Baddeley and Sergio Della Sala for supplying the materials for the dual-task test used in this paper. Copies of this material may be accessed at www.psy.ed.ac.uk/people/sdsala/tests/sdsdualtask. The authors acknowledge the late Hamish Godfrey for his assistance with this project and are grateful to the Head Injury Society (Invercargill) for their assistance in recruiting participants for this study. This research was supported by a PhD scholarship awarded to Tracy Anderson from the Neurological Foundation of New Zealand.	Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baddeley A.D., 1986, WORKING MEMORY; Baddeley A. D., 1997, METHODOLOGY FRONTAL; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Burgess P, 1996, BEHAV ASSESSMENT DYS; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; DELLASALA S, 1999, PAPER PENCIL DUAL TA; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hegarty M, 2000, MEM COGNITION, V28, P376, DOI 10.3758/BF03198553; International Labor Office, 1988, INT STAND CLASS OCC; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logie RH, 2004, NEUROPSYCHOLOGY, V18, P504, DOI 10.1037/0894-4105.18.3.504; Miyake A., 1999, MODELS WORKING MEMOR; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rosin FM, 1999, BRAZ J MED BIOL RES, V32, P1249, DOI 10.1590/S0100-879X1999001000012; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sylwan RP, 1999, BRAZ J MED BIOL RES, V32, P1263, DOI 10.1590/S0100-879X1999001000013; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q; [No title captured]	35	12	13	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	10					1074	1082	PII 922305187	10.1080/13803391003733560			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	692JV	WOS:000285150000005	20486007				2022-02-06	
J	Bajracharya, A; Agrawal, A; Yam, BR; Agrawal, CS; Lewis, O				Bajracharya, A.; Agrawal, A.; Yam, B. R.; Agrawal, C. S.; Lewis, Owen			Spectrum of surgical trauma and associated head injuries at a university hospital in eastern Nepal	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Craniotomy; laparatomy; trauma		Background: Trauma is one of the common surgical emergencies presenting at B.P. Koirala Institute of Health Sciences (BPKIHS), Nepal, a tertiary referral center catering to the needs of the population of Eastern Nepal and nearby districts of India. Objective: The objective of this study is to analyze the magnitude, epidemiological, clinical profile and outcome of trauma at B P Koirala Institute of Health Sciences. Materials and Methods: This descriptive case series study includes all patients with history of trauma coming to BPKIHS emergency and referred to the surgery department. We noted the detailed clinical history and examination, demographics, mechanism of injury, nature of injury, time of reporting in emergency, treatment offered (operative or non operative management) and analyzed details of operative procedure (i.e. laparotomy, thoracotomy, craniotomy etc.), average length of hospital stay, morbidity and outcome (according to Glasgow outcome scale). Collected data were analyzed using EpiInfo 2000 statistical software. Results: There were 1848 patients eligible to be included in the study. The mean age of the patients was 28.9 +/- 19.3 years. Majority of the patients (38%) belonged to the age group of 21 - 40 years and the male to female ratio was 2.7: 1. Most of the trauma victims were students (30%) followed by laborers (27%) and farmers (22%) respectively. The commonest causes of injury were fall from height (39%), road traffic accident (38%) and physical assault (18%); 78% of the patients were managed conservatively and 22% underwent operative management. Postoperative complications were seen in 18%. Wound infection 7.5%, neurological deficit including cerebrospinal fluid (CSF) otrorrhea was seen in 2.2% patients. Good recovery was seen in 84%, moderate disability in 5.2% patients and severe disability in 1.4% patients. The mortally was 6.3% and most of the deaths were related to traumatic brain injuries. Conclusions: In Nepal, trauma-related injury contributes significantly to morbidity and mortality and is the third leading cause of death. There are very few studies on trauma from this country and hence this study will help in understanding the etiology and outcome particularly in the Eastern region of Nepal.	[Bajracharya, A.; Agrawal, A.; Yam, B. R.; Agrawal, C. S.; Lewis, Owen] BP Koirala Inst Hlth Sci, Dept Surg, Dharan, Nepal		Bajracharya, A (corresponding author), BP Koirala Inst Hlth Sci, Dharan, Nepal.	dr_amirb@hotmail.com	Agrawal, Amit/C-1511-2011	Agrawal, Amit/0000-0002-3287-5448			Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P69, DOI 10.1076/icsp.10.1.69.14107; [Anonymous], 2004, REGIONAL HLTH FORUM; Banthia P, 2006, JNMA J Nepal Med Assoc, V45, P238; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Boffard K, 2000, HAMILTON BAILEYS EME, P110; Burch JM, 2005, SCHWARTZS PRINCIPLES, V2, P129; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Chirdan LB, 2008, NIGER J CLIN PRACT, V11, P250; CIVIL ID, 1986, NEW ZEAL MED J, V99, P905; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cuschieri A, 1999, ESSENTIAL SURG PRACT, P1; Dandona R, 2004, NATL MED J INDIA, V17, P74; Deodhar S D, 1983, J Postgrad Med, V29, P96; Deodhar S D, 1976, Indian J Med Sci, V30, P95; Dharap S, 1996, J BRO, V5, P235; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Ferris JD, 2008, EUR J EMERG MED, V15, P67, DOI 10.1097/MEJ.0b013e328125fef5; Gonzales MM, 2005, ANN EMERG MED, V45, P140, DOI 10.1016/j.annemergmed.2004.08.039; GORMAN DF, 1987, ARCH EMERG MED, V4, P141; GROSSMAN DC, 1995, J TRAUMA, V38, P14, DOI 10.1097/00005373-199501000-00006; Heindel W, 2003, ROFO-FORTSCHR RONTG, V175, P1207; Henderson KIM, 2000, BRIT J SURG, V87, P472, DOI 10.1046/j.1365-2168.2000.01392.x; Hijar Martha, 2003, Inj Control Saf Promot, V10, P37, DOI 10.1076/icsp.10.1.37.14108; Hoyt DB, 2005, SABISTON TXB SURG, P483; Jha N., 1997, JNMA, Journal of the Nepal Medical Association, V35, P241; Kara A, 2008, TURK NEUROSURG, V18, P1; Kulshrestha P, 2004, J TRAUMA, V57, P576, DOI 10.1097/01.TA.0000091107.00699.C7; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; Mohan Dinesh, 2004, J Coll Physicians Surg Pak, V14, P746; Moharamzad Y, 2008, CHIN J TRAUMATOL, V11, P329, DOI 10.1016/S1008-1275(08)60067-X; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Onwudike M, 2001, WORLD J SURG, V25, P112, DOI 10.1007/s002680020369; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; RICHTER ED, 1981, INT J EPIDEMIOL, V10, P145, DOI 10.1093/ije/10.2.145; Roberts I, 1996, BRIT MED J, V313, P1239, DOI 10.1136/bmj.313.7067.1239; Russell R C, 2000, BAILEY LOVES SHORT P, P279; Sabariah F J, 2008, Med J Malaysia, V63 Suppl C, P45; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; St Bernard Godfrey, 2003, Inj Control Saf Promot, V10, P21, DOI 10.1076/icsp.10.1.21.14104; Starnes MJ, 2008, J EMERG MED IN PRESS; Stuart G, 1998, J CLIN NEUROSCI, V5, P402, DOI 10.1016/S0967-5868(98)90271-5; Swaddiwudhipong Witaya, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P37; Wang Sheng-Yong, 2003, Inj Control Saf Promot, V10, P83, DOI 10.1076/icsp.10.1.83.14105; Yates DW, 1992, BMJ-BRIT MED J, V6, P737; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zargar Moosa, 2007, Chin J Traumatol, V10, P259	49	12	12	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-JUN	2010	1	1					2	8		10.4103/0976-3147.63092			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3V2Y	WOS:000218619100002	21799609	gold, Green Published			2022-02-06	
J	Bentz, K; Molcanyi, M; Schneider, A; Riess, P; Maegele, M; Bosche, B; Hampl, JA; Hescheler, J; Patz, S; Schafer, U				Bentz, Kristine; Molcanyi, Marek; Schneider, Annette; Riess, Peter; Maegele, Marc; Bosche, Bert; Hampl, Juergen A.; Hescheler, Juergen; Patz, Silke; Schaefer, Ute			Extract Derived from Rat Brains in the Acute Phase Following Traumatic Brain Injury Impairs Survival of Undifferentiated Stem Cells and Induces Rapid Differentiation of Surviving Cells	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						TBI; Stem cell; Differentiation; Inhibition; Oct-4; Nestin; Fgf5	FLUID-PERCUSSION MODEL; NEURONAL DIFFERENTIATION; INFLAMMATORY RESPONSE; INHIBITING ACTIVITY; COGNITIVE FUNCTION; TRANSPLANTATION; TISSUE; PROGENITORS; MIGRATE	Dramatic cerebral responses following brain injury (TBI) comprise inflammation, cell death, and modulation of trophic factor release. These cerebral modulations might induce and /or attenuate acute neuronal damage. Here, we investigated the effect of tissue extract derived from healthy (HBE) or injured rat brain (TBE) on the differentiation of cultured embryonic stem cells in vitro. Rats were sacrificed at t = 45 minutes following lateral fluid-percussion injury and extracts of cerebral tissue were prepared from 4-6 healthy or injured rat brain hemispheres. Murine embryonic stem cells (CGR8) cultured in serum-free medium were then conditioned for a week with HBE or TBE. Omission of serum from the culture medium induced neural differentiation of CGR8 stem cells, as indicated by a significant time dependent down-regulation of oct-4 with a concomitant upregulation of nestin after 7 days. In parallel cell loss was observed that seemed to be largely due to apoptotic cell death. In TBE treated cells, on the other hand, a significant amplification of apoptotic cell death, enhancement of nestin and MAP2 expression and marked morphological changes such as axonal-like outgrowth was observed within 3 days of conditioning. Treatment of stem cells with HBE resulted in less pronounced neuronal differentiation processes. Axonal-like outgrowth was not observed. Our data suggest that during the early acute phase of traumatic injury the cerebral environment is disposed to detrimental as well as potent protective signals that seem to rapidly induce neurogenic processes. Copyright (C) 2010 S. Karger AG, Basel	[Patz, Silke; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, A-8036 Graz, Austria; [Bentz, Kristine] Syddanskuniv, Bonn, Germany; [Molcanyi, Marek; Bosche, Bert; Hampl, Juergen A.] Univ Cologne, Clin Neurosurg, Bonn, Germany; [Schneider, Annette] Univ Witten Herdecke, Inst Res Operat Med, Bonn, Germany; [Riess, Peter] Waldklin, Dept Trauma & Orthopaed Surg, Bonn, Germany; [Maegele, Marc] Univ Witten Herdecke, Clin Trauma & Orthopaed Surg, Bonn, Germany; [Hescheler, Juergen] Univ Cologne, Dept Neurophysiol, Fac Med, Bonn, Germany		Schafer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Auenbrugger Pl 2, A-8036 Graz, Austria.	ute.schaefer@medunigraz.at	Bosche, Bert/AAB-7150-2020	Bosche, Bert/0000-0002-5313-3195			Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; HEATH JK, 1988, J CELL SCI, P257; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Potts Mathew B, 2006, NeuroRx, V3, P143; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Tseng HC, 2006, NEUROBIOL DIS, V22, P88, DOI 10.1016/j.nbd.2005.10.007; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	27	12	12	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2010	26	6					821	830		10.1159/000323991			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	702FY	WOS:000285881200003	21220913	Bronze			2022-02-06	
J	Davis, AS; Dean, RS				Davis, Andrew S.; Dean, Raymond S.			Assessing Sensory-Motor Deficits in Pediatric Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						children; neuropsychological assessment; sensory-motor; traumatic brain injury	CHILDREN; RECOVERY; GAIT	The assessment of sensory-motor functions is a key component of pediatric neuropsychological evaluations following traumatic brain injury (TBI). Sensory-motor processes have recently been shown to be related to larger neural structures and functions, rather than a secondary role played in the past. Recent research has shown sensory-motor functioning serves as a marker for the integrity of the central nervous system. Children's behavior following a TBI has greater variation than seen in adults, which may well relate to greater natural variation and maturational effects. With the recent findings of greater importance of sensory-motor functions, the need for psychometrically sound measures is stressed and various measures are outlined.	[Davis, Andrew S.] Ball State Univ, Teachers Coll, Dept Educ Psychol, Muncie, IN 47306 USA		Davis, AS (corresponding author), Ball State Univ, Teachers Coll, Dept Educ Psychol, Room 515, Muncie, IN 47306 USA.	davis@bsu.edu					*AM AC NEUR, 1996, WHIT PAP NEUR PROV N; Andrewes D, 2002, NEUROPSYCHOLOGY THEO; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Davis AS, 2009, ARCH CLIN NEUROPSYCH, V24, P273, DOI 10.1093/arclin/acp032; Dean R. S., 2003, EXAMINERS MANUAL DEA; DEAN RS, 2003, DEANWOODCOCK NEUROPS; DEAN RS, 1999, DEANWOODCOCK NEUROPS; DECKER SL, 2002, THESIS BALL STATE U; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GOLDEN C, 1987, MANUAL LURIA NEBRASK; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Korkman M, 1998, DEV NEUROPSYCHOLOGIC; Korkman M., 2007, NEPSY 2; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Reitan R, 1969, MANUAL ADM NEUROPSYC; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1996, CLIN NEUROPSYCHOL, V10, P37, DOI 10.1080/13854049608406661; TITUS JB, 2002, THESIS BALL STATE U; Volpe AG, 2006, ARCH CLIN NEUROPSYCH, V21, P203, DOI 10.1016/j.acn.2005.12.005; Wolfson, 1993, HALSTEAD REITAN NEUR; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE	23	12	12	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					104	109	PII 922158471	10.1080/09084281003708951			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800005	20467950				2022-02-06	
J	Erkmen, N; Taskin, H; Kaplan, T; Sanioglu, A				Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet			BALANCE PERFORMANCE AND RECOVERY AFTER EXERCISE WITH WATER INTAKE, SPORT DRINK INTAKE AND NO FLUID	JOURNAL OF EXERCISE SCIENCE & FITNESS			English	Article						dehydration; fatiguing exercise; fluid intake; postural sway; sweat	ERROR SCORING SYSTEM; POSTURAL STABILITY; FATIGUE; DEHYDRATION; RELIABILITY; CONCUSSION; MUSCLE	The objective of the present study was to determine the effects of exercise with water intake sport drink intake and no fluid on balance performance and recovery Seventeen physically active men (age 22 29 +/- 1 61 years height 176 24 +/- 5 18 cm weight 69 47 +/- 9 20 kg) volunteered to take part in this study The Biodex Balance System was used to evaluate balance performance and Overall Stability Index (OSI) scores were used to assess balance performance The exercise protocol consisted of a 1 hour exercise session at 75% and 85% of maximal heart rate The recovery period was 20 minutes of rest without fluid intake In all experiment conditions balance tests were applied three times as pretest posttest and recovery In each one of the three experimental conditions balance tests were consecutively performed with eyes open and eyes closed All the measurements and exercise protocols were performed in the morning (between 9 AM and 12 PM) in a specially designed and equipped room with room temperature at 21-24 degrees C Repeated measures ANOVA was used to examine all the conditions OSI post exercise was significantly higher than pre exercise (p < 0 01) and recovery (p < 0 05) For exercise with no fluid and eyes open There was a non significant difference in OSI between pre exercise and recovery No significant differences in OSI for exercise with sport drink intake and water intake were observed among pre exercise post exercise and recovery The results of this study show that balance performance decreases after prolonged exercise without fluid intake and that fluid ingested during sport activities could prevent the decrease in balance performance [J Exerc Sci Fit . Vol 8 . No 2 . 105-112 . 2010]	[Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet] Selcuk Univ, Sch Phys Educ & Sport, TR-42079 Konya, Turkey		Erkmen, N (corresponding author), Selcuk Univ, Sch Phys Educ & Sport, Alaaddin Keykubat Campus, TR-42079 Konya, Turkey.		Erkmen, Nurtekin/L-2341-2018	Erkmen, Nurtekin/0000-0002-5220-887X	Coordinating Office of Selcuk UniversitySelcuk University [08401108]	This study was supported by the Scientific Research Projects (BAP) Coordinating Office of Selcuk University (project no 08401108) The authors wish to thank the subjects and the distributor of Coca Cola in Konya Turkey for their invaluable contribution to the study	Ageberg E, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-14; Alderton A.-K., 1996, Scandinavian Journal of Medicine and Science in Sports, V6, P211; [Anonymous], 2000, MED SCI SPORT EXER, V32, P2130; BALESTRA C, 1992, ELECTROEN CLIN NEURO, V85, P46, DOI 10.1016/0168-5597(92)90101-G; Barr SI, 1999, CAN J APPL PHYSIOL, V24, P164, DOI 10.1139/h99-014; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Costa PB, 2009, J STRENGTH COND RES, V23, P141, DOI 10.1519/JSC.0b013e31818eb052; Derave W, 1998, ERGONOMICS, V41, P782, DOI 10.1080/001401398186630; Gauchard GC, 2002, INT J NEUROSCI, V112, P1191, DOI 10.1080/00207450290026157; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen MS, 2000, KNEE SURG SPORT TR A, V8, P180, DOI 10.1007/s001670050211; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Khanna P, 2008, INDIAN J PHYSIOTHER, V2, P42; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; MANCUSO JJ, 2002, J ATHL TRAINING, V37, pS10; Maughan RJ, 1997, J SPORT SCI, V15, P297; MCKINNEY JL, 2005, P 4 ANN COLL ED RES; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nordahl SHG, 2000, AVIAT SPACE ENVIR MD, V71, P889; Ostojic Sergej M, 2002, J Sports Sci Med, V1, P47; Patel AV, 2007, J ATHL TRAINING, V42, P66; Pendergrass TL, 2003, MIL MED, V168, P896, DOI 10.1093/milmed/168.11.896; PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202; Pincivero DM., 1995, J ATHL TRAINING, V30, pS35; POWERS SK, 1990, EXERCISE PHYSL THEOR, P417; Salavati M, 2007, GAIT POSTURE, V26, P214, DOI 10.1016/j.gaitpost.2006.09.001; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Susco TM, 2004, J ATHL TRAINING, V39, P241; Testerman C, 1999, FOOT ANKLE INT, V20, P317, DOI 10.1177/107110079902000510; Tripp BL, 2007, J ATHL TRAINING, V42, P90; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	37	12	12	1	25	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1728-869X			J EXERC SCI FIT	J. Exerc. Sci. Fit.		2010	8	2					105	112		10.1016/S1728-869X(10)60016-0			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	694BG	WOS:000285269400008		gold			2022-02-06	
J	Eve, DJ; Fillmore, RW; Borlongan, CV; Sanberg, PR				Eve, David J.; Fillmore, Randolph W.; Borlongan, Cesar V.; Sanberg, Paul R.			Stem cells have the potential to rejuvenate regenerative medicine research	MEDICAL SCIENCE MONITOR			English	Article						stem cells; cell transplantation; regenerative medicine; tissue engineering; biomaterials	UMBILICAL-CORD BLOOD; LONG-TERM SURVIVAL; NEURAL PROGENITOR CELLS; MARROW STROMAL CELLS; AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; MEDIATED GENE-TRANSFER; HEMATOPOIETIC GROWTH-FACTORS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION	The increasing number of publications featuring the use of stem cells in regenerative processes supports the idea that they are revolutionizing regenerative medicine research. In an analysis of the articles published in the journal Cell Transplantation - The Regenerative Medicine Journal between 2008 and 2009, which reveals the topics and categories that are on the cutting edge of regenerative medicine research, stem cells are becoming increasingly relevant as the "runner-up" category to "neuroscience" related articles. The high volume of stem cell research casts a bright light on the hope for stem cells and their role in regenerative medicine as a number of reports deal with research using stem cells entering, or seeking approval for, clinical trials. The "methods and new technologies" and "tissue engineering" sections were almost equally as popular, and in part, reflect attempts to maximize the potential of stem cells and other treatments for the repair of damaged tissue. Transplantation studies were again more popular than non-transplantation, and the contribution of stem cell-related transplants was greater than other types of transplants. The non-transplantation articles were predominantly related to new methods for the preparation, isolation and manipulation of materials for transplant by specific culture media, gene therapy, medicines, dietary supplements, and co-culturing with other cells and further elucidation of disease mechanisms. A sizeable proportion of the transplantation articles reported on how previously new methods may have aided the ability of the cells or tissue to exert beneficial effects following transplantation.	[Eve, David J.; Fillmore, Randolph W.; Borlongan, Cesar V.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA		Eve, DJ (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	deve@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			Abbah SA, 2008, CELL TRANSPLANT, V17, P1181, DOI 10.3727/096368908787236648; Abbas A, 2009, MED SCI MONITOR, V15, pMT121; Abu-Hammad T, 2008, MED SCI MONITOR, V14, pCR262; Acosta SA, 2008, CELL TRANSPLANT, V17, P457; Acosta SA, 2009, CELL TRANSPLANT, V18, P207; Agrawal A, 2008, CELL TRANSPLANT, V17, P1315, DOI 10.3727/096368908787648065; Airavaara M, 2009, CELL TRANSPLANT, V18, P207; AIRAVAARA M, 2008, CELL TRANSPLANT, V17, P457; Akesson E, 2008, CELL TRANSPLANT, V17, P1115, DOI 10.3727/096368908787236585; Akiyama M, 2009, CELL TRANSPLANT, V18, P443, DOI 10.3727/096368909788809820; Alberti E, 2009, MED SCI MONITOR, V15, pBR47; Alexander I, 2009, CELL TRANSPLANT, V18, P255, DOI 10.3727/096368909788534997; Ali MM, 2008, CELL TRANSPLANT, V17, P458; Alvarez-Mercado AI, 2008, CELL TRANSPLANT, V17, P845, DOI 10.3727/096368908786516837; Alvarez-Mercado AI, 2009, CELL TRANSPLANT, V18, P1069, DOI 10.3727/096368909X12483162197088; Amable RJ, 2008, CELL TRANSPLANT, V17, P458; Amann B, 2009, CELL TRANSPLANT, V18, P371, DOI 10.3727/096368909788534942; Amir G, 2009, CELL TRANSPLANT, V18, P275, DOI 10.3727/096368909788534898; Andres RH, 2008, CELL TRANSPLANT, V17, P458; Andres RH, 2009, CELL TRANSPLANT, V18, P208; Asiedu C, 2008, CELL TRANSPLANT, V17, P713, DOI 10.3727/096368908786092748; Astradsson A, 2008, CELL TRANSPLANT, V17, P459; Azari H, 2008, CELL TRANSPLANT, V17, P459; Aziz MTA, 2008, MED SCI MONITOR, V14, pBR249; Bachstetter AD, 2008, CELL TRANSPLANT, V17, P459; Bachstetter AD, 2009, CELL TRANSPLANT, V18, P208; Badri VK, 2008, CELL TRANSPLANT, V17, P460; Bae JY, 2009, CELL TRANSPLANT, V18, P505, DOI 10.1177/096368970901805-604; Bae JY, 2009, CELL TRANSPLANT, V18, P459, DOI 10.3727/096368909788809776; Baek SH, 2009, CELL TRANSPLANT, V18, P209; Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774; Bakay RAE, 2008, CELL TRANSPLANT, V17, P460; Bankiewicz K, 2008, CELL TRANSPLANT, V17, P460; Barone TA, 2008, CELL TRANSPLANT, V17, P461; Barton FB, 2009, CELL TRANSPLANT, V18, P753, DOI 10.3727/096368909X470874; Behrouz B, 2009, CELL TRANSPLANT, V18, P209; Behrstock S, 2008, CELL TRANSPLANT, V17, P753, DOI 10.3727/096368908786516819; Benabdallah BF, 2009, CELL TRANSPLANT, V18, P709, DOI 10.3727/096368909X470865; Benabdallah BF, 2008, CELL TRANSPLANT, V17, P337, DOI 10.3727/096368908784153913; Berk MA, 2009, CELL TRANSPLANT, V18, P209; Bernal GM, 2009, CELL TRANSPLANT, V18, P210; Bertuzzi F, 2009, CELL TRANSPLANT, V18, P203, DOI 10.3727/096368909788341270; Bidzan L, 2008, MED SCI MONITOR, V14, pCR473; Bierinx AS, 2008, CELL TRANSPLANT, V17, P1193, DOI 10.3727/096368908787236530; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Bjugstad KB, 2009, CELL TRANSPLANT, V18, P210; Block A, 2008, MED SCI MONITOR, V14, pBR88; Bobek V, 2008, CELL TRANSPLANT, V17, P461; Bobek V, 2009, CELL TRANSPLANT, V18, P211; Boger HA, 2008, CELL TRANSPLANT, V17, P461; Boger HA, 2009, CELL TRANSPLANT, V18, P211; Boldrin L, 2008, CELL TRANSPLANT, V17, P577, DOI 10.3727/096368908785095980; Bombard MC, 2008, CELL TRANSPLANT, V17, P462; Bonora-Centelles A, 2009, CELL TRANSPLANT, V18, P1319, DOI 10.3727/096368909X12483162197321; Borlongan CV, 2008, CELL TRANSPLANT, V17, P462; Bosio E, 2008, CELL TRANSPLANT, V17, P587, DOI 10.3727/096368908786092784; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Brunet JF, 2009, CELL TRANSPLANT, V18, P787, DOI 10.3727/096368909X470847; Buchwald P, 2009, CELL TRANSPLANT, V18, P1223, DOI 10.3727/096368909X476968; Buzzeo MP, 2008, CELL TRANSPLANT, V17, P489, DOI 10.3727/096368908785096042; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Carty N, 2008, CELL TRANSPLANT, V17, P462; Carvey PM, 2008, CELL TRANSPLANT, V17, P463; Castanheira P, 2009, CELL TRANSPLANT, V18, P423, DOI 10.3727/096368909788809811; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao KC, 2008, CELL TRANSPLANT, V17, P657, DOI 10.3727/096368908786092801; Chen JC, 2008, CELL TRANSPLANT, V17, P495, DOI 10.3727/096368908785095971; Chermenina M, 2009, CELL TRANSPLANT, V18, P211; Cho DY, 2009, CELL TRANSPLANT, V18, P977, DOI 10.3727/096368909X12483162196962; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Choi UK, 2008, FOOD SCI BIOTECHNOL, V17, P899; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Cicchetti F, 2009, CELL TRANSPLANT, V18, P211; Cobacho N, 2009, CELL TRANSPLANT, V18, P1341, DOI 10.3727/096368909X12483162197367; Cobianchi L, 2008, CELL TRANSPLANT, V17, P559, DOI 10.3727/096368908785096060; Coffey LCK, 2009, CELL TRANSPLANT, V18, P1213, DOI 10.3727/096368909X12483162196728; Collado LM, 2009, CELL TRANSPLANT, V18, P212; COLLIER TJ, 2008, CELL TRANSPLANT, V17, P457; Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252; Daadi MM, 2009, CELL TRANSPLANT, V18, P212; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; Souza BSD, 2009, CELL TRANSPLANT, V18, P1261, DOI 10.3727/096368909X470522; DELCASTILLO, 2009, CELL TRANSPLANT, V18, P1237; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Diaz-Ruiz O, 2008, CELL TRANSPLANT, V17, P463; Dodiya HB, 2009, CELL TRANSPLANT, V18, P212; Dobrossy MD, 2008, CELL TRANSPLANT, V17, P1125; Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620; Drowley L, 2009, CELL TRANSPLANT, V18, P1137, DOI 10.3727/096368909X471305; Ducray A, 2008, CELL TRANSPLANT, V17, P463; Dufour JM, 2008, CELL TRANSPLANT, V17, P525, DOI 10.3727/096368908785096033; Eidelberg D, 2008, CELL TRANSPLANT, V17, P464; El-Moursy SA, 2009, MED SCI MONITOR, V15, pBR339; ELBADRI N, 2008, CELL TRANSPLANT, V17, P464; Ellis-Behnke RG, 2009, CELL TRANSPLANT, V18, P1047, DOI 10.3727/096368909X471242; Emborg EM, 2009, CELL TRANSPLANT, V18, P213; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Epple-Farmer J, 2009, CELL TRANSPLANT, V18, P769, DOI 10.3727/096368909X470856; Estrada EJ, 2008, CELL TRANSPLANT, V17, P1295, DOI 10.3727/096368908787648119; Eve DJ, 2008, CELL TRANSPLANT, V17, P464; Eve DJ, 2009, CELL TRANSPLANT, V18, P213; Fan HB, 2008, CELL TRANSPLANT, V17, P1389, DOI 10.3727/096368908787648047; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; Federici T, 2009, CELL TRANSPLANT, V18, P213; Fenjves ES, 2008, CELL TRANSPLANT, V17, P793, DOI 10.3727/096368908786516828; Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498; Fortress AM, 2009, CELL TRANSPLANT, V18, P214; Freed WJ, 2008, CELL TRANSPLANT, V17, P465; Freeman L, 2009, CELL TRANSPLANT, V18, P214; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Fu RH, 2009, CELL TRANSPLANT, V18, P1029, DOI 10.3727/096368909X471260; Fujimoto KL, 2009, CELL TRANSPLANT, V18, P477, DOI 10.3727/096368909788809785; Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611; Furlani D, 2009, CELL TRANSPLANT, V18, P319, DOI 10.3727/096368909788534906; Furmanski O, 2008, CELL TRANSPLANT, V17, P466; Gajavelli S, 2008, CELL TRANSPLANT, V17, P466; Gajavelli S, 2008, CELL TRANSPLANT, V17, P445; Galoyan AA, 2008, CELL TRANSPLANT, V17, P1061, DOI 10.3727/096368908786991579; Gao LR, 2009, CELL TRANSPLANT, V18, P1311, DOI 10.3727/096368909X474843; Gao YX, 2008, CELL TRANSPLANT, V17, P723, DOI 10.3727/096368908786516729; Garbuzova-Davis S, 2008, CELL TRANSPLANT, V17, P466; Garbuzova-Davis S, 2009, CELL TRANSPLANT, V18, P214; Garkavenko O, 2008, CELL TRANSPLANT, V17, P1381, DOI 10.3727/096368908787648056; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gemma C, 2008, CELL TRANSPLANT, V17, P467; Ghanem A, 2009, CELL TRANSPLANT, V18, P1289, DOI 10.3727/096368909X12483162197286; Ghosh D, 2008, CELL TRANSPLANT, V17, P351, DOI 10.3727/096368908784153869; Ghosh M, 2009, CELL TRANSPLANT, V18, P215; Glavaski-Joksimovic A, 2009, CELL TRANSPLANT, V18, P801, DOI 10.3727/096368909X470801; Golat BT, 2008, CELL TRANSPLANT, V17, P1135, DOI 10.3727/096368908787236512; Golshani R, 2009, CELL TRANSPLANT, V18, P215; Gombash SE, 2009, CELL TRANSPLANT, V18, P216; Gorenkova N, 2009, CELL TRANSPLANT, V18, P216; Granholm AC, 2008, CELL TRANSPLANT, V17, P467; Granholm AC, 2009, CELL TRANSPLANT, V18, P216; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCR248; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCS67; Grondin M, 2009, CELL TRANSPLANT, V18, P79, DOI 10.3727/096368909788237104; Grondin R, 2008, CELL TRANSPLANT, V17, P373, DOI 10.3727/096368908784423256; Gross RE, 2008, CELL TRANSPLANT, V17, P467; Gunji T, 2008, CELL TRANSPLANT, V17, P619, DOI 10.3727/096368908786092720; Hallett PJ, 2009, CELL TRANSPLANT, V18, P217; Hanson MS, 2008, CELL TRANSPLANT, V17, P1337, DOI 10.3727/096368908787648038; Hardjo M, 2009, CELL TRANSPLANT, V18, P89, DOI 10.3727/096368909788237140; Harvey BK, 2009, CELL TRANSPLANT, V18, P217; Hatayama N, 2009, CELL TRANSPLANT, V18, P529, DOI 10.1177/096368970901805-607; Hayashi T, 2009, CELL TRANSPLANT, V18, P217; Helbig G, 2008, MED SCI MONITOR, V14, pCR584; Heng BC, 2009, CELL TRANSPLANT, V18, P1111, DOI 10.3727/096368909X12483162197006; Hess DC, 2009, CELL TRANSPLANT, V18, P218; Hess S, 2009, CELL TRANSPLANT, V18, P261, DOI 10.3727/096368909788534979; Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919; Horne PH, 2008, CELL TRANSPLANT, V17, P829, DOI 10.3727/096368908786516792; Hossne NA, 2009, CELL TRANSPLANT, V18, P1299, DOI 10.3727/096368909X484671; Hu CJ, 2008, CELL TRANSPLANT, V17, P1067, DOI 10.3727/096368908786991506; Huang XS, 2009, CELL TRANSPLANT, V18, P887, DOI 10.3727/096368909X471152; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Iken M, 2009, CELL TRANSPLANT, V18, P745, DOI 10.3727/096368909X470838; Imamura R, 2008, CELL TRANSPLANT, V17, P135, DOI 10.3727/000000008783907044; Imamura T, 2008, CELL TRANSPLANT, V17, P267, DOI 10.3727/096368908784153850; Iop L, 2008, CELL TRANSPLANT, V17, P679, DOI 10.3727/096368908786092739; Isacson O, 2008, CELL TRANSPLANT, V17, P468; Ismail A, 2009, MED SCI MONITOR, V15, pBR243; Ito M, 2008, CELL TRANSPLANT, V17, P165, DOI 10.3727/000000008783906883; Jain A, 2009, CELL TRANSPLANT, V18, P218; JENSEN P, 2009, CELL TRANSPLANT, V18, P218; Jergova S, 2009, CELL TRANSPLANT, V18, P219; Jha RK, 2008, MED SCI MONITOR, V14, pBR14; Jiang Z, 2008, CELL TRANSPLANT, V17, P969, DOI 10.3727/096368908786576525; Jiang ZY, 2008, MED SCI MONITOR, V14, pCR515; Jinwal UK, 2009, CELL TRANSPLANT, V18, P219; Johansson S, 2009, CELL TRANSPLANT, V18, P219; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Gomez-Lechon MJ, 2008, CELL TRANSPLANT, V17, P887, DOI 10.3727/096368908786576534; Juang JH, 2008, CELL TRANSPLANT, V17, P641, DOI 10.3727/096368908786092766; Jung M, 2009, CELL TRANSPLANT, V18, P923, DOI 10.3727/096368909X471297; Kabatas S, 2008, CELL TRANSPLANT, V17, P468; Kaczmarek R, 2009, MED SCI MONITOR, V15, pBR227; Kandel I, 2009, MED SCI MONITOR, V15, pPH13; Karakostas T, 2008, CELL TRANSPLANT, V17, P468; Kawazoe T, 2008, CELL TRANSPLANT, V17, P203, DOI 10.3727/000000008783906964; Kawecki D, 2009, MED SCI MONITOR, V15, pCR628; Keene CD, 2008, CELL TRANSPLANT, V17, P469; Kelly L, 2009, CELL TRANSPLANT, V18, P220; Kenmochi T, 2008, CELL TRANSPLANT, V17, P61, DOI 10.3727/000000008783907026; KHAING ZZ, 2009, CELL TRANSPLANT, V18, P220; Kihara Y, 2009, CELL TRANSPLANT, V18, P639, DOI 10.1177/096368970901805-620; Kim H, 2009, CELL TRANSPLANT, V18, P513, DOI 10.1177/096368970901805-605; Kim HI, 2009, CELL TRANSPLANT, V18, P31, DOI 10.3727/096368909788237113; Kim YH, 2008, CELL TRANSPLANT, V17, P609, DOI 10.3727/096368908786092694; Kinomura M, 2008, CELL TRANSPLANT, V17, P143, DOI 10.3727/000000008783907008; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Kitazawa Y, 2009, CELL TRANSPLANT, V18, P627, DOI 10.1177/096368970901805-619; Klein JA, 2008, CELL TRANSPLANT, V17, P585, DOI 10.3727/096368908785096015; Kneser M, 2009, MED SCI MONITOR, V15, pCR436; Kobayashi M, 2008, CELL TRANSPLANT, V17, P291, DOI 10.3727/096368908784153904; Kobayashi N, 2008, CELL TRANSPLANT, V17, P19, DOI 10.3727/000000008783906982; Kobayashi N, 2008, CELL TRANSPLANT, V17, P11, DOI 10.3727/000000008783907107; Kobayashi N, 2008, CELL TRANSPLANT, V17, P1; Kobayashi N, 2008, CELL TRANSPLANT, V17, P3, DOI 10.3727/000000008783907099; Kobayashi N, 2009, CELL TRANSPLANT, V18, P491, DOI 10.1177/096368970901805-602; Kobayashi N, 2009, CELL TRANSPLANT, V18, P489, DOI 10.1177/096368970901805-601; Kobayashi T, 2008, CELL TRANSPLANT, V17, P1243, DOI 10.3727/096368908787236602; Koenig S, 2009, CELL TRANSPLANT, V18, P69, DOI 10.3727/096368909788237186; Koestenbauer S, 2009, CELL TRANSPLANT, V18, P1059, DOI 10.3727/096368909X471288; Kordower JH, 2008, CELL TRANSPLANT, V17, P469; Kordower JH, 2008, CELL TRANSPLANT, V17, P361; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Krausgrill B, 2009, CELL TRANSPLANT, V18, P847, DOI 10.3727/096368909X471134; Krynska B, 2008, CELL TRANSPLANT, V17, P469; Kuleshova LL, 2009, CELL TRANSPLANT, V18, P135, DOI 10.3727/096368909788341298; Kumaraswamy GK, 2008, CELL TRANSPLANT, V17, P469; Kuo TK, 2009, CELL TRANSPLANT, V18, P1013, DOI 10.3727/096368909X471206; Kuruba R, 2009, CELL TRANSPLANT, V18, P221; Kusaka M, 2008, CELL TRANSPLANT, V17, P129, DOI 10.3727/000000008783907116; Kusaka M, 2009, CELL TRANSPLANT, V18, P647, DOI 10.1177/096368970901805-621; Laconi S, 2008, CELL TRANSPLANT, V17, P1415, DOI 10.3727/096368908787648128; Lafreniere JF, 2009, CELL TRANSPLANT, V18, P719, DOI 10.3727/096368909X470900; Lane MA, 2008, CELL TRANSPLANT, V17, P470; Lau J, 2009, CELL TRANSPLANT, V18, P23, DOI 10.3727/096368909788237131; Lebson LA, 2008, CELL TRANSPLANT, V17, P470; Lee CT, 2009, CELL TRANSPLANT, V18, P221; Lee DC, 2008, CELL TRANSPLANT, V17, P471; Lee DC, 2009, CELL TRANSPLANT, V18, P222; Lee EJ, 2009, CELL TRANSPLANT, V18, P731, DOI 10.3727/096368909X470919; Lee JI, 2008, CELL TRANSPLANT, V17, P51, DOI 10.3727/000000008783907035; Lee SW, 2009, CELL TRANSPLANT, V18, P1123, DOI 10.3727/096368909X12483162196809; Lehec SC, 2009, CELL TRANSPLANT, V18, P941, DOI 10.3727/096368909X471323; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li Q, 2008, CELL TRANSPLANT, V17, P471; Li Q, 2009, CELL TRANSPLANT, V18, P222; Li QY, 2008, CELL TRANSPLANT, V17, P397; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Li W, 2009, MED SCI MONITOR, V15, pBR357; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Licznerski P, 2008, CELL TRANSPLANT, V17, P471; Lieu CA, 2008, CELL TRANSPLANT, V17, P471; Lieu CA, 2009, CELL TRANSPLANT, V18, P222; Lim JY, 2008, CELL TRANSPLANT, V17, P472; Lin SZ, 2008, CELL TRANSPLANT, V17, P472; Lin SZ, 2009, CELL TRANSPLANT, V18, P949, DOI 10.3727/096368909X471215; Lindquist J, 2008, CELL TRANSPLANT, V17, P473; Liu DD, 2008, CELL TRANSPLANT, V17, P473; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Liu XL, 2008, CELL TRANSPLANT, V17, P649, DOI 10.3727/096368908786092711; Lopez C, 2008, CELL TRANSPLANT, V17, P859, DOI 10.3727/096368908786516783; Lopez-Gonzalez R, 2009, CELL TRANSPLANT, V18, P1171, DOI 10.3727/096368909X12483162197123; Lu N, 2009, MED SCI MONITOR, V15, pBR99; Lu XM, 2008, CELL TRANSPLANT, V17, P1423, DOI 10.3727/096368908787648155; Luan LM, 2008, CELL TRANSPLANT, V17, P417; Luebke-Wheeler JL, 2009, CELL TRANSPLANT, V18, P1281, DOI 10.3727/096368909X474258; Luo Y, 2008, CELL TRANSPLANT, V17, P473; Luo Y, 2009, CELL TRANSPLANT, V18, P223; Ma BF, 2009, CELL TRANSPLANT, V18, P223; Macklis JD, 2009, CELL TRANSPLANT, V18, P223; Macri R, 2008, CELL TRANSPLANT, V17, P473; Madhavan L, 2008, CELL TRANSPLANT, V17, P474; Madhavan L, 2009, CELL TRANSPLANT, V18, P224; Magalhaes R, 2008, CELL TRANSPLANT, V17, P813, DOI 10.3727/096368908786516765; Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306; Maksoud YA, 2009, CELL TRANSPLANT, V18, P224; Mancarella R, 2008, CELL TRANSPLANT, V17, P1271, DOI 10.3727/096368908787236639; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P225; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P224; Marschinke F, 2009, CELL TRANSPLANT, V18, P225; Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915; Martinez I, 2008, CELL TRANSPLANT, V17, P987, DOI 10.3727/096368908786576499; Marupudi NI, 2008, CELL TRANSPLANT, V17, P474; Marupudi NI, 2009, CELL TRANSPLANT, V18, P225; Matsuda R, 2009, CELL TRANSPLANT, V18, P39, DOI 10.3727/096368909788237122; Matsumoto S, 2009, CELL TRANSPLANT, V18, P549, DOI 10.1177/096368970901805-610; Matsumoto S, 2009, CELL TRANSPLANT, V18, P557, DOI 10.1177/096368970901805-611; Matsumura K, 2009, CELL TRANSPLANT, V18, P521, DOI 10.1177/096368970901805-606; McGregor L, 2008, CELL TRANSPLANT, V17, P475; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Melzi R, 2008, CELL TRANSPLANT, V17, P1361, DOI 10.3727/096368908787648146; Mervis RF, 2008, CELL TRANSPLANT, V17, P475; Mervis RF, 2009, CELL TRANSPLANT, V18, P226; Meyburg J, 2009, CELL TRANSPLANT, V18, P777, DOI 10.3727/096368909X470775; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; Mijiti A, 2009, CELL TRANSPLANT, V18, P657, DOI 10.1177/096368970901805-622; Miki A, 2009, CELL TRANSPLANT, V18, P13, DOI 10.3727/096368909788237159; Miller C, 2009, CELL TRANSPLANT, V18, P226; Ming D, 2009, MED SCI MONITOR, V15, pMT105; Miyagi S, 2008, CELL TRANSPLANT, V17, P173, DOI 10.3727/000000008783906874; Miyamoto Y, 2009, CELL TRANSPLANT, V18, P677, DOI 10.1177/096368970901805-624; Miyamoto Y, 2009, CELL TRANSPLANT, V18, P619, DOI 10.1177/096368970901805-618; Monahan AJ, 2009, CELL TRANSPLANT, V18, P226; Monahan AJ, 2008, CELL TRANSPLANT, V17, P363; Moradian S, 2009, CELL TRANSPLANT, V18, P227; Moreira RO, 2009, MED SCI MONITOR, V15, pBR65; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Musso J, 2009, CELL TRANSPLANT, V18, P227; Nasseri BA, 2009, CELL TRANSPLANT, V18, P361, DOI 10.3727/096368909788534924; Naujok O, 2008, CELL TRANSPLANT, V17, P1231, DOI 10.3727/096368908787236549; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900; Neckel ND, 2009, CELL TRANSPLANT, V18, P227; Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462; Nevalainen N, 2009, CELL TRANSPLANT, V18, P228; Newman MB, 2008, CELL TRANSPLANT, V17, P475; Newman MB, 2009, CELL TRANSPLANT, V18, P228; Nguyen T, 2009, CELL TRANSPLANT, V18, P228; Nikas JB, 2009, CELL TRANSPLANT, V18, P229; NIKKHAH G, 2008, CELL TRANSPLANT, V17, P476; Nikkhah G, 2009, CELL TRANSPLANT, V18, P119, DOI 10.3727/096368909788341324; Nikolic WV, 2008, CELL TRANSPLANT, V17, P477; Nishie M, 2009, CELL TRANSPLANT, V18, P665, DOI 10.1177/096368970901805-623; Noguchi H, 2008, CELL TRANSPLANT, V17, P69, DOI 10.3727/000000008783907062; Noguchi H, 2008, CELL TRANSPLANT, V17, P121, DOI 10.3727/000000008783906991; Noguchi H, 2009, CELL TRANSPLANT, V18, P563, DOI 10.1177/096368970901805-612; Noguchi H, 2009, CELL TRANSPLANT, V18, P541, DOI 10.1177/096368970901805-609; Noguchi H, 2009, CELL TRANSPLANT, V18, P497, DOI 10.1177/096368970901805-603; Nolan K, 2008, CELL TRANSPLANT, V17, P241, DOI 10.3727/096368908784153931; O'Malley JA, 2008, CELL TRANSPLANT, V17, P477; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Oishi K, 2008, CELL TRANSPLANT, V17, P35, DOI 10.3727/000000008783906937; Oishi K, 2009, CELL TRANSPLANT, V18, P581, DOI 10.1177/096368970901805-614; Oishi K, 2009, CELL TRANSPLANT, V18, P573, DOI 10.1177/096368970901805-613; Olson L, 2008, CELL TRANSPLANT, V17, P477; Ono M, 2008, CELL TRANSPLANT, V17, P231, DOI 10.3727/000000008783907143; Pabon MM, 2009, CELL TRANSPLANT, V18, P229; Parihar VK, 2009, CELL TRANSPLANT, V18, P229; Park DH, 2009, CELL TRANSPLANT, V18, P230; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Park DH, 2009, MED SCI MONITOR, V15, pRA233; Park DH, 2008, MED SCI MONITOR, V14, pRA206; Park DH, 2009, MED SCI MONITOR, V15, pRA23; Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922; Patel AN, 2009, CELL TRANSPLANT, V18, P243, DOI 10.3727/096368909788534960; Paumier KL, 2008, CELL TRANSPLANT, V17, P478; Pendharkar AV, 2009, CELL TRANSPLANT, V18, P230; Petrofsky JS, 2009, MED SCI MONITOR, V15, pCR325; Piao CS, 2008, CELL TRANSPLANT, V17, P478; Piao CS, 2009, CELL TRANSPLANT, V18, P231; Praud C, 2008, CELL TRANSPLANT, V17, P1035, DOI 10.3727/096368908786991588; Priest C, 2009, CELL TRANSPLANT, V18, P231; Qi YY, 2009, CELL TRANSPLANT, V18, P1161, DOI 10.3727/096368909X12483162197169; Quaglia A, 2008, CELL TRANSPLANT, V17, P1403, DOI 10.3727/096368908787648083; Quarta M, 2008, MED SCI MONITOR, V14, pBR286; Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453; Rachubinski A, 2009, CELL TRANSPLANT, V18, P231; RAFAEL H, 2008, MED SCI MONITOR, V14, pCR473; Rafael H, 2008, MED SCI MONITOR, V14, pLE15; Rafael H, 2009, MED SCI MONITOR, V15, pLE5; Rajab A, 2008, CELL TRANSPLANT, V17, P1015, DOI 10.3727/096368908786991533; Ramachandra R, 2008, CELL TRANSPLANT, V17, P479; Rehnmark A, 2009, CELL TRANSPLANT, V18, P232; Revoltella RP, 2008, CELL TRANSPLANT, V17, P665, DOI 10.3727/096368908786092685; Rising A, 2008, CELL TRANSPLANT, V17, P479; Rodriguez-Mulero S, 2008, CELL TRANSPLANT, V17, P1025, DOI 10.3727/096368908786991524; Ross JM, 2009, CELL TRANSPLANT, V18, P232; Rossignol J, 2009, CELL TRANSPLANT, V18, P233; Sabek OM, 2008, CELL TRANSPLANT, V17, P785, DOI 10.3727/096368908786516747; Sakai S, 2009, CELL TRANSPLANT, V18, P933, DOI 10.3727/096368909X471143; Sanchez-Ramos J, 2009, CELL TRANSPLANT, V18, P233; Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289; Sanz-Ruiz R, 2009, CELL TRANSPLANT, V18, P245, DOI 10.3727/096368909788534889; Sasaki K, 2008, CELL TRANSPLANT, V17, P1221, DOI 10.3727/096368908787236666; Schafer R, 2008, CELL TRANSPLANT, V17, P923, DOI 10.3727/096368908786576480; Seidel M, 2009, CELL TRANSPLANT, V18, P695, DOI 10.3727/096368909X470810; Selenica MB, 2008, CELL TRANSPLANT, V17, P479; Selenica MLB, 2009, CELL TRANSPLANT, V18, P233; Shahaduzzaman SD, 2009, CELL TRANSPLANT, V18, P234; Sharma AD, 2008, CELL TRANSPLANT, V17, P313, DOI 10.3727/096368908784153896; Sherman W, 2009, CELL TRANSPLANT, V18, P333, DOI 10.3727/096368909788534933; Shytle RD, 2008, CELL TRANSPLANT, V17, P480; Silva SA, 2009, CELL TRANSPLANT, V18, P343, DOI 10.3727/096368909788534951; Sinden J, 2009, CELL TRANSPLANT, V18, P234; Singec I, 2009, CELL TRANSPLANT, V18, P234; Singh RP, 2008, CELL TRANSPLANT, V17, P480; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Singh RP, 2009, CELL TRANSPLANT, V18, P55, DOI 10.3727/096368909788237177; Sladek JR, 2008, CELL TRANSPLANT, V17, P480; Sladek JR, 2008, CELL TRANSPLANT, V17, P427; Sladek JR, 2009, CELL TRANSPLANT, V18, P234; Sladek JR, 2009, CELL TRANSPLANT, V18, P689, DOI 10.3727/096368909X470892; Smith AJ, 2009, CELL TRANSPLANT, V18, P235; Snyder EY, 2009, CELL TRANSPLANT, V18, P207, DOI 10.3727/096368909788341315; Soderstrom KE, 2008, CELL TRANSPLANT, V17, P585; Solan A, 2009, CELL TRANSPLANT, V18, P915, DOI 10.3727/096368909X471161; Sommaggio R, 2009, CELL TRANSPLANT, V18, P1381, DOI 10.3727/096368909X474249; Sortwell CE, 2008, CELL TRANSPLANT, V17, P481; Spieles-Engemann AL, 2008, CELL TRANSPLANT, V17, P481; Spieles-Engemann AL, 2009, CELL TRANSPLANT, V18, P235; Stancati JA, 2008, CELL TRANSPLANT, V17, P482; Steece-Collier K, 2008, CELL TRANSPLANT, V17, P482; Steece-Collier K, 2009, CELL TRANSPLANT, V18, P236; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Stoner S, 2009, CELL TRANSPLANT, V18, P236; Storn V, 2008, CELL TRANSPLANT, V17, P543, DOI 10.3727/096368908785095999; Stromberg I, 2008, CELL TRANSPLANT, V17, P482; Stromberg I, 2009, CELL TRANSPLANT, V18, P237; Suarez-Pinzon WL, 2008, CELL TRANSPLANT, V17, P631, DOI 10.3727/096368908786092775; Sumitran-Holgersson S, 2009, CELL TRANSPLANT, V18, P183, DOI 10.3727/096368909788341333; Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878; Suzuki C, 2008, CELL TRANSPLANT, V17, P223, DOI 10.3727/000000008783907053; Suzuki M, 2008, CELL TRANSPLANT, V17, P482; Tai JH, 2008, CELL TRANSPLANT, V17, P1349, DOI 10.3727/096368908787648092; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Tate CC, 2008, CELL TRANSPLANT, V17, P483; Tateishi K, 2008, CELL TRANSPLANT, V17, P549, DOI 10.3727/096368908785096024; Taupin P, 2008, MED SCI MONITOR, V14, pLE6; Taupin P, 2009, MED SCI MONITOR, V15, pLE1; Teng YD, 2009, CELL TRANSPLANT, V18, P237; Terpstra BT, 2008, CELL TRANSPLANT, V17, P483; Thai HM, 2009, CELL TRANSPLANT, V18, P283, DOI 10.3727/096368909788535004; Thanos CG, 2009, CELL TRANSPLANT, V18, P1395, DOI 10.3727/096368909X12483162197402; Tharavanij T, 2009, CELL TRANSPLANT, V18, P453, DOI 10.3727/096368909788809848; Thompson VB, 2009, CELL TRANSPLANT, V18, P237; Tian C, 2008, CELL TRANSPLANT, V17, P325, DOI 10.3727/096368908784153841; Timmer M, 2009, CELL TRANSPLANT, V18, P238; Tokdemir M, 2009, MED SCI MONITOR, V15, pPI1; Tokiwa T, 2008, CELL TRANSPLANT, V17, P179, DOI 10.3727/000000008783907080; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Torres EM, 2008, CELL TRANSPLANT, V17, P535, DOI 10.3727/096368908785096006; Tredget EB, 2008, CELL TRANSPLANT, V17, P599, DOI 10.3727/096368908786092757; Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542; Ueda M, 2008, CELL TRANSPLANT, V17, P91, DOI 10.3727/000000008783906892; Valeikiene V, 2008, MED SCI MONITOR, V14, pCR221; van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515; Vaysse L, 2008, CELL TRANSPLANT, V17, P484; VAZEY EM, 2008, CELL TRANSPLANT, V17, P484; Vazin T, 2008, CELL TRANSPLANT, V17, P485; Vazin T, 2009, CELL TRANSPLANT, V18, P238; Vergani A, 2009, CELL TRANSPLANT, V18, P827, DOI 10.3727/096368909X472278; Vidal I, 2008, CELL TRANSPLANT, V17, P507, DOI 10.3727/096368908785096051; Vinerean HV, 2008, CELL TRANSPLANT, V17, P567, DOI 10.3727/096368908785095962; Vorobyeva TM, 2009, CELL TRANSPLANT, V18, P239; Vriens AP, 2008, CELL TRANSPLANT, V17, P1199, DOI 10.3727/096368908787236521; Wakeman DR, 2009, CELL TRANSPLANT, V18, P239; Walczak P, 2009, CELL TRANSPLANT, V18, P239; Wang L, 2009, CELL TRANSPLANT, V18, P240; Wee YM, 2008, CELL TRANSPLANT, V17, P1257, DOI 10.3727/096368908787236657; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; Weeks BS, 2009, MED SCI MONITOR, V15, pBR43; Weeks BS, 2008, MED SCI MONITOR, V14, pBR279; Wehberg KE, 2009, CELL TRANSPLANT, V18, P353, DOI 10.3727/096368909788534988; Wei YY, 2009, CELL TRANSPLANT, V18, P159, DOI 10.3727/096368909788341261; Wei YD, 2008, MED SCI MONITOR, V14, pBR198; Weyrauch UM, 2009, CELL TRANSPLANT, V18, P471, DOI 10.3727/096368909788809802; White TE, 2008, CELL TRANSPLANT, V17, P485; Womble TA, 2008, CELL TRANSPLANT, V17, P485; Womble TA, 2009, CELL TRANSPLANT, V18, P240; Woods RL, 2009, CELL TRANSPLANT, V18, P241; Worden LT, 2009, CELL TRANSPLANT, V18, P241; Xue YQ, 2008, CELL TRANSPLANT, V17, P486; Yamasaki T, 2008, MED SCI MONITOR, V14, pCS23; Yamashita T, 2009, CELL TRANSPLANT, V18, P999, DOI 10.3727/096368909X471233; Yang T, 2009, CELL TRANSPLANT, V18, P391, DOI 10.3727/096368909788809767; Yerebakan C, 2009, CELL TRANSPLANT, V18, P855, DOI 10.3727/096368909X471170; Yokokawa M, 2008, CELL TRANSPLANT, V17, P1145, DOI 10.3727/096368908787236594; Yoshida Y, 2008, CELL TRANSPLANT, V17, P83, DOI 10.3727/000000008783907017; Yoshida Y, 2009, CELL TRANSPLANT, V18, P535, DOI 10.1177/096368970901805-608; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Yu CH, 2009, CELL TRANSPLANT, V18, P1081, DOI 10.3727/096368909X12483162196647; Yu DH, 2008, CELL TRANSPLANT, V17, P1371, DOI 10.3727/096368908787648029; Yu GL, 2008, MED SCI MONITOR, V14, pRA163; Yu S, 2009, CELL TRANSPLANT, V18, P241; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Yuasa T, 2008, CELL TRANSPLANT, V17, P187, DOI 10.3727/000000008783906973; Yuasa T, 2009, CELL TRANSPLANT, V18, P683, DOI 10.1177/096368970901805-625; Yukawa H, 2008, CELL TRANSPLANT, V17, P43, DOI 10.3727/000000008783907071; Yukawa H, 2009, CELL TRANSPLANT, V18, P591, DOI 10.1177/096368970901805-615; Yukawa H, 2009, CELL TRANSPLANT, V18, P611, DOI 10.1177/096368970901805-617; Yukawa H, 2009, CELL TRANSPLANT, V18, P601, DOI 10.1177/096368970901805-616; Yurek DM, 2009, CELL TRANSPLANT, V18, P1183, DOI 10.3727/096368909X12483162196881; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140; Zayko O, 2008, CELL TRANSPLANT, V17, P486; Zhang D, 2008, CELL TRANSPLANT, V17, P159, DOI 10.3727/000000008783907134; Zhang HQ, 2008, CELL TRANSPLANT, V17, P195, DOI 10.3727/000000008783906955; Zhang JH, 2008, MED SCI MONITOR, V14, pRA1; Zhao LR, 2008, CELL TRANSPLANT, V17, P487; Zhao XD, 2008, CELL TRANSPLANT, V17, P99, DOI 10.3727/000000008783906928; Zhao YM, 2008, CELL TRANSPLANT, V17, P775, DOI 10.3727/096368908786516846; Zheng CL, 2009, CELL TRANSPLANT, V18, P1093, DOI 10.3727/096368909X12483162197042; Zhu Y, 2009, CELL TRANSPLANT, V18, P242; Zinnanti WJ, 2008, CELL TRANSPLANT, V17, P487; Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839	489	12	13	0	25	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor		2010	16	10					RA197	RA217					21	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	670SF	WOS:000283446900020	20885363				2022-02-06	
J	Ilves, P; Lintrop, M; Talvik, I; Sisko, A; Talvik, T				Ilves, Pilvi; Lintrop, Mare; Talvik, Inga; Sisko, Annika; Talvik, Tiina			Predictive value of clinical and radiological findings in inflicted traumatic brain injury	ACTA PAEDIATRICA			English	Article						Head trauma; Infants; Inflicted traumatic brain injury; Shaken baby syndrome	SHAKEN BABY SYNDROME; YOUNG-CHILDREN; HEAD-INJURY; PRACTICAL SCALE; CHILDHOOD; INFANTS; ESTONIA; ABUSE; IMPACT; MILD	Aims: The aim of this study is to evaluate the value of early radiological investigations in predicting the long-term neurodevelopmental outcome of infants with inflicted traumatic brain injury (ITBI). Methods: Clinical and radiological investigations of 24 infants with ITBI were performed during the acute phase of injury (1-3 days), and during the early (4 days up to 3 months) and late (> 9 months) postinjury phases. The clinical outcome in survivors (n = 22) was based on the Rankin Disability Scale and the Glasgow Outcome Score. Results: Five out of 24 infants (21%) had a poor neurodevelopmental outcome (death and severe disability), 17 infants (71%) had different developmental problems and 2 infants were normal at the mean age of 62 (54-70) (95% CI) months. A low initial Glasgow Coma Scale score of 8 or below [p < 0.05, OR 13.0 (1.3-133.3)], the development of brain oedema [p < 0.005, OR 13.0 (1.6-773)], focal changes in the basal ganglia during the acute phase [p < 0.01, OR 45 (2.1-937.3)], the development of new intracerebral focal changes early postinjury [p < 0.05, OR 24.1(1.0-559.1)], a decrease in white matter [p < 0.01, OR 33 (1.37-793.4)] and the development of severe atrophy before 3 months postinjury [p < 0.05, OR 24 (11.0-559.1)] were significantly correlated with a poor neurodevelopmental outcome. Conclusions: Early clinical and radiological findings in ITBI are of prognostic value for neurodevelopmental outcome.	[Ilves, Pilvi; Lintrop, Mare] Univ Tartu, Dept Radiol, EE-51014 Tartu, Estonia; [Ilves, Pilvi; Lintrop, Mare] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Talvik, Inga; Talvik, Tiina] Univ Tartu, Dept Pediat, EE-51014 Tartu, Estonia; [Sisko, Annika] N Estonia Med Ctr, Diagnost Clin, Tallinn, Estonia; [Talvik, Inga; Talvik, Tiina] Tartu Univ Hosp, Childrens Clin, Tartu, Estonia		Ilves, P (corresponding author), Univ Tartu, Dept Radiol, L Puusepa 2, EE-51014 Tartu, Estonia.	pilvi.ilves@kliinikum.ee	Ilves, PIlvi/G-4934-2017	Ilves, PIlvi/0000-0002-0094-4998	TARLA 2695; GARLA 6627;  [SF0180161s08]	The study was supported by grant SF0180161s08, TARLA 2695, GARLA 6627. The authors wish to thank P. Kool for help in the statistical analysis of the data.	ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Husson B, 2002, STROKE, V33, P1280, DOI 10.1161/01.STR.0000014504.18199.0D; Ilves P, 2009, ACTA PAEDIATR, V98, P459, DOI 10.1111/j.1651-2227.2008.01119.x; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; RANKIN J, 1957, Scott Med J, V2, P200; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Talvik I, 2007, ACTA PAEDIATR, V96, P1164, DOI 10.1111/j.1651-2227.2007.00362.x; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; TEASDALE G, 1974, LANCET, V2, P81; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; ZEPP F, 1992, NEUROPEDIATRICS, V23, P188, DOI 10.1055/s-2008-1071338	30	12	12	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.		2010	99	9					1329	1336		10.1111/j.1651-2227.2010.01820.x			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	639JH	WOS:000280970600020	20377537				2022-02-06	
J	Kazerooni, R; Bounthavong, M				Kazerooni, Rashid; Bounthavong, Mark			Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury	CLINICOECONOMICS AND OUTCOMES RESEARCH			English	Article						phenytoin; levetiracetam; seizure prophylaxis; cost-effectiveness; traumatic brain injury (TBI); and neurosurgery		Objective: There has been growing interest in newer anti-epileptic drugs (AEDs) for seizure prophylaxis in the intensive care setting because of safety and monitoring issues associated with conventional AEDs like phenytoin. This analysis assessed the cost-effectiveness of levetiracetam versus phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury (TBI). Methods: A cost-effectiveness analysis was conducted from the US hospital perspective using a decision analysis model. Probabilities of the model were taken from three studies comparing levetiracetam and phenytoin in post neurosurgery or TBI patients. The outcome measure was successful seizure prophylaxis regimen (SSPR) within 7 days, which was defined as patients who did not seize or require discontinuation of the AED due to adverse drug reactions (ADRs). One-way sensitivity analyses and probabilistic sensitivity analysis were conducted to test robustness of the base-case results. Results: The total direct costs for seizure prophylaxis were $8,784.63 and $8,743.78 for levetiracetam and phenytoin, respectively. The cost-effectiveness ratio of levetiracetam was $10,044.91 per SSPR compared to $11,525.63 per SSPR with phenytoin. The effectiveness probability (patients with no seizures and no ADR requiring change in therapy) was higher in the levetiracetam group (87.5%) versus the phenytoin group (75.9%). The incremental cost effectiveness ratio for levetiracetam versus phenytoin was $360.82 per additional SSPR gained. Conclusions: Levetiracetam has the potential to be more cost-effective than phenytoin for early onset seizure prophylaxis after neurosurgery if the payer's willingness-to-pay is greater than $360.82 per additional SSPR gained.	[Kazerooni, Rashid; Bounthavong, Mark] Vet Affairs San Diego Healthcare Syst, Pharmacoeconom Formulary Management, San Diego, CA 92161 USA; UCSD Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA		Bounthavong, M (corresponding author), UCSD Skaggs Sch Pharm & Pharmaceut Sci, Vet Affairs San Diego Healthcare Syst, 3350 Jolla Village Dr 119, San Diego, CA 92161 USA.	mark.bounthavong@va.gov		Bounthavong, Mark/0000-0002-7343-9458; Kazerooni, Rashid/0000-0003-3223-2597			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ALLEN JP, 1979, CLIN PHARMACOL THER, V26, P445, DOI 10.1002/cpt1979264445; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; BRIGGS A, 2006, DECISION MODELING HL; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Coplin W, 2001, P 70 AM ASS NEUR SUR; DEUTSCHMAN CS, 1985, NEUROSURGERY, V17, P510, DOI 10.1227/00006123-198509000-00021; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Fleming T, 2008, REDBOOK PHARM FUNDAM; FOY PM, 1981, ACTA NEUROCHIR, V57, P15, DOI 10.1007/BF01665108; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Holland JP, 1994, P 125 M SOC BRIT NEU; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Manaka S, 2003, NEUROL MED-CHIR, V43, P589, DOI 10.2176/nmc.43.589; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; Pagni CA, 2005, ACT NEUR S, V93, P27; Petitti DB, 2000, METAANALYSIS DECISIO; Scheinfeld Noah, 2004, Expert Opin Drug Saf, V3, P655, DOI 10.1517/14740338.3.6.655; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Shaw JW, 2002, FORMULARY, V37, P32; SHAW MDM, 1991, J ROY SOC MED, V84, P221, DOI 10.1177/014107689108400412; Swadron SP, 2004, ACAD EMERG MED, V11, P244, DOI 10.1197/j.aem.2003.10.022; Szaflarski JP, 2009, NEUROCRIT CARE; Temkin Nancy R., 2002, Epilepsy Curr, V2, P105, DOI 10.1046/j.1535-7597.2002.00038.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x	32	12	12	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6981			CLINICOECONOMIC OUTC	CLINICOECONOMICS OUTCOMES RES.		2010	2						15	23					9	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	V06RQ	WOS:000213957700002	21935311				2022-02-06	
J	Kochanek, PM; Bell, MJ; Bayir, H				Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya			Quo Vadis 2010? - Carpe Diem: Challenges and Opportunities in Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Head injury; Head trauma; Child abuse; Biomarker; Imaging; Treatment	NEURON-SPECIFIC ENOLASE; IMPAIRED CEREBRAL AUTOREGULATION; CONTROLLED CORTICAL IMPACT; TISSUE OXYGEN-TENSION; SEVERE HEAD-INJURY; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; MODERATE HYPOTHERMIA; OXIDATIVE STRESS; IMMATURE BRAIN	Traumatic brain injury (TBI) in infants and children remains a public health problem of enormous magnitude. It is a complex and heterogeneous condition that presents many diagnostic, therapeutic and prognostic challenges. A number of investigative teams are studying pediatric TBI both in experimental models and in clinical studies at the bedside. This review builds on work presented in a prior supplement to Developmental Neuroscience that was published in 2006, and addresses several active areas of research on this topic, including (1) the application of novel imaging methods, (2) the use of serum and/or CSF biomarkers of injury, (3) advances in neuromonitoring, (4) the development and testing of novel therapies, (5) developments in modeling pediatric TBI, (6) the consideration of a new approach to classification of pediatric TBI, and (7) assessing the potential impact of the development of pediatric and neonatal neurocritical care services on the management and outcome of pediatric TBI. Copyright (C) 2011 S. Karger AG, Basel	[Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.; Bayir, Huelya] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	 [NS30318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318] Funding Source: NIH RePORTER	Work on this review was supported in part by NS30318. We thank Cara Boyer, Fran Mistrick and Marci Provins for their assistance with manuscript preparation.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Baltagi SA, 2010, PEDIATR CRIT CARE ME, V11, P179, DOI 10.1097/PCC.0b013e3181cf4652; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; CLIFTON G, 2009, P 3 INT HYP S LUND, P8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; EXO J, 2010, PEDIAT CRIT CARE MED; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FRASER DD, 2010, PEDIAT CRIT CARE MED; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Glass HC, 2010, NEUROCRIT CARE, V12, P421, DOI 10.1007/s12028-009-9324-7; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; KERNIE SG, 2009, P 2 JOINT S INT NAT; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek PM, 2010, JAMA-J AM MED ASSOC, V303, P2190, DOI 10.1001/jama.2010.715; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MAEKAWA T, 2009, P 3 INT HYP S LUND, P8; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Richards EM, 2006, FREE RADICAL BIO MED, V40, P1960, DOI 10.1016/j.freeradbiomed.2006.01.022; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; TASKER RC, 2010, DEV NEUROSCI; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; WRIGHT J, 2010, DEV NEUROSCI; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	81	12	13	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					335	342		10.1159/000323016			8	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900002	21252553	Green Published, Bronze			2022-02-06	
J	Munjal, SK; Panda, NK; Pathak, A				Munjal, Sanjay K.; Panda, Naresh K.; Pathak, Ashis			Audiological Deficits After Closed Head Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Closed head injury; Audiological deficits; Hearing loss	HEARING-LOSS; EVOKED-POTENTIALS; BRAIN-INJURY; TRAUMA; RESPONSES	Background: Damage to the peripheral auditory structures has long been recognized as a common component of head injury. It is estimated that a majority of patients with skull trauma have resultant hearing impairment. Damage to the peripheral and/or central auditory pathways can occur as a primary or secondary injury. Considering the high incidence of hearing loss, it was considered worthwhile to conduct an in-depth investigation by administering a comprehensive audiological test battery on head-injured patients. Method: The sample population consisted of 290 subjects with closed head injury (study group) and 50 subjects with otologically normal subjects (control group). The subjects in the study group were further divided into mild (n = 150), moderate (n = 100), and severe (it = 40) category on the basis of Glasgow Coma Scale score. The audiological assessment consisted of pure tone audiometry, speech audiometry, tympanometry, acoustic reflex testing, auditory brain stern response audiometry, and middle latency re-spouse audiometry. Results and Conclusions: It is concluded that there is higher prevalence of hearing impairment in the study group compared with control group. Majority of the patients who incur hearing loss after closed head injury have mild degree of hearing impairment. A significant difference between the study and control group observed on majority of the auditory brain stern response and middle latency response parameters studied.	[Munjal, Sanjay K.; Panda, Naresh K.] Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India; [Pathak, Ashis] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India		Munjal, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India.	sanjaymunjall@rediffmail.com		Munjal, Sanjay/0000-0002-5738-6114			ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; GHORAYEB BY, 1987, ARCH OTOLARYNGOL, V113, P749; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; GROVE WE, 1947, ANN OTO RHINOL LARYN, V56, P264; HALL JW, 1986, EAR HEARING, V7, P383, DOI 10.1097/00003446-198612000-00007; Heid Lorant, 2004, Int Tinnitus J, V10, P94; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; KAYE AH, 1991, HEAD INJURIES, P59; Lew HL, 2004, AM J PHYS MED REHAB, V83, P210, DOI 10.1097/01.PHM.0000113402.85460.59; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P176; LIDEN G, 1974, ARCH OTOLARYNGOL, V99, P23; Nosan DK, 1997, OTOLARYNG HEAD NECK, V117, P67, DOI 10.1016/S0194-5998(97)70209-2; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, P1181; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	25	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2010	68	1					13	18		10.1097/TA.0b013e3181c9f274			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	543NR	WOS:000273585800004	20065751				2022-02-06	
S	Olden, M; Cukor, J; Rizzo, A; Rothbaum, B; Difede, J		Barchas, JD; Difede, J		Olden, Megan; Cukor, Judith; Rizzo, Albert 'Skip'; Rothbaum, Barbara; Difede, JoAnn			House calls revisited: leveraging technology to overcome obstacles to veteran psychiatric care and improve treatment outcomes	PSYCHIATRIC AND NEUROLOGIC ASPECTS OF WAR	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	89th Annual Conference of the Association for Research in Nervous and Mental Disease	DEC 16, 2009	Rockefeller Univ, New York, NY		Rockefeller Univ	telemedicine; virtual reality; videoconferencing; OIF/OEF veterans; barriers to care	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; EXPOSURE THERAPY; FAMILY CAREGIVERS; RANDOMIZED-TRIAL; ANGER MANAGEMENT; TELEPSYCHIATRY; TELEMEDICINE	Despite an increasing number of military service members in need of mental health treatment following deployment to Iraq and Afghanistan, numerous psychological and practical barriers limit access to care. Perceived stigma about admitting psychological difficulties as well as frequent long distances to treatment facilities reduce many veterans' willingness and ability to receive care. Telemedicine and virtual human technologies offer a unique potential to expand services to those in greatest need. Telemedicine-based treatment has been used to address multiple psychiatric disorders, including posttraumatic stress disorder, depression, and substance use, as well as to provide suicide risk assessment and intervention. Clinician education and training has also been enhanced and expanded through the use of distance technologies, with trainees practicing clinical skills with virtual patients and supervisors connecting with clinicians via videoconferencing. The use of these innovative and creative vehicles offers a significant and as yet unfulfilled promise to expand delivery of high-quality psychological therapies, regardless of clinician and patient location.	[Olden, Megan; Cukor, Judith; Difede, JoAnn] Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA; [Rizzo, Albert 'Skip'] Univ So Calif, Dept Psychiat, Inst Creat Technol, Playa Vista, CA USA; [Rizzo, Albert 'Skip'] Univ So Calif, Sch Gerontol, Playa Vista, CA USA; [Rothbaum, Barbara] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA		Olden, M (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA.	meo9011@med.cornell.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR024998] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1 RR024998] Funding Source: Medline		Barretro A, 2006, J APPL BEHAV ANAL, V39, P333, DOI 10.1901/jaba.2006.173-04; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Beutler LE, 2004, J CLIN PSYCHOL, V60, P317, DOI 10.1002/jclp.10266; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Burnam A, 2009, HEALTH AFFAIR, V28, P771, DOI 10.1377/hlthaff.28.3.771; Burnam MA, 2008, INVISIBLE WOUNDS WAR, P245; Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173; Caspar F, 2004, J CLIN PSYCHOL, V60, P221, DOI 10.1002/jclp.10260; Cawkill P, 2004, J R Army Med Corps, V150, P91; Courtois CA, 2009, PSYCHOL TRAUMA-US, V1, P3, DOI 10.1037/a0015224; Deitsch SE, 2000, J TELEMED TELECARE, V6, P184, DOI 10.1258/1357633001935194; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; DIFEDE J, 2006, NOVEL APPROACHES DIA, P219; Dobscha SK, 2005, TELEMED J E-HEALTH, V11, P84, DOI 10.1089/tmj.2005.11.84; Druss BG, 1997, PSYCHOSOMATICS, V38, P451, DOI 10.1016/S0033-3182(97)71422-1; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; FOA EB, 1999, AM J CLIN PSYCHIAT, V60, P5; Fortney JC, 2007, J GEN INTERN MED, V22, P1086, DOI 10.1007/s11606-007-0201-9; Frueh BC, 2007, BEHAV MODIF, V31, P856, DOI 10.1177/0145445507302125; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Garcia-Lizana F, 2010, PERSPECT PSYCHIATR C, V46, P119, DOI 10.1111/j.1744-6163.2010.00247.x; Germain Vanessa, 2009, Cognitive Behaviour Therapy, V38, P42, DOI 10.1080/16506070802473494; Gilkey SL, 2009, FAM SOC, V90, P37, DOI 10.1606/1044-3894.3843; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Himle MB, 2010, COGN BEHAV PRACT, V17, P329, DOI 10.1016/j.cbpra.2010.02.006; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder Board on Population Health and Public Health Practice, 2008, TREATM POSTTR STRESS; Jong Michael, 2004, Int J Circumpolar Health, V63, P422; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; King VL, 2009, J SUBST ABUSE TREAT, V36, P331, DOI 10.1016/j.jsat.2008.06.011; Langston V, 2007, MIL MED, V172, P931, DOI 10.7205/MILMED.172.9.931; Lutz BJ, 2009, DISABIL REHABIL, V31, P402, DOI 10.1080/09638280802069558; Morland LA, 2004, J TELEMED TELECARE, V10, P286, DOI 10.1258/1357633042026387; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Myers K, 2006, J ADOLESCENT HEALTH, V38, P643, DOI 10.1016/j.jadohealth.2005.07.015; Myers KM, 2008, TELEMED J E-HEALTH, V14, P131, DOI 10.1089/tmj.2007.0035; Nelson EL, 2006, COUNS PSYCHOTHER RES, V6, P191, DOI 10.1080/14733140600862303; Oakes J, 2008, J GAMBL STUD, V24, P107, DOI 10.1007/s10899-007-9074-4; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Rees CS, 2005, PROF PSYCHOL-RES PR, V36, P649, DOI 10.1037/0735-7028.36.6.649; Reilly RO, 2007, PSYCHIAT SERV, V58, P836; RIZZO AA, 2010, AM BEHAV SC IN PRESS; Rotondi AJ, 2005, REHABIL PSYCHOL, V50, P325, DOI 10.1037/0090-5550.50.4.325; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Savin D, 2006, J AM ACAD CHILD PSY, V45, P484, DOI 10.1097/01.chi.0000198594.68820.59; Shepherd L, 2006, J PAIN SYMPTOM MANAG, V32, P453, DOI 10.1016/j.jpainsymman.2006.05.018; Shore JH, 2007, GEN HOSP PSYCHIAT, V29, P199, DOI 10.1016/j.genhosppsych.2007.01.013; Shore JH, 2004, TELEMED J E-HEALTH, V10, pS64; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Steffen AM, 2000, BEHAV THER, V31, P281, DOI 10.1016/S0005-7894(00)80016-7; Taylor DM, 2009, TELEMED J E-HEALTH, V15, P646, DOI 10.1089/tmj.2008.0165; Tuerk PW, 2010, J TRAUMA STRESS, V23, P116, DOI 10.1002/jts.20494; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Warner CH, 2008, MIL MED, V173, P563, DOI 10.7205/MILMED.173.6.563; WILLIAMS JB, 2007, ANN GEN PSYCHIAT, V6; Witmans MB, 2008, BEHAV SLEEP MED, V6, P207, DOI 10.1080/15402000802371312; WRAY BT, 2003, AUSTR ASS COGN BEH T; Yellowlees PM, 2008, J AM ACAD CHILD PSY, V47, P103, DOI 10.1097/chi.0b013e31815a56a7	63	12	12	0	21	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-804-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1208						133	+		10.1111/j.1749-6632.2010.05756.x			4	Neurosciences; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	BSK28	WOS:000284742000017	20955335	Green Accepted			2022-02-06	
J	Theobald, P; Whitelegg, L; Nokes, LDM; Jones, MD				Theobald, Peter; Whitelegg, Liam; Nokes, Leonard D. M.; Jones, Michael D.			The predicted risk of head injury from fall-related impacts on to third-generation artificial turf and grass soccer surfaces: A comparative biomechanical analysis	SPORTS BIOMECHANICS			English	Article						Artificial; head; injury; soccer; turf	CONCUSSION; SYSTEM	The risk of soccer players sustaining mild traumatic brain injury (MTBI) following head impact with a playing surface is unclear. This study investigates MTBI by performing headform impact tests from varying heights onto a range of third-generation artificial turf surfaces. Each turf was prepared as per manufacturers specifications within a laboratory, before being tested immediately following installation and then again after a bedding-in period. Each turf was tested dry and when wetted to saturation. Data from the laboratory tests were compared to an in situ third-generation surface and a professional grass surface. The surface performance threshold was set at a head impact criterion (HIC)=400, which equates to a 10% risk of the head impact causing MTBI. All six third-generation surfaces had a 10% risk of MTBI from a fall 0.77m; the inferior surfaces required a fall from just 0.46m to have a 10% MTBI risk. Wetting the artificial turf did not produce a statistically significant improvement (P 0.01). The in situ third-generation playing surface produced HIC values within the range of bedded-in experimental values. However, the natural turf pitch was the superior performer - necessitating fall heights exceeding those achievable during games to achieve HIC=400.	[Theobald, Peter; Whitelegg, Liam; Nokes, Leonard D. M.; Jones, Michael D.] Cardiff Univ, Inst Med Engn & Med Phys, Trauma Biomech Res Grp, Cardiff CF24 3AA, S Glam, Wales		Jones, MD (corresponding author), Cardiff Univ, Inst Med Engn & Med Phys, Trauma Biomech Res Grp, Cardiff CF24 3AA, S Glam, Wales.	JonesMD1@Cardiff.ac.uk	Theobald, Peter S/C-2490-2013	Theobald, Peter S/0000-0002-3227-7130			Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; BJORNEBOE J, 2008, BRIT J SPORT MED, V42, P494; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; *BSI, 1998, 71881998 BSI; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; *FIFA, 2008, QUAL CONC FOOTB TURF; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hrysomallis C, 2004, J SCI MED SPORT, V7, P156, DOI 10.1016/S1440-2440(04)80005-7; KING AI, 2003, INT C BIOM IMP LISB; Mahieu NN, 2006, AM J SPORT MED, V34, P226, DOI 10.1177/0363546505279918; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Naunheim R, 2002, J TRAUMA, V53, P691, DOI 10.1097/00005373-200210000-00012; PRASAD P, 1985, 851246 SAE; Shorten MR, 2003, SPORTS SURFACES; SOLIGARD T, 2008, BRIT J SPORT MED, V42, P494; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; STOJSIH S, 2008, BRIT J SPORTS MED	20	12	12	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.		2010	9	1					29	37	PII 920020742	10.1080/14763141003690245			9	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	597IR	WOS:000277750800003	20446637				2022-02-06	
J	Wong, MN; Murdoch, B; Whelan, BM				Wong, Min Ney; Murdoch, Bruce; Whelan, Brooke-Mai			Language disorders subsequent to mild traumatic brain injury (MTBI): Evidence from four cases	APHASIOLOGY			English	Article						MTBI; Cognition; General language; High-level language	CLOSED-HEAD-INJURY; REHABILITATION; PERFORMANCE; IMPAIRMENT; DISCOURSE; FLUENCY; ADULTS	Background: The majority of cognitive research conducted within the mild traumatic brain injury (MTBI) population has been predominantly neuropsychologically based, lacking in-depth linguistic analysis. The effect of MTBI on language function has received little attention and remains largely unexplored. Aims: This study was undertaken to explore in detail cognitive-linguistic impairments following MTBI, via the application of a comprehensive assessment battery. Methods & Procedures: Four participants with MTBI were administered a comprehensive battery of cognitive-linguistic assessments at 6 months post injury. The control group consisted of 10 age-, sex- and education-level-matched, non-neurologically impaired participants. Non-parametric group comparisons between the MTBI and matched controls participants were carried out, followed by case-by-case analysis. Outcomes & Results: Non-parametric between-group comparisons failed to reveal statistically significant differences between the MTBI and control participants across subtests. In case-by-case analyses, however, below normal performance on a range of subtests was demonstrated by the MTBI participants. Conclusions: Findings suggest high-level cognitive-linguistic deficits may occur as a consequence of MTBI and imply that MTBI mechanisms may have the capacity to alter frontal lobe functioning. It is suggested that more sensitive measures of cognitive and high-level language function are needed in the assessment of MTBI.	[Wong, Min Ney] Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Wong, MN (corresponding author), Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	min.wong@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Wong, Min Ney/0000-0003-0585-3566; Whelan, Brooke-Mai/0000-0002-7909-3160			Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Chapey R., 2008, LANGUAGE INTERVENTIO; Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; De Gaspari D, 2006, PARKINSONISM RELAT D, V12, P289, DOI 10.1016/j.parkreldis.2006.01.001; DODD DH, 1980, COGNITION MENTAL STR; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Frattali C. M., 1995, AM SPEECH LANGUAGE H; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Guilford J. P., 1967, NATURE HUMAN INTELLI; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hinchliffe FJ, 2001, TRAUMATIC BRAIN INJU, P199; Holland A., 1999, COMMUNICATION ACTIVI; Huisingh R, 1990, WORD TEST REVISED TE; Isaki E, 2000, BRAIN INJURY, V14, P441; Japp J., 2005, BRAIN INJURY RETURNI; Kaplan E, 1983, BOSTON NAMING TEST; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kertesz A., 1982, W APHASIA BATTERY; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Levin H.S., 1989, MILD HEAD INJURY; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINDFORS J, 1987, CHILDRENS LANGUAGE L; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Randolph C, 1999, ARCH CLIN NEUROPSYCH, V14, P489, DOI 10.1016/S0887-6177(98)00023-7; Randolph C., 2001, REPEATABLE BATTERY A; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; Spreen O., 1969, NEUROSENSORY CTR COM; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Terrell TR, 2004, SOUTH MED J, V97, P837, DOI 10.1097/01.SMJ.0000140091.58338.1E; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; *UN DAT SYST MED R, 1996, FUNCT IND MEAS; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wrightson P, 1999, MILD HEAD INJURY GUI; Ylvisaker M., 2001, LANGUAGE INTERVENTIO; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	60	12	12	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2010	24	10					1155	1169		10.1080/02687030903168212			15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	659PV	WOS:000282580300003					2022-02-06	
B	Ylvisaker, M; Feeney, T		Anderson, V; Jacobs, R; Anderson, PJ		Ylvisaker, Mark; Feeney, Timothy			Helping children without making them helpless: Facilitating development of executive self-regulation in children and adolescents	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; LONG-TERM METHYLPHENIDATE; READING-COMPREHENSION; BEHAVIORAL INTERVENTIONS; YOUNG-CHILDREN; STUDENTS; TBI; SUPPORTS; OUTCOMES; CHOICE		[Ylvisaker, Mark] Coll St Rose, Sch Educ, Albany, NY 12203 USA; [Feeney, Timothy] Sch Community Support Serv, Schenectady, NY USA		Ylvisaker, M (corresponding author), Coll St Rose, Sch Educ, Albany, NY 12203 USA.						ABIKOFF H, 1991, J LEARN DISABIL, V24, P205, DOI 10.1177/002221949102400404; Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P820, DOI 10.1097/01.chi.0000128797.91601.1a; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Aspinwall LG, 2000, LAWS LIF SYMP SER, V2, P163; Baker S., 2002, LEARNING DISABILITIE, V17, P65, DOI DOI 10.1111/1540-5826.00032; Barkley R.A., 1997, ADHD NATURE SELF CON; Barkley Russell A, 2004, J Psychiatr Pract, V10, P39, DOI 10.1097/00131746-200401000-00005; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Berk Laura E., 2001, AWAKENING CHILDRENS; Block C., 2002, COMPREHENSION INSTRU; Borkowski J. G., 1996, ATTENTION MEMORY EXE, P235; Borkowski J. G., 2000, ISSUES MEASUREMENT M; BORKOWSKI JG, 1988, J EDUC PSYCHOL, V80, P46, DOI 10.1037/0022-0663.80.1.46; Borkowski JohnG., 1990, DIMENSIONS THINKING, V1, P53; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Brown R, 1996, J EDUC PSYCHOL, V88, P18, DOI 10.1037/0022-0663.88.1.18; BULGREN JA, 2006, TEACHING ADOLESCENTS, P79; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Curtis, 1988, ALTERNATIVE ED DELIV, P391; Damasio A., 1994, DESCARTES ERROR EMOT; Deci E., 2002, HDB SELF DETERMINATI; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Detterman DL, 1993, TRANSFER TRIAL INTEL; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FEENEY T, J POSITIVE IN PRESS; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fitzsimons G.M., 2004, HDB SELF REGULATION, P151; Gersten R, 2001, REV EDUC RES, V71, P279, DOI 10.3102/00346543071002279; Gillham JE, 2000, LAWS LIF SYMP SER, V2, P3; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; Graham S., 2003, HDB LEARNING DISABIL, P323; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331, DOI 10.1177/001440290106700303; GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890; GROLNICK WS, 1989, J EDUC PSYCHOL, V81, P143, DOI 10.1037/0022-0663.81.2.143; Guthrie JT, 2000, J EDUC PSYCHOL, V92, P331, DOI 10.1037/0022-0663.92.2.331; Hechtman L, 2004, J AM ACAD CHILD PSY, V43, P812, DOI 10.1097/01.chi.0000128796.84202.eb; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Kaemingk K, 1999, DEV NEUROPSYCHOL, V15, P111, DOI 10.1080/87565649909540741; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Kim AH, 2004, J LEARN DISABIL-US, V37, P105, DOI 10.1177/00222194040370020201; Landry SH, 2003, DEV NEUROPSYCHOL, V24, P559, DOI 10.1207/S15326942DN242&3_04; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Larsen R.J., 2004, HDB SELF REGULATION, P40; Laurent AC, 2004, TOP LANG DISORD, V24, P286, DOI 10.1097/00011363-200410000-00006; Mann L, 1979, TRAIL PROCESS HIST P; Martin JE, 2003, EXCEPT CHILDREN, V69, P431, DOI 10.1177/001440290306900403; McCabe L. A., 2004, HDB SELF REGULATION, P340; Meichenbaum, 1977, COGNITIVE BEHAV MODI; MEICHENBAUM D, 1998, NURTURING INDEPENDEN; Miller S.A., 2002, COGNITIVE DEV, V4th; Mischel W., 2004, HDB SELF REGULATION, P99; Nybo T, 1999, BRAIN INJURY, V13, P759; PALINSCAR AS, 1989, TEACHING UNDERSTANDI, V1; Peterson C., 1993, LEARNED HELPLESSNESS; Pressley M., 2006, READING INSTRUCTION, V3rd ed; PRESSLEY M, 1995, COGNITIVE STRATEGY I; Reeve J, 1999, J EDUC PSYCHOL, V91, P537, DOI 10.1037/0022-0663.91.3.537; Reeve J., 2002, HDB SELF DETERMINATI, V2, P183; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Resnick LB., 1987, ED LEARNING THINK; Robinson TR, 1999, J EDUC PSYCHOL, V91, P195, DOI 10.1037/0022-0663.91.2.195; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1998, PREFRONTAL CORTEX EX, P67; RUSSELL J, 1998, AUTISM EXECUTIVE DIS; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SAMSOTI FJ, 2004, FOCUS AUTISM OTHER D, V19, P194; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schmeichel B.J., 2004, HDB SELF REGULATION, DOI DOI 10.1016/J.CEDPSYCH.2015.01.001; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Skinner BF., 1953, SCI HUMAN BEHAV; SWANSON HL, 1999, LEARN DISABIL RES PR, V14, P129, DOI DOI 10.1207/SLDRP1403_; SWANSON HL, 2001, LEARN DISABIL RES PR, V16, P109, DOI DOI 10.1111/0938-8982.00012; Sweet AP, 2002, IMPROVING COMPREHENS, P17; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Vohs K. D., 2004, HDB SELF REGULATION, P1; Vohs KD, 2004, HDB SELF REGULATION; Vygotsky L. S., 1962, THOUGHT LANGUAGE; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wehmeyer M, 1997, EXCEPT CHILDREN, V63, P245, DOI 10.1177/001440299706300207; Wehmeyer M. L., 1998, TEACHING SELF DETERM; Wehmeyer ML, 2000, EXCEPT CHILDREN, V66, P439, DOI 10.1177/001440290006600401; Wehmeyer ML., 1995, ARCS SELF DETERMINAT; Williams GC, 1996, J PERS SOC PSYCHOL, V70, P767, DOI 10.1037/0022-3514.70.4.767; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P181; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	105	12	12	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							409	438					30	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500020					2022-02-06	
J	Fietzek, UM; Kossmehl, P; Barthels, A; Ebersbach, G; Zynda, B; Wissel, J				Fietzek, U. M.; Kossmehl, P.; Barthels, A.; Ebersbach, G.; Zynda, B.; Wissel, J.			Botulinum toxin B increases mouth opening in patients with spastic trismus	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						botulinumtoxin; bruxism; movement disorders; neurorehabilitation; spasticity; trismus	ANTIBODY-FORMATION; CERVICAL DYSTONIA; DOUBLE-BLIND; NEUROTOXIN; MANAGEMENT; DISORDERS; EFFICACY; SPREAD; SAFETY	Background: Severe generalized spastic movement disorders of various aetiologies often involve the jaw muscles and lead to a spastic trismus with masseter muscle hypertonia. We report a placebo-controlled randomized study on patients with spastic trismus. Methods: Eleven patients with masseter hypertonia because of stroke, hypoxic encephalopathy or traumatic brain injury were allocated to either botulinum toxin serotype B (BoNT/B) injections into the masseter muscles or placebo treatment. The dental gap, the amount of saliva, salivation scales, and a clinical goal attainment were evaluated. Results: Three weeks after injection the BoNT/B group showed a significantly increased mouth opening compared with placebo treatment (P < 0.05). In addition to the muscle paralysing effect, a goal attainment scale demonstrated a clinical benefit for the BoNT/B group (P < 0.01). Conclusions: Botulinum toxin serotype B injections into the masseter muscles effectively reduce hypertonia and provide for better mouth opening, thereby contributing to a positive and desired clinical goal.	[Fietzek, U. M.; Kossmehl, P.; Wissel, J.] Kliniken Beelitz GmbH, Neurol Rehabil Klin, D-14547 Beelitz, Germany; [Fietzek, U. M.] Neurol Krankenhaus Munchen, Ctr Parkinsons Dis & Movement Disorders, D-80804 Munich, Germany; [Barthels, A.; Zynda, B.] MEDIAN Klin Grunheide, Rehabil Klin Neurol, D-15537 Grunheide, Germany; [Ebersbach, G.] Kliniken Beelitz GmbH, Movement Disorder Clin, D-14547 Beelitz, Germany		Wissel, J (corresponding author), Kliniken Beelitz GmbH, Neurol Rehabil Klin, Paracelsusring 6A, D-14547 Beelitz, Germany.	wissel@rehaklinik-beelitz.de		Ebersbach, Georg/0000-0003-3403-6987; Fietzek, Urban/0000-0002-4323-9930			Andrade L A, 1994, Arq Neuropsiquiatr, V52, P410; Aoki KR, 2002, TOXICON, V40, P923, DOI 10.1016/S0041-0101(02)00086-7; Berweck S, 2007, DEV MED CHILD NEUROL, V49, P62, DOI 10.1017/S0012162207000151; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brashear A, 1999, NEUROLOGY, V53, P1439, DOI 10.1212/WNL.53.7.1439; Brin MF, 1997, MUSCLE NERVE, pS208; BRINKE MAD, 2003, NEUROL REHABIL, V9, P153; BUCHBINDER D, 1993, J ORAL MAXIL SURG, V51, P863, DOI 10.1016/S0278-2391(10)80104-1; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; Dijkstra PU, 2004, ORAL ONCOL, V40, P879, DOI 10.1016/j.oraloncology.2004.04.003; Dodd SL, 1998, EUR J NEUROL, V5, P181, DOI 10.1046/j.1468-1331.1998.520181.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dressler D, 2003, EUR NEUROL, V49, P34, DOI 10.1159/000067023; Dressler D, 2006, NEUROTOX RES, V9, P121, DOI 10.1007/BF03033929; Herrmann J, 2004, ANN NEUROL, V55, P732, DOI 10.1002/ana.20098; JANKOVIC J, 1987, NEUROLOGY, V37, P616, DOI 10.1212/WNL.37.4.616; Kadyan V, 2005, ARCH PHYS MED REHAB, V86, P594, DOI 10.1016/j.apmr.2004.06.061; Kim HJ, 2000, ARCH NEUROL-CHICAGO, V57, P576, DOI 10.1001/archneur.57.4.576; Lew MF, 1997, NEUROLOGY, V49, P701, DOI 10.1212/WNL.49.3.701; LOU JS, 1995, MOVEMENT DISORD, V10, P680, DOI 10.1002/mds.870100527; Marien Manuel Jr., 1997, General Dentistry, V45, P350; Pal PK, 2000, NEUROLOGY, V54, P244, DOI 10.1212/WNL.54.1.244; Pathak MS, 2006, EUR J NEUROL, V13, P42, DOI 10.1111/j.1468-1331.2006.01444.x; Porta M, 2001, J NEUROL NEUROSUR PS, V70, P538, DOI 10.1136/jnnp.70.4.538; Restivo DA, 2005, NEUROLOGY, V64, P2152, DOI 10.1212/01.WNL.0000167410.39109.1C; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schwartz M, 2002, CLIN J PAIN, V18, pS198, DOI 10.1097/00002508-200211001-00013; Schwerin A, 2004, PEDIATR NEUROL, V31, P109, DOI 10.1016/j.pediatrneurol.2003.12.016; SHAARI CM, 1991, LARYNGOSCOPE, V101, P960; SIMPSON DM, 1997, MUSCLE NERVE       S, V6, P169; Spillane KS, 2003, AM J PHYS MED REHAB, V82, P485, DOI 10.1097/01.PHM.0000070110.26037.86; Tan EK, 2000, J AM DENT ASSOC, V131, P211, DOI 10.14219/jada.archive.2000.0149; TVETERAS K, 1986, CLIN OTOLARYNGOL, V11, P383, DOI 10.1111/j.1365-2273.1986.tb00141.x; VITA GM, 1995, ANESTHESIOLOGY, V82, P1097, DOI 10.1097/00000542-199505000-00002; Winterholler MGM, 2002, NEUROLOGY, V58, P502, DOI 10.1212/WNL.58.3.502; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9	36	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	DEC	2009	16	12					1299	1304		10.1111/j.1468-1331.2009.02723.x			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522BT	WOS:000271973400008	19566902				2022-02-06	
J	Curcoy, AI; Trenchs, V; Morales, M; Serra, A; Pineda, M; Pou, J				Curcoy, A. I.; Trenchs, V.; Morales, M.; Serra, A.; Pineda, M.; Pou, J.			Do retinal haemorrhages occur in infants with convulsions?	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							SHAKEN-BABY SYNDROME; INFLICTED CHILDHOOD NEUROTRAUMA; NOTHING GOES WRONG; HEAD-INJURY; YOUNG-CHILDREN; NUMERATORS; IF	Aim: To determine the prevalence of retinal haemorrhages in infants presenting with convulsions and admitted to hospital, and to consider whether this finding indicates shaken baby syndrome. Methods: Prospective study of children aged 15 days to 2 years admitted with a diagnosis of first convulsion over a 2-year period ( May 2004-May 2006). All infants were examined by an experienced ophthalmologist using indirect ophthalmoscopy within 72 h of admission. Results: 182 of 389 children seen in the accident and emergency department were admitted and two were found to have retinal haemorrhages. Both children were eventually diagnosed as being abused. Conclusions: Convulsions alone are unlikely to cause retinal haemorrhages in children under 2 years of age.	[Curcoy, A. I.; Trenchs, V.; Pou, J.] Hosp Univ St Joan de Deu, Dept Pediat, Barcelona, Spain; [Morales, M.; Serra, A.] Hosp Univ St Joan de Deu, Dept Ophthalmol, Barcelona, Spain; [Pineda, M.] Hosp Univ St Joan de Deu, Dept Neurol, Barcelona, Spain		Curcoy, AI (corresponding author), Passeig St Joan de Deu 2, Barcelona 08950, Spain.	acurcoy@hsjdbcn.org					Aghadoost D, 2004, Indian Pediatr, V41, P1271; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; CAFFEY J, 1974, PEDIATRICS, V54, P396; Barcenilla AIC, 2006, PEDIATR EMERG CARE, V22, P495, DOI 10.1097/01.pec.0000227385.46143.20; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Gardner HB, 2008, PEDIATR NEUROSURG, V44, P434, DOI 10.1159/000149917; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Gayle Michael O., 1995, Journal of Emergency Medicine, V13, P233, DOI 10.1016/0736-4679(94)00145-6; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Greeley CS, 2008, PEDIATR NEUROSURG, V44, P90, DOI 10.1159/000111260; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; KAUR B, 1990, ARCH DIS CHILD, V65, P1369, DOI 10.1136/adc.65.12.1369; King WJ, 2003, CAN MED ASSOC J, V168, P155; LeFanu J, 2004, BMJ-BRIT MED J, V328, P767, DOI 10.1136/bmj.328.7442.767; Mei-Zahav M, 2002, ARCH DIS CHILD, V86, P334, DOI 10.1136/adc.86.5.334; NEWMAN TB, 1995, JAMA-J AM MED ASSOC, V274, P1013, DOI 10.1001/jama.1995.03530130019013; Punt J, 2006, ARCH DIS CHILD, V91, P714; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Sandramouli S, 1997, ARCH DIS CHILD, V76, P449, DOI 10.1136/adc.76.5.449; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Tyagi AK, 1998, BRIT J OPHTHALMOL, V82, P659, DOI 10.1136/bjo.82.6.659	24	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888			ARCH DIS CHILD	Arch. Dis. Child.	NOV	2009	94	11					873	875		10.1136/adc.2007.132522			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	511UD	WOS:000271194000012	19666457				2022-02-06	
J	Arien-Zakay, H; Lecht, S; Bercu, MM; Amariglio, N; Rechavi, G; Galski, H; Lazarovici, P; Nagler, A				Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Amariglio, N.; Rechavi, G.; Galski, H.; Lazarovici, P.; Nagler, A.			Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors	LEUKEMIA			English	Article						human umbilical cord blood; neuronal progenitors; IFN-gamma; NGF; neuronal differentiation; gene expression	NERVE GROWTH-FACTOR; NEUROBLASTOMA-CELL-DIFFERENTIATION; TRAUMATIC BRAIN INJURY; STEM-CELLS; IFN-GAMMA; NEURITE OUTGROWTH; GENE-EXPRESSION; IN-VITRO; PC12 CELLS; PROMOTES DIFFERENTIATION	Human umbilical cord blood (HUCB) provides a source of progenitors for cell therapy. We isolated and characterized an HUCB-derived population of progenitors (HUCBNP), differentiated toward neuronal phenotype by human neuroblastoma-conditioning medium (CM) and nerve growth factor (NGF), which have been found to confer neuroprotection toward hypoxia-mediated neuronal injury. This study investigated whether interferon-gamma (IFN-gamma) contributes to HUCBNP differentiation. IFN-gamma was detected in the CM used for the induction of differentiation of HUCBNP and a neutralizing antibody of IFN-gamma significantly inhibited either IFN-gamma or CM-induced differentiation. Transcriptome analysis of CM-differentiated HUCBNP, identified 86 genes as highly upregulated, among them 25 were IFN-induced (such as 2',5'-oligoadenylate synthetase 1 and 2, IFN-induced protein and transmembrane proteins, STAT1 (IFN-gamma-creceptor signal transducer and activator of transcription) and chemokine C-X-C motif ligand 5). Treatment of HUCBNP with human recombinant IFN-gamma, inhibited cell proliferation in a dose-dependent manner. IFN-gamma (1-100 ng/ml) enhanced neuronal differentiation, expressed by neurite outgrowths and increased expression of the neuronal markers beta-tubulin III, microtubule-associated protein 2, neuronal nuclei, neurofilament M and neuronal-specific enolase. IFN-gamma additively cooperated with NGF to induce the differentiation of HUCBNP. These data indicate that IFN-gamma promotes neuronal differentiation of HUCB-derived progenitors, proposing its use in future protocols towards cell therapy. Leukemia (2009) 23, 1790-1800; doi: 10.1038/leu.2009.106; published online 21 May 2009	[Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Galski, H.; Lazarovici, P.] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Fac Med, IL-91120 Jerusalem, Israel; [Amariglio, N.; Rechavi, G.] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, G.; Nagler, A.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Galski, H.; Nagler, A.] Chaim Sheba Med Ctr, Lab Mol Immunobiol, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [Galski, H.; Nagler, A.] Chaim Sheba Med Ctr, Cord Blood Bank, IL-52621 Tel Hashomer, Israel		Lazarovici, P (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Fac Med, POB 12065, IL-91120 Jerusalem, Israel.	philipl@ekmd.huji.ac.il	Lazarovici, Philip/S-5261-2018; Lecht, Shimon/AAC-5890-2019	Lazarovici, Philip/0000-0003-3650-4721; Lecht, Shimon/0000-0002-6499-2390	Molecular Pharmacology and Therapeutics at The Hebrew University of Jerusalem, Israel	The authors would like to thank Mrs Jasmine Jacob-Hirsch for the technical help with functional genomics. PL is affiliated with and supported in part by David R Bloom Center for Pharmacy and the Dr Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at The Hebrew University of Jerusalem, Israel.	Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Cetinkaya C, 2007, MOL CANCER THER, V6, P2634, DOI 10.1158/1535-7163.MCT-06-0492; Chen Chun-Ta, 2008, Pediatrics and Neonatology, V49, P77, DOI 10.1016/S1875-9572(08)60017-0; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Cho SG, 2005, NEUROSCI LETT, V378, P49, DOI 10.1016/j.neulet.2004.12.073; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; CORRIAS MV, 1995, INT J CANCER, V62, P223, DOI 10.1002/ijc.2910620219; Dafny N, 2005, EUR J PHARMACOL, V523, P1, DOI 10.1016/j.ejphar.2005.08.029; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Domanska-Janik K, 2008, INT J DEV BIOL, V52, P237, DOI 10.1387/ijdb.072315kd; El-Badri NS, 2006, STEM CELLS DEV, V15, P497, DOI 10.1089/scd.2006.15.497; GAVIRIA JM, 2008, CLIN USE RECOMBINANT; Goldstein G, 2007, CURR PHARM DESIGN, V13, P1363, DOI 10.2174/138161207780618759; Harris DT, 2007, EXPERT OPIN BIOL TH, V7, P1311, DOI 10.1517/14712598.7.9.1311; Hooker A, 1998, J INTERF CYTOK RES, V18, P287, DOI 10.1089/jir.1998.18.287; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; JONAKAIT GM, 1994, NEURON, V12, P1149; Kamolz LP, 2006, BURNS, V32, P16, DOI 10.1016/j.burns.2005.08.020; Katzir I, 2002, J MOL NEUROSCI, V18, P251, DOI 10.1385/JMN:18:3:251; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Margalit O, 2005, BLOOD REV, V19, P223, DOI 10.1016/j.blre.2004.11.003; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McGuckin C, 2008, NAT PROTOC, V3, P1046, DOI 10.1038/nprot.2008.69; Mousa A, 1999, CYTOKINE, V11, P55, DOI 10.1006/cyto.1998.0381; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Nunes VA, 2007, BIOL CELL, V99, P185, DOI 10.1042/BC20060075; Parish CL, 2002, J NEUROSCI, V22, P8034; PLIOPLYS AV, 1988, J NEUROL SCI, V85, P209, DOI 10.1016/0022-510X(88)90157-8; PONZONI M, 1992, CANCER RES, V52, P931; Ridge J, 1996, IN VITRO CELL DEV-AN, V32, P238; Rozzo C, 1997, CELL DEATH DIFFER, V4, P713, DOI 10.1038/sj.cdd.4400304; Shearer WT, 1999, CLIN DIAGN LAB IMMUN, V6, P311, DOI 10.1128/CDLI.6.3.311-315.1999; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Stoll G, 2000, J NEURAL TRANSM-SUPP, P81; Tan JQ, 2000, BLOOD, V96, P1230, DOI 10.1182/blood.V96.4.1230.h8001230_1230_1238; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Uwabe KI, 2005, J BIOL CHEM, V280, P34268, DOI 10.1074/jbc.M502667200; Vasaturo F, 1998, INT J ONCOL, V12, P895; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023	55	12	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	OCT	2009	23	10					1790	1800		10.1038/leu.2009.106			11	Oncology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Hematology	506YX	WOS:000270816300012	19458627	Bronze			2022-02-06	
J	Harris, JL; Reeves, TM; Phillips, LL				Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.			Injury Modality, Survival Interval, and Sample Region Are Critical Determinants of qRT-PCR Reference Gene Selection during Long-Term Recovery from Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						genomics; molecular biological approaches; neuroplasticity; synaptic loss and deafferentation; traumatic brain injury	TIME RT-PCR; REAL-TIME; MESSENGER-RNA; HOUSEKEEPING GENES; QUANTITATIVE PCR; RIBOSOMAL-RNA; BETA-ACTIN; INSITU HYBRIDIZATION; SYNAPTIC PLASTICITY; DENERVATED NEUROPIL	In the present study we examined expression of four real-time quantitative RT-PCR reference genes commonly applied to rodent models of brain injury. Transcripts for beta-actin, cyclophilin A, GAPDH, and 18S rRNA were assessed at 2-15 days post-injury, focusing on the period of synaptic recovery. Diffuse moderate central fluid percussion injury (FPI) was contrasted with unilateral entorhinal cortex lesion (UEC), a model of targeted deafferentation. Expression in UEC hippocampus, as well as in FPI hippocampus and parietotemporal cortex was analyzed by qRT-PCR. Within-group variability of gene expression was assessed and change in expression relative to paired controls was determined. None of the four common reference genes tested was invariant across brain region, survival time, and type of injury. Cyclophilin A appeared appropriate as a reference gene in UEC hippocampus, while beta-actin was most stable for the hippocampus subjected to FPI. However, each gene may fail as a suitable reference with certain test genes whose RNA expression is targeted for measurement. In FPI cortex, all reference genes were significantly altered over time, compromising their utility for time-course studies. Despite such temporal variability, certain genes may be appropriate references if limited to single survival times. These data provide an extended baseline for identification of appropriate reference genes in rodent studies of recovery from brain injury. In this context, we outline additional considerations for selecting a qRT-PCR normalization strategy in such studies. As previously concluded for acute post-injury intervals, we stress the importance of reference gene validation for each brain injury paradigm and each set of experimental conditions.	[Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Sch Med, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Sch Med, POB 980709, Richmond, VA 23298 USA.	llphilli@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS44372, NS57758]; Virginia Commonwealth Neurotrauma Initiative [07-302F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044372, R01NS057758, R56NS044372] Funding Source: NIH RePORTER	The authors wish to thank Lesley K. Harris, Raiford T. Black, and Nancy N. Lee for excellent technical assistance. All qRT-PCR was performed in the Nucleic Acids Research Facilities, Center for the Study of Biological Complexity, Virginia Commonwealth University. This work was supported by NIH grants NS44372 and NS57758, and Virginia Commonwealth Neurotrauma Initiative 07-302F.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arckens L, 2003, EUR J NEUROSCI, V18, P61, DOI 10.1046/j.1460-9568.2003.02726.x; Blain JF, 2004, NEUROBIOL DIS, V15, P510, DOI 10.1016/j.nbd.2003.12.001; Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2005, EXPERT REV MOL DIAGN, V5, P493, DOI 10.1586/14737159.5.4.493; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Farwell W, 1998, NEUROCHEM RES, V23, P539, DOI 10.1023/A:1022486619201; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Harris J, 2008, J NEUROTRAUM, V25, P857; Harris J, 2006, J NEUROTRAUM, V23, P988; Harris JL, 2005, J NEUROTRAUM, V22, P1166; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Keppel G., 1991, DESIGN ANAL RES HDB; Kerber G, 2003, J MOL NEUROSCI, V21, P149, DOI 10.1385/JMN:21:2:149; Kobayashi MS, 2004, J NEUROSCI RES, V76, P512, DOI 10.1002/jnr.20094; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PHILLIPS LL, 1987, MOL BRAIN RES, V2, P251, DOI 10.1016/0169-328X(87)90032-5; PHILLIPS LL, 1990, MOL BRAIN RES, V8, P249, DOI 10.1016/0169-328X(90)90024-8; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; [No title captured]	48	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1669	1681		10.1089/neu.2009.0875			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200006	19505177	Green Published			2022-02-06	
J	Marinaro, J; Smith, J; Tawil, I; Billstrand, M; Crookston, KP				Marinaro, Jonathan; Smith, Jessica; Tawil, Isaac; Billstrand, Mary; Crookston, Kendall P.			HBOC-201 use in traumatic brain injury: case report and review of literature	TRANSFUSION			English	Article							JEHOVAH-WITNESS; OXYGEN CARRIER; BLOOD SUBSTITUTES; HEMORRHAGIC-SHOCK; HEMOGLOBIN; RESUSCITATION; INFARCTION; EFFICACY; SAFETY; MODEL	BACKGROUND: The first use of HBOC-201 in severe traumatic brain injury (TBI) is presented. The use of noninvasive cerebral oximetric devices to follow clinical progress in a patient infused with HBOC-201 is reported and the literature of hemoglobin-based oxygen carriers (HBOCs) in brain injury is reported. CASE REPORT: A 21-year-old Jehovah's Witness who was hit and dragged by a motor vehicle was admitted to the University of New Mexico Hospital Level 1 Trauma Center Trauma Surgical Intensive Care Unit with severe TBI and extensive soft tissue loss resulting in profound anemia. The patient received infusion of HBOC-201 with regional and global oximetric monitoring. RESULTS: Chart abstraction was performed to identify clinically relevant physiologic markers of patient progress. We observed a marked increase in brain tissue oxygen saturations, central venous oxygen saturation, and hemodynamic variables after administration of HBOC-201. The patient subsequently suffered massive cerebral edema and died. CONCLUSIONS: Major HBOC trials to date have excluded severe TBI. We report the first use of an HBOC in severe TBI to correct profound anemia. The HBOC-201 rapidly corrected cerebral venous and central venous oxygen saturations. The patient's death may have been due to massive reperfusion injury from delayed repayment of cerebral oxygen debt in a severely ischemic brain.	[Marinaro, Jonathan] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Anesthesiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA		Marinaro, J (corresponding author), Univ New Mexico, Dept Surg, MSC10-5610,1 Univ New Mexico, Albuquerque, NM 87131 USA.	jmarinaro@salud.unm.edu					Agrawal YP, 2005, TRANSFUSION, V45, P1735, DOI 10.1111/j.1537-2995.2005.00599.x; Allison G, 2004, SOUTH MED J, V97, P1257, DOI 10.1097/01.SMJ.0000140857.11967.2D; *BIOP CORP, 2008, OX SOL; Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cothren C, 2002, NEW ENGL J MED, V346, P1097, DOI 10.1056/NEJM200204043461420; Creteur J, 2003, CRIT CARE MED, V31, pS698, DOI 10.1097/01.CCM.0000098037.40520.81; Gannon CJ, 2002, CRIT CARE MED, V30, P1893, DOI 10.1097/00003246-200208000-00036; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Greenburg AG, 2004, CRIT CARE, V8, pS61, DOI 10.1186/cc2455; GUYTON A, 2002, GOLDFRANKS TOXICOLOG, P1438; Hare GMT, 2004, ANESTH ANALG, V99, P528, DOI 10.1213/01.ANE.0000136769.65960.D1; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; Hughes GS, 1996, CRIT CARE MED, V24, P756; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; Lurie F, 2003, ANESTH ANALG, V96, P46, DOI 10.1097/00000539-200301000-00010; Margulies DR, 2002, J TRAUMA, V52, P796, DOI 10.1097/00005373-200204000-00037; Mokhlesi B, 2003, CHEST, V123, P897, DOI 10.1378/chest.123.3.897; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Saxena R, 1999, STROKE, V30, P993, DOI 10.1161/01.STR.30.5.993; Schalte G, 2005, BRIT J ANAESTH, V94, P442, DOI 10.1093/bja/aei068; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Winslow RM, 2000, BRIT J HAEMATOL, V111, P387, DOI 10.1046/j.1365-2141.2000.02326.x	28	12	12	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	OCT	2009	49	10					2054	2059		10.1111/j.1537-2995.2009.02235.x			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	502BW	WOS:000270430100010	19497051				2022-02-06	
J	Otto, F; Illes, S; Opatz, J; Laryea, M; Theiss, S; Hartung, HP; Schnitzler, A; Siebler, M; Dihne, M				Otto, Frauke; Illes, Sebastian; Opatz, Jessica; Laryea, Maurice; Theiss, Stephan; Hartung, Hans-Peter; Schnitzler, Alfons; Siebler, Mario; Dihne, Marcel			Cerebrospinal Fluid of Brain Trauma Patients Inhibits in vitro Neuronal Network Function via NMDA Receptors	ANNALS OF NEUROLOGY			English	Article							EMBRYONIC STEM-CELLS; PRECURSORS	Neurological diseases frequently induce pathological changes of cerebrospinal fluid (CSF) that might secondarily influence brain activity, as the CSF-brain barrier is partially permeable. However, functional effects of CSF on neuronal network activity have not been specified to date. Here, we report that CSF specimens from patients with reduced Glasgow Coma Scale values caused by severe traumatic brain injury suppress synchronous activity of in vitro-generated neuronal networks in comparison with controls. We present evidence that underlying mechanisms include increased N-methyl-D-aspartate receptor activity mediated by a CSF fraction containing elevated amino acid concentrations. These proof-of-principle data suggest that determining effects of CSF specimens on neuronal network activity might be of diagnostic value.	[Otto, Frauke; Illes, Sebastian; Opatz, Jessica; Theiss, Stephan; Hartung, Hans-Peter; Schnitzler, Alfons; Siebler, Mario; Dihne, Marcel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Laryea, Maurice] Univ Dusseldorf, Dept Gen Pediat, D-40225 Dusseldorf, Germany; [Schnitzler, Alfons] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany		Dihne, M (corresponding author), Univ Dusseldorf, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Marcel.Dihne@uni-duesseldorf.de	Schnitzler, Alfons/AAT-1054-2021; Illes, Sebastian/N-3598-2015; Schnitzler, Alfons/K-4625-2014; Dihne, Marcel/G-1995-2010; Schnitzler, Alfons/Q-5520-2019	Illes, Sebastian/0000-0002-2328-5382; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Theiss, Stephan/0000-0002-5881-6067	Bundesministerium fur Bildung Lind Forschung (BMBF)Federal Ministry of Education & Research (BMBF) [01GN0503]; Christiane & Claudia Hempel-Stiftung fur Klinische Stammzellforschung; Hannelore-Kohl-Stiftung ZNS; Forschungskommission der medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf	This work was supported by the Bundesministerium fur Bildung Lind Forschung (BMBF, 01GN0503, M.D.), the "Christiane & Claudia Hempel-Stiftung fur Klinische Stammzellforschung" (M.D.), the "Hannelore-Kohl-Stiftung ZNS" (M.S.) and the Forschungskommission der medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf (FOKO, F.O.).	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ban J, 2007, STEM CELLS, V25, P738, DOI 10.1634/stemcells.2006-0246; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Danysz W, 1998, PHARMACOL REV, V50, P597; DAVSON H, 1987, PHYSL PATHOPHYSIOLOG; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Illes S, 2007, EXP NEUROL, V207, P171, DOI 10.1016/j.expneurol.2007.05.020; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Otto F, 2003, J NEUROSCI METH, V128, P173, DOI 10.1016/S0165-0270(03)00186-9; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	12	12	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2009	66	4					546	555		10.1002/ana.21808			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507SJ	WOS:000270874700015	19847897				2022-02-06	
J	de Groot, V; Beckerman, H; Uitdehaag, BM; Hintzen, RQ; Minneboo, A; Heymans, MW; Lankhorst, GJ; Polman, CH; Bouter, LM				de Groot, Vincent; Beckerman, Heleen; Uitdehaag, Bernard M.; Hintzen, Rogier Q.; Minneboo, Arjan; Heymans, Martijn W.; Lankhorst, Gustaaf J.; Polman, Chris H.; Bouter, Lex M.		Functional Prognostication Disabil	Physical and Cognitive Functioning After 3 Years Can Be Predicted Using Information From the Diagnostic Process in Recently Diagnosed Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cohort studies; Disability evaluation; Multiple sclerosis; Prognosis; Rehabilitation	LOGISTIC-REGRESSION ANALYSIS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SMALL DATA SETS; PROGNOSTIC MODELS; NATURAL-HISTORY; FOLLOW-UP; EXTERNAL VALIDATION; DISABILITY; COHORT	Objective: To predict functioning after 3 years in patients with recently diagnosed multiple sclerosis (MS). Design: Inception cohort with 3 years of follow-up. At baseline, predictors were obtained from medical history taking, neurologic examination, and magnetic resonance imaging (MRI). Setting: Neurology outpatient clinic. Participants: Patients with MS (N=156); 146 with complete follow-up. Interventions: Not applicable. Main Outcome Measures: Inability to walk at least 500m, impaired dexterity, cognitive impairments, incontinence, in ability to drive a car or use public transportation, social dysfunction, and reliance on a disability pension. Results: Clinical prediction rules were constructed for the models that were well calibrated (sufficient agreement between predicted and observed outcomes, based on Visual inspection of calibration curves) and that showed sufficient discrimination (area under the receiver operation characteristic curve >.70) after internal bootstrap validation. The models for the inability to walk at least 500m, impaired dexterity, and cognitive impairments were well calibrated. Discrimination was sufficient for all 7 models, except the one predicting social dysfunction (.67). The inability to walk at least 500m was predicted by the perceived ability to walk, impairment of the cerebellar tract, and the number of MRI lesions in the spinal cord. Impaired dexterity was predicted by the perceived ability to use the hands, impairments of the pyramidal, cerebellar, and sensory tracts, and the T2-weighted infratentorial lesion load. Cognitive impairment was predicted by age, gender, the perceived ability to concentrate, and the T2-weighted supratentorial lesion load. Conclusions: Inability to walk at least 500m, impaired dexterity, and cognitive impairments can be predicted with predictors that are derived from medical history taking, neurologic examination, and MRI shortly after a definite diagnosis of MS has been made.	[de Groot, Vincent; Beckerman, Heleen; Lankhorst, Gustaaf J.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands; [Uitdehaag, Bernard M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; [Uitdehaag, Bernard M.; Polman, Chris H.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Minneboo, Arjan] Vrije Univ Amsterdam Med Ctr, Dept Radiol, NL-1007 MB Amsterdam, Netherlands; [de Groot, Vincent; Beckerman, Heleen; Heymans, Martijn W.; Lankhorst, Gustaaf J.; Bouter, Lex M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; [Hintzen, Rogier Q.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands		de Groot, V (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	v.degroot@vumc.nl	De Groot, Vincent/S-3482-2019; Bouter, Lex/X-1003-2019; de Groot, Vincent/J-8977-2013; de Groot, I.J.M./L-4339-2015	Bouter, Lex/0000-0002-2659-5482; de Groot, Vincent/0000-0002-6073-6250; Heymans, Martijn/0000-0002-3889-0921; Beckerman, Heleen/0000-0002-8421-3630	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [NWO 940-33-009]	Supported by The Netherlands Organization for Scientific Research (grant no. NWO 940-33-009).	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO;2-X; Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Bot JCJ, 2004, NEUROLOGY, V62, P226, DOI 10.1212/WNL.62.2.226; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; de Groot V, 2005, MULT SCLER, V11, P713, DOI 10.1191/1352458505ms1238oa; de Groot V, 2008, J REHABIL MED, V40, P151, DOI 10.2340/16501977-0145; Dent A, 2000, BRIT J CLIN PSYCHOL, V39, P311, DOI 10.1348/014466500163329; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Janssens ACJW, 2004, J CLIN EPIDEMIOL, V57, P180, DOI 10.1016/S0895-4356(03)00260-9; Janssens ACJW, 2003, EUR J NEUROL, V10, P287, DOI 10.1046/j.1468-1331.2003.00583.x; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kalkers NF, 2001, NEUROLOGY, V56, P215, DOI 10.1212/WNL.56.2.215; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LAMAN H, 1994, DISABIL REHABIL, V16, P198, DOI 10.3109/09638289409166613; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; Matheny ME, 2005, J BIOMED INFORM, V38, P367, DOI 10.1016/j.jbi.2005.02.007; NORM, 1999, MULT IMP INC MULT DA; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pittock SJ, 2004, NEUROLOGY, V62, P51, DOI 10.1212/01.WNL.0000101724.93433.00; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Righini M, 2004, CURR OPIN PULM MED, V10, P345, DOI 10.1097/01.mcp.0000130329.21799.7b; RUNMARKER B, 1994, J NEUROL, V241, P597, DOI 10.1007/BF00920623; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Solari A, 2002, MULT SCLER, V8, P169, DOI 10.1191/1352458502ms780oa; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Uitdehaag BMJ, 2002, MULT SCLER, V8, P366, DOI 10.1191/1352458502ms835oa; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANBENNEKOM CAM, 1995, ARCH PHYS MED REHAB, V76, P501, DOI 10.1016/S0003-9993(95)80502-8; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045	46	12	12	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1478	1488		10.1016/j.apmr.2009.03.018			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	496AA	WOS:000269938100004	19735774	Green Published			2022-02-06	
J	Malmivaara, K; Hernesniemi, J; Salmenpera, R; Ohman, J; Roine, RP; Siironen, J				Malmivaara, Kirsi; Hernesniemi, Juha; Salmenpera, Ritva; Ohman, Juha; Roine, Risto P.; Siironen, Jari			SURVIVAL AND OUTCOME OF NEUROSURGICAL PATIENTS REQUIRING VENTILATORY SUPPORT AFTER INTENSIVE CARE UNIT STAY	NEUROSURGERY			English	Article						Cost-effectiveness; Health-related quality of life; Prolonged treatment; Quality-adjusted life years	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; COST-EFFECTIVENESS ANALYSIS; LONG-TERM MORTALITY; QUALITY-OF-LIFE; INTRACEREBRAL HEMORRHAGE; SUBDURAL HEMATOMAS; WITHDRAWAL; SURGERY; COHORT	OBJECTIVE: The aim of this study was to analyze the clinical outcome of severely ill neurosurgical patients whose need for artificial life support was extended. We sought to determine whether these patients benefit from extended treatment both in life expectancy and quality of life. Furthermore, we evaluated the direct cost of the neurosurgical treatment. METHODS: The study group comprised a consecutive series of 346 neurosurgical patients in poor condition who were discharged from the intensive care unit but still in need of artificial respiratory support. The patients had various neurosurgical diagnoses and were treated between 2000 and 2003 at the Department of Neurosurgery, Helsinki University Central Hospital. We followed the outcome of these patients by specially formatted questionnaires 6 months and 1, 2, and 5 years after treatment. Their health-related quality of life was evaluated with EuroQol EQ-5D; quality-adjusted life years (QALY) gained with the treatment and the costs of a QALY were calculated. RESULTS: The median follow-up time was 5 years. The mortality rate was 27% at 30 days, 45% at 1 year, and 59% at 5 years after treatment. Of the patients, 20% had a good recovery (Glasgow Outcome Scale [GOS] scores 4 and 5), 18% had severe disability (GOS score 3), none was in a vegetative state (GOS score 2), 59% were dead (GOS score 1), and 3% were lost to follow-up. Of the survivors, 69% lived at home, 22% in a nursing home, 2% were in a hospital, and 7% were lost to follow-up. The median EQ-5D index value was lower than the median index value for the general population: 0.71 (25th percentile [Q1] 0.38 and 75th percentile [Q3] 0.85) versus 0.85 (Q1 0.73 and Q3 1.00). The median cost of the direct neurosurgical treatment per patient was 15 000 (sic) (25th percentile, 10 000 (sic) 75th percentile, 22 000 (sic)). Surviving patients gained a mean of 17 +/- 13 QALYs. The cost of 1 QALY was 2521 (sic). CONCLUSION: Prolonged intensive care unit and step-down unit treatment of critically ill neurosurgical patients seems to be clinically justified. Moreover, direct costs of neurosurgical treatment were reasonably low.	[Malmivaara, Kirsi; Hernesniemi, Juha; Salmenpera, Ritva; Siironen, Jari] Univ Helsinki, Cent Hosp, Dept Neurosurg, FI-00260 Helsinki 26, Finland; [Ohman, Juha] Tampere Univ, Cent Hosp, Dept Neurosurg, SF-33520 Tampere, Finland; [Roine, Risto P.] Hosp Dist Helsinki, Helsinki, Finland; [Roine, Risto P.] Uusimaa Hosp, Grp Adm External Examinat & Evaluat, Helsinki, Finland		Malmivaara, K (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurosurg, Topeliuksenkatu 5, FI-00260 Helsinki 26, Finland.	kirsi.malmivaara@helsinki.fi		Ohman, Juha/0000-0002-6592-1367			Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brunner-La Rocca HP, 2007, LANCET, V370, P1552; Burke RE, 2005, J EMERG MED, V29, P9, DOI 10.1016/j.jemermed.2005.01.003; Cook D, 2006, CRIT CARE MED, V34, pS317, DOI 10.1097/01.CCM.0000237042.11330.A9; Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jeremic B, 2004, AM J CLIN ONCOL-CANC, V27, P195, DOI 10.1097/01.coc.0000055059.97106.15; Karinen P, 1999, NEUROSURGERY, V45, P780, DOI 10.1097/00006123-199910000-00009; Kind P., 1999, UK POPULATION NORMS; Lacut K, 2007, FUND CLIN PHARMACOL, V21, P327, DOI 10.1111/j.1472-8206.2007.00488.x; LAUKONTAUS S, 2006, THESIS HELSINKI U HE; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Manno EM, 2006, NEUROL CLIN, V24, P159, DOI 10.1016/j.ncl.2005.10.005; McGuire AJ, 2007, CEREBROVASC DIS, V23, P221, DOI 10.1159/000097645; Patel ST, 2000, J VASC SURG, V32, P247, DOI 10.1067/mva.2000.105959; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; POON WS, 1992, NEUROSURGERY, V30, P681; Ronkainen A, 2001, STROKE, V32, P2850, DOI 10.1161/hs1201.099711; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Teno JM, 2000, J AM GERIATR SOC, V48, pS70, DOI 10.1111/j.1532-5415.2000.tb03144.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; WEINSTEIN M, 1995, COST EFFECTIVENESS R, P77	36	12	12	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2009	65	3					530	538		10.1227/01.NEU.0000350861.97585.CE			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	488CB	WOS:000269325600013	19687698				2022-02-06	
J	Javouhey, E; Guerin, AC; Martin, JL; Floret, D; Chiron, M				Javouhey, Etienne; Guerin, Anne-Celine; Martin, Jean-Louis; Floret, Daniel; Chiron, Mireille		SERAC Grp	Management of severely injured children in road accidents in France: Impact of the acute care organization on the outcome	PEDIATRIC CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	34th Congress of the Societe-de-Reanimation-de-Langue-Francaise	JAN 18-20, 2006	Paris, FRANCE	Soc Reanimat Langue Francaise		severe trauma; children; acute care management; healthcare organization; outcome; road accident	SEVERE HEAD-INJURY; TRAUMATIC-BRAIN-INJURY; INTENSIVE-CARE; IMPLEMENTATION; SURVIVAL; THERAPY	Objective: To examine the impact of acute care management on outcome in children severely injured in road accidents. Design and Setting: Prospective follow-up study conducted in 12 French pediatric intensive care units over a 24-month period. Patients: Excluding those in refractory shock or in brain death at admission, a total of 125 children aged < 17 years admitted to the pediatric intensive care unit with severe trauma (Injury Severity Score >= 16) were included. Results: Intracranial pressure (ICP) monitoring and admission into a trauma resuscitation room (TRR) were used as proxy markers for the center management aggressiveness. Centers which admitted to TRR and monitored ICP when indicated in > 75% of cases were called aggressive centers. Children with an ICP monitoring indication admitted to a TRR and monitored, as well as those without an indication treated in a TRR, were judged appropriately managed. A poor outcome at pediatric intensive care unit discharge was defined as a difference between the baseline and discharge pediatric overall performance category above 3, or a hospital death. Children with traumatic brain injury appropriately managed in a less-aggressive center were more likely to have a poor outcome than those appropriately managed in an aggressive center (odds ratio 7.56, 95% confidence interval 1.5-38.4), after adjustment for severity, age, and type of road user. Conclusions: The management in a more aggressive center for children admitted to TRR and monitored for ICP, when indicated, is associated with a better outcome. This could be explained by a more extensive experience in trauma management. (Pediatr Crit Care Med 2009; 10:472-478)	[Javouhey, Etienne; Floret, Daniel] Hosp Civils Lyon, Serv Reanimat & Urgences Pediat, Hop Femme Mere Enfant, Grpment Hosp Est, Bron, France; [Javouhey, Etienne; Guerin, Anne-Celine; Martin, Jean-Louis; Floret, Daniel; Chiron, Mireille] Joint Unit INRETS, UMR T 9405, Bron, France; InVS, F-94415 St Maurice, France; Univ Lyon 1, F-69622 Villeurbanne, France		Javouhey, E (corresponding author), Hosp Civils Lyon, Serv Reanimat & Urgences Pediat, Hop Femme Mere Enfant, Grpment Hosp Est, Bron, France.	etienne.javouhey@chu-lyon.fr	Martin, Jean-Louis/X-6588-2019; Javouhey, Etienne/G-3651-2013	Martin, Jean-Louis/0000-0002-3426-9601; Liet, Jean-Michel/0000-0002-4104-673X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS5; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Allouch H, 1999, PRESSE MED, V28, P799; [Anonymous], 1990, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boulard G, 1999, PRESSE MED, V28, P793; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; *CAR CHILDR EM DEP, 2001, PEDIATRICS, V107, P777; Cheron G, 2004, ARCH PEDIATRIE, V11, P44, DOI 10.1016/j.arcped.2003.09.031; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Meyer P G, 2001, Curr Opin Crit Care, V7, P81, DOI 10.1097/00075198-200104000-00005; *MIN SANT PROT SOC, 2004, B OFF SOC MDLSEDLP; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Ruchholtz S, 2002, INTENS CARE MED, V28, P1395, DOI 10.1007/s00134-002-1446-8; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wetzel RC, 2002, CRIT CARE MED, V30, pS468, DOI 10.1097/00003246-200211001-00012	32	12	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2009	10	4					472	478		10.1097/PCC.0b013e318198b1cb			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Pediatrics	468SI	WOS:000267840500007	19307817				2022-02-06	
J	Moriello, G; Frear, M; Seaburg, K				Moriello, Gabriele; Frear, Matthew; Seaburg, Kristin			The Recovery of Running Ability in an Adolescent Male After Traumatic Brain Injury: A Case Study	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						treadmill training; body weight support; rehabilitation program; traumatic brain injury; running	BODY-WEIGHT SUPPORT; ASSESSMENT-TOOL HIMAT; TREADMILL WALKING; MENTAL PRACTICE; GAIT; RELIABILITY; SPEED; LOCOMOTION; STROKE; LEVEL	Background and Purpose: The purpose of this case study was to document outcomes after a rehabilitation program in an adolescent male after traumatic brain injury. Three years after sustaining an injury in a skiing accident, a 17-year-old boy participated in a rehabilitation program with the goal of acquiring the ability to run one mile with his peers. On initial evaluation, the individual had significant left lower extremity weakness, impaired standing balance, limited endurance, and running limitations. He was able to run 10 m wearing a plastic ankle-foot orthosis on the left side but required supervision for safety. Methods: The intervention included strength training once weekly for 17 weeks, body weight-supported, treadmill-based locomotor training once weekly for 15 weeks followed by a combination of overground locomotor training and strengthening exercise once weekly for six weeks. Outcomes: After the intervention, muscle strength of the lower extremities increased and the individual was able to run one mile independently. The quality of his running improved, with better mechanics to absorb forces at impact during the absorption phase and increased lower extremity extension during the propulsion phase. Discussion: A rehabilitation program consisting of strengthening and locomotor training improved running speed, quality, and endurance in an adolescent male after traumatic brain injury. He was able to progress to a less restrictive carbon fiber brace as a result of gains in lower extremity strength. This change in ability allowed him to participate in physical education by running on a track and playing softball with his peers.	[Moriello, Gabriele; Frear, Matthew; Seaburg, Kristin] Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA		Moriello, G (corresponding author), Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA.	morieg@sage.edu					American Physical Therapy Association, 2005, EX PHYS ACT GUID STR; American Physical Therapy Association, 2001, GUID PHYS THER PRACT; [Anonymous], 2008, 7 DYNAMIC STRETCHES; [Anonymous], 1998, REH PERS TRAUM BRAIN; Arnetz J, 2004, ADV PHYSIOTHER, V6, P50, DOI DOI 10.1080/14038190310017147; ARNHEIM DD, 1997, PRINCIPLES ATHLETIC; Balogun JA, 1998, EUR J PHYS MED REHAB, V8, P48; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Brown L.E., 2005, TRAINING SPEED AGILI; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Colby SM, 1999, GAIT POSTURE, V10, P200, DOI 10.1016/S0966-6362(99)00035-1; DELECLUSE C, 1995, MED SCI SPORT EXER, V27, P1203; Dugan Sheila A, 2005, Phys Med Rehabil Clin N Am, V16, P603, DOI 10.1016/j.pmr.2005.02.007; Farley CT, 1998, EXERCISE SPORT SCI R, V26, P253; Fisk J., 2008, AAOS ATLAS ORTHOSES; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Green J, 2002, CLIN REHABIL, V16, P306, DOI 10.1191/0269215502cr495oa; HALL CM, 1999, THERAPEUTIC EXERCISE; Hasegawa H, 2002, PERIODIZED TRAINING, P69; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Hesse S, 1997, J NEUROL REHABIL, V11, P15; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; Hesse S, 1999, ARCH PHYS MED REHAB, V80, P421, DOI 10.1016/S0003-9993(99)90279-4; Jung AP, 2003, SPORTS MED, V33, P539, DOI 10.2165/00007256-200333070-00005; Kimura, 1994, J SPORT REHABIL, V3, P125, DOI [10.1123/jsr.3.2.125., DOI 10.1123/JSR.3.2.125]; Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; MACPHERSON K, 1995, J ORTHOP SPORT PHYS, V21, P147, DOI 10.2519/jospt.1995.21.3.147; Milgrom C, 2003, BRIT J SPORT MED, V37, P160, DOI 10.1136/bjsm.37.2.160; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Miller MG, 2006, J SPORT SCI MED, V5, P459; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Motl RW, 2007, ADAPT PHYS ACT Q, V24, P245, DOI 10.1123/apaq.24.3.245; Myer GD, 2007, J STRENGTH COND RES, V21, P831; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; OSullivan S., 2007, PHYS REHABILITATION, VFifth; Paris D L, 1992, J Athl Train, V27, P253; Polit F. D., 2004, NURSING RES PRINCIPL; Ranchos Los Amigos Hospital, 1979, REH HEAD INJ AD; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Schmidt R, 2005, MOTOR CONTROL LEARNI, V4th; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Shepherd R, 1999, NEUROREHAB NEURAL RE, V13, P171, DOI 10.1177/154596839901300303; Sidaway B, 2005, PHYS THER, V85, P1053, DOI 10.1093/ptj/85.10.1053; The Ohio State University Medical Center, STAND LEG THER EX; Thordarson DB, 1997, CLIN SPORT MED, V16, P239, DOI 10.1016/S0278-5919(05)70019-3; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2001, BRAIN INJURY, V15, P831; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922; Woollacott, 2007, MOTOR CONTROL TRANSL; Woolley S M, 2001, Top Stroke Rehabil, V7, P1; Zafeiridis A, 2005, J SPORT MED PHYS FIT, V45, P284	63	12	12	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUN	2009	33	2					111	120		10.1097/NPT.0b013e3181a6ab6b			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V23BN	WOS:000208318400006	19556920				2022-02-06	
J	Choi, R; Andres, RH; Steinberg, GK; Guzman, R				Choi, Raymond; Andres, Robert H.; Steinberg, Gary K.; Guzman, Raphael			Intraoperative hypothermia during vascular neurosurgical procedures	NEUROSURGICAL FOCUS			English	Article						intraoperative hypothermia; vascular cerebral aneurysm; subarachnoid hemorrhage	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; INTRACRANIAL ANEURYSM SURGERY; TRANSIENT FOREBRAIN ISCHEMIA; HOSPITAL CARDIAC-ARREST; COLD INTRAVENOUS FLUID; CIRCULATORY ARREST; MILD HYPOTHERMIA; DEEP HYPOTHERMIA; CARDIOPULMONARY BYPASS	Increasing evidence in animal models and clinical trials for stroke, hypoxic encephalopathy for children, and traumatic brain injury have shown that mild hypothermia may attenuate ischemic damage and improve neurological outcome. However, it is less clear if mild intraoperative hypothermia during vascular neurosurgical procedures results in improved outcomes for patients. This review examines the scientific evidence behind hypothermia as a treatment and discusses factors that may be important for the use of this adjuvant technique, including cooling temperature, duration of hypothermia, and rate of rewarming. (DOI: 10.3171/2009.3.FOCUS0927)	[Choi, Raymond; Andres, Robert H.; Steinberg, Gary K.; Guzman, Raphael] Stanford Univ, Dept Neurosurg, Med Ctr, Stanford, CA 94305 USA		Guzman, R (corresponding author), Stanford Univ, Dept Neurosurg, Med Ctr, 300 Pasteur Dr,R211, Stanford, CA 94305 USA.	raphaelg@stanford.edu		Guzman, Raphael/0000-0001-9620-0581			Aebert H, 1998, EUR J CARDIO-THORAC, V13, P223, DOI 10.1016/S1010-7940(98)00018-9; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; BAKER KZ, 1994, ANESTHESIOLOGY, V81, P361, DOI 10.1097/00000542-199408000-00014; BAUMGARTNER WA, 1983, SURGERY, V94, P242; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Clifton G L, 1992, Tex Med, V88, P66; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DAW E F, 1964, Can Anaesth Soc J, V11, P382, DOI 10.1007/BF03003422; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Foroohar M, 2000, SURG NEUROL, V54, P304, DOI 10.1016/S0090-3019(00)00294-9; Gluckman PD, 2006, NEW ENGL J MED, V354, P1644; Grady RE, 2002, J NEUROSURG ANESTH, V14, P137, DOI 10.1097/00008506-200204000-00008; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; Horstmann S, 2003, STROKE, V34, P2165, DOI 10.1161/01.STR.0000088062.86084.F2; Ibayashi S, 2000, NEUROCHEM RES, V25, P369, DOI 10.1023/A:1007593004806; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kawai N, 2000, ACT NEUR S, V76, P529; Kawanishi M, 2003, ACT NEUR S, V86, P453; Kimura T, 2002, EXP BRAIN RES, V145, P83, DOI 10.1007/s00221-002-1095-8; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; KWAK R, 1972, BRAIN NERVE, V24, P403; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lawton MT, 1998, NEUROSURGERY, V43, P10, DOI 10.1097/00006123-199807000-00009; Levati A, 2007, J NEUROSURG ANESTH, V19, P25, DOI 10.1097/01.ana.0000211022.96054.4d; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Maxwell WL, 2005, J NEUROTRAUM, V22, P873, DOI 10.1089/neu.2005.22.873; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MICHENFELDER JD, 1965, SURG CLIN N AM, V45, P889; MICHENFELDER JD, 1992, J CEREBR BLOOD F MET, V12, P877, DOI 10.1038/jcbfm.1992.120; MILDE LN, 1992, J NEUROSURG ANESTH, V4, P211, DOI 10.1097/00008506-199207000-00012; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Pemberton PL, 2003, ANAESTHESIA, V58, P370; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, CRIT CARE MED, V32, P313, DOI 10.1097/01.CCM.0000104936.28288.7A; Preston E, 2004, ACTA NEUROPATHOL, V108, P406, DOI 10.1007/s00401-004-0905-4; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sato K, 2000, ACTA NEUROCHIR, V142, P1013, DOI 10.1007/s007010070056; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shimohata T, 2007, STROKE, V38, P375, DOI 10.1161/01.STR.0000254616.78387.ee; SILVERBERG GD, 1981, J NEUROSURG, V55, P337, DOI 10.3171/jns.1981.55.3.0337; SPETZLER RF, 1988, J NEUROSURG, V68, P868, DOI 10.3171/jns.1988.68.6.0868; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; SUTTON LN, 1991, STROKE, V22, P1567, DOI 10.1161/01.STR.22.12.1567; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; UIHLEIN A, 1966, J AMER MED ASSOC, V195, P639, DOI 10.1001/jama.195.8.639; Van Hemelrijck A, 2003, J NEUROCHEM, V87, P66, DOI 10.1046/j.1471-4159.2003.01977.x; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Young WL, 2002, ANESTHESIOLOGY, V96, P497, DOI 10.1097/00000542-200202000-00038; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	68	12	14	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2009	26	5							E24	10.3171/2009.3.FOCUS0927			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	439VY	WOS:000265656800024	19409003	Bronze			2022-02-06	
J	Azam, MQ; Iraqi, AA; Sherwani, MKA; Abbas, M; Alam, A; Bin Sabir, A; Asif, N				Azam, Md Quamar; Iraqi, A. A.; Sherwani, M. K. A.; Abbas, M.; Alam, Afzal; Bin Sabir, Amir; Asif, Naiyer			Delayed fixation of displaced type II and III pediatric femoral neck fractures	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Delayed fixation; femoral neck fracture; pediatric fractures	HIP-FRACTURES; CHILDREN; FEMUR; HEAD	Background: Time from injury to fixation of femoral neck fractures has been postulated as a vital determinant for rate of complications; however, no prospective study is available in the English literature. Delay, unfortunately, is inevitable in developing countries. The aim of the present study is to retrospectively review the outcome after delayed fixation of displaced type II and III femoral neck fractures in children. Materials and Methods: Using a standard assessment chart, we retrospectively reviewed medical records of all pediatric patients having femoral neck fractures presenting to our institution from June 1999 to May 2006. Inclusion criteria were children between 5 and 15 years of age sustaining displaced Delbet type II and III femoral neck fractures having a complete follow-up of at least 2 years. Patients with known metabolic disease, poliomyelitis or cerebral palsy, were excluded from the study. After application of inclusion and exclusion criteria, 22 patients having 22 fractures (13 type II and 9 type III) were studied. Surgery could be performed after a mean delay of 11.22 days (ranging from 2 to 21 days). Closed reduction was achieved in 14 cases and 8 cases required open reduction through anterolateral approach. Result: Osteonecrosis was noted in eight patients (36.37) who included two of nine patients (22.22) operated in the first week, three of eight patients (37.51) operated in the second week, and three of five patients (60) operated in the third week of injury. Nonunion was seen in four (18.18) cases, and two of them were associated with failure of implants. One was treated by valgus osteotomy and the other by Meyers procedure. Fractures united in both children but the latter developed avascular necrosis. Functional results, as assessed using Ratliffs criteria, were good in 14 (63.63), fair in 2 (9), and poor in 6 (27.27) patients. Conclusion: Delay in fixation, type of fracture, and ability to achieve and maintain reduction are factors primarily responsible for the outcome. We also found that delay after the first week further adversely affects the outcome.	[Azam, Md Quamar; Iraqi, A. A.; Sherwani, M. K. A.; Abbas, M.; Alam, Afzal; Bin Sabir, Amir; Asif, Naiyer] Aligarh Muslim Univ, Dept Orthopaed, JN Med Coll, Aligarh 202002, Uttar Pradesh, India		Azam, MQ (corresponding author), Aligarh Muslim Univ, Dept Orthopaed, JN Med Coll, Aligarh 202002, Uttar Pradesh, India.	qazam47@rediffmail.com					Bagatur AE, 2002, J PEDIATR ORTHOP B, V11, P219; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P338; CHUNG SMK, 1976, J BONE JOINT SURG AM, V58, P961, DOI 10.2106/00004623-197658070-00011; Colonna PC, 1929, AM J SURG, V6, P793, DOI [10.1016/S0002-9610(29)90726-1, DOI 10.1016/S0002-9610(29)90726-1, 10.1016/s0002-9610(29)90726-1]; DAVISON BL, 1992, J PEDIATR ORTHOPED, V12, P355, DOI 10.1097/01241398-199205000-00014; Dhammi IK, 2005, J ORTHOP SCI, V10, P173, DOI 10.1007/s00776-004-0875-3; DURBIN FC, 1959, J BONE JOINT SURG BR, V41, P758, DOI 10.1302/0301-620X.41B4.758; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; HUANG CH, 1986, CLIN ORTHOP RELAT R, P117; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; KAY SP, 1971, CLIN ORTHOP RELAT R, P53; LAM SF, 1971, J BONE JOINT SURG AM, VA 53, P1165, DOI 10.2106/00004623-197153060-00013; Magu NK, 2007, J ORTHOP TRAUMA, V21, P237, DOI 10.1097/BOT.0b013e31804cfdad; MOON SE, 2007, J ORTHOP TRAUMA, V20, P323; Nagi O N, 1992, J Orthop Trauma, V6, P306, DOI 10.1097/00005131-199209000-00007; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; SWIONTKOWSKI MF, 1986, J TRAUMA, V26, P384, DOI 10.1097/00005373-198604000-00013; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; WEINER DS, 1969, J TRAUM, V9, P62, DOI 10.1097/00005373-196901000-00007	23	12	14	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	APR-JUN	2009	43	3					253	258		10.4103/0019-5413.53455			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	505WJ	WOS:000270729800007	19838347	Green Published			2022-02-06	
J	Pastuszko, P; Pirzadeh, A; Reade, E; Kubin, J; Mendoza, A; Schears, GJ; Greeley, WJ; Pastuszko, A				Pastuszko, Peter; Pirzadeh, Afsaneh; Reade, Erin; Kubin, Joanna; Mendoza, Alberto; Schears, Gregory J.; Greeley, William J.; Pastuszko, Anna			The effect of hypothermia on neuronal viability following cardiopulmonary bypass and circulatory arrest in newborn piglets	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	22nd Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	SEP 14-17, 2008	Lisbon, PORTUGAL	European Assoc Cardio Thorac Surg		Newborn; Brain; Cardiopulmonary bypass; Circulatory arrest; Hypothermia; Apoptosis	ASPHYXIAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; PROTEIN EXPRESSION; GLOBAL-ISCHEMIA; DOPAMINE; RAT; REPERFUSION; APOPTOSIS; NEUROPROTECTION	Objective: To determine the effect of recovery with mild hypothermia after cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) on the activity of selected key proteins involved in initiation (Bax, Caspase-3) or inhibition of apoptotic injury (Bcl-2, increased ratio Bcl-2/Bax) in the brain of newborn piglets. Methods: The piglets were placed on CPB, cooled with pH-stat management to 18 degrees C, subjected to 30 min of DHCA followed by 1 h of tow flow at 20 ml/kg/min, rewarmed to 37 degrees C (normothermia) or to 33 degrees C (hypothermia), separated from CPB, and monitored for 6 h. Expression of above proteins was measured in striatum, hippocampus and frontal cortex by Western blots. The results are mean for six experiments +/- SEM. Results: There were no significant differences in Bcl-2 level between normothermic and hypothermic groups. The Bax levels in normothermic group in cortex, hippocampus and striatum were 94 +/- 9, 136 +/- 22 and 125 +/- 34 and decreased in the hypothermic group to 59 +/- 17 (p = 0.028), 70 +/- 6 (p = 0.002) and 48 +/- 8 (p = 0.01). In cortex, hippocampus and striatum Bcl-2/Bax ratio increased from 1.23, 0.79 and 0.88 in normothermia to 1.96, 1.28 and 2.92 in hypothermia. Expression of Caspase-3 was 245 +/- 39, 202 +/- 74 and 244 +/- 31 in cortex, hippocampus and striatum in the normothermic group and this decreased to 146 +/- 24 (p = 0.018), 44 +/- 16 (p = 7 x 10(-7)) and 81 +/- 16 (p = 0.01) in the hypothermic group. Conclusion: In neonatal piglet model of cardiopulmonary bypass with circulatory arrest, mild hypothermia during post bypass recovery provides significant protection from cellular apoptosis, as indicated by lower expression of Bax and Caspase-3 and an increased Bcl-2/Bax ratio. The biggest protection was observed in striatum probably by decreasing of neurotoxicity of striatal dopamine. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.	[Pastuszko, Peter] Univ Calif San Diego, Dept Surg, San Diego, CA 92123 USA; [Pirzadeh, Afsaneh; Reade, Erin; Greeley, William J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Kubin, Joanna; Mendoza, Alberto; Pastuszko, Anna] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Schears, Gregory J.] Mayo Clin, Dept Anesthesiol & Crit Care, Rochester, MN USA		Pastuszko, P (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, 3030 Childrens Way,Suite 202, San Diego, CA 92123 USA.	ppastuszko@rchsd.org	pirzadeh, Akbar/R-7722-2017	pirzadeh, Akbar/0000-0001-9168-2147	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL058669-08, HL058669, R01 HL058669] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD041484, R01 HD041484-04] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS031465, NS031465, R01 NS031465-14] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL058669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031465] Funding Source: NIH RePORTER		BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; Corbett D, 1997, STROKE, V28, P2238, DOI 10.1161/01.STR.28.11.2238; Eberspacher E, 2003, J NEUROSURG ANESTH, V15, P200, DOI 10.1097/00008506-200307000-00007; Fritz KI, 2003, NEUROSCI LETT, V352, P211, DOI 10.1016/j.neulet.2003.08.049; Hicks SD, 2000, NEUROSCIENCE, V98, P677, DOI 10.1016/S0306-4522(00)00169-X; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; Horiguchi T, 2002, BRAIN RES, V952, P222, DOI 10.1016/S0006-8993(02)03242-0; Hoyt KR, 1997, EXP NEUROL, V143, P269, DOI 10.1006/exnr.1996.6374; HUANG CC, 1995, J NEUROCHEM, V65, pS97; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Kochanek PM, 2001, PEDIATR CLIN N AM, V48, P661, DOI 10.1016/S0031-3955(05)70333-3; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1996, CRIT CARE MED, V24, pS81; Noh JS, 1999, EXP NEUROL, V159, P217, DOI 10.1006/exnr.1999.7144; Nussmeier NA, 2005, TEX HEART I J, V32, P472; OLANO M, 1995, J NEUROCHEM, V65, P1205; Pastuszko P, 2007, EUR J CARDIO-THORAC, V31, P899, DOI 10.1016/j.ejcts.2007.01.049; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Porat S, 1999, ANN NY ACAD SCI, V893, P372, DOI 10.1111/j.1749-6632.1999.tb07858.x; Schleien CL, 2001, ANN EMERG MED, V37, pS182, DOI 10.1067/mem.2001.114170; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Yue X, 1997, NEUROPATH APPL NEURO, V23, P16; Zhao H, 1997, NEUROREPORT, V8, P2389, DOI 10.1097/00001756-199707070-00057	25	12	13	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	APR	2009	35	4					577	581		10.1016/j.ejcts.2009.01.001			5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Respiratory System; Surgery	438RO	WOS:000265573300005	19217795	Green Accepted, Bronze			2022-02-06	
J	Makwana, M; Serchov, T; Hristova, M; Bohatschek, M; Gschwendtner, A; Kalla, R; Liu, ZQ; Heumann, R; Raivich, G				Makwana, Milan; Serchov, Tsvetan; Hristova, Mariya; Bohatschek, Marion; Gschwendtner, Andreas; Kalla, Roger; Liu, ZhiQiang; Heumann, Rolf; Raivich, Genndij			Regulation and function of neuronal GTP-Ras in facial motor nerve regeneration	JOURNAL OF NEUROCHEMISTRY			English	Article						axonal regeneration; central sprouting; lymphocyte influx; motor neuron cell death; oncogene	GROWTH-FACTOR; SYMPATHETIC NEURONS; AXONAL REGENERATION; SENSORY NEURONS; INJURED BRAIN; SCIATIC-NERVE; NEUROGLIAL ACTIVATION; RETROGRADE TRANSPORT; SIGNAL-TRANSDUCTION; NEUROTROPHIC FACTOR	Activation of Ras into the GTP-binding, 'ON' state is a key switch in the neurotrophin-mediated neuronal survival and neurite outgrowth, in vitro as well as in vivo. In the current study we explored changes in GTP-Ras levels following facial nerve injury and the ensuing regeneration and the effects of perturbing these changes in vivo using synapsin-promoter mediated neuronal expression of constitutively active Val12H-Ras (synRas). Quantification of GTP-Ras and total Ras revealed a precipitous drop in the relative GTP-Ras levels in the axotomized facial motor nucleus, to 40% of normal levels at 2 days after cut, followed by a partial recovery to 50-65% at 4-28 days. On western blots, control and axotomized nuclei from synRas mutants showed a 2.2- and 2.5-fold elevation in GTP-Ras, respectively, compared with their wild type littermate controls (p < 5%, anova, TUKEY post-hoc), with the levels in the axotomized synRas nucleus slightly but not significantly above that in the uninjured littermate control (p = 9.9%). Similar increase was also observed in the pERK but not pAKT targets of the Ras cascade. This moderate elevation of GTP-Ras strongly curtailed post-traumatic neuronal cell death (-65%), the influx of T-cells (-48%) as well as other parameters of neuroinflammatory response. Although synRas did not affect the speed of axonal regeneration or functional recovery it caused a very pronounced increase in central axonal sprouting. These current data emphasize the role of reduced active Ras, and by extension, the reduced overall level of retrograde neurotrophin signalling after axotomy, in mediating post-traumatic cell death and inflammation and in restricting the sprouting response. Moreover, the neuroprotective and central sprouting-enhancing effects of neuronal Val12H-Ras could help promote recovery in CNS injury.	[Makwana, Milan; Hristova, Mariya; Bohatschek, Marion; Raivich, Genndij] UCL, EGA Inst Womens Hlth, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, London WC1E 6HX, England; [Serchov, Tsvetan; Heumann, Rolf] Ruhr Univ Bochum, Fak Chem, Dept Mol Neurobiochem NC7, D-4630 Bochum, Germany; [Gschwendtner, Andreas; Kalla, Roger; Liu, ZhiQiang] Max Planck Inst Neurobiol, Dept Neuromorphol, Martinsried, Germany; [Raivich, Genndij] UCL, Dept Anat & Dev Biol, London, England		Raivich, G (corresponding author), UCL, EGA Inst Womens Hlth, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	g.raivich@ucl.ac.uk	Kalla, Roger/O-3126-2016; Heumann, Rolf/ABB-9675-2021; Heumann, Rolf/AAK-4390-2020; Raivich, Gennadij/AAL-7229-2021; Raivich, Gennadij/A-6770-2011	Heumann, Rolf/0000-0003-4364-2655; Serchov, Tsvetan/0000-0002-2234-2875; Makwana, Milan/0000-0002-5198-5466			ABERCROMBIE M, 1946, J ANAT, V80, P37; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Eleore L, 2005, EUR J NEUROSCI, V21, P669, DOI 10.1111/j.1460-9568.2005.03887.x; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; GRAEBER MB, 1986, J NEUROCYTOL, V15, P363; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Ha GK, 2008, J NEUROIMMUNOL, V199, P18, DOI 10.1016/j.jneuroim.2008.04.027; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; HENDRY IA, 1992, PHARMACOL THERAPEUT, V56, P265, DOI 10.1016/0163-7258(92)90020-Z; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Heumann R, 2000, J CELL BIOL, V151, P1537, DOI 10.1083/jcb.151.7.1537; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MAKWANA M, 2007, SOC NEUR ABS, V136, P15; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Michalski B, 2008, J NEUROCHEM, V105, P1244, DOI 10.1111/j.1471-4159.2008.05224.x; Moller JC, 1996, GLIA, V17, P121; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; NAGATA Y, 1987, J NEUROCHEM, V49, P296, DOI 10.1111/j.1471-4159.1987.tb03429.x; Namikawa K, 2000, J NEUROSCI, V20, P2875; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Omidvar N, 2006, MOL CELL BIOL, V26, P3966, DOI 10.1128/MCB.26.10.3966-3975.2006; PARAVICINI U, 1975, BRAIN RES, V84, P279, DOI 10.1016/0006-8993(75)90982-8; Park JI, 2005, EXP CELL RES, V303, P79, DOI 10.1016/j.yexcr.2004.09.028; Raivich G, 1998, J NEUROSCI, V18, P5804; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 1995, PROG BRAIN RES, V104, P3; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Romero MI, 2007, J NEUROSCI, V27, P2124, DOI 10.1523/JNEUROSCI.4363-06.2007; RUFER M, 1994, J NEUROSCI RES, V39, P412, DOI 10.1002/jnr.490390408; SCHWAB ME, 1977, AGENTS ACTIONS, V7, P361, DOI 10.1007/BF01969569; Serpe CJ, 1999, J NEUROSCI, V19; Shoemaker SE, 2006, J NEUROBIOL, V66, P1322, DOI 10.1002/neu.20297; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; VERGE VMK, 1990, J NEUROSCI, V10, P926; VIRDEE K, 1995, EUR J NEUROSCI, V7, P2159, DOI 10.1111/j.1460-9568.1995.tb00637.x; Werner A, 2000, J NEUROSCI, V20, P1822; Werner A, 2001, CELL TISSUE RES, V305, P25, DOI 10.1007/s004410100393; Xin JP, 2008, BRAIN BEHAV IMMUN, V22, P528, DOI 10.1016/j.bbi.2007.10.006; Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817; Yan CYI, 1998, J NEUROSCI, V18, P4042; ZHOU XF, 1994, J NEUROSCI METH, V54, P95, DOI 10.1016/0165-0270(94)90163-5; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	62	12	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2009	108	6					1453	1463		10.1111/j.1471-4159.2009.05890.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	412AT	WOS:000263696300012	19284475	Bronze			2022-02-06	
J	Beretta, E; Cimolin, V; Piccinini, L; Turconi, A; Galbiati, S; Crivellini, M; Galli, M; Strazzer, S				Beretta, Elena; Cimolin, Veronica; Piccinini, Luigi; Turconi, Anna Carla; Galbiati, Sara; Crivellini, Marcello; Galli, Manuela; Strazzer, Sandra			Assessment of gait recovery in children after traumatic brain injury	BRAIN INJURY			English	Article						Children; traumatic brain injury; gait analysis; kinematics; kinetics	MOTOR FUNCTION MEASURE; GROSS MOTOR; ADOLESCENTS; REHABILITATION; PERFORMANCE; PREVALENCE; DISABILITY; SCORES	Objective: The aims were: (1) to quantify the functional limitation of children at the beginning of recovery of independent ambulation after Traumatic Brain Injury (TBI), using clinical-functional scales; (2) to evaluate the changes in gait pattern during rehabilitation (about 5 months later), using 3D Gait Analysis (GA) in post-acute phase; (3) to investigate the presence of correlation among parameters obtained by 3DGA, clinical assessment and measures connected with the trauma. Methods: Fourteen children with hemiplegia after severe TBI were evaluated at independent gait recovery (S0) and 5.5 months later (S1) by clinical assessment (GOS, DRS, WeeFIM and GMFM) and 3D GA (spatio-temporal parameters, kinematics and kinetics). Results: At S1 all clinical measures had improved. Regarding spatio-temporal parameters, velocity and step length improved. Significant progress was evident at the ankle joint, while an unchanged condition appeared at pelvis and hip in sagittal plane with a worsening of hip rotation which increased its internal rotation. Significant correlations were found between motor performance, clinical assessment and trauma-related measures. Conclusions: Repeated GA and clinical evaluations were useful in quantifying the motor recovery of children with TBI during rehabilitation underpinning the role of GA in quantifying these modifications in an objective and non-invasive way.	[Beretta, Elena; Piccinini, Luigi; Turconi, Anna Carla; Galbiati, Sara; Strazzer, Sandra] IRCCS E Medea Nostra Famiglia, I-23842 Bosisio Parini, LC, Italy; [Cimolin, Veronica; Crivellini, Marcello; Galli, Manuela] Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy; [Galli, Manuela] IRCCS San Raffaele Pisana San Raffaele SPA, Rome, Italy		Beretta, E (corresponding author), IRCCS E Medea Nostra Famiglia, Via don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	elena.beretta@bp.lnf.it	Turconi, Anna Carla/AAX-6521-2020; Cimolin, Veronica/AAA-3326-2021; Galbiati, Sara/AAA-7115-2020; Strazzer, Sandra/AAH-5712-2019; Beretta, Elena/AAH-5369-2019; piccinini, luigi/AAH-5470-2019; Galli, Manuela/AAH-8783-2019; Turconi, Anna Carla/ABE-6747-2020	Cimolin, Veronica/0000-0001-6299-7254; Galbiati, Sara/0000-0001-6810-359X; Strazzer, Sandra/0000-0001-8414-6565; Beretta, Elena/0000-0002-8036-7624; piccinini, luigi/0000-0001-7027-6676; Turconi, Anna Carla/0000-0002-5482-924X; Galli, Manuela/0000-0003-2772-4837			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Drouin LM, 1996, DEV MED CHILD NEUROL, V38, P1007; Emanuelson IM, 1997, DEV MED CHILD NEUROL, V39, P502; ESQUENAZI A, 2006, J HEAD TRAUMA REHAB, V87, P437; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Poggi G, 2000, BRAIN INJURY, V14, P833, DOI 10.1080/026990500421930; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wechsler D., 1974, WECHSLER INTELLIGENC; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	31	12	12	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	9					751	759	PII 913451840	10.1080/02699050903133988			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	475UR	WOS:000268387600006	19637000				2022-02-06	
J	Heffelfinger, AK; Koop, JI				Heffelfinger, A. K.; Koop, J. I.			A DESCRIPTION OF PRESCHOOL NEUROPSYCHOLOGICAL ASSESSMENT IN THE PINT CLINIC AFTER THE FIRST 5 YEARS	CLINICAL NEUROPSYCHOLOGIST			English	Article						Assessment; Childhood; Preschool	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTIONS; YOUNG-CHILDREN; ATTENTIONAL SKILLS; EARLY INTERVENTION; EARLY-CHILDHOOD; SHORT-TERM; OUTCOMES	Assessment of preschool-aged children constitutes a dilemma for many neuropsychologists because of a limited set of standardized measures with normative data as well as inadequate understanding of typical developmental trajectories for neuropsychological functions during the first years of life. However, numerous neurological disorders, medical disorders with central nervous system involvement, and even psychiatric disorders have their onset during this time and subsequently impact cognition by altering functional developmental trajectories. Comprehensive neuropsychological evaluations can help to delineate this alteration in developmental trajectory and assist in determining need for specific interventions services so that they can be implemented early as possible in hopes of reducing developmental cognitive impairments. In this descriptive report, potential preschool neuropsychological evaluation procedures are described and a discussion of appropriate reasons for referral and pertinent testing considerations is presented. Additionally, the Preschool and Infant Neuropsychology (P.I.N.T.) Clinic is presented to describe a methodology for conducting preschool neuropsychological assessment.	[Heffelfinger, A. K.] Med Coll Wisconsin, Div Neuropsychol, Milwaukee, WI 53212 USA		Heffelfinger, AK (corresponding author), Med Coll Wisconsin, Div Neuropsychol, 9200 W Wisconsin Ave, Milwaukee, WI 53212 USA.	aheffelfinger@mcw.edu					Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Bach-y-Rita P., 1980, RECOVERY FUNCTION TH; Bakker K, 1999, Pediatr Rehabil, V3, P149; BARLOW KR, 2005, PEDIATRICS, V116, P2004; Bates E, 2001, DEV COGN NEUROSCI, P281; Beery K.E., 2004, BEERY BUKTENICA DEV; Bell MA, 2007, DEV NEUROPSYCHOL, V31, P21, DOI 10.1207/s15326942dn3101_2; Berlin LJ, 1998, PREV MED, V27, P238, DOI 10.1006/pmed.1998.0282; Boyer K., 1989, J CLIN EXPT NEUROPSY, V11, P83; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Clark R., 1985, PARENT CHILD EARLY R; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Corkum V, 1995, CHILD NEUROPSYCHOL, V1, P3, DOI 10.1080/09297049508401338; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; DeWolfe NA, 1999, CLIN NEUROPSYCHOL, V13, P458, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT458; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A, 2005, DEV NEUROPSYCHOL, V28, P689, DOI 10.1207/s15326942dn2802_7; DIAMOND A, 1991, J PIAGET SY, P67; Egger H.L., 2006, HDB PRESCHOOL MENTAL, P137; Elliott C.D., 2007, DIFFERENTIAL ABILITI; Elliott C. D., 1990, DIFFERENTIAL ABILITI; Espy KA, 2005, DEV NEUROPSYCHOL, V28, P669, DOI 10.1207/s15326942dn2802_6; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Gathercole SE, 1998, J CHILD PSYCHOL PSYC, V39, P3, DOI 10.1111/1469-7610.00301; HEFFELFINGER AK, 2006, HDB PRESCHOOL MENTAL; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kaufman A. S, 1983, KAUFMAN ASSESSMENT B; Kemp, 1998, NEPSY DEV NEUROPSYCH; Korkman M., 2007, NEPSY 2 CLIN INTERPR, V2nd ed ed; Laurent-Vannier A, 2006, DEV MED CHILD NEUROL, V48, P120, DOI 10.1017/S0012162206000260; LEBANC S, 2005, DEV NEUROPSYCHOL, V28, P829; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lomax-Bream LE, 2007, DEV NEUROPSYCHOL, V31, P1, DOI 10.1207/s15326942dn3101_1; Luby J. L., 2006, HDB PRESCHOOL MENTAL; Luby JL, 1997, INFANT MENT HEALTH J, V18, P209, DOI 10.1002/(SICI)1097-0355(199722)18:2<209::AID-IMHJ9>3.0.CO;2-J; Majnemer A, 1998, Semin Pediatr Neurol, V5, P62, DOI 10.1016/S1071-9091(98)80020-X; MARKS I, 1987, J CHILD PSYCHOL PSYC, V28, P667, DOI 10.1111/j.1469-7610.1987.tb01552.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P976, DOI 10.1017/S1355617704107066; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; MRAKOTSKY CM, 2006, HDB PRESCHOOL MENTAL, P283; Msall M E, 1998, Semin Pediatr Neurol, V5, P52, DOI 10.1016/S1071-9091(98)80019-3; Mullen E.M., 1995, MULLEN SCALES EARLY; Nass R, 1997, Semin Pediatr Neurol, V4, P109, DOI 10.1016/S1071-9091(97)80027-7; Petersen M C, 1998, Semin Pediatr Neurol, V5, P2, DOI 10.1016/S1071-9091(98)80012-0; Piaget J., 1954, CONSTR REALITY CHILD; Piaget J., 1936, ORIGINS INTELLIGENCE; Ramey CT, 1998, PREV MED, V27, P224, DOI 10.1006/pmed.1998.0279; REYCASSERLY C, 1999, ASSESSING SCREENING, P281; RUED MR, 2005, P NATL ACAD SCI USA, V41, P14931; Rueda MR, 2005, DEV NEUROPSYCHOL, V28, P573, DOI 10.1207/s15326942dn2802_2; RUFF HA, 1990, DEV PSYCHOL, V26, P85, DOI 10.1037/0012-1649.26.1.85; Ruff HA, 2003, DEV PSYCHOL, V39, P877, DOI 10.1037/0012-1649.39.5.877; Ruff HA, 1998, DEV PSYCHOL, V34, P454, DOI 10.1037/0012-1649.34.3.454; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Shevell M I, 1998, Semin Pediatr Neurol, V5, P21, DOI 10.1016/S1071-9091(98)80014-4; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Stiles J, 2003, J INT NEUROPSYCH SOC, V9, P604, DOI 10.1017/S135561770394001X; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; WECHSLER D, 1989, WECHSLER PRIMARY PRE; Weikart DP, 1998, PREV MED, V27, P233, DOI 10.1006/pmed.1998.0280; Wiig E., 1992, CLIN EVALUATION LANG; Wiig E. H., 2004, CLIN EVALUATION LANG; WOODCOCK RS, 2006, WOODCOCK JOHNSON 3 T; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zelazo PD., 2003, DEV EXECUTIVE FUNCTI, V68; Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S; Zimmerman IL, 1992, PRESCHOOL LANGUAGE S	82	12	12	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	1					51	76		10.1080/13854040801945052			26	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	399LR	WOS:000262801900005	18609330				2022-02-06	
J	Jonsson, CA; Smedler, AC; Ljungmark, ML; Emanuelson, I				Jonsson, Catherine Aaro; Smedler, Ann-Charlotte; Ljungmark, Mia Leis; Emanuelson, Ingrid			Long-term cognitive outcome after neurosurgically treated childhood traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; long-term; outcome; cognitive	HEAD-INJURY; NORMATIVE DATA; INTRACRANIAL-PRESSURE; MEMORY FUNCTION; WORKING-MEMORY; PEDIATRIC TBI; YOUNG-ADULTS; LUND CONCEPT; CHILDREN; RECOVERY	Objective: To explore the cognitive long-term outcome of two cohorts of patients neurosurgically treated for childhood traumatic brain injury (CTBI), either in 1987-1991 according to an older concept or 1997-2001 with a stronger emphasis on volume targeted interventions. Research design and methods: Participants in the two cohorts were subject to an extensive neuropsychological assessment, 13.2 and 6.1 years post-injury, respectively. In a between-group design, assessment results of the two cohorts, n = 18 and n = 23, were compared to each other and to controls. Data were analysed with multivariate analyses of variance. Results: Long-term cognitive deficits for both groups of similar magnitude and character were observed in both groups. Abilities were especially low regarding executive and memory function and verbal IQ. The cognitive results are discussed in terms of vulnerability of verbal functions and decreased executive control over memory-functions. Conclusions: There is a definite need for long-term follow-up of cognitive deficits after neurosurgically treated CTBI, also with the newer neurosurgical concept. Verbal learning and the executive control over memory functions should be addressed with interventions aimed at restoration, coping and compensation.	[Jonsson, Catherine Aaro] Stockholm Univ, Dept Psychol, Jamtland Cty Council, Res & Dev Unit, S-10691 Stockholm, Sweden; [Ljungmark, Mia Leis; Emanuelson, Ingrid] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden		Jonsson, CA (corresponding author), Stockholm Univ, Dept Psychol, Jamtland Cty Council, Res & Dev Unit, S-10691 Stockholm, Sweden.	catherine.aaro.jonsson@jll.se			Research and Development Unit, Jamtland County Council, Department of Psychology, Stockholm University; Cancer and Traffic Injury Fund, Stockholm	This research was supported by The Research and Development Unit, Jamtland County Council, Department of Psychology, Stockholm University and The Cancer and Traffic Injury Fund, Stockholm. We thank the persons that generously contributed their time to this research and Goran Horneman and Per Folkesson who made their assembled data available for this study. We are also grateful to Bertil Rydenhag, Sahlgrenska Academy, Institute of Neuroscience and Physiology, for helpful information and important feed-back about the neurosurgical background.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Birkenkamp R., 1998, D2 TEST ATTENTION; BOLL T, 1993, CHILDRENS CATEGORY T; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Eker C, 2000, BRAIN INJURY, V14, P605; EMANUELSON I, TRAUMATIC BRAI UNPUB; Emanuelson I, 1998, PEDIAT REHABILITATIO, V65, P70; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FINLAYSON MAJ, 1976, PERCEPT MOTOR SKILL, V43, P475, DOI 10.2466/pms.1976.43.2.475; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GILLETT J, 2004, NEUROREHABILITATION, V207, P218; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; JENNETT B, 1975, LANCET, V1, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P449; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Meyers JE., 1995, REY COMPLEX FIGURE T; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; *PSYK, 1996, MAN WAIS R; *PSYK AB, 1999, WISC 3 MAN; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schneider W., 1997, MEMORY DEV 2 20; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618; YEATES KO, 2005, J AM ACAD CHILD PSY, V44, P6; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	52	12	12	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	13-14					1008	1016		10.3109/02699050903379354			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000003	19909050				2022-02-06	
J	Liu, Y; Liu, XJ; Sun, DD				Liu, Yan; Liu, Xiang-jun; Sun, Dandan			Ion transporters and ischemic mitochondrial dysfunction	CELL ADHESION & MIGRATION			English	Article						ischemia; intracellular Ca2+ dysregulation; changes of mitochondrial Ca2+; cytochrome c; apoptosis		Ischemia-induced ionic imbalance leads to the activation of numerous events including mitochondrial dysfunction and eventual cell death. Dysregulation of mitochondrial Ca2+ (Ca-m(2+)) plays a critical role in cell damage under pathological conditions including traumatic brain injury and stroke. High Ca-m(2+) levels can induce the persistent opening of the mitochondrial permeability transition pore and trigger mitochondrial membrane depolarization, Ca2+ release, cessation of oxidative phosphorylation, matrix swelling and eventually outer membrane rupture with release of cytochrome c and other apoptogenic proteins. Thus, the dysregulation of mitochondrial Ca2+ homeostasis is now recognized to play a crucial role in triggering mitochondrial dysfunction and subsequent apoptosis. Recent studies show that some secondary active transport proteins, such as Na+-dependent chloride transporter and Na+/Ca2+ exchanger, contribute to ischemia-induced dissipation of ion homeostasis including Ca-m(2+).	[Liu, Yan; Sun, Dandan] Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Liu, Yan; Liu, Xiang-jun] Tsinghua Univ, Sch Med, Inst Biomed Informat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China		Sun, DD (corresponding author), Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, T513 Waisman Ctr,1500 Highland Ave, Madison, WI 53705 USA.	sun@neurosurg.wisc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS-38118]; Tsinghua-Yue-Yuen Medical Sciences Fund; China Scholarship CouncilChina Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038118] Funding Source: NIH RePORTER	We thank Douglas Kintner for critical reading of the manuscript and many helpful suggestions. This work was supported by National Institutes of Health Grant R01NS-38118 (D.S.), Tsinghua-Yue-Yuen Medical Sciences Fund (X.J.L), and China Scholarship Council Postgraduate Scholarship Program (Y.L).	Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Beck J, 2003, J NEUROSCI, V23, P5061; Beresewicz M, 2006, NEUROCHEM INT, V48, P568, DOI 10.1016/j.neuint.2005.11.020; Bernardi P., 2007, V45, P481; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2004, CELL CYCLE, V3, P252; Bondarenko A, 2005, GLIA, V49, P143, DOI 10.1002/glia.20107; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Cao GD, 2004, J NEUROSCI, V24, P6189, DOI 10.1523/JNEUROSCI.1426-04.2004; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen H, 2007, J NEUROCHEM; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fall CP, 2001, J THEOR BIOL, V210, P151, DOI 10.1006/jtbi.2000.2292; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; FORBUSH B, 1983, J BIOL CHEM, V258, P1787; GOLDMAN WF, 1994, J NEUROSCI, V14, P5834; Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674; GRINWALD PM, 1982, J MOL CELL CARDIOL, V14, P359, DOI 10.1016/0022-2828(82)90251-6; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Iwamoto T, 2007, ANN NY ACAD SCI, V1099, P516, DOI 10.1196/annals.1387.039; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Kintner DB, 2005, AM J PHYSIOL-CELL PH, V289, pC934, DOI 10.1152/ajpcell.00092.2005; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Longuemare MC, 1999, NEUROSCIENCE, V93, P285, DOI 10.1016/S0306-4522(99)00152-9; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rose CR, 1998, J NEUROSCI, V18, P3554; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SARIS NEL, 1995, ACTA ANAESTH SCAND, V39, P171, DOI 10.1111/j.1399-6576.1995.tb04353.x; Schomberg SL, 2001, J NEUROPHYSIOL, V85, P2563, DOI 10.1152/jn.2001.85.6.2563; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Smith JP, 2000, BRAIN RES, V887, P98, DOI 10.1016/S0006-8993(00)02973-5; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	58	12	12	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA		1933-6926		CELL ADHES MIGR	Celll Adhes. Migr.	JAN-MAR	2009	3	1					94	98		10.4161/cam.3.1.7516			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	V21VD	WOS:000208234200018	19276659	gold, Green Published			2022-02-06	
J	Scott, CA; Rapport, LJ; Bryer, RC; Griffen, J; Hanks, R; Mckay, C				Scott, Carolyn A.; Rapport, Lisa J.; Bryer, Renee Coleman; Griffen, Julie; Hanks, Robin; McKay, Cherisse			Self-assessment of driving ability and the decision to resume driving following stroke	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Stroke; Driving; Self-assessment; Decision making; Cognitive estimation	TRAUMATIC BRAIN-INJURY; RIGHT-HEMISPHERE STROKE; COGNITIVE ESTIMATION; ALZHEIMERS-DISEASE; OLDER DRIVERS; REHABILITATION; ACCIDENT; SKILL; PREDICTORS; AWARENESS	The decision to resume driving after stroke can be complicated by the sequelae of stroke as well as the established finding that even healthy adults overestimate their driving ability. This study evaluated whether stroke survivors (n = 67) disproportionately overestimated their driving ability as compared to healthy significant others ( n = 67). Comparison to a known target reduced self-bias among both groups, but shift toward enhanced accuracy was significantly greater among survivors than significant others. Additionally, self-bias may reflect a pervasive trait of cognitive ability, as overestimation of driving ability was paralleled on a cognitive estimation task. Use of a specific criterion can facilitate accurate self-ratings of driving ability among survivors; however, actual decisions regarding driving status may be unrelated to self-view.	[Scott, Carolyn A.; Rapport, Lisa J.; Bryer, Renee Coleman; Griffen, Julie; Hanks, Robin] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [McKay, Cherisse] Bloorview Kids Rehab Toronto, Toronto, ON, Canada		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523	National Institute on Disabilities and Rehabilitation Research [H133G050134]; Wayne State University Thesis	This research was supported by a grant from the National Institute on Disabilities and Rehabilitation Research, awarded to the second author (H133G050134), and by a Wayne State University Thesis grant, awarded to the first author.	*AM HEART ASS, 2003, STROK FACTS US; AXELROD BN, 1994, ASSESSMENT, V0001, P00269, DOI DOI 10.1177/107319119400100307; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; BREWER MB, 1994, J PERS SOC PSYCHOL, V66, P268, DOI 10.1037/0022-3514.66.2.268; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Della Sala S, 2004, J NEUROL, V251, P156, DOI 10.1007/s00415-004-0292-8; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FINN P, 1986, ACCIDENT ANAL PREV, V18, P289, DOI 10.1016/0001-4575(86)90043-6; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Freeman MR, 1995, INT J NEUROSCI, V83, P269, DOI 10.3109/00207459508986343; GILLEN G, 1998, STROKE REHABILITATIO; Glendon AI, 1996, RISK ANAL, V16, P755, DOI 10.1111/j.1539-6924.1996.tb00826.x; Gregersen NP, 1996, ACCIDENT ANAL PREV, V28, P243, DOI 10.1016/0001-4575(95)00066-6; Groeger JA, 1996, BRIT J PSYCHOL, V87, P61, DOI 10.1111/j.2044-8295.1996.tb02577.x; GROEGER JA, 1989, ACCIDENT ANAL PREV, V21, P155, DOI 10.1016/0001-4575(89)90083-3; Hartman-Maeir A, 2003, DISABIL REHABIL, V25, P35, DOI 10.1080/0963828021000007897; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Liddle J., 2003, BRIT J OCCUPATIONAL, V66, P125, DOI DOI 10.1177/030802260306600307; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Mackenzie C, 2003, APHASIOLOGY, V17, P107, DOI 10.1080/729255215; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; MATHEWS ML, 1986, ACCIDENT ANAL PREV, V18, P299; MCCORMICK IA, 1986, ACCIDENT ANAL PREV, V18, P205, DOI 10.1016/0001-4575(86)90004-7; McKenna FP, 2006, HEALTH PSYCHOL, V25, P163, DOI 10.1037/0278-6133.25.2.163; MCKENNA FP, 1991, ACCIDENT ANAL PREV, V23, P45, DOI 10.1016/0001-4575(91)90034-3; Milner DA, 1995, VISUAL BRAIN ACTION; Muise JG, 1997, PERCEPT MOTOR SKILL, V85, P1203, DOI 10.2466/pms.1997.85.3f.1203; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Poissant L, 2003, BIOMED CENTRAL, V43, P225; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Tesser, 1988, ADV EXPT SOCIAL PSYC, V21, P181, DOI [10.1016/S0065-2601(08)60227-0, DOI 10.1016/S0065-2601(08)60227-0]; Titchener E. B., 1908, LECT ELEMENTARY PSYC; Unsworth C., 2001, AUSTR OCCUPATIONAL T, V48, P118, DOI [DOI 10.1046/J.0045-0766.2001.00246.X, 10.1046/j.0045-0766.2001.00246.x]; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245	50	12	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	3					353	362		10.1080/13803390802169067			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	423QF	WOS:000264510100009	18608674				2022-02-06	
J	Seo, W; Oh, H				Seo, WhaSook; Oh, HyunSoo			Comparisons of Acute Physiological Parameters Influencing Outcome in Patients with Traumatic Brain Injury and Hemorrhagic Stroke	WORLDVIEWS ON EVIDENCE-BASED NURSING			English	Article						physiological parameters; outcome; traumatic brain injury; hemorrhagic stroke	DISABILITY RATING-SCALE; MORTALITY; PREDICTORS	Background: Although several factors are known to influence prognosis after acute brain injury, physiologic derangements were found to be associated with, or contributing to, increased mortality and disability in these patients. Aims: This study was conducted to identify acute physiological parameters that significantly predict outcome and compare the identified parameters in patients with traumatic brain injury (TBI) and hemorrhagic stroke. Methods: Participants were 190 adult patients with TBI or hemorrhagic stroke who were admitted within 24 hours of injury. Details concerning potential physiological predictors were collected, that is, blood pressure (BP), heart rate, respiratory rate, body temperature, hematocrit, partial pressure of oxygen and carbon dioxide in arterial blood, serum osmolality, pH, total cholesterol, and glucose levels on admission. Mortality and functional and cognitive ability 6 months after injury were measured as outcome variables. Results: Most physiological parameters, with the exceptions of blood glucose, total cholesterol, and osmolality, were significant prognostic predictors in TBI and hemorrhagic stroke. However, the physiological parameters and their predictabilities differed in patients with TBI and hemorrhagic stroke, which indicated that physiological predictors depend on chosen outcome and brain injury type. Conclusions and Implications: In critical care units, the most important aims of nursing care are decreasing mortality and disability rates. In order to achieve such goals, acute physiological parameters such as BP, respiratory rate, heart rate, PaO2, PaCO2, and temperature should be monitored and managed, with the aim of reducing the risk of secondary brain injury.	[Seo, WhaSook; Oh, HyunSoo] Inha Univ, Coll Med, Dept Nursing, Inchon 402751, South Korea		Seo, W (corresponding author), Inha Univ, Coll Med, Dept Nursing, YongHyun Dong 253, Inchon 402751, South Korea.	wschang@inha.ac.kr					Bhalla A, 2001, QJM-INT J MED, V94, P167, DOI 10.1093/qjmed/94.3.167; Caronna JJ, 2000, CRIT CARE MED, V28, P1656, DOI 10.1097/00003246-200005000-00071; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Horenstein RB, 2002, STROKE, V33, P1863, DOI 10.1161/01.STR.0000020093.67593.0B; Labi MLC, 1998, J NEUROL REHABIL, V12, P45; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rordorf G, 2000, CRIT CARE MED, V28, P1301, DOI 10.1097/00003246-200005000-00007; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; WANG Y, 1954, J CLIN EPIDEMIOL, V54, P766; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646	12	12	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-102X	1741-6787		WORLDV EVID-BASED NU	Worldviews Evid.-Based Nurs.		2009	6	1					36	43		10.1111/j.1741-6787.2008.00139.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	419TN	WOS:000264242700005	19302545				2022-02-06	
J	West, SL; Graham, CW; Cifu, DX				West, Steven L.; Graham, Carolyn W.; Cifu, David X.			Rates of Alcohol/Other Drug Treatment Denials to Persons With Physical Disabilities: Accessibility Concerns	ALCOHOLISM TREATMENT QUARTERLY			English	Article						Persons with disabilities; treatment access; treatment denials; physical accessibility; programmatic accessibility		A growing body of research has developed indicating that substance abuse treatment facilities have numerous physical and programmatic barriers that could inhibit the ability of persons with disabilities (PWDs) to access care. Research has found that physical barriers do, in fact, result in service denials for individuals with spinal cord injury (SCI) and traumatic brain injury (TBI). The current research was undertaken to validate these findings with regard to persons with SCI and TBI, as well as to examine the impact of such barriers on the ability of individuals with other physical disabilities, including multiple sclerosis (MS), muscular dystrophy (MD), and other significant mobility impairments. Findings indicate that PWDs from each of these groups are denied services due to the presence of physical barriers at notable rates. Denial rates ranged from 65% for those with other significant mobility impairments to 87% for individuals with MS. Such extreme rates of services declines indicate a need for immediate action to address the accessibility of substance abuse treatment centers.	[West, Steven L.; Cifu, David X.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Graham, Carolyn W.] George Washington Univ, Washington, DC 20052 USA		West, SL (corresponding author), Virginia Commonwealth Univ, Dept Rehabil Counseling, POB 980330, Richmond, VA 23298 USA.	slwest2@vcu.edu		Cifu, David/0000-0003-1600-9387			ADLAF EM, 1992, AM J DRUG ALCOHOL AB, V18, P371, DOI 10.3109/00952999209051036; [Anonymous], AM J PHYS MED REHABI, V78, P306; Barrowclough C, 2001, AM J PSYCHIAT, V158, P1706, DOI 10.1176/appi.ajp.158.10.1706; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Burgard JF, 2000, J PSYCHOACTIVE DRUGS, V32, P293, DOI 10.1080/02791072.2000.10400452; Cherry L., 1993, SUBSTANCE ABUSE PHYS, P181; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DILLMAN D, 1991, CONDUCT YOUR OWN SUR; Drubach D A, 1993, Md Med J, V42, P989; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; MCCRONE WP, 1994, J AM DEAFNESS REHABI, V28, P1; Nelipovich M, 1998, J VISUAL IMPAIR BLIN, V92, P567, DOI 10.1177/0145482X9809200805; OGBORNE AC, 1995, AM J DRUG ALCOHOL AB, V21, P137, DOI 10.3109/00952999509095234; Olek M. J., 2002, NEUROLOGY CLIN PRACT, V2; RADNITZ CL, 1995, INT J ADDICT, V30, P1117, DOI 10.3109/10826089509055831; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Triffleman E, 1998, MED PSYCHIATRY, V8, P263; TYAS S, 1993, J STUD ALCOHOL, V54, P275, DOI 10.15288/jsa.1993.54.275; Voss C. P., 2002, TOPICS SPINAL CORD I, V7, P47; Waldrop J., 2003, DISABILITY STATUS 20; Weiss R. D., 1998, CLIN TXB ADDICTIVE D, P291; West S. L., J SUBSTANCE USE; West SL, 2007, J SUBST ABUSE TREAT, V33, P1, DOI 10.1016/j.jsat.2006.11.001; West SL, 2007, ADDICT BEHAV, V32, P1494, DOI 10.1016/j.addbeh.2006.10.009; Westermeyer J, 1996, AM J ADDICTION, V5, P23	26	12	12	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0734-7324	1544-4538		ALCOHOL TREAT Q	Alcohol. Treat. Q.		2009	27	3					305	316		10.1080/07347320903008190			12	Substance Abuse	Emerging Sources Citation Index (ESCI)	Substance Abuse	V1W9P	WOS:000217310400008					2022-02-06	
J	Yard, EE; Comstock, RD				Yard, Ellen E.; Comstock, R. Dawn			Effects of Field Location, Time in Competition, and Phase of Play on Injury Severity in High School Football	RESEARCH IN SPORTS MEDICINE			English	Article						epidemiology; competition intensity; concussion; kickoff; punt	AMERICAN FOOTBALL; RISK-FACTORS; LIFE STRESS; PROFESSIONAL FOOTBALL; CONCUSSION; SPORTS; ANXIETY; LEVEL; RATES; ANKLE	This study evaluated the effects of competitive intensity, represented by the variables time in competition, phase of play, and field location, on injury severity in U.S. high school football. The injury rate was higher in competition than practice (RR = 4.75, 95% CI: 4.34-5.20). Mild and moderate injuries were frequently lower leg/foot/ankle sprains/strains and concussions. Severe injuries were frequently knee Sprains/strains and arm fractures. Severe injuries composed a greater proportion of injuries sustained during the beginning and middle of competition compared with injuries sustained during the end/overtime (IPR = 1.83, 95% CI: 1.25-2.69). Compared with injuries sustained during general play, a greater proportion of kickoff/punt injuries were severe (IPR = 1.69, 95% CI: 1.07-2.68) or were concussions (IPR = 1.86, 95% CI: 1.05-3.30). Identifying factors contributing to severe injury is a crucial first step toward developing targeted evidence-based interventions aimed at reducing the incidence of severe injuries among the millions of high school football players.	[Yard, Ellen E.; Comstock, R. Dawn] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Coll Publ Hlth, Div Epidemiol, Columbus, OH USA		Yard, EE (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Yard@NationwideChildrens.org			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674] Funding Source: NIH RePORTER	This report was funded by the Centers for Disease Control and Prevention (CDC) grant #R49/CE000674-01.	Alsop J C, 2000, J Sci Med Sport, V3, P97, DOI 10.1016/S1440-2440(00)80072-9; *AM FOOTB MONTHL, 2006, LONG RED LIN     JUN; Beynnon BD, 2005, AM J SPORT MED, V33, P1485, DOI 10.1177/0363546505275490; Bishop PJ, 1996, AM J SPORT MED, V24, P235, DOI 10.1177/036354659602400222; BLACKWELL B, 1990, Athletic Training, V25, P25; CANALE ST, 1981, AM J SPORT MED, V9, P384, DOI 10.1177/036354658100900608; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CODDINGTON RD, 1980, J HUM STRESS, V6, P3, DOI 10.1080/0097840X.1980.9936100; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gomez JE, 1998, CLIN J SPORT MED, V8, P115, DOI 10.1097/00042752-199804000-00010; HANSON SJ, 1992, J SPORT EXERCISE PSY, V14, P262, DOI 10.1123/jsep.14.3.262; Junge A, 2000, AM J SPORT MED, V28, pS10; Kaplan LD, 2005, AM J SPORT MED, V33, P1142, DOI 10.1177/0363546505274718; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; KOLT GS, 1994, PERCEPT MOTOR SKILL, V78, P955, DOI 10.2466/pms.1994.78.3.955; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; *NAT FED STAT HIGH, 2005, 2004 05 NFHS HIGH SC; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; PARGMAN D, 1989, SPORTS TRAINING MED, V1, P203; PASSER MW, 1983, J HUM STRESS, V9, P11, DOI 10.1080/0097840X.1983.9935025; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Peterson L, 2000, AM J SPORT MED, V28, pS51; PETRIE TA, 1993, J SPORT EXERCISE PSY, V15, P261, DOI 10.1123/jsep.15.3.261; Powell JW, 1999, J ATHL TRAINING, V34, P277; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stuart Michael J, 2005, Med Sport Sci, V49, P62, DOI 10.1159/000085392; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Tyler TF, 2006, AM J SPORT MED, V34, P471, DOI 10.1177/0363546505280429; *US BUR CENS, 2007, CENS REG DIV US; *US FOOTB, 2006, COACH GUID SPEC TEAM	40	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2009	17	1					35	49		10.1080/15438620802678495			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	451RW	WOS:000266488800004	19266392				2022-02-06	
J	Khaled, SMCN; Raihan, MZ; Chowdhury, FH; Ashadullah, ATM; Sarkar, MH; Hossain, SS				Khaled, Chowdhury Noman S. M.; Raihan, M. Z.; Chowdhury, F. H.; Ashadullah, A. T. M.; Sarkar, M. H.; Hossain, S. S.			Surgical management of traumatic extradural haematoma: Experiences with 610 patients and prospective analysis	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						extradural haematoma; head injury		This study was carried out to find out the age, sex, mode of injury, localization, clinical presentation, CT findings, operative measures and outcome of extradural haematoma in the patient population at Dhaka Medical College. 610 consecutive patients with cranial extradural haematoma who underwent surgery in department of Neurosurgery from 1st January 2006 to 6th October 2008 were included in this prospective study. Each of the patients were evaluated in term of age, sex, mode of injury, localization of haematoma, clinical presentation, CT findings, operative measures and outcome. Out of 610 cases 86.32 % were male and 13.78 % were female. The male and female ratio was 6.27: 1. Age ranged from 2.5 to 83 years. Commonest age group was 21 to 30 years. Commonest mode of injury was Road traffic Accident 53.45%, followed by Assaults. Most common clinical presentation was headache / Vomiting 63.61 %, followed by altered sensorium 60.66 %. In this present prospective study of 610 cases of EDH, temporo parietal site was involved in 33.45 % followed by frontal region in 23.28 %. Sixty five patients (10.66 %) died; 19 of these had associated brain injuries and 28 cases were deeply unconscious. Extradural haematoma is a neurosurgical emergency where early surgical intervention is associated with the best prognosis. Many factors affects the outcome of extradural haematoma surgery and the most important one is the duration of time between incident/accident and operation in neurosurgical operation theater; mortality can be close to 0% if this time interval can be minimized.	[Khaled, Chowdhury Noman S. M.; Raihan, M. Z.; Chowdhury, F. H.; Ashadullah, A. T. M.; Sarkar, M. H.; Hossain, S. S.] Dhaka Med Coll Hosp, Dept Neurosurg, Dhaka, Bangladesh		Khaled, SMCN (corresponding author), Dhaka Med Coll Hosp, Dept Neurosurg, Dhaka, Bangladesh.	nomankhaled@yahoo.com					Ammirati M, 1985, REV NEUROSCI, V12, P123; Babu ML, 2005, JK SCI, V7, P205; Basavaraj KG, 2005, INDIAN J ANAESTH, V49, P24; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Carlos UP, 2005, INTERNET J EMERGENCY, V2; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; CUCCINIELLO B, 1993, ACTA NEUROCHIR, V120, P47, DOI 10.1007/BF02001469; DHARKER SR, 1991, ACTA NEUROCHIR, V110, P29, DOI 10.1007/BF01402044; ERSAHIN Y, 1993, CHILD NERV SYST, V9, P96, DOI 10.1007/BF00305316; Gallagher JP, 1968, J NEUROSURG, V29, P1; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; IWAKUMA T, 1973, J NEUROSURG, V38, P488, DOI 10.3171/jns.1973.38.4.0488; Jacobson HA, 1964, GUYS HOS REP, V43, P143; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JAMJOOM A, 1992, Acta Neurochirurgica, V115, P86, DOI 10.1007/BF01406363; Jamjoom AB, 1997, NEUROSURG REV, V20, P227, DOI 10.1007/BF01105892; JONES NR, 1993, BRIT J NEUROSURG, V7, P465, DOI 10.3109/02688699308995068; Kaye AH, 2005, ESSENTIAL NEUROSURGE, P81; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KVARNES TL, 1978, ACTA NEUROCHIR, V41, P223, DOI 10.1007/BF01809151; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lobato R, 1989, J NEUROSURG, V59, P762; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; MCKISSOCK W, 1960, LANCET, V2, P167; MCLAURIN RL, 1964, J NEUROSURG, V21, P364, DOI 10.3171/jns.1964.21.5.0364; MEIER U, 1994, UNFALLCHIRURG, V97, P406; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; PHONPRASERT C, 1980, J TRAUMA, V20, P679, DOI 10.1097/00005373-198008000-00008; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Uzkan U, 2007, DICLE TIP DERGISI, V34, P14; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; ZUCCARELLO M, 1981, NEUROSURGERY, V8, P434, DOI 10.1227/00006123-198104000-00005	43	12	12	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2008	5	2					75	79					5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0P	WOS:000218379000004					2022-02-06	
J	von Ruden, C; Benninger, E; Mayer, D; Trentz, O; Labler, L				von Rueden, Christian; Benninger, Emanuel; Mayer, Dieter; Trentz, Otmar; Labler, Ludwig			Bogota-VAC - A Newly Modified Temporary Abdominal Closure Technique	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Abdominal compartment syndrome (ACS); Intra-abdominal pressure (IAP); Temporary abdominal closure (TAC); Vacuum-assisted closure (VAC); Volume reserve capacity (VRC)	COMPARTMENT SYNDROME; TRAUMA; PACK	Background: We present Bogota-VAC, a newly modified temporary abdominal closure (TAC) technique for open abdomen condition after abdominal compartment syndrome (ACS). Methods: A thin isolation bag (Bogota bag) and a vacuum assisted closure (VAC) system were combined. A matching bag was tension-free fixed on the abdominal fascia by fascia suture. A ring shaped black polyurethane foam of the VAC system was placed into the gap between Bogota bag, abdominal fascia and the wound edge. A constant negative topic pressure of 50-75 mmHg was used in the VAC system. Results: Intra-abdominal pressure (IAP: 22 +/- 2 mmHg) of four patients with ACS after severe traumatic brain injury and one patient with isolated ACS after blunt abdominal trauma decreased significantly (p = 0.01) after decompressive laparotomy and treatment with Bogota-VAC (IAP: 10 +/- 2 mmHg) and remained low, measured via urinary bladder pressure. Intracranial pressure (ICP) in the four traumatic brain injury patients decreased from 42 +/- 13 mmHg to 15 +/- 3 mmHg after abdominal decompression. Cerebral perfusion pressure (57 14 mmHg) increased to 74 +/- 2 mmHg. Conclusion: The advantage of the presented Bogota-VAC is leak tightness, wound conditioning (soft tissue/fascia), skin protection and facilitation of nursing in combination with highest volume reserve capacity (VRC), thus preventing recurrent increased intra-abdominal and intracranial pressure in the initial phase after decompression of ACS compared to other TAC techniques.	[von Rueden, Christian; Benninger, Emanuel; Trentz, Otmar; Labler, Ludwig] Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland; [Mayer, Dieter] Univ Zurich Hosp, Dept Surg, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland		von Ruden, C (corresponding author), Univ Zurich Hosp, Dept Surg, Div Trauma Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	christian.vonrueden@usz.ch	Mayer, Dieter O/E-7617-2011	Mayer, Dieter O/0000-0001-5933-7749			Balogh Z, 2003, SHOCK, V20, P483, DOI 10.1097/01.shk.0000093346.68755.43; Barker DE, 2000, J TRAUMA, V48, P201, DOI 10.1097/00005373-200002000-00001; Benninger E, 2008, J SURG RES, V144, P102, DOI 10.1016/j.jss.2007.02.021; BROCK WB, 1995, AM SURGEON, V61, P30; COLLICOTT P E, 1980, Journal of the American Medical Association, V243, P1156, DOI 10.1001/jama.243.11.1156; CUESTA MA, 1991, WORLD J SURG, V15, P74, DOI 10.1007/BF01658968; Fernstrom A., 1996, Scandinavian Journal of Nutrition/Naringsforskning, V40, P2; HOWDIESHELL TR, 1995, WORLD J SURG, V19, P154, DOI 10.1007/BF00317004; Labler L, 2005, EUR J TRAUMA, V31, P488; Saggi B, 1998, J TRAUMA, V45, P597, DOI 10.1097/00005373-199809000-00033; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; Suliburk JW, 2003, J TRAUMA, V55, P1155, DOI 10.1097/01.TA.0000100218.03754.6A; *WORLD SOC ABD COM, CONS DEF REC	13	12	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2008	34	6					582	586		10.1007/s00068-008-8007-y			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	384EB	WOS:000261726000010	26816283	Green Submitted			2022-02-06	
J	Conti, A; Angileri, FF; Longo, M; Pitrone, A; Granata, F; La Rosa, G				Conti, Alfredo; Angileri, Filippo Flavio; Longo, Marcello; Pitrone, Antonio; Granata, Francesca; La Rosa, Giovanni			Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report	ACTA NEUROCHIRURGICA			English	Article						Intra-arterial Nimodipine; Endovascular; Cerebral vasospasm; Brain injury	PAPAVERINE INFUSION; ARTERIAL SPASM; BLOOD-FLOW; HEMORRHAGE; ANGIOPLASTY; MANAGEMENT; EFFICACY; THERAPY	Intra-arterial Nimodipine administration can be an effective alternative to papaverine or balloon angioplasty for the treatment of cerebral vasospasm refractory to medical therapy. It has been used for intractable vasospasm due to aneurysmal subarachnoid haemorrhage (SAH) with convincing results and no significant complications in small case series. This report describes of a patient with symptomatic and angiographically documented vasospasm following traumatic SAH which was refractory to maximal medical therapy and successfully treated with intra-arterial infusion of Nimodipine. This first reported technical note is with special reference to the nimodipine administration modalities, clinical and neuroradiological criteria of selection as well as the follow up of the patient.	[Conti, Alfredo; Angileri, Filippo Flavio; La Rosa, Giovanni] Univ Messina, Policlin Univ, Dept Neurosurg, I-98125 Messina, Italy; [Longo, Marcello; Pitrone, Antonio; Granata, Francesca] Univ Messina, Dept Neuroradiol, I-98125 Messina, Italy		Conti, A (corresponding author), Univ Messina, Policlin Univ, Dept Neurosurg, Via Consolare Valeria 1, I-98125 Messina, Italy.	alfredo.conti@unime.it	Conti, Alfredo/H-3022-2019; Angileri, Filippo/AAL-4851-2021; Angileri, Filippo Flavio/J-3533-2012; Longo, Marcello/K-5854-2016; Granata, Francesca/K-5842-2016; Angileri, Filippo/N-8556-2019	Conti, Alfredo/0000-0002-9408-2662; Angileri, Filippo Flavio/0000-0002-1107-4115; Longo, Marcello/0000-0003-1117-1772; Granata, Francesca/0000-0002-6939-1009; Angileri, Filippo/0000-0002-1107-4115			Arakawa Y, 2001, NEUROSURGERY, V48, P723, DOI 10.1097/00006123-200104000-00004; Biondi A, 2004, AM J NEURORADIOL, V25, P1067; Boker D K, 1985, Neurochirurgia (Stuttg), V28 Suppl 1, P118; CLOUSTON JE, 1995, AM J NEURORADIOL, V16, P27; Elliott JP, 1998, J NEUROSURG, V88, P277, DOI 10.3171/jns.1998.88.2.0277; Feng L, 2002, AM J NEURORADIOL, V23, P1284; Firat MM, 2005, AM J NEURORADIOL, V26, P1357; GROTENHUIS JA, 1984, J NEUROSURG, V61, P231, DOI 10.3171/jns.1984.61.2.0231; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hui C, 2005, CLIN RADIOL, V60, P1030, DOI 10.1016/j.crad.2005.04.004; Langham J, 2003, COCHRANE DB SYST REV; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Polin RS, 2000, J NEUROSURG, V92, P284, DOI 10.3171/jns.2000.92.2.0284; Rosenwasser RH, 1999, NEUROSURGERY, V44, P975, DOI 10.1097/00006123-199905000-00022; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Terada T, 1997, ACTA NEUROCHIR, V139, P227, DOI 10.1007/BF01844756; Vajkoczy P, 2001, STROKE, V32, P498, DOI 10.1161/01.STR.32.2.498	18	12	13	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	NOV	2008	150	11					1197	1202		10.1007/s00701-008-0141-0			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	371MG	WOS:000260834800012	18958388				2022-02-06	
J	Denninghoff, KR; Griffin, MJ; Bartolucci, AA; LoBello, SG; Fine, PR				Denninghoff, Kurt R.; Griffin, Mervin J.; Bartolucci, Alfred A.; LoBello, Steven G.; Fine, Phillip R.			Emergent Endotracheal Intubation and Mortality in Traumatic Brain Injury	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article								Objectives: To determine the relationship between emergent intubation (emergency department and field intubation cases combined) and mortality in patients with traumatic brain injury while controlling for injury severity. Methods: Retrospective observational study of 981 (35.2% intubated, 64.8% not intubated) patients with TBI evaluating the association between intubation status and mortality. Logistic regression was used to analyze the data. Injury severity measures included Head/Neck Abbreviated Injury Scale (H-AIS), systolic blood pressure, type of head injury (blunt vs. penetrating), and a propensity score combining the effects of several other potential confounding variables. Age was also included in the model. Results: The simple association of emergent endotracheal intubation with death had an odds ratio (OR) of 14.3 (95% CI = 9.4-21.9). The logistic regression model including relevant covariates and a propensity score that adjusted for injury severity and age yielded an OR of 5.9 (95% CI = 3.2-10.9). Conclusions: This study indicates that emergent intubation is associated with increased risk of death after controlling for a number of injury severity indicators. We discuss the need for optimal paramedic training, and an understanding of the factors that guide patient selection and the decision to intubate in the field.	[Denninghoff, Kurt R.] Univ Arizona, Dept Emergency Med, Tucson, AZ 85721 USA; [Bartolucci, Alfred A.; Fine, Phillip R.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35233 USA; [Denninghoff, Kurt R.; Griffin, Mervin J.; Bartolucci, Alfred A.; LoBello, Steven G.; Fine, Phillip R.] Univ Alabama Birmingham, Injury Control Res Ctr, Birmingham, AL 35233 USA; [LoBello, Steven G.] Auburn Univ, Montgomery, AL 36117 USA		Denninghoff, KR (corresponding author), Univ Arizona, Sch Med, Dept Emergency Med, 1501 N Campbell Ave,POB 245057, Tucson, AZ 85724 USA.	kdenninghoff@aemrc.arizona.edu			US Department of Health and Human Services Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CE000191]; National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	This study was supported in part by Grant No. R49-CE000191 from the US Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Injury Prevention and Control to the University of Alabama at Birmingham, Injury Control Research Center.	Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Batchelor J.S., 2001, TRAUMA, V1, P175, DOI DOI 10.1177/146040860100300305; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Floccare DJ, 2005, HOSP MED, V66, P89; Gennarelli TA, 1994, J TRAUMA; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stephens SW, 2006, ACAD EMERG MED S1, V13, pS85; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Thomas JB, 2007, PREHOSP EMERG CARE, V11, P219, DOI 10.1080/10903120701205802; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717; Wang HE, 2002, ANN EMERG MED, V40, P168, DOI 10.1067/mem.2002.126370; Wang HE, 2007, PREHOSP EMERG CARE, V11, P234, DOI 10.1080/10903120701204987; Wang Henry E, 2005, Prehosp Emerg Care, V9, P145; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Warner KJ, 2007, TRAUMA, V9, P283, DOI 10.1177/1460408607088317; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	31	12	12	0	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	NOV	2008	9	4					184	189					6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9W2N	WOS:000422581200001	19561742				2022-02-06	
J	[Anonymous]				[Anonymous]			Selected Issues for the Adolescent Athlete and the Team Physician: A Consensus Statement	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article							ANTERIOR CRUCIATE LIGAMENT; LOW-BACK-PAIN; MUSCULOSKELETAL MEDICINE; INFECTIOUS-MONONUCLEOSIS; ELBOW INJURIES; EXPERT OPINION; HIGH-SCHOOL; SPORTS; CONCUSSION; SHOULDER										Allen TW, 2005, CLIN J SPORT MED, V15, P421, DOI 10.1097/01.jsm.0000186684.59158.45; *AM AC FAM PHYS AM, 2006, MED SCI SPORTS EXERC, V38, P395; *AM AC FAM PHYS AM, 2000, MED SCI SPORTS EXERC, V32, P877; *AM AC FAM PHYS AM, 2001, MED SCI SPORTS EXERC, V33, P846; *AM AC FAM PHYS AM, 2007, MED SCI SPORTS EXERC, V39, P2058; *AM AC FAM PHYS AM, 2002, MED SCI SPORTS EXERC, V34, P1212; *AM AC FAM PHYS AM, 2006, MED SCI SPORTS EXERC, V38, P2030; *AM AC FAM PHYS AM, 2004, MED SCI SPORTS EXERC, V36, P2004; Anderson SJ, 1997, PEDIATRICS, V99, P904; [Anonymous], 2001, MED SCI SPORT EXER, V33, P1789; Asgari MM, 1997, YALE J BIOL MED, V70, P175; Auwaerter PG, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.11.529; Bales CP, 2004, AM J SPORT MED, V32, P1978, DOI 10.1177/0363546504271209; BARKUN AN, 1991, AM J MED, V91, P512, DOI 10.1016/0002-9343(91)90188-4; Bono CM, 2004, J BONE JOINT SURG AM, V86A, P382, DOI 10.2106/00004623-200402000-00027; BRADLEY JP, 2002, DELEE DREZS ORTHOPAE, P1249; Burkhart SS, 2000, CLIN SPORT MED, V19, P125, DOI 10.1016/S0278-5919(05)70300-8; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; DALTON SE, 1992, SPORTS MED, V13, P58, DOI 10.2165/00007256-199213010-00006; DEFELICE GS, 2001, ATHLETES ELBOW, P99; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fulkerson JP, 2002, AM J SPORT MED, V30, P447, DOI 10.1177/03635465020300032501; GORWITZ RJ, 2006, M MAN MRSA COMM STRA; Gregory AJM, 2007, PEDIATR CLIN N AM, V54, P797, DOI 10.1016/j.pcl.2007.07.001; Griffin LY, 2003, MED SCI SPORT EXER, V35, P1785; Guzzanti V, 2003, AM J SPORT MED, V31, P941, DOI 10.1177/03635465030310063301; Hoagland RJ, 1975, PRIMARY CARE, V96, P505; Hosey RG, 2006, BRIT J SPORT MED, V40, P251, DOI 10.1136/bjsm.2005.022376; Hutchinson Mark R, 2003, Instr Course Lect, V52, P25; Kentta G, 2001, INT J SPORTS MED, V22, P460, DOI 10.1055/s-2001-16250; Kibler WB, 2003, J SCI MED SPORT, V6, P51, DOI 10.1016/S1440-2440(03)80008-7; Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127; Kocher MS, 2002, AM J SPORT MED, V30, P697, DOI 10.1177/03635465020300051201; Kocher MS, 2001, AM J SPORT MED, V29, P292, DOI 10.1177/03635465010290030601; LAINE C, 2006, AM COLL PHYS ITC, V6, P1; Lattavo A, 2007, PEDIATR CLIN N AM, V54, P735, DOI 10.1016/j.pcl.2007.04.009; *LITTL LEAG BAS, 2007, LITTL LEAG IMPL NEW; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; LOVELL MR, 2008, NEUROL CLIN, V26, pR8; Lyman S, 2001, MED SCI SPORT EXER, V33, P1803, DOI 10.1097/00005768-200111000-00002; McKenzie DC, 2002, CLIN J SPORT MED, V12, P225, DOI 10.1097/00042752-200207000-00004; Myers JB, 2005, AM J SPORT MED, V33, P263, DOI 10.1177/0363546504268138; Nattiv A., 2007, MED SCI SPORTS EXERC, V39, P1867; Olsen SJ, 2006, AM J SPORT MED, V34, P905, DOI 10.1177/0363546505284188; Oppliger RA, 1996, MED SCI SPORT EXER, V28, pR9; PAPPAS AM, 1982, CLIN ORTHOP RELAT R, V164, P30; Putukian M, 2008, CLIN J SPORT MED, V18, P309, DOI 10.1097/JSM.0b013e31817e34f8; Rudzki JR, 2004, CLIN SPORT MED, V23, P581, DOI 10.1016/j.csm.2004.05.001; Shah SW, 2006, ROTHMANSIMEON SPINE, P565; Shelbourne KD, 2004, AM J SPORT MED, V32, P1218, DOI 10.1177/0363546503262169; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Standaert CJ, 2008, PHYS MED REH CLIN N, V19, P287, DOI 10.1016/j.pmr.2008.01.002; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P1077, DOI 10.1016/j.apmr.2007.06.002; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P537, DOI 10.1016/j.apmr.2007.01.007; Teeple Erin, 2006, Med Health R I, V89, P236; Terjung RL, 2000, MED SCI SPORT EXER, V32, P706, DOI 10.1097/00005768-200003000-00024; Turbeville SD, 2006, AM J SPORT MED, V34, P1860, DOI 10.1177/0363546505285385; Washington RL, 2005, PEDIATRICS, V116, P1557, DOI 10.1542/peds.2005-2314; Washington RL, 2005, PEDIATRICS, V115, P1103, DOI 10.1542/peds.2005-0085; Wilson JJ, 2006, CLIN J SPORT MED, V16, P357, DOI 10.1097/00042752-200607000-00014	62	12	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2008	40	11					1997	2012		10.1249/MSS.0b013e31818acdcb			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	365VA	WOS:000260435800018	19430330				2022-02-06	
J	Cattelani, R; Roberti, R; Lombardi, F				Cattelani, R.; Roberti, R.; Lombardi, F.			Adverse effects of apathy and neurobehavioral deficits on the community integration of traumatic brain injury subjects	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						neurobehavioral manifestations; brain injuries; interpersonal relations	MENTAL-RETARDATION; PARTICIPATION; INDIVIDUALS; TRANSITION; DISABILITY; EMPLOYMENT; PEOPLE; ADULTS; WORK	Aim. The aim of this study was to provide insight into the adverse effects of neurobehavioral features on the community integration of young adults who have had prior severe traumatic brain injury (TBI) with a positive longterm outcome in either functional or intellectual abilities. TBI subjects were compared with patients suffering from a health condition classified as mild intellectual disability (MID). Methods. Twenty-five subjects with prior severe TBI, but with substantially normalized perceptual-motor and intellectual functioning, were retrospectively selected according to demographic and clinical admission criteria. The TBI subject group was compared with a selected group of 34 MID subjects. The measures used were: the Wechsler Adult Intelligence Scale-Revised (WAIS-R), Instrumental Activity of Daily Living Scale (IADLS), Community Integration Questionnaire (CIQ), and Social Behaviour Check-list (SBC). The presence/absence of dysfunctional family environment and affective close relationships were also reported. Results. Significant differences between TBI and MID subjects (with greatest scores in TBI group) refer to: WAIS-R Full Scale IQ (FSIQ, indicating an average intellectual level), CIQ-Social integration (indicating a greater level than MID group), and SBC-Defective-type behaviour (indicating a greater level of apathy than MID group). Conclusion. Defective-type behaviour-synthesized into the term 'apathy'-has the following features: 1) can explain the unsatisfying community integration of TBI subjects with respect to the general population; and 2) best explains the similar CIQ-home integration and CIQ-productive activities compared to subjects presenting a higher intellectual disadvantage (MID patients). The multidisciplinary approach to the complex community integration process of TBI subjects might consider the high frequency of apathy as a primarily target of the community integration management.	[Cattelani, R.] Univ Parma, Fac Med & Chirurg, Dept Neurosci, Sez Neurol,Neurol Unit, I-43100 Parma, Italy; [Roberti, R.] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Lombardi, F.] Sebastiano Hosp Correggio, Reggio Emilia, Italy		Cattelani, R (corresponding author), Univ Parma, Fac Med & Chirurg, Dept Neurosci, Sez Neurol,Neurol Unit, Via Gramsci 14, I-43100 Parma, Italy.	cattel@unipr.it		LOMBARDI, Francesco/0000-0002-7184-6391			*AAMR, 2002, MENT RET DEF CLASS S; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Borod J., 2000, NEUROPSYCHOLOGY EMOT; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cattelani R., 2006, NEUROPSICOLOGIA SIND; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clegg J, 2001, BRIT J MED PSYCHOL, V74, P151, DOI 10.1348/000711201160885; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Hughes C, 2001, MENT RETARD DEV D R, V7, P84, DOI 10.1002/mrdd.1012; HUGHES C, 2000, TRANSITION HDB; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lombardi F., 1997, GIORNALE ITALIANO ME, V1, P23; Luftig RL, 2005, RES DEV DISABIL, V26, P317, DOI 10.1016/j.ridd.2003.08.001; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; ORSINI A, 1997, CONTRIBUTO TARATURA; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reiss S, 2004, MENT RETARD, V42, P77, DOI 10.1352/0047-6765(2004)42<77:CAMRBI>2.0.CO;2; REISS S, 2000, WHO I AM 16 BASIC DE; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Wechsler D., 1981, WAIS R MANUAL; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; [No title captured]	39	12	16	1	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2008	44	3					245	251					7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	347DZ	WOS:000259122100003	18762734				2022-02-06	
J	Cho, J; Moon, CT; Kang, HS; Choe, WJ; Chang, SK; Koh, YC; Roh, HG				Cho, Joon; Moon, Chang Taek; Kang, Hyun Seung; Choe, Woo Jin; Chang, Sang Keun; Koh, Young Cho; Roh, Hong Gee			Traumatic entrapment of the vertebrobasilar junction due to a longitudinal clival fracture: A case report	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						cranial fossa, posterior; skull fracture, basilar; vertebral artery; brain infarction	BASILAR ARTERY; OCCLUSION; INCARCERATION; SKULL	Vertebrobasilar junction entrapment due to a clivus fracture is a rare clinical observation. The present case report describes a 54-yr-old man who sustained a major craniofacial injury. The patient displayed a stuporous mental state (Glasgow Coma Scale [GCS]=8) and left hemiparesis (Grade 3). The initial computed tomography (CT) scan revealed a right subdural hemorrhage in the frontotemporal region, with a midline shift and longitudinal clival fracture. A decompressive craniectomy with removal of the hematoma was performed. Two days after surgery, a follow-up CT scan showed cerebellar and brain stem infarction, and a CT angiogram revealed occlusion of the left vertebral artery and entrapment of vertebrobasilar junction by the clival fracture, A decompressive suboccipital craniectomy was performed and the patient gradually recovered, This appears to be a rare case of traumatic vertebrobasilar junction entrapment due to a longitudinal clival fracture, including a cerebellar infarction caused by a left vertebral artery occlusion. A literature review is provided.	[Cho, Joon; Moon, Chang Taek; Kang, Hyun Seung; Choe, Woo Jin; Chang, Sang Keun; Koh, Young Cho] Konkuk Univ Hosp, Dept Neurosurg, Seoul 143729, South Korea; [Roh, Hong Gee] Konkuk Univ Hosp, Dept Radiol, Seoul 143729, South Korea		Moon, CT (corresponding author), Konkuk Univ Hosp, Dept Neurosurg, 4-12 Hwayang Dong, Seoul 143729, South Korea.	ctmoon@kuh.ac.kr	Kang, Hyun-Seung/J-5365-2012				ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; Bala A, 2004, J CLIN NEUROSCI, V11, P660, DOI 10.1016/j.jocn.2003.11.008; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; LINDENBERG R, 1966, J NEUROSURG, V24, P908, DOI 10.3171/jns.1966.24.5.0908; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; SATO H, 1990, Neurological Surgery, V18, P1147; Sato M, 1999, SURG NEUROL, V51, P613, DOI 10.1016/S0090-3019(98)00091-3; Sato S, 2001, NEUROL MED-CHIR, V41, P541, DOI 10.2176/nmc.41.541; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588; Taguchi Y, 2000, J TRAUMA, V48, P1148, DOI 10.1097/00005373-200006000-00023; Zhu BL, 2002, FORENSIC SCI INT, V126, P40, DOI 10.1016/S0379-0738(02)00029-4	15	12	12	0	3	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934			J KOREAN MED SCI	J. Korean Med. Sci.	AUG	2008	23	4					747	751		10.3346/jkms.2008.23.4.747			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344OG	WOS:000258936600033	18756072	gold, Green Published			2022-02-06	
J	Yard, EE; Comstock, RD				Yard, E. E.; Comstock, R. D.			A comparison of pediatric freestyle and Greco-Roman wrestling injuries sustained during a 2006 US national tournament	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						sports; injury; tournament; risk factors	HIGH-SCHOOL SPORTS; CATASTROPHIC INJURIES; PATTERNS	The purpose of this study was to compare the epidemiology of freestyle and Greco-Roman wrestling injuries sustained during a 2006 United States (US) national tournament. A prospective injury surveillance study was conducted at the US 2006 ASICS/Vaughan Cadet and Junior National Championships. There were 83 freestyle- and 55 Greco-Roman-related injuries sustained, with the rate of injury per 1000 athlete-matches higher in freestyle (7.0) compared with Greco-Roman (4.6) wrestling [Rate ratio (RR)=1.51, 95% confidence interval (CI): 1.07-2.12]. Compared with Greco-Roman wrestling, there was a greater proportion of knee injuries in freestyle wrestling [injury proportion ratio (IPR)=4.17, 95% CI: 1.30-13.41]. In GrecoRoman wrestling, there were greater proportions of elbow (IPR=9.11, 95% CI: 1.13-73.59) and head/face/neck (IPR=1.72, 95% CI: 1.10-2.67) injuries and a greater proportion of concussions (IPR=1.95, 95% CI: 0.92-4.12), although the latter was statistically insignificant. Greco-Roman wrestlers sustained a greater proportion of injuries from being driven into the mat (IPR=2.97, 95% CI: 1.72-5.14). There were no statistically significant differences in injury outcome by wrestling style. The differing injury rates and patterns of injury between freestyle and Greco-Roman wrestling are likely due to the different rules between these styles that allow lower leg attacks in freestyle wrestling and encourage the use of throws in Greco-Roman wrestling.	[Yard, E. E.; Comstock, R. D.] Childrens Hosp, Columbia Childrens Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Comstock, R. D.] Ohio State Univ, Div Epidemiol, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Comstock, R. D.] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA		Yard, EE (corresponding author), Childrens Hosp, Columbia Childrens Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	YardE@pediatrics.ohio-state.edu					ACIKGOZ B, 1990, PARAPLEGIA, V28, P265, DOI 10.1038/sc.1990.34; *AM SPORTS DAT INC, 2004, SUP STUD SPORTS PART, V2; Beachy G, 1997, AM J SPORT MED, V25, P675, DOI 10.1177/036354659702500515; Berson B L, 1979, Am J Sports Med, V7, P348; Boden Barry P, 2005, Curr Sports Med Rep, V4, P45; Boden BP, 2002, AM J SPORT MED, V30, P791, DOI 10.1177/03635465020300060601; Brindle TJ, 1998, J ORTHOP SPORT PHYS, V27, P444, DOI 10.2519/jospt.1998.27.6.444; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Cohn B T, 1986, Orthop Rev, V15, P590; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Estwanik J J, 1978, Am J Sports Med, V6, P335, DOI 10.1177/036354657800600605; GARRICK JG, 1978, PEDIATRICS, V61, P465, DOI 10.1542/peds.61.3.465; GIFFIN CS, 1992, ANN PLAS SURG, V28, P131, DOI 10.1097/00000637-199202000-00002; Hoffman H., 1990, J ATHL TRAINING, V25, P125; Jarrett GJ, 1998, AM J SPORT MED, V26, P674, DOI 10.1177/03635465980260051301; Johnson R, 2004, CLIN SPORT MED, V23, P473, DOI 10.1016/j.csm.2004.02.003; KERSEY RD, 1983, AM J SPORT MED, V11, P147, DOI 10.1177/036354658301100307; Lightfoot Andrew J, 2005, Iowa Orthop J, V25, P145; LORISH TR, 1992, AM J SPORT MED, V20, P199, DOI 10.1177/036354659202000218; MARTIN WR, 1999, PHYS MED REHABIL CLI, V10, pR7; MUELLER FO, 1990, MED SCI SPORT EXER, V22, P737, DOI 10.1249/00005768-199012000-00001; MYSNYK MC, 1986, AM J SPORT MED, V14, P46, DOI 10.1177/036354658601400109; *NAT FED STAT HIGH, 2005 06 HIGH SCH ATH; Pasque CB, 2000, AM J SPORT MED, V28, P509, DOI 10.1177/03635465000280041101; Powell JW, 1999, J ATHL TRAINING, V34, P277; RONTOYANNIS GP, 1988, INT J SPORTS MED, V9, P353, DOI 10.1055/s-2007-1025040; SNOOK GA, 1982, AM J SPORT MED, V10, P142, DOI 10.1177/036354658201000303; STANISH WD, 1986, CAN J APPL SPORT SCI, V11, P173; STRAUSS RH, 1982, JAMA-J AM MED ASSOC, V248, P2016, DOI 10.1001/jama.248.16.2016; WROBLE RR, 1986, AM J SPORT MED, V14, P55, DOI 10.1177/036354658601400110; WROBLE RR, 1986, CLIN SPORT MED, V5, P295	31	12	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	AUG	2008	18	4					491	497		10.1111/j.1600-0838.2007.00716.x			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	332JA	WOS:000258078100012	18067522				2022-02-06	
J	Whiting, MD; Hamm, RJ				Whiting, Mark D.; Hamm, Robert J.			Mechanisms of anterograde and retrograde memory impairment following experimental traumatic brain injury	BRAIN RESEARCH			English	Article						brain injury; amnesia; retrieval; memory impairment; rat	MEDIAL TEMPORAL-LOBE; LONG-TERM-MEMORY; DEFICITS; CONSOLIDATION; AMNESIA; RETRIEVAL; RATS; HIPPOCAMPUS; MODEL	Memory impairment is common following traumatic brain injury. However, the specific processes underlying the impairments remain unknown. Traumatic brain injury may interfere with several of the stages of the learning and memory process. In two separate experiments, we examined the specific nature of both anterograde and retrograde memory dysfunction following fluid percussion brain injury in rats. In Experiment 1, we examined the retention of spatial memory in the MWM after equating initial learning between sham and injured animals. Animals were trained to criterion and then tested for retention 4, 8, or 24 h post-training. Although injured animals displayed deficits in task acquisition, retention performance was not significantly different between groups. In Experiment 2, we examined the effects of injury on the retention of retrograde spatial memories in the MWM. Animals were injured either 1 or 14 days post-training and then received retention probe trials followed by a reminding procedure and second probe trial 14 days post-injury. All injured animals displayed retention deficits in the probe trials 14 days post-injury. However, after the reminding procedure, injured animals displayed sham-level performance during the second probe trial. The results of these experiments suggest that with anterograde memory impairment induced by traumatic brain injury, the primary deficit lies in task acquisition, not the retention of information within long-term memory. Retrograde memory impairment following injury appears to be mediated primarily by deficits in memory retrieval. (c) 2008 Elsevier B.V. All rights reserved.	[Whiting, Mark D.] Quinnipiac Univ, Dept Psychol, Hamden, CT 06518 USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23221 USA		Whiting, MD (corresponding author), Quinnipiac Univ, Dept Psychol, LW LIB,275 Mt Carmel Ave, Hamden, CT 06518 USA.	mark.whiting@quinnipiac.edu					ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCKEE RD, 1992, J NEUROSCI, V12, P3765; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sellal FO, 2002, CORTEX, V38, P499, DOI 10.1016/S0010-9452(08)70019-4; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; ZHOU YL, 1995, PHYSIOL BEHAV, V57, P1107, DOI 10.1016/0031-9384(95)00019-F	20	12	12	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 5	2008	1213						69	77		10.1016/j.brainres.2008.01.107			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	319TD	WOS:000257186000008	18455704				2022-02-06	
J	Stocchetti, N; Longhi, L; Zanier, ER				Stocchetti, N.; Longhi, L.; Zanier, E. R.			Intracranial pressure monitoring for traumatic brain injury: available evidence and clinical implications	MINERVA ANESTESIOLOGICA			English	Article						intracranial pressure; intracranial hypertension; brain injuries	SEVERE HEAD-INJURY; PULMONARY-ARTERY CATHETER; INTENSIVE-CARE MANAGEMENT; EARLY-DIAGNOSIS; HYPERTENSION; COMPLICATIONS; TOMOGRAPHY; MORTALITY; INFECTION; DRAINAGE	Following traumatic brain injury, uncontrollable intracranial hypertension remains the most frequent cause of death. Despite general agreement on the deleterious effects of elevated intracranial pressure (ICP), however, the evidence supporting the use of ICP monitoring has recently been questioned. The aim of this review was to evaluate the pros and cons of ICP monitoring and to discuss the hypothetical desirability and feasibility of a trial testing the benefits of ICP monitoring.	Univ Milan, Dept Anesthesia & Crit Care Med, I-20122 Milan, Italy; IRCCS Hosp Milan, Maggiore Policlin, Neurosci ICU, Milan, Italy		Stocchetti, N (corresponding author), Osped Maggiore Policlin, Mangiagalli & Regina Elena IRCCS, Neurosci ICU, Via F Sforza 35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	Zanier, Elisa/AAA-8095-2020; Stocchetti, Nino/O-7444-2017; Longhi, Luca/AAF-9903-2021	Zanier, Elisa/0000-0002-3011-8718; Stocchetti, Nino/0000-0003-3250-6834; Longhi, Luca/0000-0001-9894-8788			American Society of Anesthesiologists, STAND BAS AN MON; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Birnbaum S, 2007, BMJ-BRIT MED J, V334, P1006, DOI 10.1136/bmj.39205.757870.47; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chieregato A, 2007, CRIT CARE MED, V35, P673, DOI 10.1097/01.CCM.0000254054.56103.35; CLARK WC, 1989, NEUROSURGERY, V25, P20; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ferdinande P, 1997, INTENS CARE MED, V23, P226, DOI 10.1007/s001340050321; Friese RS, 2006, CRIT CARE MED, V34, P1597, DOI 10.1097/01.CCM.0000217918.03343.AA; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; KLAUBER MR, 1984, J NEUROSURG, V61, P695, DOI 10.3171/jns.1984.61.4.0695; Le H, 2001, J NEUROSURG, V95, P720, DOI 10.3171/jns.2001.95.4.0720; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; MAGNANO M, 1994, AUDIOLOGY, V33, P237; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MILLER JD, 1989, INTRACRANIAL PRESSUR, V7, P5; OSPINATASCON GA, 2008, INTENSIVE CARE MED; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; PITLYK PJ, 1985, NEUROSURGERY, V17, P581, DOI 10.1227/00006123-198510000-00008; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rossi S, 1998, ACT NEUR S, V71, P91; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Shimbles S, 2005, PHYSIOL MEAS, V26, P1085, DOI 10.1088/0967-3334/26/6/017; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2007, INTENS CARE MED, V33, P1682, DOI 10.1007/s00134-007-0798-5; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Sundbarg G, 1988, Br J Neurosurg, V2, P485, DOI 10.3109/02688698809029603; Takala J, 2006, CRIT CARE, V10, DOI 10.1186/cc5021; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Ueno T, 2003, AVIAT SPACE ENVIR MD, V74, P882; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	49	12	17	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2008	74	5					199	205					7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	299MU	WOS:000255760500006	18414362				2022-02-06	
J	Whyte, J; Hart, T; Ellis, CA; Chervoneva, I				Whyte, John; Hart, Tessa; Ellis, Colin A.; Chervoneva, Inna			The moss attention rating scale for traumatic brain injury: Further explorations of reliability and sensitivity to change	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						attention; brain injuries; rehabilitation	NETWORKS	Objective: To examine the interrater agreement and responsiveness to change of the Moss Attention Rating Scale (MARS), 22-item version, during acute inpatient rehabilitation after traumatic brain injury (TBI). Design: Observational Study of clinician ratings (physical therapy [PT], occupational therapy [OT], speech-lanouage pathology [SLP], nursing) of each patient's attentional function at 2 points in time, near the time of admission and near the time of discharge from inpatient rehabilitation. Setting: Dedicated acute inpatient brain injury rehabilitation program. Participants: Inpatients (N=149) with moderate to severe TBI (58% enrolled in the National Institute on Disability Rehabilitation Research-funded Traumatic Brain Injury Model System); age 16 years or older; receiving OT, PT, SLP, and nursing care on the inpatient TBI rehabilitation unit; and having Rancho Los Amigos Levels of Cognitive Functioning Scale scores of IV (confused/agitated) or higher at enrollment. Patients were excluded if they had premorbid history of attention deficit hyperactivity disorder, major psychiatric disorder (eg, bipolar), or neurologic impairment (eg, stroke). Interventions: Not applicable. Main Outcome Measure: Scores on the MARS (12-item version) and its 3 factor scores. Results: Intraclass correlations among ratings from PT. OT, and SLP ranged from .69 to .78 at the initial assessment and .67 to .72 at the follow-up assessment. Agreement between nursing and the other disciplines Was somewhat lower (at initial assessment, .59-68; at follow-up, .48-59), although still substantial. Agreement for 2 of the factor scores (restlessness and/or distractibility, initiation) was similar but agreement for the third factor (consistent and/or Sustained attention) was lower (.25-.27). The total MARS scores were highly significantly improved (P<.001) at follow-up compared with initial assessment (mean, 27.6d between ratings: median, 21d; range, 4-125d) for each of the rating disciplines. with change scores ranging from 7.8 points (OT) to 13.1 points (nursing). Factor scores also improved significantly during the same interval. When different Occupational therapists provided the initial and follow-up OT ratings, these follow-up ratings were significantly cantly lower, but this pattern was not seen among other rating disciplines. Conclusions: The 22-item MARS showed good interrater C agreement among PT, OT, and SLP and lower but still acceptable agreement between nursing and the other disciplines. Two of the 3 factor scores also showed good agreement. The 22 item total score and all 3 factor scores were highly sensitive to change occurring during inpatient rehabilitation. These results show that the 22-item MARS is a reliable instrument for the observational rating of attentiveness in an acute TBI rehabilitation sample. Lower agreement between nursing and the other, disciplines suggests that the less structured environment of the nursing unit compared with therapy sessions reduces interrater agreement. The utility of the factor scores, particularly the least reliable sustained and/or consistent attention factor, requires additional investigation. Further research on construct validity and impact of the use of the MARS on clinical practice are warranted.	[Whyte, John; Hart, Tessa; Ellis, Colin A.] Moss Rehabil Res Inst, Philadelphia, PA 19027 USA; [Whyte, John; Hart, Tessa] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Chervoneva, Inna] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Div Biostat, Philadelphia, PA 19107 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 60 E Township Line Rd,Elkins Pk, Philadelphia, PA 19027 USA.	jwhyte@einstein.edu		Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A020505]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133A020505).	Chinchilli, 1997, LINEAR NONLINEAR MOD; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Whyte J., 2004, REHABILITATION MED P, P1677	10	12	12	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					966	973		10.1016/j.apmr.2007.12.031			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900024	18452747				2022-02-06	
J	Hoerold, D; Dockree, PM; O'Keeve, FM; Bates, H; Pertl, M; Robertson, IH				Hoerold, Doreen; Dockree, Paul M.; O'Keeve, Fiadhnait M.; Bates, Helen; Pertl, Maria; Robertson, Ian H.			Neuropsychology of self-awareness in young adults	EXPERIMENTAL BRAIN RESEARCH			English	Article						insight; self-awareness; sustained attention; frontal lobes; executive functions	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; ALZHEIMERS-DISEASE; ERROR-AWARENESS; ANOSOGNOSIA; DEFICITS; DEMENTIA; HEMIPLEGIA; DEPRESSION; INSIGHT	Disorders of self-awareness are common following cortical damage, particularly to the frontal lobes, but there have been few studies of individual differences in self-awareness in the normal population. In the current study, we explored patterns of metacognitive awareness among healthy young adults, based on discrepancies of self- and other-ratings on the Frontal Systems Behavior Scale (FrSBe; Grace and Malloy, 2002). Those who showed poor metacognitive awareness showed more frequent lapses of attention, and higher levels of everyday absentmindedness, than those who accurately appraised their own behavior or those who overestimated their own FrSBe scores. Furthermore, among those with poor metacognitive awareness, online emergent awareness correlated positively with prospective memory performance, and negatively with anxiety scores. Our results suggest that accurate self-awareness in non-neurological participants relies on efficient sustained attention functioning, supporting the role of frontal control systems in neuroanatomical models of self-awareness.	[Hoerold, Doreen; Dockree, Paul M.; O'Keeve, Fiadhnait M.; Bates, Helen; Pertl, Maria; Robertson, Ian H.] Univ Dublin Trinity Coll, Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Hoerold, Doreen; Dockree, Paul M.; O'Keeve, Fiadhnait M.; Bates, Helen; Pertl, Maria; Robertson, Ian H.] Univ Dublin Trinity Coll, Trinity Coll, Sch Psychol, Dublin 2, Ireland		Hoerold, D (corresponding author), Univ Dublin Trinity Coll, Trinity Coll, Inst Neurosci, Dublin 2, Ireland.	hoeroldd@tcd.ie		Pertl, Maria/0000-0001-7326-2763; Robertson, Ian H/0000-0001-8637-561X			Aalten P, 2005, AGING MENT HEALTH, V9, P414, DOI 10.1080/13607860500143075; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BREIER JI, 1995, NEUROLOGY, V45, P65, DOI 10.1212/WNL.45.1.65; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DALLABARBA G, 1995, NEUROPSYCHOLOGIA, V33, P247; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Evyapan D, 1999, NEUROLOGY, V53, P647, DOI 10.1212/WNL.53.3.647; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hjaltason H, 1996, NEUROPSYCHOLOGIA, V34, P1229, DOI 10.1016/0028-3932(96)00044-9; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Malloy PF., 2002, FRONTAL SYSTEMS BEHA; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; MCDANIEL KD, 1995, ALZ DIS ASSOC DIS, V9, P101, DOI 10.1097/00002093-199509020-00007; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Nelson H.E., 1982, NATL ADULT READING T; Nelson HE, 1991, REVISED NATL ADULT R; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1996, BLACKWELL DICT NEURO, P80; Rankin KP, 2005, J NEUROL NEUROSUR PS, V76, P632, DOI 10.1136/jnnp.2004.042879; REED BR, 1993, J CLIN EXP NEUROPSYC, V15, P231, DOI 10.1080/01688639308402560; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Souchay C, 2003, NEUROCASE, V9, P482, DOI 10.1076/neur.9.6.482.29376; Spreen O., 1998, COMPENDIUM NEUROPSYC, P2; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; STUSS DT, 2001, FRONTAL IOBES NEUROP; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; WALKER D, 2003, THESIS U READING; Wechsler D, 1998, WECHSLER MEMORY SCAL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	12	12	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	APR	2008	186	3					509	515		10.1007/s00221-008-1341-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	277XT	WOS:000254248700016	18340439				2022-02-06	
J	Keenan, HT				Keenan, Heather T.			Practical aspects of conducting a prospective statewide incidence study: The incidence of serious inflicted traumatic brain injury in north Carolina	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							YOUNG-CHILDREN	The article describes practical problems encountered in setting up and maintaining an active statewide surveillance system for a low-frequency but high-impact injury, inflicted traumatic brain injury (inflicted TBI). A system was designed to identify prospectively all children aged <2 years with a traumatic brain injury (TBI) admitted to any of the nine pediatric intensive care units (ICUs) in North Carolina in 2000 and 2001. Children who died prior to admission to hospital were identified from the records of the Office of the Chief Medical Examiner. The study design had strengths and weaknesses for ongoing surveillance. Strengths included a clear definition of a case, mechanisms to jury undecided cases, and a high level of quality control. Difficulties included appropriately addressing investigators' ethical and legal obligations in the study of child abuse, differing requirements of multiple institutional review boards (IRBs), and the time-intensive nature of the system. The described surveillance system produced high-quality data, but may not be practical for ongoing multi-year injury surveillance. Incorporation of inflicted TBI into an existing surveillance system, such as a trauma database, may be a feasible solution to many of the problems encountered.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT USA		Keenan, HT (corresponding author), 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD041040] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD041040-06, K23 HD041040] Funding Source: Medline		Alexander J, 2001, N C Med J, V62, P359; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; *PRACT MAN INF COR, 1998, INT CLASS DIS 9 REV; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277	10	12	12	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797			AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S120	S125		10.1016/j.amepre.2007.11.001			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300005	18374261	Green Accepted			2022-02-06	
J	Runyan, DK; Berger, RP; Barr, RG				Runyan, Desmond K.; Berger, Rachel P.; Barr, Ronald G.			Defining an ideal system to establish the incidence of inflicted traumatic brain injury - Summary of the consensus conference	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							HEAD-INJURY; CHILDHOOD; SURVEILLANCE; MALTREATMENT; CHILDREN; EXPERIENCES; CHALLENGES; PREVENTION; ISSUES; ABUSE	A conference addressing how to establish the incidence of inflicted traumatic brain injury in young children provided the opportunity to examine issues of definitions, passive versus active surveillance, study designs, proxy measures, and statistical issues. Data were presented that had been collected in alternative ways. The participants concluded that an ideal System for measurement of the incidence does not yet exist. A new surveillance system will take a significant amount of time and money to establish. Such a system will require a combination of ascertainment approaches, attention to case finding, a large population, careful attention to coding and data quality. The ethical issues involved in measuring stigmatized and illegal behavior are not inconsequential. In an ideal system data from different sources-medical, legal, and social service, among others-will need to be linked. Perhaps most importantly, any surveillance approach will need to be maintained so that trend data can be used to assess the effectiveness of prevention efforts.	[Runyan, Desmond K.] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27599 USA; [Berger, Rachel P.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Barr, Ronald G.] Univ British Columbia, Child & Family Res Inst, Ctr Community Child Hlth Res, Vancouver, BC V5Z 1M9, Canada		Runyan, DK (corresponding author), Univ N Carolina, Dept Social Med, Campus Box 7240, Chapel Hill, NC 27599 USA.	drunyan@unc.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029			Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barr RG, 2008, AM J PREV MED, V34, pS106, DOI 10.1016/j.amepre.2008.01.021; Bennett S, 2008, AM J PREV MED, V34, pS140, DOI 10.1016/j.amepre.2008.01.026; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Dong MX, 2005, ARCH PEDIAT ADOL MED, V159, P1104, DOI 10.1001/archpedi.159.12.1104; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; GARRISON HG, 1994, ANN EMERG MED, V24, P849, DOI 10.1016/S0196-0644(94)70203-9; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Melton G B, 1990, Violence Vict, V5, P67; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; *PREV CHILD AB AM, 2001, TEST EST COST CHILD; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Rivara FP, 2008, AM J PREV MED, V34, pS148, DOI 10.1016/j.amepre.2007.11.021; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Runyan DK, 2005, CHILD ABUSE NEGLECT, V29, P461, DOI 10.1016/j.chiabu.2004.06.015; RUNYAN DK, 2006, 13 INT C CHILD AB NE; Ryan MAK, 2008, AM J PREV MED, V34, pS143, DOI 10.1016/j.amepre.2007.12.020; Shapiro ED, 2008, AM J PREV MED, V34, pS153, DOI 10.1016/j.amepre.2008.01.022; SOCOLAR RS, 1995, J FAM ISSUES, V16, P565, DOI 10.1177/019251395016005004; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; *USDHHS, 2007, CHILD MEAS 2005; Wirtz SJ, 2008, AM J PREV MED, V34, pS134, DOI 10.1016/j.amepre.2007.11.004	30	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S163	S168		10.1016/j.amepre.2008.01.010			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300013	18374269				2022-02-06	
J	Kunene, KN; Weistroffer, HR				Kunene, K. Niki; Weistroffer, H. Roland			An approach for predicting and describing patient outcome using multicriteria decision analysis and decision rules	EUROPEAN JOURNAL OF OPERATIONAL RESEARCH			English	Article; Proceedings Paper	23rd EURO Summer Institute on OR in Health Care	JUL 24, 2005	Univ Southampton, Southampton, ENGLAND	EURO	Univ Southampton	data mining; knowledge-based systems; decision support systems; multicriteria decision analysis; traumatic brain injury	SEVERE HEAD-INJURY	Patient outcome in brain trauma patients is affected by a multiplicity of factors, beginning with ambulatory transportation and routing, to the grade of the receiving facility and treatment therein, and finally the treatment and monitoring in definitive care (the brain trauma intensive care unit). Factors and events in each of these phases can be modeled as a multicriteria problem, where the objective is to optimize patient outcome; moreover, a more comprehensive model can embody the interactions of all three phases. This study focuses on modeling the factors that affect patient outcome in definitive care and on expressing these in machine readable format so that we can better describe or predict patient outcome using data mining tools. We use multicriteria decision analysis and decision rules for knowledge representation. Preliminary results suggest that the incorporation of a priori knowledge does help better predict or describe patient outcome when using decision tree induction. (C) 2006 Elsevier B.V.. All rights reserved.	Univ Louisville, Coll Business, Louisville, KY 40292 USA; Virginia Commonwealth Univ, Sch Business, Dept Informat Syst, Richmond, VA 23284 USA		Weistroffer, HR (corresponding author), Univ Louisville, Coll Business, Louisville, KY 40292 USA.	hrweistr@vcu.edu	Weistroffer, Heinz Roland/B-8389-2009	Weistroffer, Heinz Roland/0000-0002-3745-5143			Belton V., 2002, MULTIPLE CRITERIA DE; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 2000, GUIDELINES MANAGEMEN; Cabena P., 1997, DISCOVERING DATA MIN; DANIELS H, 2001, COMBINING DOMAIN KNO; Fayyad U, 1996, COMMUN ACM, V39, P27, DOI 10.1145/240455.240464; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feelders A, 2000, INFORM MANAGE, V37, P271, DOI 10.1016/S0378-7206(99)00051-8; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; Freitas AA, 1999, KNOWL-BASED SYST, V12, P309, DOI 10.1016/S0950-7051(99)00019-2; Han J., 2001, DATA MINING CONCEPTS; Hilderman R. J., 2001, Advances in Knowledge Discovery and Data Mining. 5th Pacific-Asia Conference, PAKDD 2001. Proceedings (Lecture Notes in Artificial Intelligence Vol.2035), P247; Hilderman RJ, 2000, LECT NOTES COMPUT<D>, V1910, P432; HUBER PJ, 1997, P 3 INT C KNOWL DIS; JENNETT B, 1975, LANCET, V1, P480; KOHAVI R, 1998, DATA MINING MINESET; Kopanas I, 2002, LECT NOTES ARTIF INT, V2308, P288; LIU HM, 1995, J TRAUMA, V38, P330, DOI 10.1097/00005373-199503000-00003; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Saaty T.L., 1992, MULTICRITERIA DECISI; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; SAATY TL, 1994, EUR J OPER RES, V74, P426, DOI 10.1016/0377-2217(94)90222-4; SAATY TL, 1990, FUNDAMENTALS DECISIO; Saaty TL, 1994, FUNDAMENTALS DECISIO; Sibbritt David, 2004, Health Care Manag Sci, V7, P163, DOI 10.1023/B:HCMS.0000039379.32963.9e; TEASDALE G, 1974, LANCET, V2, P81	28	12	12	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0377-2217	1872-6860		EUR J OPER RES	Eur. J. Oper. Res.	MAR 16	2008	185	3					984	997		10.1016/j.ejor.2006.02.054			14	Management; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Business & Economics; Operations Research & Management Science	233DL	WOS:000251070500007					2022-02-06	
J	Arroyos-Jurado, E; Savage, TA				Arroyos-Jurado, Elsa; Savage, Todd A.			Intervention Strategies for Serving Students With Traumatic Brain Injury	INTERVENTION IN SCHOOL AND CLINIC			English	Article						interventions; traumatic brain injury; children			[Arroyos-Jurado, Elsa] New Mexico State Univ, Dept Counseling & Educ Psychol, Sch Psychol, Las Cruces, NM 88003 USA		Arroyos-Jurado, E (corresponding author), New Mexico State Univ, Dept Counseling & Educ Psychol, Sch Psychol, POB 30001,MSC 3CEP, Las Cruces, NM 88003 USA.	elsaaj@nmsu.edu					Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Begali V., 1992, HEAD INJURY CHILDREN; *BRAIN INJ ASS, 2005, FACTS TRAUM BRAIN IN; Bullock LM, 2005, PREV SCH FAIL, V49, P6, DOI 10.3200/PSFL.49.4.6-10; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; CLARK E, 2002, CHILDRENS NEEDS, V3, P897; Clark E., 1997, CHILDHOOD TRAUMATIC, P191; COHEN SB, 1991, J HEAD TRAUMA REHAB, V6, P56; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DOELLING J, 1997, TEACHING EXCEPTIONAL, V30, P56; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; GARCIA JG, 1998, PROFESSIONAL SCH COU, V2, P33; HARVEY JM, 2006, BEST PRACTICES SCH P, V4, P1433; JANUS PL, 1994, ED DIMENSIONS ACQUIR, P475; Mayfield J, 2005, PREV SCH FAIL, V49, P17, DOI 10.3200/PSFL.49.4.17-22; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	18	12	12	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1053-4512			INTERV SCH CLIN	Interv. Sch. Clin.	MAR	2008	43	4					252	254		10.1177/1053451208314907			3	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	370MY	WOS:000260767500010					2022-02-06	
J	Lange, RT; Iverson, GL; Franzen, MD				Lange, Rael T.; Iverson, Grant L.; Franzen, Michael D.			Comparability of neuropsychological test profiles in patients with chronic substance abuse and mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	26th Annual Meeting of the National-Academy-of-Neuropsychology	OCT 25-28, 2006	San Antonio, TX	Natl Acad Neuropsychol		cluster analysis; mild traumatic brain injury; substance abuse	TERM BENZODIAZEPINE USE; EMOTIONAL RISK-FACTORS; FAKE-BAD SCALE; HEAD-INJURY; ALCOHOL-USE; CONCUSSION; OUTCOMES; COMPENSATION; PERCEPTION; SYMPTOMS	The purpose of this study was to compare 104 patients with acute uncomplicated mild traumatic brain injury (MTBI) to a sample of 104 patients from an inpatient substance abuse program to determine whether these patients could be differentiated by their pattern of relative cognitive strengths and weaknesses. Patients were matched on age, education, and gender. Eight cognitive measures were used that included tests of attention, memory, and processing speed. There were no statistically significant differences between the two groups on any of the cognitive measures. Using a two-step cluster analysis procedure (i.e., hierarchical and k-means analyses), seven common profiles were identified. There was no significant difference in the proportions of patients from the MTBI or substance abuse group in each of the seven profiles. These results show that patients with uncomplicated MTBIs could not be reliably differentiated from patients with substance abuse problems on these cognitive measures. This is of particular concern for clinicians evaluating the neuropsychological effects of MTBI in individuals with a comorbid history of substance abuse.	[Lange, Rael T.; Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Riverview Hosp, Dept Res, Coquitlam, BC V3C 4J2, Canada; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Franzen, Michael D.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA		Lange, RT (corresponding author), British Columbia Mental Hlth & Addict Serv, Riverview Hosp, Dept Res, Room 124-ADMIN Bldg,Main Floor,2601 Lougheed High, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca		Iverson, Grant/0000-0001-7348-9570			Aldenderfer FA, 1984, CLUSTER ANAL; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Bates ME, 1999, ASSESSMENT OF NEUROPSYCHOLOGICAL FUNCTIONS IN PSYCHIATRIC DISORDERS, P373; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Beatty M. E., 1994, DRUG ALCOHOL DEPEN, V37, P247; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; *CAN I HLTH INF, 2002, ONT TRAUM REG B; CARLIN AS, 1996, NEUROPSYCHOLOGICAL A, P486; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, 2003, TRAUM BRAIN INF US R; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; COWIE SE, 2005, DOCUMENTATION SUBSTA; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Drubach D A, 1993, Md Med J, V42, P989; ERRICO AL, 1990, PSYCHOL ASSESSMENT, V2, P45, DOI DOI 10.1037/1040-3590.2.1.45; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Everitt B. S., 1993, CLUSTER ANAL; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Heaton R. K., 2004, REVISED COMPREHENSIV; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; JERNIGAN T, 1992, IMAGING ALCOHOL RES, P121; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange R. T., 2002, J COGNITIVE REHABILI, V20, P16; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; Miller Norman S., 1994, P471; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MORRIS JA, 1998, ALCOHOLISM TREATMENT, V16, P101; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paraherakis A, 2001, SUBST USE MISUSE, V36, P257, DOI 10.1081/JA-100102625; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reitan RM, 1992, TRAIL MAKING TEST MA; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Rosselli M, 1996, J CLIN EXP NEUROPSYC, V18, P122, DOI 10.1080/01688639608408268; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selby MJ, 1998, DRUG ALCOHOL DEPEN, V50, P39, DOI 10.1016/S0376-8716(98)00002-7; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; STRANG J, 1989, BRIT J ADDICT, V84, P1011; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	81	12	12	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAR	2008	22	2					209	227		10.1080/13854040701290062			19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	279ZA	WOS:000254393500003	17853134				2022-02-06	
J	Nakstad, PH; Gjertsen, O; Pedersen, HK				Nakstad, P. Hj.; Gjertsen, O.; Pedersen, H. Kr.			Correlation of Head Trauma and Traumatic Aneurysms	INTERVENTIONAL NEURORADIOLOGY			English	Article						trauma; skull; fracture; aneurysm; endovascular treatment	SUPERIOR CEREBELLAR ARTERY; INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; PERICALLOSAL ANEURYSM; INJURY; ANGIOGRAPHY; DIAGNOSIS; SECONDARY; BRAIN	Subarachnoid hemorrhage following severe trauma to the head is relatively common. In most cases the bleed originates front superficial veins and occasionally from arteries. Following the replacement of cerebral angiography with CT in the diagnostic evaluation of head traumas fewer traumatic aneurysms have been observed. This may indicate that some traumatic aneurysms are missed if angiographic procedures are not performed in patients with severe head injury. Trauma patients admitted to our institution are submitted to CT including a bone algorithm. In case of subarachnoid hemorrhage, especially in the basal cisterns, CT- angiography is performed. Digital subtraction angiography is performed as well in cases with uncertain interpretations. During one year 81 patients were admitted with subarachnoid hemorrhage following head trauma. Thirteen (16%) of them underwent CT-angiography and in five (6.2%) with SAH in the basal cistern traumatic aneurysms were found. Four of these cases had a skull base fracture including fractures through the clivus. Four cases were embolized and one very small extradural aneurysm is still not treated. One small pericallosal aneurysm was operated. A traumatic aneurysm should always be suspected n patients with skull base fractures and subarachnoid hemorrhage in the basal cisterns.	[Nakstad, P. Hj.] Univ Oslo, Ulleval Univ Hosp, Dept Neuroradiol, Div Med Serv, N-0407 Oslo, Norway		Nakstad, PH (corresponding author), Univ Oslo, Ulleval Univ Hosp, Dept Neuroradiol, Div Med Serv, N-0407 Oslo, Norway.						Chambers N, 2002, PAEDIATR ANAESTH, V12, P356, DOI 10.1046/j.1460-9592.2002.00831.x; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GIANNOTTA SL, 1982, CLIN NEUR, V29, P288; Gjertsen O, 2007, INTERV NEURORADIOL, V13, P167, DOI 10.1177/159101990701300207; HALBACH VV, 1987, AM J NEURORADIOL, V8, P627; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Marx MV, 2005, J VASC INTERV RADIOL, V16, P631, DOI 10.1016/S1051-0443(07)60643-5; MCDONALD EJ, 1976, AM J RADIOL, V16, P792; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MIRVIS SE, 1990, AJNR, V11, P335; NAKSTAD P, 1987, NEURORADIOLOGY, V29, P312, DOI 10.1007/BF00451778; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NAKSTAD PH, 1992, ACTA RADIOL, V33, P145; Pedersen HK, 2001, ACTA RADIOL, V42, P43, DOI 10.1080/028418501127346224; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; SCHWARTZ RB, 1994, RADIOLOGY, V192, P717, DOI 10.1148/radiology.192.3.8058939; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SONG JK, 1999, AM J RADIOL, V173, P111; TAVERAS JM, 1976, CEREBRAL ANGIOGRAPHY, V2, P543; Tsubokawa T, 1975, No Shinkei Geka, V3, P663; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	26	12	12	0	1	EDIZIONI CENTAURO	BOLOGNA	VIA DEL PRATELLO, 8, 40122 BOLOGNA, ITALY	1123-9344			INTERV NEURORADIOL	Interv. Neuroradiol.	MAR	2008	14	1					33	38		10.1177/159101990801400104			6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	407NF	WOS:000263370900004	20557783	Green Published			2022-02-06	
J	Nikitin, AG; Chudakova, DA; Strokov, IA; Bursa, TR; Chistiakov, DA; Nosikov, VV				Nikitin, Alexey G.; Chudakova, Dariya A.; Strokov, Igor A.; Bursa, Tamara R.; Chistiakov, Dimitry A.; Nosikov, Valery. V.			Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						diabetic polyneuropathy; poly(ADP-ribose)polymerase-1; Leu54Phe and Val762Ala; polymorphisms; type 1 diabetes; association	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; POLYMERASE ACTIVATION; PERIPHERAL NEUROPATHY; POLY(ADP-RIBOSYL)ATION; DNA; DISEASE; TESTS; RISK	Poly(ADP-ribose) polymerase-1 (PARP-1) is an ubiquitous DNA-binding protein involved in the cellular response to various genotoxic agents. Excessive PARP-1 activation is known to lead to the depletion of intracellular NAD+ and ATP pools and hence to threat cell survival. Therefore, PARP-1 could be involved in neuronal death and contribute to the development of diabetic polyneuropathy (DPN). This study addressed the association of Leu54Phe and Val762Ala polymorphisms of PARP-1 with DPN in Russian type 1 diabetic (T1D) patients. Eighty-six T1D patients with severe DPN and 93 T1D patients with no clinical signs of DPN have been studied by a polymerase chain reaction restriction fragment length polymorphism approach. Using Fisher's exact test revealed the association of the Phe54 and Val762 variants of PARP-1 (odds ratio (OR), 1.66 and 2.88, respectively) with increased risk of DPN in T1D. These results suggest that the PARP1 gene is involved in the pathogenesis of diabetic neuropathy in a Russian population. Additionally, a logistic regression analysis revealed a significant association between the neurological variances such as vibration detection threshold (OR, 2.08), vibration and temperature perception thresholds (OR, 1.32 and 1.67, respectively), and sensory and motor nerve conduction velocities (OR, 2.34 and 2.58, respectively), with DPN. (C) 2007 Elsevier Ireland Ltd. All rights reserved.	[Nikitin, Alexey G.; Chudakova, Dariya A.; Chistiakov, Dimitry A.; Nosikov, Valery. V.] Natl Res Ctr GosNIIgenetika, Moscow 113545, Russia; [Strokov, Igor A.; Bursa, Tamara R.] IM Sechenov Med Acad, Dept Neurol, Moscow, Russia		Chistiakov, DA (corresponding author), Natl Res Ctr GosNIIgenetika, Bldg 1,1st Dorozhny Proezd, Moscow 113545, Russia.	dmitry_chistyakov@verizon.net	Nikitin, Alexey G/M-7220-2014	Strokov, Igor/0000-0001-6950-7166			Baba M, 2001, Arch Physiol Biochem, V109, P234, DOI 10.1076/apab.109.3.234.11595; Berciano MT, 1999, J NEUROPATH EXP NEUR, V58, P1234, DOI 10.1097/00005072-199912000-00004; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chistiakov DA, 2006, DIABETES METAB, V32, P63, DOI 10.1016/S1262-3636(07)70248-3; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Cottet F, 2000, J MOL MED, V78, P431, DOI 10.1007/s001090050488; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1991, NEUROLOGY, V41, P799, DOI 10.1212/WNL.41.6.799; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; Dyck PJ, 1997, DIABETES, V46, pS5, DOI 10.2337/diab.46.2.S5; HERZOG H, 1989, P NATL ACAD SCI USA, V86, P3514, DOI 10.1073/pnas.86.10.3514; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Infante J, 2007, J NEUROL SCI, V256, P68, DOI 10.1016/j.jns.2007.02.008; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Koh DW, 2005, CELL MOL LIFE SCI, V62, P760, DOI 10.1007/s00018-004-4508-y; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Kuchmerovska T, 2004, J DIABETES COMPLICAT, V18, P198, DOI 10.1016/S1056-8727(03)00039-4; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; Mathew C. G. P., 1984, METHOD MOL BIOL, V2, P31, DOI DOI 10.1385/0-89603-064-4:31; Olaleye D, 2001, DIABETES RES CLIN PR, V54, P115, DOI 10.1016/S0168-8227(01)00278-9; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; ROLLI V, 2000, DNA DAMAGE STRESS SI, P35; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Siemionow M, 2004, J RECONSTR MICROSURG, V20, P241; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Strokov IA, 2003, ACTA DIABETOL, V40, pS375, DOI 10.1007/s00592-003-0123-x; van de Poll-Franse LV, 2002, DIABETIC MED, V19, P771, DOI 10.1046/j.1464-5491.2002.00778.x; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Yorek MA, 2003, FREE RADICAL RES, V37, P471, DOI 10.1080/1071576031000083161; Zhang XM, 2005, CANCER RES, V65, P722; Zheng L, 2004, DIABETES, V53, P2960, DOI 10.2337/diabetes.53.11.2960	45	12	19	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	MAR	2008	79	3					446	452		10.1016/j.diabres.2007.10.020			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	281OC	WOS:000254506200010	18054108				2022-02-06	
J	Zhang, ZR; Fauser, U; Schluesener, HJ				Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.			Dexamethasone suppresses infiltration of RhoA(+) cells into early lesions of rat traumatic brain injury	ACTA NEUROPATHOLOGICA			English	Article						RhoA; dexamethasone; traumatic brain injury; microglia; macrophages; weight-drop model	CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; RHO-GTPASES; LEUKOCYTE RECRUITMENT; CLOSTRIDIUM-BOTULINUM; ACTIN CYTOSKELETON; AXON REGENERATION; ADP-RIBOSYLATION	Inflammatory cell infiltration is a major part of secondary tissue damage in traumatic brain injury (TBI). RhoA is an important member of Rho GTPases and is involved in leukocyte migration. Inhibition of RhoA and its downstream target, Rho-associated coiled kinase (ROCK), has been proven to promote axon regeneration and function recovery following injury in the central nervous system (CNS). Previously, we showed that dexamethasone, an immunosuppressive corticosteroid, attenuated early expression of three molecules associated with microglia/macrophages activation following TBI in rats. Here, the effects of dexamethasone on the early expression of RhoA have been investigated in brains of TBI rats by immunohistochemistry. In brains of rats treated with TBI alone, significant RhoA(+) cell accumulation was observed at 18 h post-injury and continuously increased during our observed time period. The accumulated RhoA(+) cells were distributed to the areas of pannecrosis and selective neuronal loss. Most accumulated RhoA(+) cells were identified as active microglia/macrophages by double-labelling. Dexamethasone (1 mg/kg body weight) was intraperitoneally injected on day 0 and 2 immediately following brain injury. Numbers of RhoA(+) cells were significantly reduced on day 1 and 2 following administration of dexamethasone but returned to vehicle control level on day 4. However, dexamethasone treatment did not change the proportion of RhoA(+) cells. These observations suggest that dexamethasone has only a transient effect on early leukocyte recruitment.	[Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.] Univ Tubingen, Brain Res Inst, D-72076 Tubingen, Germany		Zhang, ZR (corresponding author), Univ Tubingen, Brain Res Inst, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Zhang, Zhiren/O-1012-2019	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835			Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Dergham P, 2002, J NEUROSCI, V22, P6570; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; Hendricks JJA, 2004, J EXP MED, V200, P1667, DOI 10.1084/jem.20040819; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Irazuzta J, 2005, INTENS CARE MED, V31, P146, DOI 10.1007/s00134-004-2462-7; Kim JS, 2005, EXP MOL MED, V37, P575, DOI 10.1038/emm.2005.71; Knaus UG, 2000, IMMUNOL RES, V21, P103, DOI 10.1385/IR:21:2-3:103; Kubes P, 2000, BRAIN PATHOL, V10, P127; LANG P, 1992, J BIOL CHEM, V267, P11677; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maderna P, 2002, AM J PATHOL, V160, P2275, DOI 10.1016/S0002-9440(10)61175-3; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pixley FJ, 2005, J CELL SCI, V118, P1873, DOI 10.1242/jcs.02314; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Skaper SD, 2001, PROG NEUROBIOL, V65, P593, DOI 10.1016/S0301-0082(01)00017-X; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Walters CE, 2002, J IMMUNOL, V168, P4087, DOI 10.4049/jimmunol.168.8.4087; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhang ZR, 2006, EXP NEUROL, V197, P252, DOI 10.1016/j.expneurol.2005.09.015	56	12	13	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAR	2008	115	3					335	343		10.1007/s00401-007-0301-y			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	265GB	WOS:000253346000007	17929039				2022-02-06	
J	Lovell, M				Lovell, Mark			The neurophysiology and assessment of sports-related head injuries	NEUROLOGIC CLINICS			English	Article							HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; PROFESSIONAL FOOTBALL; AGREEMENT STATEMENT; CEREBRAL CONCUSSION; RECOVERY; PERFORMANCE; IMPAIRMENT; RETURN; PLAY	This article provides a review of contemporary standards for the management of athletes who have sustained a sports-related head injury. Recent research regarding concussion management is reviewed with specific reference to clinical care. The use of neuropsychologic testing in sports also is reviewed, and a systematic protocol for the management of sports-related concussion is presented.	Univ Pittsburgh, Med Ctr Sports Med, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA		Lovell, M (corresponding author), Univ Pittsburgh, Med Ctr Sports Med, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	lovellmr@upmc.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 1989, MILD HEAD INJURY, P257; Bergschneider M, 2003, J NEUROSURG, V86, P241; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; COLLINS MW, 1999, JAMA-J AM MED ASSOC, V282, P2383; *CTR DIS CONTR, 2006, HEADS SPORTS CONC; DELANEY JS, 2004, CLIN J SPORT MED, V12, P331; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, 2000, NEUROLOGIC ATHLETIC, P109; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schnirring L, 2001, PHYSICIAN SPORTSMED, V29, P11; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; WOJYTS ED, 1999, AM J SPORTS MED, V27, P676	44	12	12	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2008	26	1					45	+		10.1016/j.ncl.2007.12.001			19	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281ID	WOS:000254489200004	18295083				2022-02-06	
J	Moinard, C; Gupta, S; Besson, V; Morio, B; Marchand-Leroux, C; Chaumeil, JC; Cynober, L; Charrueau, C				Moinard, Christophe; Gupta, Severine; Besson, Valerie; Morio, Beatrice; Marchand-Leroux, Catherine; Chaumeil, Jean-Claude; Cynober, Luc; Charrueau, Christine			Evidence for impairment of hepatic energy homeostasis in head-injured rat	JOURNAL OF NEUROTRAUMA			English	Article						ATP; glycogen; head trauma; liver; mitochondria	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION; MUSCLE; LIVER; PRESERVATION; METABOLISM; EXPRESSION; OXIDATION; STATE	Traumatic brain injury (TBI) is known to induce a metabolic adaptation characterized by a nitrogen transfer from the periphery to the liver. However, the consequences of TBI on liver energy status are poorly documented. We evaluated the consequences of TBI on liver energy homeostasis in rats. In a first set of experiments, rats were randomized into two groups: a TBI group traumatized by fluid percussion, and an ad libitum fed group (AL) of healthy rats. The rats were sacrificed at 2, 3, or 4 days (D2, D3, and D4, respectively to determine the kinetic of hepatic energy changes). Since TBI leads to a profound anorexia, in a second set of experiments TBI rats received enteral nutrition (TBI-EN group) for 4 days to specifically assess the role of anorexia in the hepatic disturbances. TBI led to a decrease in hepatic glycogen (D2: TBI 3.9 +/- 1.9 vs. AL 18.9 +/- 2.6 mg/g, p < 0.05) and ATP (D2: TBI 540 +/- 57 vs. AL 850 +/- 44 nmol/g, p < 0.05) contents. These effects were not linked to anorexia, since they were observed when rats were fed using continuous enteral nutrition. Interestingly, there was no adaptation of the mitochondrial oxidative capacity to compensate for the increase in energy requirements (cytochrome C oxidase activity: AL, 82 +/- 5; TBI, 82 +/- 4; and TBI-EN, 87 +/- 3 mu mol/min/g, NS). These findings demonstrate that TBI is responsible for an impairment of liver energy homeostasis. Moreover, these alterations are related neither to anorexia nor to decreased mitochondrial oxidative capacity.	[Gupta, Severine; Chaumeil, Jean-Claude; Charrueau, Christine] Univ Paris 05, Fac Pharm, Pharm Galen Lab, EA 2498, F-75270 Paris 06, France; [Moinard, Christophe; Cynober, Luc] Univ Paris 05, Fac Pharm, Lab Biol Nutr, EA 2498, F-75270 Paris, France; [Besson, Valerie; Marchand-Leroux, Catherine] Univ Paris 05, Fac Pharm, Lab Pharmacol Circulat, EA 2510, F-75270 Paris 06, France; [Morio, Beatrice] Univ Auvergne, INRA, UMR 1019, Unite Nutr Humaine, Clermont Ferrand, France; [Cynober, Luc] AP HP, Hotel Dieu, Biochim Lab, Paris, France		Charrueau, C (corresponding author), Univ Paris 05, Fac Pharm, Pharm Galen Lab, EA 2498, 4 Ave Obeserv, F-75270 Paris 06, France.	christine.charrueau@univ-paris5.fr	Cynober, Luc/ABB-2368-2020; Morio, Beatrice/G-3571-2018; MARCHAND-LEROUX, Catherine/L-7453-2017; besson, valerie C/L-7388-2017; BESSON, VALERIE/AAZ-9989-2020	Morio, Beatrice/0000-0002-2418-1438; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; besson, valerie C/0000-0002-1491-2380; BESSON, VALERIE/0000-0002-1491-2380			Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BOOSALIS MG, 1989, CRIT CARE MED, V17, P741, DOI 10.1097/00003246-198908000-00004; BOUDJEMA K, 1990, TRANSPLANTATION, V50, P943, DOI 10.1097/00007890-199012000-00008; CARROLL NV, 1956, J BIOL CHEM, V220, P583; Cui X, 2003, BBA-GEN SUBJECTS, V1619, P325, DOI 10.1016/S0304-4165(02)00491-9; Gondret F, 2004, J MUSCLE RES CELL M, V25, P405, DOI 10.1007/s10974-004-2768-7; HU HY, 1994, METABOLISM, V43, P913, DOI 10.1016/0026-0495(94)90276-3; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kessova IG, 2007, FREE RADICAL BIO MED, V42, P1470, DOI 10.1016/j.freeradbiomed.2007.01.044; Loi C, 2005, NUTRITION, V21, P255, DOI 10.1016/j.nut.2004.05.021; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Morio B, 2001, AM J PHYSIOL-ENDOC M, V280, pE143, DOI 10.1152/ajpendo.2001.280.1.E143; Neveuz N, 2002, SCAND J GASTROENTERO, V37, P1057, DOI 10.1080/003655202320378266; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	19	12	12	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2008	25	2					124	129		10.1089/neu.2007.0391			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	266RZ	WOS:000253456000005	18260795				2022-02-06	
J	Bloom, GA; Loughead, TM; Shapcott, EJB; Johnston, KM; Delaney, JS				Bloom, Gordon A.; Loughead, Todd M.; Shapcott, Erin J. B.; Johnston, Karen M.; Delaney, J. Scott			The prevalence and recovery of concussed male and female collegiate athletes	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						concussion; university athletes; team sports	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; GENDER-DIFFERENCES; UNITED-STATES; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; UNIVERSITY FOOTBALL; CONTACT SPORTS; ICE HOCKEY; SYMPTOMS	The aims of the present study were two-fold: (1) to examine whether gender and explanatory style influence the number of concussions an athlete has sustained and the amount of time to recover from this type of injury; and (2) to determine whether gender and the type of sport influence the number of and recovery from concussion injuries. University varsity athletes (n=170) who had sustained at least one concussion over the previous 12 months from six sports completed both the Sport History Questionnaire (Delaney, Lacroix, Leclerc, & Johnston, 2000), used to measure concussions, and the Attributional Style Questionnaire (Peterson et al., 1982), used to measure explanatory style. Overall, males sustained more concussions than female athletes (F-1,F-153=43.92, P<0.05). Regarding the type of concussion, male athletes sustained more unrecognized concussions than female athletes (F-1,F-168=6.18, P<0.05), but there was no difference between the sexes for recognized concussions (F-1,F-168=0.44, P>0.05). Male basketball players took longer to recover (mean=6.17 days) than female basketball players (mean=1.15 days). In contrast, female hockey players took longer to recover (mean=9.56 days) than male hockey players (mean=1.00 day). Finally, gender did not influence an athlete's explanatory style.	[Bloom, Gordon A.; Shapcott, Erin J. B.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada; [Loughead, Todd M.] Univ Windsor, Dept Kinesiol, Windsor, ON N9B 3P4, Canada; [Johnston, Karen M.] Univ Toronto, Toronto Rehabil Hosp, Toronto, ON, Canada; [Delaney, J. Scott] McGill Univ, McGill Sport Med Clin, Montreal, PQ H2W 1S4, Canada		Bloom, GA (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	gordon.bloom@mcgill.ca					Almeida SA, 1999, MED SCI SPORT EXER, V31, P1807, DOI 10.1097/00005768-199912000-00017; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Bunce SC, 1997, PERS INDIV DIFFER, V23, P639, DOI 10.1016/S0191-8869(97)00072-X; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CARVER CS, 1979, J PERS SOC PSYCHOL, V37, P1186, DOI 10.1037/0022-3514.37.7.1186; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DAVIS MA, 1981, J HEALTH SOC BEHAV, V22, P298, DOI 10.2307/2136523; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gould D, 1997, SPORT PSYCHOL, V11, P379, DOI 10.1123/tsp.11.4.379; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hjelle L, 1996, PSYCHOL REP, V78, P507, DOI 10.2466/pr0.1996.78.2.507; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Martinez R., 2000, COLL STUDENT J, V34, P72; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nunally J. C., 1978, PSYCHOMETRIC THEORY; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037/0033-295X.91.3.347; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; REED GM, 1994, HEALTH PSYCHOL, V13, P299, DOI 10.1037/0278-6133.13.4.299; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schilsky M L, 2001, Curr Gastroenterol Rep, V3, P54, DOI 10.1007/s11894-001-0041-4; Seligman M., 1998, LEARNED OPTIMISM CHA; Shapcott EJB, 2007, NEUROREHABILITATION, V22, P161; Tabachnick B.G., 2001, USING MULTIVARIATE S; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Udry E, 1997, J SPORT EXERCISE PSY, V19, P71, DOI 10.1123/jsep.19.1.71; VANWIJK CMTG, 1991, WOMEN HEALTH, V17, P91; [No title captured]	48	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.		2008	8	5					295	303		10.1080/17461390802251836			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	356EV	WOS:000259762400008					2022-02-06	
J	Martelli, MF; Nicholson, K; Zasler, ND				Martelli, Michael F.; Nicholson, Keith; Zasler, Nathan D.			Skill reacquisition after acquired brain injury: A holistic habit retraining model of neurorehabilitation	NEUROREHABILITATION			English	Article						neurorehabilitation; holistic rehabilitation; cognitive rehabilitation; traumatic brain injury; habit retraining	INDUCED MOVEMENT THERAPY; COGNITIVE REHABILITATION; VANISHING CUES; ERRORLESS; ASSOCIATIONS; ACQUISITION; DISABILITY; AVOIDANCE; AMNESIA; STROKE	Persistent cognitive, emotional and behavioral dysfunction following brain injury present formidable challenges in the area of neurorehabilitation. This paper reviews a model and practical methodology for community based neurorehabilitation based upon: 1. Evidence from the "automatic learning" and "errorless learning" literature for skills relearning after brain injury; 2. A widely applicable task analytic approach to designing relevant skills retraining protocols; 3. Analysis of organic, reactive, developmental, and characterological obstacles to strategy utilization and relearning, and generation of effective therapeutic interventions; and 4. Procedures for (a) promoting rehabilitative strategy use adapted to acute and chronic neurologic losses, (b) an individual's inherent reinforcement preferences and coping style, (c) reliant on naturalistic reinforcers which highlight relationships to functional goals, utilize social networks, and (d) employ a simple and appealing cognitive attitudinal system and set of procedures. This Holistic Habit Retraining Model and methodology integrates core psychotherapeutic and learning principles as rehabilitation process ingredients necessary for optimal facilitation of skills retraining. It presents a model that generates practical, utilitarian strategies for retraining adaptive cognitive, emotional, behavioral and social skills, as well as strategies for overcoming common obstacles to utilizing methods that promote effective skills acquisition.	[Martelli, Michael F.; Zasler, Nathan D.] Tree Life Serv Inc, Glen Allen, VA USA; [Martelli, Michael F.] Virginia Commonwealth Univ, Dept Psychol & Psychiat, Richmond, VA USA; [Martelli, Michael F.; Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Nicholson, Keith] Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] NW Ctr Special Care, Lake Katrine, NY USA		Martelli, MF (corresponding author), Tree Life Serv Inc, 13458 N Gayton, Richmond, VA 23233 USA.	mfmartelli@villamartelli.com					Akhtar S, 2006, NEUROPSYCHOL REHABIL, V16, P329, DOI 10.1080/09602010500176674; Anderson ND, 2006, NEUROPSYCHOLOGIA, V44, P2806, DOI 10.1016/j.neuropsychologia.2006.05.026; Bender MC, 2003, WILL TRAUM BRAIN INJ; BENYISHAY Y, 2000, INT HDB NEUROPSYCHOL; Bergin AE, 1994, HDB PSYCHOTHERAPY BE; Clare L, 2002, NEUROPSYCHOLOGY, V16, P538, DOI 10.1037//0894-4105.16.4.538; DUBOVSKY SL, 1997, MIND BODY DECEPTIONS; Ducharme JM, 2003, J HEAD TRAUMA REHAB, V18, P88, DOI 10.1097/00001199-200301000-00009; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Frank, 1991, PERSUASION HEALING C; Frank J., 1993, PERSUASION HEALING C; FRANK JD, 1974, J NERV MENT DIS, V159, P325, DOI 10.1097/00005053-197411000-00003; FRANK JD, 1983, BEHAV BRAIN SCI, V6, P291, DOI 10.1017/S0140525X00015958; FRANK JD, 1982, PSYCHOTHERAPY RES BE, P9; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Goldstein K, 1995, ORGANISM HOLISTIC AP; Greenwood R, 2001, BRIT MED J, V323, P1082, DOI 10.1136/bmj.323.7321.1082; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; HOPEWELL CA, 2001, NEUROPSYCHOLOGICAL A; Hubble MA, 1999, HEART SOUL CHANGE WH; James W., 1890, PRINCIPLES PSYCHOL; Jerome J, 2007, J APPL BEHAV ANAL, V40, P185, DOI 10.1901/jaba.2007.41-06; JONASSEN DH, 1999, TASK ANAL METHODS IN; Kern RS, 2002, AM J PSYCHIAT, V159, P1921, DOI 10.1176/appi.ajp.159.11.1921; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; Kern RS, 2003, PSYCHOL MED, V33, P433, DOI 10.1017/S0033291702007298; KESSELS RP, 2005, J INT NEUROPSYCHOLOG, V11; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; LENG NRC, 1991, BEHAV PSYCHOTHER, V19, P173, DOI 10.1017/S0141347300012209; MACMILLAN P, 1989, REH PROGR ANN M RICH; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Martelli MF, 2005, BRAIN INJURY PROFESS, V2, P10; MARTELLI MF, 1999, HEADS RSS NEWSLETTER, V2; MARTELLI MF, 1999, V MARTELLI INTERNET; MARTELLI MF, 1997, 1 COMB TRAIN C VA RE; MARTELLI MF, 2003, U SEV CENTR REH DAN; MARTELLI MF, 2002, NEW YORK AC TRAUM BR; MARTELLI MF, 2002, 21 ANN S BRAIN INJ A; MARTELLI MF, 2003, 4 ANN M BRAIN INJ AS; MARTELLI MF, 2003, ANN M COAL CLIN PRAC; MARTELLI MF, 2005, ANN M COAL CLIN PRAC; MARTELLI MF, 2002, B NATL ACAD NEUROPSY, V17, P8; Martins S, 2006, NEUROPSYCHOLOGIA, V44, P2792, DOI 10.1016/j.neuropsychologia.2006.05.022; Masters J. C., 1987, BEHAV THERAPY TECHNI; MASTERS RS, 2007, CONSCIOUS COGNI 0428; Masters RSW, 2004, REHABIL PSYCHOL, V49, P79, DOI 10.1037/0090-5550.49.1.79; Miller L, 2000, NEUROREHABILITATION, V14, P25; Miller SD, 1997, ESCAPE BABEL UNIFYIN; Miotto EC, 2007, NEUROPSYCHOL REHABIL, V17, P551, DOI 10.1080/09602010701202188; Ormrod J.E., 1999, HUMAN LEARNING; Orrell AJ, 2006, PHYS THER, V86, P369, DOI 10.1093/ptj/86.3.369; Page M, 2006, NEUROPSYCHOLOGIA, V44, P90, DOI 10.1016/j.neuropsychologia.2005.04.004; PATTERSON CH, 1989, PSYCHOTHERAPY, V26, P427, DOI 10.1037/h0085461; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; Pope JW, 2006, J CLIN EXP NEUROPSYC, V28, P101, DOI 10.1080/13803390490918138; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; RIM DC, 1979, BEHAV THERAPY TECHNI; Sbordone R.J., 1990, PSYCHOTHERAPY PRIVAT, V8, P129; SCHACTER DL, 1996, SEARCHING MEMORY; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; SELIGMAN MEP, 2000, ENCY STRESS; SPIEGLER MD, CONT BEHAV THERAPY; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; TODD DD, 1998, COGNIPHOBIA SCLAE C; VERFAELLIE M, 1990, BRAIN COGNITION, V13, P178, DOI 10.1016/0278-2626(90)90049-T; Wampold, 2001, GREAT PSYCHOTHERAPY; Wilson FC, 2003, NEUROPSYCHOL REHABIL, V13, P537, DOI 10.1080/09602010343000200; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZASLER ND, 2005, TXB TRAUMATIC BRAIN, P419; ZASLER ND, 2002, STATE ART REV FUNCTI; [No title captured]	78	12	12	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2008	23	2					115	126					12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	311II	WOS:000256593500001	18525133				2022-02-06	
J	Namiki, C; Yamada, M; Yoshida, H; Hanakawa, T; Fukuyama, H; Murai, T				Namiki, Chihiro; Yamada, Makiko; Yoshida, Hidefumi; Hanakawa, Takashi; Fukuyama, Hidenao; Murai, Toshiya			Small orbitofrontal traumatic lesions detected by high resolution MRI in a patient with major behavioural changes	NEUROCASE			English	Article						Traumatic brain injury; Orbitofrontal cortex damage; Personality changes; High resolution MRI; Social problems	PREFRONTAL CORTEX; DECISION-MAKING; HEAD-INJURY; DAMAGE; EMOTION	We report a case of a male patient who showed personality changes and marked social problems after a traumatic brain injury. Although suspected to have lesions in the orbitofrontal cortex because of the typical characteristics of his behavioural change, lesions were not apparent using conventional imaging techniques. However, investigation using high-resolution MRI revealed lesions in the orbitofrontal cortex. Our case suggests that standard MRI scanning techniques may have only limited power. Hence, we stress the important role played by qualitative assessments of emotion, personality, and social behaviour in evaluating sequelae of traumatic orbitofrontal injuries.	[Namiki, Chihiro] Kyoto Univ, Grad Sch Med, Dept Neuropsychiat, Sakyo Ku, Kyoto 6068507, Japan; [Namiki, Chihiro; Yoshida, Hidefumi; Hanakawa, Takashi; Fukuyama, Hidenao] Human Brain Res Ctr, Kyoto, Japan		Namiki, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neuropsychiat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	cnamiki@kuhp.kyoto-u.ac.jp	Hanakawa, Takashi/A-6536-2011; Fukuyama, Hidenao/AAI-7118-2020		Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [16500367]	This report was supported by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science ( 16500367).	Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Benton A. L., 1983, FACIAL RECOGNITION S; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Burgess P, 1996, BEHAV ASSESSMENT DYS; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Ekman P., 1975, PICTURES FACIAL AFFE; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Yoshizumi U. K., 2007, SEISHIN IGAKU, V49, P137	25	12	12	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794			NEUROCASE	Neurocase		2008	14	6					474	479	PII 905557322	10.1080/13554790802459494			6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	372OQ	WOS:000260911300002	19012167				2022-02-06	
J	Payette, DJ; Xie, J; Shirwany, N; Guo, Q				Payette, Daniel J.; Xie, Jun; Shirwany, Najeeb; Guo, Qing			Exacerbation of Apoptosis of Cortical Neurons Following Traumatic Brain Injury in Par-4 Transgenic Mice	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Traumatic brain injury; cerebral cortex; apoptosis; prostate apoptosis response-4; cell culture	AMYLOID-BETA-PEPTIDE; MITOCHONDRIAL PERMEABILITY TRANSITION; ZIPPER PROTEIN PAR-4; CELL-DEATH; ISCHEMIA-REPERFUSION; HIPPOCAMPAL-NEURONS; CASPASE ACTIVATION; OXIDATIVE DAMAGE; NERVOUS-SYSTEM; EXPRESSION	Traumatic brain injury (TBI) is a significant clinical problem, yet few effective strategies for treating it have emerged. People that sustain and survive a TBI are left with significant cognitive, behavioral, and communicative disabilities. Apoptotic neuronal death occurs following TBI. Prostate apoptosis response-4 (Par-4) is a death domain-containing protein initially characterized as a critical regulator of apoptosis in prostate cancer cells. We have recently generated and characterized Par-4 transgenic mice in which the expression of the par-4 transgene was limited to cells of neuronal lineage. We now provide evidence that, in cortical neurons from these mice, Par-4 drastically increases apoptotic neuronal death in both in vitro and in vivo models of TBI. In vitro experiments were performed in 7-day-old primary cultures of cortical neurons using a previously published, scratch-induced mechanical trauma model. Neurons that overexpress Par-4 showed not only a significant decrease in overall neuron survival after TBI compared to wild-type cells, but also exhibited a sharper decrease in mitochondrial transmembrane potential, a higher degree of free radical accumulation, and earlier activation of caspase-3 than wild-type cells did. In vivo experiments were performed utilizing a weight drop TBI model. A significantly increased volume of cortical injury and exacerbated activation of caspase-3 were observed in Par-4 transgenic mice when compared to those in wild-type mice. These data suggests that aberrant Par-4 expression exacerbates neuronal cell death following TBI by altering mitochondrial function, enhancing oxidative damage, and execution of apoptosis via caspase activation.	[Payette, Daniel J.; Xie, Jun; Shirwany, Najeeb; Guo, Qing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA		Guo, Q (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.	qing-guo@ouhsc.edu			University of Oklahoma Health Sciences Center (OUHSC)	We thank Paul Tompkins in the Department of Neurosurgery at the University of Oklahoma Health Sciences Center for his excellent technical assistance in establishing the mouse cortical impact models. This work was supported by a research startup fund to Q.G. from The University of Oklahoma Health Sciences Center (OUHSC).	Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Chung H, 2007, J ENDOCRINOL, V194, P77, DOI 10.1677/JOE-07-0073; Cole K, 2004, INT J DEV NEUROSCI, V22, P485, DOI 10.1016/j.ijdevneu.2004.07.015; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dhillon HS, 2001, EXP NEUROL, V170, P140, DOI 10.1006/exnr.2001.7685; DRESSLER J, 2006, INT J LEGAL MED; El-Guendy N, 2003, MOL CELL BIOL, V23, P5516, DOI 10.1128/MCB.23.16.5516-5525.2003; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hutchins JB, 1998, ANAT REC, V253, P79, DOI 10.1002/(SICI)1097-0185(199806)253:3<79::AID-AR4>3.0.CO;2-9; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Khodorov B I, 2002, Neurosci Behav Physiol, V32, P541, DOI 10.1023/A:1019819925257; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Mattson MP, 1999, J MOL NEUROSCI, V13, P17, DOI 10.1385/JMN:13:1-2:17; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Qiu GF, 1999, ONCOGENE, V18, P623, DOI 10.1038/sj.onc.1202344; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rangnekar VM, 1998, APOPTOSIS, V3, P61, DOI 10.1023/A:1009666705875; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Xie J, 2005, J NEUROCHEM, V92, P59, DOI 10.1111/j.1471-4159.2004.02834.x; Xie J, 2004, J BIOL CHEM, V279, P28266, DOI 10.1074/jbc.M401495200; Xie J, 2004, NEUROBIOL DIS, V16, P150, DOI 10.1016/j.nbd.2004.02.003; Xie J, 2001, BRAIN RES, V915, P1, DOI 10.1016/S0006-8993(01)02803-7; Xie J, 2007, AM J PHYSIOL-RENAL, V292, pF107, DOI 10.1152/ajprenal.00083.2006; Xie J, 2006, J AM SOC NEPHROL, V17, P3336, DOI 10.1681/ASN.2006040311; Yildirim Erkan, 2006, Heart Lung Circ, V15, P124, DOI 10.1016/j.hlc.2005.10.001; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	49	12	15	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2008	1	1					44	56					13	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	V18RE	WOS:000208021100006	18784822				2022-02-06	
J	Rusnak, M; Mauritz, W; Lecky, F; Kaniansky, M; Brazinova, A				Rusnak, M.; Mauritz, W.; Lecky, F.; Kaniansky, M.; Brazinova, A.			Evaluation of traumatic brain injury guidelines using AGREE instrument	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						guidelines; traumatic brain injury; AGREE	SEVERE HEAD-INJURY; CARE MANAGEMENT; QUALITY; COMA	Background: This study aims to assess the quality of four selected traumatic brain injuries management guidelines used mainly in the US and in Europe. Methods: The instrument Appraisal of Guidelines Research & Evaluation was selected to provide a framework for guidelines appraisal. Four guidelines addressing a specific topic related to the treatment of traumatic brain injury were selected for evaluation: three developed in the United States of America and one from the United Kingdom. A trauma surgeon, one anaesthesiologist, one emergency physician and a public health specialist evaluated the guidelines. Results: In the overall assessment of all guidelines, the United Kingdom guidelines attracted the best score, achieving the highest score of all four guidelines in five of six domains. The scientific quality of collected evidence was excellent and well documented in all four guidelines. Overall, the domains of Stakeholder involvement and Applicability were the lowest scoring for all the guidelines. Conclusion: A Broad spectrum of stakeholders should be represented in the brain trauma management guidelines development. The potential organizational and financial barriers for the application of guidelines need to be considered during their development. The paper provides suggestions for those who develop new guidelines for the management of patients with head injuries (Tab. 8, Ref. 29). Full Text (Free, PDF) www.bmj.sk.	[Rusnak, M.; Mauritz, W.; Brazinova, A.] Int Neurotrauma Res Org, A-1080 Vienna, Austria; [Rusnak, M.] Trnava Univ, Sch Hlth & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Mauritz, W.] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Lecky, F.] Univ Manchester, Hope Hosp, Salford M6 8HD, Lancs, England; [Kaniansky, M.] FD Roosevelt Hosp, Dept Traumatol, Banska, Bystrica, Slovakia		Brazinova, A (corresponding author), Int Neurotrauma Res Org, Molkergasse 4-3, A-1080 Vienna, Austria.	abrazinova@igeh.org	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X			AGREE Collaboration, APPR GUID RES EV AGR; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Boluyt N, 2005, PEDIATRICS, V115, P1378, DOI 10.1542/peds.2004-0575; *BRAIN TRAUM FDN, 1996, GUID MAN SEV HEAD IN; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Elit L M, 2006, Curr Oncol, V13, P94; Fervers B, 2005, INT J QUAL HEALTH C, V17, P123, DOI 10.1093/intqhc/mzi011; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hulshof C, 2007, IND HEALTH, V45, P26, DOI 10.2486/indhealth.45.26; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; *MAN PROGN PEN BRA, 2001, J TRAUMA INJURY IN S, V51; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; *NICE UK NHS, 2003, HEAD INJ TRIAG ASS I; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Stiegler M, 2005, EUR PSYCHIAT, V20, P554, DOI 10.1016/j.eurpsy.2005.05.012; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81	29	12	12	0	8	COMENIUS UNIV	BRATISLAVA I	SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA	0006-9248	1336-0345		BRATISL MED J	Bratisl. Med. J.		2008	109	8					374	380					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355MH	WOS:000259712500011	18837249				2022-02-06	
J	Schwartz, I; Tuchner, M; Tsenter, J; Shochina, M; Shoshan, Y; Katz-Leurer, M; Meiner, Z				Schwartz, Isabella; Tuchner, Maya; Tsenter, Jeanna; Shochina, Mara; Shoshan, Yigal; Katz-Leurer, Michal; Meiner, Zeev			Cognitive and functional outcomes of terror victims who suffered from traumatic brain injury	BRAIN INJURY			English	Article						traumatic; brain; injury; terrorism; outcomes; rehabilitation	SPINAL-CORD INJURY; SEVERITY SCORE; REHABILITATION OUTCOMES; INDEPENDENCE; VALIDATION; DISABILITY; PREDICTION; EXPLOSION; RECOVERY; VALIDITY	Primary objective: To describe the outcomes of terror victims suffered from traumatic brain injury (TBI). Research design: Retrospective chart review of 17 terror and 39 non-terror TBI patients treated in a rehabilitation department during the same period. Methods and procedure: Variables include demographic data, Injury Severity Scale (ISS), length of stay (LOS) and imaging results. ADL was measured using the Functional Independence Measurement (FIM), cognitive and memory functions were measured using the Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) battery and the Rivermead Battery Memory Test (RBMT), respectively. Main outcome and results: Terror TBI patients were significantly younger, had higher ISS score and higher rates of intracerebral haemorrhage (ICH), brain surgery and penetrating brain injuries than the non-terror TBI group. There was no difference in mean LOS, mean FIM values, mean FIM gain and mean cognitive and memory improvement between groups. Terror victims suffered from a higher percentage of post-traumatic epilepsy (35% vs. 10%, p = 0.05), whereas the rate of PTSD and the rate of return to previous occupation were similar between groups. Conclusions: Although TBI terror victims had more severe injury, they gained most of ADL functions and their rehabilitation outcomes were similar to non-terror TBI patients. These favourable results were achieved due to a comprehensive interdisciplinary approach to terror victims and also by national support which allowed an adequate period of treatment and sufficient resources as needed.	[Schwartz, Isabella; Tuchner, Maya; Tsenter, Jeanna; Shochina, Mara; Meiner, Zeev] Hadassah Univ Hosp, Dept Phys Med & Rehabil, IL-91420 Jerusalem, Israel; [Katz-Leurer, Michal] Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Ramat Aviv, Israel; [Shoshan, Yigal] Hadassah Univ Hosp, Dept Neurosurg, IL-91420 Jerusalem, Israel		Meiner, Z (corresponding author), Hadassah Univ Hosp, Dept Phys Med & Rehabil, POB 24035 Mt Scopus, IL-91420 Jerusalem, Israel.	meiner@hadassah.org.il					Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; AVENSANI R, 2005, BRAIN INJURY, V19, P933; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cockburn J, 1996, EUR REV APPL PSYCHOL, V46, P201; COCKCROFT VB, 1990, MOL NEUROBIOL, V4, P129, DOI 10.1007/BF02780338; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DEROGATIS LR, 1982, ADM PROCEDURES BSI M; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Einav S, 2006, ANN SURG, V243, P533, DOI 10.1097/01.sla.0000206417.58432.48; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Gidron Y, 2004, ISRAEL MED ASSOC J, V6, P387; GRANGER CV, 1986, GUIDE USE UNIFORM DA; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jehel L, 2001, ENCEPHALE, V27, P393; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; KATZ N, 1989, AM J OCCUP THER, V43, P184, DOI 10.5014/ajot.43.3.184; Katz N, 2000, OCCUP THER J RES, V20, P3, DOI 10.1177/153944920002000101; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; Kluger Y, 2004, Scand J Surg, V93, P11; Maurer E, 2004, TRAUMA, P87; Mintz Y, 2002, ISRAEL MED ASSOC J, V4, P554; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Peleg K, 2006, J AM COLL SURGEONS, V202, P643, DOI 10.1016/j.jamcollsurg.2005.12.019; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Shalev AY, 2005, AM J PSYCHIAT, V162, P1188, DOI 10.1176/appi.ajp.162.6.1188; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Singer Pierre, 2005, Crit Care Med, V33, pS61, DOI 10.1097/01.CCM.0000151068.33935.3E; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	49	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	3					255	263		10.1080/02699050801941763			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	267LW	WOS:000253511500006	18297597				2022-02-06	
J	Sharp, NCC				Sharp, N. C. Craig			The human genome and sport, including epigenetics and athleticogenomics: A brief look at a rapidly changing field	JOURNAL OF SPORTS SCIENCES			English	Article						athleticogenomics; epigenetics; gene doping; genome; sport	TRAUMATIC BRAIN-INJURY; HUMAN GENE; EXPRESSION; EXERCISE; FATIGUE; MAP	Since Hugh Montgomery discovered the first of what are now nearly 200 fitness genes, together with rapid advances in human gene therapy, there is now a real prospect of the use of genes, genetic elements, and/or cells that have the capacity to enhance athletic performance (to paraphrase the World Anti-Doping Agency's definition of gene doping). This overview covers the main areas of interface between genetics and sport, attempts to provide a context against which gene doping may be viewed, and suggests a futuristic legitimate use of genomic (and possibly epigenetic) information in sport.	Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England		Sharp, NCC (corresponding author), Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England.	c.sharp90@btinternet.com					Abbott A, 2006, NATURE, V443, P488, DOI 10.1038/443488a; *AM PHYSL SOC, PHYSL GENOMICS; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Booth FW, 2005, AM SCI, V93, P28; BOUCHARD C, 1999, GENETICS FITNESS PHY; Brenner S, 2007, NATURE, V446, P725, DOI 10.1038/446725a; Budgett R, 2000, BRIT J SPORT MED, V34, P67, DOI 10.1136/bjsm.34.1.67; Check E, 2007, NATURE, V448, P11; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; CULVER KW, 1991, HUM GENE THER, V2, P107, DOI 10.1089/hum.1991.2.2-107; DELACHAPELLE A, 1993, LANCET, V341, P82, DOI 10.1016/0140-6736(93)92558-B; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; GEE H, 2004, J LADDER HIST HUMAN; GOLDSPINK G, 1992, NEW SCI, V135, P28; HAMER C, 1998, LIVING OUR GENES; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Knight J, 2003, NATURE, V426, P114, DOI 10.1038/426114a; KODADEK T, 2007, NATURE, V446, P472; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lyon Mary F., 2007, Biologist (London), V54, P94; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; MACARTHUR DG, 2007, E AFRICAN RUNNING CR, P217; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MIAH A, 2004, GENETICALLY MODIFIED; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Noakes TD, 2004, BRIT J SPORT MED, V38, P511, DOI 10.1136/bjsm.2003.009860; PANDO OJ, 2007, CELL, V128, P655; Parisotto R., 2006, BLOOD SPORTS INSIDE; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RIGGS AD, 1996, EPIGENETICS MECH GEN; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; Savulescu J., 2005, GENETIC TECHNOLOGY S, P136; Schjerling P, 2005, GENETIC TECHNOLOGY S, P19; Shadan S, 2007, NATURE, V447, P275, DOI 10.1038/447275b; Sharp C, 1999, NATURE, V398, P675; SHARP NCC, 2007, E AFRICAN RUNNING CR, P1; SHARP NCC, 2006, PEAK PERFORMANCE, V230, P8; SHARP NCC, 2004, PHYSL NEWS, V57, P15; Slot O, 2006, TIMES           0202; Sweeney HL, 2004, SCI AM, V291, P62, DOI 10.1038/scientificamerican0704-62; Tannsjo, 2005, GENETIC TECHNOLOGY S; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wagner RW, 1998, NATURE, V391, P744, DOI 10.1038/35750; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a; [No title captured]	60	12	13	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2008	26	11					1127	1133		10.1080/02640410801912117			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	345YY	WOS:000259036600002	18618365				2022-02-06	
J	Silverberg, ND; Hanks, RA; Buchanan, L; Fichtenberg, N; Millis, SR				Silverberg, Noah D.; Hanks, Robin A.; Buchanan, Lori; Fichtenberg, Norm; Millis, Scott R.			Detecting response bias with performance patterns on an expanded version of the controlled oral word association test	CLINICAL NEUROPSYCHOLOGIST			English	Article						effort; malingering; phonemic fluency; response bias; traumatic brain injury; verbal fluency	VERBAL-LEARNING TEST; QUALITATIVE-ANALYSIS; INCOMPLETE EFFORT; NORMATIVE DATA; POOR EFFORT; FLUENCY; VALIDATION; RELIABILITY; STRATEGIES; EDUCATION	The present study investigated whether speeded word generation performance patterns seen in healthy subjects are also produced in genuine and feigned traumatic brain injury ( TBI). An expanded version of the Controlled Oral Word Association Test was administered to healthy controls, TBI patients, simulated malingerers, and probable clinical malingerers. Four performance patterns were operationalized. Three of these patterns were replicated in the healthy control sample and found to he unaltered by genuine TBI. They were then combined into a logistic regression model that discriminated well between examinees who put forth adequate effort and those who evidenced response bias.	[Silverberg, Noah D.; Buchanan, Lori] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Hanks, Robin A.; Fichtenberg, Norm; Millis, Scott R.] Rehabil Inst Michigan, Detroit, MI USA; [Hanks, Robin A.; Fichtenberg, Norm; Millis, Scott R.] Wayne State Univ, Detroit, MI 48202 USA		Silverberg, ND (corresponding author), Univ Windsor, Dept Psychol, 173 Chrysler Hall S,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	noahsilverberg@hotmail.com					Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; BENTON AL, 1969, J NEUROL SCI, V9, P39, DOI 10.1016/0022-510X(69)90057-4; Benton AL, 1994, MULTILINGUAL APHASIA; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Burgess C, 1998, BEHAV RES METH INS C, V30, P272, DOI 10.3758/BF03200655; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Crowe SF, 2001, BRAIN COGNITION, V47, P323; da Silva CG, 2004, J CLIN EXP NEUROPSYC, V26, P266, DOI 10.1076/jcen.26.2.266.28089; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 2003, CLIN NEUROPSYCHOL, V17, P322, DOI 10.1076/clin.17.3.322.18081; Diaz M, 2004, BRAIN LANG, V89, P108, DOI 10.1016/S0093-934X(03)00307-9; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Gouvier WD, 1999, STUD NEUROPSYCHOL DE, P27; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; GREEN P, 1996, WORLD MEMORY TEST US; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hilsabeck RC, 2003, ARCH CLIN NEUROPSYCH, V18, P71, DOI 10.1016/S0887-6177(01)00180-9; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kuera H., 1967, COMPUTATIONAL ANAL P; Lamar M, 2002, NEUROPSYCHOLOGIA, V40, P435, DOI 10.1016/S0028-3932(01)00125-7; Mayr U, 2002, NEUROPSYCHOLOGIA, V40, P562, DOI 10.1016/S0028-3932(01)00132-4; Millikin CP, 2004, J CLIN EXP NEUROPSYC, V26, P933, DOI 10.1080/13803390490510842; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 2002, NEUROPSYCHOLOGY, V2, P147; Milner B., 1964, FRONTAL GRANULAR COR; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Silverberg N, 2005, J CLIN EXP NEUROPSYC, V27, P907, DOI 10.1080/13803390490919326; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Suhr J, 2004, J CLIN EXP NEUROPSYC, V26, P416, DOI 10.1080/13803390490510121; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Thurstone L. L, 1962, PRIMARY MENTAL ABILI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; Troster AI, 1998, NEUROPSYCHOLOGIA, V36, P295, DOI 10.1016/S0028-3932(97)00153-X; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; [No title captured]	56	12	12	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN	2008	22	1					140	157		10.1080/13854040601160597			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	258TF	WOS:000252891700011	17853150				2022-02-06	
J	Stallones, L; Gibbs-Long, J; Gabella, B; Kakefuda, I				Stallones, Lorann; Gibbs-Long, Julie; Gabella, Barbara; Kakefuda, Itsumi			Community readiness and prevention of traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury (TBI); prevention; community readiness; community-based intervention; surveillance	PUBLIC-HEALTH; HEAD-INJURY	Primary objective: The study aimed to understand the readiness of rural communities to engage in community-initiated traumatic brain injury (TBI) prevention. The utility of state-wide TBI surveillance to monitor outcomes of local TBI prevention efforts was also assessed. Research design: A quasi-experimental design was used to evaluate the effects of community-initiated TBI prevention programmes. Methods and procedures: The Community Readiness model was used to assess changes in communities before and after programmes. Four rural counties in Colorado, US, were selected based on population composition and TBI rates. Key informants in each county were interviewed to determine community readiness stages to engage in prevention. The interviews were repeated 2 years later. Results: In two study counties TBI prevention activities were initiated. One county conducted a number of prevention activities and moved from 'vague awareness' to 'preplanning' stage. Three counties moved from 'denial' to 'vague awareness'. TBI surveillance did not capture rate changes in the counties. Conclusions: The Community Readiness model identified counties more likely to engage in prevention and change was observed in readiness where programmes were undertaken as well as in counties where no new programmes were initiated. Detailed local TBI data is necessary to monitor outcomes of community interventions.	[Stallones, Lorann] Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA; [Gabella, Barbara] Colorado Traumat Brain Injury Surveillance, Colorado Dept Publ Hlth & Environm, Denver, CO USA		Stallones, L (corresponding author), Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA.	lorann@colostate.edu	Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR811509] Funding Source: Medline		ALCALDE MG, 2002, CHILD FATALITY REV U; Boyd C R, 1989, J Med Assoc Ga, V78, P341; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUKASKI W, 1994, DRUG ABUSE PREVENTIO; *COL DEP PUBL HLTH, COL HLTH INF DAT; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; Donnermeyer J. F., 1997, J COMMUNITY DEV SOC, V28, P65; Edwards RW, 2000, J COMMUNITY PSYCHOL, V28, P291, DOI 10.1002/(SICI)1520-6629(200005)28:3<291::AID-JCOP5>3.3.CO;2-0; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GAMM LD, 2004, RURAL HLTH PEOPLE 20, V3; GARKOVICH LE, 1989, LOCAL ORG LEADERSHIP; HALPERIN W, 1992, PUBLIC HLTH SURVEILL; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KELLY KJ, 2003, MARKETING THEORY, V3, P411, DOI DOI 10.1177/1470593103042006; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Marr A., 2004, CENTRAL NERVOUS SYST; Minkler M., 2003, COMMUNITY BASED PART; NICHOLSON R, 2002, COMMON GROUND COMMON; Nolen Sixten, 2002, Inj Control Saf Promot, V9, P89, DOI 10.1076/icsp.9.2.89.8695; OETTING ER, 1995, INT J ADDICT, V30, P659, DOI 10.3109/10826089509048752; Oetting ER, 2001, SUBST USE MISUSE, V36, P825, DOI 10.1081/JA-100104093; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rogers E., 1983, DIFFUSION INNOVATION; ROGERS EM, 1989, SOCIAL CHANGES RURAL; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 1996, WESTERN J MED, V165, P192; WARREN ROLAND L., 1978, COMMUNITY AM; Wysong E., 1990, POLICY STUD REV, V9, P727; Ytterstad Borge, 2003, Int J Circumpolar Health, V62, P61	32	12	12	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	7-8					555	564		10.1080/02699050802132487			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	318MG	WOS:000257095300006	18568708				2022-02-06	
J	Toung, TJ; Nyquist, P; Mirski, MA				Toung, Thomas J.; Nyquist, Paul; Mirski, Marek A.			Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model	CRITICAL CARE MEDICINE			English	Article						hypertonic saline; osmotic therapy; intravascular volume; sodium; diuresis; blood-brain barrier; intracranial pressure	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEMORRHAGIC-SHOCK; FLUID MANAGEMENT; HEAD-INJURY; BLOOD-FLOW; RESUSCITATION; HYPERTENSION; OSMOTHERAPY; MANNITOL	Objective: Hypertonic saline has been shown to be an effective osmotic agent to reduce brain water and hence brain volume and intracranial pressure. A direct correlation between dose and effect has been demonstrated, but no studies have compared the effects of different concentrations of the same osmotic load of hypertonic saline over time. We compared the effects of different tonicity of infused hypertonic saline on cerebral, lung, and small bowel water extraction over time under controlled conditions. Design: Laboratory study. Setting. Medical school. Subjects. Male Wistar rats (280-450 g). Interventions. Anesthetized rats were randomized to a 15-min intravenous bolus infusion of 0.9% NaCl or five equisodium but different concentrations of hypertonic saline: 4.2%, 7.5%, 10%, 23.4%, and 30%. Following infusion, animals remained anesthetized for 60, 180, or 300 mins without additional fluids given (n >= 6 per group). Blood was sampled, total urine output was measured, and the animal was then killed under deep anesthesia. Cerebral, lung, and small bowel water contents were derived by wet/dry weight measures. Measurements and Main Results. After 60 mins, hypertonic saline administered at 50 mosm/kg resulted in an increase in serum osmolarity in all hypertonic saline groups (p < .05 vs. normal saline), with a significantly greater increase measured using 23.4% or 30% hypertonic saline (23.4%, 365.0 +/- 8.8 mosm/L, p <.05 vs. other lesser hypertonic saline doses). The durable effect was present throughout the 300-min period by all but the lowest hypertonic saline (4.2% NaCl). Lung but not small bowel organ water was diminished by hypertonic saline. Brain water content (79.1 +/- 0.2% in normal saline controls) was, however, significantly reduced. Conclusions: Hypertonic saline is effective in reducing organ water content in a setting of preserved blood-brain barrier but is not as effective in visceral organs. At equiosmotic doses of hypertonic saline, concentration plays no substantial role in altering serum osmolarity but appears to benefit duration of action. At very high concentrations, such as 23.4% NaCl, additional water extraction is also manifested. At such high concentration of NaCl, tonicity, indeed, matters, especially in water shifts across the blood-brain barrier.	[Toung, Thomas J.; Nyquist, Paul; Mirski, Marek A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Nyquist, Paul; Mirski, Marek A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Mirski, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	mmirski@jhmi.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38684] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038684] Funding Source: NIH RePORTER		Al-Rawi PG, 2005, ACTA NEUROCHIR SUPPL, V95, P123; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Bender R, 2007, RESUSCITATION, V72, P74, DOI 10.1016/j.resuscitation.2006.05.019; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bhardwaj, 1999, Curr Treat Options Neurol, V1, P179, DOI 10.1007/s11940-999-0002-z; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; HEBESTREIT A, 2007, EUR J APPL PHYS 0223; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KOENIG MA, IN PRESS CRIT CARE M; Levin MH, 2006, J BIOL CHEM, V281, P25803, DOI 10.1074/jbc.M604332200; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Noppens RR, 2006, CRIT CARE MED, V34, P2194, DOI 10.1097/01.CCM.0000228915.94169.B1; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; SEELINGER E, 2001, J PHYSL, V15, P941; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Toung TJK, 2007, CRIT CARE MED, V35, P526, DOI 10.1097/01.CCM.0000253309.44567.A6; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; ULATOWSKI JA, 2004, CUR OPIN CRIT CARE, V10, P126; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	36	12	13	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2008	36	1					256	261		10.1097/01.CCM.0000295306.52783.1E			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YA	WOS:000255232100036	18090381				2022-02-06	
J	Fernandez-Duque, D; Black, SE				Fernandez-Duque, Diego; Black, Sandra E.			Metacognitive judgment and denial of deficit: Evidence from frontotemporal dementia	JUDGMENT AND DECISION MAKING JOURNAL			English	Article						frontotemporal dementia; metacognition; overconfidence; generality	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; SELF-AWARENESS; WORK GROUP; ANOSOGNOSIA; DIAGNOSIS; UNAWARE; AD	Patients suffering from the behavioral variant of Frontotemporal Dementia (FTD-b) often exaggerate their abilities. Are those errors in judgment limited to domains in which patients under-perform, or do FTD-b patients overestimate their abilities in other domains? Is overconfidence in FTD-b patients domain-specific or domain-general? To address this question, we asked patients at early stages of FTD-b to judge their performance in two domains (attention, perception) in which they exhibit relatively spared abilities. In both domains, FTD-b patients overestimated their performance relative to patients with Dementia of Alzheimer Type (DAT) and healthy elderly subjects. Results are consistent with a domain-general deficit in metacognitive judgment. We discuss these findings in relation to "regression to the mean" accounts of overconfidence and the role of emotions in metacognitive judgments.	[Fernandez-Duque, Diego] Villanova Univ, Dept Psychol, Villanova, PA 19085 USA; [Black, Sandra E.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada		Fernandez-Duque, D (corresponding author), Villanova Univ, Dept Psychol, 800 Lancaster Ave, Villanova, PA 19085 USA.	diego.fernandezduque@villanova.edu	Black, Sandra E./C-7294-2011				ALLISON ST, 1989, SOC COGNITION, V7, P275, DOI 10.1521/soco.1989.7.3.275; Barrett AM, 2005, NEUROLOGY, V64, P693, DOI 10.1212/01.WNL.0000151959.64379.1B; Beck MR, 2007, CONSCIOUS COGN, V16, P31, DOI 10.1016/j.concog.2006.01.003; Benton A.L., 1983, CONTRIBUTION NEUROPS, P30; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burson KA, 2006, J PERS SOC PSYCHOL, V90, P60, DOI 10.1037/0022-3514.90.1.60; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; DELIS D, 1987, CALIFORNIA VERBAL LE; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; FISCHHOFF B, 1977, J EXP PSYCHOL HUMAN, V3, P552, DOI 10.1037/0096-1523.3.4.552; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P185, DOI DOI 10.1016/0022-3956(75)90026-6; GILOVICH T, 2002, HEURISTICS JUDGMENT; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; Kaplan E, 1982, BOSTON NAMING TEST; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Kertesz A., 1982, W APHASIA BATTERY; Krueger J, 2002, J PERS SOC PSYCHOL, V82, P180, DOI 10.1037//0022-3514.82.2.180; Krueger JI., 2005, SELF SOCIAL JUDGMENT, P85, DOI DOI 10.1111/J.1559-1816.2011.00752.X; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LICHTENSTEIN S, 1977, ORGAN BEHAV HUM PERF, V20, P159, DOI 10.1016/0030-5073(77)90001-0; Malle BF, 2001, J PERS SOC PSYCHOL, V81, P278, DOI 10.1037//0022-3514.81.2.278; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mendez ME, 2005, J NEUROPSYCH CLIN N, V17, P413, DOI 10.1176/appi.neuropsych.17.3.413; MICHON A, 1994, J NEUROL NEUROSUR PS, V57, P805, DOI 10.1136/jnnp.57.7.805; Moulin CJA, 2000, NEUROPSYCHOLOGIA, V38, P1242, DOI 10.1016/S0028-3932(00)00037-3; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rankin KP, 2005, J NEUROL NEUROSUR PS, V76, P632, DOI 10.1136/jnnp.2004.042879; Salmon E, 2006, HUM BRAIN MAPP, V27, P588, DOI 10.1002/hbm.20203; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Souchay C, 2003, NEUROCASE, V9, P482, DOI 10.1076/neur.9.6.482.29376; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Starkstein SE, 1996, J NEUROL NEUROSUR PS, V61, P485, DOI 10.1136/jnnp.61.5.485; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Weschler D, 1987, WESCHLER MEMORY SCAL	45	12	12	0	4	SOC JUDGMENT & DECISION MAKING	TALLAHASSEE	FLORIDA STATE UNIV, TALLAHASSEE, FL 32306-1110 USA	1930-2975			JUDGM DECIS MAK	Judgm. Decis. Mak.	DEC	2007	2	6					359	370					12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	348SK	WOS:000259230000004					2022-02-06	
J	Lok, J; Wang, H; Murata, Y; Zhu, HH; Qin, T; Whalen, MJ; Lo, EH				Lok, Josephine; Wang, Hui; Murata, Yoshihiro; Zhu, Hai Hao; Qin, Tao; Whalen, Michael J.; Lo, Eng H.			Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; neuregulin; neuroprotection; probe; spatial memory; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; CEREBRAL-ISCHEMIA; TISSUE-DAMAGE; RATS; DEATH; RECOVERY; SURVIVAL; DEFICITS; STROKE	Neuregulin-1 is a pleiotropic endogenous growth factor that is neuroprotective in experimental models of cerebral ischemia. We tested the hypothesis that pretreatment with neuregulin-1 would be similarly protective after traumatic brain injury in mice. Mice were administered neuregulin-1 or equal amounts of vehicle intravenously immediately before controlled cortical impact. Injured mice were subjected to motor and cognitive testing, and brain tissue loss was quantitated at 4 weeks. Compared to vehicle, pretreatment with neuregulin-1 had no effect on brain tissue loss, motor function, or acquisition of a spatial learning task. However, neuregulin-1 treated mice showed improved retention of spatial memory versus vehicle-treated mice in subsequent probe trials (p < 0.05). These proof-of-principle data suggest that neuregulin-1 may improve some functional outcomes after brain trauma. Further studies are therefore warranted to more carefully explore molecular mechanisms, dose-responses, and relationships between morphological outcome and long-term recovery.	[Lok, Josephine; Murata, Yoshihiro; Zhu, Hai Hao; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol & Neurol,Neuroprotect Res Lab, Boston, MA USA; [Lok, Josephine; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Boston, MA 02114 USA; [Wang, Hui] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA USA; [Qin, Tao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci, Boston, MA USA		Lok, J (corresponding author), Neuroprotect Res Lab, MGH E 149-2401, Charlestown, MA 02129 USA.	jlok1@partners.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS55104, R01-NS37074, R01-NS53560, R01-NS48422, R01-NS47447] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447, R01NS053560, R01NS037074, R01NS048422, P01NS055104] Funding Source: NIH RePORTER		Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Di Segni A, 2005, J MOL NEUROSCI, V26, P57, DOI 10.1385/JMN:26:1:057; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flores AI, 2000, J NEUROSCI, V20, P7622; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Guo WP, 2006, BRAIN RES, V1087, P180, DOI 10.1016/j.brainres.2006.03.007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; Shyu WC, 2004, NEUROBIOL AGING, V25, P935, DOI 10.1016/j.neurobiolaging.2003.10.012; SINSON G, 1995, J NEUROCHEM, V65, P2209; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Vaynman S, 2007, NEUROSCIENCE, V144, P825, DOI 10.1016/j.neuroscience.2006.10.005; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497	23	12	12	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2007	24	12					1817	1822		10.1089/neu.2007.0372			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	245BR	WOS:000251910000004	18159993				2022-02-06	
J	Venetsanou, K; Vlachos, K; Moles, A; Fragakis, G; Fildissis, G; Baltopoulos, G				Venetsanou, Kyriaki; Vlachos, Konstantinos; Moles, Athanassios; Fragakis, Gerassimos; Fildissis, George; Baltopoulos, George			Hypolipoproteinemia and hyperinflammatory cytokines in serum of severe and moderate traumatic brain injury (TBI) patients	EUROPEAN CYTOKINE NETWORK			English	Article						low-density lipoprotein cholesterol; traumatic brain injury; cytokines	CEREBROSPINAL-FLUID; TNF-ALPHA; INTERLEUKIN-8; SEPSIS; IL-6	Traumatic brain injury (TBI) acts as an inducer of the inflammatory reaction expressed by the release of pro-inflammatory cytokines (interieukin-1 beta [IL-1 beta], interleukin-6 [IL-6] and interleukin-8 [IL-8]), and causes metabolic alterations in the early, post-traumatic state, either in the brain or/and the systemic circulation. The metabolic changes involve carbohydrates, proteins and lipids. We focused on the serum lipid profile, the impact of trauma on lipoproteins, and their subsequent effects, on inflammation. We investigated the role of cytokines and serum lipids, in patient outcome, reviewing 30-day mortality and the Glasgow Coma Scale (GCS). total of 75 patients with severe or moderate TBI (GCS <= 13) were allocated to two groups (group 1 non-survivors and group 2 survivors). One blood sample was collected from each patient within 24h of admission. Cytokines were measured in serum by ELISA and serum lipids using an enzymatic method. We found significantly decreased serum lipid levels and increased cytokines levels for all patients compared with healthy volunteers. Comparing the two groups, IL-6 and IL-8 levels were higher (p < 0.0001) and LDL levels lower (p = 0.003) in non-survivors than in survivors. We observed a significant inverse correlation between IL-8 and LDL (p = 0.04) in patients with an unfavorable outcome. Our results suggest that LDL alone, or in combination with IL-6 and IL-8, could be a possible prognostic factor for outcome in patients with TBI, as regards 30-day mortality.	[Venetsanou, Kyriaki; Moles, Athanassios; Fildissis, George; Baltopoulos, George] Univ Athens, KAT Gen Hosp, Sch Nursing, ICU,Res Unit, Athens 14561, Greece; [Vlachos, Konstantinos; Fragakis, Gerassimos] KAT Gen Hosp, Neurosurg Clin, Athens 14561, Greece		Venetsanou, K (corresponding author), Univ Athens, KAT Gen Hosp, Sch Nursing, ICU,Res Unit, Nikis 2, Athens 14561, Greece.	icuru@nurs.uoa.gr		Vlachos, Konstantinos/0000-0003-2794-1065			BENVENISTE EN, 1995, HUMAN CYTOKINES THEI, P159; CHIARETTI A, 2007, EUR J PAEDIAT NEUROL; CHIHKANG C, 2005, BLOOD PURIFICAT, V23, P134; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; MAIER B, 2007, SHOCK; Nicholson G, 2005, ANAEST INTENS CARE M, V6, P313, DOI 10.1383/anes.2005.6.9.313; NOFLER JR, 2002, ATHEROSCLEROSIS, V161, P1; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Wilson RF, 2003, CRIT CARE, V7, P413, DOI 10.1186/cc2390; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82	14	12	13	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE		1952-4005		EUR CYTOKINE NETW	Eur. Cytokine Netw.	DEC	2007	18	4					206	209		10.1684/ecn.2007.0112			4	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	246IP	WOS:000252001000006	17993453				2022-02-06	
J	Hiekikanen, H; Kurki, T; Brandstack, N; Kairisto, V; Tenovuo, O				Hiekikanen, Heli; Kurki, Timo; Brandstack, Nina; Kairisto, Veli; Tenovuo, Olli			MRI changes and ApoE genotype, a prospective 1-year follow-up of traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						apolipoprotein E genotype; magnetic resonance imaging; traumatic brain injury	APOLIPOPROTEIN-E POLYMORPHISM; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; PROMOTER POLYMORPHISMS; POSTTRAUMATIC AMNESIA; REGULATORY REGION; GENE; ASSOCIATION; RISK; E4	Primary objective: To examine the association between apolipoprotein E (ApoE) genotype and visibility of traumatic brain lesions during the first year after traumatic brain injury (TBI). Research design: A prospective 1-year follow-up study in unselected victims of TBI. Methods: The number and extent of contusions, ventricular size index and semi-quantitative score of other traumatic intraparenchymal lesions were determined with MRI similar to 1 week and 1 year after TBI and the results were analysed in relation to the ApoE genotype in 33 patients after acute non-trivial TBI. Results: The ApoE genotype was not associated with the visible changes occurring during this follow-up. Conclusions: The presence of ApoE4 was not associated with MRI changes during the first year after TBI. This suggests that if the ApoE4 is associated with an unfavourable outcome after TBI, the processes responsible for the repair of visible lesions are not dependent on ApoE genotype.	[Hiekikanen, Heli; Tenovuo, Olli] Univ Turku, Dept Neurol, Cent Hosp, FIN-20520 Turku, Finland; [Kurki, Timo; Brandstack, Nina] Univ Turku, Dept Radiol, Cent Hosp, FIN-20520 Turku, Finland; [Kairisto, Veli] Univ Turku, Dept Clin Chem, Cent Hosp, FIN-20520 Turku, Finland		Tenovuo, O (corresponding author), Univ Turku, Dept Neurol, Cent Hosp, Kiinanmyllynkatu 4-8, FIN-20520 Turku, Finland.	olli.tenovuo@tyks.fi		Kurki, Timo/0000-0001-5532-3534			Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Berr C, 2001, NEUROBIOL AGING, V22, P227, DOI 10.1016/S0197-4580(00)00227-X; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Donohoe GG, 2000, CLIN CHEM, V46, P1540; Donohoe GG, 1999, CLIN CHEM, V45, P143; EHNHOLM C, 1986, J LIPID RES, V27, P227; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Graham DI, 1999, CELL MOL NEUROBIOL, V19, P19, DOI 10.1023/A:1006937205905; Graham DI, 1999, ACT NEUR S, V73, P89; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; Heesen C, 2006, J NEUROL NEUROSUR PS, V77, P34, DOI 10.1136/jnnp.2005.065805; Heijmans BT, 2002, AM J MED GENET, V107, P201, DOI 10.1002/ajmg.10142; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; JENNETT B, 1975, LANCET, V1, P480; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ME, 1999, ADV EXP MED BIOL, V471, P117; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; Lambert JC, 2002, NEUROLOGY, V59, P59, DOI 10.1212/WNL.59.1.59; Lambert JC, 2001, LANCET, V357, P608, DOI 10.1016/S0140-6736(00)04063-0; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; Laws SM, 1999, NEUROREPORT, V10, P879, DOI 10.1097/00001756-199903170-00038; Laws SM, 2002, MOL PSYCHIATR, V7, P886, DOI 10.1038/sj.mp.4001097; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mui S, 1996, NEUROLOGY, V47, P196, DOI 10.1212/WNL.47.1.196; Myllykangas L, 2002, AM J MED GENET, V114, P288, DOI 10.1002/ajmg.10202; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pahnke J, 2003, ACTA NEUROPATHOL, V105, P25, DOI 10.1007/s00401-002-0602-0; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Roks G, 2002, AM J MED GENET, V114, P570, DOI 10.1002/ajmg.10407; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Son BC, 2000, ACT NEUR S, V76, P13; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teter B, 2004, J MOL NEUROSCI, V23, P167, DOI 10.1385/JMN:23:3:167; Ti LK, 2003, J THORAC CARDIOV SUR, V125, P211, DOI 10.1067/mtc.2003.123; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Weir CJ, 2001, NEUROLOGY, V57, P1097, DOI 10.1212/WNL.57.6.1097; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401	70	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1307	1314		10.1080/02699050701739549			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200010	18236205				2022-02-06	
J	Karon, SL; Lazarus, JAC; Holman, L				Karon, Sarita L.; Lazarus, Jo-Anne C.; Holman, Laurie			Challenges and approaches to the identification of traumatic brain injury among nursing home residents	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; nursing homes; screening; prevalence		The Minimum Data Set (MDS) is a standardized, federally mandated assessment tool used to identify the needs of nursing home residents and rehabilitation and nursing services received on a routine basis. These data can be used to identify people with traumatic brain injury (TBI), where a diagnosis is recorded. However, both limitations of the MDS and the presence of other neurological issues that can be confused with TBI can reduce the likelihood that brain injury is identified where it exists. The article discusses innovative methodological approaches and challenges to using the MDS data to identify people with TBI in nursing homes.	Univ Wisconsin, Ctr Hlth Syst Res & Anal, Madison, WI 53706 USA; Univ Wisconsin, Dept Kinesiol, Madison, WI USA		Karon, SL (corresponding author), Univ Wisconsin, Ctr Hlth Syst Res & Anal, Madison, WI 53706 USA.						BAKKENIST K, 1999, NURS HOMES, V48, P47; BERUBE J, 2003, J HEAD TRAUMA REHAB, V68, P68926; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; *CTR MED MED SERV, 2005, MDS QUAL MEAS IND RE; *CTR MED MED SERV, 2007, REV LONG TERM CAR FA; *CTR MED MED SERV, 2004, MDS CURR RES INF REP; *CTR MED MED SERV, MED WAIV DEM LIST; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gabella BA, 2007, J HEAD TRAUMA REHAB, V22, P368, DOI 10.1097/01.HTR.0000300232.98242.ce; Marr A., 2004, CENTRAL NERVOUS SYST; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	12	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					350	359		10.1097/01.HTR.0000300230.13490.11			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500005	18025967				2022-02-06	
J	Becker, F; Reinvang, I				Becker, Frank; Reinvang, Ivar			Event-related potentials indicate bi-hemispherical changes in speech sound processing during aphasia rehabilitation	JOURNAL OF REHABILITATION MEDICINE			English	Article						aphasia; rehabilitation; event-related potentials; mismatch negativity; MMN; N1; N2; P3; plasticity	MISMATCH NEGATIVITY; LANGUAGE; REORGANIZATION; STROKE	Objective: To investigate changes in brain activation related to tone and speech sound processing during aphasia rehabilitation. Design: Longitudinal study investigating patients with stroke, subarachnoid hemorrhage and traumatic brain injury 3 and 7 months post-injury. Subjects: Eight patients with aphasia, reflecting a wide range of auditory comprehension impairment. Methods: Token test and Norwegian Basic Aphasia Assessment were used to measure auditory comprehension function. Brain event-related potentials were recorded in passive paradigms with harmonically rich tones and syllables in order to obtain the mismatch negativity component that reflects automatic stimulus discrimination. In an active syllable discrimination paradigm, stimulus feature integration (N1), attended stimulus discrimination and classification (N2), and target detection (P3) were studied. Results: Auditory comprehension scores improved approximately 10% during the observation period. Ipsilesional frontal P3- and N2-amplitude increased significantly. A significant shift in topographical distribution from the contralesional to the ipsilesional hemisphere was observed for the N2 component. The study of individual waveforms indicates inter-individual differences in reorganization after brain injury. Conclusion: Hemispherical distribution of brain activation correlating with speech sound processing in aphasia can change during the first months after brain injury. Eventrelated potentials are a potentially useful method for detecting individual activation patterns relevant to recovery in aphasia rehabilitation.	Univ Oslo, Fac Div Ulleval Hosp, Sunnaas Rehabil Hosp, Oslo, Norway; Sunnaas Rehabil Hosp, NO-1450 Nesoddtangen, Norway; Univ Oslo, Dept Psychol, Oslo, Norway		Becker, F (corresponding author), Sunnaas Rehabil Hosp, NO-1450 Nesoddtangen, Norway.	frank.becker@sunnaas.no		Becker, Frank/0000-0002-0857-0628			Becker F, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-6; Becker F, 2007, BRAIN LANG, V100, P69, DOI 10.1016/j.bandl.2006.09.004; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Giaquinto S, 2004, FUNCT NEUROL, V19, P219; Hyde M, 1997, AUDIOL NEURO-OTOL, V2, P281, DOI 10.1159/000259253; Ilvonen TM, 2001, PSYCHOPHYSIOLOGY, V38, P622, DOI 10.1111/1469-8986.3840622; Knecht S, 2002, NAT NEUROSCI, V5, P695, DOI 10.1038/nn868; Mazzini Letizia, 2004, Phys Med Rehabil Clin N Am, V15, P163, DOI 10.1016/S1047-9651(03)00101-3; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Pulvermuller F, 2005, NEUROIMAGE, V28, P481, DOI 10.1016/j.neuroimage.2005.06.038; Reinvang I., 1985, APHASIA BRAIN ORG; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090	14	12	17	0	14	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	OCT	2007	39	8					658	661		10.2340/16501977-0112			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	225UK	WOS:000250543400012	17896059	Green Submitted, gold			2022-02-06	
J	Chung, RS; Fung, SJ; Leung, YK; Walker, AK; McCormack, GH; Chuah, MI; Vickers, JC; West, AK				Chung, R. S.; Fung, S. J.; Leung, Y. K.; Walker, A. K.; McCormack, G. H.; Chuah, M. I.; Vickers, J. C.; West, A. K.			Metallothionein expression by NG2 glial cells following CNS injury	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						traumatic brain injury; reactive glia; axon regeneration; inhibitory molecules	CHONDROITIN SULFATE PROTEOGLYCAN; NEURITE GROWTH; BRAIN-INJURY; GENE-EXPRESSION; AXON GROWTH; ASTROCYTES; DIFFERENTIATION; REGENERATION; INHIBITION; PATHOLOGY	Metallothionein (MT) expression is rapidly up-regulated following CNS injury, and there is a strong correlation between the presence or absence of MTand improved or impaired (respectively) recovery from such trauma.We now report that a distinct subset of NG2-positive, GFAP-negative glial cells bordering the injury tract express MT following focal injury to the adult rat neocortex. To confirm the ability of these NG2 glial cells to express MT, we have isolated and cultured them and identified that they can express MT following stimulation with zinc. To investigate the functional importance of MT expression by NG2 glial cells, we plated cortical neurons onto these cells and found that expression of MT enhanced the permissivity of NG2 glial cells to neurite outgrowth. Our data suggest that expression of MT by NG2 glial cells may contribute to the overall permissiveness of these cells to axon regeneration.	Univ Tasmania, NeuroRepair Grp, Menzies Res Inst, Hobart, Tas 7001, Australia		Chung, RS (corresponding author), Univ Tasmania, NeuroRepair Grp, Menzies Res Inst, Private Bag 58, Hobart, Tas 7001, Australia.	rschung@utas.edu.au	Walker, Adam Keith/B-7418-2009; Chuah, Meng Inn/J-7671-2014; West, Adrian/AAR-8857-2021; Fung, Samantha/C-9660-2011; Vickers, James C/J-7464-2014; Chung, Roger/ABF-8395-2020	Walker, Adam Keith/0000-0001-7954-5801; Vickers, James C/0000-0001-5671-4879; Chung, Roger/0000-0002-9286-947X			Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Carrasco J, 2006, NEUROSCIENCE, V143, P911, DOI 10.1016/j.neuroscience.2006.08.054; Chen ZJ, 2002, J NEUROCYTOL, V31, P481, DOI 10.1023/A:1025791614468; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; Chung RS, 2003, J NEUROSCI, V23, P3336; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; DOU CL, 1994, J NEUROSCI, V14, P7616; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Jones LL, 2003, J NEUROSCI, V23, P9276; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2002, J COMP NEUROL, V444, P174, DOI 10.1002/cne.10149; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2006, FEBS J, V273, P1857, DOI 10.1111/j.1742-4658.2006.05207.x; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Stankovic RK, 2007, INT J BIOCHEM CELL B, V39, P484, DOI 10.1016/j.biocel.2006.09.010; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Ughrin YM, 2003, J NEUROSCI, V23, P175; West AK, 2004, REV NEUROSCIENCE, V15, P157; Xie T, 2004, J NEUROSCI, V24, P7043, DOI 10.1523/JNEUROSCI.1626-04.2004; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006	28	12	12	0	5	BIRKHAUSER VERLAG AG	BASEL	VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND	1420-682X			CELL MOL LIFE SCI	Cell. Mol. Life Sci.	OCT	2007	64	19-20					2716	2722		10.1007/s00018-007-7267-8			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225SQ	WOS:000250538200023	17896077				2022-02-06	
J	Bennouna, M; Greene, VB; Defranoux, L				Bennouna, M.; Greene, V. B.; Defranoux, L.			Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						acetylcholine; acetylcholinesterase inhibitors; Galantamine; schizophrenia; schizophrenia-like psychosis; traumatic brain injury	MUSCARINIC RECEPTOR-BINDING; CLOSED-HEAD INJURY; ACETYLCHOLINE-RELEASE; ADJUVANT GALANTAMINE; SUSTAINED ATTENTION; NEGATIVE SYMPTOMS; PATIENT; CORTEX; RIVASTIGMINE; DISORDER	Introduction - While traumatic brain injury is a major public health issue, schizophrenia-like psychosis following traumatic brain injury is relatively rare and poorly studied. Yet the risk of developing schizophrenia-like psychosis after traumatic brain injury is 3 times more important than in the general population. Literature findings - Risk factors associated with onset of psychosis after traumatic brain injury include: left hemispheric lesions, closed head injury and coma of duration superior to 24 hours. Most patients develop symptoms of psychosis after a moderate to severe traumatic brain injury and often have lesions of the frontal and temporal lobes. Cholinergic hypothesis: arguments - Neuropathologic, electrophysiological and pharmacologic evidence show that cognitive impairment including attention, memory and executive functioning impairment may be related with cholinergic dysfunction in patients with traumatic brain injury. The cholinergic hypothesis is also incriminated in the genesis of schizophrenia. The same biochemical disorders found in schizophrenia which imply many neurotransmitters are often present immediately after traumatic brain injury. However in chronic cognitive disorders secondary to traumatic brain injury, the cholinergic system alone seems to be specifically implied. This is due to the fragility of the cholinergic fibres and a chronic yet reversible reduction of the cholinergic reserves after traumatic brain injury. Cholinergic function can be studied by the P50 evoked response to paired auditory stimuli. While this is disturbed in patients presenting with cognitive impairment after traumatic brain injury its normalisation can be obtained after administration of an acetylcholine esterase inhibitor. In schizophrenic patients there is also an abnormal P50 evoked response due in part to a low number of alpha 7 nicotinic receptors which are implicated in sensory filtering in the frontal lobe. Moreover in schizophrenia, post-mortem studies show a negative correlation between the activity of acetylcholine transferase in the parietal cortex and the severity of the cognitive deficits, as well as a lesser density of the muscarinic M1 and M4 receptors in the frontal lobe. The lower concentration of M1 receptors in the frontal cortex is correlated with the severity of the positive symptoms. Therapeutical perspectives - Antipsychotics have emerged as the first line treatment of psychotic disorders. In research, their ability for enhancing cognitive function could result in the increase of acetylcholine in the medial prefrontal cortex. Acetylcholinesterase inhibitors have been widely used for treatment of cognitive impairment in Alzheimer's disease. Galantamine could be interesting in schizophrenia and psychosis following traumatic brain injury because it has a dual mechanism of action: selective competitive inhibition of acetylcholinesterase and allosteric potentialisation of nicotinic receptor response. Therefore Galantamine remains active in nicotine addicted schizophrenic patients who may smoke as an auto treatment. Galantamine has shown efficacy in adjunction to Risperidone in one patient presenting with psychosis following traumatic brain injury and in 3 case reports of schizophrenic patients. Conclusion - Further systematic studies are needed to confirm this hypothesis.	[Bennouna, M.] CHS Sarreguemines, F-57206 Sarreguemines, France; [Defranoux, L.] CHU Strasbourg, Chef Serv 2E Secteur, Strasbourg, France		Bennouna, M (corresponding author), CHS Sarreguemines, 3E Secteur,1 Rue Calmette, F-57206 Sarreguemines, France.						Aasen I, 2005, J CLIN PSYCHOPHARM, V25, P311, DOI 10.1097/01.jcp.0000169267.36797.76; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Allen T, 2003, 11 C INT PSYCH ASS I; Allen TB, 2002, AM J PSYCHIAT, V159, P1244, DOI 10.1176/appi.ajp.159.7.1244; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Arnold DS, 2004, J CLIN PSYCHIAT, V65, P1723, DOI 10.4088/JCP.v65n1219e; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bora E, 2005, CLIN NEUROPHARMACOL, V28, P139, DOI 10.1097/01.wnf.0000162555.68729.04; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Crook JM, 2001, AM J PSYCHIAT, V158, P918, DOI 10.1176/appi.ajp.158.6.918; DAVISON K, 1969, BRIT J PSYCHIAT, V114, P113; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Drimer T, 2004, INT CLIN PSYCHOPHARM, V19, P27, DOI 10.1097/00004850-200401000-00005; Friedman JI, 2004, PSYCHOPHARMACOLOGY, V174, P45, DOI 10.1007/s00213-004-1794-x; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Ichikawa J, 2002, NEUROPSYCHOPHARMACOL, V26, P325, DOI 10.1016/S0893-133X(01)00312-8; KANE JM, 1982, ARCH GEN PSYCHIAT, V39, P473; KRAEPELIN E, 1919, DEMEMTIA PRAECOX PAR; LADDOMADA A, 1999, EUR NEUROPSYCHOPHARM, V9, P257; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lenzi A, 2003, CLIN NEUROPHARMACOL, V26, P317, DOI 10.1097/00002826-200311000-00011; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Lovell Mark R., 1994, P133; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Nelson CL, 2002, PSYCHOPHARMACOLOGY, V161, P168, DOI 10.1007/s00213-002-1004-7; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Powchik P, 1998, SCHIZOPHRENIA BULL, V24, P325, DOI 10.1093/oxfordjournals.schbul.a033330; Raedler TJ, 1998, CURR OPIN NEUROBIOL, V8, P157, DOI 10.1016/S0959-4388(98)80019-6; Raedler TJ, 2003, AM J PSYCHIAT, V160, P118, DOI 10.1176/appi.ajp.160.1.118; Rosse RB, 2002, CLIN NEUROPHARMACOL, V25, P272, DOI 10.1097/00002826-200209000-00010; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; TANDON R, 1992, PSYCHOPHARMACOL BULL, V28, P297; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Umansky R, 2000, INT J NEUROPSYCHOPH, V3, P81, DOI 10.1017/S1461145700001723; VONFRAFTEBING R, 1868, UEBER DURCH GEHIRNER	43	12	13	0	5	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2007	33	4					616	620					5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	257IX	WOS:000252793600013	18033152				2022-02-06	
J	Campbell, KA; Berger, RP; Ettaro, L; Roberts, MS				Campbell, Kristine A.; Berger, Rachel P.; Ettaro, Lorraine; Roberts, Mark S.			Cost-effectiveness of head computed tomography in infants with possible inflicted traumatic brain injury	PEDIATRICS			English	Article						abuse; shaken-baby syndrome; cost-effectiveness; computed tomography	QUALITY-OF-LIFE; CHILD-ABUSE; YOUNG-CHILDREN; ECONOMIC-ANALYSIS; CARE PROVIDERS; HEALTH-STATUS; OUTCOMES; INTERVENTIONS; HEMORRHAGES; PARENTS	Objective. Early diagnosis of inflicted traumatic brain injury may reduce morbidity and mortality associated with repeated inflicted traumatic brain injuries. We undertook this study to estimate the cost-effectiveness of a policy of head computed tomography (CT) for inflicted traumatic brain injury in selected infants seen in an emergency department. Methods. We constructed Markov models to compare a policy of CT to no CT in an asymptomatic 5-week-old infant with either (1) unexplained scalp bruising or (2) a history of an apparent life-threatening event. Health states modeled were no inflicted traumatic brain injury, misdiagnosed inflicted traumatic brain injury, mild inflicted traumatic brain injury (diagnosed or undiagnosed), and severe and fatal inflicted traumatic brain injury. Infants with undiagnosed inflicted traumatic brain injury were at increased risk of repeat inflicted traumatic brain injury. We used available literature to estimate probabilities, costs, and outcomes. The models terminated at death or at 52 weeks of age. Outcomes considered were severe and fatal inflicted traumatic brain injury cases averted through early detection of mild inflicted traumatic brain injury. Data Sources. We conducted a literature review for estimates of inflicted traumatic brain injury incidence, outcome probabilities, and medical and societal costs. Wide ranges were set for sensitivity and Monte Carlo analyses. Results. From a medical payer perspective, head CT for inflicted traumatic brain injury in infants with unexplained scalp bruising saved money. Sensitivity analysis demonstrated costs less than $50 000 per severe or fatal inflicted traumatic brain injury averted in scenarios in which initial inflicted traumatic brain injury prevalence was > 3%. From a societal perspective, costs of child protection made head CT for inflicted traumatic brain injury more expensive. Conclusions. From a medical payer perspective, our models demonstrate that CT for inflicted traumatic brain injury can be cost-effective and improve outcomes. The finding of higher societal cost reflects the substantial short-term costs of child protection. Our study supports a low medical threshold for CT screening and highlights the need for improved understanding of long-term costs and outcomes of child abuse.	Univ Utah, Dept Pediat, Div Safe & Healthy Families, Salt Lake City, UT 84158 USA; Childrens Hosp Pittsburgh, Div Child Advocacy, Dept Pediat, Pittsburgh, PA USA; Univ Pittsburgh, Ctr Rural Hlth Practice, Bradford, PA, England; Univ Pittsburgh, Div Gen Internal Med, Sect Decis Sci, Div Gen Internal Med, Bradford, PA, England; Univ Pittsburgh, Div Gen Internal Med, Clin Syst Modeling, Div Gen Internal Med, Bradford, PA, England		Campbell, KA (corresponding author), Univ Utah, Dept Pediat, Div Safe & Healthy Families, 296 Chipeta Way,Box 581289, Salt Lake City, UT 84158 USA.	kristine.campbell@hsc.utah.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000005] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [D55HP05156-01-00] Funding Source: Medline		ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; ARMSTRONG KA, 1983, CHILD WELFARE, V62, P3; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BENEDICT MI, 1994, CHILD ABUSE NEGLECT, V18, P577, DOI 10.1016/0145-2134(94)90084-1; Bennett JE, 2000, ARCH PEDIAT ADOL MED, V154, P43; Bishop S J, 2001, Child Maltreat, V6, P243, DOI 10.1177/1077559501006003005; BOPP K, 1997, EC COSTS SBS SURVIVO; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brenner RA, 1999, PEDIATRICS, V103, P968, DOI 10.1542/peds.103.5.968; Carty H, 2002, EUR RADIOL, V12, P2919, DOI 10.1007/s00330-002-1436-9; Corso PS, 2006, CHILD ABUSE NEGLECT, V30, P727, DOI 10.1016/j.chiabu.2005.12.006; Courtney ME, 1999, CHILD ABUSE NEGLECT, V23, P975, DOI 10.1016/S0145-2134(99)00073-3; Courtney ME, 1998, FUTURE CHILD, V8, P88, DOI 10.2307/1602630; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUBOWITZ H, 1990, CHILD ABUSE NEGLECT, V14, P177, DOI 10.1016/0145-2134(90)90029-S; Erly WK, 2003, AM J ROENTGENOL, V180, P1727, DOI 10.2214/ajr.180.6.1801727; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Flaherty EG, 2000, ARCH PEDIAT ADOL MED, V154, P489, DOI 10.1001/archpedi.154.5.489; Glaser AW, 1997, QUAL LIFE RES, V6, P43; GOLD M. R., 1996, COSTEFFECTIVENESS HL; GOULD MS, 1995, CHILD MALTREATMENT C; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; Ireys HT, 1997, PEDIATRICS, V100, P197, DOI 10.1542/peds.100.2.197; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; JELLINEK MS, 1995, CHILD ABUSE NEGLECT, V19, P1051, DOI 10.1016/0145-2134(95)00067-I; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lavin A, 1999, JAMA-J AM MED ASSOC, V282, P1421, DOI 10.1001/jama.282.15.1421; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Miller T.R., 1990, J FORENSIC EC, V3, P17; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Panepinto JA, 2000, J PEDIATR-US, V136, P201, DOI 10.1016/S0022-3476(00)70102-8; Pitetti RD, 2002, PEDIATRICS, V110, P557, DOI 10.1542/peds.110.3.557; Plotnick RD, 1999, CHILD WELFARE, V78, P381; Quinn GE, 2004, ARCH OPHTHALMOL-CHIC, V122, P1659; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; RIVARA FP, 1985, CHILD ABUSE NEGLECT, V9, P81, DOI 10.1016/0145-2134(85)90095-X; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Sane SM, 2000, PEDIATRICS, V105, P1345; SCARCELLA CA, 2004, COST PROTECTING VULN; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; VISCUSI WK, 1993, J ECON LIT, V31, P1912; [No title captured]	57	12	12	0	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2007	120	2					295	304		10.1542/peds.2007-0437			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	196SY	WOS:000248503500006	17671055				2022-02-06	
J	Doi, R; Morita, K; Shigemori, M; Tokutomi, T; Maeda, H				Doi, R.; Morita, K.; Shigemori, M.; Tokutomi, T.; Maeda, H.			Characteristics of cognitive function in patients after traumatic brain injury assessed by visual and auditory event-related potentials	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; event-related potentials; visual and auditory stimuli; facial affect	CLOSED-HEAD-INJURY; FACIAL AFFECT RECOGNITION; P300; STIMULI	Objective: Using auditory and visual stimuli including facial affective stimuli, we analyzed the P300 components of event-related potentials (ERPs) in patients after traumatic brain injury (TBI) to assess their cognitive characteristics. Design: Twenty TBI patients and 32 age-matched control subjects were recruited. Using conventional oddball paradigms, visual ERPs were recorded using images of crying and smiling babies as visual stimuli. Auditory ERPs were obtained using 2-kHz tones as stimuli without affective stimuli. The peak amplitude and latency for P300, and the latency for N200, were recorded. Results: In visual ERPs, the P300 amplitudes were significantly smaller in patients than in controls for the crying baby, but the amplitudes were similar between groups for the smiling baby. Controls showed smaller P300 amplitudes for the smiling baby than for the crying baby, but patients showed no, difference. In patients, the P300 latency for both smiling and crying babies was longer than in the controls. Patients' auditory ERPs showed smaller P300 amplitudes but similar P300 latencies compared with controls. The N200 latency In patients was significantly longer than in controls only for the crying baby. Conclusions: Visual ERPs are a potentially useful marker for evaluating cognitive dysfunction in patients after TBI.	Kurume Univ, Sch Med, Cognit & Mol Res Inst & Neuropsychiat, Dept Neurosurg, Kurume, Fukuoka 830, Japan		Morita, K (corresponding author), Kurume Univ, Sch Med, Cognit & Mol Res Inst & Neuropsychiat, Dept Neurosurg, Asahimachi67, Kurume, Fukuoka 830, Japan.						CAMPBELL K, 1986, ELECTROENCEPHALOGR C, V38, P48; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSTON VS, 1986, PSYCHOPHYSIOLOGY, V23, P684, DOI 10.1111/j.1469-8986.1986.tb00694.x; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; LANG SF, 1990, J CLIN EXP NEUROPSYC, V12, P946, DOI 10.1080/01688639008401033; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Maeda H, 1996, BIOL PSYCHIAT, V39, P743, DOI 10.1016/0006-3223(95)00612-5; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Mazzini Letizia, 2004, Phys Med Rehabil Clin N Am, V15, P163, DOI 10.1016/S1047-9651(03)00101-3; Morita Y, 2001, NEUROSCI RES, V41, P89, DOI 10.1016/S0168-0102(01)00248-6; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; POLICH J, 1991, American Journal of EEG Technology, V31, P201; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; PRICHARD WS, 1986, PSYCHOL BULL, V100, P43; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; Yamamoto Masashi, 2000, Kurume Medical Journal, V47, P285; YEE CM, 1987, CURRENT TRENDS EVE S, V40, P300	27	12	15	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2007	86	8					641	649		10.1097/PHM.0b013e318115aca9			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	194ZX	WOS:000248383400006	17667194				2022-02-06	
J	Jacka, MJ; Zygun, D				Jacka, Michael J.; Zygun, David			Survey of management of severe head injury in Canada	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; GUIDELINES; HYPERVENTILATION	Objective: To determine: 1. the degrees of consensus and disagreement among Canadian critical care clinicians regarding the appropriateness (benefit exceeding risk) of common therapeutic manoeuvres in patients with severe closed head injury (CHI), and 2. the frequency with which clinicians employed these manoeuvres. Methods: The study design was a systematic scenario-based survey of all neurosurgeons and critical care physicians treating patients with severe CHI in Canada. Results: In the scenario of acute epidural hematoma with mass effect, respondents agreed very strongly that surgery was appropriate. Clinicians reported mannitol and hypertonic saline as appropriate. Beyond these two interventions, agreement was less strong, and the use of the extraventricular drain (EVD), phenytoin, cooling, hyperventilation, nimodipine, and jugular venous oximetry (JVO) were of uncertain appropriateness. Steroids were considered inappropriate. In a scenario of diffuse axonal injury (DAI), clinicians agreed strongly that fever reduction, early enteral feeding, intensive glucose control, and cerebral perfusion pressure (CPP)-directed management were appropriate. The use of mannitol, hypertonic saline, EVD, JVO, narcotics and propofol were also appropriate. Neuromuscular blockade, surgery, and hyperventilation were of uncertain appropriateness. The appropriateness ratings of the interventions considered in the scenario of an intracranial contusion mirrored the DAI scenario. In general, correlations between the reported appropriateness and frequency of use of each intervention were very high. An exception noted was the use of the JVO. The correlation between CPP-guided therapy and the use of the EVD was weak. Conclusions: This survey has described current practice with regard to treatment of patients with severe CHI. Areas of variation in perceived appropriateness were identified that may benefit from further evaluation. Suggested priorities for evaluation include the use of osmotic diuretics, anticonvulsants, and intracranial manometry.	Univ Alberta, Dept Anesthesiol, Div Crit Care, Edmonton, AB T6G 2M7, Canada; Univ Calgary, Dept Crit Care Med, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada		Jacka, MJ (corresponding author), Univ Alberta, WCM HSC, GSICU, 112 St NW, Edmonton, AB T6G 2B7, Canada.						Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Hutchinson PJ, 2005, ACTA NEUROCHIR SUPPL, V95, P441; Kerr J, 2005, EMERG MED J, V22, P850, DOI 10.1136/emj.2004.022673; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Price SJ, 2003, INJURY, V34, P834, DOI 10.1016/S0020-1383(03)00028-7; Sekula Raymond F Jr, 2005, Clin Neurosurg, V52, P306; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930; 2000, J NEUTOTRAUMA, V17, P450	18	12	12	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	AUG	2007	34	3					307	312		10.1017/S0317167100006727			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199BD	WOS:000248670300008	17803027				2022-02-06	
J	DeGracia, DJ; Kreipke, CW; Kayali, FM; Rafols, JA				DeGracia, Donald J.; Kreipke, Christian W.; Kayali, Foaz M.; Rafols, Jose A.			Brain endothelial HSP-70 stress response coincides with endothelial and pericyte death after brain trauma	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; heat shock response; cell death	HEAT-SHOCK-PROTEIN; CEREBRAL-BLOOD-FLOW; GROWTH-FACTOR; INJURY; EXPRESSION; CELLS; INDUCTION; RATS; HEAT-SHOCK-PROTEIN-70; INHIBITION	Objectives: Our objective was to characterize the heat shock response (HSR) in a model of traumatic brain injury (TBI) and to determine the association of HSR to cell death. Methods: We used immunofluorescent detection of HSP-70 to characterize HSR and TUNEL labeling to determine the pattern of cell death. Results: HSP-70 immunofluorescence revealed a steady increase from 4 to 48 hours following TBI, culminating in a ubiquitous expression with the capillary bed 48 hours post-TBI. TUNEL labeling revealed a small subset of endothelial cell death and a most robust staining of putative pericyte cell death. Discussion: Our results show that while injury causes a detectable stress response, cell death is not a direct consequence of the HSR.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860, R01NS044100] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044100, NS039860] Funding Source: Medline		Armstead WM, 2005, AM J PHYSIOL-HEART C, V289, pH1184, DOI 10.1152/ajpheart.00276.2005; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; Dore-Duffy P, 1999, MICROVASC RES, V57, P75, DOI 10.1006/mvre.1998.2112; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Fraser HM, 2006, REPRODUCTION, V132, P589, DOI 10.1530/rep.1.01064; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; *I LAB AN RES COMM, 1996, NIH PUBL; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; KETIS NV, 1988, CANCER RES, V48, P2101; KREIPKE CW, 2007, NEUROL RES, V29; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Pickard JD, 2005, ACT NEUR S, V95, P459; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; Portig I, 1996, ELECTROPHORESIS, V17, P803, DOI 10.1002/elps.1150170431; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Soti C, 2006, HANDB EXP PHARM, V172, P417; Suzuki H, 1998, SURG NEUROL, V49, P67, DOI 10.1016/S0090-3019(97)98983-7; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wang JH, 1997, AM J PHYSIOL-CELL PH, V272, pC1543, DOI 10.1152/ajpcell.1997.272.5.C1543; Wong HR, 1996, AM J RESP CELL MOL, V15, P745, DOI 10.1165/ajrcmb.15.6.8969269; Xu LJ, 2006, NEUROBIOL AGING, V27, P562, DOI 10.1016/j.neurobiolaging.2005.09.032; ZHU W, 1994, BIOCHEM BIOPH RES CO, V200, P389, DOI 10.1006/bbrc.1994.1461	36	12	12	0	3	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUN	2007	29	4					356	361		10.1179/016164107X204666			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	192PM	WOS:000248214200004	17626730				2022-02-06	
J	Kreipke, CW; Morgan, R; Roberts, G; Bagchi, M; Rafols, JA				Kreipke, Christian W.; Morgan, Randy; Roberts, George; Bagchi, Mihir; Rafols, Jose A.			Calponin phosphorylation in cerebral cortex microvessels mediates sustained vasoconstriction after brain trauma	NEUROLOGICAL RESEARCH			English	Article						contractile protein; microvascular tone; traumatic brain injury	INOS EXPRESSION; ENDOTHELIN-1; CONTRACTION; CALDESMON; INJURY; RATS; MICROCIRCULATION; CYTOSKELETON; HIPPOCAMPUS; PLASMA	Objectives: The purpose of this study was to determine the molecular and biochemical changes in the contractile protein, calponin (Cp), which temporally coincide with a previously reported state of sustained contractility following traumatic brain injury (TBI). Methods: Double immunofluorescence, western analysis and two- dimensional non-equilibrium pH gradient gel electrophoresis (NEPHGE)/SDS-PAGE techniques were utilized to determine both the location and extent of Cp within smooth muscle cells (SM) and the phosphorylation state of Cp following TBI, as induced using a weight drop acceleration impact model. Results: Double immunofluorescence for Cp and SM indicate that following injury, Cp migrates from the cytosol to a location subjacent to the SM membrane. Western analysis revealed a significant increase in Cp protein expression following injury that was maintained up to 48 hours post-injury. Combined Western analysis and NEPHGE indicated that Cp is phosphorylated following TBI. Discussion: Cp migration and phosphorylation may underlie the mechanism for increased vasoreactivity leading to hypoperfusion following TBI.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Scott Hall,Room 9312,540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		BARANY K, 1992, BIOCHEM BIOPH RES CO, V187, P847, DOI 10.1016/0006-291X(92)91274-T; Egnaczyk GF, 2003, PROTEOMICS, V3, P689, DOI 10.1002/pmic.200300407; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gimona M, 1996, BIOCH SMOOTH MUSCLE, P91; *I LAB AN RES COMM, 1996, NIH PUBL; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; KREIPKE CW, 2007, NEUROL RES, V29; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; LIN Y, 1993, J BIOCHEM-TOKYO, V113, P643, DOI 10.1093/oxfordjournals.jbchem.a124096; Mabuchi K, 1996, J MUSCLE RES CELL M, V17, P243, DOI 10.1007/BF00124246; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MINO T, 1995, BIOCHEM BIOPH RES CO, V208, P397, DOI 10.1006/bbrc.1995.1351; NORTH AJ, 1994, J CELL SCI, V107, P437; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrov T, 2003, J NEUROL SCI, V209, P31, DOI 10.1016/S0022-510X(02)00461-6; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; RAFOLS JA, 2007, NEUROL RES, V29; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; SUZUKI N, 1990, BIOCHEM BIOPH RES CO, V167, P941, DOI 10.1016/0006-291X(90)90614-S; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yang JX, 2004, ACTA BIOCH BIOPH SIN, V36, P529, DOI 10.1093/abbs/36.8.529; Yuasa U, 1999, J MOL CELL CARDIOL, V31, P1281, DOI 10.1006/jmcc.1999.0960	29	12	12	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2007	29	4					369	374		10.1179/016164107X204684			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	192PM	WOS:000248214200006	17626732				2022-02-06	
J	Kuhne, CA; Zettl, RP; Baume, B; Vogt, FM; Taeger, G; Ruchholtz, S; Stolke, D; Nast-Kolb, D				Kuehne, C. A.; Zettl, R. P.; Baume, B.; Vogt, F. M.; Taeger, G.; Ruchholtz, S.; Stolke, D.; Nast-Kolb, D.			Penetrating gunshot injuries to the head and brain. Diagnosis, management and prognosis	UNFALLCHIRURG			German	Article						gunshot injuries to the head; standard diagnosis; standard management; mortality; prognosis	CRANIOCEREBRAL MISSILE INJURIES; GLASGOW COMA SCALE; WOUNDS; INFECTIONS; CIVILIANS; MODEL	Gunshot injuries to the head and brain are rare in Germany and the rest of western Europe. With the relatively low number of these injuries here, there are no standard methods of diagnosis and management, and there is some controversy over both. Quite a high proportion of such injuries result from suicide attempts and accidents. The main diagnostic procedure available is computed tomography of the head with contrast medium; in certain cases MRI is indicated. The operative management depends on the extent and prognosis of the injury; a ventricular drain is probably indicated in most cases. Debridement of the bullet's path and removal of the projectile are more controversial. Mortality is extremely high after such injuries; if the victim does survive the prognosis is comparable to that following closed cranial injuries.	Univ Klinikum Essen, Unfallchirurg Klin, D-45122 Essen, Germany; Univ Klinikum Essen, Klin & Poliklin Neurochirurg, D-45122 Essen, Germany; Univ Klinikum Essen, Abt Diagnost & Intervent Radiol & Neuroradiol, D-45122 Essen, Germany		Kuhne, CA (corresponding author), Univ Klinikum Essen, Unfallchirurg Klin, Hufelandstr 55, D-45122 Essen, Germany.	christian.kuehne@uni-essen.de					Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BERG SO, 1974, CRIMINOLOGIST, V9, P51; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COOPER GJ, 1990, BRIT J SURG, V77, P606, DOI 10.1002/bjs.1800770604; CROCKARD HA, 1975, J TRAUMA, V15, P339, DOI 10.1097/00005373-197504000-00011; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; GERBER AM, 1972, J NEUROSURG, V36, P43, DOI 10.3171/jns.1972.36.1.0043; GIESE A, 2002, RECHTSMEDIZIN, V1, P13; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; GRUMME T, 1986, CHIRURG, V57, P674; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HELLING TS, 1992, J TRAUMA, V32, P398, DOI 10.1097/00005373-199203000-00019; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; Hess U, 2000, J TRAUMA, V49, P704, DOI 10.1097/00005373-200010000-00019; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; JACOBS DG, 1995, AM SURGEON, V61, P647; JOURDAN P, 1989, Journal de Radiologie (Paris), V70, P685; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013	30	12	12	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	APR	2007	110	4					341	349		10.1007/s00113-007-1244-4			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	156SN	WOS:000245670000007	17364161				2022-02-06	
J	Salluh, JIF; Martins, GAR; Santino, MS; Araujo, LV; Freitas, GG; Verdeal, JCR				Salluh, J. I. F.; Martins, G. A. R.; Santino, M. S.; Araujo, L. V.; Freitas, G. G.; Verdeal, J. C. R.			Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						traumatic brain injury; terlipressin; shock; vasopressin; cerebral perfusion pressure; jugular oxygen venous saturation	SEPTIC SHOCK; VASOPRESSIN; PATIENT	Background Maintaining adequate cerebral perfusion pressure is an essential aspect in the treatment of severe acute brain injury. To accomplish this therapeutic goal vasopressors are usually required. Vasopressin is an important endogenous stress hormone and the infusion of low-dose vasopressin and terlipressin has been used to reverse severe hypotension. Case report A 14-year-old male patient was admitted to the emergency room after a motorcycle accident. The patient had suffered severe traumatic brain injury, the Glasgow coma score (GCS) was four and there were signs of aspiration of gastric contents. Systemic inflammatory response syndrome and shock refractory to fluid management, norepinephrine and steroid replacement ensued. A terlipressin infusion, as a bolus dose of 1 mg, is associated with the ability to improve cerebral perfusion pressure with concomitant reduction of 80% of norepinephrine doses. Discussion The present report illustrates the potential benefits of terlipressin in refractory shock in a patient with severe traumatic brain injury. An increase in cerebral perfusion pressure (CPP) and a huge decrease in the dose of norepinephrine were observed. In the setting of severe brain injury associated with refractory hypotension, terlipressin may improve mean arterial pressure and cerebral perfusion pressure. Conclusions In the setting of severe brain injury associated with refractory hypotension, terlipressin may have a role as a rescue therapy.	Hosp Barra DOr, Intens Care Unit, Rio De Janeiro, Brazil; Hosp Canc 1, Inst Nacl Canc, Rio De Janeiro, Brazil; Fundacao Oswaldo Cruz, Immunopharmacol Lab, IOC, Rio De Janeiro, Brazil		Salluh, JIF (corresponding author), Hosp Barra DOr, Intens Care Unit, Rio De Janeiro, Brazil.	jorgesalluh@yahoo.com.br	Salluh, Jorge IF/F-6779-2012; dantas, vicente c souza/L-2648-2013; Salluh, Jorge/AAF-2682-2021	Salluh, Jorge/0000-0002-8164-1453			Boerma EC, 2005, ACTA ANAESTH SCAND, V49, P1387, DOI 10.1111/j.1399-6576.2005.00752.x; Bradley PG, 2004, ANAESTHESIA, V59, P619, DOI 10.1111/j.1365-2044.2004.03816.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dunser MW, 2003, CRIT CARE MED, V31, P1394, DOI 10.1097/01.CCM.0000059722.94182.79; Holmes Cheryl L, 2004, Curr Opin Crit Care, V10, P442, DOI 10.1097/01.ccx.0000144769.19213.0c; Kam PCA, 2004, ANAESTHESIA, V59, P993, DOI 10.1111/j.1365-2044.2004.03877.x; Landry DW, 1997, CIRCULATION, V95, P1122; Leone M, 2004, SHOCK, V22, P314, DOI 10.1097/01.shk.0000136097.42048.bd; Nolan JP, 2004, NEW ENGL J MED, V350, P2206; O'Brien A, 2002, LANCET, V359, P1209, DOI 10.1016/S0140-6736(02)08225-9; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Sharshar T, 2003, CRIT CARE MED, V31, P1752, DOI 10.1097/01.CCM.0000063046.82359.4A; Shawcross DL, 2004, HEPATOLOGY, V39, P471, DOI 10.1002/hep.20044; SUZUKI Y, 1993, STROKE, V24, P1049, DOI 10.1161/01.STR.24.7.1049; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6	15	12	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2007	51	4					505	508		10.1111/j.1399-6576.2006.01252.x			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	145PR	WOS:000244877500019	17378791				2022-02-06	
J	Hachemi, M; Jourdan, C; Di Roio, C; Turjman, F; Ricci-Franchi, A; Mottolese, C; Artru, F				Hachemi, M.; Jourdan, C.; Di Roio, C.; Turjman, F.; Ricci-Franchi, A.; Mottolese, C.; Artru, F.			Delayed rupture of traumatic aneurysm after civilian craniocerebral gunshot injury in children	CHILDS NERVOUS SYSTEM			English	Article						traumatic aneurysm; civilian craniocerebral gunshot injury; pediatrics; endovascular treatment; high-velocity missile injury	INTRACRANIAL ANEURYSMS; CEREBELLAR ARTERY; CEREBRAL-ARTERIES; MISSILE INJURIES; WOUNDS; BRAIN; MANAGEMENT; SECONDARY	Background There are few published large series on civilian craniocerebral gunshot injuries in children. Traumatic intracranial aneurysms (TICAs) are rare and highly unstable lesions. They represent less than 1% of all aneurysms and can either rupture within minutes after formation or remain quiescent for several weeks or years, manifesting with delayed hemorrhage and neurologic deterioration. Case history We report the case of a 10-year-old girl who was referred for coma after high-velocity craniocerebral gunshot wound and neurological deterioration 7 days after the initial injury. A massive right posterior occipital hematoma caused by the rupture of an unsuspected right posterior cerebral artery TICA was discovered. TICA was treated by coil embolization, with a good neurological recovery at 6-month follow-up. Discussion We discuss the pathogenesis and the management of TICA in a child after civilian craniocerebral gunshot injuries. Conclusions TICAs should be suspected in patients with civilian craniocerebral gunshot injuries, presenting with secondary neurological deterioration, to carry out emergent CT scan and angiographic exploration before contemplating definitive endovascular treatment. Endovascular management may be a prompt safe-to-use technique and a valuable option, especially when surgery is highly risky.	Hop Neurol & Neurochirurg P Wertheimer, Dept Anesthesia, F-69677 Bron, France; Hop Neurol & Neurochirurg P Wertheimer, Dept Neuroradiol, F-69677 Bron, France; Hop Neurol & Neurochirurg P Wertheimer, Dept Neurosurg B, F-69677 Bron, France		Hachemi, M (corresponding author), Hop Neurol & Neurochirurg P Wertheimer, Dept Anesthesia, F-69677 Bron, France.	mohamed.hachemi@chu-lyon.fr					AMATO JJ, 1970, ARCH SURG-CHICAGO, V101, P167; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; CROWELL RM, 1995, SURG MANAGEMENT NEUR, P377; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GERBER AM, 1972, J NEUROSURG, V36, P43, DOI 10.3171/jns.1972.36.1.0043; Guyot LL, 2001, NEUROL RES, V23, P291, DOI 10.1179/016164101101198442; HADDAD FS, 1978, CAN J SURG, V21, P233; HARVEY EN, 1948, ADV MILITARY MED, V1, P191; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JOURDAN C, 1993, PEDIATRIE, V48, P389; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Kumar M, 1998, NEUROSURG CLIN N AM, V9, P577; Lasjaunias P, 2005, CHILD NERV SYST, V21, P437, DOI 10.1007/s00381-004-1125-x; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; Nishioka T, 2002, ACTA NEUROCHIR, V144, P839, DOI 10.1007/s00701-002-0952-3; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; Tan TC, 2001, BRIT J NEUROSURG, V15, P137	29	12	12	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAR	2007	23	3					283	287		10.1007/s00381-006-0269-2			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	130MD	WOS:000243802800003	17119977				2022-02-06	
J	Le Roux, AA; Nadvi, SS				Le Roux, A. A.; Nadvi, S. S.			Acute extradural haematoma in the elderly	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Proceedings Paper	Congress of the World-Federation-of Neurosurgical-Societies (WFNS)	JUN 19-24, 2005	Marrakesh, MOROCCO	WFNS		acute extradural haematoma; elderly	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURIES; INTRACRANIAL HEMATOMAS; MANAGEMENT; MORTALITY; COMA	The world's population of persons over 65 years of age (elderly) is increasing. Acute extradural haematoma (AEDH) in the elderly is rare. There has not been a publication dedicated solely to the evaluation of AEDH in the elderly. We undertook this study in order to establish a clinical profile in this important subgroup. It took the form of a retrospective evaluation of the inpatient charts of elderly patients with AEDH, performed over a 23-year period (1983 - 2005) at a single institution. Of 3249 patients with AEDH, 32 (< 1%) were defined as elderly. Assault was the commonest causative factor (56%), followed by falls (25%) and motor vehicle accidents (19%). Eight patients died (25% mortality). Only a third of patients, (34%) made a good outcome, the majority of these were assault victims. No patient in coma, or over 75 years made a good outcome. The prognosis of elderly patients with AEDH is poor. Conservative treatment for comatose patients and the over 75s is justified.	Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Neurosurg, Inkosi Albert Luthuli Cent Hosp, Durban, South Africa		Nadvi, SS (corresponding author), POB 31076, ZA-4058 Durban, KwaZulu Natal, South Africa.	mwnadvi@iafrica.com					AMACHER AL, 1987, NEUROSURGERY, V20, P954; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Heiskanen O, 1975, Surg Neurol, V4, P23; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; Jennett B., 1982, NEUROLOGICAL DISORDE, P202; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; MAURICEWILLIAMS RS, 1993, AGE AGEING, V22, P337, DOI 10.1093/ageing/22.5.337; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; OHNO K, 1987, Neurological Surgery, V15, P607; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Rakier A., 2000, Harefuah, V138, P359; SIBATA S, 1989, Neurological Surgery, V17, P177; STRANG I, 1978, INJURY, V10, P154; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456	30	12	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2007	21	1					16	20		10.1080/02688690601170692			5	Clinical Neurology; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	159GR	WOS:000245853900006	17453769				2022-02-06	
J	Ballesteros, MA; Lopez-Hoyos, M; Munoz, P; Marin, MJ; Minambres, E				Ballesteros, Maria Angeles; Lopez-Hoyos, Marcos; Munoz, Pedro; Marin, Maria Jose; Minambres, Eduardo			Apoptosis of neuronal cells induced by serum of patients with acute brain injury: a new in vitro prognostic model	INTENSIVE CARE MEDICINE			English	Article						acute brain injury; apoptosis; in vitro; PC12 cells; outcome	FATAL HEAD-INJURY; CEREBROSPINAL-FLUID; JUGULAR BULB; DEATH; BCL-2; VALIDATION; CONTUSIONS	Objective: To investigate whether serum draining from the jugular bulb of patients with traumatic or haemorrhagic brain injury induced apoptosis of neuronal PC12 cells in vitro and whether the apoptotic rate correlated with patients' outcome at 6 months. Design and setting: Prospective clinical investigation in a 21-bed intensive care unit (ICU) in a university hospital. Patients: Seventy patients who had suffered from acute brain injury requiring intensive care. Interventions: Jugular bulb vein and systemic samples were obtained on admission to the ICU and after 48 h. PC12 cells were incubated in the presence of 10% of heat-inactivated patient's sera and apoptotic rate was determined by flow cytometry using annexin V and 7-aminoactinomycin D. Results: Regional serum draining from the lesions induced higher early apoptosis of PC12 cells than systemic serum. Early apoptotic rate, Glasgow coma score, APACHE II score and the presence of pupil abnormalities were associated with mortality at 6 months in univariate statistical analyses. In logistic regression analysis only early apoptotic rate was an independent factor associated with mortality at 6 months ( odds ratio: 1.502, 95% CI 1.2-1.9; p < 0.001). The final model has a sensitivity of 82.4% and a specificity of 84.8% for predicting death within 6 months. Conclusions: We developed a simple and reproducible in vitro model for predicting outcome in patients with traumatic or haemorrhagic brain injury that survived in the early phase. Our in vitro model combined with clinical and radiological measurements might improve the value of prognostic models to predict acute brain injury patients' outcome.	Hosp Univ Marques de Valdecilla, Dept Med Intens, Santander 39008, Spain; Fdn Publ Marques de Valdecilla, IFIMAV, Santander, Spain; Hosp Univ Marques de Valdecilla, Serv Inmunol, Santander 39008, Spain; Atenc Primaria, Serv Cantabro Salud, Santander, Spain		Minambres, E (corresponding author), Hosp Univ Marques de Valdecilla, Dept Med Intens, Avda Valdecilla S-N, Santander 39008, Spain.	eminambres@yahoo.es	MUNOZ, PEDRO/C-8361-2015; Lopez-Hoyos, Marcos/ABC-1024-2020; Minambres, Eduardo/H-7761-2019	Lopez-Hoyos, Marcos/0000-0003-0562-427X; Ballesteros, Maria A/0000-0002-4032-9973			ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bilbault P, 2004, INTENS CARE MED, V30, P408, DOI 10.1007/s00134-003-2118-z; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Castellanos M, 2005, J NEUROL NEUROSUR PS, V76, P691, DOI 10.1136/jnnp.2004.044347; Diaz-Reganon G, 2002, INTENS CARE MED, V28, P1724, DOI 10.1007/s00134-002-1543-8; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Hosmer D, 1989, APPL LOGISTIC REGRES; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Le Berre R, 2004, INTENS CARE MED, V30, P1204, DOI 10.1007/s00134-004-2165-0; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; MINAMBRES E, 2004, MED INTENSIVA, V28, P319; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RINK A, 1995, AM J PATHOL, V147, P1575; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; TEASDALE G, 1974, LANCET, V2, P81; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Zhang F, 2004, NEUROL RES, V26, P835, DOI 10.1179/016164104X3824	38	12	15	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JAN	2007	33	1					58	65		10.1007/s00134-006-0361-9			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125TB	WOS:000243464300011	16964482				2022-02-06	
J	Brewer, KL; Nolan, TA				Brewer, Kori L.; Nolan, Todd A.			Spinal and supraspinal changes in tumor necrosis factor-alpha expression following excitotoxic spinal cord injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						inflammation; excitotoxicity; cytokines; spinal cord injury pain; quisqualic acid	TNF-ALPHA; MESSENGER-RNA; CELL-DEATH; INFLAMMATORY CYTOKINE; TRAUMATIC INJURY; PAIN; INTERLEUKIN-10; INCREASE; NEURONS; BRAIN	The role of tumor necrosis factor-alpha (TNF-alpha) after spinal cord injury (SCI) is well characterized in the cord, but the impact of this inflammatory process on supraspinal levels is unknown. This study examines TNF-alpha mRNA and protein levels in the brains and spinal cords of mice after SCL Mice received intraspinal injections of quisqualic acid (QUIS) to create an excitotoxic injury that is known to result in pain behaviors. An ELISA determined serum levels of TNF-alpha, whereas real-time PCR and Western blot analysis were used to determine mRNA and protein levels, respectively, at 3,6,12,24,48, 72 h, or 14 d postinjury. No difference existed in serum TNF-(x levels between sham- and QUIS-injected animals. TNF-alpha mRNA in the cord was increased at 3, 6, 12, and 24 h in QUIS-injected animals relative to shams. TNF-a protein was elevated at 12 and 48 h postinjury. TNF-alpha mRNA levels in the brain were elevated at 12 and 24 h, with elevated protein levels at 6 h. Animals that developed pain behaviors had increased levels of TNF-alpha mRNA in the brain. Excitotoxic SCI results in altered TNF-alpha mRNA and protein levels in the cords and brains of mice within 6 h of injury These changes likely contribute to the pathogenesis of injury within the cord. The role of TNF-alpha in the brain postinjury has not been defined but might contribute to the development of pain post-SCI.	E Carolina Univ, Brody Sch Med, Dept Accid & Emergency, PCMH,3ED304, Greenville, NC 27834 USA		Brewer, KL (corresponding author), E Carolina Univ, Brody Sch Med, Dept Accid & Emergency, PCMH,3ED304, Greenville, NC 27834 USA.	brewerk@ecu.edu					Abraham KE, 2004, NEUROSCIENCE, V124, P945, DOI 10.1016/j.neuroscience.2004.01.004; Abraham KE, 2001, PAIN, V90, P181, DOI 10.1016/S0304-3959(00)00402-4; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; Brewer KL, 2003, MOL BRAIN RES, V118, P171, DOI 10.1016/j.molbrainres.2003.08.006; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Covey WC, 2002, REGION ANESTH PAIN M, V27, P357, DOI 10.1053/rapm.2002.31930; Covey WC, 2000, BRAIN RES, V859, P113, DOI 10.1016/S0006-8993(00)01965-X; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Ignatowski TA, 1999, BRAIN RES, V841, P70, DOI 10.1016/S0006-8993(99)01782-5; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Lenz F A, 2000, Prog Brain Res, V129, P259; LENZ FA, 1987, PAIN, V31, P225, DOI 10.1016/0304-3959(87)90038-8; Melzack R, 2001, J Dent Educ, V65, P1378; Morrow TJ, 2000, EXP NEUROL, V161, P220, DOI 10.1006/exnr.1999.7246; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Plunkett JA, 2001, EXP NEUROL, V168, P144, DOI 10.1006/exnr.2000.7604; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Shinpo K, 1999, BRAIN RES, V819, P170, DOI 10.1016/S0006-8993(98)01354-7; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; Vierck CJ, 2000, PAIN, V89, P1, DOI 10.1016/S0304-3959(00)00463-2; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Wang YP, 2002, POLYM ADVAN TECHNOL, V13, P11, DOI 10.1002/pat.100; Watkins LR, 2003, ADV EXP MED BIOL, V521, P1; WATKINS LR, 1995, BRAIN RES, V692, P244, DOI 10.1016/0006-8993(95)00715-3; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116	41	12	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.		2007	31	1					13	21		10.1007/BF02686114			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	144ML	WOS:000244800200002	17416966				2022-02-06	
J	Bute, JJ; Donovan-Kicken, E; Martins, N				Bute, Jennifer J.; Donovan-Kicken, Erin; Martins, Nicole			Effects of communication-debilitating illnesses and injuries on close relationships: A relational maintenance perspective	HEALTH COMMUNICATION			English	Article; Proceedings Paper	89th Annual Meeting of the National-Communication-Association	NOV 19-23, 2003	MIAMI, FL	Natl Commun Assoc			TRAUMATIC BRAIN-INJURY; STROKE; INDIVIDUALS; CAREGIVERS; HUSBANDS; DISTRESS; APHASIA; SUPPORT; NEEDS	A communication-debilitating illness or injury (CDI) presents significant challenges for patients as well as for friends and family. In a qualitative study of the effects of a CDI on close relationships, 28 individuals with loved ones who had experienced a CDI were interviewed. Participants described adjustments in communication with the patient and explained what it is like to experience a relationship with a CDI patient. Themes that emerged transcended the type of illness and relationship. Recommendations are made for further research that focuses on patients' relationships with a variety of social network members, beyond primary caregivers.	Ohio Univ, Sch Commun Studies, Athens, OH 45701 USA; Univ Illinois, Dept Speech Commun, Urbana, IL 61801 USA		Bute, JJ (corresponding author), Ohio Univ, Sch Commun Studies, Lasher Hall, Athens, OH 45701 USA.	bute@ohio.edu		Bute, Jennifer/0000-0001-7203-5585			ALLEN P, 1994, AGR HUM VALUES, V9, P29; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Baxter LA, 2002, J APPL COMMUN RES, V30, P1, DOI 10.1080/00909880216576; BRERETON L, 2000, J CLIN NURS, V11, P22; Burleson B.R., 2000, CLOSE RELATIONSHIPS, P745, DOI DOI 10.4135/9781452220437.N18; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Canary D. J., 2000, COMMUNICATION YB, V23, P305, DOI 10.1080/23808985.2000.11678976; Canary Daniel J., 1993, INTERPERSONAL COMMUN, P237; Canary DJ, 2001, CLOSED ROMANTIC RELATIONSHIPS: MAINTENANCE AND ENHANCEMENT, P133; CANARY DJ, 1992, COMMUN MONOGR, V59, P242; CANARY DJ, 1993, COMMUN RES REP, V10, P3, DOI DOI 10.1080/08824099309359913; Denman A, 1998, DISABIL REHABIL, V20, P411, DOI 10.3109/09638289809166103; Ellis DG, 1996, COMMUN RES, V23, P472, DOI 10.1177/009365096023004007; GEISTMARTIN P, 2001, QUALITATIVE RES APPL, P121; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; GUAY J, 1982, CANADAS MENTAL HLTH, V30, P22; JONGBLOED L, 1994, AM J OCCUP THER, V48, P1006, DOI 10.5014/ajot.48.11.1006; KEMPER S, 1995, DISCOURSE PROCESS, V20, P205, DOI 10.1080/01638539509544938; Lyons R.F., 1995, RELATIONSHIPS CHRONI; Michallet B, 2001, APHASIOLOGY, V15, P731, DOI 10.1080/02687040143000087; Mishel M H, 1999, Annu Rev Nurs Res, V17, P269; MORGAN M, 1984, SOC SCI MED, V19, P489, DOI 10.1016/0277-9536(84)90044-3; Morse J.M., 1991, ILLNESS EXPERIENCE D; Orange JB, 1998, J APPL COMMUN RES, V26, P120, DOI 10.1080/00909889809365495; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Planalp S., 1994, DYNAMICS RELATIONSHI, P1; Pring T, 1999, APHASIOLOGY, V13, P914, DOI 10.1080/026870399401687; ROBERTSON EK, 1968, J PSYCHOSOM RES, V12, P189, DOI 10.1016/0022-3999(68)90045-7; Rusbult C.E., 1987, READINGS SOCIAL PSYC, P147; Rusbult CE, 2001, CLOSED ROMANTIC RELATIONSHIPS: MAINTENANCE AND ENHANCEMENT, P87; Santos ME, 1999, BRAIN INJURY, V13, P23, DOI 10.1080/026990599121845; SMAGTDUIJNSTEE ME, 2001, J ADV NURS, V33, P301; STAFFORD L, 1991, J SOC PERS RELAT, V8, P217, DOI 10.1177/0265407591082004; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A.L., 1975, CHRONIC ILLNESS QUAL; Sundin K, 2000, J CLIN NURS, V9, P481, DOI 10.1046/j.1365-2702.2000.00379.x; Sundin Karin, 2002, Nurs Inq, V9, P93, DOI 10.1046/j.1440-1800.2002.00135.x; WILLIAMSON GM, 1990, PSYCHOL AGING, V5, P502, DOI 10.1037/0882-7974.5.4.502	38	12	12	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.		2007	21	3					235	246		10.1080/10410230701307675			12	Communication; Health Policy & Services	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Communication; Health Care Sciences & Services	188SX	WOS:000247940700004	17567255	Green Submitted			2022-02-06	
J	Campbell, L; Wilson, FC; McCann, J; Kernahan, G; Rogers, RG				Campbell, Loretta; Wilson, F. Colin; McCann, John; Kernahan, George; Rogers, Rosalind Gray			Single case experimental design study of Carer facilitated Efforless Learning in a patient with severe memory impairment following TBI	NEUROREHABILITATION			English	Article						memory rehabilitation; errorless learning; family and carers; brain injury	ACQUIRED BRAIN-INJURY; COGNITIVE REHABILITATION; ERRORLESS; AMNESIA; PROGRAM	Objectives: To investigate if errorless learning applied by carer(s) in an everyday setting can reduce the frequency of everyday memory problems following severe traumatic brain injury (TBI). Research design: Multiple baseline single case experimental design. Methods and procedures: A patient with severe memory impairment, six years post TBI was recruited via an outpatient neurorehabilitation clinic. ABA analysis was conducted using daily frequency counts of everyday memory problems as an index of change. Experimental intervention: Errorless learning delivered by the patient's carer, aimed at reducing the occurrence of identified everyday memory problems. The carer was guided in treatment implementation by an Occupational Therapist. Main outcomes and results: Incidence of frequently occurring memory lapses was significantly reduced (p < 0.001) and this was maintained at 3 months post intervention. Conclusion: This study highlights the potential clinical value of errorless learning with self-generated cues applied by carers within an everyday setting.	Royal Victoria Hosp, Dept Rehabil Med, Occupat Therapy Dept, Belfast Hlth & Social Care Trust, Belfast BT12 6BA, Antrim, North Ireland; Belfast Hlth & Social Care Trust, Musgrave Pk Hosp, Reg Acquired Brain Injury Unit, Belfast, Antrim, North Ireland; Univ Ulster, Sch Nursing, Jordanstown, North Ireland; Univ Ulster, Sch Commun, Jordanstown, North Ireland		Campbell, L (corresponding author), Royal Victoria Hosp, Dept Rehabil Med, Occupat Therapy Dept, Belfast Hlth & Social Care Trust, Belfast BT12 6BA, Antrim, North Ireland.	loretta.campbell@belfasttrust.hscni.net		Kernohan, George/0000-0002-1309-446X			BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bier N, 2003, J COGNITIVE REHABILI, V20, P12; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clare L, 2003, AGING MENT HEALTH, V7, P15, DOI 10.1080/1360786021000045854; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kim K.H., 1999, SCI MATH, V2, P147; Kime SK, 1996, BRAIN INJURY, V10, P17; MATEER C, 2002, CARD U C SEPT; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Snaith R., 1994, HOSP ANXIETY DEPRESS; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1995, HDB MEMORY DISORDERS, P452	21	12	12	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2007	22	4					325	333					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	233KE	WOS:000251089000011	17971624				2022-02-06	
J	Clarke, DE; Van Reekum, R; Patel, J; Simard, M; Gomez, E; Streiner, DL				Clarke, Diana E.; Van Reekum, Robert; Patel, Jigisha; Simard, Martine; Gomez, Everlyne; Streiner, David L.			An appraisal of the psychometric properties of the Clinician version of the Apathy Evaluation Scale (AES-C)	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						apathy; AES-C; reliability; validity; psychometric properties	TRAUMATIC BRAIN-INJURY; DEPRESSION; RELIABILITY; DEMENTIA; VALIDITY	This article examines the psychometric properties of the clinician version of the Apathy Evaluation Scale (AES-C) to determine its ability to characterize, quantify and differentiate apathy. Critical appraisals of the item-reduction processes, effectiveness of the administration, coding and scoring procedures, and the reliability and validity of the scale were carried out. For training, administration and rating of the AES-C, clearer guidelines, including a more standardized list of verbal and non-verbal apathetic cues, are needed. There is evidence of high internal consistency for the scale across studies. In addition, the original study reported good test-retest and inter-rater reliability coefficients. However, there is a lack of replication on these more stable and informative measures of reliability and as such they warrant further investigation. The research evidence confirms that the AES-C shows good discriminant, convergent and criterion validity. However, evidence of its predictive validity is limited. As this aspect of validity refers to the scale's ability to predict future outcomes, which is important for treatment and rehabilitation planning, further assessment of the predictive validity of the AES-C is needed. In conclusion, the AES-C is a reliable and valid measure for the characterization and quantification of apathy. Copyright (c) 2007 John Wiley & Sons, Ltd.	Baycrest Ctr Geriatr Care, Dept Psychiat, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Inst Rehabil, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Univ Toronto, Div Geriatr Psychiat, Toronto, ON, Canada; Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; Univ Moncton, Ecole Psychol, Moncton, NB E1A 3E9, Canada; Univ Laval, Ecole Psychol, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Ctr Rech, Quebec City, PQ G1K 7P4, Canada; Baycrest Ctr Geriatr Care, Dept Psychiat, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada			dclarke@jhsph.edu	Streiner, David/E-6563-2011; Simard/Q-9675-2019	Streiner, David/0000-0003-0610-6271; Simard/0000-0003-1257-8275			Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Andreasen N.C., 1990, SCHIZOPHRENIA POSITI; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Clarke DE, 2007, J NEUROPSYCH CLIN N, V19, P57, DOI 10.1176/appi.neuropsych.19.1.57; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Gorsuch R.L., 1983, FACTOR ANAL; GUILFORD RP, 1954, PSYCHOMETRIC METHODS; GUILLIKSEN H, 1960, PSYCHOL SCALING THEO; Guyatt GH, 2000, MED CARE, V38, P175; KANE RA, 1981, ASSESSING ELDERLY PR, P13; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kiang M, 2003, SCHIZOPHR RES, V63, P79, DOI 10.1016/S0920-9964(02)00433-4; Kim JO., 1978, FACTOR ANAL STAT MET; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Lampe IK, 2004, INT PSYCHOGERIATR, V16, P481, DOI 10.1017/S1041610204000766; Lampe IK, 2001, J GERIATR PSYCH NEUR, V14, P11, DOI 10.1177/089198870101400104; Landis JR, 1977, MEASUREMENT OBSERVER, V33, P159; MARIN RS, 1993, J AFFECT DISORDERS, V28, P117, DOI 10.1016/0165-0327(93)90040-Q; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1994, J NERV MENT DIS, V182, P235, DOI 10.1097/00005053-199404000-00008; MARIN RS, 2002, GUIDELINES APATHY EV; Marx RG, 1999, J CLIN EPIDEMIOL, V52, P105, DOI 10.1016/S0895-4356(98)00148-6; Mueller C., 1978, INTRO FACTOR ANAL; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Norman, 2003, HLTH MEASUREMENT SCA; Norman, 1995, HLTH MEASUREMENT SCA; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; PORTNEY LG, 2000, STAT MEASURES RELIAB; Rabkin JG, 2000, J NEUROPSYCH CLIN N, V12, P451, DOI 10.1176/appi.neuropsych.12.4.451; Resnick B, 1998, Rehabil Nurs, V23, P141; Sheatsley PB, 1983, HDB SURVEY RES; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134	37	12	13	0	23	WHURR PUBLISHERS LTD	LONDON	19B COMPTON TERRACE, LONDON N1 2UN, ENGLAND	1049-8931			INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.		2007	16	2					97	110		10.1002/mpr.207			14	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	185GP	WOS:000247699700006	17623389	Green Published			2022-02-06	
J	Harvey, AR				Harvey, Alan R.			Combined therapies in the treatment of neurotrauma: Polymers, bridges and gene therapy in visual system repair	NEURODEGENERATIVE DISEASES			English	Article						transplantation; peripheral nerve; growth factors; viral vectors; retinal ganglion cells; ciliary neurotrophic factor; brain-derived neurotrophic factor; optic nerve; optic tract	ADENOASSOCIATED VIRAL VECTORS; GANGLION-CELL SURVIVAL; AXONAL REGENERATION; CNS REPAIR; CNTF; TRANSPLANTATION; RETINA	Background: The mature central nervous system (CNS) has limited capacity for self-renewal and repair after injury or neurodegeneration, and therapeutic strategies are needed to promote the viability of damaged neurons and the regrowth of their axons. The retina and optic nerve (ON) are part of the CNS, and the visual system is widely used in experimental studies on injury and repair. Objective: To test various cellular and molecular approaches in attempts to replace retinal ganglion cells (RGCs) in depleted retinas or, more usually, promote the survival of endogenous injured RGCs and stimulate axonal regeneration after ON or intracranial optic tract (OT) injury. Methods and Results: Intraocular injections of brain-derived neurotrophic factor and ciliary neurotrophic factor (CNTF) temporarily increase RGC survival after ON injury. More sustained neuroprotection is obtained using adeno-associated viral vectors to transfect RGCs with brain-derived neurotrophic factor or CNTF genes. After ON crush, intravitreal adeno-associated viral CNTF injections also increase RGC axonal regrowth. Additional protective and growth effects are obtained after intraocular elevation of cAMP and by manipulation of protein kinase signalling pathways in RGCs. Regeneration is increased by transplanting a segment of peripheral nerve onto the cut ON. Schwann cells in peripheral nerve grafts can be genetically modified using lentiviral vectors to over-express CNTF, resulting in increased regrowth of RGC axons. After OT lesions, hydrogels have been used to bridge the injury, sometimes with the incorporation of signalling peptides or cells genetically modified to express neurotrophic factors. Conclusions: There is now a general consensus that combinatorial approaches are needed to elicit sustained and effective regenerative responses in injured adult CNS neurons. Copyright (c) 2007 S. Karger AG, Basel.	Univ Western Australia, Sch Anat & Human Biol, Crawley, Australia		Harvey, AR (corresponding author), Univ Western Australia, Sch Anat & Human Biol, M309,35 Stirling Highway, Perth, WA 6009, Australia.	arharvey@anhb.uwa.edu.au	Harvey, Alan R/A-4911-2008	, Alan/0000-0002-2590-831X			Chierzi S, 2001, RESTOR NEUROL NEUROS, V19, P109; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cui Q, 2003, J NEUROTRAUM, V20, P17, DOI 10.1089/08977150360517155; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Gates M A, 2000, Prog Brain Res, V127, P115; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; Lund RD, 2003, J LEUKOCYTE BIOL, V74, P151, DOI 10.1189/jlb.0103041; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Mellough CB, 2004, EXP NEUROL, V186, P6, DOI 10.1016/j.expneurol.2003.10.021; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407; Shen S., 1989, NEURON, V23, P285; Surace EM, 2003, PROG RETIN EYE RES, V22, P705, DOI 10.1016/S1350-9462(03)00052-1; Thanos S, 1997, SURV OPHTHALMOL, V42, pS5, DOI 10.1016/S0039-6257(97)80024-0; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239	23	12	13	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1660-2854	1660-2862		NEURODEGENER DIS	Neurodegener. Dis.		2007	4	4					300	305		10.1159/000101886			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	193TZ	WOS:000248299200003	17627133				2022-02-06	
J	Olson, DM; Thoyre, SM; Turner, DA; Bennett, S; Graffagnino, C				Olson, DaiWai M.; Thoyre, Suzanne M.; Turner, Dennis A.; Bennett, Stacey; Graffagnino, Carmelo			Changes in intracranial pressure associated with chest physiotherapy	NEUROCRITICAL CARE			English	Article						intracranial hypertensions; brain injury; chest physiotherapy		Introduction Management of intracranial hypertension is pivotal in the care of brain-injured patients. Summary of Case We report the case of a patient with both a closed head injury and anoxic encephalopathy, who subsequently experienced episodes of refractory intracranial hypertension. The patient's care was complicated by the development of a pneumonia, which required frequent turning of the patient and chest physiotherapy. Conventional wisdom suggests that these interventions may stimulate the patient and worsen intracranial pressure, and therefore should be avoided. Results Our observations on this patient, however, contradict this belief. This single-subject study presents data to support the use of chest physiotherapy in patients at risk for intracranial hypertension. Conclusions Further, the evidence is compelling that a randomized-controlled trial is indicated to test the hypothesis that chest physiotherapy may actually result in short-term resolution of high intracranial pressure, and thus provide one more clinical tool in the management of elevated intracranial pressure.	Univ N Carolina, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Durham, NC USA		Olson, DM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dmolson@email.unc.edu		Olson, DaiWai/0000-0002-9280-078X			ALSPACH J, 1998, CORE CURRICULUM CRIT; Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Beeby J P, 2000, Intensive Crit Care Nurs, V16, P151, DOI 10.1054/iccn.2000.1490; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; deBoisblanc BP, 1997, CRIT CARE MED, V25, P1456, DOI 10.1097/00003246-199709000-00008; ERSSON U, 1990, ACTA ANAESTH SCAND, V34, P99, DOI 10.1111/j.1399-6576.1990.tb03051.x; Grap Mary Jo, 2004, Crit Care Nurs Clin North Am, V16, P349, DOI 10.1016/j.ccell.2004.03.005; Greenberg MS, 2001, HDB NEUROSURGERY; Koch SM, 1996, J CRIT CARE, V11, P176, DOI 10.1016/S0883-9441(96)90028-3; Mahanes Dea, 2004, Crit Care Nurs Clin North Am, V16, P387, DOI 10.1016/j.ccell.2004.03.007; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; Marik PE, 2002, CRIT CARE MED, V30, P2146, DOI 10.1097/00003246-200209000-00035; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Wijdicks EFM, 1998, NEUROLOGY, V50, P11, DOI 10.1212/WNL.50.1.11; Yanko J R, 2001, Crit Care Nurs Q, V23, P1	15	12	12	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	6	2					100	103		10.1007/s12028-007-0015-y			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	179DW	WOS:000247270700005	17522792				2022-02-06	
J	Otani, N; Nawashiro, H; Fukui, S; Ooigawa, H; Ohsumi, A; Toyooka, T; Shima, K				Otani, Naoki; Nawashiro, Hiroshi; Fukui, Shinji; Ooigawa, Hidetoshi; Ohsumi, Atsushi; Toyooka, Terushige; Shima, Katsuji			Role of the activated extracellular signal-regulated kinase pathway on histological and behavioral outcome after traumatic brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						extracellular signal-regulated kinase (ERK); lateral fluid percussion; signal transduction; traumatic brain injury; U0126	PROTEIN-KINASES; HEAD TRAUMA; INHIBITION; EXPRESSION; PROTECTION; ISCHEMIA; DEFICITS; CULTURES; NEURONS; DAMAGE	The extracellular signal-regulated kinase (ERK) pathway, which modulates the activity of many transcriptional factors leading to the proliferation of various cells, is activated in lesions in regions of selective vulnerability after traumatic brain injury (TBI). In the present study, using the ERK inhibitor U0126, we investigated the role of the ERK pathway in histopathological and behavioral outcomes after TBI. Adult male Sprague-Dawley rats, weighing 300-400 g were subjected to lateral fluid percussion brain injury. The ERK inhibitor U0126 was injected intravenously before injury at 100, 200 and 400 mu g/kg. The severity of CA3 neuronal damage was evaluated by the number of surviving CA3 neurons 7 days after injury. The contusional lesion volume 72 h after injury was analysed using a computer-assisted analysis system. Three different motor skill tasks were measured on days 1-5, 7, 14 anal 21 after injury. Pretreatment with U0126 significantly reduced both CA3 neuronal damage and contusional lesion volume after injury. In addition, administration of U0126 ameliorated motor function recovery on days 3, 4 and 5 after injury. Therefore, inhibition of ERK phosphorylation could be a potentially effective therapeutic target after TBI. (C) 2006 Elsevier Ltd. All rights reserved.	Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan		Otani, N (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	naotani1993@aol.com					Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Carbonell WS, 2003, J NEUROTRAUM, V20, P327, DOI 10.1089/089771503765172282; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pereira DB, 2002, NEUROPHARMACOLOGY, V42, P9, DOI 10.1016/S0028-3908(01)00162-9; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Runden E, 1998, J NEUROSCI, V18, P7296; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Zubkov AY, 2000, STROKE, V31, P526, DOI 10.1161/01.STR.31.2.526	33	12	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2007	14	1					42	48		10.1016/j.jocn.2005.11.044			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	122EN	WOS:000243208600009	17138068				2022-02-06	
J	Quintana, A; Giralt, M; Molinero, A; Campbell, IL; Penkowa, M; Hidalgo, J				Quintana, Albert; Giralt, Mercedes; Molinero, Amalia; Campbell, Iain L.; Penkowa, Milena; Hidalgo, Juan			Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: Importance of IL-6	NEUROIMMUNOMODULATION			English	Article; Proceedings Paper	2nd Iberoamerican Congress on Neuroimmunomodulation	APR 19-22, 2007	Madrid, SPAIN			IL-6 microarrays; cryoinjury; GFAP-IL6 mice; transcriptome	ASTROCYTE-TARGETED EXPRESSION; CENTRAL-NERVOUS-SYSTEM; II-DEFICIENT MICE; IMPAIRED INFLAMMATORY RESPONSE; GENE-EXPRESSION; METALLOTHIONEIN-I; TRANSGENIC MICE; PLUS II; MICROARRAY TECHNOLOGY; OXIDATIVE STRESS	Traumatic brain injury is one of the leading causes of incapacity and death among young people. Injury to the brain elicits a potent inflammatory response, comprising recruitment of inflammatory cells, reactive astrogliosis and activation of brain macrophages. Under the influence of presumably several cytokines and growth factors, a cascade of events is activated that result ultimately in increased oxidative stress and tissue damage, but also in activation of counterregulatory factors and tissue regeneration. The complexity of this response is being unraveled by high-throughput methodologies such as microarrays. The combination of these modern techniques with the comparison of normal and genetically modified mice boosts the significance of the results obtained. With this approach, we have demonstrated that a cytokine such as interleukin-6 is one of the key players in the response of the brain to injury. Copyright (C) 2007 S. Karger AG, Basel.	Univ Autonoma Barcelona, Fac Sci, Anim Physiol Unit, Dept Cell Biol Physiol & Immunol,Inst Neurosci, ES-08193 Barcelona, Spain; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW, Australia; Univ Copenhagen, Fac Hlth Sci, Ctr Inflammat & Metab, Sect Neuroprotect, Copenhagen, Denmark		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Sci, Anim Physiol Unit, Dept Cell Biol Physiol & Immunol,Inst Neurosci, ES-08193 Barcelona, Spain.	juan.hidalgo@uab.cat	Giralt, Mercedes/K-1626-2014; molinero, amalia/K-2147-2014; Quintana, Albert/N-5544-2015; Hidalgo, Juan/C-9082-2011	Giralt, Mercedes/0000-0002-1806-1528; molinero, amalia/0000-0001-8661-8570; Quintana, Albert/0000-0003-1674-7160; Hidalgo, Juan/0000-0003-0921-1122			Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Giralt M, 2002, NEUROBIOL DIS, V9, P319, DOI 10.1006/nbdi.2002.0480; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Insel TR, 2004, NAT NEUROSCI, V7, P426, DOI 10.1038/nn0504-426; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Lee DK, 1999, BIOCHEM J, V337, P59, DOI 10.1042/0264-6021:3370059; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu PK, 2001, TRENDS NEUROSCI, V24, P581, DOI 10.1016/S0166-2236(00)01918-4; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Molinero A, 2003, J NEUROPATH EXP NEUR, V62, P315, DOI 10.1093/jnen/62.3.315; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Penkowa M, 2000, GLIA, V32, P247, DOI 10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Read SJ, 2001, J CEREBR BLOOD F MET, V21, P755, DOI 10.1097/00004647-200107000-00001; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x	44	12	12	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401			NEUROIMMUNOMODULAT	Neuroimmunomodulation		2007	14	3-4					139	143		10.1159/000110637			5	Endocrinology & Metabolism; Immunology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	238HI	WOS:000251437700005	18073505				2022-02-06	
J	Tilford, JM; Aitken, ME; Goodman, AC; Fiser, DH; Killingsworth, JB; Green, JW; Adelson, PD				Tilford, John M.; Aitken, Mary E.; Goodman, Allen C.; Fiser, Debra H.; Killingsworth, Jeffrey B.; Green, Jerril W.; Adelson, P. David			Child health-related quality of life following neurocritical care for traumatic brain injury: an analysis of preference-weighted outcomes	NEUROCRITICAL CARE			English	Article						utility values; economic evaluation; outcome assessment; quality of life	PEDIATRIC INTENSIVE-CARE; SEVERE HEAD-INJURY; STATES WORSE; UTILITY; SF-6D; MANAGEMENT; VALIDITY; THERAPY; DISEASE; TRIAL	Background Cost-effectiveness analysis relies on preference-weighted health outcome measures as they form the basis for quality adjusted life years. Studies of preference-weighted outcomes for children following traumatic brain injury are lacking. Objective This study seeks to describe the preference-weighted health outcomes of children following a traumatic brain injury at 3- and 6-months following pediatric intensive care unit (ICU) discharge. Setting/Patients Children aged 5-17 who required ICU admission and endotracheal intubation or mechanical ventilation. Main Outcome Measures The Quality of Well-being (QWB) score was used to describe preference-weighted outcomes. Clinical measures from the intensive care unit stay were used to estimate risk of mortality. Risk of mortality, Glasgow coma scores, patient length of stay in the intensive care unit, and parent-reported items from the Child Health Questionnaire (CHQ) were used to test construct validity. Methods Subject data were obtained from nine pediatric intensive care units with consent procedures approved by representative institutional review boards. Medical records containing clinical information from the ICU stay were abstracted by the study coordinating center. Caregivers of children were contacted by telephone for follow-up interviews at 3- and 6-months following ICU discharge. All interviews were conducted by telephone with the primary caregiver of the injured child. Preference score statistics are presented overall and in relation to characteristics of the patient and their ICU admission. Results A response rate of 59% was achieved for the 3-month interviews (N = 56) and 67% for the 6-month interviews (N = 65) for caregivers of children aged 5 years and above that consented to participate. Overall, QWB scores averaged 0.508 (95% Cl: 0.454-0.562) at the 3-month interview and 0.582 (95% Cl: 0.526-0.639) at the 6-month interview. For both interview periods, scores ranged from 0.093 to 1.0 on a 0-1 value scale, where 0 represents death and 1 represents perfect health. Specific acute and chronic health problems from the QWB scale were present more often in patients with higher injury severity. Mortality risk, ICU length of stay, Glasgow Coma Scales, and parental reported summary scores from the CHQ all correlated correctly with the QWB scores. Conclusions The findings support the use of the QWB score with parental report to measure preference-weighted health outcomes of children following a traumatic brain injury. Information from the study can be used in economic evaluations of interventions to prevent or treat traumatic brain injuries in children.	Univ Arkansas Med Sci, Arkansas Childrens Hosp, Coll Med, Dept Pediat, Little Rock, AR 72202 USA; Wayne State Univ, Dept Econ, Detroit, MI 48212 USA; Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA		Tilford, JM (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Hosp, Coll Med, Dept Pediat, Little Rock, AR 72202 USA.	tilfordmickj@uams.edu	Aitken, Mary/ABG-6119-2021; Adelson, David/W-2083-2019	Aitken, Mary/0000-0002-8318-9755			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Aitken ME, 2002, PEDIATRICS, V110, P337, DOI 10.1542/peds.110.2.337; BELL CM, 1999, MED DECIS MAKING, V19, P519; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brent RJ, 2003, COST-BENEFIT ANALYSIS AND HEALTH CARE EVALUATIONS, P1; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; CZYZEWSKI DI, 1994, MED CARE, V32, P965, DOI 10.1097/00005650-199409000-00007; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Frosch DL, 2004, ARTHRIT RHEUM-ARTHR, V51, P28, DOI 10.1002/art.20071; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JB, 1996, NEUROTRAUMA; Gold M., 1996, COST EFFECTIVENESS H; Gold MR., 1996, COST EFFECTIVENESS H, P82; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Groessl EJ, 2004, AM J PREV MED, V26, P126, DOI 10.1016/j.amepre.2003.10.007; Groessl EJ, 2003, ARTHRIT RHEUM-ARTHR, V49, P23, DOI 10.1002/art.10903; Hatoum HT, 2004, VALUE HEALTH, V7, P602, DOI 10.1111/j.1524-4733.2004.75011.x; Heard C, 2002, CRIT CARE MED, V30, P1403, DOI 10.1097/00003246-200206000-00059; KAPLAN RM, 1989, MED CARE, V27, pS27, DOI 10.1097/00005650-198903001-00003; KAPLAN RM, 1988, HEALTH SERV RES, V23, P203; Kaplan RM, 1996, QUALITY LIFE PHARMEA, P309; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; Landgraf JM, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P105; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; O'Brien BJ, 2003, HEALTH ECON, V12, P975, DOI 10.1002/hec.789; Parsons SK, 1999, INT J CANCER, P46; PATRICK DL, 1994, MED DECIS MAKING, V14, P9, DOI 10.1177/0272989X9401400102; Pyne JM, 2003, J AFFECT DISORDERS, V76, P237, DOI 10.1016/S0165-0327(03)00106-X; Robinson A, 2006, HEALTH ECON, V15, P393, DOI 10.1002/hec.1069; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; SMITHOLINDE L, 2006, HLTH STATE PREFERENC; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tilford JM, 2002, AMBUL PEDIATR, V2, P330, DOI 10.1367/1539-4409(2002)002<0330:CEAAEM>2.0.CO;2; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; TILFORD JM, 2006, AM ASS HLTH EC NAT M; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Ware JE., 1996, CHQ USERS MANUAL	50	12	14	1	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	7	1					64	75		10.1007/s12028-007-0037-5			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	200EN	WOS:000248746800012	17657658				2022-02-06	
J	Vorst, MV; Ono, K; Chan, P; Stuhmiller, J				Vander Vorst, Michael; Ono, Koshiro; Chan, Philemon; Stuhmiller, James			Correlates to traumatic brain injury in nonhuman primates	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury (TBI); concussion; subarachnoid hemorrhage (SAH); brain contusion; subdural hematoma (SDH); injury criteria; statistical analysis; risk factors; correlate; regression	CONCUSSION; FOOTBALL	Background: Traumatic brain injury (TBI) is a major health problem, both in terms of the economic cost to society and the survivor's quality of life. The development of devices to protect against TBI requires criteria that relate observed injury to measurements of head kinematics. The objective of this study is to find the best statistical correlates to impact-induced TBI in nonhuman primates using a qualified, self-consistent set of historical kinematic and TBI data from impact tests on nonhuman primates. Methods: A database was constructed and qualified from historical head impact tests on nonhuman primates. Multivariate logistic regression analysis with backwards stepwise elimination was performed. Variables considered are the peak rotational acceleration (Omega(max)), the peak linear acceleration (A(max)), and the number of impacts (N). Results: Bivariate combinations of angular acceleration and the number of impacts are the best correlates to all modes of TBI considered, i.e., concussion, subarachnoid hemorrhage, brain contusion, and subdural hematoma. For a nonhuman primate with 100-g brain mass, the criteria that the probability of TBI is less than 10% by injury mode are: Concussion: Omega N-max(0.84) < 70 krad/s/s SAH: Omega N-max(0.70) < 160 krad/s/s Contusion: Omega N-max(0.35) < 160 krad/s/s SDH: Omega N-max(0.60) < 280 krad/s/s Conclusions: Based on this dataset, the best statistically based risk factor for all modes of TBI in nonhuman primates is the bivariate combination of rotational acceleration and number of impacts.	Titan Corp, San Diego, CA 92121 USA		Vorst, MV (corresponding author), Titan Corp, 3394 Carmel Mt Rd, San Diego, CA 92121 USA.	mvandervorst@titan.com					Abel JM, 1978, P 22 STAPP CAR CRASH; Centers for Disease Control, 2004, TRAUM BRAIN INJ FACT; DUMA S, 2004, P AM SOC BIOM C; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hodgson VR, 1970, P 14 STAPP CAR CRASH; Hosmer D, 1989, APPL LOGISTIC REGRES; KIKUCHI A, 1982, P 9 INT TECHN C EXPT; NEWMAN JA, 2000, P 2000 IRCOBI C; NUSHOLTZ GS, 1987, AVIAT SPACE ENVIR MD, V58, P9; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; OMMAYA AK, 1970, SOC AUTOMOTIVE ENG; Ono K., 1980, P 24 STAPP CAR CRASH; PATRICK LM, 1965, SOC AUTOMOTIVE ENG; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; STALNAKER RL, 1977, DOTHS802; STAPP JP, 1957, AM J SURG, V93, P374; Suresh S., 1991, FATIGUE MAT	18	12	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2007	62	1					199	206		10.1097/01.ta.0000238665.09611.4b			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	126CP	WOS:000243490100038	17215755				2022-02-06	
J	Zou, H; Kleiven, S; Schmiedeler, JP				Zou, H.; Kleiven, S.; Schmiedeler, J. P.			The effect of brain mass and moment of inertia on relative brain-skull displacement during low-severity impacts	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						head impact; sensitivity analysis; analytical method; finite element method; brain displacement; brain mass; brain moment of inertia	AXONAL INJURY; HEAD IMPACT; DEFORMATION; MOTION	Traumatic brain injury is the leading cause of death in automobile crashes. The sensitivity of human brain injury prediction to small parameter changes is a critical element of both experimental and mathematical work yet to be adequately investigated. This work proposes a new analytical human brain injury model to determine the parameters to which injury prediction is most sensitive. The trajectory sensitivity analysis explicitly indicates that injury prediction is most sensitive to brain mass moment of inertia, followed by brain mass. A number of finite element (FE) simulations were executed with various brain sizes. The maximum relative brain motions decrease with decreased brain size, and they are very close in the FE and analytical models. We conclude that brain mass moment of inertia, primarily, and brain mass, secondarily, should be varied in focused experimental and FE modeling work to ensure that conclusions are not drawn from individual data points at which injury predictions are highly sensitive to small parameter changes.	Ohio State Univ, Dept Mech Engn, Columbus, OH 43210 USA; Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden		Zou, H (corresponding author), Ohio State Univ, Dept Mech Engn, 201 W 19th Ave, Columbus, OH 43210 USA.	zou.26@osu.edu	/B-9681-2012	/0000-0002-1692-4414			Alem N. M., 1974, P 18 STAPP CAR CRASH, P579; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Becker E., 1972, P 16 STAPP CAR CRASH, P160; BRINN J, 1970, P 14 STAPP CAR CRASH, P188; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GURDJIAN ES, 1963, P 7 STAPP CAR CRASH, P470; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; King A. I., 2003, IRCOBI C LISB PORT; KING AI, 2002, P 4 WORLD C BIOM; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; KLEIVEN S, 2005, P 2005 IRCOBI C, P41; Kleiven S, 2002, TRAFFIC INJ PREV, V3, P303, DOI DOI 10.1080/15389580214633; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LOW TC, 1986, THESIS OHIO STATE U; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MCCONVILLE JT, 1980, AFAMRLTR80119 WRIGHT; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; MILLER RT, 1998, P 42 STAPP CAR CRASH, P155; NEWMAN JA, 2000, P INT RES C BIOM IMP, P223; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1967, P 11 STAPP CAR CRASH, P73; Ono K, 1980, P 24 STAPP CAR CRASH, P103; SLATTENSCHEK A, 1970, INT AUT SAF C COMP, P1084; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thibault L., 1971, P 15 STAPP CAR CRASH; ZATSIORSKY V, 1983, HUMAN KINETICS, P1152; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	34	12	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2007	12	4					341	353		10.1080/13588260701433024			13	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	224II	WOS:000250440300002					2022-02-06	
J	Ang, JHY; Man, DWK				Ang, Josephine Hui Yung; Man, David Wai Kwong			The discriminative power of the Wolf motor function test in assessing upper extremity functions in persons with stroke	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						assessment; function; motor; rehabilitation; stroke	TRAUMATIC BRAIN-INJURY; UPPER-LIMB FUNCTION; BARTHEL INDEX; REHABILITATION; RELIABILITY; PERFORMANCE; POSTSTROKE; RECOVERY	The Wolf motor function test is a new time-based method to evaluate upper extremity function both on a joint-specific level and on total limb movements, while performing some functional tasks. The purpose of this paper is to investigate the discriminating power of the Wolf motor function test in classifying individuals with stroke into different levels according to Brunnstrom's stages of recovery. Discriminant analysis was used and the results showed that the Wolf motor function test can classify 86.7% of original grouped cases into the correct groupings. A high correlation was found between the Wolf motor function test, the Brunnstrom stages of recovery and the Fugl-Meyer Assessment. The Wolf motor function test is found to be an instrument capable of discriminating the upper extremity motor function of the individuals with stroke into different functional groups.	Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; Hosp Author, Occupat Therapy Dept, MacLehose Med Rehab Ctr, Hong Kong, Hong Kong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	rsdavid@polyu.edu.hk					ARNADOTTIR G, 1990, BRAIN BEHAV ASSESSIN; AUGER C, 1991, PHYSIOTHER CAN, V43, P6; Brunnstrom S, 1966, Phys Ther, V46, P357; Caplan L., 2001, STROKE SYNDROMES; Caplan L.R, 2000, CAPLANS STROKE CLIN, VThird; CLARKE B, 1983, PHYSIOTHER CAN, V35, P207; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; De Souza L H, 1980, Int Rehabil Med, V2, P3; DESROSIERS J, 1991, TEMPA ADM MANUAL; Ebrahim S, 1999, STROKE EPIDEMIOLOGY; FILIATRAULT J, 1991, AM J OCCUP THER, V45, P806, DOI 10.5014/ajot.45.9.806; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P85; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GRANGER CV, 1990, STROKE, V21, P46; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; GRANGER CV, 1982, KRUSENS HDB PHYSICAL, P253; GRESHAM GE, 1984, FUNCTIONAL ASSESSMEN, P65; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Higgins J, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2003.10.0156; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kaste M, 1998, PUBLIC HEALTH, V112, P103; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Lincoln N, 1979, Physiotherapy, V65, P48; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MAHONEY F I, 1965, Md State Med J, V14, P61; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Parker V M, 1986, Int Rehabil Med, V8, P69; Perry C E, 1967, Am J Phys Med, V46, P789; Richards L, 2001, OCCUP THER J RES, V21, P201, DOI 10.1177/153944920102100304; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Smith Rosemary Hastings, 1994, Physiotherapy Theory and Practice, V10, P87, DOI 10.3109/09593989409047445; Sodring KM, 1995, SCAND J REHABIL MED, V27, P211; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; WILSON DJ, 1984, AM J OCCUP THER, V38, P159, DOI 10.5014/ajot.38.3.159; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; YARKONY GM, 1987, ARCH NEUROL-CHICAGO, V44, P93, DOI 10.1001/archneur.1987.00520130071020	39	12	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2006	29	4					357	361					5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	134JP	WOS:000244079600016	17106357				2022-02-06	
J	Bornstein, SR; Wong, ML; Licinio, J				Bornstein, S. R.; Wong, M. -L.; Licinio, J.			150 years of Sigmund Freud: what would Freud have said about the obesity epidemic?	MOLECULAR PSYCHIATRY			English	Article						Sigmund Freud; unconscious; obesity	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AMYGDALA; MODELS; MEMORY	The 150th birthday of Sigmund Freud has triggered widespread interest and media coverage on his unique contribution and impact on society. Recent evidence from neuroscience and advanced imaging technology has provided support for some of his major concepts including the unconscious and the key role of early life events. In this perspective, we attempt to write on his behalf an updated version of a Freudian way of thinking focused on the current high rates of obesity and depression.	Univ Dresden, Dept Med, D-01307 Dresden, Germany; Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33152 USA		Bornstein, SR (corresponding author), Univ Dresden, Dept Med, Carl Gustav Carus,Fetscherstr 74, D-01307 Dresden, Germany.	Stefan.Bornstein@uniklinikum-dresden.de	Wong, Ma-Li/D-7903-2011; Licinio, Julio/L-4244-2013; Wong, Ma-Li/ABD-5525-2020	Wong, Ma-Li/0000-0003-1512-3073; Licinio, Julio/0000-0001-6905-5884; 			BORNSTEIN SR, 2006, MOL PSYCHIAT    0801; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gunstad J, 2006, PSYCHIAT RES, V142, P31, DOI 10.1016/j.psychres.2005.11.007; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Keeley MB, 2006, LEARN MEMORY, V13, P135, DOI 10.1101/lm.86906; Kirkham T. C., 2006, CNS & Neurological Disorders-Drug Targets, V5, P275, DOI 10.2174/187152706777452272; Kosten TA, 2006, BRAIN RES, V1087, P142, DOI 10.1016/j.brainres.2006.03.009; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974	15	12	12	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	DEC	2006	11	12					1070	1072		10.1038/sj.mp.4001912			3	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	110ZH	WOS:000242419600004	17130885	Bronze			2022-02-06	
J	Stoll, M; Capper, D; Dietz, K; Warth, A; Schleich, A; Schlaszus, H; Meyermann, R; Mittelbronn, M				Stoll, M.; Capper, D.; Dietz, K.; Warth, A.; Schleich, A.; Schlaszus, H.; Meyermann, R.; Mittelbronn, M.			Differential microglial regulation in the human spinal cord under normal and pathological conditions	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						human; microglia; regulation; spinal cord	INFLAMMATORY FACTOR-I; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; BRAIN-INJURY; RAT-BRAIN; EXPRESSION; ACTIVATION; LESIONS; CELLS	As the primary intrinsic immune effector cells of the central nervous system, microglia are involved in virtually all pathological processes of the brain and spinal cord including inflammatory, neurodegenerative, traumatic, neoplastic and vascular diseases. Despite this important role, there is a lack of data concerning microglial distribution and protein expression in the human spinal cord. In this study, we immunohistochemically investigated 10 normal human spinal cords to establish reference data and compared these results with 15 pathological human spinal cords deriving from distinct pathologies. Each spinal cord was evaluated at eight different levels for three white and two grey matter areas for both constitutive (MHC-II, CD68, IL-16, AIF-1, LCA, CD4) and reactive (MRP-8, MRP-14) microglial antigens. Whereas previous studies revealed significant regional differences in microglial distribution and protein expression in human brain, normal spinal cord displayed a uniform expression pattern, reaching levels of up to 17% MHC-II positive cells of the total cell population. This datum formed the basis for the further evaluation of microglia expression levels in pathological spinal cords, where levels of up to 45% positive cells were observed. Our results represent important reference values for future neuropathological diagnostic and therapeutical approaches in spinal cord pathologies.	Univ Tubingen, Inst Brain Res, Sch Med, D-72076 Tubingen, Germany; Univ Tubingen, Dept Med Biometry, Tubingen, Germany; Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany		Mittelbronn, M (corresponding author), Univ Tubingen, Inst Brain Res, Sch Med, Calwer St 3, D-72076 Tubingen, Germany.	michel-guy-andr.mittelbronn@med.uni-tuebingen.de	Capper, David/I-8500-2014; Dietz, Klaus/R-9268-2016	Capper, David/0000-0003-1945-497X; Dietz, Klaus/0000-0001-8503-9737; Mittelbronn, Michel/0000-0002-2998-052X			Abe M, 1999, J NEUROL, V246, P358, DOI 10.1007/s004150050363; Baron P, 2005, MUSCLE NERVE, V32, P541, DOI 10.1002/mus.20376; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; Center DM, 1997, INT J BIOCHEM CELL B, V29, P1231, DOI 10.1016/S1357-2725(97)00053-8; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Deininger MH, 2002, FEBS LETT, V514, P115, DOI 10.1016/S0014-5793(02)02430-4; Drew PD, 2000, BRAIN RES BULL, V52, P391, DOI 10.1016/S0361-9230(00)00275-6; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; FALINI B, 1993, AM J PATHOL, V142, P1359; FREI K, 1994, J IMMUNOL, V152, P2720; GEHRMANN J, 1993, J NEUROIMMUNOL, V48, P189, DOI 10.1016/0165-5728(93)90191-Z; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Guo LH, 2004, J NEUROIMMUNOL, V146, P39, DOI 10.1016/j.jneuroim.2003.09.017; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; Hirikoshi Y, 2003, ACTA NEUROPATHOL, V105, P157, DOI 10.1007/s00401-002-0627-4; HOLNESS CL, 1993, BLOOD, V81, P1607; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Jellinger K, 1975, Acta Neuropathol Suppl, VSuppl 6, P95; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; LING EA, 1976, ACTA ANAT, V96, P188; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Mathy NL, 2000, J IMMUNOL, V164, P4429, DOI 10.4049/jimmunol.164.9.4429; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; MORI S, 1969, J COMP NEUROL, V135, P57, DOI 10.1002/cne.901350104; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; Nau R, 2002, TRENDS NEUROSCI, V25, P38, DOI 10.1016/S0166-2236(00)02024-5; PERRY VH, 1987, J EXP MED, V166, P1138, DOI 10.1084/jem.166.4.1138; Postler E, 2000, J NEUROIMMUNOL, V108, P244, DOI 10.1016/S0165-5728(00)00283-6; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Rauschka H, 2003, EUR J NEUROL, V10, P479, DOI 10.1046/j.1468-1331.2003.00644.x; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; Rezaie P, 1999, MICROSC RES TECHNIQ, V45, P359, DOI 10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.3.CO;2-4; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Sasaki A, 2004, NEUROPATH APPL NEURO, V30, P447, DOI 10.1111/j.1365-2990.2004.00556.x; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Schluesener HJ, 1998, GLIA, V24, P244, DOI 10.1002/(SICI)1098-1136(199810)24:2<244::AID-GLIA9>3.0.CO;2-3; Schmitt AB, 2000, ACTA NEUROPATHOL, V100, P528, DOI 10.1007/s004010000221; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; VASS K, 1990, AM J PATHOL, V137, P789; VOLK HD, 1991, BEHRING I MITT, V88, P208; Wierzba-Bobrowicz T, 2001, FOLIA NEUROPATHOL, V39, P49; Zeinstra E, 2000, NEUROREPORT, V11, P89, DOI 10.1097/00001756-200001170-00018; Zhou Y, 2005, MOL CELL PROTEOMICS, V4, P1471, DOI 10.1074/mcp.M500114-MCP200	53	12	13	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	DEC	2006	32	6					650	661		10.1111/j.1365-2990.2006.00774.x			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	101XM	WOS:000241774600009	17083479				2022-02-06	
J	Barrow, IM; Collins, JN; Britt, LD				Barrow, Irene M.; Collins, Jay N.; Britt, L. D.			The influence of an auditory distraction on rapid naming after a mild traumatic brain injury: A longitudinal study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						mild traumatic brain injury; latency; accuracy; naming; auditory distraction; recovery	HEAD-INJURY; REACTION-TIME; PERCEPTUAL DIFFERENTIATION; OBJECT RECOGNITION; ATTENTION DEFICITS; LEXICAL RETRIEVAL; TASK; IMPAIRMENTS; ADOLESCENTS; ACQUISITION	Objective: The purpose of this investigation was to examine speeded performance over time and the impact of a common auditory distraction on performance after a mild traumatic brain injury (MTBI). Methods: Fourteen adults (ages 1853) treated for a MTBI and 14 age and education-matched controls were asked to perform two speeded naming tasks. Both tasks were presented with or without the presence a common auditory distraction. The MTBI group was tested within 5 days, 30 days, 60 days, and 6 months postinjury. Latency (ms) and accuracy of response were recorded. Results: Initially, the MTBI group demonstrated significantly longer response latencies and lower accuracy levels for both tasks. Similar results were found at 30 days postinjury. At 60 days postinjury, no significant difference was found for task 1 accuracy. Significant differences remained for task 1 latency, task 2 latency, and task 2 accuracy. At 6 months postinjury, no significant differences were found. The presence of an auditory distraction differentially affected the MTBI group for task 2 accuracy upon initial testing and at 30 days postinjury only. Conclusions: The MTBI group performed both tasks significantly slower and less accurately than the control group upon initial testing and at 30 days postinjury. The presence of pop music further influenced accuracy of complex processing. At 60 days postinjury, accuracy of simple processing returned to preinjury levels and the auditory distraction no longer differentially influenced the MTBI group. All performance differences were resolved at 6 months postinjury.	Hampton Univ, Dept Communicat Sci & Disorders, Hampton, VA 23668 USA; Eastern Virginia Med Sch, Dept Surg, Norfolk, VA 23501 USA		Barrow, IM (corresponding author), Hampton Univ, Dept Communicat Sci & Disorders, 201 Sci & Technol, Hampton, VA 23668 USA.	irene.barrow@hamptonu.edu					ABBOUD H, 1997, SUPERLAB PRO COMPUTE; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COEHLO CA, 1996, J SPEECH HEARING S 1, V39, pS5; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Hayden M E, 1997, AAOHN J, V45, P635; Humphreys G. W., 1987, VISUAL OBJECT PROCES; JENKINS A, 1986, LANCET, V2, P445; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LloydJones T, 1997, MEM COGNITION, V25, P606, DOI 10.3758/BF03211303; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; Robinson-Boone KA, 1999, J MED SPEECH-LANG PA, V7, P47; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	38	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2006	61	5					1142	1149		10.1097/01.ta.0000241238.70269.c1			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	105TB	WOS:000242054100019	17099520				2022-02-06	
J	Doninger, NA; Ehde, DM; Bode, RK; Knight, K; Bombardier, CH; Heinemann, AW				Doninger, Nicholas A.; Ehde, Dawn M.; Bode, Rita K.; Knight, Kristin; Bombardier, Charles H.; Heinemann, Allen W.			Measurement properties of the Neurobehavioral Cognitive Status Examination (Cognistat) in traumatic brain injury rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						neuropsychological tests; brain injury; psychometrics; rating scale analysis	STATUS EXAMINATION NCSE; NEUROPSYCHOLOGICAL IMPAIRMENT; HEAD-INJURY; VALIDITY; ACCURACY; PATTERNS; SCALE	Objective: Evaluate measurement properties of the Neurobehavioral Cognitive Status Examination (Cognistat) using Rasch analysis. Design: Calibration of item responses from 120 individuals admitted to a rehabilitation medicine service for traumatic brain injury (TBI) and 296 community-dwelling adults with TBI. Results: Three strata of performance were differentiated despite a skewed distribution toward high performance among the community sample. Elimination of easier items created a better targeted instrument (i.e., generated more spread among individuals) without a significant increase in error. Memory and verbal reasoning were the most difficult domains for each sample; however, analyses indicated significant measurement error. Conclusions: As a screening instrument, the Cognistat reliably classifies multiple levels of cognitive status in both acute and postacute TBI settings; however, this measure is unsuitable for generating a profile of neurocognitive strengths and weaknesses.	Wright State Univ, Sch Med, Dayton, OH 45435 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Northwestern Univ, Evanston, IL 60208 USA		Doninger, NA (corresponding author), Wallace Kettering Neurosci Inst, 3533 So Blvd,Suite 5200, Kettering, OH 45429 USA.	nicholas.doninger@kmcnetwork.org	Bombardier, Charles H./AAZ-3260-2021; Ehde, Dawn/K-1883-2016; Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Bombardier, Charles H./0000-0003-4758-6283; Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Ehde, Dawn/0000-0002-9555-2347			Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; BOND MR, 1990, REHABILITATION ADULT, P59; Cammermeyer M, 1988, J Neurosci Nurs, V20, P314; Cammermeyer M, 1997, J Neurosci Nurs, V29, P163; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Drane DL, 2003, J CLIN EXP NEUROPSYC, V25, P133, DOI 10.1076/jcen.25.1.133.13628; FalsStewart W, 1997, EXP CLIN PSYCHOPHARM, V5, P269, DOI 10.1037/1064-1297.5.3.269; Fields S D, 1992, Int Psychogeriatr, V4, P93, DOI 10.1017/S1041610292000929; Fisher W., 1992, RASCH MEAS T, V6, P238; Fladby T, 1999, J GERIATR PSYCH NEUR, V12, P16, DOI 10.1177/089198879901200105; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; LINACRE JM, 1999, WINSTEPS PC COMPATIB; LOGUE PE, 1993, J CLIN PSYCHOL, V49, P80, DOI 10.1002/1097-4679(199301)49:1<80::AID-JCLP2270490111>3.0.CO;2-Z; Marcotte TD, 1997, J CLIN EXP NEUROPSYC, V19, P386, DOI 10.1080/01688639708403867; MITRUSHINA M, 1994, J PSYCHIATR RES, V28, P85, DOI 10.1016/0022-3956(94)90037-X; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; *NO CAL NEUR GROUP, 1988, MAN NEUR COGN STAT E; Oehlert ME, 1997, J CLIN PSYCHOL, V53, P733, DOI 10.1002/(SICI)1097-4679(199711)53:7<733::AID-JCLP11>3.0.CO;2-M; OSMON DC, 1992, ARCH PHYS MED REHAB, V73, P414; Poon WS, 2005, ACT NEUR S, V93, P207; Rasch Georg, 1980, PROBABILISTIC MODELS; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wallace JJ, 2000, BRAIN INJURY, V14, P63, DOI 10.1080/026990500120934; Wright B., 2002, RASCH MEAS T, V16, P888; Wright B, 1982, RATING SCALE ANAL RA	36	12	12	0	7	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2006	51	4					281	288		10.1037/0090-5550.51.4.281			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	107AY	WOS:000242144300002					2022-02-06	
J	Whiteside, JW				Whiteside, John W.			Management of head and neck injuries by the sideline physician	AMERICAN FAMILY PHYSICIAN			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE INJURY; FOOTBALL EQUIPMENT; CONTACT-SPORTS; 2ND IMPACT; SEVERITY; RETURN; REMOVAL	Injuries to the head and neck are common in sports. Sideline physicians must be attentive and prepared with an organized approach to detect and manage these injuries. Because head and neck injuries often occur simultaneously, the sideline physician can combine the head and neck evaluations. When assessing a conscious athlete, the physician initially evaluates the neck for spinal cord injury and determines whether the athlete can be moved safely to the sideline for further evaluation. This decision is made using an on-field assessment of the athlete's peripheral sensation and strength, as well as neck tenderness and range of motion. If these evaluations are normal, axial loading and Spurling testing can be performed. Once the neck has been determined to be normal, the athlete can be assisted to the sideline for assessment of concussion symptoms and severity. This assessment should include evaluations of the athlete's reported symptoms, recently acquired memory, and postural stability. Injured athletes should be monitored with serial examinations, and those with severe, prolonged, or progressive findings require transport to an emergency department for further evaluation.	Mayo Clin, Dept Family Med, Scottsdale, AZ 85259 USA; Mayo Clin, Coll Med, Rochester, MN USA		Whiteside, JW (corresponding author), Mayo Clin, Dept Family Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.						Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Donaldson WF, 1998, SPINE, V23, P1729, DOI 10.1097/00007632-199808150-00003; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; FELDICK HG, 1976, PHYSICIAN SPORTSMED, V4, P77; Gastel JA, 1998, ANN EMERG MED, V32, P411, DOI 10.1016/S0196-0644(98)70168-4; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haight RR, 2001, PHYSICIAN SPORTSMED, V29, P45, DOI 10.3810/psm.2001.03.672; HAIGHT RR, 2001, PHYSICIAN SPORTSMED, V29, P59; HAIGHT RR, 2001, PHYSICIAN SPORTSMED, V29, P62; HAIGHT RR, 2001, PHYSICIAN SPORTSMED, V29, P53; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kelly JP, 1997, NEUROLOGY, V48, P581; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Nissen SJ, 1996, PHYSICIAN SPORTSMED, V24, P57, DOI 10.3810/psm.1996.06.1378; Palumbo MA, 1996, AM J SPORT MED, V24, P446, DOI 10.1177/036354659602400407; PATTERSON D, 1987, CLIN SPORT MED, V6, P197; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	35	12	13	0	5	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	OCT 15	2006	74	8					1357	1362					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097ES	WOS:000241430300009	17087430				2022-02-06	
J	Heep, A; Bartmann, P; Stoffel-Wagner, B; Bos, A; Hoving, E; Brouwer, O; Teelken, A; Schaller, C; Sival, D				Heep, Axel; Bartmann, Peter; Stoffel-Wagner, Birgit; Bos, Arie; Hoving, Eelco; Brouwer, Oebele; Teelken, Albert; Schaller, Carlo; Sival, Deborah			Cerebrospinal fluid obstruction and malabsorption in human neonatal hydrocephaly	CHILDS NERVOUS SYSTEM			English	Article						congenital hydrocephalus; CSF; TGF beta-1; procollagen type 1 N propeptide; IL-6	TISSUE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PROCOLLAGEN PROPEPTIDES; LEPTOMENINGEAL CELLS; REACTIVE ASTROCYTES; PRETERM INFANTS; DEPOSITION	Introduction: The pathophysiology involved in human neonatal high-pressure hydrocephalus (HC) includes both cerebrospinal fluid (CSF) malabsorption and obstruction. Objective: The aim was to estimate the relative contribution between CSF malabsorption and obstruction in three different etiological groups of neonatal high-pressure HC by assessment of specific CSF biomarkers indicative of growth factor- and fibrosis-related CSF malabsorption (transforming growth factor beta-1 (TGF beta-1), aminoterminal propeptide of type 1 collagen (PC1NP)]. Materials and methods: Patients were subdivided into three groups. Group A: spina bifida HC (n=12); group B: non-haemorrhagic triventricular HC (n=4); and group C: posthaemorrhagic HC (n=6). To exclude for confounding differences in pro-inflammatory state between the three groups, interleukin-6 (IL-6) CSF concentrations were assessed. Consecutively, the CSF concentrations of TGF beta-1 and PC1NP were compared between the different groups. Results: Median CSF concentrations of IL-6 were low and did not differ between groups. Median CSF concentrations of PC1NP were significantly lower in group A (median: 180 ng/ml, range 90-808) than in group C (median: 1,060, range 396-1194; p=0.002). TGF beta-1 concentrations were significantly higher in group C (median 355 pg/ml, range 129-843) than in groups A (median 103, range 78-675 pg/ml) and B (median 120 pg/ml, range 91-188; p=0.01 and 0.03, respectively). Conclusion: In neonatal posthaemorrhagic HC, high concentrations of malabsorption-related biomarkers contrast with lower concentrations in SB and non-haemorrhagic triventricular HC. During the early development of high pressure HC in SB neonates, CSF biomarkers strongly indicate that CSF obstruction contributes more to the development of HC than malabsorption.	Univ Bonn, Dept Neonatol, D-53113 Bonn, Germany; Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany; Univ Groningen, Med Ctr, Dept Pediat, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Neurosurg, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Neurol, NL-9700 RB Groningen, Netherlands; Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany		Heep, A (corresponding author), Univ Bonn, Dept Neonatol, Adenauerallee 119, D-53113 Bonn, Germany.	axel.heep@ukb.uni-bonn.de					Baumeister FAM, 2000, INFECTION, V28, P234, DOI 10.1007/s150100070043; Bell MJ, 1997, ACT NEUR S, V70, P96; BELL WO, 1995, PEDIATR NEUROSURG, V23, P42, DOI 10.1159/000120934; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boillat CA, 1997, EXP NEUROL, V147, P377, DOI 10.1006/exnr.1997.6617; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Cai X, 1999, EUR J PEDIATR SURG, V9, P35, DOI 10.1055/s-2008-1072312; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P220; Heep A., 2000, Biology of the Neonate, V78, P153; Heep A, 2004, PEDIATR RES, V56, P768, DOI 10.1203/01.PDR.0000141524.32142.53; Heep A, 2004, EUR J PEDIATR, V163, P44, DOI 10.1007/s00431-003-1333-5; Heep A, 2002, ARCH DIS CHILD-FETAL, V87, pF34, DOI 10.1136/fn.87.1.F34; Heep A, 2001, CHILD NERV SYST, V17, P47, DOI 10.1007/s003810000363; Johanson CE, 1999, AM J PHYSIOL-REG I, V277, pR263, DOI 10.1152/ajpregu.1999.277.1.R263; Johanson Conrad E., 2001, Trends in Neurosciences, V24, P631, DOI 10.1016/S0166-2236(00)02040-3; JOHNSON MD, 1992, LAB INVEST, V67, P360; KIM RC, 1989, NEUROSURGERY, V24, P771, DOI 10.1227/00006123-198905000-00022; KITAZAWA K, 1994, STROKE, V25, P1400, DOI 10.1161/01.STR.25.7.1400; Koch D, 2004, CHILD NERV SYST, V20, P405, DOI 10.1007/s00381-004-0958-7; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Li XF, 2005, CHILD NERV SYST, V21, P32, DOI 10.1007/s00381-004-1034-z; Massicotte EM, 1999, J NEUROSURG, V91, P80, DOI 10.3171/jns.1999.91.1.0080; Moinuddin SM, 2000, NEUROL RES, V22, P215, DOI 10.1080/01616412.2000.11741064; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; MORI K, 1995, CHILD NERV SYST, V11, P523, DOI 10.1007/BF00822842; MOTOHASHI O, 1995, ACTA NEUROCHIR, V136, P88, DOI 10.1007/BF01411441; Nakazato F, 2002, NEUROL MED-CHIR, V42, P151, DOI 10.2176/nmc.42.151; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Paneth N, 1999, J PEDIATR-US, V134, P527, DOI 10.1016/S0022-3476(99)70231-3; PATTISAPU JV, 2003, EUR J SURG, V13, pS55; RISTELI J, 1995, J HEPATOL, V22, P77; RISTELI L, 1987, METHOD ENZYMOL, V145, P391; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2; Sajanti J, 2000, NEUROLOGY, V55, P359, DOI 10.1212/WNL.55.3.359; Sajanti J, 1999, J NEUROL NEUROSUR PS, V67, P185, DOI 10.1136/jnnp.67.2.185; Schwab JM, 2000, NEUROPATH APPL NEURO, V26, P434, DOI 10.1046/j.1365-2990.2000.00271.x; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; SUZUKI S, 1977, ACTA NEUROCHIR, V39, P1, DOI 10.1007/BF01405236; TADA T, 1994, J NEUROIMMUNOL, V50, P153, DOI 10.1016/0165-5728(94)90041-8; Takei F, 1995, PEDIATR NEUROSURG, V23, P246, DOI 10.1159/000120967; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Volpe J J, 2001, NEUROLOGY NEWBORN, P428; Wang JF, 2004, WOUND REPAIR REGEN, V12, P205, DOI 10.1111/j.1067-1927.2004.012113.x; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Xia YX, 2000, NEUROSCI LETT, V280, P220, DOI 10.1016/S0304-3940(00)00782-5; XIAO L, 2002, HUNAN YI KE DA XUE, V28, P13	50	12	14	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2006	22	10					1249	1255		10.1007/s00381-006-0102-y			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	087CY	WOS:000240721300009	16699804				2022-02-06	
J	Rasmussen, IA; Antonsen, IK; Berntsen, EM; Xu, J; Lagopoulos, J; Haberg, AK				Rasmussen, Inge-Andre, Jr.; Antonsen, Ida Kristin; Berntsen, Erik Magnus; Xu, Jian; Lagopoulos, Jim; Haberg, Asta Kristine			Brain activation measured using functional magnetic resonance imaging during the Tower of London task	ACTA NEUROPSYCHIATRICA			English	Article						fMRI; TBI; Tower of London	DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; PARKINSONS-DISEASE; HEAD-INJURY; FMRI; PET; SEGMENTATION; INFORMATION; PERFORMANCE; IMPAIRMENT	Background: Individuals with traumatic brain injury (TBI) often suffer from a number of enduring cognitive impairments such as in attention, memory, speed of processing information and dual-task performance. Objective: The aim of this study was to assess the patterns of regional brain activation in response to the Tower of London (ToL) task in a group of patients suffering from chronic TBI using functional magnetic resonance imaging (fMRI). Methods: fMRI was performed during performance of the ToL planning task in 10 patients suffering from severe TBI and in 10 age- and sex-matched controls using a 3 T magnetic resonance scanner. Results: Performance data showed no difference in response accuracy between the TBI group and the healthy control group. Statistical parametric brain maps showed that the TBI group activates larger and additional areas of the cerebral cortex than the healthy control group both for tasks and for a subtraction contrast between the tasks. Conclusions: The results of this study are interpreted as a cortical reorganization inside the executive system of vigilance and working memory in patients with TBI. Both parietal and frontal areas are recruited to compensate for damaged brain tissue.	Norwegian Univ Sci & Technol, Dept Circulat & Imaging, Fac Med, N-7006 Trondheim, Norway; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Black Dog Inst, Neurosci Res Grp, Mood Disorders Unit, Sydney, NSW, Australia; Westmead Hosp, Dept Neurol, Sydney, NSW, Australia		Rasmussen, IA (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Imaging, Fac Med, N-7006 Trondheim, Norway.	inge.rasmussen@ntnu.no	Berntsen, Erik Magnus/AAM-7134-2020				ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BROUWER WH, 1994, INT NEUR SOC 1994 AN; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS RG, 1993, NEUROPSYCHOLOGIA, V31, P1367, DOI 10.1016/0028-3932(93)90104-8; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrides M, 2000, J NEUROSCI, V20, P7496; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rasser PE, 2005, NEUROIMAGE, V26, P941, DOI 10.1016/j.neuroimage.2004.11.054; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schall U, 2003, NEUROIMAGE, V20, P1154, DOI 10.1016/S1053-8119(03)00338-0; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Seidman LJ, 1998, NEUROPSYCHOLOGY, V12, P505, DOI 10.1037/0894-4105.12.4.505; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Talairach J., 1988, COPLANAR STEREOTAXIC; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Walsh K. W., 1985, UNDERSTANDING BRAIN; [No title captured]	36	12	12	0	13	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0924-2708			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	OCT	2006	18	5					216	225		10.1111/j.1601-5215.2006.00145.x			10	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	107QW	WOS:000242187100005	26989921				2022-02-06	
J	Sarajuuri, JM; Koskinen, SK				Sarajuuri, Jaana M.; Koskinen, Sanna K.			Holistic neuropsychological rehabilitation in Finland: The INSURE program - a transcultural outgrowth of perspectives from Israel to Europe via the USA	INTERNATIONAL JOURNAL OF PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY	Given the interaction of cognitive, behavioural, psychological, and physical factors resulting from traumatic brain injury (TBI), a comprehensive, multidisciplinary, and neuropsychologically oriented rehabilitation could prove to be particularly promising and efficacious in the neuropsychological rehabilitation of post-acute brain-injured individuals. Kurt Goldstein, an eminent pioneer in the development of holistic rehabilitation, stated that brain-injured patients need environments that help them to avoid catastrophic reactions. In his view, the tasks of rehabilitation are to create, for the brain-injured individual, an environment that will minimize the chances for the occurrence of catastrophic responses. In this environment, the individual can engage optimally in various remedial activities, which will gradually culminate in the individual finding new meaning in life after rehabilitation. Yehuda Ben-Yishay incorporated many of Goldstein's ideas and developed a milieu or holistic rehabilitation program in 1978 in New York. The emerging role of psychotherapy for patients and their family members was characteristic of the Neuropsychological Rehabilitation Program that Prigatano established in 1980 in Oklahoma. In Europe, Anne-Lise Christensen, who was also influenced by the work of A. R. Luria, started a holistic program at Copenhagen University in 1985. Based on these pioneering programs, several similar programs were established in Europe. A Finnish program, INSURE, was established in 1993 in Helsinki. The INSURE program is a post-acute, interdisciplinary, 6-week rehabilitation program for selected groups of TBI patients. The core of the program is neuropsychological rehabilitation and psychotherapy with vocational interventions, and follow-up support. In recent years, a holistic rehabilitation program was also established in Turku for children with acquired brain injury. The European Holistic Working Group was founded in 2001, and the authors will also discuss their personal experiences and future of holistic neurospychological rehabilitation in terms of ongoing research work, computer-administered cognitive remediation, and quality of life assessment.	Kapyla Rehabil Ctr, FIN-00251 Helsinki, Finland		Sarajuuri, JM (corresponding author), Kapyla Rehabil Ctr, Nordenskioldinkatu 18 B,POB 103, FIN-00251 Helsinki, Finland.	jaana.sarajuuri@invalidiliitto.fi	Sarajuuri, Jaana/AAD-8665-2019	Sarajuuri, Jaana/0000-0002-6432-0295			Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; BENYISHAY Y, 2001, JAPANESE J REHABIL S, V38, P6465; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BULLINGER M, 2002, RESTORATIVE NEUROLOG, V20, P1; Christensen A. L, 2000, INT HDB NEUROPSYCHOL, P151; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; EAMES P, 1989, MODELS BRAIN INJURY, P31; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; GOLDSTEIN K, 1959, J INDIV PSYCHOL, V15, P5; Goldstein K, 1942, EFFECTS BRAIN INJURI; JANSSON T, 1962, TALES MOOMINVALLEY; Kaipio M.-L., 2000, INT HDB NEUROPSYCHOL, P247; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KOSKINEN S, 2004, 9 C EUR MULT NEUR BU; Koskinen S. K., 2004, SVENSK NEUROPSYKOLOG, V4, P10; MAKI H, 2004, 8 NORD M NEUR TURK F; PRIGATANO G, 2004, INT S HOL REH INSURE; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 2000, BRIEF OVERVIEW 4 PRI, P115, DOI DOI 10.1007/978-1-4757-5569-5_7; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SARAJUURI J, 2003, BRAIN INJURY S1, V17, P155; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; TRUELLE JL, 2004, 9 C EUR MULT NEUR BU; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y	34	12	12	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0020-7594			INT J PSYCHOL	Int. J. Psychol.	OCT	2006	41	5					362	370		10.1080/01650250500346103			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	095WF	WOS:000241338300007					2022-02-06	
J	Kurtz, JE; Putnam, SH				Kurtz, John E.; Putnam, Steven H.			Patient-informant agreement on personality ratings and self-awareness after head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; SIGNIFICANT OTHERS; 5-FACTOR MODEL; BEHAVIORAL LIMITATIONS; IMPAIRED AWARENESS; SPOUSE RATINGS; REHABILITATION; SIMILARITY; RELATIVES; SCALE	To address concerns about self-awareness deficits and the validity of self-ratings by patients with head injury (HI), the current study examines mean differences and correlations between self-ratings from 52 patients with HI and ratings of the patient by informants using the revised NEO Personality Inventory (NEO-PI-R). Patient self-ratings were significantly lower than informant ratings on neuroticism and extraversion and significantly higher on conscientiousness. Patient-informant correlations ranged from .42 for conscientiousness to .67 for agreeableness, and these agreement correlations compare favorably with those obtained from normal adult samples. Hierarchical multiple regression equations for each of the five NEO-PI-R trait domains showed that more severe injuries were associated with higher agreement for extraversion. For all five traits, the strongest predictors of informant personality ratings were the patients' self-ratings. The implications of these findings for clinical assessment and improved research on self-awareness deficits after HI are discussed.	Villanova Univ, Dept Psychol, Villanova, PA 19085 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Kurtz, JE (corresponding author), Villanova Univ, Dept Psychol, 800 Lancaster Ave, Villanova, PA 19085 USA.	John.Kurtz@Villanova.edu	Kurtz, John/AAR-2598-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007421] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32 HD07421-04] Funding Source: Medline		ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Allen M., 1979, INTRO MEASUREMENT TH; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BORKENAU P, 1993, J PERS SOC PSYCHOL, V65, P546, DOI 10.1037/0022-3514.65.3.546; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Coetzer BR, 2001, J COGN REHABIL, V19, P8; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen J., 1983, APPL MULTIPLE REGRES; Costa P. T., 1992, REVISED NEO PERSONAL; Costa PT., 1992, PSYCHOL ASSESS, V4, P5, DOI [10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5]; Damasio A., 1994, DESCARTES ERROR EMOT; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.ps.41.020190.002221; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; ELLIOTT TR, 1995, PSYCHOL ASSESSMENT M, P301, DOI DOI 10.1037/10175-008; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 2002, J COGNITIVE REHABILI, V20, P28; Foltz C, 1997, ASSESSMENT, V4, P287, DOI 10.1177/107319119700400308; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FUNDER DC, 1995, J PERS SOC PSYCHOL, V69, P656, DOI 10.1037/0022-3514.69.4.656; Funder DC, 1997, HDB PERSONALITY PSYC, P617, DOI DOI 10.1016/B978-012134645-4/50025-1; Furnham AF, 1997, J PERS ASSESS, V69, P229, DOI 10.1207/s15327752jpa6901_14; JOHN OP, 1993, J PERS, V61, P521, DOI 10.1111/j.1467-6494.1993.tb00781.x; JOHN OP, 1994, J PERS SOC PSYCHOL, V66, P206, DOI 10.1037/0022-3514.66.1.206; John OP., 1999, HDB PERSONALITY THEO, P102; Kenny David A., 1994, INTERPERSONAL PERCEP; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Klein SB, 1996, J EXP PSYCHOL GEN, V125, P250, DOI 10.1037/0096-3445.125.3.250; Kurtz JE, 2003, J PERS, V71, P21, DOI 10.1111/1467-6494.t01-1-00005; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; McCrae, 1994, Assessment, V1, P159, DOI 10.1177/1073191194001002006; McCrae RR, 1998, J PERS, V66, P285, DOI 10.1111/1467-6494.00013; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MUTEN E, 1991, J PERS ASSESS, V57, P449, DOI 10.1207/s15327752jpa5703_5; Newman AC, 2000, BRAIN INJURY, V14, P333; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Ross SR, 1997, ASSESSMENT, V4, P395, DOI 10.1177/107319119700400410; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wallace CA, 2000, BRAIN INJURY, V14, P549; Watson D, 2000, J PERS SOC PSYCHOL, V78, P546, DOI 10.1037/0022-3514.78.3.546	58	12	12	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					453	468		10.1080/13854040590967090			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000007	16895858				2022-02-06	
J	Reisner, AD				Reisner, Andrew D.			A case of lightning injury with delayed-onset psychiatric and cognitive symptoms	BRAIN INJURY			English	Article						lightning injury; lightning stroke; cognitive deficits; post traumatic stress disorder; PTSD; delayed symptoms; oxidative stress; neurodegenerative disease; ALS	ELECTRICAL INJURY; OXIDATIVE STRESS; DISORDERS; BRAIN; NEUROREHABILITATION; CONSEQUENCES; TRAUMA	A case is presented of a man who was struck by lighting but, per his report, developed psychiatric and cognitive symptoms between 1-2 years after the incident. The case is discussed in light of the literature on lightning injury with particular emphasis on the aetiology of delayed symptoms. In this case it appears that some cognitive dysfunction may have occurred at the time of the lightning injury, but deficits were exacerbated after a delayed-onset of PTSD and other psychiatric symptoms. The author suggests possible mechanisms for delayed memory impairment in cases of lightning injury.	Appalachian Behav Healthcare, Cambridge, OH 43725 USA		Reisner, AD (corresponding author), Appalachian Behav Healthcare, Cambridge Campus,66737 Old 21 Rd, Cambridge, OH 43725 USA.	reisnera@mh.state.oh.us					AIDMAN EV, 2001, 14 MENTAL MEASUREMEN, P168; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Chamberlin E, 1998, HARVARD REV PSYCHIAT, V5, P307, DOI 10.3109/10673229809003579; Cherington M, 2005, NEUROREHABILITATION, V20, P3; Cherington M, 2003, NEUROLOGY, V60, P182, DOI 10.1212/01.WNL.0000033801.15204.B5; Cooper MA, 2003, LIGHTNING INJURY RES; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEVANAND DP, 1994, AM J PSYCHIAT, V151, P957; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; Duman RS, 1998, J ECT, V14, P181; Janus Todd J., 1996, Journal of Burn Care and Rehabilitation, V17, P409, DOI 10.1097/00004630-199609000-00007; Martin TA, 2003, BRAIN INJURY, V17, P817, DOI 10.1080/0269905031000088604; MEHTA S, 2001, 14 MENTAL MEASUREMEN, P170; Muehlberger T, 2001, BURNS, V27, P829, DOI 10.1016/S0305-4179(01)00029-8; PRIMEAU M, 1995, SEMIN NEUROL, V15, P279, DOI 10.1055/s-2008-1041033; Primeau M, 2005, NEUROREHABILITATION, V20, P25; Reisner AD, 2003, NEUROPSYCHOL REV, V13, P199, DOI 10.1023/B:NERV.0000009484.76564.58; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; STEWART C, 1994, NEUROREPORT, V5, P1041, DOI 10.1097/00001756-199405000-00006; Tonkonogy J, 1997, BRIEF NEUROPSYCHOLOG; van Zomeren AH, 1998, J NEUROL NEUROSUR PS, V64, P763, DOI 10.1136/jnnp.64.6.763; WEINER RD, 1984, BEHAV BRAIN SCI, V7, P1, DOI 10.1017/S0140525X00025887; Yarnell PR, 2005, NEUROREHABILITATION, V20, P15	25	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1093	1097		10.1080/02699050600832007			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100012	17060143				2022-02-06	
J	Bates, G				Bates, Gordon			Medication in the treatment of the behavioural sequelae of traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							EPISODIC DYSCONTROL; CONDUCT DISORDER; HEAD-INJURIES; DOUBLE-BLIND; CHILDREN; METHYLPHENIDATE; ADOLESCENTS; SECONDARY	A significant proportion of children who sustain traumatic brain injury will go on to experience disturbance in their academic, emotional, and social functioning. There is a role for medication in the treatment of these late onset changes. This review will focus on the recognition and pharmacological treatment of the most common and most problematic presentations that may follow head injury, and supports the use of stimulant medication for secondary attention-deficit-hyperactivity disorder despite the small evidence base for use in children.	Birmingham Childrens Hosp, Parkview Clin, Birmingham B13 8QE, W Midlands, England		Bates, G (corresponding author), Birmingham Childrens Hosp, Parkview Clin, 60 Queensbridge Rd, Birmingham B13 8QE, W Midlands, England.	gordon.bates@bch.nhs.uk					Adams A, 2001, BCS CONF SERIES, P49; ALDRICH MS, 1992, NEUROLOGY, V42, P34; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arango C, 2002, J AM ACAD CHILD PSY, V41, P1147, DOI 10.1097/00004583-200210000-00004; BATES GDL, 1995, BEHAV NEUROL, V8, P103, DOI 10.3233/BEN-1995-8205; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Broughton RJ, 1997, NEUROLOGY, V49, P444, DOI 10.1212/WNL.49.2.444; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BROWN RT, 1991, J CLIN CHILD PSYCHOL, V20, P282, DOI 10.1207/s15374424jccp2003_7; CAMPBELL M, 1995, J AM ACAD CHILD PSY, V34, P445, DOI 10.1097/00004583-199504000-00011; Childs A, 1987, Brain Inj, V1, P49, DOI 10.3109/02699058709034444; CLARKE DJ, 1989, MED SCI LAW, V29, P136, DOI 10.1177/002580248902900209; Conners C. K., 1997, MANUAL CONNERS RATIN; *DEP HLTH, 2004, HOSP EP STAT; DILLEY M, 2006, ADV PSYCHIAT TREAT, V12, P23; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GOLDSTEIN DJ, 1995, BRIT J PSYCHIAT, V166, P660, DOI 10.1192/bjp.166.5.660; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gordon N, 1999, DEV MED CHILD NEUROL, V41, P786, DOI 10.1017/S0012162299001565; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri CT, 2002, BRAIN INJURY MENTAL; GUALTIERI CT, 2002, BRAIN INJURY MENTAL, P21; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; LeBlanc JC, 2005, INT CLIN PSYCHOPHARM, V20, P275, DOI 10.1097/01.yic.0000166403.03732.72; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; LIPPER S, 1977, J NERV MENT DIS, V5, P366; Lustig RH, 1999, J PEDIATR-US, V135, P162, DOI 10.1016/S0022-3476(99)70017-X; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; OSHANICK, 1998, TRAUMATIC BRAIN INJU, P53; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; Shapira NA, 2000, J CLIN PSYCHIAT, V61, P368, DOI 10.4088/JCP.v61n0508; STEWART JT, 1985, J CLIN PSYCHIAT, V46, P496; Stores G, 2001, CLIN DEV MED, P126; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86	43	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	AUG	2006	48	8					697	701		10.1017/S0012162206001472			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	068DY	WOS:000239353800016	16836786				2022-02-06	
J	Iosifidis, MI; Giannoulis, I; Traios, S; Giantsis, G				Iosifidis, Michael I.; Giannoulis, Ioannis; Traios, Stavros; Giantsis, Georgios			Simultaneous bilateral posterior dislocation of the shoulder: diagnostic problems and management	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						bilateral posterior shoulder dislocation; computed tomography; reverse Hill-Sachs lesion	CHRONIC UNREDUCED DISLOCATIONS; FRACTURE-DISLOCATION; RECONSTRUCTION	We present the case of a patient who sustained simultaneous bilateral posterior dislocation of the shoulder after a possible epileptic fit. The confirmation of the diagnosis was reached only by a computed tomography (CT) scan, after the clinical suspicion. Under general anesthesia, close reduction of both shoulder dislocations was done. Posterior dislocation of the shoulder-especially the bilateral one-is very rare. When the history describes an electric shock or convulsive seizure, any shoulder injury demands a careful clinical and radiological evaluation. It is usually associated with reverse Hill-Sachs lesion (an impression defect of the anteromedial aspect of the humeral head), in which the size determines the treatment options.	Naoussa Gen Hosp, Dept Orthopaed, Naousa, Greece		Iosifidis, MI (corresponding author), Filiaton 21 Ikarou, Thessaloniki, Greece.	iosfyl@med.auth.gr					Aparicio G, 2000, J Orthop Sci, V5, P37, DOI 10.1007/s007760050006; ARNDT JH, 1965, AMER J ROENTGENOL RA, V94, P639; BECKER R, 1990, UNFALLCHIRURG, V93, P66; CAVE ER, 1974, TRAUMA MANAGEMENT; Checchia SL, 1998, J SHOULDER ELB SURG, V7, P53, DOI 10.1016/S1058-2746(98)90183-5; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; CICAK N, 2003, EUR INSTR COURSE LEC, V6, P24; CISTERNINO SJ, 1978, AM J ROENTGENOL, V130, P951, DOI 10.2214/ajr.130.5.951; Connor PM, 1997, J SHOULDER ELB SURG, V6, P480, DOI 10.1016/S1058-2746(97)80002-X; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Delcogliano A, 2005, KNEE SURG SPORT TR A, V13, P151, DOI 10.1007/s00167-004-0524-6; DIMON JH, 1967, SOUTHERN MED J, V60, P661, DOI 10.1097/00007611-196706000-00022; Dubousset J, 1967, Rev Chir Orthop Reparatrice Appar Mot, V53, P65; ELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P1136, DOI 10.2106/00004623-198668080-00002; Engel T, 1999, UNFALLCHIRURG, V102, P897, DOI 10.1007/s001130050499; FINKELSTEIN JA, 1995, J ORTHOP TRAUMA, V9, P190; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; Hashmi FR, 2002, AM J EMERG MED, V20, P127, DOI 10.1053/ajem.2002.31132; Hawkins R J, 1985, Instr Course Lect, V34, P258; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; HELLER KD, 1995, UNFALLCHIRURG, V98, P6; HUGHES M, 1975, PHYS THER, V9, P37; KEPPLER P, 1994, J ORTHOP TRAUMA, V8, P286, DOI 10.1097/00005131-199408000-00003; MCLAUGHLIN H, 1952, J BONE JOINT SURG AM, V24, P584; MICHOS IB, 1993, ACTA ORTHOP SCAND, V64, P599, DOI 10.3109/17453679308993703; Montoli E, 1968, Minerva Ortop, V19, P146; PAGE AE, 1995, J ORTHOP TRAUMA, V9, P526, DOI 10.1097/00005131-199509060-00012; Petersen SA, 2000, ORTHOP CLIN N AM, V31, P263, DOI 10.1016/S0030-5898(05)70146-2; PRITCHETT JW, 1987, CLIN ORTHOP RELAT R, P89; RANDELLI M, 2001, CHRONIC POSTERIOR DI; ROCKWOOD CA, 1965, J BONE JOINT SURG AM, V46, P1220; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; VOKUV V, 1985, INT ORTHOP, V9, P37	34	12	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	AUG	2006	14	8					766	770		10.1007/s00167-006-0066-1			5	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	081ID	WOS:000240309700012	16501951				2022-02-06	
J	Mann, NM; Vento, JA				Mann, Norman M.; Vento, John A.			A Study, comparing SPECT and MRI in patients with anosmia after traumatic brain injury	CLINICAL NUCLEAR MEDICINE			English	Article						anosmia; head trauma; SPECT; MRI	TECHNETIUM-99M-HMPAO SPECT; SMELL; TASTE	Purpose: The initial or first clinical presentation of altered sensation of smell is directly linked to the degree of impaired sensitivity. We took the opportunity to examine normal and nonspecific MRI findings in 6 patients with known anosmia after traumatic brain injury with perfusion SPECT brain imaging. Material and Methods: Patients included those with primary loss of smell after bead injury. All patients under-went standard testing by the Taste & Smell Center. Normal or nonspecific near normal brain MRI studies were subsequently referred for SPECT perfusion neuroimaging. Results: MRI studies were negative in 3 cases. In the remaining studies, one case showed nonspecific white matter change, another low signal in the left frontal gyrus, and the sixth case merely some cortical atrophy. All 6 cases demonstrated lesions on SPECT involving the frontal, temporal, and temporoparietal cortex. Conclusion: This study identified altered blood perfusion pattern in otherwise normal anatomic structures on MRI.	Univ Connecticut, Ctr Hlth, Dept Med, Taste & Smell Clin Div, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Diagnost Imaging & Therapeut, Div Nucl Med, Farmington, CT 06030 USA		Mann, NM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Taste & Smell Clin Div, Farmington, CT 06030 USA.	tasteandsmell@neuron.uchc.edu					ALLISON AC, 1949, BRAIN, V72, P186, DOI 10.1093/brain/72.2.186; ALTOCHI PH, 1996, NEUROLOGY, V46, P278; Fujibayashi Y, 1998, NUCL MED BIOL, V25, P375, DOI 10.1016/S0969-8051(97)00221-7; ICHISE M, 1994, J NUCL MED, V35, P217; JUNI JE, 1994, J NUCL MED, V35, P1891; LEVIN JM, 1994, J NUCL MED, V35, P1902; Mann NM, 2004, OTOLARYNG CLIN N AM, V37, P289, DOI 10.1016/S0030-6665(03)00157-9; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; Mann Norman M, 2003, Conn Med, V67, P545; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; ROGER SN, 1991, J NUCL MED, V32, P1684; Scott A E, 1989, Ear Nose Throat J, V68, P297; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; TIKOFSKY RS, 1994, J NUCL MED, V34, P227	16	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	AUG	2006	31	8					458	462		10.1097/01.rlu.0000227010.72925.6d			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	091KP	WOS:000241026700004	16855430				2022-02-06	
J	Jin, JS; Sakaeda, T; Kakumoto, M; Nishiguchi, K; Nakamura, T; Okamura, N; Okumura, K				Jin, Jiang-shu; Sakaeda, Toshiyuki; Kakumoto, Mikio; Nishiguchi, Kohshi; Nakamura, Tsutomu; Okamura, Noboru; Okumura, Katsuhiko			Effect of therapeutic moderate hypothermia on multi-drug resistance protein 1-mediated transepithelial transport of drugs	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						therapeutic moderate hypothermia; pharmacokinetics; multi-drug resistance protein 1; digoxin; quinidine; tetracycline	TRAUMATIC BRAIN-INJURY; P-GLYCOPROTEIN; MILD HYPOTHERMIA; COMATOSE SURVIVORS; ORGANIC CATIONS; INFANTS; PHARMACOKINETICS; PHARMACOGENETICS; PHARMACODYNAMICS; FEASIBILITY	To clarify the effect of therapeutic moderate hypothermia on drug distribution, transepithelial transport via multi-drug resistance protein 1 (MDR1) (also called P-glycoprotein or ABCB1) was evaluated at various temperatures in vitro using LLC-GA5-COL150 cells, which were established by transfecting human MDR1 complementary deoxyribonucleic acid into kidney epithelial LLC-PK1 cells and express MDR1 on the apical membrane. MDR1 is expressed in the blood-brain barrier to limit drug distribution to the brain by exporting exogenous substances including calcium blockers and antiarrhythmic drugs. Digoxin was used as a typical substrate, as well as the non-substrate tetracycline and paracellular marker inulin. MDR1-mediated transport of digoxin decreased at lower temperatures. Transport of tetracycline also decreased at lower temperatures, probably due to changes in membrane fluidity. However, no change was found at over 32 degrees C, suggesting that passive diffusion does not change during moderate hypothermia. The distribution of MDR1 substrates should be considered during hypothermic conditions, as the clinical outcome could be affected.	Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 650, Japan; Kobe Univ, Grad Sch Med, Dept Clin Evaluat Pharmacotherapy, Kobe, Hyogo, Japan		Sakaeda, T (corresponding author), Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 650, Japan.	sakaedat@med.kobe-u.ac.jp		Nakamura, Tsutomu/0000-0001-7395-4305			Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Babu E, 2002, JPN J PHARMACOL, V88, P69, DOI 10.1254/jjp.88.69; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Beaufort TM, 2001, ANESTHESIOLOGY, V94, P270, DOI 10.1097/00000542-200102000-00017; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Darby JM, 2002, NEW ENGL J MED, V347, P63; Fritz HG, 2005, ANESTH ANALG, V100, P996, DOI 10.1213/01.ANE.0000146517.17910.54; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Heier T, 2002, ANESTHESIOLOGY, V97, P90, DOI 10.1097/00000542-200207000-00013; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Holzer M, 2002, NEW ENGL J MED, V346, P549; HORI R, 1993, AM J PHYSIOL, V264, pF975, DOI 10.1152/ajprenal.1993.264.6.F975; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Karibe H, 2000, NEUROSURGERY, V47, P594, DOI 10.1097/00006123-200009000-00012; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Lin JH, 2003, DRUG METAB REV, V35, P417, DOI 10.1081/DMR-120026871; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; OTT RJ, 1993, PHARMACEUT RES, V10, P1169, DOI 10.1023/A:1018968218573; Padosch SA, 2002, NEW ENGL J MED, V347, P63; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, NEW ENGL J MED, V347, P64; Polderman KH, 2001, J NEUROSURG, V94, P853; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; SAITO H, 1992, AM J PHYSIOL, V262, pC59, DOI 10.1152/ajpcell.1992.262.1.C59; Sakaeda T, 1998, J DRUG TARGET, V6, P261, DOI 10.3109/10611869808996834; Sakaeda T, 2004, CURR TOP MED CHEM, V4, P1385; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Sakaeda T, 2002, J PHARM PHARMACOL, V54, P419, DOI 10.1211/0022357021778493; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Somogyi AA, 1996, J PHARMACOL EXP THER, V278, P31; Su J, 2003, INT J DEV NEUROSCI, V21, P353, DOI 10.1016/S0736-5748(03)00070-4; Tabayashi K, 2002, ACTA CHIR BELG, V102, P224; TAKANO M, 1992, BIOCHIM BIOPHYS ACTA, V1108, P133, DOI 10.1016/0005-2736(92)90017-G; Takara K, 2002, LIFE SCI, V70, P1491, DOI 10.1016/S0024-3205(01)01494-1; TANIGAWARA Y, 1992, J PHARMACOL EXP THER, V263, P840; UEDA K, 1992, J BIOL CHEM, V267, P24248; Withington D, 2000, CAN J ANAESTH, V47, P1188, DOI 10.1007/BF03019867; Yamazaki M, 2001, J PHARMACOL EXP THER, V296, P723; Yanagawa Y, 1998, RESUSCITATION, V39, P61, DOI 10.1016/S0300-9572(98)00118-X; Zhang JN, 2004, J TRAUMA, V57, P216, DOI 10.1097/01.TA.0000093366.98819.FE; Zuideveld KP, 2002, EUR J PHARMACOL, V445, P43, DOI 10.1016/S0014-2999(02)01665-5	54	12	13	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2006	46	7					321	327		10.2176/nmc.46.321			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	063UA	WOS:000239044200001	16861824	Bronze			2022-02-06	
J	Olasode, BJ; Komolafe, IE; Komolafe, M; Olasode, OA				Olasode, Babatunde J.; Komolafe, I. E.; Komolafe, M.; Olasode, Olayinka A.			Traumatic spinal cord injuries in Ile-Ife, Nigeria, and its environs	TROPICAL DOCTOR			English	Article							PATHOPHYSIOLOGY	In Ile-Ife, Nigeria, traumatic brain injuries are largely due to traffic accidents caused mainly by the bad maintenance of the roads and unsafe driving. Young men in the productive stage of their lives are those most affected. The resultant disabilities include quadriplegia (in more than half the patients) and paraplegia. The cost of treating and providing adequate facilities for these patients imposes a heavy economic burden upon developing countries.	Obafemi Awolowo Univ, Dept Morbid Anat, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Neurosurg, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Neurol, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Dermatol, Ife, Osun State, Nigeria		Olasode, BJ (corresponding author), Obafemi Awolowo Univ, Dept Morbid Anat, PMB 5538, Ife, Osun State, Nigeria.	bjshalom428@yahoo.com	Olasode, Olayinka/AAL-6831-2020	KOMOLAFE, MORENIKEJI/0000-0002-0592-5120			Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HUGHES JT, 1997, BROCKS INJURIES BRAI, P668; LEESTMA JE, 1997, NEUROPATHOLOGY DIAGN, P475; TATOR CH, 1990, BRIT J SURG, V77, P485; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x	7	12	12	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-4755	1758-1133		TROP DOCT	Trop. Dr.	JUL	2006	36	3					181	182		10.1258/004947506777978136			2	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	073FW	WOS:000239729400023	16884634				2022-02-06	
J	Mukhida, K; Sharma, MR; Shilpakar, SK				Mukhida, K; Sharma, MR; Shilpakar, SK			Pediatric neurotrauma in Kathmandu, Nepal: implications for injury management and control	CHILDS NERVOUS SYSTEM			English	Article						brain injury; developing countries; epidemiology; Nepal; preventive measures; spinal cord injury	TRAUMATIC BRAIN-INJURY; LIFE-SUPPORT PROGRAM; LOW-INCOME COUNTRIES; CHILDHOOD INJURIES; MEDICAL-SERVICES; GLOBAL BURDEN; CHILDREN; HEALTH; CARE; NEUROSURGERY	There is a scarcity of data regarding childhood neurological injuries in developing countries such as Nepal. The epidemiology of acute pediatric neurotrauma in Kathmandu was studied to assess the implications of these data for injury prevention programs. The clinical records of patients <= 18 years who presented to Tribhuvan University Teaching Hospital between April 1, 2001 and April 1, 2004 with acute neurological trauma and were subsequently admitted to hospital were retrospectively reviewed. A standard proforma was used to collect information on patient demographics, the nature and etiology of the injuries, their acute management, and outcomes. Four hundred sixteen injured children were admitted to hospital, and the charts for 352 (85%) were available for review. Spinal injuries were relatively rare (4%) compared to head injuries (96%). Falls were the most common cause of injuries (61%). It took significantly longer (p < 0.001) for children injured in rural Nepal (62%) to obtain neurosurgical care (30.1 h) than those injured within Kathmandu (7.1 h). A Glasgow Outcome Score of 5 was obtained for 96%, 76%, and 22% of patients with mild, moderate, or severe head injuries, respectively. Besides efforts to improve prehospital transport and acute management of these injuries, preventive measures that are applicable to the Nepalese scenario are urgently needed. Interventions should focus on health education programs directed at parents and children and upgrading of road safety measures. Neurological injuries must also be viewed in the context of the broader social issues in Nepal that contribute to injury.	Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Cell Restorat Lab, Dept Surg, Halifax, NS B3H 4H7, Canada; Univ Toronto, Div Neurosurg, Toronto, ON, Canada; Tribhuvan Univ, Inst Med, Div Neurosurg, Kathmandu, Nepal		Mukhida, K (corresponding author), Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, 5850 Coll St,12th Floor,Sir Charles Tupper Med Bl, Halifax, NS B3H 4H7, Canada.	kmukhida@dal.ca	Sharma, Mohan/AAP-9322-2021				Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Ad Hoc Committee on Health Research Relating to Future Intervention Options, 1996, INV HLTH RES DEV REP; ADELOYE A, 1986, CHILD NERV SYST, V2, P309, DOI 10.1007/BF00271945; Albright AL, 2004, J NEUROSURG, V101, P125, DOI 10.3171/ped.2004.101.2.0125; ALI J, 1994, J TRAUMA, V36, P391, DOI 10.1097/00005373-199403000-00020; ALI J, 1993, J TRAUMA, V34, P890, DOI 10.1097/00005373-199306000-00022; ALLHOUSE MJ, 1993, PEDIATR EMERG CARE, V9, P159; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; *B TRAUM FDN, 2000, GUID PREH MAN TRAUM; *B TRAUM TASK FORC, 2000, J NEUROTRAUM, V17, P451; Bagan M, 1997, SURG NEUROL, V47, P512, DOI 10.1016/S0090-3019(96)00546-0; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; BERGER LR, 1996, INJURY CONTROL GLOBA; Bernstein E, 1994, Acad Emerg Med, V1, P277; *BRIT BROADC CORP, 2004, NEP VIOL LEAV DEAD; *BRIT BROADC CORP, 2004, STRIK CONT CRIPPL NE; *BRIT BROADC CORP, 2004, CONC NEP REB THREAT; *BRIT BROADC CORP, 2004, REB CUT LINKS NEP CA; Devkota UP, 2001, BRIT J NEUROSURG, V15, P13, DOI 10.1080/02688690020024328; Faillace WJ, 2002, SURG CLIN N AM, V82, P349, DOI 10.1016/S0039-6109(02)00010-5; FORJUOH S, 1999, PREHOSPITAL IMMEDIAT, V3, P66; GEDLU E, 1994, E AFR MED J, V71, P807; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hauswald M, 1997, AM J EMERG MED, V15, P600, DOI 10.1016/S0735-6757(97)90167-4; Husum H, 2003, J TRAUMA, V54, P1188, DOI 10.1097/01.TA.0000073609.12530.19; Ibbotson G, 2003, CAN MED ASSOC J, V169, P1301; Istre GR, 2003, INJURY PREV, V9, P349, DOI 10.1136/ip.9.4.349; JANSON S, 1994, J TROP PEDIATRICS, V40, P88, DOI 10.1093/tropej/40.2.88; Jimba M, 2001, LANCET, V358, P1017, DOI 10.1016/S0140-6736(01)06148-7; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; Joseph M, 2003, NEUROL INDIA, V51, P333; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MANCIAUX MRG, 1985, ACTA PAEDIATR SCAND, V74, P163, DOI 10.1111/j.1651-2227.1985.tb10944.x; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; MICHAUD C, 1994, B WORLD HEALTH ORGAN, V72, P639; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; Mock CN, 2002, J TRAUMA, V53, P90, DOI 10.1097/00005373-200207000-00018; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Poudel-Tandukar K, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-a; Poudyal AK, 2003, TROP MED INT HEALTH, V8, P956, DOI 10.1046/j.1365-3156.2003.01094.x; Rajbhandari KC, 2004, CAN J NEUROL SCI, V31, P257, DOI 10.1017/S0317167100053919; Ramamurthi B, 2004, SURG NEUROL, V61, P109, DOI 10.1016/j.surneu.2003.08.034; Razzak JA, 2004, PUBLIC HEALTH, V118, P114, DOI 10.1016/S0033-3506(03)00147-1; REICHENHEIM ME, 1989, HEALTH POLICY PLANN, V4, P162; Roberts I, 1996, BRIT MED J, V313, P784; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwarz R, 2004, CLEFT PALATE-CRAN J, V41, P199, DOI 10.1597/03-016; SHILPAKAR SK, 2003, J SOC SURG NEPAL, V6, P33; Shokunbi T, 1994, West Afr J Med, V13, P38; Shrestha MK, 2004, BRIT J OPHTHALMOL, V88, P319, DOI 10.1136/bjo.2003.026260; Singh S, 2004, CAN MED ASSOC J, V171, P1499, DOI 10.1503/cmaj.1040777; SPIEGEL CN, 1977, AM J PUBLIC HEALTH, V67, P1143, DOI 10.2105/AJPH.67.12.1143; Stevenson PC, 2002, LANCET, V359, P1495, DOI 10.1016/S0140-6736(02)08472-6; Stevenson PC, 2001, LANCET, V358, P752, DOI 10.1016/S0140-6736(01)05844-5; STREEFLAND P, 1985, SOC SCI MED, V20, P1151, DOI 10.1016/0277-9536(85)90192-3; Tursz A, 1986, World Health Stat Q, V39, P257; *UNICEF, 2004, AT GLANC NEP; Waxweiler R J, 1994, Acad Emerg Med, V1, P204; *WORLD BANK, 2004, NEP DAT PROF; Yagmur Y, 2004, INJURY, V35, P425, DOI 10.1016/S0020-1383(03)00198-0; Zwi A B, 1996, Inj Prev, V2, P91, DOI 10.1136/ip.2.2.91	66	12	15	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2006	22	4					352	362		10.1007/s00381-005-1235-0			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	026YL	WOS:000236379300005	16170573				2022-02-06	
J	Nayak, C; Nayak, D; Raja, A; Rao, AJ				Nayak, C; Nayak, D; Raja, A; Rao, AJ			Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						ceruloplasmin; Glasgow Coma Scale; head injury; lipid peroxidation	TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM TRAUMA; FREE-RADICALS; LIPID-PEROXIDATION; CERULOPLASMIN; DAMAGE; PROTEINS; STROKE; RATS	Background: Oxidative stress is said to strongly influence the neurological recovery of patients following a severe head injury. Estimation of the markers of oxidative stress in the blood of such patients can hence aid in predicting the prognosis of head injury. Methods: Erythrocyte thiobarbituric acid-reactive substances ( TBARS) and plasma ceruloplasmin ( CP) levels were estimated in 24 severe head-injury patients on days 1, 7 and 21 of the post-traumatic period and compared with levels in 25 healthy age- and sex-matched controls. These parameters reflecting oxidative stress status were related to the Glasgow Coma Scale ( GCS) scores of patients noted at the same time points of the study period. Results: Lipid peroxidation as indicated by increased levels of erythrocyte TBARS remained significantly elevated in severe head injury patients compared to controls on day 1 ( p<0.001), day 7 ( p<0.001) and 21 ( p<0.001) of the post-traumatic period. Plasma CP levels remained significantly elevated ( p<0.001) at these three time points compared to controls. The significant decrease in lipid peroxidation products ( p<0.01) and significant increase in CP levels ( p<0.001) on day 21 compared to day 1 in head injury patients correlated well with the significant improvement in GCS scores of patients on day 21 compared to day 1 ( p<0.05). Conclusion: The above results could account for the adaptation of the study patients to severe oxidative stress, as evidenced by their clinical recovery trend during the study period.	Int Ctr Hlth Sci, Melaka Manipal Med Coll, Dept Biochem, Manipal 576104, Karnataka, India; Kasturba Med Coll & Hosp, Dept Pediat, Manipal, Karnataka, India; Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal, Karnataka, India; Kasturba Med Coll & Hosp, Dept Biochem, Manipal, Karnataka, India		Nayak, C (corresponding author), Int Ctr Hlth Sci, Melaka Manipal Med Coll, Dept Biochem, Manipal Campus, Manipal 576104, Karnataka, India.	chandrikadinesh@yahoo.com		Rao, Anjali/0000-0002-2676-2762; Nayak, Dinesh M/0000-0001-7384-8916; Nayak, Chandrika D/0000-0002-4674-7359			Atanasiu RL, 1998, MOL CELL BIOCHEM, V189, P127, DOI 10.1023/A:1006945713860; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CHERUBINI A, 2001, 2 VIRT C CARD; DESILVA DM, 1993, CAN J PHYSIOL PHARM, V71, P715, DOI 10.1139/y93-107; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GOLDSTEIN IM, 1982, ANN NY ACAD SCI, V389, P368, DOI 10.1111/j.1749-6632.1982.tb22150.x; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nishio S, 1997, ACT NEUR S, V70, P84; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; RAO GM, 1998, THESIS MANIPAL ACAD; RAVIN HA, 1961, J LAB CLIN MED, V58, P161; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SIEMS WG, 2000, CLIN NEPHROL, V53, P17; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	30	12	13	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	APR	2006	44	4					460	463		10.1515/CCLM.2006.068			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	034UO	WOS:000236956300017	16599841				2022-02-06	
J	Gonzalez-Rothi, LJ				Gonzalez-Rothi, LJ			Cognitive rehabilitation - The role of theoretical rationales and respect for the maturational process needed for our evidence	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Galveston Brain Injury Conference (GBIC)	APR, 2005	Galveston, TX	Moody Fdn		clinical trials; cognition; rehabilitation		The challenge to presenters at the Galveston Brain Injury Conference held in April 2005 was to discuss examples of the use of theory to motivate the design of treatments for cognitive deficits resulting from traumatic brain injury This article considers the role of theoretical rationales as well as the new optimism embracing neurorehabilitation today. However, caution to respect the maturational process needed to adequately prepare treatment evidence for clinical application is affected.	Univ Florida, Gainesville, FL 32610 USA; Malcom Randall VA Med Ctr, VA RR&D Brain Rehabil Res Ctr, Gainesville, FL USA		Gonzalez-Rothi, LJ (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	gonzalj@neurology.ufl.edu					Balas EA, 2004, MED CARE, V42, P610, DOI 10.1097/01.mlr.0000128008.12117.f8; BERNDT RS, 1992, NIH PUBLICATION; CAJA RYS, 1928, DEGENERATION REGENER; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; ERGEZINGER ER, 2000, CEREBRAL REORGANIZAT, P68; FERGUSON JH, 1994, NEUROLOGY, V44, P566; FINGER S, 1994, ORIGINGS NEUROSCIENC; GORDON WA, 2006, TREATMENT POST TBI E, V21; Hillis AE, 1998, J INT NEUROPSYCH SOC, V4, P648, DOI 10.1017/S135561779846613X; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kolb B., 1995, BRAIN PLASTICITY BEH; Merriam-Webster, 1991, WEBSTERS 9 NEW COLLE; Mitchum C. C., 1992, NIH PUBLICATION, V93-3424; Nudo RJ, 1997, SEMIN NEUROSCI, V9, P13, DOI 10.1006/smns.1997.0102; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Robey RR, 1998, APHASIOLOGY, V12, P787, DOI 10.1080/02687039808249573; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; WHYTE J, 2006, USING TREATMENT THEO, V21; [No title captured]	21	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2006	21	2					194	197		10.1097/00001199-200603000-00011			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	031PK	WOS:000236716300010	16569992				2022-02-06	
J	Moreira, T; Cebers, G; Salehi, M; Wagner, A; Liljequist, S				Moreira, T; Cebers, G; Salehi, M; Wagner, A; Liljequist, S			Impaired long-term habituation is dissociated from increased locomotor activity after sensorimotor cortex compression	BEHAVIOURAL BRAIN RESEARCH			English	Article						open-field; cognitive impairments; brain injury; hippocampal damage; thalamus; striatum; Fluoro-Jade	TRAUMATIC BRAIN-INJURY; FLUORO-JADE; EXTRADURAL COMPRESSION; ACETYLCHOLINE-RELEASE; OPEN-FIELD; HIPPOCAMPAL ACETYLCHOLINE; SOMATOSENSORY CORTEX; CEREBRAL-ISCHEMIA; RAT; MODEL	Behavioural habituation to a novel environment is a simple form of learning in rodents. We Studied the habituation and locomotor activity (LMA) of Wistar rats subjected to unilateral, transient (30 min) extradural compression (EC of the right sensorimotor cortex. One group of rats was tested every 24 h during the first 5 days (D1-D5) post-EC. Two other groups were tested for the first time in the LMA boxes on D3 and D6 post-EC and their performance was compared with the group tested on D1 (activity in a novel environment). Total and center locomotion, vertical activity and time spent in the center of the LMA box were reduced on D1 post-EC and normalized by D2. The EC-induced motor paresis was undetectable on the rotarod by D2 and on the beam-walking by D3. Total locomotion, vertical activity and time spent in the center of EC-rats significantly increased from D1 to D3. EC caused neurodegeneration in the cortex, caudate putamen and thalamus as detected by Fluoro-Jade staining. The size of the cortical damage decreased from D2 to D5 in the medial and caudal regions of the compressed hemisphere, in accordance with recovery of motor function. LMA provided additional information in the follow-up of recovery from brain injury and habituation to the environment. Thus, long-term, inter-session habituation was impaired from D1 to D3 but dissociated front increased LMA intra-session on D3, when the motor deficits provoked by EC were already undetectable in the rotarod and beam-walking tests. (c) 2005 Elsevier B.V. All rights reserved.	Karolinska Univ Hosp, Dept Clin Neurosci, Div Drug Dependence Res, SE-17176 Stockholm, Sweden; Karolinska Inst, Div Neurol, SE-17176 Stockholm, Sweden		Liljequist, S (corresponding author), AstraZeneca R&D Sodertalje, S-15185 Sodertalje, Sweden.	Sture.Liliequist@cns.ki.se					Acquas E, 1996, J NEUROSCI, V16, P3089; Aggleton JP, 2001, PHILOS T R SOC B, V356, P1467, DOI 10.1098/rstb.2001.0946; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Arckens L, 1998, NEUROSCIENCE, V83, P381, DOI 10.1016/S0306-4522(97)00422-3; Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; BORLONGAN CV, 1995, PHARMACOL BIOCHEM BE, V52, P225, DOI 10.1016/0091-3057(95)00108-9; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Braun C, 2001, CLIN NEUROPHYSIOL, V112, P336, DOI 10.1016/S1388-2457(00)00508-3; BuchkremerRatzmann I, 1997, NEUROREPORT, V8, P519, DOI 10.1097/00001756-199701200-00028; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; CASSADAY HJ, 1995, BEHAV NEUROSCI, V109, P594, DOI 10.1037/0735-7044.109.4.594; Cassaday HJ, 1997, BEHAV NEUROSCI, V111, P1228, DOI 10.1037/0735-7044.111.6.1228; CERBONE A, 1994, NEUROSCI BIOBEHAV R, V18, P497, DOI 10.1016/0149-7634(94)90004-3; Conti AC, 1998, J NEUROSCI, V18, P5663; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; GERFEN CR, 1996, HDB CHEM NEUROANATOM, V12, P365; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kelly MK, 1999, J NEUROSCI, V19, P9117, DOI 10.1523/JNEUROSCI.19-20-09117.1999; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KOSOWSKI A, 2004, BEHAV BRAIN RES; Krinke GJ, 2001, EXP TOXICOL PATHOL, V53, P365, DOI 10.1078/0940-2993-00202; Kundrotiene J, 2004, ACTA NEUROBIOL EXP, V64, P153; Kundrotiene J, 2004, J NEUROTRAUM, V21, P83, DOI 10.1089/089771504772695977; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; McNeill TH, 2003, J COMP NEUROL, V467, P32, DOI 10.1002/cne.10907; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Moreira T, 2005, BEHAV BRAIN RES, V164, P250, DOI 10.1016/j.bbr.2005.06.013; NOVACK GD, 1982, DRUG DEVELOP RES, V2, P383, DOI 10.1002/ddr.430020407; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Orsetti M, 1996, BRAIN RES, V724, P89, DOI 10.1016/0006-8993(96)00292-2; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.0.CO;2-T; Stephens S, 2004, INT J GERIATR PSYCH, V19, P1053, DOI 10.1002/gps.1209; Thiel CM, 1998, NEUROSCIENCE, V85, P1253, DOI 10.1016/S0306-4522(98)00030-X; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Torres-Munoz JE, 2004, MOL BRAIN RES, V127, P105, DOI 10.1016/j.molbrainres.2004.05.017; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; van Groen T, 2002, BEHAV BRAIN RES, V136, P329, DOI 10.1016/S0166-4328(02)00199-7; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	63	12	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 15	2006	167	1					9	22		10.1016/j.bbr.2005.06.048			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	008QL	WOS:000235055700002	16337698				2022-02-06	
J	Ross, SR; Putnam, SH; Adams, KM				Ross, SR; Putnam, SH; Adams, KM			Psychological disturbance, incomplete effort, and compensation-seeking status as predictors of neuropsychological test performance in head injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							RECOGNITION MEMORY TEST; TRAUMATIC BRAIN-INJURY; ADULT INTELLIGENCE SCALE; SYMPTOM VALIDITY TESTS; CROSS-VALIDATION; TEST-SCORES; BASE RATES; MMPI-2; VARIABLES; DEFICITS	Indices from the Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) representing cognitive and emotional disturbance as well as incomplete effort on the Recognition Memory Test (RMT; Warrington, 1984) were examined as predictors of performance on the Halstead-Reitan Neuropsychological Test Battery (HRB; Reitan & Wolfson, 1993). In the current study, which included a large sample (N = 369) of patients referred for neuropsychological (NP) evaluation after presumptive head injury, MMPI-2 measures of psychological disturbance accounted for as much as 25% of the variance in HRB test scores, resulting in a moderate overall effect size (median Adj. R-2 = .16; R = .40). When demographic variables, head injury severity, and compensation-seeking status were entered in previous steps, incomplete effort as defined by chance performance on the RMT accounted for between 2% and 13% of the variance in HRB test scores, with modest overall effect size (median R-2 Delta = .07; R = .26) in multiple regression equations. Additionally, when MMPI-2 indices of psychological disturbance were included in the last step, they accounted for 2% to 11% of additional variance, retaining a modest overall effect (median R-2 Delta = .03; R = .17). Compensation-seeking status and injury severity as measured by duration of post-traumatic amnesia were, at best, modestly related to NP test performance. Findings confirm the reliable relationship between test performance and psychological disturbance as well as incomplete effort when assessing dysfunction following head injury. In contrast to previous studies, incomplete effort was unrelated to compensation-seeking status.	Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Wayne State Univ, Sch Med, Detroit, MI USA; Ann Arbor VAMC, Ann Arbor, MI USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA		Ross, SR (corresponding author), Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA.	srross@depauw.edu					Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; GASS CS, 1994, J CLIN PSYCHOL, V50, P586, DOI 10.1002/1097-4679(199407)50:4<586::AID-JCLP2270500414>3.0.CO;2-Z; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hancock P. A., 2003, J HUM PERFORM EXTREM, V7, P5, DOI [10.7771/2327-2937.1023, DOI 10.7771/2327-2937.1023]; HEATON RK, 1996, NEUROPSYCHOLOGICAL A; IVERSON GI, 1996, ASSESSMENT, V1, P323; Kaemmer, 1989, MINNESOTA MULTIPHASI; KlOve H, 1963, MED CLIN N AM; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEZAK MD, 1995, NEUROPSYCHOL ASSESSM; McKinzey RK, 1997, ARCH CLIN NEUROPSYCH, V12, P585, DOI 10.1016/S0887-6177(97)00005-X; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MILLER HG, 1961, BMJ-BRIT MED J, V1, P9; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Putzke JD, 1997, ASSESSMENT, V4, P365, DOI 10.1177/107319119700400407; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ross SR, 2003, CLIN NEUROPSYCHOL, V17, P581, DOI 10.1076/clin.17.4.581.27940; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ross SR, 2003, ARCH CLIN NEUROPSYCH, V18, P905, DOI 10.1016/S0887-6177(02)00169-5; Ross SR, 1999, CLIN NEUROPSYCHOL, V13, P112, DOI 10.1076/clin.13.1.112.1973; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tabachnik B.G., 1996, USING MULTIVARIATE S, V3rd ed.; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMS MJ, 1991, MEMORY ASSESSMENT SC; Wolfson, 1993, HALSTEAD REITAN NEUR; Wrobel NH, 1996, ARCH CLIN NEUROPSYCH, V11, P625; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; [No title captured]	63	12	12	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN	2006	28	1					111	125		10.1080/13803390590929270			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	014XX	WOS:000235515100009	16448980				2022-02-06	
J	Tenovuo, OS				Tenovuo, Olli Sakari			Cholinergic Treatment of Traumatic Brain Injury	CURRENT DRUG THERAPY			English	Article						Traumatic brain injury; acetylcholine; acetylcholinesterase inhibitors; drug treatment; review		In spite of affecting the life of millions of people, chronic traumatic brain injury (TBI) has not been hitherto treatable with effective pharmacological tools. This review gives a comprehensive summary of the theoretical data supporting the pharmacological manipulation of the cholinergic system in TBI, pointing out the most urgent targets for further studies. The published clinical evidence of cholinergic treatment in TBI is critically reviewed, with emphasis on modern available cholinergic agents. The lessons from these studies are converted to detailed suggestions for further clinical testing. In addition, the treating clinicians are provided with practical advice, based on personal experience of the cholinergic treatment in over 350 TBI patients. It is concluded that cholinergic agents offer several very promising potentials for the treatment of TBI. However, the final breakthrough requires further well-conducted studies and the potential caveats of the treatment have to be acknowledged.	[Tenovuo, Olli Sakari] Univ Turku, Dept Neurol, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland		Tenovuo, OS (corresponding author), Univ Turku, Dept Neurol, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.	olli.tenovuo@tyks.fi			NovartisNovartis	The authors 'third-party' randomized controlled study with rivastigmine in chronic TBI was financed by Novartis. The financing did not include personal compensation, and the results are fully controlled by the author.	Abe K, 1998, J NEUROL NEUROSUR PS, V65, P126, DOI 10.1136/jnnp.65.1.126; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Allain Herve, 2004, Psychol Neuropsychiatr Vieil, V2, P167; ALTERMAN AI, 1985, INT J NEUROSCI, V28, P155, DOI 10.3109/00207458508985386; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; [Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Bassant MH, 1998, INT J DEV NEUROSCI, V16, P613, DOI 10.1016/S0736-5748(98)00073-2; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BAXTER MG, 1995, BEHAV NEUROSCI, V109, P714, DOI 10.1037/0735-7044.109.4.714; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; BEAULIEU C, 1991, J COMP NEUROL, V304, P666, DOI 10.1002/cne.903040412; Benke T, 2005, EUR J NEUROL, V12, P791, DOI 10.1111/j.1468-1331.2005.01063.x; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bentivoglio M, 1990, DIENCEPHALON SLEEP M; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Berger-Sweeney J, 1998, INT J DEV NEUROSCI, V16, P603, DOI 10.1016/S0736-5748(98)00072-0; Berger-Sweeney J, 2003, NEUROSCI BIOBEHAV R, V27, P401, DOI 10.1016/S0149-7634(03)00070-8; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BIERER LM, 1995, J NEUROCHEM, V64, P749; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; Bohnen NI, 2005, J NEUROL NEUROSUR PS, V76, P315, DOI 10.1136/jnnp.2004.038729; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; Brudzynski SM, 1998, J NEUROPHYSIOL, V79, P1675, DOI 10.1152/jn.1998.79.4.1675; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Cacabelos R, 2005, EXPERT OPIN PHARMACO, V6, P1967, DOI 10.1517/14656566.6.12.1967; Castillo PE, 1999, J NEUROSCI, V19, P9180; Champagne D, 2005, EXP NEUROL, V194, P31, DOI 10.1016/j.expneurol.2005.01.016; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; CHEDOTAL A, 1994, J COMP NEUROL, V343, P57, DOI 10.1002/cne.903430105; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chez MG, 2004, J CHILD NEUROL, V19, P165; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Conti AC, 1998, J NEUROSCI, V18, P5663; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cossa FM, 1999, ITAL J NEUROL SCI, V20, P145, DOI 10.1007/s100720050024; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Crochet S, 2005, CEREB CORTEX; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dougherty KD, 1999, J NEUROSCI, V19, P10140; DRACHMAN DA, 1977, NEUROLOGY, V27, P783, DOI 10.1212/WNL.27.8.783; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fernandes MA, 2000, J EXP PSYCHOL GEN, V129, P155, DOI 10.1037/0096-3445.129.2.155; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Fine A, 1997, NEUROSCIENCE, V81, P331, DOI 10.1016/S0306-4522(97)00208-X; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Francis PT, 1994, ALZHEIMER DIS; Freo U, 2002, J NEURAL TRANSM, V109, P857, DOI 10.1007/s007020200070; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; Furey ML, 2000, BRAIN RES BULL, V51, P213, DOI 10.1016/S0361-9230(99)00219-1; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; GALLAGHER M, 1995, CURR OPIN NEUROBIOL, V5, P161, DOI 10.1016/0959-4388(95)80022-0; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GIBBS RB, 1994, ANN NY ACAD SCI, V743, P165, DOI 10.1111/j.1749-6632.1994.tb55792.x; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Giovannini MG, 1998, BRAIN RES, V784, P218, DOI 10.1016/S0006-8993(97)01161-X; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GORRY JD, 1963, ACTA ANAT, V55, P51; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greene YM, 2000, J CLIN PSYCHOPHARM, V20, P350, DOI 10.1097/00004714-200006000-00010; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Gritti I, 1997, J COMP NEUROL, V383, P163; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; HALLANGER AE, 1988, J COMP NEUROL, V278, P486, DOI 10.1002/cne.902780403; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; Hamm RJ, 1993, BRAIN RES COGN BRAIN, V1, P223, DOI [10.1016/0926-6410(93)90006-Q, DOI 10.1016/0926-6410(93)90006-Q]; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hartig W, 2002, REV NEUROSCIENCE, V13, P95; Hashimoto M, 2005, AM J PSYCHIAT, V162, P676, DOI 10.1176/appi.ajp.162.4.676; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Herholz K, 2005, J NEUROL NEUROSUR PS, V76, P305, DOI 10.1136/jnnp.2004.048405; Herron P, 1998, INT J DEV NEUROSCI, V16, P633, DOI 10.1016/S0736-5748(98)00074-4; Himanen L, NEUROLOGY; Hoang TX, 2005, NEUROSCIENCE; Hobson A, 2004, NATURE, V430, P21, DOI 10.1038/430021a; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; HOHMANN CF, 1988, DEV BRAIN RES, V42, P253, DOI 10.1016/0165-3806(88)90244-1; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Iga JI, 2001, ALCOHOL ALCOHOLISM, V36, P553, DOI 10.1093/alcalc/36.6.553; IKEDA K, 1995, BRAIN RES, V688, P171, DOI 10.1016/0006-8993(95)00530-4; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jacobsen FM, 1999, J CLIN PSYCHIAT, V60, P698, DOI 10.4088/JCP.v60n1009; JASPER HH, 1971, SCIENCE, V172, P601, DOI 10.1126/science.172.3983.601; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; JOHNSTON D, 1998, SYNAPTIC ORG BRAIN, P417; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; JONES BE, 1993, PROG BRAIN RES, V98, P61; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorgensen OS, 1997, EXP NEUROL, V144, P326, DOI 10.1006/exnr.1996.6372; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Juliano SL, 1998, SCIENCE, V279, P1653, DOI 10.1126/science.279.5357.1653; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Katsumi Y, 1999, BRAIN RES, V837, P75, DOI 10.1016/S0006-8993(99)01530-9; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kim E, 2002, NEUROREHABILITATION, V17, P297; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleifeld O, 1998, INT J DEV NEUROSCI, V16, P755, DOI 10.1016/S0736-5748(98)00084-7; Kolmac C, 1999, NEUROSCI LETT, V272, P151, DOI 10.1016/S0304-3940(99)00614-X; Krupp LB, 2004, NEUROLOGY, V63, P1579, DOI 10.1212/01.WNL.0000142989.09633.5A; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Kumari V, 2003, NEUROIMAGE, V19, P1002, DOI 10.1016/S1053-8119(03)00110-1; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lampl Y, 2004, ANN PHARMACOTHER, V38, P1967, DOI 10.1345/aph.1D445; Lekht I., 2004, APPL RADIOL S, P68; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lestage P, 1998, EUR J PHARMACOL, V357, P163, DOI 10.1016/S0014-2999(98)00562-7; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LUNTZLEYBMAN V, 1992, BRAIN RES, V587, P130, DOI 10.1016/0006-8993(92)91437-J; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Manocchia M, 2001, QUAL LIFE RES, V10, P331, DOI 10.1023/A:1012299519637; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Mansvelder HD, 2005, PSYCHOPHARMACOLOGY; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McGaughy J, 1998, BEHAV NEUROSCI, V112, P1519, DOI 10.1037/0735-7044.112.6.1519; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McNamara Patrick, 2004, Seminars in Speech and Language, V25, P309, DOI 10.1055/s-2004-837244; Mehlhorn G, 1998, INT J DEV NEUROSCI, V16, P675, DOI 10.1016/S0736-5748(98)00078-1; MESULAM MM, 1995, ANN NY ACAD SCI, V757, P169, DOI 10.1111/j.1749-6632.1995.tb17472.x; Metherate R, 2003, NEUROBIOL LEARN MEM, V80, P285, DOI 10.1016/S1074-7427(03)00062-5; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Montplaisir J, 1996, EUR NEUROL, V36, P197, DOI 10.1159/000117247; Moretti R, 2004, EXPERT OPIN PHARMACO, V5, P1399, DOI 10.1517/14656566.5.6.1399; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MRZLJAK L, 1995, J COMP NEUROL, V357, P603; Mufson EJ, 2003, J CHEM NEUROANAT, V26, P233, DOI 10.1016/S0891-0618(03)00068-1; Mumenthaler MS, 2003, NEUROPSYCHOPHARMACOL, V28, P1366, DOI 10.1038/sj.npp.1300202; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; MURRAY CL, 1986, BEHAV NEUROSCI, V100, P23, DOI 10.1037/0735-7044.100.1.23; Nagahama Y, 2005, J NEUROL NEUROSUR PS, V76, P169, DOI 10.1136/jnnp.2004.039818; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; *NATL CTR INJ PREV, 2000, EP TRAUM BRAIN INJ U; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; Okada T, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-14; Olazaran-Rodriguez J, 2004, REV NEUROLOGIA, V38, P938, DOI 10.33588/rn.3810.2003573; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; PARKER RS, 1994, J NEUROL ORTH MED S, V15, P123; Parry AMM, 2003, BRAIN, V126, P2750, DOI 10.1093/brain/awg284; Pearl GS, 1998, CLIN LAB MED, V18, P39; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Phillips LL, 1997, J NEUROSCI RES, V49, P197; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Pollak Y, 2005, ANN NEUROL, V57, P741, DOI 10.1002/ana.20454; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Power AE, 2004, P NATL ACAD SCI USA, V101, P1795, DOI 10.1073/pnas.0400237101; RAPOPORT SI, 1989, MED HYPOTHESES, V29, P147, DOI 10.1016/0306-9877(89)90185-0; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Ricceri L, 2004, EXP NEUROL, V189, P162, DOI 10.1016/j.expneurol.2004.05.025; Ridley RM, 1999, BEHAV NEUROSCI, V113, P303; Risch SC, 2001, NEUROCASE, V7, P105, DOI 10.1093/neucas/7.2.105; Ritvo PG., 1997, MULTIPLE SCLEROSIS Q; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robbins TW, 2000, SCIENCE, V290, P2275, DOI 10.1126/science.290.5500.2275; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sarter M, 1999, TRENDS NEUROSCI, V22, P67, DOI 10.1016/S0166-2236(98)01289-2; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; SARTER M, 1994, PSYCHOPHARMACOLOGY, V114, P539, DOI 10.1007/BF02244983; Sarter M, 2004, NEUROBIOL AGING, V25, P1127, DOI 10.1016/j.neurobiolaging.2003.11.011; Sarter M, 2000, NEUROSCIENCE, V95, P933; Savola O, 2005, ALCOHOL ALCOHOL; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schredl M, 2001, EXP GERONTOL, V36, P353, DOI 10.1016/S0531-5565(00)00206-0; SCHWARTZ ML, 1993, J COMP NEUROL, V327, P48, DOI 10.1002/cne.903270105; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; SEMBA K, 1988, NEUROSCI LETT, V84, P23, DOI 10.1016/0304-3940(88)90331-X; Semba K, 2000, BEHAV BRAIN RES, V115, P117, DOI 10.1016/S0166-4328(00)00254-0; SHAH KR, 1982, BRAIN RES, V233, P414, DOI 10.1016/0006-8993(82)91216-1; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shohami E, 1996, ISR J MED SCI S, V32, pS9; SHUTE CCD, 1975, PHARMACOL THER PT B, V1, P79, DOI 10.1016/0306-039X(75)90017-3; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Silver J, 2005, 6 WORLD C BRAIN INJ; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM., 1994, NEUROPSYCHIATRY TRAU; Simard M, 2004, J NEUROPSYCH CLIN N, V16, P409, DOI 10.1176/jnp.16.4.409; Simic G, 1999, NEUROSCIENCE, V89, P73, DOI 10.1016/S0306-4522(98)00304-2; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; Stevens KE, 1997, PHARMACOL BIOCHEM BE, V57, P869, DOI 10.1016/S0091-3057(96)00466-2; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STRUGAR J, 1993, J TRAUMA, V34, P555, DOI 10.1097/00005373-199304000-00012; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SZYMUSIAK R, 1995, SLEEP, V18, P478, DOI 10.1093/sleep/18.6.478; Tanaka K, 1997, REGUL PEPTIDES, V70, P173, DOI 10.1016/S0167-0115(97)01013-6; TANAKA K, 1995, NEUROCHEM RES, V20, P663, DOI 10.1007/BF01705533; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taverni JP, 1998, BRAIN INJURY, V12, P77; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale GM, 2005, BRAIN; Tellier A, 1999, BRAIN INJURY, V13, P463; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thiel CM, 2002, EUR J NEUROSCI, V16, P2199, DOI 10.1046/j.1460-9568.2002.02272.x; Thompson JC, 2000, PSYCHOPHARMACOLOGY, V150, P117, DOI 10.1007/s002130000409; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TSUJIMOTO S, 1993, ACTA NEUROCHIR, V124, P127, DOI 10.1007/BF01401134; Turchi J, 1997, COGNITIVE BRAIN RES, V6, P147, DOI 10.1016/S0926-6410(97)00027-X; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; Vizi ES, 2004, EUR J PHARMACOL, V500, P499, DOI 10.1016/j.ejphar.2004.07.018; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; WACHTLER K, 1980, COMP BIOCHEM PHYS C, V65, P1, DOI 10.1016/0306-4492(80)90038-6; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wenk GL, 1998, INT J DEV NEUROSCI, V16, P729, DOI 10.1016/S0736-5748(98)00081-1; WEST M, 1981, BRAIN RES, V225, P271, DOI 10.1016/0006-8993(81)90835-0; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Wilens TE, 2000, J CHILD ADOL PSYCHOP, V10, P217, DOI 10.1089/10445460050167322; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Wilson J. T., 1993, J NEUROL NEUROSUR PS, V56, P198, DOI 10.1136/jnnp.57.2.198; WILSON J T L, 1990, Brain Injury, V4, P349; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yesavage JA, 2002, NEUROLOGY, V59, P123, DOI 10.1212/WNL.59.1.123; YOSHIMOTO Y, 1989, BRAIN RES BULL, V23, P83, DOI 10.1016/0361-9230(89)90167-6; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	347	12	13	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-8855	1065-7630		CURR DRUG THER	Curr. Drug Ther.		2006	1	2					187	209		10.2174/157488506776930932			23	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	VC5PA	WOS:000433839400007					2022-02-06	
J	Steiner, ME; Quigley, DB; Wang, F; Balint, CR; Boland, AL				Steiner, ME; Quigley, DB; Wang, F; Balint, CR; Boland, AL			Team physicians in college athletics	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						team physician; intercollegiate athletics; athletic injuries; athletic medicine		Background: There has been little documentation of what constitutes the clinical work of intercollegiate team physicians. Team physicians could be recruited based on the needs of athletes. Hypothesis: A multidisciplinary team of physicians is necessary to treat college athletes. Most physician evaluations are for musculoskeletal injuries treated nonoperatively. Study Design: Descriptive epidemiology study. Methods: For a 2-year period, a database was created that recorded information on team physician encounters with intercollegiate athletes at a major university. Data on imaging studies, hospitalizations, and surgeries were also recorded. The diagnoses for physician encounters with all undergraduates through the university's health service were also recorded. Results: More initial athlete evaluations were for musculoskeletal diagnoses (73%) than for general medical diagnoses (27%) (P <.05). Four percent of musculoskeletal injuries required surgery. Most general medical evaluations were single visits for upper respiratory infections and dermatologic disorders, or multiple visits for concussions. Football accounted for 22% of all physician encounters, more than any other sport (P <.05). Per capita, men and women sought care at an equal rate. In contrast, 10% of physician encounters with the general pool of undergraduates were for musculoskeletal diagnoses. Student athletes did not require a greater number of physician encounters than did the general undergraduate pool of students on a per capita basis. Conclusion: Intercollegiate team physicians primarily treat musculoskeletal injuries that do not require surgery. General medical care is often single evaluations of common conditions and repeat evaluations for concussions.	Harvard Univ, Athlet Dept, Boston, MA USA; Harvard Univ, Sch Med, New England Baptist Hosp Sports Med Sect, Hlth Serv, Boston, MA USA		Steiner, ME (corresponding author), 830 Boylston St, Brookline, MA 02467 USA.	mesteinermd@cs.com					*AM BOARD MED SPEC, ANN REP REF HDB; *AM ORTH SOC SPORT, SPORTS MED SURV 1999; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; MAGEE J, 2002, SPORTS MED UPDATE, P4; Matheson GO, 2002, PHYSICIAN SPORTSMED, V30, P3, DOI [10.3810/psm.2002.02.149, 10.3810/psm.2002.04.240]; THORNDIKE A, 1956, ATHLETIC INJURIES PR; 2000, AM J SPORTS MED, V28, P440	7	12	12	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	OCT	2005	33	10					1545	1551		10.1177/0363546505275491			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	968BX	WOS:000232138000014	16009978				2022-02-06	
J	Aydin, S; Ulusoy, H; Usul, H; Yulug, E; Cobanoglu, U; Aydin, K; Yenilmez, E; Kutun, S				Aydin, S; Ulusoy, H; Usul, H; Yulug, E; Cobanoglu, U; Aydin, K; Yenilmez, E; Kutun, S			Effects of early versus delayed nutrition on intestinal mucosal apoptosis and atrophy after traumatic brain injury	SURGERY TODAY			English	Article						traumatic brain injury; enteral nutrition; apoptosis; rat	EARLY ENTERAL NUTRITION; BACTERIAL TRANSLOCATION; CELL-DEATH; PERMEABILITY; GUT; STARVATION; DEFENSE; RATS; ISCHEMIA; BLUNT	Purpose. To determine the optimal time to start nutritional support after traumatic brain injury (TBI). Methods. Rats were divided into six groups of seven. All but one of these groups were subjected to moderate closed head trauma under general anesthesia. Groups Ia and Ib were commenced on immunonutrition and standard enteral nutrition, respectively, 8 h later; groups IIa and IIb were commenced on immunonutrition and standard enteral nutrition, respectively, 72 h later; and group III was commenced on a parenteral saline infusion 8 h later. Group IV was a control group fed a laboratory diet and not subjected to trauma. The rats were killed 7 days later, and ileal segments were examined using light and electron microscopy. We used the deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) technique to detect intestinal mucosal apoptosis. Results. Group III had a lower body weight than the other groups (P < 0.005). The mean villous height was highest in groups Ia and IV and lowest in group III. The villi count was lower in groups Ib, IIa, IIb, and III than in group IV (P < 0.005). The apoptotic index counts were higher in groups IIa, IIb, and III than in group IV (P < 0.005). Conclusions. The addition of enriching immunonutrients to early enteral feeding helps preserve an almost normal gut mucosa.	Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Histol & Embryol, TR-61080 Trabzon, Turkey; Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Anesthesiol & Reanimat, TR-61080 Trabzon, Turkey; Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Neurosurg, TR-61080 Trabzon, Turkey; Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Pathol, TR-61080 Trabzon, Turkey; Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Infect Dis & Clin Microbiol, TR-61080 Trabzon, Turkey; Ankara Oncol Hosp, Dept Gen Surg 1, Ankara, Turkey		Aydin, S (corresponding author), Karadeniz Tech Univ, Farabi Hosp, Anabilim Dali, Dept Histol & Embryol, TR-61080 Trabzon, Turkey.		Usul, Haydar/AAW-2939-2021; Yulug, Esin/AAK-5597-2021; Yenilmez, Engin/AAU-4690-2020; Yulug, Esin/AAK-2077-2021; AYDIN, Sevim/AAO-5670-2020; ulusoy, hulya/A-6223-2019	Yenilmez, Engin/0000-0002-0755-4394; Yulug, Esin/0000-0002-8857-9234; AYDIN, Sevim/0000-0003-2445-2346; ulusoy, hulya/0000-0001-6645-6316; Cobanoglu, Umit/0000-0001-6429-427X			BABINEAU TJ, 1994, CRIT CARE MED, V22, P191, DOI 10.1097/00003246-199402000-00004; Braga M, 1996, EUR J SURG, V162, P105; CALBAN C, 2000, CRIT CARE MED, V28, P643; CHRISOULA DS, 2000, J AM COLL SURGEONS, V190, P423; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FRY DE, 1979, SURGERY, V85, P652; GAAL T, 1993, RES VET SCI, V55, P104, DOI 10.1016/0034-5288(93)90042-E; GARRISON RN, 1982, SURGERY, V92, P713; GIANOTTI L, 1994, CRIT CARE MED, V22, P265, DOI 10.1097/00003246-199402000-00018; GIANOTTI L, 1999, J PARENTER ENTERAL N, V23, P214; GLAVIN GB, 1992, ACTA PHYSIOL HUNG, V80, P107; GREER GG, 1975, CAN J MICROBIOL, V21, P877, DOI 10.1139/m75-130; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; INOUE S, 1989, JPEN-PARENTER ENTER, V13, P565, DOI 10.1177/0148607189013006565; Inoue S, 1989, J Burn Care Rehabil, V10, P300, DOI 10.1097/00004630-198907000-00003; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; KUDSK KA, 1982, J TRAUMA, V22, P904, DOI 10.1097/00005373-198211000-00003; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; LEE FD, 1993, J CLIN PATHOL, V46, P118, DOI 10.1136/jcp.46.2.118; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Minard G, 1994, New Horiz, V2, P156; Moss SF, 1996, GASTROENTEROLOGY, V111, P567, DOI 10.1053/gast.1996.v111.agast961110567; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; OLeary MJ, 1996, BRIT J ANAESTH, V77, P118, DOI 10.1093/bja/77.1.118; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; PREMARATNE S, 1994, SHOCK, V2, P262, DOI 10.1097/00024382-199410000-00005; PURANDARE S, 1989, SCAND J GASTROENTERO, V24, P678, DOI 10.3109/00365528909093108; Saluja SS, 2002, SURG TODAY, V32, P672, DOI 10.1007/s005950200125; Shanahan F, 1999, Semin Gastrointest Dis, V10, P8; SIMONSON SG, 1994, CIRC SHOCK, V43, P34; STEINER M, 1968, AM J PHYSIOL, V215, P75; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; Wang XD, 1996, EUR SURG RES, V28, P402, DOI 10.1159/000129484; WOHAIEB SA, 1987, DIABETES, V36, P169, DOI 10.2337/diabetes.36.2.169	41	12	12	0	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0941-1291	1436-2813		SURG TODAY	Surg. Today	SEP	2005	35	9					751	759		10.1007/s00595-005-3034-3			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	957CI	WOS:000231346600009	16133670				2022-02-06	
J	Lim, D; Robinovitch, S; Goodman, D				Lim, D; Robinovitch, S; Goodman, D			Effect of mouthguards on the transmission of force across the human jaw	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mouthguard; boil and bite; concussion; free vibration; spring-damper	HEAD-INJURY; ICE HOCKEY; CONCUSSION; MOUTH; SPORTS	Objective: To determine if impact responses (stiffness and damping values) of the jaw and neck are significantly different between mouth-guards of varying material and manufacturing properties, in controlled conditions involving specified upper limb orientation and applied loading. Design: Quasi-experimental design. Setting: Simon Fraser University biomechanical laboratory. Participants: Twelve male subjects between the ages of 19 to 28 participated in this study. All subjects were healthy, had no missing teeth, and had no mechanical (orthodontic) appliances. Main Outcome Measurements: For each condition, the system stiffness and damping values were estimated using the free vibration technique. Stiffness and damping values are relevant because they are the major determinants of impact force and, potentially, injury risk. It is the first study to show experimentally the quantitative effects of mouthguard in situ. Results: All the mouthguards lowered the system stiffness as compared with the no mouthguard condition (P < 0.001). There was no observed effect on stiffness between the 2 limb orientation positions. Excitation weight had an unexpected effect on system stiffness (P = 0.041), with increasing weight leading to increased stiffness. Conclusions: The findings suggest that wearing any mouthguard is better than wearing none at all due to their ability to reduce system stiffness and damping values after a blow to the chin.	Simon Fraser Univ, Dept Kinesiol, Burnaby, BC V5A 1S6, Canada		Goodman, D (corresponding author), Simon Fraser Univ, Dept Kinesiol, Burnaby, BC V5A 1S6, Canada.	goodman@sfu.ca		Robinovitch, Stephen/0000-0003-3881-6227			Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Chalmers DJ, 1998, SPORTS MED, V25, P339, DOI 10.2165/00007256-199825050-00006; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Hoffmann J, 1999, ENDOD DENT TRAUMATOL, V15, P157; JAGGER RG, 1995, BRIT DENT J, V178, P31, DOI 10.1038/sj.bdj.4808640; Maestrello Christopher L., 1999, Pediatric Dentistry, V21, P340; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2001, BRIT J SPORT MED, V35, P146, DOI 10.1136/bjsm.35.3.146; Milward P J, 1997, J Prosthodont, V6, P292, DOI 10.1111/j.1532-849X.1997.tb00110.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 2001, J ATHL TRAINING, V36, P307; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x	22	12	12	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2005	15	5					313	319		10.1097/01.jsm.0000180019.22018.3c			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	975OR	WOS:000232672300006	16162989				2022-02-06	
J	Turkstra, LS; Bourgeois, M				Turkstra, LS; Bourgeois, M			Intervention for a modern day HM: Errorless learning of practical goals	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ORGANIC AMNESIA; IMPLICIT MEMORY; EXPRESSIONS; STRATEGIES; EXPLICIT; DOMAIN	Impairments in declarative learning are a common consequence of traumatic brain injury (TBI), and limit participation in daily life for many survivors. Procedural learning and memory, however, typically are spared. In this article, we describe a memory therapy technique, Spaced Retrieval (SR), which is designed to capitalize on preserved procedural memory processes. SR is an errorless learning procedure previously reported to be effective for teaching practical goals to individuals with dementia. To illustrate the potential use of SR in TBI, we present the case of an individual with profound anterograde amnesia who received SR therapy via telephone. The positive results support future studies in TBI and suggest consideration of the role of errors in speech and language therapy.	Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA; Florida State Univ, Tallahassee, FL 32306 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021; Bourgeois, Michelle/F-9397-2015	Bourgeois, Michelle/0000-0003-1458-6842; Turkstra, Lyn/0000-0002-6948-6921			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BOURGEOIS M, 2003, AM SPEECH LANG HEAR; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; Brush JA, 1998, THERAPY TECHNIQUE IM; Camp C.J, 2000, COGNITIVE REHABILITA, P224; CAMP CJ, 1997, PROSPECTIVE MEMORY T, P311; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GUGER S, 2001, 29 ANN M INT NEUR SO; HOMBERG V, 1993, NEUROSCI LETT, V150, P187, DOI 10.1016/0304-3940(93)90532-P; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; SCHACTER DL, 1987, HUM NEUROBIOL, V6, P107; Stark C, 2005, NEUROPSYCHOLOGY, V19, P139, DOI 10.1037/0894-4105.19.2.139; TURKSTRA LS, 1995, BRAIN INJURY, V9, P61, DOI 10.3109/02699059509004573; Turkstra Lyn S., 2001, Seminars in Speech and Language, V22, P147; VERFAELLIE M, 1991, BRAIN COGNITION, V15, P10, DOI 10.1016/0278-2626(91)90012-W; Wechsler, 1997, WECHSLER ADULT INTEL; WILKINSON GS, 1973, WIDE RANGE ACHIEVEME; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson B. A., 1999, COGNITIVE NEUROREHAB, P333; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	27	12	12	0	11	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2005	13	3					205	212					8	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	963GO	WOS:000231792200005					2022-02-06	
J	Alexander, AI; Mayfield, J				Alexander, AI; Mayfield, J			Latent factor structure of the Test of Memory and Learning in a pediatric traumatic brain injured sample: Support for a general memory construct	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						factor structure; memory; neuropsychology; pediatric; structural equation modeling; traumatic brain injury	WIDE-RANGE ASSESSMENT; EQUATION ANALYSIS	The Test of Memory and Learning (TOMAL; Reynolds, C. R., & Bigler, E. D. (1994a). Test of Memory and Learning (TOMAL). Austin, Texas: Pro-Ed; Reynolds, C. R., & Bigler, E. D. (1994b). Test of Memory and Learning (TOMAL): Examiner's manual. Austin, Texas: Pro-Ed) was published to ameliorate the paucity of developmentally appropriate instruments for the assessment of memory in children and adolescents. No studies have confirmed the latent factor structure of the TOMAL. Two structural models were subjected to confirmatory factor analysis using the TOMAL performances of 140 subjects, age 5-19, with traumatic brain injury (TBI). Model 1 was a four-factor model with a large "Complex Memory" factor and three smaller factors. Model 2 was a two-factor model with Verbal and Nonverbal Memory factors, both of which loaded on a second-order "General" memory factor. Results indicated that the model with a higher order structure demonstrated better fit than the four-factor model. Further analysis suggested that the TOMAL factor structure is characterized by a large Complex Memory and smaller, Sustained Attention factor. The study provides tentative support for a "general memory" construct. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Texas Womans Univ, Denton, TX 76204 USA; Our Childrens House Baylor, Dallas, TX USA		Alexander, AI (corresponding author), Texas Womans Univ, Denton, TX 76204 USA.	alexanderai@lisd.net					Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Bollen K. A., 1989, STRUCTURAL EQUATIONS, DOI 10.1002/9781118619179; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Burton DB, 1999, CHILD NEUROPSYCHOL, V5, P34, DOI 10.1076/chin.5.1.34.7077; Burton DB, 1996, CHILD NEUROPSYCHOL, V2, P39, DOI 10.1080/09297049608401349; Cohen M.J., 1997, CHILDRENS MEMORY SCA; GERBING DW, 1984, J CONSUM RES, V11, P572, DOI 10.1086/208993; GIOIA GA, 1991, M INT NEUR SOC SAN A; Gorsuch R.L., 1983, FACTOR ANAL; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; Hatcher L., 1994, STEP STEP APPROACH U; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Joreskog K. G., 1993, LISREL 8 USERS REFER; KAMPHAUS RW, 1993, CLIN ASSESSMENT CHIL; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Lawley D.N., 1971, FACTOR ANAL STAT MET; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; *NAT INF CTR CHILD, 2004, TRAUM BRAIN INJ FACT; Phelps LA, 1995, J PSYCHOEDUC ASSESS, V13, P384, DOI 10.1177/073428299501300405; Ramsay MC, 1995, NEUROPSYCHOL REV, V5, P151, DOI 10.1007/BF02214760; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds CR, 1996, ARCH CLIN NEUROPSYCH, V11, P29, DOI 10.1016/0887-6177(95)00027-5; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; TABACHNICK BG, 1996, APPL MULTIVARIATE ST; THOMPSON B, 1992, EDUC PSYCHOL MEAS, V52, P69, DOI 10.1177/001316449205200107; Wechsler D., 1997, WECHSLER MEMORY SCAL; Weiskrantz L., 1993, ATTENTION SELECTION, P152; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	32	12	12	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2005	20	5					587	598		10.1016/j.acn.2004.12.005			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	942EY	WOS:000230266900003	15939184	Bronze			2022-02-06	
J	De Monte, VE; Geffen, GM; Kwapil, K				De Monte, VE; Geffen, GM; Kwapil, K			Test-retest reliability and practice effects of a rapid screen of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							VERBAL-LEARNING TEST; HEAD-INJURY; SENSITIVITY; CONCUSSION; SPORTS; FORM	Test-retest reliabilities and practice affects of measures from the Rapid Screen of Concussion (RSC), in addition to the Digit Symbol Substitution Test (Digit Symbol), were examined. Twenty five male participants were tested three times; each testing session scheduled a week apart. The test-retest reliability estimates for most measures were reasonably good, ranging from .79 to .97. An exception was the delayed word recall test, which has had a reliability estimate of .66 for the first retest, and .59 for the second retest. Practice effects were evident from Times 1 to 2 on the sentence comprehension and delayed recall subtests of the RSC, Digit Symbol and a composite score. There was also a practice effect of the same magnitude found from Time 2 to Time 3 on Digit Symbol, delayed recall and the composite score. Statistics on measures for both the first and second retest intervals, with associated practice affects, are presented to enable the calculation of reliable change indices (RCI). The RCI may be used to assess any improvement in cognitive functioning after mild Traumatic Brain Injury.	Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Brisbane, Qld 4006, Australia		De Monte, VE (corresponding author), Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	comerf@psy.uq.edu.au					Baddeley A., 1992, SPEED CAPACITY LANGU; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; Mateer CA, 2000, NEUROPSYCHOLOGICAL M, P3; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RASMUSSON DX, 1995, ARCH CLIN NEUROPSYCH, V10, P21, DOI 10.1016/0887-6177(94)E0001-6; Sattler J. M., 1988, ASSESSMENT CHILDREN; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; UCHIYAMA CL, 1995, ARCH CLIN NEUROPSYCH, V10, P133, DOI 10.1016/0887-6177(94)E0034-M; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler, 1997, WECHSLER ADULT INTEL; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOL, V6, P276, DOI DOI 10.1080/13854049208404129	26	12	12	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2005	27	5					624	632		10.1080/13803390490918589			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	936WB	WOS:000229885000010	16019639				2022-02-06	
J	Maeda, M; Ampo, KI; Kiryu-Seo, S; Konishi, H; Ohba, N; Kadono, C; Kiyama, H				Maeda, M; Ampo, KI; Kiryu-Seo, S; Konishi, H; Ohba, N; Kadono, C; Kiyama, H			The p53-independent nuclear translocation of cyclin G1 in degenerating neurons by ischemic and traumatic insults	EXPERIMENTAL NEUROLOGY			English	Article						cell cycle arrest; ischemia; trauma; MCA; p53; cyclin-G; degeneration; NMDA	GENE-TRANSFER; FLUORO-JADE; CELL-DEATH; EXPRESSION; DNA; P53; INJURY; DAMAGE; BRAIN; P21(WAF1/CIP1)	Cyclin G1 (CG1) was identified as a p53-transactivated target gene, and yet its physiological and pathological roles have been unclear. Here, we demonstrate that CG1 is translocated from cytoplasm to the nuclei of neurons in response to variety of injuries. In the normal matured rodent brain, CG1 immunoreactivity was hardly observed; however, some brain injuries exhibited intense CG1 immunoreactivity in the nuclei of the damaged neurons. Transient common carotid artery occlusion (CCAO) in the gerbil showed strong CG1-like immunoreactivity in the hippocampal CA1 neurons, and permanent middle cerebral artery occlusion (MCAO) in the mouse showed strong CG1-like immunoreactivity in the nuclei of neurons located in the ischemic brain regions. TUNEL staining did not exactly overlap with the CG1-positive cells, but overlapped highly with Fluoro-Jade B staining, a degeneration marker. Brain trauma caused by knife cut, cold injury, and kinate injection also showed CG1 accumulation in the neuronal nuclei located near the injury site. These observations were obtained in p53-deficient mice as well, suggesting that the accumulation of CG1 in the injured neurons is p53-independent. A similar nuclear translocation of endogenous CG1 was confirmed in a primary Culture of cortical neurons when a toxic level of N-methyl-D-aspartate (NMDA) was applied. These results demonstrate that nuclear translocation of CG1 from cytoplasmic region occurs in damaged and degenerating neurons in a p53-independent manner, and the CG1 nuclear staining could be a good marker for the neurons received fatal damages. (c) 2005 Elsevier Inc. All rights reserved.	Osaka City Univ, Grad Sch Med, Dept Anat, Abeno Ku, Osaka 5458585, Japan; Osaka City Univ, Grad Sch Med, Dept Neurobiol, Abeno Ku, Osaka 5458585, Japan		Kiyama, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Anat, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kiyama@med.osaka-cu.ac.jp	Kiryu-Seo, Sumiko/M-8865-2014; Kiyama, Hiroshi/M-8867-2014; KONISHI, Hiroyuki/M-8871-2014	Kiryu-Seo, Sumiko/0000-0001-6213-1258; Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339			Bates S, 1996, ONCOGENE, V13, P1103; Campagne MV, 1998, J NEUROSCI RES, V53, P279; Campagne MV, 1998, NEUROSCIENCE, V84, P1097, DOI 10.1016/S0306-4522(97)00580-0; Campagne MV, 1999, MOL BRAIN RES, V64, P1; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; INUZUKA T, 1990, STROKE, V21, P917, DOI 10.1161/01.STR.21.6.917; Jensen MR, 1998, HEPATOLOGY, V28, P537, DOI 10.1002/hep.510280235; Jensen MR, 2003, HEPATOLOGY, V37, P862, DOI 10.1053/jhep.2003.50137; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kiryu S, 1995, J NEUROSCI, V15, P7872; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Kurtkaya-Yapicier O, 2002, NEUROSURGERY, V51, P1246, DOI 10.1227/01.NEU.0000032035.74395.12; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lurton D, 1996, NEUROSCI LETT, V213, P181; Maeda M, 1997, ACTA NEUROPATHOL, V94, P116, DOI 10.1007/s004010050682; Morita N, 1996, J NEUROSCI, V16, P5961; Ohba N, 2003, MOL BRAIN RES, V115, P147, DOI 10.1016/S0169-328X(03)00181-5; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Okamoto K, 1999, ONCOGENE, V18, P4606, DOI 10.1038/sj.onc.1202821; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shimizu A, 1998, BIOCHEM BIOPH RES CO, V242, P529, DOI 10.1006/bbrc.1997.8004; SKOTZKO M, 1995, CANCER RES, V55, P5493; Smith ML, 1997, EXP CELL RES, V230, P61, DOI 10.1006/excr.1996.3402; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; TAMURA K, 1993, ONCOGENE, V8, P2113; Yagi T, 2000, BRAIN RES, V885, P273, DOI 10.1016/S0006-8993(00)02956-5; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361; Zhao L, 2003, MOL CANCER RES, V1, P195	35	12	17	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2005	193	2					350	360		10.1016/j.expneurol.2005.01.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	926PK	WOS:000229134900008	15869937				2022-02-06	
J	Tudor, M; Tudor, L; Tudor, KI				Tudor, M; Tudor, L; Tudor, KI			Complications of missile craniocerebral injuries during the Croatian Homeland War	MILITARY MEDICINE			English	Article							INTRACRANIAL BONE FRAGMENTS; TRAUMATIC EPILEPSY; LEBANESE CONFLICT; PRACTICAL SCALE; BRAIN; WOUNDS; HEAD; VIETNAM	Objective: Complications of penetrating craniocerebral injuries in war can be early (during the first week after wounding) or late (after that period). Postoperative hematomas, infections, seizures, and cerebrospinal fluid fistulas (CSFFs) are counted among the early complications, whereas foreign bodies migrating intracranially, seizures, infections, and posttraumatic hydrocephalus represent late complications. A total of 176 patients with well-defined head injuries from missiles, sustained during the Croatian Homeland War (1991-1995), developed a total of 61 (34.5%) complications. Methods: A retrospective statistical analysis of the medical records of the patients in our series was performed to determine the risk factors for the onset of complications, which have unfavorable effects on outcomes. Results: There were a total of 28 (15.9%) infections (deep or superficial), 21 (11.9%) cases of CSFFs, 9 (5.11%) cases of early epilepsy, and 3 cases of post-traumatic hydrocephalus. A total of 47.6% of patients with CSFFs developed intracranial infections. Of eight patients with meningoencephalitis, five had CSFFs and four had intracranially retained foreign bodies. Only one patient developed a cerebral abscess. Two patients died because of infectious complications (13.3%). Post-traumatic hydrocephalus (1.7%) required shunt placement. For 60% of patients with deep-seated intracranial infectious complications and 76% of patients with CSFFs, reoperations had to be performed, whereas this was the case for only 8% of patients without infections (chi(2) = 43.6, p = 0.00001). Conclusions: Intracranially retained foreign bodies, wound age, wound site, and operations performed outside the neurosurgical services were the main risk factors for the development of complications. Complications themselves exerted a very unfavorable influence on outcomes. The development of complications reflects very reliably the neurosurgical technique applied.	Clin Hosp Split, Dept Neurosurg, Split 21000, Croatia		Tudor, M (corresponding author), Clin Hosp Split, Dept Neurosurg, Vjekoslava Spineica 1, Split 21000, Croatia.		Car, Lorainne Tudor/E-1205-2017	Car, Lorainne Tudor/0000-0001-8414-7664			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; AWASTHI D, 1991, SURG NEUROL, V36, P441, DOI 10.1016/0090-3019(91)90157-5; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; CAREY M, 1989, J NEUROSURG, V71, P572; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; Dillon J D Jr, 1975, Surg Neurol, V4, P515; FREYTAG E, 1963, ARCH PATHOL, V76, P215; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; IVEKOVIC V, 1992, ACTA MED CROAT S, V46, P13; JENNETT B, 1975, LANCET, V1, P480; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; ROSENWASSER RH, 1991, SURG CLIN N AM, V71, P305; SANDE JJ, 1978, J NEUROSURG, V94, P357; SEKULIC A, 1992, ACTA MED CROAT S, V46, P47; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TEASDALE G, 1974, LANCET, V2, P81; Tudor M, 1998, MIL MED, V163, P486, DOI 10.1093/milmed/163.7.486; TUDOR M, 1996, THESIS ZAGREB CROATI; Wagstaffe WW, 1928, LANCET, V2, P861; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	28	12	12	0	1	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	MAY	2005	170	5					422	426		10.7205/MILMED.170.5.422			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019JL	WOS:000235831300017	15974211	Bronze			2022-02-06	
J	Wei, WH; Sambamoorthi, U; Crystal, S; Findley, PA				Wei, WH; Sambamoorthi, U; Crystal, S; Findley, PA			Mental illness, traumatic brain injury, and Medicaid expenditures	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; comorbidity; Medicaid; Mental Health; rehabilitation	HEAD-INJURY; PSYCHIATRIC-DISORDERS; REHABILITATION; HEALTH; SCHIZOPHRENIA; INDIVIDUALS; DISABILITY; DEPRESSION; SERVICES	Objective: To estimate the rates of mental illness among Medicaid beneficiaries with traumatic brain injury (TBI) and associated Medicaid-paid expenditures. Design: Retrospective claims-based calendar year data. Setting: Claims data. Participants: Medicaid recipients with diagnosed TBI and mental illness who received Medicaid services in 4 states in 1995. Interventions: Not applicable. Main Outcome Measures: Annual expenditures for total, inpatient, and noninpatient services, as derived from Medicaid personal summary files. Mental illness and TBI were identified by using International Classification of Diseases, 9th Revision, Clinical Modification codes recorded in Medicaid claims. Results: Of a total of 493,663 Medicaid recipients, 3641 (0.7%) were diagnosed with TBI in the 4 states. Significant demographic and racial differences were found in the rates of TBI; 18% of patients with TBI were diagnosed with serious mental illness. People with TBI in the age group 40 to 49 years were more likely to have a mental disorder. There were significant differences in estimated total, inpatient, and noninpatient expenditures between those with and without mental illness. In general, those with serious mental illness had higher Medicaid-paid expenditures than those without any mental illness. Conclusions: Psychiatric comorbidity in TBI increases the overall expenditures in this population. This increased cost is an important consideration in programming for those with TBI.	Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, Program Disabil Res, New Brunswick, NJ 08901 USA		Wei, WH (corresponding author), Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, 30 Coll Ave, New Brunswick, NJ 08901 USA.	wwh@rci.rutgers.edu	Findley, Patricia/AAC-7539-2019	Findley, Patricia/0000-0001-6924-8248; Sambamoorthi, Usha/0000-0001-8311-1360	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH043450, R01MH060831] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD040779] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH 60831, P-30 MH 43450, P20 MH 11825, R01 MH060831] Funding Source: Medline		Appelbaum PS, 2003, HEALTH AFFAIR, V22, P110, DOI 10.1377/hlthaff.22.5.110; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CONNORS S, 2003, GUIDE STAT GOVERNMEN; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Deb S, 1999, AM J PSYCHIAT, V156, P374; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frank RG, 2003, HEALTH AFFAIR, V22, P101, DOI 10.1377/hlthaff.22.1.101; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; *KAIS COMM MED UN, 2002, MED ROL WOM; Kessler R.C., 1998, MENTAL HLTH US 1998, P99; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; PRIGATANO G, 1986, NEUROPSYCHOLOICAL RE; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Reynolds WE, 2001, J HEAD TRAUMA REHAB, V16, P34, DOI 10.1097/00001199-200102000-00006; ROSENTHAL M, 1998, REHABILITATION ADULT; Rowland D, 2003, HEALTH AFFAIR, V22, P73, DOI 10.1377/hlthaff.22.5.73; Sambamoorthi U, 2001, J Health Soc Policy, V14, P19, DOI 10.1300/J045v14n01_02; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SORENSON SB, 1991, J HEAD TRAUMA REHAB, P1; *TRAUM BRAIN INJ M, 2004, TBI RES REV POL PRAC, V1, P1; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vaughn SL, 2001, J HEAD TRAUMA REHAB, V16, P20, DOI 10.1097/00001199-200102000-00005; Yanos PT, 2001, PSYCHIATR SERV, V52, P1644, DOI 10.1176/appi.ps.52.12.1644	39	12	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2005	86	5					905	911		10.1016/j.apmr.2004.09.026			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	928NM	WOS:000229278500009	15895335	Green Accepted			2022-02-06	
J	Bodo, M; Pearce, FJ; Baranyi, L; Armonda, RA				Bodo, M; Pearce, FJ; Baranyi, L; Armonda, RA			Changes in the intracranial rheoencephalogram at lower limit of cerebral blood flow autoregulation	PHYSIOLOGICAL MEASUREMENT			English	Article; Proceedings Paper	12th International Conference on Electrical Bio-Impedance/5th Electrical Impedance Tomography Conference	JUN 20-24, 2004	Gdansk, POLAND				TRAUMATIC BRAIN-INJURY; ELECTRICAL-IMPEDANCE; PRESSURE AUTOREGULATION; HEMORRHAGIC HYPOTENSION; CLINICAL-APPLICATIONS; PERFUSION-PRESSURE; BIOPHYSICAL BASIS; ELECTRODE SIZE; HEAD-INJURY; TISSUE	Cerebral blood flow (CBF) reactivity monitoring is an appropriate primary parameter to evaluate cerebral resuscitation due to a systemic or regional cerebral injury leading to possible irreversible brain injury. Use of the electrical impedance method to estimate CBF is rare, as the method's anatomical background is not well understood. Use of intracranial rheoencephalography (iREG) during hemorrhage and comparison of iREG to other CBF measurements have not been previously reported. Our hypothesis was that iREG would reflect early cerebrovascular alteration (CBF autoregulation). Studies comparing iREG, laser Doppler flowmetry and ultrasound were undertaken on anesthetized rats to define CBF changes during hemorrhage. Blood was removed at a rate required to achieve a mean arterial blood pressure (MABP) of 40 mm Hg over 15 min. Estimation of CBF was taken with intracranial, bipolar REG (REG I; n = 14), laser Doppler flowmetry (LDF; n = 3) and carotid flow by ultrasound (n = 11). Data were processed off-line. During the initial phase of hemorrhage, when MABP was close to 40 mm Hg, intracranial REG amplitude transiently increased (80.94%); LDF (77.92%) and carotid flow (52.04%) decreased and changed with systemic arterial pressure. Intracranial REG amplitude change suggests classical CBF autoregulation, demonstrating its close relationship to arteriolar changes. The studies indicate that iREG might reflect cerebrovascular responses more accurately than changes in local CBF measured by LDF and carotid flow. REG may indicate promise as a continuous, non-invasive life-sign monitoring tool with potential advantages over ultrasound, the CBF measurement technique normally applied in clinical practice. REG has particular advantages in non-hospital settings such as military and emergency medicine.	Walter Reed Army Inst Res, Dept Resuscitat Med, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Membrane Biochem, Silver Spring, MD 20910 USA; Walter Reed Army Med Ctr, Div Neurosurg, Natl Capital Consortium, Sect Cerebrovasc Surg & Intervent Neuroradiol, Washington, DC 20307 USA		Bodo, M (corresponding author), Walter Reed Army Inst Res, Dept Resuscitat Med, Silver Spring, MD 20910 USA.	michael.bodo@us.army.mil					Aaslid R, 1999, ACT NEUR S, V72, P47; Aaslid Rune, 2002, Eur J Ultrasound, V16, P3, DOI 10.1016/S0929-8266(02)00045-9; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Basano L, 2001, PHYSIOL MEAS, V22, P341, DOI 10.1088/0967-3334/22/2/306; Beaumont A, 2002, ACT NEUR S, V81, P193; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BENABID AL, 1978, J LIFE SCI, V8, P59; Bertemes P, 2003, PHYSIOL MEAS, V24, P517, DOI 10.1088/0967-3334/24/2/362; Bodo M, 2004, PHYSIOL MEAS, V25, P1371, DOI 10.1088/0967-3334/25/6/003; Bodo M, 2003, AVIAT SPACE ENVIR MD, V74, P506; BODO M, 1995, MED PROG TECHNOL, V21, P53; BODO M, 1986, PHARM CEREBRAL ISCHE, P265; BODO M, 1998, ANTIAGING MED THERAP, V2, P86; BODO M, 2004, ADV TECHNOLOGY APPL; Borisenko V. V., 1993, Fiziologicheskii Zhurnal Imeni I M Sechenova, V79, P103; Bouma G J, 1995, New Horiz, V3, P384; CARTHEUSER CF, 1988, CAN J PHYSIOL PHARM, V66, P1398, DOI 10.1139/y88-228; CHILLON JM, 2002, CEREBRAL BLOOD FLOW, P395; COOPER R, 1980, EEG TECHNOLOGY; Czosnyka M, 2000, ACT NEUR S, V76, P483; Demchenko I T, 1971, Fiziol Zh SSSR Im I M Sechenova, V57, P1553; Edvinsson L, 2002, CEREBRAL BLOOD FLOW, P384; Ganong W. F, 2001, REV MED PHYSL; GEDDES LA, 1989, PRINCIPLES APPL BIOM; GRISWOLD WR, 1981, CRIT CARE MED, V9, P573, DOI 10.1097/00003246-198108000-00003; Gupta A K, 2002, J Postgrad Med, V48, P218; GUR AY, 2001, NEUR J NEUROCHIR P S, V3, P51; Guyton AC, 2000, TXB MED PHYSL; Hadjiev D, 1968, Brain Res, V8, P213, DOI 10.1016/0006-8993(68)90186-8; HATSELL CP, 1991, IEEE T BIO-MED ENG, V38, P665, DOI 10.1109/10.83566; HEILIG J, 1998, REDIREC US COPYRIGHT; HEROLD S, 1988, NEUROL NEUROSURG PSY, V151, P1045; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; JACQUY J, 1980, NEUROPSYCHOBIOLOGY, V6, P341, DOI 10.1159/000117780; JACQUY J, 1974, ELECTROENCEPHALOGR C, V37, P501; Jenkner FL, 1986, CLIN RHEOENCEPHALOGR; JOHNSON KB, 1995, SHOCK, V3, P343; JONES WP, 1989, COMBUST SCI TECHNOL, V63, P13, DOI 10.1080/00102208908947115; KAVEC M, 2001, MAGMA, V2, P32; Kim SG, 2002, CURR OPIN NEUROBIOL, V12, P607, DOI 10.1016/S0959-4388(02)00355-0; King JC, 1996, MUSCLE NERVE, V19, P1310, DOI 10.1002/(SICI)1097-4598(199610)19:10<1310::AID-MUS8>3.0.CO;2-H; Kirsch JR, 1996, INT ANESTHESIOL CLIN, V34, P73, DOI 10.1097/00004311-199603440-00007; Komjati K, 1996, Acta Physiol Hung, V84, P229; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kovach A G, 1988, Prog Clin Biol Res, V264, P147; LAITINEN L, 1968, SCAND J CLIN LAB I S, V102, pDR11; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lechner H, 1968, Elektromed Biomed Tech, V13, P30; LEVY MM, 2004, HIGHLIGHTS COMPUTERS; LIFSHITZ K, 1963, J NERV MENT DIS, V137, P285, DOI 10.1097/00005053-196309000-00010; LIFSHITZ K, 1963, J NERV MENT DIS, V136, P388, DOI 10.1097/00005053-196304000-00010; Lingwood BE, 2002, BRAIN RES, V945, P97, DOI 10.1016/S0006-8993(02)02744-0; Livshitz LM, 2001, IEEE T NEUR SYS REH, V9, P355, DOI 10.1109/7333.1000115; Malmivuo J.A., 1992, P 8 ICEBI KUOP, P18; Manno EM, 2004, NEUROL CLIN, V22, P347, DOI 10.1016/j.ncl.2003.12.002; Manz H J, 1979, Pathobiol Annu, V9, P359; MARKOVICH S, 1967, J NEUROL SCI, V5, P267, DOI 10.1016/0022-510X(67)90135-9; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; MCHENRY LC, 1965, NEUROLOGY, V15, P507, DOI 10.1212/WNL.15.6.507; MONTGOMERY LD, 1989, AVIAT SPACE ENVIR MD, V60, P1116; Moskalenko Iu E, 1996, Fiziol Zh Im I M Sechenova, V82, P36; MOSKALENKO YE, 1980, BIOPHYS ASPECTS CERE; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; NYBOER J, 1970, ANN NY ACAD SCI, V170, P410, DOI 10.1111/j.1749-6632.1970.tb17711.x; NYBOER J, 1960, AMA ARCH INT MED, V105, P64; Oostendorp TF, 2000, IEEE T BIO-MED ENG, V47, P1487, DOI 10.1109/TBME.2000.880100; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PATTERSON R, 1995, BIOMEDICAL ENG HDB, P1223; PEARCE WJ, 1980, STROKE, V11, P190, DOI 10.1161/01.STR.11.2.190; Perez JJ, 2000, CLIN NEUROPHYSIOL, V111, P1306, DOI 10.1016/S1388-2457(00)00304-7; PRALL JA, 1995, J TRAUMA, V38, P776, DOI 10.1097/00005373-199505000-00017; PRONK RAF, 1986, HDB ELECTROENCEPHALO, V2, P93; REIVICH M, 1980, CEREBROVASCULAR SURV; Roberts I, 2000, COCHRANE DATABASE SY, V2; ROFFEY P, 1999, CRIT CARE MED, V27, P2147; ROSNER MJ, 1995, NEUROSURG CLIN N AM, V6, P761; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; SAFAR P, 1998, ANTIAGING MED THERAP, V2, P37; Sandor P, 2003, BRAIN RES BULL, V59, P433, DOI 10.1016/S0361-9230(02)00947-4; Schmidt EA, 2002, ACT NEUR S, V81, P133; SCHUHFRIED F, 1974, WIEN KLIN WOCHENSCHR, V86, P228; SEIPEL JH, 1967, NEUROLOGY, V17, P443, DOI 10.1212/WNL.17.5.443; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Shulman RG, 2002, Q REV BIOPHYS, V35, P287, DOI 10.1017/S0033583502003803; SOKOLOVA IV, 1982, KOSM BIOL AVIAK MED+, V16, P81; Steiner LA, 2002, BRIT J NEUROSURG, V16, P429, DOI 10.1080/0268869021000030221; STRANDGAARD S, 1989, AM J HYPERTENS, V2, P486, DOI 10.1093/ajh/2.6.486; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Strandgaard S, 1995, J Cardiovasc Risk, V2, P34, DOI 10.1097/00043798-199502000-00005; SYMON L, 1986, PHARM CEREBRAL ISCHE, P31; SZABO L, 1983, ACTA PHYSIOL HUNG, V62, P113; VAINRUB A, 2004, BIOMEDICAL TECHNOLOG; VAINSHTEIN G B, 1980, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V66, P777; VAINSHTEIN G B, 1978, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V64, P564; Vainshtein G. B., 1992, Fiziologicheskii Zhurnal Imeni I M Sechenova, V78, P44; VESPA P, 2003, NEUROSURG FOCUS, V15, pE15; Waschke KF, 2004, J TRAUMA, V56, P591, DOI 10.1097/01.TA.0000075335.35705.E2; WEINDLING AM, 1982, MED BIOL ENG COMPUT, V20, P545, DOI 10.1007/BF02443401; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; WIGGERS CJ, 1950, PHYSL SHOCK, P121; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8; WOOD JH, 1987, CEREBRAL BLOOD FLOW; YONAS H, 1994, CEREBROVAS BRAIN MET, V6, P325; [No title captured]; 1997, CODE FEDERAL REGULAT, V8; 2004, PHYS SYMPTOMS EPONYM	112	12	13	1	7	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	APR	2005	26	2			SI		S1	S17		10.1088/0967-3334/26/2/001			17	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Engineering; Physiology	918QW	WOS:000228563700002	15798222				2022-02-06	
J	Xin, WK; Zhao, XH; Xu, J; Lei, G; Kwan, CL; Zhu, KM; Cho, JS; Duff, M; Ellen, RP; McCulloch, CAG; Yu, XM				Xin, WK; Zhao, XH; Xu, J; Lei, G; Kwan, CL; Zhu, KM; Cho, JS; Duff, M; Ellen, RP; McCulloch, CAG; Yu, XM			The removal of extracellular calcium: a novel mechanism underlying the recruitment of N-methyl-D-aspartate (NMDA) receptors in neurotoxicity	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						channel gating; extracellular calcium; intracellular sodium; neuronal injury; NMDA; toxicity	RAT HIPPOCAMPAL-NEURONS; FLUOROCHROME-LABELED INHIBITORS; TRAUMATIC BRAIN INJURY; ACUTE ISCHEMIC-STROKE; CELL-DEATH; INTRACEREBRAL MICRODIALYSIS; INTRACELLULAR SODIUM; GLUTAMATE RECEPTORS; CASPASE ACTIVATION; CEREBRAL-ISCHEMIA	The involvement of NMDA-type glutamate receptor in neuronal injury established in experimental stroke and neurotrauma models has been recently challenged by failures in treatment of stroke/neurotrauma patients with NMDA receptor antagonists. NMDA receptor activity is known to be essential for mediating a multitude of physiological functions. However, how NMDA receptors are recruited to cause neuronal injury remains unclear. Here we report that the time period during which initial NMDA receptor up-regulation occurs is critical for the recruitment of NMDA receptors causing neuronal injury during extracellular calcium (Ca2+) reperfusion in cultured hippocampal neurons, and represents the key period for neuronal protection by NMDA receptor antagonists. Furthermore, we identified that via intracellular sodium (Na+), extracellular Ca2+ depletion induces the up-regulation of NMDA receptor gating. Taken together, our study provides direct experimental evidence suggesting that determination of when and how NMDA receptors are recruited to cause neurotoxicity is essential for guiding treatment via antagonism of NMDA receptor functions.	Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; Univ Toronto, Fac Dent, Toronto, ON, Canada; Ctr Addict & Mental Hlth, Toronto, ON, Canada; Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON, Canada		Yu, XM (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	xianmin.yu@utoronto.ca					Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Albers GW, 1999, STROKE, V30, P508, DOI 10.1161/01.STR.30.3.508; Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; Bedner E, 2000, EXP CELL RES, V259, P308, DOI 10.1006/excr.2000.4955; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BIBBY KJ, 1994, AM J PHYSIOL, V266, pC1639; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Brewer GJ, 1999, EXP NEUROL, V159, P237, DOI 10.1006/exnr.1999.7123; Burgo A, 2003, J PHYSIOL-LONDON, V549, P537, DOI 10.1113/jphysiol.2003.041871; CHOI DW, 1993, PROG BRAIN RES, V96, P137; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COLQUHOUN D, 1990, PROC R SOC SER B-BIO, V240, P453, DOI 10.1098/rspb.1990.0048; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; EKHOLM A, 1995, EXP BRAIN RES, V104, P462; Giardina SF, 2002, BRIT J PHARMACOL, V135, P1733, DOI 10.1038/sj.bjp.0704636; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HEINEMANN U, 1986, EXP BRAIN RES, V65, P1; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; Hille B., 1992, IONIC CHANNELS EXCIT, V2nd; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kyrozis A, 1996, J PHYSIOL-LONDON, V495, P449, DOI 10.1113/jphysiol.1996.sp021606; Lei G, 1999, J CELL BIOCHEM, V75, P160, DOI 10.1002/(SICI)1097-4644(19991001)75:1<160::AID-JCB16>3.0.CO;2-B; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Ohyashiki T, 2002, TOXICOLOGY, V176, P195, DOI 10.1016/S0300-483X(02)00139-7; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; SAWYER TW, 1995, CLIN EXP PHARMACOL P, V22, P295, DOI 10.1111/j.1440-1681.1995.tb02000.x; Smolewski P, 2001, CYTOMETRY, V44, P73, DOI 10.1002/1097-0320(20010501)44:1<73::AID-CYTO1084>3.0.CO;2-S; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Verkhratsky AJ, 1998, CELL CALCIUM, V24, P333, DOI 10.1016/S0143-4160(98)90057-4; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; Westbrook GL, 1997, SOC GEN PHY, V52, P163; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xin WK, 2005, J NEUROSCI, V25, P139, DOI 10.1523/JNEUROSCI.3791-04.2005; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang L, 1997, J NEUROCHEM, V69, P1983; ZIMMERMAN AN, 1966, NATURE, V211, P646, DOI 10.1038/211646a0	57	12	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2005	21	3					622	636		10.1111/j.1460-9568.2005.03888.x			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	906OU	WOS:000227652300003	15733081				2022-02-06	
J	LaChapelle, DL; Alfano, DP				LaChapelle, DL; Alfano, DP			Revised neurobehavioral scales of the MMPI: Sensitivity and specificity in traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						MMPI; MMPI-2; neuropsychological assessment; traumatic brain injury	CLOSED-HEAD-INJURY; SPINAL-CORD INJURY; VALIDITY; PATTERNS	The ability of 23 previously identified Minnesota Multiphasic Personality Inventory (MMPI) "neurologic content" items to distinguish between individuals with traumatic brain injury (TBI; n = 32) or spinal cord injury (SCI; n = 17) was examined. Principal-components analysis of the 23 items revealed three conceptually coherent, nonoverlapping, and uncorrelated factors (Cognitive, Somatic, Inactivity) that together accounted for 44% of the total variance. Coefficients of internal consistency for the,factors were in the moderate to high range. Together, the factors were named the Revised Neurobehavioral Scales of the MMPI. The group with TBI scored significantly higher on the Cognitive scale and significantly lower on the Inactivity scale than the group with SCI (with or without depression as a covariate). The Glasgow Coma Scale correlated significantly and negatively with the Cognitive scale in the group with TBI. Discriminant function analysis revealed that together the scales correctly classified individuals with sensitivity and a positive predictive value (with respect to TBI) of 87% and 81%, respectively. Specificity and a negative predictive value (with respect to SCI) were 68% and 76%, respectively. The overall rate of correct classification of individual cases was 80% (with or without depression in the analysis). The Cognitive scale alone correctly classified individuals in the group with TBI with a positive predictive value of 84%. Findings are discussed in terms of the discriminative validity and potential utility of TBI-related MMPI items, as well as the issue of "neurocorrection" of the MMPI (or MMPI-2) in verified cases of TBI.	Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada; Univ New Brunswick, Dept Psychol, Fredericton, NB, Canada		Alfano, DP (corresponding author), Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada.	dennis.alfano@uregina.ca					Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P117; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ARTZY G, 1994, THESIS U VICTORIA BR; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cripe LI, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P291; FARR SP, 1988, MMPI USE SPECIFIC PO, P214; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; HENRYSSON S, 1962, PSYCHOMETRIKA, V27, P41; Jackson D.N., 1970, CURRENT TOPICS CLIN, VVol. 2, P61, DOI [DOI 10.1016/B978-0-12-153502-5.50008-4, 10.1016/B978-0-12-153502-5.50008-4]; LUBIN B, 1985, AM PSYCHOL, V40, P857, DOI 10.1037/0003-066X.40.7.857; McCaffrey RJ, 1996, ARCH CLIN NEUROPSYCH, V11, P11; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; [No title captured], DOI DOI 10.1177/014662167700100306	24	12	13	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	3					143	150		10.1207/S15324826AN1203_4			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965OR	WOS:000231960500004	16131341				2022-02-06	
J	Marshall, JC				Marshall, JC			The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation	SHOCK			English	Article; Proceedings Paper	Symposium on the Translational Biology of Shock and Sepsis	JUN 04-06, 2004	Lunenburg, CANADA			G-CSF (Granulocyte Colony Stimulating Factor); sepsis; shock; neutropenia; neutrophils; pre-clinical models	ACUTE LUNG INJURY; TUMOR-NECROSIS-FACTOR; FACTOR G-CSF; PSEUDOMONAS-AERUGINOSA PNEUMONIA; FULMINANT INTRAABDOMINAL SEPSIS; RANDOMIZED CONTROLLED-TRIAL; CANDIDA-ALBICANS INFECTION; TRAUMATIC BRAIN-INJURY; ESCHERICHIA-COLI; FACTOR FILGRASTIM	The cytokine granulocyte colony-stimulating factor (G-CSF) is a potent endogenous trigger for the release of neutrophils from bone marrow stores and for their activation for enhanced antimicrobial activity. G-CSF has been widely evaluated in preclinical models of acute illness, with generally promising though divergent results. A recombinant G-CSF molecule has recently undergone clinical trials to assess its efficacy as an adjuvant therapy in community-acquired and nosocomial pneumonia, however, these studies failed to provide convincing evidence of benefit. We undertook a systematic review of the published literature reporting the effects of modulation of G-CSF in preclinical in vivo models to determine whether evidence of differential efficacy might explain the disappointing results of human studies and point to disease states that might be more likely to benefit from G-CSF therapy. G-CSF has been evaluated in 86 such studies involving a variety of different models. The strongest evidence of benefit was seen in studies involving intraperitoneal challenge with live organisms; benefit was evident whether the agent was given before or after challenge. G-CSF demonstrates anti-inflammatory activity in models of systemic challenge with viable organisms or endotoxin, but only when the agent is given before challenge; evidence of benefit after challenge was minimal. Preclinical models of intrapulmonary challenge only show efficacy when the cytokine is administered before the infectious challenge, and suggested harm in gram-negative pneumonia resulting from challenge with Escherichia coli or Klebsiella. There is little evidence for therapeutic efficacy in noninfectious models of acute illness. We conclude that the most promising populations for evaluation of G-CSF are neutropenic patients with invasive infection and patients with intra-abdominal infection, particularly those with the syndrome of tertiary, or recurrent, peritonitis. Significant variability in the design and reporting of studies of preclinical models of acute illness precludes more sophisticated data synthesis.	Univ Toronto, Toronto Gen Hosp, Dept Surg, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto Gen Hosp, Interdept Div Crit Care, Toronto, ON M5G 2C4, Canada		Marshall, JC (corresponding author), 9 EN 234,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	John.Marshall@uhn.on.ca					ABRAHAM E, 1992, CRIT CARE MED, V20, P1127, DOI 10.1097/00003246-199208000-00011; Agalar F, 1998, J SURG RES, V78, P143, DOI 10.1006/jsre.1998.5386; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; AOKI Y, 1995, BLOOD, V86, P1420, DOI 10.1182/blood.V86.4.1420.bloodjournal8641420; Attalah HL, 2002, CRIT CARE MED, V30, P2107, DOI 10.1097/00003246-200209000-00026; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Azoulay E, 2003, CRIT CARE MED, V31, P157, DOI 10.1097/00003246-200301000-00025; Babalola CP, 2004, J ANTIMICROB CHEMOTH, V53, P1098, DOI 10.1093/jac/dkh237; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Barsig J, 1996, J INFECT DIS, V174, P790, DOI 10.1093/infdis/174.4.790; Basu S, 2000, BLOOD, V95, P3725; Bauhofer A, 2003, SHOCK, V20, P326, DOI 10.1097/01.shk.0000084342.58020.1e; Bauhofer A, 2002, BRIT J SURG, V89, P1457, DOI 10.1046/j.1365-2168.2002.02227.x; Boneberg EM, 2002, INFLAMM RES, V51, P119, DOI 10.1007/PL00000283; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; Buisman AM, 1996, J INFECT DIS, V174, P417, DOI 10.1093/infdis/174.2.417; CAIRO MS, 1990, BLOOD, V76, P1788; Canturk Z, 1998, ENDOCR RES, V24, P141, DOI 10.1080/07435809809135524; CEBON J, 1994, BRIT J HAEMATOL, V86, P265, DOI 10.1111/j.1365-2141.1994.tb04725.x; CHENG AC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004400.PUB3; Clark OA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003039; Dallaire F, 2001, J INFECT DIS, V183, P70, DOI 10.1086/317652; Davis KA, 1999, SURGERY, V126, P305, DOI 10.1067/msy.1999.98742; de Lalla F, 2001, ANTIMICROB AGENTS CH, V45, P1094, DOI 10.1128/AAC.45.4.1094-1098.2001; DEMARSH PL, 1994, IMMUNOPHARMACOLOGY, V27, P199, DOI 10.1016/0162-3109(94)90016-7; Dunne JR, 1996, J SURG RES, V61, P348, DOI 10.1006/jsre.1996.0128; EavesPyles T, 1996, J TRAUMA, V41, P1013, DOI 10.1097/00005373-199612000-00012; EICHACKER PQ, 1994, J APPL PHYSIOL, V77, P2366, DOI 10.1152/jappl.1994.77.5.2366; FINK MP, 1993, J TRAUMA, V34, P571, DOI 10.1097/00005373-199304000-00015; Freeman BD, 1996, J APPL PHYSIOL, V80, P2066, DOI 10.1152/jappl.1996.80.6.2066; Freeman BD, 1997, J APPL PHYSIOL, V83, P1467, DOI 10.1152/jappl.1997.83.5.1467; GORGEN I, 1992, J IMMUNOL, V149, P918; Gough A, 1997, LANCET, V350, P855, DOI 10.1016/S0140-6736(97)04495-4; GOYA T, 1993, CLIN IMMUNOL IMMUNOP, V69, P278, DOI 10.1006/clin.1993.1181; GRAYBILL JR, 1995, EUR J CLIN MICROBIOL, V14, P700, DOI 10.1007/BF01690878; Haberstroh J, 1998, SHOCK, V9, P128, DOI 10.1097/00024382-199802000-00009; HABERSTROH J, 1995, SHOCK, V4, P216, DOI 10.1097/00024382-199509000-00011; HAMOOD M, 1994, MYCOSES, V37, P93, DOI 10.1111/j.1439-0507.1994.tb00783.x; Hanaoka M, 1998, EXP LUNG RES, V24, P15, DOI 10.3109/01902149809046051; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Hebert JC, 1997, J TRAUMA, V43, P875, DOI 10.1097/00005373-199712000-00001; Held TK, 1998, BLOOD, V91, P2525; Hubel K, 2002, J INFECT DIS, V185, P1490, DOI 10.1086/340221; Hustinx W, 1997, EUR J CLIN INVEST, V27, P1044, DOI 10.1046/j.1365-2362.1997.2290787.x; ICHIKAWA Y, 1966, P NATL ACAD SCI USA, V56, P488, DOI 10.1073/pnas.56.2.488; IGUCHI K, 1991, EXP HEMATOL, V19, P352; Ishikawa K, 1998, J TRAUMA, V44, P1047, DOI 10.1097/00005373-199806000-00018; KANAZAWA M, 1992, AM REV RESPIR DIS, V145, P1030, DOI 10.1164/ajrccm/145.5.1030; Karzai W, 1999, AM J RESP CRIT CARE, V159, P1377, DOI 10.1164/ajrccm.159.5.9806082; Kastenbauer T, 2003, DIABETOLOGIA, V46, P27, DOI 10.1007/s00125-002-0998-z; KAWAKAMI M, 1990, BLOOD, V78, P3254; KAYASHIMA S, 1993, IMMUNOLOGY, V80, P471; KING J, 1995, AM J RESP CRIT CARE, V151, P302, DOI 10.1164/ajrccm.151.2.7531097; KOIKE K, 1992, J SURG RES, V52, P656, DOI 10.1016/0022-4804(92)90145-P; KOIZUMI T, 1993, AM REV RESPIR DIS, V148, P132, DOI 10.1164/ajrccm/148.1.132; Kullberg BJ, 1998, J INFECT DIS, V177, P175, DOI 10.1086/513812; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; LISTER PD, 1993, J INFECT DIS, V168, P922, DOI 10.1093/infdis/168.4.922; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; LORENZ W, 1994, SURGERY, V116, P925; Lundblad R, 1996, CRIT CARE MED, V24, P820, DOI 10.1097/00003246-199605000-00016; LUNDBLAD R, 1995, SHOCK, V4, P68, DOI 10.1097/00024382-199507000-00011; Marshall John C, 1998, Sepsis (Boston), V2, P213, DOI 10.1023/A:1009829712638; MATSUMOTO M, 1991, J ANTIMICROB CHEMOTH, V28, P447, DOI 10.1093/jac/28.3.447; Meng ZH, 2000, SHOCK, V14, P41, DOI 10.1097/00024382-200014010-00008; METCALF D, 1983, J CELL PHYSIOL, V116, P198, DOI 10.1002/jcp.1041160211; Metcalf D, 1996, BLOOD, V88, P3755, DOI 10.1182/blood.V88.10.3755.bloodjournal88103755; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Nathens AB, 1998, WORLD J SURG, V22, P158, DOI 10.1007/s002689900364; Nelson S, 1996, CLIN CHEST MED, V17, P319, DOI 10.1016/S0272-5231(05)70317-8; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Nelson S, 2000, J INFECT DIS, V182, P970, DOI 10.1086/315775; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Nose M, 2001, J RADIAT RES, V42, P191, DOI 10.1269/jrr.42.191; NOVALES JS, 1993, BLOOD, V81, P923; OREILLY M, 1992, J TRAUMA, V33, P679, DOI 10.1097/00005373-199211000-00014; Oz N, 2001, Int J Surg Investig, V2, P347; Pajkrt D, 1997, BLOOD, V90, P1415, DOI 10.1182/blood.V90.4.1415.1415_1415_1424; Patton JH, 1998, J TRAUMA, V44, P750, DOI 10.1097/00005373-199805000-00002; Peter FW, 1999, BURNS, V25, P477, DOI 10.1016/S0305-4179(99)00036-4; Piper RD, 1996, CRIT CARE MED, V24, P2059, DOI 10.1097/00003246-199612000-00021; POLAKWYSS A, 1991, MYCOSES, V34, P109, DOI 10.1111/j.1439-0507.1991.tb00630.x; Pollmacher T, 1996, BLOOD, V87, P900, DOI 10.1182/blood.V87.3.900.bloodjournal873900; Preheim LC, 1996, J INFECT DIS, V174, P225, DOI 10.1093/infdis/174.1.225; QUEZADO Z, 2004, AM J PHYSL INTEGR CO, V281, pR1177; Rao R, 1996, SURGERY, V119, P657, DOI 10.1016/S0039-6060(96)80190-5; Schaefer H, 2004, ANN SURG, V240, P68, DOI 10.1097/01.sla.0000129705.00210.24; Schafer H, 2000, ANN HEMATOL, V79, P143, DOI 10.1007/s002770050570; Schneider C, 2004, ANN SURG, V239, P75, DOI 10.1097/01.sla.0000103062.21049.82; SERUSHAGO BA, 1992, IMMUNOLOGY, V75, P475; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; SHINOMIYA N, 1991, INFECT IMMUN, V59, P4740, DOI 10.1128/IAI.59.12.4740-4743.1991; Shirai R, 1997, CLIN EXP IMMUNOL, V109, P73, DOI 10.1046/j.1365-2249.1997.4211317.x; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; SMITH WS, 1995, BLOOD, V86, P1301, DOI 10.1182/blood.V86.4.1301.bloodjournal8641301; STEINSHAMN S, 1993, J INFECT DIS, V168, P1444, DOI 10.1093/infdis/168.6.1444; Takahashi Y, 1999, ACTA HAEMATOL-BASEL, V101, P124, DOI 10.1159/000040937; TERASHIMA T, 1994, AM J RESP CRIT CARE, V149, P1295, DOI 10.1164/ajrccm.149.5.7513596; Tian SS, 1998, SCIENCE, V281, P257, DOI 10.1126/science.281.5374.257; TODA H, 1993, STEM CELLS, V11, P228, DOI 10.1002/stem.5530110310; Torossian A, 2003, ANESTHESIOLOGY, V99, P1087, DOI 10.1097/00000542-200311000-00014; UCHIDA K, 1992, J MED VET MYCOL, V30, P293; Villa P, 1998, J INFECT DIS, V178, P471, DOI 10.1086/515643; Vollmar B, 1997, J LEUKOCYTE BIOL, V62, P710, DOI 10.1002/jlb.62.6.710; WAKIYAMA H, 1993, CLIN EXP IMMUNOL, V92, P218; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Winston DJ, 1999, TRANSPLANTATION, V68, P1298, DOI 10.1097/00007890-199911150-00014; Wolkoff LI, 2002, LUNG, V180, P229, DOI 10.1007/s004080000097; Wunderink RG, 2001, CHEST, V119, P523, DOI 10.1378/chest.119.2.523; Yalcin O, 1997, SURG TODAY, V27, P154, DOI 10.1007/BF02385906; Yonem A, 2001, DIABETES OBES METAB, V3, P332, DOI 10.1046/j.1463-1326.2001.00142.x; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang P, 1997, SHOCK, V7, P193, DOI 10.1097/00024382-199703000-00007; Zhang P, 1998, CRIT CARE MED, V26, P315, DOI 10.1097/00003246-199802000-00035	115	12	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock		2005	24			1			120	129		10.1097/01.shk.0000191344.21228.b6			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	999XR	WOS:000234425400019	16374383				2022-02-06	
S	Pillay, NS; Kellaway, LA; Kotwal, GJ		Kotwal, GJ; Lahiri, DK		Pillay, NS; Kellaway, LA; Kotwal, GJ			Administration of vaccinia virus complement control protein shows significant cognitive improvement in a mild injury model	NATURAL PRODUCTS AND MOLECULAR THERAPY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	1st International Conference on Natural Products and Molecular Medicine	JAN 13-15, 2005	Univ Cape Town, Cape Town, SOUTH AFRICA		Univ Cape Town	complement control; cognition; mild injury; vaccinia virus; VCP; Morris water maze (MWM); fluid percussion injury (FPI); traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; FLUID; RAT; EXTRAVASATION; EXPRESSION	Previous studies have shown that traumatic mild brain injury in a rat model is accompanied by breakdown of the blood brain barrier and the accumulation of inflammatory cells. A therapeutic agent, vaccinia virus complement control protein (VCP), inhibits both the classic and the alternative pathways of the complement system and, in so doing, prevents cell death and inflammation. With the use of a rat mild injury model, the effects of VCP on spatial learning and memory were tested. Training in a Morris water maze consisted of a total of 16 trials over a 2-day period before rats were anesthetized and subjected to mild (1.0-1.1 atm) lateral fluid percussion injury (FPI) 3.0 mm lateral to the sagittal suture and 4.5 mm posterior to bregma. Ten mu l of VCP (1.7 mg/ml) was injected into the injury site immediately after FPI. Two weeks post-FPI the rats were assessed in the Morris water maze for spatial learning and memory. Neurologic motor function tests were carried out after FPI for 14 consecutive days and again after 28 days. The Morris water maze data show that FPI plus saline-injected rats spent a significantly (P < 0.05) larger amount of time in one of the incorrect quadrants than did the FPI plus VCP-injected group. Neurologic evaluations 24 hours postinjury revealed differences in sensorimotor function between groups. The results suggest that in a mild injury model, VCP influences neurologic outcome and offers some enhancement in spatial memory and learning.	Univ Cape Town, Sch Med, Div Med Virol, Observ, ZA-7925 Cape Town, South Africa; Univ Cape Town, Div Neurosci, ZA-7925 Cape Town, South Africa		Kotwal, GJ (corresponding author), Univ Cape Town, Sch Med, Div Med Virol, Observ, Anzio Rd, ZA-7925 Cape Town, South Africa.	gjkotw01@yahoo.corn			Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pillay Nirvana S., 2004, Current Alzheimer Research, V1, P295, DOI 10.2174/1567205043331965; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; PRINS ML, 1996, DEV BRAIN RES, V95, P115; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; vanderStaay FJ, 1996, BRAIN RES, V735, P271; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; [No title captured]	25	12	12	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-595-8; 1-57331-594-X	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2005	1056						450	461		10.1196/annals.1352.021			12	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Medicine, Research & Experimental; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Research & Experimental Medicine; Science & Technology - Other Topics	BDU43	WOS:000235433100037	16387708				2022-02-06	
J	Seki, Y; Kimura, M; Mizutani, N; Fujita, M; Aimi, Y; Suzuki, Y				Seki, Y; Kimura, M; Mizutani, N; Fujita, M; Aimi, Y; Suzuki, Y			Cerebrospinal fluid taurine after traumatic brain injury	NEUROCHEMICAL RESEARCH			English	Article						cytotoxic edema; regulatory volume decrease; taurine; traumatic brain injury	AMINO-ACIDS; GLUTAMATE; RELEASE; ANION; POTASSIUM; INCREASES; VOLUME	In the experimental setting, taurine is known to be released from swollen cells to reestablish their normal volume. However, its clinical relevance has not been fully understood. This study was undertaken to reveal changes in cerebrospinal fluid (CSF) amino acids concentration in patients with severe traumatic brain injury (TBI). The study included eight patients, in whom a ventricular catheter was inserted to measure intracranial pressure and obtain CSF samples for 5 days. CSF obtained from patients with normal pressure hydrocephalus served as a control. CSF taurine concentration increased 1.8 times control (P < 0.05) after TBI and returned to control value approximately 67 h after injury. Taurine decreased further and remained lower than control thereafter. Phosphoethanolamine showed similar increase, whereas glutamine decreased transiently and arginine remained close to control value. The present data support the period of astrocytic swelling observed after TBI in other morphological studies. The mechanism and consequences of CSF taurine decrease in the subacute stage of TBI need to be elucidated.	Chubu Rousai Hosp, Dept Neurosurg, Minato Ku, Nagoya, Aichi 4558530, Japan; Daini Red Cross Hosp, Dept Neurosurg, Nagoya, Aichi, Japan		Seki, Y (corresponding author), Chubu Rousai Hosp, Dept Neurosurg, Minato Ku, 1-10-6 Komei, Nagoya, Aichi 4558530, Japan.	seki.nes@chubuh.rofuku.go.jp	Fujita, Mitsugu/A-6690-2009	Fujita, Mitsugu/0000-0002-0000-9879			Anderson RM, 1998, AM J FOREN MED PATH, V19, P1, DOI 10.1097/00000433-199803000-00001; Birdsall T C, 1998, Altern Med Rev, V3, P128; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Estevez AY, 1999, NEUROCHEM RES, V24, P447, DOI 10.1023/A:1020902104056; HAYES KC, 1985, NUTR REV, V43, P65, DOI 10.1111/j.1753-4887.1985.tb06862.x; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; LEE PLY, 1988, CLIN CHEM, V34, P719; Liu Y, 1998, MOL BRAIN RES, V59, P189, DOI 10.1016/S0169-328X(98)00145-4; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; PAAUW JD, 1990, AM J CLIN NUTR, V52, P657, DOI 10.1093/ajcn/52.4.657; Park E, 1998, ADV EXP MED BIOL, V442, P177; Pasantes-Morales H, 1998, ADV EXP MED BIOL, V442, P209; PASANTESMORALES H, 1989, GLIA, V2, P45, DOI 10.1002/glia.440020105; POMARA N, 1992, AM J PSYCHIAT, V149, P251; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; ROSENBERG GA, 1980, AM J PHYSIOL, V238, pF42, DOI 10.1152/ajprenal.1980.238.1.F42; SCHOUSBOE A, 1992, CAN J PHYSIOL PHARM, V70, pS356, DOI 10.1139/y92-283; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SOLIS JM, 1988, NEUROSCI LETT, V91, P53, DOI 10.1016/0304-3940(88)90248-0; Stapleton PP, 1998, JPEN-PARENTER ENTER, V22, P42, DOI 10.1177/014860719802200142; STAUB F, 1990, J CEREBR BLOOD F MET, V10, P866, DOI 10.1038/jcbfm.1990.143; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135	25	12	12	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2005	30	1					123	128		10.1007/s11064-004-9693-4			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	896OQ	WOS:000226943800015	15756940				2022-02-06	
J	Schmitter-Edgecombe, M; Woo, E				Schmitter-Edgecombe, M; Woo, E			Memory self-awareness and memory self-monitoring following severe closed-head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; FRONTAL-LOBE LESIONS; TASK-PERFORMANCE; WORKING-MEMORY; METAMEMORY; ADULTS; ACCURACY; DAMAGE; PREDICTIONS	Objective: To examine the accuracy of memory self-awareness and memory self-monitoring abilities in participants with severe closed-head injury (CHI). Design and methods: A performance-prediction paradigm was used to evaluate meta-memory abilities in 31 participants with severe CHI (>1 year post-injury) and 31 controls. To assess memory self-awareness, before completing story recall, visual reproduction and list learning memory tasks, participants predicted the amount of information they would remember for each task. Memory self-monitoring was evaluated by examining participants' ability to increase the accuracy of their predictions following experience with each memory task. Results: Although participants with CHI exhibited poorer recall than controls, they were equally aware of how differing task demands influence recall. They also successfully modified their predictions following task exposure. Conclusions: Meta-memory was better preserved than actual memory performance. It may be possible to build on meta-memory skills to help patients with CHI more consistently use strategies that aid memory performance.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Cohen J, 1983, APPL MULTIPLE REGRES, P56; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DELIS D, 1987, CALIFORNIA VERBAL LE; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; DEVOLDER PA, 1989, CAN PSYCHOL, V30, P578, DOI 10.1037/h0079822; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Golden J. C., 1978, STROOP COLOR WORD TE; Heaton RK, 1981, MANUAL WISCONSIN CAR; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; HERTZOG C, 1994, AGING COGNITION, V1, P203, DOI DOI 10.1080/13825589408256577; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Jurado MA, 1998, J CLIN EXP NEUROPSYC, V20, P353, DOI 10.1076/jcen.20.3.353.816; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Mattis S, 1988, DEMENTIA RATING SCAL; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P933, DOI 10.1076/jcen.25.7.933.16493; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328	50	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2004	18	10					997	1016		10.1080/02699050410001719934			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	845LQ	WOS:000223244600004	15370899				2022-02-06	
J	Esselman, PC; Dikmen, SS; Bell, K; Temkin, NR				Esselman, PC; Dikmen, SS; Bell, K; Temkin, NR			Access to inpatient rehabilitation after violence-related traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; violence	MODEL SYSTEMS; OUTCOMES	Objectives: To examine injury characteristics, demographics, and discharge disposition after traumatic brain injury of violent or nonviolent cause. Design: Cohort study. Setting: Level I trauma center. Participants: Patients (N = 1807) admitted with a Head Abbreviated Injury Score (AIS) of 2 or more over a 2-year period. Interventions: Not applicable. Main Outcome Measures: Injury cause was classified as violent or nonviolent. Discharge disposition was classified as home, inpatient rehabilitation, skilled nursing facility (SNF), and other. Results: The violence group was more likely to be male, to include individuals from diverse racial groups, to have an alcohol level above the legal limit, to have a more severe Head AIS, and to have Medicaid funding and equal access to inpatient rehabilitation compared with the nonviolence group. The violence group, though, was more likely to be discharged to home than to inpatient rehabilitation and more likely to be discharged to inpatient rehabilitation than to an SNF. The nonviolence group had a longer acute care length of stay and a higher rate of injuries to other body systems. Conclusions: People with violence-related injuries often present unique rehabilitation challenges. After accounting for injury severity and demographics, there was no evidence of bias against the violently injured in gaining access to inpatient rehabilitation services.	Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; Univ Washington, Dept Biostat, Seattle, WA 98104 USA		Esselman, PC (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, 325 9Th Ave, Seattle, WA 98104 USA.	esselman@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046			*AM MED ASS, 1997, INT CLASS DIS; *ASS ADV AUT MED, 1990, ABBR INJ SC; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; TEASDALE G, 1974, LANCET, V2, P81; *US DHHS CDC NAT C, 1999, TRAUM BRAIN INJ US	12	12	12	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2004	85	9					1445	1449		10.1016/j.apmr.2003.10.018			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	852DW	WOS:000223736400009	15375814				2022-02-06	
J	Simpson, G; Long, E				Simpson, G; Long, E			An evaluation of sex education and information resources and their provision to adults with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability process evaluation; sex education; traumatic brain injury		Objectives: To evaluate sex education and information resources developed to address the sexual health concerns of persons with traumatic brain injury (TBI) and the means by which agencies have introduced this clinically sensitive program initiative. Design: A process evaluation methodology was used to assess program reach, participant satisfaction, program component usage, and quality of materials. Subjects: Two samples comprising multidisciplinary rehabilitation and disability staff (n = 37) from 36 brain injury agencies that had been utilizing the resources and 12 people with brain injury, respectively. Settings: A diverse range of rehabilitation and community brain injury agencies. Outcome Measures: Two purpose-designed evaluation protocols for staff and consumers, respectively, and a readability analysis to assess the comprehensibility of program materials (eg, information sheets) for people with TBI. Results: Agencies strongly endorsed their role in addressing consumer sexual health concerns. Agencies generally used a selective rather than a universal approach to sex education, with an average of 10% of consumers within agency caseloads receiving some intervention within the previous 12 months. The 4 issues most frequently addressed in education programs were sexual dysfunction, how to meet people, what is sexuality, and sexual adjustment in the context of established preinjury relationships. Finally, the average reading age needed to comprehend the resources was higher than the recommended levels for communicating health information. Conclusion: The sex education program resources have been positively evaluated by both rehabilitation and community agencies as a means of providing education and information to address the sexual health concerns of people with TBI.	Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW 1871, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Sydney, NSW 1871, Australia.	grahame.simpson@swahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Balakrishna J, 1998, EUR EAT DISORD REV, V6, P136; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; COUGHLIN A, 2003, PERSONAL SEXUAL RELA; CRAFT A, 1992, LIVING LIFE SEX ED P; CRAFT A, 1994, INT J ADOLESCENT MED, V7, P133; CRENSHAW TL, 1985, MED ASPECTS HUMAN SE, V19, P115; CUSHMAN LA, 1988, J REHABIL, V54, P65; DAWSON H, 1999, SEXUALITY ACQUIRED B; DUCHARME S, 1994, INT J ADOLESC MED HL, V7, P174; *ED UN FAM PLANN A, 1990, DOUBL TAB SEX DIS SY; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; FRY E, 1977, J READING, V21, P242; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Griffith ER, 1993, SEXUALITY PERSON TRA; GRIFFITHS D, 1992, STILL SMILING SEXUAL; Gunning R., 1952, TECHNIQUE CLEAR WRIT; HAWE P, 1993, EVALUATING HLTH PROM; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; HORSLEY P, 1990, SEXUALITY RIGHTS CHO; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LAWRENCE P, 1993, DISABILITY HANDICAP, V8, P405, DOI DOI 10.1080/02674649366780381; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; MCLAUGHLIN GH, 1969, J READING, V12, P639; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; MEDLAR TM, 1998, SEX DISABIL, V16, P1; MILLER L, 1994, J COGN REHABIL, V6, P12; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; POWERS RD, 1958, J EDUC PSYCHOL, V49, P99, DOI 10.1037/h0043254; RICHARDSON D, 1986, SEXUAL THERAPY GUIDE; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SHAPIRO ES, 1985, APPL RES MENT RETARD, V6, P307, DOI 10.1016/0270-3092(85)90004-9; Simpson G, 2003, BRAIN INJURY, V17, P723, DOI 10.1080/0269905031000110481; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; SIMPSON GK, 2002, P 13 EUR C PHYS MED, P204; SIMPSON GK, 1997, YOU ME GUIDE SEX SEX; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 2003, BRAIN INF S, V17, P105; Tepper MS., 1992, SEX DISABIL, V10, P15, DOI [10.1007/BF01102245, DOI 10.1007/BF01102245]; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TORNAS TS, 2003, BRAIN INJURY, V17, P97; *US DEP HHS, 1984, PRET HLTH COMM METH; ZASLER N, 1992, SEXUALITY ISSUES FLO; ZASLER ND, 1995, PHYS MED REHABIL STA, V9, P361; ZILBERGELD B, 1978, MED SEX GUIDE SEXUAL; Zinn W M, 1981, Int Rehabil Med, V3, P18; [No title captured]	54	12	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					413	428		10.1097/00001199-200409000-00006			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300006	15597032				2022-02-06	
J	Dong, K; Li, B; Guan, QL; Huang, T				Dong, Ke; Li, Bo; Guan, Quan-Lin; Huang, Tao			Analysis of multiple factors of postsurgical gastroparesis syndrome after pancreaticoduodenectomy and cryotherapy for pancreatic cancer	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article								AIM: To explore the etiology, pathogenesis, diagnosis, and treatment of postsurgical gastroparesis syndrome (PGS) after pancreatic cancer cryotherapy (PCC) or pancreatico-duodenectomy (PD), and to analyze the correlation between the multiple factors and PGS caused by the operations. METHODS: Clinical data of 210 patients undergoing PD and 46 undergoing PCC were analyzed retrospectively. RESULTS: There were 31 (67%, 31/46) patients suffering PGS in PCC group, including 29 with pancreatic head and uncinate tumors and 2 with pancreatic body and tail tumors. Ten patients (4.8%, 10/210) developed PGS in PD group, which had a significantly lower incidence of PGS than PCC group (chi = 145, P<0.001). In PCC group, 9 patients with PGS were managed with non-operative treatment (drugs, diet, nasogastric suction, etc.), and one received reoperation at the 16th day, but the symptoms were not relieved. In PD group, all the patients with PGS were managed with non-operative treatment. The PGS in patients undergoing PCC had close association with PCC, tumor location, but not with age, gender, obstructive jaundice, hypoproteinemia, preoperative gastric outlet obstruction and the type and number of gastric biliary tract operations. The mechanisms of PGS caused by PD were similar to those of PGS following gastrectomy. The damage to interstitial cells of Cajal might play a role in the pathogenesis of PGS after PCC, for which multiple factors were possibly responsible, including ischemic and neural injury to the antropyloric muscle and the duodenum after freezing of the pancreatico-duodenal regions or reduced circulating levels of motilin. CONCLUSION: PGS after PCC or PD is induced by multiple factors and the exact mechanisms, which might differ between these two operations, remain unknown. Radiography of the upper gastrointestinal tract and gastroscopy are main diagnostic modalities for PGS. Non-operative treatments are effective for PGS, and reoperation should be avoided in patients with PGS caused by PCC. Dong K, Li B, Guan QL, Huang T. Analysis of multiple factors of postsurgical gastroparesis syndrome after pancreaticodu-odenectomy and cryotherapy for pancreatic cancer. World J Gastroenterol 2004; 10(16): 2434-2438 http://www.wjgnet.com/1007-9327/10/2434.asp	[Dong, Ke; Li, Bo; Guan, Quan-Lin; Huang, Tao] Sichuan Univ, W China Hosp, Dept Gen Surg, Chengdu 610041, Sichuan Provinc, Peoples R China		Li, B (corresponding author), Sichuan Univ, W China Hosp, Dept Gen Surg, Chengdu 610041, Sichuan Provinc, Peoples R China.	cdlibo@medmail.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	Research Foundation of Department of Health of Sichuan Province [000050]	Supported by the Research Foundation of Department of Health of Sichuan Province, No. 000050	Abell T, 2003, JPEN-PARENTER ENTER, V27, P277, DOI 10.1177/0148607103027004277; B Li, 2000, ZHONGGUO PUWAI JICHU, V7, P390; Cai YT, 1999, ZHONGGUO SHIYONG WAI, V19, P338; Chen XL, 1998, ZHONGGUO PUWAI JICHU, V5, P324; DONAHUE PE, 1984, SURGERY, V96, P585; HOROWITZ M, 1994, DIGEST DIS SCI, V39, pS7, DOI 10.1007/BF02300360; Jones MP, 2003, AM J GASTROENTEROL, V98, P2122, DOI 10.1016/S0002-9270(03)00754-8; Koch K L, 2001, Diabetes Technol Ther, V3, P51; Kovach SJ, 2002, SURGERY, V131, P463, DOI 10.1067/msy.2002.121231; Lawlor PM, 2001, IRISH J MED SCI, V170, P126, DOI 10.1007/BF03168826; Lehmann R, 2003, EXP CLIN ENDOCR DIAB, V111, P255, DOI 10.1055/s-2003-41283; Lin ZY, 2003, DIGEST DIS SCI, V48, P837, DOI 10.1023/A:1023099206939; Liu FL, 2002, ZHONGHUA WEICHANG WA, V5, P245; MALFERTHEINER P, 1989, GASTROENTEROLOGY, V96, P200, DOI 10.1016/0016-5085(89)90781-6; Matsunaga H, 2000, WORLD J SURG, V24, P1236, DOI 10.1007/s002680010244; Naritomi G, 1996, SURGERY, V120, P831, DOI 10.1016/S0039-6060(96)80091-2; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Patiutko Iu I, 1991, Vopr Onkol, V37, P695; Qin XY, 2000, ZHONGGUO WEICHANG WA, V3, P7; SCHIRMER BD, 1994, GASTROENTEROL CLIN N, V23, P327; Stanciu G O, 2001, Rev Med Chir Soc Med Nat Iasi, V105, P451; Toyota N, 1998, HEPATO-GASTROENTEROL, V45, P1005; Watkins PJ, 2003, DIABETIC MED, V20, P58, DOI 10.1046/j.1464-5491.2003.00872.x; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	24	12	15	0	2	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	AUG 15	2004	10	16					2434	2438					5	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	V23BF	WOS:000208317600029	15285038				2022-02-06	
J	Chan, RCK; Chen, EYH; Cheung, ERC; Chen, RYL; Cheung, HK				Chan, RCK; Chen, EYH; Cheung, ERC; Chen, RYL; Cheung, HK			Problem-solving ability in chronic schizophrenia - A comparison study of patients with traumatic brain injury	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						problem-solving; schizophrenia; brain injury	SPATIAL WORKING-MEMORY; TEMPORAL-LOBE LESIONS; FRONTAL-LOBE; ATTENTIONAL DEFICITS; PLANNING ABILITY; HANOI; PERFORMANCE; TOWER	We tested the hypothesis that patients with schizophrenia are more prone to impairment in planning and problem-solving as compared with normal controls and patients with traumatic brain injury (TBI) by administering the Tower of Hanoi (TOH) task. A total of one hundred and fifty-three participants (51 in each group) were recruited. The performance of the patient groups was markedly worse than normal controls in terms of profile score, number of rule-breaking behaviour, and mean execution time. Two-way 3 (group) x 6 (complexity) ANOVAs indicated that significant main effects of group and complexity were observed in the number of moves, planning time to initiate the first move and subsequent execution time. The general performance of TOH in the schizophrenia group was very similar to that of the TBI group. Subsequent comparison of sub-groups of frontal and posterior lobe damage indicated the pattern of performance in schizophrenia patients lie between them. Taken together, these findings suggest that neither focal frontal nor temporal lobe damage is a sufficient explanation for the problem-solving deficits in patients with schizophrenia.	Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Peoples R China; Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Castle Peak Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China		Chan, RCK (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Peoples R China.	rckchan@hkucc.hku.hk	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X; Chen, Eric/0000-0002-5247-3593			American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Bustini M, 1999, J PSYCHIATR RES, V33, P285, DOI 10.1016/S0022-3956(98)00063-6; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chan RCK, 2002, J INT NEUROPSYCH SOC, V8, P771, DOI 10.1017/S1355617702860052; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; Falkai P, 2003, EUR ARCH PSY CLIN N, V253, P92, DOI 10.1007/s00406-003-0414-9; GATTAZ WF, 1990, SEARCH CAUSES SCHIZO, V2, P242; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Goldberg T E, 1990, J Neuropsychiatry Clin Neurosci, V2, P165; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; GOLDMANRAKIC PS, 1990, PSYCHOPATHOLOGY BRAI, P1; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Marczewski P., 2001, COGNITIVE NEUROPSYCH, V6, P175, DOI DOI 10.1080/13546800042000115; Morris RG, 1997, COGN NEUROPSYCHOL, V14, P1007, DOI 10.1080/026432997381330; MORRIS RG, 1995, SCHIZOPHR RES, V14, P235, DOI 10.1016/0920-9964(94)00044-9; Newell A., 1972, HUMAN PROBLEM SOLVIN; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; Rushe TM, 1999, SCHIZOPHR RES, V37, P21, DOI 10.1016/S0920-9964(98)00129-7; SCHMAND B, 1992, SCHIZOPHR RES, V8, P157, DOI 10.1016/0920-9964(92)90032-Z; SHARPIRO RM, 1993, SCHIZOPHR RES, V10, P187; Tiryaki A, 2003, EUR ARCH PSY CLIN N, V253, P221, DOI 10.1007/s00406-003-0434-5; WEINBERGER DR, 1988, TRENDS NEUROSCI, V11, P367, DOI 10.1016/0166-2236(88)90060-4	26	12	12	0	4	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY	0940-1334			EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	AUG	2004	254	4					236	241		10.1007/s00406-004-0486-1			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	846JA	WOS:000223310600007	15309393				2022-02-06	
J	Marshall, RC; Karow, CM; Morelli, CA; Iden, KK; Dixon, J; Cranfill, TB				Marshall, RC; Karow, CM; Morelli, CA; Iden, KK; Dixon, J; Cranfill, TB			Effects of interactive strategy modelling training on problem-solving by persons with traumatic brain injury	APHASIOLOGY			English	Article							FRONTAL-LOBE DAMAGE; QUESTIONING STRATEGIES; DEFICITS; CHILDREN	Background : Problem-solving skills may be affected by traumatic brain injury (TBI). Because the ability to solve problems is integral to the social, educational, and vocational reintegration of persons who have sustained a TBI, interventions to improve this executive function have become an important part of rehabilitation. Aims : This Phase I study examined the effects of a behavioural intervention, interactive strategy modelling training (ISMT), on problem solving by individuals who had incurred a TBI. Methods & Procedures : Study participants were 20 individuals recruited from TBI support groups. All lived at home and were several months post-injury. Participants received a period of ISMT intended to train them to use meta-cognitive strategies to solve 20-questions problems. RAPS (Rapid Assessment of Problem Solving), a clinical test of problem solving was used to assess the effects of ISMT (Marshall, Karow, Morelli, Iden, & Dixon, 2003a). RAPS was administered before (Pre-training), after (Post-training), and 1-month after training (Follow-up). Outcomes & Results : Participants improved in problem solving significantly on RAPS from the Pre- to the Post-training tests. Specifically, they (a) solved problems with fewer questions, (b) asked more constraint-seeking questions, and (c) increased their question-asking efficiency scores. These improvements were maintained on the Follow-up test. Conclusions : Improved problem solving on RAPS was associated with better planning and strategy use, less impulsivity, and strategy shifting. Results suggest that IMST had a therapeutic effect and indicate a need to develop further hypotheses for testing ISMT in functional contexts.	Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40536 USA; Univ Kentucky, Div Commun Disorders, Lexington, KY 40536 USA; Univ Rhode Isl, Kingston, RI 02881 USA; Univ Florida, Gainesville, FL USA; Vet Adm Med Ctr, Providence, RI 02908 USA; Massachusetts Hosp Sick Children, Boston, MA USA		Marshall, RC (corresponding author), Univ Kentucky, Dept Rehabil Sci, Room 124-F,900 S Limestone, Lexington, KY 40536 USA.						ADAMOVICH B, 1985, CCOGNITIVE REHABILIT; AITKEN S, 1993, ARCH CLIN NEUROPSYCH, V8, P212; ALLEN G, 1976, COMMUNITY PSYCHOL SC; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARTON JA, 1988, J EDUC PSYCHOL, V80, P184, DOI 10.1037/0022-0663.80.2.184; Ben-Yishay Y, 1983, REHABILITATION HEAD, P367; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Burgess P, 1996, BEHAV ASSESSMENT DYS; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; DENNEY DR, 1975, J EXP CHILD PSYCHOL, V19, P476, DOI 10.1016/0022-0965(75)90077-6; DENNEY DR, 1973, DEV PSYCHOL, V8, P202, DOI 10.1037/h0034144; DENNEY DR, 1972, CHILD DEV, V43, P810, DOI 10.2307/1127633; DENNEY NW, 1974, DEV PSYCHOL, V10, P458, DOI 10.1037/h0036444; DENNEY NW, 1985, INT J AGING HUM DEV, V21, P161, DOI 10.2190/A3J2-75L4-01C3-W81W; DENNEY NW, 1974, CHILD DEV, V45, P1108; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; GILLIS R, 1996, TRAUMATIC BRAIN INJU; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GRATTAN LM, 1994, NEUROPSY NEUROPSY BE, V7, P251; Kaplan E, 1983, BOSTON NAMING TEST; KING A, 1991, J EDUC PSYCHOL, V83, P307, DOI 10.1037/0022-0663.83.3.307; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria A.R., 1973, WORKING BRAIN INTRO; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Marshall RC, 2003, AM J SPEECH-LANG PAT, V12, P333, DOI 10.1044/1058-0360(2003/079); Marshall RC, 2003, BRAIN INJURY, V17, P589, DOI 10.1080/0269905031000088496; MERTZGARCIA J, 1986, J COMMUN DISORD, V19, P395; Mosher F.A., 1966, STUDIES COGNITIVE GR, P86; MURRAY L, 2001, LANGUAGE INTERVENTIO, P85; NEZU CM, 1991, RES DEV DISABIL, V12, P371, DOI 10.1016/0891-4222(91)90033-O; O'Reilly MF, 2000, J VOCAT REHABIL, V14, P187; ODDY M, 1984, CLOSED HEAD INJURY P, P285; PURDY M, 2000, APHASIOLOGY, V16, P549; Raven J.C., 1984, COLOURED PROGR MATRI; Rende Barbara, 2000, Seminars in Speech and Language, V21, P121, DOI 10.1055/s-2000-7560; SAARNIO P, 1993, ALCOHOL ALCOHOLISM, V28, P585; SELINGER M, 1993, APHASIOLOGY, V7, P165, DOI 10.1080/02687039308249504; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SOHBERG MM, 1989, INTRO COGNITIVE REHA; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; TWOMBLY CA, 1998, AM J OCCUPATIONAL TH, V52, P810; VILKKI J, 1988, CORTEX, V24, P119, DOI 10.1016/S0010-9452(88)80020-0; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YLVISAKER M, 1987, COMMUNITY REENTRY HE	51	12	12	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	AUG	2004	18	8					659	673		10.1080/02687030444000237			15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	835ZK	WOS:000222524300001					2022-02-06	
J	Wood, RL; Rutterford, NA				Wood, RL; Rutterford, NA			Relationships between measured cognitive ability and reported psychosocial activity after bilateral frontal lobe injury: An 18-year follow-up	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; HEAD-INJURY; ECOLOGICAL VALIDITY; SIMPLIFIED VERSION; EMPLOYMENT; DEFICITS; WORK; REHABILITATION; BEHAVIOR	This case study illustrates a well-established paradox often seen after serious frontal injury. Some individuals have little or no neurological abnormality, perform well on cognitive tests, and display an apparently "normal" social appearance, yet have serious, if subtle, neurobehavioural disability that prevents reliable and efficient performance in a number of daily activities. In this case study, we report the psychosocial progress of a young man who suffered serious bilateral frontal injury in a road traffic accident at the age of 20 years. He made a good neurological recovery and relatively few cognitive deficits were recorded. His performance on a range of neuropsychological tests, including specialist tests of "frontal function", was mainly in the above average or superior range. In contrast, observations of his functional activities revealed a number of dysexecutive problems that had an adverse impact on his life. Changes in his personality and social behaviour, reflecting a number of "frontal" characteristics, only marginally improved as a result of post-acute neuropsychological rehabilitation. He did not receive long-term professional support but, with the passage of time and continued support from his family, he has married and manages to maintain a basic level of social integration, but not one commensurate with his pre-accident potential. Problems of planning, organisation, initiative, and self-awareness that were not recognised early in his recovery, and are not evident from neuropsychological assessment, remain as major obstacles to full social independence.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Wood, RL (corresponding author), Univ Coll Swansea, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swan.ac.uk					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A.D., 1986, WORKING MEMORY; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Benson D.F., 1986, FRONTAL LOBES; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BUTTERS N, 1972, PERCEPT MOTOR SKILL, V34, P27, DOI 10.2466/pms.1972.34.1.27; Corcoran R, 1997, SCHIZOPHR RES, V24, P319, DOI 10.1016/S0920-9964(96)00117-X; Damasio A R, 1993, CLIN NEUROPSYCHOLOGY; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Dimitrov M, 1999, NEUROCASE, V5, P345, DOI 10.1093/neucas/5.4.345; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Eslinger PJ, 1999, NEUROCASE, V5, P299, DOI 10.1093/neucas/5.4.299; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 1999, NEUROCASE, V5, P263, DOI 10.1080/13554799908402731; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Manchester D, 2001, BRAIN DAM B, P157; Metzler C, 2000, NEUROPSYCHOLOGIA, V38, P363, DOI 10.1016/S0028-3932(99)00097-4; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Possl O, 2001, BRAIN INJURY, V15, P15; Powell GE, 2001, BRAIN DAM B, P65; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1	46	12	12	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL	2004	14	3					329	350		10.1080/09602010343000255			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	829WZ	WOS:000222083400004					2022-02-06	
J	Caner, H; Can, A; Atalay, B; Erdogan, B; Albayrak, AH; Kilinc, K; Bavbek, M; Altinors, N				Caner, H; Can, A; Atalay, B; Erdogan, B; Albayrak, AH; Kilinc, K; Bavbek, M; Altinors, N			Early effects of mild brain trauma on the cytoskeletal proteins neurofilament(160) and MAP(2), and the preventive effects of mexilitine	ACTA NEUROCHIRURGICA			English	Article						mild head injury; neurofilament protein (NF160); microtubule-associated protein-2 (MAP2); lipid peroxidation mexilitine	MICROTUBULE-ASSOCIATED PROTEINS; LIPID-PEROXIDATION; SPECTRIN PROTEOLYSIS; AXONAL INJURY; CALPAIN; MEXILETINE; EXPRESSION; ALPHA; PHASE; RISK	Objective. The aims were to investigate the early effects of graded, closed, mild head injury on neurofilament protein (NF160) and microtubule-associated protein-2 (MAP(2)) and to examine the levels of lipid peroxidation and the impact of mexilitine, inhibitor of lipid peroxidation, pretreatment on tissue damage. Material and method. One hundred and twenty-six rats were divided into groups as follows: Group 1 (n=14) were controls; group 2 (n=56) sustained trauma alone; and group 3 (n=56) were pretreated with mexilitine (50 mg/kg). Groups 2 and 3 were subdivided into subgroups (n=14 each), which were subjected to 100 g/cm(2), 125 g/cm(2), 150 g/cm(2), and 175 g/cm(2) trauma forces, respectively. Two hours after trauma, the frontal lobes from all groups were removed and processed for lipid peroxidation H&E staining, immunofluorescent labelling of neurofilaments and microtubules with anti-NF160 and anti-MAP(2) antibodies. Results. Compared to control findings, all the trauma-only animals showed increased lipid peroxidation levels and the elevations paralleled the amount of force applied. Administration of mexilitine significantly reduced the level of lipid peroxidation. In NF160 stainings, in group 2, the degree of impairment in axonal organization paralleled the different levels of force that were applied. Groups 3C and 3D (mexilitine pretreated) showed well-preserved axons and intact perikarya. In MAP(2) stainings group 2 animals showed remarkably less MAP(2) staining throughout the sections. There were no significant differences in MAP(2) staining intensity or pattern among the group 2 subgroups. In contrast, in the sections from the group 3 animals, the level of MAP(2) positivity was markedly preserved. Conclusion. In conclusion, our results show that the cytoskeletal proteins we investigated have different capacities for resisting injury, and that MAP(2) is more vulnerable to injury than NF160. One of the reason for this cytoskeletal disruption may be increased lipid peroxidation. Inhibition of lipid peroxidation by pre-treatment with 50-mg/kg mexilitine significantly reduces the level of lipid peroxidation and may protect MAP(2) and NF160 integrity in closed mild head injury. This protection is inversely proportional to the magnitude of the applied force.	Baskent Univ, Fac Med, Dept Neurosurg, TR-06490 Ankara, Turkey; Ankara Univ, Sch Med, Dept Histol Embryol, TR-06100 Ankara, Turkey; Hacettepe Univ, Sch Med, Dept Biochem, Ankara, Turkey		Caner, H (corresponding author), Baskent Univ, Fac Med, Dept Neurosurg, TR-06490 Ankara, Turkey.	hakanc@baskent-ank.edu.tr	Can, Alp/AAO-5734-2020				Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Baldwin SA, 1996, GLIA, V16, P266; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Can A, 1997, MUTAT RES-FUND MOL M, V373, P139, DOI 10.1016/S0027-5107(96)00184-4; Can A, 2000, MOL HUM REPROD, V6, P154, DOI 10.1093/molehr/6.2.154; Caner H, 2000, ACTA NEUROCHIR, V142, P455, DOI 10.1007/s007010050457; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Demirpence E, 1999, JPN J PHARMACOL, V81, P7, DOI 10.1254/jjp.81.7; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kaptanoglu E, 1999, J NEUROSURG, V91, P200, DOI 10.3171/spi.1999.91.2.0200; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; MATHEWS CK, 2000, BIOCHEMISTRY-US, P724; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Paroczai M, 1997, PHARMACOL RES, V35, P279, DOI 10.1006/phrs.1997.0128; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SLATER TF, 1984, BIOCHEM J, V222, P1; Tymianski M, 1996, NEUROSURGERY, V38, P1176; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082	41	12	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2004	146	6					611	621		10.1007/s00701-003-0209-9			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	824GN	WOS:000221674600021	15168230				2022-02-06	
J	Cunningham, MG; Bolay, H; Scouten, CW; Moore, C; Jacoby, D; Moskowitz, M; Sorensen, JC				Cunningham, MG; Bolay, H; Scouten, CW; Moore, C; Jacoby, D; Moskowitz, M; Sorensen, JC			Preclinical evaluation of a novel intracerebral microinjection instrument permitting electrophysiologically guided delivery of therapeutics	NEUROSURGERY			English	Article						cerebral ischemia; electrophysiology; functional neurosurgery; intracerebral injection; microcannula; neural transplantation; stereotactic surgery	FETAL VENTRAL MESENCEPHALON; TRAUMATIC BRAIN-INJURY; DOPAMINE NEURONS; NEUROTROPHIC FACTOR; STRIATAL REINNERVATION; PARKINSONS-DISEASE; CAUDATE-NUCLEUS; CEREBRAL-CORTEX; GRAFT-SURVIVAL; TRANSPLANTATION	OBJECTIVE: This series of studies was designed to evaluate the function of a new neurosurgical instrument for precision injection of therapeutics within the central nervous system. METHODS: An intracerebral microinjection instrument was designed to 1) allow multiple injections to be placed in three-dimensional space within a target structure from a single proximal brain penetration, 2) incur minimal injury at the site of injection, 3) enable accurate microvolume injections, and 4) permit electrophysiological recording during the injection procedure. Rats received injections of fluorescent microspheres or suspensions of labeled cells to test instrument function and level of induced trauma. A rodent model of stroke was used to test the instrument's ability to record electrocorticograms or somatosensory evoked potentials from normal and damaged tissue. RESULTS: Microliter volumes of fluorescent microspheres; were accurately placed at predetermined sites within the rat striatum. Reactive gliosis was markedly reduced using the intracerebral microinjection instrument when compared with standard cannulas. in a stroke model, electrophysiological recording with the instrument allowed discrimination between viable and nonviable ischemic tissue, and function of pathways or circuits was assessed using evoked potentials. Embryonic stem cells grafted immediately after electrophysiological recordings demonstrated robust long-term survival. CONCLUSION: The intracerebral microinjection instrument enables electrophysiologically guided microinjection of therapeutics to target areas with exquisite accuracy while incurring minimal local trauma and reactive gliosis at the injection site. The instrument also permits minimally invasive, multiple injections to be disseminated in three-dimensional space within the target region from a single proximal penetration of the brain.	McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; Harvard Univ, Sch Med, Lab Neural Reconstruct, Belmont, MA 02178 USA; Gazi Univ, Dept Neurol, Ankara, Turkey; MyNeuroLab Inc, St Louis, MO USA; MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA USA; Diacrin Inc, Charlestown, MA USA; Massachusetts Gen Hosp, Stroke & Neurovasc Regulatory Lab, Charlestown, MA USA; Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark		Cunningham, MG (corresponding author), McLean Hosp, Dept Psychiat, 115 Mill St,MRC 333, Belmont, MA 02478 USA.	mcunningham@mclean.harvard.edu	Bolay, Hayrunnisa/ABG-8829-2020; Moskowitz, Michael A/D-9916-2011	Bolay, Hayrunnisa/0000-0002-3357-7733; SCOUTEN, CHARLES/0000-0003-2299-3464	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS036869] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2 R44 NS36869-02] Funding Source: Medline		Bolay H, 1998, STROKE, V29, P1988, DOI 10.1161/01.STR.29.9.1988; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Costa S, 2001, EUR J PHARMACOL, V412, P45, DOI 10.1016/S0014-2999(00)00933-X; Fawcett J. W., 2001, BRAIN DAMAGE BRAIN R; FINSEN BR, 1990, PROG BRAIN RES, V82, P111; FINSEN BR, 1991, J NEUROIMMUNOL, V32, P159, DOI 10.1016/0165-5728(91)90008-U; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREEMAN T, 1994, NEUROLOGY, V44, pA324; Galpern WR, 1996, EXP NEUROL, V140, P1, DOI 10.1006/exnr.1996.0109; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mendez I, 2000, J NEUROSURG, V92, P493, DOI 10.3171/jns.2000.92.3.0493; Miyazaki H, 1999, NEUROSCIENCE, V89, P643, DOI 10.1016/S0306-4522(98)00592-2; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Roitberg B, 1999, SURG NEUROL, V52, P13; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; Watts C, 2000, CELL TRANSPLANT, V9, P223, DOI 10.1177/096368970000900208; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	36	12	12	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2004	54	6					1497	1507		10.1227/01.NEU.0000125007.03145.00			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	828IB	WOS:000221965900045	15157308				2022-02-06	
J	Boivin, DB; Caliyurt, O; James, FO; Chalk, C				Boivin, DB; Caliyurt, O; James, FO; Chalk, C			Association between delayed sleep phase and hypernyctohemeral syndromes: A case study	SLEEP			English	Article						delayed sleep phase syndrome; non-24-hour sleep-wake disorder; brain injury	TRAUMATIC BRAIN INJURY; WAKE SYNDROME; CIRCADIAN-RHYTHMS; BLIND MAN; MELATONIN TREATMENT; TEMPERATURE; DISORDER; CYCLE; LIGHT; ENTRAINMENT	Study Objective: We investigated whether the hypernyetohemeral syndrome (non-24-hour sleep-wake syndrome) may show a clinical association with the delayed sleep phase syndrome (DSPS) in a 39-year-old woman who developed sleep disturbances following a traumatic brain injury. Measurements and Results: Sleep-wake log documentation and wrist-activity recordings for more than 6 consecutive months confirmed the patient's tendency to live on longer-than-24-hour "days." Episodes of relative coordination to the 24-hour day were also noted, suggesting that the patient was transiently in and out of phase with environmental synchronizers too weak to fully entrain her to the geophysical environment. Interestingly, we noted a tendency to initiate sleep between 3:00 am and 5:00 am and wake up from sleep between noon and 1:00 pm. Conclusions: These results support an association between the hypernyctohemeral syndrome and the DSPS. This association may carry implications for the treatment of circadian rhythms disorders.	Douglas Hosp, Res Ctr, Ctr Study & Treatment Circadian Rhythms, Verdun, PQ H4H 1R3, Canada; McGill Univ, Dept Psychiat, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Gen Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada		Boivin, DB (corresponding author), Douglas Hosp, Res Ctr, Ctr Study & Treatment Circadian Rhythms, 6875 LaSalle Blvd,Suite F-1127, Verdun, PQ H4H 1R3, Canada.	boidia@douglas.mcgill.ca	Caliyurt, Okan/ABE-7339-2020	Caliyurt, Okan/0000-0002-0513-0619			Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; COHEN RA, 1991, NEUROLOGY, V41, P726, DOI 10.1212/WNL.41.5.726; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; EASTMAN CI, 1988, SLEEP RES, V17, P372; ELIOTT AL, 1971, J PHYSIOL-LONDON, V212, pP30; FERBER R, 1983, SLEEP RES, V12, P364; FOLKARD S, 1990, NEUROSCI LETT, V113, P193, DOI 10.1016/0304-3940(90)90302-P; GIEDKE H, 1983, SLEEP RES, V12, P365; Hebert M, 1998, CHRONOBIOL INT, V15, P59; KAMGARPARSI B, 1983, SLEEP, V6, P257, DOI 10.1093/sleep/6.3.257; KLEIN T, 1993, SLEEP, V16, P333, DOI 10.1093/sleep/16.4.333; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; KOKKORIS CP, 1978, SLEEP, V1, P177, DOI 10.1093/sleep/1.2.177; LAPIERRE O, 1995, BIOL PSYCHIAT, V38, P119, DOI 10.1016/0006-3223(95)00072-O; McArthur AJ, 1996, SLEEP, V19, P544, DOI 10.1093/sleep/19.7.544; MILES LEM, 1977, SCIENCE, V198, P421, DOI 10.1126/science.910139; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; NAKAGAWA H, 1992, SLEEP, V15, P330, DOI 10.1093/sleep/15.4.330; OKAWA M, 1987, SLEEP, V10, P101, DOI 10.1093/sleep/10.2.101; OKAWA M, 1986, J NEUROL, V233, P274, DOI 10.1007/BF00314159; OKAWA M, 1981, J NEUROL, V266, P63; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; OREN DA, 1992, NEW ENGL J MED, V327, P1762; PALM L, 1991, ANN NEUROL, V29, P336, DOI 10.1002/ana.410290318; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; Smits MG, 2000, NEUROLOGY, V55, P902, DOI 10.1212/WNL.55.6.902; STROGATZ SH, 1986, LECT NOTES BIOMATH, V69, P1; Uchiyama M, 2000, NEUROSCI LETT, V294, P101, DOI 10.1016/S0304-3940(00)01551-2; Uchiyama M, 2002, SLEEP, V25, P83, DOI 10.1093/sleep/25.1.83; Watanabe T, 2003, SLEEP, V26, P657, DOI 10.1093/sleep/26.6.657; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; WOLLMAN M, 1986, SLEEP, V9, P324, DOI 10.1093/sleep/9.2.324; WRIGHT KPJ, P NATL ACAD SCI US, V98, P14027	36	12	12	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1550-9109			SLEEP	Sleep	MAY 1	2004	27	3					417	421		10.1093/sleep/27.3.417			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844OU	WOS:000223169000010	15164893	Bronze			2022-02-06	
J	Burke, R; Beukelman, DR; Hux, K				Burke, R; Beukelman, DR; Hux, K			Accuracy, efficiency and preferences of survivors of traumatic brain injury when using three organization strategies to retrieve words	BRAIN INJURY			English	Article								The primary objective was to compare the accuracy and preferences of adult survivors of traumatic brain injury (TBI) when using three organization strategies--semantic topic, geographic place and a word's first letter (alphabet)--to retrieve words using augmentative and alternative communication (AAC) technology. A repeated measures research design was employed. Twelve adult survivors of TBI ranging in age from 18-50 years participated in the study. These participants retrieved words using an AAC system organized using the three experimental conditions. In addition, they rank-ordered their preferences for each of the three strategies. Results showed that adults with TBI retrieve words more accurately and more efficiently when using the alphabet organization strategy than when using the topic or place strategies. Despite this, participants expressed a preference for using the topic strategy. Explanations for the findings and implications for AAC use are provided.	Univ Nebraska, Barkley Mem Ctr 318E, Lincoln, NE 68583 USA; Univ Nebraska, Med Ctr, Lincoln, NE 68583 USA; Inst Rehabil Sci & Engn, Lincoln, NE USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318E, Lincoln, NE 68583 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020	Hux, Karen/0000-0001-9462-1876			Beukelman D. R., 1991, AUGMENT ALTERN COMM, V7, P171, DOI [10.1080/07434619112331275883, DOI 10.1080/07434619112331275883]; Beukelman D R, 1998, AUGMENTATIVE ALTERNA; Blockberger S., 1995, J SPEECH LANGUAGE PA, V19, P221; BURKE R, UNPUB OLDER ADULTS A; CHERNEY LR, 1991, CLIN MANAGEMENT COMM, P9; DeRuyter F., 1987, AUGMENTATIVE ALTERNA, V3, P18, DOI DOI 10.1080/07434618712331274209; DeRuyter F, 1991, COMMUNICATION DISORD, P317; DERUYTER F, 1989, AUGMENTATIVE ALTERNA, V5, P49, DOI DOI 10.1080/07434618912331274966; Dongilli P, 1992, J HEAD TRAUMA REHAB, V7, P91; GARRY F, 1989, VET CLIN N AM-FOOD A, V5, P55, DOI 10.1016/S0749-0720(15)31003-3; HAGEN C, 1979, ANN M AM SPEECH LANG; Hagen C., 2000, TBI REH MAN CAR ENV; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; Kertesz A., 1982, W APHASIA BATTERY; Ladtkow M, 1992, AUGMENTATIVE COMMUNI, P139; Ladtkow Margaret, 1993, Seminars in Speech and Language, V14, P61, DOI 10.1055/s-2008-1064159; MALKMUS D, 1974, RANCHO LOS AMIGOS LE; WOODCOCK RW, 1990, WOODCOCKJOHNSON TEST	18	12	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2004	18	5					497	507		10.1080/02699050310001645784			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	800SS	WOS:000220048600007	15195796				2022-02-06	
J	Kennedy, MRT				Kennedy, MRT			Self-monitoring traumatic brain recall during two tasks after injury: A preliminary study	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	32nd Annual Clinical Aphasiology Conference	JUN, 2002	RIDGEDALE, MO			self-monitoring; memory; metamemory; brain injury; learning	LEARNING JOLS; PREDICTING PERFORMANCE; METAMEMORY; MEMORY; AWARENESS; ACCURACY; JUDGMENTS; CALIBRATION; ABSOLUTE; TEXT	Impaired recall is a common consequence of traumatic brain injury (TBI). Predicting recall during learning is a critical part of self-monitoring. Adults with TBI and noninjured controls made recall predictions of noun pairs that varied in prediction timing (immediate, delayed), and predictions of narrative information that varied in salience (main idea and details) and explicitness (stated and implied). For both groups, delayed recall predictions for noun pairs and stated (narrative) information were relatively accurate, whereas immediate recall predictions of noun pairs and delayed predictions of implied information were relatively inaccurate. Both groups were more confident making predictions of stated information than implied information. Neither predictive accuracy nor confidence generalized across tasks. Working memory load across tasks and individual differences are proposed explanations. The lack of generalization highlights the need to train domain or task-specific self-monitoring.	Univ Minnesota, Dept Commun Disorders, Minneapolis, MN 55455 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@umn.edu					ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Brookshire R. H., 1993, DISCOURSE COMPREHENS; Byrne, 1991, DEDUCTION; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cohen J., 2013, STAT POWER ANAL BEHA; Connor LT, 1997, PSYCHOL AGING, V12, P50, DOI 10.1037/0882-7974.12.1.50; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Damasio AR, 1989, NEURAL COMPUT, V1, P123, DOI 10.1162/neco.1989.1.1.123; Detterman D. K., 1993, TRANSFER TRIAL INTEL, P1; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelemen WL, 2000, MEM COGNITION, V28, P92, DOI 10.3758/BF03211579; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; KENNEDY MRT, IN PRESS NEUROPSYCHO, V13; Kertesz A., 1982, W APHASIA BATTERY; LEONESIO RJ, 1990, J EXP PSYCHOL LEARN, V16, P464, DOI 10.1037/0278-7393.16.3.464; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MAKI RH, 1990, J EXP PSYCHOL LEARN, V16, P609, DOI 10.1037/0278-7393.16.4.609; MAKI RH, 1987, MEM COGNITION, V15, P72, DOI 10.3758/BF03197713; Maki RH, 1998, MEM COGNITION, V26, P959, DOI 10.3758/BF03201176; Maki RH, 1999, J EXP PSYCHOL LEARN, V25, P1011, DOI 10.1037/0278-7393.25.4.1011; Maki RH, 1998, EDUC PSYCHO, P117; Matvey G, 2001, MEM COGNITION, V29, P222, DOI 10.3758/BF03194916; McGuire MJ, 2001, J EXP PSYCHOL LEARN, V27, P1172, DOI 10.1037//0278-7393.27.5.1172; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Nelson TO, 1996, APPL COGNITIVE PSYCH, V10, P257, DOI 10.1002/(SICI)1099-0720(199606)10:3<257::AID-ACP400>3.0.CO;2-9; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Newman AC, 2000, BRAIN INJURY, V14, P333; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1985, HALSTAD REITAN NEURO; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; SCHRAW G, 1995, J EDUC PSYCHOL, V87, P433, DOI 10.1037/0022-0663.87.3.433; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Thiede KW, 2003, J EDUC PSYCHOL, V95, P66, DOI 10.1037/0022-0663.95.1.66; Thiede KW, 1999, J EXP PSYCHOL LEARN, V25, P1024, DOI 10.1037/0278-7393.25.4.1024; Thiede KW, 1999, PSYCHON B REV, V6, P662, DOI 10.3758/BF03212976; Thorndike E.L., 1906, PRINCIPLES TEACHING; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; WEAVER CA, 1990, J EXP PSYCHOL LEARN, V16, P214, DOI 10.1037/0278-7393.16.2.214; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D., 1997, WECHSLER MEMORY SCAL; Yates JF, 1990, JUDGMENT DECISION MA	67	12	12	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2004	13	2					142	154		10.1044/1058-0360(2004/015)			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	970CR	WOS:000232283300005	15198633				2022-02-06	
J	Arce, FI; Katz, N; Sugarman, H				Arce, FI; Katz, N; Sugarman, H			The scaling of postural adjustments during bimanual load-lifting in traumatic brain-injured adults	HUMAN MOVEMENT SCIENCE			English	Article						traumatic brain injury; postural control; coordination; center of pressure	CENTRAL SET; RESPONSES; MOVEMENTS; BALANCE; SWAY; TASK; HUMANS	Previous postural studies of traumatic brain injury (TBI) patients have been limited to identifying deficits in static and quasi-dynamic postural control tasks such as weight shifting. In this study, we examined whether or not patients with TBI are able to scale adequately their postural adjustments during the performance of the dynamic task of bimanual load-lifting. An age matched group of healthy adults served as controls. We used the Tetrax posturography system that calculates a stability score (ST) based on fluctuations in vertical ground reaction forces, normalized for body weight. During quiet standing, the ST scores of the TBI group were significantly higher than the control group. Forward weight shift and percentage change in the vertical ground reaction forces (lift postural adjustment (LPA) and post-lift postural adjustment (PLPA) scores) linearly increased with increasing load weight in both healthy and TBI subjects. Group differences were found in the magnitude of forward weight shift but not in the relative increase of the LPA and PLPA scores during the lifting and post-lifting phases respectively. The forward weight shift of the TBI group was lower-than-normal and asymmetrical - there was significantly less forward weight shift on the more affected than on the less affected limb. In addition, a significant amplitude coupling was found between the scaling of the weight shift of the heel and forefoot of each limb. However, no coupling was found between the weight shift amplitudes of homologous parts of both limbs in the TBI group. The results showed that scaling based on prior experience was preserved in the TBI group, though some TBI subjects demonstrated absent scaling in either the more affected or less affected heel or forefoot. The differences between the normal and TBI groups in postural adjustments are not necessarily a sign of pathology; rather they may represent a deliberate choice of the central nervous system to counteract predictable disturbances. (C) 2004 Elsevier B.V. All rights reserved.	Hebrew Univ Jerusalem, Sch Occupat Therapy, IL-91120 Jerusalem, Israel; Int Ctr Enhancement Learning Potential, Jerusalem, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Aly Larson Motor Control Lab, IL-84105 Beer Sheva, Israel		Arce, FI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Higher Brain Funct Physiol, POB 12272, IL-91120 Jerusalem, Israel.	arcef@mscc.huji.ac.il		Arce-McShane, Fritzie/0000-0001-6616-3564			[Anonymous], 1995, GAIT POSTURE; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; Caldwell C., 1986, PHYSIOTHERAPY PRACTI, V2, P109; Commissaris DACM, 1997, HUM MOVEMENT SCI, V16, P407, DOI 10.1016/S0167-9457(97)00007-9; DIENER HC, 1991, EXP BRAIN RES, V84, P219; ENG JJ, 1992, NEUROSCI RES COMMUN, V11, P73; Forssberg H, 1999, NEUROSCI LETT, V273, P9, DOI 10.1016/S0304-3940(99)00619-9; Gentile A., 1987, MOVEMENT SCI FDN PHY, V1st Edn, P93; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; KARLSSON A, 2000, CLIN BIOMECH, V15, P193; KOHENRAZ R, 1991, PERCEPT MOTOR SKILL, V73, P635, DOI 10.2466/PMS.73.5.635-656; Kusoffsky A, 2001, ARCH PHYS MED REHAB, V82, P650, DOI 10.1053/apmr.2001.22611; LATASH ML, 1995, ELECTROMYOGR MOTOR C, V97, P77, DOI 10.1016/0924-980X(94)00272-9; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; MIZRAHI J, 1989, CLIN PHYS PHYSIOL M, V10, P25, DOI 10.1088/0143-0815/10/1/003; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Timmann D, 1998, EXP BRAIN RES, V119, P73, DOI 10.1007/s002210050321; Timmann D, 1997, BRAIN, V120, P327, DOI 10.1093/brain/120.2.327; Toussaint HM, 1998, EXP BRAIN RES, V120, P85, DOI 10.1007/s002210050380; TURNER DM, 1998, THESIS U SOUTHAMPTON; Vernazza-Martin S, 1999, BRAIN RES, V846, P12, DOI 10.1016/S0006-8993(99)01846-6; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	28	12	14	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457			HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2004	22	6					749	768		10.1016/j.humov.2003.12.002			20	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	814BD	WOS:000220949300010	15063052				2022-02-06	
J	Leahy, B; Suchy, Y; Sweet, JJ; Lam, CS				Leahy, B; Suchy, Y; Sweet, JJ; Lam, CS			Behavioral dyscontrol scale deficits among traumatic brain injury patients, part I: Validation with nongeriatric patients	CLINICAL NEUROPSYCHOLOGIST			English	Article							HEAD-INJURY; MEMORY COMPLAINTS; 15-ITEM TEST; REHABILITATION; VALIDITY; PERFORMANCE; TASK; INDIVIDUALS; PREDICTION; INPATIENTS	The Behavioral Dyscontrol Scale is a measure of executive abilities initially designed to predict functional independence in geriatric populations. The current study examined the utility of two Behavioral Dyscontrol Scale (BDS) scoring systems in a nongeriatric sample. The BDS was administered to 49 TBI patients undergoing inpatient and outpatient rehabilitation. The results demonstrate slightly greater utility of the BDS-II scoring system, and support clinical utility of the instrument with nongeriatric patients. Specifically, the Motor Programming Factor and Environmental Independence Factor were more impaired among patients with severe, as compared to mild to moderate, TBIs. In contrast, the Fluid Intelligence Factor was more impaired among patients with frontal, as compared to nonfrontal, injuries. However, when patients were categorized by severity, lesion location differences on the BDS total score and factors were found only for patients with mild to moderate injuries. Similarly, when patients were categorized by lesion location, severity effects were only present among the nonfrontal group. Receiver Operating Characteristic curves demonstrated sensitivity and specificity rates that ranged from 60% to 100% for clinically meaningful cutting scores.	Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; IIT, Chicago, IL 60616 USA; Evanston NW Healthcare, Evanston, IL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Suchy, Y (corresponding author), Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			ACKER MB, 1989, NEUROPSYCHOLOGY, V3, P1; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Benson D.F., 1986, FRONTAL LOBES; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bond M. R., 1990, REHABILITATION ADULT, P179; BOND MR, 1986, NEUROPSYCHOLOGICAL A; *CDCP, 1999, EP TRAUM BRAIN INJ U; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EISENBERG HM, 1985, CENTRAL NERVOUS SYST, P271; Eslinger Paul J., 1996, P415; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Griffin GAE, 1996, PSYCHOL ASSESSMENT, V8, P383; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Grigsby J, 1996, BEHAV DYSCONTROL SCA; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KAYE K, 1990, J AM GERIATR SOC, V38, P1304, DOI 10.1111/j.1532-5415.1990.tb03452.x; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; MATEER CA, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P277; MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037/0033-2909.108.3.420; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Suchy Y, 1997, CLIN NEUROPSYCHOL, V11, P258, DOI 10.1080/13854049708400454; Suchy Y, 1999, CLIN NEUROPSYCHOL, V13, P487, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT487; Tombaugh T.N., 1996, TEST MEMORY MALINGER; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	44	12	12	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					474	491		10.1076/clin.17.4.474.27941			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400005	15168913				2022-02-06	
J	Lucas, SK; Carstairs, JR; Shores, EA				Lucas, SK; Carstairs, JR; Shores, EA			A comparison of methods to estimate premorbid intelligence in an Australian sample: Data from the Macquarie University Neuropsychological Normative Study (MUNNS)	AUSTRALIAN PSYCHOLOGIST			English	Article							CONTEXTUAL-READING-TEST; CLOSED-HEAD INJURY; SPOT-THE-WORD; WAIS-R IQ; VERBAL INTELLIGENCE; DEMOGRAPHIC-VARIABLES; OLDER PERSONS; PERFORMANCE; VALIDATION; EQUATIONS	A variety of methods for estimating premorbid intelligence were compared in an Australian sample participating in the Macquarie University Neuropsychological Normative Study (MUNNS). Predictors included a contextual version of the AUSNART, the WRAT-3 Reading subtest, Spot-the-Word Test and sub-tests from the WAIS-R. The study involved 244 healthy participants aged between 18 and 34 years, with half of them serving as a cross-validation sample. Multiple regression was used for all analyses. When taking into account both the statistical results and clinical utility of the methods, the Sydney Premorbid Intelligence Estimate (SPIE), consisting of Vocabulary and Picture Completion subtests from the WAIS-R, was considered to be the best predictor. Combining all measures into one regression did not substantially increase the amount of variance explained. Base rate tables for predicted IQ versus obtained IQ, and the discrepancy between predicted IQ and Delayed Recall Index of the WMS-R are provided for each of the prediction methods. Further research to examine the clinical utility of these methods is required.	Macquarie Univ, N Ryde, NSW 2113, Australia		Lucas, SK (corresponding author), Westmead Hosp, Dept Psychol Med, Westmead, NSW 2145, Australia.	sara_lucas@wsahs.nsw.gov.au		Shores, Edwin A/0000-0003-1553-5131			ALEKOUMBIDES A, 1987, INT J CLIN NEUROPSYC, V9, P11; Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Baddeley A., 1992, SPEED CAPACITY LANGU; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bassett R, 2000, POWER ENG J, V14, P3; Beardsall L, 1998, BRIT J CLIN PSYCHOL, V37, P229, DOI 10.1111/j.2044-8260.1998.tb01297.x; BEARDSALL L, 1994, J CLIN EXP NEUROPSYC, V16, P232, DOI 10.1080/01688639408402634; BEARDSALL L, 1990, BRIT J CLIN PSYCHOL, V29, P217; BOONE DE, 1992, J CLIN PSYCHOL, V48, P72, DOI 10.1002/1097-4679(199201)48:1<72::AID-JCLP2270480111>3.0.CO;2-0; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; CARSTAIRS JR, 2000, AUSTR PSYCHOL, V35, P1; Cohen J., 1983, APPL MULTIPLE REGRES; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; CRAWFORD JR, 1990, THESIS U ABERDEEN; DELBRIDGE A, 1998, MACQUARIE CONCISE DI; DELEMOS M, 1981, WAIS R AUSTR S; Gladsjo JA, 1999, J INT NEUROPSYCH SOC, V5, P247, DOI 10.1017/S1355617799533079; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Grove WM, 2001, PSYCHOL ASSESSMENT, V13, P396, DOI 10.1037/1040-3590.13.3.396; Hennessy M., 1995, TREATMENT ISSUES LON, P183; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Nelson H.E., 1982, NATL ADULT READING T; Nelson HE, 1991, REVISED NATL ADULT R; REYNOLDS CR, 1986, J COUNS DEV, V64, P540, DOI 10.1002/j.1556-6676.1986.tb01196.x; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Shores EA, 2000, AUST PSYCHOL, V35, P41, DOI 10.1080/00050060008257467; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stevens K B, 1999, Appl Neuropsychol, V6, P68, DOI 10.1207/s15324826an0602_2; TELLEGEN A, 1967, J CONSULT PSYCHOL, V31, P499, DOI 10.1037/h0024963; Tremont G, 1997, ARCH CLIN NEUROPSYCH, V12, P757, DOI 10.1016/S0887-6177(97)00049-8; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; WARD AW, 1995, 12 MENTAL MEASUREMEN, P1106; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler, 1997, WECHSLER ADULT INTEL; WECHSLER D, 1987, WECHSLER MEMORY SALE; WECHSLER D, 1952, MANUAL WECHSLER ADUL; Wilkinson, 1984, WIDE RANGE ACHIEVEME; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038; Yuspeh RL, 2000, ARCH CLIN NEUROPSYCH, V15, P319, DOI 10.1016/S0887-6177(99)00020-7	45	12	12	0	2	AUSTRALIAN PSYCHOLOGICAL SOC	CARLTON	1 GRATTAN STREET, CARLTON, VICTORIA 3053, AUSTRALIA	0005-0067			AUST PSYCHOL	Aust. Psychol.	NOV	2003	38	3					227	237		10.1080/00050060310001707257			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	771PD	WOS:000188794400010					2022-02-06	
J	Knouse, CL; Gould, TE; Caswell, SV; Deivert, RG				Knouse, CL; Gould, TE; Caswell, SV; Deivert, RG			Efficacy of rugby headgear in attenuating repetitive linear impact forces	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; protective equipment; Gadd Severity Index; peak g	PERFORMANCE PROJECT; PROTECTIVE HEADGEAR; FOOTBALL; INJURY; CONCUSSION; UNION; LEAGUE; SPORTS	Objective: To determine the effectiveness of rugby headgear and the effect of impact site and headgear type on attenuating repetitive linear impact forces. Design and Setting: We obtained 10 headgear of 2 different types (n = 20) from 2 popular manufacturers: type I was Honeycomb headgear and type 11 was Vanguard headgear. Both headgear types were approved by the International Rugby Board. Headgear were tested according to National Operating Committee on Standards for Athletic Equipment protocols with one modification. The headgear were dropped from a height of 30 cm according to the International Rugby Board standards. Headgear were tested at a National Athletic Equipment Reconditioners Association facility. Measurements: We recorded peak acceleration of gravity (g) and Gadd Severity Index readings for each impact. The design of the study was 4 one-way, within-subjects, repeated-meaures analyses of variance with alpha = .05. Descriptive statistics were calculated for all categoric variables. Results: Peak g and Gadd Severity Index increased with repetitive impacts, resulting in a headgear's decreased ability to attenuate linear impact forces. Attenuation differed significantly between headgear type I and type 11 at both impact sites and between the parietal-lateral and occipital impact sites for both headgear types. Conclusions: The headgear initially attenuated impact forces from a drop height of 30 cm. However, over 10 drops, both headgear decreased in their ability to attenuate repetitive linear impact forces. Decreased attenuation in the occipital region as well as significant differences in attenuation abilities between headgear types support the need for further investigation to examine the efficacy of rugby headgear.	Ohio Univ, Grover Ctr, Athens, OH 45701 USA; Univ So Mississippi, Hattiesburg, MS 39406 USA; George Mason Univ, Fairfax, VA 22030 USA		Deivert, RG (corresponding author), Ohio Univ, Grover Ctr, Athens, OH 45701 USA.	deiveif@ouvaxa.cats.ohiou.edu					Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; CALVANO NJ, 1979, MED SCI SPORT EXER, V11, P293; Caswell SV, 2002, J ATHL TRAINING, V37, P164; FINCH C, 2000, SPORT HLTH, V3, P35; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; Gissane C, 1997, Aust J Sci Med Sport, V29, P91; HODGSON VR, 1991, ATHLETIC INJURIES HE, P28; *INT RUGB BOARD, 1998, STAND PERF SPEC SPEC; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; *NAT OP COMM STAND, 1996, FOOTB HELM STAND NEW, P2; *NAT RES COUNC, 1998, FAIR TEST EXAMIN FAL, P1; National Fire Protection Association, 1997, FOOTB HELM STAND NEW, P1; Phillips LH, 1998, BRIT J SPORT MED, V32, P144, DOI 10.1136/bjsm.32.2.144; Powell JW, 2001, J ATHL TRAINING, V36, P307; Thibault L.E.O.A., 1993, BIOMECHANICS IMPACT, P411; *US RUGB, 2002, US RUGB ALL CLUBS ME; Wekesa M, 1996, BRIT J SPORT MED, V30, P61, DOI 10.1136/bjsm.30.1.61; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005; 1996, FOOTBALL HELMET STAN, P1; 1997, FOOTBALL HELMET STAN, P1; 1996, FOOTBALL HELMET STAN, P3; 1998, FOOTBALL HELMET STAN, P1; 2001, HARDGEAR PACKAGE INS	30	12	12	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT-DEC	2003	38	4					330	335					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	762CD	WOS:000187952000009	14737216				2022-02-06	
J	Samuelsson, C; Kumlien, E; Elfving, A; Lindholm, D; Ronne-Engstrom, E				Samuelsson, C; Kumlien, E; Elfving, A; Lindholm, D; Ronne-Engstrom, E			The effects of PBN (phenyl-butyl-nitrone) on GLT-1 levels and on the extracellular levels of amino acids and energy metabolites in a model of iron-induced posttraumatic epilepsy	EPILEPSY RESEARCH			English	Article						iron; epilepsy; traumatic brain injury; amino acids; glutamate uptake; nitrones	GLUTAMATE TRANSPORTER GLT-1; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; INTRACEREBRAL MICRODIALYSIS; EPILEPTIFORM DISCHARGES; ANTISENSE KNOCKDOWN; NEURONAL DAMAGE; HEAD-INJURY; FOCUS; PEROXYNITRITE	This study investigates astrocytic glutamate uptake in the iron-induced animal model of posttraumatic epilepsy. Since formation of free radicals may be involved in epileptogenesis after brain trauma and hemorrhage the effects of the nitrone radical scavenger alpha-phenyl-tert-N-butyl nitrone (PBN) were also studied. Animals received an intracortical iron injection, or were sham-operated. They were given PBN intraperitoneally or saline as control. Twenty-four hours after lesion, brain tissue was collected and the level of glial glutamate transporter (GLT-1) was analyzed using immunoblotting. The extracellular concentrations of amino acids and energy metabolites were measured using microdialysis. The results showed significantly decreased levels of GLT-1 (70 kDa), higher basal levels of glutamate, and lower levels of glutamine as well as low arginine/citrulline ratios at the lesion compared to controls. PBN significantly attenuated the decrease of 70 kDa GLT-1 in the lesioned animals and attenuated the alterations in amino acid levels but not to a significant level. PBN also increased the arginine/citrulline ratios indicating reduced nitric oxide synthase activity. Our results suggest that astrocytic uptake of glutamate is oxidatively impaired in iron-induced epileptogenesis and that the administration of a radical scavenger can attenuate this process. (C) 2003 Elsevier B.V. All rights reserved.	Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Neurol Sect, Dept Neurosci, S-75185 Uppsala, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Univ Uppsala Hosp, Neurobiol Sect, Dept Neurosci, BMC, S-75123 Uppsala, Sweden		Samuelsson, C (corresponding author), Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden.	carolina.samuelsson@neurokir.uu.se	Lindholm, Dan/B-3777-2014	Kumlien, Eva/0000-0002-1952-8791			Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; CHEN GM, 1990, FREE RADICAL BIO MED, V9, P93, DOI 10.1016/0891-5849(90)90110-5; CHENG HY, 1993, FREE RADICAL BIO MED, V14, P243, DOI 10.1016/0891-5849(93)90021-L; Dabrosin C, 1997, CLIN SCI, V92, P493, DOI 10.1042/cs0920493; De Micheli E, 2000, ADV EXP MED BIOL, V483, P595; Engstrom ER, 2001, EPILEPSY RES, V43, P135, DOI 10.1016/S0920-1211(00)00191-1; ERNSTER L, 1988, CRIT CARE MED, V16, P947, DOI 10.1097/00003246-198810000-00005; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x; Kabuto H, 1996, EPILEPSY RES, V25, P65, DOI 10.1016/0920-1211(96)00063-0; Kotake Y, 1998, BBA-MOL CELL RES, V1448, P77, DOI 10.1016/S0167-4889(98)00126-8; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; MORIWAKI A, 1992, ELECTROEN CLIN NEURO, V83, P281, DOI 10.1016/0013-4694(92)90087-X; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Petroff OAC, 2002, EPILEPSIA, V43, P703, DOI 10.1046/j.1528-1157.2002.38901.x; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Szabo C, 1996, FREE RADICAL BIO MED, V21, P855, DOI 10.1016/0891-5849(96)00170-0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Xu GY, 1998, NEUROSCIENCE, V86, P1011, DOI 10.1016/S0306-4522(98)00063-3; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x	37	12	15	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	OCT	2003	56	2-3					165	173		10.1016/j.eplepsyres.2003.09.004			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	753TZ	WOS:000187247800010	14643001				2022-02-06	
J	Wells, RG; Sty, JR				Wells, RG; Sty, JR			Traumatic low attenuation subdural fluid collections in children younger than 3 years	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							CLINICAL-SIGNIFICANCE; BRAIN INJURY; HEAD-INJURY; HYGROMA; HEMATOMA; AGE	Objective: To determine the time course for the development of posttraumatic nonhemic subdural fluid collections in infants and young children. Design: Retrospective consecutive case series during 16 years. Patients: Fifty-five head trauma patients younger than 3 years with low attenuation subdural fluid on computed tomography. Main Outcome Measure: Time after head trauma when low attenuation fluid first becomes visible. Setting: Regional pediatric medical center. Results: The initial visualization of low attenuation sub dural fluid was within 4 days of the trauma for 44 of the patients. The mean +/-SD size of the subdural fluid collections when first identified was 4.6 2.0 mm (range, 2-12 mm), and the maximum observed size was 7.7 +/- 3.5 mm (range, 3-21 mm). The mean +/-SD time after injury until the maximum observed size was 16 +/- 18 days (range, 0-87 days). Low attenuation subdural fluid and high attenuation intracranial hemorrhage coexisted on at least 1 computed tomographic study during the first week after the trauma in 42 (81%) of the 52 patients with hemorrhage. Conclusion: Low attenuation subdural fluid collections (distinct from clotted blood) in infants and young children with head injuries most often develop during the first week after the traumatic event.	Childrens Hosp Wisconsin, Dept Radiol, Milwaukee, WI 53201 USA		Wells, RG (corresponding author), Childrens Hosp Wisconsin, Dept Radiol, Mail Stop 721,900 W Wisconsin Ave,POB 1997, Milwaukee, WI 53201 USA.						Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; Borzone M, 1983, J Neurosurg Sci, V27, P161; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; FRENCH BN, 1978, SURG NEUROL, V9, P145; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; Hwang SK, 2000, CHILD NERV SYST, V16, P590, DOI 10.1007/s003810000312; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Sargent S, 1996, J FORENSIC SCI, V41, P314; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252	16	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	1072-4710			ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	OCT	2003	157	10					1005	1010		10.1001/archpedi.157.10.1005			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	730DZ	WOS:000185815100011	14557162	Bronze			2022-02-06	
J	Gil, AM				Gil, AM			Neurocognitive outcomes following pediatric brain injury: A developmental approach	JOURNAL OF SCHOOL PSYCHOLOGY			English	Article						brain injury; cognition; achievement; development; assessment	CLOSED-HEAD INJURY; CHILDREN; CHILDHOOD; PLASTICITY; ATTENTION; RECOVERY; AGE; HEMISPHERECTOMY; REORGANIZATION; ADOLESCENTS	Developmental neuropsychologists postulate that "immaturity" of the cerebral cortex should no longer be perceived as a protective factor. They argue that injury to the young brain may affect new learning by disrupting the skills in the midst of being acquired and skills that are yet to be developed. Cognitive deficits or weaknesses that are not detectable in the acute phase following a traumatic brain injury (TBI) may emerge over development as more complex skills are needed, thereby creating a developmental lag between children who sustained a pediatric TBI and typical age peers. This literature review was conducted to evaluate the developmental perspective on neurocognitive recovery/development following a TBI Overall, the described findings support a developmental view and suggest that predictions of prognosis should be based on the child's remaining ability to learn. (C) 2003 Society for the Study of School Psychology. Published by Elsevier Science Ltd. All rights reserved.	Univ Georgia, Dept Educ Psychol, Athens, GA 30602 USA		Gil, AM (corresponding author), Univ Georgia, Dept Educ Psychol, 325 Aderhold Hall, Athens, GA 30602 USA.	armande@arches.uga.edu					Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson VA, 2000, BRAIN INJURY, V14, P679; Bakker K, 1999, Pediatr Rehabil, V3, P149; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BJORKLUND D, 2000, CHILDRENS THINKING; BROWN JW, 1975, NEUROPSYCHOLOGIA, V13, P107, DOI 10.1016/0028-3932(75)90054-8; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chiron C, 1997, BRAIN, V120, P1057, DOI 10.1093/brain/120.6.1057; CHUGANI HT, 1993, EPILEPSIA, V34, P764, DOI 10.1111/j.1528-1157.1993.tb00459.x; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 1999, CHANGING NERVOUS SYSTEM, P172; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1999, COGNITIVE ASPECTS OF CHRONIC ILLNESS IN CHILDREN, P262; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; GLAUB VE, 1994, J PSYCHOEDUC ASSESS, V12, P270, DOI 10.1177/073428299401200306; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Holmes CS, 1999, SCHOOL PSYCHOL REV, V28, P215; Kay JB, 1999, J CLIN EXP NEUROPSYC, V21, P186, DOI 10.1076/jcen.21.2.186.927; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; KOLB B, 1989, PROG NEUROBIOL, V32, P235, DOI 10.1016/0301-0082(89)90023-3; Kolb B., 1995, BRAIN PLASTICITY BEH; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Mash Eric J., 1996, P3; McArdle J.J., 2003, HDB PSYCHOL, P447, DOI [10.1002/0471264385.wei0218, DOI 10.1002/0471264385.WEI0218]; MULLER F, 1991, NEUROPSYCHOLOGIA, V29, P125, DOI 10.1016/0028-3932(91)90016-2; NORMAN MG, 1998, TXB PEDIAT NEUROPSYC, P43; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Plante E, 2000, J COMMUN DISORD, V33, P271, DOI 10.1016/S0021-9924(00)00024-1; Rakic Pasko, 1995, P127; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; Rosenberg S., 1987, ADV APPLIED PSYCHOLI, V1, P1, DOI DOI 10.1017/CBO9780511571374.002; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; TINUPER P, 1988, ANN NEUROL, V24, P27, DOI 10.1002/ana.410240107; VARGHAKHADEM F, 1991, BRAIN, V114, P473, DOI 10.1093/brain/114.1.473; Verger K, 2000, BRAIN INJURY, V14, P495; Vicari S, 2000, CORTEX, V36, P31, DOI 10.1016/S0010-9452(08)70834-7; VOELLER KKS, 1998, TXB PEDIAT NEUROPSYC, P769	50	12	12	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4405	1873-3506		J SCHOOL PSYCHOL	J. Sch. Psychol.	SEP-OCT	2003	41	5					337	353		10.1016/S0022-4405(03)00085-2			17	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	723FD	WOS:000185421000003					2022-02-06	
J	Machamer, JE; Temkin, NR; Dikmen, SS				Machamer, JE; Temkin, NR; Dikmen, SS			Neurobehavioral outcome in persons with violent or nonviolent traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; craniocerebral trauma; follow-up studies; violence	PENETRATING HEAD-INJURY; BRIEF SYMPTOM INVENTORY; MODEL SYSTEMS; RISK-FACTORS	Objective: To broaden the investigation of those injured violently by examining neuropsychological and psychosocial outcomes in relation to circumstances of traumatic brain injury and preinjury factors. Design: A prospective, longitudinal study. Participants: A total of 752 adults with traumatic brain injury was grouped into those injured by violent or nonviolent circumstances and followed to 1-year post injury. Main outcome measures: Circumstance groups were compared on demographics, preexisting conditions, brain injury severity, and neuropsychological and psychosocial outcomes. Results: The results indicate significant differences between the groups on demographics, preexisting conditions, and head injury severity. Neuropsychological and psychosocial outcome did not differ between the circumstance groups when all other factors were taken into account. Conclusions: Injury severity and characteristics of the person that predate the injury were important to outcome rather than the circumstances of the injury itself.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA USA; Univ Washington, Dept Biostat, Seattle, WA USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA USA		Machamer, JE (corresponding author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS19643] Funding Source: Medline; BHP HRSA HHS [AHRQ HS06497] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER		BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Brown E, 2000, VET ECON, V41, P1; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Deering CG, 1996, COMPR PSYCHIAT, V37, P336, DOI 10.1016/S0010-440X(96)90015-2; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Lemeshow S, 2000, APPL LOGISTIC REGRES; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Reitan R.M., 1993, HALSTEADREITAN NEURO; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWEENEY JK, 1983, PHYS THER, V63, P2018, DOI 10.1093/ptj/63.12.2018; TEASDALE G, 1974, LANCET, V2, P81; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; Teuber H L, 1975, Ciba Found Symp, P159; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949	29	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2003	18	5					387	397		10.1097/00001199-200309000-00001			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	725BF	WOS:000185522200001	12973269				2022-02-06	
J	Ulusoy, H; Usul, H; Aydin, S; Kaklikkaya, N; Cobanoglu, U; Reis, A; Akyol, A; Ozen, I				Ulusoy, H; Usul, H; Aydin, S; Kaklikkaya, N; Cobanoglu, U; Reis, A; Akyol, A; Ozen, I			Effects of immunonutrition on intestinal mucosal apoptosis, mucosal atrophy, and bacterial translocation in head injured rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; immunonutrition; intestinal atrophy; apoptosis; bacterial translocation	TOTAL PARENTERAL-NUTRITION; IMMUNE-ENHANCING DIET; TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; EPITHELIAL-CELLS; CRITICALLY ILL; SEPTIC COMPLICATIONS; ENTERAL DIETS; GLUTAMINE; GUT	Background: Immunonutrition has been demonstrated to modulate gut function, reduce infectious complications, hospital stay, and ventilator days in the critical patients. Aim of the study: We assessed the effect of immunonutrition for the prevention of intestinal mucosal atrophy, apoptosis, and bacterial translocation in head injured rats. Methods: Thirty five rats were randomised into 5 groups. Following moderate closed head injury, in Group 1; Standard Enteral Nutrition, Group 2; Immunonutrition, Group 3; TPN, Group 4; pe. saline were applied. Group 5 was control group (chow-fed). The rats were sacrificed and segments of the ileum were removed for histologic examination, and samples of tissues taken for microbiologic evaluation. Results: Both intestinal apoptosis and mucosal atrophy were significantly lower in Group 2 and Group 5 (p < 0.008). Bacterial translocation was significantly lower in Group 2 than Group 1 (p < 0.008). Conclusion: The enteral immunonutrition prevents intestinal barrier function in brain injured rats. (C) 2003 Elsevier Science Ltd. All rights reserved.	Black Sea Tech Univ, Farabi Hosp, Dept Anesthesiol & Reanimat, Trabzon, Turkey; Black Sea Tech Univ, Farabi Hosp, Dept Neurosurg, Trabzon, Turkey; Black Sea Tech Univ, Farabi Hosp, Dept Histol & Embriol, Trabzon, Turkey; Black Sea Tech Univ, Farabi Hosp, Dept Microbiol, Trabzon, Turkey; Black Sea Tech Univ, Farabi Hosp, Dept Pathol, Trabzon, Turkey		Ulusoy, H (corresponding author), Black Sea Tech Univ, Farabi Hosp, Dept Anesthesiol & Reanimat, Trabzon, Turkey.		AYDIN, Sevim/AAO-5670-2020; KAKLIKKAYA, NESE/AAL-9100-2021; ulusoy, hulya/A-6223-2019; Usul, Haydar/AAW-2939-2021	AYDIN, Sevim/0000-0003-2445-2346; ulusoy, hulya/0000-0001-6645-6316; Cobanoglu, Umit/0000-0001-6429-427X			ALVERDY J, 1985, ANN SURG, V202, P681, DOI 10.1097/00000658-198512000-00003; ALVERDY JC, 1990, JPEN-PARENTER ENTER, V14, pS109, DOI 10.1177/014860719001400415; ALVERDY JC, 1988, SURGERY, V104, P185; Archer S B, 1996, Adv Surg, V29, P165; Atkinson S, 1998, CRIT CARE MED, V26, P1164, DOI 10.1097/00003246-199807000-00013; Barton R G, 1997, Nutr Clin Pract, V12, P51, DOI 10.1177/011542659701200251; Bastian L, 1999, Anaesthesiol Reanim, V24, P95; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Boza JJ, 1999, J NUTR, V129, P1340, DOI 10.1093/jn/129.7.1340; *BRAIN TRAUMA FDN, 2000, NUTR J NEUROTRAUMA, V17, P539; CUMMINGS MC, 1997, APOPTOSIS HISTOLOGY, P3; Deitch EA, 1994, GUT               S1, V35, pS23; DIETCH EA, 1990, GASTROENTEROLOGY, V98, P243; DIETCH EA, 1989, ARCH SURG-CHICAGO, V124, P699; Ersin S, 2000, J SURG RES, V89, P121, DOI 10.1006/jsre.1999.5808; GALHAN C, 1998, JPEN J PARENTER ENTE, V22, pS13; Gentilini O, 2000, Minerva Anestesiol, V66, P362; Gu Y, 2001, CLIN NUTR, V20, P159, DOI 10.1054/clnu.2000.0379; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Iwakiri R, 2001, SCAND J GASTROENTERO, V36, P39, DOI 10.1080/00365520150218048; Jeschke MG, 2000, DIGEST DIS SCI, V45, P415, DOI 10.1023/A:1005445501016; KING BK, 1998, ADV SURG, V31, P53; Kudsk K A, 1994, Nutr Clin Pract, V9, P165, DOI 10.1177/0115426594009005165; KUDSK KA, 1983, J TRAUMA, V23, P605, DOI 10.1097/00005373-198307000-00010; Kudsk KA, 1996, ANN SURG, V224, P531, DOI 10.1097/00000658-199610000-00011; Marino PL, 1996, CRIT CARE CLIN, V12, P667, DOI 10.1016/S0749-0704(05)70270-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATES JM, 2000, CELL BIOL, V34, P439; Mendez C, 1997, J TRAUMA, V42, P933, DOI 10.1097/00005373-199705000-00026; Militsa B, 2001, Neurol India, V49 Suppl 1, pS75; MOORE FA, 1989, J TRAUMA, V29, P916, DOI 10.1097/00005373-198907000-00003; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; MOORE FA, 1994, J TRAUMA, V37, P607, DOI 10.1097/00005373-199410000-00014; Noda T, 1998, AM J PHYSIOL, V274, P270; OLeary MJ, 1996, BRIT J ANAESTH, V77, P118, DOI 10.1093/bja/77.1.118; Papaconstantinou HT, 2000, J GASTROINTEST SURG, V4, P416, DOI 10.1016/S1091-255X(00)80022-0; Papaconstantinou HT, 1998, SURGERY, V124, P152, DOI 10.1067/msy.1998.90562; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; SAITO H, 1987, JPEN-PARENTER ENTER, V11, P1, DOI 10.1177/014860718701100101; SHEIFTER E, 1978, SURGERY, V84, P224; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; TAMION F, 1997, AM J PHYSIOL, V273, P314; Thomas S, 1998, ACT NEUR S, V71, P135; WILMORE DW, 1988, SURGERY, V104, P917; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; Wyncoll D, 2001, Curr Opin Crit Care, V7, P128, DOI 10.1097/00075198-200104000-00012; YANGAWA T, 2002, COCHRANE DATABASE SY, V3, DOI UNSP CD001530; Young B, 1991, Neurosurg Clin N Am, V2, P301; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; ZALOGA GP, 1991, CRIT CARE MED, V19, P54, DOI 10.1097/00003246-199101000-00015; Zaloga GP, 1998, CRIT CARE MED, V26, P1143, DOI 10.1097/00003246-199807000-00001; Zaloga GP, 1990, J CRIT ILLNESS, V5, P1180	55	12	14	1	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2003	10	5					596	601		10.1016/S0967-5868(03)00142-5			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727ZT	WOS:000185691300015	12948467				2022-02-06	
J	Vinchon, M; Defoort-Dhellemmes, S; Nzeyimana, C; Vallee, L; Dhellemmes, P				Vinchon, M; Defoort-Dhellemmes, S; Nzeyimana, C; Vallee, L; Dhellemmes, P			Infantile traumatic subdural hematomas: Outcome after five years	PEDIATRIC NEUROSURGERY			English	Article						infantile head injury; subdural hematoma; outcome	BRAIN-INJURY; CHILDREN	Objective: Although subdural hematomas (SDH) are common in infants, their long-term outcome is poorly documented in the literature. Methods: Infants operated for SDH were followed prospectively and evaluated during their sixth year with systematic neurological evaluation and standard neuropsychological testing. Results: We studied 48 infants operated for SIDH. At the last checkup, 39 were normal, 5 had mild deficits, 3 had severe deficits and 1 was in a vegetative state. IQ measurements did not differ significantly from normal values, but did not accurately reflect the outcome. The only independent factor significantly affecting the final outcome was initial clinical severity. Age at surgery, surgical complications and the nature of the trauma (inflicted or accidental) did not independently influence the outcome. Conclusion: Long-term follow-up is required after treatment of SIDH, to evaluate the child's changing needs in terms of medical and educational care. Copyright (C) 2003 S. Karger AG, Basel.	Hop Roger Salengro, Dept Pediat Neurosurg, FR-59037 Lille, France; Hop Roger Salengro, Dept Neuroophthalmol, FR-59037 Lille, France; Hop Roger Salengro, Dept Neuropediat, FR-59037 Lille, France		Vinchon, M (corresponding author), Hop Roger Salengro, Dept Pediat Neurosurg, FR-59037 Lille, France.	m-vinchon@chru-lille.fr		Vinchon, Matthieu/0000-0002-9122-6165			Adelson PD, 1999, TRAUMATIC BRAIN INJU, P283; DESCHAMPS G, 1982, NEUROPSYCHIAT ENFAN, V30, P671; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUNCAN CC, 1989, CONCEPTS PEDIAT NEUR, V9, P211; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LEVIN HS, 2001, PEDIAT NEUROSURGERY, P654; MORSE CW, 1970, AM J DIS CHILD, V120, P439, DOI 10.1001/archpedi.1970.02100100103011; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; PARENT AD, 1999, PEDIATR NEUROSURG, V18, P266; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2001, J NEUROSURG, V95, P249, DOI 10.3171/jns.2001.95.2.0249; Wechsler D, 1967, MANUAL WECHSLER PRES	18	12	12	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	SEP	2003	39	3					122	128		10.1159/000071648			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	712BF	WOS:000184775000002	12876390				2022-02-06	
J	Gray, C; Nukada, H; Jackson, DM; McMorran, PD; Wu, A; Ma, F				Gray, C; Nukada, H; Jackson, DM; McMorran, PD; Wu, A; Ma, F			Neuroprotective effects of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats	BRAIN RESEARCH			English	Article						ischemic neuropathy; reperfusion; peripheral nerve; S-PBN; rat; pathology	FOCAL CEREBRAL-ISCHEMIA; CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN INJURY; SCIATIC-NERVE; FIBER DEGENERATION; OXIDATIVE DAMAGE; PERIPHERAL-NERVE; DIABETIC NERVE; BLOOD-FLOW; SPIN TRAP	The nitrone-based free radical scavengers have potent neuroprotective activities in models of stroke in which oxidative stress plays a key role in its development. We examined the effects of S-PBN (sodium 4-[(tert-butylimino) methyl]benzene-3-sulfonate N-oxide), a spin trap nitrone, on reperfusion injury in rat peripheral nerves. Immediately after the onset of 4-h ischaemia in rat right hindlimb, S-PBN was administered via mini-osmotic pumps, containing 2 ml of S-PBN (1.2 M), inserted subcutaneously. S-PBN, in addition, was given by a single injection (50 mg/kg BW, i.p.). Mean plasma concentrations of S-PBN were significantly greater in S-PBN-treated rats than in controls after 24, 48 and 72 h of reperfusion. Pump and dosing solution analysis indicated that the rats received between 82 and 99% of the target S-PBN concentration. Morphology in sciatic, tibial and peroneal nerves was assessed after 4 It of ischaemia followed by 72 It and 7 days of reperfusion. After 72 h of reperfusion, saline-treated control rats showed endoneurial oedema at the thigh level and diffuse axonal degeneration of myelinated nerve fibres distally. S-PBN-treated nerves were normal or revealed less severe abnormalities in myelinated fibres after 72 h and 7days of reperfusion, when compared with those in saline-treated control nerves. Morphometrically, the frequency of abnormal myelinated fibres at calf levels was significantly less in S-PBN-treated nerves than in controls. In conclusion, post-ischaemic administration of S-PBN exhibits substantial neuroprotective properties in ischemia/reperfusion nerve injury. (C) 2003 Elsevier B.V. All rights reserved.	Univ Otago, Sch Med, Dept Med, Dunedin 9015, New Zealand; Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Dunedin 9015, New Zealand; Cent Pharmaceut Inc, Los Angeles, CA USA		Nukada, H (corresponding author), Univ Otago, Sch Med, Dept Med, POB 913,201 Great King St, Dunedin 9015, New Zealand.						Anderson GM, 1997, BRAIN RES, V772, P156, DOI 10.1016/S0006-8993(97)00800-7; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; DAY TJ, 1989, EXP NEUROL, V103, P173, DOI 10.1016/0014-4886(89)90079-4; Dehouck MP, 2002, BRAIN RES, V955, P229, DOI 10.1016/S0006-8993(02)03469-8; Fallon J, 1997, EXP NEUROL, V144, P193, DOI 10.1006/exnr.1997.6416; Floyd RA, 2002, MECH AGEING DEV, V123, P1021, DOI 10.1016/S0047-6374(01)00385-2; Floyd RA, 2002, ANN NY ACAD SCI, V959, P321, DOI 10.1111/j.1749-6632.2002.tb02103.x; Floyd RA, 2000, ANN NY ACAD SCI, V899, P222; He K, 1999, NEUROSCIENCE, V94, P909, DOI 10.1016/S0306-4522(99)00350-4; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Maples KR, 2001, FREE RADICAL RES, V34, P417, DOI 10.1080/10715760100300351; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Mitsui Y, 1999, J NEUROL SCI, V163, P11, DOI 10.1016/S0022-510X(99)00017-9; Mitsui Y, 1999, BRAIN RES, V844, P192, DOI 10.1016/S0006-8993(99)01830-2; Myhre O, 2001, J NEUROSCI RES, V66, P992, DOI 10.1002/jnr.10049; Nagamatsu M, 1996, MUSCLE NERVE, V19, P37, DOI 10.1002/mus.880190103; NUKADA H, 1992, MUSCLE NERVE, V15, P1116, DOI 10.1002/mus.880151010; Nukada H, 2002, J PERIPHER NERV SYST, V7, P37, DOI 10.1046/j.1529-8027.2002.02004.x; Nukada H, 1997, J Peripher Nerv Syst, V2, P60; Nukada H, 2000, ANN NEUROL, V47, P71, DOI 10.1002/1531-8249(200001)47:1<71::AID-ANA12>3.3.CO;2-G; NUKADA H, 1984, AM J PATHOL, V115, P275; NUKADA H, 1994, J ANAT, V185, P259; SCHMELZER JD, 1989, P NATL ACAD SCI USA, V86, P1639, DOI 10.1073/pnas.86.5.1639; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Sturgess NC, 2000, ARCH TOXICOL, V74, P153, DOI 10.1007/s002040050668; WRIGHT A, 1994, ACTA NEUROPATHOL, V88, P571; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364; Yoshimoto T, 2002, BRAIN RES, V947, P191, DOI 10.1016/S0006-8993(02)02922-0; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x; Zhao ZG, 2001, BRAIN RES, V909, P46, DOI 10.1016/S0006-8993(01)02618-X	34	12	12	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 29	2003	982	2					179	185		10.1016/S0006-8993(03)03006-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721KR	WOS:000185316000005	12915253				2022-02-06	
J	Glover, A				Glover, A			An exploration of the extent to which attending Headway enhances quality of life after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article							HEALTH; REHABILITATION	Purpose: This paper explores the perception of quality of life (QOL) of four men following traumatic brain injury (TBI) and the effects of their injury on family, social and working life. Method: It also highlights their on going difficulties 6, 8, 10 and 11 years post injury and that long term support is not available from rehabilitation services often due to the NHS financial restraints. Results: Participants in this study have highlighted: (a) the need for long term support over an unspecified continuum;, (b) the value of peer support; (c) the value of an understanding environment prepared to address individual needs which encourages independence; (d) the need for a social outlet; (e) the benefit of structure and boundaries after rehabilitation; and (f) the need for ongoing information for the survivor and family. Conclusions: Headway, the brain injury association has provided a continuum of care revealing a lengthy process of adjustment towards a new self, a new role and a new life.	Headway Essex, Colchester CO4 5HG, Essex, England		Glover, A (corresponding author), Headway Essex, Headway House,2 Boxted Rd, Colchester CO4 5HG, Essex, England.	AnnabelleGlover.info@headwayessex.org.uk					Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Bethoux F, 1996, INT J REHABIL RES, V19, P291, DOI 10.1097/00004356-199612000-00001; Bond A E, 1997, Crit Care Nurse, V17, P112; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bowling A, 1997, MEASURING HLTH; *BSRM, 1998, REH BRAIN INJ WORK P, V45; Carlson Hannah Bick, 1993, Brain Injury, V7, P183, DOI 10.3109/02699059309008172; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Ehrlich J. S, 1985, COGNITIVE REHABILITA, P32; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GARNER R, 1990, ACUTE HEAD INJURY PR; Gosling J, 1999, BRAIN INJURY, V13, P785; *HFBC, 1997, NHS ADV SERV HAS THE; *HIDD DIS, 1996, REP SSI TRAUM BRAIN; Hyland ME, 1997, PSYCHOL HEALTH, V12, P389, DOI 10.1080/08870449708406715; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McMillan TM, 2001, NEUROBEHAVIOURAL DIS; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; *NOTT TRENT U PROJ, ASS LONG TERM RES NE; *NTBIS, 1998, CTR HLTH SERV STUD U; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Parr S., 1997, TALKING APHASIA; Pepin M, 2000, BRAIN INJURY, V14, P563; Richie J., 1994, ANAL QUALITATIVE DAT; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SIMPSON G, INT PERSPECTIVES TRA, P403; Skevington SM, 1997, BRIT J HEALTH PSYCH, V2, P55, DOI 10.1111/j.2044-8287.1997.tb00523.x; Sohlberg MM, 1998, BRAIN INJURY, V12, P333; Stonnington HH, 2000, BRAIN INJURY, V14, P393, DOI 10.1080/026990500120501; TYERMAN A, 1984, INT J REHABILITATION, V7, P373; TYERMAN A, 1997, REHABILITATION PHYSI; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Woodend AK, 1997, INT J REHABIL RES, V20, P71, DOI 10.1097/00004356-199703000-00006	38	12	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 8	2003	25	13					750	760		10.1080/0963828021000058503			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	695YH	WOS:000183857600007	12791560				2022-02-06	
J	Swaine, BR; Dutil, T; Demers, L; Gervais, M				Swaine, BR; Dutil, T; Demers, L; Gervais, M			Evaluating clients' perceptions of the quality of head injury rehabilitation services: development and validation of a questionnaire	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; PATIENT SATISFACTION; FAMILY NEEDS; CARE; PARENTS; SYSTEM	Objective: The objective of this research was to develop a tool to assess clients' perception of the quality of head injury rehabilitation services. Methods and results: A questionnaire PQRS-Montreal 1.0 was developed in Montreal, Quebec using a standardized methodology that incorporated a new technique to reach consensus regarding the tool's contents. Five dimensions of care (i.e. ecological approach, client-centred approach, accessibility, quality of the service providers and continuity) and their corresponding standards were identified as pertinent to include in the tool and were subsequently validated by experts. A phase of item generation followed that led to the development of an 87-item prototype of the questionnaire. The questionnaire is to be administered during an interview and employs a 5-point rating scale. Discussion and conclusion: The implications for the use of PQRS-Montreal 1.0 in the accreditation process of head injury rehabilitation services are discussed, as well as plans for future quantitative research in the development of the tool.	Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; Inst Readaptat Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; Univ Laval, Dept Readaptat, Montreal, PQ, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.						CHARRON L, 1992, ANAL DIRECTION ETUDE; *COAORF, 1993, STAND MAN ORG SERV P; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Crocker L., 1986, INTRO CLASSICAL MODE; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; DUTIL E, 1998, PROGRAMME CONJOINT F; Dutil E, 1998, CANADIAN J REHABILIT, V11, P268; Eldar R, 2000, DISABIL REHABIL, V22, P163, DOI 10.1080/096382800296854; Elliott-Burke TL., 1997, J REHABIL OUTCOMES M, V1, P18; Gerbing DW, 1996, STRUCT EQU MODELING, V3, P62, DOI 10.1080/10705519609540030; GERVAIS M, 1999, ETUDE EXPLORATOIRE B, P1; Gervais M, 2000, REV Q ERGO, V9, P11; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Heinemann A, 1997, J REHABIL OUTCOMES M, V1, P52; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; *INT ORG STAND, 1990, QUAL MAN QUAL SYST 2; Johnston MV, 1997, ARCH PHYS MED REHAB, V78, pS1, DOI 10.1016/S0003-9993(97)90148-9; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; King GA, 1997, CHILD CARE HLTH DEV, V23, P47, DOI 10.1046/j.1365-2214.1997.840840.x; KOSCIULEK J, 1997, J REHABILITATION APR; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCCOMAS J, 1995, AM J OCCUP THER, V49, P980, DOI 10.5014/ajot.49.10.980; MCNEIL R, 1999, 1994 1997 SATISFACTI; Pound P, 1999, STROKE, V30, P49, DOI 10.1161/01.STR.30.1.49; Pound P, 1994, CLIN REHABIL, V8, P7, DOI DOI 10.1177/026921559400800102; *QUEB LSDAAD, 1996, ENT AGR TYP SOC ASS, P1; ROSSI PH, 1993, EVALUATION SYSTEMATI; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Streiner D.L., 1989, HLTH MEASUREMENT SCA; SWAINE B, 2002, 6 WORLD C INJ PREV C; Swaine BR, 1999, AM J PHYS MED REHAB, V78, P323, DOI 10.1097/00002060-199907000-00006; *SYST INF CLIENT T, 2000, INT JOINT C EBIS EMN; VANCAMPEN C, 1995, MED CARE RES REV, V52, P109, DOI 10.1177/107755879505200107; [No title captured]	38	12	12	1	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2003	17	7					575	587		10.1080/0269905031000088568			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	690HG	WOS:000183541900004	12775270				2022-02-06	
J	Iglesias-Pais, M; Gelabert-Gonzalez, M; Lopez-Garcia, E; Allut, AG; Fernandez-Villa, JM; Gonzalez-Garcia, J; Rumbo, RM				Iglesias-Pais, M; Gelabert-Gonzalez, M; Lopez-Garcia, E; Allut, AG; Fernandez-Villa, JM; Gonzalez-Garcia, J; Rumbo, RM			De novo Arachnoid cyst treated with a cystoperitoneal shunt	REVISTA DE NEUROLOGIA			Spanish	Article						Arachnoid cyst; bypass valve; computerised tomography; transfontanellar echography	CHILDREN	Introduction. Arachnoid cysts (A Q are benign pathological structures that are typically found during childhood, and represent approximately 1% of all intracranial lesions. Unlike cases of secondary cysts with a known causation, which can be attributed to inflammatory processes or traumatic brain injuries, the causation of the primary cysts is unknown. In the cases reported to date, the cysts present from the first imaging study conducted, which is why they are considered to be of a prenatal origin. Case report. A boy who, at the age of 5 months, is found to have an AC of considerable dimensions that did not appear in a transfontanellar echographic study carried out for other reasons at the age of 2 months. Conclusion. The importance of this case lies in the fact that it has been possible to show the appearance of a cyst after birth in a sequence of images in the case of a pathology which, according to all the theories and tests, is considered to have a congenital causation. [REVNEVROL 2003; 36:1149-52].	Univ Santiago de Compostela, Hosp Clin, Serv Neurochirurg, Santiago De Compostela, Spain					Gelabert-Gonzalez, Miguel/0000-0002-9462-0045			Ballerini M, 1990, Riv Neurol, V60, P171; BASAURI L, 1992, CHILD NERV SYST, V8, P101, DOI 10.1007/BF00298451; Daneyemez M, 1999, J Neurosurg Sci, V43, P115; DIROCCO C, 1981, CHILD BRAIN, V8, P119; Galarza M, 2002, PEDIATR NEUROL, V27, P180, DOI 10.1016/S0887-8994(02)00414-9; GelabertGonzalez M, 1997, REV NEUROLOGIA, V25, P1095; GO KG, 1984, J NEUROSURG, V60, P803, DOI 10.3171/jns.1984.60.4.0803; Gomez-Escalonilla CI, 2001, REV NEUROLOGIA, V33, P305, DOI 10.33588/rn.3304.2000633; HORCAJADAS A, 1996, NEUROCIRUGIA 21, V2, P131; KUMAGAI M, 1986, CHILD NERV SYST, V2, P211, DOI 10.1007/BF00706815; Martinez-Lage JF, 1999, CHILD NERV SYST, V15, P94, DOI 10.1007/s003810050340; OKUMURA Y, 1995, J NEUROSURG, V82, P1075, DOI 10.3171/jns.1995.82.6.1075; ROBINSON RG, 1964, BRAIN, V88, P87; Santamarta D, 1995, MINIM INVAS NEUROSUR, V38, P133, DOI 10.1055/s-2008-1053473; Shibata T, 2001, SPINAL CORD, V39, P599, DOI 10.1038/sj.sc.3101217; Yanaka K, 1998, CHILD NERV SYST, V4, P302, DOI 10.1007/BF00271930	16	12	12	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JUN 16	2003	36	12					1149	1152		10.33588/rn.3612.2003084			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699MX	WOS:000184061500010	12833234				2022-02-06	
J	Burger, R; Zuechner, M; Bendszus, M; Vince, GH; Roosen, K				Burger, R; Zuechner, M; Bendszus, M; Vince, GH; Roosen, K			Moderate hypothermia improves neurobehavioral deficits after an epidural focal mass lesion in rodents	JOURNAL OF NEUROTRAUMA			English	Article						behavior; focal mass lesion; hypothermia, ischemia; magnetic resonance imaging, outcome; trauma	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; GLOBAL FOREBRAIN ISCHEMIA; TERM BEHAVIORAL DEFICITS; HISTOPATHOLOGICAL CONSEQUENCES; REPRODUCIBLE MODEL; BLOOD-FLOW; DAMAGE; HIPPOCAMPAL; SENSORIMOTOR	The objective of this study was to evaluate the effects of a moderate, intraischemic hypothermia on the behavorial deficits up to 4 weeks after induction of a focal mass lesion. A focal epidural mass lesion was induced by an epidural balloon. The severity of the trauma was defined by the balloon volume and flattening of electroencephalography. Hypothermia (32degreesC) was induced as soon as maximum balloon inflation was reached. Ischemia was extended over 30 min. After reperfusion, normothermic (n = 24) and hypothermic animals (n = 25) were monitored for 3 h followed by a rewarming of the cooled animals. Results were compared to sham-operated animals (n = 10). Behavioral deficits were assessed by postural reflex (PR), open field (OF), beam balance (BB), beam walking (BW), and water maze tests (WMT). MRI follow-up and histology was evaluated. Sham-operated rats showed normal test results. Rats with normothermia showed worsening of test performance (PR, p < 0.05; OF, p < 0.05; BB, p < 0.05; BW, p < 0.05; WMT, p < 0.05) compared to controls over the whole observation period. A significantly better behavioral outcome was observed in animals treated with hypothermia which showed no differences from controls 3-4 days after injury (PR, OF, BB, BW, WMT, p > 0.05). Lesion induced mortality was reduced in cooled animals but overall mortality rates were not influenced by this therapeutic measure. Neuronal cell loss in the CA1-CA4 region (p < 0.05) was reduced and the lesion size smaller (21 %/p > 0.05) in hypothermic animals. Magnetic resonance imaging revealed that the lesion was more pronounced in the cortical grey matter after normothermia, whereas hypothermic animals showed more subcortical brain lacerations. In conclusion, intraischemic hypothermia significantly improved the behavioral outcome, and decreased lesion-induced mortality and the size of the lesion after an epidural focal mass lesion.	Univ Regensburg, Dept Neurosurg, D-93053 Regensburg, Germany; Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany		Burger, R (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	RBurger@t-online.de		Vince, Giles/0000-0002-0222-8733			ALEXIS NE, 1995, STROKE, V26, P2338, DOI 10.1161/01.STR.26.12.2338; Avitsur R, 1997, NEUROIMMUNOMODULAT, V4, P258, DOI 10.1159/000097345; BALDWIN WA, 1991, AM J PHYSIOL, V261, pH774, DOI 10.1152/ajpheart.1991.261.3.H774; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bendszus M, 2002, J NEUROSURG, V97, P1419, DOI 10.3171/jns.2002.97.6.1419; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Burger R, 1998, NEUROL RES, V20, pS52; Burger R, 1999, J NEUROTRAUM, V16, P1149, DOI 10.1089/neu.1999.16.1149; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Colbourne F, 1998, STROKE, V29, P1967, DOI 10.1161/01.STR.29.9.1967; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Ebmeyer U, 1998, J NEUROTRAUM, V15, P323, DOI 10.1089/neu.1998.15.323; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GERMANO IM, 1987, J NEUROSURG, V67, P81, DOI 10.3171/jns.1987.67.1.0081; GOLDSTEIN LB, 1990, BEHAV NEUROSCI, V104, P320, DOI 10.1037/0735-7044.104.2.320; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayasaki K, 1997, ACT NEUR S, V70, P75; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hill AG, 1996, AM J PHYSIOL-REG I, V271, pR1142, DOI 10.1152/ajpregu.1996.271.5.R1142; Hoffman WE, 1996, NEUROL RES, V18, P185; JARRARD LE, 1973, PSYCHOL BULL, V79, P1, DOI 10.1037/h0033792; JASPERS RMA, 1990, NEUROSCI LETT, V117, P149, DOI 10.1016/0304-3940(90)90135-V; Jiang JY, 2000, J NEUROSURG, V93, P718; KIMBLE DP, 1963, J COMP PHYSIOL PSYCH, V56, P273, DOI 10.1037/h0048903; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MILESON BE, 1991, NEUROSCI LETT, V128, P71, DOI 10.1016/0304-3940(91)90762-I; MIYAZAWA T, 1992, J CEREBR BLOOD F MET, V12, P817, DOI 10.1038/jcbfm.1992.113; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Nelson A, 1997, BEHAV BRAIN RES, V85, P93, DOI 10.1016/S0166-4328(96)00167-2; PACKARD MG, 1989, J NEUROSCI, V9, P1465; PERSSON L, 1989, STROKE, V20, P641, DOI 10.1161/01.STR.20.5.641; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; SUTHERLAND RJ, 1982, J COMP PHYSIOL PSYCH, V96, P563, DOI 10.1037/h0077914; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; WINOCUR G, 1990, BEHAV NEUROSCI, V104, P544, DOI 10.1037/0735-7044.104.4.544	71	12	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2003	20	6					543	558		10.1089/089771503767168474			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	697DL	WOS:000183926900003	12906739				2022-02-06	
J	Ruttan, LA; Heinrichs, RW				Ruttan, LA; Heinrichs, RW			Depression and neurocognitive functioning in mild traumatic brain injury patients referred for assessment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; MEMORY TEST-PERFORMANCE; NEUROPSYCHOLOGICAL DEFICITS; RECOVERY; SYMPTOMS; IMPACT	The relationship between depression and performance on selected neurocognitive tests was examined in two mild head injury samples (n(1) = 72, n(2) = 50). A series of hierarchical regression analyses showed that scores on depression-related scales of both the MCMI-II (Millon Clinical Multi-Axial Inventory; Millon, 1987) and MMPI-2 (Minnesota Multiphasic Personality Inventory; Hathaway & McKinley, 1989) were largely independent of cognitive performance. Depression may be prevalent in mild injury, but it is unlikely to mediate deficits observed on commonly used measures of problem solving, visual-niotor speed, prose and figural recall.	York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; Toronto Rehabil Inst, Toronto, ON, Canada		Heinrichs, RW (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	walterh@yorku.ca					Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Christensen LB., 1985, EXPT METHODOLOGY, V3; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1986, J CONSULT CLIN PSYCH, V54, P261, DOI 10.1037/0022-006X.54.2.261; GASS CS, 1990, PSYCHOL ASSESSMENT J, V2, P175, DOI DOI 10.1037//1040-3590.2.2.175; Gronwall D, 1989, MILD HEAD INJURY, P153; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; Jennett B, 1989, MILD HEAD INJURY, P22; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MACNIVEN E, 1990, CLIN NEUROPSYCHOL, V4, P305; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M., 1993, HALSTEADREITAN NEURO; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; SAPIENZA MM, 1989, THESIS YORK U N YORK; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sherman EMS, 2000, BRAIN INJURY, V14, P621; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tabachnick B. G., 1989, USING MULTIVARIATE S; Tellier A, 1999, BRAIN INJURY, V13, P463; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; WETZLER S, 1993, J PERS ASSESS, V60, P1, DOI 10.1207/s15327752jpa6001_1; [No title captured]	56	12	12	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2003	25	3					407	419		10.1076/jcen.25.3.407.13812			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	683GX	WOS:000183141200010	12916653				2022-02-06	
J	Liu, Y; Ishida, Y; Shinoda, K; Nakamura, S				Liu, Y; Ishida, Y; Shinoda, K; Nakamura, S			Effects of repeated stress on regeneration of serotonergic and noradrenergic axons in the cerebral cortex of adult rats	NEUROSCIENCE LETTERS			English	Article						noradrenaline; serotonin; restraint stress; regeneration; degeneration; denervation area	LOCUS-CERULEUS NEURONS; TRAUMATIC BRAIN INJURY; DEPRESSION; PROJECTIONS; COERULEUS	We examined whether regeneration of serotonergic (5-HT) and noradrenergic (NA) axons might be affected by stress. Neurotoxins to 5-HT or NA axons were injected into the frontal cortex to cause partial denervation. Mild restraint stress (40 min/day) was started 16 days later and given for 14 consecutive days (30-day stressed group). Non-stressed animals were divided into two groups, animals sacrificed at 14 days (14-day control group) and those sacrificed at 30 days (30-day control group) after the toxin injection. In immunohistochemical study, the denervation area of 5-HT axons but not that of NA axons was significantly smaller in the 30-day control group than in the 14-day control group. However, there was no significant difference between the 14-day control and 30-day stressed groups. These findings suggested that regeneration of 5-HT axons occurred earlier than that of NA axons, and that stress exerted inhibitory influence on regeneration of 5-HT axons. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.	Yamaguchi Univ, Sch Med, Dept Neurosci, Ube, Yamaguchi 7558505, Japan		Nakamura, S (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosci, Ube, Yamaguchi 7558505, Japan.			Nakamura, Shoji/0000-0002-8004-8893			Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Belzung C, 2001, NEUROPHARMACOLOGY, V41, P400, DOI 10.1016/S0028-3908(01)00072-7; BJORKLUND A, 1980, BRAIN RES, V191, P109, DOI 10.1016/0006-8993(80)90318-2; FRANKFURT M, 1984, BRAIN RES, V298, P273, DOI 10.1016/0006-8993(84)91426-4; FRITSCHY JM, 1990, J CHEM NEUROANAT, V3, P309; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Huether G, 1996, PROG NEUROBIOL, V48, P569, DOI 10.1016/0301-0082(96)00003-2; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P188, DOI 10.1016/S0893-133X(98)00058-X; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; NAKAMURA S, 1989, NEUROSCI LETT, V100, P147, DOI 10.1016/0304-3940(89)90675-7; NAKAMURA S, 1991, NEUROREPORT, V2, P525, DOI 10.1097/00001756-199109000-00007; NAKAMURA S, 1991, PROG BRAIN RES, V88, P587; Nowakowska E, 2001, POL J PHARMACOL, V53, P227; PLAZNIK A, 1989, PROG NEURO-PSYCHOPH, V13, P623, DOI 10.1016/0278-5846(89)90050-X; RODE J, 1983, HUM PATHOL, V14, P464, DOI 10.1016/S0046-8177(83)80294-9; SAKAGUCHI T, 1990, NEUROSCI LETT, V118, P193, DOI 10.1016/0304-3940(90)90624-I; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; WATERHOUSE BD, 1983, J COMP NEUROL, V217, P418, DOI 10.1002/cne.902170406	19	12	12	1	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAR 27	2003	339	3					227	230		10.1016/S0304-3940(03)00014-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	656ZU	WOS:000181641600014	12633894				2022-02-06	
J	Golding, EA; Robertson, CS; Fitch, JCK; Goodman, JC; Bryan, RM				Golding, EA; Robertson, CS; Fitch, JCK; Goodman, JC; Bryan, RM			Segmental vascular resistance after mild controlled cortical impact injury in the rat	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral blood flow; pial arteriole; rat; servo-nulling pressure system; traumatic brain injury	CEREBRAL-BLOOD-FLOW; PERCUSSION BRAIN INJURY; ARTERIAL-PRESSURE; MICROCIRCULATION; REACTIVITY; ISCHEMIA; STIMULATION; OCCLUSION; RESPONSES; PERFUSION	In an effort to localize the site at which increased resistance occurs after brain trauma, pial arteriole diameter and pressure were assessed after mild controlled cortical impact (CCI) injury in rats using an open cranial window technique. The authors tested the hypothesis that an increase in resistance accompanied by vasoconstriction occurs at the level of the pial arterioles within the injured cortex of the brain. At I hour after mild CCI injury, ipsilateral cerebral blood flow was significantly reduced by 42% compared with sham injury (n = 4; P < 0.05). Pial arteriole diameter and pressure remained unchanged. Resistance in the larger arteries (proximal resistance), however, was significantly greater after CCI injury (1.87 +/- 0.26 mm Hg/[mL . 100 g . min]) compared with sham injury (0.91 +/- 0.21 mm Hg/[mL . 100 g . min]; P < 0.0001). Resistance in small vessels, arterioles, and venules (distal resistance) was also significantly greater after CCI injury (1.13 +/- 0.05 mm Hg/[mL . 100 g . min]) compared with sham injury (0.74 +/- 0.13 rum Hg/[mL . 100 g . min]; P = 0.0001). The authors conclude that, at I hour after mild CCI injury, changes in vascular resistance comprise a 53% increase in the resistance distal to the area of injury and, surprisingly, a 105% increase in resistance in the arteries proximal to the injury site.	Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Univ Oklahoma, Dept Anesthesiol, Oklahoma City, OK USA		Golding, EA (corresponding author), Baylor Coll Med, Dept Anesthesiol, 1 Baylor Plaza,Suite 434D, Houston, TX 77030 USA.	egolding@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BAUMBACH GL, 1989, J PHYSIOL-LONDON, V416, P123, DOI 10.1113/jphysiol.1989.sp017753; BAUMBACH GL, 1983, CIRC RES, V52, P527, DOI 10.1161/01.RES.52.5.527; BERNE RM, 1988, PHYSIOLOGY, P472; BRYAN RM, 1988, AM J PHYSIOL, V255, pR295, DOI 10.1152/ajpregu.1988.255.2.R295; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; GOBEL U, 1990, CIRC RES, V66, P271, DOI 10.1161/01.RES.66.2.271; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Golding EM, 2000, J CEREBR BLOOD F MET, V20, P820, DOI 10.1097/00004647-200005000-00008; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; HAJDU MA, 1993, AM J PHYSIOL, V264, pH2136, DOI 10.1152/ajpheart.1993.264.6.H2136; HARPER SL, 1984, HYPERTENSION, V6, P408, DOI 10.1161/01.HYP.6.3.408; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; LANGFITT TW, 1977, ANN SURG, V186, P411, DOI 10.1097/00000658-197710000-00002; Li PA, 1998, NEUROSCI LETT, V253, P191, DOI 10.1016/S0304-3940(98)00643-0; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; SCHMIDTKASTNER R, 1987, J CEREBR BLOOD F MET, V7, P109, DOI 10.1038/jcbfm.1987.16; SHAPIRO HM, 1971, AM J PHYSIOL, V221, P279, DOI 10.1152/ajplegacy.1971.221.1.279; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; THEILEN H, 1994, J CEREBR BLOOD F MET, V14, P1055, DOI 10.1038/jcbfm.1994.138; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Thomale UW, 2001, J NEUROSCI METH, V108, P85, DOI 10.1016/S0165-0270(01)00375-2; Tompkins P., 1999, Society for Neuroscience Abstracts, V25, P312; Uhl E, 2000, PROG APPL MICROCIR, V24, P72; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	35	12	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2003	23	2					210	218		10.1097/01.WCB.0000044739.64940.B5			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	643ZQ	WOS:000180893800008	12571452				2022-02-06	
J	Kowianski, P; Karwacki, Z; Dziewiatkowski, J; Domaradzka-Pytel, B; Ludkiewicz, B; Wojcik, S; Litwinowicz, B; Narkiewicz, O; Morys, J				Kowianski, P; Karwacki, Z; Dziewiatkowski, J; Domaradzka-Pytel, B; Ludkiewicz, B; Wojcik, S; Litwinowicz, B; Narkiewicz, O; Morys, J			Evolution of microglial and astroglial response during experimental intracerebral haemorrhage in the rat	FOLIA NEUROPATHOLOGICA			English	Article						astrocytes; inflammation; intracerebral haemorrhage; microglia	TUMOR-NECROSIS-FACTOR; CEREBRAL-ARTERY OCCLUSION; EDEMA FORMATION; BRAIN EDEMA; TNF-ALPHA; GLOBAL-ISCHEMIA; BLOOD-FLOW; CELL-DEATH; IN-VITRO; EXPRESSION	Intracerebral haemorrhage is a strong stimulus for both microglial and astroglial activations. There are some important pathophysiological features during haemorrhage that do not occur in ischaemic or traumatic brain injuries, and may influence the dynamics and intensity of glial activation. Studies on the evolution of glial reaction may have practical importance to the introduction of new therapeutic methods for influencing the inflammatory reaction during haemorrhage. Microglial and astroglial responses to experimental intracerebral haematoma were studied in 50 adult rats for 5 minutes after injection of 100 mul autologous arterial blood into the striatum. The survival period varied from 1 to 21 days. Microglial-macrophage lineage cells were immunocytochemically stained with antibodies OX42, OX6 and ED1. The astrocytic population was studied by means of anti-GFAP staining. Changes in cellular morphology and intensity of staining were time-dependent reactions in both microglial and astroglial cells. Strong activation of microglial-macrophage lineage cells revealed with OX6-and OX42-immunoreactivity started during the first postoperative day. The complete pattern of activation for ED1-immunoreactivity was observed from the third postoperative day. At this stage, numerous phagocytic macrophages started to appear in the perihaematoma region. Morphological changes were most intensive during the second postoperative week. The astroglial (anti-GFAP) reaction was observed after the third postoperative day and proceeded less dynamically. The glial reaction gradually stopped but not completely during the period of observation. The early occurrence of glial activation, pattern of morphological changes and characteristic sequence of antigens expression indicate a very intense type of glial reaction. Evolution of glial response to haemorrhage reveals characteristic features. In our opinion, the initial phase of glial activation, comprising 72 hours after the occurrence of haemorrhage, is potentially the most promising period for influencing the extent of glial reaction with therapeutic agents.	Med Acad Gdansk, Dept Anat & Neurobiol, PL-80211 Gdansk, Poland; Med Univ Gdansk, Dept Anaesthesiol & Intens Therapy, Gdansk, Poland		Kowianski, P (corresponding author), Med Acad Gdansk, Dept Anat & Neurobiol, Ul Debiniki 1, PL-80211 Gdansk, Poland.		Janusz Morys, Professor//ABF-9423-2020; Kowianski, Przemyslaw/W-9953-2018; Wojcik, Slawomir/U-5266-2018	Janusz Morys, Professor//0000-0002-4048-1721; Kowianski, Przemyslaw/0000-0001-6257-5780; Wojcik, Slawomir/0000-0002-9635-2005; Ludkiewicz, Beata/0000-0001-7065-6126; Morys, Janusz/0000-0001-5037-4607			Abraham H, 2000, BRAIN RES, V862, P63, DOI 10.1016/S0006-8993(00)02072-2; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Brown RD, 1996, STROKE, V27, P373; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GEHRMANN J, 1992, ACTA NEUROPATHOL, V84, P588; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Kaplanski G, 1997, J IMMUNOL, V158, P5435; Kaufman HH, 1996, NEUROSURGERY, V2, P2567; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Lambertsen KL, 2002, J CEREBR BLOOD F MET, V22, P785, DOI 10.1097/00004647-200207000-00004; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Masada T, 2001, J NEUROSURG, V95, P680, DOI 10.3171/jns.2001.95.4.0680; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Orzylowska O, 1999, NEUROSCI LETT, V263, P72, DOI 10.1016/S0304-3940(99)00043-9; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Qureshi AI, 2001, NEUROSURGERY, V49, P416, DOI 10.1097/00006123-200108000-00027; Qureshi AI, 2001, CRIT CARE MED, V29, P152, DOI 10.1097/00003246-200101000-00030; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; WAGA S, 1983, STROKE, V14, P480, DOI 10.1161/01.STR.14.4.480; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	38	12	21	0	4	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1641-4640			FOLIA NEUROPATHOL	Folia Neuropathol.		2003	41	3					123	130					8	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	732HR	WOS:000185935200001	14604292				2022-02-06	
J	Turkstra, LS; Flora, TL				Turkstra, LS; Flora, TL			Compensating for executive function impairments after TBI: a single case study of functional intervention	JOURNAL OF COMMUNICATION DISORDERS			English	Article						executive; strategy; employment; brain injury	CLOSED-HEAD INJURY; MEMORY PERFORMANCE; CHILDREN	The purpose of this study was to demonstrate the effectiveness of compensatory strategies for impairments in executive function. The strategies were designed to enable a client with traumatic brain injury (TBI) to obtain professional employment, In a series of individual speech-language therapy sessions, compensatory strategies were developed, refined, and trained in mock-interview situations. Significant improvements were noted in report-writing accuracy and self-reported stress during report-writing. The client was able to obtain and maintain competitive employment in his chosen profession. The results support the use of strategies aimed at supporting executive function to improve performance on verbal tasks, and were informative regarding the effects of self-perceived efficacy and stress on performance after TBI. They illustrate that intervention based oil real-life supports may be effective even many years post-TBI. Learning outcomes: At the conclusion of this article, readers will: ( 1) identify aspects of executive function that relate to communication in the work-place, (2) describe the steps in considering intervention within a single subject research design framework, and (3) consider the effects of stress and perceived self-efficacy on performance of communication tasks. (C) 2002 Elsevier Science Inc. All rights reserved.	Case Western Reserve Univ, Dept Commun Sci, Cleveland, OH 44106 USA		Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave, Cleveland, OH 44106 USA.	lst2@po.cwru.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00163] Funding Source: Medline		Armor DA, 1998, ADV EXP SOC PSYCHOL, V30, P309, DOI 10.1016/S0065-2601(08)60386-X; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Dirette DK, 1999, J HEAD TRAUMA REHAB, V14, P595, DOI 10.1097/00001199-199912000-00008; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GROSS TF, 1980, J EDUC PSYCHOL, V72, P605; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hoffman KB, 2000, J ABNORM PSYCHOL, V109, P651, DOI 10.1037//0021-843X.109.4.651; Isaki E, 2000, BRAIN INJURY, V14, P441; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; KRATOCHWILL TR, 1984, RES METHODS CLIN PSY, P55; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; MacDonald S., 1998, FUNCTIONAL ASSESSMEN; Marlowe WB, 2000, DEV NEUROPSYCHOL, V18, P445, DOI 10.1207/S1532694209Marlowe; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1988, BNI Q, V4, P40; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Scott CherylM., 1988, LATER LANGUAGE DEV A, P49; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spitzer RL, 1994, DSM 4 CASEBOOK LEARN, V4th; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; WEBSTER, 1996, WEBSTERS COLL DICT; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	31	12	12	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	NOV-DEC	2002	35	6					467	482	PII S0021-9924(02)00118-1	10.1016/S0021-9924(02)00118-1			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	615YB	WOS:000179274000001	12443048				2022-02-06	
J	Das-Gupta, R; Turner-Stokes, L				Das-Gupta, R; Turner-Stokes, L			Traumatic brain injury	DISABILITY AND REHABILITATION			English	Article							DISABILITY RATING-SCALE; HETEROTOPIC OSSIFICATION; HEAD-INJURY; REHABILITATION; ADULTS	Purpose: Traumatic brain injury (TBI) leading to severe disability is fortunately rare. but when it occurs, the effect on patients and their families can be devastating. Issue: In the UK at the current time, there are insufficient specialist rehabilitation services to cater for the case-load and many patients receive their care in general wards. Conclusion: This educational article outlines the principles of management of severe TBI from a practical clinical viewpoint, reviews briefly the evidence for effectiveness of rehabilitation and offers an approach to consistent outcome measurement.	Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England		Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.turner-stokes@kcl.ac.uk	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Banovac K, 2000, J Spinal Cord Med, V23, P40; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Creedon SD, 1997, INT J REHABIL HLTH, V3, P171; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARRATT AM, 1993, BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRONWALL D, 1975, LANCET, V2, P995; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HARVEY RF, 1983, ARCH PHYSICAL MED RE, V64, P868; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; Ko C K, 1997, Br J Hosp Med, V58, P400; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MAHONEY F I, 1965, Md State Med J, V14, P61; MARTIN J, 1 OFF POP CONS SURV; MCLELLAN DL, 1998, REHABILITATION TRAUM; MCQUEEN JD, 1974, SURG NEUROL, V2, P271; Medical Research Council, 1976, AIDS EX PER NERV SYS; Nyein K, 1999, CLIN REHABIL, V13, P56, DOI 10.1191/026921599701532135; Pistarini Caterina, 1995, Recenti Progressi in Medicina, V86, P483; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rice-Oxley M, 2000, CLIN REHABIL, V14, P548, DOI 10.1191/0269215500cr359oa; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON I, 1990, APHASIOLOGY, V4, P381, DOI 10.1080/02687039008249090; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SCHIERHOUT G, 2000, COCHRANE LIB, V4; Schurch B, 1997, ARCH PHYS MED REHAB, V78, P687, DOI 10.1016/S0003-9993(97)90074-5; SHEIL A, 2000, CLIN REHABIL, V14, P408; SHIEL A, 1998, CLIN REHABIL, V13, P76; SLADE A, 1998, CLIN REHABIL, V13, P80; Sosnowski C, 1994, J Neurosci Nurs, V26, P336; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TENNANT A, 1995, TRAUMATIC BRAIN INJU; Thomas B J, 1987, Hip, P59; TRUDELLE JL, 1990, BRAIN INJURY, V4, P305; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; TURNERSTOKES L, 1999, CLIN REHABILITATIO S, V13; Wade D, 1992, MEASUREMENT NEUROLOG; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Young B, 1991, Neurosurg Clin N Am, V2, P301; 1995, SEVERE HEAD INJURIES	54	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	SEP 10	2002	24	13					654	665		10.1080/09638280110109282			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	594CE	WOS:000178030500002	12296981				2022-02-06	
J	Nathoo, N; Chite, SH; Edwards, PJ; van Dellen, JR				Nathoo, N; Chite, SH; Edwards, PJ; van Dellen, JR			Civilian infratentorial gunshot injuries: Outcome analysis of 26 patients	SURGICAL NEUROLOGY			English	Article						civilian; infratentorial missile; outcome; hydrocephalus; treatment	PENETRATING CRANIOCEREBRAL INJURIES; CEREBRAL MISSILE INJURY; PRACTICAL SCALE; WOUNDS; BRAIN; HEAD; PROGNOSIS; MORTALITY; SERIES; MODEL	BACKGROUND Craniocerebral missile injuries have steadily increased to become the most common form of penetrating neurotrauma in our environment resulting in continued morbidity and neuropsychological sequelae. Civilian infratentorial gunshot injuries are uncommon but generally regarded as fatal injuries, with many patients dying before reaching hospital. METHODS A retrospective analysis of 1,069 patients with civilian gunshot wounds (GSW), admitted to our unit over a 14-year period (1986-2000), identified 26 patients with infratentorial gunshot injuries (2.4%). A detailed analysis of these patients was carried out, which included demographic factors, clinical and anatomic correlation, computed tomography scans, surgical management, and outcome. RESULTS All patients were male. The mean age was 26.5 +/- 11.5 years and the mean admission Glasgow Coma Score 11.8 +/- 2.7. Twenty-four of 26 patients required cerebrospinal fluid (CSF) diversion to control secondary hydrocephalus. The second commonest surgical procedure was posterior fossa decompression. Five of 26 patients died (19.2%). Severe morbidity was noted in 9 of 21 surviving patients (42.8%). Significant predictors: good outcome was associated with primary missile entry of the infratentorial compartment (p = 0.005), while patients with supratentorial to infratentorial missile trajectory were noted to have a poorer outcome (p = 0.041). Location of cerebellar injury (lateral or medial) and missile caliber had no significant influence on patient outcome. CONCLUSION Early control of incipient or established hydrocephalus and aggressive surgical management where appropriate, with careful postoperative monitoring, is necessary for good outcome in patients with civilian infratentorial missile injuries. (C) 2002 by Elsevier Science Inc.	Wentworth Provincial Hosp, Dept Neurosurg, ZA-4026 Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; UCL, Inst Child Hlth, London, England; Charing Cross Hosp, W London Neurosci Ctr, London, England; Charing Cross Hosp, Imperial Coll, Sch Med, London, England		Nathoo, N (corresponding author), Wentworth Provincial Hosp, Dept Neurosurg, Private Bag Jacobs, ZA-4026 Durban, South Africa.			Edwards, Phil/0000-0003-4431-8822			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; CROCKARD HA, 1975, J TRAUMA, V15, P339, DOI 10.1097/00005373-197504000-00011; CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Cushing H, 1918, BRIT J SURG, V5, P558; GERBER AM, 1972, J NEUROSURG, V36, P43, DOI 10.3171/jns.1972.36.1.0043; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HELLING TS, 1992, J TRAUMA, V32, P398, DOI 10.1097/00005373-199203000-00019; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1983, ACTA NEUROCHIR, V67, P115, DOI 10.1007/BF01401671; Nadvi SS, 1997, NEUROSURGERY, V41, P61, DOI 10.1097/00006123-199707000-00013; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; NAROTAM PK, 1995, J NEUROSURG, V82, P406, DOI 10.3171/jns.1995.82.3.0406; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Nathoo N, 1997, NEUROSURGERY, V41, P1263, DOI 10.1097/00006123-199712000-00005; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHAFFREY ME, 1992, NEUROTRAUMA, V9, pS279; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; STONE JL, 1991, NEUROSURGERY, V128, P603; TEASDALE G, 1974, LANCET, V2, P81	29	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP-OCT	2002	58	3-4					225	233	PII S0090-3019(02)00828-5	10.1016/S0090-3019(02)00828-5			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	625RE	WOS:000179828700009	12480225				2022-02-06	
J	Glass, TF; Reeves, B; Sharp, FR				Glass, TF; Reeves, B; Sharp, FR			Modeling both the mechanical and hypoxic features of traumatic brain injury in vitro in rats	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; hypoxia; ischemia; model; neuron; axon; death	QUANTITATIVE-DETERMINATION; INDUCIBLE FACTOR-1; NEURONAL INJURY; CELL-CULTURE; ASSAY	In traumatic brain injury, the brain is subjected to mechanical shear and varying degrees of hypoxia/ischemia. To compare effects of stretch injury, hypoxia, and the combination of both insults on neurons, mixed neuronal and astrocytic cultures were established from day 17 fetal rat brains. On days 17-19 in vitro, cultures were subjected to stretch injury or hypoxia of varying degrees, alone and in combination. Cultures were assayed for lactate dehydrogenase release and Trypan Blue uptake. Hypoxia or Stretch injury alone induced a graded response (P < 0.05) on both assays. Stretch + Hypoxia (4 or 6 h) resulted in significantly greater injury as compared with controls (P < 0.05), and as compared with either isolated Stretch or Hypoxia (1, 2, 4 or 6 h) alone (P < 0.05). (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Cincinnati, OH 45229 USA; Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Neurosci Program, Cincinnati, OH 45267 USA		Glass, TF (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Locat C 2008,3333 Burnet Ave, Cincinnati, OH 45229 USA.	glast0@chmcc.org					Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Boswell WC, 1996, SOUTHERN MED J, V89, P218, DOI 10.1097/00007611-199602000-00012; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Uliasz TF, 2000, J NEUROSCI METH, V100, P157, DOI 10.1016/S0165-0270(00)00248-X	14	12	13	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 9	2002	328	2					133	136	PII S0304-3940(02)00510-4	10.1016/S0304-3940(02)00510-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JA	WOS:000177520600015	12133573				2022-02-06	
J	Wedekind, C; Hesselmann, V; Klug, N				Wedekind, C; Hesselmann, V; Klug, N			Comparison of MRI and electrophysiological studies for detecting brainstem lesions in traumatic brain injury	MUSCLE & NERVE			English	Article						brainstem auditory evoked potential (BAEP); brainstern reflexes; magnetic resonance imaging (MRI); traumatic brain injury		The yield of magnetic resonance imaging (MRI) and electrophysiological studies in detecting brainstem lesions was assessed in 35 patients suffering from traumatic brain injury (Glasgow Coma Scale, 3-10). As an inclusion criterion, all patients had brainstem trauma as revealed by early MRI or electrophysiological studies. Of the 35 cases, 7 (20%) had brainstem lesions detected by MRI only, whereas in 10 patients (29%), electrophysiological examination disclosed impairment of brainstem function with normal MRI. In 18 (51%) subjects, both diagnostic techniques revealed brainstem lesions. The midbrain was the most common location of lesions. Masseter reflex recording had the highest yield (93%) of abnormal findings. No mismatch with respect to site and side of abnormality occurred between MRI and electrophysiological studies. Outcome analysis indicated an unfavorable course for the vast majority (83%) of patients, regardless of the diagnostic means disclosing traumatic brainstem injury. Therefore, both techniques are effective in disclosing traumatic brainstem injury, with diagnostic overlap in about 50% of cases. In contrast to MRI, electrophysiological investigation is easily performed and repeated at low cost in the setting of an intensive care unit, where such patients are typically hospitalized after trauma. In addition to electrophysiological assessment of brainstem function, MRI is recommended in each case having normal electrophysiological findings when brainstem injury is suspected. (C) 2002 Wiley Periodicals, Inc.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany; Univ Cologne, Dept Radiol, D-50924 Cologne, Germany		Wedekind, C (corresponding author), Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany.	drchrwedekind@web.de					Chiappa K.H., 1997, EVOKED POTENTIALS CL; COMI G, 1993, EUR NEUROL, V33, P232, DOI 10.1159/000116943; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; HOPF HC, 1994, MUSCLE NERVE, V17, P475, DOI 10.1002/mus.880170502; JENNETT B, 1975, LANCET, V1, P480; Kimura J, 1989, ELECTRODIAGNOSIS DIS; SACHS L, 1997, ANGEWNADTE STAT; SALCMAN M, 1992, NEUROCHIRURGIE, V38, P329; THOEMKE F, 1994, Z EEG EMG, V25, P259; Thomke F, 1999, J NEUROL NEUROSUR PS, V66, P340, DOI 10.1136/jnnp.66.3.340; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010	12	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	AUG	2002	26	2					270	273		10.1002/mus.10187			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	580LR	WOS:000177236500014	12210392				2022-02-06	
J	Orihara, Y; Nakasono, I				Orihara, Y; Nakasono, I			Induction of apolipoprotein E after traumatic brain injury in forensic autopsy cases	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						apolipoprotein E; traumatic brain injury; immunohistochemistry; astrocyte; neuron	E EPSILON 4; ALZHEIMERS-DISEASE; E IMMUNOREACTIVITY; NEURONS; HIPPOCAMPUS; HEMORRHAGE; ISCHEMIA; GENOTYPE; APOE	We investigated the dynamics of the induction of apolipoprotein E (apoE) in the human brain after death caused by traumatic brain injury (TBI). A striking difference in apoE immunoreactivity in the traumatised cortical hemisphere compared with the contralateral non-traumatised hemisphere was observed. ApoE was detected within the neurons of the traumatised cortical hemisphere in cases surviving only about 2 h, as well as in those surviving for extended periods. In contrast, no apoE staining within the neurons was seen in the contralateral cortical hemisphere. ApoE staining within astrocytes was faint in both traumatised and contralateral hemispheres of cases surviving only 2 h. However, staining was intense in the traumatised hemispheres in short as well as long surviving cases, even those surviving more than 1 month. ApoE immunoreactivity was also observed in areas adjacent to capillaries and surrounding the neuropil of the injured hemisphere. These observations corroborated the idea of a prolonged induction of apoE within the neurons and also in the extracellular matrix after TBI. Furthermore, the possibility is suggested that the alteration of apoE distribution may contribute to a cerebroprotective mechanism immediately after TBI.	Kagoshima Univ, Fac Med, Dept Legal Med, Kagoshima 8908520, Japan; Nagasaki Univ, Sch Med, Dept Legal Med, Nagasaki 8528523, Japan		Orihara, Y (corresponding author), Kagoshima Univ, Fac Med, Dept Legal Med, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	orihara@m3.kufm.kagoshima-u.ac.jp					ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Graham DI, 1999, ACT NEUR S, V73, P89; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; HALL ED, 1995, EXP NEUROL, V135, P17, DOI 10.1006/exnr.1995.1062; HAN SH, 1994, J NEUROPATH EXP NEUR, V53, P535, DOI 10.1097/00005072-199409000-00013; HAN SH, 1994, EXP NEUROL, V128, P13, DOI 10.1006/exnr.1994.1108; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Horsburgh K, 1996, NEUROPATH APPL NEURO, V22, P342, DOI 10.1111/j.1365-2990.1996.tb01113.x; Horsburgh K, 1996, ALZHEIMER RES, V2, P37; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KIDA E, 1995, BRAIN RES, V674, P341, DOI 10.1016/0006-8993(94)01467-V; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nicoll JAR, 1996, ANN NEUROL, V39, P682, DOI 10.1002/ana.410390521; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Quan L, 2001, INT J LEGAL MED, V114, P310, DOI 10.1007/s004140000192; REBECK GW, 1993, NEURON, V11, P575; Seliger G, 1997, NEUROLOGY, V48, P28001; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303	30	12	15	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	APR	2002	116	2					92	98		10.1007/s00414-001-0265-8			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	552JU	WOS:000175617700007	12056527				2022-02-06	
J	Segura, T; Jimenez, P; Jerez, P; Garcia, F; Corcoles, V				Segura, T; Jimenez, P; Jerez, P; Garcia, F; Corcoles, V			Prolonged clinical pattern of brain death in patients under barbiturate sedation: usefulness of transcranial Doppler	NEUROLOGIA			Spanish	Article						brain death; transcraneal Doppler; barbiturates at high dosages; severe head injury; intracraneal hypertension; electroencephalography		INTRODUCTION: Throughout the world, is fully accepted that a person is dead when brain death exists. In most situations, neurological criteria permit the diagnosis of brain death, but in some instances, as when high-dose barbiturate therapy has been used, confirmatory testing are required by law. CLINICAL CASE: We report the case of a 17 year-old women who suffered high-dose barbiturate therapy due to post traumatic intracranial hypertension. During the period of the barbiturate infusion and until six days after the suppression of this therapy, neurological exploration and EEG findings seem to confirm brain death, while transcranial Doppler (TCD) study remained normal. CONCLUSIONS: TCD is a fast, simple and accurate confirmatory testing in the determination of brain death and its findings are not affected by high-dose barbiturate therapy. We think that TCD must be present in all hospitals where mechanical ventilation and support of patients are carried out.	Hosp Gen Albacete, Secc Neurol, Albacete 02006, Spain; Hosp Gen Albacete, Sev Med Intens, Albacete 02006, Spain; Hosp Gen Albacete, Serv Neurofisiol, Albacete 02006, Spain		Segura, T (corresponding author), Hosp Gen Albacete, Secc Neurol, Hermanos Falco S-N, Albacete 02006, Spain.	tseguram@meditex.es		Serrano-Heras, Gemma/0000-0001-9368-4832; Segura, Tomas/0000-0003-3625-0987			[Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1990, Neurology, V40, P680; DAVALOS A, 1993, MED CLIN-BARCELONA, V100, P249; GANES T, 1983, J NEUROL NEUROSUR PS, V46, P509, DOI 10.1136/jnnp.46.6.509; Goldfrank LR, 1998, GOLDFRANKS TOXICOLOG; LUNDAR T, 1983, CRIT CARE MED, V11, P559, DOI 10.1097/00003246-198307000-00017; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; Segura T, 1999, Neurologia, V14, P437; THOMPSON AE, 1989, CRIT CARE MED, V17, P194, DOI 10.1097/00003246-198902000-00019; TURCANT A, 1985, ANESTHESIOLOGY, V63, P50, DOI 10.1097/00000542-198507000-00007; YANG KL, 1991, CHEST, V99, P1037, DOI 10.1378/chest.99.4.1037	13	12	13	0	0	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	APR	2002	17	4					219	222					4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	544HV	WOS:000175152900007	11940411				2022-02-06	
J	Hadley, MN				Hadley, MN			Occipital condyle fractures	NEUROSURGERY			English	Article							HYPOGLOSSAL NERVE PALSY; COLLET-SICARD SYNDROME; CLOSED-HEAD-INJURY; FORGOTTEN CONDYLE; LIGAMENT INJURY; CT; IMPAIRMENT; DIAGNOSIS; SKULL		Univ Alabama, Div Neurol Surg, Birmingham, AL 35294 USA		Hadley, MN (corresponding author), Univ Alabama, Div Neurol Surg, 516 Med Educ Bldg,1813 6th Ave S, Birmingham, AL 35294 USA.						ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; BELL C, 1817, MIDDLESEX HOSP J, V4, P469; BETTINI N, 1993, SKELETAL RADIOL, V22, P187; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; Bloom AI, 1996, PEDIATR RADIOL, V26, P786, DOI 10.1007/BF01396202; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BOZBOGA M, 1992, SPINE, V17, P1119, DOI 10.1097/00007632-199209000-00019; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; CASTLING B, 1995, BRIT J ORAL MAX SURG, V33, P171, DOI 10.1016/0266-4356(95)90292-9; COTTALORDA J, 1996, J PEDIATR ORTHOPED, V5, P161; Curri D, 1988, J Neurosurg Sci, V32, P157; DEEB Z L, 1988, Journal of Computed Tomography, V12, P261, DOI 10.1016/0149-936X(88)90081-1; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; DESAI SS, 1990, J TRAUMA, V30, P240, DOI 10.1097/00005373-199002000-00023; Emery E, 1995, Eur Spine J, V4, P191, DOI 10.1007/BF00298245; GOLDSTEIN SJ, 1982, SURG NEUROL, V17, P350, DOI 10.1016/0090-3019(82)90308-1; HARDINGSMITH J, 1981, J BONE JOINT SURG AM, V63, P1170, DOI 10.2106/00004623-198163070-00016; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; Ide C, 1998, J NEUROSURG, V88, P773, DOI 10.3171/jns.1998.88.4.0773; JACOBY CG, 1979, AM J ROENTGENOL, V132, P500, DOI 10.2214/ajr.132.3.500-b; JONES DN, 1990, AM J NEURORADIOL, V11, P1181; Lam CH, 1996, CAN J NEUROL SCI, V23, P145, DOI 10.1017/S0317167100038890; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Leone A, 2000, RADIOLOGY, V216, P635, DOI 10.1148/radiology.216.3.r00se23635; LEVENTHAL MR, 1992, ORTHOPEDICS, V15, P944; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; MANN FA, 1994, AM J ROENTGENOL, V163, P193, DOI 10.2214/ajr.163.1.8010212; MARIANI PJ, 1990, ANN EMERG MED, V19, P1447, DOI 10.1016/S0196-0644(05)82618-6; MASSARO F, 1993, INJURY, V24, P419, DOI 10.1016/0020-1383(93)90110-R; MODY BS, 1992, INJURY, V23, P350, DOI 10.1016/0020-1383(92)90194-W; Noble ER, 1996, AM J NEURORADIOL, V17, P507; OLSSON R, 1994, ACTA RADIOL, V35, P90; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; PALEY MD, 1995, BRIT J ORAL MAX SURG, V33, P239, DOI 10.1016/0266-4356(95)90008-X; RAILA FA, 1993, SKELETAL RADIOL, V22, P269; Savolaine E R, 1989, J Orthop Trauma, V3, P71, DOI 10.1097/00005131-198903010-00014; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; STROOBANTS J, 1994, J NEUROSURG, V81, P137, DOI 10.3171/jns.1994.81.1.0137; STROOBANTS J, 1994, J TRAUMA, V36, P440, DOI 10.1097/00005373-199403000-00037; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; VALASKATZIS EP, 1990, S AFR MED J, V77, P47; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; WASSERBERG J, 1995, NEURORADIOLOGY, V37, P370; WESSELS LS, 1990, S AFR J SURG, V28, P155; YOUNG WF, 1994, NEUROSURGERY, V34, P257, DOI 10.1227/00006123-199402000-00008	47	12	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2002	50	3		S			S114	S119					6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	527VU	WOS:000174209300027					2022-02-06	
J	Hawkins, KA; Plehn, K; Borgaro, S				Hawkins, KA; Plehn, K; Borgaro, S			Verbal IQ-performance IQ differentials in traumatic brain injury samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						verbal IQ; performance IQ; traumatic brain injury	ADULT INTELLIGENCE SCALE; HEAD-INJURY; WAIS-R; MILD; DYSFUNCTION	Several studies of head trauma utilizing the Wechsler Adult Intelligence Scale (WAIS) reported large sample differentials between verbal IQ (VIQ) and performance IQ (PIQ), leading some writers to claim that the VIQ is largely unaffected by traumatic brain injury (TBI), and that a superiority of VIQ over PIQ should be expected. In contrast, our review of Wechsler Adult Intelligence Scale-Revised (WAIS-R) studies indicates that although TBI sample PIQ means are often depressed relative to VIQ means, the differences are small and sometimes in the opposite direction. Possible reasons for the discrepancy between our WAIS-R review and those of an earlier review of WAIS studies are discussed. Clinically, the lack of a VIQ-PIQ difference should never be used to infer that a TBI has not occurred. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA		Hawkins, KA (corresponding author), CMHC, Room 530,34 Pk St, New Haven, CT 06519 USA.	keith.hawkins@yale.edu		Hawkins, Keith/0000-0003-3494-2103			Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BORNSTEIN RA, 1983, J CONSULT CLIN PSYCH, V51, P779, DOI 10.1037/0022-006X.51.5.779; BORNSTEIN RA, 1982, J CLIN NEUROPSYCHOL, V4, P319, DOI 10.1080/01688638208401140; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P345, DOI 10.1080/13854049708400463; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FARR SP, 1986, HDB CLIN NEUROPSYCHO, P213; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; Guilmette TJ, 1999, ASSESSMENT, V6, P33, DOI 10.1177/107319119900600104; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; HAWKINS KA, 1994, CLIN NEUROPSYCHOL, V8, P394, DOI 10.1080/13854049408402042; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kraiuhin C, 1996, BRAIN INJURY, V10, P677, DOI 10.1080/026990596124098; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; MATTIS PJ, 1994, J CLIN PSYCHOL, V50, P605, DOI 10.1002/1097-4679(199407)50:4<605::AID-JCLP2270500418>3.0.CO;2-V; MOORE AD, 1993, CAN J BEHAV SCI, V25, P605, DOI 10.1037/h0078849; PANIAK CE, 1992, J CLIN PSYCHOL, V48, P219, DOI 10.1002/1097-4679(199203)48:2<219::AID-JCLP2270480212>3.0.CO;2-K; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; *PSYCH CORP, 1997, WAIS 2 WMS 3 TECHN M; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1958, MEASUREMENT APPRAISA	24	12	12	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2002	17	1					49	56		10.1016/S0887-6177(00)00099-8			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	504XD	WOS:000172880700004	14589752	Bronze			2022-02-06	
J	Berthier, ML; Posada, A; Puentes, C				Berthier, ML; Posada, A; Puentes, C			Dissociative flashbacks after right frontal injury in a Vietnam veteran with combat-related posttraumatic stress disorder	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN INJURY; POSITRON EMISSION TOMOGRAPHY; CHILDHOOD SEXUAL ABUSE; SCRIPT-DRIVEN IMAGERY; CEREBRAL BLOOD-FLOW; ANXIETY DISORDERS; MEMORIES; SPECT; CORTEX; RECALL	A Vietnam veteran with a combat-related post-traumatic stress disorder developed recurrent dissociative flashbacks (related to the atrocities of a specific war incident) several months after suffering a traumatic brain injury. CT disclosed a small lesion in the right dorsolateral prefrontal cortex. SPECT demonstrated more extensive functional changes in prefrontal and anterior paralimbic brain regions, mainly in the right hemisphere. This case further implicates the provocative effect of physical stimuli (brain damage) in reawakening old dormant memories and the preferential role of the right hemisphere for the storage of traumatic memories.	Univ Malaga, Dept Med & Dermatol, Fac Med, E-29071 Malaga, Spain; Carlos Haya Univ Hosp, Dept Radiol, Nucl Med Serv, Malaga, Spain		Berthier, ML (corresponding author), Univ Malaga, Dept Med & Dermatol, Fac Med, Campus Univ Teatinos, E-29071 Malaga, Spain.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P963; BAUER RM, 1993, CLIN NEUROPSYCHOLOGY, P523; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Berthier ML, 1997, EUR J NEUROL, V4, P551, DOI 10.1111/j.1468-1331.1997.tb00405.x; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; BRIGGS AC, 1993, BRIT J PSYCHIAT, V163, P828, DOI 10.1192/bjp.163.6.828; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; CASSIDAY KL, 1992, J TRAUMA STRESS, V5, P627, DOI 10.1007/BF00979230; DAVIDOFF DA, 1988, COGNITIVE REHABI MAR, P8; DECRISTOFARO MTR, 1993, BIOL PSYCHIAT, V33, P505, DOI 10.1016/0006-3223(93)90004-W; DOERFLER LA, 1994, GEN HOSP PSYCHIAT, V16, P193, DOI 10.1016/0163-8343(94)90101-5; Epstein Richard S., 1994, P285; Fink GR, 1996, J NEUROSCI, V16, P4275; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEMAN TW, 2000, J NEUROPSYCHIATRY CL, V13, P99; GOENJIAN AK, 1994, ACTA PSYCHIAT SCAND, V90, P214, DOI 10.1111/j.1600-0447.1994.tb01580.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Krikorian R, 1998, J NEUROPSYCH CLIN N, V10, P359, DOI 10.1176/jnp.10.3.359; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; MAYBERG HS, 1994, J NUCL MED, V35, P929; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; O'Brien M, 1998, BRIT J PSYCHIAT, V173, P102, DOI 10.1192/bjp.173.2.102; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; SAIGH PA, 1992, BRIT J PSYCHIAT, V161, P704, DOI 10.1192/bjp.161.5.704; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHIFFER F, 1995, J NEUROPSYCH CLIN N, V7, P169; Shin LM, 1999, AM J PSYCHIAT, V156, P575; SOUTHWICK SM, 1994, PSYCHIAT CLIN N AM, V17, P251; Spitzer R. L., 1990, STRUCTURED CLIN INTE; TOMB DA, 1994, PSYCHIAT CLIN N AM, V17, P237; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; WOODS SW, 1992, J CLIN PSYCHIAT, V53, P20	40	12	13	0	1	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2001	13	1					101	105		10.1176/appi.neuropsych.13.1.101			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	401TR	WOS:000166944800014	11207336				2022-02-06	
J	Dumas, HM; Haley, SM; Rabin, JP				Dumas, HM; Haley, SM; Rabin, JP			Short-term durability and improvement of function in traumatic brain injury: a pilot study using the Paediatric Evaluation of Disability Inventory (PEDI) classification levels	BRAIN INJURY			English	Article							CHILDREN; ADOLESCENTS; PERFORMANCE; RECOVERY; COHORT	Primary objective: To describe the short-term durability and improvement of functional outcomes for children and adolescents with traumatic brain injury (TBI) up to 6 months after discharge from inpatient rehabilitation. Research design: Retrospective, descriptive. Methods and procedures: Twenty-five (28.1%) of 89 children discharged from inpatient rehabilitation were available for outpatient follow-up within 6 months. The Paediatric Evaluation of Disability Inventory (PEDI) functional skill classification levels in the domains of self-care, mobility, and social function, recorded at discharge and follow-up, were examined using the Wilcoxon matched pairs signed rank test (two-tailed). Main outcomes and results: Most (64-80%) of the children sustained the outcome level achieved at hospital discharge in one or more of the three domains. Significant differences (p<0.05) from discharge to follow-up were detected in mobility and social function levels. Differences between children with and without follow-up were non-significant in all but one variable (social function level at hospital discharge). Conclusions : The results of this study suggest that children after TBI sustain outcomes achieved during inpatient rehabilitation and make significant gains in mobility and social function skills within 6 months of returning home. More research is needed to predict those children who will continue to recover and to identify factors that facilitate recovery in the community setting.	Franciscan Childrens Hosp & Rehabil Ctr, Boston, MA 02135 USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA		Dumas, HM (corresponding author), Franciscan Childrens Hosp & Rehabil Ctr, 30 Warren St, Boston, MA 02135 USA.	fchcenter@tiac.net					BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BURKE W H, 1990, Brain Injury, V4, P371, DOI 10.3109/02699059009026190; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Cockrell J. L., 1990, COMMUNITY INTEGRATIO, P287; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; HALEY SM, 1992, PEDIAT PHYS THERAPY, V4, P24; Haley SM, 1992, PAEDIAT EVALUATION D; Haley SM, 1993, PHYS MED REH CLIN N, V4, P529, DOI [10.1016/S1047-9651(18)30568-0, DOI 10.1016/S1047-9651(18)30568-0]; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Nichols DS., 1996, PEDIATR PHYS THER, V8, P15, DOI DOI 10.1097/00001577-199600810-00004; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Proctor EK, 1995, SOC WORK HEALTH CARE, V22, P1, DOI 10.1300/J010v22n01_01; SILVER BV, 1994, ARCH PHYS MED REHAB, V75, P742; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; *TRAC, 2000, MED REH STAND MAN; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Wright FV, 1993, CAN J REHABIL, V7, P41; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447	26	12	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2001	15	10					891	902		10.1080/02699050110065691			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483HF	WOS:000171627000005	11595085				2022-02-06	
J	Alberti, A; Sarchielli, P; Mazzotta, G; Gallai, V				Alberti, A; Sarchielli, P; Mazzotta, G; Gallai, V			Event-related potentials in posttraumatic headache	HEADACHE			English	Article						posttraumatic headache; event-related potentials; cognitive impairment	COGNITIVE EVOKED-POTENTIALS; AXONAL INJURY; P300; DEPRESSION; SYMPTOMS; LATENCY; STRESS; MEMORY	Objectives-To assess impairment of cognitive functions occurring in patients with posttraumatic headache as a consequence of a minor cranial trauma in the absence of organic damage involving the central nervous system. Background.-The term posttraumatic syndrome defines a stereotypic set of symptoms following traumatic brain injury that are subjective and varied. A deficit of cognitive function and impairment of the rapid processes of learning, attention, and short-term memory have frequently been identified. Moreover, headache is the most frequent symptom reported by the patients. Due to the nature of the symptoms, a great limitation in defining the posttraumatic syndrome is represented by the lack of methods and diagnostic tools that allow quantification of the subjective disturbances and evidence of the signs indicative of central nervous system involvement in this pathological condition. Methods.-Twenty-five subjects (16 women, 9 men; mean age, 28 +/- 9 years) were examined between 3 and 6 months after the traumatic event. The P300 event-related potential was recorded by an odd-ball paradigm with an acoustic modality. The patients underwent electroencephalography and brain stem auditory evoked potentials; magnetic resonance imaging was performed to exclude the presence of cerebral lesions. Results.-The mean latency of P300 was increased in both central electrodes (Cz and Pt) in patients with posttraumatic syndrome compared with controls (P < .001); assuming the value of mean +/- 2 SD was the cutoff point between normal and abnormal results, the P300 latency results were altered in 13 patients (52%). In the patient group, a significant correlation was demonstrated between Zung Depression Scale score and P3 and N2 wave latencies (r = 0.54, P < .004; r = 0.56, P < .003) and between Zung Anxiety Scale scores and P3 wave latencies (r = 0.46, P < .02). Conclusions.-These data suggest the usefulness of the P300 event-related potential in evaluating cognitive disturbances in patients affected by posttraumatic syndrome. Alteration of cognitive potential in such patients, even in the absence of lesions detectable by neuroimaging, indicate the functional impairment of specific cerebral areas that can occur after a traumatic event.	Interuniv Ctr Study Headache & Neurotransmitter D, Perugia, Italy		Alberti, A (corresponding author), Univ Perugia, Dept Neurosci, Via E Dal Pozzo 79, I-06126 Perugia, Italy.		Sarchielli, Paola/K-2127-2014	Sarchielli, Paola/0000-0002-7595-9246			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bange F, 1998, EVOKED POTENTIAL, V108, P472, DOI 10.1016/S0168-5597(98)00024-0; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BLACKWOOD DHR, 1986, BIOL PSYCHIAT, V21, P557, DOI 10.1016/0006-3223(86)90201-5; Boudarene M, 1998, ENCEPHALE, V24, P557; CALLAWAY E, 1983, PSYCHOPHYSIOLOGY, V20, P359, DOI 10.1111/j.1469-8986.1983.tb00915.x; GALLAI V, 1995, ACTA NEUROL SCAND, V91, P358, DOI 10.1111/j.1600-0404.1995.tb07021.x; Gallai V, 1994, Electromyogr Clin Neurophysiol, V34, P397; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOODIN DS, 1986, BRAIN, V109, P1103, DOI 10.1093/brain/109.6.1103; Granovsky Y, 1998, EVOKED POTENTIAL, V108, P554, DOI 10.1016/S0168-5597(98)00036-7; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P497, DOI 10.1111/j.1469-8986.1985.tb01639.x; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MEADOR KJ, 1987, NEUROLOGY, V37, P526, DOI 10.1212/WNL.37.3.526; Miller J. D., 1989, TXB HEAD INJURY, P507; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Packard RC, 1996, HEADACHE Q-CURR TREA, V7, P218; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHLEGEL S, 1991, ACTA PSYCHIAT SCAND, V83, P438, DOI 10.1111/j.1600-0447.1991.tb05571.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; SPEED WG, 1986, PRACTICING PHYSICIAN, P113; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Vandoolaeghe E, 1998, J AFFECT DISORDERS, V48, P105, DOI 10.1016/S0165-0327(97)00165-1; Zampolini M, 1997, EUR J NEUROL, V4, P246, DOI 10.1111/j.1468-1331.1997.tb00343.x	34	12	23	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2001	41	6					579	585		10.1046/j.1526-4610.2001.041006579.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	447TC	WOS:000169587700010	11437894				2022-02-06	
J	Arenth, PM; Bogner, JA; Corrigan, JD; Schmidt, L				Arenth, PM; Bogner, JA; Corrigan, JD; Schmidt, L			The utility of the Substance Abuse Subtle Screening Inventory-3 for use with individuals with brain injury	BRAIN INJURY			English	Article							ALCOHOL-ABUSE; SETTINGS	The utility of the Substance Abuse Subtle Screening Inventory (SASSI-3) for the use with individuals with traumatic brain injuries (TBI) was investigated. The SASSI-3 was administered to 78 subjects prior to discharge from inpatient rehabilitation. The SASSI-3 diagnosis of chemical dependency was compared with the diagnosis of staff psychologists. Lower accuracy, sensitivity, and specificity were found in SASSI-3 diagnosis for the subjects with brain injury, as compared to a normative sample of persons with disabilities participating in a vocational rehabilitation programme. When a diagnosis of 'dependence or abuse' was used, accuracy of the SASSI-3 increased. Comparison of diagnosis based on SASSI-3 versus Blood Alcohol Level (BAL) at the time of injury showed comparable accuracy; however, BAL was found to have higher specificity. For dependence or abuse, BAL continued to be more specific than the SASSI-3; however, the SASSI-3 was more sensitive. Based on these findings, a clinical approach to screening using both BAL and the SASSI-3 is discussed.	Ohio State Univ, Columbus, OH 43210 USA		Bogner, JA (corresponding author), 480 W 9th Ave, Columbus, OH 43210 USA.		Corrigan, John D./E-2921-2011; Bogner, Jennifer/E-2773-2011				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BABOR TF, 1989, ADDICT BEHAV, V14, P139, DOI 10.1016/0306-4603(89)90043-9; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1999, TRAUM BRAIN INJ PUBL; EWING J, 1970, 29 INT C ALC DRUG DE; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Horrigan T J, 1996, J Perinatol, V16, P326; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lazowski LE, 1998, J PERS ASSESS, V71, P114, DOI 10.1207/s15327752jpa7101_8; MAGRUDERHABIB K, 1991, J FAM PRACTICE, V32, P406; Miller, 1985, SUBSTANCE ABUSE SUBT; Miller F. G., 1997, SASSI 3 USERS GUIDE; Selzer ML, 1971, AM J PSYCHIAT, V127, P89; SKINNER HA, 1984, ANN INTERN MED, V101, P847, DOI 10.7326/0003-4819-101-6-847; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004	18	12	12	0	7	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2001	15	6					499	510		10.1080/02699050010006002			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600003	11394969				2022-02-06	
J	Swaine, BR; Friedman, DS				Swaine, BR; Friedman, DS			Activity restrictions as part of the discharge management for children with a traumatic head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; concussion; emergency department; head injury; intervention; trauma center	BRAIN-INJURY; MILD; CONCUSSION; ADOLESCENTS; SEIZURES; TRENDS	This article describes a proactive management strategy that is currently part of the discharge protocol for children seeking care for a head injury (HI) at a pediatric and adolescent trauma center. The strategy consists of setting activity restrictions for children hospitalized and those seen in the emergency department after a HI that may or not have been sports related. It was developed based on extensive clinical experiments with families of children with a HI and existing guidelines for returning athletes to sports. Possible merits and pitfalls of the strategy are discussed.	Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Pediat Program, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Adolescent Neurotrauma & Trauma Program, Montreal, PQ, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Ecole Readaptat, CP 6128,Succurasale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca					*AM MED ASS, 1990, OFF QUAL INS HLTH CA; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CASEY R, 1986, PEDIATRICS, V78, P497; CERNAN J, 1966, HEAD INJURY POSTCONC; *COL MED SOC, 1991, REP SPORTS MED COMM; DAVIES RL, 1995, PEDIATRICS, V95, P345; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; GREENSPAN A, 1996, CURR PROB PEDIAT MAY, P170; GRONWALL D, 1975, LANCET, V2, P995; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Kelly JP, 1997, NEUROLOGY, V48, P581; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; Moss NE., 1994, CLIN REHABIL, V8, P149; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parker APJ, 1997, SEIZURE-EUR J EPILEP, V6, P499, DOI 10.1016/S1059-1311(97)80028-3; PARTINGTON MW, 1960, ARCH DIS CHILD, V35, P215, DOI 10.1136/adc.35.181.215; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; SWAINE B, 2000, ARCH PHYS MED REHAB, V81, P1617; WALLER J, 1980, PUBLIC HLTH PREVENTA; 1999, HEADLINE NEWS, V1; 1999, P 3 WORLD C BRAIN IN, P230	40	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2001	16	3					292	301		10.1097/00001199-200106000-00008			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	442YY	WOS:000169313600008	11346451				2022-02-06	
J	Yanagawa, Y; Marcillo, A; Garcia-Rojas, R; Loor, KE; Dietrich, WD				Yanagawa, Y; Marcillo, A; Garcia-Rojas, R; Loor, KE; Dietrich, WD			Influence of posttraumatic hypoxia on behavioral recovery and histopathological outcome following moderate spinal cord injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						behavior; hypoxia; secondary insults; spinal cord injury	PERCUSSION BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; BLOOD-FLOW; AMINO-ACIDS; ULTRASTRUCTURAL EVIDENCE; SECONDARY DAMAGE; IMPACT INJURY; ANOXIC INJURY; HEAD-INJURY; TRAUMA	Pulmonary dysfunction leading to secondary hypoxia is a common complication of spinal cord injury (SCI). The purpose of this study was to clarify the behavioral and histopathological consequences of posttraumatic hypoxia in an established model of traumatic SCI. Forty-five female Sprague-Dawley rats were randomly assigned to one of four groups, including (1) laminectomy and normoxia (n = 10), (2) laminectomy and hypoxia (n = 11), (3) NYU weight-drop and normoxia (n 12), and (4) NYU weight-drop and hypoxia (n = 11). For these studies, a moderate injury was induced by adjusting the height of the weight drop (10 g) to 12.5 mm above the exposed spinal cord (T10). Immediately after injury, PaO2 in the hypoxic rats was kept between 30 and 35 mm Hg for 30 min. PaO2 in the normoxic group was maintained over 100 mm Hg, while PaCO2 in all rats was maintained at 35-40 mm Hg. The behavior of the rats was checked every 7 days using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale. Rats were sacrificed at 8 weeks for quantitative histopathological analysis of lesion areas. During the hypoxic insults, the mean arterial blood pressure dropped in both sham control and weight-drop rats (p < 0.01). At the end of the 8-week monitoring period, BBB scores were 12.5 +/- 3.1 (mean +/- SEM) and 14.2 +/- 3.4 in the normoxic and hypoxic traumatized rats, respectively. No significant difference between the traumatized groups was documented with BBB monitoring. In contrast, the percent of gray matter necrosis at the impact epicenter was significantly increased in hypoxic versus normoxic SCI rats (p < 0.01). These data demonstrate that posttraumatic hypoxia complicated by mild hypotension aggravates the histopathological consequences of SCI and further emphasize the need to control for secondary hypoxic insults after experimental and clinical SCI. Potential explanations for the lack of a correlation between the behavioral and histopathological findings are discussed.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Dietrich, WD (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, 1600 NW 10 Ave R-49, Miami, FL 33136 USA.	ddietrich@miami.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [38665] Funding Source: Medline		Agrawal SK, 1997, J NEUROSCI, V17, P1055; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ANDERSON DK, 1980, J NEUROSURG, V52, P387, DOI 10.3171/jns.1980.52.3.0387; Anthes DL, 1996, NEUROSURGERY, V39, P804, DOI 10.1097/00006123-199610000-00032; Atkinson PP, 1996, MAYO CLIN PROC, V71, P384, DOI 10.4065/71.4.384; BALENTINE JD, 1978, LAB INVEST, V39, P236; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; CAWTHON DF, 1980, J NEUROSURG, V52, P801, DOI 10.3171/jns.1980.52.6.0801; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; CLANCY RR, 1989, ANN NEUROL, V25, P185, DOI 10.1002/ana.410250213; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; COLES JC, 1986, ANN THORAC SURG, V41, P551, DOI 10.1016/S0003-4975(10)63040-8; CURZ J, 1998, CRIT CARE MED, V26, P344; DANIELISOVA V, 1990, NEUROLOGY, V40, P1125, DOI 10.1212/WNL.40.7.1125; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; DeWitt D S, 1995, New Horiz, V3, P376; DOLAN EJ, 1982, J NEUROSURG, V56, P350, DOI 10.3171/jns.1982.56.3.0350; DUCKER TB, 1971, CURRENT TOP SURG RES, V3, P163; FADEN AI, 1982, NEUROLOGY, V32, P677, DOI 10.1212/WNL.32.6.677; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Galley HF, 1999, CRIT REV CL LAB SCI, V36, P35, DOI 10.1080/10408369991239178; GEISLER FH, 1996, PRINCIPLES SPINAL SU, P769; Goldstein B, 1998, ARCH PHYS MED REHAB, V79, P107, DOI 10.1016/S0003-9993(98)90217-9; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HALAT G, 1989, NEUROCHEM RES, V14, P1089, DOI 10.1007/BF00965615; Hall ED, 1991, J NEUROTRAUM, V8, P86; HUKUDA S, 1980, NEUROSURGERY, V6, P644, DOI 10.1227/00006123-198006000-00005; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148, DOI 10.1001/archneur.1988.00520260034016; KOYANAGI I, 1993, NEUROSURGERY, V33, P285, DOI 10.1227/00006123-199308000-00016; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEMAY DR, 1987, J VASC SURG, V6, P383, DOI 10.1067/mva.1987.avs0060383; LEVY DE, 1975, ARCH NEUROL-CHICAGO, V32, P450, DOI 10.1001/archneur.1975.00490490054004; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P526, DOI 10.1038/jcbfm.1994.65; McAdoo DJ, 1997, J NEUROTRAUM, V14, P507, DOI 10.1089/neu.1997.14.507; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P102, DOI 10.1097/00002060-199903000-00002; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; PALLESKE H, 1969, Acta Neurochirurgica, V21, P319, DOI 10.1007/BF01402965; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; POE RH, 1978, J TRAUMA, V18, P71, DOI 10.1097/00005373-197801000-00016; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; SINHA RP, 1973, JAMA-J AM MED ASSOC, V224, P1258, DOI 10.1001/jama.224.9.1258; SLACK RS, 1994, CLIN CHEST MED, V15, P739; SMITH AJK, 1978, J NEUROSURG, V48, P239, DOI 10.3171/jns.1978.48.2.0239; STYS PK, 1992, J NEUROSCI, V12, P430; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Taylor DL, 1999, BRAIN PATHOL, V9, P93; Tyroch AH, 1997, ARCH SURG-CHICAGO, V132, P778; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; WAXMAN SG, 1994, BRAIN RES, V644, P197, DOI 10.1016/0006-8993(94)91680-2; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; YOUNG W, 1993, RES P ARNMD, V71, P191; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200	73	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2001	18	6					635	644		10.1089/089771501750291873			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	445ZQ	WOS:000169488800007	11437086				2022-02-06	
J	Komiyama, M; Morikawa, T; Nakajima, H; Yasui, T; Kan, M				Komiyama, M; Morikawa, T; Nakajima, H; Yasui, T; Kan, M			"Early" apoplexy due to traumatic intracranial aneurysm - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						diagnostic angiography; subarachnoid hemorrhage; timing of angiography; traumatic intracranial aneurysm	ANTERIOR CEREBRAL-ARTERY; INTERNAL CAROTID-ARTERY; MASSIVE EPISTAXIS; FALSE ANEURYSM; STAB WOUNDS; HEAD-INJURY; BRAIN; ANGIOGRAPHY; SURGERY; FISTULA	A 76-year-old man presented with a traumatic aneurysm of the left infernal carotid artery which caused repeated subarachnoid hemorrhages within 20 hours of a fall from a height. Early computed tomography (CT) detected no brain abnormalities, but repeat CT found subarachnoid hemorrhage. Internal carotid angiography detected a pseudoaneurysm, which was not treated because of his poor clinical condition. He died of multiple organ failure. Early detection of a traumatic infracranial aneurysm is important for the prevention of aneurysmal rupture, or "delayed" apoplexy. Review of 171 cases with traumatic aneurysms from the literature found that false negative angiography occurred only in three cases on post-trauma day 7 and thereafter. Early diagnostic angiography within a week of the initial trauma is indicated if traumatic aneurysm is suspected to detect early signs of irregularity, spasm, and narrowing of the arterial wall. Repeat angiography is indicated if aneurysmal formation is still highly suspected in spite of negative initial angiography.	Osaka City Gen Hosp, Dept Neurosurg, Miyakojima Ku, Osaka 5340021, Japan; Osaka City Gen Hosp, Emergency & Crit Care Ctr, Miyakojima Ku, Osaka 5340021, Japan		Komiyama, M (corresponding author), Osaka City Gen Hosp, Dept Neurosurg, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.			komiyama, masaki/0000-0003-0998-6315			AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; AMAGASA M, 1986, Neurological Surgery, V14, P1585; ARAKI C, 1965, J NEUROSURG, V23, P64, DOI 10.3171/jns.1965.23.1.0064; Asari S, 1976, No To Shinkei, V28, P793; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; CABEZUDO JM, 1981, J NEUROSURG, V54, P118, DOI 10.3171/jns.1981.54.1.0118; CAPANNA AH, 1984, SURG NEUROL, V22, P263, DOI 10.1016/0090-3019(84)90011-9; COCKRILL HH, 1977, J NEUROSURG, V46, P377, DOI 10.3171/jns.1977.46.3.0377; COSGROVE GR, 1983, J NEUROSURG, V58, P291; COURVILLE C B, 1960, Bull Los Angel Neuro Soc, V25, P48; CRESSMAN MR, 1966, J NEUROSURG, V24, P102, DOI 10.3171/jns.1966.24.1.0102; DITMORE M, 1980, NEUROSURGERY, V6, P293; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; Endo S, 1974, No Shinkei Geka, V2, P329; ENOMOTO H, 1984, NEUROSURGERY, V15, P700, DOI 10.1227/00006123-198411000-00011; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FUJIWARA K, 1976, TRAUMATOLOGY, V7, P377; Funahashi K, 1977, No Shinkei Geka, V5, P619; Funakoshi T, 1976, No Shinkei Geka, V4, P405; GOALD HJ, 1961, J NEUROSURG, V18, P401, DOI 10.3171/jns.1961.18.3.0401; Handa H, 1967, No To Shinkei, V19, P1063; HANDA J, 1970, AMER J ROENTGENOL RA, V109, P127, DOI 10.2214/ajr.109.1.127; HIGAZI I, 1969, J NEUROSURG, V30, P172, DOI 10.3171/jns.1969.30.2.0172; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; IDE Y, 1987, Neurological Surgery, V15, P1353; ITO H, 1975, NO TO SHINKEI, V27, P787; Jackson F E, 1970, J Trauma, V10, P1158, DOI 10.1097/00005373-197012000-00008; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; Kamijo Y, 1968, No To Shinkei, V20, P965; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KOMIYAMA M, 1991, SURG NEUROL, V36, P126, DOI 10.1016/0090-3019(91)90230-7; KUHN RA, 1964, J NEUROSURG, V21, P92, DOI 10.3171/jns.1964.21.2.0092; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; LIU MY, 1985, NEUROSURGERY, V17, P569, DOI 10.1227/00006123-198510000-00006; Marubayashi T, 1975, No Shinkei Geka, V3, P177; MCCORMICK WF, 1964, J NEUROSURG, V21, P678, DOI 10.3171/jns.1964.21.8.0678; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MENEZES AH, 1974, J NEUROSURG, V40, P544, DOI 10.3171/jns.1974.40.4.0544; Miyahara S, 1977, No Shinkei Geka, V5, P991; MIYAZAKI S, 1981, Neurological Surgery, V9, P531; MOORE D, 1979, SURG NEUROL, V11, P115; NAGASAWA S, 1976, TRAUMATOLOGY, V7, P373; Nakamura T, 1977, No Shinkei Geka, V5, P371; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NOTERMAN J, 1985, NEUROSURGERY, V17, P807, DOI 10.1097/00006123-198511000-00014; PAILLAS JE, 1964, J NEUROSURG, V21, P667, DOI 10.3171/jns.1964.21.8.0667; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PAULLUS WS, 1979, J NEUROSURG, V51, P707, DOI 10.3171/jns.1979.51.5.0707; PETTY J M, 1969, Journal of Neurosurgery, V30, P741, DOI 10.3171/jns.1969.30.6.0741; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; Sakuta Y, 1997, NEUROL SURG TOKYO, V25, P357; SALAR G, 1978, J NEUROSURG, V49, P100, DOI 10.3171/jns.1978.49.1.0100; SALCMAN M, 1985, NEUROSURGERY, V16, P218; Sasaoka Y, 1997, NEUROL SURG TOKYO, V25, P337; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; SEDZIMIR CB, 1968, J NEUROSURG, V29, P636, DOI 10.3171/jns.1968.29.6.0636; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHALLAT RF, 1981, NEUROSURGERY, V8, P569, DOI 10.1227/00006123-198105000-00010; SHIGEMORI M, 1982, Neurologia Medico-Chirurgica, V22, P241, DOI 10.2176/nmc.22.241; Shima T, 1978, No Shinkei Geka, V6, P1025; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TANI S, 1982, Neurological Surgery, V10, P423; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; Tokuno Tatsuya, 1994, Neurological Surgery, V22, P1073; Tsubokawa T, 1975, No Shinkei Geka, V3, P663; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VORIS HC, 1961, J NEUROSURG, V18, P841, DOI 10.3171/jns.1961.18.6.0841; WORTZMAN D, 1980, SURG NEUROL, V13, P329; YAMAURA A, 1978, SURG NEUROL, V10, P327; YOKOTA H, 1983, Neurological Surgery, V11, P521; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	86	12	13	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2001	41	5					264	270		10.2176/nmc.41.264			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	434YA	WOS:000168842400014	11396307				2022-02-06	
J	Bareyre, FM; Raghupathi, R; Saatman, KE; McIntosh, TK				Bareyre, FM; Raghupathi, R; Saatman, KE; McIntosh, TK			DNase I disinhibition is predominantly associated with actin hyperpolymerization after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; caspase; DNA fragmentation; head injury; rats	CELL-DEATH; DEOXYRIBONUCLEASE-I; TEMPORAL PROFILE; APOPTOSIS; RAT; FRAGMENTATION; CASPASE-3; CLEAVAGE; POLYMERIZATION; BINDING	To elucidate a role for the cytoskeletal protein actin in posttraumatic apoptotic cell death, the ability of actin-containing tissue extracts to inhibit exogenous DNase I was evaluated. In addition, cortical, hippocampal and thalamic extracts were examined for caspase-mediated actin cleavage and changes in actin polymerization state. Rats were anesthetized, subjected to lateral fluid percussion brain injury of moderate severity, and euthanized at 1 h, 6 h, 24 h, 1 week or 3 weeks post-injury (n = 3 per time-point). Tissue extracts from all brain regions of sham (uninjured) animals inhibited exogenous DNase I activity to a significant extent. However, inhibition of DNase I was significantly reduced at 1 h and 6 h in the injured hippocampus, and at 1, h, 6 h and 3 weeks in the thalamus. DNase I in cortical extracts of all injured animals was inhibited to a similar extent as that in uninjured animals. Actin fragments consistent with caspase-mediated proteolysis were observed in immunoblots of the injured hippocampus and thalamus at 1 h and 24 h, respectively, and were present up to 3 weeks post-injury. Transient actin hyperpolymerization was observed at 1 and 6 h post-injury in the thalamus and hippocampus, while actin depolymerization was observed at 1 and 3 weeks in the cortex and thalamus. Collectively our data suggest that DNase I disinhibition following brain trauma is associated predominantly with actin hyperpolymerization but also with actin depolymerization and concomitant caspase-mediated actin proteolysis.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		McIntosh, TK (corresponding author), 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01-N540978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER		Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Friedman JE, 1998, NEUROSCIENCE, V82, P421; Guenal I, 1997, J CELL SCI, V110, P489; Janmey PA, 1998, CHEM BIOL, V5, pR81, DOI 10.1016/S1074-5521(98)90631-7; Kayalar C, 1996, P NATL ACAD SCI USA, V93, P2234, DOI 10.1073/pnas.93.5.2234; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; LEVEE MG, 1996, AM J PHYSIOL-CELL PH, V40, pC1981; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650; PEITSCH MC, 1992, BIOCHEM BIOPH RES CO, V186, P739, DOI 10.1016/0006-291X(92)90808-X; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.biochem.55.1.987; RINK A, 1995, AM J PATHOL, V147, P1575; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Song QZ, 1997, P NATL ACAD SCI USA, V94, P157, DOI 10.1073/pnas.94.1.157; SUTOH K, 1984, BIOCHEMISTRY-US, V23, P1942, DOI 10.1021/bi00304a009; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; UCKER DS, 1992, MOL CELL BIOL, V12, P3060, DOI 10.1128/MCB.12.7.3060; Villa PG, 1998, J CELL SCI, V111, P713; Wyllie A H, 1992, Semin Immunol, V4, P389; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang GY, 1998, J CEREBR BLOOD F MET, V18, P840, DOI 10.1097/00004647-199808000-00004; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x	37	12	13	0	0	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	APR	2001	77	1					173	181		10.1046/j.1471-4159.2001.t01-1-00215.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	417KY	WOS:000167835200018	11279273				2022-02-06	
J	Murgio, A; Patrick, PD; Andrade, FA; Boetto, S; Leung, KM; Sanchez, MAM				Murgio, A; Patrick, PD; Andrade, FA; Boetto, S; Leung, KM; Sanchez, MAM			International study of emergency department care for pediatric traumatic brain injury and the role of CT scanning	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	ICRAN 99 Conference	NOV 20-23, 1999	TAIPEI, TAIWAN			head injury; children; CT scan; emergency department	HEAD-INJURY; CHILDREN	Objects: Our objective was to investigate the use of CT and its relationship to head injury severi ty and age. Method: The multi-center group International Study of Head Injury Project (ISHIP) serves as the administrative body for research design, data collection and analysis. This is a nonrandomized prospective study of longitudinal outcomes following examination and care in emergency department in five different countries. The subjects of our study were 4,690 children from birth to 15 years of age, all of whom were systematically evaluated. Each child was medically evaluated and categorized as to injury severity, mechanism of injury and findings on X-ray and CT scan. Follow-up interview and assessment was completed for comparison with the presenting clinical state. Results: CT scans were performed for 674 (14.3%) of the children: 438 scans were normal and 236 were abnormal(P <0.001). Of the children with abnormal CT scans, 23.3% had mild head injuries, 42.7% had moderate injuries, and 33.8% had severe injuries, as determined by the GCS. By age, 10.5% of the positive CTs were in children aged 0-2 years, 56.3% in 3- to 9-year-olds, and 33% in 10- to 15-year-olds; only in 2% of cases were both CT and X-ray positive. Conclusions: The majority of children did not need significant medical intervention. Physicians ordered X-ray investigations more frequently than CT scanning. The use of X-ray to decide whether or not CT is necessary is not warranted. The implications of positive CTs in mild or moderate injuries were most noteworthy, as were age-related interactions with positive CT findings.	Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; Hosp Virgen Rocio, Emergency Dept, Seville, Spain		Murgio, A (corresponding author), Quintana 1256,B7602GDZ, Mar Del Plata, Argentina.						ALLISON M, 1992, EFFECTS NEUROLOGIC I; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BUTCHART A, 1991, S AFR MED J, V79, P472; CAMPANA MB, 1994, CIENCIA MED, V3, P32; DAVIES RL, 1995, PEDIATRICS, V95, P345; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DISCALA C, 1996, CHILDREN ADOLESCENTS; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; NAKAYAMA DK, 1991, J TRAUMA, V31, P1521, DOI 10.1097/00005373-199111000-00010; OSHANICK G, 1998, 4 ANN ASP NEUR C 5 9; QUAYLE KS, 1997, PEDIATRICS, V99, P11; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; ZAFONTE RD, 1996, MED REHAEBILITATION, P267	16	12	12	0	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2001	17	4-5					257	262		10.1007/s003810000403			6	Clinical Neurology; Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	434AX	WOS:000168793900012	11398946				2022-02-06	
J	Bruder, N; Bonnet, M				Bruder, N; Bonnet, M			Epileptogenic pharmacologic properties in anaesthesia	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	22nd Conference of the Association-de-Neuroanesthesie-et-Reanimation-de-Langue-Francaise	NOV 23-24, 2000	DIJON, FRANCE	Assoc Neuroanesthes & Reanimat Langue Francaise		anaesthetics; epilepsy	REFRACTORY STATUS EPILEPTICUS; FENTANYL-INDUCED SEIZURES; TRAUMATIC BRAIN INJURY; SEVOFLURANE ANESTHESIA; PROPOFOL SEDATION; PARTIAL EPILEPSY; POSTOPERATIVE SEIZURES; ISOFLURANE ANESTHESIA; MIDAZOLAM; ELECTROENCEPHALOGRAM	Most anaesthetics and analgesics have both pro- and anticonvulsant activity. The data in the literature should be analysed with respect to the patient population, the recording of epileptic activity and the method of EEG analysis. Among inhaled anaesthetics, isoflurane has strong anticonvulsant properties. In some circumstances, sevoflurane may induce an epileptic activity. With the exception of ketamine and etomidate, all intravenous hypnotics may be used for anesthesia of the epileptic patient. Midazolam is a potent anticonvulsant. Among narcotics, fentanyl and alfentanil may induce clinical or electroencephalographic seizures. Considering the large number of patients treated with these agents without any neurological adverse effect, the clinical relevance of these data is unclear. Neuromuscular blocking agents do not possess pro- or anticonvulsant properties. (C) 2001 Editions scientifiques et medicales Elsevier SAS.	CHU Timone, Dept Anesthesie Reanimat, F-13385 Marseille, France		Bruder, N (corresponding author), CHU Timone, Dept Anesthesie Reanimat, F-13385 Marseille, France.	nbruder@ap-hm.fr					Abouleish EI, 1998, BRIT J ANAESTH, V80, P843, DOI 10.1093/bja/80.6.843; ADACHI M, 1992, BRIT J ANAESTH, V68, P214, DOI 10.1093/bja/68.2.214; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; AVRAMOV MN, 1995, ANESTH ANALG, V81, P596, DOI 10.1097/00000539-199509000-00031; Bausch SB, 1998, J PHARMACOL EXP THER, V284, P1147; BEEMER GH, 1989, ANAESTH INTENS CARE, V17, P504, DOI 10.1177/0310057X8901700421; Beenen LFM, 1999, J NEUROL NEUROSUR PS, V67, P474, DOI 10.1136/jnnp.67.4.474; Begemann M, 2000, EPILEPSIA, V41, P105, DOI 10.1111/j.1528-1157.2000.tb01513.x; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BEVAN JC, 1993, CAN J ANAESTH, V40, P805, DOI 10.1007/BF03009247; Bosenberg AT, 1997, PAEDIATR ANAESTH, V7, P477; BRUDER N, 1997, REANIM URGENCES, V6, P773; CASCINO GD, 1993, J CLIN NEUROPHYSIOL, V10, P520, DOI 10.1097/00004691-199310000-00010; COLLIER C, 1991, ANAESTH INTENS CARE, V19, P573, DOI 10.1177/0310057X9101900416; Constant I, 1999, ANESTHESIOLOGY, V91, P1604, DOI 10.1097/00000542-199912000-00010; EBRAHIM ZY, 1994, ANESTH ANALG, V78, P275, DOI 10.1213/00000539-199402000-00013; EBRAHIM ZY, 1986, ANESTH ANALG, V65, P1004; FERRERALLADO T, 1973, ANESTHESIOLOGY, V38, P333, DOI 10.1097/00000542-197304000-00006; FISHER MMD, 1974, ANAESTH INTENS CARE, V2, P266, DOI 10.1177/0310057X7400200313; Fountain NB, 1999, CLIN NEUROPHARMACOL, V22, P261; Fukuda H, 1996, ANESTH ANALG, V83, P570, DOI 10.1097/00000539-199609000-00023; GANCHER S, 1984, ANESTHESIOLOGY, V61, P616, DOI 10.1097/00000542-198411000-00029; Gilbert DL, 1999, J CHILD NEUROL, V14, P602, DOI 10.1177/088307389901400909; Hagen N, 1997, J PAIN SYMPTOM MANAG, V14, P51, DOI 10.1016/S0885-3924(97)00001-8; Harrigan PWJ, 1996, ANAESTH INTENS CARE, V24, P261; HARRISON JL, 1986, ANESTH ANALG, V65, P1235; Herrick IA, 1997, ANESTH ANALG, V84, P1280, DOI 10.1097/00000539-199706000-00020; HIRSHMAN CA, 1982, ANESTHESIOLOGY, V56, P464, DOI 10.1097/00000542-198206000-00012; Holmes GL, 1999, PEDIATR NEUROL, V20, P259, DOI 10.1016/S0887-8994(98)00155-6; Huggins NJ, 1999, BRIT J ANAESTH, V82, P952, DOI 10.1093/bja/82.6.952; HUTCHISON GL, 1993, ANAESTHESIA, V48, P824, DOI 10.1111/j.1365-2044.1993.tb07610.x; HYMES JA, 1985, ANESTH ANALG, V64, P367; Igartua J, 1999, CRIT CARE MED, V27, P1982, DOI 10.1097/00003246-199909000-00043; INGVAR M, 1981, EUR NEUROL, V20, P219, DOI 10.1159/000115237; INGVAR M, 1981, ANESTHESIOLOGY, V54, P33, DOI 10.1097/00000542-198101000-00007; Islander G, 2000, ACTA ANAESTH SCAND, V44, P144, DOI 10.1034/j.1399-6576.2000.440203.x; JONES GW, 1988, ANAESTHESIA, V43, P905; Kaisti KK, 1999, ANESTHESIOLOGY, V91, P1952, DOI 10.1097/00000542-199912000-00052; KAYAMA Y, 1972, ANESTHESIOLOGY, V36, P316, DOI 10.1097/00000542-197204000-00004; Keene DL, 1997, CAN J NEUROL SCI, V24, P37; Koepp MJ, 1998, LANCET, V352, P952, DOI 10.1016/S0140-6736(97)09077-6; Kofke WA, 1997, J NEUROSURG ANESTH, V9, P269, DOI 10.1097/00008506-199707000-00012; KOFKE WA, 1989, ANESTHESIOLOGY, V71, P653, DOI 10.1097/00000542-198911000-00005; KOFKE WA, 1993, ANESTH ANALG, V77, P330; KOMATSU H, 1994, ANESTHESIOLOGY, V81, P1535, DOI 10.1097/00000542-199412000-00030; Kronenberg MF, 1998, PAIN, V75, P383, DOI 10.1016/S0304-3959(97)00173-5; LANIER WL, 1988, BRIT J ANAESTH, V60, P74, DOI 10.1093/bja/60.1.74; Lee VC, 1998, ANESTH ANALG, V86, P652, DOI 10.1097/00000539-199803000-00040; LOWSON S, 1990, BRIT J ANAESTH, V64, P59, DOI 10.1093/bja/64.1.59; MACKENZIE SJ, 1990, ANAESTHESIA, V45, P1043, DOI 10.1111/j.1365-2044.1990.tb14884.x; MAEKAWA T, 1984, J CEREBR BLOOD F MET, V4, P88, DOI 10.1038/jcbfm.1984.11; MAKELA JP, 1993, EPILEPSIA, V34, P832, DOI 10.1111/j.1528-1157.1993.tb02098.x; Manninen PH, 1999, ANESTH ANALG, V88, P1101, DOI 10.1097/00000539-199905000-00025; MCMANUS KF, 1992, ANAESTH INTENS CARE, V20, P245; MICHENFELDER JD, 1990, J NEUROSURG, V72, P703, DOI 10.3171/jns.1990.72.5.0703; MODICA PA, 1990, ANESTH ANALG, V70, P433; MODICA PA, 1990, ANESTH ANALG, V70, P303; Momota YH, 1998, ANESTH ANALG, V87, P900, DOI 10.1097/00000539-199810000-00029; NOWACK WJ, 1994, CLIN ELECTROENCEPHAL, V25, P110, DOI 10.1177/155005949402500308; Ohmura S, 1999, ANESTH ANALG, V88, P155, DOI 10.1097/00000539-199901000-00029; OSAWA M, 1994, ANESTH ANALG, V79, P52; PAECH MJ, 1990, ANAESTH INTENS CARE, V18, P585; PITTMILLER PL, 1994, ANESTH ANALG, V78, P1193; Polc P, 1996, EPILEPSIA, V37, P1007, DOI 10.1111/j.1528-1157.1996.tb00540.x; POULTON TJ, 1984, ANESTHESIOLOGY, V61, P471, DOI 10.1097/00000542-198410000-00022; Raeder JC, 1999, ACTA ANAESTH SCAND, V43, P794, DOI 10.1034/j.1399-6576.1999.430802.x; RAMPIL IJ, 1991, ANESTHESIOLOGY, V74, P434, DOI 10.1097/00000542-199103000-00008; RAMPIL IJ, 1993, ANESTH ANALG, V77, P1071; SAMRA SK, 1995, ANESTHESIOLOGY, V82, P843; SCHELLER MS, 1990, BRIT J ANAESTH, V65, P388, DOI 10.1093/bja/65.3.388; Schultz A, 2000, ANAESTH INTENS CARE, V28, P205, DOI 10.1177/0310057X0002800216; SCHULZE BA, 2000, EPILEPSIA, V41, P186; SCOTT JC, 1985, ANESTHESIOLOGY, V62, P812, DOI 10.1097/00000542-198506000-00024; Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; SLATER BL, 1995, ANAESTH INTENS CARE, V23, P517; Sneyd JR, 1999, BRIT J ANAESTH, V82, P168, DOI 10.1093/bja/82.2.168; Stecker MM, 1998, EPILEPSIA, V39, P18, DOI 10.1111/j.1528-1157.1998.tb01269.x; TATEISHI A, 1989, BRIT J ANAESTH, V62, P548, DOI 10.1093/bja/62.5.548; TEMPELHOFF R, 1992, J NEUROSURG, V77, P201, DOI 10.3171/jns.1992.77.2.0201; Terasako K, 1996, ACTA ANAESTH SCAND, V40, P953, DOI 10.1111/j.1399-6576.1996.tb04566.x; Tobias JD, 1998, PEDIATR EMERG CARE, V14, P248, DOI 10.1097/00006565-199806000-00022; TOMMASINO C, 1984, ANESTHESIOLOGY, V60, P283, DOI 10.1097/00000542-198404000-00003; Towne AR, 1999, J EMERG MED, V17, P323, DOI 10.1016/S0736-4679(98)00170-X; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Wang BG, 1997, J NEUROSURG ANESTH, V9, P335, DOI 10.1097/00008506-199710000-00008; Watanabe S, 1998, ANESTH ANALG, V86, P677, DOI 10.1097/00000539-199803000-00052; WIKINSKI JA, 1970, ANESTH ANAL CURR RES, V49, P504; Woodforth IJ, 1997, ANESTHESIOLOGY, V87, P1579, DOI 10.1097/00000542-199712000-00041; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009	90	12	18	0	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2001	20	2					171	179					9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	411LC	WOS:000167500700009	11270238				2022-02-06	
J	Jenkins, LW; DeWitt, DS; Johnston, WE; Davis, KL; Prough, DS				Jenkins, LW; DeWitt, DS; Johnston, WE; Davis, KL; Prough, DS			Intraischemic mild hypothermia increases hippocampal CA1 blood flow during forebrain ischemia	BRAIN RESEARCH			English	Article						hypothermia; brain; blood flow; forebrain ischemia; hippocampus; rat	GLOBAL CEREBRAL-ISCHEMIA; LASER-DOPPLER FLOWMETRY; TRAUMATIC BRAIN-INJURY; NEURONAL DAMAGE; POSTISCHEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; ENERGY-METABOLISM; RAT HIPPOCAMPUS; TEMPERATURE; NIMODIPINE	The hippocampal CA1 sector is selectively vulnerable to forebrain ischemia but protected by mild hypothermia. However, the consequence of intraischemic hypothermia on CA1 blood flow during the insult has not been adequately characterized. The effects of mild intraischemic hypothermia on relative changes in regional hippocampal CA1 blood how were recorded continuously using laser Doppler flowmetry (LDF) during and 30 min after 6 min of forebrain ischemia. Six experimental groups (n=6/group) of fasted male Wistar rats were compared. Groups 1, 3 and 5 consisted of normothermic rats that underwent either 6 (for CBF measurements) and 6 or 10 (for 7 day survival-CA1 neuronal death measurements) min of transient forebrain ischemia using bilateral carotid clamping and hemorrhagic hypotension. Groups 2, 4 and 6 rats were subjected to mild hypothermia (34 degreesC) before, during, and 30 min after 6 (for CBF measurements) and 6 or 10 (for 7 day survival-CA1 neuronal death measurements) min of transient forebrain ischemia. CA1 blood Row and electroencephalogram (EEG) were continuously recorded. During the ischemic insult there were intergroup differences in the magnitude of CBF decreases in the CA1 region. In both groups 1 and 2, CBF returned to preischemic values within 1 min of reperfusion but hypothermic rats had more sustained hyperemia. Hypothermic rats had a quicker recovery of EEG activity and less delayed CA1 neuronal death (group 2 versus 4). These data suggest ischemic blood Row to the CA1 sector was altered by intraischemic mild hypothermia which may contribute to the greater benefit of intraischemic hypothermic neuroprotection. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Jenkins, LW (corresponding author), Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA.	ljenkins@pitt.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [N535365] Funding Source: Medline		ALLEN KL, 1993, NMR BIOMED, V6, P181, DOI 10.1002/nbm.1940060303; BECK T, 1988, EUR J PHARMACOL, V158, P271, DOI 10.1016/0014-2999(88)90078-7; BIELENBERG GW, 1987, J CEREBR BLOOD F MET, V7, P480, DOI 10.1038/jcbfm.1987.91; BIELENBERG GW, 1989, N-S ARCH PHARMACOL, V339, P230; CARROLL M, 1992, METAB BRAIN DIS, V7, P45, DOI 10.1007/BF01000440; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; COIMBRA C, 1994, ACTA NEUROPATHOL, V87, P325, DOI 10.1007/bf00313599; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Davis KL, 1998, J NEUROTRAUM, V15, P615, DOI 10.1089/neu.1998.15.615; Dietrich WD, 1996, ADV NEUROL, V71, P177; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FUJIKURA H, 1994, BRAIN RES, V636, P103, DOI 10.1016/0006-8993(94)90181-3; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GIONET TX, 1992, BRAIN RES, V586, P188, DOI 10.1016/0006-8993(92)91626-P; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; Hoffman WE, 1996, NEUROL RES, V18, P185; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HOSSMANN KA, 1990, PROTECTION BRAIN ISC, P21; Jenkins LW, 1999, BRAIN RES, V817, P132, DOI 10.1016/S0006-8993(98)01237-2; JONES SB, 1984, J APPL PHYSIOL, V57, P808, DOI 10.1152/jappl.1984.57.3.808; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KIKKAWA K, 1994, STROKE, V25, P474, DOI 10.1161/01.STR.25.2.474; KLOIBER O, 1993, NMR BIOMED, V6, P144, DOI 10.1002/nbm.1940060207; KRIEGLSTEIN J, 1989, EUR NEUROL, V29, P224, DOI 10.1159/000116416; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; KUROIWA T, 1992, STROKE, V23, P1349, DOI 10.1161/01.STR.23.9.1349; KURZ A, 1995, ANESTHESIOLOGY, V82, P870, DOI 10.1097/00000542-199504000-00008; KURZ A, 1995, ANESTHESIOLOGY, V83, P491, DOI 10.1097/00000542-199509000-00007; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; MIYAZAWA T, 1992, J CEREBR BLOOD F MET, V12, P817, DOI 10.1038/jcbfm.1992.113; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P488; NAKASHIMA K, 1995, ANESTHESIOLOGY, V82, P1199, DOI 10.1097/00000542-199505000-00015; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; NUGLISCH J, 1990, J CEREBR BLOOD F MET, V10, P654, DOI 10.1038/jcbfm.1990.118; ROGERS AT, 1988, ANESTHESIOLOGY, V69, P547, DOI 10.1097/00000542-198810000-00015; Sagher O, 1997, J NEUROSURG, V87, P431, DOI 10.3171/jns.1997.87.3.0431; SAUER D, 1988, NEUROSCI LETT, V91, P327, DOI 10.1016/0304-3940(88)90701-X; Schwab M, 1997, EXP TOXICOL PATHOL, V49, P105; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; SMITH ML, 1983, J CEREBR BLOOD F MET, V3, P543, DOI 10.1038/jcbfm.1983.83; SZABO L, 1989, ARZNEIMITTELFORSCH, V39-1, P314; Toung TJK, 1996, CRIT CARE MED, V24, P103, DOI 10.1097/00003246-199601000-00018; VERHAEGEN M, 1995, ANESTHESIOLOGY, V82, P1209, DOI 10.1097/00000542-199505000-00016; VERHAEGEN MJ, 1992, ANESTHESIOLOGY, V76, P743, DOI 10.1097/00000542-199205000-00013; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; WELSCH M, 1990, STROKE, V21, P105; Werner C, 1997, ANASTH INTENSIV NOTF, V32, P210, DOI 10.1055/s-2007-995040; YOUNG WL, 1987, ANESTHESIOLOGY, V67, P54, DOI 10.1097/00000542-198707000-00010	53	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 26	2001	890	1					1	10		10.1016/S0006-8993(00)03011-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397CU	WOS:000166676400001	11164763				2022-02-06	
J	Demery, JA; Hanlon, RE; Bauer, RM				Demery, JA; Hanlon, RE; Bauer, RM			Profound amnesia and confabulation following traumatic brain injury	NEUROCASE			English	Article							ANTERIOR COMMUNICATING ARTERY; EPISODIC MEMORY; ANEURYSM; RETRIEVAL; RUPTURE; DISEASE; LESIONS	Amnesia and confabulation may persist following acute: aneurysmal hemorrhage of the anterior communicating artery, chronic alcoholic Korsakoff's syndrome, and late-stage dementia of the Alzheimer type. However, there is a paucity of information regarding the persistence of these symptoms following traumatic brain injury. We present the case of JL, a 43-year-old male with persistent and severe anterograde amnesia for verbal and visual information with co-occurring provoked confabulation which persists well into the chronic phase of recovery after a severe traumatic brain injury. Neuropsychological testing at 7 weeks post-injury demonstrated severe anterograde amnesia with co-occurring confabulation. Follow-up testing at 9.5 months post-injury showed persistent and severe anterograde amnesia and provoked confabulation despite superior non-verbal intelligence and above average attentional and perceptual abilities. Late computed tomography showed chronic hypodense: regions in the temporal lobes, bilaterally (L > R), and in the region of the left ventrolateral frontal lobe. This case demonstrates that anterograde amnesia and provoked confabulation may persist long after the acute phase of recovery after traumatic brain injury, and also supports previous research which asserts that medial temporal lobe damage must be accompanied by ventral frontal lobe pathology to produce the amnestic-confabulatory syndrome.	Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA		Demery, JA (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	jdemery@ufl.edu					ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BENTON A L, 1978, Archives of Neurology, V35, P364; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Butters N., 1980, ALCOHOLIC KORSAKOFFS; BUTTERS N, 1989, HDB NEUROPSYCHOLOGY, V3; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P263, DOI 10.1001/archneur.1985.04060030081013; DELIS D, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; GOLDBERG E, 1985, REMOTE MEMORY BATTER; GRAFFRADFORD NR, 1980, BRAIN, V113, P1; Heaton PDRK., 1993, WISCONSIN CARD SORTI; KAPLAN E, 1983, BOSTON NAMING; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Kertesz A., 1982, W APHASIA BATTERY; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LINDQVIST G, 1966, ACTA PSYCHIAT SCAND, V42, P24, DOI 10.1111/j.1600-0447.1966.tb01913.x; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; PHILLIPS S, 1987, ARCH NEUROL-CHICAGO, V44, P1134, DOI 10.1001/archneur.1987.00520230024008; Raven J., 1996, PROGR MATRICES PERCE; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; SIGNORET JL, 1985, PRINCIPLES BEHAV NEU; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VILKKI J, 1985, CORTEX, V21, P431, DOI 10.1016/S0010-9452(85)80007-1; VOLPE BT, 1983, J NEUROL NEUROSUR PS, V46, P704, DOI 10.1136/jnnp.46.8.704; VONCRAMON DY, 1985, BRAIN, V108, P993, DOI 10.1093/brain/108.4.993; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; WEINSTEIN EA, 1968, ARCH GEN PSYCHIAT, V18, P348; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	42	12	12	1	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1355-4794			NEUROCASE	Neurocase		2001	7	4					295	301		10.1076/neur.7.4.295.16258			7	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	487LV	WOS:000171877400002	11557825				2022-02-06	
J	Gomez, JF; Thatcher, RW				Gomez, JF; Thatcher, RW			Frequency domain equivalence between potentials and currents using Loreta	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						source location; EEG/MEG inverse problem; low resolution electromagnetic tomography current density	RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; CLOSED-HEAD INJURY; BIOPHYSICAL LINKAGE; BRAIN; MRI	Analyzing the preferences of brain regions to oscillate at specific frequencies gives important functional information. Application of discrete inverse solutions for the EEG/MEG inverse problem in the frequency domain usually involves the use of many current sources (sometimes 10(4) or more) restricted to gray matter points, as the solution space for the possible generators. This number can progressively increase with the level of detail of the MRI when it is used in co-registration with EEG/MEG. However, the computation of the Fourier transform to all these sources is computationally intensive. We illustrate with a simple example how this procedure can be simplified by applying the Fourier transform to the signals in the sensors using a popular inverse method (LORETA). We also suggest how the search space of current sources at specific frequencies of oscillation can be limited to some regions constrained by other technologies such as fMRI, PET and SPECT.	Vet Adm Med Ctr, Bay Pines Fdn, Res & Dev Serv 151, Bay Pines, FL 33744 USA; Def & Vet Head Injury Program, Washington, DC USA		Gomez, JF (corresponding author), Vet Adm Med Ctr, Bay Pines Fdn, Res & Dev Serv 151, Bay Pines, FL 33744 USA.						Anderer P, 1998, EVOKED POTENTIAL, V108, P160, DOI 10.1016/S0168-5597(97)00080-4; Anderer P, 1998, NEUROPSYCHOBIOLOGY, V37, P20, DOI 10.1159/000026472; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Gomez JF, 1999, MED HYPOTHESES, V53, P263, DOI 10.1054/mehy.1999.0769; HANDERSON E, 1975, ELECTROEN CLIN NEURO, V79, P119; JOHN ER, 1998, BRAIN TOPOGRAPHY, V11; LAGERLUND TD, 1993, ELECTROEN CLIN NEURO, V86, P7, DOI 10.1016/0013-4694(93)90062-Z; Lantz G, 1997, ELECTROEN CLIN NEURO, V102, P414, DOI 10.1016/S0921-884X(96)96551-0; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Malmivuo J, 1995, BIOELECTROMAGNETISM; MARQUI RP, 1994, BRAIN TOPOGRAPHY, V7, P180; MENKE W, GEPHYSICAL DATA ANAL; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; SALETU B, 1998, BRAIN TOPOGRAPHY, V11, P71; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; STRIK WK, 1998, 3 DIMENSIONAL TOMOGR; Thatcher R W, 1995, J Neuroimaging, V5, P35; Thatcher R. W., 1977, FUNCTIONAL NEUROSCIE, VI; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; THATCHER RW, 1999, NEUROIMAGE, V9, pS110; THATCHER RW, 1994, FUNCTIONAL NEUROIMAG, V1; TORO C, 1994, FUNCTOINAL NEUROIMAG, V1; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; VALDES P, 1998, NEUROIMAGE, pS636; VALDESSOSA P, 1997, ELECTROENCEPHALOGR C, V103, P19	26	12	12	0	3	GORDON BREACH PUBLISHING, TAYLOR & FRANCIS GROUP	PHILADELPHIA	325 CHESTNUT ST, 8TH FL, PHILADELPHIA, PA 19106 USA	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		2001	107	3-4					161	171		10.3109/00207450109150683			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	428DA	WOS:000168444800002	11328689				2022-02-06	
J	Iwasaki, M; Nakasato, N; Kanno, A; Hatanaka, K; Nagamatsu, K; Nagamine, Y; Yoshimoto, T				Iwasaki, M; Nakasato, N; Kanno, A; Hatanaka, K; Nagamatsu, K; Nagamine, Y; Yoshimoto, T			Somatosensory evoked fields in comatose survivors after severe traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						somatosensory evoked potentials; magnetoencephalography; traumatic brain injury; diffuse axonal injury; consciousness disturbance	HEAD-INJURY; POTENTIALS; DISSOCIATION; STIMULATION; RESPONSES; RECOVERY; HUMANS; CORTEX; SLEEP	Objective: To evaluate the cortical function quantitatively in patients in the chronic phase of severe traumatic brain injury. Methods: Thirteen patients with severe traumatic brain injury due to traffic accident followed by persistent consciousness disturbance and disability were studied. Somatosensory evoked magnetic fields (SEFs) for unilateral median nerve stimulation were measured using a whole-head magnetoencephalography system. The latency and electrical current dipole (ECD) moment for the N20m, P30m, N45m and P60m components were calculated and compared with those of 14 age-matched healthy adults. Results: The peak latency of N20m was longer (P < 0.05) and those of P30m and N45m were shorter (P < 0.01) in the patients than in normal adults. The ECD moment of N20m and P30m was smaller and that of N45m and P60m was larger in the patients than in normal adults (P < 0.01). Conclusions: These results can be explained by the hypothesis that diffuse brain injury induces decreased and delayed input of the somatosensory afferent and compensational amplification of the response in the primary somatosensory cortex. Middle-latency SEFs may be applicable as a cortical functional measure for patients with severe traumatic brain injury. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; Kohnan Hosp, Ryogo Ctr, Sendai, Miyagi, Japan; ELEKTA KK, Tokyo, Japan		Iwasaki, M (corresponding author), Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	iwa@nsg.med.tohoku.ac.jp	Iwasaki, Masaki/AAH-4985-2020; Nakasato, Nobukazu/AAC-3650-2019	Iwasaki, Masaki/0000-0002-4204-7144; 			ADDY RO, 1989, ELECTROEN CLIN NEURO, V74, P105, DOI 10.1016/0168-5597(89)90015-4; AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; BORAH NC, 1985, ACTA NEUROL SCAND, V71, P331; CARENINI L, 1988, EPILEPSIA, V29, P145, DOI 10.1111/j.1528-1157.1988.tb04410.x; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; COBB WA, 1979, ELECTROEN CLIN NEURO, V47, P251, DOI 10.1016/0013-4694(79)90278-5; DEWEERD AW, 1985, ELECTROEN CLIN NEURO, V62, P45, DOI 10.1016/0168-5597(85)90034-6; FACCO E, 1991, ELECTROEN CLIN NEURO, V80, P469, DOI 10.1016/0168-5597(91)90128-K; FUJIWARA S, 1993, SOC TREATMENT COMA, V2, P89; GUTLING E, 1993, ELECTROEN CLIN NEURO, V88, P369, DOI 10.1016/0168-5597(93)90013-F; Huttunen J, 1999, BRAIN RES, V818, P196, DOI 10.1016/S0006-8993(98)01215-3; KAKIGI R, 1991, ELECTROEN CLIN NEURO, V80, P364, DOI 10.1016/0168-5597(91)90083-A; KAKIGI R, 1991, J CLIN NEUROPHYSIOL, V8, P320, DOI 10.1097/00004691-199107010-00008; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KARHU J, 1992, ELECTROEN CLIN NEURO, V83, P192, DOI 10.1016/0013-4694(92)90144-7; Kawamura T, 1996, EVOKED POTENTIAL, V100, P44, DOI 10.1016/0168-5597(95)00217-0; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Kitamura Y, 1996, COGNITIVE BRAIN RES, V4, P275, DOI 10.1016/S0926-6410(96)00066-3; LUDERS H, 1970, ELECTROEN CLIN NEURO, V29, P450, DOI 10.1016/0013-4694(70)90062-3; Mauguiere F, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P27; Mazzini L, 1999, ARCH PHYS MED REHAB, V80, P33, DOI 10.1016/S0003-9993(99)90304-0; NAKANO S, 1995, EVOKED POTENTIAL, V96, P385, DOI 10.1016/0168-5597(95)00023-L; NAKASHIMA K, 1985, J NEUROL SCI, V70, P117, DOI 10.1016/0022-510X(85)90081-4; Pierantozzi M, 1999, CLIN NEUROPHYSIOL, V110, P1700, DOI 10.1016/S1388-2457(99)00113-3; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; SHIBASAKI H, 1985, BRAIN, V108, P225, DOI 10.1093/brain/108.1.225; SKINNER JE, 1971, ELECTROEN CLIN NEURO, V31, P1, DOI 10.1016/0013-4694(71)90284-7; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Srisaan P, 1996, J CLIN NEUROPHYSIOL, V13, P156, DOI 10.1097/00004691-199603000-00006; Tinazzi M, 1998, BRAIN, V121, P1785, DOI 10.1093/brain/121.9.1785; Tinazzi M, 1997, NEUROSCI LETT, V223, P21, DOI 10.1016/S0304-3940(97)13382-1; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479	34	12	13	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JAN	2001	112	1					205	211		10.1016/S1388-2457(00)00506-X			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	396TE	WOS:000166652000026	11137679				2022-02-06	
J	Ameh, EA				Ameh, EA			Major injuries from "domestic" animals in children	PEDIATRIC SURGERY INTERNATIONAL			English	Article						domestic animals; children; injury; evaluation; prevention	DOG	Domestic animals are a potential cause of serious injury to handlers and children. In developed countries dogs are the most common cause of such injuries, but in developing countries childhood injuries from domestic animals have not been given much attention. A retrospective analysis of major injuries from domestic animal attacks in children aged 12 years or less in a developing country showed 17 injuries in 16 children. The locations were the abdomen (6), head and neck (4), extremities (3), external genitalia (3), and back (1). A big-horned cow was the cause of injury in 11 patients, a donkey in 4 and a ram in 1. Children under 10 years were injured by provoked animals, mostly as bystanders, while older children were handlers. Four abdominal injuries were penetrating with evisceration and contusion of bowel and required a laparotomy. One blunt splenic injury was managed non operatively and one by partial splenectomy. Two head injuries were managed non operatively. All other injuries were examined and explored with the child under general anaesthesia. These injuries were debrided and closed primarily or closure was delayed when contamination was heavy or adequate debridement was limited by vital neighbouring structures. Broad-spectrum antibiotics and tetanus prophylaxis were given for all open wounds. The average duration of hospital stay was 7.3 days. Three patients had wound infections resulting in long hospitalizations. Two patients died (12.5%), 1 from a severe head injury and 1 from an overwhelming infection. The management of major injuries from domestic animals in children requires meticulous evaluation and examination during general anaesthesia to establish the extent of injury and avoid missed injuries. Prevention of these injuries requires public education about the proper and compassionate handling of domestic animals.	Ahmadu Bello Univ, Teaching Hosp, Dept Surg, Paediat Surg Unit, Zaria, Nigeria		Ameh, EA (corresponding author), Ahmadu Bello Univ, Teaching Hosp, Dept Surg, Paediat Surg Unit, Zaria, Nigeria.			Ameh, Emmanuel/0000-0003-2386-3039			GEDLU E, 1994, E AFR MED J, V71, P807; JANJUA KJ, 1994, TROP DOCT, V24, P84, DOI 10.1177/004947559402400220; NWAURA LN, 1994, E AFR MED J, V71, P506; REDMAN JF, 1995, CLIN PEDIATR, V34, P331, DOI 10.1177/000992289503400607; TAHGIB F, 1984, TROP DOCT, V14, P187; WISEMAN NE, 1983, J PEDIATR SURG, V18, P533, DOI 10.1016/S0022-3468(83)80353-4	6	12	12	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0179-0358			PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2000	16	8					589	591		10.1007/s003830000419			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	378XY	WOS:000165611700014	11149402				2022-02-06	
J	Devlin, JW; Coplin, WM; Murry, KR; Rengachary, SS; Wilson, RF				Devlin, JW; Coplin, WM; Murry, KR; Rengachary, SS; Wilson, RF			Nimodipine-induced acute hypoxemia: Case report	NEUROSURGERY			English	Article						calcium channel blockers; dihydropyridines; hypoxemia; nimodipine; subarachnoid hemorrhage; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CONTROLLED TRIAL; PREVENTION	OBJECTIVE AND IMPORTANCE: Nimodipine is commonly used to improve neurological outcomes after subarachnoid hemorrhage. Although nimodipine reportedly has high specificity for the cerebral vasculature, adverse systemic effects such as hypotension have been described. This case report describes a patient with traumatic subarachnoid hemorrhage who experienced two episodes of previously undescribed, life-threatening hypoxemia that was directly related to nimodipine therapy. CLINICAL PRESENTATION: The patient experienced acute hypoxemia (partial pressures of oxygen of 32.9 and 58.7 mm Hg), on two separate occasions (3 d apart), that was temporally related to single doses of nimodipine therapy for traumatic subarachnoid hemorrhage. Other disease- and medication-related causes did not explain these episodes. INTERVENTION: After the inspired oxygen concentration was increased to 100% (both episodes) and the positive end expiratory pressure was increased to 7.5 mm Hg (first episode), the arterial oxygen saturation of the patient returned to baseline levels (>99%) within 40 minutes in each instance. Nimodipine therapy was discontinued after each episode. CONCLUSION: It is hypothesized that, in the presence of concomitant adult respiratory distress syndrome, nimodipine increased ventilation/perfusion ratio mismatch, through its direct vasodilatory effects on the pulmonary artery, and possibly interfered with the reflex hypoxic pulmonary vasoconstriction necessary to maintain adequate oxygenation for this patient. Clinicians should carefully monitor the oxygenation status of patients when nimodipine therapy is initiated.	Wayne State Univ, Detroit Receiving Hosp, Dept Pharm, Detroit, MI USA; Wayne State Univ, Detroit Receiving Hosp, Dept Neurol, Detroit, MI USA; Wayne State Univ, Detroit Receiving Hosp, Dept Neurol Surg, Detroit, MI USA; Wayne State Univ, Detroit Receiving Hosp, Dept Surg, Detroit, MI USA		Devlin, JW (corresponding author), Detroit Receiving Hosp, Dept Pharm Serv, 4201 St Antoine, Detroit, MI 48201 USA.						ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOLDT J, 1987, INTENS CARE MED, V13, P52, DOI 10.1007/BF00263558; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; GORE JM, 1984, HDB HEMODYNAMIC MONI, P83; HAN DH, J NEUROSURG, V78, pA346; LANGLEY MS, 1989, DRUGS, V37, P669, DOI 10.2165/00003495-198937050-00004; LOVELL AT, 1992, ANAESTHESIA, V47, P409, DOI 10.1111/j.1365-2044.1992.tb02223.x; MESSETER K, 1987, NEUROSURGERY, V20, P548, DOI 10.1227/00006123-198704000-00007; Muller H, 1988, Acta Neurochir Suppl (Wien), V45, P29; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NEIL-DWYER G, 1987, European Heart Journal, V8, P41; OHMAN J, 1988, J NEUROSURG, V69, P683, DOI 10.3171/jns.1988.69.5.0683; PETRUK KC, 1988, J NEUROSURG, V68, P505, DOI 10.3171/jns.1988.68.4.0505; PHILIPPON J, 1986, ACTA NEUROCHIR, V82, P110, DOI 10.1007/BF01456369; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Rhoney DH, 1999, NEUROLOGY, V52, pA60; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TETTENBORN D, 1985, NEUROCHIRURGIA ST S1, V28, pS84	24	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	NOV	2000	47	5					1243	1246		10.1097/00006123-200011000-00048			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	368YE	WOS:000090144400115	11063120				2022-02-06	
J	Elangovan, V; Kohen, R; Shohami, E				Elangovan, V; Kohen, R; Shohami, E			Neurological recovery from closed head injury is impaired in diabetic rats	JOURNAL OF NEUROTRAUMA			English	Article						diabetes; closed head injury; reactive oxygen species; oxidative stress; low molecular weight antioxidants	OXIDATIVE STRESS; LIPID-PEROXIDATION; CYCLIC VOLTAMMETRY; PERIPHERAL-NERVE; SPINAL-CORD; ALPHA-TOCOPHEROL; BRAIN-DAMAGE; ANTIOXIDANT; NEUROPATHY; TISSUE	Diabetes mellitus is a metabolic disorder associated with central nervous system impairments. Recent studies implicate oxidative stress mediated by reactive oxygen species (ROS) in the pathogenesis of diabetic complications. ROS have been shown to play role in the pathophysiology of brain injury. In the present study, closed head injury (CHI) was induced in diabetic rats to test the hypothesis that chronic oxidative stress exacerbates brain damage following CHI. Neurological recovery, edema, levels of low molecular weight antioxidants (LMWA), and markers of lipid peroxidation were determined at different intervals after injury. Diabetic rats (4 weeks after induction with streptozotocin) were subjected to CHI. Brain edema (percent water) and clinical status (neurological severity score) were assessed during 7 days. Brain LMWA were determined using cyclic voltammetry (CV) and HPLC-EC. In addition, conjugated dienes and thiobarbituric acid reactive substances (TBARS) were measured. Diabetic-CHI rats exhibited a lower rate of recovery and greater and more sustained edema (p < 0.01), as compared with the controls. At all times diabetic rats had higher levels of TEARS and conjugated dienes and lower concentrations of LMWA, and of vitamins C and E, suggesting chronic oxidative stress. At 5 min of CHI, the amounts of LMWA in control-CHI brains decreased (<similar to>50%,p < 0.01) and returned to normal by 48 h and 7 days. In the diabetic-CHI brain only one class of LMWA slightly declined but remained low for 7 days. The present results support the hypothesis that diabetic rats are under chronic oxidative stress, and suffer greater neurological dysfunction, associated with further lipid peroxidation following CHI.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, POB 12065, IL-91120 Jerusalem, Israel.	esty@cc.huji.ac.il					BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Buege J A, 1978, Methods Enzymol, V52, P302; CAMERON NE, 1994, DIABETES METAB REV, V10, P189, DOI 10.1002/dmr.5610100302; CHAN PH, 1989, CELLULAR ANTIOXIDANT, P89; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; CIUFFI M, 1991, NEUROCHEM RES, V16, P43, DOI 10.1007/BF00965826; COTTER MA, 1995, DIABETOLOGIA, V38, P1285; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; DYCK PJ, 1989, NEUROLOGY, V39, P111, DOI 10.1212/WNL.39.1.111; EKSTROM PAR, 1990, EXP NEUROL, V109, P200, DOI 10.1016/0014-4886(90)90074-3; Elangovan V, 2000, FREE RADICAL RES, V32, P125, DOI 10.1080/10715760000300131; Gohshi A, 1998, BIOL PHARM BULL, V21, P795; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1994, NUTR REV, V52, P253; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Hounsom L, 1998, DIABETOLOGIA, V41, P839, DOI 10.1007/s001250050996; Kohen R., 1996, Cellular Pharmacology, V3, P355; KOHEN R, 1993, J PHARMACOL TOXICOL, V29, P185, DOI 10.1016/1056-8719(93)90024-9; Kohen R, 1999, METHOD ENZYMOL, V300, P285; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Li C, 1998, NEUROBIOL DIS, V5, P117, DOI 10.1006/nbdi.1998.0189; Li WY, 1999, CELL MOL BIOL, V45, P59; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Lin BW, 2000, NEUROSCI LETT, V278, P1, DOI 10.1016/S0304-3940(99)00889-7; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOW PA, 1991, DIABETES, V40, P873, DOI 10.2337/diabetes.40.7.873; McIntosh TK, 1996, LAB INVEST, V74, P315; NICKANDER KK, 1994, J NEUROL SCI, V126, P6, DOI 10.1016/0022-510X(94)90088-4; NUKADA H, 1986, DIABETES, V35, P1058, DOI 10.2337/diabetes.35.9.1058; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PHILLIS JW, 1994, PROG NEUROBIOL, V42, P441, DOI 10.1016/0301-0082(94)90046-9; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; SUZUKI E, 1994, J LAB CLIN MED, V124, P627; Tariq M, 1998, J NEUROTRAUM, V15, P239, DOI 10.1089/neu.1998.15.239; TOMLINSON DR, 1992, DIABETES METAB REV, V8, P67, DOI 10.1002/dmr.5610080107; VANDAM PS, 1995, DIABETES METAB REV, V11, P181, DOI 10.1002/dmr.5610110303; WATSON BD, 1993, PROG BRAIN RES, V96, P69; WOHAIEB SA, 1987, DIABETES, V36, P1014, DOI 10.2337/diabetes.36.9.1014; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; Yukido I, 1990, NEUROSURGERY, V27, P1	53	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2000	17	11					1013	1027		10.1089/neu.2000.17.1013			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	374KY	WOS:000165345400002	11101205				2022-02-06	
J	Rosenfeld, JV; McDermott, FT; Laidlaw, JD; Cordner, SM; Tremayne, AB				Rosenfeld, JV; McDermott, FT; Laidlaw, JD; Cordner, SM; Tremayne, AB		Consultative Comm Road Traffic	The preventability of death in road traffic fatalities with head injury in Victoria, Australia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						neurotrauma; mortality; traffic accidents; prevention; evaluation studies; injuries	TRAUMA SYSTEM; ORANGE COUNTY; MANAGEMENT; MORTALITY; QUALITY; CARE; REGIONALIZATION; IDENTIFICATION; EXPERIENCE; MORBIDITY	Since 1992 the Consultative Committee on Road Traffic Fatalities in Victoria (CCRTF) has examined the medical management of patients who died following motor vehicle accidents. Three hundred and fifty-five fatalities with head injury occurring between I July, 1992 and 31 December 1997 were assessed by the CCRTF They represented 79% of the total 449 fatalities examined by the Committee. Following examination of the complete medical records and multidisciplinary discussion, the Committee considered 237 (67%) of the 355 neurotrauma deaths to be non-preventable, 105 (30%) potentially preventable and 13 (4%) preventable. The present analysis excludes the non-preventable deaths in order to focus on preventable factors. Problems identified in the 118 patients pre-hospital included: no intubation; prolonged scene time; and no intravenous access; in 139 emergency room attendances: inappropriate reception including delay in arrival of a consultant, no neurosurgical consultation, no CT scan of the head, inadequate blood gases and oxygen monitoring, inadequate fluid resuscitation, delayed respiratory resuscitation and delayed despatch to the operating room; in 111 operating room visits: no ICF monitoring, inadequate fluid administration and inappropriate anaesthetic technique; and in 90 intensive care unit admissions: no ICP monitoring. Overall, 1745 individual problems in the various areas of care were identified, of which 1104 (63%) were judged to have contributed to death. Improved delivery and quality of trauma care could reduce the identified problems in emergency services and clinical management. Basic principles of trauma management remain the most important means of reducing morbidity and death following road trauma. The leadership role of the neurosurgeon in neurotrauma care is emphasised. (C) 2000 Harcourt Publishers Ltd.	Victorian Inst Forens Med, Consultat Comm Rd Traff Fatal, Southbank 3006, Australia; Royal Childrens Hosp, Dept Neurosurg, Parkville, Vic 3052, Australia; Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia; Monash Univ, Alfred Hosp, Dept Surg, Prahran, Vic, Australia; Alfred Hosp, Dept Neurosurg, Prahran, Vic 3181, Australia; Monash Univ, Dept Forens Med, Victorian Inst Forens Med, Southbank, Australia		Rosenfeld, JV (corresponding author), Victorian Inst Forens Med, Consultat Comm Rd Traff Fatal, 57-83 Kavanagh St, Southbank 3006, Australia.		Rosenfeld, Jeffrey V/B-7249-2011; Morley, Peter/G-5280-2017	Morley, Peter/0000-0003-2653-090X			*AM ASS AUT MED CO, 1992, ABBR INJ SCAL 1990 R; *AM ASS AUT MED CO, 1985, ABBR INJ SCAL 1985 R; *AM COLL SURG, 1990, RES OPT CAR INJ PAT; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CALES H, 1985, JAMA-J AM MED ASSOC, V253, P1059; CALES RH, 1984, ANN EMERG MED, V13, P1, DOI 10.1016/S0196-0644(84)80375-3; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; Civil IDS, 1997, AUST NZ J SURG, V67, P587, DOI 10.1111/j.1445-2197.1997.tb04601.x; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; DEANE SA, 1988, AUST NZ J SURG, V58, P147, DOI 10.1111/j.1445-2197.1988.tb01025.x; DRAAISMA JMT, 1989, J TRAUMA, V29, P1552; Kelly AM, 1997, AUST NZ J SURG, V67, P591, DOI 10.1111/j.1445-2197.1997.tb04603.x; KREIS DJ, 1986, J TRAUMA, V26, P649, DOI 10.1097/00005373-198607000-00010; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; McDermott FT, 1997, AUST NZ J SURG, V67, P611, DOI 10.1111/j.1445-2197.1997.tb04608.x; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; McDermott FT, 1997, J TRAUMA, V43, P831, DOI 10.1097/00005373-199711000-00016; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NORUSIS MJ, 1996, STAT DATA ANAL; *QUANT LTD, 1993, QUANT V5D5 US MAN; Rosenfeld JV, 1997, J CLIN NEUROSCI, V4, P287, DOI 10.1016/S0967-5868(97)90095-3; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SELECKI BR, 1986, AUST NZ J SURG, V56, P529, DOI 10.1111/j.1445-2197.1986.tb07095.x; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; *TRANSP ACC COMM I, 1997, TAC ROAD SAF MONTHL; *TRAUM COMM, 1992, EARL MAN SEV TRAUM E; WEST JG, 1983, ARCH SURG-CHICAGO, V118, P740; WILSON DS, 1992, J TRAUMA, V32, P45, DOI 10.1097/00005373-199201000-00010	33	12	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2000	7	6					507	514		10.1054/jocn.1999.0694			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	384ME	WOS:000165946000007	11029231				2022-02-06	
J	Van den Heuvel, C; Finnie, JW; Blumbergs, PC; Manavis, J; Jones, NR; Reilly, PL; Pereira, RA				Van den Heuvel, C; Finnie, JW; Blumbergs, PC; Manavis, J; Jones, NR; Reilly, PL; Pereira, RA			Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						amyloid precursor protein; head injury model; in-situ hybridization; magnesium sulphate; messenger RNA; northern blot hybridization; sheep	HEAD IMPACT MODEL; HUMAN-ENDOTHELIAL-CELLS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; SECRETED FORMS; AXONAL INJURY; TRANSCRIPTIONAL ACTIVATION; RAT HIPPOCAMPUS; MESSENGER-RNA; UP-REGULATION	The aim of this study was to assess and quantitate topographically the effects of posttraumatic intravenous magnesium sulphate (MgSO4) on neuronal perikaryal APP antigen and messenger RNA (mRNA) expression in sheep brains 2 h after a controlled focal head impact. The percentage brain rea with APP immunoreactive neuronal perikarya was 71, 56, 27.5 and 5.5%, respectively, in MgSO4-treated head-injured animals, head-injured animals without any treatment, MgSO4 treated nonimpacted animals, and nontreated nonimpacted control sheep. Although there was no statistically significant difference in APP immunoreactive neuronal perikarya in the MgSO4-treated Hf group (mean 71%) compared to the HI group without any treatment (mean 56%), northern analysis showed that there was a 2.3- +/- 0.2-fold increase in APP mRNA in the thalamus of treated impacted animals compared to untreated impacted animals (p < 0.005), However, MgSO4 treated nonimpacted control animals also showed a 1.6- +/-0.1-fold increase in APP mRNA compared to untreated nonimpacted controls (p < 0.005), MgSO4 therapy results in upregulation of neuronal APP mRNA and APP expression that is quantitatively greater following a focal head impact.	Inst Med & Vet Sci, Dept Neuropathol, Neuropathol Lab, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Vet Div, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Infect Dis Lab, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Dept Neuropathol, Neuropathol Lab, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.	peter.blumbergs@imvs.sa.gov.au	van den Heuvel, Cameron J./E-1993-2012	van den Heuvel, Cameron J./0000-0001-7264-4655; Reilly, Peter/0000-0003-3173-0666			ARTHUR J, 1993, J GEN VIROL, V74, P1363, DOI 10.1099/0022-1317-74-7-1363; Bourbonniere M, 1997, J NEUROCHEM, V68, P909; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; CIALLELLA JR, 1994, J NEUROSCI RES, V37, P769, DOI 10.1002/jnr.490370611; CLARK AF, 1980, J BIOL CHEM, V255, P6556; DEWJI NN, 1995, MOL BRAIN RES, V33, P245, DOI 10.1016/0169-328X(95)00131-B; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; DONNELLY RJ, 1990, CELL MOL NEUROBIOL, V10, P485, DOI 10.1007/BF00712843; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GARFINKEL L, 1985, Magnesium, V4, P60; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Griffin WST, 1998, BRAIN PATHOL, V8, P65; GRUBBS RD, 1987, MAGNESIUM, V6, P113; HAJIMOHAMMADREZA I, 1994, BRAIN RES, V640, P25, DOI 10.1016/0006-8993(94)91853-8; HEALTH DL, 1999, J NEUROSURG, V90, P504; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; HOFFMAN DJ, 1994, BRAIN RES, V644, P144, DOI 10.1016/0006-8993(94)90357-3; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; Johnson D, 1997, EDN, V42, P94; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; Lee RKK, 1997, P NATL ACAD SCI USA, V94, P5422, DOI 10.1073/pnas.94.10.5422; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lin L, 1998, NEUROREPORT, V9, P547, DOI 10.1097/00001756-199802160-00030; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; May C, 1998, AUST VET J, V76, P752, DOI 10.1111/j.1751-0813.1998.tb12307.x; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; Morimoto T, 1998, J NEUROSCI RES, V51, P185, DOI 10.1002/(SICI)1097-4547(19980115)51:2<185::AID-JNR7>3.0.CO;2-9; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Panegyres PK, 1998, J NEUROL SCI, V154, P123, DOI 10.1016/S0022-510X(97)00214-1; Pierce JES, 1996, J NEUROSCI, V16, P1083; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; RICHARDS IS, 1982, AUST VET J, V58, P115, DOI 10.1111/j.1751-0813.1982.tb00606.x; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SHIGEMATSU K, 1992, BRAIN RES, V593, P117, DOI 10.1016/0006-8993(92)91272-G; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; Tominaga K, 1997, NEUROREPORT, V8, P2067, DOI 10.1097/00001756-199705260-00051; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; Yang YX, 1998, MOL BRAIN RES, V60, P40, DOI 10.1016/S0169-328X(98)00164-8; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	77	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2000	17	11					1041	1053		10.1089/neu.2000.17.1041			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	374KY	WOS:000165345400004	11101207				2022-02-06	
J	Calvanio, R; Burke, DT; Kim, HJ; Cheng, J; Lepak, P; Leonard, J; Dwyer, MA; Gavande, V				Calvanio, R; Burke, DT; Kim, HJ; Cheng, J; Lepak, P; Leonard, J; Dwyer, MA; Gavande, V			Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury	BRAIN INJURY			English	Article							ENDOGENOUS OPIOIDS; AMANTADINE; ANTAGONISTS; NALOXONE; AGONIST; THERAPY; STATE	Evidence from many studies has suggested that endogenous opioid peptides participate in a number of pathophysiological responses to brain injury. This provides the rationale for the use of opioid antagonists for the enhancement of neural recovery after brain injury. A case is presented of an 18-year-old male who had loss of consciousness for 1 month after a severe brain injury. Three months of intensive rehabilitative therapies did not change his functional status. A trial of naltrexone was given while his performance in mobility, speech and overall Functional Independence Measure (FIM) scores were monitored. Results indicate an accelerated improvement in functional status and statistically improved FIM score.	Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Univ Texas, SW Med Sch, Dallas, TX 75230 USA		Burke, DT (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 125 Nashua St, Boston, MA 02114 USA.	daverir@aol.com					ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; Backman CL, 1999, AM J PHYS MED REHAB, V78, P170, DOI 10.1097/00002060-199903000-00022; DOBKIN BH, 1993, ANN NEUROL, V33, P313, DOI 10.1002/ana.410330315; EDBY K, 1995, CHILD NERV SYST, V11, P607, DOI 10.1007/BF00301001; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCNICHOLAS LF, 1984, DRUGS, V27, P81, DOI 10.2165/00003495-198427010-00004; MELEGER A, 1999, AM J PHYSICAL MED RE, V78, P190; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Seliger GM, 1998, J NEUROL REHABIL, V12, P29; TENNANT FS, 1987, AM J PSYCHIAT, V144, P813; VINK R, 1990, J NEUROSCI, V10, P3524; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Zafonte RD, 1998, BRAIN INJURY, V12, P617	22	12	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2000	14	10					933	942					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	364QG	WOS:000089902900007	11076138				2022-02-06	
J	Hux, K; Manasse, N; Wright, S; Snell, J				Hux, K; Manasse, N; Wright, S; Snell, J			Effect of training frequency on face-name recall by adults with traumatic brain injury	BRAIN INJURY			English	Article							IMAGERY; PERFORMANCE	Many TBI survivors have difficulty recalling the names of people with whom they frequently interact. Researchers have established that mnemonics and visual imagery strategies are often effective in facilitating encoding and recall of such information; however, no research exists pertaining to the frequency that such training should occur. The purpose of this study was to assess the relative effectiveness of three frequencies of intervention sessions-once per day, two times per week, and five times per day-on TBI survivors' ability to recall face-name associations. Results showed that sessions held daily and twice a week were more effective than sessions held five times per day. Mnemonics and visual imagery strategies were effective for four of the seven participants, regardless of frequency of intervention sessions. Implications for treatment and future research are discussed.	Univ Nebraska, Barkley Mem Ctr Special Educ & Commun Disorders 3, Lincoln, NE 68583 USA; Qual Living Inc, Omaha, NE USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr Special Educ & Commun Disorders 3, Lincoln, NE 68583 USA.		Hux, Karen/AAQ-2078-2020				DELLAROSA D, 1985, MEM COGNITION, V13, P529, DOI 10.3758/BF03198324; DEMPSTER FN, 1988, AM PSYCHOL, V43, P627, DOI 10.1037/0003-066X.43.8.627; Downes JJ, 1997, NEUROPSYCHOL REHABIL, V7, P195, DOI 10.1080/713755535; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; Kertesz A., 1982, W APHASIA BATTERY; LEE TD, 1988, RES Q EXERCISE SPORT, V59, P277, DOI 10.1080/02701367.1988.10609373; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; MADIGAN SA, 1969, J VERB LEARN VERB BE, V8, P828, DOI 10.1016/S0022-5371(69)80050-2; Mateer CA, 1988, NEUROPSYCHOLOGICAL S, P202; REYNOLDS JH, 1964, J EDUC PSYCHOL, V55, P297, DOI 10.1037/h0040734; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; Rustad RA, 1993, COGNITIVE ASSESSMENT; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674	16	12	15	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2000	14	10					907	920					14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	364QG	WOS:000089902900005	11076136				2022-02-06	
J	Galvin, JE; Nakamura, M; McIntosh, TK; Saatman, KE; Sampathu, D; Raghupathi, R; Lee, VMY; Trojanowski, JQ				Galvin, JE; Nakamura, M; McIntosh, TK; Saatman, KE; Sampathu, D; Raghupathi, R; Lee, VMY; Trojanowski, JQ			Neurofilament-rich intraneuronal inclusions exacerbate neurodegenerative sequelae of brain trauma in NFH/LacZ transgenic mice	EXPERIMENTAL NEUROLOGY			English	Article						neuronal cytoplasmic inclusions; Lewy bodies; neurofilament; apoptosis; traumatic brain injury; transgenic mice; Parkinson's disease; neurodegeneration	AMYLOID PRECURSOR PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRAMMED CELL-DEATH; MOTOR-NEURON DISEASE; PARKINSONS-DISEASE; LEWY BODIES; MONOCLONAL-ANTIBODIES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; NERVOUS-SYSTEM	Several neurodegenerative disorders are characterized by filamentous inclusions in neurons that selectively degenerate. The role these inclusions play in neuron degeneration is unclear, but this issue can, be investigated experimentally in relevant animal models. The NFH/LacZ transgenic (TG) mice overexpress the high-molecular-weight neurofilament (NF) subunit (NFH) fused to beta-galactosidase, and these hybrid proteins aggregate into NF-rich, filamentous neuronal cytoplasmic inclusions (NCIs) that have been implicated in the progressive, age-dependent degeneration in subsets of affected neurons. Thus, these TG mice recapitulate some of the key pathology of neurodegenerative disorders with intraneuronal inclusions. To determine if the NCIs compromise neuron survival following traumatic brain injury (TBI), 3- to 6-month old TG and wild-type (WT) mice were subjected to TBI or sham injury. At 2 weeks post-TBI, the TG group showed increased TUNEL staining and activated caspase-3 immunoreactivity in cells of cerebral cortex, adjacent white matter, and hippocampus underlying the injury site, relative to control mice, but this labeling decreased at 4 weeks and was minimal thereafter. Compared to control mice, by 8 weeks postinjury, the TG mice showed a marked decrease in neuron density and increased gliosis in the hippocampal dentate gyrus and CA3 region as well as in the lateral thalamus, while the few remaining CA3 neurons exhibited cytoskeletal alterations, decreased synaptic protein immunoreactivity, and dissolution of NCIs. The more profound long-term neurodegenerative sequelae of TBI in the NFH/LacZ mice compared to WT mice suggest that the presence of intraneuronal inclusions may impair the recovery and long-term viability of injured neurons. (C) 2000 Academic Press.	Med Coll Penn & Hahnemann Univ, Dept Neurol, Philadelphia, PA 19102 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Galvin, JE (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Neurol, Philadelphia, PA 19102 USA.		Galvin, James/AAM-7492-2021; Raghupathi, Ramesh/AAX-5538-2021		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG10124, AG09215] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG009215, P30AG010124] Funding Source: NIH RePORTER		ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; Baba M, 1998, AM J PATHOL, V152, P879; BANKIEWICZ K, 1993, EXP NEUROL, V124, P140, DOI 10.1006/exnr.1993.1185; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Brinkley B R, 1980, Int Rev Cytol, V63, P59, DOI 10.1016/S0074-7696(08)61757-X; Burke RE, 1998, ANN NEUROL, V44, pS126, DOI 10.1002/ana.410440719; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Conti AC, 1998, J NEUROSCI, V18, P5663; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Cronford M.E., 1995, BRAIN COGNITION, V28, P321; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; DICKSON DW, 2000, NEURODEGENERATIVE DE, P247; DIXON CE, 1991, J NEUROSCI METH, V39, P1; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Frautschy SA, 1998, AM J PATHOL, V152, P307; Galvin J E, 1999, Adv Neurol, V80, P313; Galvin JE, 1997, ANN NEUROL, V42, P595, DOI 10.1002/ana.410420410; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIASSON BI, 2000, NEURODEGENERATIVE DE, P219; GINSBERG SD, 1999, CEREB CORTEX, V14, P603; GOLDMAN JE, 1986, ANN NEUROL, V19, P209, DOI 10.1002/ana.410190302; HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811; HILL WD, 1993, J COMP NEUROL, V329, P328, DOI 10.1002/cne.903290304; HILL WD, 1991, J COMP NEUROL, V309, P150, DOI 10.1002/cne.903090111; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LEE VMY, 1986, J NEUROSCI, V6, P2179; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakajo S, 1996, BRAIN RES, V741, P180, DOI 10.1016/S0006-8993(96)00914-6; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Namura S, 1998, J NEUROSCI, V18, P3659; Pierce JES, 1996, J NEUROSCI, V16, P1083; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; RINK A, 1995, AM J PATHOL, V147, P1575; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SCHMIDT ML, 1994, EXP NEUROL, V130, P311, DOI 10.1006/exnr.1994.1209; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; SELKOE DJ, 1997, MOL GENETIC BASIS NE, P601; SHAW G, 1988, P NATL ACAD SCI USA, V85, P2854, DOI 10.1073/pnas.85.8.2854; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SMITH DH, 1997, J NEUROTRAUM, V14, P215; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tompkins MM, 1997, AM J PATHOL, V150, P119; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Tu PH, 1997, LAB INVEST, V76, P441; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Tu PH, 1997, J NEUROSCI, V17, P1064; VANGROEN T, 1992, J COMP NEUROL, V324, P427, DOI 10.1002/cne.903240310; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	75	12	12	1	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	2000	165	1					77	89		10.1006/exnr.2000.7461			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	353VC	WOS:000089295300008	10964487				2022-02-06	
J	Sbordone, RJ; Seyranian, GD; Ruff, RM				Sbordone, RJ; Seyranian, GD; Ruff, RM			The use of significant others to enhance the detection of malingerers from traumatically brain-injured patients	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	8th Annual Meeting of the American-Neuropsychiatric-Association	FEB 02-04, 1997	ORLANDO, FL	Amer Neuropsychiat Assoc			SIMULATED MEMORY IMPAIRMENT; MMPI-2 VALIDITY SCALES; FORCED-CHOICE METHOD; FAKE BAD SCALE; BELIEVABLE DEFICITS; SYMPTOM VALIDITY; COMPLAINTS; PERFORMANCE; INDIVIDUALS; CLAIMANTS	Cognitive and neurobehavioral symptoms are common following traumatic brain injuries (TBIs). Because malingerers are likely to complain of such symptoms and perform poorly on neuropsychological tests, clinicians may have considerable difficulty distinguishing malingerers from TBI patients. In this study, we compared the subjective complaints of malingerers to TBI patients and then compared both groups to the problems observed by their respective significant others. We rested the assumption whether significant others could add one more piece to the challenging puzzle of diagnosing malingering. Our results demonstrated that the malingerers complained of more problems than patients who had sustained moderate or severe TBI. However, the significant others of the malingerers observed fewer cognitive, emotional-behavioral, and total problems than did the significant others of patients with severe, moderate and even mild TBI. These findings suggest that the detection of malingering can be enhanced by interviews with significant others. (C) 2000 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Calif Irvine, Irvine, CA USA		Sbordone, RJ (corresponding author), 7700 Ctr Dr,Suite 750, Irvine, CA 92618 USA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; DAVIDSON H, 1991, ANN M INT NEUR SOC S; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FRANZEN MD, 1998, CLIN NEUROPSYCHOLOGY, P88; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Gough H.G., 1950, J CONSULT PSYCHOL, V14, P408, DOI [10.1037/h0054506, DOI 10.1037/H0054506]; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEZAK MD, 1983, NEUROPSYCHOLGICAL AS; Long, 1996, ECOLOGICAL VALIDITY, P15; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; PURISCH AD, 2000, LURIA NEBRASKA NEURO, V1, P165; Reitan RM, 1998, CRIT ISS NE, P163; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1994, ASSESSMENT, V1, P227, DOI DOI 10.1177/107319119400100302; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sbordone RJ, 1996, NEUROREHABILITATION, V7, P15, DOI 10.3233/NRE-1996-7103; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; WONG TH, 1994, INT POLYM PROC, V9, P3, DOI 10.3139/217.940003; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	45	12	12	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2000	15	6					465	477					13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	343AB	WOS:000088678600001	14590202				2022-02-06	
J	Anderson, GD; Lin, YX; Temkin, NR; Fischer, JH; Winn, HR				Anderson, GD; Lin, YX; Temkin, NR; Fischer, JH; Winn, HR			Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin	ANNALS OF PHARMACOTHERAPY			English	Article						intravenous therapy; phenytoin; valproate; neurotrauma	POSTTRAUMATIC SEIZURES; FOSPHENYTOIN; PREVENTION; INFUSION	OBJECTIVE: To determine the incidence of intravenous site reactions to phenytoin and valproate in a large population of patients with neurotrauma. DESIGN: Retrospective chart review of two double-blind, randomized clinical trials evaluating the use of antiepileptic drugs to prevent posttraumatic seizures in patients with neurotrauma: phenytoin versus placebo (n = 390), and valproate versus phenytoin with placebo (n = 385). Information collected from the charts included the number, type, and location of intravenous lines and intravenous site events. SETTING: Tertiary care trauma and university teaching hospital. MAIN RESULTS: Intravenous site reactions occurred in 18% and 25% of patients receiving valproate or phenytoin, respectively, with the majority of events (70%) occurring in the first intravenous site. Patients received the neurosurgery study drug (NSSD) by either central or peripheral lines; all intravenous site reactions occurred in peripheral administration sites. When patients who received the drug by central line during the course of therapy were excluded, the estimated incidence of site reactions was 21% and 30% for valproate and phenytoin, respectively (p = 0.056). The time to the first event was shorter with phenytoin compared with valproate (2.0 +/- 1.3 vs. 3.0 +/- 1.9 d; p = 0.009). Fewer adverse events were noted with phenytoin in the phenytoin-without-valproate study than in the phenytoin-with:valproate study, with 4.3% and 8.2% of intravenous site events recorded in patients receiving placebo or phenytoin, respectively. There was no significant difference in the number of intravenous lines per patient used during NSSD drug infusion for phenytoin versus placebo or phenytoin Versus valproate. CONCLUSIONS: Both intravenous phenytoin and valproate resulted in intravenous site reactions, with the loading doses responsible the majority of the events.	Univ Washington, Dept Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; Univ Illinois, Dept Pharm Practice, Chicago, IL USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA.						Boucher BA, 1996, PHARMACOTHERAPY, V16, P638; CARDUCCI B, 1984, ANN EMERG MED, V13, P1027, DOI 10.1016/S0196-0644(84)80063-3; DELACRUZ FG, 1988, CLIN PHARMACY, V7, P219; DONOVAN PJ, 1991, ANN EMERG MED, V20, P139, DOI 10.1016/S0196-0644(05)81211-9; EARNEST MP, 1983, JAMA-J AM MED ASSOC, V249, P762, DOI 10.1001/jama.249.6.762; JAMERSON BD, 1994, PHARMACOTHERAPY, V14, P47, DOI 10.1002/j.1875-9114.1994.tb02788.x; KILARSKI DJ, 1984, NEW ENGL J MED, V311, P1186; SALEM RB, 1981, AM J HOSP PHARM, V38, P354, DOI 10.1093/ajhp/38.3.354; SPENGLER RF, 1988, ARCH INTERN MED, V148, P1329, DOI 10.1001/archinte.148.6.1329; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593	11	12	12	0	0	HARVEY WHITNEY BOOKS CO	CINCINNATI	PO BOX 42696, CINCINNATI, OH 45242 USA	1060-0280			ANN PHARMACOTHER	Ann. Pharmacother.	JUN	2000	34	6					697	702					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	321GF	WOS:000087447200001	10860128				2022-02-06	
J	Bara, BG; Bucciarelli, M; Geminiani, GC				Bara, BG; Bucciarelli, M; Geminiani, GC			Development and decay of extra-linguistic communication	BRAIN AND COGNITION			English	Article; Proceedings Paper	10th Annual Meeting on Tennet - Theoretical and Experimental Neuropsychology	JUN 17-19, 1999	MONTREAL, CANADA	Univ Quebec				Cognitive Pragmatics theory is concerned with analyzing the cognitive processes underlying communication. In previous works we have explained the emergence of communication in context, as revealed by very young children, and the communicative deficits shown by closed head injury patients. The aim of the present work is an extension of Cognitive Pragmatics to the emergence and the decay of extra-linguistic communication. In I,articular, we investigate the performance of 2- to 7 year-old children and that of Alzheimer's patients in standard and nonstandard (irony and deceit) pragmatic tusks. The predictions derived by Cognitive Pragmatics are confirmed. Comprehension of pragmatic phenomena which are more complex according to the theory emerges later in the development (Experiment 1), and their decay is most severe in Alzheimer's patients (Experiment 2). We conclude that the framework provided by Cognitive Pragmatics can accommodate both the development and the decay of extra-linguistic communication. (C) 2000 Academic Press.	Univ Turin, Dipartimento Psicol, I-10124 Turin, Italy; Univ Turin, Ctr Cognit Sci, I-10124 Turin, Italy		Bara, BG (corresponding author), Univ Turin, Dipartimento Psicol, I-10124 Turin, Italy.						AIRENTI G, 1993, COGNITIVE SCI, V17, P197, DOI 10.1207/s15516709cog1702_2; AIRENTI G, 1993, J PRAGMATICS, V20, P303, DOI 10.1016/0378-2166(93)90055-T; AIRENTI G, 1984, COMPUTATIONAL MODELS; Bara B. G., 1998, COGNITION CONTEXT, P317; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; BRAZZELLI M, 1994, J NEUROL NEUROSUR PS, V57, P1510, DOI 10.1136/jnnp.57.12.1510; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661	7	12	13	0	0	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN-AUG	2000	43	1-3					21	27					7	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	316FU	WOS:000087157600034	10857656				2022-02-06	
J	Haroun, RI; Li, KW; Rigamonti, D				Haroun, RI; Li, KW; Rigamonti, D			Surgical resection of a cerebral arteriovenous malformation for treatment of superficial siderosis: Case report	SURGICAL NEUROLOGY			English	Article						arteriovenous malformation; subarachnoid hemorrhage; superficial siderosis	CENTRAL-NERVOUS-SYSTEM; MRI	BACKGROUND To our knowledge, there are only two reported cases of cerebral arteriovenous malformation associated with superficial siderosis. In both cases, the patients were asymptomatic and were discovered on retrospective review of magnetic resonance imaging. CASE DESCRIPTION We describe a case of superficial siderosis in a 47-year-old male with a remote history of closed head injury that presented with progressive hearing loss, cerebellar ataxia, and urinary incontinence. Lumbar puncture was indicative of active subarachnoid bleeding. Cerebral angiography revealed a small vascular malformation that was resected. RESULTS: Pathological examination confirmed the diagnosis of the arteriovenous malformation. Six months after surgery the patient is neurologically stable with no further progression of clinical signs or symptoms. CONCLUSIONS We report the first case of surgical resection of an intracranial arteriovenous malformation for the treatment of superficial siderosis. We emphasize the necessity of a detailed evaluation when superficial siderosis is suspected to localize and resect potential bleeding sources, because the disease is progressive and often irreversible. (C) 2000 by Elsevier Science Inc.	Johns Hopkins Hosp, Dept Neurol Surg, Baltimore, MD 21287 USA		Rigamonti, D (corresponding author), Dept Neurol Surg, Meyer 5-181,600 N Wolfe St, Baltimore, MD 21287 USA.						Arnaud A, 1998, REV NEUROL, V154, P243; BONITO V, 1994, J NEUROSURG, V80, P931, DOI 10.3171/jns.1994.80.5.0931; CAMMERMEYER J, 1947, J NEUROPATH EXP NEUR, V6, P111, DOI 10.1097/00005072-194704000-00001; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; FONCIN JF, 1967, REV NEUROL, V116, P685; Hashimoto M, 1996, J NEURO-OPHTHALMOL, V16, P277; HUGHES JT, 1969, ACTA NEUROPATHOL, V13, P56; KOEPPEN AH, 1988, J NEUROPATH EXP NEUR, V47, P249, DOI 10.1097/00005072-198805000-00005; Matsumoto S, 1998, J NEUROSURG, V88, P890, DOI 10.3171/jns.1998.88.5.0890; MCGEE DA, 1962, NEUROLOGY, V12, P108, DOI 10.1212/WNL.12.2.108; OFFENBACHER H, 1991, NEUROLOGY, V41, P1987, DOI 10.1212/WNL.41.12.1987; Offenbacher H, 1996, NEURORADIOLOGY, V38, pS51, DOI 10.1007/BF02278119; PARNES SM, 1992, OTOLARYNG HEAD NECK, V107, P69, DOI 10.1177/019459989210700111; PINKSTON JW, 1983, J COMPUT ASSIST TOMO, V7, P1073, DOI 10.1097/00004728-198312000-00025; Schievink WI, 1998, J NEUROSURG, V89, P1029, DOI 10.3171/jns.1998.89.6.1029; STEVENS I, 1991, EUR ARCH PSY CLIN N, V241, P57, DOI 10.1007/BF02193756; Tapscott SJ, 1996, ANN NEUROL, V40, P936, DOI 10.1002/ana.410400620	17	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2000	53	6					554	558		10.1016/S0090-3019(00)00217-2			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	343UZ	WOS:000088722000011	10940422				2022-02-06	
J	Lomnitski, L; Nyska, A; Shohami, E; Chen, Y; Michaelson, DM				Lomnitski, L; Nyska, A; Shohami, E; Chen, Y; Michaelson, DM			Increased levels of intracellular iron in the brains of ApoE-deficient mice with closed head injury	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						apolipoprotein E; head injury, iron, intracellular; brain, intracellular iron; oxidation-stress	CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; DISEASE; EXPRESSION; METABOLISM; RADICALS; MODEL	Previous studies have revealed that apolipoprotein E (apoE)-deficient mice have distinct memory deficits and neurochemical derangements and are oxidatively stressed prior to and following closed head injury. The objective of this study was to evaluate the possibility that the enhanced susceptibility of apoE-deficient mice to closed head injury is related to impairments in their antioxidative iron-chelating mechanisms. ApoE-deficient and control mice were subjected to closed had injury, after which the extent of brain-damage and the level of iron-containing cells were assessed. Examination of the brain-damaged areas in the injured mice revealed that, by Day 3 post injury, animals of both groups were maximally and similarly affected. While the size of the damaged area of the injured control mice diminished significantly by Day 7, however recovery was not observed in injured apoE-deficient mice up to at least 14 days post-injury. Histopathologically, the decrease in the damaged areas in the control mice was interpreted as related to decreased edema. Numbers of iron-containing cells at Days 3 and 7 after injury were greater in the brains of control mice than in the apoE-deficient mice. Whereas the number of iron-containing cells in injured control mice decreased at days 9 and 14-post injury, that of the injured apoE-deficient mice plateaued by Day 9 at a level more than two-fold higher than the maximal level seen for controls. The size of the damaged areas and the number of iron-containing cells were correlated (P < 0.03) for both mouse groups at days 9 and 14 after injury. The data suggest that the increased susceptibility of apoE-deficient mice to closed head injury may be due, at least in part, to impaired iron scavenging and sustained oxidative stress.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; NIEHS, Res Triangle Pk, NC 27709 USA; Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel		Michaelson, DM (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel.						BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; BOCHICCHIO M, 1990, INTENS CARE MED, V16, P444, DOI 10.1007/BF01711223; Chapman S, 1998, J NEUROCHEM, V70, P708; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CIUFFI M, 1991, NEUROCHEM RES, V16, P43, DOI 10.1007/BF00965826; CLINTON SK, 1992, AM J PATHOL, V140, P301; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GENIS I, 1995, NEUROSCI LETT, V199, P5, DOI 10.1016/0304-3940(95)12007-Q; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; GRISHAM MB, 1990, NATO ADV SCI I A-LIF, V189, P81; GUTTERIDGE JMC, 1992, ANN NEUROL, V32, pS16, DOI 10.1002/ana.410320705; HALL ED, 1994, FREE RADICAL DAMAGE, P217; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; ISHIBASHI S, 1993, HORM METAB RES, V25, P82, DOI 10.1055/s-2007-1002048; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; LMONITSKI L, 1999, BIOCHIM BIOPHYS ACTA, V1453, P359; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Matthews RT, 1996, BRAIN RES, V718, P181, DOI 10.1016/0006-8993(95)01576-0; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NYSKA A, 1989, HUM VET TOXICOL, V31, P218; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; TOMIMOTO H, 1995, ACTA NEUROPATHOL, V90, P608; *US DEP HHS, 1996, GUID CAR US LAB AN	35	12	15	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993			EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAY	2000	52	2					177	183					7	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Toxicology	319KY	WOS:000087341100014	10965994				2022-02-06	
J	Bauer, R; Fritz, H; Walter, B; Schlonski, O; Jochum, T; Hoyer, D; Zwiener, U; Reinhart, K				Bauer, R; Fritz, H; Walter, B; Schlonski, O; Jochum, T; Hoyer, D; Zwiener, U; Reinhart, K			Effect of mild hypothermia on cerebral oxygen uptake during gradual cerebral perfusion pressure decrease in piglets	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow; cerebral oxygen consumption; intracranial pressure; epidural balloon inflation; extracorporeal arterial blood pressure controller; piglets; hypothermia; colored microspheres; neurologic emergencies; brain	TRAUMATIC BRAIN INJURY; REGIONAL BLOOD-FLOW; COMA DATA-BANK; HEAD-INJURY; MODERATE HYPOTHERMIA; CIRCULATORY ARREST; NEWBORN PIGLETS; METABOLIC-RATE; CHILDREN; PROTECTION	Objective: To study the effect of mild hypothermia on cerebral oxygen metabolism and brain function in piglets during reduced cerebral blood flow because of gradual reduction of the effective cerebral perfusion pressure (CPP). Design: Comparison of two randomized treatment groups: normothermic group (NT; n = 7) and hypothermic group (HT; n = 7). Setting: Work was conducted in the research laboratory of the Institute for Pathophysiology, Friedrich Schiller University, Jena, Germany. Subjects: Fourteen piglets (14 days old) of mixed German domestic breed. Intervention: Animals were anesthetized and mechanically ventilated. An epidural balloon was gradually inflated to increase intracranial pressure to 25 mm Hg, 35 mm Hg, and 45 mm Hg every 30 mins at adjusted mean arterial blood pressures. After determination of baseline CPP (NT, 79 +/- 14 mm Hg; HT, 84 +/- 9 mm Hg), CPP was reduced to similar to 70%, 50%, and 30% of baseline (NT, 38.1 +/- 0.5 degrees C; HT, 31.7 +/- 0.5 degrees C). Measurements and Main Results: Every 25 mins after the gradual CPP reductions. Mild hypothermia induced a reduction of the cerebral metabolic rate of oxygen (CMRO2) to 50% +/- 15% of baseline values (baseline values, 352 +/- 99 mu mol.100 g(-1).min(-1)) (p < .05). Moreover, the electrocorticogram was altered to a pattern of reduced delta activity (p < .05) but unchanged higher frequency activity. The cerebral oxygen balance in HT animals remained improved until CPP reduction to 50%, indicated by a reduced cerebral arteriovenous difference of oxygen but elevated brain tissue PO2 (p < .05). Further CPP reduction gave rise to a strong CMRO2 reduction (NT, 19 +/- 21%; HT, 15 +/- 15%; p < .05). However, the high-frequency band of electrocorticogram was less reduced in hypothermic animals (p < .05). Conclusions: Mild whole body hypothermia improves cerebral oxygen balance by reduction of brain energy demand in juvenile piglets. The improvement of brain oxygen availability continues during a mild to moderate CPP decrease. A loss of the difference in CMRO2 between the hypothermic and normothermic piglets together with the fact that brain electrical activity was less suppressed under hypothermia during severe cerebral blood flow reduction indicates that hypothermic protection may involve some other mechanisms than reduction of brain oxidative metabolism.	Univ Jena, Inst Pathophysiol, Traumat Brain Injury & Perinatal Res Grp, D-07740 Jena, Germany; Univ Jena, Clin Anesthesiol & Intens Care, D-07740 Jena, Germany		Bauer, R (corresponding author), Univ Jena, Inst Pathophysiol, Traumat Brain Injury & Perinatal Res Grp, D-07740 Jena, Germany.						ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bauer R, 1997, EXP TOXICOL PATHOL, V49, P469, DOI 10.1016/S0940-2993(97)80139-X; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BUSIJA DW, 1987, AM J PHYSIOL, V253, pH869, DOI 10.1152/ajpheart.1987.253.4.H869; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COYLE MG, 1993, AM J PHYSIOL, V264, pH141, DOI 10.1152/ajpheart.1993.264.1.H141; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, NEUROTRAUMA, P1491; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HIRAMATSU T, 1995, J THORAC CARDIOV SUR, V109, P948, DOI 10.1016/S0022-5223(95)70321-7; Hoyer D, 1997, BIOMED TECH, V42, P284, DOI 10.1515/bmte.1997.42.10.284; INGVAR DH, 1958, ACTA PHYSIOL SCAND, V42, P130, DOI 10.1111/j.1748-1716.1958.tb01547.x; JONAS RA, 1993, J THORAC CARDIOV SUR, V106, P362; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KOWALLIK P, 1991, CIRCULATION, V83, P974, DOI 10.1161/01.CIR.83.3.974; Kurth CD, 1997, CIRCULATION, V96, P358; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MAKOWSKI EL, 1968, CIRC RES, V23, P623, DOI 10.1161/01.RES.23.5.623; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MEYER JS, 1969, ELECTROEN CLIN NEURO, V26, P125, DOI 10.1016/0013-4694(69)90203-X; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; NEMOTO EM, 1995, CRIT CARE MED, V23, pA246; POWNALL R, 1973, BRIT VET J, V129, P583, DOI 10.1016/S0007-1935(17)36340-6; RUPP SM, 1986, ANESTHESIA, P1195; Satas S, 1996, ACTA ANAESTH SCAND, V40, P452, DOI 10.1111/j.1399-6576.1996.tb04468.x; SCHRADER H, 1985, ACTA NEUROL SCAND, V72, P283; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; USIJA DW, 1988, AM J PHYSIOL, V255, pH343; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; Wass CT, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603440-00008	35	12	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2000	28	4					1128	1135		10.1097/00003246-200004000-00036			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311AV	WOS:000086862800036	10809294				2022-02-06	
J	Numan, B; Sweet, JJ; Ranganath, C				Numan, B; Sweet, JJ; Ranganath, C			Use of the California Verbal Learning Test to detect proactive interference in the traumatically brain injured	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						proactive interference; CVLT; traumatic brain injury	DISEASE; MEMORY	Recent studies using the California Verbal Learning Test (CVLT) to investigate the learning and memory capacities of traumatically-brain injured (TBI) individuals have suggested that this population does not show the expected buildup of proactive interference (PI). The purpose of this study was to investigate whether PI could be detected on the CVLT. in a TBI sample, if PI were calculated using alternative methods. CVLT data from 25 TBI individuals with varying degrees of brain injury and 21 healthy controls were compared. Results from the various analyses suggested that TBI individuals show buildup and release from PI when learning and attempting to recall competing forms of information if appropriate methods of analysis are used. Although the CVLT differs considerably from traditional PI paradigms (e.g.. Wickens. 1970), our results suggest it can be used to detect PI in TBI individuals. (C) 2000 John Wiley & Sons, Inc.	Northwestern Univ, Dept Psychiat, Evanston Hosp, Evanston, IL 60201 USA		Sweet, JJ (corresponding author), Northwestern Univ, Dept Psychiat, Evanston Hosp, 2650 Ridge Ave, Evanston, IL 60201 USA.						CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CUSHMAN LA, 1988, J CLIN EXP NEUROPSYC, V10, P685, DOI 10.1080/01688638808402807; DELIS D, 1990, ADV PSYCHOL ASSESSME, V7; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DUPONT RM, 1990, ARCH GEN PSYCHIAT, V47, P55; Fridlund A, 1987, CVLT RES EDITION ADM; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; HERMANN BP, 1988, CORTEX, V24, P245, DOI 10.1016/S0010-9452(88)80033-9; Jennett B., 1983, REHABILITATION HEAD, P3; KARAKEN DA, 1996, J INT NEUROPSYCH SOC, V2, P486; KRAMER JH, 1989, J CONSULT CLIN PSYCH, V57, P257, DOI 10.1037/0022-006X.57.2.257; LOESS H, 1967, J EXP PSYCHOL, V74, P556, DOI 10.1037/h0024787; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PETERSON LR, 1959, J EXP PSYCHOL, V54, P157; POSTMAN L, 1971, EXPT PSYCHOL; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; VANDERPLOEG RD, 1990, ANN M AM PSYCH ASS B; WICKENS DD, 1970, PSYCHOL REV, V77, P1, DOI 10.1037/h0028569; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19; [No title captured]	23	12	13	0	2	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	APR	2000	56	4					553	562		10.1002/(SICI)1097-4679(200004)56:4<553::AID-JCLP8>3.0.CO;2-Q			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	301WD	WOS:000086332600008	10775047				2022-02-06	
J	Simpson, A; Schmitter-Edgecombe, M				Simpson, A; Schmitter-Edgecombe, M			Intactness of inhibitory attentional mechanisms following severe closed-head injury	NEUROPSYCHOLOGY			English	Article							SELECTIVE ATTENTION; OLD ADULTS; INTERFERENCE; TASK	Attentional problems are a common sequelae of closed-head injury (CHI). Research in the area of selective attention has pointed to the role of inhibitory mechanisms in the suppression of irrelevant information. In the current study, a negative priming paradigm was used to assess the inhibitory mechanisms of individuals suffering from a severe CHI. Twenty participants with severe CHIs (greater than 1 year postinjury) and 20 matched controls completed a negative priming task, as well as several other standardized tests of cognitive functioning. Within the negative priming task, 2 conditions were used to elicit information regarding facilitation by attended and ignored information and 1 condition was used to elicit inhibition of ignored information, as compared with a neutral control condition. Despite poorer performances on several tests of attention, there were no significant differences in the amount of inhibition displayed by the CHI participants as compared with the controls. Findings suggest that inhibitory processing deficits may not underlie the selective attention difficulties commonly seen following a severe CHI.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 RO3 HD35838-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Allport D. A., 1985, ATTENTION PERFORM, P107; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BROADBENT DE, 1970, ATTENTION CONT THEOR, P51; Bruning JL., 1997, COMPUTATIONAL HDB ST, V4th ed.; DRIVER J, 1993, B PSYCHONOMIC SOC, V31, P45; DULANEY CL, 1994, J EXP PSYCHOL LEARN, V20, P470, DOI 10.1037/0278-7393.20.2.470; FOX E, 1994, PERCEPT PSYCHOPHYS, V56, P565, DOI 10.3758/BF03206952; HASHER L, 1991, J EXP PSYCHOL LEARN, V17, P163, DOI 10.1037/0278-7393.17.1.163; Heaton RK, 1981, MANUAL WISCONSIN CAR; Kane MJ, 1997, J EXP PSYCHOL HUMAN, V23, P632, DOI 10.1037/0096-1523.23.3.632; KANE MJ, 1994, PSYCHOL AGING, V9, P103, DOI 10.1037/0882-7974.9.1.103; Kaplan E., 1987, MANUAL CALIFORNIA VE; KUCERA H, 1967, COMPUTTIONAL ANAL PR; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOWE DG, 1979, MEM COGNITION, V7, P382, DOI 10.3758/BF03196943; MAY CP, 1995, PSYCHOL BULL, V118, P35, DOI 10.1037/0033-2909.118.1.35; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P565, DOI 10.1037/0278-7393.18.3.565; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; NEILL WT, 1978, PERCEPT PSYCHOPHYS, V23, P80, DOI 10.3758/BF03214299; NEUMANN E, 1991, J EXP PSYCHOL LEARN, V17, P1136, DOI 10.1037/0278-7393.17.6.1136; *PAT BEH CHECKL, 1991, S MAT; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Spreen O., 1969, NEUROSENSORY CTR COM; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; SULLIVAN MP, 1993, PSYCHOL AGING, V8, P589, DOI 10.1037/0882-7974.8.4.589; SULLIVAN MP, 1995, NEUROPSYCHOLOGY, V9, P537, DOI 10.1037/0894-4105.9.4.537; TEASDALE G, 1974, LANCET, V2, P81; TIPPER SP, 1988, MEM COGNITION, V16, P64, DOI 10.3758/BF03197746; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; TIPPER SP, 1991, B PSYCHONOMIC SOC, V29, P45; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; TIPPER SP, 1992, B PSYCHONOMIC SOC, V30, P77; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Trenerry MR, 1990, VISUAL SEARCH ATTENT; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D, 1981, WECHSLER ADULT INTEL; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WILLIAMS LM, 1995, BRIT J CLIN PSYCHOL, V34, P193, DOI 10.1111/j.2044-8260.1995.tb01454.x; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	48	12	12	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	APR	2000	14	2					310	319		10.1037//0894-4105.14.2.310			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	321XM	WOS:000087480700014	10791870				2022-02-06	
J	Carstairs, JR; Shores, EA				Carstairs, JR; Shores, EA			The Macquarie University Neuropsychological Normative Study (MUNNS): Rationale and methodology	AUSTRALIAN PSYCHOLOGIST			English	Article							MINOR HEAD-INJURY; READING TEST	The Macquarie University Neuropsychological Normative Study (MUNNS) was conducted during the period January 1996 to March 1998, and involved the assessment of a sample of 399 healthy 18- to 34-year-olds in Sydney, Australia. The primary aim of the MUNNS was to establish normative data on neuropsychological measures commonly used in the rehabilitation and medico-regal assessments of patients with traumatic brain injuries. These norms provide local standards on tests of intelligence, memory, and higher neuropsychological function against which brain-injured patients can be compared. The present paper provides the rationale underpinning the MUNNS as well as an overview of the methodology used and an assessment of the representativeness of the MUNNS sample.	Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Carstairs, JR (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	jane.carstairs@mq.edu.au		Shores, Edwin A/0000-0003-1553-5131			ATKINSON L, 1991, BRIT J CLIN PSYCHOL, V30, P87, DOI 10.1111/j.2044-8260.1991.tb00923.x; Baddeley A., 1992, SPEED CAPACITY LANGU; BEARDSALL L, 1994, J CLIN EXP NEUROPSYC, V16, P232, DOI 10.1080/01688639408402634; Bowden SC, 1999, PSYCHOL ASSESSMENT, V11, P339, DOI 10.1037/1040-3590.11.3.339; *CAMBR COGN, 1995, CAMBR NEUR TEST AUT; COCHA J, 1994, CAT COMPUTER CATEGOR; Crawford JR, 1995, J INT NEUROPSYCH SOC, V1, P321; *DEP ED TRAIN YOUT, 1998, SEL HIGH ED STUD STA; Hennessy M., 1995, TREATMENT ISSUES LON, P183; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MITTENBERG W, 1992, PSYCHOL ASSESSMENT, V4, P3363; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured]; [No title captured]	19	12	12	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067			AUST PSYCHOL	Aust. Psychol.	MAR	2000	35	1					36	40		10.1080/00050060008257466			5	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	301VM	WOS:000086331000006					2022-02-06	
J	O'Neill, B				O'Neill, B			Head restraints - the neglected countermeasure	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	World Congress on Whiplash Associated Disorders	1999	VANCOUVER, CANADA			head restraints; whiplash; neck injuries; occupant protection; motor vehicle crashes		In a rear-end crash, if an occupant's head is unsupported it lags behind as the torso is accelerated forward. This causes the neck to change shape, first taking an s-shape and then bending backward in a 'whiplash' motion. This sudden differential movement of the head and torso can cause 'whiplash' injuries to the neck. This paper reviews methods to minimize the differential head/torso movement and reduce the resulting injuries, focusing on the necessary first step for prevention, which is a head restraint that is behind and close to the back of an occupant's head during the crash. The history of head restraints since the 1950s is reviewed, with particular attention to advanced restraint designs that are proving effective in reducing whiplash injury risk in dynamic tests using a new crash test dummy neck and a new neck injury criterion. (C) 2000 Elsevier Science Ltd. All rights reserved.	Insurance Inst Highway Safety, Arlington, VA USA		O'Neill, B (corresponding author), Insurance Inst Highway Safety, 1005 N Glebe Rd, Arlington, VA USA.						CAMERON MH, 1979, EFFECTIVENESS AUSTR; CAMERON MH, 1980, EFFECT AUSTR DESIGN; *COUNC EUR COMM, 1978, OFFICIAL J EUROPEAN, V21, P1; Council of the European Communities, 1996, OFFICIAL J EUROPEAN, V39, P28; CROWE K, 1962, COMMUNICATION   1221; DAVIES J. M., 1998, P IRCOBI C BIOM IMP, P377; EICHBERGER A, 1998, P INT C BIOM IMP IRC, P321; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P719, DOI 10.1016/S0001-4575(99)00035-4; GARRETT JW, 1972, SAE TECHNICAL PAPER; Haland Y., 1996, P IRCOBI C, P123; KAHANE CJ, 1982, 202 US DEP TRANSP; LUNDELL B, 1998, SAE TECHNICAL PAPER; MCINTIRE RT, 1957, J INT COLL SURG, V228, P54; MCNAB I, 1965, P ANN M AM ASS AUT M, P11; Mertz H.J., 1967, SAE TECHNICAL PAPER; MORRIS CR, 1998, MEASUREMENT EVALUATI; Olsson I, 1990, P INT IRCOBI C BIOM, P269; ONEILL B, 1972, AM J PUBLIC HEALTH, V62, P309; RUEDEMANN AD, 1957, JAMA-J AM MED ASSOC, V164, P1889, DOI 10.1001/jama.1957.62980170001006; SEVERY DM, 1968, SAE TECHNICAL PAPER; SEVRY DM, 1967, P 11 STAPP CAR CRASH, P337; *SOC AUT ENG, 1995, DEV US DEF MEAS VEH, pJ826; States JD, 1972, P 16 STAPP CAR CRASH, P228; Svensson M.Y., 1993, P INT RES COMM BIOM, P189; *UN EC SOC COUNC, 1997, EC COMM EUR STAT AGR, P79; Vann, 1995, MEASUREMENT EVALUATI; WIKLUND K, 1998, SAE TECHNICAL PAPER	27	12	12	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	2000	32	2					143	150		10.1016/S0001-4575(99)00057-3			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	282GG	WOS:000085209300002	10688470				2022-02-06	
J	Huh, PW; Belayev, L; Zhao, WZ; Clemens, JA; Panetta, JA; Busto, R; Ginsberg, MD				Huh, PW; Belayev, L; Zhao, WZ; Clemens, JA; Panetta, JA; Busto, R; Ginsberg, MD			Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						LY341122; cerebral ischemia, focal; neuroprotection; stroke; oxygen radical; (rat)	CEREBRAL-ARTERY OCCLUSION; INTRALUMINAL SUTURE; REPERFUSION INJURY; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; INFARCT VOLUME; BLOOD-FLOW; MODEL; U-101033E; DEFICITS	LY341122 (2-(3,5-di-t-butyl-4-hydroxyphenyl)-4-(2-(4-methylethylaminomethyl-phenyloxy)ethyl)oxazole) is a potent inhibitor of lipid peroxidation which has been shown to protect against global ischemia and traumatic brain injury in rats. The purpose of this study was to examine the effect of LY341122 on ischemic injury in a highly reproducible model of focal cerebral ischemia in rats. Male Sprague-Dawley rats were anesthetized with halothane and subjected to 120 min of temporary middle cerebral artery occlusion by retrograde insertion of an intraluminal nylon suture coated with poly-L-lysine. The drug (LY341122, n = 19) or vehicle (phosphate-buffered saline (PBS), n = 10) was administered i.v. las a 5 or 10 mg/kg bolus followed by a 5 or 10 mg/kg/h infusion for 20 h, respectively, starting 1 or 2 h after the onset of middle cerebral artery occlusion). Neurological status was evaluated during middle cerebral artery occlusion (60 min) and daily for 3 days thereafter. Three days after ischemia, brains were perfusion-fixed and infarct volumes and brain edema were determined. LY341122 significantly improved the neurological score compared to vehicle at 24, 48 and 72 h after middle cerebral artery occlusion. Treatment with LY341122 significantly reduced total infarct volume in all treated groups compared to vehicle rats. Cortical infarct volume was significantly reduced by LY341122 treatment in the 10 mg/kg (1 h) and LY341122 10 mg/kg (2 h) groups compared to vehicle rats (14.7 +/- 9.5 vs. 106.8 +/- 20.9 mm(3), and 36.9 +/- 20.1 vs. 106.8 +/- 20.9 mm(3), respectively (mean +/- S.E.M.)). Striatal infarct volume was also significantly reduced by treatment with LY341122 in the 10 mg/kg (1 h) group compared to vehicle (23.7 +/- 3.4 vs. 68.2 +/- 6.7 mm(3)). These results demonstrate the neuroprotective efficacy of LY341122 in focal cerebral ischemia. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Miami, Sch Med, Dept Neurol D4 5, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA; Lilly Res Labs, Indianapolis, IN 46285 USA		Belayev, L (corresponding author), Univ Miami, Sch Med, Dept Neurol D4 5, Cerebral Vasc Dis Res Ctr, POB 016960, Miami, FL 33101 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS005820, P01NS005820] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 05820] Funding Source: Medline		BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 1998, BRAIN RES, V787, P277, DOI 10.1016/S0006-8993(97)01499-6; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CHAN PH, 1993, NEUROREPORT, V5, P293, DOI 10.1097/00001756-199312000-00028; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CLEMENS JA, 1999, J CEREB BLOOD FLO S1, V19, pS183; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Ginsberg M. D, 1995, NEUROSCIENTIST, P164; Ginsberg MD, 1995, NEUROSCIENTIST, V1, P95; Hall ED, 1997, J PHARMACOL EXP THER, V281, P895; HALL ED, 1994, FREE RADICAL DAMAGE, P217; HALL ED, 1998, CEREBROVASC DIS, P710; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; LAING RJ, 1993, STROKE, V24, P294, DOI 10.1161/01.STR.24.2.294; LIU TH, 1989, AM J PHYSIOL, V256, P589; LIU XH, 1994, BRAIN RES, V644, P257, DOI 10.1016/0006-8993(94)91688-8; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; MARTZ D, 1990, J CEREBR BLOOD F MET, V10, P352, DOI 10.1038/jcbfm.1990.64; Moore L E, 1994, Adv Pharmacol, V31, P565, DOI 10.1016/S1054-3589(08)60642-0; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; OLIFF HS, 1995, BRAIN RES, V699, P329, DOI 10.1016/0006-8993(95)01045-W; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; SchmidElsaesser R, 1997, STROKE, V28, P2018, DOI 10.1161/01.STR.28.10.2018; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Soehle M, 1998, STROKE, V29, P1240, DOI 10.1161/01.STR.29.6.1240; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Watson BD, 1998, CELL MOL NEUROBIOL, V18, P581, DOI 10.1023/A:1020209616428; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Zea Longa E. L., 1989, STROKE, V20, P84; Zhao WZ, 1996, STROKE, V27, P1112, DOI 10.1161/01.STR.27.6.1112; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003	36	12	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 11	2000	389	1					79	88		10.1016/S0014-2999(99)00768-2			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	286YH	WOS:000085476100010	10686299				2022-02-06	
J	Milders, M				Milders, M			Naming famous faces and buildings	CORTEX			English	Article						dissociation; proper name retrieval; task difficulty	PROPER NAME ANOMIA; PEOPLES NAMES; ANEMIA	Reports of a dissociation between impaired retrieval of people's names and spared retrieval of other categories of proper names have led to the suggestion that there are separate brain mechanisms for processing different categories of proper names. An alternative explanation states that geographical proper names (e.g. cities, countries) may be spared in patients with proper name anemia because they are easier to retrieve than people's names. Unlike people's names, geographical names are also used as adjectives. However, this explanation can not explain why retrieval of proper names that are never used as adjectives (e.g. buildings) was spared in some patients. This study investigated whether retrieving people's names is equally difficult as retrieving the names of buildings. Results from normal subjects and closed-head injured patients revealed no differences between retrieval of people's names and buildings names, and suggested that both categories of proper names are equally vulnerable to brain injury.	Univ Aberdeen, Dept Psychol, Aberdeen AB24 2UB, Scotland		Milders, M (corresponding author), Univ Aberdeen, Dept Psychol, Aberdeen AB24 2UB, Scotland.		Milders, Maarten/C-5560-2008				BRENNEN T, 1990, MEM COGNITION, V18, P339, DOI 10.3758/BF03197123; CARNEY R, 1993, COGNITIVE NEUROPSYCH, V10, P185, DOI 10.1080/02643299308253460; COHEN L, 1994, J NEUROL NEUROSUR PS, V57, P1283, DOI 10.1136/jnnp.57.10.1283; FERY P, 1995, CORTEX, V31, P191, DOI 10.1016/S0010-9452(13)80117-7; Hanley JR, 1998, CORTEX, V34, P155, DOI 10.1016/S0010-9452(08)70745-7; HARRIS DM, 1995, CORTEX, V31, P575, DOI 10.1016/S0010-9452(13)80068-8; HARRIS DM, 1995, BRIT J PSYCHOL, V86, P345, DOI 10.1111/j.2044-8295.1995.tb02757.x; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HITTMAIRDELAZER M, 1994, NEUROPSYCHOLOGIA, V32, P465, DOI 10.1016/0028-3932(94)90091-4; Lucchelli F, 1997, COGNITIVE NEUROPSYCH, V14, P881, DOI 10.1080/026432997381385; LUCCHELLI F, 1992, CORTEX, V28, P221, DOI 10.1016/S0010-9452(13)80050-0; MCKENNA P, 1980, J NEUROL NEUROSUR PS, V43, P781, DOI 10.1136/jnnp.43.9.781; Milders M, 1999, J CLIN EXP NEUROPSYC, V21, P171, DOI 10.1076/jcen.21.2.171.932; Papagno C, 1998, NEUROPSYCHOLOGIA, V36, P669, DOI 10.1016/S0028-3932(97)00142-5; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; [No title captured]	18	12	12	1	5	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	FEB	2000	36	1					139	145		10.1016/S0010-9452(08)70842-6			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	291MN	WOS:000085740800011					2022-02-06	
J	Potter, DD; Pickles, CD; Roberts, RC; Rugg, MD				Potter, DD; Pickles, CD; Roberts, RC; Rugg, MD			The effect of cholinergic receptor blockade by scopolamine on memory performance and the auditory P3	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						ACh; N1; P2; N2; P300; P3a; P3b ERP; memory; attention; amnesia	EVENT-RELATED POTENTIALS; SINGLE-STIMULUS PARADIGM; MEDIAL TEMPORAL-LOBE; CLOSED HEAD-INJURY; BRAIN POTENTIALS; COGNITIVE POTENTIALS; RECOGNITION MEMORY; ODDBALL TASK; TOPOGRAPHY; LESIONS	previous research has suggested a possible link between the effects of scopolamine-induced muscarinic cholinergic receptor blockade on memory and its effect on auditory P3 amplitude and latency. A potential problem with this hypothesis is that, although scopolamine has been reported to increase P3 latency in both visual and auditory modalities, amplitude reductions have been reported only in the case of auditory P3 at Ct. In the present study, subjects were injected intravenously with 5.7 mu g/kg of scopolamine of saline in a double blind design. A significant reduction in verbal recognition memory performance was observed. This memory impairment was shown to be largely specific to the encoding of verbal material. The drug effect was of equal magnitude when words of either high or low word frequency were used. Auditory P3 was recorded from frontal central and parietal sites along the midline and over left and right hemispheres. In contrast to a number of earlier reports using a similar drug dose, only limited evidence was found of either latency increase or amplitude reduction of the auditory P3. Importantly, two potentially confounding drug-related ERP modulations were observed prior to and during the latency range of the P3. The first was a widespread increase in N2 amplitude and latency preceding the P3. The second was that ERPs became relatively more negative at frontal and central sites in the 200-450 ms latency range in both target and non-target conditions. Whether this effect is the result of an increase in negativity or a reduction in P3a amplitude remains to be determined. Interestingly, ERPs to target stimuli became significantly less positive at frontal sites in the drug condition in the latency range 400-900 ms. This is consistent with recent reports highlighting the importance of frontal regions in normal memory function. Previously hypothesized links between cholinergic receptor blockade, effects on P3 latency and amplitude, and drug-induced memory impairments are discussed in the light of these findings.	Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland; Univ St Andrews, Sch Psychol, St Andrews KY16 9AJ, Fife, Scotland; Univ Dundee, Dept Med, Dundee DD1 4HN, Scotland; Dundee Royal Infirm, Dept Neurol, Dundee, Scotland; Keele Univ, Dept Psychol, Keele, Staffs, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England; UCL, Dept Psychol, London WC1E 6BT, England		Potter, DD (corresponding author), Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland.	d.d.potter@dundee.ac.uk					Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; ALTAFULLAH I, 1986, ELECTROEN CLIN NEURO, V63, P503, DOI 10.1016/0013-4694(86)90138-0; BRANDT D, 1992, WRIT COMMUN, V9, P315, DOI 10.1177/0741088392009003001; CALLAWAY E, 1985, PSYCHOPHARMACOLOGY, V85, P133, DOI 10.1007/BF00428401; CALLAWAY E, 1984, BIOL PSYCHIAT, V19, P649; CALLAWAY E, 1992, BIOL PSYCHOL, V33, P1, DOI 10.1016/0301-0511(92)90002-C; CRAIK F, 1993, 34 ANN M PSYCH SOC W; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V103, P83; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; FRITH CD, 1984, Q J EXP PSYCHOL-A, V36, P133, DOI 10.1080/14640748408401507; GRAHAM JDP, 1979, INTRO HUMAN PHARM; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Johnson R, 1998, COGNITIVE BRAIN RES, V7, P119, DOI 10.1016/S0926-6410(98)00017-2; JORY SH, IN PRESS J PSYCHOPHY; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; KNOPMAN D, 1991, J EXP PSYCHOL LEARN, V17, P1017, DOI 10.1037/0278-7393.17.5.1017; KOPELMAN MD, 1988, BRAIN, V111, P1079, DOI 10.1093/brain/111.5.1079; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MEADOR KJ, 1987, INT J NEUROSCI, V33, P199, DOI 10.3109/00207458708987404; MEADOR KJ, 1989, J CLIN EXP NEUROPSYC, V11, P252, DOI 10.1080/01688638908400887; MEADOR KJ, 1988, ARCH NEUROL-CHICAGO, V45, P465, DOI 10.1001/archneur.1988.00520280119029; MEADOR KJ, 1988, J GERONTOL, V43, pM158, DOI 10.1093/geronj/43.6.M158; MEADOR KJ, 1989, NEUROPSY NEUROPSY BE, V2, P161; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NAUMANN E, 1992, ELECTROEN CLIN NEURO, V83, P254, DOI 10.1016/0013-4694(92)90119-3; Naveh-Benjamin M, 1998, J EXP PSYCHOL LEARN, V24, P1091, DOI 10.1037/0278-7393.24.5.1091; ONOFRJ M, 1992, NEUROLOGY, V42, P1762, DOI 10.1212/WNL.42.9.1762; ONOFRJ M, 1991, ELECTROEN CLIN NEURO, V78, P480, DOI 10.1016/0013-4694(91)90065-C; OTOOLE DM, 1987, PSYCHOPHYSIOLOGY, V24, P487, DOI 10.1111/j.1469-8986.1987.tb00325.x; PINEDA JA, 1992, BRAIN RES BULL, V28, P485, DOI 10.1016/0361-9230(92)90051-X; PINEDA JA, 1991, ELECTROEN CLIN NEURO, P165; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P747, DOI 10.1111/j.1469-8986.1996.tb02371.x; POLICH J, 1993, ELECTROEN CLIN NEURO, V86, P408, DOI 10.1016/0013-4694(93)90136-J; POLSTER MR, 1993, PSYCHOL BULL, V114, P477, DOI 10.1037/0033-2909.114.3.477; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; POTTER DD, 1993, NEW DEVELOPMENTS IN EVENT-RELATED POTENTIALS, P303; POTTER DD, 1992, PSYCHOPHYSIOLOGY, V29, P29, DOI 10.1111/j.1469-8986.1992.tb02007.x; POTTER DD, IN PRESS BIOL PSCHOL; ROBBINS TW, 1995, COGNITIVE NEUROSCIEN, P684; ROGERS RL, 1992, ELECTROEN CLIN NEURO, V83, P146, DOI 10.1016/0013-4694(92)90028-G; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Rugg MD., 1994, COGNITIVE ELECTROPHY, P124, DOI 10.1007/978-1-4612-0283-7%5F5; RUGG MD, 1994, HDB NEUROPSYCHOLOGY, V9; RUSTED JM, 1989, NEUROPSYCHOBIOLOGY, V21, P31, DOI 10.1159/000118548; Sahakian B., 1988, HDB PSYCHOPHARMCOLOG, P393, DOI [10.1007/978-1-4613-0933-8_9, DOI 10.1007/978-1-4613-0933-8_9]; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SMITH ME, 1990, ELECTROEN CLIN NEURO, V76, P235, DOI 10.1016/0013-4694(90)90018-F; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Van Horn JD, 1998, BRAIN RES, V793, P29, DOI 10.1016/S0006-8993(98)00051-1; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANPETTEN C, 1991, J COGNITIVE NEUROSCI, V3, P129; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; WARBURTON DM, 1987, COGNITIVE NEUROCHEMI, P135; Woods DL., 1990, EVENT RELATED BRAIN, P178	66	12	12	0	0	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	ROHNSWEG 25, D-37085 GOTTINGEN, GERMANY	0269-8803			J PSYCHOPHYSIOL	J. Psychophysiol.		2000	14	1					11	23		10.1027//0269-8803.14.1.11			13	Psychology, Biological; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	302LP	WOS:000086366800002					2022-02-06	
J	Smith, RV; Krevitt, L; Yi, SM; Beitler, JJ				Smith, RV; Krevitt, L; Yi, SM; Beitler, JJ			Early wound complications in advanced head and neck cancer treated with surgery and Ir-192 brachytherapy	LARYNGOSCOPE			English	Article; Proceedings Paper	Meeting of the Eastern Section of the American-Laryngological-Rhinological-and-Otological-Society Inc	JAN 29-31, 1999	PROVIDENCE, RHODE ISLAND	Amer Laryngol Rhinol & Otol Soc Inc, Eastern Sect		wound complications; brachytherapy; iridium 192; adjuvant therapy; head and neck cancer	FREE-FLAP RECONSTRUCTION; I-125 SEED IMPLANTATION; INTERSTITIAL RADIOTHERAPY; SALVAGE TREATMENT; RECURRENT HEAD; LOCAL-CONTROL; TUMORS	Objectives: Brachytherapy, either as primary or adjuvant therapy, is increasingly used to treat head and neck cancer. Reports of complications from, the use of brachytherapy as adjuvant therapy to surgical excision have been limited and primarily follow Iodine 125 (I-125) therapy, Early complications include wound breakdown, infection, flap failure, and sepsis, and late complications may include osteoradionecrosis, bone marrow suppression, or carotid injuries. The authors sought to identify the early wound complications that follow adjuvant interstitial brachytherapy with iridium 192 (Ir-192). Study Design: A retrospective chart review of all patients receiving adjuvant brachytherapy at a tertiary medical center over a 4-year period. Methods: Nine patients receiving Ir-192 brachytherapy via afterloading catheters placed during surgical resection for close or microscopically positive margin control were evaluated. It was used during primary therapy in six patients and at salvage surgery in three. Early complications were defined as those occurring within 6 weeks of surgical therapy. Results: The overall complication rate was 55% (5/9), and included significant wound breakdown in two patients, minor wound dehiscence in three, and wound infection, bacteremia, and local tissue erosion in one patient each. All complications occurred in patients receiving Bap reconstruction and one patient required further surgery to manage the complication. Complication rates were not associated with patient age, site, prior radiotherapy, timing of therapy, number of catheters, or dosimetry, Conclusions: The relatively high complication rate is acceptable, given the minor nature of most and the potential benefit of radiotherapy. Further study should be undertaken to identify those patients who will achieve maximum therapeutic benefit without prohibitive local complications.	Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otolaryngol, Bronx, NY 10467 USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Therapy, Bronx, NY 10467 USA; Univ Iowa, Dept Otolaryngol, Iowa City, IA USA		Smith, RV (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otolaryngol, 111 E 210th St, Bronx, NY 10467 USA.						Beitler JJ, 1998, INT J RADIAT ONCOL, V40, P313, DOI 10.1016/S0360-3016(97)00717-7; BILLER HF, 1981, ARCH OTOLARYNGOL, V107, P23; CLOSE LG, 1993, LARYNGOSCOPE, V103, P231; Cornes PGS, 1996, BRIT J SURG, V83, P1620, DOI 10.1002/bjs.1800831141; FEE WE, 1983, ARCH OTOLARYNGOL, V109, P727; FONTANESI J, 1989, INT J RADIAT ONCOL, V17, P365, DOI 10.1016/0360-3016(89)90452-5; LANGLOIS D, 1988, INT J RADIAT ONCOL, V14, P849, DOI 10.1016/0360-3016(88)90004-1; LEE DJ, 1991, RADIOLOGY, V178, P879, DOI 10.1148/radiology.178.3.1994436; MEHRHOF AI, 1983, AM J SURG, V146, P478, DOI 10.1016/0002-9610(83)90235-0; MOSCOSO JF, 1994, ARCH OTOLARYNGOL, V120, P965; PANCHAL JI, 1993, BRIT J PLAST SURG, V46, P511, DOI 10.1016/0007-1226(93)90227-3; PARK RI, 1991, LARYNGOSCOPE, V101, P405; Righi PD, 1997, LARYNGOSCOPE, V107, P1464, DOI 10.1097/00005537-199711000-00008; STAFFORD N, 1988, BRIT J SURG, V75, P62, DOI 10.1002/bjs.1800750123; SYED AMN, 1978, BRIT J RADIOL, V51, P814, DOI 10.1259/0007-1285-51-610-814	15	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-852X			LARYNGOSCOPE	Laryngoscope	JAN	2000	110	1					8	12		10.1097/00005537-200001000-00002			5	Medicine, Research & Experimental; Otorhinolaryngology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	275DY	WOS:000084805200002	10646707	Bronze			2022-02-06	
J	Docking, K; Jordan, FM; Murdoch, BE				Docking, K; Jordan, FM; Murdoch, BE			Interpretation and comprehension of linguistic humour by adolescents with head injury: a case-by-case analysis	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; LANGUAGE PERFORMANCE; CHILDREN; CHILDHOOD; SKILLS	The aim of the present study was to examine the Linguistic humour abilities of a group of adolescents with head injury on a case-by-case basis. Nine adolescents with head injury ag;ed between 12 years 1 month and 15 years 4 months, and nine individually matched adolescents aged between 12 years 1 month and 16 years 1 month were administered a humour test, a standard language battery, the CELF-3, and the Self-Esteem Index. The test of humour abilities required each subject to recognize and select an explanation from a group of three, as to what made each item funny. Items were based on morphological, semantic and syntactic humour elements. Examination of the individual profiles of each subject with head injury illustrated the existence of variability between subjects representing three main trends: reduced humour abilities together with below average language skills; intact humour and language abilities in the presence of mild head injury; and impaired humour ability with concurrent language skills that are within normal limits. This third pattern supports previous studies, which have documented the occurrence of high-level language impairment while language abilities are intact. The present study emphasized the importance of investigating the abilities of individuals who have had a head injury in childhood, within a developmental framework. This perspective serves to highlight the context of contributing aspects that impact on future language development and recovery of injury, such as the time that the injury occurred in a child's development, in addition to injury severity and the time that has elapsed post-injury.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia; Royal Childrens Hosp, Brisbane, Qld 4029, Australia		Murdoch, BE (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012				BERNSTEIN DK, 1986, TOP LANG DISORD, V6, P65, DOI 10.1097/00011363-198609000-00008; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Brown L., 1991, SELF ESTEEM INDEX; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; DENNIS M, 1987, ENCY NEUROSCIENCE, P559; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P89; DOCKING K, IN PRESS BRAIN INJUR; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; HAMERSKY J, 1995, CARTOON CUT UPS TEAC; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; JORDAN FM, 1989, INT J NEUROSCI, V46, P12; LEES JA, 1993, CHILDREN ACQUIRED AP; Lehr E, 1990, PSYCHOL MANAGEMENT T; Nelson C., 1991, PRACTICAL PROCEDURES; Nippold M., 1983, LANG SPEECH HEAR SER, V14, P171, DOI DOI 10.1044/0161-1461.1403.171; NIPPOLD MA, 1985, TOP LANG DISORD, V5, P1, DOI 10.1097/00011363-198506000-00004; Semel E. M., 1995, CLIN EVALUATION LANG; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	29	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	1999	13	12					953	972					20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	264UJ	WOS:000084200600002	10628501				2022-02-06	
J	Garri, JI; Perlyn, CA; Johnson, MJ; Mobley, SR; Shatz, DV; Kirton, OC; Thaller, SR				Garri, JI; Perlyn, CA; Johnson, MJ; Mobley, SR; Shatz, DV; Kirton, OC; Thaller, SR			Patterns of maxillofacial injuries in powered watercraft collisions	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							PERSONAL WATERCRAFT	Because of the widespread popularity of water sports, plastic and reconstructive surgeons can expect to manage an increasing number of injuries associated with these activities, particularly those related to powered watercraft vehicles. Although seat belts for motorists and helmets for motorcyclists may be efficacious, such devices currently do not serve a similar role in powered watercraft sports. In this study, a retrospective chart review of 194 consecutive patients who presented to the University of Miami/Jackson Memorial Hospital (Level I trauma center) as a result of powered watercraft collisions is presented. The purpose of this investigation was to assess the incidence, cause, demographics, and available management options for head and neck injuries secondary to powered watercraft. Identified were 194 patients who presented because of watersports-related injuries during the period January 1, 1991, through December 31, 1996. From this group, 81 patients (41.8 percent) sustained injuries directly attributable to powered watercraft collisions, including 41 personal watercraft collisions (50.6 percent), 39 boat collisions (48.1 percent), and 1 airboat collision (1.2 percent). The patient population, as expected, tended to be young and male with an average age of 29 years (range, 8 to 64 years old). Interestingly, 41 of the patients (50.6 percent) who presented to this trauma center as a result of powered watercraft collisions also sustained associated head and neck trauma. Of 74 injuries 24 were facial fractures (32.4 percent), 18 were facial lacerations (24.3 percent), 14 were closed head injuries (18.9 percent), 8 were skull fractures (10.8 percent), 4 were scalp lacerations (5.4 percent), 4 were C-spine fractures (5.4 percent), 1 was an ear laceration (1.4 percent), and 1 was a fatality (1.4 percent). Le Fort fractures were the most commonly identified facial fracture in this series. The number of these injuries seen in hospital emergency rooms will most likely increase in the future as the popularity of water-related recreational activities becomes even more widespread. Based on these findings, it is strongly recommended that future efforts be directed toward the prevention of these injuries through patient education and the eventual development of efficacious and safe protective equipment.	Univ Miami, Sch Med, Jackson Mem Hosp, Dept Otolaryngol,Div Plast Surg, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Trauma Crit Care, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Plast & Reconstruct Surg, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Oral & Maxillofacial Surg, Miami, FL 33101 USA		Garri, JI (corresponding author), Univ Miami, Sch Med, Jackson Mem Hosp, Dept Otolaryngol,Div Plast Surg, POB 016968 R-88, Miami, FL 33101 USA.		Thaller, Seth/AAO-1801-2020				*AM DENT ASS HOUS, 1995, RES 80H; Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; *CAN HOSP INJ REP, INJ ASS PERS POW WAT; GOMEZ GA, 1991, SURG CLIN N AM, V71, P419; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Jeffery R S, 1991, Br J Sports Med, V25, P232; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; *NAT YOUTH SPORTS, 1992, DENT INJ FACT SHEET; PeekAsa C, 1997, ANN EMERG MED, V29, P630, DOI 10.1016/S0196-0644(97)70252-X; Shatz D V, 1997, J Fla Med Assoc, V84, P458; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; *US DEP TRANSP, 1988, BOAT STAT 1986; VERNBERG D, 1989, JAMA-J AM MED ASSOC, V261, P1883, DOI 10.1001/jama.1989.03420130045021; WOODMANSEY KF, 1997, J AM COLL HLTH, V45, P178	14	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052			PLAST RECONSTR SURG	Plast. Reconstr. Surg.	SEP	1999	104	4					922	927		10.1097/00006534-199909040-00005			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	231HN	WOS:000082302500005	10654729				2022-02-06	
J	Hendler, T; Goshen, E; Tadmor, R; Lustig, M; Zwas, ST; Zohar, J				Hendler, T; Goshen, E; Tadmor, R; Lustig, M; Zwas, ST; Zohar, J			Evidence for striatal modulation in the presence of fixed cortical injury in obsessive-compulsive disorder (OCD)	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						head injury; cortical lesions; single photon emission computerised tomography (SPECT); computerized tomography (CT); magnetic resonance imaging (MRI); neural circuit	TRAUMATIC BRAIN INJURY; BASAL GANGLIA; BEHAVIORAL-CHANGES; SPECT; TOMOGRAPHY; PERFUSION; THERAPY; LESIONS; DRUG	A patient with obsessive-compulsive disorder (OCD) onset resulting from a traumatic head injury underwent longitudinal brain imaging evaluation. Structural and functional brain imaging studies were repeatedly performed before and after treatment. Computerized tomography (CT) demonstrated bilateral prefrontal contusions immediately following the trauma and prior to the onset of OCD. Magnetic resonance imaging (MRI) demonstrated bilateral cortical abnormalities in the prefrontal and anterior-temporal regions a few months following the onset of OCD. Almost concurrently, single photon emission computerised tomography (SPECT) demonstrated bilateral perfusion deficits in fronto-temporal regions, and asymmetric increased perfusion in the anterior striatum. Six months later, after clinical improvement, a second SPECT study demonstrated improvement of brain perfusion, mostly in the striatum. The reflection of these results on a possible model of brain pathogenesis in OCD, and the role of brain imaging in neuropsychiatric evaluation, are demonstrated. (C) 1999 Elsevier Science B.V./ECNP. All rights reserved.	Chaim Sheba Med Ctr, Dept Psychiat, IL-52621 Tel Hashomer, Israel; Sackler Sch Med, Dept Nucl Med, Tel Aviv, Israel; Tel Aviv Univ, Dept Imaging, IL-69978 Tel Aviv, Israel		Hendler, T (corresponding author), Chaim Sheba Med Ctr, Dept Psychiat, IL-52621 Tel Hashomer, Israel.	talma@tasmc.health.gov.il	hendler, talma/C-7677-2012				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AMES D, 1994, J NEUROPSYCH CLIN N, V6, P100; BAXTER LR, 1992, PSYCHIAT CLIN N AM, V15, P871; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; DONOVAN NJ, 1994, AM J PSYCHIAT, V151, P618; EBLEN F, 1995, J NEUROSCI, V15, P5999; GOSHEN E, 1994, EUR J NUCL MED, V21, pS70; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; HOEHNSARIC R, 1994, CURRENT INSIGHTS OCD; HOLMAN BL, 1992, J NUCL MED, V33, P1888; ICHISE M, 1994, J NUCL MED, V35, P217; INSEL TR, 1992, ARCH GEN PSYCHIAT, V49, P739; KIM JS, 1977, BRAIN RES, V132, P370, DOI 10.1016/0006-8993(77)90430-9; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LUXENBERG JS, 1988, AM J PSYCHIAT, V145, P1089; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; MOLINA V, 1995, J NUCL MED, V36, P2234; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; RAPOPORT JL, 1988, PSYCHOPHARMACOL BULL, V24, P380; ROGERS MP, 1994, PSYCHOSOMATICS, V35, P402, DOI 10.1016/S0033-3182(94)71763-1; SCARONE S, 1994, PSYCHIAT RES, V45, P115; SCATTON B, 1982, BRAIN RES, V232, P331, DOI 10.1016/0006-8993(82)90277-3; SIMPSON S, 1995, BRIT J PSYCHIAT, V166, P390, DOI 10.1192/bjp.166.3.390; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; TIKOFSKY RS, 1994, J NUCL MED, V35, P227; VILLABLANCA JR, 1976, EXP NEUROL, V52, P389, DOI 10.1016/0014-4886(76)90213-2; VOLKOW ND, 1991, AM J PSYCHIAT, V148, P439	31	12	12	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	SEP	1999	9	5					371	376					6	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	244RK	WOS:000083064400001	10523043				2022-02-06	
J	McNair, ND				McNair, ND			Traumatic brain injury	NURSING CLINICS OF NORTH AMERICA			English	Article							CEREBRAL BLOOD-FLOW; ARTERIOVENOUS OXYGEN DIFFERENCE; CLOSED HEAD-INJURY; COMATOSE PATIENTS; INTRACRANIAL HYPERTENSION; PRACTICAL SCALE; METABOLISM; AGITATION; ALCOHOL	Every year, approximately 7 million people sustain some type of traumatic brain injury (TBI) in the United States. Of these, approximately 500,000 require hospitalization.(24) Another 100,000 are permanently disabled and approximately 2000 remain in a persistent vegetative state.(16) The societal cost of care for the survivors of TBI is estimated to be between $48 and $83.5 billion annually. Of patients admitted to the emergency room, more than 50% have high alcohol or drug levels. Most individuals are men younger than 30 years of age.(24) TBIs can change the lives of patients and their families significantly. Motor vehicle accidents, falls, assault, or sports injury can result in TBI. Injury may be classified based on severity, location, mechanism, Glasgow Coma Scale (GCS) score, or the results of neuroimaging studies.(16,24) The purpose of this article is to describe TBIs, treatment options, multidisciplinary management, and expected outcomes. Severity of injury is based on the postresuscitation GCS.(33) A GCS Of 13 to 15 is considered a mild injury, 8 to 12 is a moderate injury, and less than 8 is a severe brain injury (Fig. 1). A mild head. injury may include transient signs and symptoms such as unsteady gait or mild confusion. Most patients seen in the emergency room have mild head injuries.(24) Most patients make a full recovery, but others may have postinjury sequelae such as a postconcussion syndrome for a few weeks to a few months. In postconcussion syndrome, patients complain of headache, difficulty concentrating, short-term memory deficits, depression, anxiety, irritability, and fatigue. These symptoms are often not appreciated initially until difficulty with work or school is encountered and medical attention is sought.	Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Med Ctr, Liver Transplant & Surg Subspecialties Intens Car, Los Angeles, CA 90024 USA		McNair, ND (corresponding author), 2307 Ocean Ave,215, Los Angeles, CA 90045 USA.						ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; *BRAIN TRAUM FDN, 1995, GUID MAN SEV HEAD IN; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; *COMM TRAUM AM COL, 1993, ADV TRAUM LIF SUPP C; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; CRUZ J, 1998, NEUROLOGIC NEUROSURG, P405; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; GOTOH F, 1965, ARCH NEUROL-CHICAGO, V12, P410, DOI 10.1001/archneur.1965.00460280080008; HAYEK DA, 1992, CRITICAL CARE, P1449; HICKEY JV, 1997, CLIN PRACTICE NEUROL, P385; JENNETT B, 1976, LANCET, V1, P1031; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PETERSON PL, 1998, NEUROLOGICAL NEUROSU, P1; *RANCH LOS AM HOSP, 1980, REH HEAD INJ AD; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SANDEL ME, 1998, NEUROLOGICAL NEUROSU, P503; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; TEASDALE G, 1974, LANCET, V2, P81; *UN DAT SYST MED R, 1989, FUNCT IND MEAS FIM G; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581	35	12	15	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0029-6465			NURS CLIN N AM	Nurs. Clin. North Am.	SEP	1999	34	3					637	+					25	Nursing	Social Science Citation Index (SSCI)	Nursing	235BM	WOS:000082519100008	10433652				2022-02-06	
J	Cossa, FM; Fabiani, M; Farinato, A; Laiacona, M; Capitani, E				Cossa, FM; Fabiani, M; Farinato, A; Laiacona, M; Capitani, E			The 'preliminary neuropsychological battery'. An instrument to grade the cognitive level of minimally responsive patients	BRAIN INJURY			English	Article							HEAD-INJURED PATIENTS; TRAUMATIC BRAIN INJURY; ATTENTIONAL DEFICITS; COMA; IMPAIRMENT; SCORES; SCALE; TOOL	An early, formalized cognitive evaluation of 'minimally responsive' patients could be important in the planning of their care and rehabilitation as well as in providing a realistic prognosis and studying the modality of the cognitive recovery. A shea, bedside, neuropsychologically-oriented test-battery, the Preliminary Neuropsychological Battery, a psychometric tool which enables the cognitive evaluation of these patients and of patients unable to give verbal or complex motor answers, has been devised. The BNP was administered to a sample of 40 head-injured patients and to a sample of 34 healthy subjects. The aim was (i) to evaluate its usefulness, and (ii) to study its correlation with cortical functions as assessed by a more extensive battery. The findings suggest that the BNP is useful for assessing the general cognitive level of head-injured post-comatose patients. It was able to detect patients deserving a wider, analytic, neuropsychological assessment. Attentional defects emerged as an important variable determining the BNP score.	Rehabil Inst Veruno, Salvatore Maugeri Fdn IRCCS, Dept Neurol, Neuropsychol Unit, I-28010 Veruno, NO, Italy; Rehabil Inst Veruno, Salvatore Maugeri Fdn IRCCS, Psychol Serv, I-28010 Veruno, NO, Italy; Univ Milan, San Paolo Hosp, Clin Nervous Dis, Milan, Italy		Cossa, FM (corresponding author), Rehabil Inst Veruno, Salvatore Maugeri Fdn IRCCS, Dept Neurol, Neuropsychol Unit, I-28010 Veruno, NO, Italy.	fcossa@fsm.it		Fabiani, Monica/0000-0002-7579-2773			ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; BARBAROTTO R, 1999, ASSISTENZA CLIN RICE, P29; Basso A, 1987, Funct Neurol, V2, P189; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; CAPITANI E, 1988, DEV NEUROPSYCHOL, V4, P325, DOI 10.1080/87565648809540416; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Flannery J, 1993, West J Nurs Res, V15, P465, DOI 10.1177/019394599301500406; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Guilford J. P., 1965, FUNDAMENTAL STAT PSY, V4th; HAJEK VE, 1989, ARCH PHYS MED REHAB, V70, P114; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; MALKMUS D, 1980, COGNITIVE ASSESSMENT, P1; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; Novelli GLM, 1986, ARCH PSICOL NEUROL P, V2, P278; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P621, DOI 10.1016/S0003-9993(97)90428-7; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Spreen O., 1983, CONTRIBUTION NEUROPS; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Walker WC, 1996, BRAIN INJURY, V10, P65; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5	34	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	1999	13	8					583	592					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	239YW	WOS:000082799200003	10901687				2022-02-06	
J	Beaumont, A; Marmarou, A				Beaumont, A; Marmarou, A			Treatment of raised intracranial pressure following traumatic brain injury	CRITICAL REVIEWS IN NEUROSURGERY			English	Article						refractory intracranial pressure (ICP) management; vasopressors; mannitol; glycerol; hypertonic saline; bifrontal craniectomy	EDEMA; THERAPY; SALINE	Appropriate treatment of raised intracranial pressure (ICP) after traumatic brain injury (TBI) remains a controversial topic in neurotraumatology. Several techniques are employed clinically, which include vasopressors, osmotically active substances, hyperventilation, and decompressive surgery. This article reviews six recent papers that have examined alternative methods of treating elevated ICP. The first two papers consider a new and controversial alternative to cerebral perfusion pressure (CPP) management, which involves mild hypotension coupled with pre-capillary vasoconstriction using dihydroergotamine. The authors claim success with this treatment, and although the patient numbers are small, there is no evidence that they fare any less well than patients treated with conventional techniques. The third and fourth papers consider hypertonic saline (HTS) as a possible osmotic treatment for raised ICP. The third examines HTS given as a 23.4% bolus and found beneficial effects. The fourth examines HTS as a 1.6% constant infusion for fluid replacement and found that patients fared less well. The reason for this difference between the results for the two administration methods is unknown, although it may relate to the triggering of body homeostatic mechanisms in the case of constant infusion. The fifth paper compares glycerol and mannitol as osmotic ICP agents and found no significant differences between them. The final study reports for the first time a series of patients treated for refractory elevations in ICP with bifrontal craniectomy. They report good results, and suggest that this therapy should be formalized as a treatment option for severely elevated ICP. The pathophysiological mechanisms underlying the generation of a raised ICP belie the use of one therapy to treat all cases. Analysis of these studies demonstrates how problematic heterogeneity in the injury population can be for the assessment of possible treatments. It is clear, therefore, that effective analysis of treatments for raised ICP requires appropriate subdivision of the injured population into common pathophysiological processes and, furthermore, that the future of clinical TBI management may well require a similar stratification in order to tailor treatments for the individual patient.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA				Beaumont, Andrew/AAJ-7457-2020				ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038	6	12	12	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0939-0146			CRIT REV NEUROSURG	Crit. Rev. Neurosurg.	JUL	1999	9	4					207	216		10.1007/s003290050135			10	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	223PK	WOS:000081849300002	10436209				2022-02-06	
J	Schwab, S; Schwarz, S; Bertram, M; Spranger, M; Hacke, W				Schwab, S; Schwarz, S; Bertram, M; Spranger, M; Hacke, W			Benefit and side effects of moderate hypothermia in the therapy of malignant MCA infarction	NERVENARZT			German	Article						brain edema; hypothermia; therapy	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; RATS; COAGULATION; ARREST; STROKE; EDEMA	Moderate hypothermia was induced in 30 patients with malignant middle cerebral artery (MCA) territory infarction. Patients were kept at 33 degrees C body-core temperature for 48 to 72 h, and ICP, CPP, and brain temperature were monitored. Outcome at 4 weeks and at 3 months after the stroke as well as side effects of moderate hypothermia were analysed. Mortality of malignant MCA infarction could be reduced from 80% in historical controls, to 43% (13/30) under hypothermia. During hypothermia elevated ICP values could be significantly reduced. Herniation due to a secondary rise of ICP after rewarming was the cause of death in all 13 patients. The most frequent complication of moderate hypothermia was pneumonia in 12 of the 30 patients (40%). Other severe side effects of hypothermia could not be detected. Moderate hypothermia may improve clinical outcome in patients with malignant MCA infarction.	Heidelberg Univ, Neurol Klin, D-69120 Heidelberg, Germany		Schwab, S (corresponding author), Heidelberg Univ, Neurol Klin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.		Hacke, Werner/ABE-8661-2020				[Anonymous], 1985, Stroke, V16, P885; AOYAGI M, 1975, CIRCULATION, V52, P52; AUSMAN JI, 1993, J NEUROSURG, V79, P810, DOI 10.3171/jns.1993.79.6.0810; BERRY RG, 1957, NEUROLOGY, V7, P223, DOI 10.1212/WNL.7.4.223; BIGGAR WD, 1983, INFECT IMMUN, V40, P708, DOI 10.1128/IAI.40.2.708-712.1983; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BOUNDS JV, 1981, STROKE, V12, P474, DOI 10.1161/01.STR.12.4.474; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; CHIARA O, 1987, CRIT CARE MED, V15, P995, DOI 10.1097/00003246-198711000-00001; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; COIMBRA C, 1994, ACTA NEUROPATHOL, V87, P325, DOI 10.1007/bf00313599; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; DUGUID H, 1961, LANCET, V2, P1213; FOULIS AK, 1982, J CLIN PATHOL, V35, P1244, DOI 10.1136/jcp.35.11.1244; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HAYASHI N, 1994, ACTA NEUROCHIR, P541; HERVEY GR, 1973, P ROY SOC MED, V66, P1053, DOI 10.1177/003591577306601034; HIRANO T, 1992, BRIT J SURG, V79, P803, DOI 10.1002/bjs.1800790832; KARIBE H, 1994, J NEUROSURG, V80, P112, DOI 10.3171/jns.1994.80.1.0112; MAHONEY F I, 1965, Md State Med J, V14, P61; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; MORALES P, 1957, ANN SURG, V145, P488, DOI 10.1097/00000658-195704000-00005; RANKIN J, 1957, Scott Med J, V2, P200; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; RUIZSANTANA S, 1987, CRIT CARE MED, V15, P930, DOI 10.1097/00003246-198710000-00007; Safar P, 1996, CRIT CARE MED, V24, P911, DOI 10.1097/00003246-199606000-00004; Schwab S, 1996, AKTUEL NEUROL, V23, P155, DOI 10.1055/s-2007-1017853; SCHWAB S, 1994, NERVENARZT, V65, P828; Schwab S, 1998, ACT NEUR S, V71, P131; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; TEASDALE G, 1976, LANCET, V1, P484; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; WHITE OB, 1979, STROKE, V10, P743, DOI 10.1161/01.STR.10.6.743; YOSHIHARA H, 1985, THROMB RES, V37, P503, DOI 10.1016/0049-3848(85)90096-9	47	12	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	JUN	1999	70	6					539	+		10.1007/s001150050477			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	206ZJ	WOS:000080910500009	10412699				2022-02-06	
J	Crowe, SF; Ponsford, J				Crowe, SF; Ponsford, J			The role of imagery in sexual arousal disturbances in the male traumatically brain injured individual	BRAIN INJURY			English	Article								Over 50% of individuals who suffer traumatic brain injury (TBI) demonstrate a decrease in sexual arousal posl-injury. This study investigated the basis of this loss and hypothesized that it occurred as a consequence of the effect of the injury on cognition: specifically, diminution of the ability to form and manipulate sexually arousing imagery. The study compared 14 male participants who identified themselves as having alteration in sexual functioning following traumatic brain injury with a further 14 non-brain injured participants, case matched to them for age and education. All TBI participants were assessed after 2 years following injury, and had had a loss of consciousness of 3 days or greater. The results indicated that the two groups differed in terms of their performance on the Bett's QMI Scale, the Gordon Test of Visual Imagery Control, the Vividness of Sexual Imagery Scale of the Imaginal Processes Inventory, the State Trait Anxiety Inventory, and the Beck Depression Inventory. After correction for the level of depression by analysis of covariance, the TBI participants still featured lower levels of performance on the Sexual Imagery sub-scale of the Imaginary Processes Inventory. The results indicate that sexual arousal disturbances may exist above and beyond the disturbances to affect associated with the psychosocial effects of the TBI.	La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia; Bethesda Hosp, Richmond, Vic, Australia		Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia.			Crowe, Simon/0000-0002-4407-8542			Beck AT, 1987, BECK DEPRESSION INVE; BRECHER J, 1977, INT J HEALTH SERV, V7, P89, DOI 10.2190/NBK8-VL8W-ADHV-JKTC; Britton KR, 1998, BRAIN INJURY, V12, P703, DOI 10.1080/026990598122269; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; GARDEN F, 1990, J HEAT TRAUMA REHABI, V5, P53; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; KAUFMAN DM, 1981, CLIN NEUROLOGY PSYCH, P257; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; MEDLAR T, 1990, J HEAD TRAUMA REHAB, V5, P46; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Hara CC, 1991, REHABILITATION BRAIN; Richardson A., 1969, MENTAL IMAGERY; SEAGRAVES RT, 1996, NEUROPSYCHIATRY, P757; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; SMITH D, 1990, ARCH SEX BEHAV, V19, P477, DOI 10.1007/BF02442349; SMITH D, 1987, ARCH SEX BEHAV, V16, P395, DOI 10.1007/BF01541422; Spielberger CD., 1983, STATE TRAIT ANXIETY; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; Zinn W M, 1981, Int Rehabil Med, V3, P18	24	12	13	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1999	13	5					347	354					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	200LE	WOS:000080541100003	10367145				2022-02-06	
J	Andersen, G; Stylsvig, M; Sunde, N				Andersen, G; Stylsvig, M; Sunde, N			Citalopram treatment of traumatic brain damage in a 6-year-old boy	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; child; citalopram; crying; motor paresis; serotonin; sleep	INJURY; DEPRESSION	Traumatic brain damage may cause acute emotional symptoms such as uncontrolled crying, apathy, and sleep problems. Rehabilitation may be less effective in patients afflicted by these symptoms. Citalopram, a selective serotonin reuptake inhibitor (SSRI), has a documented immediate and dramatic effect on pathological crying in stroke patients. The present case history of a 6-year-old boy with a traumatic right-sided hemorrhage in the basal ganglia indicates that early SSRI treatment has a dramatic effect on pathological crying and in addition may have a concomitant beneficial effect on motor paresis, sleep disturbance, and neurobehavioral problems.	Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Neuropsychol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark		Andersen, G (corresponding author), Aarhus Univ Hosp, Dept Neurol F, Norrebrogade 44, DK-8000 Aarhus, Denmark.			Andersen, Grethe/0000-0001-6807-2500			ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HYTTEL J, 1994, INT CLIN PSYCHOPHARM, V9, P19, DOI 10.1097/00004850-199403001-00004; KORKMAN M, 1993, NEPSY NEUROPSYCHOLOG; MELTZER HY, 1987, PSYCHOPHARMACOLOGY 3, P513; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Noble S, 1997, CNS DRUGS, V8, P410, DOI 10.2165/00023210-199708050-00009; Poeck K., 1985, HDB CLIN NEUROLOGY, V45, P219; *PSYCH CORP, 1949, WECHSL INT SCAL CHIL; REIS DJ, 1973, BRAIN RES, V57, P307, DOI 10.1016/0006-8993(73)90139-X; Role LW, 1991, PRINCIPLES NEURAL SC, P683; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; WELCH KMA, 1977, STROKE, V8, P341, DOI 10.1161/01.STR.8.3.341	16	12	14	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1999	16	4					341	344		10.1089/neu.1999.16.341			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	190AM	WOS:000079939400007	10225220				2022-02-06	
J	Guan, DW; Ohshima, T; Jia, JT; Kondo, T; Li, DX				Guan, DW; Ohshima, T; Jia, JT; Kondo, T; Li, DX			Morphological findings of 'cardiac concussion' due to experimental blunt impact to the precordial region	FORENSIC SCIENCE INTERNATIONAL			English	Article						non-penetrating cardiac trauma; cardiac concussion; immunohistochemistry; myoglobin; lanthanum; creatine kinase	MYOCARDIAL CONTUSION; COMMOTIO-CORDIS; SPORTS ACTIVITIES; CHEST; TRAUMA; DEATH; ARREST	The dog's precordial region at the sternum was impacted with a mechanical elastic-cord propelled impactor at the velocity of 8.0 m/s. The left and right intraventricular pressures and electrocardiogram (ECG) were monitored continuously for 60 min after the impact. The micro- and ultra-structure of myocardium were examined. Localization of myocardial myoglobin (Mb), creatine kinase BE (CK-BB) and creatine kinase MM (CK-MM) as well as plasma membrane permeability were studied by immunohistochemical and lanthanum probe techniques. Upon the impact, abrupt over-pressures within both ventricles were recorded with transient depression of the left ventricular systolic pressure. In all the dogs, some rhythm- and conduction-disorders were noted, which lasted transiently and resumed to normal sinus rhythm. At autopsy, no gross injuries of the heart were detected, and microscopic examination showed no visible myocardial lesions. However, immunohistochemically, focal patchy loss of myocardial Mb, CK-BB and CK-MM was identified with scattered deposition of these substances between myocardial fibers elsewhere. Such changes as relaxed myofibrils with widened I band, contracted myofibrils and broken cristae of the mitochondria were observed in myocardial ultrastructure. Lanthanum particles deposited inside the mitochondria. These results indicate that increase in cardiac cell membrane permeability and ultrastructural damage in myocardium may be involved even in cardiac concussion. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Kanazawa Univ, Fac Med, Sch Med, Dept Legal Med, Kanazawa, Ishikawa 9208640, Japan; China Med Univ, Fac Forens Med, Dept Forens Pathol, Shenyang 110001, Peoples R China		Ohshima, T (corresponding author), Kanazawa Univ, Fac Med, Sch Med, Dept Legal Med, Takara-machi 13-1, Kanazawa, Ishikawa 9208640, Japan.			Kondo, Toshikazu/0000-0002-5059-8309			ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; AKENSIDE M, 1983, JAMA-J AM MED ASSOC, V250, P2189; ANDERSON AE, 1975, J TRAUMA, V15, P237, DOI 10.1097/00005373-197503000-00011; Dickman Gerald L, 1978, Phys Sportsmed, V6, P85, DOI 10.1080/00913847.1978.11948393; EDLICH R F JR, 1987, Journal of Emergency Medicine, V5, P181, DOI 10.1016/0736-4679(87)90176-4; FABIAN TC, 1988, J TRAUMA, V28, P50, DOI 10.1097/00005373-198801000-00007; FRAZEE RC, 1986, J TRAUMA, V26, P510, DOI 10.1097/00005373-198606000-00004; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; HOFFSTEIN S, 1975, AM J PATHOL, V79, P207; JANSSEN W, 1984, FORENSIC HISTOPATHOL, P192; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; KAROFSKY PS, 1990, PHYSICIAN SPORTSMED, V18, P99, DOI 10.1080/00913847.1990.11709976; Kissane RW, 1937, ANN INTERN MED, V11, P907, DOI 10.7326/0003-4819-11-6-907; KULBS H, 1908, VERH DTSCH PATH GES, V12, P172; LIEDTKE AJ, 1974, AM J PHYSIOL, V226, P377, DOI 10.1152/ajplegacy.1974.226.2.377; LINDSEY D, 1978, CHEST, V74, P15, DOI 10.1378/chest.74.1.15; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Moritz AR, 1938, ARCH PATHOL, V25, P445; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; Viano DC, 1992, CLIN J SPORT MED, V2, P166; VIANO DC, 1992, CLIN J SPORT MED, V2, P161	25	12	13	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	MAR 29	1999	100	3					211	220		10.1016/S0379-0738(99)00002-X			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	194MW	WOS:000080199000005	10423847				2022-02-06	
J	Milovanovic, AV; DiMaio, VJM				Milovanovic, AV; DiMaio, VJM			Death due to concussion and alcohol	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						concussion; brain injuries; alcohol; blunt trauma; apnea; death		We encountered 5 deaths following blunt trauma to the face and head in which the injuries were predominantly soft tissue in nature with absence of skull fractures, intracranial bleeding, or detectible injury to the brain. All individuals were intoxicated, with blood ethanol levels ranging from 0.22 to 0.33 g/dl. We feel that in these deaths, ethanol augmentation of the effects of concussive brain injury, with resultant posttraumatic apnea, was the mechanism of death.	Beth Israel Med Ctr, New York, NY 10003 USA		Milovanovic, AV (corresponding author), Beth Israel Med Ctr, 1st Ave & 16th St, New York, NY 10003 USA.						BECKER DP, 1987, ENCY NEUROSCIENCE, V1, P174; DiMaio D., 1989, FORENSIC PATHOLOGY; Gennarelli TA, 1993, HEAD INJURY, P137; LEVINE JE, 1979, NEW ENGL J MED, V301, P109; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	7	12	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	1999	20	1					6	9		10.1097/00000433-199903000-00002			4	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	181QR	WOS:000079453800002	10208327				2022-02-06	
J	Audouy, S; Mallet, J; Privat, A; Ribotta, MGY				Audouy, S; Mallet, J; Privat, A; Ribotta, MGY			Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis	GLIA			English	Article						gene therapy; adenovirus; herpes simplex thymidine kinase; astrocytes; reactive gliosis	HERPES-SIMPLEX VIRUS; FIBRILLARY ACIDIC PROTEIN; THYMIDINE KINASE GENE; EXPERIMENTAL BRAIN-TUMORS; SPINAL-CORD; RECOMBINANT RETROVIRUS; SIALOSYL CHOLESTEROL; EXPERIMENTAL GLIOMAS; ASTROGLIAL RESPONSE; MESSENGER-RNA	Adenovirus-mediated herpes simplex thymidine kinase/ganciclovir (HSV-tk/GCV) system has been demonstrated to be efficient for the treatment of experimental brain tumors. However, no study has been directed to the elimination of proliferating cellular populations in other pathological conditions. In this study we used this suicide gene approach in a primary culture of astrocytes, as a model of reactive gliosis, in order to evaluate its efficiency as a therapeutic strategy for post-traumatic astrogliosis in vivo. First, we evaluated the peak of astrocytic proliferation to characterize our model. Second, the efficiency of adenovirus-mediated lacZ gene transfer is shown to be dependent on vector multiplicity of infection (MOI). As expected, the cells transfected with the HSV-tk gene showed an increase in sensibility to GCV compared with cells transfected with lacZ gene. Finally, an unexpected interaction between the adenoviral vector and bromodeoxyuridine (BrdU) or [H-3]-Thymidine ([H-3]-Thy) was evidenced in transfected cultures, whose interpretation is discussed. The present study demonstrates that a recombinant adenoviral vector carrying the th gene confers to in vitro cultured astrocytes a cytotoxic sensibility to GCV, and that this system constitutes a potentially efficient tool to eliminate the hyperplasia of astrocytes following injury to the central nervous system in vivo. (C) 1999 Wiley-Liss, Inc.	Univ Montpellier 2, INSERM U336, DPVSN, F-34095 Montpellier, France; CNRS C 9923, Lab Mixte Rhone Poulenc Rorer, Paris, France		Privat, A (corresponding author), Univ Montpellier 2, INSERM U336, DPVSN, Pl E Bataillon,BP 106, F-34095 Montpellier, France.	u336@univ-montp2.fr					ABEDOHMAE S, 1990, NEUROCHEM INT, V17, P93, DOI 10.1016/0197-0186(90)90072-2; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BALZARINI J, 1993, J BIOL CHEM, V268, P6332; BALZARINI J, 1995, GENE THER, V2, P317; BI WL, 1993, HUM GENE THER, V4, P725, DOI 10.1089/hum.1993.4.6-725; BIGNAMI A, 1989, INT J DEV NEUROSCI, V7, P343, DOI 10.1016/0736-5748(89)90056-7; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Bignami Amico, 1995, P843; BOHMAN C, 1994, J BIOL CHEM, V269, P8036; BOVIATSIS EJ, 1994, HUM GENE THER, V5, P183, DOI 10.1089/hum.1994.5.2-183; BROWN JO, 1947, J COMP NEUROL, V87, P131, DOI 10.1002/cne.900870204; CARLSTEDT T, 1985, NEUROSCIENCE, V15, P507, DOI 10.1016/0306-4522(85)90229-5; CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; CHEN CY, 1995, HUM GENE THER, V6, P1467, DOI 10.1089/hum.1995.6.11-1467; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; CHEN SH, 1994, P NATL ACAD SCI USA, V91, P3054, DOI 10.1073/pnas.91.8.3054; COLAK A, 1995, HUM GENE THER, V6, P1317, DOI 10.1089/hum.1995.6.10-1317; COLAK A, 1995, BRAIN RES, V691, P76, DOI 10.1016/0006-8993(95)00616-X; COLOMBO BM, 1995, HUM GENE THER, V6, P763, DOI 10.1089/hum.1995.6.6-763; COULDWELL WT, 1990, J NEUROSURG, V73, P594, DOI 10.3171/jns.1990.73.4.0594; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; CULVER KW, 1995, BRIT MED BULL, V51, P192, DOI 10.1093/oxfordjournals.bmb.a072946; CULVER KW, 1994, COLD SPRING HARB SYM, V59, P685, DOI 10.1101/SQB.1994.059.01.079; Elion G B, 1980, Adv Enzyme Regul, V18, P53, DOI 10.1016/0065-2571(80)90008-4; FREEMAN SM, 1993, CANCER INVEST, V11, P676, DOI 10.3109/07357909309046941; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GOLDMAN JE, 1984, J NEUROCHEM, V42, P175, DOI 10.1111/j.1471-4159.1984.tb09714.x; Goodman JC, 1996, HUM GENE THER, V7, P1241, DOI 10.1089/hum.1996.7.10-1241; HANCOCK MB, 1982, J HISTOCHEM CYTOCHEM, V30, P578; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HORELLOU P, 1995, RESTOR NEUROL NEUROS, V8, P63, DOI 10.3233/RNN-1995-81214; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; ISACSON O, 1987, NEUROSCIENCE, V20, P1043, DOI 10.1016/0306-4522(87)90262-4; IshiiMorita H, 1997, GENE THER, V4, P244, DOI 10.1038/sj.gt.3300379; ITO J, 1994, J NEUROCHEM, V62, P235; ITO J, 1993, J NEUROCHEM, V61, P80, DOI 10.1111/j.1471-4159.1993.tb03539.x; Izquierdo M, 1996, GENE THER, V3, P491; IZQUIERDO M, 1995, GENE THER, V2, P66; KRAMM CM, 1995, BRAIN PATHOL, V5, P345, DOI 10.1111/j.1750-3639.1995.tb00615.x; KREMER EJ, 1995, BRIT MED BULL, V51, P31, DOI 10.1093/oxfordjournals.bmb.a072951; LE GLS, 1993, SCIENCE, V259, P988; LINDSAY RM, 1986, ASTROCYTES, P231; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; LOWENSTEIN PR, 1995, GENETIC MANIPULATION, P1; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; Maron A, 1996, GENE THER, V3, P315; Maron A, 1997, GENE THER, V4, P25, DOI 10.1038/sj.gt.3300353; MATSUOKA Y, 1992, EMBO J, V11, P2895, DOI 10.1002/j.1460-2075.1992.tb05358.x; MOOLTEN FL, 1986, CANCER RES, V46, P5276; MOOLTEN FL, 1990, J NATL CANCER I, V82, P297, DOI 10.1093/jnci/82.4.297; Nathaniel EJ., 1981, ADV CELLULAR NEUROBI, P249, DOI [10.1016/B978-0-12-008302-2.50012-2, DOI 10.1016/B978-0-12-008302-2.50012-2]; NEVE RL, 1993, TRENDS NEUROSCI, V16, P251, DOI 10.1016/0166-2236(93)90174-K; NOETZEL MJ, 1990, J NEUROSCI RES, V27, P184, DOI 10.1002/jnr.490270208; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; PEREZCRUET MJ, 1994, J NEUROSCI RES, V39, P506, DOI 10.1002/jnr.490390417; Privat Alain, 1995, P3; QIAN C, 1995, HEPATOLOGY, V22, P118, DOI 10.1002/hep.1840220119; Ramon y Cajal S, 1913, ESTUDIOS DEGENERACIO; RATABOUL P, 1988, J NEUROSCI RES, V20, P165, DOI 10.1002/jnr.490200204; Reier P., 1983, SPINAL CORD RECONSTR, P163; REIER PJ, 1989, ASTROCYTES, P263; REIER PJ, 1989, FRONTIERS CLIN NEURO, P183; RIBOTTA MGY, 1995, J NEUROSCI RES, V41, P79, DOI 10.1002/jnr.490410110; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SHINE HD, 1995, GENETIC MANIPULATION, P53; Stensaas LJ, 1987, PROG BRAIN RES <D>, V71, P457; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; TAKAMIYA Y, 1992, J NEUROSCI RES, V33, P493, DOI 10.1002/jnr.490330316; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; TETZLAFF W, 1988, GLIA, V1, P90, DOI 10.1002/glia.440010110; VIOLA JJ, 1995, J NEUROSURG, V82, P70, DOI 10.3171/jns.1995.82.1.0070; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109; [No title captured]	78	12	12	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB 1	1999	25	3					293	303		10.1002/(SICI)1098-1136(19990201)25:3<293::AID-GLIA9>3.0.CO;2-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160UX	WOS:000078250600009	9932875				2022-02-06	
J	Bauer, R; Walter, B; Fritz, H; Zwiener, U				Bauer, R; Walter, B; Fritz, H; Zwiener, U			Ontogenetic aspects of traumatic brain edema - facts and suggestions	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain edema; pathogenesis; brain development; blood-brain barrier; traumatic brain edema; edema, brain	PEDIATRIC HEAD-INJURY; CEREBRAL BLOOD-FLOW; NEONATAL RAT-BRAIN; COMA DATA-BANK; DELAYED DEPOLARIZATION; MODERATE HYPOTHERMIA; CORTICAL-NEURONS; CHILDREN; GLUTAMATE; DAMAGE	Diffuse brain swelling (DBS) after severe traumatic brain injury (TBI) occurs more commonly in children than adults. Most of the recent clinical studies suggest that young children are more negatively affected by DBS. Until now studies in young animals in which the pathophysiology of DBS was evaluated remained seldom. However, pathogenetic mechanisms of edema formation after TBI in the immature brain appeared to be different in comparison to adult brains. There are evidences that vasogenic as well as cytotoxic edema components may be responsible for the development of DBS. Besides mechanical disturbance, the blood-brain barrier seems to be strongly endangered by oxidative stress after TBI because regional antioxidative capacity is obviously diminished. In addition, cytotoxic components of DBS may be caused by at least two different mechanisms. First, it was shown that a sustained posttraumatic cerebral hypoperfusion occurs in the immature brain. Moreover, a transient increase of NMDA receptor expression at this period of life may be responsible for an increased threat of intracellular sodium ion accumulation in brain cells. Obviously, brain swelling can be detrimental because it can elevate intracranial pressure, impair CBF, and may represent ongoing secondary brain injury.	Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany; Univ Jena, Dept Anesthesiol & Intens Care, D-07740 Jena, Germany		Bauer, R (corresponding author), Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany.	rbau@mti-n.uni-jena.de					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAUER R, PFLUGERS ARCH SR, V435, P89; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CIRIOLO MR, 1991, MECH AGEING DEV, V61, P287, DOI 10.1016/0047-6374(91)90061-4; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, NEUROTRAUMA, P1491; Dijkhuizen RM, 1996, NMR BIOMED, V9, P84, DOI 10.1002/(SICI)1099-1492(199604)9:2<84::AID-NBM401>3.0.CO;2-B; Dobbing J, 1968, Prog Brain Res, V29, P417; DSOUZA SW, 1992, LANCET, V339, P1240, DOI 10.1016/0140-6736(92)91188-E; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ginsberg MD, 1997, CEREBROVASC DIS, V7, P7, DOI 10.1159/000108237; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JOHNSTON MV, 1998, FETAL NEONATAL PHYSL, P2110; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A., 1996, NEUROTRAUMA, P413; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; ORR EL, 1984, J NEUROCHEM, V42, P727, DOI 10.1111/j.1471-4159.1984.tb02743.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATT A, 1988, J CLIN INVEST, V81, P1556, DOI 10.1172/JCI113488; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; SCHILLING L, 1997, KIDNEY INT S59, V51, pS69; SCHULZE C, 1992, DEV BRAIN RES, V69, P85, DOI 10.1016/0165-3806(92)90125-G; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SLATER P, 1993, BRIT J PHARMACOL, V108, P1143, DOI 10.1111/j.1476-5381.1993.tb13518.x; SPERBER EF, 1988, DEV BRAIN RES, V39, P295, DOI 10.1016/0165-3806(88)90033-8; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Symon L, 1977, Adv Exp Med Biol, V94, P775; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; UNTERBERG A, 1987, ACTA NEUROPATHOL, V73, P209, DOI 10.1007/BF00686613; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; VERHEUL HB, 1993, BRAIN RES, V618, P203, DOI 10.1016/0006-8993(93)91267-V; Walter B, 1999, EXP TOXICOL PATHOL, V51, P124, DOI 10.1016/S0940-2993(99)80085-2; WALTER B, 1998, PFLUGERS ARCH S, V435, pR238; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; Wass CT, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603440-00008; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zauner A, 1996, ACT NEUR S, V67, P40	58	12	12	0	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					143	150		10.1016/S0940-2993(99)80088-8			8	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000006	10192583				2022-02-06	
J	Doppenberg, EMR; Rice, MR; Alessandri, B; Qian, Y; Di, X; Bullock, R				Doppenberg, EMR; Rice, MR; Alessandri, B; Qian, Y; Di, X; Bullock, R			Reducing hemoglobin oxygen affinity does not increase hydroxyl radicals after acute subdural hematoma in the rat	JOURNAL OF NEUROTRAUMA			English	Article						free radicals; normoxic and hyperoxic conditions; subdural hematoma; traumatic brain injury	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; ALLOSTERIC MODIFIERS; SUBSTRATE DELIVERY; INITIAL EXPERIENCE; GLOBAL-ISCHEMIA; FOCAL ISCHEMIA	Extensive evidence is available to show the importance of ischemia after severe human head injury. We have previously shown that pharmacologically increasing the release of oxygen in brain tissue where the local oxygen pressure is low reduces infarct size in animal models. To study the possible negative effects of this strategy, we tested the effect of an allosteric modifier of hemoglobin (RSR13) on free radical production in the rat acute subdural hematoma (ASDH) model, both under normoxic as well as under hyperoxic, normobaric conditions. When compared to baseline, induction of ASDH resulted in a significant increase (p < 0.05) in 2,3-DHBA (2,3 dihydroxybenzoic acid, produced from salicylate after attack by hydroxyl radicals) at 30 and 60 min postinduction, both for the control group (39% and 91%) as well as the RSR13-treated group (41% and 62%). The 2,5-DHBA also increased significantly (p < 0.05) in the drug-treated animals at the 30- and 60-min time points when compared to baseline (49% and 77%). At all time points, except the 30-min, the increase in 2,3-DHBA was less marked in the RSR13 animals than in the control group. Similarly, the 2,5-DHBA increase after ASDH was lower at all time points except for the 30-min time point in the RSR13-treated group. These results indicate that enhanced tissue oxygen release by the allosteric modifier of hemoglobin RSR13 does not increase hydroxyl radical production after ASDH. Clinical trials are needed to test this compound in humans after severe head injury.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Doppenberg, EMR (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980631, Richmond, VA 23298 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER		ABRAHAM DJ, 1992, BIOCHEMISTRY-US, V31, P9141, DOI 10.1021/bi00153a005; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOISVERT DP, 1991, J CEREB BLOOD FLOW M, V11, pS637; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Di X, 1996, RESTOR NEUROL NEUROS, V9, P231, DOI 10.3233/RNN-1996-9406; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P241, DOI 10.1111/j.1749-6632.1997.tb48435.x; Doppenberg EMR, 1997, J NEUROSURG, V87, P809, DOI 10.3171/jns.1997.87.6.0809; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; FLOYD RA, 1990, P NATL ACAD SCI USA, V87, P5144; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; Greenburg A G, 1997, Adv Surg, V31, P149; Habler OP, 1998, TRANSFUSION, V38, P145, DOI 10.1046/j.1537-2995.1998.38298193096.x; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1991, FREE RADICAL BIO MED, V10, P439, DOI 10.1016/0891-5849(91)90052-5; INGLIS FM, 1990, ACT NEUR S, V51, P277; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KHANDELWAL SR, 1993, AM J PHYSIOL, V265, pH1450, DOI 10.1152/ajpheart.1993.265.4.H1450; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; MOON S, 1991, STROKE, V22, P915; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; OLIVER CN, 1990, J NEUROSCI, V10, P1035; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PERUTZ MF, 1983, LANCET, V2, P881; RANDAD RS, 1991, J MED CHEM, V34, P752, DOI 10.1021/jm00106a041; ROCKSWOLD GL, 1991, BRAIN RES, V554, P186; Sakas DE, 1996, CEREBROVAS BRAIN MET, V8, P209; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WATSON BD, 1984, J NEUROCHEM, V42, P268, DOI 10.1111/j.1471-4159.1984.tb09728.x; Watson JC, 1997, STROKE, V28, P1624, DOI 10.1161/01.STR.28.8.1624; WEI EP, 1993, AM J PHYSIOL, V265, pH1439; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	57	12	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	1999	16	2					123	133		10.1089/neu.1999.16.123			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	173BA	WOS:000078960000002	10098957				2022-02-06	
J	Blanken, G; Schafer, C; Tucha, O; Lange, KW				Blanken, G; Schafer, C; Tucha, O; Lange, KW			Serial processing in graphemic encoding: evidence from letter exchange errors in a multilingual patient	JOURNAL OF NEUROLINGUISTICS			English	Article							ACQUIRED DYSGRAPHIA; SELECTIVE DEFICIT; BUFFER; REPRESENTATIONS	We report on the spelling performance of a multilingual patient who developed symptoms of pure dysgraphia after concussion. In all languages studied (German, English, Finnish) her main error type consisted of adjacent letter exchanges (e,g. and --> adn). Closer examinations showed that LM's spelling impairment could be attributed to a relatively selective disorder of the Graphemic Buffer. It is suggested that her exchange errors result from anticipations and complementary perseverations during graphemic selection and can be located between the activation of graphemic strings coded in parallel and serial conversion into subgraphemic units. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Freiburg, Inst German Language, D-79085 Freiburg, Germany; Univ Freiburg, Inst Psychol, D-79085 Freiburg, Germany; Univ Regensburg, Dept Neuropsychol, D-93040 Regensburg, Germany		Blanken, G (corresponding author), Univ Freiburg, Inst German Language, Hugstetter Str 55, D-79085 Freiburg, Germany.		Tucha, Oliver/AAD-1403-2019				BASSO A, 1978, J NEUROL NEUROSUR PS, V41, P556, DOI 10.1136/jnnp.41.6.556; BLANKEN G, 1994, GRUPPENSTUDIE NEUROL, V8, P59; CARAMAZZA A, 1987, COGNITION, V26, P59, DOI 10.1016/0010-0277(87)90014-X; CARAMAZZA A, 1990, COGNITION, V37, P243, DOI 10.1016/0010-0277(90)90047-N; CLEMENTS GN, 1983, CV PHONOLOGY GENERAT; CUBELLI R, 1991, NATURE, V353, P258, DOI 10.1038/353258a0; DELL GS, 1988, J MEM LANG, V27, P124, DOI 10.1016/0749-596X(88)90070-8; Ellis A.W., 1988, LANG COGNITIVE PROC, V3, P99, DOI [10.1080/01690968808402084, DOI 10.1080/01690968808402084, https://doi.org/10.1080/01690968808402084]; ELLIS AW, 1979, VISIBLE LANG, V13, P265; ELLIS AW, 1987, COGNITIVE NEUROPSYCH, V4, P465, DOI 10.1080/02643298708252048; ELLIS AW, 1982, NORMALITY PATHOLOGY; Garrett M. F., 1975, PSYCHOL LEARNING MOT, V9; HILLIS AE, 1989, BRAIN LANG, V36, P208, DOI 10.1016/0093-934X(89)90062-X; HOTOPF N, 1980, COGNITIVE PROCESSES; Huber W., 1983, AACHENER APHASIE TES; Jonsdottir MK, 1996, COGNITION, V59, P169, DOI 10.1016/0010-0277(95)00693-1; KATZ RB, 1991, CORTEX, V27, P111, DOI 10.1016/S0010-9452(13)80274-2; KAY J, 1994, HDB SPELLING THEORY; MAI N, 1993, NEUROPSYCHOLOGISCHE; MAI N, 1992, CS COMPUTER ASSISTED; Margolin D. I., 1992, COGNITIVE NEUROPSYCH; MARGOLIN DI, 1984, Q J EXP PSYCHOL-A, V36, P459, DOI 10.1080/14640748408402172; MCCLOSKEY M, 1994, COGNITIVE NEUROPSYCH, V11, P341, DOI 10.1080/02643299408251979; MICELI G, 1985, BRAIN LANG, V25, P187, DOI 10.1016/0093-934X(85)90080-X; MICELI G, 1995, CORTEX, V31, P161, DOI 10.1016/S0010-9452(13)80114-1; MORTON J, 1980, COGNITIVE PROCESSES; POSTERARO L, 1988, BRAIN LANG, V35, P274, DOI 10.1016/0093-934X(88)90112-5; RAPCSAK SZ, 1997, APRAXIA NEUROPSYCHOL; ROELTGEN DP, 1993, LINGUISTIC DISORDERS; Ruoff Arno., 1981, HAUFIGKEITSWORTERBUC; SGARAMELLA TM, 1991, CORTEX, V27, P29, DOI 10.1016/S0010-9452(13)80266-3; SHALLICE T, 1995, LANG COGNITIVE PROC, V10, P25; SHATTUCKHUFNAGEL S, 1992, COGNITION, V42, P213, DOI 10.1016/0010-0277(92)90044-I; Tainturier MJ, 1996, J MEM LANG, V35, P53, DOI 10.1006/jmla.1996.0003; WING AM, 1980, COGNITIVE PROCESSES; [No title captured]	36	12	12	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	JAN	1999	12	1					13	39		10.1016/S0911-6044(99)00002-0			27	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	221KV	WOS:000081727000002					2022-02-06	
J	Gidday, JM; Beetsch, JW; Park, TS				Gidday, JM; Beetsch, JW; Park, TS			Endogenous glutathione protects cerebral endothelial cells from traumatic injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; edema; endothelium; glutathione peroxidase; oxygen free radicals; oxypurinol; traumatic brain injury	CONJUGATED SUPEROXIDE-DISMUTASE; EXPERIMENTAL BRAIN INJURY; STRETCH-INDUCED INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; BARRIER DISRUPTION; ISCHEMIC-INJURY; NITRIC-OXIDE; RATS; FLUID	Blood-brain barrier breakdown and edema, indicative of cerebrovascular injury, are characteristic pathophysiologic outcomes following head trauma. These injuries result from both primary mechanical damage and from secondary events initiated by the traumatic insult. Free radicals are recognized as mediators of secondary injury in a number of trauma models. In this study, we used a navel in vitro model of traumatic microvascular injury to test the hypothesis that endogenous glutathione protects cerebral endothelial cells from secondary autooxidative injury following mechanical trauma. Porcine brain cerebral endothelial cells were grown in tissue culture wells with Silastic membrane bottoms, and cellular injury was induced by displacing the membrane different distances with user-defined pressure pulses from a customized device. The resultant endothelial cell injury 2 h following stretch was determined by measuring lactate dehydrogenase in the culture media. Significant stretch-dependent increases in endothelial injury were elicited that depended in a nonlinear fashion on the degree of membrane displacement. Depletion of intracellular glutathione with buthionine sulfoximine (1 mM) increased the extent of traumatic endothelial cell injury by 17-56%, particularly at low to moderate levels of traumatic injury (30-40% of total endothelial cell LDH release). Conversely, traumatic injury was reduced by 22-45% when endothelial cell glutathione levels were augmented threefold (to 140 +/- 8 nmol/mg protein) by preincubating cells with 2 mM glutathione; the extent of protection was inversely proportional to the extent of the traumatic stretch. Traumatic endothelial cell injury was also significantly and dose-dependently attenuated (up to 40%) by treatment with the xanthine oxidase inhibitor oxypurinol (50 and 100 mu M). These results demonstrate that cerebral endothelial cells are the targets of hydrogen peroxide-mediated injury secondary to trauma-induced superoxide radical formation via the xanthine oxidase pathway. The neutralization of peroxides by the endogenous glutathione redox cycle provides endothelial cells a finite capacity to reduce free radical-mediated traumatic injury; this cycle may be amenable to therapeutic manipulation to mitigate posttraumatic edema and other manifestations of vascular dysfunction.	St Louis Childrens Hosp, Dept Neurosurg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA		Park, TS (corresponding author), St Louis Childrens Hosp, Dept Neurosurg, 1 Childrens Pl, St Louis, MO 63110 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [21045] Funding Source: Medline		Barker JE, 1996, DEV NEUROSCI-BASEL, V18, P391, DOI 10.1159/000111432; Beckman JS, 1996, ADV NEUROL, V71, P339; Beetsch JW, 1998, BRAIN RES, V786, P89, DOI 10.1016/S0006-8993(97)01407-8; Betz A. Lorris, 1993, P303; BETZ AL, 1985, J NEUROCHEM, V44, P574, DOI 10.1111/j.1471-4159.1985.tb05451.x; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHEN SH, 1992, PROSTAG LEUKOTR ESS, V45, P299, DOI 10.1016/0952-3278(92)90087-Y; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; ELLIOTT SJ, 1995, AM J PHYSIOL-HEART C, V268, pH278, DOI 10.1152/ajpheart.1995.268.1.H278; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gobbel GT, 1997, J PHARMACOL EXP THER, V282, P1600; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Gourin CG, 1996, J TRAUMA, V41, P129, DOI 10.1097/00005373-199607000-00021; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1992, J NEUROTRAUMA, V9, P425; HALL ED, 1996, NEUROTRAUMA, P1405; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hsu CY, 1996, NEUROTRAUMA, P1433; HSU P, 1993, AM J PHYSIOL, V264, pH1485, DOI 10.1152/ajpheart.1993.264.5.H1485; KALARIA RN, 1986, J NEUROCHEM, V47, P1849, DOI 10.1111/j.1471-4159.1986.tb13098.x; KINNULA VL, 1992, AM J RESP CELL MOL, V6, P175, DOI 10.1165/ajrcmb/6.2.175; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MIZUI T, 1992, AM J PHYSIOL, V262, pH313, DOI 10.1152/ajpheart.1992.262.2.H313; MOORHOUSE CP, 1987, FEBS LETT, V213, P23; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PLATEEL M, 1995, J NEUROCHEM, V65, P2138; SEN S, 1993, NEUROSCI LETT, V162, P117, DOI 10.1016/0304-3940(93)90574-5; SHI MM, 1994, AM J PHYSIOL-LUNG C, V267, pL414, DOI 10.1152/ajplung.1994.267.4.L414; SHIVAKUMAR BR, 1995, J PHARMACOL EXP THER, V274, P1167; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; SIFLINGERBIRNBOIM A, 1993, J CELL PHYSIOL, V155, P234, DOI 10.1002/jcp.1041550203; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Weisbrot-Lefkowitz M, 1998, MOL BRAIN RES, V53, P333, DOI 10.1016/S0169-328X(97)00313-6; Wolin Michael S., 1996, Microcirculation (Philadelphia), V3, P1, DOI 10.3109/10739689609146778; Xu J, 1991, J NEUROTRAUM, V8, P11, DOI 10.1089/neu.1991.8.11; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; ZIMMERMAN BJ, 1988, AM J PHYSIOL, V255, pH202, DOI 10.1152/ajpheart.1988.255.1.H202	54	12	12	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1999	16	1					27	36		10.1089/neu.1999.16.27			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	162BL	WOS:000078325300003	9989464				2022-02-06	
J	Kanelos, SK; McDeavitt, JT				Kanelos, SK; McDeavitt, JT			Neural transplantation: Potential role in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fetal tissue; Huntington's disease; neural tissue transplantation; Parkinson's disease; spinal cord injury; traumatic brain injury	PARKINSONS-DISEASE; FETAL TISSUE; SPINAL-CORD; ADULT-RATS; GRAFTS; CELLS; LESION; AXONS	Neuroscientists have been transplanting neurological tissue into humans and animals for more than a century. Recently, a number of animal studies have demonstrated a degree of central nervous system protection after brain injury using transplanted tissue. This article reviews the history of neural tissue transplantation. Clinical efficacy in Huntington's disease, Parkinson's disease, and spinal cord injury is discussed. In addition, possible implications for the treatment of traumatic brain injury are reviewed. Ethical issues in the use of fetal tissue are also discussed.	Charlotte Inst Rehabil, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA		Kanelos, SK (corresponding author), Charlotte Inst Rehabil, Dept Phys Med & Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						AHLSKOG JE, 1993, MAYO CLIN PROC, V68, P578, DOI 10.1016/S0025-6196(12)60373-5; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1985, FERNSTROM FDN SERIES, P5; BOER GJ, 1994, J NEUROL, V242, P1, DOI 10.1007/BF00920568; BOYER KL, 1995, NEUROSURG CLIN N AM, V6, P113; Clark WELG, 1940, J NEUROL PSYCHIATRY, V3, P263, DOI 10.1136/jnnp.3.3.263; Defer GL, 1996, BRAIN, V119, P41, DOI 10.1093/brain/119.1.41; Dunn EH, 1917, J COMP NEUROL, V27, P565, DOI 10.1002/cne.900270403; ESCOBAR M, 1989, BRAIN RES, V478, P368, DOI 10.1016/0006-8993(89)91519-9; FINE A, 1994, CAN MED ASSOC J, V151, P1261; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; GOPAL DD, 1980, AM J ANAT, V158, P135; HAINLINE BE, 1995, OBSTET GYNECOL, V85, P619, DOI 10.1016/0029-7844(95)00003-A; HAUN F, 1984, DEV BRAIN RES, V15, P290, DOI 10.1016/0165-3806(84)90108-1; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Krauss JK, 1996, AM FAM PHYSICIAN, V54, P1621; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; LINDVALL O, 1995, CELL TRANSPLANT, V4, P393, DOI 10.1016/0963-6897(95)00022-P; MADRAZO I, 1991, Society for Neuroscience Abstracts, V17, P902; MARTIN D, 1991, NEUROSCI LETT, V124, P44, DOI 10.1016/0304-3940(91)90818-E; Newman-Gage H, 1996, J Hematother, V5, P189, DOI 10.1089/scd.1.1996.5.189; NORNES H, 1984, NEURAL TRANSPLANTS D; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Quinn N, 1996, MOVEMENT DISORD, V11, P143; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; Saltykow S, 1905, ARCH PSYCHIAT NERVEN, V40, P329, DOI 10.1007/BF02071085; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; THOMPSON WG, 1890, NY MED J, V51, P107; TURNER DA, 1993, NEUROSURGERY, V33, P1031; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B	35	12	12	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1998	13	6					1	9		10.1097/00001199-199812000-00003			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	141KF	WOS:000077142300003	9885314				2022-02-06	
J	Paniak, C; MacDonald, J; Toller-Lobe, G; Durand, A; Nagy, J				Paniak, C; MacDonald, J; Toller-Lobe, G; Durand, A; Nagy, J			A preliminary normative profile of mild traumatic brain injury diagnostic criteria	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							AMNESIA	This study investigated how mild traumatic brain injury (MTBI) diagnostic and related variables present in a large, nonreferred MTBI sample. Participants were 119 adults with MTBI, drawn from consecutive admissions to two hospital emergency wards. Within 3 weeks of injury, they were asked how the 1993 American Congress of Rehabilitation Medicine MTBI diagnostic criteria and related phenomena presented in their particular cases. Results showed that retrograde amnesia was not reported or was generally very brief; retrograde amnesia was not reported unless posttraumatic amnesia was also reported; and the median ratio of posttraumatic amnesia to retrograde amnesia duration, when both were reported, was 300:1. These and other data provide a preliminary normative profile of such MTBI phenomena, and can help with differential diagnosis of MTBI in individual cases.	Glenrose Rehabil Hosp, Psychol Serv, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Edmonton, AB, Canada		Paniak, C (corresponding author), Glenrose Rehabil Hosp, Psychol Serv, 10230-111 Ave, Edmonton, AB T5G 0B7, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KRAUS JF, 1989, MILD HEAD INJURY, P8; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; OMMAYA AK, 1969, LANCET, V2, P237; PANIAK C, IN PRESS BRAIN INJUR; Parkin AJ, 1996, ACTA NEUROL BELG, V96, P43; WOLPAW JR, 1971, LANCET, V2, P356	11	12	12	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1998	20	6					852	855		10.1076/jcen.20.6.852.1108			4	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	204RQ	WOS:000080778300008	10484696				2022-02-06	
J	Tiersky, LA; Cicerone, KD; Natelson, BH; DeLuca, J				Tiersky, LA; Cicerone, KD; Natelson, BH; DeLuca, J			Neuropsychological functioning in chronic fatigue syndrome and mild traumatic brain injury: A comparison	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINOR HEAD-INJURY; MULTIPLE-SCLEROSIS; CHRONIC PAIN; POSTCONCUSSION SYNDROME; ATTENTION; SYMPTOMS; DEFICITS; MEMORY; DEPRESSION; IMPAIRMENT	Persons with chronic fatigue syndrome (CFS) (n = 30), individuals who had sustained a mild traumatic brain injury with postconcussive symptoms (MTBI) (n = 33), and healthy controls (n = 20), who were age and education-matched, were compared on measures of complex information processing, attention/concentration, memory, and higher-order cognitive processes. MTBI and CFS patients demonstrated a similar deficit in complex information processing and verbal learning. Overall, however, individuals who suffered a MTBI demonstrated a greater degree of impairment than did individuals with CFS and healthy controls. Implications for treatment and future research are discussed.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Chron Fatigue Syndrome Ctr, Newark, NJ USA; JFK Johnson Rehabil Inst, Edison, NJ USA; Rehabil & Educ Corp, Kessler Med Res, W Orange, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA		Tiersky, LA (corresponding author), Fatigue Res Ctr, 385 Tremont Ave,127A, E Orange, NJ 07018 USA.	ltiersky@nbunj.jvnc.net					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Buchwald D, 1996, RHEUM DIS CLIN N AM, V22, P219, DOI 10.1016/S0889-857X(05)70270-2; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COPE H, 1995, BRIT J PSYCHIAT, V167, P86, DOI 10.1192/bjp.167.1.86; DEFILIPPIS NA, 1993, CATEGORY TEST COMPUT; DeFilippis NA, 1979, BOOKLET CATEGORY TES; Delis DC, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1993, ARCH NEUROL-CHICAGO, V50, P301, DOI 10.1001/archneur.1993.00540030065016; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GRAFMAN J, 1993, J NEUROL NEUROSUR PS, V56, P684, DOI 10.1136/jnnp.56.6.684; Grafman J., 1994, CHRONIC FATIGUE SYND, P263; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; HARTLAGE S, 1993, PSYCHOL BULL, V113, P247, DOI 10.1037/0033-2909.113.2.247; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnson SK, 1996, PERCEPT MOTOR SKILL, V83, P51, DOI 10.2466/pms.1996.83.1.51; Joyce E, 1996, J NEUROL NEUROSUR PS, V60, P495, DOI 10.1136/jnnp.60.5.495; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Marshall PS, 1996, BIOL PSYCHIAT, V39, P199, DOI 10.1016/0006-3223(95)00131-X; Marshall PS, 1997, PSYCHOSOM MED, V59, P58, DOI 10.1097/00006842-199701000-00008; MCDONALD E, 1993, J NEUROL NEUROSUR PS, V56, P812, DOI 10.1136/jnnp.56.7.812; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MossMorris R, 1996, J NEUROL NEUROSUR PS, V60, P474, DOI 10.1136/jnnp.60.5.474; PRASHER D, 1990, J NEUROL NEUROSUR PS, V53, P247, DOI 10.1136/jnnp.53.3.247; RASKIN S, 1994, M INT NEUR SOC ANG; RASKIN S, 1993, SOC COGN REH ATL; RAY C, 1993, BRIT J CLIN PSYCHOL, V32, P357, DOI 10.1111/j.2044-8260.1993.tb01068.x; REITAN RM, 1959, J NERV MENT DIS, V129, P257, DOI 10.1097/00005053-195909000-00006; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHEFFERS MK, 1992, NEUROLOGY, V42, P1667, DOI 10.1212/WNL.42.9.1667; SCHLOMAN BF, 1992, HEALTH EDUC RES, V7, P117, DOI 10.1093/her/7.1.117; SMITH A, 1991, POSTVIRAL FATIGUE SY, P179; SMITH AP, 1993, BRIT J PSYCHOL, V84, P411, DOI 10.1111/j.2044-8295.1993.tb02492.x; SOHLBERG M, 1993, MANUAL APT 2; TIERSKY L, 1997, M AM PSYCH ASS CHIC; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Visser RSH, 1973, MANUAL COMPLEX FIGUR; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; Weingartner H, 1982, Psychopharmacol Bull, V18, P27; [No title captured]	58	12	12	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1998	12	4					503	512		10.1076/clin.12.4.503.7237			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	203GF	WOS:000080699400007					2022-02-06	
J	Sharma, AC; Misra, M; Prat, R; Alden, K; Sam, AD; Markiv, VZ; Dujovny, M; Ferguson, JL				Sharma, AC; Misra, M; Prat, R; Alden, K; Sam, AD; Markiv, VZ; Dujovny, M; Ferguson, JL			A differential response of diffuse brain injury on the concentrations of endothelin and nitric oxide in the plasma and brain regions in rats	NEUROLOGICAL RESEARCH			English	Article						diffuse brain injury; cerebral blood flow; mean arterial pressure; endothelin-1; nitric oxide; anesthetized rats	CEREBRAL BLOOD-FLOW; CLOSED-HEAD-INJURY; SUBARACHNOID HEMORRHAGE; MODEL; CIRCULATION; REVERSAL	In the present study, we hypothesized that acute diffuse brain injury (DBI) in rats would produce an increase in endothelin-1 (ET-1), a potent vasoconstrictor, and/or nitric oxide (NO), a potent vasodilator, in plasma and brain areas in rats. DBI was induced in anesthetized male Sprague-Dawley rats (350-400 g) using a 350 g weight dropped from 1 meter height impact through a device designed by Marmarou et at., 1994. Blood plasma and brain tissue (cerebral cortex, diencephalon and brain stem) samples were collected for estimation of ET-1 and NO at zero or 6 h from rats (n = 6) subjected to DBI as well as control rats (n = 6), i.e., not subjected to DBI. In a separate group of animals, cerebral blood flow (CBF) was recorded at 0, 5, 10, 15, 30, 60, 120, 240 and 360 min after induction of DBI or sham-DBI. Acute DBI produced a significant decrease in CBF at 120 min after induction of DBI. Plasma levels of ET-1 was found to be significantly increased (from 0.89 +/- 0.09 to 2.09 +/- 0.29 pg ml(-1)), at 6 h following DBI. DBI produced a significant decrease in the levels of ET-1 in diencephalon (from 70.97 +/- 9.47 to 51.64 +/- 2.65 pg g(-1)). In contrast to ET-1, DBI produced a significant increase in the concentrations of NO in the diencephalon, cerebral cortex and brain stem at 6 h Post DBI. II appears that DBI-induced increase in the levels of NO in brain regions Which might De down regulating the synthesis of ET-1 in diencephalon. It is concluded that ET and NO homeostatic mechanisms may play a role in the regional and vascular responses associated with acute DBI.	Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Neurosurg, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Surg, Chicago, IL 60612 USA		Sharma, AC (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, M-C 901,835 S Wolcott Ave, Chicago, IL 60612 USA.				NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL07692] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01 48219] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007692] Funding Source: NIH RePORTER		BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; COLOMBANI PM, 1985, J PEDIATR SURG, V20, P8, DOI 10.1016/S0022-3468(85)80382-1; EKELUND L, 1974, NEURORADIOLOGY, V7, P209, DOI 10.1007/BF00342700; FIESCHI C, 1972, EUR NEUROL, V8, P192, DOI 10.1159/000114577; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gennarelli TA, 1993, HEAD INJURY, P137; Gulati A, 1997, AM J PHYSIOL-HEART C, V273, pH827, DOI 10.1152/ajpheart.1997.273.2.H827; HARBEL RL, 1993, ACTA NEUROCHIR WIE S, V59, P64; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Kwan AL, 1997, J NEUROSURG, V87, P281, DOI 10.3171/jns.1997.87.2.0281; Lang E W, 1995, New Horiz, V3, P400; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MASAKI T, 1995, ANNU REV PHARMACOL, V35, P235, DOI 10.1146/annurev.pa.35.040195.001315; MCCULLOUGH D, 1971, J TRAUM, V11, P422, DOI 10.1097/00005373-197105000-00007; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Sharma AC, 1997, J MOL CELL CARDIOL, V29, P1469, DOI 10.1006/jmcc.1997.0386; SHARMA AC, 1995, ENDOTHELIN ROLE HLTH, P215; Thomas JE, 1997, NEUROSURGERY, V40, P1245, DOI 10.1097/00006123-199706000-00026; TRACEY WR, 1995, J PHARMACOL EXP THER, V272, P1011; Wijdicks EFM, 1997, J NEUROSURG, V87, P275, DOI 10.3171/jns.1997.87.2.0275; YAMADA G, 1995, J CARDIOVASC PHARM, V26, pS486; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	26	12	16	0	2	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	OCT	1998	20	7					632	636					5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124LQ	WOS:000076184200010	9785592				2022-02-06	
J	Demirhan, M; Akpinar, S; Atalar, AC; Akman, S; Akalin, Y				Demirhan, M; Akpinar, S; Atalar, AC; Akman, S; Akalin, Y			Primary replacement of the humeral head in iatrogenically displaced fracture-dislocations of the shoulder: a report about six cases	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article								Dislocation of the shoulder is a common injury and may be associated with a variety of complications. We report six cases of primary replacement of the humeral head where closed reduction of a shoulder dislocation associated with an undisplaced fracture of the humeral neck led to displacement of the neck fracture. All dislocations examined were anterior with a displaced greater tubercle fracture. The patients had undergone closed reduction at of her medical centres and were referred to us because of iatrogenically displaced fracture-dislocations of the shoulder. Three were women and three were men with a mean age of 52.8 years (range 38-72). Primary replacement of the humeral head was done in an average of 9.3 days (range 2-30 days) following the injury. The average follow-up period was 30.2 months (range 12-55 months). Postoperative pain, active range of motion and function were evaluated with the American Shoulder and Elbow Surgeons Criteria. The forward flexion averaged 124 degrees, active external rotation averaged 29 degrees and internal rotation (achieved movement) to the second lumbar vertebra. Because of the high risk of avascular necrosis and severe collapse of the humeral head, we conclude that the primary replacement of the humeral head is the superior treatment option in iatrogenically displaced fracture dislocations of the shoulder. (C) 1998 Elsevier Science Ltd. All rights reserved.	Istanbul Univ, Istanbul Sch Med, Dept Orthopaed & Traumatol, TR-34390 Istanbul, Turkey		Demirhan, M (corresponding author), Istanbul Univ, Istanbul Sch Med, Dept Orthopaed & Traumatol, TR-34390 Istanbul, Turkey.						DEMOURGUES G, 1965, REV CHIR ORTHOP, V51, P151; FERKEL RD, 1984, J TRAUMA, V24, P363, DOI 10.1097/00005373-198404000-00016; FOURRIER P, 1977, INT ORTHOP, V1, P187, DOI 10.1007/BF00266336; Goldman R T, 1995, J Shoulder Elbow Surg, V4, P81, DOI 10.1016/S1058-2746(05)80059-X; HERSCHE O, 1994, J BONE JOINT SURG BR, V76B, P30, DOI 10.1302/0301-620X.76B1.8300677; KRAULIS J, 1976, INJURY, V8, P129, DOI 10.1016/0020-1383(76)90048-6; KRISTIANSEN B, 1987, ACTA ORTHOP SCAND, V58, P124, DOI 10.3109/17453678709146455; MAROTTE JH, 1978, CHIRURGIE, V104, P816; NEER CS, 1988, REV CHIR ORTHOP, V74, P31; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Neer CS, 1986, ORTHOP T, V10, P475; Norris T R, 1995, J Shoulder Elbow Surg, V4, P271, DOI 10.1016/S1058-2746(05)80020-5; Schai P, 1995, J Shoulder Elbow Surg, V4, P319, DOI 10.1016/S1058-2746(95)80015-8; STABLEFORTH PG, 1984, J BONE JOINT SURG BR, V66, P104, DOI 10.1302/0301-620X.66B1.6693466; TANNER MW, 1983, CLIN ORTHOP RELAT R, P116; WILLEMS WJ, 1985, ACTA ORTHOP SCAND, V56, P394, DOI 10.3109/17453678508994355; Zyto K, 1995, J Shoulder Elbow Surg, V4, P331, DOI 10.1016/S1058-2746(95)80016-6	17	12	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	1998	29	7					525	528		10.1016/S0020-1383(98)00124-7			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	115GK	WOS:000075655100008	10193495				2022-02-06	
J	Gutentag, SS; Naglieri, JA; Yeates, KO				Gutentag, SS; Naglieri, JA; Yeates, KO			Performance of children with traumatic brain injury on the cognitive assessment system	ASSESSMENT			English	Article						TBI; children; assessment; cognitive processing; PASS theory	CLOSED-HEAD-INJURY; RECOVERY; MEMORY	Children End adolescents with traumatic brain injury (TBI) were compared to a matched sample of neurologically normal children and adolescents on several measures of cognitive processing. Each of the children in the TBI group had experienced a closed head injury of moderate to severe magnitude. Participants in both the TBI (n = 22) and control (n = 22) groups ranged in age from 9 to 17 years and lived in the midwestern United States. They were all administered the Cognitive Assessment System (Naglieri & Das, 1997a). Children with TBI earned significantly lower scores in the domains of Planning and Attention than the matched control group. Within-group comparisons showed that the TBI group's Planning and Attention scores were significantly lower than their Simultaneous and Successive scores. The results are consistent with previous literature demonstrating poor performance on measures of attention and executive functions among children who have experienced TBI.	Univ N Carolina, Chapel Hill, NC 27515 USA; Ohio State Univ, Columbus, OH 43210 USA; Childrens Hosp, Columbus, OH 43205 USA		Gutentag, SS (corresponding author), New Hope Elementary Sch, 1900 New Hope Church Rd, Chapel Hill, NC 27514 USA.		Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAXTER R, 1985, HEAD INJURY REHABILI, P247; Begali V., 1992, HEAD INJURY CHILDREN; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Das J. P., 1994, ASSESSMENT COGNITIVE; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LEHR E, 1990, PSYCHOL MANAGEMENT T, P99; LEHR E, 1990, PSYCHOL MANAGEMENT T, P1; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Luria A.R., 1973, WORKING BRAIN INTRO; Naglieri J. A., 1997, COGNITIVE ASSESSMENT; NAGLIERI JA, 1989, J SCHOOL PSYCHOL, V27, P347, DOI 10.1016/0022-4405(89)90012-5; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; PRIOER M, 1994, AUST PSYCHOL, V29, P116, DOI 10.1080/00050069408257334; Sattler J., 1990, ASSESSMENT CHILDREN; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P3; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Ylvisaker M., 1994, ED DIMENSIONS ACQUIR, P69; [No title captured]	31	12	12	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	1998	5	3					263	272		10.1177/107319119800500306			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	118WT	WOS:000075864500006	9728033				2022-02-06	
J	Gurevich, B; Artru, AA; Lam, AM; Mueller, AL; Merkind, V; Talmor, D; Katchko, L; Shapira, Y				Gurevich, B; Artru, AA; Lam, AM; Mueller, AL; Merkind, V; Talmor, D; Katchko, L; Shapira, Y			Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats	JOURNAL OF NEUROSURGERY			English	Article						brain injury; edema; excitotoxicity; ion; neuroprotection; N-methyl-D-aspartate; rat	EXPERIMENTAL BRAIN INJURY; EXCITATORY AMINO-ACIDS; CEREBRAL EDEMA; 5-PERCENT DEXTROSE; GLUTAMATE RELEASE; ISCHEMIC-INJURY; RAPID INFUSION; NMDA RECEPTOR; MAGNESIUM; KETAMINE	Object. The authors sought to determine whether 3,3-bis (3-fluorophenyl) propylamine (NPS 846), a novel noncompetitive N-methyl-D-aspartate receptor antagonist, alters outcome after closed head trauma in rats. Methods. The experimental variables were: presence or absence of closed head trauma, treatment with NPS 846 or no treatment, and time at which the rats were killed (24 or 48 hours). The NPS 846 (1 mg/kg) was administered intraperitoneally at 1 and 3 hours after closed head trauma or sham operation. Outcome measures were the neurological severity score (NSS), ischemic tissue volume, hemorrhagic necrosis volume, and specific gravity, water content, and concentrations of calcium, sodium, potassium, and magnesium in brain tissue. The following closed head trauma-induced changes in the injured hemisphere (expressed as the mean +/- the standard deviation) were reversed by NPS 846: decreased specific gravity of 1.035 +/- 0.006 at 24 hours was increased to 1.042 +/- 0.004; the decreased potassium level of 0.583 +/- 0.231 mg/L at 48 hours and at 24 hours was increased to 2.442 +/- 0.860 mg/L; the increased water content of 84.7 +/- 2.6% at 24 hours was decreased to 79.8 +/- 2%; the increased calcium level of 0.592 +/- 0.210 mg/L at 24 hours was decreased to 0.048 +/- 0.029 mg/L; and the increased sodium level of 2.035 +/- 0.649 mg/L was decreased to 0.631 +/- 0.102 mg/L. Administration of NPS 846 also lowered the NSS (improved neurological status) at 48 hours (7 +/- 3) and caused no significant changes in ischemic tissue or hemorrhagic necrosis volumes in the injured hemisphere at 24 or 48 hours. Conclusions. In this model of closed head trauma, NPS 846 improved neurological outcome, delayed the onset of brain edema, and improved brain tissue ion homeostasis.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Kaplan Hosp, Dept Anesthesiol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anesthesiol, IL-91010 Jerusalem, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel; NPS Pharmaceut Inc, Salt Lake City, UT USA		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.						ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; Artman L. D., 1996, Society for Neuroscience Abstracts, V22, P1282; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bullock R, 1995, ANN NY ACAD SCI, V765, P272, DOI 10.1111/j.1749-6632.1995.tb16584.x; BULLOCK R, 1992, J NEUROTRAUMA S2, V9, P443; Chien Y., 1996, Society for Neuroscience Abstracts, V22, P1282; CHOI DW, 1990, J NEUROSCI, V10, P2493; DIEMER NH, 1990, STROKE, V21, P39; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KOHMURA E, 1990, J CEREBR BLOOD F MET, V10, P877, DOI 10.1038/jcbfm.1990.144; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; LEVY DI, 1990, NEUROLOGY, V40, P852, DOI 10.1212/WNL.40.5.852; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MATSUMIYA N, 1991, STROKE, V22, P1193, DOI 10.1161/01.STR.22.9.1193; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MEYER FB, 1989, BRAIN RES REV, V14, P227, DOI 10.1016/0165-0173(89)90002-7; MORLEY P, 1994, BRAIN PATHOL, V4, P37; Mueller A. L., 1996, Society for Neuroscience Abstracts, V22, P1282; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; VANWAGENEN BC, 1996, 212 NAT M AM CHEM SO; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	46	12	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	1998	88	6					1066	1074		10.3171/jns.1998.88.6.1066			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZP267	WOS:000073735200018	9609302				2022-02-06	
J	Cypser, DA; Davis, SD				Cypser, DA; Davis, SD			Induced seismicity and the potential for liability under US law	TECTONOPHYSICS			English	Article; Proceedings Paper	IASPEI Symposium on New Trends in Seismological Research - Studies of Seismicity Induced by Mining, Petroleum and Geothermal Activities at the IUGG Meeting	JUL, 1995	BOULDER, COLORADO	IASPEI, Gen Assembly Int Union Geodesy & Geophys		triggered induced seismicity; earthquakes; liability; legal	RESERVOIR-INDUCED SEISMICITY; TRIGGERED EARTHQUAKES; CALIFORNIA; FIELD; TEXAS; STATE	Research by seismologists over the past 30+ years has firmly established that some human activities induce seismicity. Sometimes induced seismicity causes injuries to people or property. The activities which induce seismicity generally involve extraction of energy, or natural resources, or the disposal of wastes. As the human population increases these extraction and disposal activities will increase in number of sites and intensity of effort as the demands became greater and the resources scarcer. With these increases the number and severity of damaging induced earthquakes is likely to increase. Induced seismicity may cause injuries by vibrations or by seismically induced ground failure. In either case compensation for injuries caused by induced seismicity should be paid for by the inducer. In the United States the inducer of damaging seismicity can be made to pay for the harm caused. Liability for damage caused by vibrations can be based on several legal theories: trespass, strict liability, negligence and nuisance. Our research revealed no cases in which an appellate court has upheld or rejected the application of tort liability to an induced earthquake situation. However, there are numerous analogous cases that support the application of these legal theories to induced seismicity. Vibrations or concussions due to blasting or heavy machinery are sometimes viewed as a 'trespass' analogous to a physical invasion. In some states activities which induce earthquakes might be considered 'abnormally dangerous' activities that require companies engaged in them to pay for injuries the quakes cause regardless of how careful the inducers were. In some circumstances, a court may find that an inducer was negligent in its site selection or in maintenance of the project. If induced seismicity interferes with the use or enjoyment of another's land, then the inducing activity may be a legal nuisance, even if the seismicity causes little physical damage. In most states of the United States owners of land owe a duty of lateral support to adjacent landowners, and, in some states, mineral estate owners and lessees owe a duty of subjacent support to the surface owners. Failure to meet those duties of support can result in liability. Seismicity induced by one source might accelerate failure of support originating from another source, leaving both of the parties at fault proportionally liable to the injured parties. Geoscientists can use their roles as investigators, educators and advisors to help companies in the petroleum, mining and geothermal fields avoid liability. (C) 1998 Elsevier Science B.V. All rights reserved.	NOAA, Natl Geophys Data Ctr, Cooperat Inst Res Environm Sci, Boulder, CO 80303 USA		Cypser, DA (corresponding author), POB 2187, Boulder, CO 80306 USA.	dcypser@nyx.net					AKE J, 1992, SEISMOL RES LETT, V63, P19; ALLEN C. R., 1982, CALIF GEOL, V35, P248; American Law Institute, 1979, REST 2 TORTS; BECK JL, 1976, B SEISMOL SOC AM, V66, P1121; BELL ML, 1978, J GEOPHYS RES, V83, P4469, DOI 10.1029/JB083iB09p04469; BUFE CG, 1976, SCIENCE, V192, P72, DOI 10.1126/science.192.4234.72; CARDER D, 1970, ENG GEOL CASE HIST, V8, P51; COOK NGW, 1976, ENG GEOL, V10, P99, DOI 10.1016/0013-7952(76)90015-6; Cox R. T., 1991, Seismological Research Letters, V62, P113; Cypser DA, 1994, J ENV LAW LITIG, V9, P551; Davis S. D., 1993, Seismological Research Letters, V64, P207; Davis SD, 1995, B SEISMOL SOC AM, V85, P1888; DAVIS SD, 1989, B SEISMOL SOC AM, V79, P1477; EBERHARTPHILLIPS D, 1984, J GEOPHYS RES, V89, P1191, DOI 10.1029/JB089iB02p01191; FLETCHER JB, 1977, J GEOPHYS RES, V82, P3767, DOI 10.1029/JB082i026p03767; GRASSO JR, 1992, PURE APPL GEOPHYS, V139, P507, DOI 10.1007/BF00879949; Gupta H K, 1992, RESERVOIR INDUCED EA; GUPTA HK, 1985, TECTONOPHYSICS, V118, P257, DOI 10.1016/0040-1951(85)90125-8; Gupta HK, 1976, DEV GEOTECHNICAL ENG; HASEGAWA HS, 1989, PURE APPL GEOPHYS, V129, P423, DOI 10.1007/BF00874518; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; JANSEN RB, 1967, J SOIL MECH, V4, P551; KANAMORI H, 1992, B SEISMOL SOC AM, V82, P2087; LONG LT, 1989, PURE APPL GEOPHYS, V129, P415, DOI 10.1007/BF00874517; MCGARR A, 1991, B SEISMOL SOC AM, V81, P948; NICHOLSON C, 1992, PURE APPL GEOPHYS, V139, P561, DOI 10.1007/BF00879951; NICHOLSON C, 1990, US GEOL SURV B, V1951; PENNINGTON WD, 1986, B SEISMOL SOC AM, V76, P939; POMEROY PW, 1976, B SEISMOL SOC AM, V66, P685; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; RASTOGI BK, 1995, IUGG 21 GEN ASS BOUL, pA367; Redmayne D.W., 1988, GEOL SOC SPEC PUBL, V5, P405; SEEBER L, 1988, RECENT HIST SEISMICI; SEGALL P, 1989, GEOLOGY, V17, P942, DOI 10.1130/0091-7613(1989)017<0942:ETBFE>2.3.CO;2; SEGALL P, 1994, J GEOPHYS RES-SOL EA, V99, P15423, DOI 10.1029/94JB00989; SIMPSON DW, 1988, B SEISMOL SOC AM, V78, P2025; SIMPSON DW, 1986, ANNU REV EARTH PL SC, V14, P21, DOI 10.1146/annurev.ea.14.050186.000321; SWANSON PL, 1995, 8695 US BUR MIN; VONHAKE CA, 1969, US EARTHQUAKES 1967; WONG IG, 1992, ROCK MECHANICS : PROCEEDINGS OF THE 33RD U S SYMPOSIUM, P1103; ZOBACK ML, 1980, J GEOPHYS RES, V85, P6113, DOI 10.1029/JB085iB11p06113; 1920, SE REPORTER, V105, P425; 1987, FEDERAL REPORTER, V814, P258; 1909, FEDERAL REPORTER, V172, P792; 1980, PACIFIC REPORTER, V612, P889; 1993, SUPREME COURT REPORT, V113, P2786; 1928, PACIFIC REPORTER, V270, P952; 1972, PACIFIC REPORTER, V497, P340; 1979, NW REPORTER, V281, P520; 1986, FEDERAL S, V647, P303; 1961, NE REPORTER, V173, P292; 1968, SO REPORTER, V229, P524; 1920, NW REPORTER, V175, P45; 1947, FEDERAL REPORTER, V159, P169; 1892, SE REPORTER, V16, P12; 1942, SW REPORTER, V158, P134; 1960, ATLANTIC REPORTER, V157, P740; 1945, PACIFIC REPORTER, V154, P428; 1984, FEDERAL REPORTER, V732, P1375; 1971, AM JURISPRUDENCE, V54, P376; 1985, SO REPORTER, V482, P662; 1988, FEDERAL REPORTER, V845, P1307; 1934, PACIFIC REPORTER, V28, P862; 1992, PACIFIC REPORTER, V824, P783; 1963, NE REPORTER, V188, P406; 1986, PACIFIC REPORTER, V720, P152; 1923, FEDERAL REPORTER, V293, P1013; 1944, NE REPORTER, V58, P517; 1961, SW REPORTER, V344, P411; 1927, SW REPORTER, V298, P554; 1983, SW REPORTER, V644, P339; 1972, SW REPORTER, V487, P651; 1982, PACIFIC REPORTER, V772, P640; 1916, NW REPORTER, V156, P188; 1931, FEDERAL REPORTER, V54, P510	75	12	12	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0040-1951			TECTONOPHYSICS	Tectonophysics	APR 15	1998	289	1-3					239	255		10.1016/S0040-1951(97)00318-1			17	Geochemistry & Geophysics	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Geochemistry & Geophysics	ZR956	WOS:000074033200017					2022-02-06	
J	McHugh, GJ				McHugh, GJ			Anaphylactoid reaction to pentastarch	CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							HYDROXYETHYL STARCH; PLASMA SUBSTITUTES	Purpose: To report a probable anaphylactoid reaction to pentastarch, a low molecular weight hydroxyethyl starch (HES) colloid solution. Clinical features: Following a closed head injury, an 18-yr-old male was admitted to the Intensive Care Unit. Therapy was directed towards control of intracranial pressure (ICP) and maintenance of cerebral perfusion pressure (CPP), In the first 12 hr after admission, he had received 2500 ml polygeline (Haemaccel(R), Hoechst Marion Roussel Ltd.) and a dopamine infusion (up to 10 mu g.kg(-1).min(-1)) titrated to achieve a mean arterial pressure (MAP) of greater than or equal to 80 mmHg. Subsequent failure to achieve the target MAP resulted in commencement of a noradrenaline infusion (2.67 mu g.min(-1)), and rapid administration of 500ml pentastarch (Pentaspan(R), duPont Pharmaceuticals). During the HES infusion, marked hypotension (MAP < 60 mmHg) developed associated with marked truncal urticaria. The hypotension was resistant to escalation of noradrenaline to 36 mu g.min(-1). Haemodynamic stability was rapidly restored and maintained with adrenaline boluses (total 450 mu g) and infusion (1.67 mu g.min(-1)). The remainder of the patient's ICU and hospital stay was unremarkable. A serum tryptase drawn in the first 40 min of the reaction was not elevated. Other biochemical markers were not assayed, Skin testing has not been carried out. Conclusion: The temporal relationship and clinical manifestations observed in this case, together with the resistance to inotropes/vasopressors other than adrenaline is highly suggestive of an anaphylactoid reaction to pentastarch. The diagnostic value of serum tryptase may be compromised when blood samples are drawn too early.	Palmerston N Hosp, Dept Anaesthesia & Intens Care, Palmerston North, New Zealand		McHugh, GJ (corresponding author), Palmerston N Hosp, Dept Anaesthesia & Intens Care, Private Bag 11036, Palmerston North, New Zealand.						CULLEN MJ, 1990, ANAESTHESIA, V45, P1041, DOI 10.1111/j.1365-2044.1990.tb14883.x; FISHER M, 1994, EUR J ANAESTH, V11, P263; KRAFT D, 1992, EUR SURG RES, V24, P138, DOI 10.1159/000129200; KREIMEIER U, 1995, LANCET, V346, P49, DOI 10.1016/S0140-6736(95)92677-1; LAROCHE D, 1991, ANESTHESIOLOGY, V75, P945, DOI 10.1097/00000542-199112000-00004; LAXENAIRE MC, 1994, ANN FR ANESTH, V13, P301, DOI 10.1016/S0750-7658(94)80038-3; LORENZ W, 1975, ANAESTHESIST, V24, P228; MAURER PH, 1968, TRANSFUSION, V8, P265, DOI 10.1111/j.1537-2995.1968.tb02422.x; PORTER SS, 1986, CAN J ANAESTH, V33, P394, DOI 10.1007/BF03010756; RING J, 1977, LANCET, V1, P466; RING J, 1976, EUR SURG RES, V8, P389, DOI 10.1159/000127883; RING J, 1985, INT ANESTHESIOL CLIN, V23, P67	12	12	12	0	0	CANADIAN ANAESTHETISTS SOC INC	TORONTO	1 EGLINTON AVE EAST, SUITE 208, TORONTO, ONTARIO M4P 3A1, CANADA	0832-610X			CAN J ANAESTH	Can. J. Anaesth.-J. Can. Anesth.	MAR	1998	45	3					270	272		10.1007/BF03012915			3	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ZK214	WOS:000073296800015	9579268	Bronze			2022-02-06	
J	Al Moutaery, K; Arshaduddin, M; Tariq, M; Al Deeb, S				Al Moutaery, K; Arshaduddin, M; Tariq, M; Al Deeb, S			Functional recovery and vitamin E level following sciatic nerve crush injury in normal and diabetic rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						vitamin E; sciatic nerve; diabetes; crush injury; neuropathy	SPINAL-CORD INJURY; ALPHA-TOCOPHEROL; LIPID-PEROXIDATION; BLOOD-FLOW; CONDUCTION-VELOCITY; OXIDATIVE STRESS; TIBIAL NERVE; E-DEFICIENCY; ANTIOXIDANT; BRAIN	Extensive biochemical data document the involvement of oxygen derived free radicals (ODFR) in recovery following neurotrauma as well as diabetic neuropathy. Vitamin E is considered as one of the principle protective mechanism against oxidative damage in neuronal tissue. The present study was undertaken to determine the association between functional recovery and vitamin E levels following sciatic nerve crush injury in normal and diabetic rats. The sciatic nerve of normal and streptozotocin (STZ) induced diabetic rats was crushed using a haemostat. The walking track analysis and vitamin E levels were recorded on 10, 20 and 30th day. Maximum functional deficiency and depletion of vitamin E in sciatic nerve was observed on 10th day following crush injury in both normal and diabetic animals. A progressive motor recovery and repletion of vitamin E was observed on day 20 and 30 following injury in both diabetic and normal rats. The functional recovery was slower whereas vitamin E level was higher in diabetic animals as compared to normal injured rats during healing phase suggesting that vitamin E alone may not be an efficient indicator of oxidative stress during regeneration of axons following trauma in diabetic rats.	Armed Forces Hosp, Dept Neurosurg, Riyadh 11159, Saudi Arabia; Armed Forces Hosp, Res Ctr, Riyadh 11159, Saudi Arabia		Tariq, M (corresponding author), Armed Forces Hosp, Dept Neurosurg, W-912 POB 7897, Riyadh 11159, Saudi Arabia.						ANDERSON DK, 1980, J NEUROSURG, V53, P575; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BOWE CM, 1987, DEV BRAIN RES, V34, P123, DOI 10.1016/0165-3806(87)90201-X; BRIN MF, 1986, NEUROLOGY, V36, P669, DOI 10.1212/WNL.36.5.669; CAMERON NE, 1994, DIABETOLOGIA, V37, P449, DOI 10.1007/s001250050131; CARSTEN RE, 1989, DIABETES, V38, P730, DOI 10.2337/diabetes.38.6.730; Ceriello A, 1997, DIABETES CARE, V20, P1589, DOI 10.2337/diacare.20.10.1589; CLENDENON NR, 1978, J NEUROSURG, V49, P563, DOI 10.3171/jns.1978.49.4.0563; CUPPINI R, 1993, J NEUROL SCI, V117, P61, DOI 10.1016/0022-510X(93)90155-R; DEKONING P, 1986, J NEUROL SCI, V74, P237, DOI 10.1016/0022-510X(86)90109-7; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; DEXTER DT, 1992, ANN NEUROL, V32, P591, DOI 10.1002/ana.410320420; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; HALL ED, 1987, BRAIN RES, V413, P175, DOI 10.1016/0006-8993(87)90166-1; HALLIWELL B, 1984, LANCET, V1, P1396; HELLWEG R, 1994, EXP NEUROL, V130, P24, DOI 10.1006/exnr.1994.1181; HOLTZ A, 1990, NEUROSURGERY, V26, P952, DOI 10.1227/00006123-199006000-00005; JAMES AK, 1991, PAIN, V47, P31; LONGO FM, 1986, MUSCLE NERVE, V9, P385, DOI 10.1002/mus.880090502; LOW PA, 1991, DIABETES, V40, P873, DOI 10.2337/diabetes.40.7.873; MARKLUND SL, 1985, J NEUROL SCI, V67, P319, DOI 10.1016/0022-510X(85)90156-X; MARTINOLI L, 1993, INT J VITAM NUTR RES, V63, P87; MCCAY PB, 1985, ANNU REV NUTR, V5, P323, DOI 10.1146/annurev.nu.05.070185.001543; MEISTER A, 1988, J BIOL CHEM, V263, P17207; NAVARRO X, 1988, BRAIN RES, V447, P133, DOI 10.1016/0006-8993(88)90973-0; NICKANDER KK, 1994, J NEUROL SCI, V126, P6, DOI 10.1016/0022-510X(94)90088-4; NIKI E, 1987, CHEM PHYS LIPIDS, V44, P227, DOI 10.1016/0009-3084(87)90052-1; NUKADA H, 1993, J NEUROL SCI, V119, P162, DOI 10.1016/0022-510X(93)90129-M; NUKADA H, 1986, DIABETES, V35, P1058, DOI 10.2337/diabetes.35.9.1058; PERUMAL AS, 1989, BRAIN RES, V504, P139, DOI 10.1016/0006-8993(89)91611-9; ROMERO FJ, 1991, NEUROCHEM RES, V16, P157, DOI 10.1007/BF00965704; SATYAMURTI S, 1986, NEUROLOGY, V36, P917, DOI 10.1212/WNL.36.7.917; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; Tariq M, 1995, INT J NEUROSCI, V83, P165, DOI 10.3109/00207459508986336; THURSTON JH, 1995, DIABETES, V44, P190, DOI 10.2337/diabetes.44.2.190; WALLACE MC, 1986, NEUROSURGERY, V18, P433; YOUNG IS, 1995, FREE RADICAL BIO MED, V18, P833, DOI 10.1016/0891-5849(94)00202-U	38	12	12	0	0	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1998	96	3-4					245	254					10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	155EL	WOS:000077933300010	10069624				2022-02-06	
J	Fertl, E; Steinhoff, N; Schofl, R; Potzi, R; Doppelbauer, A; Muller, C; Auff, E				Fertl, E; Steinhoff, N; Schofl, R; Potzi, R; Doppelbauer, A; Muller, C; Auff, E			Transient and long-term feeding by means of percutaneous endoscopic gastrostomy in neurological rehabilitation	EUROPEAN NEUROLOGY			English	Article						percutaneous endoscopic gastrostomy; neurological rehabilitation; long-term PEG feeding; transient PEG feeding; traumatic brain injury; posthypoxic encephalopathy	ENTERAL NUTRITION; ACUTE STROKE; HEAD-INJURY; DYSPHAGIA; SUPPORT	In 28 patients of a neurological rehabilitation unit of a hospital the use of enteral nutrition via percutaneous endoscopic gastrostomy (PEG) tubes was reviewed. During a total observation period of 5,172 days no life-threatening complications occurred. Minor complications were observed in 12 patients (43%) in the first 2 weeks after the insertion and in 5 patients (18%) afterwards. The nutritional status stabilized in all subjects. Transient PEG feeding was performed in 11 patients (39%) with a mean duration of 150 days. We conclude that hesitation in the application of PEG feeding in neurological rehabilitation should be abandoned. The timing and monitoring of PEG feeding in patients undergoing neurological rehabilitation for acute remitting neurological disorders is discussed.	Univ Clin Vienna, Dept Neurol Rehabil, A-1090 Vienna, Austria; Univ Clin Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria		Fertl, E (corresponding author), Univ Clin Vienna, Dept Neurol Rehabil, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.						BARER DH, 1989, J NEUROL NEUROSUR PS, V52, P236, DOI 10.1136/jnnp.52.2.236; BIESALSKI HK, 1995, ERNAHRUNGSMEDIZIN; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Britton JER, 1997, J NEUROL, V244, P431, DOI 10.1007/s004150050117; BRUNELLI E, 1993, LANCET, V341, P1534, DOI 10.1016/0140-6736(93)90668-7; DEUTSCH E, 1990, LEHRBUCH INTERNISTIS; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; Gossner L, 1995, DEUT MED WOCHENSCHR, V120, P1768, DOI 10.1055/s-2008-1055540; Grimble GK, 1996, CURR OPIN GASTROEN, V12, P174, DOI 10.1097/00001574-199603000-00012; HULL MA, 1993, LANCET, V341, P869, DOI 10.1016/0140-6736(93)93072-9; KEYMLING M, 1985, MED WELT, V36, P1297; MCWIRTHER JP, 1994, BRIT MED J, V308, P945; MEIER R, 1994, SCHWEIZ MED WSCHR, V124, P655; PARK RHR, 1992, BRIT MED J, V304, P1406, DOI 10.1136/bmj.304.6839.1406; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; UNOSSON M, 1994, STROKE, V25, P366, DOI 10.1161/01.STR.25.2.366; Wade D, 1992, MEASUREMENT NEUROLOG; WAXMANN I, 1992, DIGEST DIS SCI, V36, P251; WEEKES E, 1992, CLIN NUTR, V11, P18, DOI 10.1016/0261-5614(92)90058-X; WILLIG TN, 1995, SEMIN NEUROL, V15, P18, DOI 10.1055/s-2008-1041002; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	22	12	14	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022			EUR NEUROL	Eur. Neurol.		1998	40	1					27	30		10.1159/000007952			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105MZ	WOS:000075078500006	9693229				2022-02-06	
J	Wang, HD; Duan, GS; Zhang, J; Zhu, DB				Wang, HD; Duan, GS; Zhang, J; Zhu, DB			Clinical studies on diffuse axonal injury in patients with severe closed head injury	CHINESE MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; HUMANS; TRAUMA	Objective To discuss the clinical criteria for diagnosing diffuse axonal injury (DAI). Methods Clinical and computed tomographic features of 117 patients with severe closed head injury were analyzed. The authors preliminarily put forward CT diagnostic criteria of DAI, that is, 1) single or multiple small intraparenchymal hemorrhages in the cerebral hemispheres (< 2 cm in diameter); 2) intraventricular hemorrhage; 3) hemorrhage in the corpus callosum; 4) small focal areas of hemorrhage adjacent to the third ventricle (< 2 cm in diameter); and 5) brain stem hemorrhage. All patients were divided into two groups, DAI and non-DAI group, according to the criteria. There were 42 patients in the DAI group and 75 patients in the non-DAI group. The injury causes, Glasgow coma scale (GCS) scores on admission, coexisting injuries and outcomes were compared between the two groups. The relationship between DAI and the outcomes in the patients with severe head injury was analyzed. Results Traffic accident was the main injury cause in the cases of DAI. GCS scores on admission in patients with DAI were significantly lower than those in patients without DAI. The incidence of diffuse brain swelling (DBS) in the DAI group was significantly higher than that in the non-DAI group, whereas the incidences of both skull fracture and epidural hematoma (EDH) in the DAI group were significantly lower than those in non-DAI group. There was no significant difference between the incidence of subarachnoid hemorrhage (SAH) and subdural hematoma (SDH) in the two groups. The incidence of poor outcome in the DAI group was significantly higher than that in the non-DAI group, although there was no significant difference between the mortalities in the two groups. Conclusions Because DAI is a very important factor worsening the outcome of patients with head injury, it is essential to make a diagnosis as soon as possible. The clinical manifestations of DAI, however, are not specific and DAI does not show directly on CT scans, so it is difficult to make a definite diagnosis. The CT diagnostic criteria of DAI put forward in this article are practicable, though they are by no means perfect.	Nanjing Univ, Sch Clin Med, Nanjing Gen Hosp PLA, Dept Neurosurg, Nanjing 210002, Peoples R China; Gen Hosp PLA, Dept Neurosurg, Beijing 100853, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Sch Clin Med, Nanjing Gen Hosp PLA, Dept Neurosurg, Nanjing 210002, Peoples R China.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MITCHELL DE, 1973, LANCET, V2, P215; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	14	12	14	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JAN	1998	111	1					59	62					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV690	WOS:000071853000020	10322656				2022-02-06	
J	Takami, H; Takahashi, S; Ando, M				Takami, H; Takahashi, S; Ando, M			Irreducible isolated dislocation of the radial head	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ANTERIOR DISLOCATION	Isolated dislocation of the radial head in adults is a rare injury, A 20-year-old man received a direct blow to his elbow and sustained an isolated anterior dislocation of the radial head, Open reduction was required because soft tissue interposition prevented reduction by closed manipulation. At operation the annular ligament was found to be ruptured and interposed between the articular surfaces, preventing reduction, A satisfactory result was obtained 1 year after surgery.	Kanto Rosai Hosp, Sect Orthopaed Surg, Nakahara Ku, Kawasaki, Kanagawa, Japan		Takami, H (corresponding author), Kanto Rosai Hosp, Sect Orthopaed Surg, Nakahara Ku, Kawasaki, Kanagawa, Japan.						BENJAMIN A, 1976, WATSON JONES FRACT J, P666; BONATUS T, 1995, J ORTHOP TRAUMA, V9, P441, DOI 10.1097/00005131-199505000-00014; HAMILTON W, 1973, CLIN ORTHOP RELAT R, V97, P94; HEIDT RS, 1982, CLIN ORTHOPAEDICS, V168, P136; HUME AC, 1957, J BONE JOINT SURG BR, V39, P508, DOI 10.1302/0301-620X.39B3.508; KONG KC, 1993, ARCH ORTHOP TRAUM SU, V112, P304, DOI 10.1007/BF00452972; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402, DOI 10.1302/0301-620X.59B4.925049; RYU J, 1984, CLIN ORTHOP RELAT R, V183, P169; SALAMA R, 1977, CLIN ORTHOPAEDICS, V125, P156; WILEY JJ, 1974, J BONE JOINT SURG BR, VB 56, P501, DOI 10.1302/0301-620X.56B3.501	10	12	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	DEC	1997		345					168	170					3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	YL426	WOS:000070953800023	9418635				2022-02-06	
J	Karger, B; Banaschak, S				Karger, B; Banaschak, S			Two cases of exenteration of the brain from Brenneke shotgun slugs	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Brenneke shotgun slug; gunshot; exenteration of the brain; incomplete Kronlein shot	INJURIES	A case of extended suicide resulted in two fatalities due to craniocerebral gunshots from a 12-gauge shotgun firing Brenneke shotgun slugs. In each case, the gunshot shattered the skull and the brain and in one case, large parts of the brain including a complete hemisphere were ejected similar to a ''Kronlein shot''. The location of the trajectory close to the base of the skull, the muzzle gases and the ballistic characteristics of the missile contributed to this rare form of head injury. The high mass and the large diameter of the lead missile do not necessitate a high muzzle velocity to crush large amounts of tissue or to produce an explosive type of head injury. The wadding material and the metal screw attached to the Brenneke slug can be of forensic significance.			Karger, B (corresponding author), UNIV MUNSTER,INST LEGAL MED,VON ESMARCH STR 62,D-48129 MUNSTER,GERMANY.		Banaschak, Sibylle/AAE-2104-2020	Banaschak, Sibylle/0000-0002-1413-1250			Bohnert M, 1995, Arch Kriminol, V195, P85; DAVIS GJ, 1993, AM J FOREN MED PATH, V14, P162, DOI 10.1097/00000433-199306000-00013; DIMAIO, 1985, GUNSHOT WOUNDS, P179; FACKLER ML, 1985, J TRAUMA, V25, P522, DOI 10.1097/00005373-198506000-00009; FRANZ C, 1910, ARCH KLIN CHIR, V93, P497; Gestring ML, 1996, J TRAUMA, V40, P650, DOI 10.1097/00005373-199604000-00025; IKEDA N, 1989, MED SCI LAW, V29, P156, DOI 10.1177/002580248902900211; Karger B, 1996, INT J LEGAL MED, V108, P252, DOI 10.1007/BF01369820; KILLAM EW, 1991, CRIME LAB DIGEST, V18, P36; KNEUBUEHL BP, 1994, GESCHOSSE, P169; Kronlein RU, 1899, ARCH KLIN CHIR, V59, P67; MERTENS, 1917, BEITR KLIN CHIR, V108, P371; PANKRATZ H, 1985, Z RECHTSMED, V95, P213; Petty C S, 1968, J Forensic Sci, V13, P114; PIVA C, 1988, J MED LEG DROIT MED, V31, P423; Pollak S, 1990, Beitr Gerichtl Med, V48, P507; RAO VJ, 1987, J FORENSIC SCI, V32, P1435; Risse M, 1988, Arch Kriminol, V182, P75; SELLIER K, 1982, SCHUSSWAFFEN SCHUSSW, P148; Strauch Hansjuerg, 1995, Archiv fuer Kriminologie, V195, P27	20	12	13	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	NOV	1997	110	6					323	325		10.1007/s004140050096			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	YF831	WOS:A1997YF83100006	9387015				2022-02-06	
J	Henry, JM; Talukder, NK; Lee, AB; Walker, ML				Henry, JM; Talukder, NK; Lee, AB; Walker, ML			Cerebral trauma-induced changes in corpus striatal dopamine receptor subtypes	JOURNAL OF INVESTIGATIVE SURGERY			English	Article						cerebral trauma; corpus striatum; dopamine receptors; Wistar rat	ISCHEMIC BRAIN INJURY; UPTAKE SITES; RAT; BINDING; LIGAND; D-2	A device designed specifically for mild to severe concussions was used to produce quantitative experimental blunt brain injury in male Wistar rats. We have examined the effects of varying magnitudes of cerebral trauma on the maximal binding capacity (B-max) of D1 and D2 dopamine (DA) receptors. The B-max for each receptor subtype was obtained from Scatchard analyses of [H-3]-SCH 23390 and [H-3]Spiperone binding to striatal membrane. Anesthetized rats were injured-one, two, or three times-once every 24 h, with either a 68- or 268-g rubber-headed reflex hammer accelerated from a predetermined distance. Uninjured nonanesthetized (NA) and anesthetized (A) rats served as controls. No significant difference in receptor density was observed between NA and A rats for each receptor subtype. Immediately (0 h) following injury from the 68-g hammer weight, the density of D1 receptors decreased (50%), then increased (30%) above control levels by 24 h. The same pattern was observed with the 268-g hammer weight. Analysis of variance (ANOVA) showed that there was no overall effect of number of injuries or treatment on the density of D1 and D2 receptor subtypes. However, there was an interaction of both variables on the DI, but not D2, receptor subtype. Partial ANOVA for receptor densities after rats were injured either one, two, or three times showed that receptor density was altered only after the rats were injured one time. These results suggest that striatal DA D1 receptors are downregulated and then upregulated following isolated injury to the cerebral cortex.	MOREHOUSE SCH MED,DEPT SURG,ATLANTA,GA 30310; CLARK ATLANTA UNIV,DEPT PHYS,ATLANTA,GA 30314						NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003034] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12-RR03034] Funding Source: Medline		BILLARD W, 1984, LIFE SCI, V35, P1885, DOI 10.1016/0024-3205(84)90540-X; BLAKE MJ, 1990, NEUROBIOL AGING, V12, P193; GRABOW JD, 1970, AM J PUBLIC HEALTH, V74, P710; HAMBLIN MW, 1984, BIOCHEM PHARMACOL, V33, P877, DOI 10.1016/0006-2952(84)90441-6; HYTELL J, 1982, ADV DOPAMINE RES; JENNETT B, 1972, LANCET, V1, P734; KOSTIC V, 1991, J NEUROCHEM, V57, P1962, DOI 10.1111/j.1471-4159.1991.tb06410.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OBOYLE KM, 1984, EUR J PHARMACOL, V105, P171, DOI 10.1016/0014-2999(84)90663-0; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PRZEDBORSKI S, 1991, J NEUROCHEM, V57, P1951, DOI 10.1111/j.1471-4159.1991.tb06409.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x	14	12	12	0	0	TAYLOR & FRANCIS	BRISTOL	1900 FROST ROAD, SUITE 101, BRISTOL, PA 19007-1598	0894-1939			J INVEST SURG	J. Invest. Surg.	SEP-OCT	1997	10	5					281	286		10.3109/08941939709032167			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YD803	WOS:A1997YD80300006	9361992				2022-02-06	
J	Karakucuk, EI; Pasaoglu, H; Pasaoglu, A; Oktem, S				Karakucuk, EI; Pasaoglu, H; Pasaoglu, A; Oktem, S			Endogenous neuropeptides in patients with acute traumatic head injury .2. Changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma	NEUROPEPTIDES			English	Article; Proceedings Paper	International Congress on Free Radicals in Health and Disease	SEP 06-10, 1995	ISTANBUL, TURKEY				BIOGENIC-AMINE CONTENT; NERVOUS-SYSTEM INJURY; BRAIN INJURY; SPINAL-CORD; CEREBRAL METABOLISM; FREE-RADICALS; RATS; RESPONSES	The cerebrospinal fluid (CSF) levels of substance P (SP), serotonin (5-HT) and lipid peroxidation (LPx) products were measured in patients with traumatic head injury and then compared to the levels obtained from control subjects. CSF samples were collected from 45 patients (31 male, 14 female, aged 19.2 +/- 17.79) within 24 h of the head trauma and the control CSF samples were obtained from 25 healthy subjects (23 male, 2 female, aged 51.44 +/- 17.6 years) having minor surgical operations under spinal anaesthesia. CSF SP and 5-HT levels in patients with head trauma were significantly lower than the levels in controls (P < 0.005, P < 0.001, respectively). On the other hand, the CSF Lpx products were significantly increased in patients with head trauma (P < 0.001). No significant correlation was found between the CSF changes and the admission Glasgow Coma Scale scores of the patients. This study constitutes the second part of our work on endogenous neuropeptides in patients with traumatic head injury and it emphasizes the role of SP, 5-HT and lipid peroxidation as additional endogenous factors in traumatic head injuries.	ERCIYES UNIV, DEPT BIOCHEM, FAC MED, TR-38039 KAYSERI, TURKEY; ERCIYES UNIV, DEPT NEUROSURG, FAC MED, TR-38039 KAYSERI, TURKEY		Karakucuk, EI (corresponding author), ERCIYES UNIV, DEPT CLIN BIOCHEM, FAC MED, TR-38039 KAYSERI, TURKEY.						BOCHICCHIO M, 1990, INTENS CARE MED, V16, P444, DOI 10.1007/BF01711223; Caron M J, 1991, Neurosurg Clin N Am, V2, P483; Choi Byung Ho, 1993, Yonsei Medical Journal, V34, P1; COOPER JR, 1986, BIOCH BASIS NEUROPHA, P352; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; EGHWRUDJAKPOR PO, 1991, SURG NEUROL, V35, P273, DOI 10.1016/0090-3019(91)90004-S; Faden A I, 1988, Adv Neurol, V47, P531; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; FADEN AI, 1985, NEUROPEPTIDES, V6, P215, DOI 10.1016/0143-4179(85)90092-7; FADEN AI, 1988, BRAIN RES, V450, P94, DOI 10.1016/0006-8993(88)91548-X; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; GADE GF, 1990, NEUROLOGICAL SURG, V3, P1965; GENNARELLI TA, 1990, NEUROLOGICAL SURG VA, V3, P1953; GUOLIANG W, 1991, CHIN MED J, V104, P764; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HUNTER MIS, 1985, NEUROCHEM RES, V10, P1645, DOI 10.1007/BF00988606; IKEDA Y, 1990, NEUROSURGERY, V27, P1; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; MANTYH PW, 1991, ANN NY ACAD SCI, V632, P263, DOI 10.1111/j.1749-6632.1991.tb33114.x; MARKIANOS M, 1992, ACTA NEUROL SCAND, V86, P190, DOI 10.1111/j.1600-0404.1992.tb05064.x; MIONE MC, 1990, PHARMACOL THERAPEUT, V46, P429, DOI 10.1016/0163-7258(90)90027-Y; NAFTCHI NE, 1978, BRAIN RES, V153, P507, DOI 10.1016/0006-8993(78)90335-9; NAFTCHI NE, 1990, ANN NY ACAD SCI, V579, P168; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; PAPPIUS HM, 1989, PROG NEURO-PSYCHOPH, V13, P353, DOI 10.1016/0278-5846(89)90124-3; PAPPIUS HM, 1988, J CEREBR BLOOD F MET, V8, P324, DOI 10.1038/jcbfm.1988.67; Pasaoglu H, 1996, NEUROPEPTIDES, V30, P47; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; SEN S, 1993, NEUROSCI LETT, V162, P117, DOI 10.1016/0304-3940(93)90574-5; SINGH S, 1986, INDIAN J EXP BIOL, V24, P505; VITA G, 1990, NEUROPEPTIDES, V17, P147, DOI 10.1016/0143-4179(90)90078-D; Wills E. D., 1987, BIOCH TOXICOLOGY PRA, P127	37	12	12	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	JUN	1997	31	3					259	263		10.1016/S0143-4179(97)90057-3			5	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Neurosciences & Neurology	XJ769	WOS:A1997XJ76900009	9243523				2022-02-06	
J	Lowenstein, SR; KoziolMcLain, J; Glazner, J				Lowenstein, SR; KoziolMcLain, J; Glazner, J			The Colorado Motorcycle Safety Survey: Public attitudes and beliefs	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						legislation; head protective devices; motorcycles; polling	HELMET-USE-LAW; INJURY PREVENTION; HEAD-INJURIES; FATALITIES	Background: Motorcycle riders have a high risk of traumatic brain injury, disability, and death, Epidemiologic studies have proven that helmets reduce the severity of brain injuries and the cost of care. Yet, Colorado remains one of three states with no helmet law for riders. Objectives: This study measured public support for (1) a mandatory motorcycle helmet use law and (2) mandatory motorcycle operator safety training. We also sought to ascertain citizens' attitudes toward traffic safety mandates from the federal government. Methods: Structured telephone interviews were conducted with 407 Colorado adults selected by random-digit dialing. Results: Sixty-five percent of respondents believed that motorcycle riders of all ages should be required to wear helmets. An additional 18% believed that only riders under age 21 should be required to wear helmets, Only 17% of respondents opposed all helmet laws, Even among motorcyclists, most supported helmet laws for all riders (47%) or for those <21 years of age (26%), In a multiple logistic regression, there were three significant independent predictors of a pro-helmet law stance: older age, female gender, and not possessing a motorcycle operator's license, Most respondents also supported mandatory motorcycle operator safety training, Despite supporting state helmet use regulations, a large proportion (41%) opposed mandatory Federal mandates to enact them. Conclusion: Even in Colorado, a state with no helmet use requirements, there is strong public support for a regulatory strategy of motorcycle helmet use laws.	UNIV COLORADO, HLTH SCI CTR, DEPT PREVENT MED & BIOMETR, DENVER, CO 80262 USA		Lowenstein, SR (corresponding author), UNIV COLORADO, HLTH SCI CTR, DIV EMERGENCY MED, COLORADO EMERGENCY MED RES CTR, 4200 E 9TH AVE, DENVER, CO 80262 USA.			Koziol-McLain, Jane/0000-0003-3453-023X			BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; BAKER SP, 1980, AM J PUBLIC HEALTH, V70, P573, DOI 10.2105/AJPH.70.6.573; BRIED JM, 1987, CLIN ORTHOP RELAT R, P252; *CO DEP HLTH HLTH, 1992, COL VIT STAT 1990; COBLE YD, 1994, JAMA-J AM MED ASSOC, V272, P1535, DOI 10.1001/jama.1994.03520190081039; DARE CE, 1979, I TRANSPORTATIO 1009; EVANS L, 1988, ACCIDENT ANAL PREV, V20, P447, DOI 10.1016/0001-4575(88)90043-7; GABELLA B, 1995, ACCIDENT ANAL PREV, V27, P363, DOI 10.1016/0001-4575(94)00079-2; Krane S. W., 1980, IMPACT MOTORCYCLE HE; KRAUS JF, 1995, AM J PUBLIC HEALTH, V85, P96, DOI 10.2105/AJPH.85.1.96; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; LOWENSTEIN SR, 1993, J TRAUMA, V35, P786, DOI 10.1097/00005373-199311000-00023; MCKNIGHT AJ, 1995, ACCIDENT ANAL PREV, V27, P493, DOI 10.1016/0001-4575(95)00008-N; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; *NAT HIGHW TRAFF S, 1997, ANN EMERG MED, V29, P282; OFFNER PJ, 1992, J TRAUMA, V32, P636, DOI 10.1097/00005373-199205000-00016; POLEN MR, 1988, JAMA-J AM MED ASSOC, V259, P76, DOI 10.1001/jama.259.1.76; RUTLEDGE R, 1993, ACCIDENT ANAL PREV, V25, P347, DOI 10.1016/0001-4575(93)90028-U; SALZBERG P, 1991, MOTORCYCLE HELMET US; SHANKAR BS, 1992, ACCIDENT ANAL PREV, V24, P385, DOI 10.1016/0001-4575(92)90051-J; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; THORNBERRY OT, 1988, WILEY S PRO, P25; *US BUR CENS, 1990, 1990 CENS POP HOUS S; *US DEP TRANSP, 1994, TRAFF SAF FACTS 1994; US General Accounting Office, 1991, GAORCED91170 US GEN; VERNICK JS, 1993, HEALTH AFFAIR, V12, P198, DOI 10.1377/hlthaff.12.4.198; WILSON D, 1989, 807416 HS US DEP TRA	27	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	1997	42	6					1124	1128		10.1097/00005373-199706000-00024			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	XH700	WOS:A1997XH70000031	9210553				2022-02-06	
J	Hollis, GJ				Hollis, GJ			Sixth cranial nerve palsy following closed head injury in a child	JOURNAL OF ACCIDENT & EMERGENCY MEDICINE			English	Article						abducens nerve palsy; closed head injury; child	INTERNAL CAROTID-ARTERY; DISSECTION; ANEURYSM	A five year old female had an isolated abducens nerve palsy following closed head injury, There was no associated skull fracture, haematoma, or other cranial nerve injury, The significance, frequency, and differential diagnosis of traumatic sixth cranial nerve injury is discussed, particularly in paediatric patients, Management is symptomatic; occlusion with an eye pad may be used if diplopia is significant, In young children alternate day occlusion of each eye will help prevent amblyopia. Most cases improve within three months and many resolve by six months. Residual palsy at six months is likely to be permanent and surgical treatment may be needed.			Hollis, GJ (corresponding author), ST GEORGE HOSP, DEPT EMERGENCY MED, KOGARAH, NSW 2217, AUSTRALIA.						ARIAS MJ, 1985, NEUROSURGERY, V16, P232, DOI 10.1227/00006123-198502000-00020; BERLIT P, 1989, FORTSCHR NEUROL PSYC, V57, P32, DOI 10.1055/s-2007-1000743; DEPPER MH, 1993, AM J ROENTGENOL, V160, P837, DOI 10.2214/ajr.160.4.8456676; GLASTER JS, 1994, DUANES CLIN OPHTHALM, V2, P3; HARLEY RD, 1980, OPHTHALMOLOGY, V87, P24; HIPWELL G, 1992, MODERN MED AUSTR OCT, P141; INSEL TR, 1980, NEW ENGL J MED, V303, P703; LAL V, 1994, COMPUT MED IMAG GRAP, V18, P381, DOI 10.1016/0895-6111(94)90009-4; LIMNAIOS EE, 1980, OPHTHALMOLOGICA, V181, P326, DOI 10.1159/000309071; MAITLAND CG, 1983, ARCH NEUROL-CHICAGO, V40, P448, DOI 10.1001/archneur.1983.04050070078022; Marconi F, 1994, J Neurosurg Sci, V38, P177; MILLER EA, 1982, ARCH OPHTHALMOL-CHIC, V100, P603, DOI 10.1001/archopht.1982.01030030605012; MORIOKA T, 1992, J CLIN NEURO-OPHTHAL, V12, P263; MOSTER ML, 1984, ARCH OPHTHALMOL-CHIC, V102, P1328; ODELL KB, 1990, ANN EMERG MED, V19, P1063, DOI 10.1016/S0196-0644(05)82574-0; PARKS MM, 1994, DUANES CLIN OPHTHALM, V1, P12; RENZI ED, 1977, EUR NEUROL, V15, P227, DOI 10.1159/000114837; ROBERTSON DM, 1970, ARCH OPHTHALMOL-CHIC, V83, P574; RUSH JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P76, DOI 10.1001/archopht.1981.03930010078006; SHIFRIN LZ, 1991, SPINE, V16, P374, DOI 10.1097/00007632-199103000-00024; STRACCIARI A, 1988, ACTA NEUROL BELG, V88, P148; Takagi H, 1976, No Shinkei Geka, V4, P963; Yamashita K, 1995, No To Shinkei, V47, P286	23	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0622			J ACCID EMERG MED	J. Accid. Emerg. Med.	MAY	1997	14	3					172	175					4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XF573	WOS:A1997XF57300014	9193985				2022-02-06	
J	Patterson, DE; Braverman, SE; Belandres, PV				Patterson, DE; Braverman, SE; Belandres, PV			Speech dysfunction due to trazodone-fluoxetine combination in traumatic brain injury	BRAIN INJURY			English	Article; Proceedings Paper	1995 Association-of-Academic-Psychiatrists Meeting	MAR, 1995	SCOTTSDALE, AZ	Assoc Acad Physiatrists			DRUG-DRUG INTERACTIONS; MOTOR RECOVERY; ANTIDEPRESSANTS; DEPRESSION; PATIENT	New serotonin reuptake inhibitors are available for the treatment of affective disorders and sleep dysfunction in traumatic brain injury (TBI) patients. Commonly reported serotonergic side-effects include nausea, headache, dizziness, nervousness, and orthostatic hypotension. Trazodone, a nonselective serotonin reuptake inhibitor, is often used in conjunction with fluoxetine, a selective serotonin reuptake inhibitor, in order to combat the insomnia associated with fluoxetine. Successful use of this combination is generally limited by the cumulative serotonergic side-effects of the two medications. This paper describes the first reported case of speech dysfunction as a complication of combined trazodone and fluoxetine use. A 43-year-old male suffered bilateral wrist fractures and a moderate TBI during a fall. Within 1 week of adding fluoxetine to trazodone the patient developed new-onset dysarthria and speech blocking. Upon discontinuation of fluoxetine, speech returned to normal. Possible mechanisms include inhibition of hepatic metabolism, unmasking of caudate nucleus injury, increased noradrenergic activity or previously unreported serotonergic effects. This case illustrates the importance of monitoring drug combinations for unexpected side-effects in the TBI population.	WALTER REED ARMY MED CTR,DEPT PHYS MED & REHABIL,RES TRAINING PROGRAM,WASHINGTON,DC 20307								ALBERT ML, 1988, JAMA-J AM MED ASSOC, V259, P1043, DOI 10.1001/jama.259.7.1043; ARANOW RB, 1989, AM J PSYCHIAT, V146, P911; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; CIRAULO DA, 1990, J CLIN PSYCHOPHARM, V10, P213; CIRAULO DA, 1990, J CLIN PSYCHOPHARM, V10, P48, DOI 10.1097/00004714-199002000-00009; COLE JO, 1990, J CLIN PSYCHIAT, V51, P21; FEIGHNER JP, 1988, PSYCHOPHARMACOLOGY, V95, pS50; FISHER S, 1993, J CLIN PSYCHOPHARM, V13, P235; LEVINSON ML, 1991, DICP ANN PHARMAC, V25, P657; METZ A, 1990, INT CLIN PSYCHOPHARM, V5, P191, DOI 10.1097/00004850-199007000-00004; NIERENBERG AA, 1992, J CLIN PSYCHIAT, V53, P83; SAUNDERS M, 1977, BRIT MED J, V275, P317; SCHATZBERG AF, 1987, J CLIN PSYCHOPHARM, V7, P445; SHATZBERG AF, 1978, AM J PSYCHIAT, V135, P600; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; VAUGHAN DA, 1988, AM J PSYCHIAT, V145, P1478; WROBLEWSKI BA, 1992, AM J PSYCHIAT, V149, P273	19	12	12	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1997	11	4					287	291		10.1080/026990597123593			5	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WQ736	WOS:A1997WQ73600006	9134203				2022-02-06	
J	Sakuta, Y; Arai, S				Sakuta, Y; Arai, S			Penetrating brain injury and traumatic aneurysm caused by a nail gun	NEUROLOGICAL SURGERY			Japanese	Article						penetrating brain injury; nail gun; traumatic aneurysm		A rare case of penetrating brain injury and traumatic aneurysm caused by a nail gun was described. A 45-year-old male was admitted to our hospital on October 13, 1995 due to a penetrating head injury. He had used a nail gun in a suicide attempt. On admission, he presented with moderate consciousness disturbance, right hemiparesis and aphasia. Several small wounds were observed at the bilateral temporal scalp. The skull films showed that there were five nails in the left side and four nails in the right side perforating the skull. The CT revealed a small hematoma at the left temporal lobe. The cerebral angiograms did not show any particular findings. Under local anesthesia, each nail was extracted carefully. Suddenly, his neurological damage aggravated and the CT showed a massive hematoma in the left temporal lobe. Emergent craniotomy was performed and the hematoma was totally evacuated. Rehabilitation was carried out and he recovered enough to be able to walk. Angiograms four months after the injury revealed the formation of a traumatic aneurysm at the peripheral part of the left middle cerebral artery (cortical cerebral aneurysm). We did not perform a direct operation for the aneurysm since the contrast medium remained in the aneurysm until the late venous phase. This aneurysm disappeared spontaneously after another four months' observation. Although many penetrated head injuries have been previously reported, the present case is the first report of a traumatic aneurysm associated with nail gun injury.	NAGOYA CITY UNIV,DEPT NEUROSURG,NAGOYA,AICHI,JAPAN								ALMEFTY O, 1986, AM J NEURORADIOL, V7, P164; BAKAY L, 1977, ACTA NEUROCHIR, V39, P219, DOI 10.1007/BF01406732; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Birley JL, 1928, BRAIN, V51, P184, DOI 10.1093/brain/51.2.184; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GOERAN K, 1971, ACTA CHIR SCAND, V137, P474; JACOBY W, 1959, Chirurg, V30, P423; MALTBY GL, 1963, NEW ENGL J MED, V269, P111; NORTH JB, 1970, MED J AUSTRALIA, V2, P183, DOI 10.5694/j.1326-5377.1970.tb87380.x; OHAEGBULAM SC, 1980, SURG NEUROL, V14, P393; Okada Takashi, 1993, Neurologia Medico-Chirurgica, V33, P703, DOI 10.2176/nmc.33.703; OVERTON MC, 1966, J NEUROSURG, V24, P672, DOI 10.3171/jns.1966.24.3.0672; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; Wu W Q, 1975, Surg Neurol, V3, P83	16	12	12	0	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	APR	1997	25	4					357	362					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WX240	WOS:A1997WX24000010	9125720				2022-02-06	
J	Callahan, CD; Schopp, L; Johnstone, B				Callahan, CD; Schopp, L; Johnstone, B			Clinical utility of a seven subtest WAIS-R short form in the neuropsychological assessment of traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								Comparison of IQ scores from the standard Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the Ward (1990) seven-subtest short form (WAIS-R/7 SF) was performed on a sample of 459 patients with traumatic brain injury due to head trauma. The results indicate that this short form provides Verbal, Performance, and Full Scale IQ scores that vary little from the complete WAIS-R, at approximately one-half the typical administration time. The seven subtest short form predicted WAIS-R Full Scale IQ within 6 points in 95% of this clinical sample, with Verbal-Performance Ie discrepancies that were highly correlated (r(s) = .85, p < .0001). No differential gender effect in proration of IQs was found. Applications and pitfalls of abbreviated neuropsychological testing batteries are discussed, with utilization of the WAIS-R/7 SF offered as a means to reduce intelligence resting time while maintaining the ability to detect subtle information processing abnormalities with appropriate supplemental tasks. (C) 1997 National Academy of Neuropsychology.	UNIV MISSOURI,COLUMBIA SCH MED,COLUMBIA,MO 65211		Callahan, CD (corresponding author), MEM MED CTR,CTR NEUROMUSCULAR SCI,800 N RUTLEDGE,SPRINGFIELD,IL 62781, USA.			Johnstone, Brick/0000-0001-8845-9649			*BAXT HEALTHC CORP, 1994, M CUST REQ PART GUID; Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; BENTON A, 1992, J CLIN EXP NEUROPSYC, V14, P407, DOI 10.1080/01688639208407616; DOPELT JE, 1956, J CLIN PSYCHOL, V20, P63; FAUST D, 1995, COPING PSYCHIAT PSYC, P916; Franzen M. D., 1989, RELIABILITY VALIDITY; JOHNSTONE B, 1995, PROF PSYCHOL-RES PR, V26, P341, DOI 10.1037/0735-7028.26.4.341; KAUFMAN AS, 1991, J PSYCHOEDUC ASSESS, V9, P4, DOI 10.1177/073428299100900101; KAUFMAN AS, 1977, J CONSULT CLIN PSYCH, V45, P1159, DOI 10.1037/0022-006X.45.6.1159; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; REITAN RM, 1993, B NATL ACAD NEUROPSY, V10, P1; SATTERFIELD WA, 1994, J PSYCHOEDUC ASSESS, V12, P364, DOI 10.1177/073428299401200406; SATZ P, 1962, J CLIN PSYCHOL, V18, P77, DOI 10.1002/1097-4679(196201)18:1<77::AID-JCLP2270180124>3.0.CO;2-R; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; SILVERSTEIN AB, 1977, J CONSULT CLIN PSYCH, V45, P1162, DOI 10.1037/h0078060; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler, 1997, WECHSLER ADULT INTEL; WILLIAMS JM, 1993, B NATL ACAD NEUROPSY, V10, P1	19	12	12	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	2					133	138		10.1016/S0887-6177(96)00029-7			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	WV548	WOS:A1997WV54800004	14588424	Bronze			2022-02-06	
J	Harrington, C; Salloway, S; Malloy, P				Harrington, C; Salloway, S; Malloy, P			Dramatic neurobehavioral disorder in two cases following bilateral anteromedial frontal lobe injury: Delayed psychosis and marked change in personality	NEUROCASE			English	Article						closed head injury; frontal lobe deficits; psychosis; mood lability	TRAUMATIC BRAIN INJURY; REDUPLICATIVE PARAMNESIA; HEAD TRAUMA; INTERICTAL BEHAVIOR; HUMAN AUTONOMY; EPILEPSY; DYSFUNCTION; DELUSIONS; DEPRESSION; DIAGNOSIS	This paper describes two cases of closed head injury causing bilateral frontal lobe contusions that resulted in enduring changes in self-control, perception, mood and cognition. In the first case the primary feature was delayed-onset psychosis. In the second case the patient developed mood lability, poor impulse control, a dramatic change in personality and impaired cognition. Midline, anterior frontal regions were most severely affected in both cases. The diagnostic evaluation and the clinical course are described. The neuropsychiatric syndromes are discussed with reference to lesion location and the literature on the neurobehavioral sequelae of closed head injury.	BROWN UNIV, SCH MED, DEPT CLIN NEUROSCI & PSYCHIAT & HUMAN BEHAV, PROVIDENCE, RI 02912 USA				Malloy, Paul F/A-8581-2009				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; BARNHILL LJ, 1989, NEUROPSY NEUROPSY BE, V2, P211; BEAR DM, 1977, ARCH NEUROL-CHICAGO, V34, P454, DOI 10.1001/archneur.1977.00500200014003; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CAMPBELL JJ, 1994, J NEUROPSYCH CLIN N, V6, P411; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DONGIER S, 1959, EPILEPSIA, V1, P117; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Feinberg T.E., 1989, NEUROPSY NEUROPSY BE, V2, P39; FILLEY CM, 1987, NEUROLOGY, V37, P701, DOI 10.1212/WNL.37.4.701; FORSTL H, 1991, PSYCHOL MED, V21, P905, DOI 10.1017/S0033291700029895; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; HAKIM H, 1988, J NEUROL NEUROSUR PS, V51, P839, DOI 10.1136/jnnp.51.6.839; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; KAPUR N, 1988, J NEUROL NEUROSUR PS, V51, P579, DOI 10.1136/jnnp.51.4.579; KOUFEN P, 1987, EUROPEAN ARCH PSYCHI, V237, P2; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; MALLOY P, 1992, NEUROPSY NEUROPSY BE, V5, P83; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P399; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P455; MALLOY PF, 1985, INT J CLIN NEUROPSYC, V7, P88; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; PRITCHARD PB, 1980, NEUROLOGY, V30, P227, DOI 10.1212/WNL.30.3.227; Rabins P V, 1991, J Neuropsychiatry Clin Neurosci, V3, P6; Richardson E D, 1991, J Geriatr Psychiatry Neurol, V4, P160, DOI 10.1177/089198879100400307; Robinson R G, 1990, J Neuropsychiatry Clin Neurosci, V2, P1; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROBINSON RG, 1994, NEUROPSYCHIATRY TRAU; RUFF RL, 1981, J NEUROL NEUROSUR PS, V44, P382, DOI 10.1136/jnnp.44.5.382; SALLOWAY SP, 1994, J NEUROPSYCH CLIN N, V6, P388; SHEPHERD M, 1961, J MENT SCI, V107, P687; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1992, APA TXB NEUROPSYCHIA; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V155, P79, DOI 10.1192/bjp.155.1.79; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TUCKER GJ, 1986, J NERV MENT DIS, V174, P348, DOI 10.1097/00005053-198606000-00007; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; WAXMAN SG, 1975, ARCH GEN PSYCHIAT, V32, P1580; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P125; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P249	55	12	12	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		1997	3	2					137	149		10.1093/neucas/3.2.137			13	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100007					2022-02-06	
J	Lundberg, F; Tegenfeldt, JO; Montelius, L; Ransjo, U; Appelgren, P; Siesjo, P; Ljungh, A				Lundberg, F; Tegenfeldt, JO; Montelius, L; Ransjo, U; Appelgren, P; Siesjo, P; Ljungh, A			Protein depositions on one hydrocephalus shunt and on fifteen temporary ventricular catheters	ACTA NEUROCHIRURGICA			English	Article						shunt; protein; ventricular catheter	COAGULASE-NEGATIVE STAPHYLOCOCCI; ACUTE INFLAMMATORY RESPONSES; HUMAN-PLASMA; AFFINITY-CHROMATOGRAPHY; SURFACE HEPARINIZATION; POLYMER SURFACES; BINDING-SITES; FIBRONECTIN; FIBRINOGEN; VITRONECTIN	Biomaterials are commonly used in modem medicine. Proteins are adsorbed to the surface of the biomaterial immediately after insertion. This report demonstrates the presence of adsorbed proteins in one infected cerebrospinal shunt from a child with hydrocephalus and on fifteen temporary ventricular catheters from adult patients with spontaneous or traumatic brain injuries. Depositions of vitronectin, fibrinogen and thrombospondin-fibronectin to some extent - on the shunt surface was imaged by field-emission scanning electron microscopy. Vitronectin, fibronectin, fibrinogen, and thrombospondin on the ventricular catheters were shown with radio-actively labelled antibodies. Furthermore, protein adsorption from human cerebrospinal fluid to heparinized and unheparinized polymers was studied under flowing conditions in vitro. On heparinized polymer, significantly reduced levels of vitronectin, fibronectin, and thrombospondin were exposed, as measured after 4 hours in vitro perfusion. After 24 hours perfusion, the differences in protein exposition between heparinized and unheparinized polymers were substantially reduced.	LUND UNIV, DEPT MED MICROBIOL, S-22362 LUND, SWEDEN; LUND INST TECHNOL, DEPT SOLID STATE PHYS, LUND, SWEDEN; KAROLINSKA HOSP, DEPT LAB MED, S-10401 STOCKHOLM, SWEDEN; KAROLINSKA HOSP, DEPT MED, S-10401 STOCKHOLM, SWEDEN; UNIV LUND HOSP, DEPT NEUROSURG, S-22185 LUND, SWEDEN				Montelius, Lars/B-9071-2008; Tegenfeldt, Jonas/B-9506-2008	Montelius, Lars/0000-0001-9563-2307; Tegenfeldt, Jonas/0000-0002-3695-6886; Siesjo, Peter/0000-0002-5848-690X			AMMIRATI M, 1987, CHILD NERV SYST, V3, P106, DOI 10.1007/BF00271135; Appelgren P, 1996, CRIT CARE MED, V24, P1482, DOI 10.1097/00003246-199609000-00009; APPLEYARD ME, 1991, BRIT J OPHTHALMOL, V75, P276, DOI 10.1136/bjo.75.5.276; BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2; BAYSTON R, 1989, HYDROCEPHALUS SHUNT; CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177; CLERI DJ, 1980, J INFECT DIS, V141, P781, DOI 10.1093/infdis/141.6.781; FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Gardner P, 1988, Curr Clin Top Infect Dis, V9, P185; GEBB C, 1986, J BIOL CHEM, V261, P6698; GEORGE R, 1979, J NEUROSURG, V51, P804, DOI 10.3171/jns.1979.51.6.0804; GYRING J, 1989, ALFRED BENZON SYMP S, V27, P80; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hook M, 1989, FIBRONECTIN, P295; HWANG RQ, 1991, PHYS REV LETT, V67, P3279, DOI 10.1103/PhysRevLett.67.3279; Hynes R. O., 1990, FIBRONECTINS; JACOBSEN RJ, 1983, J BIOMED MATER RES, V16, P199; KOST C, 1992, J BIOL CHEM, V267, P12098; LARM O, 1987, THROMB HAEMOSTASIS, V58, P84; LINDON JN, 1986, BLOOD, V68, P355; LJUNGH A, 1995, METHOD ENZYMOL, V253, P501; Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285; Lundberg F, 1997, INFECT IMMUN, V65, P897, DOI 10.1128/IAI.65.3.897-902.1997; LUNDBERG N, 1960, ACTA PSYCHIATR S149, V36, P7; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; PARISE LV, 1993, BIOCHEM J, V289, P445, DOI 10.1042/bj2890445; PAULSSON M, 1992, J CLIN MICROBIOL, V30, P2006, DOI 10.1128/JCM.30.8.2006-2012.1992; PEKNA M, 1993, BIOMATERIALS, V14, P189, DOI 10.1016/0142-9612(93)90022-T; PITT WG, 1986, BIOMATERIALS, V7, P340, DOI 10.1016/0142-9612(86)90004-9; PODACK ER, 1979, J BIOL CHEM, V254, P9908; RAPOZA R, 1990, J BIOMED MATER RES, P1263; RENIER D, 1984, J NEUROSURG, V61, P1072, DOI 10.3171/jns.1984.61.6.1072; ROZALSKA B, 1995, FEMS IMMUNOL MED MIC, V11, P307, DOI 10.1016/0928-8244(95)00039-A; RUGE JR, 1993, BRAIN SURGERY COMPLI, P1463; SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105; STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549; VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633; VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; WOOD JM, 1985, NEUROSURGERY, V1, P161; YABKOWITZ R, 1989, J BIOL CHEM, V264, P10888; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3; YU JL, 1995, J SURG RES, V59, P596, DOI 10.1006/jsre.1995.1210; Yu JL, 1997, BIOMATERIALS, V18, P421, DOI 10.1016/S0142-9612(96)00154-8; ZARDI L, 1980, J IMMUNOL METHODS, V34, P155, DOI 10.1016/0022-1759(80)90169-6	50	12	13	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1997	139	8					734	742		10.1007/BF01420046			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XT967	WOS:A1997XT96700015	9309288				2022-02-06	
J	Di, X; Lyeth, BG; Hamm, RJ; Bullock, MR				Di, X; Lyeth, BG; Hamm, RJ; Bullock, MR			Voltage-dependent Na+/K+ ion channel blockade fails to ameliorate behavioral deficits after traumatic brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						tetrodotoxin (TTX); microdialysis; neurotrauma; fluid percussion; voltage-gated channel; behavioral performance; traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; COMPLETE ISCHEMIA; FOCAL ISCHEMIA; EDEMA; SODIUM; GERBIL; MK-801; MODEL; TETRODOTOXIN; ANTAGONISTS	Traumatic brain injury (TBI) induces massive, transient ion flux, after impact. This may be via agonist gated channels, such as the muscarinic, cholinergic or NMDA receptor, or via voltage-dependent channels. Pharmacological blockade of the former, is neuroprotective in most TBI models, but the role of voltage-dependent Na+/K+ channels has not been tested. We have therefore tested the hypothesis that intraventricular tetrodotoxin (TTX) (20 mu l, 5 mM) induced blockade of post-TBI ion flux will prevent cytotoxic cell swelling, Na+ and K+ flux, and behavioral deficit. Microdialysis demonstrated blockade of [K+]d flux in the TTX group compared to controls. Behavioral evaluation of motor (days 1-5) and memory function (days 11-15) after TBI revealed no beneficial effect in the TTX group compared to controls. Thus, although evidence of reduced ionic flux was demonstrated in the TTX group, memory and behavior were unaffected, suggesting that agonist-operated channel-mediated ion flux is more important after TBI.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298					Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		ANDINE P, 1992, J CEREBR BLOOD F MET, V12, P773, DOI 10.1038/jcbfm.1992.108; BETA AL, 1989, STROKE, V20, P1253; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; BULLOCK R, 1993, KLINISCHE ERNAHRUNG, V36, P113; DELUGA KS, 1991, STROKE, V22, P1259, DOI 10.1161/01.STR.22.10.1259; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELEFF SM, 1991, STROKE, V22, P233, DOI 10.1161/01.STR.22.2.233; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; GUELDRY S, 1990, STROKE, V21, P1458, DOI 10.1161/01.STR.21.10.1458; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HATASHITA S, 1990, STROKE, V21, P582, DOI 10.1161/01.STR.21.4.582; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1992, J NEUROTRAUMA, V9, P547; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYSKO PG, 1994, STROKE, V25, P2476, DOI 10.1161/01.STR.25.12.2476; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; NELLGARD B, 1992, J CEREB BLOOD FLOW M, V12, P8; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; SYMON L, 1979, STROKE, V10, P184, DOI 10.1161/01.STR.10.2.184; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; UEMATSU D, 1991, J CEREBR BLOOD F MET, V11, P779, DOI 10.1038/jcbfm.1991.135; WARNER MA, 1991, J CEREBR BLOOD F MET, V11, P600, DOI 10.1038/jcbfm.1991.110; XIE YX, 1994, BRAIN RES, V652, P216, DOI 10.1016/0006-8993(94)90230-5; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751	31	12	12	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	1996	13	9					497	504		10.1089/neu.1996.13.497			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VP266	WOS:A1996VP26600002	8913966				2022-02-06	
J	Mayer, NH; Esquenazi, A; Wannstedt, G				Mayer, NH; Esquenazi, A; Wannstedt, G			Surgical planning for upper motoneuron dysfunction: The role of motor control evaluation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						motor control; surgical planning; upper motoneuron dysfunction	MANAGEMENT; GAIT	After severe traumatic brain injury, the upper motoneuron syndrome results in a variety of common patterns of movement dysfunction attributable, in part, to imbalance of musculotendinous forces acting across joints. Surgical options for rebalancing these deforming forces may include tendon lengthenings and transfers, muscle releases, neurectomies, and release of joint contracture. This article describes the key role of motor control evaluation in assisting surgical planning and making appropriate selections from among the available options.	TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19122; MOSSREHAB HOSP,GAIT & MOT ANAL LAB,PHILADELPHIA,PA 19141		Mayer, NH (corresponding author), MOSSREHAB HOSP,MOTOR CONTROL ANAL LAB,1200 W TABOR RD,PHILADELPHIA,PA 19141, USA.						ANMUTH CJ, 1994, STATE ART REV PHYS M, V8, P547; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI; BOTTE MJ, 1989, J HAND SURG-AM, V14, P174, DOI 10.1016/0363-5023(89)90002-6; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P34; ESQUENAZI A, 1993, REHABILITATION MED P; ESQUENAZI A, 1991, PHYS MED REH CLIN N, V2, P473; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; GRIFFITH ER, 1990, REHABILITATION ADULT; Heiden JS, 1979, NEURAL TRAUMA; Hoffer M M, 1979, J Hand Surg Am, V4, P424; HOUSE JH, 1981, J BONE JOINT SURG AM, V63, P216, DOI 10.2106/00004623-198163020-00006; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1987, J BONE JOINT SURG AM, V69A, P1127, DOI 10.2106/00004623-198769080-00003; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P734, DOI 10.1016/S0363-5023(87)80059-X; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575, DOI 10.1016/S0363-5023(87)80211-3; KEENAN MAE, 1989, J BONE JOINT SURG AM, V71A, P120, DOI 10.2106/00004623-198971010-00018; KLEIN RB, 1995, NEUROLOGY S4, V45, P330; LANCE JW, 1980, SPATISCITY DISORDERE; MAYER NH, 1996, MED REHABILITATION T; ORCUTT SA, 1990, J HAND SURG-AM, V13, P940; PEAT M, 1976, ARCH PHYS MED REHAB, V57, P421; WINTER DA, 1984, ARCH PHYS MED REHAB, V65, P393; [No title captured]	23	12	12	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					37	56		10.1097/00001199-199608000-00007			20	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600007					2022-02-06	
J	Kirkby, BS; VanHorn, JD; Ostrem, JL; Weinberger, DR; Berman, KF				Kirkby, BS; VanHorn, JD; Ostrem, JL; Weinberger, DR; Berman, KF			Cognitive activation during PET: A case study of monozygotic twins discordant for closed head injury	NEUROPSYCHOLOGIA			English	Article						regional cerebral blood flow; frontal lobe; recovery of function; hippocampus; working memory; Wisconsin Card Sorting Test	CEREBRAL BLOOD-FLOW; CONTUSION INDEX; DYSFUNCTION; TOMOGRAPHY; RECOVERY; CORTEX; BRAIN	Using positron emission tomography (PET), we studied physiological changes in a patient with frontal lobe damage resulting from closed head injury by assessing his regional cerebral blood flow (rCBF) pattern relative to that of his uninjured monozygotic (MZ) cotwin and against normal variability between cotwins in 10 comparably-aged, uninjured MZ twin pairs. rCBF was measured during the Wisconsin Card Sorting Test (WCST) and a sensorimotor control task. Differences between the index twins in rCBF activation (WCST-control) in regions determined on coplanar MRIs were compared to within pair differences in the control group using the Z-statistic. Activation differences between the index twins extending beyond normal variability were found in two regions-relative to his uninjured cotwin, the injured twin showed less activation in the inferior portion of the left inferior frontal gyrus while showing greater activation in the left hippocampus (P < 0.04). This pattern contrasts with that of normal subjects during WCST performance of augmented rCBF in the prefrontal cortex and not in the hippocampus. These rCBF differences appear to reflect the utilization of different neural systems when performing a frontal-lobe task. The use of the hippocampus by the injured twin might reflect an attempt to compensate for compromised frontal lobe functioning.	NIMH,CLIN BRAIN DISORDERS BRANCH,INTRAMURAL RES PROGRAM,NEUROSCI CTR ST ELIZABETHS,WASHINGTON,DC 20032					Van Horn, John/0000-0003-1537-0816			ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; BERMAN KF, 1994, NEUROLOGY, V44, pA376; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; DELIS D, 1987, CALIFORNIA VERBAL LE; DUARA R, 1987, J CEREBR BLOOD F MET, V7, P266, DOI 10.1038/jcbfm.1987.62; FORD I, 1991, J CEREBR BLOOD F MET, V11, pA89, DOI 10.1038/jcbfm.1991.43; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V5, P362; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Heaton PDRK., 1993, WISCONSIN CARD SORTI; ICHISE M, 1994, J NUCL MED, V35, P217; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1951, PHARMACOL REV, V3, P1; KOEPPE RA, 1985, J CEREBR BLOOD F MET, V5, P224, DOI 10.1038/jcbfm.1985.29; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; SABATINI U, 1994, STROKE, V25, P514, DOI 10.1161/01.STR.25.2.514; STUSS DT, 1982, J COMP PHYSIOL PSYCH, V96, P913, DOI 10.1037/0735-7036.96.6.913; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Weinberger D. R., 1993, Society for Neuroscience Abstracts, V19, P7; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267	31	12	12	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUL	1996	34	7					689	697					9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	UQ417	WOS:A1996UQ41700007	8783220				2022-02-06	
J	Sall, JM; Morehead, M; Murphy, S; Goldman, H; Walker, PD				Sall, JM; Morehead, M; Murphy, S; Goldman, H; Walker, PD			Alterations in CNS gene expression in a rodent model of moderate traumatic brain injury complicated by acute alcohol intoxication	EXPERIMENTAL NEUROLOGY			English	Article							IMMEDIATE EARLY GENES; PREPROENKEPHALIN MESSENGER-RNA; PROTEIN-LIKE IMMUNOREACTIVITY; CENTRAL NERVOUS-SYSTEM; C-FOS PROTEIN(S); RAT-BRAIN; INSITU HYBRIDIZATION; FOREBRAIN ISCHEMIA; CELL-DEATH; INDUCTION	The combined effects of acute alcoholic intoxication and moderate traumatic brain injury (TBI) on zif/268, glial fibrillary acidic protein (GFAP), and preproenkephalin (PPE) mRNA expression were examined. Adult male Wistar rats received ip injections of a 5% alcohol solution (2.4 g/kg in a final volume of 20 ml isotonic saline) 10 min prior to fixed-head, mechanical injury. Using Northern analysis, a transient three- to fourfold induction of zif/268 mRNA levels was observed 45 min after injury in both TBI and alcohol-treated rats. This induction occurred in regions close to the impact site, namely, the olfactory bulb (OB) and frontal cortex (FTCTX) but not in the more distal piriform/amygdala cortex (P/A). No PPE mRNA changes were observed at 45 min for any experimental group. By 6 h, zif/268 transcript levels returned to or fell below basal levels in the OB and FTCTX while GFAP mRNA levels began to increase in TBI rats. At 24 h, GFAP mRNA levels were greatly increased in all three brain regions of TBI rats. However, alcohol inhibited the temporal induction of GFAP mRNA in the FTCTX and P/A triggered by TBI at 6 and 24 h. These results suggest that although acute alcohol intoxication prior to TBI does not influence gene expression patterns immediately after injury, it may minimize the transcriptional activation of astrocytes particularly in more distant brain regions that were influenced by the impact in nonintoxicated rats. (C) 1996 Academic Press, Inc.	WAYNE STATE UNIV,SCH MED,DEPT ANAT & CELL BIOL,DETROIT,MI 48201		Sall, JM (corresponding author), WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,540 E CANFIELD AVE,DETROIT,MI 48201, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030550] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30550] Funding Source: Medline		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COLLINS RC, 1986, METAB BRAIN DIS, V1, P231, DOI 10.1007/BF00999353; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; DRAGUNOW M, 1993, INT J DEV NEUROSCI, V11, P249, DOI 10.1016/0736-5748(93)90083-P; EARNEST DJ, 1990, EXP NEUROL, V109, P353, DOI 10.1016/S0014-4886(05)80027-5; FALLON JH, 1986, J COMP NEUROL, V249, P293, DOI 10.1002/cne.902490302; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GASS P, 1993, NEUROSCIENCE, V53, P749, DOI 10.1016/0306-4522(93)90621-L; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GRAZZIZUCCONI G, 1993, EUR J NEUROSCI, V5, P1071; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; HAYES RL, CENTRAL NERVOUS SYST, P173; HERDEGEN T, 1993, J COMP NEUROL, V333, P271, DOI 10.1002/cne.903330212; HONKANIEMI J, 1995, MOL BRAIN RES, V28, P157, DOI 10.1016/0169-328X(94)00200-X; HUGHES P, 1995, PHARMACOL REV, V47, P133; JORGENSEN MB, 1989, BRAIN RES, V484, P393, DOI 10.1016/0006-8993(89)90388-0; Klatzo I, 1980, Adv Neurol, V28, P359; KOISTINAHO J, 1990, HISTOCHEMISTRY, V95, P73, DOI 10.1007/BF00737230; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; MENEGAZZI M, 1994, NEUROSCI LETT, V182, P295, DOI 10.1016/0304-3940(94)90820-6; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MUCKE L, 1991, NEW BIOL, V3, P465; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; NOWAK TS, 1990, STROKE, V21, P107; ONODERA H, 1989, NEUROSCI LETT, V98, P101, DOI 10.1016/0304-3940(89)90381-9; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; PYYKONEN I, 1991, ACTA NEUROPATHOL, V82, P66, DOI 10.1007/BF00310925; RUZDIJIC S, 1993, BRAIN RES, V60, P230; SAITOH T, 1991, LAB INVEST, V64, P596; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SHARP FR, 1989, NEUROSCI LETT, V100, P117, DOI 10.1016/0304-3940(89)90670-8; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Siesj? BK., 1978, BRAIN ENERGY METABOL; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; TAKEUCHI J, 1993, NEURON, V11, P825, DOI 10.1016/0896-6273(93)90112-5; VACCARINO FM, 1992, MOL BRAIN RES, V12, P233, DOI 10.1016/0169-328X(92)90089-T; WALKER PD, 1993, J NEUROSCI RES, V36, P588, DOI 10.1002/jnr.490360511; WESSEL TC, 1991, BRAIN RES, V567, P231, DOI 10.1016/0006-8993(91)90800-B; YOSHIKAWA K, 1984, J BIOL CHEM, V259, P4301	53	12	12	0	1	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0014-4886			EXP NEUROL	Exp. Neurol.	JUN	1996	139	2					257	268		10.1006/exnr.1996.0099			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UP253	WOS:A1996UP25300008	8654528				2022-02-06	
J	Girard, J; Panizzon, K; Wallis, RA				Girard, J; Panizzon, K; Wallis, RA			Azelastine protects against CA1 traumatic neuronal injury in the hippocampal slice	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						azelastine; traumatic brain injury; leukotriene; NMDA (N-methyl-D-aspartate); hippocampus; (in vitro)	LONG-TERM POTENTIATION; BRAIN-BARRIER PERMEABILITY; LEUKOTRIENE PRODUCTION; ARACHIDONIC-ACID; HEAD-INJURY; ISCHEMIA; RAT; INDUCTION	Activation of NMDA receptors appears to play a important role in traumatic neuronal injury. Additionally, N-methyl-D-aspartate (NMDA) excitotoxicity may involve leukotriene production. Therefore, we investigated whether azelastine, an anti-allergic agent inhibiting the synthesis and release of leukotrienes, could protect against CA1 traumatic neuronal injury in the hippocampal slice. Fluid percussion trauma produced evidence of severe neuronal injury with CA1 antidromic population spike amplitude recovering after 95 min to only a mean 16 +/- 1% S.E. of initial amplitude. With 15 mu M azelastine treatment given after trauma for 35 min this recovery improved to 112 +/- 17%. The azelastine EC(50) for this protection was 10 mu M Significant protection was also seen with azelastine application begun 15 min after trauma. Azelastine also protected the ability to induce long-term potentiation after trauma. The specific leukotriene inhibitors, MK-571 and MK-886, similarly provided significant neuroprotection. These findings suggest that CAI traumatic neuronal injury may be mediated by leukotriene production.	VET ADM MED CTR,NEURONAL INJURY LAB IIINI,SEPULVEDA,CA 91343								ACHTERRATHTUCKERMANN U, 1988, AGENTS ACTIONS, V24, P217, DOI 10.1007/BF02028274; AKTAN S, 1991, PROSTAG LEUKOTR ESS, V43, P247, DOI 10.1016/0952-3278(91)90037-6; AKTAN S, 1991, PROSTAG LEUKOTR ESS, V42, P67, DOI 10.1016/0952-3278(91)90069-H; AUER RN, 1989, J NEUROSCI, V9, P1641; BABA T, 1991, J CEREBR BLOOD F MET, V11, P638, DOI 10.1038/jcbfm.1991.115; BLACK KL, 1985, ANN NEUROL, V18, P349, DOI 10.1002/ana.410180313; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; CASALE TB, 1989, J ALLERGY CLIN IMMUN, V83, P771, DOI 10.1016/0091-6749(89)90013-4; COLLINGRIDGE GL, 1992, EXP PHYSIOL, V77, P771, DOI 10.1113/expphysiol.1992.sp003645; DUMMUIS A, 1988, NATURE, V336, P68; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GRONWALL D, 1974, LANCET, V2, P605; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MOSKOWITZ MA, 1984, SCIENCE, V224, P886, DOI 10.1126/science.6719118; NISHIHIRA J, 1989, INT ARCH ALLER A IMM, V90, P285, DOI 10.1159/000235039; PELLERIN L, 1991, NEUROCHEM RES, V16, P983, DOI 10.1007/BF00965841; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SCHURR A, 1984, BRAIN RES, V297, P357, DOI 10.1016/0006-8993(84)90576-6; UMEKI S, 1992, BIOCHEM PHARMACOL, V43, P1109, DOI 10.1016/0006-2952(92)90619-T; WALLIS RA, 1993, EUR J PHARMACOL, V238, P165, DOI 10.1016/0014-2999(93)90844-8; WALLIS RA, 1992, STROKE, V23, P546; WILLIAMS JH, 1989, NEUROSCI LETT, V107, P301, DOI 10.1016/0304-3940(89)90835-5; YAVIN E, 1992, ADV EXP MED BIOL, V318, P314; YOUNG RN, 1991, AGENT ACTION SUPPL, V34, P179; ZECHEL HJ, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1184	29	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	APR 4	1996	300	1-2					43	49		10.1016/0014-2999(95)00804-7			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UG949	WOS:A1996UG94900006	8741163				2022-02-06	
J	Goldstein, FC; Levin, HS; Roberts, VJ; Goldman, WP; Kalechstein, AS; Winslow, M; Goldstein, SJ				Goldstein, FC; Levin, HS; Roberts, VJ; Goldman, WP; Kalechstein, AS; Winslow, M; Goldstein, SJ			Neuropsychological effects of closed head injury in older adults: A comparison with Alzheimer's disease	NEUROPSYCHOLOGY			English	Article; Proceedings Paper	International-Neuropsychological-Society Meeting	JAN, 1995	SEATTLE, WA	Int Neuropsychol Soc			SEMANTIC MEMORY; PRACTICAL SCALE; RISK FACTOR; IMPAIRMENT; DEMENTIA	In this study, neuropsychological profiles of 14 older adult patients with mild or moderate closed head injury (CHI), 14 patients with probable Alzheimer's disease (AD), and 14 community residing elderly controls were compared. The groups were similar in demographic features, and the CHI and AD patients had comparable Mini-Mental State Examination scores. Tests of verbal learning and memory, letter and category fluency, and naming were administered. Relative to the CHI group, AD patients exhibited more devastated memory and did not show a normal facilitation on the category retrieval task. The patient groups exhibited similar levels of categorical clustering and naming accuracy for both high- and low-frequency words. These results suggest that neuropsychological markers of memory and semantic processing may be useful in differentiating the cognitive effects from AD versus early recovery from CHI.	UNIV MARYLAND, SCH MED, DIV NEUROL SURG, BALTIMORE, MD 21201 USA		Goldstein, FC (corresponding author), EMORY UNIV, SCH MED,WESLEY WOODS HLTH CTR,DEPT NEUROL, NEUROBEHAV PROGRAM, 1841 CLIFTON RD NE, ATLANTA, GA 30329 USA.						Auriacombe S., 1993, NEUROPSYCHOLOGY, V7, P182, DOI [DOI 10.1037/0894-4105.7.2.182, 10.1037/0894-4105.7.2.182]; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; COHEN BH, 1954, 10 U CONN; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CRUMMINGS JL, 1992, DEMENTIA CLIN APPROA; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDSTEIN FC, 1992, BRAIN LANG, V43, P308, DOI 10.1016/0093-934X(92)90132-X; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Hamsher K., 1989, MULTILINGUAL APHASIA; Haut MW, 1991, NEUROPSYCHOLOGY, V5, P81, DOI 10.1037/0894-4105.5.2.81; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P1089, DOI 10.1136/jnnp.53.12.1089; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; Kaplan E, 1983, BOSTON NAMING TEST; Kraus JF, 1987, HEAD INJURY, V2, P1; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monsch AU, 1994, NEUROPSYCHOLOGY, V8, P25, DOI 10.1037/0894-4105.8.1.25; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NEBES RD, 1989, PSYCHOL BULL, V106, P377, DOI 10.1037/0033-2909.106.3.377; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Ober B. A, 1988, CALIFORNIA VERBAL LE; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V51, P65; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SHUTTLEWORTH EC, 1988, BRAIN LANG, V34, P222, DOI 10.1016/0093-934X(88)90134-4; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; WEINGARTNER H, 1981, J ABNORM PSYCHOL, V90, P187, DOI 10.1037/0021-843X.90.3.187; ZEC RF, 1993, NEUROPSYCHOLOGY ALZH, P1; [No title captured]; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19	46	12	12	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	1996	10	2					147	154					8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	UD704	WOS:A1996UD70400001					2022-02-06	
J	Warschausky, S; Kewman, DG; Selim, A				Warschausky, S; Kewman, DG; Selim, A			Attentional performance of children with traumatic brain injury: A quantitative and qualitative analysis of digit span	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; MEMORY	Previous studies have indicated that digit span performance is not particularly sensitive to the effects of traumatic brain injury (Baddeley & Warrington, 1970; Brooks, 1975; Sterne, 1969). However clinical lore posits poorer backward vs. forward performance compared to normals due to the greater attentional demands of the backward task. This study examined qualitative aspects of Digit Span performance including forward/backward span discrepancies and error patterns in children with traumatic brain injury (n = 20) and normals (n = 19). The hypothesis of greater forward/backward discrepancy with traumatic brain injury was not supported Children with traumatic brain injury make a significantly greater number of preceiling errors than normals, consistent with other findings of increased performance variability. Preceiling errors are errors that occur in trials prior to the two failed trials resulting in discontinuation of the task In addition, cognitive correlates of error types, such as WISC-R factor scores, were significantly different between groups. The results of this study suggest that a more detailed analysis of performance on attentional tasks previously described as resilient to brain injury may shed further light on the nature of acquired attentional deficits.	UNIV MICHIGAN,SCH MED,DEPT PHYS MED & REHABIL,ANN ARBOR,MI 48109								BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BLACK FW, 1983, J CLIN PSYCHOL, V39, P263, DOI 10.1002/1097-4679(198303)39:2<263::AID-JCLP2270390223>3.0.CO;2-R; BLEIBERG J, 1994, ANN M INT NEUROPSYCH; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BUCHTEL HA, 1987, NEUROBEHAVIORAL RECO, P372; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; DAS JP, 1975, J EDUC PSYCHOL, V67, P213, DOI 10.1037/h0076929; FRANKEL F, 1974, AM J MENT DEF, V79, P311; GARDNER RA, 1981, J CLIN CHILD PSY SUM, P131; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; KAUFMAN AS, 1975, J CONSULT CLIN PSYCH, V43, P135, DOI 10.1037/h0076502; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROBERTSON IH, 1990, NEUROPSYCHOLOGIA, V28, P217, DOI 10.1016/0028-3932(90)90103-U; RUDEL RG, 1974, NEUROPSYCHOLOGIA, V12, P109, DOI 10.1016/0028-3932(74)90032-3; STERNE DM, 1969, J CLIN PSYCHOL, V25, P173, DOI 10.1002/1097-4679(196904)25:2<173::AID-JCLP2270250216>3.0.CO;2-9; WEINBERG J, 1972, J CLIN PSYCHOL, V28, P361, DOI 10.1002/1097-4679(197207)28:3+<361::AID-JCLP2270280315>3.0.CO;2-5; Werner H, 1937, HARVARD EDUC REV, V7, P353; [No title captured]; [No title captured]	20	12	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1996	11	2					147	153		10.1016/0887-6177(95)00004-6			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TT914	WOS:A1996TT91400006	14588915	Green Published, Bronze			2022-02-06	
J	Donahue, DJ; Sanford, RA; Muhlbauer, MS; Chadduck, WM				Donahue, DJ; Sanford, RA; Muhlbauer, MS; Chadduck, WM			Cranial burst fracture in infants: Acute recognition and management	CHILDS NERVOUS SYSTEM			English	Article						head injury; children; diastatic fracture; burst fracture; skull fracture	EROSION GROWING FRACTURE; SKULL; TOMOGRAPHY; CHILDREN	In the past, the diagnosis of ''growing skull fracture'' or ''diastatic fracture'' has included a subset of injuries better referred to as ''cranial burst fracture.'' Cranial burst fracture, typically associated with severe injury in infants less than 1 year of age, is a closed, widely diastatic skull fracture accompanied by acute cerebral extrusion outside the calvarium. We treated 11 such infants at the LeBonheur Children's Medical Center and 2 at the Children's National Medical Center from January 1986 through December 1994. Infants ranged in age from 1 to 17 months, with an average age of 5.7 months. All presented with marked scalp swelling and a Glasgow Coma Scale score of 10 or less. Twelve had a history consistent with severe injury (motor vehicle accident, 7, abuse 5). The cause of injury in one patient remains unproven. Surgery (reduction of herniated cerebral tissue, repair of large dural laceration, and cranioplasty) was usually performed within 10 days of injury, a time period long enough to assure hemodynamic stability and resolution of acute cerebral swelling, yet sufficiently brief to avoid the chronic changes (scarring, parasitization of scalp vessels by damaged cortex) associated with a ''growing skull fracture.'' Prompt repair of cranial burst. fracture may prevent ongoing brain injury such as has been neuropathologically demonstrated in patients with ''growing skull fracture.'' Magnetic resonance imaging establishes the diagnosis of cranial burst fracture in equivocal cases, rendering unnecessary a ''waiting period'' to see if scalp swelling resolves. Our experience, together with information in the neuropathological and neurosurgical literature, suggests that cranial burst fracture is associated with severe trauma, requires expeditious treatment, and has been underdiagnosed in the past, leading to ''growing skull fracture,'' a condition requiring more extensive surgery.	UNIV TENNESSEE,LE BONHEUR CHILDRENS MED CTR,COLL MED,MEMPHIS,TN		Donahue, DJ (corresponding author), GEORGE WASHINGTON UNIV,CHILDRENS NATL MED CTR,111 MICHIGAN AVE NW,WASHINGTON,DC 20010, USA.						ARSENI C, 1981, CHILD BRAIN, V8, P161; Ben Jelloun R, 1992, Ann Pediatr (Paris), V39, P49; DIMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45; EISENBERG HM, 1989, PEDIATRIC NEUROSURGE, P290; EPSTEIN JA, 1961, J PEDIATR-US, V59, P562, DOI 10.1016/S0022-3476(61)80240-0; GOLDSTEIN F, 1967, J NEUROSURG, V27, P541, DOI 10.3171/jns.1967.27.6.0541; HOFFMAN HJ, 1995, CHILD NERV SYST, V11, P268, DOI 10.1007/BF00301757; JOHNSON DL, 1995, CHILD NERV SYST, V11, P265, DOI 10.1007/BF00301756; KINGSLEY D, 1978, J NEUROL NEUROSUR PS, V41, P312, DOI 10.1136/jnnp.41.4.312; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P333; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; LYE RH, 1981, J NEUROSURG, V55, P470, DOI 10.3171/jns.1981.55.3.0470; MATSON DD, 1969, NEUROSURGERY INFANCY, P304; NALLS G, 1990, AM J EMERG MED, V8, P34, DOI 10.1016/0735-6757(90)90291-7; RAMAMURTHI B, 1970, J NEUROSURG, V32, P427, DOI 10.3171/jns.1970.32.4.0427; ROSENTHAL SA, 1970, J NEUROSURG, V32, P431, DOI 10.3171/jns.1970.32.4.0431; ROY S, 1987, ACTA NEUROCHIR, V87, P112, DOI 10.1007/BF01476061; SEKHAR LN, 1980, NEUROSURGERY, V6, P285, DOI 10.1227/00006123-198003000-00011; STEIN BM, 1972, ARCH NEUROL-CHICAGO, V26, P137, DOI 10.1001/archneur.1972.00490080055005; TANDON PN, 1987, ACTA NEUROCHIR, V88, P1, DOI 10.1007/BF01400508; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; TENNER MS, 1970, RADIOLOGY, V94, P351, DOI 10.1148/94.2.351; THOMPSON JB, 1973, J NEUROSURG, V39, P493, DOI 10.3171/jns.1973.39.4.0493; WINSTON K, 1983, J NEUROSURG, V59, P839, DOI 10.3171/jns.1983.59.5.0839	24	12	12	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	DEC	1995	11	12					692	697		10.1007/BF00262233			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TM909	WOS:A1995TM90900006	8750951				2022-02-06	
J	Olver, JH				Olver, JH			Brain injury: The need to assess outcome	CURRENT OPINION IN NEUROLOGY			English	Article								After traumatic brain injury, outcome measures can be used to monitor the effectiveness of preventative programmes and of therapy in acute management and rehabilitation. Early prediction of outcome can help with the planning of intervention in terms of cost and improving function. Outcome studies have determined that problems with psychosocial adjustment and quality of life are the most important in the long term.	UNIV MELBOURNE,DEPT REHABIL,MELBOURNE,VIC,AUSTRALIA; BETHESDA HOSP,MELBOURNE,VIC,AUSTRALIA					Olver, John/0000-0001-7069-1191			BANJA J, 1994, ARCH PHYS MED REHABI, V75; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; Hall KM, 1994, ARCH PHYS MED REHABI, V75, pSC; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JOHNSTON MV, 1994, ARCH PHYS MED REHABI, V75; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCMILLAN TM, 1993, CLIN REHABIL, V7, P248; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHALEN W, 1995, BRAIN INJURY, V9, P49; STRATTON M, 1995, BRAIN INJURY, V8, P631; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797	27	12	12	0	0	CURRENT SCIENCE	PHILADELPHIA	400 MARKET STREET,SUITE 750 ATTN:SARAH WHEALEN/SUB MGR, PHILADELPHIA, PA 19106	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1995	8	6					443	446		10.1097/00019052-199512000-00008			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TR416	WOS:A1995TR41600008	8845928				2022-02-06	
J	HESTAD, K; UPDIKE, M; SELNES, OA; ROYAL, W				HESTAD, K; UPDIKE, M; SELNES, OA; ROYAL, W			COGNITIVE SEQUELAE OF REPEATED HEAD-INJURY IN A POPULATION OF INTRAVENOUS-DRUG-USERS	SCANDINAVIAN JOURNAL OF PSYCHOLOGY			English	Article						HEAD INJURY; SEVERITY; REPEATED; NEUROPSYCHOLOGY; DRUG USE	SOCCER INJURIES; NEUROPSYCHOLOGICAL DEFICITS; FOOTBALL PLAYERS; BRAIN-DAMAGE; COCAINE USE; ALCOHOL; ETHANOL; ABUSERS; TRAUMA	The relationship between closed head injury acid performance on neuropsychological (NP) tests was investigated in a group of intravenous drug users (IVDUs). Subjects with repeated head traumas involving loss of consciousness (LOC) performed worse than both a control group without LOC and reference group with only a single episode of LOG. There were no significant differences between the last two groups. Performance on tests of memory, attention, and motor performance was significantly worse in the group with repeated head injury. The average time since the last episode of LOC was more than 11 years. We conclude from these findings that a single episode of LOC does not result in significant cognitive impairment in this population. Two or more episodes, however, are more likely to produce chronic cognitive impairment.	JOHNS HOPKINS UNIV,DEPT NEUROL,BALTIMORE,MD 21218		HESTAD, K (corresponding author), UNIV BERGEN,DEPT CLIN PSYCHOL,CLIN NEUROPSYCHOL SECT,SYDNESPLASS 13,N-5007 BERGEN,NORWAY.						ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; BRUHN P, 1975, AM J PSYCHIAT, V138, P397; DeCrescito V, 1974, Surg Forum, V25, P438; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; FIELDS FJJ, 1974, NEWS NEWSLETTER RES; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRANT I, 1978, ARCH GEN PSYCHIAT, V35, P1063; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1975, LANCET, V22, P995; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; Ingraham L J, 1990, J Neuropsychiatry Clin Neurosci, V2, P174; KELLY J P, 1990, Neurology, V40, P252; KLONOFF DC, 1989, ARCH NEUROL-CHICAGO, V46, P989, DOI 10.1001/archneur.1989.00520450059019; Klove H, 1972, Scand J Rehabil Med, V4, P55; KlOve H, 1963, MED CLIN N AM; LEONE AP, 1990, NEUROLOGY, V40, P404; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS., 1982, NEUROBEHAVIORAL CONS; LINNOILA M, 1983, ACTA PSYCHIAT SCAND, V68, P175, DOI 10.1111/j.1600-0447.1983.tb11121.x; LOBERG T, 1986, NEUROPSYCHOLOGICAL A, P415; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; MALLOY P, 1990, ADDICT BEHAV, V15, P431, DOI 10.1016/0306-4603(90)90029-W; MATSER E, 1992, PSYCHOLOOG, V27, P515; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; OSCARBERMAN M, 1987, NEUROBEHAVIORAL RECO, P178; Reitan R., 1979, MANUAL ADM NEUROPSYC; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROYAL W, 1991, NEUROLOGY, V41, P1905, DOI 10.1212/WNL.41.12.1905; RUTHERFORD WH, 1977, LANCET, V1, P1; SELNES OA, 1989, 5 P INT C AIDS MONTR; Smith A., 1982, SYMBOL DIGIT MODALIT; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; TYSVAER A T, 1992, Tidsskrift for den Norske Laegeforening, V112, P1268; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; VLAHOV D, 1991, LONGITUDINAL STUDIES; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wechsler, 1997, WECHSLER ADULT INTEL; [No title captured]; 1990, STATISTIX MANUAL VER	48	12	12	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5564			SCAND J PSYCHOL	Scand. J. Psychol.	SEP	1995	36	3					246	255		10.1111/j.1467-9450.1995.tb00984.x			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	RW615	WOS:A1995RW61500002	7481597				2022-02-06	
J	MADDOCKS, DL; SALING, M; DICKER, GD				MADDOCKS, DL; SALING, M; DICKER, GD			NOTE ON NORMATIVE DATA FOR A TEST SENSITIVE TO CONCUSSION IN AUSTRALIAN RULES FOOTBALLERS	AUSTRALIAN PSYCHOLOGIST			English	Article							MILD CONCUSSION	The medical diagnosis of concussion and assessment of recovery in athletes has traditionally been subjectively based on clinical symptoms such as headache, nausea, and dizziness. Recently, there has been increasing interest in the use of neuropsychological tests as objective measures of recovery from concussion. In particular, performance on tests of speed of information processing, such as the Digit-Symbol subtest (DS) from the Wechsler Adult Intelligence Scale-Revised (WAIS-R), has been found to be reduced in the first weeks after concussion. In the present study, baseline DS data were obtained from Australian Rules footballers. DS was administered to a sample of 200 professional Australian Rules football players according to standard WAIS-R procedures. Players were then grouped according to concussive history. No player had been concussed within six months of the study. No significant differences were found between the groups. Therefore, while previous research suggests that performance on DS may be affected in the first few weeks following concussive injury, the present results demonstrated that DS performance does not differentiate concussed and nonconcussed players by the sixth month posttrauma. These data constitute normative values against which the DS can be interpreted in concussed footballers in the early stages of recovery.	MONASH UNIV,CLAYTON,VIC,AUSTRALIA		MADDOCKS, DL (corresponding author), UNIV MELBOURNE,FAC MED,SCH BEHAV SCI,DEPT PSYCHOL,PARKVILLE,VIC 3052,AUSTRALIA.						*AUSTR NAT FOOTB C, 1992, STAT NAT AUSTR RUL F; Barth JT, 1989, MILD HEAD INJURY, P257; Dicker G, 1993, Aust Fam Physician, V22, P750; DICKER G, 1986, AUSTR FAMILY PHYSICI, V145, P455; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1974, LANCET, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL D, 1975, LANCET          1122, P995; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; NORUSIS MJ, 1988, STATISTICAL PACKAGES; Smith, 1973, SYMBOL DIGIT MODALIT; Wechsler, 1997, WECHSLER ADULT INTEL; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554	16	12	12	0	2	AUSTRALIAN PSYCHOL SOC	CARLTON	1 GRATTAN STREET, CARLTON VICTORIA 3053, AUSTRALIA	0005-0067			AUST PSYCHOL	Aust. Psychol.	JUL	1995	30	2					125	127		10.1080/00050069508258916			3	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	RT403	WOS:A1995RT40300012					2022-02-06	
J	BURG, JS; BURRIGHT, RG; DONOVICK, PJ				BURG, JS; BURRIGHT, RG; DONOVICK, PJ			PERFORMANCE DATA FOR TRAUMATIC BRAIN-INJURED SUBJECTS ON THE GORDON DIAGNOSTIC SYSTEM (GDS) TESTS OF ATTENTION	BRAIN INJURY			English	Article								Thirty adults with traumatic brain injury (TBI) (20 males and 10 females, mean age 40 years) and a non-injured control soup (12 males and 13 females, mean age 41 years) were tested on 16 tests of attention including three tasks of the Gordon Diagnostic System (GDS), a relatively new set of attention tasks. No differences between groups were found on age or education. Both groups had estimated IQs in the average range. Performance data for the GDS are presented for the TBI and CON groups. Mild to moderate deficits of attention were seen in the TBI soup relative to controls on the Vigilance and Distractibility tasks. No differences between groups were seen on the Standard Delay groups. Pearson product moment correlations suggested different patterns of relationships between the GDS tasks and other tests of attention for the TBI and CON groups. These results support the utility of the Vigilance and Distractibility tasks for assessment of attention in a mild to moderately injured population.	SUNY BINGHAMTON,DEPT PSYCHOL,ENVIRONM NEUROPSYCHOL LAB,BINGHAMTON,NY 13902; UNITED HLTH SERV,DEPT PSYCHIAT & NEUROSCI,BINGHAMTON,NY								BURG JS, UNPUB CLOSED HEAD IN; Gordon M, 1988, INSTRUCTION MANUAL G; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; Kaufman A., 1990, KBIT KAUFMAN BRIEF I; POSNER MI, 1984, J NEUROSCI, V4, P1863; RASILE DA, IN PRESS INT J PSYCH; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; VANZOMEREN AH, 1990, TRAUMATIC BRAIN INJU, P33; Wechsler, 1981, WAISR MANUAL WECHSLE; Wechsler D, 1987, WMSR WECHSLER MEMORY	13	12	12	0	1	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1995	9	4					395	403		10.3109/02699059509005779			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QY080	WOS:A1995QY08000007	7640685				2022-02-06	
J	Donders, J; Strom, D				Donders, J; Strom, D			Factor and cluster analysis of the intermediate Halstead Category Test	CHILD NEUROPSYCHOLOGY			English	Article							CHILDREN; INJURY; SCALE	The factorial invariance of the six subtests of the Intermediate version of the Halstead Category Test (IHCT), as well as clusters of IHCT subtest patterns, were evaluated in a sample of 87 children with traumatic brain injuries. A two-factor solution was found which partially replicated that found in previous research with children with learning disabilities, supporting the assumption that the IHCT measures multiple underlying constructs in clinical populations. Four clusters were found, with differences between clusters determined to a substantial extent by relative accuracy on subtest III, and to a less substantial extent by relative accuracy on subtests IV and V Clinical and research implications are discussed.	MARY FREE BED HOSP,GRAND RAPIDS,MI 49503								CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DONDERS J, 1993, CLIN NEUROPSYCHOL, V7, P430, DOI 10.1080/13854049308401533; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GEWEKE JF, 1980, J AM STAT ASSOC, V75, P133, DOI 10.2307/2287400; JARVIS PE, 1984, HALSTEAD REITAN TEST; KELLY MD, 1992, ARCH CLIN NEUROPSYCH, V7, P415, DOI 10.1016/0887-6177(92)90154-F; Leckliter Ingrid N, 1992, Clin Neuropsychol, V6, P201, DOI 10.1080/13854049208401856; RATTAN AI, 1989, J PSYCHOEDUCATIONAL, V7, P296; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan R., 1979, MANUAL ADM NEUROPSYC; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; STRANG JD, 1983, J CLIN CHILD PSYCHOL, V12, P33, DOI 10.1080/15374418309533110; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J SCHOOL PSYCHOL, V25, P93, DOI 10.1016/0022-4405(87)90064-1; THINGSTROM DH, 1988, J CLIN PSYCHOL, V44, P799; Wechsler D., 1974, WECHSLER INTELLIGENC; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; 1990, SAS STAT USERS GUIDE; [No title captured]	20	12	12	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	APR	1995	1	1					19	25		10.1080/09297049508401339			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TY623	WOS:A1995TY62300003					2022-02-06	
J	VUILLEUMIER, P				VUILLEUMIER, P			CALLOSAL LESIONS AND INTERHEMISPHERIC DISCONNECTION SYNDROMES AFTER HEAD-INJURY	NEUROCHIRURGIE			French	Article						HEAD INJURY; CORPUS CALLOSUM; INTERHEMISPHERIC DISCONNECTION; FORNIX; AMNESIA; DIFFUSE AXONAL INJURY	DIFFUSE AXONAL INJURY; PERSISTENT VEGETATIVE STATE; CORPUS-CALLOSUM; MULTIPLE-SCLEROSIS; TRAUMATIC LESIONS; MEMORY; FEATURES; BRAIN; IMPAIRMENT; TOMOGRAPHY	We review the different kinds of injury to the corpus callosum in closed head trauma, as well as their different mechanisms. Most frequent lesions are either diffuse and at the microscopic level, secondary to disruption of axons at the time of the trauma, or focal and at macroscopic level, also due to torsion or shearing strains on the corpus callosum. They are associated with diffuse axonal injury of hemispheric and brainstem white matter. Focal macroscopic lesions, sometimes extensive, are encountered in 16-40% of autopsies after fatal head injury. Likewise, MRI allows nowadays to show them in 22-49% of nonfatal head injuries. Such lesions can produce an interhemispheric disconnection syndrome. However, clinical observation of an interhemispheric disconnection after head trauma has been only rarely reported in the literature, as it is showed by a brief overview of those cases, which suggests that this pathology is probably often overlooked. Focal damage to the corpus callosum seems to be a marker of severe injury, with often long-lasting coma and sometimes tansitory vegetative state or mutism. Extension of posterior callosal lesions towards adjacent midline structures, such as the fornix, could contribute to the important memory impairment which is particularly frequently associated with posttraumatic interhemispheric disconnection syndromes.	CHU VAUDOIS, DIV AUTONOME NEUROPSYCHOL, CH-1011 LAUSANNE, SWITZERLAND		VUILLEUMIER, P (corresponding author), CHU VAUDOIS, SERV NEUROL, CH-1011 LAUSANNE, SWITZERLAND.			Vuilleumier, Patrik/0000-0002-8198-9214			Adams J.H., 1990, HDB CLIN NEUROLOGY, V13, P43; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; ARNE J, 1975, HDB CLIN NEUROLOGY, V23, P459; Bakay L, 1980, HEAD INJURY; BARNARD RO, 1974, J NEUROL NEUROSUR PS, V37, P1259, DOI 10.1136/jnnp.37.11.1259; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Blinkov SM, 1971, BRAIN DISPLACEMENTS; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bogen J.E., 1993, INT J CLIN NEUROPSYC, Vthird, P337; BOLDRINI P, 1992, CORTEX, V28, P135, DOI 10.1016/S0010-9452(13)80172-4; BRION S, 1975, TROUBLES TRANSFERT I; CECCALDI M, 1994, REV NEUROL-FRANCE, V150, P229; CHESTER CS, 1987, ANN NEUROL, V22, P77; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; DEGE A, 1920, NEUE DTSCH CHIRURG, V18, P1; DEGOS JD, 1988, ENCY MED CHIR NEUROL; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1991, MAGNETIC RESONANCE I, P439; Gordon HW, 1990, HDB NEUROPSYCHOLOGY, P85; GRAFMAN J, 1985, ARCH NEUROL-CHICAGO, V42, P1162, DOI 10.1001/archneur.1985.04060110044014; Graham D I, 1983, Acta Neurochir Suppl (Wien), V32, P65; HUBER SJ, 1987, ARCH NEUROL-CHICAGO, V44, P732, DOI 10.1001/archneur.1987.00520190040015; JUNET W, 1938, HELV MED ACTA, V42, P375; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LINDENBERG R, 1955, AM J PATHOL, V31, P297; LONG CG, 1992, HDB HEAD TRAUMA; MCCORMICK WF, 1985, NEUROSURGERY, V2, P1544; MCCORMICK WF, 1983, CLIN NEUROSCIENCES, V3, P241; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Nakagawa Y, 1991, Rinsho Shinkeigaku, V31, P6; RAO SM, 1989, ARCH NEUROL-CHICAGO, V46, P918, DOI 10.1001/archneur.1989.00520440114028; RAPOPORT AM, 1980, HEADACHE, V20, P279, DOI 10.1111/j.1526-4610.1980.hed2005279.x; REINARZ SJ, 1988, AM J ROENTGENOL, V151, P791, DOI 10.2214/ajr.151.4.791; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; ROWBOTHAM GF, 1949, ACUTE INJURIES HEAD, P1; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; RUBENS AB, 1985, ANN NEUROL, V18, P459, DOI 10.1002/ana.410180408; RUDGE P, 1991, BRAIN, V114, P349, DOI 10.1093/brain/114.1.349; SCHNIDER A, 1993, NEUROLOGY, V43, P1243, DOI 10.1212/WNL.43.6.1243; SCHOTT B, 1969, REV NEUROL-FRANCE, V120, P359; SHIGEMORI M, 1986, ACTA NEUROCHIR, V81, P36, DOI 10.1007/BF01456262; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P215, DOI 10.1136/jnnp.42.3.215; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SUSSMAN NM, 1983, J NEUROSURG, V59, P514, DOI 10.3171/jns.1983.59.3.0514; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; TUCKER DM, 1988, CORTEX, V24, P465, DOI 10.1016/S0010-9452(88)80010-8; Yamadori A, 1988, Behav Neurol, V1, P11, DOI 10.3233/BEN-1988-1103; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; 1991, JAMA-J AM MED ASSOC, V263, P420	64	12	12	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie		1995	41	2					98	107					10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RG171	WOS:A1995RG17100004	7630468				2022-02-06	
J	GOLDING, EM; VINK, R				GOLDING, EM; VINK, R			INHIBITION OF PHOSPHOLIPASE-C WITH NEOMYCIN IMPROVES METABOLIC AND NEUROLOGIC OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN RESEARCH			English	Article						MAGNESIUM; NUCLEAR MAGNETIC RESONANCE; TRAUMA; BIOENERGETICS; TREATMENT	NUCLEAR-MAGNETIC-RESONANCE; INTRACELLULAR FREE MG-2+; EXCITATORY AMINO-ACIDS; P-31 NMR-SPECTROSCOPY; FREE MAGNESIUM; SPINAL-CORD; RAT; ANTAGONIST; RELEASE; SYSTEM	Activation of phospholipase C has been implicated as a factor in the development of irreversible tissue damage following injury to the central nervous system. We have used phosphorus magnetic resonance spectroscopy and a battery of postinjury motor function tests to characterize the role that phospholipase C activity may play in determining biochemical and neurologic outcome following traumatic brain injury in rats. Moderate (2.7 atmospheres) fluid percussion induced lateral brain injury caused a decline in free magnesium concentration, phosphorylation potential, and increased mitochondrial rate of oxidative phosphorylation. Neurologic motor score at 24 h and 1 week posttrauma in these animals was consistent with moderate injury. In contrast, treatment with the phospholipase C inhibitor neomycin B (15 mg/kg i.v.) immediately prior to injury significantly improved free magnesium status, bioenergetic state and neurological outcome (P < 0.01) after injury. We propose that phospholipase C activated second messenger pathways affecting magnesium homeostasis are involved in determining outcome after brain injury.	JAMES COOK UNIV N QUEENSLAND,DIV BIOCHEM & HUMAN PHYSIOL,TOWNSVILLE,QLD 4811,AUSTRALIA				Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Aikawa J.K., 1981, MAGNESIUM ITS BIOL S, V1st ed.; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIRNBAUMER L, 1990, CRIT REV BIOCHEM MOL, V25, P225, DOI 10.3109/10409239009090610; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1986, P NATL ACAD SCI USA, V83, P9458, DOI 10.1073/pnas.83.24.9458; COHN M, 1962, J BIOL CHEM, V237, P176; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; CUNNINGHAM CC, 1986, BIOCHIM BIOPHYS ACTA, V885, P12, DOI 10.1016/0167-4889(86)90033-9; DIAMANT S, 1988, J NEUROCHEM, V51, P795, DOI 10.1111/j.1471-4159.1988.tb01814.x; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; FADEN AI, 1989, UPDATE INTENSIVE CAR, V9, P14; GUPTA RK, 1983, PHYSIOL CHEM PHYS, V15, P265; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; HAYES RL, 1992, CENTRAL NERVOUS SYST, P173; HEADRICK JP, 1991, J MOL CELL CARDIOL, V23, P991, DOI 10.1016/0022-2828(91)91635-5; HOVDA DA, 1992, CENTRAL NERVOUS SYST, P47; JANE JA, 1992, 1991 CTR NERV SYST T; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KEITH RA, 1992, J MOL NEUROSCI, V3, P147, DOI 10.1007/BF02919406; KENDALL DA, 1993, BIOCHEM SOC T, V21, P1120, DOI 10.1042/bst0211120; KUSHMERICK MJ, 1986, J BIOL CHEM, V261, P4420; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; LITOSCH I, 1991, J BIOL CHEM, V266, P4764; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NICOLETTI F, 1987, J NEUROCHEM, V48, P967, DOI 10.1111/j.1471-4159.1987.tb05611.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NIOKA S, 1990, J APPL PHYSIOL, V68, P2527, DOI 10.1152/jappl.1990.68.6.2527; PEARSON HA, 1993, NEUROPHARMACOLOGY, V32, P1171, DOI 10.1016/0028-3908(93)90011-Q; PETITTI N, 1991, J NEUROCHEM, V56, P628, DOI 10.1111/j.1471-4159.1991.tb08196.x; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RECASENS M, 1991, CURRENT ASPECTS NEUR, V3, P103; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; STREB H, 1985, J BIOL CHEM, V260, P7309; SUGANO T, 1974, BIOCHIM BIOPHYS ACTA, V347, P340, DOI 10.1016/0005-2728(74)90074-7; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; UMEMURA A, 1992, J NEUROSURG, V76, P648, DOI 10.3171/jns.1992.76.4.0648; UMEMURA A, 1992, STROKE, V23, P1163, DOI 10.1161/01.STR.23.8.1163; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1989, BIOCHEM BIOPH RES CO, V165, P913, DOI 10.1016/S0006-291X(89)80053-1; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1990, J NEUROSCI, V10, P3524; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; VINK R, 1988, J NEUROTRAUMA, V5, P365; VINK R, 1991, MAGNESIUM EXCITABLE, P695; WADE A, 1977, BOOK MARTINDALE EXTR; WALLACE MA, 1993, NEUROCHEM RES, V18, P139, DOI 10.1007/BF01474676; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; YOUNG W, 1992, 1991 CTR NERV SYST T, P9; ZHENG LX, 1994, ENDOCRINOLOGY, V134, P1446, DOI 10.1210/en.134.3.1446	61	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 30	1994	668	1-2					46	53		10.1016/0006-8993(94)90509-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QB354	WOS:A1994QB35400006	7704617				2022-02-06	
J	YANG, KY; TAFT, WC; DIXON, CE; YU, RK; HAYES, RL				YANG, KY; TAFT, WC; DIXON, CE; YU, RK; HAYES, RL			ENDOGENOUS PHOSPHORYLATION OF A 61,000-DALTON HIPPOCAMPAL PROTEIN INCREASES FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							MR 60,000 PROTEIN; KINASE-C ACTIVITY; FOREBRAIN ISCHEMIA; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; NMDA RECEPTORS; CELL-DEATH; RAT; GLUTAMATE; NEUROTOXICITY	Acute biochemical consequences of moderate traumatic brain injury (TBI) include activation of kinases, including protein kinase C (PKC). To determine the possible consequences of PKC activation at the substrate level, we have examined protein phosphorylation patterns 1 h following injury. Although the phosphorylation of most proteins remained unchanged following injury, we observed a significant increase in the phosphorylation of a 61,000 dalton protein (TBI61) in injured rat hippocampus (121% higher than sham control) in vitro. TBI61 phosphorylation could be enhanced by phosphatidyl serine and diacylglycerol or by addition of exogenous PKC. In addition, TBI61 phosphorylation was inhibited by the PKC inhibitor, staurosporine, suggesting further that this protein may be a PKC substrate. These data suggest that TBI increases the phosphorylation of a 61 kD hippocampal protein in vitro. Increases in the protein level and activity of PKC could contribute to this increased phosphorylation.	UNIV TEXAS,HLTH SCI CTR,DEPT NEUROSURG,DIV NEUROSURG,HOUSTON,TX 77030; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT BIOCHEM,RICHMOND,VA 23298						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458, P01NS031998] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21458, NS31998] Funding Source: Medline		AHMED Z, 1990, BRAIN RES, V516, P165, DOI 10.1016/0006-8993(90)90914-W; ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1990, J NEUROSCI, V10, P2493; CHURN SB, 1992, J NEUROCHEM, V59, P1221, DOI 10.1111/j.1471-4159.1992.tb08431.x; CRUMRINE RC, 1990, J NEUROCHEM, V55, P2001, DOI 10.1111/j.1471-4159.1990.tb05788.x; DELORENZO RJ, 1978, BIOCHEM BIOPH RES CO, V80, P183, DOI 10.1016/0006-291X(78)91121-X; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FINEMAN I, 1990, Society for Neuroscience Abstracts, V16, P778; FLOREZ JC, 1991, EXP NEUROL, V112, P264, DOI 10.1016/0014-4886(91)90126-W; GREENGARD P, 1987, MOL NEUROBIOL, V1, P81, DOI 10.1007/BF02935265; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOCHHAR A, 1989, J NEUROCHEM, V53, P946, DOI 10.1111/j.1471-4159.1989.tb11797.x; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MASLIAH E, 1991, J NEUROSCI, V11, P2759; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MERRILL CR, 1981, SCIENCE, V211, P67; NELSON RB, 1985, EXP NEUROL, V89, P213, DOI 10.1016/0014-4886(85)90277-8; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; PRASAD MR, 1993, J NEUROCHEM, V63, P1; SAITOH T, 1988, J NEUROPATH EXP NEUR, V47, P1, DOI 10.1097/00005072-198801000-00001; SAITOH T, 1991, LAB INVEST, V64, P596; SAITOH T, 1986, P NATL ACAD SCI USA, V83, P9764, DOI 10.1073/pnas.83.24.9764; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAFT WC, 1988, BRAIN RES, V447, P159, DOI 10.1016/0006-8993(88)90978-X; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; WIELOCH T, 1991, J NEUROCHEM, V56, P1227, DOI 10.1111/j.1471-4159.1991.tb11415.x; Yang K., 1994, Society for Neuroscience Abstracts, V20, P424; YANG K, 1993, SOC NEUR ABSTR, V767, P13; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287	41	12	12	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1994	11	5					523	532		10.1089/neu.1994.11.523			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PR237	WOS:A1994PR23700006	7861445				2022-02-06	
J	LLOYD, LF; CUVO, AJ				LLOYD, LF; CUVO, AJ			MAINTENANCE AND GENERALIZATION OF BEHAVIORS AFTER TREATMENT OF PERSONS WITH TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							SKILLS; ADULTS	This review of behavioural research literature was conducted to determine if persons who have experienced a traumatic brain injury are able to maintain and generalize behaviours after training, and to identify formal programming strategies that might have been utilized to enhance maintenance and generalization. Studies reviewed included those that employed behavioural procedures to increase adaptive behaviours or reduce maladaptive behaviours and collected maintenance and generalization data. Results of the review indicate that persons who have experienced a traumatic brain injury have experienced successful response maintenance and generalization of community-referenced tasks. It is suggested that impaired memory does not keep persons from maintaining and generalizing such tasks, and that strategies to promote maintenance and generalization need to be included in behavioural programming.			LLOYD, LF (corresponding author), SO ILLINOIS UNIV,INST REHABIL,CARBONDALE,IL 62901, USA.						Arnie Zencius, 1991, BEHAV RESIDENTIAL TR, V6, P1, DOI DOI 10.1002/BIN.2360060102; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; COOPER JO, 1987, APPLIED BEHAVIOR ANA, P585; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; GARCIA J G, 1990, Brain Injury, V4, P203, DOI 10.3109/02699059009026167; KAY T, 1986, MINOR HEAD INJURY IN, P1; KENTUDOLF L, 1984, BEHAVIORAL ASSESSMEN, P23; LANE IM, 1989, J BEHAV THER EXP PSY, V20, P79, DOI 10.1016/0005-7916(89)90011-6; LEWIS FD, 1990, BEHAVIORAL RESIDENTI, V1, P61; O'Reilly M. F., 1989, BEHAV RESIDENTIAL TR, V4, P359, DOI 10. 1002/bin. 2360040406; OREILLY MF, 1990, J APPL BEHAV ANAL, V23, P431, DOI 10.1901/jaba.1990.23-431; REIDY TJ, 1979, ARCH PHYS MED REHAB, V60, P226; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; SULZERAZAROFF B, 1991, BEHAVIOR ANAL LASTIN, P522; TURNER JM, 1990, BEHAVIORAL RESIDENTI, V5, P1; ZAHARA DJ, 1984, CLIN PSYCHOL REV, V4, P477, DOI 10.1016/0272-7358(84)90022-9; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163; Zencius A. H., 1991, BEHAV INTERVENT, V6, P155, DOI DOI 10.1002/BIN.236006; ZENCUIUS AH, 1990, BEHAVIORAL RESIDENTI, V5, P61; 1982, BRINGING RES EFFECTI, V5, P1; 1989, INTERAGENCY HEAD INJ, P1; 1985, INJURY AM CONTINUING	25	12	12	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1994	8	6					529	540		10.3109/02699059409151005			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PE682	WOS:A1994PE68200005	7987289				2022-02-06	
J	WONG, PP; DORNAN, J; KEATING, AM; SCHENTAG, CT; IP, RY				WONG, PP; DORNAN, J; KEATING, AM; SCHENTAG, CT; IP, RY			RE-EXAMING THE CONCEPT OF SEVERITY IN TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							HEAD	This paper re-examines the theoretical concept of severe brain injury focusing on the duration of coma as a precise indicator of the clinical profile. A retrospective hospital chart study of 361 traumatic brain-injured patients was undertaken to determine the homogeneity of the subsample of the severely brain-injured (defined as 2 or more days of coma) with respect to the probability of four types of impairment: ataxia, contractures, paralysis and speech impairment. The current concept of severity assumes homogeneity among the 'severely brain-injured'. However, our results indicate significant differences in impairment within this population. The authors feel strongly that future studies must describe coma duration in finer gradations, and test for homogeneity within samples before inferences are made. Improvements in life-sustaining technologies have resulted in longer coma durations. The need to use coma days as an indicator of impairment rather than a broad category of severity is emphasized.			WONG, PP (corresponding author), COLUMBIA HLTH CARE INC,NEUROREHABIL SERV,180 DUNDAS ST W,4TH FLOOR,TORONTO M5G 1Z8,ON,CANADA.						ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Annoni J M, 1992, Disabil Rehabil, V14, P23; COHADON F, 1991, J NEUROL SCI, V103, P27; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; MacPherson Valerie, 1992, Brain Injury, V6, P489, DOI 10.3109/02699059209008146; MILLER JD, 1990, REHABILITATION ADULT, P236; MINDERHOUD JM, 1990, TRAUMATIC BRAIN INJU, P23; MOORE A D, 1990, Brain Injury, V4, P379, DOI 10.3109/02699059009026191; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; WONG P, BRAIN INJURY, V7, P283; Wong P P, 1993, Leadersh Health Serv, V2, P25	18	12	13	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1994	8	6					509	518		10.3109/02699059409151003			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	PE682	WOS:A1994PE68200003	7527268				2022-02-06	
J	GURNS, S; KAPPENBERG, R; MCKENNA, A; WOOD, C				GURNS, S; KAPPENBERG, R; MCKENNA, A; WOOD, C			BRAIN INJURY - PERSONALITY, PSYCHOPATHOLOGY AND NEUROPSYCHOLOGY	BRAIN INJURY			English	Article							LESION LOCATION; MOOD DISORDERS; STROKE; DYSFUNCTION; DEPRESSION; DISEASE; INJURY	This study investigated the relationship between brain injury and personality, using the Luria-Nebraska Neuropsychological Battery and the Clinical Analysis Questionnaire as measurement tools. Psychopathological factors, as opposed to normal personality traits, were highly correlated with measures of brain injury. Depression, in particular, was found to be substantially involved in the sequelae of brain injury for this sample. A trend in the data revealed that suicidal depression and anxious depression were differentially related to deficits on two scales of the LNNB. Patients with evidence of suicidal depression were also more sensitive to emotional dysfunction in other areas. Few differences were found between patients with traumatic brain injury and those with other types of brain injuries. Results suggest that measures of psychopathology can provide important supplementary information to neuropsychological assessment, above that obtained from measures of brain functioning alone. Controlled studies should investigate the relationship between psychopathology and neuropsychology more thoroughly to provide clearer determinations of its involvement in the rehabilitation of the brain-injured person.	PACIFIC INST BEHAV MED,HONOLULU,HI; KANSAS REHABIL HOSP,TOPEKA,KS								Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; BOYAR J J, 1981, Clinical Neuropsychology, V3, P15; BUROS OK, 1978, 5TH MENTAL MEASUREME; CATTELL RB, 1973, J MULTIVARIATE EXPT, V1, P34; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; DAM H, 1989, ACTA PSYCHIAT SCAND, V80, P118, DOI 10.1111/j.1600-0447.1989.tb01312.x; DIKMEN S, 1977, J NERV MENT DIS, V165, P247, DOI 10.1097/00005053-197710000-00004; FILSKOV S, 1981, HDB CLIN NEUROPSYCHO; FLOR-HENRY P, 1990, Neuropsychology Review, V1, P103, DOI 10.1007/BF01108713; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Franzen M. D., 1989, RELIABILITY VALIDITY; Golden CJ., 1980, LURIA NEBRASKA NEURO; Goldstein G, 1987, Arch Clin Neuropsychol, V2, P215; GRACA J, 1983, DISSERT ABSTR INT, V43, P2707; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; Hathaway S., 1970, MINNESOTA MULTIPHASI; HEILMAN KM, 1983, NEUROPSYCHOLOGY HUMA; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; Jennett B, 1981, MANAGEMENT HEAD INJU; KAMEOKA VA, 1986, MULTIVAR BEHAV RES, V21, P105, DOI 10.1207/s15327906mbr2101_6; KOLB B, 1989, AM PSYCHOL, V44, P1203, DOI 10.1037/0003-066X.44.9.1203; Krug S. E., 1980, CLIN ANAL QUESTIONNA; Krug S. E., 1976, HDB IPAT ANXIETY SCA; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEWIS GP, 1979, J CONSULT CLIN PSYCH, V47, P1003, DOI 10.1037/0022-006X.47.6.1003; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Luria A.R., 1973, WORKING BRAIN; LURIA AR, 1980, CLIN NEUROPSYCHOLOGY, V2, P1; LURIA AR, 1969, SOVIET STUDIES PSYCH, V1; Luria AR, 1963, RESTORATION FUNCTION; MAGNI G, 1984, J NEUROL NEUROSUR PS, V47, P567, DOI 10.1136/jnnp.47.5.567; MORRIS PLP, 1992, NEUROPSY NEUROPSY BE, V5, P75; Newman P J, 1987, Arch Clin Neuropsychol, V2, P115, DOI 10.1016/0887-6177(87)90039-4; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO; ROBINSON RG, 1987, STROKE, V18, P837, DOI 10.1161/01.STR.18.5.837; Sacks O., 1985, MAN WHO MISTOOK HIS; SHARPE M, 1990, PSYCHOL MED, V20, P815, DOI 10.1017/S0033291700036503; STARKSTEIN S, 1989, BRIT J PSYCHIAT, V133, P79; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; Strub R. L., 1981, ORGANIC BRAIN SYNDRO; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TSUSHIMA WT, 1987, INT J CLIN NEUROPSYC, V9, P120; WATSON CG, 1984, J CLIN PSYCHOL, V40, P1008, DOI 10.1002/1097-4679(198407)40:4<1008::AID-JCLP2270400425>3.0.CO;2-9; WIEBE J, 1988, JUL BRAIN INJ OUTC C	46	12	12	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					413	427		10.3109/02699059409150993			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200003	7951204				2022-02-06	
J	KOTANI, M; MASAMOTO, Y; WATANABE, M				KOTANI, M; MASAMOTO, Y; WATANABE, M			AN ALTERNATIVE STUDY OF THE SKIN IRRITANT EFFECT OF AN HOMOLOGOUS SERIES OF SURFACTANTS	TOXICOLOGY IN VITRO			English	Article								An attempt has been made to differentiate between in vivo and in vitro skin reactions to a homologous series of surfactants (sodium alkyl sulfate, R-OSO3 Na) and to determine the usefulness of percutaneous absorption in vitro as an alternative test system. Sodium alkyl sulfate showed considerable biological activity by virtue of its polar head groups. The length of the lipophilic chain in the surfactants was an important factor in their overall activity. The following in vivo tests were performed: a primary skin irritation test in guinea pigs, a primary eye irritation test in rabbits and a closed patch test in humans. Peak skin irritation occurred with C-10-C-16 sodium alkyl sulfate, which had lipophilic groups of different alkyl chain lengths. Cell injury was also evaluated by the neutral red dye uptake assay in rabbit corneal (RC) cells. C-4 and C-6 compounds had no effect, while maximal effects occurred with C-18. Protein denaturation and haemolysis occurred with C-10-C-16 compounds. In the percutaneous absorption test in guinea pig skin, permeation was low for the C-18 compound and high for the C-4 compound. The results with the C-18 compound suggest that differences between cell injury and skin irritation result from skin permeation. Although the C-18 compound caused cell injury, membrane destruction and protein denaturation were more severely with the C-10-C-16 compounds, owing to their strong haemolytic and protein-denaturation action.	NAGASAKI UNIV,SCH PHARM,DIV RADIAT BIOL,NAGASAKI 852,JAPAN		KOTANI, M (corresponding author), SUNSTAR INC,CTR SAFETY ANAL,TECH HQ,MFG,R&D,3-1 ASAHI MACHI,TAKATSUKI,OSAKA 569,JAPAN.						DAWEKE H, 1959, Arch Klin Exp Dermatol, V209, P520, DOI 10.1007/BF00492397; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; DUGARD PH, 1973, J INVEST DERMATOL, V60, P263, DOI 10.1111/1523-1747.ep12722895; FIKER S, 1972, Acta Facultatis Medicae Universitatis Brunensis, V41, P177; GLOXHUBER C, 1975, DETERGENCY THEORY TE, P695; IMOKAWA G, 1975, J AM OIL CHEM SOC, V52, P484, DOI 10.1007/BF02640737; KONDO T, 1968, J PHARM SCI, V57, P1246, DOI 10.1002/jps.2600570740; OKAMOTO K, 1976, SHINSHU IGAKU ZASSHI, V24, P243; PAPE W J W, 1987, Molecular Toxicology, V1, P525; PROTTEY C, 1975, J SOC COSMET CHEM, V26, P29; SCHULZ K H, 1957, Arch Klin Exp Dermatol, V205, P254, DOI 10.1007/BF00482575; SUGAI T, 1978, J COSMETIC SCI SOC, V2, P19	12	12	12	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	APR	1994	8	2					229	233		10.1016/0887-2333(94)90187-2			5	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	NK547	WOS:A1994NK54700012	20692910				2022-02-06	
J	TODD, MM; WU, B; WARNER, DS				TODD, MM; WU, B; WARNER, DS			THE HEMISPHERIC CEREBROVASCULAR RESPONSE TO HEMODILUTION IS ATTENUATED BY A FOCAL CRYOGENIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; NITRIC-OXIDE SYNTHESIS; SPREADING DEPRESSION; RAT-BRAIN; OXYGEN-CONSUMPTION; NMDA-RECEPTOR; ISOVOLEMIC HEMODILUTION; HEMATOCRIT VARIATIONS; HYPOXIC HYPOXIA	Experimental brain injury attenuates the normal increase in cerebral blood flow (CBF) that accompanies a fall in PaO2, and this may contribute to the well-known detrimental effects of hypoxia following closed head injury. Anemia is also known to adversely affect posttraumatic survival, and it is reasonable to hypothesize that this too may be related to an altered cerebrovascular response. Therefore, to examine this possibility, pentobarbital-anesthetized rabbits were subjected to a left posterior parietal cryogenic cortical injury, followed 90 min later by isovolemic hemodilution with hetastarch. Unlesioned control animals underwent an identical degree of hemodilution. CBF was measured using radioactive microspheres. In control animals, hemodilution was accompanied by a marked increase in CBF in all brain regions. For example, in the left posterior cortex, CBF increased from 30 +/- 14 mL/100 g/min (baseline Hct = 42 +/- 2%, mean +/- SD) to 100 +/- 20 mL/100 g/min at Hct = 12 +/- 1%. By contrast, there was a markedly attenuated response throughout the left (ipsilateral) hemisphere of injured animals, even in cortical regions distant from the injury. For example, in the left posterior cortex, CBF changed from a baseline of 32 +/- 21 mL/100 g/min (baseline) to 40 +/- 14 mL/100 g/min at the lowest Hct. CBF responses to hemodilution were unaltered in the contralateral hemisphere and in the hindbrain. These data indicate that a localized brain lesion can produce widespread ipsilateral alterations in the CBF response to hemodilution, with resultant compromise in cerebral O-2 delivery. These data support the argument that the CBF increase produced by hemodilution is an active vasodilatory process rather than a passive response to changing blood viscosity.			TODD, MM (corresponding author), UNIV IOWA, COLL MED, DEPT ANESTHESIA, NEUROANESTHESIA RES LAB, IOWA CITY, IA 52242 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS24517] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS024517] Funding Source: NIH RePORTER		ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P423, DOI 10.1111/j.1748-1716.1975.tb05832.x; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLASEN RA, 1957, SURG GYNECOL OBSTET, V104, P591; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAN FC, 1980, AM J PHYSIOL, V238, pH545, DOI 10.1152/ajpheart.1980.238.4.H545; FEUSTEL PJ, 1987, J SURG RES, V43, P86, DOI 10.1016/0022-4804(87)90051-5; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; GENTLEMAN D, 1992, INT SURG, V77, P297; GOADSBY PJ, 1992, BRAIN RES, V595, P167, DOI 10.1016/0006-8993(92)91470-Y; HUDAK ML, 1986, AM J PHYSIOL, V251, pH63, DOI 10.1152/ajpheart.1986.251.1.H63; HUDAK ML, 1989, AM J PHYSIOL, V257, pH912, DOI 10.1152/ajpheart.1989.257.3.H912; IKEDA Y, 1990, NEUROSURGERY, V27, P1; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JOHANNSSON H, 1975, ACTA PHYSIOL SCAND, V93, P269, DOI 10.1111/j.1748-1716.1975.tb05815.x; JONES MD, 1981, AM J PHYSIOL, V240, pH209, DOI 10.1152/ajpheart.1981.240.2.H209; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KONTOS HA, 1993, STROKE, V24, P427, DOI 10.1161/01.STR.24.3.427; KOROSUE K, 1992, STROKE, V23, P1487, DOI 10.1161/01.STR.23.10.1487; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; LAURITZEN M, 1984, J CEREBR BLOOD F MET, V4, P546, DOI 10.1038/jcbfm.1984.79; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1992, AM J PHYSIOL, V262, pH949, DOI 10.1152/ajpheart.1992.262.4.H949; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; RAMANI R, 1991, J CEREBR BLOOD F MET, V11, P388, DOI 10.1038/jcbfm.1991.79; REILLY PL, 1977, J NEUROL NEUROSUR PS, V40, P1092, DOI 10.1136/jnnp.40.11.1092; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHINOZUKA T, 1989, J CEREBR BLOOD F MET, V9, P187, DOI 10.1038/jcbfm.1989.28; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; TRAYSTMAN RJ, 1981, AM J PHYSIOL, V241, pH724, DOI 10.1152/ajpheart.1981.241.5.H724; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; TSUDA Y, 1987, J NEUROL SCI, V82, P171, DOI 10.1016/0022-510X(87)90016-5; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; WOOD JH, 1985, STROKE, V16, P765, DOI 10.1161/01.STR.16.5.765; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	54	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	1994	11	2					149	160		10.1089/neu.1994.11.149			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NR684	WOS:A1994NR68400002	7932795				2022-02-06	
J	PACKARD, RC; HAM, LP				PACKARD, RC; HAM, LP			PROMISING TECHNIQUES IN THE ASSESSMENT OF MILD HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article							POSITRON EMISSION TOMOGRAPHY; EVENT-RELATED POTENTIALS; TRANSCRANIAL DOPPLER EVALUATION; CEREBRAL BLOOD-FLOW; EVOKED-POTENTIALS; COMPUTERIZED-TOMOGRAPHY; ULTRASONIC FEATURES; SELECTIVE ATTENTION; GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE	Closed head injury may result in varying degrees of brain injury, from slight to severe and irreversible. Severe or even moderate head injuries often result in obvious structural damage, which is usually easily detected by imaging or neurophysiologic assessment. Mild head injuries (MHI; defined by Rimel et al1 as a period of unconsciousness less than 20 minutes, a Glasgow Coma Scale of 13 or greater, a negative neurologic examination, and a duration of posttraumatic amnesia less than 48 hours) are typically more subtle. In spite of persisting symptomatology, there is typically no anatomic evidence of injury as traditionally assessed.2,3 (See Young and Silberstein in this issue of Seminars). A variety of distressing symptoms often follow MHI or neck injury. The most common are headache, dizziness, impaired concentration, memory difficulties, fatigue, irritability, depression, and anxiety.2-5 Paradoxically, individuals sustaining MHI often have more intense posttraumatic symptoms than those who sustain more severe head injuries.3 The persistence of these symptoms often results in feelings of distrust from the public, the legal profession, insurance companies, and even other physicians.4,6 Even in the face of legitimate posttraumatic symptoms, patients may still be labeled as ''accident neurosis,'' ''personality disorder,'' or ''malingering in order to receive compensation.'' New technologic advances in experimental head injury and neuroimaging techniques have revealed that even MHIs result in subtle changes in the structure and physiology of the brain.7,8 Such cerebral alterations may explain the persistence of memory difficulties, depression, distractibility, dizziness, and headache. Traditional studies, however, including radiographs, electroencephalography (EEG), computerized tomography (CT), and magnetic resonance imaging (MRI) are often normal in MHI. Transcranial Doppler (TCD), positron emission tomography (PET), single photon emission computerized tomography (SPECT), and quantitative analysis of EEG and evoked potentials (brain mapping) have only recently become available for clinical use. These new and promising techniques will be reviewed in detail in this article.	UNIV W FLORIDA, DEPT PSYCHOL, PENSACOLA, FL 32514 USA		PACKARD, RC (corresponding author), HEADACHE MANAGEMENT & NEUROL, 5500 N DAVIS HIGHWAY, PENSACOLA, FL 32503 USA.						AASLID R, 1902, TRANSCRANIAL DOPPLER, P1; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ALAVI A, 1987, J CEREB BLOOD FLO S1, V7, pS646; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; [Anonymous], 1989, Neurology, V39, P1100; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; BARON JC, 1983, POSITRON EMISSION TO, P212; BENNETT TL, 1988, COGN REHABIL, P34; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; BROOKS DJ, 1984, J CEREBR BLOOD F MET, V4, P458, DOI 10.1038/jcbfm.1984.65; BUCHSBAUM MS, 1986, J AFFECT DISORDERS, V10, P137, DOI 10.1016/0165-0327(86)90036-4; DEVOUS MD, 1989, BRAIN IMAGING APPLIC, P147; DOPPLER CA, 1992, TRANSCRANIAL DOPPLER, P1; EMERSON RG, 1992, 27TH ANN COURS CLIN; ENGEL J, 1982, ANN NEUROL, V12, P518, DOI 10.1002/ana.410120604; EPSTEIN C, 1992, 27TH AM EL SOC ANN C; FARKAS T, 1984, ARCH GEN PSYCHIAT, V41, P293; FERROMILONE D, 1984, JUN INT S EV POT ASS, P79; FRACKOWIAK RSJ, 1983, FUNCTIONAL RADIONUCL, P305; GAWEL MJ, 1990, HEADACHE REV, V3, P3; GEORGE J K, 1989, Journal of Nuclear Medicine, V30, P802; GERARD G, 1992, HEADACHE Q-CURR TREA, V3, P217; GOODIN DS, 1992, AAN BREAKFAST S, V211; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; GRAY BG, 1992, J NUCL MED, V33, P52; GREEN J, 1992, CLIN ELECTROENCEPHAL, V23, P79, DOI 10.1177/155005949202300207; GROLIMUND P, 1987, STROKE, V18, P1018, DOI 10.1161/01.STR.18.6.1018; GRONWALL D, 1974, LANCET, V2, P605; GROSS MM, 1965, ELECTROEN CLIN NEURO, V18, P451, DOI 10.1016/0013-4694(65)90125-2; GRUBB RL, 1978, ANN NEUROL, V4, P322, DOI 10.1002/ana.410040407; GUR RC, 1983, NEUROPSYCHOLOGIA, V21, P601, DOI 10.1016/0028-3932(83)90057-X; HAYES RL, 1989, MILD HEAD INJURY, P54; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HOLCOMB HH, 1989, BRAIN IMAGING APPLIC, P235; JAMIESON D, 1988, RADIOL CLIN N AM, V26, P1075; JOLLES PR, 1989, J NUCL MED, V30, P1589; JONES SC, 1985, J CEREBR BLOOD F MET, V5, P566, DOI 10.1038/jcbfm.1985.85; KRELINA M, 1989, CAN J NEUROL SCI, V2, P279; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; McCarthy G, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P331; MCGEER PL, 1986, CAN MED ASSOC J, V134, P597; MEADOR KJ, 1992, AAN BREAKFAST S, V211; MITGUY J, 1992, HEADLINES        MAY, P6; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; NAATANEN R, 1975, BIOL PSYCHOL, V2, P237, DOI 10.1016/0301-0511(75)90038-1; NEWELL DW, 1992, TRANSCRANIAL DOPPLER, P109; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; NIMMON C C, 1989, European Journal of Nuclear Medicine, V15, P507; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OLBRICH HM, 1986, ACTA NEUROCHIR, V80, P116, DOI 10.1007/BF01812285; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PATTERSON JV, 1988, ELECTROEN CLIN NEURO, V71, P450, DOI 10.1016/0168-5597(88)90049-4; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; PODOSHIN L, 1990, J LARYNGOL OTOL, V104, P191, DOI 10.1017/S0022215100112241; POOICH J, 1991, AM J EEG TECHNOL, V1, P201; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; PRATT H, 1981, ELECTROEN CLIN NEURO, V51, P80, DOI 10.1016/0013-4694(81)91511-X; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; PRITCHARD WS, 1986, PSYCHOL BULL, V100, P43, DOI 10.1037/0033-2909.100.1.43; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; RASKIN NH, 1988, HEADACHE, P289; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; REIVICH M, 1982, J CEREBR BLOOD F MET, V2, P307, DOI 10.1038/jcbfm.1982.32; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUTH RA, 1982, AM SPEECH HEARING AS; SCHLAKE HP, 1989, HEADACHE, V29, P344, DOI 10.1111/j.1526-4610.1989.hed2906344.x; SCHLAKE HP, 1990, HEADACHE Q-CURR TREA, V1, P303; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; SKYHOJ OT, 1989, HEADACHE, V29, P15; SMITH ME, 1989, J EXP PSYCHOL LEARN, V15, P50, DOI 10.1037/0278-7393.15.1.50; STOCKARD JJ, 1980, ELECTRODIAGNOSIS CLI, P503; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; TEBANO RW, 1989, ELECTROENCEPHALOGR C, V73, P94; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; THIE A, 1990, HEADACHE, V30, P209, DOI 10.1111/j.1526-4610.1990.hed3004209.x; THIE A, 1990, HEADACHE, V30, P201, DOI 10.1111/j.1526-4610.1990.hed3004201.x; THIVIERGE J, 1988, CAN J PSYCHIAT, V33, P552, DOI 10.1177/070674378803300619; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; WILKINSON RT, 1967, ELECTROEN CLIN NEURO, V23, P50, DOI 10.1016/0013-4694(67)90140-X; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; ZWETSLOOT CP, 1991, HEADACHE, V31, P593, DOI 10.1111/j.1526-4610.1991.hed3109593.x; [No title captured]; 1991, NEUROLOGY, V41, pA13	92	12	12	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					74	83		10.1055/s-2008-1041062			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE151	WOS:A1994NE15100013	8029563				2022-02-06	
J	MESTDAGH, H; MAYNOU, C; DELOBELLE, JM; URVOY, P; BUTIN, E				MESTDAGH, H; MAYNOU, C; DELOBELLE, JM; URVOY, P; BUTIN, E			TRAUMATIC POSTERIOR DISLOCATION OF THE SHOULDER IN ADULTS - REVIEW OF 25 CASES	ANNALES DE CHIRURGIE			French	Article						SHOULDER; POSTERIOR DISLOCATION; LOCKED DISLOCATION; CLOSED REDUCTION; SURGICAL TREATMENT		In a series of 25 traumatic posterior dislocations of the shoulder treated from 1960 to 1985, 16 were overlooked and the time from injury to treatment ranged from 3 weeks to 14 months. 11 cases were secondary to motor vehicle accident and 14 occurred after a convulsive fit. Early closed reduction was effective in only 4 cases ; in 2 cases, reduction was unstable and further screwing of an associated fracture of the tuberculum majus was performed to prevent redislocation; 3 locked dislocations necessitated open reduction and stabilization by subscapularis transposition into the defect of the humeral head. Most of the 16 chronic unreduced dislocations were treated by the same procedure. Overall, 21 cases were reviewed with a mean follow-up of 14 years. Functional outcome was more often satisfactory in acute (5/7) than in old unreduced dislocations (6/14). Mc Laughlin or Neer's procedures yielded good results in 9 out of 14 cases ; they are indicated irrespective of the patient's age whenever Mc Laughlin's notch does not involve more than one third of the articular surface of the humeral head.			MESTDAGH, H (corresponding author), CHRU LILLE,SERV ORTHOPED TRAUMATOL D,PL VERDUN,F-59037 LILLE,FRANCE.							0	12	12	0	1	EXPANSION SCI FRANCAISE	PARIS	31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE	0003-3944			ANN CHIR	Ann. Chir.		1994	48	4					355	363					9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	NK132	WOS:A1994NK13200011	8085761				2022-02-06	
J	WOOLLEY, SM; RUBIN, AM; KANTNER, RM; ARMSTRONG, CW				WOOLLEY, SM; RUBIN, AM; KANTNER, RM; ARMSTRONG, CW			DIFFERENTIATION OF BALANCE DEFICITS THROUGH EXAMINATION OF SELECTED COMPONENTS OF STATIC STABILOMETRY	JOURNAL OF OTOLARYNGOLOGY			English	Article								Stabilometry, which measures the body's center of pressure (COP) movements, during relaxed standing, has been used to distinguish individuals with vestibular and neurologic dysfunctions from normal subjects. The purpose of this study was to determine whether mathematical differences in the magnitudes of the COP obtained from six somatosensory testing conditions could be used to discriminate between different types of balance deficits. Stabilometry measures, using a fixed force platform, were obtained from normal (N = 52) and dizzy (N = 149), peripheral vestibular dysfunction (PVD), post-concussion syndrome (PCS), psychogenic (PSG), and unknown/undetermined etiology (UNK). The data significantly differentiated CVD, PVD and PSG patients from normals and between some of the dizzy groups: CVD versus PVD, PCS; and PSG versus CVD, PVD, PCS and UNK. The measures of anterior-posterior COP movements provided the greatest discrimination.			WOOLLEY, SM (corresponding author), MED COLL OHIO,DEPT REHABIL MED,POB 10008,TOLEDO,OH 43699, USA.							0	12	13	0	0	DECKER PERIODICALS INC	HAMILTON	4 HUGHSON STREET SOUTH PO BOX 620, LCD 1, HAMILTON ON L8N 3K7, CANADA	0381-6605			J OTOLARYNGOL	J. Otolaryngol.	OCT	1993	22	5					368	375					8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	MH125	WOS:A1993MH12500008	8283507				2022-02-06	
J	MYSIW, WJ; TAN, J; JACKSON, RD				MYSIW, WJ; TAN, J; JACKSON, RD			HETEROTOPIC OSSIFICATION - THE UTILITY OF OSTEOCALCIN IN DIAGNOSIS AND MANAGEMENT	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						HETEROTOPIC OSSIFICATION; OSTEOCALCIN; TRAUMATIC BRAIN INJURY	BONE GLA-PROTEIN; ALKALINE-PHOSPHATASE; SERUM OSTEOCALCIN; PAGETS-DISEASE; OSTEOPOROSIS	The status of 12 patients after severe traumatic brain injury was investigated to determine the clinical significance of serum osteocalcin levels during the active phase of neurogenic heterotopic ossification. The diagnosis of heterotopic ossification was confirmed on the basis of radiologic, findings. The mean interval between the initial injury and diagnosis of heterotopic ossification was 29 weeks. At the time of diagnosis, serum osteocalcin and total alkaline phosphatase levels were determined along with 24-hour urinary calcium and hydroxyproline excretion. The mean serum osteocalcin level was normal at 4.3 ng/ml (normal range 1.6-6.6 ng/ml) in contrast to the elevated mean values for serum alkaline phosphatase (mean = 173 units/liter; normal range 0-105 units/liter) and urinary hydroxyproline concentration (mean = 39.6 mg/24 h; normal range 7-25 mg/24 hr). Only 17% of the subjects demonstrated an elevated serum osteocalcin level, whereas 58% of the patients had an elevated serum alkaline phosphatase level. Urinary calcium excretion and hydroxyproline excretion were elevated in 33% and 70% of subjects, respectively. These data did not reveal a significant correlation between serum osteocalcin and serum alkaline phosphatase, urinary calcium excretion or urinary hydroxyproline at the time of diagnosis or in serial measurements. Therefore, serum osteocalcin is not a valuable adjunct in confirming the diagnosis of neurogenic heterotopic ossification once the diagnosis has been suggested on the basis of clinical findings and it does not appear to play a role in assessing the maturation of heterotopic ossification.	OHIO STATE UNIV,DIV ENDOCRINOL & METAB INTERNAL MED,COLUMBUS,OH 43210		MYSIW, WJ (corresponding author), OHIO STATE UNIV,DEPT PHYS MED & REHABIL,1048 DODD HALL,480 W 9TH AVE,COLUMBUS,OH 43210, USA.		Mysiw, Walter/E-3724-2011				BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; DELMAS PD, 1986, CALCIFIED TISSUE INT, V38, P60, DOI 10.1007/BF02556596; DIAMOND T, 1989, AM J MED, V86, P282, DOI 10.1016/0002-9343(89)90297-0; DUDA RJ, 1988, J CLIN ENDOCR METAB, V66, P951, DOI 10.1210/jcem-66-5-951; EASTELL R, 1988, J CLIN ENDOCR METAB, V67, P741, DOI 10.1210/jcem-67-4-741; FORTUNE CL, 1989, ENDOCRINOLOGY, V124, P2785, DOI 10.1210/endo-124-6-2785; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; HYLDSTRUP L, 1988, SCAND J CLIN LAB INV, V48, P611, DOI 10.3109/00365518809085780; JACKSON RD, 1989, AM J PHYS MED REHAB, V68, P18, DOI 10.1097/00002060-198902000-00006; JENSEN LL, 1988, AM J PHYS MED, V66, P351; JOHNSON JS, 1990, METABOLISM, V39, P1122; LIAN JB, 1988, CLIN ORTHOP RELAT R, V226, P267; NIELSEN HK, 1991, J BONE MINER RES, V6, P435; NIELSEN HK, 1990, CALCIFIED TISSUE INT, V46, P173, DOI 10.1007/BF02555040; ORZEL JA, 1985, J NUCL MED, V26, P125; PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954; TORRES R, 1989, SCAND J CLIN LAB INV, V49, P279, DOI 10.3109/00365518909089096; WEINREB M, 1990, J BONE MINER RES, V5, P831	18	12	13	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	1993	72	4					184	187		10.1097/00002060-199308000-00002			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LU176	WOS:A1993LU17600002	8363811				2022-02-06	
J	MATTEUCCI, MJ; WISNER, DH; GUNTHER, RA; WOOLLEY, DE				MATTEUCCI, MJ; WISNER, DH; GUNTHER, RA; WOOLLEY, DE			EFFECTS OF HYPERTONIC AND ISOTONIC FLUID INFUSION ON THE FLASH EVOKED-POTENTIAL IN RATS - HEMORRHAGE, RESUSCITATION, AND HYPERNATREMIA	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SMALL-VOLUME RESUSCITATION; LACTATED RINGERS SOLUTION; CEREBRAL WATER-CONTENT; SALINE-DEXTRAN; INTRACRANIAL-PRESSURE; TRAUMATIC SHOCK; BRAIN-INJURY; HEAD-INJURY	In resuscitation from hemorrhagic shock, very small volumes of hypertonic saline (HS) improve blood pressure while reducing intracranial pressure and edema formation. The effects of hypertonic resuscitation fluids and hypernatremia on electrophysiologic brain function have not been studied. The present study was done in two parts. First we examined the effects of hemorrhagic shock and resuscitation with either 7.5% HS or lactated Ringer's (LR) solution on the flash evoked potential (FEP). Rats were bled to a mean arterial pressure (MAP) of 35 mm Hg for 1 hour, then resuscitated with HS (n = 10) or LR (n = 10) to a MAP of 80 mm Hg for another hour. Resuscitation required 3.8 +/- 0.5 mL/kg HS and 42.9 +/- 7.5 mL/kg LR (p < 0.05). During hemorrhage, FEP latencies increased and amplitudes decreased. During resuscitation, these variables returned toward baseline values. There were no significant differences between groups, although HS tended to restore the FEP better than LR. We next examined the effects on the FEP of hypernatremia and hyperosmolarity produced by two different hyperosmotic fluids. Over a 1-hour period, 16 mL/kg HS (n = 8), 16 mL/kg IsoSal (4.5% saline, 5.9% glucose, 6.4% mixed amino acids; n = 8), or 40 mL/kg LR (n = 8) was infused into normovolemic rats. Plasma sodium levels increased in both hyperosmotic groups (baseline = 145.2 +/- 0.7 mEq/L; after infusion, HS = 202.4 +/- 9.8 mEq/L, IsoSal = 163.3 +/- 4.2 mEq/L; p < 0.05). Plasma osmolarity also increased in these two groups (baseline = 303.1 +/- 1.6 mOsm/L; after infusion, HS = 404.6 +/- 17.6 mOsm/L, IsoSal = 357.9 +/- 6.7 mOsm/L; p < 0.05). Brain tissue water content was slightly decreased in both hyperosmotic groups compared with the LR group (HS = 77.4% +/- 0.7%; IsoSal = 77.5% +/- 0.6%; LR = 78.2% +/- 0.4%) although the differences were not significant. Some deterioration was seen in the FEP at very high levels of serum sodium and osmolarity. Neural tissue dehydration as a result of hypertonic saline infusion in hemorrhaged and normovolemic rats has no apparent deleterious effects on acute brain function as measured by the FEP until very high levels of sodium and osmolarity are reached.	UNIV CALIF DAVIS,SACRAMENTO MED CTR,MED CTR,DEPT SURG,4301 X ST,ROOM 2310,SACRAMENTO,CA 95817; UNIV CALIF DAVIS,DEPT ANIM PHYSIOL,DAVIS,CA 95616								BATTISTELLA F D, 1989, Surgical Forum (Chicago), V40, P40; DUCEY JP, 1989, J TRAUMA, V29, P1510, DOI 10.1097/00005373-198911000-00010; DUCEY JP, 1990, CRIT CARE MED, V18, P744, DOI 10.1097/00003246-199007000-00013; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; HAGHIGHI SS, 1989, NEUROSURGERY, V24, P246, DOI 10.1227/00006123-198902000-00015; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; KRAMER GC, 1986, SURGERY, V100, P239; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MATTSSON JL, 1988, NEUROTOXICOL TERATOL, V10, P435, DOI 10.1016/0892-0362(88)90005-0; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; Wisner D H, 1983, Curr Surg, V40, P32; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WISNER DH, 1992, J TRAUMA, V32, P351, DOI 10.1097/00005373-199203000-00013; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	19	12	17	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1993	34	1					1	7		10.1097/00005373-199301000-00001			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	KP908	WOS:A1993KP90800001	8437174				2022-02-06	
J	DAILEY, SW; BARSAN, WG				DAILEY, SW; BARSAN, WG			HEAD-INJURIES IN SOCCER - A CASE FOR PROTECTIVE HEADGEAR	PHYSICIAN AND SPORTSMEDICINE			English	Article								Two soccer goalies, a 20-year-old woman and a 28-year-old man, sustained head injuries as they fielded shots on goal. One was kicked, the other kneed by another player. The female goalie suffered a mild concussion. The male goalie lost consciousness and was transported to a hospital where he scored a 7 of 15 on the Glasgow Coma Scale. Three months after the injury, he still suffered from decreased concentration and hearing loss and had not returned to work.			DAILEY, SW (corresponding author), UNIV CINCINNATI,COLL MED,DEPT EMERGENCY MED,CINCINNATI,OH 45221, USA.							0	12	12	0	7	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	AUG	1992	20	8					79	&		10.1080/00913847.1992.11947468			0	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	JH413	WOS:A1992JH41300013	29272675				2022-02-06	
J	COLOHAN, ART; OYESIKU, NM				COLOHAN, ART; OYESIKU, NM			MODERATE HEAD-INJURY - AN OVERVIEW	JOURNAL OF NEUROTRAUMA			English	Article							TRAUMATIC BRAIN INJURY; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE; RAT; SEQUELAE; RECOVERY; DEFICIT; COMA; PH	This review summarizes currently available epidemiologic, clinical, pathologic, and outcome data in patients with moderate head injury (MHI, GCS 9-12). This important subset comprises about 20% of head injuries in the United States. Affected patients usually are young, and most injuries are due to vehicular accidents. Current evidence (mortality rate and outcome) from various studies suggests an apparent dichotomy within the MHI category (9-10 vs 11-12). The former is more in keeping with the favorable subgroup of severe head injuries, and the latter is more appropriate to the mild head injury group. Should there be a reclassification based on this dichotomy? This is obviously important for clinical management and prognostication in these patients. The experimental evidence for a pathologic and biochemical substrate of MHI is reviewed. It is becoming increasing evident that biochemical mediators of secondary neuronal injury in MHI are at least as important as those attributed to severe head injury, but MHI may be more amenable to therapy. It may be prudent, therefore, to direct further effort to this subgroup of patients. Although additional study is required, the pattern of recovery in MHI as determined by extant neurobehavioral studies is analyzed.	EMORY UNIV,SCH MED,ATLANTA,GA 30322		COLOHAN, ART (corresponding author), GRADY MEM HOSP,DIV NEUROL SURG,80 BUTLER ST NE,ATLANTA,GA 30335, USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; DICKMAN S, 1986, ARCH PHYS MED REHAB, V67, P507; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRONWALL D, 1975, LANCET, V2, P995; HAYES R, 1987, IEEE T SOFTWARE ENG, V13, P1254, DOI 10.1109/TSE.1987.232879; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SIESJO BK, 1985, CENTRLA NERVOUS SYST; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105	26	12	12	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1992	9			1			S259	S264					6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HN806	WOS:A1992HN80600024	1588614				2022-02-06	
J	YAMAKI, T; MURAKAMI, N; IWAMOTO, Y; NAKAGAWA, Y; UEDA, S; IRIZAWA, Y; KOMURA, S; MATSUURA, T				YAMAKI, T; MURAKAMI, N; IWAMOTO, Y; NAKAGAWA, Y; UEDA, S; IRIZAWA, Y; KOMURA, S; MATSUURA, T			PATHOLOGICAL-STUDY OF DIFFUSE AXONAL INJURY PATIENTS WHO DIED SHORTLY AFTER IMPACT	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; EARLY DEATH; DIFFUSE AXONAL INJURY; PATHOLOGICAL STUDY	NONMISSILE HEAD-INJURY; BRAIN INJURY; DAMAGE; HUMANS; NERVE	It is generally considered that axonal injury is apparent only on electron microscopy in the very early stage after a closed head injury. To clarify the pathological findings in head injury patients dying very shortly after the impact, we analyzed 8 fatal cases of diffuse axonal injury (DAI) who underwent medicolegal autopsy at the Department of Forensic Medicine of Kyoto Prefectural University of Medicine. Seven cases died within one hour after injury and another one case died 3 days after injury. We studied these cases macroscopically, microscopically, and electron microscopically. Macroscopically all cases showed the typical findings of diffuse axonal injury. Microscopical study of the cases who died within one hour revealed no characteristic findings of DAI such as appearance of retraction balls or microglia. On the other hand, in the case who died only 3 days after injury it showed the typical retraction balls. Electron microscopic study showed the remarkable destruction of cytoskeletal structure of axons in all cases. From our results, it is reasonable to speculate that DAI may be common among head injury patients who die very soon after the impact.	KYOTO PREFECTURAL UNIV MED, DEPT FORENS MED, KYOTO 602, JAPAN; MEIJI COLL ORIENTAL MED, DEPT ANAT, KYOTO, JAPAN		YAMAKI, T (corresponding author), KYOTO PREFECTURAL UNIV MED, DEPT NEUROSURG, KAWARAMACHI HIROKOJI, KAMIGYO KU, KYOTO 602, JAPAN.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CROMPTON MR, 1971, LANCET, V1, P669; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GRAHAM DI, 1985, NEUROPATH APPL NEURO, V11, P319; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	18	12	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1992	119	1-4					153	158		10.1007/BF01541800			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KD133	WOS:A1992KD13300028	1481741				2022-02-06	
J	HALL, S; BORNSTEIN, RA				HALL, S; BORNSTEIN, RA			SERIAL-POSITION EFFECTS IN PARAGRAPH RECALL FOLLOWING MILD CLOSED-HEAD INJURY	PERCEPTUAL AND MOTOR SKILLS			English	Article							PERFORMANCE; EDUCATION; DISEASE		OHIO STATE UNIV,COLL MED,NEUROPSYCHOL LAB,COLUMBUS,OH 43210								BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECKER DP, 1979, ARCH NEUROL-CHICAGO, V36, P750, DOI 10.1001/archneur.1979.00500480024005; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BORNSTEIN RA, 1983, J CLIN PSYCHOL, V39, P470, DOI 10.1002/1097-4679(198307)39:4<470::AID-JCLP2270390403>3.0.CO;2-F; FINLAYSON MAJ, 1977, J CONSULT CLIN PSYCH, V45, P536, DOI 10.1037/0022-006X.45.4.536; HALL S, IN PRESS J NEUROSURG; LEZAK M, 1983, NEUROPSYCHOLOGICAL A, P414; VALLAR G, 1986, BRAIN COGNITION, V5, P428, DOI 10.1016/0278-2626(86)90044-8; Wechsler D, 1987, MEMORY SCALE REVISED	10	12	12	0	1	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	1991	72	3	2				1295	1298		10.2466/PMS.72.4.1295-1298			4	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	GA987	WOS:A1991GA98700048	1961678				2022-02-06	
J	MOORE, TJ; ANDERSON, RB				MOORE, TJ; ANDERSON, RB			THE USE OF OPEN PHENOL BLOCKS TO THE MOTOR BRANCHES OF THE TIBIAL NERVE IN ADULT ACQUIRED SPASTICITY	FOOT & ANKLE			English	Article								Spasticity of the posterior calf muscles often occurs following head injury or spinal cord injury. If left untreated, equinovarus contractures of the foot and ankle may occur in a relatively short time period. This paper retrospectively reviews nine patients with either closed head injury (six patients) or spinal cord injury (three patients) who underwent open phenol injections into the motor branches of the tibial nerve in 16 limbs. Spasticity was decreased in all patients. No significant equinus contractures had occurred at final follow-up. Five of the patients were subsequently able to ambulate. One patient had recurrence of spasticity requiring a second surgical procedure (split anterior tibial tendon transfer), and two patients had significant toe clawing at final follow-up. Open phenol injections to the motor branches of the tibial nerve safely and effectively prevent foot and ankle contractures following spinal cord injury or head injury.			MOORE, TJ (corresponding author), MILLER ORTHOPAED CLIN,1001 BLYTHE BLVD,SUITE 200,CHARLOTTE,NC 28203, USA.							0	12	13	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0198-0211			FOOT ANKLE		FEB	1991	11	4					219	221		10.1177/107110079101100406			3	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	FA272	WOS:A1991FA27200006	1855707				2022-02-06	
J	BROWN, DSO; NELL, V				BROWN, DSO; NELL, V			EPIDEMIOLOGY OF TRAUMATIC BRAIN INJURY IN JOHANNESBURG .1. METHODOLOGICAL ISSUES IN A DEVELOPING-COUNTRY CONTEXT	SOCIAL SCIENCE & MEDICINE			English	Article						EPIDEMIOLOGY; METHODOLOGY; TRAUMATIC BRAIN INJURY; SAMPLING; JOHANNESBURG; DEVELOPING COUNTRY	HEAD-INJURY; CAPE-TOWN; CHILDREN		UNIV S AFRICA,HLTH PSYCHOL UNIT,POB 392,PRETORIA,SOUTH AFRICA								ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; AUSTEN MH, 1987, S AFR MED J, V72, P770; AUSTIN RL, 1983, J CRIM JUST, V11, P93, DOI 10.1016/0047-2352(83)90045-4; AUSTIN RL, 1987, J CRIM JUST, V15, P437, DOI 10.1016/0047-2352(87)90001-8; BOTHA JL, 1988, SOC SCI MED, V26, P851; BROWN DSO, 1990, 904 U S AFR HLTH PSY; DEBEER C, 1984, S AFRICAN DISEASE AP; DEVILLIERS JC, 1984, S AFR MED J, V66, P801; ENGELHART H, 1986, HOSPITAL NURSING YB; GUTHKELCH AN, 1979, ACTA NEUROCHIR S, V1, P120; *INT ROAD FED, 1988, WORLD ROAD STAT; JANSEN CP, 1988, THESIS U S AFRICA PR; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KOK PC, 1986, BEVOLKINGS HERVERSPR; KUSTNER HGV, 1987, EPIDEMIOLOGICAL COMM, V14, P2; MURRAY GD, 1986, STAT MED, V5, P103, DOI 10.1002/sim.4780050202; PANG D, 1985, HEAD INJURY REHABILI; ROSEINNES AP, 1974, S AFR MED J, V48, P2548; Sanders D., 1985, STRUGGLE HLTH; TEASDALE G, 1974, LANCET, V2, P81; VANDELLEN JR, UNPUB ANN STATISTICS; *WHO, 1977, MAN INT STAT CLASS D, V2; *WHO, 1986, PROBL MENT HLTH AFR; *WHO, 1986, POP CENS 1985; *WHO, 1984, 698 TECHN REP; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; World Health Organization,, 1977, MAN INT STAT CLASS D, VI	28	12	12	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0277-9536			SOC SCI MED	Soc. Sci. Med.		1991	33	3					283	287		10.1016/0277-9536(91)90362-G			5	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	GA785	WOS:A1991GA78500007	1925692				2022-02-06	
J	STAMBROOK, M; MOORE, AD; KOWALCHUK, S; KASSUM, DA; PETERS, LC; MCCLARTY, BM; HAWRYLUK, GA				STAMBROOK, M; MOORE, AD; KOWALCHUK, S; KASSUM, DA; PETERS, LC; MCCLARTY, BM; HAWRYLUK, GA			EARLY METABOLIC AND NEUROLOGIC PREDICTORS OF LONG-TERM QUALITY OF LIFE AFTER CLOSED HEAD-INJURY	CANADIAN JOURNAL OF SURGERY			English	Article									UNIV MANITOBA,FAC MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,HLTH SCI CLIN RES CTR,NEUROPSYCHOL RES UNIT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT PSYCHOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; ST BONIFACE GEN HOSP,SURG INTENS CARE UNIT,WINNIPEG R2H 2A6,MANITOBA,CANADA; UNIV MANITOBA,DEPT PSYCHIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT RADIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; HLTH SCI CTR,WINNIPEG R3E 0W1,MANITOBA,CANADA		STAMBROOK, M (corresponding author), SOC MANITOBANS DISABIL,825 SHERBROOK ST,WINNIPEG R3A 1M5,MANITOBA,CANADA.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; EISENBERG HM, 1987, HEAD INJURY, P20; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; KASSUM DA, 1984, CAN J SURG, V27, P64; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kraus JF, 1987, HEAD INJURY, V2, P1; McNair DM, 1971, EITS MANUAL PROFILE; MCSWEENY AJ, 1982, ARCH INTERN MED, V142, P473, DOI 10.1001/archinte.142.3.473; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; PARKINSON D, 1985, CAN J SURG, V28, P79; SMITH JS, 1978, SURG GYNECOL OBSTET, V147, P18; STAMBROOK M, 1988, CANADIAN J REHABI S4, V1, P74	15	12	12	0	0	CANADIAN MEDICAL ASSOCIATION	OTTAWA	1867 ALTA VISTA DR, OTTAWA ON K1G 3Y6, CANADA	0008-428X			CAN J SURG	Can. J. Surg.	APR	1990	33	2					115	118					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DA996	WOS:A1990DA99600009	2268809				2022-02-06	
J	ADAMOVICH, BB				ADAMOVICH, BB			INFORMATION-PROCESSING, COGNITION, ATTENTION, AND COMMUNICATION FOLLOWING CLOSED-HEAD INJURY	FOLIA PHONIATRICA			English	Article											ADAMOVICH, BB (corresponding author), MERCY HOSP,WELDON CTR REHABIL,271 CAREW ST,SPRINGFIELD,MA 01102, USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; ADAMOVICH BB, 1984, CLIN APHASIOLOGY C P; ADAMOVICH BB, 1983, AM SPEECH LANG HEAR; ADAMOVICH BB, 1982, AM SPEECH LANG HEAR; ADAMOVICH BB, 1978, CLIN APHASIOLOGY C P, P327; ADAMOVICH BL, 1981, CLIN APHASIOLOGY C P, P244; BATES E, 1976, J CHILD LANG, V6, P29; BELLUGI U, 1980, DAHLEM WORKSHOP BERL; BENYISHAY Y, 1978, WORKING APPROACHES R; BEVER TG, 1975, ANN NY ACAD SCI, V265, P252; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; GALIN D, 1974, ARCH GEN PSYCHIAT, V31, P572; GAZZANIGA M, 1978, DISORDERS ATTENTION; GESCHWIND N, 1982, PHILOS T ROY SOC B, V298, P173, DOI 10.1098/rstb.1982.0080; GREENFIELD PM, 1978, INFORMATIVENESS PRES; Guilford J.P., 1971, ANAL INTELLIGENCE; HAGEN C, 1983, LANGUAGE DISABILITIE; HAGEN C, 1981, C MODELS TECHNIQUES; KIRBY JR, 1980, COGNITION DEV INSTRU; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; MANN L, 1985, F COGNITIVE PROCESS; MARSHALL J, 1980, SIGNED SPOKEN LANGUA; MAYER R, 1981, PROMISE COGNITIVE PS; *MED, PROV B 217; MUMA JR, 1978, LANGUAGE HDB CONCEPT; Neisser U., 1976, COGNITION REALITY; NORMAN DA, 1979, COGNITIVE PSYCHOL, V11, P107, DOI 10.1016/0010-0285(79)90006-9; PARRILLBURNSTEI.M, 1981, PROBLEM SOLVING LEAR; PATTEN BM, 1982, MODALITY SPECIFIC ME; PEA RD, 1979, J CHILD LANG, V6, P397, DOI 10.1017/S0305000900002440; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SHAW RE, 1980, DAHLEM WORKSHOP BERL; WETZEL CD, 1982, BRAIN LANG, V15, P70, DOI 10.1016/0093-934X(82)90047-5	34	12	12	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0015-5705			FOLIA PHONIATR	Folia Phoniatr.	JAN-FEB	1990	42	1					11	23		10.1159/000266015			13	Linguistics	Social Science Citation Index (SSCI)	Linguistics	CM922	WOS:A1990CM92200002	2307386				2022-02-06	
J	SELECKI, BR; BERRY, G; DAN, NG; KWOK, B; MANDRYK, JA; NORTH, JB; RING, IT; SEWELL, MF; SIMPSON, DA; STENING, WA; VANDERFIELD, GK				SELECKI, BR; BERRY, G; DAN, NG; KWOK, B; MANDRYK, JA; NORTH, JB; RING, IT; SEWELL, MF; SIMPSON, DA; STENING, WA; VANDERFIELD, GK			PREVENTABLE CAUSES OF DEATH AND DISABILITY FROM NEUROTRAUMA	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article																		0	12	12	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	JUL	1986	56	7					529	534		10.1111/j.1445-2197.1986.tb07095.x			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	D5284	WOS:A1986D528400002	2943259				2022-02-06	
J	GEETS, W; DEZEGHER, F				GEETS, W; DEZEGHER, F			EEG AND BRAIN-STEM ABNORMALITIES AFTER CEREBRAL CONCUSSION - SHORT-TERM OBSERVATIONS	ACTA NEUROLOGICA BELGICA			English	Article											GEETS, W (corresponding author), ST ELIZABETH HOSP,DEPT NEUROL,AVE DEFRE 206,B-1180 BRUSSELS,BELGIUM.						FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Geets W, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P253, DOI 10.1016/S0370-4475(83)80036-7; GEETS W, 1961, Acta Neurol Psychiatr Belg, V61, P460; GEETS W, 1983, ACTA NEUROL BELG, V83, P126; GEETS W, 1984, REV EEG NEUROPHYSIOL, V14, P333; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; JENNETT WB, 1962, EPILEPSY BLUNT HEAD; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P511, DOI 10.1016/0013-4694(55)90077-8; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; PENFIELD W, 1956, Acta Neurol Psychiatr Belg, V56, P75; Shetter A G, 1979, Adv Neurol, V22, P5; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2	13	12	12	0	2	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9009			ACTA NEUROL BELG	Acta Neurol. Belg.		1985	85	5					277	283					7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AUC38	WOS:A1985AUC3800002	3934918				2022-02-06	
J	GOETHE, KE; LEVIN, HS				GOETHE, KE; LEVIN, HS			BEHAVIORAL MANIFESTATIONS DURING THE EARLY AND LONG-TERM STAGES OF RECOVERY AFTER CLOSED HEAD-INJURY	PSYCHIATRIC ANNALS			English	Article									UNIV TEXAS, MED BRANCH, DIV NEUROSURG E17, GALVESTON, TX 77550 USA; UNIV TEXAS, MED BRANCH, DEPT NEUROL, GALVESTON, TX 77550 USA; UNIV TEXAS, MED BRANCH, NEUROPSYCHOL LAB, GALVESTON, TX 77550 USA								BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1977, J NERV MENT DIS, V165, P247, DOI 10.1097/00005053-197710000-00004; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P605; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Moore BE, 1944, NEW ENGL J MED, V230, P445, DOI 10.1056/NEJM194404132301501; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OVERALL JE, 1962, PSYCHOL REP, V10, P799; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruesch J, 1943, ARCH NEURO PSYCHIATR, V50, P165, DOI 10.1001/archneurpsyc.1943.02290200065005; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SANO K, 1983, J NEUROSURG, V58, P223, DOI 10.3171/jns.1983.58.2.0223; SISLER GC, 1978, PSYCHIATR CLIN N AM, V1, P137; Symonds C P, 1937, Proc R Soc Med, V30, P1081; TEASDALE G, 1974, LANCET, P45; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEINSTEIN EA, 1968, ARCH GEN PSYCHIAT, V18, P348	33	12	12	0	4	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.		1984	14	7					540	546		10.3928/0048-5713-19840701-11			7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	SY923	WOS:A1984SY92300007					2022-02-06	
J	WOOD, F; NOVACK, TA; LONG, CJ				WOOD, F; NOVACK, TA; LONG, CJ			POST-CONCUSSION SYMPTOMS - COGNITIVE, EMOTIONAL, AND ENVIRONMENTAL ASPECTS	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article									UNIV TENNESSEE MEMPHIS STATE UNIV,NEUROPSYCHOL LAB,MEMPHIS,TN; VANDERBILT UNIV,MED CTR,SCH MED,NASHVILLE,TN 37232								LEWIN H, 1982, NEUROSURGERY, V11, P668; LIDVALL H, 1974, ACTA NEUROLOGICA S S, V50; LONG CJ, 1982, NEUROPSYCHOLOGY COGN, V2; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; OMMAYA A, 1968, BRAIN, V97, P633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; [No title captured]	9	12	12	0	0	BAYWOOD PUBL CO INC	AMITYVILLE	26 AUSTIN AVE, AMITYVILLE, NY 11701	0091-2174			INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		1984	14	4					277	283					7	Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	ABA68	WOS:A1984ABA6800001					2022-02-06	
J	PARKINSON, D; DELBIGIO, M; JELL, RM				PARKINSON, D; DELBIGIO, M; JELL, RM			SPINAL-CORD CONCUSSION	SURGICAL NEUROLOGY			English	Article									UNIV MANITOBA,FAC MED,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA		PARKINSON, D (corresponding author), UNIV MANITOBA,FAC MED,NEUROSURG SECT,WINNIPEG R3E 0W3,MANITOBA,CANADA.			Del Bigio, Marc/0000-0001-8366-0394			CROFT TJ, 1972, J NEUROSURG, V36, P402, DOI 10.3171/jns.1972.36.4.0402; Denny-Brown D, 1944, J NEUROL NEUROSUR PS, V7, P76, DOI 10.1136/jnnp.7.3-4.76; DOHRMANN GJ, 1978, J NEUROSURG, V48, P993, DOI 10.3171/jns.1978.48.6.0993; GRAY JAB, 1954, J PHYSIOL-LONDON, V124, P84, DOI 10.1113/jphysiol.1954.sp005087; KANDEL E, 1979, SCI AM, V241, P67; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; LLOYD DPC, 1942, J NEUROPHYSIOL, V6, P435; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; RICHARDSON PM, 1979, J NEUROSURG, V51, P178, DOI 10.3171/jns.1979.51.2.0178; Shetter A G, 1979, Adv Neurol, V22, P5	11	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.		1981	16	5					347	349		10.1016/0090-3019(81)90272-X			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MS212	WOS:A1981MS21200008	6977881				2022-02-06	
J	ROBINSON, RG; GWYNNE, JF				ROBINSON, RG; GWYNNE, JF			BILATERAL INTERNAL CAROTID-ARTERY THROMBOSIS AFTER CLOSED HEAD-INJURY	ACTA NEUROCHIRURGICA			English	Article									UNIV OTAGO,SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND		ROBINSON, RG (corresponding author), UNIV OTAGO,SCH MED,DEPT SURG,NEUROSURG UNIT,DUNEDIN,NEW ZEALAND.						Adams WE, 1958, COMP MORPHOLOGY CARO; BAUER RB, 1969, J AMER MED ASSOC, V208, P509, DOI 10.1001/jama.208.3.509; BERGAN F, 1963, J CARDIOVASC SURG, V4, P300; BLAAUW G, 1976, HDB CLIN NEUROLOGY 2, V26, P43; BLAISDELL WF, 1969, J AMER MED ASSOC, V209, P1889, DOI 10.1001/jama.209.12.1889; BOLDREY E, 1956, J NEUROSURG, V13, P127, DOI 10.3171/jns.1956.13.2.0127; Boyd JD., 1937, ANAT ANZEIGER, V84, P386; DINNING TAR, 1976, I NEUROL MADRAS P, V6, P239; FLEMING JFR, 1968, CAN J SURG, V11, P166; GARG AG, 1968, BRIT J SURG, V55, P4, DOI 10.1002/bjs.1800550103; MURATORI D, 1966, ANAT ANZEIGER, V119, P466; SCHOTER I, 1975, ADV NEUROSURGERY, V3, P401; TOWNE JB, 1972, ARCH SURG-CHICAGO, V104, P565; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001; YASHON D, 1964, J NEUROL NEUROSUR PS, V27, P547, DOI 10.1136/jnnp.27.6.547; YATES PO, 1961, 300 MED RES COUN SPE	16	12	12	1	2	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1978	44	1-2					137	142		10.1007/BF01401637			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FY825	WOS:A1978FY82500010	726960				2022-02-06	
J	EDVINSSON, L; OWMAN, C; ROSENGREN, E; WEST, KA				EDVINSSON, L; OWMAN, C; ROSENGREN, E; WEST, KA			BRAIN CONCENTRATIONS OF DOPAMINE, NORADRENALINE, 5-HYDROXYTRYPTAMINE, AND HOMOVANILLIC ACID DURING INTRACRANIAL HYPERTENSION FOLLOWING TRAUMATIC BRAIN INJURY IN RABBIT	ACTA NEUROLOGICA SCANDINAVICA			English	Article														Edvinsson, Lars/0000-0002-1805-1346			ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P313, DOI 10.1111/j.1748-1716.1966.tb03318.x; ANDEN NE, 1963, LIFE SCI, P448; BERTLER A, 1961, ACTA PHYSIOL SCAND, V51, P75, DOI 10.1111/j.1748-1716.1961.tb02115.x; BERTLER AKE, 1958, K FYSIOGR SALLSKAPETS I LUND FORHANDL, V28, P121; BOGDANSKI DF, 1956, J PHARMACOL EXP THER, V117, P82; EDVINSSON L, IN PRESS; HAGGENDAL J, 1963, ACTA PHYSIOL SCAND, V59, P242, DOI 10.1111/j.1748-1716.1963.tb02739.x; OWMAN C, 1970, BRAIN RES, V18, P469, DOI 10.1016/0006-8993(70)90130-7; OWMAN C, IN PRESS	9	12	12	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.		1971	47	4					458	+		10.1111/j.1600-0404.1971.tb07500.x			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	K2750	WOS:A1971K275000007	5123487				2022-02-06	
J	OLSSON, Y; RINDER, L; LINDGREN, S; STALHAMMAR, D				OLSSON, Y; RINDER, L; LINDGREN, S; STALHAMMAR, D			STUDIES ON VASCULAR PERMEABILITY CHANGES IN EXPERIMENTAL BRAIN CONCUSSION .3. COMPARISON BETWEEN EFFECTS OF SINGLE AND REPEATED SUDDEN MECHANICAL LOADING OF BRAIN	ACTA NEUROPATHOLOGICA			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GUTH L, 1968, EXP NEUROL, V22, P590, DOI 10.1016/0014-4886(68)90151-9; HAMBERGER A, 1966, Z ZELLFORSCH MIK ANA, V70, P386, DOI 10.1007/BF00336504; HOGDSON VR, 1968, THESIS WAYNE STATE U; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; RINDER L, 1968, ACTA NEUROPATHOL, V11, P201; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; SPILLANE JD, 1962, BRIT MED J, P1205; STEINWALL O, 1965, ACTA NEUROL SCAN S13, pR31; UNTERHARNSCHEIDT F, 1971, FORTSCHR NEUROL P I, V39, P109; Unterharnscheidt F, 1963, GEDECKTEN SCHADEN GE; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; [No title captured]	17	12	12	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.		1971	19	3					225	+		10.1007/BF00684599			1	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	L1513	WOS:A1971L151300005	5134158				2022-02-06	
J	MASTAGLIA, FL; SAVAS, S; KAKULAS, BA				MASTAGLIA, FL; SAVAS, S; KAKULAS, BA			INTRACRANIAL THROMBOSIS OF INTERNAL CAROTID ARTERY AFTER CLOSED HEAD INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article													Bozbas, Serife Savas/AAI-8064-2021	Bozbas, Serife Savas/0000-0002-7230-202X			BERAUD R, 1966, CAN MED ASSOC J, V94, P537; CALDWELL HW, 1948, ANN INTERN MED, V28, P1132, DOI 10.7326/0003-4819-28-6-1132; CLARKE PRR, 1955, BRIT J SURG, V43, P215, DOI 10.1002/bjs.18004317816; Colledge L, 1917, LANCET, V1, P57; FISHER CM, 1951, ARCH NEUROL PSYCHIAT, V65, P346; FISHER M, 1954, AMA ARCH NEUROL PSY, V72, P187, DOI 10.1001/archneurpsyc.1954.02330020055006; FISHER RG, 1959, JAMA-J AM MED ASSOC, V170, P1918, DOI 10.1001/jama.1959.63010160001010; FRANTZEN E, 1961, NEUROLOGY, V11, P695, DOI 10.1212/WNL.11.8.695; GURDJIAN ES, 1963, J NEUROSURG, V20, P418, DOI 10.3171/jns.1963.20.5.0418; HOCKADAY TDR, 1959, J NEUROL NEUROSUR PS, V22, P229, DOI 10.1136/jnnp.22.3.229; HOUCK WS, 1964, ANN SURG, V159, P219, DOI 10.1097/00000658-196402000-00006; HUGHES JT, 1968, J NEUROL NEUROSUR PS, V31, P307, DOI 10.1136/jnnp.31.4.307; HUMPHREY JG, 1960, BRAIN, V83, P565, DOI 10.1093/brain/83.4.565; LAWRENCE KB, 1948, AM J SURG, V76, P29, DOI 10.1016/S0002-9610(48)90181-0; LUESSENHOP AJ, 1959, J NEUROSURG, V16, P705, DOI 10.3171/jns.1959.16.6.0705; Makins GH, 1916, LANCET, V2, P543; MILLER JDR, 1967, RADIOLOGY, V89, P95, DOI 10.1148/89.1.95; MURPHEY F, 1959, J NEUROSURG, V16, P1, DOI 10.3171/jns.1959.16.1.0001; MURRAY DS, 1957, BRIT J SURG, V44, P556, DOI 10.1002/bjs.18004418803; PAILLAS JE, 1955, THROMBOSES CAROTIDE; PEARCE GW, 1969, PERSONAL COMMUNICATI; PEERLESS SJ, 1967, CAN MED ASSOC J, V97, P247; PITNER SE, 1966, NEW ENGL J MED, V274, P764, DOI 10.1056/NEJM196604072741403; RALPH LL, 1954, J FAC RADIOL-LONDON, V5, P210, DOI 10.1016/S0368-2242(54)80032-7; RANEY AA, 1948, ARCH NEURO PSYCHIATR, V60, P425, DOI 10.1001/archneurpsyc.1948.02310050002001; SCHNEIDER RC, 1952, J NEUROSURG, V9, P495, DOI 10.3171/jns.1952.9.5.0495; SEDZIMIR CB, 1955, J NEUROL NEUROSUR PS, V18, P293, DOI 10.1136/jnnp.18.4.293; THERKELSEN J, 1963, CIRCULATION, V28, P101, DOI 10.1161/01.CIR.28.1.101; THOMSON JLG, 1963, BRIT J RADIOL, V36, P840, DOI 10.1259/0007-1285-36-431-840; TOAKLEY G, 1965, Aust N Z J Surg, V34, P261, DOI 10.1111/j.1445-2197.1965.tb04371.x; VERBIEST H, 1969, FOLIA PSYCHIAT NEERL, V62, P371	31	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1969	32	5					383	+		10.1136/jnnp.32.5.383			1	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	E6019	WOS:A1969E601900003	5360046	Green Published, Bronze			2022-02-06	
J	YARNELL, P; OMMAYA, AK				YARNELL, P; OMMAYA, AK			EXPERIMENTAL CEREBRAL CONCUSSION IN RHESUS MONKEY	BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE			English	Article																	Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1956, PERSONAL COMMUNICATI; Ommaya A, 1967, 11 P STAPP CAR CRASH, P47; Ommaya A, 1966, 10 P STAPP CAR CRASH, P197; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211	8	12	12	0	1	NEW YORK ACAD MEDICINE	NEW YORK	1216 FIFTH AVE, NEW YORK, NY 10029	0028-7091			B NEW YORK ACAD MED	Bull. N. Y. Acad. med.		1969	45	1					39	&					0	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	C3685	WOS:A1969C368500004	4977441				2022-02-06	
J	Schaller, WF; Tamaki, K; Newman, HW				Schaller, WF; Tamaki, K; Newman, HW			Petechial hemorrhages of the brain - Experimentally produced in rats by concussion	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article									Stanford Univ, Sch Med, Dept Neuropsychiat, San Francisco, CA USA								DURET H, 1877, GAZ MED PARIS, V6, P598; DURET H, 1877, GAZ MED PARIS, V6, P624; DURET H, 1877, GAZ MED PARIS, V6, P612; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; Ricker G, 1919, VIRCHOWS ARCH A, V226, P180, DOI 10.1007/BF02039959; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; Schaller WT, 1937, ARCH NEURO PSYCHIATR, V37, P1048, DOI 10.1001/archneurpsyc.1937.02260170076004; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470	8	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0096-6754			ARCH NEURO PSYCHIATR		JAN	1941	45	1					1	23					23	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	V23XK	WOS:000201615600001					2022-02-06	
J	Dixon, KC				Dixon, KC			Mechanism of cerebral concussion	LANCET			English	Article																	Dixon KC, 1940, BRAIN, V63, P191, DOI 10.1093/brain/63.2.191; Greenfield J G, 1938, Proc R Soc Med, V32, P43; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Trotter W, 1925, LANCET, V2, P953	4	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1940	2						360	360					1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9610	WOS:000188728700263					2022-02-06	
J	Ferraro, A				Ferraro, A			Experimental medullary concussion of the spinal cord in rabbits - Histologic study of the early stages	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article									St Elizabeths Hosp, Washington, DC USA								CLAUDE, 1915, AM MED, V11, P479; CORNIL L, 1921, THESIS PARIS; DABUNDO G, 1916, RIV ITAL NEUROPAT, V9, P145; DELISI L, 1915, RIV SPER FRENIATR, V41, P249; DUMENIL, 1885, ARCH NEUROL, V9, P149; FERRARO A, 1922, CERVELLO ANNO, V1, P361; FRAZIER CH, 1921, SURG SPINAL CORD NEW; GUILLAIN G, 1921, TRAUVAUX NEUROLOGIQU; HARTMANN, 1900, JB PSYCHIAT, V19, P380; Hassin GB, 1925, ARCH NEURO PSYCHIATR, V13, P369, DOI 10.1001/archneurpsyc.1925.02200090083003; JAKOB A, 1919, Z GES NEUROL PSYCH, V51, P297; KIRCHGASSER G, 1897, DTSCH Z NERVENH, V2, P400; LAQUER, 1915, MONATSCHR PSYCHIAT N, V29, P35; LAX, 1898, DTSCH Z NERVENHEILKU, V12, P333; MAIRET, 1918, REV NEUROL, V35, P97; MAIRET, 1918, REV NEUROL, V35, P228; MAIRET, 1918, REV NEUROL, V35, P110; MARBURG, 1921, DTSCH Z NERVENHEILK, V70, P10; Mussen A, 1916, REV NEUROL PSYCHIAT, V14, P417; ROSSI O, 1921, TIPOGRAFIA SASSARESE; SCHMAUS H, 1901, VORLESUNGEN PATHOLOG; Schterbach H., 1907, ENCEPHALE V, V2, P521; SOUQUES, 1916, REV NEUROL, V29, P101; Spatz H, 1920, Z GESAMTE NEUROL PSY, V58, P327, DOI 10.1007/BF02902040; SPILLER WG, 1903, M B, V15, P483; TODDE G, 1907, RIV SPER FRENIATR, V33, P751; TROMMER, 1915, NEUROL CENTRALBL, V34, P617; WARRINGTON, 1910, REV NEUROL PSYCHIAT, V8, P271	28	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0096-6754			ARCH NEURO PSYCHIATR		SEP	1927	18	3					357	373		10.1001/archneurpsyc.1927.02210030037003			17	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	V23UG	WOS:000201607400003					2022-02-06	
J	Caccese, JB; Buckley, TA; Tierney, RT; Rose, WC; Glutting, JJ; Kaminski, TW				Caccese, Jaclyn B.; Buckley, Thomas A.; Tierney, Ryan T.; Rose, William C.; Glutting, Joseph J.; Kaminski, Thomas W.			Blood Biomarkers of Sports-Related Concussion in Pediatric Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports-related head trauma; axonal injury; mild traumatic brain injury; biomarkers	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; IN-VIVO; PROTEIN; FOOTBALL; TAU; STATEMENT; MARKER	Objective: To examine changes in blood biomarkers, serum neurofilament light (Nf-L), and plasma tau, as well as the relationship between blood biomarkers and symptom reports, in athletes with a sports-related concussion. Design: Prospective cohort study. Setting: Private community-based concussion clinic. Participants: Athletes aged 13 to 18 years old with a diagnosed sports-related concussion presenting to a concussion clinic within 7 days of injury and noninjured athletes with no history of concussion aged 13 to 23 years old. Assessment and Main Outcome Measures: Injured athletes provided a blood sample at the initial clinical evaluation and again at least 6 months after injury. Noninjured athletes provided a single blood sample. All participants completed symptom reports during each visit. Statistical comparisons of biomarker concentrations and symptom reports were conducted. Results: The mean rank for tau was significantly lower for concussed athletes compared with nonconcussed athletes. In contrast, the mean rank of Nf-L was higher for concussed athletes than for nonconcussed athletes, although the difference was nonsignificant. Plasma tau was significantly lower postinjury compared with 6 months after injury, whereas serum Nf-L was significantly higher postinjury. There was a weak but significant inverse relationship observed between tau and the number of symptoms reported, but no relationship was observed between Nf-L and the number of symptoms reported. Conclusions: These data indicate that in the days following a sports-related concussion, the blood biomarkers tau and Nf-L display contrasting patterns of change but may not be related to self-reported symptom scores.	[Caccese, Jaclyn B.; Buckley, Thomas A.; Rose, William C.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, 540 S Coll Ave, Newark, DE 19716 USA; [Buckley, Thomas A.; Rose, William C.; Kaminski, Thomas W.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA; [Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Philadelphia, PA USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE 19716 USA		Caccese, JB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 540 S Coll Ave, Newark, DE 19716 USA.	jcaccese@udel.edu	Caccese, Jaclyn B./AAH-4571-2020	Caccese, Jaclyn B./0000-0003-2329-3603			Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Fournier AJ, 2014, FASEB J, V28, P5277, DOI 10.1096/fj.14-251942; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hardin AP, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2151; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG., 2014, FRONT CELL NEUROSCI, V8, P10; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	35	11	11	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					266	272		10.1097/JSM.0000000000000709			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900012	30550416		Y	N	2022-02-06	
J	Fair, KA; Farrell, DH; McCully, BH; Rick, EA; Dewey, EN; Hilliard, C; Dean, R; Lin, A; Hinson, H; Barbosa, R; Schreiber, MA; Rowell, SE				Fair, Kelly A.; Farrell, David H.; McCully, Belinda H.; Rick, Elizabeth A.; Dewey, Elizabeth N.; Hilliard, Cole; Dean, Rondi; Lin, Amber; Hinson, Holly; Barbosa, Ronald; Schreiber, Martin A.; Rowell, Susan E.			Fibrinolytic Activation in Patients with Progressive Intracranial Hemorrhage after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						coagulopathy; fibrinolysis; thrombelastography; traumatic brain injury		Progression of intracranial hemorrhage (PICH) is a significant cause of secondary brain injury in patients with traumatic brain injury (TBI). Previous studies have implicated a variety of mediators that contribute to PICH. We hypothesized that patients with PICH would display either a hypocoagulable state, hyperfibrinolysis, or both. We conducted a prospective study of adult trauma patients with isolated TBI. Blood was obtained for routine coagulation assays, platelet count, fibrinogen, thrombelastography, markers of thrombin generation, and markers of fibrinolysis at admission and 6, 12, 24, and 48 h. Univariate analyses were performed to compare baseline characteristics between groups. Linear regression models were created, adjusting for baseline differences, to determine the relationship between individual assays and PICH. One hundred forty-one patients met entry criteria, of whom 71 had hemorrhage progression. Patients with PICH had a higher Injury Severity Score and Abbreviated Injury Scale score (head), a lower Glasgow Coma Scale score, and lower plasma sodium on admission. Patients with PICH had higher D-dimers on admission. After adjusting for baseline differences, elevated D-dimers remained significantly associated with PICH compared to patients without PICH at admission. Hypocoagulation was not significantly associated with PICH in these patients. The association between PICH and elevated D-dimers early after injury suggests that fibrinolytic activation may contribute to PICH in patients with TBI.	[Fair, Kelly A.; Farrell, David H.; McCully, Belinda H.; Rick, Elizabeth A.; Dewey, Elizabeth N.; Hilliard, Cole; Dean, Rondi; Lin, Amber; Hinson, Holly; Schreiber, Martin A.; Rowell, Susan E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Barbosa, Ronald] Legacy Emanuel Hosp & Hlth Ctr, Portland, OR USA		Farrell, DH (corresponding author), Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, Mail Code L611,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrelld@ohsu.edu	Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000128] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS110828] Funding Source: Medline		[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Giesen PLA, 2000, SEMIN THROMB HEMOST, V26, P379, DOI 10.1055/s-2000-8456; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Khan M, 2017, J NEUROIMAGING, V27, P144, DOI 10.1111/jon.12370; Knisel W, 1991, J Clin Apher, V6, P11, DOI 10.1002/jca.2920060103; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; PENICK G D, 1960, Int Rec Med, V173, P491; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN TP, 1978, AM J PHYSIOL, V234, pE504, DOI 10.1152/ajpendo.1978.234.5.E504; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774	40	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					960	966		10.1089/neu.2018.6234			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500003	31382848		Y	N	2022-02-06	
J	Kowalski, RG; Hammond, F; Weintraub, AH; Nakase-Richardson, R; Zafonte, RD; Whyte, J; Giacino, JT				Kowalski, Robert G.; Hammond, FloraM.; Weintraub, Alan H.; Nakase-Richardson, Risa; Zafonte, Ross D.; Whyte, John; Giacino, Joseph T.			Recovery of Consciousness and Functional Outcome in Moderate and Severe Traumatic Brain Injury	JAMA NEUROLOGY			English	Article								IMPORTANCE Traumatic brain injury (TBI) leads to 2.9 million visits to US emergency departments annually and frequently involves a disorder of consciousness (DOC). Early treatment, including withdrawal of life-sustaining therapies and rehabilitation, is often predicated on the assumed worse outcome of disrupted consciousness. OBJECTIVE To quantify the loss of consciousness, factors associated with recovery, and return to functional independence in a 31-year sample of patients with moderate or severe brain trauma. DESIGN, SETTING, AND PARTICIPANTS This cohort study analyzed patients with TBI who were enrolled in the Traumatic Brain Injury Model Systems National Database, a prospective, multiyear, longitudinal database. Patients were survivors of moderate or severe TBI who were discharged from acute hospitalization and admitted to inpatient rehabilitation from January 4, 1989, to June 19, 2019, at 1 of 23 inpatient rehabilitation centers that participated in the Traumatic Brain Injury Model Systems program. Follow-up for the study was through completion of inpatient rehabilitation. EXPOSURES Traumatic brain injury. MAIN OUTCOMES AND MEASURES Outcome measures were Glasgow Coma Scale in the emergency department, Disability Rating Scale, posttraumatic amnesia, and Functional Independence Measure. Patient-related data included demographic characteristics, injury cause, and brain computed tomography findings. RESULTS The 17 470 patients with TBI analyzed in this study had a median (interquartile range [IQR]) age at injury of 39 (25-56) years and included 12 854 male individuals (74%). Of these patients, 7547 (57%) experienced initial loss of consciousness, which persisted to rehabilitation in 2058 patients (12%). Those with persisting DOC were younger; had more high-velocity injuries; had intracranial mass effect, intraventricular hemorrhage, and subcortical contusion; and had longer acute care than patients without DOC. Eighty-two percent (n = 1674) of comatose patients recovered consciousness during inpatient rehabilitation. In a multivariable analysis, the factors associated with consciousness recovery were absence of intraventricular hemorrhage (adjusted odds ratio [OR], 0.678; 95% CI, 0.532-0.863; P=.002) and intracranial mass effect (adjusted OR, 0.759; 95% CI, 0.595-0.968; P=.03). Functional improvement (change in total functional independence score from admission to discharge) was +43 for patients with DOC and +37 for those without DOC (P=.002), and 803 of 2013 patients with DOC (40%) became partially or fully independent. Younger age, male sex, and absence of intraventricular hemorrhage, intracranial mass effect, and subcortical contusion were associated with better functional outcome. Findings were consistent across the 3 decades of the database. CONCLUSIONS AND RELEVANCE This study found that DOC occurred initially in most patients with TBI and persisted in some patients after rehabilitation, but most patients with persisting DOC recovered consciousness during rehabilitation. This recovery trajectorymay inform acute and rehabilitation treatment decisions and suggests caution is warranted in consideration of withdrawing or withholding care in patients with TBI and DOC.	[Kowalski, Robert G.] Univ Colorado, Sch Med, Dept Neurol, 13001 E 17th Pl, Aurora, CO 80045 USA; [Kowalski, Robert G.; Weintraub, Alan H.] Craig Hosp, Res Dept, Englewood, CO USA; [Hammond, FloraM.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Weintraub, Alan H.] CNS Med Grp, Englewood, CO USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Sleep Med Div, Tampa, FL 33620 USA; [Zafonte, Ross D.; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.; Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross D.; Giacino, Joseph T.] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross D.; Giacino, Joseph T.] Harvard Med Sch, Boston, MA 02115 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA		Kowalski, RG (corresponding author), Univ Colorado, Sch Med, Dept Neurol, 13001 E 17th Pl, Aurora, CO 80045 USA.	robert.2.kowalski@cuanschutz.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	NIDILRR within the Administration for Community Living, US Department of Health and Human Services (HHS) [90DRTB0002, 90DPTB0007, 90DPTB0011, 90DPTB0004]; Veterans Health Administration Central Office VA TBI Model Systems Program of Research	This study was funded by grant 90DRTB0002 to Indiana University School of Medicine, grant 90DPTB0007 to Craig Hospital, grant 90DPTB0011 to Spaulding-Harvard TBI Model System, and grant 90DPTB0004 to Moss Rehabilitation Research Institute from NIDILRR within the Administration for Community Living, US Department of Health and Human Services (HHS), and Veterans Health Administration Central Office VA TBI Model Systems Program of Research.	Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; [Anonymous], TRAUMATIC BRAIN INJU; Camarano JG, 2021, INJURY, V52, P147, DOI 10.1016/j.injury.2020.10.051; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Foster M, 2000, BRAIN INJURY, V14, P1035; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kowalski RG, 2015, ANN NEUROL, V77, P804, DOI 10.1002/ana.24381; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lucca LF, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1293-7; Malone C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01314; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pratt AK, 2019, CRIT CARE MED, V47, P591, DOI 10.1097/CCM.0000000000003647; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sise MJ, 2012, J TRAUMA ACUTE CARE, V72, P1186, DOI 10.1097/TA.0b013e31824d0e57; Swaine B, 2018, DISABIL REHABIL, V40, P697, DOI 10.1080/09638288.2016.1262911; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury Model Systems National Data and Statistical Center, STANDARDIZED OPERATI; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Uniform Data System for Medical Rehabilitation, 2012, FIM INSTRUMENT ITS B; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	42	11	11	4	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	MAY	2021	78	5					548	557		10.1001/jamaneurol.2021.0084		MAR 2021	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SB7YI	WOS:000625439400006	33646273		Y	N	2022-02-06	
J	Witcher, KG; Bray, CE; Chunchai, T; Zhao, FL; O'Neil, SM; Gordillo, AJ; Campbell, WA; McKim, DB; Liu, XY; Dziabis, JE; Quan, N; Eiferman, DS; Fischer, AJ; Kokiko-Cochran, ON; Askwith, C; Godbout, JP				Witcher, Kristina G.; Bray, Chelsea E.; Chunchai, Titikorn; Zhao, Fangli; O'Neil, Shane M.; Gordillo, Alan J.; Campbell, Warren A.; McKim, Daniel B.; Liu, Xiaoyu; Dziabis, Julia E.; Quan, Ning; Eiferman, Daniel S.; Fischer, Andy J.; Kokiko-Cochran, Olga N.; Askwith, Candice; Godbout, Jonathan P.			Traumatic Brain Injury Causes Chronic Cortical Inflammation and Neuronal Dysfunction Mediated by Microglia	JOURNAL OF NEUROSCIENCE			English	Article						CSF1R antagonist; microglia; neuroinflammation; neurotrauma; traumatic brain injury	AXONAL INJURY; COGNITIVE IMPAIRMENT; CELL; ACTIVATION; DEPRESSION; DRIVES; NEUROINFLAMMATION; NEURODEGENERATION; MORPHOLOGY; RECOVERY	Traumatic brain injury (TBI) can lead to significant neuropsychiatric problems and neurodegenerative pathologies, which develop and persist years after injury. Neuroinflammatory processes evolve over this same period. Therefore, we aimed to determine the contribution of microglia to neuropathology at acute [1 d postinjury (dpi)], subacute (7 dpi), and chronic (30 dpi) time points. Microglia were depleted with PLX5622, a CSF1R antagonist, before midline fluid percussion injury (FPI) in male mice and cortical neuropathology/inflammation was assessed using a neuropathology mRNA panel. Gene expression associated with inflammation and neuropathology were robustly increased acutely after injury (1 dpi) and the majority of this expression was microglia independent. At 7 and 30 dpi, however, microglial depletion reversed TBI-related expression of genes associated with inflammation, interferon signaling, and neuropathology. Myriad suppressed genes at subacute and chronic endpoints were attributed to neurons. To understand the relationship between microglia, neurons, and other glia, single-cell RNA sequencing was completed 7 dpi, a critical time point in the evolution from acute to chronic pathogenesis. Cortical microglia exhibited distinct TBI-associated clustering with increased type-1 interferon and neurodegenerative/damage-related genes. In cortical neurons, genes associated with dopamine signaling, long-term potentiation, calcium signaling, and synaptogenesis were suppressed. Microglial depletion reversed the majority of these neuronal alterations. Furthermore, there was reduced cortical dendritic complexity 7 dpi, reduced neuronal connectively 30 dpi, and cognitive impairment 30 dpi. All of these TBI-associated functional and behavioral impairments were prevented by microglial depletion. Collectively, these studies indicate that microglia promote persistent neuropathology and long-term functional impairments in neuronal homeostasis after TBI.	[Witcher, Kristina G.; Bray, Chelsea E.; Chunchai, Titikorn; Zhao, Fangli; O'Neil, Shane M.; Gordillo, Alan J.; Campbell, Warren A.; McKim, Daniel B.; Dziabis, Julia E.; Fischer, Andy J.; Kokiko-Cochran, Olga N.; Askwith, Candice; Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Chunchai, Titikorn] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit, Chiang Mai 50200, Thailand; [McKim, Daniel B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Liu, Xiaoyu; Quan, Ning] Florida Atlantic Univ, Charles E Schmidt Coll Med, Jupiter, FL 33458 USA; [Liu, Xiaoyu; Quan, Ning] Florida Atlantic Univ, Brain Inst, Jupiter, FL 33458 USA; [Liu, Xiaoyu; Quan, Ning; Kokiko-Cochran, Olga N.; Godbout, Jonathan P.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Eiferman, Daniel S.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Kokiko-Cochran, Olga N.; Godbout, Jonathan P.] Ohio State Univ, Chron Brain Injury Discovery Themes Initiat, Columbus, OH 43210 USA		Godbout, JP (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.; Godbout, JP (corresponding author), Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA.; Godbout, JP (corresponding author), Ohio State Univ, Chron Brain Injury Discovery Themes Initiat, Columbus, OH 43210 USA.	jonathan.godbout@osumc.edu		O'Neil, Shane/0000-0002-6045-2012; Fischer, Andy/0000-0001-6123-7405; Liu, Xiaoyu/0000-0002-4971-0164	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56-NS-090311]; National Institute of Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG-051902]; National Institute of Dental and Craniofacial Research Training Grant [T32-DE-014320]; Ohio State University Presidential FellowshipOhio State University; Thailand Research Fund-Royal Golden Jubilee Program [PHD/0146/2558]; Plexxikon, Inc. [PLX5622];  [NINDS P30-NS-045758]	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Grant R56-NS-090311 and the National Institute of Aging (NIA) Grant R01-AG-051902 (to J.P.G.). In addition, this work was supported by a P30 Core Grant (NINDS P30-NS-045758). K.G.W. and S.M.O. were supported by the National Institute of Dental and Craniofacial Research Training Grant T32-DE-014320 and K.G.W. by the Ohio State University Presidential Fellowship. T.C. was supported by the Thailand Research Fund-Royal Golden Jubilee Program Grant PHD/0146/2558 TC&SCC. We thank Plexxikon, Inc. for the use of PLX5622, Dr. Paolo Fadda at the Ohio State University Comprehensive Cancer Center Genomics Shared Resource (P30-CA-016058), and the Chronic Brain Injury Discovery Themes Initiative at Ohio State University. Our scRNA-sequencing (scRNAseq) analysis was made possible by an allotment of resources from the Ohio Supercomputing Center.	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bachstetter AD, 2017, NEUROBIOL AGING, V52, P98, DOI 10.1016/j.neurobiolaging.2016.12.028; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao VY, 2015, NEURON, V86, P1385, DOI 10.1016/j.neuron.2015.05.022; Chunchai T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1055-2; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Denninger JK, 2018, JOVE-J VIS EXP, DOI 10.3791/58593; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gotz S, 2021, GLIA, V69, P346, DOI 10.1002/glia.23900; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Guimaraes JC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1104-z; Hao S, 2016, BRAIN BEHAV IMMUN, V51, P230, DOI 10.1016/j.bbi.2015.08.023; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ji P, 2016, BRAIN BEHAV IMMUN, V54, P243, DOI 10.1016/j.bbi.2016.02.010; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morel L, 2019, GLIA, V67, P171, DOI 10.1002/glia.23545; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pestana F, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10030168; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos RL, 2008, NEUROSCIENCE, V153, P654, DOI 10.1016/j.neuroscience.2008.02.069; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Weber MD, 2019, BIOL PSYCHIAT, V85, P667, DOI 10.1016/j.biopsych.2018.10.009; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	67	11	11	3	13	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	FEB 17	2021	41	7					1597	1616		10.1523/JNEUROSCI.2469-20.2020			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QK9EJ	WOS:000620681200007	33452227	Bronze, Green Published			2022-02-06	
J	McDonald, SJ; O'Brien, WT; Symons, GF; Chen, ZB; Bain, J; Major, BP; Costello, D; Yamakawa, G; Sun, MJ; Brady, RD; Mitra, B; Mychasiuk, R; O'Brien, TJ; Shultz, SR				McDonald, Stuart J.; O'Brien, William T.; Symons, Georgia F.; Chen, Zhibin; Bain, Jesse; Major, Brendan P.; Costello, Daniel; Yamakawa, Glenn; Sun, Mujun; Brady, Rhys D.; Mitra, Biswadev; Mychasiuk, Richelle; O'Brien, Terence J.; Shultz, Sandy R.			Prolonged elevation of serum neurofilament light after concussion in male Australian football players	BIOMARKER RESEARCH			English	Article						Mild traumatic brain injury; Sports-related concussion; Blood biomarker; Diagnosis; Recovery; Return to play; GFAP; Tau; UCHL1; NfL	TRAUMATIC BRAIN-INJURY; TEMPORAL WINDOW; FLUID BIOMARKERS; SEX-DIFFERENCES; BASE-LINE; RECOVERY; VULNERABILITY; SYMPTOMS; TAU	Background: Biomarkers that can objectively guide the diagnosis of sports-related concussion, and consequent return-to-play decisions, are urgently needed. In this study, we aimed to determine the temporal profile and diagnostic ability of serum levels of neurofilament light (NfL), ubiquitin carboxy-terminal hydrolase L1 (UCHL1), glial fibrillary acidic protein (GFAP), and tau in concussed male and female Australian footballers. Methods: Blood was collected from 28 Australian rules footballers (20 males, 8 females) at 2-, 6-, and 13-days after a diagnosed concussion for comparison to their levels at baseline (i.e. pre-season), and with 27 control players (19 males, 8 females) without a diagnosis of concussion. Serum concentrations of protein markers associated with damage to neurons (UCHL1), axons (NfL, tau), and astrocytes (GFAP) were quantified using a Simoa HD-X Analyzer. Biomarker levels for concussed players were compared over time and between sex using generalised linear mixed effect models, and diagnostic performance was assessed using area under the receiver operating characteristic curve (AUROC) analysis. Results: Serum NfL was increased from baseline in male footballers at 6- and 13-days post-concussion. GFAP and tau were increased in male footballers with concussion at 2- and 13-days respectively. NfL concentrations discriminated between concussed and non-concussed male footballers at all time-points (AUROC: 2d = 0.73, 6d = 0.85, 13d = 0.79), with tau also demonstrating utility at 13d (AUROC = 0.72). No biomarker differences were observed in female footballers after concussion. Conclusions: Serum NfL may be a useful biomarker for the acute and sub-acute diagnosis of concussion in males, and could inform neurobiological recovery and return-to-play decisions. Future adequately powered studies are still needed to investigate biomarker changes in concussed females.	[McDonald, Stuart J.; O'Brien, William T.; Symons, Georgia F.; Chen, Zhibin; Bain, Jesse; Major, Brendan P.; Yamakawa, Glenn; Sun, Mujun; Brady, Rhys D.; Mychasiuk, Richelle; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Chen, Zhibin] Monash Univ, Clin Epidemiol, Melbourne, Vic, Australia; [Costello, Daniel; Brady, Rhys D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Mitra, Biswadev] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Mitra, Biswadev] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia		McDonald, SJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.; McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia.	stuart.mcdonald@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Chen, Zhibin/T-1567-2017	Chen, Zhibin/0000-0002-1888-6917; McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913; Yamakawa, Glenn/0000-0003-3079-6532	TOB by the Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This project was funded by grants and fellowships awarded to SRS, RM, and TOB by the Australian National Health and Medical Research Council.	Asken BM, 2020, J NEUROTRAUM, V37, P1537, DOI 10.1089/neu.2019.6831; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Costello DM, 2018, J CLIN NEUROSCI, V56, P88, DOI 10.1016/j.jocn.2018.07.003; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Pham L, 2020, NEUROBIOL DIS; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Piantella S, 2020, ARCH CLIN NEUROPSYCH; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	44	11	11	4	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2050-7771		BIOMARK RES	Biomark. Res.	JAN 10	2021	9	1							4	10.1186/s40364-020-00256-7			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Research & Experimental Medicine	PQ3HK	WOS:000606438200001	33422120	Green Published, gold	Y	N	2022-02-06	
J	Vazquez-Rosa, E; Shin, MK; Dhar, M; Chaubey, K; Cintron-Perez, CJ; Tang, XM; Liao, XD; Miller, E; Koh, Y; Barker, S; Franke, K; Crosby, DR; Schroeder, R; Emery, J; Yin, TC; Fujioka, H; Reynolds, JD; Harper, MM; Jain, MK; Pieper, AA				Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Tang, Xinmiao; Liao, Xudong; Miller, Emiko; Koh, Yeojung; Barker, Sarah; Franke, Kathryn; Crosby, Danyel R.; Schroeder, Rachel; Emery, Josie; Yin, Terry C.; Fujioka, Hisashi; Reynolds, James D.; Harper, Matthew M.; Jain, Mukesh K.; Pieper, Andrew A.			P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						blood-brain barrier; traumatic brain injury; inflammation; neurodegeneration; neuroprotection	NEUROPROTECTIVE EFFICACY; AMINOPROPYL CARBAZOLES; ALZHEIMERS-DISEASE; DEMENTIA RISK; UNITED-STATES; MOUSE MODEL; INJURY; DEGENERATION; DISRUPTION; COMPOUND	Chronic neurodegeneration in survivors of traumatic brain injury (TBI) is a major cause of morbidity, with no effective therapies to mitigate this progressive and debilitating form of nerve cell death. Here, we report that pharmacologic restoration of the blood-brain barrier (BBB), 12 mo after murine TBI, is associated with arrested axonal neurodegeneration and cognitive recovery, benefits that persisted for months after treatment cessation. Recovery was achieved by 30 d of once-daily administration of P7C3-A20, a compound that stabilizes cellular energy levels. Four months after P7C3-A20, electron microscopy revealed full repair of TBI-induced breaks in cortical and hippocampal BBB endothelium. Immunohistochemical staining identified additional benefits of P7C3-A20, including restoration of normal BBB endothelium length, increased brain capillary pericyte density, increased expression of BBB tight junction proteins, reduced brain infiltration of immunoglobulin, and attenuated neuroinflammation. These changes were accompanied by cessation of TBI-induced chronic axonal degeneration. Specificity for P7C3-A20 action on the endothelium was confirmed by protection of cultured human brain microvascular endothelial cells from hydrogen peroxide-induced cell death, as well as preservation of BBB integrity in mice after exposure to toxic levels of lipopolysaccharide. P7C3-A20 also protected mice from BBB degradation after acute TBI. Collectively, our results provide insights into the pathophysiologic mechanisms behind chronic neurodegeneration after TBI, along with a putative treatment strategy. Because TBI increases the risks of other forms of neurodegeneration involving BBB deterioration (e.g., Alzheimer's disease, Parkinson's disease, vascular dementia, chronic traumatic encephalopathy), P7C3-A20 may have widespread clinical utility in the setting of neurodegenerative conditions.	[Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Miller, Emiko; Koh, Yeojung; Barker, Sarah; Franke, Kathryn; Crosby, Danyel R.; Reynolds, James D.; Jain, Mukesh K.; Pieper, Andrew A.] Univ Hosp Cleveland, Harrington Discovery Inst, Med Ctr, Cleveland, OH 44106 USA; [Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Miller, Emiko; Koh, Yeojung; Barker, Sarah; Franke, Kathryn; Crosby, Danyel R.; Pieper, Andrew A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Miller, Emiko; Koh, Yeojung; Barker, Sarah; Franke, Kathryn; Crosby, Danyel R.; Pieper, Andrew A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA; [Tang, Xinmiao; Liao, Xudong; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Dept Med, Cleveland, OH 44106 USA; [Tang, Xinmiao; Liao, Xudong; Jain, Mukesh K.] Univ Hosp Cleveland, Harrington Heart & Vasc Inst, Med Ctr, Cleveland, OH 44106 USA; [Schroeder, Rachel; Emery, Josie; Yin, Terry C.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Cryoelectron Microscopy Core, Sch Med, Cleveland, OH 44106 USA; [Reynolds, James D.; Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Reynolds, James D.] Univ Hosp Cleveland, Dept Anesthesiol & Perioperat Med, Med Ctr, Cleveland, OH 44106 USA; [Harper, Matthew M.] Vet Affairs Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA 52246 USA; [Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Weill Cornell Med Cornell Univ, Weill Cornell Autism Res Program, New York, NY 10065 USA; [Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA		Pieper, AA (corresponding author), Univ Hosp Cleveland, Harrington Discovery Inst, Med Ctr, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Louis Stokes Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Weill Cornell Med Cornell Univ, Weill Cornell Autism Res Program, New York, NY 10065 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	Andrew.Pieper@HarringtonDiscovery.org		Tang, Xinmiao/0000-0002-4864-8995; Dhar, Matasha/0000-0003-1714-0424; Barker, Sarah/0000-0002-3927-6966; Miller, Emiko/0000-0003-3396-591X; Harper, Matthew/0000-0003-3395-2406; Koh, Yeo Jung/0000-0002-4294-7871	Brockman Foundation; Elizabeth Ring Mather & William Gwinn Mather Fund; S. Livingston Samuel Mather Trust; G. R. Lincoln Family Foundation; Wick Foundation; Leonard Krieger Fund of the Cleveland Foundation; Maxine and Lester Stoller Parkinson's Research Fund; Louis Stokes VA Medical Center; Department of Defense GrantUnited States Department of Defense [W81XWH-13-CRMRP-VRP-TRA]; AHA/Allen Initiative in Brain Health and Cognitive Impairment [19PABH134580006]; Free Radical and Radiation Biology, University of Iowa [T32 CA078586]; Case Western Reserve University [R25 CA221718]	This project was supported by a grant to A.A.P. from the Brockman Foundation. A.A.P. was also supported by the Elizabeth Ring Mather & William Gwinn Mather Fund, the S. Livingston Samuel Mather Trust, the G. R. Lincoln Family Foundation, the Wick Foundation, Gordon & Evie Safran, the Leonard Krieger Fund of the Cleveland Foundation, the Maxine and Lester Stoller Parkinson's Research Fund, and Louis Stokes VA Medical Center resources and facilities. A.A.P. and M.M.H. were supported by Department of Defense Grant W81XWH-13-CRMRP-VRP-TRA for this work. A.A.P., M.K.J., and J.D.R. are supported by Project 19PABH134580006-AHA/Allen Initiative in Brain Health and Cognitive Impairment. E.V.-R. was supported by T32 CA078586 Free Radical and Radiation Biology, University of Iowa. D. R.C. was supported by R25 CA221718, Case Western Reserve University.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauman MD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0244-1; Bayley CC, 2021, MOL PSYCHIATR, V26, P2286, DOI 10.1038/s41380-020-0730-8; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benamer HTS, 2009, EUR NEUROL, V61, P11, DOI 10.1159/000165343; Bertrand E, 2008, FOLIA NEUROPATHOL, V46, P255; Blaya MO, 2019, NEUROPHARMACOLOGY, V145, P268, DOI 10.1016/j.neuropharm.2018.09.024; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; De Jesus-Cortest H, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.10; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Farkas E, 2006, ACTA NEUROPATHOL, V111, P150, DOI 10.1007/s00401-005-0007-y; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Harper MM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03374; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lee AS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0006-16.2016; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Loris ZB, 2018, TRANSL STROKE RES, V9, P146, DOI 10.1007/s12975-017-0565-z; Loris ZB, 2017, EXP NEUROL, V290, P63, DOI 10.1016/j.expneurol.2017.01.006; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Naidoo J, 2014, J MED CHEM, V57, P3746, DOI 10.1021/jm401919s; Naidoo J, 2013, TETRAHEDRON LETT, V54, P4429, DOI 10.1016/j.tetlet.2013.06.024; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pieper AA, 2018, COLD SH Q B, V83, P207, DOI 10.1101/sqb.2018.83.037622; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Reiss Y, 2018, J VIS EXP, V132, P57038; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sweeney MD, 2020, ALZHEIMERS DEMENT, V16, P821, DOI 10.1002/alz.12061; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Voorhees JR, 2018, BIOL PSYCHIAT, V84, P488, DOI 10.1016/j.biopsych.2017.10.023; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	74	11	11	2	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 3	2020	117	44					27667	27675		10.1073/pnas.2010430117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OO6QW	WOS:000587503000077	33087571	hybrid, Green Published			2022-02-06	
J	Singh, T; Joshi, S; Williamson, JM; Kapur, J				Singh, Tanveer; Joshi, Suchitra; Williamson, John M.; Kapur, Jaideep			Neocortical injury-induced status epilepticus	EPILEPSIA			English	Article						burst suppression; cobalt; edema; Fluoro-Jade C; seizure	CONVULSIVE STATUS EPILEPTICUS; CONTINUOUS EEG; ELECTROGRAPHIC SEIZURES; EPILEPSY; HYPOXIA; COBALT; HOMOCYSTEINE; PATTERNS; ADULTS; MODEL	Objective To characterize neocortical onset status epilepticus (SE) in the C57BL/6J mouse. Methods We induced SE by administering homocysteine 16-18 hours after cobalt (Co) implantation. SE was monitored by video and electroencephalography (EEG). We evaluated brain structure with magnetic resonance imaging (MRI). Neurodegeneration was evaluated 72 hours after SE using Fluoro-Jade C staining. Results Cobalt triggered seizures in a dose-dependent manner (median effective dose, ED50 = 0.78 mg) and the latency to peak seizure frequency shortened with increased dose. Animals developed SE after homocysteine administration. SE began with early intermittent focal seizures, consisting of frontal onset rhythmic spike-wave discharges manifested as focal dystonia with clonus. These focal seizures then evolved into generalized continuous convulsive activity. Behavioral manifestations of SE included tonic stiffening, bilateral limb clonus, and bilateral tonic-clonic movements, which were accompanied by generalized rhythmic spike-wave discharges on EEG. After prolonged seizures, animals became comatose with intermittent bilateral myoclonic seizures or jerks. During this period, EEG showed seizures interspersed with generalized periodic discharges on a suppressed background. MRI obtained when animals were in a coma revealed edema, midline shift in frontal lobe around the Co implantation site, and ventricular effacement. Fluoro-Jade C staining revealed neurodegeneration in the cortex, amygdala, and thalamus. Significance We have developed a mouse model of severe, refractory cortical-onset SE, consisting of convulsions merging into a coma, EEG patterns of cortical seizures, and injury, with evidence of widespread neocortical edema and damage. This model replicates many features of acute seizures and SE resulting from traumatic brain injury, subarachnoid, and lobar hemorrhage.	[Singh, Tanveer; Joshi, Suchitra; Williamson, John M.; Kapur, Jaideep] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Kapur, Jaideep] Univ Virginia, UVA Brain Inst, Charlottesville, VA USA; [Kapur, Jaideep] Univ Virginia, Dept Neurosci, Charlottesville, VA USA		Kapur, J (corresponding author), Univ Virginia, Hlth Sci Ctr, UVA Brain Inst, POB 801330, Charlottesville, VA 22908 USA.	jk8t@virginia.edu	Singh, Tanveer/ABH-7735-2020	Singh, Tanveer/0000-0002-9038-8082; Joshi, Suchitra/0000-0003-3524-2061	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 040337, R01 NS 044370, R01 NS110863]	This study was supported by National Institutes of Health grants R01 NS 040337, R01 NS 044370 to JK and R01 NS110863 to SJ.	Amzica F, 2015, EPILEPSY BEHAV, V49, P234, DOI 10.1016/j.yebeh.2015.06.012; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Andre-Obadia N, 2015, NEUROPHYSIOL CLIN, V45, P39, DOI 10.1016/j.neucli.2014.11.003; Bauer G, 2013, J CLIN NEUROPHYSIOL, V30, P477, DOI 10.1097/WNP.0b013e3182a73e47; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Chang JH, 2004, EPILEPSY RES, V61, P153, DOI 10.1016/j.eplepsyres.2004.07.012; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Djuric D, 2018, CAN J PHYSIOL PHARM, V96, P991, DOI 10.1139/cjpp-2018-0112; ESCLAPEZ M, 1989, EXP BRAIN RES, V76, P369; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; HALL R, 1990, CAN J ANAESTH, V37, P762, DOI 10.1007/BF03006535; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; HOOVER DB, 1977, EXP BRAIN RES, V29, P501; Kim J, 2011, J NEUROSCI, V31, P4063, DOI 10.1523/JNEUROSCI.4493-10.2011; KUBOVA H, 1995, EPILEPSIA, V36, P750, DOI 10.1111/j.1528-1157.1995.tb01611.x; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; Lee Bruce, 2005, NeuroRx, V2, P372; Lewczuk E, 2018, EPILEPSIA, V59, P369, DOI 10.1111/epi.13972; Mares P, 2019, PHYSIOL RES, V68, pS361, DOI 10.33549/physiolres.934347; Neligan A, 2010, ARCH NEUROL-CHICAGO, V67, P931, DOI 10.1001/archneurol.2010.169; Paxinos G, 2008, THE MOUSE BRAIN IN S; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Rasic-Markovic A, 2016, CAN J PHYSIOL PHARM, V94, P1083, DOI 10.1139/cjpp-2016-0076; Rubaj A, 2003, PHARMACOL BIOCHEM BE, V74, P303, DOI 10.1016/S0091-3057(02)00998-X; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WALTON NY, 1988, EPILEPSY RES, V2, P79, DOI 10.1016/0920-1211(88)90023-X; Wang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118086; Zanelli SA, 2015, NEUROSCIENCE, V310, P279, DOI 10.1016/j.neuroscience.2015.09.046	36	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	DEC	2020	61	12					2811	2824		10.1111/epi.16715		OCT 2020	14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PB5ZC	WOS:000577558700001	33063874	Green Accepted			2022-02-06	
J	Hajiaghamemar, M; Margulies, SS				Hajiaghamemar, Marzieh; Margulies, Susan S.			Multi-Scale White Matter Tract Embedded Brain Finite Element Model Predicts the Location of Traumatic Diffuse Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal tractography; brain injury localization; finite element-histopathology coregistration; meso-; macroscale computational model; neuropathology mapping	INTRACRANIAL HEMORRHAGE; COMPUTATIONAL APPROACH; DYNAMIC-RESPONSE; HEAD ROTATIONS; IN-VITRO; STRAIN; RECONSTRUCTIONS; DIRECTION; STRETCH; METRICS	Finite element models (FEMs) are used increasingly in the traumatic brain injury (TBI) field to provide an estimation of tissue responses and predict the probability of sustaining TBI after a biomechanical event. However, FEM studies have mainly focused on predicting the absence/presence of TBI rather than estimating the location of injury. In this study, we created a multi-scale FEM of the pig brain with embedded axonal tracts to estimate the sites of acute (<= 6 h) traumatic axonal injury (TAI) after rapid head rotation. We examined three finite element (FE)-derived metrics related to the axonal bundle deformation and three FE-derived metrics based on brain tissue deformation for prediction of acute TAI location. Rapid head rotations were performed in pigs, and TAI neuropathological maps were generated and colocalized to the FEM. The distributions of the FEM-derived brain/axonal deformations spatially correlate with the locations of acute TAI. For each of the six metric candidates, we examined a matrix of different injury thresholds (th(x)) and distance to actual TAI sites (d(s)) to maximize the average of two optimization criteria. Three axonal deformation-related TAI candidates predicted the sites of acute TAI within 2.5 mm, but no brain tissue metric succeeded. The optimal range of thresholds for maximum axonal strain, maximum axonal strain rate, and maximum product of axonal strain and strain rate were 0.08-0.14, 40-90, and 2.0-7.5 s(-1), respectively. The upper bounds of these thresholds resulted in higher true-positive prediction rate. In summary, this study confirmed the hypothesis that the large axonal-bundle deformations occur on/close to the areas that sustained TAI.	[Hajiaghamemar, Marzieh] Univ Texas San Antonio, Dept Biomed Engn, Appl Engn & Technology AET Bldg,Room 1-330, San Antonio, TX 78249 USA; [Hajiaghamemar, Marzieh; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Whitaker Bldg,Suite 2116,313 Ferst Dr, Atlanta, GA 30332 USA; [Hajiaghamemar, Marzieh; Margulies, Susan S.] Emory Univ, Whitaker Bldg,Suite 2116,313 Ferst Dr, Atlanta, GA 30322 USA		Hajiaghamemar, M (corresponding author), Univ Texas San Antonio, Dept Biomed Engn, Appl Engn & Technology AET Bldg,Room 1-330, San Antonio, TX 78249 USA.; Margulies, SS (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Whitaker Bldg,Suite 2116,313 Ferst Dr, Atlanta, GA 30332 USA.; Margulies, SS (corresponding author), Emory Univ, Whitaker Bldg,Suite 2116,313 Ferst Dr, Atlanta, GA 30322 USA.	marzieh.memar@utsa.edu; susan.margulies@gatech.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	Football Research, Inc. (FRI); Biomechanics Consulting and Research, LLC (Biocore); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097549, R56NS055951]	Research reported in this publication was supported by a grant from Football Research, Inc. (FRI) and Biomechanics Consulting and Research, LLC (Biocore) and the National Institutes of Health under award numbers R01NS097549 and R56NS055951. The views expressed are solely those of the authors and do not represent those of any funding sources or their affiliates.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Atlan L.S., 2018, THESIS; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duda JT, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00046; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Garimella HT, 2017, NEURAL REGEN RES, V12, P23, DOI 10.4103/1673-5374.198967; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hajiaghamemar M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051786; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim N.G., 2009, THESIS; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; King A.I., 2003, IRCOBI C LOND PORT; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kulich M, 2019, NEUROSENSORY DISORDERS IN MILD TRAUMATIC BRAIN INJURY, P23, DOI 10.1016/B978-0-12-812344-7.00003-0; KWAN MK, 1992, ACTA ORTHOP SCAND, V63, P267, DOI 10.3109/17453679209154780; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; Maltese M.R., 2012, THESIS; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Nakadate H., 2017, 61 STAPP CAR CRASH C; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prange M.T., 2002, THESIS; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Untaroiu C., 2007, P 20 INT TECHN C ENH; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yadav S, 2016, INT CONF ADV COMPU, P78, DOI 10.1109/IACC.2016.25; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62	60	11	11	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					144	157		10.1089/neu.2019.6791		SEP 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000574500500001	32772838	Green Published			2022-02-06	
J	Braaf, S; Ameratunga, S; Ponsford, J; Cameron, P; Collie, A; Harrison, J; Ekegren, C; Christie, N; Nunn, A; Gabbe, B				Braaf, Sandy; Ameratunga, Shanthi; Ponsford, Jennie; Cameron, Peter; Collie, Alex; Harrison, James; Ekegren, Christina; Christie, Nicola; Nunn, Andrew; Gabbe, Belinda			Traumatic injury survivors' perceptions of their future: a longitudinal qualitative study	DISABILITY AND REHABILITATION			English	Article						Trauma; injury; interviews; disability; ageing; future expectations; qualitative	SPINAL-CORD-INJURY; ADAPTIVE SELF-REGULATION; BRAIN-INJURY; RECOVERY EXPECTATIONS; FUNCTIONAL OUTCOMES; GOAL DISENGAGEMENT; PEER SUPPORT; RESILIENCE; PEOPLE; HEALTH	Aim:Persistent disability following traumatic injuries can disrupt future plans and create uncertainty about how to mitigate future impacts. It is unknown how or whether perceptions of the future change in the years after injury. Therefore, the aim of this study was to explore trauma survivors' perceptions of their future over time. Methods:A longitudinal qualitative study, nested within a population-based longitudinal cohort study, was undertaken in Victoria, Australia with survivors of serious injury. Sixty-six seriously injured adults (>= 16 years) without severe neurotrauma were interviewed at 3 years post-injury (n = 66), and re-interviewed at 4 (n = 63) and 5 years (n = 57) post-injury. A longitudinal thematic analysis was performed. Results:Many traumatically injured people had persistent physical and mental impacts. Participants reported being anxious about pain, mobility, work, housing and accommodation, social activities, and finances in their future. Others were hopeful and optimistic regarding their future and developed coping strategies and adopted new viewpoints. Conclusion:Over time, most seriously injured people's perceptions of the future remained consistent. Some had enduring anxiety and others sustained hopeful approaches. Personalised and targeted interventions that address specific concerns could reduce anxiety and support positive adjustment following traumatic injury.	[Braaf, Sandy; Cameron, Peter; Ekegren, Christina; Gabbe, Belinda] Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Collie, Alex] Monash Univ, Insurance Work & Hlth Grp, Melbourne, Vic, Australia; [Harrison, James] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA, Australia; [Christie, Nicola] UCL, Dept Civil Environm & Geomat Engn, London, England; [Nunn, Andrew] Austin Hosp, Victorian Spinal Cord Serv, Heidelberg, Vic, Australia		Braaf, S (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	sandra.braaf@monash.edu	Ekegren, Christina L./AAX-7887-2021; Harrison, James/B-8958-2009; Ponsford, Jennie/H-8341-2014	Ekegren, Christina L./0000-0002-7656-6209; Collie, Alex/0000-0003-2617-9339; Harrison, James/0000-0001-9893-8491; Ponsford, Jennie/0000-0003-0430-125X; Christie, Nicola/0000-0001-7152-5240; nunn, andrew/0000-0002-0222-9410			Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Australian Institute of Health and Welfare, 2015, AUSTRALIA, V95; Australian Prudential Regulatory Authority, 2018, PRIV HLTH INS Q STAT; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bates E, 2014, BRIT J OCCUP THER, V77, P289, DOI 10.4276/030802214X14018723137995; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Braaf S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2971-7; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Christie N, 2017, J TRANSP HEALTH, V6, P84, DOI 10.1016/j.jth.2017.07.004; Clay FJ, 2013, J OCCUP REHABIL, V23, P318, DOI 10.1007/s10926-012-9400-2; Collie A, 2018, ANN SURG; Cornish F, 2014, COLLABORATIVE ANAL Q; Creswell J.W ., 2007, QUAL INQ; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Department of Health, 2017, VICT STAT TRAUM REG; Dunne S, 2014, DISABIL REHABIL, V36, P1990, DOI 10.3109/09638288.2014.885993; Finlayson M, 2004, AM J OCCUP THER, V58, P54, DOI 10.5014/ajot.58.1.54; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2015, INJURY PREV, V21, P348, DOI 10.1136/injuryprev-2014-041336; Gabbe BJ, 2014, INJURY, V45, P1445, DOI 10.1016/j.injury.2014.01.019; Galvin LR, 2001, SPINAL CORD, V39, P615, DOI 10.1038/sj.sc.3101221; Grossoehme Daniel, 2016, BMC Res Notes, V9, P136, DOI 10.1186/s13104-016-1954-1; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Haas BM, 2013, SPINAL CORD, V51, P295, DOI 10.1038/sc.2012.143; Hall WA, 2005, QUAL HEALTH RES, V15, P394, DOI 10.1177/1049732304272015; Harcombe H, 2015, INJURY, V46, P1275, DOI 10.1016/j.injury.2015.04.004; Hayes SC, 2011, ANNU REV CLIN PSYCHO, V7, P141, DOI 10.1146/annurev-clinpsy-032210-104449; Hofmann SG, 2010, INT J PSYCHOPHYSIOL, V78, P35, DOI 10.1016/j.ijpsycho.2009.12.016; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Horstman MJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014842; Ioannou L, 2018, INJURY, V49, P990, DOI 10.1016/j.injury.2018.03.013; Jorgensen CR, 2018, QUAL HEALTH RES, V28, P292, DOI 10.1177/1049732317721477; Kendrick D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625139; Khanjani Mohammad Saeed, 2017, Electron Physician, V9, P3544, DOI 10.19082/3544; Kornhaber R, 2018, J ADV NURS, V74, P23, DOI 10.1111/jan.13396; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; Ljungberg I, 2011, J CLIN NURS, V20, P351, DOI 10.1111/j.1365-2702.2010.03432.x; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Maes S, 2005, APPL PSYCHOL-INT REV, V54, P267, DOI 10.1111/j.1464-0597.2005.00210.x; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; MAXWELL JA, 1992, HARVARD EDUC REV, V62, P279, DOI 10.17763/haer.62.3.8323320856251826; McAllister S, 2013, SOC SCI MED, V85, P93, DOI 10.1016/j.socscimed.2013.02.041; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Ogilvie R, 2012, INT NURS REV, V59, P312, DOI 10.1111/j.1466-7657.2012.00993.x; Ogilvie R, 2015, INJURY, V46, P1841, DOI 10.1016/j.injury.2015.05.036; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Richmond TS, 2000, J ADV NURS, V32, P1341, DOI 10.1046/j.1365-2648.2000.01629.x; Ritchie J., 2002, ANAL QUALITATIVE DAT, P305, DOI 10.4135/9781412986274; Roussis P, 2008, ANXIETY STRESS COPIN, V21, P213, DOI 10.1080/10615800801889600; Saldana J., 2003, LONGITUDINAL QUALITA; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P1167, DOI 10.1097/TA.0000000000001140; Silverman AM, 2015, ARCH PHYS MED REHAB, V96, P1262, DOI 10.1016/j.apmr.2015.02.023; Sippel LM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07832-200410; Tan KL, 2008, INT NURS REV, V55, P110, DOI 10.1111/j.1466-7657.2007.00581.x; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Thompson RW, 2011, TRAUMA VIOLENCE ABUS, V12, P220, DOI 10.1177/1524838011416375; Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038; Tucker M, 2013, AUST J REHABIL COUNS, V19, P135, DOI 10.1017/jrc.2013.16; Van Horn ER, 2013, INT J ORTHOP TRAUMA, V17, P180, DOI 10.1016/j.ijotn.2013.03.001; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2014, INJ VIOL FACTS 2014; Wright CC, 2003, BRIT J HEALTH PSYCH, V8, P465, DOI 10.1348/135910703770238310; Wrosch C, 2003, PERS SOC PSYCHOL B, V29, P1494, DOI 10.1177/0146167203256921; Wrosch C, 2003, SELF IDENTITY, V2, P1, DOI 10.1080/15298860309021	75	11	11	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	SEP 10	2020	42	19					2707	2717		10.1080/09638288.2019.1571116			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NN5ZG	WOS:000568865800004	30739506	Green Submitted			2022-02-06	
J	Bailey, A; Funk, J; Lessley, D; Sherwood, C; Crandall, J; Neale, W; Rose, N				Bailey, Ann; Funk, James; Lessley, David; Sherwood, Chris; Crandall, Jeff; Neale, William; Rose, Nathan			Validation of a videogrammetry technique for analysing American football helmet kinematics	SPORTS BIOMECHANICS			English	Article						Injury biomechanics; rotational kinematics; head; model-based image matching	BRAIN-INJURY; HEAD; CONCUSSION; RECONSTRUCTION; IMPACTS; SYSTEM	Professional American football games are recorded in digital video with multiple cameras, often at high resolution and high frame rates. The purpose of this study was to evaluate the accuracy of a videogrammetry technique to calculate translational and rotational helmet velocity before, during and after a helmet impact. In total, 10 football impacts were staged in a National Football League (NFL) stadium by propelling helmeted 50th percentile male crash test dummies into each other or the ground at speeds and orientations representative of concussive impacts for NFL players. The tests were recorded by experienced sports film crews to obtain video coverage and quality typically available for NFL games. A videogrammetry procedure was used to track the position and rotation of the helmet throughout the relevant time interval of the head impact. Compared with rigidly mounted retroreflective marker three dimensional (3-D) motion tracking that was concurrently collected in the experiments, videogrammetry accurately calculated changes in translational and rotational velocity of the helmet using high frame rate (two cameras at 240 Hz) video (7% and 15% error, respectively). Low frame rate (2 cameras at 60 Hz) video was adequate for calculating pre-impact translational velocity but not for calculating the translational or rotational velocity change of the helmet during impact.	[Bailey, Ann; Funk, James; Lessley, David; Sherwood, Chris; Crandall, Jeff] Biomech Consulting & Res, Charlottesville, VA 22911 USA; [Neale, William; Rose, Nathan] Kineticorp, Greenwood Village, CO USA		Bailey, A (corresponding author), Biomech Consulting & Res, Charlottesville, VA 22911 USA.	abailey@biocorellc.com					[Anonymous], 1995, J211 SAE; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Gehre C., 2009, P INT TECHN C ENH SA, V2009; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Lessley D., 2011, J BIOSENSORS BIOELEC, VS1, P2, DOI [10.4172/2155-6210.S1-002, DOI 10.4172/2155-6210.S1-002]; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; National Operating Committee on Standards for Athletic Equipment, 2015, 08712M15A NOCSAE; Neale W. T., 2011, 2011010286 SAE; Neale W. T., 2016, 2016011478 SAE; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153	21	11	11	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.	SEP 2	2020	19	5					678	700		10.1080/14763141.2018.1513059			23	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	NG9KN	WOS:000564300200009	30274537				2022-02-06	
J	Bin Zahid, A; Hubbard, ME; Lockyer, J; Podolak, O; Dammavalam, VM; Grady, M; Nance, M; Scheiman, M; Samadani, U; Master, CL				Bin Zahid, Abdullah; Hubbard, Molly E.; Lockyer, Julia; Podolak, Olivia; Dammavalam, Vikalpa M.; Grady, Matthew; Nance, Michael; Scheiman, Mitchell; Samadani, Uzma; Master, Christina L.			Eye Tracking as a Biomarker for Concussion in Children	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						accommodation; brain injury; concussion; convergence; eye tracking	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; 4TH INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; UNITED-STATES; SYMPTOMS; ACCOMMODATION; ADOLESCENTS; DIAGNOSIS; ZURICH	Objective: Concussion is the most common type of brain injury in both pediatric and adult populations and can potentially result in persistent postconcussion symptoms. Objective assessment of physiologic "mild" traumatic brain injury in concussion patients remains challenging. This study evaluates an automated eye-tracking algorithm as a biomarker for concussion as defined by its symptoms and the clinical signs of convergence insufficiency and accommodation dysfunction in a pediatric population. Design: Cross-sectional case-control study. Setting: Primary care. Patients: Concussed children (N = 56; mean age = 13 years), evaluated at a mean of 22-week post-injury, compared with 83 uninjured controls. Independent Variables: Metrics comparing velocity and conjugacy of eye movements over time were obtained and were compared with the correlation between Acute Concussion Evaluation (ACE) scores, convergence, and accommodation dysfunction. Main Outcome Measures: Subjects' eye movements recorded with an automated eye tracker while they watched a 220-second cartoon film clip played continuously while moving within an aperture. Results: Twelve eye-tracking metrics were significantly different between concussed and nonconcussed children. A model to classify concussion as diagnosed by its symptoms assessed using the ACE achieved an area under the curve (AUC) = 0.854 (71.9% sensitivity, 84.4% specificity, a cross-validated AUC = 0.789). An eye-tracking model built to identify near point of convergence (NPC) disability achieved 95.8% specificity and 57.1% sensitivity for an AUC = 0.810. Reduced binocular amplitude of accommodation had a Spearman correlation of 0.752(Pvalue <0.001) with NPC. Conclusion: Eye tracking correlated with concussion symptoms and detected convergence and accommodative abnormalities associated with concussion in the pediatric population. It demonstrates utility as a rapid, objective, noninvasive aid in the diagnosis of concussion.	[Bin Zahid, Abdullah; Hubbard, Molly E.; Dammavalam, Vikalpa M.; Samadani, Uzma] Hennepin Cty Med Ctr, Dept Surg, Minneapolis, MN USA; [Bin Zahid, Abdullah; Hubbard, Molly E.; Dammavalam, Vikalpa M.; Samadani, Uzma] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Bin Zahid, Abdullah; Dammavalam, Vikalpa M.; Samadani, Uzma] Minneapolis VA Hlth Care Sys, Surg Serv, Minneapolis, MN USA; [Lockyer, Julia; Podolak, Olivia; Grady, Matthew; Nance, Michael; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Grady, Matthew; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scheiman, Mitchell] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA		Samadani, U (corresponding author), 701 Pk Ave S PL 610, Minneapolis, MN 55415 USA.	Uzma.Samadani@hcmed.org		Scheiman, Mitchell/0000-0002-9274-5696			Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Brodersen KH, 2010, 20 INT C PATT REC IC; Centers for Disease Control, 2016, TRAUM BRAIN INJ US F; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Food and Drug Administration, 2018, PED MED DEV; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kolecki R, 2018, J NEUROSURG, V128, P811, DOI 10.3171/2016.12.JNS161265; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pillai C, 2017, SEMIN OPHTHALMOL, V32, P144, DOI 10.1080/08820538.2016.1228412; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Samadani U, 2015, CONCUSSION, V1, P1; Samadani U, 2015, NEURAL REGEN RES, V10, P1231, DOI 10.4103/1673-5374.162752; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheiman M., 2014, CLIN MANAGEMENT BINO; Singman E., 2013, MED INSTRUM, DOI [10.7243/2052-6962-1-3, DOI 10.7243/2052-6962-1-3]; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	43	11	11	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					433	443		10.1097/JSM.0000000000000639			11	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300019	30095503				2022-02-06	
J	Vespa, PM; Olson, DM; John, S; Hobbs, KS; Gururangan, K; Nie, K; Desai, MJ; Markert, M; Parvizi, J; Bleck, TP; Hirsch, LJ; Westover, MB				Vespa, Paul M.; Olson, DaiWai M.; John, Sayona; Hobbs, Kyle S.; Gururangan, Kapil; Nie, Kun; Desai, Masoom J.; Markert, Matthew; Parvizi, Josef; Bleck, Thomas P.; Hirsch, Lawrence J.; Westover, M. Brandon			Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study	CRITICAL CARE MEDICINE			English	Article						Ceribell electroencephalography; diagnostic device evaluation; electroencephalography; epilepsy; nonconvulsive status epilepticus; rapid response electroencephalography; seizure	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; ELECTROGRAPHIC SEIZURES; PERIODIC DISCHARGES; CARDIAC-ARREST; EEG; HEMORRHAGE; MANAGEMENT; CRITERIA	Objectives: To measure the diagnostic accuracy, timeliness, and ease of use of Ceribell rapid response electroencephalography. We assessed physicians' diagnostic assessments and treatment plans before and after rapid response electroencephalography assessment. Primary outcomes were changes in physicians' diagnostic and therapeutic decision making and their confidence in these decisions based on the use of the rapid response electroencephalography system. Secondary outcomes were time to electroencephalography, setup time, ease of use, and quality of electroencephalography data. Design: Prospective multicenter nonrandomized observational study. Setting: ICUs in five academic hospitals in the United States. Subjects: Patients with encephalopathy suspected of having non-convulsive seizures and physicians evaluating these patients. Interventions: Physician bedside assessment of sonified electroencephalography (30 s from each hemisphere) and visual electroencephalography (60 s) using rapid response electroencephalography. Measurements and Main Results: Physicians (29 fellows or residents, eight attending neurologists) evaluated 181 ICU patients; complete clinical and electroencephalography data were available in 164 patients (average 58.6 +/- 18.7 yr old, 45% females). Relying on rapid response electroencephalography information at the bedside improved the sensitivity (95% CI) of physicians' seizure diagnosis from 77.8% (40.0%, 97.2%) to 100% (66.4%, 100%) and the specificity (95% CI) of their diagnosis from 63.9% (55.8%, 71.4%) to 89% (83.0%, 93.5%). Physicians' confidence in their own diagnosis and treatment plan were also improved. Time to electroencephalography (median [interquartile range]) was 5 minutes (4-10 min) with rapid response electroencephalography while the conventional electroencephalography was delayed by several hours (median [interquartile range] delay = 239 minutes [134-471 min] [p < 0.0001 using Wilcoxon signed rank test]). The device was rated as easy to use (mean +/- sd: 4.7 +/- 0.6 [1 = difficult, 5 = easy]) and was without serious adverse effects. Conclusions: Rapid response electroencephalography enabled timely and more accurate assessment of patients in the critical care setting. The use of rapid response electroencephalography may be clinically beneficial in the assessment of patients with high suspicion for nonconvulsive seizures and status epilepticus.	[Vespa, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Olson, DaiWai M.] Univ Texas Southwestern Med Sch, Dept Neurol, Dallas, TX USA; [John, Sayona] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA; [Hobbs, Kyle S.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Gururangan, Kapil] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Nie, Kun] Clindata Insight Inc, Moraga, CA USA; [Desai, Masoom J.; Bleck, Thomas P.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Markert, Matthew; Parvizi, Josef] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Hirsch, Lawrence J.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Westover, M. Brandon] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA		Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	pvespa@mednet.ucla.edu		Hirsch, Lawrence/0000-0002-6333-832X; Gururangan, Kapil/0000-0001-5247-8303	Ceribell	This trial was funded and supported by Ceribell.	Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Avdic U, 2018, EPILEPSIA, V59, P945, DOI 10.1111/epi.14070; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Flores-Cordero JM, 2003, INTENS CARE MED, V29, P1967, DOI 10.1007/s00134-003-1935-4; Govindarajan P, 2020, CLIN UTILITY CERIBEL; Gururangan K, 2020, NEUROCRIT CARE, V32, P193, DOI 10.1007/s12028-019-00804-6; Gururangan K, 2018, CLIN NEUROPHYS PRACT, V3, P65, DOI 10.1016/j.cnp.2018.03.001; Gururangan K, 2016, CLIN NEUROPHYSIOL, V127, P3335, DOI 10.1016/j.clinph.2016.08.013; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hill CE, 2019, NEUROLOGY, V92, pE9, DOI 10.1212/WNL.0000000000006689; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hobbs K, 2018, NEUROCRIT CARE, V29, P302, DOI 10.1007/s12028-018-0543-7; Kamousi B, 2019, CLIN NEUROPHYS PRACT, V4, P69, DOI 10.1016/j.cnp.2019.02.002; Kolls BJ, 2018, NEUROCRIT CARE, V28, P229, DOI 10.1007/s12028-017-0468-6; Krsek P, 2004, EPILEPSY BEHAV, V5, P180, DOI 10.1016/j.yebeh.2003.11.032; Krumholz A, 1999, J CLIN NEUROPHYSIOL, V16, P314, DOI 10.1097/00004691-199907000-00003; Legriel S, 2009, NEUROCRIT CARE, V11, P338, DOI 10.1007/s12028-009-9246-4; Leitinger M, 2015, EPILEPSY BEHAV, V49, P158, DOI 10.1016/j.yebeh.2015.05.007; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; Mecarelli O, 2011, CEREBROVASC DIS, V31, P191, DOI 10.1159/000321872; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V29, P82, DOI 10.1001/archneur.1973.00490260026003; Parvizi J, 2018, EPILEPSIA, V59, P877, DOI 10.1111/epi.14043; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Quigg M, 2001, J CLIN NEUROPHYSIOL, V18, P162, DOI 10.1097/00004691-200103000-00007; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ronner HE, 2009, SEIZURE-EUR J EPILEP, V18, P257, DOI 10.1016/j.seizure.2008.10.010; Rossetti AO, 2007, NEUROLOGY, V69, P255, DOI 10.1212/01.wnl.0000265819.36639.e0; Rundgren M, 2006, INTENS CARE MED, V32, P836, DOI 10.1007/s00134-006-0178-6; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Tu Bin, 2017, Epilepsia Open, V2, P67, DOI 10.1002/epi4.12034; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Westover MB, 2020, NEUROCRIT CARE, V33, P479, DOI 10.1007/s12028-019-00911-4; Yazbeck M, 2019, J NEUROSCI NURS, V51, P308, DOI 10.1097/JNN.0000000000000476; Young GB, 1996, NEUROLOGY, V47, P83; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d	50	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2020	48	9					1249	1257		10.1097/CCM.0000000000004428			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NI3RD	WOS:000565272500020	32618687	Green Accepted			2022-02-06	
J	Lafrenaye, AD; Mondello, S; Wang, KK; Yang, ZH; Povlishock, JT; Gorse, K; Walker, S; Hayes, RL; Kochanek, PM				Lafrenaye, Audrey D.; Mondello, Stefania; Wang, Kevin K.; Yang, Zhihui; Povlishock, John T.; Gorse, Karen; Walker, Susan; Hayes, Ronald L.; Kochanek, Patrick M.			Circulating GFAP and Iba-1 levels are associated with pathophysiological sequelae in the thalamus in a pig model of mild TBI	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; TERMINAL HYDROLASE-L1; VESICLE FORMATION; BIOMARKERS; MICROGLIA; ACTIVATION; PHYSIOLOGY; INTERLEUKIN-6; TRAFFICKING	Serum biomarkers are promising tools for evaluating patients following traumatic brain injury (TBI). However, their relationship with diffuse histopathology remains unclear. Additionally, translatability is a focus of neurotrauma research, however, studies using translational animal models are limited. Here, we evaluated associations between circulating biomarkers and acute thalamic histopathology in a translational micro pig model of mTBI. Serum samples were collected pre-injury, and 1 min-6 h following mTBI. Markers of neuronal injury (Ubiquitin Carboxy-terminal Hydrolase L1 [UCH-L1]), microglial/macrophage activation (Ionized calcium binding adaptor molecule-1 [Iba-1]) and interleukin-6 [IL-6]) and astrogliosis/astrocyte damage (glial fibrillary acidic protein [GFAP]) were measured. Axonal injury and histological features of neurons and glia were also investigated using immunofluorescent labeling and correlated to serum levels of the associated biomarkers. Consistent with prior experimental and human studies, GFAP, was highest at 6 h post-injury, while no substantial changes were observed in UCH-L1, Iba-1 or IL-6 over 6 h. This study also found promising associations between thalamic glial histological signatures and ensuing release of Iba-1 and GFAP into the circulation. Our findings suggest that in diffuse injury, monitoring serum Iba-1 and GFAP levels can provide clinically relevant insight into the underlying acute pathophysiology and biomarker release kinetics following mTBI, providing previously underappreciated diagnostic capability.	[Lafrenaye, Audrey D.; Povlishock, John T.; Gorse, Karen; Walker, Susan] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, POB 980709, Richmond, VA 23298 USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Via Consolare Valeria, I-98125 Messina, Italy; [Mondello, Stefania] Oasi Res Inst IRCCS, Troina, Italy; [Wang, Kevin K.; Yang, Zhihui] Univ Florida, McKnight Brain Inst, Dept Emergency Med Psychiat & Neurosci, Program Neurotrauma Neuroprote & Biomarkers Res N, 1149 Newell Dr, Gainesville, FL 32611 USA; [Hayes, Ronald L.] Banyan Labs, 13400 Progress Blvd, Alachua, FL 32615 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA		Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, POB 980709, Richmond, VA 23298 USA.	Audrey.Lafrenaye@vcuhealth.org	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614	United States ArmyUnited States Department of Defense [W81XWH-10-1-0623, WH81XWH-14-2-0018]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS096143]	We are grateful to the United States Army grants W81XWH-10-1-0623& WH81XWH-14-2-0018 and the National Institutes of Health grant 1R01NS096143.The authors would also like to thank Lynn Davis, Judy Williamson, and Frances White for invaluable technical assistance.	Aimale V, 2018, LANGUAGE ENV STAT CO; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Asken BM, 2019, JAMA NEUROL, V76, P515, DOI 10.1001/jamaneurol.2019.0125; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Karve IP, 2015, BR J PHARM, DOI [10.1111/bph.131254742296, DOI 10.1111/BPH.131254742296]; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2019, J NEUROTRAUMA, DOI [10.1089/neu.2018.62036551973, DOI 10.1089/NEU.2018.62036551973]; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Larsen K, 2012, MOL BIOL REP, V39, P1095, DOI 10.1007/s11033-011-0836-9; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marklund N, 2017, FRONT NEUROL, V8, P4; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Posti J. P., CORRELATION BLOOD BI, DOI [10.1089/neu.2018.6254, DOI 10.1089/NEU.2018.6254]; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schwaninger M, 1999, J NEUROCHEM, V73, P1461, DOI 10.1046/j.1471-4159.1999.0731461.x; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Tschiffely A. E., ASSESSING BLAST RELA, DOI [10.1089/neu.2019.6512, DOI 10.1089/NEU.2019.6512]; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0790-0; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Yue J. K., 2020, MEDICINA, V56; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; [No title captured]	78	11	11	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 7	2020	10	1							13369	10.1038/s41598-020-70266-w			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7XQ	WOS:000561428300024	32770054	Green Published, gold			2022-02-06	
J	Bharadwaj, VN; Copeland, C; Mathew, E; Newbern, J; Anderson, TR; Lifshitz, J; Kodibagkar, VD; Stabenfeldt, SE				Bharadwaj, Vimala N.; Copeland, Connor; Mathew, Ethan; Newbern, Jason; Anderson, Trent R.; Lifshitz, Jonathan; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.			Sex-Dependent Macromolecule and Nanoparticle Delivery in Experimental Brain Injury	TISSUE ENGINEERING PART A			English	Article						sex-dependence; blood-brain barrier; nanoparticle; traumatic brain injury; drug delivery; intravital microscopy	CONTROLLED CORTICAL IMPACT; BARRIER PERMEABILITY; MOUSE MODEL; FEMALE RATS; TIME-COURSE; EDEMA; PROGESTERONE; CONTUSION; BREAKDOWN; GENDER	The development of effective therapeutics for brain disorders is challenging, in particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma. Traumatic brain injury (TBI) may lead to transient BBB permeability that affords a unique opportunity for therapeutic delivery via intravenous administration ranging from macromolecules to nanoparticles (NPs) for developing precision therapeutics. In this regard, we address critical gaps in understanding the range/size of therapeutics, delivery window(s), and moreover, the potential impact of biological factors for optimal delivery parameters. Here we show, for the first time, to the best of our knowledge, that 24-h postfocal TBI female mice exhibit a heightened macromolecular tracer and NP accumulation compared with male mice, indicating sex-dependent differences in BBB permeability. Furthermore, we report for the first time the potential to deliver NP-based therapeutics within 3 days after focal injury in both female and male mice. The delineation of injury-induced BBB permeability with respect to sex and temporal profile is essential to more accurately tailor time-dependent precision and personalized nanotherapeutics. Impact statement In this study, we identified a sex-dependent temporal profile of blood/brain barrier disruption in a preclinical mouse model of traumatic brain injury (TBI) that contributes to starkly different macromolecule and nanoparticle delivery profiles post-TBI. The implications and potential impact of this work are profound and far reaching as it indicates that a demand of true personalized medicine for TBI is necessary to deliver the right therapeutic at the right time for the right patient.	[Bharadwaj, Vimala N.; Copeland, Connor; Mathew, Ethan; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.] Arizona State Univ, Ira A Fulton Sch Engn, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Newbern, Jason] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Anderson, Trent R.] Univ Arizona, Coll Med Phoenix, Basic Med Sci, Phoenix, AZ USA; [Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Ira A Fulton Sch Engn, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	sarah.stabenfeldt@asu.edu	Bharadwaj, Vimala/AAV-1040-2021	Newbern, Jason/0000-0003-2865-0112; Bharadwaj, Vimala/0000-0002-6243-0861			Bailey ZS, 2020, J NEUROTRAUM, V37, P1452, DOI 10.1089/neu.2016.4644; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; BHARADWAJ VN, 2016, SCI REP, V6, P1; Bickel U, 2001, ADV DRUG DELIVER REV, V46, P247, DOI 10.1016/S0169-409X(00)00139-3; Bobo D, 2016, PHARM RES-DORDR, V33, P2373, DOI 10.1007/s11095-016-1958-5; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Fortress AM, 2019, EXP NEUROL, V315, P42, DOI 10.1016/j.expneurol.2019.01.017; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hohl A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00029; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Masserini Massimo, 2013, ISRN Biochem, V2013, P238428, DOI 10.1155/2013/238428; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Mostany Ricardo, 2008, J Vis Exp, DOI 10.3791/680; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Oztas B, 1998, HORM METAB RES, V30, P500, DOI 10.1055/s-2007-978920; Oztas B, 2001, PHARMACOL RES, V43, P469, DOI 10.1006/phrs.2001.0797; Pardridge William M, 2005, NeuroRx, V2, P3; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Ping XJ, 2014, J NEUROTRAUM, V31, P1172, DOI 10.1089/neu.2013.3147; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Saunders Norman R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7378.1; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sohrabji F, 2007, GENE EXPRESSION, V13, P311; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; STEWART PA, 1992, J NEUROSCI METH, V41, P75, DOI 10.1016/0165-0270(92)90125-W; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Usmani SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181748; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Ventola C Lee, 2017, P T, V42, P742; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wu P, 2019, INT J NANOMED, V14, P4059, DOI 10.2147/IJN.S202353; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	60	11	11	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	JUL 1	2020	26	13-14					688	701		10.1089/ten.tea.2020.0040			14	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	MN8KE	WOS:000551090000002	32697674	Green Submitted, Green Published			2022-02-06	
J	Maldonado, T; Orr, JM; Goen, JRM; Bernard, JA				Maldonado, Ted; Orr, Joseph M.; Goen, James R. M.; Bernard, Jessica A.			Age Differences in the Subcomponents of Executive Functioning	JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES			English	Article						Aging; Executive function; Unity-Diversity Model; Meta-analysis	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY CAPACITY; PREPOTENT RESPONSE SUPPRESSION; REACTIVE COGNITIVE CONTROL; WHITE-MATTER INTEGRITY; DUAL-TASK PERFORMANCE; HEALTHY OLDER-ADULTS; CARD SORTING TEST; INHIBITORY CONTROL; LIFE-SPAN	Objectives: Across the life span, deficits in executive functioning (EF) are associated with poor behavioral control and failure to achieve goals. Though EF is often discussed as one broad construct, a prominent model of EF suggests that it is composed of three subdomains: inhibition, set shifting, and updating. These subdomains are seen in both younger (YA) and older adults (OA), with performance deficits across subdomains in OA. Therefore, our goal was to investigate whether subdomains of EF might be differentially affected by age, and how these differences may relate to broader global age differences in EF. Methods: To assess these age differences, we conducted a meta-analysis at multiple levels, including task level, subdomain level, and of global EF. Based on previous work, we hypothesized that there would be overall differences in EF in OA. Results: Using 1,268 effect sizes from 401 articles, we found overall differences in EF with age. Results suggested that differences in performance are not uniform, such that variability in age effects emerged at the task level, and updating was not as affected by age as other subdomains. Discussion: These findings advance our understanding of age differences in EF, and stand to inform early detection of EF decline.	[Maldonado, Ted; Orr, Joseph M.; Goen, James R. M.; Bernard, Jessica A.] Texas A&M Univ, Dept Psychol & Brain Sci, 4235 TAMU, College Stn, TX 77843 USA; [Orr, Joseph M.; Bernard, Jessica A.] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX USA		Maldonado, T (corresponding author), Texas A&M Univ, Dept Psychol & Brain Sci, 4235 TAMU, College Stn, TX 77843 USA.	tmaldonado1821@tamu.edu		Maldonado, Ted/0000-0002-7937-1546			Abel LA, 2007, NEUROBIOL AGING, V28, P627, DOI 10.1016/j.neurobiolaging.2006.02.003; Aguirre C, 2014, PSYCHOL AGING, V29, P128, DOI 10.1037/a0035598; Aisenberg D, 2014, ACTA PSYCHOL, V153, P169, DOI 10.1016/j.actpsy.2014.10.005; Aisenberg D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117151; Aizpurua A, 2010, PSYCHOL AGING, V25, P193, DOI 10.1037/a0018198; Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Albinet CT, 2012, BRAIN COGNITION, V79, P1, DOI 10.1016/j.bandc.2012.02.001; Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Allard E, 2008, AGING NEUROPSYCHOL C, V15, P725, DOI 10.1080/13825580802348562; Allen PA, 2009, EXP AGING RES, V35, P369, DOI 10.1080/03610730903175766; Alperin BR, 2015, BRAIN COGNITION, V99, P118, DOI 10.1016/j.bandc.2015.08.001; Alperin BR, 2014, NEUROSCI LETT, V577, P6, DOI 10.1016/j.neulet.2014.05.049; Anderson JAE, 2014, PSYCHOL AGING, V29, P648, DOI 10.1037/a0037243; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Andres P, 2000, J GERONTOL B-PSYCHOL, V55, pP373, DOI 10.1093/geronb/55.6.P373; Andres P, 2004, MEMORY, V12, P248, DOI 10.1080/09658210244000612; Andres P, 2008, DEV NEUROPSYCHOL, V33, P101, DOI 10.1080/87565640701884212; Angel L, 2016, BRAIN RES, V1631, P53, DOI 10.1016/j.brainres.2015.10.009; Angel L, 2011, J COGNITIVE NEUROSCI, V23, P3767, DOI 10.1162/jocn_a_00104; Angel L, 2010, NEUROPSYCHOLOGIA, V48, P3540, DOI 10.1016/j.neuropsychologia.2010.08.003; Archer JA, 2016, BRAIN CONNECT, V6, P169, DOI 10.1089/brain.2015.0345; Ashendorf L, 2008, CLIN NEUROPSYCHOL, V22, P262, DOI 10.1080/13854040701218436; Aslan A, 2015, PSYCHOL AGING, V30, P824, DOI 10.1037/a0039874; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Balouch S, 2013, J INT NEUROPSYCH SOC, V19, P763, DOI 10.1017/S1355617713000519; Bangert AS, 2010, NEUROPSYCHOLOGIA, V48, P1165, DOI 10.1016/j.neuropsychologia.2009.11.013; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Barry RJ, 2016, CLIN NEUROPHYSIOL, V127, P2273, DOI 10.1016/j.clinph.2016.02.010; Barulli DJ, 2013, J INT NEUROPSYCH SOC, V19, P841, DOI 10.1017/S1355617713000593; Baudouin A, 2006, BRAIN COGNITION, V62, P17, DOI 10.1016/j.bandc.2006.03.003; Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Bernard JA, 2013, CEREBELLUM, V12, P721, DOI 10.1007/s12311-013-0481-z; Bernstein DM, 2011, EXP AGING RES, V37, P481, DOI 10.1080/0361073X.2011.619466; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2014, PSYCHOL AGING, V29, P696, DOI 10.1037/a0037254; Binder JC, 2016, PSYCHOL AGING, V31, P390, DOI 10.1037/pag0000081; Blair M, 2011, Q J EXP PSYCHOL, V64, P1157, DOI 10.1080/17470218.2010.540670; Bojko A, 2004, PSYCHOL AGING, V19, P226, DOI 10.1037/0882-7974.19.1.226; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Borella E, 2011, J GERONTOL B-PSYCHOL, V66, P311, DOI 10.1093/geronb/gbr002; Borenstein M., 2009, HDB RES SYNTHESIS ME, V2nd, P221; Bottiroli S, 2016, ARCH GERONTOL GERIAT, V62, P152, DOI 10.1016/j.archger.2015.09.009; Bouazzaoui B, 2014, CAN J EXP PSYCHOL, V68, P59, DOI 10.1037/cep0000005; Bouazzaoui B, 2010, ACTA PSYCHOL, V135, P59, DOI 10.1016/j.actpsy.2010.05.007; Brand M, 2013, J CLIN EXP NEUROPSYC, V35, P9, DOI 10.1080/13803395.2012.740000; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Brennan M, 1997, PERCEPT MOTOR SKILL, V84, P1187, DOI 10.2466/pms.1997.84.3c.1187; Brickman AM, 2007, NEUROBIOL AGING, V28, P284, DOI 10.1016/j.neurobiolaging.2005.12.016; Brown SW, 2015, J EXP PSYCHOL HUMAN, V41, P1063, DOI 10.1037/xhp0000078; Bryan J, 2002, J NUTR, V132, P1345, DOI 10.1093/jn/132.6.1345; Bryan J, 2001, J CLIN EXP NEUROPSYC, V23, P608, DOI 10.1076/jcen.23.5.608.1250; Buchler NG, 2008, MEM COGNITION, V36, P735, DOI 10.3758/MC.36.4.735; Bucur B, 2010, EXP AGING RES, V36, P153, DOI 10.1080/03610731003613482; Buczylowska D, 2016, ARCH CLIN NEUROPSYCH, V31, P254, DOI 10.1093/arclin/acw005; Bugaiska A, 2007, CONSCIOUS COGN, V16, P797, DOI 10.1016/j.concog.2006.11.007; Bugg JM, 2016, PSYCHOL AGING, V31, P358, DOI 10.1037/pag0000087; Bugg JM, 2014, PSYCHOL AGING, V29, P115, DOI 10.1037/a0035270; Bunce D, 2012, ACCIDENT ANAL PREV, V49, P293, DOI 10.1016/j.aap.2012.01.001; Butler KM, 2006, PSYCHOL AGING, V21, P638, DOI 10.1037/0882-7974.21.3.638; Butler KM, 2013, PSYCHOL AGING, V28, P1024, DOI 10.1037/a0034937; Campbell KL, 2012, NEUROPSYCHOLOGIA, V50, P2212, DOI 10.1016/j.neuropsychologia.2012.05.025; Campbell KL, 2009, PSYCHOL AGING, V24, P163, DOI 10.1037/a0014106; Campbell KL, 2010, EXP BRAIN RES, V201, P385, DOI 10.1007/s00221-009-2045-5; Cansino S, 2011, MEM COGNITION, V39, P1409, DOI 10.3758/s13421-011-0109-9; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Capuana LJ, 2012, BIOL PSYCHOL, V90, P60, DOI 10.1016/j.biopsycho.2012.02.018; Castel AD, 2007, NEUROPSYCHOLOGY, V21, P170, DOI 10.1037/0894-4105.21.2.170; Cavallini E, 2013, INT J AGING HUM DEV, V76, P181, DOI 10.2190/AG.76.3.a; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; CERELLA J, 1994, J GERONTOL, V49, pP65, DOI 10.1093/geronj/49.2.P65; Chaytor N, 2004, J INT NEUROPSYCH SOC, V10, P489, DOI 10.1017/S1355617704104013; Chen TY, 2007, AGING NEUROPSYCHOL C, V14, P631, DOI 10.1080/13825580600987660; Cherry BJ, 2010, BRAIN COGNITION, V72, P218, DOI 10.1016/j.bandc.2009.09.003; Cheung MWL, 2019, NEUROPSYCHOL REV, V29, P387, DOI 10.1007/s11065-019-09415-6; Chin J, 2015, TOP COGN SCI, V7, P428, DOI 10.1111/tops.12147; Christ SE, 2001, DEV NEUROPSYCHOL, V20, P653, DOI 10.1207/875656401753549852; Circelli KS, 2013, AGING NEUROPSYCHOL C, V20, P148, DOI 10.1080/13825585.2012.675427; Clarys D, 2009, MEMORY, V17, P158, DOI 10.1080/09658210802188301; Collette F, 2009, MEMORY, V17, P104, DOI 10.1080/09658210802574146; Cona G, 2013, NEUROPSYCHOLOGY, V27, P378, DOI 10.1037/a0032708; Cooper H., 2009, RES SYNTHESIS METAAN; Cornoldi C, 2007, AGING NEUROPSYCHOL C, V14, P1, DOI 10.1080/138255890969311; Coxon JP, 2016, CEREB CORTEX, V26, P12, DOI 10.1093/cercor/bhu165; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Crawford S, 2002, AGING MENT HEALTH, V6, P12, DOI 10.1080/13607860120101130; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Czernochowski D, 2010, PSYCHOPHYSIOLOGY, V47, P637, DOI 10.1111/j.1469-8986.2009.00973.x; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; de Laar MCV, 2012, BIOL PSYCHOL, V89, P323, DOI 10.1016/j.biopsycho.2011.11.005; De Neys W, 2009, DEVELOPMENTAL SCI, V12, P123, DOI 10.1111/j.1467-7687.2008.00746.x; Debelak R, 2016, NEUROPSYCHOLOGY, V30, P346, DOI 10.1037/neu0000238; Del Re AC, 2014, MAD METAANALYSIS MEA MAD METAANALYSIS MEA MAD METAANALYSIS MEA; Del Re AC, 2010, MAD METAANALYSIS MEA; Dey A, 2015, PSYCHOL AGING, V30, P634, DOI 10.1037/pag0000033; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dirnberger G, 2010, AGE, V32, P323, DOI 10.1007/s11357-010-9134-z; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Dulaney CL, 2004, EXP AGING RES, V30, P95, DOI 10.1080/03610730490251504; Dumas JA, 2008, AGING NEUROPSYCHOL C, V15, P330, DOI 10.1080/13825580701534601; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eenshuistra RM, 2004, BRAIN COGNITION, V56, P177, DOI 10.1016/j.bandc.2004.02.077; El Haj M, 2016, MEMORY, V24, P526, DOI 10.1080/09658211.2015.1021257; El Haj M, 2014, Q J EXP PSYCHOL, V67, P2381, DOI 10.1080/17470218.2014.929719; El Haj M, 2013, BEHAV NEUROL, V26, P215, DOI [10.3233/BEN-2012-129014, 10.1155/2013/734565]; El Haj M, 2013, CORTEX, V49, P82, DOI 10.1016/j.cortex.2011.11.014; El Haj M, 2012, CONSCIOUS COGN, V21, P238, DOI 10.1016/j.concog.2011.12.005; Emery L, 2008, PSYCHOL AGING, V23, P634, DOI 10.1037/a0012577; Fernandez-Duque D, 2008, BRAIN COGNITION, V66, P221, DOI 10.1016/j.bandc.2007.08.003; Fiore F, 2012, MEMORY, V20, P14, DOI 10.1080/09658211.2011.628320; Fischer AL, 2017, J GERONTOL B-PSYCHOL, V72, P71, DOI 10.1093/geronb/gbw088; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Fjell AM, 2017, CEREB CORTEX, V27, P2303, DOI 10.1093/cercor/bhw082; Foos PW, 2010, EXP AGING RES, V36, P273, DOI 10.1080/0361073X.2010.484725; Ford JH, 2014, MEMORY, V22, P722, DOI 10.1080/09658211.2013.820325; Fortin A, 2014, CAN J AGING, V33, P60, DOI 10.1017/S0714980813000445; Fraser SA, 2010, J GERONTOL B-PSYCHOL, V65, P526, DOI 10.1093/geronb/gbq036; Frey R, 2015, COGNITION, V142, P60, DOI 10.1016/j.cognition.2015.05.004; Friedman D, 2008, AGING NEUROPSYCHOL C, V15, P95, DOI 10.1080/13825580701533769; Friedman D, 2009, COGN AFFECT BEHAV NE, V9, P91, DOI 10.3758/CABN.9.1.91; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Fristoe NM, 1997, NEUROPSYCHOLOGY, V11, P428, DOI 10.1037/0894-4105.11.3.428; Fujiyama H, 2010, PSYCHOPHYSIOLOGY, V47, P501, DOI 10.1111/j.1469-8986.2009.00954.x; Gamble KR, 2014, EXP AGING RES, V40, P513, DOI 10.1080/0361073X.2014.956618; Gazes Y, 2012, NEUROPSYCHOLOGIA, V50, P3509, DOI 10.1016/j.neuropsychologia.2012.09.039; Germain S, 2008, J INT NEUROPSYCH SOC, V14, P1014, DOI 10.1017/S135561770808123X; Gillis MM, 2013, ACTA PSYCHOL, V143, P88, DOI 10.1016/j.actpsy.2013.03.001; Glisky EL, 2008, J EXP PSYCHOL LEARN, V34, P809, DOI 10.1037/0278-7393.34.4.809; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Gollan TH, 2011, PSYCHOL SCI, V22, P1155, DOI 10.1177/0956797611417002; Gombart S, 2016, PERCEPT MOTOR SKILL, V123, P569, DOI 10.1177/0031512516664922; Gonneaud J, 2011, MEMORY, V19, P360, DOI 10.1080/09658211.2011.570765; Gorlick MA, 2013, EMOTION, V13, P250, DOI 10.1037/a0030071; Gottlob LR, 2007, AGING NEUROPSYCHOL C, V14, P586, DOI 10.1080/13825580600878752; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Grandjean J, 2011, BRAIN COGNITION, V77, P237, DOI 10.1016/j.bandc.2011.08.004; Grant JD, 2000, AM J PSYCHOL, V113, P69, DOI 10.2307/1423461; Gratton G, 2009, J COGNITIVE NEUROSCI, V21, P1380, DOI 10.1162/jocn.2009.21093; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Groeger JA, 2014, SLEEP, V37, P1127, DOI 10.5665/sleep.3776; Guerreiro MJS, 2012, J GERONTOL B-PSYCHOL, V67, P194, DOI 10.1093/geronb/gbr090; Guerreiro MJS, 2011, PSYCHOL AGING, V26, P415, DOI 10.1037/a0021507; Gutchess AH, 2007, NEUROIMAGE, V35, P1338, DOI 10.1016/j.neuroimage.2007.01.043; Gutchess AH, 2015, BRAIN RES, V1612, P118, DOI 10.1016/j.brainres.2014.08.033; Hakun JG, 2015, CORTEX, V64, P352, DOI 10.1016/j.cortex.2014.12.006; Hale J. B., 2004, SCH NEUROPSYCHOLOGY; Hale S, 2011, PSYCHOL AGING, V26, P92, DOI 10.1037/a0021483; Hannon B, 2009, EXP AGING RES, V35, P432, DOI 10.1080/03610730903175808; Hartman M, 2001, PSYCHOL AGING, V16, P385, DOI 10.1037//0882-7974.16.3.385; Hasher L, 1997, MEM COGNITION, V25, P286, DOI 10.3758/BF03211284; Haugrud N, 2010, AGING NEUROPSYCHOL C, V17, P220, DOI 10.1080/13825580903042700; Healey MK, 2013, PSYCHOL AGING, V28, P721, DOI 10.1037/a0033003; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hedden T, 2012, CEREB CORTEX, V22, P1038, DOI 10.1093/cercor/bhr172; Heilbronner U, 2013, NEUROIMAGE, V65, P408, DOI 10.1016/j.neuroimage.2012.09.066; Heinzel S, 2014, AGING NEUROPSYCHOL C, V21, P146, DOI 10.1080/13825585.2013.790338; Helfer KS, 2015, J ACOUST SOC AM, V138, P363, DOI 10.1121/1.4923155; Helfer KS, 2014, J ACOUST SOC AM, V136, P748, DOI 10.1121/1.4887463; Henry JD, 2006, AGING NEUROPSYCHOL C, V13, P529, DOI 10.1080/138255890969537; Hering A, 2014, GERONTOLOGY, V60, P73, DOI 10.1159/000355057; Hess TM, 1999, PSYCHOL AGING, V14, P77, DOI 10.1037/0882-7974.14.1.77; Hester RL, 2004, J INT NEUROPSYCH SOC, V10, P475, DOI 10.1017/S1355617704104037; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Hinault T, 2016, J GERONTOL B-PSYCHOL, V71, P613, DOI 10.1093/geronb/gbu178; Hinault T, 2016, BRAIN RES, V1630, P144, DOI 10.1016/j.brainres.2015.10.057; Hinder MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052573; Hirsch P, 2016, ACTA PSYCHOL, V170, P66, DOI 10.1016/j.actpsy.2016.06.008; Hogge M, 2008, AGING NEUROPSYCHOL C, V15, P471, DOI 10.1080/13825580701878065; Holland CA, 2012, MEMORY, V20, P779, DOI 10.1080/09658211.2012.703210; Holtzer R, 2004, MEM COGNITION, V32, P1333, DOI 10.3758/BF03206324; Hsieh S, 2017, ACTA PSYCHOL, V173, P122, DOI 10.1016/j.actpsy.2016.12.011; Hsieh SL, 2012, BIOL PSYCHOL, V90, P113, DOI 10.1016/j.biopsycho.2012.03.006; Hsieh SL, 2010, ACTA PSYCHOL, V135, P140, DOI 10.1016/j.actpsy.2010.05.010; Huang YMH, 2015, PSYCHOL AGING, V30, P675, DOI 10.1037/pag0000038; Hutter RRC, 2012, BRIT J PSYCHOL, V103, P28, DOI 10.1111/j.2044-8295.2011.02037.x; Isaacowitz DM, 2009, J GERONTOL B-PSYCHOL, V64, P188, DOI 10.1093/geronb/gbn036; Isingrini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145361; Iskandar S, 2016, AGING NEUROPSYCHOL C, V23, P1, DOI 10.1080/13825585.2015.1028326; Jennings JR, 2011, EXP AGING RES, V37, P179, DOI 10.1080/0361073X.2011.554512; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Joanisse M, 2008, J GERONTOL B-PSYCHOL, V63, pP193, DOI 10.1093/geronb/63.3.P193; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; KANE MJ, 1994, PSYCHOL AGING, V9, P103, DOI 10.1037/0882-7974.9.1.103; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Karr JE, 2018, PSYCHOL BULL, V144, P1147, DOI 10.1037/bul0000160; Keller JB, 2015, CORTEX, V64, P271, DOI 10.1016/j.cortex.2014.12.001; Kelly AJ, 2013, AGING NEUROPSYCHOL C, V20, P101, DOI 10.1080/13825585.2012.691152; Kemper S, 2006, PSYCHOL AGING, V21, P32, DOI 10.1037/0882-7974.21.1.32; Kemper S, 2014, J PSYCHOLINGUIST RES, V43, P59, DOI 10.1007/s10936-013-9240-z; Kemps E, 2006, J CLIN EXP NEUROPSYC, V28, P341, DOI 10.1080/13803390490918228; Kennedy KM, 2015, NEUROIMAGE, V104, P21, DOI 10.1016/j.neuroimage.2014.09.056; Keys BA, 2000, J INT NEUROPSYCH SOC, V6, P76, DOI 10.1017/S1355617700611098; Kieley JM, 1997, PSYCHOL AGING, V12, P22, DOI 10.1037/0882-7974.12.1.22; Kirchhoff BA, 2012, CEREB CORTEX, V22, P788, DOI 10.1093/cercor/bhr129; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Konstantopoulos K, 2013, APPL NEUROPSYCH-ADUL, V20, P47, DOI 10.1080/09084282.2012.670155; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Korotkevich Y, 2015, EXP BRAIN RES, V233, P937, DOI 10.1007/s00221-014-4169-5; Kosowicz M, 2017, APPL NEUROPSYCH-ADUL, V24, P252, DOI 10.1080/23279095.2015.1136310; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kramer AF, 1999, PSYCHOL AGING, V14, P135, DOI 10.1037/0882-7974.14.1.135; Krampe RT, 2005, J EXP PSYCHOL HUMAN, V31, P379, DOI 10.1037/0096-1523.31.3.379; Krawietz SA, 2012, PSYCHOL AGING, V27, P951, DOI 10.1037/a0028831; Kray J, 2004, ACTA PSYCHOL, V115, P143, DOI 10.1016/j.actpsy.2003.12.001; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Kray J, 2002, BRAIN COGNITION, V49, P363, DOI 10.1006/brcg.2001.1505; Kray J, 2006, ACTA PSYCHOL, V123, P187, DOI 10.1016/j.actpsy.2005.12.009; Kray J, 2015, DEV PSYCHOL, V51, P378, DOI 10.1037/a0038795; Kray J, 2009, ACTA PSYCHOL, V130, P48, DOI 10.1016/j.actpsy.2008.10.006; Krendl AC, 2009, PSYCHOL AGING, V24, P530, DOI 10.1037/a0016065; Kudiaki C, 2008, APPL NEUROPSYCHOL, V15, P194, DOI 10.1080/09084280802324416; Kuhlman A, 2006, J CLIN EXP NEUROPSYC, V28, P126, DOI 10.1080/13803390590929289; Kunimi M, 2016, NEUROSCI RES, V103, P18, DOI 10.1016/j.neures.2015.06.011; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Langley LK, 2011, ATTEN PERCEPT PSYCHO, V73, P1546, DOI 10.3758/s13414-011-0108-8; Langley LK, 2005, PSYCHOL AGING, V20, P356, DOI 10.1037/0882-7974.20.2.356; Langley LK, 1998, NEUROPSYCHOLOGY, V12, P353, DOI 10.1037/0894-4105.12.3.353; Larson MJ, 2016, BIOL PSYCHOL, V115, P50, DOI 10.1016/j.biopsycho.2016.01.008; Lawo V, 2014, J GERONTOL B-PSYCHOL, V69, P237, DOI 10.1093/geronb/gbs107; Lemaire P, 2014, EXP PSYCHOL, V61, P253, DOI 10.1027/1618-3169/a000244; Li KZH, 2008, ACTA PSYCHOL, V127, P416, DOI 10.1016/j.actpsy.2007.08.006; Little CE, 2014, EXP BRAIN RES, V232, P2049, DOI 10.1007/s00221-014-3894-0; Little DM, 2000, PSYCHOL AGING, V15, P9, DOI 10.1037//0882-7974.15.1.9; Loosli SV, 2014, DEV PSYCHOL, V50, P1060, DOI 10.1037/a0035231; Lucenet J, 2014, DEV PSYCHOL, V50, P1620, DOI 10.1037/a0035867; Ludwig C, 2010, ARCH GERONTOL GERIAT, V51, P135, DOI 10.1016/j.archger.2009.09.040; Lustig C, 2001, J EXP PSYCHOL GEN, V130, P199, DOI 10.1037//0096-3445.130.2.199; Lyons AD, 2014, PSYCHOL AGING, V29, P873, DOI 10.1037/a0038130; Madden DJ, 2007, Q J EXP PSYCHOL, V60, P644, DOI 10.1080/17470210601154347; Madden DJ, 2010, NEUROIMAGE, V52, P643, DOI 10.1016/j.neuroimage.2010.04.249; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Male SJ, 2009, AGING NEUROPSYCHOL C, V16, P589, DOI 10.1080/13825580902871026; Manard M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-7; Marshall AC, 2016, BIOL PSYCHOL, V113, P1, DOI 10.1016/j.biopsycho.2015.10.008; Martinelli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082385; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mattli F, 2014, AGING NEUROPSYCHOL C, V21, P515, DOI 10.1080/13825585.2013.837860; Maury P, 2010, EXP AGING RES, V36, P371, DOI 10.1080/0361073X.2010.511962; Maxfield M, 2012, PSYCHOL AGING, V27, P256, DOI 10.1037/a0023902; May CP, 1999, MEM COGNITION, V27, P759, DOI 10.3758/BF03198529; Maylor EA, 1998, PSYCHOL AGING, V13, P563, DOI 10.1037/0882-7974.13.4.563; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Mayr U, 2000, PSYCHOL AGING, V15, P29, DOI 10.1037//0882-7974.15.1.29; Mazaheri M, 2014, GAIT POSTURE, V40, P182, DOI 10.1016/j.gaitpost.2014.03.183; McAlister C, 2013, AGING NEUROPSYCHOL C, V20, P735, DOI 10.1080/13825585.2013.781990; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McCabe DP, 2005, J CLIN EXP NEUROPSYC, V27, P633, DOI 10.1080/13803390490919218; MCDOWD JM, 1995, PSYCHOL AGING, V10, P34, DOI 10.1037/0882-7974.10.1.34; McDowd J, 2011, NEUROPSYCHOLOGY, V25, P210, DOI 10.1037/a0021531; McLaughlin PM, 2010, CAN J EXP PSYCHOL, V64, P197, DOI 10.1037/a0020650; McVay JC, 2013, ACTA PSYCHOL, V142, P136, DOI 10.1016/j.actpsy.2012.11.006; Mell T, 2005, NEUROPSYCHOLOGIA, V43, P554, DOI 10.1016/j.neuropsychologia.2004.07.010; Mendelson DN, 2010, AGING NEUROPSYCHOL C, V17, P1, DOI 10.1080/13825580902914040; Mewborn C, 2015, ARCH CLIN NEUROPSYCH, V30, P605, DOI 10.1093/arclin/acv054; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mioni G, 2014, MEMORY, V22, P536, DOI 10.1080/09658211.2013.801987; Mioni G, 2012, STUD HEALTH TECHNOL, V181, P118, DOI 10.3233/978-1-61499-121-2-118; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moffat SD, 2007, CEREB CORTEX, V17, P1274, DOI 10.1093/cercor/bhl036; Monti JM, 2010, NEUROPSYCHOLOGIA, V48, P1697, DOI 10.1016/j.neuropsychologia.2010.02.017; Morrone I, 2010, PSYCHOL AGING, V25, P697, DOI 10.1037/a0019578; Morrow DG, 1997, J GERONTOL B-PSYCHOL, V52, pP73, DOI 10.1093/geronb/52B.2.P73; Muller LD, 2014, NEUROPSYCHOLOGIA, V56, P271, DOI 10.1016/j.neuropsychologia.2014.01.019; Mund I, 2010, PSYCHOL AGING, V25, P886, DOI 10.1037/a0019508; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; Newson RS, 2008, PSYCHOL HEALTH, V23, P369, DOI 10.1080/08870440701421545; Newson RS, 2006, J CLIN EXP NEUROPSYC, V28, P949, DOI 10.1080/13803390591004356; Nielson KA, 2004, NEUROREPORT, V15, P129, DOI 10.1097/00001756-200401190-00025; Niermeyer MA, 2017, CLIN NEUROPSYCHOL, V31, P598, DOI 10.1080/13854046.2016.1257071; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Norman JF, 2007, PSYCHOL AGING, V22, P625, DOI 10.1037/0882-7974.22.3.625; Carvalho JCN, 2012, SPAN J PSYCHOL, V15, P480, DOI 10.5209/rev_SJOP.2012.v15.n2.38858; Nugent S, 2014, AM J PHYSIOL-ENDOC M, V306, pE1315, DOI 10.1152/ajpendo.00067.2014; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; O'Connor PJ, 2015, J INT NEUROPSYCH SOC, V21, P802, DOI 10.1017/S1355617715000685; Oberauer K, 2005, J EXP PSYCHOL LEARN, V31, P714, DOI 10.1037/0278-7393.31.4.714; Oberauer K, 2001, J EXP PSYCHOL LEARN, V27, P948, DOI 10.1037/0278-7393.27.4.948; Oh-Park M, 2013, AGING CLIN EXP RES, V25, P99, DOI 10.1007/s40520-013-0014-0; Olk B, 2011, EXP BRAIN RES, V208, P139, DOI 10.1007/s00221-010-2466-1; Onor M, 2010, J NERV MENT DIS, V198, P891, DOI 10.1097/NMD.0b013e3181fe743e; Ostrosky-Solis F, 2007, APPL NEUROPSYCHOL, V14, P156, DOI 10.1080/09084280701508655; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Packwood S, 2011, J CLIN EXP NEUROPSYC, V33, P456, DOI 10.1080/13803395.2010.533157; Pala PA, 2014, DISABIL REHABIL-ASSI, V9, P463, DOI 10.3109/17483107.2014.941952; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Perez-Perez A, 2016, ARCH CLIN NEUROPSYCH, V31, P411, DOI 10.1093/arclin/acw027; PERFECT TJ, 1994, J GERONTOL, V49, pP60, DOI 10.1093/geronj/49.2.P60; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Perrot A, 2007, PERCEPT MOTOR SKILL, V104, P91, DOI 10.2466/PMS.104.1.91-101; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pesce C, 2011, J SPORT EXERCISE PSY, V33, P609, DOI 10.1123/jsep.33.5.609; Pettigrew C, 2016, Q J EXP PSYCHOL, V69, P2431, DOI 10.1080/17470218.2015.1121282; Pettigrew C, 2014, PSYCHOL AGING, V29, P187, DOI 10.1037/a0036085; Phillips LH, 2002, EMOTION, V2, P263, DOI 10.1037/1528-3542.2.3.263; Phillips LH, 2011, COGNITION, V120, P236, DOI 10.1016/j.cognition.2011.05.003; Phillips NA, 2003, PSYCHOL AGING, V18, P126, DOI 10.1037/0882-7974.18.1.126; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Plummer-D'Amato P, 2011, GAIT POSTURE, V33, P233, DOI 10.1016/j.gaitpost.2010.11.011; Popham LE, 2015, J GERONTOL B-PSYCHOL, V70, P223, DOI 10.1093/geronb/gbt093; Porto FHG, 2016, NEUROIMAGE, V130, P115, DOI 10.1016/j.neuroimage.2016.01.035; Prakash RS, 2015, PSYCHOL AGING, V30, P160, DOI 10.1037/a0038544; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Quigley C, 2012, BRAIN RES, V1469, P24, DOI 10.1016/j.brainres.2012.06.019; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1016/j.dendro.2009.12.001, DOI 10.1016/J.DENDRO.2009.12.001]; Radvansky GA, 2005, J GERONTOL B-PSYCHOL, V60, pP276, DOI 10.1093/geronb/60.5.P276; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; Ravizza SM, 2002, J COGNITIVE NEUROSCI, V14, P472, DOI 10.1162/089892902317361985; Raye CL, 2008, J COGNITIVE NEUROSCI, V20, P852, DOI 10.1162/jocn.2008.20508; Ready RE, 2016, EXP AGING RES, V42, P264, DOI 10.1080/0361073X.2016.1156971; Rey-Mermet A, 2018, J EXP PSYCHOL LEARN, V44, P501, DOI 10.1037/xlm0000450; Rey-Mermet A, 2018, PSYCHON B REV, V25, P1695, DOI 10.3758/s13423-017-1384-7; Rey-Mermet A, 2015, AGING NEUROPSYCHOL C, V22, P72, DOI 10.1080/13825585.2014.889070; Rhodes MG, 2004, PSYCHOL AGING, V19, P482, DOI 10.1037/0882-7974.19.3.482; Rizio AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087010; Robert C, 2007, J GERONTOL B-PSYCHOL, V62, pP340, DOI 10.1093/geronb/62.6.P340; Robert C, 2009, MEM COGNITION, V37, P336, DOI 10.3758/MC.37.3.336; Rodriguez-Aranda C, 2011, J INT NEUROPSYCH SOC, V17, P807, DOI 10.1017/S1355617711000828; Rodriguez-Villagra OA, 2013, DEV PSYCHOL, V49, P1683, DOI 10.1037/a0030883; Rohatgi A, 2017, WEBPLOTDIGITIZER; Roos A, 2010, COMPR PSYCHIAT, V51, P207, DOI 10.1016/j.comppsych.2009.03.007; Ros L, 2010, AGING NEUROPSYCHOL C, V17, P89, DOI 10.1080/13825580903042650; Rose NS, 2009, AGING NEUROPSYCHOL C, V16, P633, DOI 10.1080/13825580902825238; Rossit S, 2008, EXP BRAIN RES, V185, P1, DOI 10.1007/s00221-007-1126-6; Rowe G, 2008, PSYCHOL AGING, V23, P79, DOI 10.1037/0882-7974.23.1.79; Rufener KS, 2014, BRAIN BEHAV, V4, P21, DOI 10.1002/brb3.188; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; Ryan JD, 2006, BRIT J PSYCHOL, V97, P339, DOI 10.1348/000712605X74837; Salami A, 2014, NEUROIMAGE, V86, P150, DOI 10.1016/j.neuroimage.2013.08.002; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; SALTHOUSE TA, 1992, ACTA PSYCHOL, V79, P155, DOI 10.1016/0001-6918(92)90030-H; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2007, BRAIN COGNITION, V63, P279, DOI 10.1016/j.bandc.2006.09.006; Salthouse TA, 2010, BRAIN COGNITION, V73, P51, DOI 10.1016/j.bandc.2010.02.003; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samanez-Larkin GR, 2009, PSYCHOL AGING, V24, P519, DOI 10.1037/a0016952; Sambataro F, 2015, EUR J NEUROSCI, V42, P1912, DOI 10.1111/ejn.12956; Sandberg P, 2016, NEUROPSYCHOL REHABIL, V26, P761, DOI 10.1080/09602011.2015.1108205; Sandberg P, 2014, AGING NEUROPSYCHOL C, V21, P577, DOI 10.1080/13825585.2013.839777; Sanders C, 2012, J CLIN EXP NEUROPSYC, V34, P724, DOI 10.1080/13803395.2012.670210; Sanhueza C, 2011, PSICOTHEMA, V23, P209; Santorelli GD, 2015, CLIN NEUROPSYCHOL, V29, P938, DOI 10.1080/13854046.2015.1123296; Sasse LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104180; Sauzeon H, 2016, J NEUROPSYCHOL, V10, P33, DOI 10.1111/jnp.12055; Sauzeon H, 2016, BRIT J PSYCHOL, V107, P72, DOI 10.1111/bjop.12123; Schlader ZJ, 2015, AM J PHYSIOL-REG I, V308, pR847, DOI 10.1152/ajpregu.00010.2015; Schlaghecken F, 2005, J GERONTOL B-PSYCHOL, V60, pP158, DOI 10.1093/geronb/60.3.P158; Schlaghecken F, 2011, PSYCHOL AGING, V26, P905, DOI 10.1037/a0023832; Schmitt H, 2015, COGN AFFECT BEHAV NE, V15, P416, DOI 10.3758/s13415-015-0335-x; Schmitter-Edgecombe M, 2014, NEUROPSYCHOLOGY, V28, P881, DOI 10.1037/neu0000109; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Schooler C, 1997, PSYCHOL AGING, V12, P667, DOI 10.1037/0882-7974.12.4.667; Schubert CR, 2013, J CLIN EXP NEUROPSYC, V35, P669, DOI 10.1080/13803395.2013.809701; Shanmugaratnam S, 2010, ACCIDENT ANAL PREV, V42, P802, DOI 10.1016/j.aap.2009.10.002; Silva AR, 2013, AM J PREV MED, V44, P302, DOI 10.1016/j.amepre.2012.11.005; Vigliecca NS, 2015, PSYCHOGERIATRICS, V15, P163, DOI 10.1111/psyg.12104; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Smith RE, 2014, AGING NEUROPSYCHOL C, V21, P411, DOI 10.1080/13825585.2013.827150; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Sommers MS, 1999, PSYCHOL AGING, V14, P458, DOI 10.1037/0882-7974.14.3.458; Souchay C, 2004, BRAIN COGNITION, V56, P89, DOI 10.1016/j.bandc.2004.06.002; Souchay C, 2002, NEUROPSYCHOLOGIA, V40, P2386, DOI 10.1016/S0028-3932(02)00075-1; Spieler DH, 2006, PSYCHON B REV, V13, P787, DOI 10.3758/BF03193998; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Srygley JM, 2009, BRAIN RES, V1253, P92, DOI 10.1016/j.brainres.2008.11.067; Staub B, 2014, ACTA PSYCHOL, V146, P51, DOI 10.1016/j.actpsy.2013.12.003; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stolwyk R, 2015, J CLIN EXP NEUROPSYC, V37, P70, DOI 10.1080/13803395.2014.988125; SULLIVAN MP, 1993, PSYCHOL AGING, V8, P589, DOI 10.1037/0882-7974.8.4.589; Sweeney JA, 2001, NEUROBIOL AGING, V22, P39, DOI 10.1016/S0197-4580(00)00175-5; Tays WJ, 2011, BRAIN RES, V1393, P62, DOI 10.1016/j.brainres.2011.04.006; Telonio A, 2014, EXP GERONTOL, V50, P26, DOI 10.1016/j.exger.2013.11.007; Terry CP, 2012, EXP AGING RES, V38, P87, DOI 10.1080/0361073X.2012.637008; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Thompson L, 2007, EXP AGING RES, V33, P373, DOI 10.1080/03610730701525303; Thurm F, 2013, J ALZHEIMERS DIS, V35, P575, DOI 10.3233/JAD-121348; Tomaszczyk JC, 2013, EXP AGING RES, V39, P254, DOI 10.1080/0361073X.2013.779178; Tomaszczyk JC, 2012, AGING NEUROPSYCHOL C, V19, P699, DOI 10.1080/13825585.2011.646940; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; Trewartha KM, 2013, PSYCHOL AGING, V28, P701, DOI 10.1037/a0033843; Trewartha KM, 2011, J GERONTOL B-PSYCHOL, V66, P185, DOI 10.1093/geronb/gbq090; Trewartha KM, 2009, PSYCHOL AGING, V24, P450, DOI 10.1037/a0015498; Troche SJ, 2008, AGING NEUROPSYCHOL C, V15, P281, DOI 10.1080/13825580701336874; Tse CS, 2010, NEUROPSYCHOLOGY, V24, P300, DOI 10.1037/a0018274; Tsuchida N, 2013, J MOTOR BEHAV, V45, P343, DOI 10.1080/00222895.2013.806107; Uekermann J, 2006, J INT NEUROPSYCH SOC, V12, P184, DOI 10.1017/S1355617706060280; Uekermann J, 2008, BRAIN COGNITION, V67, P51, DOI 10.1016/j.bandc.2007.11.003; Uittenhove K, 2015, MEMORY, V23, P806, DOI 10.1080/09658211.2014.928730; Valentine J.C., 2019, HDB RES SYNTHESIS ME; Vallesi A, 2010, PSYCHOL AGING, V25, P963, DOI 10.1037/a0020300; Van den Noortgate W, 2013, BEHAV RES METHODS, V45, P576, DOI 10.3758/s13428-012-0261-6; VANDERLINDEN M, 1994, BRIT J PSYCHOL, V85, P145; Vandermorris S, 2013, J INT NEUROPSYCH SOC, V19, P1087, DOI 10.1017/S1355617713000982; Vannorsdall TD, 2012, NEUROPSYCHOLOGY, V26, P400, DOI 10.1037/a0027989; Vasquez BP, 2018, J INT NEUROPSYCH SOC, V24, P456, DOI 10.1017/S1355617717001266; Vasquez BP, 2016, J GERONTOL B-PSYCHOL, V71, P189, DOI 10.1093/geronb/gbu140; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Verhaeghen P, 1998, PSYCHOL AGING, V13, P435, DOI 10.1037/0882-7974.13.3.435; Verhaeghen P, 1998, PSYCHOL AGING, V13, P120, DOI 10.1037/0882-7974.13.1.120; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; Verhaeghen P, 2011, CURR DIR PSYCHOL SCI, V20, P174, DOI 10.1177/0963721411408772; Verhaeghen P, 2007, AGING NEUROPSYCHOL C, V14, P22, DOI 10.1080/138255890969357; Verrel J, 2016, GAIT POSTURE, V44, P143, DOI 10.1016/j.gaitpost.2015.12.002; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Viskontas IV, 2004, PSYCHOL AGING, V19, P581, DOI 10.1037/0882-7974.19.4.581; Vlahou EL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05101; von Hippel W, 2005, PSYCHOL AGING, V20, P519, DOI 10.1037/0882-7974.20.3.519; Wan XA, 2011, AGING NEUROPSYCHOL C, V18, P562, DOI 10.1080/13825585.2011.591771; Wang JR, 2013, CLIN NEUROPHYSIOL, V124, P2406, DOI 10.1016/j.clinph.2013.05.020; Wang Y, 2017, EXP AGING RES, V43, P124, DOI 10.1080/0361073X.2017.1276375; Wang ZW, 2013, PSYCHOL AGING, V28, P284, DOI 10.1037/a0030876; Wasylyshyn C, 2011, PSYCHOL AGING, V26, P15, DOI 10.1037/a0020912; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Wegesin DJ, 2007, AGING NEUROPSYCHOL C, V14, P301, DOI 10.1080/13825580600802893; Weissberger GH, 2012, PSYCHOL AGING, V27, P959, DOI 10.1037/a0028281; Wesnes KA, 2016, J PSYCHOPHARMACOL, V30, P263, DOI 10.1177/0269881115625116; West R, 1998, PSYCHOL AGING, V13, P206, DOI 10.1037/0882-7974.13.2.206; West R, 2005, CORTEX, V41, P570, DOI 10.1016/S0010-9452(08)70197-7; West R, 2000, PSYCHOPHYSIOLOGY, V37, P179, DOI 10.1111/1469-8986.3720179; West R, 2008, BRAIN COGNITION, V68, P67, DOI 10.1016/j.bandc.2008.03.001; West R, 2006, NEUROPSYCHOLOGY, V20, P468, DOI 10.1037/0894-4105.20.4.468; West R, 2010, CORTEX, V46, P550, DOI 10.1016/j.cortex.2009.08.001; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Whitson LR, 2012, ACTA PSYCHOL, V139, P124, DOI 10.1016/j.actpsy.2011.09.004; Wiegand I, 2013, NEUROBIOL AGING, V34, P973, DOI 10.1016/j.neurobiolaging.2012.08.002; Wierenga CE, 2013, J ALZHEIMERS DIS, V34, P921, DOI 10.3233/JAD-121897; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Wood G, 2009, CEREB CORTEX, V19, P2755, DOI 10.1093/cercor/bhp056; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523; Yi YJ, 2014, AGING NEUROPSYCHOL C, V21, P483, DOI 10.1080/13825585.2013.833581; Young LA, 2010, J CLIN ENDOCR METAB, V95, P280, DOI 10.1210/jc.2009-1346; Young-Bernier M, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-17; Zamarian L, 2008, NEUROPSYCHOLOGY, V22, P645, DOI 10.1037/0894-4105.22.5.645; Ze O, 2014, AGING MENT HEALTH, V18, P929, DOI 10.1080/13607863.2014.899973; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; Zeintl M, 2007, EXP AGING RES, V33, P163, DOI 10.1080/03610730701192815; Zeintl M, 2010, GERONTOLOGY, V56, P421, DOI 10.1159/000237875; Zellner M, 2006, J EXP PSYCHOL LEARN, V32, P290, DOI 10.1037/0278-7393.32.3.290; Zhang X, 2010, PSYCHOL AGING, V25, P310, DOI 10.1037/a0019078; Zhou SS, 2011, BRAIN COGNITION, V75, P205, DOI 10.1016/j.bandc.2010.12.003; Zhou S, 2015, J PAIN, V16, P862, DOI 10.1016/j.jpain.2015.05.012; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087; Zhu Z, 2015, CEREB CORTEX, V25, P138, DOI 10.1093/cercor/bht212; Ziaei M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137604; Zihl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084590	459	11	12	2	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5014	1758-5368		J GERONTOL B-PSYCHOL	J. Gerontol. Ser. B-Psychol. Sci. Soc. Sci.	JUL	2020	75	6					E31	E55		10.1093/geronb/gbaa005			25	Geriatrics & Gerontology; Gerontology; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychology	MA7HA	WOS:000542082400002	31943092	Bronze, Green Submitted			2022-02-06	
J	Qu, WR; Liu, NK; Wu, XB; Wang, Y; Xia, YZ; Sun, Y; Lai, ON; Li, R; Shekhar, A; Xu, XM				Qu, Wenrui; Liu, Nai-Kui; Wu, Xiangbing; Wang, Ying; Xia, Yongzhi; Sun, Yan; Lai, Yvonne; Li, Rui; Shekhar, Anantha; Xu, Xiao-Ming			Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury	CEREBRAL CORTEX			English	Article						apoptosis; neuroprotection; N-methyl-D-aspartate receptors; nNOS; PSD95; traumatic brain injury	NITRIC-OXIDE SYNTHASE; CELL-DEATH MECHANISMS; CEREBRAL-ISCHEMIA; ANNEXIN-II; DAMAGE; ACTIVATION; NEURONS; TARGETS; PROTEIN; NNOS	Excessive activation of N-methyl-D-aspartate receptors (NMDARs) and the resulting neuronal nitric oxide synthase (nNOS) activation plays a crucial role in the pathogenesis of traumatic brain injury (TBI). However, directly inhibiting NMDARs or nNOS produces adverse side effects because they play key physiological roles in the normal brain. Since interaction of nNOS-PSD95 is a key step in NMDAR-mediated excitotoxicity, we investigated whether disrupting nNOS-PSD95 interaction with ZL006, an inhibitor of nNOS-PSD95 interaction, attenuates NMDAR-mediated excitotoxicity. In cortical neuronal cultures, ZL006 treatment significantly reduced glutamate-induced neuronal death. In a mouse model of controlled cortical impact (CCI), administration of ZL006 (10 mg/kg, i.p.) at 30 min postinjury significantly inhibited nNOS-PSD95 interaction, reduced TUNEL- and phospho-p38-positive neurons in the motor cortex. ZL006 treatment also significantly reduced CCI-induced cortical expression of apoptotic markers active caspase-3, PARP-1, ratio of Bcl-2/Bax, and phosphorylated p38 MAPK (p-p38). Functionally, ZL006 treatment significantly improved neuroscores and sensorimotor performance, reduced somatosensory and motor deficits, reversed CCI-induced memory deficits, and attenuated cognitive impairment. Histologically, ZL006 treatment significantly reduced the brain lesion volume. These findings collectively suggest that blocking nNOS-PSD95 interaction represents an attractive strategy for ameliorating consequences of TBI and that its action is mediated via inhibiting neuronal apoptosis and p38 MAPK signaling.	[Qu, Wenrui; Liu, Nai-Kui; Wu, Xiangbing; Wang, Ying; Xia, Yongzhi; Sun, Yan; Xu, Xiao-Ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Neurol Surg, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Qu, Wenrui; Li, Rui] Second Hosp Jilin Univ, Dept Hand Surg, Changchun 130041, Jilin, Peoples R China; [Lai, Yvonne] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Shekhar, Anantha] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Xu, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 320 West 15th St,NB Room 500E, Indianapolis, IN 46202 USA.	xu26@iupui.edu		Qu, Wenrui/0000-0002-0178-3698	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 NS100531, 1R01 NS103481]; Merit Review Award from the U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01 BX002356, I01 BX003705]; Indiana Spinal Cord and Brain Injury Research Foundation [19919]; Mari Hulman George Endowment Funds; ISDH [A70-2-079609, A70-9-079138];  [R21 MH104018]	NIH 1R01 NS100531, 1R01 NS103481, Merit Review Award I01 BX002356, I01 BX003705 from the U.S. Department of Veterans Affairs; Indiana Spinal Cord and Brain Injury Research Foundation (No. 19919); Mari Hulman George Endowment Funds (to X.M.X.); ISDH (Grant#A70-2-079609 and A70-9-079138 to N.K.L.); R21 MH104018 (to A.S.).	Cai J, 2011, NEURAL REGEN RES, V6, P96, DOI 10.3969/j.issn.1673-5374.2011.02.003; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Chizh BA, 2005, CURR PHARM DESIGN, V11, P2977, DOI 10.2174/1381612054865082; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Dawson VL, 1996, J NEUROSCI, V16, P2479; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Han S, 2004, ACTA PHARMACOL SIN, V25, P602; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lee WH, 2015, NEUROPHARMACOLOGY, V97, P464, DOI 10.1016/j.neuropharm.2015.05.038; Li LP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0208-5; Liu N, 2004, J NEUROSCI RES, V77, P391, DOI 10.1002/jnr.20167; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Liu SG, 2017, NEUROCHEM INT, V108, P230, DOI 10.1016/j.neuint.2017.04.005; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo CX, 2014, J NEUROSCI, V34, P13535, DOI 10.1523/JNEUROSCI.1305-14.2014; Maccallini C, 2016, NEURAL REGEN RES, V11, P1731, DOI 10.4103/1673-5374.194707; Martos YV, 2017, J NEUROSCI, V37, P2849, DOI 10.1523/JNEUROSCI.3460-16.2017; McIntosh TK, 1996, LAB INVEST, V74, P315; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Palluy O, 1996, NEUROSCI LETT, V208, P1, DOI 10.1016/0304-3940(96)12532-5; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Regasa LE, 2018, J HEAD TRAUMA REHABI; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P288; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; THOR DH, 1986, PHYSIOL BEHAV, V36, P707, DOI 10.1016/0031-9384(86)90358-6; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Wu QJ, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0357-8; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	43	11	12	7	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUL	2020	30	7					3859	3871		10.1093/cercor/bhaa002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NV4LX	WOS:000574296400001	31989159	Bronze, Green Published			2022-02-06	
J	Robba, C; Pozzebon, S; Moro, B; Vincent, JL; Creteur, J; Taccone, FS				Robba, Chiara; Pozzebon, Selene; Moro, Bedrana; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio			Multimodal non-invasive assessment of intracranial hypertension: an observational study	CRITICAL CARE			English	Article						Neuro-ICU; Non-invasive intracranial pressure; Brain injury; Pupillometer; Optic nerve sheath diameter	CEREBRAL PERFUSION-PRESSURE; TRANSCRANIAL DOPPLER; PULSATILITY INDEX; HEAD-INJURY; ULTRASONOGRAPHY; ICP; POSITION; IMPACT	Background Although placement of an intra-cerebral catheter remains the gold standard method for measuring intracranial pressure (ICP), several non-invasive techniques can provide useful estimates. The aim of this study was to compare the accuracy of four non-invasive methods to assess intracranial hypertension. Methods We reviewed prospectively collected data on adult intensive care unit (ICU) patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), or intracerebral hemorrhage (ICH) in whom invasive ICP monitoring had been initiated and estimates had been simultaneously collected from the following non-invasive indices: optic nerve sheath diameter (ONSD), pulsatility index (PI), estimated ICP (eICP) using transcranial Doppler, and the neurological pupil index (NPI) measured using automated pupillometry. Intracranial hypertension was defined as an invasively measured ICP > 20 mmHg. Results We studied 100 patients (TBI = 30; SAH = 47; ICH = 23) with a median age of 52 years. The median invasively measured ICP was 17 [12-25] mmHg and intracranial hypertension was present in 37 patients. Median values from the non-invasive techniques were ONSD 5.2 [4.8-5.8] mm, PI 1.1 [0.9-1.4], eICP 21 [14-29] mmHg, and NPI 4.2 [3.8-4.6]. There was a significant correlation between all the non-invasive techniques and invasive ICP (ONSD,r = 0.54; PI,r = 0.50; eICP,r = 0.61; NPI,r = - 0.41-p < 0.001 for all). The area under the curve (AUC) to estimate intracranial hypertension was 0.78 [CIs = 0.68-0.88] for ONSD, 0.85 [95% CIs 0.77-0.93] for PI, 0.86 [95% CIs 0.77-0.93] for eICP, and 0.71 [95% CIs 0.60-0.82] for NPI. When the various techniques were combined, the highest AUC (0.91 [0.84-0.97]) was obtained with the combination of ONSD with eICP. Conclusions Non-invasive techniques are correlated with ICP and have an acceptable accuracy to estimate intracranial hypertension. The multimodal combination of ONSD and eICP may increase the accuracy to estimate the occurrence of intracranial hypertension.	[Robba, Chiara] Univ Genoa, Dept Integrated Surg & Diagnost Sci, IRCCS Oncol & Neurosci, Policlin San Martino, Genoa, Italy; [Robba, Chiara] Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Pozzebon, Selene; Moro, Bedrana; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care Med, Route Lennik 808, B-1070 Brussels, Belgium		Taccone, FS (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care Med, Route Lennik 808, B-1070 Brussels, Belgium.	ftaccone@ulb.ac.be					Abdo A, 2015, TRANSPL P, V47, P2647, DOI 10.1016/j.transproceed.2015.10.006; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Cardim D, 2020, J NEUROSURG ANESTH, V32, P349, DOI 10.1097/ANA.0000000000000622; Cardim D, 2019, RESUSCITATION, V137, P221, DOI 10.1016/j.resuscitation.2019.01.002; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Fernando SM, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4225; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Robba C, 2019, INTENS CARE MED, V45, P913, DOI 10.1007/s00134-019-05610-4; Robba C, 2020, J NEUROSURG, V132, P1279, DOI 10.3171/2018.11.JNS182077; Robba C, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0895-6; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sekhon MS, 2015, INTENS CARE MED, V41, P177, DOI 10.1007/s00134-014-3560-9; Stocchetti N, 2017, CURR OPIN CRIT CARE, V23, P110, DOI 10.1097/MCC.0000000000000393; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205	43	11	12	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUN 26	2020	24	1							379	10.1186/s13054-020-03105-z			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG3IY	WOS:000545929000001	32591024	gold, Green Published			2022-02-06	
J	Lace, JW; Grant, AF; Kosky, KM; Teague, CL; Lowell, KT; Gfeller, JD				Lace, John W.; Grant, Alexandra F.; Kosky, Karen M.; Teague, Carson L.; Lowell, Kimberly T.; Gfeller, Jeffrey D.			Identifying Novel Embedded Performance Validity Test Formulas Within the Repeatable Battery for the Assessment of Neuropsychological Status: a Simulation Study	PSYCHOLOGICAL INJURY & LAW			English	Article						Performance validity; Embedded validity test; RBANS; Mild traumatic brain injury; Simulation study	COMPLEX FIGURE TEST; TRAUMATIC BRAIN-INJURY; ADULT INTELLIGENCE SCALE; RECOGNITION MEMORY TEST; RELIABLE DIGIT SPAN; RAW SCORE CUTOFFS; STATUS RBANS; CLASSIFICATION ACCURACY; MALINGERING DETECTION; INVALID PERFORMANCE	While literature on performance validity tests (PVTs) in neuropsychological assessment has examined memory-based paradigms, other research has suggested that tests of attention, visuospatial ability, and language may also detect noncredible performance. Previous work has identified several PVTs in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), though all of them emphasize memory-based subtests. This study sought to determine if PVT formulas can be derived from exclusively non-memory RBANS subtests (i.e., Figure Copy, Line Orientation, Picture Naming, Semantic Fluency, Digit Span, and Coding) using an analog simulation study. Seventy-two undergraduate participants (Mage = 18.9) were assigned to either an asymptomatic (AS) group, which was instructed to perform optimally, or a simulated mild traumatic brain injury (S-mTBI) group, which received symptom and test coaching to help simulate mTBI-related impairment. Participants were administered a battery of neuropsychological tests, including the RBANS and standalone PVTs. Differences were found between groups for all RBANS subtests of interest except Picture Naming. Five subtests showing meaningful group differences were entered as predictor variables as one set in logistic regressions (LR); raw and norm-based scores were considered separately. Both LRs accurately classified 90.3% of cases with good sensitivity (.89) while maintaining ideal specificity (.92). Two exponentiated equations were described from LR results, with both yielding good discriminability (AUCs = .94), generally comparable with other PVTs. These findings suggested that non-memory RBANS subtests may be sensitive to noncredible performance and reiterate the importance of considering tests of various cognitive abilities when assessing performance validity during neuropsychological assessment. Limitations of this study and directions for future inquiry, including necessity for validation in a clinical sample, were discussed.	[Lace, John W.; Grant, Alexandra F.; Teague, Carson L.; Lowell, Kimberly T.; Gfeller, Jeffrey D.] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA; [Lace, John W.; Kosky, Karen M.] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA		Lace, JW (corresponding author), St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA.; Lace, JW (corresponding author), Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA.	john.lace@slu.edu; alex.grant@slu.edu; eashk@health.missouri.edu; carson.teague@slu.edu; kimberly.lowell@slu.edu; jeffrey.gfeller@health.slu.edu					Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bain KM, 2019, ASSESSMENT, V26, P1320, DOI 10.1177/1073191117725172; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; Boone KB, 2007, ASSESSMENT SIMULATED; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bouman Z, 2016, J CLIN EXP NEUROPSYC, V38, P455, DOI 10.1080/13803395.2015.1123226; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Cool D, 2016, THESIS; Dandachi-FitzGerald B, 2013, J EXP PSYCHOPATHOL, V4, P46, DOI 10.5127/jep.025511; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Emmert N, 2018, APPL NEUROPSYCH-ADUL, V25, P38, DOI 10.1080/23279095.2016.1238827; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gfeller JD, 1998, J CLIN PSYCHOL, V54, P431, DOI 10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goette WF, 2019, CLIN NEUROPSYCHOL, V33, P1044, DOI 10.1080/13854046.2018.1538429; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Iverson G L, 2001, Appl Neuropsychol, V8, P167, DOI 10.1207/S15324826AN0803_6; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Lace JW, 2021, CLIN NEUROPSYCHOL, V35, P572, DOI 10.1080/13854046.2019.1694703; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lenhard W, 2016, COMPUTATION EFFECT S; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Olsen DH, 2019, CLIN NEUROPSYCHOL, V33, P732, DOI 10.1080/13854046.2018.1501096; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Parks AC, 2017, APPL NEUROPSYCH-ADUL, V24, P429, DOI 10.1080/23279095.2016.1189426; Paulson D, 2015, ARCH CLIN NEUROPSYCH, V30, P207, DOI 10.1093/arclin/acv009; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Pearson, 2009, ADV CLIN SOL WORD CH; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Randolph C., 2012, REPEATABLE BATTERY A; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Riordan P, 2020, APPL NEUROPSYCH-ADUL, V27, P82, DOI 10.1080/23279095.2018.1485678; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Salthouse TA, 2019, PSYCHOL AGING, V34, P17, DOI 10.1037/pag0000288; Schmitt AL, 2010, APPL NEUROPSYCHOL, V17, P8, DOI 10.1080/09084280903297719; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Schwarz LR, 2006, CLIN NEUROPSYCHOL, V20, P741, DOI 10.1080/13854040590967054; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Shura RD, 2018, NEUROPSYCHOL REV, V28, P269, DOI 10.1007/s11065-018-9377-5; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Sieck BC, 2013, ARCH CLIN NEUROPSYCH, V28, P135, DOI 10.1093/arclin/acs109; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Smith A., 1982, SYMBOL DIGIT MODALIT; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Tabachnick B.G., 2013, USING MULTIVARIATE S; Victor T.L., 2013, MILD TRAUMATIC BRAIN; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2019, APPL NEUROPSYCH-ADUL, V26, P472, DOI 10.1080/23279095.2018.1443935; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Williams KD, 2020, APPL NEUROPSYCH-ADUL, V27, P181, DOI 10.1080/23279095.2018.1517768; Woods DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166439; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	103	11	11	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	SEP	2020	13	3					303	315		10.1007/s12207-020-09382-x		JUN 2020	13	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	NH9OT	WOS:000542750900001					2022-02-06	
J	Schellenberg, M; Owattanapanich, N; Cowan, S; Strickland, M; Lewis, M; Clark, DH; Inaba, K				Schellenberg, Morgan; Owattanapanich, Natthida; Cowan, Shaun; Strickland, Matt; Lewis, Meghan; Clark, Damon H.; Inaba, Kenji			Penetrating injuries to the vertebral artery: interventions and outcomes from US Trauma Centers	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Vertebral artery injury; Penetrating trauma; Stroke; Interpersonal violence; Nonoperative management of penetrating trauma	MANAGEMENT	Purpose Penetrating injuries to the vertebral artery are rare and incompletely studied. Operative, angioembolic, and nonoperative strategies are management options, although the association between management strategy and outcomes is unknown. This study endeavored to define the epidemiology, management strategy, and outcomes after penetrating injuries to the vertebral artery presenting to trauma centers nationwide. Methods Patients with veterbral artery injuries were identified from the National Trauma Data Bank (NTDB) (2016-2017) using ICD-10-CM codes. Only those with penetrating mechanisms of injury were included in the study. Transferred patients were excluded. Study groups were defined by management strategy (Operative management, OM; angioembolization, AE; and nonoperative management, NOM). Patient demographics, injury characteristics, and outcomes were compared between groups using univariate analysis. Multivariate analysis with logistic regression was used to examine independent risk factors for mortality and stroke. Results Penetrating injuries to the vertebral artery were rare (n = 476, < 1% of NTDB patient population). Median age was 28 [IQR 21-37] years and 81% (n = 385) of patients were male. Interpersonal violence was the most common injury intent (n = 374, 79%). Most patients were managed with NOM (n = 409, 86%), with AE and OM utilized less frequently (8% and 6%, respectively). Stab wounds were the most frequent mechanism of injury among patients managed with OM (62%), while gunshot wounds were most common among patients managed with NOM (84%) or AE (79%). Multivariate analysis of risk factors for stroke revealed only associated carotid artery injury (OR 4.236, 95% CI 1.284-13.970,p = 0.018) and AE (OR 6.342, 95% CI 1.417-28.399,p = 0.016) were independent predictors. Independent risk factors for mortality were advanced age (OR 1.026, 95% CI 1.001-1.052,p = 0.044); elevated ISS (OR 1.030, 95% CI 1.008-1.052,p = 0.006); and associated traumatic brain injury (OR 3.020, 95% CI 1.333-6.843,p = 0.008). Higher ED GCS was independently associated with reduced mortality (OR 0.788, 95% CI 0.731-0.849,p < 0.001). Conclusions Vertebral artery injuries after penetrating mechanisms are infrequent in the United States. Patients with these injuries tend to be young adult men who were injured by gunshot wounds as a result of interpersonal violence. The majority of these injuries were managed nonoperatively, with operative intervention required most commonly for patients injured by stab wounds. Risk factors for both stroke and mortality were principally due to patient factors and associated injuries. Increased risk of stroke among patients managed with angioembolization will need to be further investigated with future study to determine if this risk is imparted from the management strategy itself or from underlying injury characteristics.	[Schellenberg, Morgan; Owattanapanich, Natthida; Cowan, Shaun; Strickland, Matt; Lewis, Meghan; Clark, Damon H.; Inaba, Kenji] Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA		Schellenberg, M (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	morgan.schellenberg@med.usc.edu					American College of Surgeons, 2017, NAT TRAUM DAT BANK N; Asensio JA, 2020, J VASC SURG, V71, P2161, DOI 10.1016/j.jvs.2019.10.084; BLICKENSTAFF KL, 1989, AM J SURG, V158, P101, DOI 10.1016/0002-9610(89)90355-3; Demetriades D, 1996, BRIT J SURG, V83, P83, DOI 10.1002/bjs.1800830126; Demetriades D, 2019, ATLAS SURG TECHNIQUE; GOLUEKE P, 1987, J TRAUMA, V27, P856, DOI 10.1097/00005373-198708000-00003; HATZITHEOFILOU C, 1988, BRIT J SURG, V75, P234, DOI 10.1002/bjs.1800750315; MEIER DE, 1981, ARCH SURG-CHICAGO, V116, P236; Mwipatayi BP, 2004, EUR J VASC ENDOVASC, V27, P157, DOI 10.1016/j.ejvs.2003.11.008; REID JDS, 1988, J TRAUMA, V28, P1007, DOI 10.1097/00005373-198807000-00016; YEE LF, 1995, J TRAUMA, V39, P480	11	11	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01416-y		JUN 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MA1OI	WOS:000541686900001	32567022	Green Published, Bronze			2022-02-06	
J	Wright, DK; Gardner, AJ; Wojtowicz, M; Iverson, GL; O'Brien, TJ; Shultz, SR; Stanwell, P				Wright, David K.; Gardner, Andrew J.; Wojtowicz, Magdalena; Iverson, Grant L.; O'Brien, Terence J.; Shultz, Sandy R.; Stanwell, Peter			White Matter Abnormalities in Retired Professional Rugby League Players with a History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; DTI; magnetic resonance imaging; retired athletes; TBSS	TRACT ABNORMALITIES; NFL PLAYERS; DIFFUSION; BRAIN; DEPENDENCE; SYMPTOMS; ALCOHOL; DEGENERATION; VALIDATION; INJURY	The topic of potential long-term neurological consequences from having multiple concussions during a career in collision sports is controversial. We sought to investigate white matter microstructure using diffusion tensor imaging (DTI) in retired professional Australian National Rugby League (NRL) players (n = 11) with a history of multiple self-reported concussions compared with age- and education-matched controls (n = 13) who have had no history of brain trauma. Diffusion-weighted images were acquired with a Siemens 3T scanner. All participants completed a clinical interview. There were no significant differences between groups on measures of depression, anxiety, stress, or post-concussion symptoms; however, NRL players scored significantly higher on the alcohol use disorder identification test (AUDIT). Voxelwise analyses of DTI measures were performed using tract-based spatial statistics (TBSS) with age and AUDIT scores included as covariates. TBSS revealed significantly reduced fractional anisotropy (FA), and increased radial diffusivity (RD), axial diffusivity (AD), and trace (TR) in white matter regions of recently retired NRL players compared with controls. FA was significantly reduced in the right superior longitudinal fasciculus and right corticospinal tract while TR, RD, and AD were increased in these regions, as well as the corpus callosum, forceps major, right uncinate fasciculus, and left corticospinal tract. In summary, DTI in a small cohort of recently retired professional NRL players with a history of multiple concussions showed differences in white matter microstructure compared with age- and education-matched controls with no history of brain trauma.	[Wright, David K.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, New Lambton Hts, Australia; [Wojtowicz, Magdalena] York Univ, Dept Psychol, Toronto, ON, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sport Concuss Program Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Stanwell, Peter] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Callaghan, NSW, Australia		Stanwell, P (corresponding author), Univ Newcastle, Sch Hlth Sci, Callaghan, NSW 2308, Australia.	peter.stanwell@newcastle.edu.au	O'Brien, Terence/AAU-5525-2021; Stanwell, Peter/F-9136-2012; O'Brien, Terence/L-8102-2013	Stanwell, Peter/0000-0002-4780-0393; O'Brien, Terence/0000-0002-7198-8621; Gardner, Andrew/0000-0001-5031-5586	New South Wales Sporting Injuries Committee and Brain Injury Australia	This study was funded by the New South Wales Sporting Injuries Committee and Brain Injury Australia.	Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Graham MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185647; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Irfanoglu MO, 2019, MAGN RESON MED, V81, P2774, DOI 10.1002/mrm.27577; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Legarreta AD, 2018, WORLD NEUROSURG, V120, pE365, DOI 10.1016/j.wneu.2018.08.079; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Pfefferbaum A, 2014, LANCET PSYCHIAT, V1, P202, DOI 10.1016/S2215-0366(14)70301-3; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Terry DP, 2019, J INT NEUROPSYCH SOC, V25, P950, DOI 10.1017/S1355617719000754; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422	47	11	11	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					983	988		10.1089/neu.2019.6886		JUN 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000538187000001	32245344				2022-02-06	
J	Deng, YB; Jiang, X; Deng, XY; Chen, H; Xu, J; Zhang, ZS; Liu, GL; Yong, Z; Yuan, CF; Sun, XC; Wang, CD				Deng, Yongbing; Jiang, Xue; Deng, Xiaoyan; Chen, Hong; Xu, Jie; Zhang, Zhaosi; Liu, Geli; Yong, Zhu; Yuan, Chengfu; Sun, Xiaochuan; Wang, Changdong			Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPAR gamma/NF-kappa B/IL-6 signaling pathway	GENES & DISEASES			English	Article						Traumatic brain injury; IL-6; Pioglitazone; PPAR gamma; p-NF-kappa B	ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; OXIDATIVE STRESS; DNA-DAMAGE; RAT MODEL; EXPRESSION; AGONIST; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION	Traumatic brain injury (TBI) is the major cause of high mortality and disability rates worldwide. Pioglitazone is an activator of peroxisome proliferator-activated receptor-gamma (PPAR gamma) that can reduce inflammation following TBI. Clinically, neuroinflammation after TBI lacks effective treatment. Although there are many studies on PPAR gamma in TBI animals, only few could be converted into clinical, since TBI mechanisms in humans and animals are not completely consistent. The present study, provided a potential theoretical basis and therapeutic target for neuroinflammation treatment after TBI. First, we detected interleukin-6 (IL-6), nitric oxide (NO) and Caspase-3 in TBI clinical specimens, confirming a presence of a high expression of inflammatory factors. Western blot (WB), quantitative real-time PCR (qRTPCR) and immunohistochemistry (IHC) were used to detect PPAR gamma, IL-6, and p-NF-kappa B to identify the mechanisms of neuroinflammation. Then, in the rat TBI model, neurobehavioral and cerebral edema levels were investigated after intervention with pioglitazone (PPAR gamma activator) or T0070907 (PPAR gamma inhibitor), and PPAR gamma, IL-6 and p-NF-kappa B were detected again by qRT-PCR, WB and immunofluorescence (IF). The obtained results revealed that: 1) increased expression of IL-6, NO and Caspase-3 in serum and cerebrospinal fluid in patients after TBI, and decreased PPAR gamma in brain tissue; 2) pioglitazone could improve neurobehavioral and reduce brain edema in rats after TBI; 3) the protective effect of pioglitazone was achieved by activating PPAR gamma and reducing NF-kappa B and IL-6. The neuroprotective effect of pioglitazone on TBI was mediated through the PPAR gamma/NF-kappa B/IL-6 pathway. Copyright (C) 2019, Chongqing Medical University. Production and hosting by Elsevier B.V.	[Deng, Yongbing; Chen, Hong; Zhang, Zhaosi; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Yixueyuan Rd 1, Chongqing 400016, Peoples R China; [Deng, Yongbing] Chongqing Emergency Med Ctr, Dept Neurosurg, Jiankang Rd 1, Chongqing 400014, Peoples R China; [Jiang, Xue; Deng, Xiaoyan; Xu, Jie; Liu, Geli; Wang, Changdong] Chongqing Med Univ, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, Yixueyuan Rd 1, Chongqing 400016, Peoples R China; [Yong, Zhu] Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92697 USA; [Yuan, Chengfu] China Three Gorges Univ, Coll Med Sci, Yichang 443002, Hubei, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Yixueyuan Rd 1, Chongqing 400016, Peoples R China.; Wang, CD (corresponding author), Chongqing Med Univ, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, Yixueyuan Rd 1, Chongqing 400016, Peoples R China.	422275819@qq.com; richeljiang@hotmail.com; XYdeng_cqmu@126.com; hongchen0707@163.com; 494082604@qq.com; 253583549@qq.com; 1556985401@qq.com; YongZ4@uci.edu; Yuancf46@ctgu.edu.cn; sunxch1445@qq.com; wangchangdong@cqmu.edu.cn		Zhang, Zhaosi/0000-0002-4988-501X	Education Commission of Chongqing in China [KJQN201800124, CY170402]; Natural Science Foundation of Chongqing ChinaNatural Science Foundation of Chongqing [cstc2016jcyjA0220, cstc2014jcyjA10024]; Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20125503120015]	This study was financially supported by the Education Commission of Chongqing in China (Grant No. KJQN201800124 to Y.B. Deng and Grant No. CY170402 to C.D. Wang), the Natural Science Foundation of Chongqing China (Grant No. cstc2016jcyjA0220 to X. Jiang and Grant No. cstc2014jcyjA10024 to C.D. Wang), and Doctoral Program of Higher Education of China (20125503120015 to C.D. Wang).	Abbas Aamer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P124; Arnett E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007100; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; Bernardo A, 2008, PPAR RES, V2008, DOI 10.1155/2008/864140; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Dai XP, 2019, BIOL CHEM, V400, P753, DOI 10.1515/hsz-2018-0340; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dey A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00513; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Fama F, 2019, J CLIN TRANSL ENDOCR, V15, P54, DOI 10.1016/j.jcte.2018.12.008; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Ghaffarpasand F, 2019, NEUROPSYCH DIS TREAT, V15, P127, DOI 10.2147/NDT.S186865; Govindarajulu M, 2018, PPAR RES, V2018, DOI 10.1155/2018/2010675; Griffiths MR, 2018, IMMUNOLOGY, V155, P346, DOI 10.1111/imm.12974; Gupta S, 2015, MUTAT RES-GEN TOX EN, V778, P22, DOI 10.1016/j.mrgentox.2014.12.007; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Krishna GMuralidhara, 2018, J PHYSL PHARM OFFIC, V69; Kurowska P, 2017, J PHYSIOL PHARMACOL, V68, P823; Li QL, 2019, INT IMMUNOPHARMACOL, V66, P309, DOI 10.1016/j.intimp.2018.11.044; Liu C, 2019, RPS15A PROMOTES GAST; Liu Q, 2019, MOL MED REP, V19, P1396, DOI 10.3892/mmr.2018.9720; Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Nencioni A, 2003, CRIT REV IMMUNOL, V23, P1, DOI 10.1615/CritRevImmunol.v23.i12.10; Ota N, 2011, NUTRITION, V27, P955, DOI 10.1016/j.nut.2010.10.008; Ouk T, 2013, CURR DRUG TARGETS, V14, P752, DOI 10.2174/1389450111314070005; Paige E, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002413; Pierzchalski P, 2008, J PHYSIOL PHARMACOL, V59, P191; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sauer S, 2015, TRENDS PHARMACOL SCI, V36, P688, DOI 10.1016/j.tips.2015.06.010; Shang JS, 2018, ELIFE, V7, DOI 10.7554/eLife.43320; Shao ZQ, 2015, J NEUROL SCI, V349, P65, DOI 10.1016/j.jns.2014.12.027; Shi X, 2018, ONCOTARGETS THER, V11, P8107, DOI 10.2147/OTT.S173339; Storer PD, 2005, J NEUROIMMUNOL, V161, P113, DOI 10.1016/j.jneuroim.2004.12.015; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xu JH, 2007, J IMMUNOL, V178, P1904, DOI 10.4049/jimmunol.178.3.1904; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12754	50	11	12	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-4820	2352-3042		GENES DIS	Genes Dis.	JUN	2020	7	2					253	265		10.1016/j.gendis.2019.05.002			13	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	KW0MG	WOS:000520867300011	32215295	Green Published, gold			2022-02-06	
J	Chen, GZ; Zhou, ZP; Sha, WP; Wang, LM; Yan, F; Yang, XM; Qin, X; Wu, MY; Li, D; Tian, SJ; Chen, G				Chen, Guozhao; Zhou, Zhiping; Sha, Weiping; Wang, Liming; Yan, Fei; Yang, Xiaomei; Qin, Xia; Wu, Muyao; Li, Di; Tian, Shoujin; Chen, Gang			A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						C-X3-C motif chemokine receptor 1; AZD8797; tumor necrosis factor-alpha; interleukin-6; interleukin-1 beta signaling; necrosis; apoptosis; spinal cord injury	TRAUMATIC BRAIN-INJURY; TIRILAZAD MESYLATE; ISCHEMIC-STROKE; NERVOUS-SYSTEM; CHEMOKINES; METHYLPREDNISOLONE; PATHWAY; INVOLVEMENT; ACTIVATION; EXPRESSION	The present study aimed to evaluate the effect of the CX3CR1 inhibitor AZD8797 in early recovery after acute SCI and elucidate its potential mechanism in blocking inflammation and apoptosis. Adult rats were sacrificed after 3, 7, 10, or 14 days of SCI. The injured spinal tissues were collected for assessing C-X3-C motif chemokine ligand 1(CX3CL1)/C-X3-C motif chemokine receptor 1 (CX3CR1) expression at each time point via western blotting (WB) and quantitative PCR. The cellular localization of the proteins was detected by immunofluorescence. Another batch of rats (subdivided into sham, injury model, AZD8797 and methylprednisolone groups) were used to evaluate locomotive recovery with a Basso Beattie Bresnahan score. Based on the expression level of CX3CR1, these rats were sacrificed at the most prominent stage of CX3CR1 expression (10 days after SCI), for assessing the serum levels of tumor necrosis factor-alpha /interleukin (IL)-6/IL-1 beta and the expression of CX3CL1/CX3CR1/caspase 3/Bcl-2/Bax in the spinal cord tissues through WB and ELISA. Additionally, apoptosis and necrosis in the injured spinal cord were evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining/fluoro-jade B staining. Expression levels of both CX3CR1 and CX3CL1 reached their peak 10 days after the injury, followed by a dramatic downward trend at 14 days. The enhanced expression of CX3CR1 was detected in astrocytes and microglia of the injured spinal cord. AZD8797 improved locomotive recovery after 10 days of SCI and was as effective as methylprednisolone. The effect of AZD8797 was mediated by suppressing apoptosis, necrosis and inflammatory responses, as assessed by WB/ELISA and morphological examinations. The current study has demonstrated that AZD8797 can effectively block overwhelming inflammation, apoptosis and necrosis after SCI and facilitate early recovery of locomotive function.	[Chen, Guozhao; Zhou, Zhiping; Sha, Weiping; Wang, Liming; Yan, Fei; Tian, Shoujin] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Orthoped, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China; [Yang, Xiaomei] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Emergency, Suzhou 215600, Jiangsu, Peoples R China; [Qin, Xia] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept ICU, Suzhou 215600, Jiangsu, Peoples R China; [Wu, Muyao] Nanjing Univ Chinese Med, Zhangjiagang Hosp Tradit Chinese Med, Dept Rehabil, Nanjing, Jiangsu, Peoples R China; [Li, Di] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Neurosurg, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China; [Li, Di] Soochow Univ, Affiliated Zhangjiagang Hosp, Translat Med Ctr, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215031, Jiangsu, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou 215031, Jiangsu, Peoples R China		Li, D; Tian, SJ (corresponding author), Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Orthoped, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China.; Li, D (corresponding author), Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Neurosurg, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China.; Li, D (corresponding author), Soochow Univ, Affiliated Zhangjiagang Hosp, Translat Med Ctr, 68 Jiyang West Rd, Suzhou 215600, Jiangsu, Peoples R China.	zjgchenguozhao@163.com; lidilab@sina.com; zjgchenguozhao@163.com					Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Cederblad L, 2016, BIOCHEM J, V473, P641, DOI 10.1042/BJ20150520; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Cuenca PJ, 2004, J EMERG MED, V27, P37, DOI 10.1016/j.jemermed.2004.02.008; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; de Pablos RM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-34; Estes ML, 2014, BRAIN PATHOL, V24, P623, DOI 10.1111/bpa.12198; Fehlings MG, 2017, GLOB SPINE J, V7, p116S, DOI 10.1177/2192568217706366; Fitzharris M, 2014, SPINAL CORD, V52, P117, DOI 10.1038/sc.2013.135; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Huang YH, 2009, J TRAUMA, V66, P1441, DOI 10.1097/TA.0b013e318184ba88; Huhtinen A, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0439-8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Kasama T, 2010, TRANSL RES, V155, P20, DOI 10.1016/j.trsl.2009.08.009; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Khuyagbaatar B, 2014, J BIOMECH, V47, P2820, DOI 10.1016/j.jbiomech.2014.04.042; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lee HW, 2016, HISTOL HISTOPATHOL, V31, P269, DOI 10.14670/HH-11-695; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229; Liu YZ, 2017, LIFE SCI, V184, P87, DOI 10.1016/j.lfs.2017.06.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129; Persson C, 2009, J NEUROSURG-SPINE, V10, P315, DOI 10.3171/2009.1.SPINE08286; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Roseti C, 2013, EPILEPSIA, V54, P1834, DOI 10.1111/epi.12354; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Wilcox RK, 2003, J BONE JOINT SURG AM, V85A, P2184, DOI 10.2106/00004623-200311000-00020; Zhang LJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00306; Zhu WJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/480702; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	55	11	11	1	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2020	45	5					1373	1384		10.3892/ijmm.2020.4509			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	MD5XA	WOS:000544044700007	32323731	hybrid, Green Published			2022-02-06	
J	Eddy, R; Goetschius, J; Hertel, J; Resch, J				Eddy, Ryan; Goetschius, John; Hertel, Jay; Resch, Jacob			Test-Retest Reliability and the Effects of Exercise on the King-Devick Test	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; saccades; sideline measure; exercise	SCREENING TOOL; RUGBY UNION; HIGH-SCHOOL; CONCUSSION; MANAGEMENT; SPORT; TIME; STATEMENT	Objective: To determine the test-retest reliability and the influence of exercise on King-Devick (K-D) test performance. Design: Crossover study design. Setting: Controlled laboratory. Participants: Participants consisted of 63 (39 women and 24 men) healthy, recreationally active college students who were 21.0 + 1.5 years of age. Independent Variables: Participants completed the K-D test using a 2-week, test-retest interval. The K-D test was administered before and after a counterbalanced exercise or rest intervention. Reliability was assessed using testing visits (visit 1 and visit 2) as the independent variables. Exercise or rest and time (baseline, postintervention) were used as independent variables to examine the influence of exercise. Main Outcome Measures: Intraclass correlation (ICC) coefficients with 95% confidence intervals were calculated between visits to assess reliability of K-D test completion time. A repeated-measure 2 x 2 analysis of variance (intervention x time) with post hoc paired t tests was used to assess the influence of exercise on K-D test performance. Results: The K-D test was observed to have strong test-retest reliability [ICC2,1 = 0.90 (0.71, 0.96)] over time. No significant intervention-by-time interaction (P = 0.55) or intervention main effects (P = 0.68) on K-D time were observed. Mean differences of -1.5 and -1.7 seconds (P < 0.001) were observed between baseline and rest and exercise interventions for K-D test performance, respectively. Up to 32% (20/63) of participants were observed to have a false-positive K-D test performance before and after each intervention. Conclusions: Although strong test-retest reliability coefficients were observed using clinically relevant time points, a high false-positive rate warrants caution when interpreting the K-D test.	[Eddy, Ryan; Hertel, Jay; Resch, Jacob] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Goetschius, John] Adrian Coll, Dept Exercise Sci & Athlet Training, Adrian, MI USA		Resch, J (corresponding author), 210 Emmet St South, Charlottesville, VA 22904 USA.	jer6x@virginia.edu					Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Bodack MI, 2010, OPTOMETRY, V81, P476, DOI 10.1016/j.optm.2010.05.006; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CHMURA J, 1994, INT J SPORTS MED, V15, P172, DOI 10.1055/s-2007-1021042; Cohen J., 2013, STAT POWER ANAL BEHA; Connell CJW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26614; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; GODIN G, 1986, CAN J PUBLIC HEALTH, V77, P359; Goetschius J, 2013, MED SCI SPORT EXER, V45, P2314, DOI 10.1249/MSS.0b013e31829bc6ae; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Kuenze C, 2013, J SPORT REHABIL, V22, P33, DOI 10.1123/jsr.22.1.33; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Llorens F, 2015, J SPORT EXERCISE PSY, V37, P559, DOI 10.1123/jsep.2015-0087; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMorris T., 2015, EXERCISE COGNITION I; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Thomas J. R., 2015, RES METHODS PHYS ACT; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Waterhouse BD, 1998, BRAIN RES, V790, P33, DOI 10.1016/S0006-8993(98)00117-6; WESTHEIMER G, 1954, AMA ARCH OPHTHALMOL, V52, P710	35	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2020	30	3					239	244		10.1097/JSM.0000000000000586			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	LL1OQ	WOS:000531324800008	32341291				2022-02-06	
J	Maynard, ME; Redell, JB; Zhao, J; Hood, KN; Vita, SM; Kobori, N; Dash, PK				Maynard, Mark E.; Redell, John B.; Zhao, Jing; Hood, Kimberly N.; Vita, Sydney M.; Kobori, Nobuhide; Dash, Pramod K.			Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury	EXPERIMENTAL NEUROLOGY			English	Article						APP; Axonal injury; White matter; Novel object; Context discrimination; Cognition; Mild repeat TBI; Sarm1; Immunohistochemistry; Metabolism	TRAUMATIC BRAIN-INJURY; NAD(+) CLEAVAGE ACTIVITY; CINGULUM BUNDLE LESIONS; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER INJURY; WALLERIAN DEGENERATION; NICOTINAMIDE TREATMENT; UNMYELINATED AXONS; CORPUS-CALLOSUM; CORTEX LESIONS	One of the consistent pathologies associated with both clinical and experimental traumatic brain injury is axonal injury, especially following mild traumatic brain injury (or concussive injury). Several lines of experimental evidence have demonstrated a role for NAD + metabolism in axonal degeneration. One of the enzymes that metabolizes NAD+ in axons is Sarm1 (Sterile Alpha and TIR Motif Containing 1), and its activity is thought to play a key role in axonal degeneration. Using a Sand knock-out mouse, we examined if loss of Sarm1 offers axonal injury protection and improves cognitive outcome after repeated mild closed head injury (rmCHI). Our results indicate that rmCHI caused white matter damage that can be observed in the corpus callosum, cingulum bundle, alveus of the hippocampus, and fimbria of the fornix of wild-type mice. These pathological changes were markedly reduced in injured Sarm1(-/-) mice. Interestingly, the activation of astrocytes and microglia was also attenuated in the areas with white matter damage, suggesting reduced inflammation. Associated with these improved pathological outcomes, injured Sarm1(-/-) mice performed significantly better in both motor and cognitive tasks. Taken together, our results suggest that strategies aimed at inhibiting Sarm1 and/or restoring NAD+ levels in injured axons may have therapeutic utility.	[Maynard, Mark E.; Redell, John B.; Zhao, Jing; Hood, Kimberly N.; Vita, Sydney M.; Kobori, Nobuhide; Dash, Pramod K.] Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Vita, Sydney/0000-0002-8413-1782; Kobori, Nobuhide/0000-0002-3209-7156	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS109118, NS101686]	LThe work described herein was supported by grants NS109118 and NS101686 from the National Institutes of Health.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Basiri M, 2010, BRAIN RES BULL, V81, P43, DOI 10.1016/j.brainresbull.2009.11.002; BIGNAMI A, 1969, BRAIN RES, V13, P444, DOI 10.1016/0006-8993(69)90259-5; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Harker KT, 2004, HIPPOCAMPUS, V14, P224, DOI 10.1002/hipo.10159; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Hosmane S, 2012, J NEUROSCI, V32, P7745, DOI 10.1523/JNEUROSCI.0203-12.2012; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Lin CW, 2014, INNATE IMMUN-LONDON, V20, P161, DOI 10.1177/1753425913485877; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Marion CM, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113040; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; MIKLOSSY J, 1987, BRAIN RES, V426, P377, DOI 10.1016/0006-8993(87)90892-4; MIKLOSSY J, 1991, J NEUROPATH EXP NEUR, V50, P1, DOI 10.1097/00005072-199101000-00001; MIKLOSSY J, 1991, J NEUROPATH EXP NEUR, V50, P595; Neave N, 1997, EUR J NEUROSCI, V9, P941, DOI 10.1111/j.1460-9568.1997.tb01445.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pan ZG, 2018, BIOCHEM BIOPH RES CO, V498, P416, DOI 10.1016/j.bbrc.2018.02.115; PERRY S, 1987, AM J PSYCHIAT, V144, P543; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2016, EXP NEUROL, V283, P188, DOI 10.1016/j.expneurol.2016.06.011; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith AC, 2019, BEHAV BRAIN RES, V364, P123, DOI 10.1016/j.bbr.2019.02.024; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Tsao JW, 1999, J NEUROSCI, V19, P4718; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Wang JT, 2015, P NATL ACAD SCI USA, V112, P10093, DOI 10.1073/pnas.1508337112; Warburton EC, 1998, EUR J NEUROSCI, V10, P622, DOI 10.1046/j.1460-9568.1998.00074.x; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	59	11	11	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2020	327								113207	10.1016/j.expneurol.2020.113207			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX8RA	WOS:000522140800003	31962129	Green Accepted			2022-02-06	
J	Su, XQ; Wang, XY; Gong, FT; Feng, M; Bai, JJ; Zhang, RR; Dang, XQ				Su, Xiao-Qiang; Wang, Xiang-Yang; Gong, Fu-Tai; Feng, Min; Bai, Jing-Jing; Zhang, Rui-Rui; Dang, Xiao-Qian			Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury	BRAIN RESEARCH BULLETIN			English	Article						Traumatic spinal cord injury; Glycyrrhizin; Inflammation; NLRP3 inflammasome; Microglia	BRAIN-INJURY; HMGB1; MACROPHAGES; EXPRESSION; LOCOMOTOR; RECOVERY; ROOT	The inflammatory response induced by traumatic spinal cord injury (SCI) involves the activation of NLRP3 inflammasomes, which are closely related to the activation of microglia. Microglial polarization between M1/M2 phenotypes is a pivotal regulatory factor in neuroinflammatory responses to traumatic SCI -induced secondary injuries, and altering this polarization could be beneficial. Glycyrrhizin is a neuroprotective agent with a potent anti-inflammatory property in different neurological disorders and could potentially be useful in SCI. In this study, we investigated the potency of oral treatment with glycyrrhizin to reduce inflammation and improve functional recovery after traumatic SCI by inhibiting NLRP3 inflammasome activation and promoting microglial M2 polarization. After inducing traumatic SCI by dropping a 10 g impactor on the T9 and T10 spinal segments of male Sprague-Dawley rats, the animals were given glycyrrhizin orally immediately after injury and every 12 h for the next 3 d. Behavioral scores improved in glycyrrhizin-treated animals compared to the SCI group. The functional improvement in glycyrrhizin-treated rats paralleled the decreased expression of NLRP3 inflammasome components, such as ASC, NLRP3, and cleaved caspase-1, as well as IL-1 ji and IL-18. At the histopathological level, oral treatment with glycyrrhizin diminished the SCI-enhanced production of Iba-1 'CD86+ cells (Ml microglia) but improved the release of Iba-1 (+)CD206(+) cells (M2 microglia). Likewise, oral therapy with glycyrrhizin significantly enriched the protein expression levels of M2 microglia-related markers (CD206 and Arg-1) but reduced those of Ml microglia-related markers (CD86 and iNOS) in the injured spinal cord. These findings support and extend the knowledge on post-traumatic SCI glycyrrhizin-mediated neuroprotection. Glycyrrhizin's regulation of NLRP3 inflammasome activation and microglial polarization might be a new approach to understanding the anti-inflammatory potency of glycyrrhizin.	[Su, Xiao-Qiang; Dang, Xiao-Qian] Xi An Jiao Tong Univ, Dept Orthoped 1, Affiliated Hosp 2, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China; [Su, Xiao-Qiang; Wang, Xiang-Yang; Gong, Fu-Tai; Bai, Jing-Jing] Xian Hosp Tradit Chinese Med, Spine Area Orthoped, 69 Fengchengba Rd, Xian 710016, Shaanxi, Peoples R China; [Feng, Min] Shaanxi Prov Peoples Hosp, Dept Orthoped, 256 Youyixi Rd, Xian 710068, Shaanxi, Peoples R China; [Zhang, Rui-Rui] 521 Hlth Inst North Ind, Dept ICU, 12 Zhangbadong Rd, Xian 710065, Shaanxi, Peoples R China		Dang, XQ (corresponding author), Xi An Jiao Tong Univ, Dept Orthoped 1, Affiliated Hosp 2, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China.	dangxqnscience@126.com		Feng, Min/0000-0001-9801-650X			Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; CHEN X, 2014, J NEUROINFLAMM, V14, P147, DOI DOI 10.1016/S2212-5671(14)00696-0; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; David S, 2015, NEUROSCIENCE, V307, P311, DOI 10.1016/j.neuroscience.2015.08.064; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Erschbamer M, 2007, J NEUROSCI, V27, P6428, DOI 10.1523/JNEUROSCI.1037-07.2007; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Gold M, 2015, SEMIN IMMUNOPATHOL, V37, P607, DOI 10.1007/s00281-015-0518-0; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hayakawa K, 2014, J NEUROSCI RES, V92, P1647, DOI 10.1002/jnr.23448; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Huo J, 2016, NEUROSCIENCE, V330, P171, DOI 10.1016/j.neuroscience.2016.05.054; Ijaz S., 2019, J MOL NEUROSCI; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kong ZH, 2017, J MOL NEUROSCI, V63, P385, DOI 10.1007/s12031-017-0989-7; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Marques MR, 2018, NEUROSCIENCE, V392, P258, DOI 10.1016/j.neuroscience.2018.08.033; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Ni HB, 2015, J SPINAL CORD MED, V38, P199, DOI 10.1179/2045772313Y.0000000179; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Papa S, 2013, ACS NANO, V7, P9881, DOI 10.1021/nn4036014; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rocha ALL, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/859619; Sarkar S, 2017, NPJ PARKINSON DIS, V3, DOI 10.1038/s41531-017-0032-2; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shin JA, 2014, BRAIN BEHAV IMMUN, V40, P143, DOI 10.1016/j.bbi.2014.03.013; Slusarczyk J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071965; Song JH, 2013, MOLECULES, V18, P15788, DOI 10.3390/molecules181215788; Su BX, 2017, BRAIN RES, V1671, P85, DOI 10.1016/j.brainres.2017.06.020; Sun XJ, 2018, EXP CELL RES, V369, P112, DOI 10.1016/j.yexcr.2018.05.012; Sun Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01518; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Zendedel A, 2018, MOL NEUROBIOL, V55, P1364, DOI 10.1007/s12035-017-0400-2; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zhu L, 2016, NEUROSCIENCE, V315, P286, DOI 10.1016/j.neuroscience.2015.12.020	63	11	11	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAY	2020	158						1	8		10.1016/j.brainresbull.2020.02.000			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG7CD	WOS:000528253400001	32092434				2022-02-06	
J	Sivandzade, F; Alqahtani, F; Sifat, A; Cucullo, L				Sivandzade, Farzane; Alqahtani, Faleh; Sifat, Ali; Cucullo, Luca			The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study	JOURNAL OF NEUROINFLAMMATION			English	Article						Tobacco smoke; Trauma; Brain injury; Oxidative stress; Blood-brain barrier; Tight junctions; Nrf2; Antioxidant	OXIDATIVE STRESS; CIGARETTE-SMOKING; BLOOD; BARRIER; NRF2; SYSTEM; MODEL; APOPTOSIS; METFORMIN; DISEASE	Background Traumatic brain injury (TBI) is among the most prevalent causes of cerebrovascular and neurological damage worldwide. To this end, tobacco smoke (TS) has been shown to promote vascular inflammation, neurovascular impairments, and risk of cerebrovascular and neurological disorders through oxidative stress (OS) stimuli targeting the blood-brain barrier (BBB) endothelium among others. It has been recently suggested that premorbid conditions such as TS may exacerbate post-TBI brain damage and impact recovery. Methods Our study investigated the mechanisms underlying the exacerbation of TBI injury by TS using a weight drop model. For this purpose, male C57BL/6J mice, age range 6-8 weeks, were chronically exposed to premorbid TS for 3 weeks. Test animals were then subjected to TBI by guided vertical head weight drop using a 30 g metal weight free felling from an 80 cm distance before reaching the target. We analyzed the physical activity and body weight of the mice before TBI and 1 h, 24 h, and 72 h post-injury. Finally, mice were sacrificed to collect blood and brain samples for subsequent biochemical and molecular analysis. Western blotting was applied to assess the expression of Nrf2 (a critical antioxidant transcription factor) as well as tight junction proteins associated with BBB integrity including ZO-1, Occludin, and Claudin-5 from brain tissues homogenates. Levels of NF-kB (a pro-inflammatory transcript factor which antagonizes Nrf2 activity) and pro-inflammatory cytokines IL-6, IL-10, and TNF-alpha were assessed in blood samples. Results Our data revealed that premorbid TS promoted significantly increased inflammation and loss of BBB integrity in TBI when compared to TS-Free test mice. Additionally, mice chronically exposed to TS before TBI experienced a more significant weight loss, behavioral and motor activity deficiency, and slower post-TBI recovery when compared to TS-free TBI mice. Conclusion The effects of premorbid TS appear consequential to the abrogation of physiological antioxidative and anti-inflammatory response to TBI leading to worsening impairments of the BBB, OS damage, and inflammation. These factors are also likely responsible for the retardation of post-traumatic recovery observed in these animals.	[Sivandzade, Farzane; Sifat, Ali; Cucullo, Luca] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Jerry H Hodge Sch Pharm, 1300 S Coulter St, Amarillo, TX 79106 USA; [Alqahtani, Faleh] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh 11451, Saudi Arabia; [Cucullo, Luca] Texas Tech Univ, Hlth Sci Ctr, Ctr Blood Brain Barrier Res, Amarillo, TX 79106 USA		Cucullo, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Jerry H Hodge Sch Pharm, 1300 S Coulter St, Amarillo, TX 79106 USA.; Cucullo, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Blood Brain Barrier Res, Amarillo, TX 79106 USA.	luca.cucullo@ttuhsc.edu	Alqahtani, Faleh/AAF-3545-2019	Alqahtani, Faleh/0000-0003-3924-593X; Sivandzade, Farzane/0000-0001-8649-3712	National Institutes of Health/National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [2R01-DA029121-01A1, 1R01DA049737-01]	This work was supported by the National Institutes of Health/National Institute on Drug Abuse 2R01-DA029121-01A1 and 1R01DA049737-01 to Dr. Luca Cucullo.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; ADEGHE AJH, 1986, LAB ANIM, V20, P70, DOI 10.1258/002367786781062016; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Angeloni C, 2015, OXIDATIVE MED CELLUL; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Carvalho C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00806; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chen YH, 2018, INT J NEUROPSYCHOPH, V21, P949, DOI 10.1093/ijnp/pyy055; Chen Yuan-Hao, 2018, Oncotarget, V9, P10016, DOI 10.18632/oncotarget.24245; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Cojocaru Inimioara Mihaela, 2013, Rom J Intern Med, V51, P97; Conway EM, 2012, SEMINARS IMMUNOPATHO; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Enciu AM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297512; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; He YX, 2019, NEUROREPORT, V30, P344, DOI 10.1097/WNR.0000000000001205; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Kaisar MA, 2018, NEUROSCI LETT, V682, P1, DOI 10.1016/j.neulet.2018.05.045; Kaisar MA, 2017, REDOX BIOL, V13, P353, DOI 10.1016/j.redox.2017.06.006; Khan NM, 2017, FREE RADICAL BIO MED, V112, P191, DOI 10.1016/j.freeradbiomed.2017.10.300; Kostich W, 2016, J PHARMACOL EXP THER, V358, P371, DOI 10.1124/jpet.116.235333; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Mutinati M, 2014, REPROD DOMEST ANIM, V49, P7, DOI 10.1111/rda.12230; Naik P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-51; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Paulson JR, 2010, J PHARMACOL EXP THER, V332, P371, DOI 10.1124/jpet.109.157776; Prasad S, 2017, REDOX BIOL, V12, P58, DOI 10.1016/j.redox.2017.02.007; Prasad S, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0014-x; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sajja RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31137-7; Sajja RK, 2017, NEUROSCI LETT, V653, P152, DOI 10.1016/j.neulet.2017.05.059; Sajja RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122358; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sivandzade F, 2018, REDOX BIOL; Sivandzade F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174225; Sivandzade F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143433; Sivandzade F, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0497-5; Sivandzade F, 2018, J CEREBR BLOOD F MET, V38, P1667, DOI 10.1177/0271678X18788769; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; Tufekci KU, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/807426; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Wang X, 2011, TOXICOL IN VITRO, V25, P839, DOI 10.1016/j.tiv.2011.02.004; Wu L, 2018, J CEREBRAL BLOOD FLO; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou Y, 2020, IEEE WIREL COMMUN LE, V9, P480, DOI 10.1109/LWC.2019.2959579	79	11	11	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	APR 27	2020	17	1							133	10.1186/s12974-020-01818-0			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	LJ9QD	WOS:000530494300001	32340626	gold, Green Submitted, Green Published			2022-02-06	
J	Snell, DL; Siegert, RJ; Debert, C; Cairncross, M; Silverberg, ND				Snell, Deborah L.; Siegert, Richard J.; Debert, Chantel; Cairncross, Molly; Silverberg, Noah D.			Evaluation of the Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire	JOURNAL OF NEUROTRAUMA			English	Article						fear avoidance; mTBI; outcome measures; Rasch analysis	POST-CONCUSSION SYNDROME; MODEL; PAIN; ANXIETY; DISABILITY; SYMPTOMS; STATE	Fear avoidance behavior is related to symptom persistence and disability in various health conditions, such as chronic pain. Fear avoidance behavior also may impact recovery from mild traumatic brain injury (mTBI), but no measure of this construct has been psychometrically validated for the mTBI population. Adults who sustained an mTBI (n = 159) were recruited from three outpatient mTBI clinics. Participants completed the new Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire (FAB-TBI). The FAB-TBI includes 16 items drawn from well-established fear avoidance scales, primarily in the chronic pain literature. An exploratory factor analysis and Rasch analysis were conducted to evaluate the factor structure, dimensionality, and differential item functioning of the FAB-TBI. The FAB-TBI scale was found to have strong internal consistency (Cronbach's alpha = 0.9). Exploratory factor analysis suggested at least two distinct factors (activity avoidance and cogniphobia). Initial fit to the Rasch model was adequate, with one misfitting item. The model was not improved after removing the misfitting item. Best fit to the unidimensional Rasch model was achieved after items were combined into three super items based on exploratory factor analysis and retaining the misfitting item 12 (chi(2) (6, n = 159) = 2.1, p = 0.06). The FAB-TBI appears to be a psychometrically sound measure of fear avoidance behavior after mTBI. Conversion tables are made available to convert scores into interval-level data for future research.	[Snell, Deborah L.] Canterbury Dist Hlth Board, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago Christchurch, Dept Orthoped Surg & Musculoskeletal Med, Christchurch, New Zealand; [Siegert, Richard J.] Auckland Univ Technol, Dept Hlth & Environm Studies, Auckland, New Zealand; [Debert, Chantel] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Cairncross, Molly] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Debert, Chantel/0000-0002-2704-0438	VGH+UBC Hospital Foundation; Michael Smith Foundation for Health Research and Vancouver Coastal Health Research Institute	The study was partially funded by the VGH+UBC Hospital Foundation. NS receives salary support from the Michael Smith Foundation for Health Research and Vancouver Coastal Health Research Institute.	Andrich D., 2009, RUMM 2030; Asmundson GJG, 1999, CLIN PSYCHOL REV, V19, P97, DOI 10.1016/S0272-7358(98)00034-8; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hunt C, 2019, J ABNORM PSYCHOL, V128, P315, DOI 10.1037/abn0000422; IBM Corporation, 2016, BM SPSS STAT MAC VER; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kindermans HPJ, 2011, J PAIN, V12, P1049, DOI 10.1016/j.jpain.2011.04.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleinstauber M, 2013, COGN BEHAV THERAPY, V42, P84, DOI 10.1080/16506073.2012.717301; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; Martin PR, 2009, CLIN PSYCHOL REV, V29, P483, DOI 10.1016/j.cpr.2009.05.002; Medvedev O., 2018, J HLTH PSYCHOL, pprint; Medvedev ON, 2017, MINDFULNESS, V8, P995, DOI 10.1007/s12671-016-0676-8; Nakao M, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-17; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pincus T, 2010, CLIN J PAIN, V26, P739, DOI 10.1097/AJP.0b013e3181f15d45; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Siegert RJ, 2010, DISABIL REHABIL, V32, P8, DOI 10.3109/09638280902971398; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Whalley MG, 2017, COGN BEHAV PRACT, V24, P72, DOI 10.1016/j.cbpra.2016.03.003; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; World Health Organization, 1992, ICD 10 CLASSIFICATIO	35	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1566	1573		10.1089/neu.2019.6729		APR 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000523353500001	32041472				2022-02-06	
J	Hakon, J; Moghiseh, M; Poulsen, I; Oland, CML; Hansen, CP; Sabers, A				Hakon, Jakob; Moghiseh, Melika; Poulsen, Ingrid; Oland, Christoffer M. L.; Hansen, Christian P.; Sabers, Anne			Transcutaneous Vagus Nerve Stimulation in Patients With Severe Traumatic Brain Injury: A Feasibility Trial	NEUROMODULATION			English	Article						vagus nerve stimulation; Transcutaneous vagus nerve stimulation; traumatic brain injury; feasibility study	CONSCIOUSNESS; STATE; EXPRESSION; DISORDERS; EPILEPSY; LEVEL; BDNF	Objectives Preclinical studies have shown that surgically implanted vagus nerve stimulation (VNS) promotes recovery of consciousness and cognitive function following experimental traumatic brain injury (TBI). The aim of this study is to report the feasibility and safety of a noninvasive transcutaneous vagus nerve stimulation (tVNS) in patients with persistent impairment of consciousness following severe TBI. Materials and Methods The feasibility of tVNS was evaluated in five patients presenting with diffuse axonal injury and reduced dominant EEG activity one month following severe TBI. tVNS was applied to the left cymba conchae of the external ear using a skin electrode four hours daily for eight weeks. Possible effects of tVNS on physiological parameters and general side effects were recorded. In addition, we report the rate of recovery using coma recovery scale revised (CRS-R). Results The tVNS regime of four hours daily for eight weeks was feasible and well tolerated with little side effects and no clinically relevant effects on physiological parameters. Three patients showed improvements (>3 points) in the CRS-R following eight weeks tVNS. Conclusion We demonstrated that tVNS is a feasible and safe VNS strategy for patients following severe TBI. Controlled studies are needed to clarify whether tVNS has a potential to promote recovery of consciousness following severe TBI.	[Hakon, Jakob; Moghiseh, Melika; Poulsen, Ingrid; Oland, Christoffer M. L.; Hansen, Christian P.] Rigshosp, Copenhagen Univ Hosp, Dept Neurorehabil,TBI Unit, Res Unit Brain Injury Rehabil Copenhagen RUBRIC, Copenhagen, Denmark; [Hakon, Jakob] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Poulsen, Ingrid] Aarhus Univ, Res Unit Nursing & Hlth Care, Hlth, Aarhus, Denmark; [Sabers, Anne] Rigshosp, Copenhagen Univ Hosp, Epilepsy Clin, Dept Neurol, Copenhagen, Denmark		Hakon, J (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neurorehabil,TBI Unit, Res Unit Brain Injury Rehabil Copenhagen RUBRIC, Copenhagen, Denmark.	jakobhakon@gmail.com		Poulsen, ingrid/0000-0002-0342-017X			Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bauer S, 2016, BRAIN STIMUL, V9, P356, DOI 10.1016/j.brs.2015.11.003; Capone F, 2015, J NEURAL TRANSM, V122, P679, DOI 10.1007/s00702-014-1299-7; Carreno FR, 2017, NEUROTHERAPEUTICS, V14, P716, DOI 10.1007/s13311-017-0537-8; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Dietrich S, 2008, BIOMED TECH, V53, P104, DOI 10.1515/BMT.2008.022; Dong XY, 2018, NEURAL REGEN RES, V13, P244, DOI 10.4103/1673-5374.226395; Elliott RE, 2011, EPILEPSY BEHAV, V20, P57, DOI 10.1016/j.yebeh.2010.10.017; Ellrich J, 2019, J CLIN NEUROPHYSIOL, V36, P437, DOI 10.1097/WNP.0000000000000576; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hagen C, 1972, RANCHO LOS AMIGOS LE; Krahl Scott E, 2012, Surg Neurol Int, V3, pS255, DOI 10.4103/2152-7806.103015; Kraus T, 2013, BRAIN STIMUL, V6, P798, DOI 10.1016/j.brs.2013.01.011; Kreuzer Peter M, 2012, Front Psychiatry, V3, P70, DOI 10.3389/fpsyt.2012.00070; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; NOMURA S, 1984, BRAIN RES, V292, P199, DOI 10.1016/0006-8993(84)90756-X; Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089; Redgrave J, 2018, BRAIN STIMUL, V11, P1225, DOI 10.1016/j.brs.2018.08.010; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Yakunina N, 2017, NEUROMODULATION, V20, P290, DOI 10.1111/ner.12541	35	11	11	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	AUG	2020	23	6					859	864		10.1111/ner.13148		MAR 2020	6	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	ND7PA	WOS:000522083700001	32227429				2022-02-06	
J	Miao, WY; Zhao, YF; Huang, YC; Chen, D; Luo, C; Su, W; Gao, YQ				Miao, Wanying; Zhao, Yongfang; Huang, Yichen; Chen, Di; Luo, Chen; Su, Wei; Gao, Yanqin			IL-13 Ameliorates Neuroinflammation and Promotes Functional Recovery after Traumatic Brain Injury	JOURNAL OF IMMUNOLOGY			English	Article							MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; WHITE-MATTER; ALTERNATIVE ACTIVATION; DOPAMINERGIC-NEURONS; INTERLEUKIN-13; MICROGLIA; INFLAMMATION; RESPONSES; DEATH; INTERLEUKIN-4/INTERLEUKIN-13	Microglia play essential roles in neuroinflammatory responses after traumatic brain injury (TBI). Our previous studies showed that phenotypes of microglia, as well as infiltrating macrophages, altered at different stages after CNS injury, which was correlated to functional outcomes. IL-13 is an anti-inflammatory cytokine that has been reported to protect against demyelination and spinal cord injury through immunomodulation. The effects of IL-13 in microglia/macrophage-mediated immune responses after TBI remain unknown. In this study, we showed that intranasal administration of IL-13 in male C57BL/6J mice accelerated functional recovery in the controlled cortical impact model of TBI. IL-13 treatment increased the time to fall off in the Rotarod test, reduced the number of foot faults in the foot fault test, and improved the score in the wire hang test up to 28 d after TBI. Consistent with functional improvement, IL-13 reduced neuronal tissue loss and preserved white matter integrity 6 d after TBI. Furthermore, IL-13 ameliorated the elevation of proinflammatory factors and reduced the number of proinflammatory microglia/macrophages 6 d after TBI. Additionally, IL-13 enhanced microglia/macrophage phagocytosis of damaged neurons in the peri-lesion areas. In vitro studies confirmed that IL-13 treatment inhibited the production of proinflammatory cytokines in rat primary microglia in response to LPS or dead neuron stimulation and increased the ability of microglia to engulf fluorophore-labeled latex beads or dead neurons. Collectively, we demonstrated that IL-13 treatment improved neurologic outcomes after TBI through adjusting microglia/macrophage phenotypes and inhibiting inflammatory responses. IL-13 may represent a potential immunotherapy to promote long-term recovery from TBI.	[Miao, Wanying; Zhao, Yongfang; Huang, Yichen; Chen, Di; Luo, Chen; Gao, Yanqin] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Miao, Wanying; Zhao, Yongfang; Huang, Yichen; Chen, Di; Luo, Chen; Gao, Yanqin] Fudan Univ, Minist Educ, Frontiers Ctr Brain Sci, Shanghai 200032, Peoples R China; [Miao, Wanying; Zhao, Yongfang; Huang, Yichen; Chen, Di; Luo, Chen; Gao, Yanqin] Fudan Univ, Inst Brain Sci, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China; [Su, Wei] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Neurosurg, Beijing 102218, Peoples R China		Gao, YQ (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Fudan Univ, Inst Brain Sci, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Fudan Univ, Frontiers Ctr Brain Sci, Minist Educ, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	yqgao@shmu.edu.cn	Gao, Yanqin/I-6790-2016	Gao, Yanqin/0000-0002-4915-9819; Su, Wei/0000-0002-3284-7535; Miao, Wanying/0000-0003-3972-2572; Huang, Yichen/0000-0003-0737-2547; ZHao, yongfang/0000-0002-0608-7958	Chinese Key Research and Development Plan of the State Ministry of Science and Technology [2017YFC1308403]; Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81870971, 81571285]	This work was supported by the Chinese Key Research and Development Plan of the State Ministry of Science and Technology under Grant 2017YFC1308403 and Chinese Natural Science Foundation Grants 81870971 and 81571285.	An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; Baxendale S, 2019, PRACT NEUROL, V19, P476, DOI 10.1136/practneurol-2018-002113; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brombacher TM, 2017, J IMMUNOL, V198, P2681, DOI 10.4049/jimmunol.1601546; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Dai XJ, 2020, J CEREBR BLOOD F MET, V40, P639, DOI 10.1177/0271678X19830791; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; Doran E, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00139; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Guglielmetti C, 2016, GLIA, V64, P2181, DOI 10.1002/glia.23053; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Herzog C, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174698; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kurisu K, 2019, J CEREBR BLOOD F MET, V39, P1906, DOI 10.1177/0271678X18817282; Le Blon D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0756-7; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Littlefield A, 2017, NEUROSCIENCE, V343, P106, DOI 10.1016/j.neuroscience.2016.11.027; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Maher P, 2018, CYTOKINE, V103, P114, DOI 10.1016/j.cyto.2017.09.018; Mori S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0862-1; Mori S, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020018; Morrison BE, 2012, J IMMUNOL, V189, P5498, DOI 10.4049/jimmunol.1102150; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Pan HC, 2013, EUR J IMMUNOL, V43, P2854, DOI 10.1002/eji.201343301; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Seyfizadeh N, 2015, ACTA MICROBIOL IMM H, V62, P341, DOI 10.1556/030.62.2015.4.2; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Taj SH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1212-7; Vogelaar CF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2304; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yang MS, 2006, J IMMUNOL, V177, P1323, DOI 10.4049/jimmunol.177.2.1323; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330; Zhao JY, 2019, J CEREBR BLOOD F MET, V39, P1215, DOI 10.1177/0271678X18808174	57	11	14	2	6	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAR 15	2020	204	6					1486	1498		10.4049/jimmunol.1900909			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KU3BV	WOS:000519583700008	32034062	Bronze			2022-02-06	
J	Withiel, TD; Sharp, VL; Wong, DN; Ponsford, JL; Warren, N; Stolwyk, RJ				Withiel, Toni D.; Sharp, Vanessa L.; Wong, Dana; Ponsford, Jennie L.; Warren, Narelle; Stolwyk, Renerus J.			Understanding the experience of compensatory and restorative memory rehabilitation: A qualitative study of stroke survivors	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory rehabilitation; Cognitive training; Memory skills group; Compensatory strategies; Stroke rehabilitation; Qualitative analysis	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; WORKING-MEMORY; PAGING SYSTEM; STRATEGIES; FREQUENCY; EFFICACY; ADULTS	Memory impairment is common following stroke. Memory skills groups (MSGs) utilising compensatory strategies and computerised cognitive training (CCT) are two rehabilitation approaches available to improve memory function; however, there is no consensus as to which is more effective following stroke. This study aimed to explore and contrast the qualitative experiences of 20 stroke survivors (M-age = 61.90,SD = 10.48, range: 34-77 years) who received six weeks' training in MSG (manualised memory skills group,n = 10) or individual-CCT (Lumosity(TM),n = 10). Using semi-structured interviews, data were collected and analysed thematically, adopting a critical realist approach. Six themes were identified: (1)Facilitators and barriers to intervention engagement, (2)Improving knowledge and understanding, (3)Connecting with others, (4)Perception of the intervention, (5)Impact on everyday memoryand (6)Impact on emotions and sense of purpose. Encouragingly, most participants valued and enjoyed participating in the memory interventions, irrespective of rehabilitation approach. MSG participants reported learning and sharing with similar others as important to the experience and described everyday memory improvements. CCT participants described enjoyment of its game-like nature, yet reported frustration associated with game-specific characteristics, and did not report everyday memory improvements.	[Withiel, Toni D.; Sharp, Vanessa L.; Wong, Dana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Withiel, Toni D.; Wong, Dana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Withiel, Toni D.] Royal Melbourne Hosp, Allied Hlth, Melbourne, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Warren, Narelle] Monash Univ, Sch Social Sci, Melbourne, Vic, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.; Stolwyk, RJ (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.	rene.stolwyk@monash.edu	Wong, Dana/AAD-3410-2020; Warren, Narelle/H-9318-2019; Ponsford, Jennie/H-8341-2014	Warren, Narelle/0000-0003-2623-4078; Withiel, Toni/0000-0001-8075-2760; Stolwyk, Renerus/0000-0002-4975-3332; Sharp, Vanessa/0000-0002-2481-1030; Wong, Dana/0000-0001-9619-1929; Ponsford, Jennie/0000-0003-0430-125X			Arenth PM, 2006, BRAIN INJURY, V20, P253, DOI 10.1080/02699050500487662; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cadilhac DA, 2010, INT J STROKE, V5, P217, DOI 10.1111/j.1747-4949.2010.00430.x; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Connor B. B., 2012, P 9 INT C DIS VIRT R; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; Dowswell G., 2003, EVALUATION, V9, P30, DOI DOI 10.1177/1356389003009001003; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Grosdemange A, 2015, J NEUROL NEUROSUR PS, V86, P513, DOI 10.1136/jnnp-2014-308232; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hux K, 2000, BRAIN INJURY, V14, P907; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Livescribe, 2015, ECH SMART AUTH; MacQueen K., 1998, CULTURAL ANTHR METHO, V10, P31; Mowszowski L, 2016, NEUROPSYCHOL REV, V26, P252, DOI 10.1007/s11065-016-9329-x; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Paas F, 2003, EDUC PSYCHOL, V38, P1, DOI 10.1207/S15326985EP3801_1; Polit DF, 2010, INT J NURS STUD, V47, P1451, DOI 10.1016/j.ijnurstu.2010.06.004; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; QSR International, 2014, NIV QUAL DAT AN SOFT; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Radford K., 2010, MAKING MOST YOUR MEM; Sigmundsdottir L, 2016, NEUROPSYCHOL REHABIL, V26, P673, DOI 10.1080/09602011.2016.1140657; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Spreij LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00993; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Viera AJ, 2005, FAM MED, V37, P360; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	41	11	11	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 15	2020	30	3					503	522		10.1080/09602011.2018.1479275			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MB2FW	WOS:000542421300007	29886809				2022-02-06	
J	Xu, HY; Jia, ZL; Ma, K; Zhang, J; Dai, C; Yao, ZT; Deng, WS; Su, JZ; Wang, RJ; Chen, XY				Xu, Huiyou; Jia, Zhilong; Ma, Ke; Zhang, Jian; Dai, Chen; Yao, Zitong; Deng, Wusheng; Su, Jianzhong; Wang, Renjie; Chen, Xuyi			Protective Effect of Mesenchymal Stromal Cell-Derived Exosomes on Traumatic Brain Injury via miR-216a-5p	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Mesenchymal Stromal Cells; MicroRNAs	EXTRACELLULAR VESICLES; FUNCTIONAL RECOVERY; STEM-CELL; CONTRIBUTES	Background: Transplantation of exosomes derived from mesenchymal stem cells (MSCs-Exo) can improve the recovery of neurological function in rats after traumatic brain injury (TBI). We tested a new hypothesis that brain-derived neurotrophic factor (BDNF)-induced MSCs-Exo can effectively promote functional recovery and neurogenesis in rats after TBI. Material/Methods: BM-MSCs of rats were extracted by whole bone marrow culture, BDNF was added to BM-MSCs as an intervention, supernatant was collected, and exosomes were separated and purified by ultracentrifugation. Exosomes were identified by Western blot (WB), transmission electron microscopy (TEM), and particle size analysis and were subsequently used in cell and animal experiments. The experimental animals were divided into a sham group, a PBS group, an MSCs-Exo group, and a BDNF-induced MSCs-Exo group (n=12). An electric cortical contusion impactor (eCCI) was used to cause TBI in all rats except the sham group. We investigated the recovery of sensorimotor function and spatial learning ability, inflammation inhibition, and neuron regeneration in rats after TBI. Results: Compared with the MSCs-Exo group, the BDNF-induced MSCs-Exo group showed better effects in promoting the recovery of sensorimotor function and spatial learning ability. BDNF-induced MSCs-Exo successfully inhibited inflammation and promoted neuronal regeneration in vivo and in vitro. We further analyzed miRNAs in BDNF-induced MSCs-Exo and MSCs-Exo and found that the expression of miR-216a-5p in BDNF-induced MSCs-Exo was significantly higher than that in MSCs-Exo as determined by qRT-PCR. Rescue experiments indicated that miR-216a-5p had a similar function as BDNF-induced MSCs-Exo. Conclusions: We found that BDNF-induced MSCs-Exo can improve cell migration and inhibit apoptosis better than MSCs-Exo in rats after TBI, and the mechanism may be related to the high expression of miR-216a-5p.	[Xu, Huiyou; Jia, Zhilong; Ma, Ke; Zhang, Jian; Dai, Chen; Yao, Zitong; Deng, Wusheng; Su, Jianzhong; Wang, Renjie; Chen, Xuyi] Characterist Med Ctr Chinese Peoples Armed Police, Dept Neurosurg, Inst Brain Trauma & Neurol Dis Peoples Armed Poli, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Xu, Huiyou; Ma, Ke; Zhang, Jian; Dai, Chen; Yao, Zitong; Deng, Wusheng] Logist Univ Chinese Peoples Armed Police Force, Tianjin, Peoples R China		Wang, RJ; Chen, XY (corresponding author), Characterist Med Ctr Chinese Peoples Armed Police, Dept Neurosurg, Inst Brain Trauma & Neurol Dis Peoples Armed Poli, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China.	376917818@qq.com; chenxuyi19790@sina.com			National Key R&D Program of China [2016YFC1101500]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11932013, 11672332]; Tianjin Science and Technology Military-Civil Integration Major Project [18ZXJMTG00260]; Tianjin Key Scientific and Technological Support Projects [17YFZCSY00620]	This work was supported by the National Key R&D Program of China [Grant No: 2016YFC1101500], the National Natural Science Foundation of China [Key Program; Grant No: 11932013], the National Natural Science Foundation of China [General Program; Grant No: 11672332], the Tianjin Science and Technology Military-Civil Integration Major Project [Grant No: 18ZXJMTG00260], and the Tianjin Key Scientific and Technological Support Projects [Grant No: 17YFZCSY00620]	Aryani A, 2016, MOL NEUROBIOL, V53, P818, DOI 10.1007/s12035-014-9054-5; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Cao QQ, 2020, AUTOPHAGY, V16, P1236, DOI 10.1080/15548627.2019.1659654; Dewan M.C., 2018, J NEUROSURG; Dumas SJ, 2018, CIRCULATION, V137, P2371, DOI 10.1161/CIRCULATIONAHA.117.029930; Gorabi AM, 2019, MOL NEUROBIOL, V56, P8157, DOI 10.1007/s12035-019-01663-0; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jeon SA, 2019, FASEB J, V33, P14772, DOI 10.1096/fj.201901404R; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Lin QS, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1077-0; Lopez-Verrilli MA, 2016, NEUROSCIENCE, V320, P129, DOI 10.1016/j.neuroscience.2016.01.061; Lu CY, 2019, STEM CELL RES, V41, DOI 10.1016/j.scr.2019.101643; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Ortiz JB, 2014, EUR J NEUROSCI, V40, P3351, DOI 10.1111/ejn.12703; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Singh M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11028-z; Sun YQ, 2018, CANCER MANAG RES, V10, P4735, DOI 10.2147/CMAR.S178380; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Xin HQ, 2017, STROKE, V48, P747, DOI 10.1161/STROKEAHA.116.015204; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu LL, 2019, BRAIN RES, V1717, P66, DOI 10.1016/j.brainres.2019.04.009; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yin CY, 2019, BIOCHEM BIOPH RES CO, V508, P416, DOI 10.1016/j.bbrc.2018.11.060; Zhang L, 2018, BIOSCIENCE REP, V38, P1; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	35	11	13	1	11	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR 9	2020	26								e920855	10.12659/MSM.920855			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KS9AO	WOS:000518599900001	32150531	Green Published			2022-02-06	
J	Peterson, AB; Kegler, SR				Peterson, Alexis B.; Kegler, Scott R.			Deaths from Fall-Related Traumatic Brain Injury - United States, 2008-2017	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article									[Peterson, Alexis B.; Kegler, Scott R.] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Peterson, AB (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	APeterson4@cdc.gov					Ambrose AF, 2015, MATURITAS, V82, P85, DOI 10.1016/j.maturitas.2015.06.035; Arias Elizabeth, 2016, Vital Health Stat 2, P1; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Cheng XJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080763; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Jarman MP, 2016, SURGERY, V160, P1551, DOI 10.1016/j.surg.2016.06.020; Peek-Asa C, 2004, AM J PUBLIC HEALTH, V94, P1689, DOI 10.2105/AJPH.94.10.1689; Stevens JA, 2018, AM J PREV MED, V55, P290, DOI 10.1016/j.amepre.2018.04.035; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939	10	11	11	1	3	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	MAR 6	2020	69	9					225	230		10.15585/mmwr.mm6909a2			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	LR9EW	WOS:000535999400002	32134910	Green Published, gold			2022-02-06	
J	Cooper, DJ; Rosenfeld, JV; Murray, L; Arabi, YM; Davies, AR; Ponsford, J; Seppelt, I; Reilly, P; Wiegers, E; Wolfe, R				Cooper, D. James; Rosenfeld, Jeffrey, V; Murray, Lynnette; Arabi, Yaseen M.; Davies, Andrew R.; Ponsford, Jennie; Seppelt, Ian; Reilly, Peter; Wiegers, Eveline; Wolfe, Rory		DECRA Trial Investigators; Australian New Zealand Intensive C	Patient Outcomes at Twelve Months after Early Decompressive Craniectomy for Diffuse Traumatic Brain Injury in the Randomized DECRA Clinical Trial	JOURNAL OF NEUROTRAUMA			English	Article						decompressive craniectomy; intensive care; outcomes; randomized trial; traumatic brain injury	REFRACTORY INTRACRANIAL HYPERTENSION; CRANIOTOMY; GUIDELINES	Functional outcomes at 12 months were a secondary outcome of the randomized DECRA trial of early decompressive craniectomy for severe diffuse traumatic brain injury (TBI) and refractory intracranial hypertension. In the DECRA trial, patients were randomly allocated 1:1 to either early decompressive craniectomy or intensive medical therapies (standard care). We conducted planned secondary analyses of the DECRA trial outcomes at 6 and 12 months, including all 155 patients. We measured functional outcome using the Glasgow Outcome Scale-Extended (GOS-E). We used ordered logistic regression, and dichotomized the GOS-E using logistic regression, to assess outcomes in patients overall and in survivors. We adjusted analyses for injury severity using the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model. At 12 months, the odds ratio (OR) for worse functional outcomes in the craniectomy group (OR 1.68; 95% confidence interval [CI]: 0.96-2.93; p = 0.07) was no longer significant. Unfavorable functional outcomes after craniectomy were 11% higher (59% compared with 48%), but were not significantly different from standard care (OR 1.58; 95% CI: 0.84-2.99; p = 0.16). Among survivors after craniectomy, there were fewer good (OR 0.33; 95% CI: 0.12-0.91; p = 0.03) and more vegetative (OR 5.12; 95% CI: 1.04-25.2; p = 0.04) outcomes. Similar outcomes in survivors were found at 6 months after injury. Vegetative (OR 5.85; 95% CI: 1.21-28.30; p = 0.03) and severely disabled outcomes (OR 2.49; 95% CI: 1.21-5.11; p = 0.01) were increased. Twelve months after severe diffuse TBI and early refractory intracranial hypertension, decompressive craniectomy did not improve outcomes and increased vegetative survivors.	[Cooper, D. James; Murray, Lynnette; Davies, Andrew R.; Wiegers, Eveline; Wolfe, Rory] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Cooper, D. James] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Intens Care, Riyadh, Saudi Arabia; [Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Seppelt, Ian] Nepean Hosp, Dept Intens Care Med, Sydney, NSW, Australia; [Reilly, Peter] Royal Adelaide Hosp, Neurosurg Dept, Adelaide, SA, Australia; [Wiegers, Eveline] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands		Cooper, DJ (corresponding author), Monash Univ, Dept Intens Care, Alfred Hosp, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Cooper, D. James/G-7961-2013; Arabi, Yaseen/ABF-3316-2020	Cooper, D. James/0000-0002-5872-9051; Arabi, Yaseen/0000-0001-5735-6241; Wolfe, Rory/0000-0002-2126-1045; Micallef, Sharon/0000-0002-8496-2324	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [NHMRC 314502]; Transport Accident Commission of Victoria (Victorian Trauma Foundation); Transport Accident Commission of Victoria (Victorian Neurotrauma Initiative); Intensive Care Foundation (Australia); Western Australian Institute for Medical Research	YTY The DECRA trial was supported by grants from the National Health and Medical Research Council of Australia (NHMRC 314502), the Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative), the Intensive Care Foundation (Australia), and the Western Australian Institute for Medical Research. DECRA Australian Clinical Trials registry number, ACTRN012605000009617.	Access Economics , 2009, EC COST SPIN CORD IN; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N., 2016, BRAIN TRAUMA FDN GUI; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2018, INTENS CARE MED, V44, P1321, DOI 10.1007/s00134-018-5251-4; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; The DECRA (DECompressive CRAniectomy trial) protocol, 2007, DECRA DECOMPRESSIVE, DOI 10.1056/NEJMoa1102077/suppl_file/nejmoa1102077_protocol.pdf; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Valenca MM, 2010, J NEUROSURG, V113, P982, DOI 10.3171/2009.11.JNS09674; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	27	11	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					810	816		10.1089/neu.2019.6869			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200010	32027212	Green Published, hybrid, Green Submitted			2022-02-06	
J	Corwin, DJ; McDonald, CC; Arbogast, KB; Mohammed, FN; Metzger, KB; Pfeiffer, MR; Patton, DA; Huber, CM; Margulies, SS; Grady, M; Master, CL				Corwin, Daniel J.; McDonald, Catherine C.; Arbogast, Kristy B.; Mohammed, Fairuz N.; Metzger, Kristina B.; Pfeiffer, Melissa R.; Patton, Declan A.; Huber, Colin M.; Margulies, Susan S.; Grady, Matthewf.; Master, Christina L.			Clinical and Device-based Metrics of Gait and Balance in Diagnosing Youth Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						COMPLEX TANDEM GAIT; MODIFIED BALANCE ERROR SCORING SYSTEM; PEDIATRIC CONCUSSION; VISIO-VESTIBULAR EXAMINATION	DUAL-TASK; SINGLE-TASK; RELIABILITY; PERFORMANCE; DEFICITS; CHILDREN	Purpose Evaluate the discriminatory ability of two clinical measures and one device-based measure of gait and balance for concussed youth. Methods We enrolled 81 cases and 90 controls age 14-18 yr old from August 2017 to June 2018. Controls were recruited from a suburban high school, and cases were recruited from the concussion program of an academic pediatric tertiary care center. Tests included two clinical measures: 1) complex tandem gait, scored as sway/errors walking forward and backward eyes open and closed; 2) Modified Balance Error Scoring System (mBESS), scored as total number of errors on three standing tasks; and one device-based measure; 3) Modified Clinical Test of Sensory Interaction and Balance (mCTSIB) using the Biodex Biosway Balance System, scored as a sway index. Sensitivity, specificity, ideal cutpoint, and area under the receiver operating characteristic curve (AUC) were calculated for all test components. Results Ideal cutpoint for total number of sway/errors for tandem gait = 5, sensitivity 41%, specificity 90%. Ideal cutpoint for total mBESS errors = 4, sensitivity 55%, specificity 75%. Ideal cutpoint for mCTSIB = 1.37, sensitivity 37%, specificity 88%. Among each test, some individual components outperformed overall composites, in particular tandem gait (specificity forward eyes open = 99%, sensitivity backward eyes closed = 81%). Among the 40 cases and 65 controls with all three assessments, AUC (95% CI) for tandem gait = 0.63 (0.52,0.75), mBESS = 0.70 (0.60,0.81), and mCTSIB = 0.54 (0.42,0.66). Conclusions A device-based measure of balance did not produce better discriminatory ability than two clinical assessments. Complex tandem gait has the additional benefit of being an easy-to-perform and graded test with highly sensitive and specific individual components.	[Corwin, Daniel J.; McDonald, Catherine C.; Arbogast, Kristy B.; Mohammed, Fairuz N.; Metzger, Kristina B.; Pfeiffer, Melissa R.; Patton, Declan A.; Huber, Colin M.; Margulies, Susan S.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; McDonald, Catherine C.; Arbogast, Kristy B.; Grady, Matthewf.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [McDonald, Catherine C.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA; [Grady, Matthewf.; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	corwind@email.chop.edu		HUBER, COLIN/0000-0002-0045-5940; Arbogast, Kristy/0000-0002-1694-4562; McDonald, Catherine/0000-0003-3856-8542	Pennsylvania Department of Health; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549]; Shipley School administration	Funding for this research has been provided by the Pennsylvania Department of Health. Research reported in this publication was also supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS097549. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to acknowledge Ronni Kessler, Olivia Podolak, Ari Fish, Julia Vanni, and Shelly Sharma for their contributions to data collection. The authors are grateful to the students and parents from the Shipley School and families at the Children's Hospital of Philadelphia for their participation in this research study. The authors would also like thank the Shipley School administration and athletic training staff, in particular Mark Duncan, Director of Athletics, and Dr. Steve Piltch, Head of School, for their support.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2019, PED AC SOC ANN M MAY; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Fabri TL, 2017, GAIT POSTURE, V54, P154, DOI 10.1016/j.gaitpost.2017.03.002; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Imhoff S, 2016, J SPORTS MED, V2016, P5127374, DOI DOI 10.1155/2016/5127374; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Leung FT, 2019, MUSCULOSKEL SCI PRAC, V39, P144, DOI 10.1016/j.msksp.2018.12.007; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McKenna RF, 2016, NORMATIVE DATASET BA; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Starling A. J., 2015, CONCUSSION, V1, P1; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	39	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAR	2020	52	3					542	548		10.1249/MSS.0000000000002163			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KN5NU	WOS:000514884400003	31524833	Green Accepted			2022-02-06	
J	Zhao, YY; Wei, ZZ; Lee, JH; Gu, XH; Sun, JM; Dix, TA; Wei, L; Yu, SP				Zhao, Yingying; Wei, Zheng Zachory; Lee, Jin Hwan; Gu, Xiaohuan; Sun, Jinmei; Dix, Thomas A.; Wei, Ling; Yu, Shan P.			Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice	EXPERIMENTAL NEUROLOGY			English	Article						Pharmacological hypothermia; Neurotensin receptor; Neurovascular unit; Inflammation; Transient MCA occlusion; Blood-brain barrier	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; ISCHEMIC-STROKE; FUNCTIONAL RECOVERY; NEURONAL DEATH; UNIT; THROMBOLYSIS; FEASIBILITY; MECHANISMS; PREDICTION	Therapeutic hypothermia is a potential protective strategy after stroke. The present study evaluated the neurovascular protective potential of pharmacological hypothermia induced by the neurotensin receptor 1 agonist HPI-201 after severe ischemic stroke. Adult C57BL/6 mice were subjected to filament insertion-induced occlusion of the middle cerebral artery (60 min MCAO). HPI-201 was i.p. injected 120 min after the onset of MCAO to initiate and maintain the body temperature at 32-33 degrees C for 6 hrs. The infarct volume, cell death, integrity of the blood brain barrier (BBB) and neurovascular unit (NVU), inflammation, and functional outcomes were evaluated. The hypothermic treatment significantly suppressed the infarct volume and neuronal cell death, accompanied with reduced caspase-3 activation and BAX expression while Bcl-2 increased in the peri-infarct region. The cellular integrity of the BBB and NVU was significantly improved and brain edema was attenuated in HPI-201-treated mice compared to stroke controls. The hypothermic treatment decreased the expression of inflammatory factors including tumor necrosis factor-alpha (TNF-alpha), MMP-9, interleukin-1 beta (IL-1 beta), the M1 microglia markers IL-12 and inducible nitric oxide synthase (iNOS), while increased the M2 marker arginase-1 (Arg-1). Stroke mice received the hypothermic treatment showed lower neurological severity score (NSS), performed significantly better in functional tests, the mortality rate in the hypothermic group was noticeably lower compared with stroke controls. Taken together, HPI-201 induced pharmacological hypothermia is protective for different neurovascular cells after a severely injured brain, mediated by multiple mechanisms.	[Zhao, Yingying; Wei, Zheng Zachory; Lee, Jin Hwan; Gu, Xiaohuan; Sun, Jinmei; Wei, Ling; Yu, Shan P.] Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle,WMRB 620, Atlanta, GA 30322 USA; [Dix, Thomas A.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29401 USA; [Wei, Zheng Zachory; Yu, Shan P.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA		Wei, L; Yu, SP (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle,WMRB 620, Atlanta, GA 30322 USA.	lwei7@emory.edu; spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286; Yu, Shan Ping/0000-0003-1335-1398	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073378, NS091585]; VA Merit AwardUS Department of Veterans Affairs [RX000666]; AHA Postdoctoral Fellowship Award [POST25680013, POST25710112/CDA34110317]	This project was supported by the NIH grants NS073378 (SPY), NS091585 (LW), VA Merit Award RX000666 (SPY), AHA Postdoctoral Fellowship Award POST25680013 (JHL) and POST25710112/CDA34110317 (ZZW).	Bai Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124362; Balkaya M, 2013, J NEUROSCI METH, V213, P179, DOI 10.1016/j.jneumeth.2012.12.021; Baron JC, 2018, NAT REV NEUROL, V14, P325, DOI 10.1038/s41582-018-0002-2; Cariou A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0294-1; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; DEAKIN MAB, 1968, B MATH BIOPHYS, V30, P27, DOI 10.1007/BF02476937; del Zoppo GJ, 2010, J INTERN MED, V267, P156, DOI 10.1111/j.1365-2796.2009.02199.x; Doshi M, 2009, BIOL PHARM BULL, V32, P1957, DOI 10.1248/bpb.32.1957; Francke C, 1988, J Ky Med Assoc, V86, P29; Froehler MT, 2010, EXPERT REV CARDIOVAS, V8, P593, DOI [10.1586/erc.09.129, 10.1586/ERC.09.129]; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hamann GF, 2004, STROKE, V35, P764, DOI 10.1161/01.STR.0000116866.60794.21; Hammer MD, 2003, NEUROLOGIST, V9, P280, DOI 10.1097/01.nrl.0000094628.29312.2b; Horstmann S, 2009, J NEUROL SCI, V276, P75, DOI 10.1016/j.jns.2008.08.038; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Knecht T, 2018, BRAIN CIRC, V4, P99, DOI 10.4103/bc.bc_21_18; Kono S, 2014, STROKE, V45, P2404, DOI 10.1161/STROKEAHA.114.005316; Kurisu K, 2018, NEUROPHARMACOLOGY, V134, P302, DOI 10.1016/j.neuropharm.2017.08.025; Lee JH, 2017, NEURAL REGEN RES, V12, P341, DOI 10.4103/1673-5374.202915; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li H, 2018, MED GAS RES, V8, P172, DOI 10.4103/2045-9912.248269; Li H, 2011, BRAIN RES, V1368, P59, DOI 10.1016/j.brainres.2010.10.073; Madden LK, 2017, NEUROCRIT CARE, V27, P468, DOI 10.1007/s12028-017-0469-5; Mohamad O, 2013, J PHYSIOL-LONDON, V591, P149, DOI 10.1113/jphysiol.2012.239251; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saini MG, 2011, J NEUROCHEM, V119, P760, DOI 10.1111/j.1471-4159.2011.07484.x; Schonenberger S, 2016, JAMA-J AM MED ASSOC, V316, P1986, DOI 10.1001/jama.2016.16623; Serena J, 2005, STROKE, V36, P1921, DOI 10.1161/01.STR.0000177870.14967.94; Sessler DI, 2009, STROKE, V40, pE614, DOI 10.1161/STROKEAHA.108.520858; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Van Hemelrijck A, 2005, EUR J NEUROSCI, V22, P1327, DOI 10.1111/j.1460-9568.2005.04331.x; Wang SL, 2017, MAGN RESON IMAGING, V40, P24, DOI 10.1016/j.mri.2017.03.011; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; WEINRAUDER H, 1969, B ACAD POL SCI BIOL, V17, P27; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yao Z, 2018, WORLD NEUROSURG, V111, P404, DOI 10.1016/j.wneu.2018.01.020; Zgavc T, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-105; Zhang Z, 2018, AGING DIS, V9, P507, DOI 10.14336/AD.2017.0628	51	11	12	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2020	325								113133	10.1016/j.expneurol.2019.113133			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KH0CW	WOS:000510317000016	31770520				2022-02-06	
J	Huijben, JA; Wiegers, EJA; Lingsma, HF; Citerio, G; Maas, AIR; Menon, DK; Ercole, A; Nelson, D; van der Jagt, M; Steyerberg, EW; Helbok, R; Lecky, F; Peul, W; Birg, T; Zoerle, T; Carbonara, M; Stocchetti, N				Huijben, Jilske A.; Wiegers, Eveline J. A.; Lingsma, Hester F.; Citerio, Giuseppe; Maas, Andrew I. R.; Menon, David K.; Ercole, Ari; Nelson, David; van der Jagt, Mathieu; Steyerberg, Ewout W.; Helbok, Raimund; Lecky, Fiona; Peul, Wilco; Birg, Tatiana; Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino		CTR-TBI Investigators Participants	Changing care pathways and between-center practice variations in intensive care for traumatic brain injury across Europe: a CENTER-TBI analysis	INTENSIVE CARE MEDICINE			English	Article						Intensive care unit; Traumatic brain injury; Intracranial pressure; Outcome	INTRACRANIAL-PRESSURE; MANAGEMENT; EPIDEMIOLOGY	Purpose To describe ICU stay, selected management aspects, and outcome of Intensive Care Unit (ICU) patients with traumatic brain injury (TBI) in Europe, and to quantify variation across centers. Methods This is a prospective observational multicenter study conducted across 18 countries in Europe and Israel. Admission characteristics, clinical data, and outcome were described at patient- and center levels. Between-center variation in the total ICU population was quantified with the median odds ratio (MOR), with correction for case-mix and random variation between centers. Results A total of 2138 patients were admitted to the ICU, with median age of 49 years; 36% of which were mild TBI (Glasgow Coma Scale; GCS 13-15). Within, 72 h 636 (30%) were discharged and 128 (6%) died. Early deaths and long-stay patients (> 72 h) had more severe injuries based on the GCS and neuroimaging characteristics, compared with short-stay patients. Long-stay patients received more monitoring and were treated at higher intensity, and experienced worse 6-month outcome compared to short-stay patients. Between-center variations were prominent in the proportion of short-stay patients (MOR = 2.3, p < 0.001), use of intracranial pressure (ICP) monitoring (MOR = 2.5, p < 0.001) and aggressive treatments (MOR = 2.9, p < 0.001); and smaller in 6-month outcome (MOR = 1.2, p = 0.01). Conclusions Half of contemporary TBI patients at the ICU have mild to moderate head injury. Substantial between-center variations exist in ICU stay and treatment policies, and less so in outcome. It remains unclear whether admission of short-stay patients represents appropriate prudence or inappropriate use of clinical resources.	[Huijben, Jilske A.; Wiegers, Eveline J. A.; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care, Monza, Italy; [Maas, Andrew I. R.] Univ Antwerp, Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [van der Jagt, Mathieu] Erasmus MC, Stroke Ctr, Dept Intens Care Adults, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Hlth Serv Res Sect, Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Peul, Wilco] Univ Neurosurg Ctr Holland, HMC, HAGA, The Hague, Netherlands; [Peul, Wilco] LUMC, Leiden, Netherlands; [Birg, Tatiana; Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Dept Anesthesia & Crit Care, Milan, Italy; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy		Huijben, JA (corresponding author), Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.	j.a.huijben@erasmusmc.nl	Castano-Leon, Ana M/ABF-6322-2020; Posti, Jussi P./Y-2908-2019; Laureys, Steven/AAN-2097-2021; Sahuquillo, Juan/B-3577-2008; Badenes, Rafael/K-6628-2019; Helbok, Raimund/AAA-8361-2021; Volovici, Victor/AAZ-8901-2020; Cooper, D. James/G-7961-2013; Lagares, Alfonso/B-2969-2011; Ercole, Ari/B-6288-2009; Ledoux, Didier/ABA-8401-2021; Gomez, Pedro/E-2411-2014; van der Jagt, Mathieu/G-1905-2017; Raj, Rahul/K-7693-2012	Castano-Leon, Ana M/0000-0002-7918-5049; Posti, Jussi P./0000-0002-5925-5193; Laureys, Steven/0000-0002-3096-3807; Sahuquillo, Juan/0000-0003-0713-5875; Badenes, Rafael/0000-0001-7017-0150; Volovici, Victor/0000-0002-5798-5360; Cooper, D. James/0000-0002-5872-9051; Lagares, Alfonso/0000-0003-3996-0554; Ercole, Ari/0000-0001-8350-8093; Ledoux, Didier/0000-0002-9314-6564; Nelson, David/0000-0003-2530-8207; Dark, Paul/0000-0003-3309-0164; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Rossi, Sandra/0000-0002-9963-8121; Newcombe, Virginia/0000-0001-6044-9035; Gomez, Pedro/0000-0002-4185-5238; Kondziella, Daniel/0000-0001-5562-9808; Zeiler, Frederick/0000-0003-1737-0510; van der Jagt, Mathieu/0000-0003-2566-8325; Della Corte, Francesco/0000-0003-1736-2318; Raj, Rahul/0000-0003-4243-9591; Van Essen, Thomas/0000-0003-4657-5283; Kolias, Angelos/0000-0003-3992-0587; Blaabjerg, Morten/0000-0001-6007-1861; Coles, Jonathan/0000-0003-4013-679X; Sakowitz, Oliver/0000-0003-3248-6335; Sanchez-Porras, Renan/0000-0002-9084-8114; Radoi, Andreea/0000-0002-0677-3544	European Commission 7th Framework program [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	This research is funded by the European Commission 7th Framework program (602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA) and from Neurotrauma Sciences (USA). The funders had no role in the design of the study and collection, analysis, interpretation of data and in writing the manuscript.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kelly Deirdre, 2016, Radiol Case Rep, V11, P222, DOI 10.1016/j.radcr.2016.04.009; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Schrijvers LH, 2016, BRIT J HAEMATOL, V174, P454, DOI 10.1111/bjh.14072; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; van Buuren S, 2011, J STAT SOFTW, V45, P1; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	28	11	11	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2020	46	5					995	1004		10.1007/s00134-020-05965-z		FEB 2020	10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO4ZQ	WOS:000516645600001	32100061	Green Accepted, Green Published, hybrid, Green Submitted			2022-02-06	
J	Cai, ZX; Li, SY; Zhang, WJ; Pracitto, R; Wu, XA; Baum, E; Finnema, SJ; Holden, D; Toyonaga, T; Lin, SF; Lindemann, M; Shirali, A; Labaree, DC; Ropchan, J; Nabulsi, N; Carson, RE; Huang, YY				Cai, Zhengxin; Li, Songye; Zhang, Wenjie; Pracitto, Richard; Wu, Xiaoai; Baum, Evan; Finnema, Sjoerd J.; Holden, Daniel; Toyonaga, Takuya; Lin, Shu-fei; Lindemann, Marcel; Shirali, Anupama; Labaree, David C.; Ropchan, Jim; Nabulsi, Nabeel; Carson, Richard E.; Huang, Yiyun			Synthesis and Preclinical Evaluation of an F-18-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [F-18]SynVesT-2	ACS CHEMICAL NEUROSCIENCE			English	Article						SV2A; PET; non-human primate; Alzheimer's disease; Parkinson's disease; fluorine-18	MEDIATED RADIOFLUORINATION; BINDING CHARACTERISTICS; PROTEIN 2A; LATE-STAGE; SV2A; LEVETIRACETAM; TRACER; FLUORINATION; ROUTE; BRAIN	Synaptic vesicle glycoprotein 2A (SV2A) is a 12-pass transmembrane glycoprotein ubiquitously expressed in presynaptic vesicles. In vivo imaging of SV2A using PET has potential applications in the diagnosis and prognosis of a variety of neuropsychiatric diseases, e.g., Alzheimer's disease, Parkinson's disease, schizophrenia, multiple sclerosis, autism, epilepsy, stroke, traumatic brain injury, post-traumatic stress disorder, depression, etc. Herein, we report the synthesis and evaluation of a new F-18-labeled SV2A PET imaging probe, [F-18]SynVesT-2, which possesses fast in vivo binding kinetics and high specific binding signals in non-human primate brain.	[Cai, Zhengxin; Li, Songye; Zhang, Wenjie; Pracitto, Richard; Wu, Xiaoai; Baum, Evan; Finnema, Sjoerd J.; Holden, Daniel; Toyonaga, Takuya; Lin, Shu-fei; Lindemann, Marcel; Shirali, Anupama; Labaree, David C.; Ropchan, Jim; Nabulsi, Nabeel; Carson, Richard E.; Huang, Yiyun] Yale Univ, PET Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA; [Zhang, Wenjie; Wu, Xiaoai] Sichuan Univ, West China Hosp, Dept Nucl Med, Lab Clin Nucl Med, Chengdu 610041, Sichuan, Peoples R China		Cai, ZX; Li, SY (corresponding author), Yale Univ, PET Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA.	jason.cai@yale.edu; songye.li@yale.edu	Toyonaga, Takuya/ABE-1742-2021	Toyonaga, Takuya/0000-0002-0369-8294; Li, Songye/0000-0002-6096-8756; Lindemann, Marcel/0000-0002-5883-8004	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01EB023312, R01AG058773, R01AG052560]	This research was supported by NIH K01EB023312, R01AG058773, and R01AGO.52560. Z.C. is an Archer Foundation Research Scientist.	Bahri Mohamed Ali, 2017, Alzheimers Dement (N Y), V3, P481, DOI 10.1016/j.trci.2017.08.004; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Becker G, 2017, MOL PHARMACEUT, V14, P2719, DOI 10.1021/acs.molpharmaceut.7b00235; Bretin F, 2015, MOL IMAGING BIOL, V17, P557, DOI 10.1007/s11307-014-0820-6; Brooks AF, 2014, CHEM SCI, V5, P4545, DOI 10.1039/c4sc02099e; Cai HC, 2014, ACS MED CHEM LETT, V5, P1152, DOI 10.1021/ml500285t; Cai Z., 2017, J NUCL MED, V58, pS547; Cai ZX, 2019, NEUROSCI LETT, V691, P44, DOI 10.1016/j.neulet.2018.07.038; Campbell MG, 2014, ORG PROCESS RES DEV, V18, P474, DOI 10.1021/op400349g; Cardinale J, 2014, RSC ADV, V4, P17293, DOI 10.1039/c4ra00674g; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Constantinescu CC, 2019, MOL IMAGING BIOL, V21, P509, DOI 10.1007/s11307-018-1260-5; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Cunningham VJ, 2010, J CEREBR BLOOD F MET, V30, P46, DOI 10.1038/jcbfm.2009.190; Estrada S, 2016, NUCL MED BIOL, V43, P325, DOI 10.1016/j.nucmedbio.2016.03.004; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Finnema SJ, 2018, J CEREBR BLOOD F MET, V38, P2041, DOI 10.1177/0271678X17724947; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Gillard M, 2006, EUR J PHARMACOL, V536, P102, DOI 10.1016/j.ejphar.2006.02.022; Gillard M, 2003, EUR J PHARMACOL, V478, P1, DOI 10.1016/j.ejphar.2003.08.032; Mendoza-Torreblanca JG, 2013, EUR J NEUROSCI, V38, P3529, DOI 10.1111/ejn.12360; Heurling K, 2019, MOL CELL NEUROSCI, V97, P34, DOI 10.1016/j.mcn.2019.02.001; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Holmes S, 2019, CELEBR STUD, V10, P1, DOI 10.1080/19392397.2019.1565699; Jacobson O, 2015, J NUCL MED, V56, P1780, DOI 10.2967/jnumed.115.160960; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Koole M, 2019, EUR J NUCL MED MOL I, V46, P396, DOI 10.1007/s00259-018-4119-8; Li S., 2017, J NUCL MED, V58, P5851; Li SY, 2019, EUR J NUCL MED MOL I, V46, P1952, DOI 10.1007/s00259-019-04357-w; Li SY, 2019, ACS CHEM NEUROSCI, V10, P1544, DOI 10.1021/acschemneuro.8b00526; LI SY, 2018, J NUCL MED S1, V59; Loscher W, 2016, CNS DRUGS, V30, P1055, DOI 10.1007/s40263-016-0384-x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Makaravage KJ, 2016, ORG LETT, V18, P5440, DOI 10.1021/acs.orglett.6b02911; Mertens N., 2019, MOL IMAGING BIOL, DOI [10.1007/ s11307-019-01387-6., DOI 10.1007/S11307-019-01387-6.]; Mossine AV, 2015, ORG LETT, V17, P5780, DOI 10.1021/acs.orglett.5b02875; Nabulsi NB, 2016, J NUCL MED, V57, P777, DOI 10.2967/jnumed.115.168179; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Patel S, 2020, MOL IMAGING BIOL, V22, P832, DOI 10.1007/s11307-019-01428-0; PIKE VW, 1995, J CHEM SOC CHEM COMM, P2215, DOI 10.1039/C39950002215; Rossano S, 2020, J CEREBR BLOOD F MET, V40, P1890, DOI 10.1177/0271678X19879230; Rotstein BH, 2016, CHEM SCI, V7, P4407, DOI 10.1039/c6sc00197a; Rotstein BH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5365; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sander K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09941; Stephenson NA, 2015, J NUCL MED, V56, P489, DOI 10.2967/jnumed.114.151332; Stockburger C, 2016, J ALZHEIMERS DIS, V50, P201, DOI 10.3233/JAD-150687; Tokudome K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27420; Toyonaga T, 2019, J NUCL MED, V60, P1780, DOI 10.2967/jnumed.118.223867; Tredwell M, 2014, ANGEW CHEM INT EDIT, V53, P7751, DOI 10.1002/anie.201404436; Wang L, 2015, ANGEW CHEM INT EDIT, V54, P12777, DOI 10.1002/anie.201505927; Warnock GI, 2014, J NUCL MED, V55, P1336, DOI 10.2967/jnumed.113.136143; Wilson AA, 2001, APPL RADIAT ISOTOPES, V54, P203, DOI 10.1016/S0969-8043(00)00269-4; Zhang MR, 2007, TETRAHEDRON LETT, V48, P8632, DOI 10.1016/j.tetlet.2007.10.025	55	11	11	2	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	FEB 19	2020	11	4					592	603		10.1021/acschemneuro.9b00618			23	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	KN9VQ	WOS:000515195800010	31961649				2022-02-06	
J	Jones, CMC; Harmon, C; McCann, M; Gunyan, H; Bazarian, JJ				Jones, Courtney Marie Cora; Harmon, Christopher; McCann, Molly; Gunyan, Holly; Bazarian, Jeffrey J.			S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; S100B; clinical decision rules	NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; PREDICTION	Objective: To compare the classification accuracy of S100B to two clinical decision rules- Canadian CT Head Rule (CCHR) and New Orleans Criteria (NOC)-for predicting traumatic intracranial injuries (ICI) after mild traumatic brain injury (mild TBI). Methods: A secondary analysis of a prospective observational study of mild TBI patients was performed. The diagnostic performance of S100B for predicting ICI on head CT was compared to both the CHRR and NOC. Area under receiver operator characteristic (AUC) curves were used and multivariable analysis was used to create a new decision rule based on a combination of S100B and decision rule-related variables. Results: S100B had the highest negative predictive value (97.3%), positive predictive value (7.21%), specificity (33.6%) and positive likelihood ratio (1.3), and the lowest negative likelihood ratio (0.5). The proportion of mild TBI subjects with potentially avoidable head CT scans was highest using S100B (37.7%). The addition of S100B to both clinical decision rules significantly increased AUC. A novel decision rule adding S100B to three decision rule-related variables significantly improved prediction (p < 0.05). Conclusion: Serum S100B outperformed clinical decision rules for identifying mild TBI patients with ICI. Incorporating clinical variables with S100B maximized ICI prediction, but requires validation in an independent cohort.	[Jones, Courtney Marie Cora; Harmon, Christopher; McCann, Molly; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Jones, Courtney Marie Cora] Univ Rochester, Sch Med & Dent, Dept Orthopaed, Rochester, NY USA; [Jones, Courtney Marie Cora; McCann, Molly; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Gunyan, Holly] SMHC Emergency Dept, One Med Ctr Dr, Biddeford, ME USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Phys Med & Rehabil, Rochester, NY USA		Jones, CMC (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	courtney_jones@urmc.rochester.edu			New York State Department of Health [C807623]	This work was supported by the New York State Department of Health [Contract #C807623].	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Board A, 2015, NEW EV HEAD CT SCAN; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tubiana M, 2008, NEW ENGL J MED, V358, P850, DOI 10.1056/NEJMc073513; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	22	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					407	414		10.1080/02699052.2020.1725123		FEB 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000518164900001	32064945				2022-02-06	
J	Helbok, R; Hartings, JA; Schiefecker, A; Balanca, B; Jewel, S; Foreman, B; Ercole, A; Balu, R; Ayata, C; Ngwenya, L; Rosenthal, E; Boutelle, MG; Farkas, E; Dreier, JP; Fabricius, M; Shuttleworth, CW; Carlson, A				Helbok, Raimund; Hartings, Jed A.; Schiefecker, Alois; Balanca, Baptiste; Jewel, Sharon; Foreman, Brandon; Ercole, Ari; Balu, Ramani; Ayata, Cenk; Ngwenya, Laura; Rosenthal, Eric; Boutelle, Martyn G.; Farkas, Eszter; Dreier, Jens P.; Fabricius, Martin; Shuttleworth, C. William; Carlson, Andrew			What Should a Clinician Do When Spreading Depolarizations are Observed in a Patient?	NEUROCRITICAL CARE			English	Article; Proceedings Paper	International Conference on Spreading Depolarizations (iSCD)	SEP 22-24, 2018	Boca Raton, FL			Cortical spreading depression; Electroencephalography; Subarachnoid hemorrhage; Traumatic brain injury; Ischemic Stroke; Intracerebral hemorrhage; Outcome		The International Conference on Spreading Depolarizations (iCSD) held in Boca Raton, Florida, in the September of 2018 devoted a section to address the question, "What should a clinician do when spreading depolarizations are observed in a patient?" Discussants represented a wide range of expertise, including neurologists, neurointensivists, neuroradiologists, neurosurgeons, and pre-clinical neuroscientists, to provide both clinical and basic pathophysiology perspectives. A draft summary of viewpoints offered was then written by a multidisciplinary writing group of iCSD members, based on a transcript of the session. Feedback of all discussants was formally collated, reviewed, and incorporated into the final document which was subsequently approved by all authors.	[Helbok, Raimund; Schiefecker, Alois] Med Univ Innsbruck, Dept Neurol Neurocrit Care, Anichstr 35, A-6020 Innsbruck, Austria; [Hartings, Jed A.; Foreman, Brandon; Ngwenya, Laura] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Hartings, Jed A.; Foreman, Brandon; Ngwenya, Laura] Univ Cincinnati, Coll Med, Collaborat Res Acute Neurol Injury, Cincinnati, OH USA; [Hartings, Jed A.; Foreman, Brandon; Ngwenya, Laura] UC Gardner Neurosci Inst, Cincinnati, OH USA; [Balanca, Baptiste; Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Balanca, Baptiste; Dreier, Jens P.] Free Univ Berlin, Berlin, Germany; [Balanca, Baptiste; Dreier, Jens P.] Humboldt Univ, Berlin, Germany; [Balanca, Baptiste; Dreier, Jens P.] Berlin Inst Hlth, Berlin, Germany; [Balanca, Baptiste] Hop Pierre Wertheimer, Hosp Civils Lyon, Dept Anesthesiol & Intens Care Med, Lyon, France; [Balanca, Baptiste] Lyon Neurosci Res Ctr, Lyon, France; [Balanca, Baptiste] Univ Claude Bernard Lyon 1, SAMSEI, Ctr Lyonnais Enseignement Simulat Sante, Lyon, France; [Jewel, Sharon] Kings Coll London, Dept Basic & Clin Neurosci, London, England; [Foreman, Brandon; Ngwenya, Laura] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Ercole, Ari] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England; [Balu, Ramani] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Ayata, Cenk] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, Charlestown, MA USA; [Rosenthal, Eric] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jewel, Sharon; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England; [Farkas, Eszter] Univ Szeged, Dept Med Informat, H-6720 Szeged, Hungary; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Dreier, Jens P.] Einstein Ctr Neurosci Berlin, Berlin, Germany; [Fabricius, Martin] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Carlson, Andrew] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol Neurocrit Care, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021; balanca, baptiste/W-2261-2018; Carlson, Andrew P/B-4369-2012; Ercole, Ari/B-6288-2009; Rosenthal, Eric/A-2085-2017	balanca, baptiste/0000-0001-7917-9645; Carlson, Andrew P/0000-0003-2189-3699; Ercole, Ari/0000-0001-8350-8093; Rosenthal, Eric/0000-0003-3900-356X; Farkas, Eszter/0000-0002-8478-9664; Ngwenya, Laura/0000-0001-7103-971X	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R00112X/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/R00112X/1] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM109089] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS105950, R01 NS106901, U54 NS100064, R01 NS051288] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline			0	11	11	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2020	32	1					306	310		10.1007/s12028-019-00777-6			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	KK6PD	WOS:000512861100028	31338747	Green Published, hybrid, Green Accepted			2022-02-06	
J	Yang, LY; Greig, NH; Tweedie, D; Jung, YJ; Chiang, YH; Hoffer, BJ; Miller, JP; Chang, KH; Wang, JY				Yang, Ling-Yu; Greig, Nigel H.; Tweedie, David; Jung, Yoo Jin; Chiang, Yung-Hsiao; Hoffer, Barry J.; Miller, Jonathan P.; Chang, Ke-Hui; Wang, Jia-Yi			The p53 inactivators pifithrin-mu and pifithrin-alpha mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury (TBI); p53; Pifithrin analogs; PFT-alpha; PFT-mu; Autophagy; Neuroinflammation; Mitophagy	TRAUMATIC BRAIN-INJURY; SMALL-MOLECULE INHIBITOR; TUMOR-SUPPRESSOR GENE; BCL-2 FAMILY PROTEINS; FUNCTIONAL OUTCOMES; PROTECTS MICE; CELL-DEATH; APOPTOSIS; PATHOPHYSIOLOGY; INFLAMMATION	Traumatic brain injury (TBI) is one of the most common causes of death and disability worldwide. We investigated whether inhibition of p53 using pifithrin (PFT)-alpha or PFT-mu provides neuroprotective effects via p53 transcriptional dependent or -independent mechanisms, respectively. Sprague Dawley rats were subjected to controlled cortical impact TBI followed by the administration of PFT alpha or PFT-mu (2 mg/kg, i.v.) at 5 h after TBI. Brain contusion volume, as well as sensory and motor functions were evaluated at 24 h after TBI. TBI-induced impairments were mitigated by both PFT-alpha and PFT-mu. Fluoro-Jade C staining was used to label degenerating neurons within the TBI-induced cortical contusion region that, together with Annexin V positive neurons, were reduced by PFT-mu. Double immunofluorescence staining similarly demonstrated that PFT-mu significantly increased HO-1 positive neurons and mRNA expression in the cortical contusion region as well as decreased numbers of 4-hydroxynonenal (4HNE)-positive cells. Levels of mRNA encoding for p53, autophagy, mitophagy, anti-oxidant, anti-inflammatory related genes and proteins were measured by RT-qPCR and immunohistochemical staining, respectively. PFT-alpha, but not PFT-mu, significantly lowered p53 mRNA expression. Both PFT-alpha and PFT-mu lowered TBI-induced pro-inflammatory cytokines (IL-1 beta and IL-6) mRNA levels as well as TBI-induced autophagic marker localization (LC3 and p62). Finally, treatment with PFT-mu mitigated TBI-induced declines in mRNA levels of PINK-1 and SOD2. Our data suggest that both PFT-mu and PFT-alpha provide neuroprotective actions through regulation of oxidative stress, neuroinflammation, autophagy, and mitophagy mechanisms, and that PFT-mu, in particular, holds promise as a TBI treatment strategy.	[Yang, Ling-Yu; Chang, Ke-Hui; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Greig, Nigel H.; Tweedie, David; Jung, Yoo Jin] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao; Wang, Jia-Yi] Taipei Med Univ Hosp, Dept Neurosurg, 250Wu Hsing St, Taipei 110, Taiwan; [Chiang, Yung-Hsiao; Wang, Jia-Yi] Taipei Med Univ, Neurosci Res Ctr, 250Wu Hsing St, Taipei 110, Taiwan; [Hoffer, Barry J.; Miller, Jonathan P.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA		Wang, JY (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, 250Wu Hsing St, Taipei 110, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Neurosci Res Ctr, 250Wu Hsing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	National Institute on Aging, National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3, MOST 108-2321-B-038-008, MOST 108-2811-B-002-637]; National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56 AG057028]; Taipei Medical University, Taipei, Taiwan [DP2-107-21121-01-N-05]	This research was supported in part by (i) the Intramural Research Program, National Institute on Aging, National Institutes of Health, USA, and (ii) grants from (a) the Ministry of Science and Technology (MOST104-2923-B-038-001-MY3 and MOST 108-2321-B-038-008 to JYW and YHC, MOST 108-2811-B-002-637 to LYY), Taiwan. (b) DP2-107-21121-01-N-05 to JYW, Taipei Medical University, Taipei, Taiwan, and (c) National Institutes of Health R56 AG057028 to BJH, USA.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Arango D, 2001, CANCER RES, V61, P4910; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bassi L, 2002, MUTAT RES-FUND MOL M, V499, P163, DOI 10.1016/S0027-5107(01)00273-1; Charlot JF, 2006, APOPTOSIS, V11, P813, DOI 10.1007/s10495-006-5876-6; Checler F, 2014, PHARMACOL THERAPEUT, V142, P99, DOI 10.1016/j.pharmthera.2013.11.009; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen YH, 2019, NEUROTOX RES, V36, P347, DOI 10.1007/s12640-019-00050-w; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Filichia E, 2015, NEUROSCIENCE, V295, P1, DOI 10.1016/j.neuroscience.2015.03.018; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Golubovskaya VM, 2013, SURG ONCOL CLIN N AM, V22, P747, DOI 10.1016/j.soc.2013.06.003; Greig N, 2002, International Patent Application, Patent No. [WO 02/004409, 02004409]; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Gudkov AV, 2007, HUM MOL GENET, V16, pR67, DOI 10.1093/hmg/ddm052; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Havre PA, 2002, CANCER RES, V62, P1443; Hoagland MS, 2005, J PHARMACOL EXP THER, V314, P603, DOI 10.1124/jpet.105.084186; Hsueh S.-C, 2019, CELL TRANSPLANT; Huang Y., 2018, SCI REP, V8, P923; Jamil S, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0231-z; Jebelli J, 2014, NEUROSCI LETT, V583, P92, DOI 10.1016/j.neulet.2014.08.049; Jembrek MJ, 2018, PROG NEUROBIOL, V168, P104, DOI 10.1016/j.pneurobio.2018.05.001; Jiang L, 2010, DECISION MAKING P53, V2; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu PT, 2006, SHOCK, V26, P608, DOI 10.1097/01.shk.0000232273.11225.af; Lu T, 2017, NEUROTOX RES, V32, P218, DOI 10.1007/s12640-017-9723-z; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maj MA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00108; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mossalam M, 2012, MOL PHARMACEUT, V9, P1449, DOI 10.1021/mp3000259; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Neis VB, 2018, CURR PHARM DESIGN, V24, P2283, DOI 10.2174/1381612824666180717160623; Nijboer CH, 2011, ANN NEUROL, V70, P255, DOI 10.1002/ana.22413; Parrales A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00288; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qin JZ, 2002, ONCOGENE, V21, P2991, DOI 10.1038/sj.onc.1205404; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sparfel L, 2006, CARCINOGENESIS, V27, P656, DOI 10.1093/carcin/bgi256; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Szybinska A, 2017, AGING DIS, V8, P506, DOI 10.14336/AD.2016.1120; Toillon R.A, 2002, NORMAL BREAST EPITHE, V275; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wan CH, 2013, J MOL NEUROSCI, V51, P695, DOI 10.1007/s12031-013-0050-4; Wang J.Y, 2016, J NEUROINFLAMMATION, V13; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhu XX, 2002, J MED CHEM, V45, P5090, DOI 10.1021/jm020044d	65	11	11	4	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2020	324								113135	10.1016/j.expneurol.2019.113135			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF7MN	WOS:000509423400011	31778663	Green Accepted			2022-02-06	
J	Zhong, WW; Yuan, Y; Gu, XH; Kim, SIY; Chin, R; Loye, M; Dix, TA; Weil, L; Yu, SP				Zhong, Weiwei; Yuan, Yan; Gu, Xiaohuan; Kim, Samuel In-young; Chin, Ryan; Loye, Modupe; Dix, Thomas A.; Weil, Ling; Yu, Shan Ping			Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse	AGING AND DISEASE			English	Article						stroke; pharmacological hypothermia; post-stroke depression (PSD); BDNF; oxytocin	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; POSTSTROKE DEPRESSION; THERAPEUTIC HYPOTHERMIA; FUNCTIONAL RECOVERY; SERUM-LEVELS; CIRCUITS; MODEL; INTERLEUKIN-6; DEGENERATION	Stroke is a leading cause of human death and disability, with around 30% of stroke patients develop neuropsychological/neuropsychiatric symptoms, such as post-stroke depression (PSD). Basic and translational research on post-stroke psychological disorders is limited. In a focal ischemic stroke mouse model with selective damage to the sensorimotor cortex, sensorimotor deficits develop soon after stroke and spontaneous recovery is observed in 2-4 weeks. We identified that mice subjected to a focal ischemic insult gradually developed depression/anxiety like behaviors 4 to 8 weeks after stroke. Psychological/psychiatric disorders were revealed in multiple behavioral examinations, including the forced swim, tail suspension, sucrose preference, and open field tests. Altered neuronal plasticity such as suppressed long-term potentiation (LTP), reduced BDNF and oxytocin signaling, and disturbed dopamine synthesis/uptake were detected in the prefrontal cortex (PFC) during the chronic phase after stroke. Pharmacological hypothermia induced by the neurotensin receptor 1 (NTR1) agonist HPI-363 was applied as an acute treatment after stroke. A six-hr hypothermia treatment applied 45 min after stroke prevented depression and anxiety like behaviors examined at 6 weeks after stroke, as well as restored BDNF expression and oxytocin signaling. Additionally, hypothermia induced by physical cooling also showed an anti-depression and anti-anxiety effect. The data suggested a delayed beneficial effect of acute hypothermia treatment on chronically developed post-stroke neuropsychological disorders, associated with regulation of synaptic plasticity, neurotrophic factors, dopaminergic activity, and oxytocin signaling in the PFC.	[Zhong, Weiwei; Yuan, Yan; Gu, Xiaohuan; Kim, Samuel In-young; Chin, Ryan; Weil, Ling; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Zhong, Weiwei; Gu, Xiaohuan; Loye, Modupe; Yu, Shan Ping] Atlanta Vet Affairs Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA; [Yuan, Yan] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Dix, Thomas A.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29401 USA		Yu, SP (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA.	spyu@emory.edu			VA Merit grants [RX000666, RX001473]; VA ShEEP grant [BX-16-015]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085568]	This work was supported by VA Merit grants RX000666, RX001473 and the VA ShEEP grant BX-16-015. It was also supported by the NIH R01 grant NS085568. Authors are grateful for technical advices from Myles Randolph McCrary and supplemental images provided by Dr. Zheng Z. Wei.	Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Bonaccorso S, 2001, PSYCHIAT RES, V105, P45, DOI 10.1016/S0165-1781(01)00315-8; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Boyko M, 2013, COGN AFFECT BEHAV NE, V13, P847, DOI 10.3758/s13415-013-0177-3; Brecht S, 2009, ANAT REC, V292, P1993, DOI 10.1002/ar.20994; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Chen DD, 2018, NEUROTHERAPEUTICS, V15, P770, DOI 10.1007/s13311-018-0635-2; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Chun HYY, 2018, STROKE, V49, P556, DOI 10.1161/STROKEAHA.117.020078; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eagle A.L., 2016, BIOPROTOC, V6, pE1822, DOI 10.21769/bioprotoc.1822; Eagle AL, 2015, J NEUROSCI, V35, P13773, DOI 10.1523/JNEUROSCI.2083-15.2015; Egorova N, 2018, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0038-x; Eyre HA, 2016, PROG NEURO-PSYCHOPH, V68, P1, DOI 10.1016/j.pnpbp.2016.02.006; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Frijling JL, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1302652; Gelderblom M, 2012, J CEREBR BLOOD F MET, V32, P835, DOI 10.1038/jcbfm.2011.189; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Kim JS, 2016, J STROKE, V18, P244, DOI 10.5853/jos.2016.01144; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kokko KP, 2005, NEUROPHARMACOLOGY, V48, P417, DOI 10.1016/j.neuropharm.2004.10.008; Kronenberg G, 2014, BRIT J PHARMACOL, V171, P4673, DOI 10.1111/bph.12775; Kronenberg G, 2012, BIOL PSYCHIAT, V72, P273, DOI 10.1016/j.biopsych.2012.02.026; Lee JH, 2018, EXP NEUROL, V305, P1, DOI 10.1016/j.expneurol.2018.02.015; Lee JH, 2017, NEURAL REGEN RES, V12, P341, DOI 10.4103/1673-5374.202915; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Liu W, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6871089; Lokk J, 2010, NEUROPSYCH DIS TREAT, V6, P539, DOI 10.2147/NDT.S7637; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Merendino RA, 2002, MEDIAT INFLAMM, V11, P265, DOI 10.1080/096293502900000131; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Misrani A, 2019, PROG NEURO-PSYCHOPH, V88, P102, DOI 10.1016/j.pnpbp.2018.07.013; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; NEMEROFF CB, 1980, BRAIN RES, V195, P69, DOI 10.1016/0006-8993(80)90867-7; Nordborg C, 1996, ACTA NEUROPATHOL, V91, P61; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Orwig KS, 2009, J MED CHEM, V52, P1803, DOI 10.1021/jm801072v; Owen BM, 2001, ACTA PSYCHIAT SCAND, V103, P226, DOI 10.1034/j.1600-0447.2001.00162.x; Pittenger Christopher, 2013, Dialogues Clin Neurosci, V15, P455; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Shi Y, 2017, ADVANCES IN ENERGY AND ENVIRONMENT RESEARCH, P3; Sladojevic N, 2014, NEUROBIOL DIS, V67, P57, DOI 10.1016/j.nbd.2014.03.010; Song MK, 2013, CELL TRANSPLANT, V22, P2001, DOI 10.3727/096368912X657909; Spalletta G, 2013, J NEUROPSYCH CLIN N, V25, P255, DOI 10.1176/appi.neuropsych.12120399; Sugerman NT, 2009, J NEUROTRAUM, V26, P371, DOI 10.1089/neu.2008.0588; Sweatt JD, 2016, J NEUROCHEM, V139, P179, DOI 10.1111/jnc.13580; Tennant KA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15879; Vahid-Ansari F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.124; Wang LL, 2017, INT J DEV NEUROSCI, V57, P77, DOI 10.1016/j.ijdevneu.2017.01.002; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552; Yankelevitch-Yahav R, 2015, J VIS EXP; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	66	11	11	2	5	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	FEB 1	2020	11	1					1	16		10.14336/AD.2019.0507			16	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	KC9TF	WOS:000507513900001	32010477	Green Published, gold			2022-02-06	
J	Karton, C; Hoshizaki, TB; Gilchrist, MD				Karton, Clara; Hoshizaki, T. Blaine; Gilchrist, Michael D.			A novel repetitive head impact exposure measurement tool differentiates player position in National Football League	SCIENTIFIC REPORTS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; WHITE-MATTER INTEGRITY; DIFFUSE AXONAL INJURY; BRAIN-INJURY; PROFESSIONAL FOOTBALL; 1ST EXPOSURE; NFL PLAYERS; CONCUSSION; RECONSTRUCTION; TOLERANCE	American-style football participation poses a high risk of repetitive head impact (RHI) exposure leading to acute and chronic brain injury. The complex nature of symptom expression, human predisposition, and neurological consequences of RHI limits our understanding of what constitutes as an injurious impact affecting the integrity of brain tissue. Video footage of professional football games was reviewed and documentation made of all head contact. Frequency of impact, tissue strain magnitude, and time interval between impacts was used to quantify RHI exposure, specific to player field position. Differences in exposure characteristics were found between eight different positions; where three unique profiles can be observed. Exposure profiles provide interpretation of the relationship between the traumatic event(s) and how tissue injury is manifested and expressed. This study illustrates and captures an objective measurement of RHI on the field, a critical component in guiding public policy and guidelines for managing exposure.	[Karton, Clara; Hoshizaki, T. Blaine] Univ Ottawa, Hlth Sci, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland		Karton, C (corresponding author), Univ Ottawa, Hlth Sci, Ottawa, ON K1N 6N5, Canada.	ckart020@uottawa.ca			National Football League Players Association	The authors would like to thank the study participants, advisors, and staff of the Football Players Health Study. The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliated academic health care centers, or the National Football League Players Association.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Campbell K. G., 2014, THESIS; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Cournoyer J, 2019, THESIS; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Di Mascio M, 2013, J STRENGTH COND RES, V27, P909, DOI 10.1519/JSC.0b013e31825ff099; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Horgan T, 2005, THESIS; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ignacy T, 2017, THESIS; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karton C., 2016, P TRAUM BRAIN INJ CL; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M., 2016, THESIS; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nahum AM, 1977, P 21 STAPP CAR CRASH; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Neselius S, 2015, KNEE SURG SPORT TR A, V23, P2536, DOI 10.1007/s00167-014-3066-6; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Newman J., 1999, INT RES COUNC BIOM I, P17; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Oeur A, 2014, P ASTM INT C ATL GEO; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169, DOI 10.1080/02701367.1983.10605290; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Post A, 2014, J SPORTS ENG TECH, V229, P17; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Ruan J, 1994, THESIS; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith DH, 1999, J NEUROSCI, V19, P4263; Society of Automotive Engineers International, 2007, SURF VEH REC PRACT, pJ211; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2015, NEUROLOGY, V85, P1008; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zanetti K, 2013, P IRCOBI C GOTH SWED; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L, 2003, SUMM BIOENG C KEY BI; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	113	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 28	2020	10	1							1200	10.1038/s41598-019-54874-9			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NE8MP	WOS:000562859900001	31992719	Green Published, gold			2022-02-06	
J	Michinaga, S; Tanabe, A; Nakaya, R; Fukutome, C; Inoue, A; Iwane, A; Minato, Y; Tujiuchi, Y; Miyake, D; Mizuguchi, H; Koyama, Y				Michinaga, Shotaro; Tanabe, Ayami; Nakaya, Ryusei; Fukutome, Chihiro; Inoue, Anna; Iwane, Aya; Minato, Yukiko; Tujiuchi, Yu; Miyake, Daisuke; Mizuguchi, Hiroyuki; Koyama, Yutaka			Angiopoietin-1/Tie-2 signal after focal traumatic brain injury is potentiated by BQ788, an ETB receptor antagonist, in the mouse cerebrum: Involvement in recovery of blood-brain barrier function	JOURNAL OF NEUROCHEMISTRY			English	Article						angippoietin-1; Tie-2; blood-brain barrier; endothelin	ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; NEUROLOGICAL OUTCOMES; CULTURED ASTROCYTES; CEREBROSPINAL-FLUID; SPINAL-CORD; EXPRESSION; ACTIVATION; DISRUPTION; ISCHEMIA	Angiopoietin-1, an angiogenic factor, stabilizes brain microvessels through Tie-2 receptor tyrosine kinase. In traumatic brain injury, blood-brain barrier (BBB) disruption is an aggravating factor that induces brain edema and neuroinflammation. We previously showed that BQ788, an endothelin ETB receptor antagonist, promoted recovery of BBB function after lateral fluid percussion injury (FPI) in mice. To clarify the mechanisms underlying BBB recovery mediated by BQ788, we examined the involvements of the angiopoietin-1/Tie-2 signal. When angiopoietin-1 production and Tie-2 phosphorylation were assayed by quantitative reverse transcription polymerase chain reaction and western blotting, increased angiopoietin-1 production and Tie-2 phosphorylation were observed in 7-10 days after FPI in the mouse cerebrum, whereas no significant effects were obtained at 5 days. When BQ788 (15 nmol/day, i.c.v.) were administered in 2-5 days after FPI, increased angiopoietin-1 production and Tie-2 phosphorylation were observed. Immunohistochemical observations showed that brain microvessels and astrocytes contained angiopoietin-1 after FPI, and brain microvessels also contained phosphorylated Tie-2. Treatment with endothelin-1 (100 nM) decreased angiopoietin-1 production in cultured astrocytes and the effect was inhibited by BQ788 (1 mu M). Five days after FPI, increased extravasation of Evans blue dye accompanied by reduction in claudin-5, occludin, and zonula occludens-1 proteins were observed in mouse cerebrum while these effects of FPI were reduced by BQ788 and exogenous angiopoietin-1 (1 mu g/day, i.c.v.). The effects of BQ788 were inhibited by co-administration of a Tie-2 kinase inhibitor (40 nmol/day, i.c.v.). These results suggest that BQ788 administration after traumatic brain injury promotes recovery of BBB function through activation of the angiopoietin-1/Tie-2 signal.	[Michinaga, Shotaro; Tanabe, Ayami; Nakaya, Ryusei; Fukutome, Chihiro; Inoue, Anna; Iwane, Aya; Minato, Yukiko; Tujiuchi, Yu; Miyake, Daisuke; Mizuguchi, Hiroyuki] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, Tondabayashi, Osaka, Japan; [Koyama, Yutaka] Kobe Pharmaceut Univ, Lab Pharmacol, Kobe, Hyogo, Japan		Koyama, Y (corresponding author), Kobe Pharmaceut Univ, Lab Pharmacol, Higashinada Ku, Kita Ku, 4-19-1 Motoyama, Kobe, Hyogo 6588558, Japan.	koyama-y@kobepharma-u.ac.jp			Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K07981, 18K06695, 16K18890]	This work was supported by Grant-in-Aid for Scientific Research (C) (Grant Number: 15K07981 and 18K06695) and Grant-in-Aid for Young Scientists (B) (Grant Number: 16K18890) from the Japan Society for the Promotion of Science (JSPS).	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Chatfield DA, 2011, NEUROCRIT CARE, V14, P55, DOI 10.1007/s12028-010-9413-7; Cheng CJ, 2017, INT J MED SCI, V14, P927, DOI 10.7150/ijms.18812; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fischer M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-59; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kajiya K, 2012, AM J PATHOL, V180, P1273, DOI 10.1016/j.ajpath.2011.11.008; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Koyama Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-51; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Michinaga S, 2013, NEUROCHEM INT, V63, P25, DOI 10.1016/j.neuint.2013.04.004; Moss A, 2013, CYTOKINE GROWTH F R, V24, P579, DOI 10.1016/j.cytogfr.2013.05.009; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Reynolds CA, 2011, NEUROL RES, V33, P197, DOI 10.1179/016164111X12881719352499; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Shin HY, 2010, J NEUROSCI RES, V88, P1052, DOI 10.1002/jnr.22274; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Venkat P, 2018, CELL TRANSPLANT, V27, P1744, DOI 10.1177/0963689718791568; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; Wang MM, 2002, EXP NEUROL, V173, P283, DOI 10.1006/exnr.2001.7844; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006	52	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2020	154	3					330	348		10.1111/jnc.14957		JAN 2020	19	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MN9EU	WOS:000509441900001	31957020				2022-02-06	
J	Sharma, S; Ifergan, I; Kurz, JE; Linsenmeier, RA; Xu, D; Cooper, JG; Miller, SD; Kessler, JA				Sharma, Sripadh; Ifergan, Igal; Kurz, Jonathan E.; Linsenmeier, Robert A.; Xu, Dan; Cooper, John G.; Miller, Stephen D.; Kessler, John A.			Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury	ANNALS OF NEUROLOGY			English	Article							NEUROPROTECTION; NEUROINFLAMMATION; OUTCOMES; MODELS; CELLS	Objective There are currently no definitive disease-modifying therapies for traumatic brain injury (TBI). In this study, we present a strong therapeutic candidate for TBI, immunomodulatory nanoparticles (IMPs), which ablate a specific subset of hematogenous monocytes (hMos). We hypothesized that prevention of infiltration of these cells into brain acutely after TBI would attenuate secondary damage and preserve anatomic and neurologic function. Methods IMPs, composed of US Food and Drug Administration-approved 500nm carboxylated-poly(lactic-co-glycolic) acid, were infused intravenously into wild-type C57BL/6 mice following 2 different models of experimental TBI, controlled cortical impact (CCI), and closed head injury (CHI). Results IMP administration resulted in remarkable preservation of both tissue and neurological function in both CCI and CHI TBI models in mice. After acute treatment, there was a reduction in the number of immune cells infiltrating into the brain, mitigation of the inflammatory status of the infiltrating cells, improved electrophysiologic visual function, improved long-term motor behavior, reduced edema formation as assessed by magnetic resonance imaging, and reduced lesion volumes on anatomic examination. Interpretation Our findings suggest that IMPs are a clinically translatable acute intervention for TBI with a well-defined mechanism of action and beneficial anatomic and physiologic preservation and recovery. ANN NEUROL 2020	[Sharma, Sripadh; Cooper, John G.; Kessler, John A.] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Ifergan, Igal; Xu, Dan; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Ifergan, Igal; Xu, Dan; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA; [Kurz, Jonathan E.] Northwestern Univ, Davee Pediat Neurocrit Care Program, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Linsenmeier, Robert A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Linsenmeier, Robert A.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA		Sharma, S (corresponding author), Ward 10-233,303 E Chicago Ave, Chicago, IL 60611 USA.	sripadh.sharma@northwestern.edu	Ifergan, Igal/AAI-9734-2020; Ifergan, Igal/AAR-7849-2021; Sharma, Sripadh/J-2997-2018	Ifergan, Igal/0000-0003-2945-2580; Sharma, Sripadh/0000-0003-2208-130X; Kurz, Jonathan/0000-0002-2259-4263	National Institue of Neurological Disorders and Stroke [F31 NS105451-02]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG054429]; National Institue of Biomedical Imaging and Bioengineering [R01 EB-013198]	This study was supported by National Institue of Neurological Disorders and Stroke F31 NS105451-02 (S.S.), NIH R01 AG054429 (J.A.K.), and National Institue of Biomedical Imaging and Bioengineering R01 EB-013198 (S.D.M.).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aertker BM, 2019, J NEUROSCI RES, V97, P698, DOI 10.1002/jnr.24395; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; [Anonymous], 2015, C TRAUM BRAIN INJ US; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; de Souza RS, 2015, INT ARCH MED; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Glushakova OY, 2020, J NEUROTRAUM, V37, P2401, DOI 10.1089/neu.2018.6145; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jeong SJ, 2017, NEUROBIOL DIS, V108, P73, DOI 10.1016/j.nbd.2017.08.006; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yamasaki R., 2014, CLIN EXP NEUROIMMUNO, V5, P41, DOI [10.1111/cen3.12162, DOI 10.1111/CEN3.12162]	39	11	11	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAR	2020	87	3					442	455		10.1002/ana.25675		JAN 2020	14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KL4FI	WOS:000508429400001	31925846	Green Accepted			2022-02-06	
J	Maiden, MJ; Cameron, PA; Rosenfeld, JV; Cooper, DJ; McLellan, S; Gabbe, BJ				Maiden, Matthew J.; Cameron, Peter A.; Rosenfeld, Jeffrey, V; Cooper, D. James; McLellan, Susan; Gabbe, Belinda J.			Long-Term Outcomes after Severe Traumatic Brain Injury in Older Adults A Registry-based Cohort Study	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						elderly; brain trauma; critical care outcomes; functional performance	GLASGOW COMA SCALE; QUALITY-OF-LIFE; PROGNOSTIC MODELS; TRACHEOSTOMY; MORTALITY; AGE; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; MODERATE	Rationale: Older adults (>65 yr old) account for an increasing proportion of patients with severe traumatic brain injury (TBI), yet clinical trials and outcome studies contain relatively few of these patients. Objectives: To determine functional status 6 months after severe TBI in older adults, changes in this status over 2 years, and outcome covariates. Methods: This was a registry-based cohort study of older adults who were admitted to hospitals in Victoria, Australia, between 2007 and 2016 with severe TBI. Functional status was assessed with Glasgow Outcome Scale Extended (GOSE) 6, 12, and 24 months after injury. Cohort subgroups were defined by admission to an ICU. Features associated with functional outcome were assessed from the ICU subgroup. Measurements and Main Results: The study included 540 older adults who had been hospitalized with severe TBI over the 10-year period; 428 (79%) patients died in hospital, and 456 (84%) died 6 months after injury. There were 277 patients who had not been admitted to an ICU; at 6 months, 268 (97%) had died, 8 (3%) were dependent (GOSE 2-4), and 1 (0.4%) was functionally independent (GOSE 5-8). There were 263 patients who had been admitted to an ICU; at 6 months, 188 (73%) had died, 39 (15%) were dependent, and 32 (12%) were functionally independent. These proportions did not change over longer follow-up. The only clinical features associated with a lower rate of functional independence were Injury Severity Score >25 (adjusted odds ratio, 0.24 [95% confidence interval, 0.09-0.67]; P = 0.007) and older age groups (P = 0.017). Conclusions: Severe TBI in older adults is a condition with very high mortality, and few recover to functional independence.	[Maiden, Matthew J.] Barwon Hlth, Intens Care Unit, POB 281, Geelong, Vic 3220, Australia; [Maiden, Matthew J.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Maiden, Matthew J.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Prahran, Vic, Australia; [Rosenfeld, Jeffrey, V] Alfred Hosp, Dept Neurosurg, Prahran, Vic, Australia; [Cooper, D. James] Alfred Hosp, Intens Care Unit, Prahran, Vic, Australia; [Cameron, Peter A.; Cooper, D. James; McLellan, Susan; Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Gabbe, Belinda J.] Swansea Univ, Med Sch, Hlth Data Res UK, Singleton Park, Wales		Maiden, MJ (corresponding author), Barwon Hlth, Intens Care Unit, POB 281, Geelong, Vic 3220, Australia.	mjmaiden@ozemail.com.au	Cooper, D. James/G-7961-2013; Rosenfeld, Jeffrey/I-2904-2014	Cooper, D. James/0000-0002-5872-9051; Rosenfeld, Jeffrey/0000-0003-3827-9898; Maiden, Matthew/0000-0003-4345-3213; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X	Department of Health and Human Services (State Government of Victoria); Transport Accident Commission; Australian Research CouncilAustralian Research Council [FT170100048]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The Victorian State Trauma Registry is a Department of Health and Human Services (State Government of Victoria) and Transport Accident Commission-funded initiative. B.J.G. was supported by an Australian Research Council Future Fellowship (FT170100048) during preparation of the manuscript. D.J.C. and P.A.C. were supported by National Health and Medical Research Council practitioner fellowships.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Australian Bureau of Statistics, POPULATION; Baron DM, 2016, WIEN KLIN WOCHENSCHR, V128, P397, DOI 10.1007/s00508-016-1004-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2001, RAT TBI REL HOSP AG; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Department of Health & Human Services (State Government of Victoria), VICT TRAUM TRIAG GUI; Department of Health & Human Services (State Government of Victoria), VICT STAT TRAUM REG; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maiden M, 2014, AM J RESP CRIT CARE, V189, P1; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Skrifvars MB, 2018, J NEUROTRAUM, V35, P333, DOI 10.1089/neu.2017.5135; Staples JA, 2016, BRAIN INJURY, V30, P899, DOI 10.3109/02699052.2016.1146964; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	11	11	1	4	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	JAN 15	2020	201	2					167	177		10.1164/rccm.201903-0673OC			11	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	KF6TV	WOS:000509374100013	31657946				2022-02-06	
J	Tschiffely, AE; Statz, JK; Edwards, KA; Goforth, C; Ahlers, ST; Carr, WS; Gill, JM				Tschiffely, Anna E.; Statz, Jonathan K.; Edwards, Katie A.; Goforth, Carl; Ahlers, Stephen T.; Carr, Walter S.; Gill, Jessica M.			Assessing a Blast-Related Biomarker in an Operational Community: Glial Fibrillary Acidic Protein in Experienced Breachers	JOURNAL OF NEUROTRAUMA			English	Article						blast; biomarker; GFAP; military; overpressure; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EXPOSURE; BLOOD	Mild traumatic brain injury (mTBI) is a risk for military personnel due to blast overpressures, which may result from a variety of sources, including artillery and improvised explosive devices. Much research has gone into the search for a biomarker to identify patients with a TBI. The FDA recently identified two proteins, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1), as biomarkers to evaluate suspected brain injury. Our group previously observed changes in UCH-L1 in a military population exposed to repeated blast. In our current study we assessed GFAP protein levels in a military population exposed to repeated blast during a 2-week training protocol. We observed GFAP levels were reduced in the moderate blast cases on days 6 and 7 during the training. Specifically, moderate blast cases showed a 24.07% reduction from baseline on day 6 and a 29.61% reduction on day 7. Further, GFAP levels were negatively correlated with cumulative blast experienced during training and with duration of military service. We observed that repeated blast exposure at low levels may impact acute changes in GFAP. Additionally subacute cumulative blast exposure or duration of service was also a factor in influencing GFAP levels.	[Tschiffely, Anna E.; Statz, Jonathan K.; Goforth, Carl; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Statz, Jonathan K.] Henry M Jackson Fdn, Bethesda, MD USA; [Edwards, Katie A.; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Goforth, Carl] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Carr, Walter S.] Walter Reed Army Inst Res, Dept Behav Biol, Silver Spring, MD USA		Statz, JK (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jonathan.k.statz.ctr@mail.mil		Edwards, Katie/0000-0002-7682-8598	Defense Health Program (DHP) [603115HP.3730.001.A1118]	This work was supported/funded by Defense Health Program (DHP) work unit number 603115HP.3730.001.A1118.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mondello S, 2017, J NEUROTRAUM, V34, P1; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Risling M., 2012, FRONT NEUROL, P1; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Samson K., 2018, NEUROL TODAY, V18, P12, DOI 10.1097/01.NT.0000532091.01255.0b; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	24	11	11	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1091	1096		10.1089/neu.2019.6512		JAN 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000507488100001	31642374	Green Published			2022-02-06	
J	Belgrad, J; De Pace, X; Fields, RD				Belgrad, Jillian; De Pace, XRaffaella; Fields, R. Douglas			Autophagy in Myelinating Glia	JOURNAL OF NEUROSCIENCE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; SCHWANN-CELL DEDIFFERENTIATION; IMPROVES FUNCTIONAL RECOVERY; FIBRILLARY ACIDIC PROTEIN; THIN CORPUS-CALLOSUM; WHITE-MATTER INJURY; PHOSPHATIDYLINOSITOL 3-KINASE; BIOLOGICAL FUNCTIONS; CYTOSOLIC PROTEINS; ALEXANDER-DISEASE	Autophagy is the cellular process involved in transportation and degradation of membrane, proteins, pathogens, and organelles. This fundamental cellular process is vital in development, plasticity, and response to disease and injury. Compared with neurons, little information is available on autophagy in glia, but it is paramount for glia to perform their critical responses to nervous system disease and injury, including active tissue remodeling and phagocytosis. In myelinating glia, autophagy has expanded roles, particularly in phagocytosis of mature myelin and in generating the vast amounts of membrane proteins and lipids that must be transported to form new myelin. Notably, autophagy plays important roles in removing excess cytoplasm to promote myelin compaction and development of oligodendrocytes, as well as in remyelination by Schwann cells after nerve trauma. This review summarizes the cell biology of autophagy, detailing the major pathways and proteins involved, as well as the roles of autophagy in Schwann cells and oligodendrocytes in development, plasticity, and diseases in which myelin is affected. This includes traumatic brain injury, Alexander's disease, Alzheimer's disease, hypoxia, multiple sclerosis, hereditary spastic paraplegia, and others. Promising areas for future research are highlighted.	[Belgrad, Jillian; Fields, R. Douglas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Nervous Syst Dev & Plast, NIH, Bethesda, MD 20892 USA; [De Pace, XRaffaella] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intracellular Prot Trafficking, NIH, Bethesda, MD 20892 USA		Fields, RD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Nervous Syst Dev & Plast, NIH, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov		De Pace, Raffaella/0000-0002-8179-6869; Belgrad, Jillian/0000-0002-2577-2336	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ZIAHD000713-22, ZIAHD001607]	This work was supported by National Institutes of Health Intramural Research Grants ZIAHD000713-22 and ZIAHD001607. We thank Dr. Juan S. Bonifacino for helpful discussion of the manuscript.	Al-Yahyaee S, 2006, NEUROLOGY, V66, P1230, DOI 10.1212/01.wnl.0000208501.52849.dd; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bahrami AH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005817; Bankston AN, 2019, GLIA, V67, P1745, DOI 10.1002/glia.23646; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Brun S, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6030030; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Chen N, 2016, BRAIN DEV-JPN, V38, P507, DOI 10.1016/j.braindev.2015.11.002; Chung CYS, 2019, NAT CHEM BIOL, V15, P776, DOI 10.1038/s41589-019-0308-4; De Pace R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007363; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Dello Russo C, 2013, GLIA, V61, P301, DOI 10.1002/glia.22433; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Donohue E, 2011, J BIOL CHEM, V286, P7290, DOI 10.1074/jbc.M110.139915; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; Ebrahimi-Fakhari D, 2018, GENEREVIEWS; Ebrahimi-Fakhari D, 2014, PEDIATR RES, V75, P217, DOI 10.1038/pr.2013.185; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; Figlia G, 2018, GLIA, V66, P693, DOI 10.1002/glia.23273; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Gore L, 2013, CLIN CANCER RES, V19, P3649, DOI 10.1158/1078-0432.CCR-12-3166; Gould RM, 2004, CURR BIOL, V14, pR903, DOI 10.1016/j.cub.2004.09.076; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hantke J, 2014, BRAIN, V137, P2922, DOI 10.1093/brain/awu257; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hirano M, 2013, NEUROLOGY, V80, P458, DOI 10.1212/WNL.0b013e31827f0fe5; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang HC, 2016, J MOL NEUROSCI, V58, P416, DOI 10.1007/s12031-015-0672-9; Hutton EJ, 2011, J PERIPHER NERV SYST, V16, P295, DOI 10.1111/j.1529-8027.2011.00360.x; Igci M, 2016, GENE, V588, P38, DOI 10.1016/j.gene.2016.04.042; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jang SY, 2017, GLIA, V65, P1848, DOI 10.1002/glia.23200; Jang SY, 2016, GLIA, V64, P730, DOI 10.1002/glia.22957; Jang SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116624; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Jia R, 2017, AUTOPHAGY, V13, P1648, DOI 10.1080/15548627.2017.1343768; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim JK, 2014, NEURAL REGEN RES, V9, P1952, DOI 10.4103/1673-5374.145370; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Ko PY, 2018, J MOL NEUROSCI, V64, P601, DOI 10.1007/s12031-018-1056-8; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Lee S, 2018, AM J PATHOL, V188, P728, DOI 10.1016/j.ajpath.2017.10.021; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Li L, 2010, NEURODEGENER DIS, V7, P265, DOI 10.1159/000276710; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Liang PZ, 2015, NEUROSCI BULL, V31, P435, DOI 10.1007/s12264-015-1545-5; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Marinelli S, 2014, PAIN, V155, P93, DOI 10.1016/j.pain.2013.09.013; MARZELLA L, 1981, VIRCHOWS ARCH B, V36, P219, DOI 10.1007/BF02912068; Matsukawa T, 2011, NEUROGENETICS, V12, P259, DOI 10.1007/s10048-011-0284-7; Mattera R, 2017, P NATL ACAD SCI USA, V114, pE10697, DOI 10.1073/pnas.1717327114; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Muller S, 2017, AUTOIMMUN REV, V16, P856, DOI 10.1016/j.autrev.2017.05.015; Munoz-Galdeano T, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00164; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Ohri SS, 2018, J NEUROSCI, V38, P5900, DOI 10.1523/JNEUROSCI.0679-17.2018; Ohri SS, 2013, NEUROBIOL DIS, V58, P29, DOI 10.1016/j.nbd.2013.04.021; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Olmez A, 2006, NEUROPEDIATRICS, V37, P59, DOI 10.1055/s-2006-923982; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Oz-Levi D, 2012, AM J HUM GENET, V91, P1065, DOI 10.1016/j.ajhg.2012.09.015; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patergnani S, 2018, J NEUROL NEUROSUR PS, V89, P439, DOI 10.1136/jnnp-2017-316234; Pengo N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00303-2; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Roubertie A, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000217; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Satoh J, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-68; Schiffmann R, 2012, GENEREVIEWS, P1993; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Tyler WA, 2011, GLIA, V59, P1754, DOI 10.1002/glia.21221; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; Vaccari I, 2015, HUM MOL GENET, V24, P383, DOI 10.1093/hmg/ddu451; Vontell R, 2015, J NEUROPATH EXP NEUR, V74, P273, DOI 10.1097/NEN.0000000000000172; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Weiss T, 2016, GLIA, V64, P2133, DOI 10.1002/glia.23045; Winner B, 2004, ARCH NEUROL-CHICAGO, V61, P117, DOI 10.1001/archneur.61.1.117; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zare-shahabadi A, 2015, REV NEUROSCIENCE, V26, P385, DOI 10.1515/revneuro-2014-0076; Zhang JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005848; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhou CQ, 2017, CELL RES, V27, P184, DOI 10.1038/cr.2016.146	131	11	13	1	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	JAN 8	2020	40	2					256	266		10.1523/JNEUROSCI.1066-19.2019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KB0QB	WOS:000506203800001	31744863	Green Published, Bronze			2022-02-06	
J	Chalouhi, N; Mouchtouris, N; Al Saiegh, F; Starke, RM; Theofanis, T; Das, SO; Jallo, J				Chalouhi, Nohra; Mouchtouris, Nikolaos; Al Saiegh, Fadi; Starke, Robert M.; Theofanis, Thana; Das, Somnath O.; Jallo, Jack			Comparison of Outcomes in Level I vs Level II Trauma Centers in Patients Undergoing Craniotomy or Craniectomy for Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Craniectomy; Craniotomy; Traumatic brain injury; Trauma centers	CENTER DESIGNATION; AMERICAN-COLLEGE; UNITED-STATES; GUIDELINES; MANAGEMENT; ADHERENCE; MORTALITY; VOLUME	BACKGROUND: Traumatic brain injury (TBI) carries a devastatingly high rate of morbidity and mortality. OBJECTIVE: To assess whether patients undergoing craniotomy/craniectomy for severe TBI fare better at level I than level II trauma centers in a mature trauma system. METHODS: The data were extracted from the Pennsylvania Trauma Outcome Study database. Inclusion criteria were patients > 18 yr with severe TBI (Glasgow Coma Scale [GCS] score less than 9) undergoing craniotomy or craniectomy in the state of Pennsylvania from January 1, 2002 through September 30, 2017. RESULTS: Of 3980 patients, 2568 (64.5%) were treated at level I trauma centers and 1412 (35.5%) at level II centers. Baseline characteristics were similar between the 2 groups except for significantly worse GCS scores at admission in level I centers (P = .002). The rate of in-hospital mortality was 37.6% in level I centers vs 40.4% in level II centers (P = .08). Mean Functional Independence Measure (FIM) scores at discharge were significantly higher in level I (10.9 5.5) than level II centers (9.8 +/- 5.3; P < .005). In multivariate analysis, treatment at level II trauma centers was significantly associated with in-hospital mortality (odds ratio, 1.2; 95% confidence interval, 1.03-1.37; P = .01) and worse FIM scores (odds ratio, 1.4; 95% confidence interval, 1.1-1.7; P = .001). Mean hospital and ICU length of stay were significantly longer in level I centers (P < .005). CONCLUSION: This study showed superior functional outcomes and lower mortality rates in patients undergoing a neurosurgical procedure for severe TBI in level I trauma centers.	[Chalouhi, Nohra; Mouchtouris, Nikolaos; Al Saiegh, Fadi; Theofanis, Thana; Das, Somnath O.; Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Chalouhi, Nohra; Mouchtouris, Nikolaos; Al Saiegh, Fadi; Theofanis, Thana; Das, Somnath O.; Jallo, Jack] Jefferson Hosp Neurosci, Philadelphia, PA USA; [Starke, Robert M.] Miami Univ Hosp, Miami Miller Sch Med, Dept Neurosurg & Radiol, Miami, FL USA		Jallo, J (corresponding author), Thomas Jefferson Univ, Dept Neurol Surg, 909 Walnut St,2 Floor, Philadelphia, PA 19107 USA.; Jallo, J (corresponding author), Jefferson Med Coll, 909 Walnut St,2 Floor, Philadelphia, PA 19107 USA.	Jack.Jallo@jefferson.edu					Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; Mabry CD, 2015, J AM COLL SURGEONS, V220, P446, DOI 10.1016/j.jamcollsurg.2014.12.039; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Rogers FB, 2011, J TRAUMA, V70, P1354, DOI 10.1097/TA.0b013e3182183789; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419	18	11	11	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2020	86	1					107	111		10.1093/neuros/nyy634			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LS6QI	WOS:000536505700038	30690608	hybrid, Green Published			2022-02-06	
J	Nightingale, TE; Zheng, MMZ; Sachdeva, R; Phillips, AA; Krassioukov, AV				Nightingale, Tom E.; Zheng, Mei Mu Zi; Sachdeva, Rahul; Phillips, Aaron A.; Krassioukov, Andrei, V			Diverse cognitive impairment after spinal cord injury is associated with orthostatic hypotension symptom burden	PHYSIOLOGY & BEHAVIOR			English	Article						Spinal cord injuries; Cognition; Blood pressure; Autonomic dysreflexia; Orthostatic hypotension	CEREBRAL-BLOOD-FLOW; AUTONOMIC DYSREFLEXIA; ARTERIAL STIFFNESS; PULSE PRESSURE; FOLLOW-UP; HYPERTENSION; PERFORMANCE; DEFICITS; DYSFUNCTION; PERFUSION	This study: 1) compared cognitive functioning between individuals with chronic (>1 year) spinal cord injury (SCI) and non-injured controls and, 2) assessed associations between symptoms of autonomic dysreflexia and orthostatic hypotension with cognitive functioning in SCI participants with a history of unstable blood pressure (BP). Thirty-two individuals with SCI (C4-L2, American Spinal Injury Association Impairment Scale A-D) and thirty age, sex-matched non-injured controls participated in this study. Participants completed a motor-free neuropsychological test battery assessing 1) memory, 2) attention/concentration/psychomotor speed and, 3) executive function. Nineteen participants with SCI who had injuries >= T6 and a history of unstable BP also completed the Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) questionnaire. Cognitive function was significantly lower in people with SCI across measures of memory and executive function compared to non-injured controls. Significant, moderate-to-large associations were observed between cumulative (frequency x severity) orthostatic hypotension and total BP instability symptoms scores, with measures of attention/concentration/psychomotor speed and executive function. These data demonstrate a 10 - 65% reduced performance across specific realms of cognitive functioning in individuals with SCI relative to non-injured controls. Furthermore, cumulative subjective scores for symptoms of unstable BP were associated with diverse cognitive deficits. These findings, in individuals without co-occurring traumatic brain injury, imply cardiovascular dysregulation plays a role in cognitive deficits observed in this population.	[Nightingale, Tom E.; Zheng, Mei Mu Zi; Sachdeva, Rahul; Krassioukov, Andrei, V] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Nightingale, Tom E.; Sachdeva, Rahul; Krassioukov, Andrei, V] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Zheng, Mei Mu Zi] Univ British Columbia, Fac Med, MD Undergrad Program, Vancouver, BC, Canada; [Phillips, Aaron A.] Univ Calgary, Libin Cardiovasc Inst Alberta, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Phillips, Aaron A.] Univ Calgary, Libin Cardiovasc Inst Alberta, Hotchkiss Brain Inst, Dept Cardiac Sci, Calgary, AB, Canada; [Phillips, Aaron A.] Univ Calgary, Libin Cardiovasc Inst Alberta, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Krassioukov, Andrei, V] Vancouver Coastal Hlth, GF Strong Rehabil Ctr, Vancouver, BC, Canada		Krassioukov, AV (corresponding author), Univ British Columbia, ICORD BSCC, 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	krassioukov@icord.org	Nightingale, Tom E/Q-8525-2019; Sachdeva, Rahul/AAU-3280-2021	Nightingale, Tom E/0000-0003-2947-4931; 	Michael Smith Foundation for Health Research/International Collaboration On Repair Discoveries Trainee Award; Craig H. Neilsen Foundation; University of British Columbia(Bluma Tischler Postdoctoral Fellowship); Wings for Life Foundation; Compute Canada; Natural Sciences and Engineering Research Council (Canada)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Libin Cardiovascular Institute of Alberta; Hotchkiss Brain Institute; Rick Hansen Institute; Heart and Stroke FoundationHeart & Stroke Foundation of Canada; Canadian Foundation for InnovationCanada Foundation for Innovation; Heart & Stroke Canada Foundation [G-16-00012571]; Campus Alberta Neuroscience; BC Knowledge Development FundGeneral Electric	Dr. Tom E. Nightingale is supported by a Michael Smith Foundation for Health Research/International Collaboration On Repair Discoveries Trainee Award. Dr. Rahul Sachdeva is supported by Postdoctoral Fellowships from the Craig H. Neilsen Foundation, Canadian Institutes of Health Research and University of British Columbia(Bluma Tischler Postdoctoral Fellowship). The Phillips Lab is supported by the Wings for Life Foundation (Project Grant), Compute Canada (Resources for Research Groups), Natural Sciences and Engineering Research Council (Canada; Discovery Grant), the Canadian Institutes of Health Research (Project Grant), Alberta Innovates Health Solutions, Campus Alberta Neuroscience, the Libin Cardiovascular Institute of Alberta, the Hotchkiss Brain Institute, and the Rick Hansen Institute. Dr. Krassioukov's laboratory is supported by funds from the Canadian Institute for Health Research, Heart and Stroke Foundation, Canadian Foundation for Innovation, BC Knowledge Development Fund, and the Craig H. Neilsen Foundation. The study was funded by a Heart & Stroke Canada Foundation grant (#G-16-00012571).	Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Baune BT, 2010, PSYCHIAT RES, V176, P183, DOI 10.1016/j.psychres.2008.12.001; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chiaravalloti N.D., 2018, J SPINAL CORD MED, P1; Cragg J, 2012, CAN MED ASSOC J, V184, P66, DOI 10.1503/cmaj.110859; Currie K.D., 2019, SPINAL CORD; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; Duschek S, 2005, BEHAV MED, V30, P149, DOI 10.3200/BMED.30.4.149-160; Duschek S, 2004, PSYCHOPHYSIOLOGY, V41, P905, DOI 10.1111/j.1469-8986.2004.00249.x; Duschek S, 2003, CLIN AUTON RES, V13, P427, DOI 10.1007/s10286-003-0124-4; Duschek S, 2007, CLIN AUTON RES, V17, P69, DOI 10.1007/s10286-006-0379-7; Elias MF, 2012, HYPERTENSION, V60, P260, DOI 10.1161/HYPERTENSIONAHA.111.186429; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Eskey CJ, 2005, NEUROIMAG CLIN N AM, V15, P367, DOI 10.1016/j.nic.2005.05.002; Ferreira I, 2006, AM J HYPERTENS, V19, P1037, DOI 10.1016/j.amjhyper.2006.04.014; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gale CR, 1996, BRIT MED J, V312, P608; Golden CJ, 1978, STROOP COLOR WORD TE; Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c; Hubli M, 2015, AM J HYPERTENS, V28, P173, DOI 10.1093/ajh/hpu122; Iadecola C, 2014, HYPERTENSION, V64, P3, DOI 10.1161/HYPERTENSIONAHA.114.03040; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Khazaeipour Zahra, 2015, Top Spinal Cord Inj Rehabil, V21, P149, DOI 10.1310/sci2102-149; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kitzman P, 2017, J SPINAL CORD MED, V40, P147, DOI 10.1179/2045772314Y.0000000235; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINDAN R, 1980, PARAPLEGIA, V18, P285, DOI 10.1038/sc.1980.51; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Miyatani M, 2014, J SPINAL CORD MED, V37, P556, DOI 10.1179/2045772314Y.0000000261; Molina B, 2018, SPINAL CORD, V56, P796, DOI 10.1038/s41393-018-0076-0; Nightingale T.E., 2019, PM R; Nightingale TE, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0590-z; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Obisesan TO, 2009, CLIN GERIATR MED, V25, P259, DOI 10.1016/j.cger.2009.03.002; Pase MP, 2010, J HYPERTENS, V28, P1724, DOI 10.1097/HJH.0b013e32833b1ee7; Pehrson AL, 2015, EUR J PHARMACOL, V753, P19, DOI 10.1016/j.ejphar.2014.07.044; Phillips AA, 2018, J NEUROTRAUM, V35, P573, DOI 10.1089/neu.2017.5188; Phillips AA, 2015, J NEUROTRAUM, V32, P1927, DOI 10.1089/neu.2015.3903; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Phillips AA, 2013, J NEUROTRAUM, V30, P1551, DOI 10.1089/neu.2013.2972; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Rawlings AM, 2018, NEUROLOGY, V91, pE759, DOI 10.1212/WNL.0000000000006027; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sachdeva R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102464; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Sankari A, 2019, CHEST, V155, P438, DOI 10.1016/j.chest.2018.10.002; Sforza Emilia, 2012, Front Neurol, V3, P87, DOI 10.3389/fneur.2012.00087; Shem Kazuko, 2018, Spinal Cord Ser Cases, V4, P9, DOI 10.1038/s41394-018-0038-y; Sierra C, 2012, CURR HYPERTENS REP, V14, P548, DOI 10.1007/s11906-012-0315-2; Squair JW, 2016, CAN MED ASSOC J, V188, P1100, DOI 10.1503/cmaj.151311; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Wagg AS, 2012, DRUG AGING, V29, P539, DOI 10.2165/11631610-000000000-00000; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Waldstein SR, 2003, CURR DIR PSYCHOL SCI, V12, P9, DOI 10.1111/1467-8721.01212; Wan D, 2014, J SPINAL CORD MED, V37, P2, DOI 10.1179/2045772313Y.0000000098; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Wecht JM, 2004, J SPINAL CORD MED, V27, P255, DOI 10.1080/10790268.2004.11753757; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wolf MS, 2012, J GEN INTERN MED, V27, P1300, DOI 10.1007/s11606-012-2079-4; Wu JC, 2012, NEUROLOGY, V78, P1051, DOI 10.1212/WNL.0b013e31824e8eaa; 2019, TEACH LEARN SOC STUD, P1	68	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN 1	2020	213								112742	10.1016/j.physbeh.2019.112742			6	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	LE6SG	WOS:000526852700012	31738949	Green Published			2022-02-06	
J	Sherer, M; Poritz, JMP; Tulsky, D; Kisala, P; Leon-Novelo, L; Ngan, E				Sherer, Mark; Poritz, Julia M. P.; Tulsky, David; Kisala, Pamela; Leon-Novelo, Luis; Ngan, Esther			Conceptual Structure of Health-Related Quality of Life for Persons With Traumatic Brain Injury: Confirmatory Factor Analysis of the TBI-QOL	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Factor analysis; statistical; Patient reported outcome measures; Quality of life; Rehabilitation	FIT INDEXES	Objective: To determine the factor structure of the Traumatic Brain Injury-Quality of Life (TBI-QOL) measurement system. Design: Observational. Setting: 3 TBI Model Systems rehabilitation centers. Participants: Twenty TBI-QOL item banks were administered to a sample of community-dwelling adults with TBI (N=504) as part of a study of TBI classification. A subsample of participants (n=200) was randomly selected for exploratory factor analyses, while data from the remaining participants (n=304) were used for the confirmatory factor analysis. To examine a wide range of conceptual models, confirmatory factor analyses were conducted on a total of 16 models, ranging from 1 to 7 factors. Interventions: Not applicable. Main Outcome Measures: Not applicable. Results: Initial exploratory factor analysis yielded support for a 5-factor model (negative emotion, cognitive impairment, functioning and participation, positive emotion, pain). Confirmatory factor analysis results, however, indicated a 7-factor model including physical function, physical symptoms, cognition, negative emotion, positive emotion, sense of self, and social participation (model 16; robust fit statistics root mean square error of approximation =.063, standardized root mean square residual =.035, comparative fit index =.955, Tucker-Lewis Index =.943, Bayes Information Criterion =40059.44). Conclusions: The complex 7-factor model of the TBI-QOL provides a more nuanced framework for understanding health-related quality of life for persons with TBI than the commonly used 3-factor model including physical health, mental health, and social health. (C) 2016 by the American Congress of Rehabilitation Medicine	[Sherer, Mark; Poritz, Julia M. P.] TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA; [Sherer, Mark; Poritz, Julia M. P.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Tulsky, David; Kisala, Pamela] Univ Delaware, Coll Hlth Sci, Dept Phys Therapy, Newark, DE USA; [Tulsky, David] Kessler Fdn, W Orange, NJ USA; [Leon-Novelo, Luis; Ngan, Esther] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org	Poritz, Julia/N-9831-2018	Sherer, Mark/0000-0003-1784-7008; Tulsky, David/0000-0002-4335-4509	U.S. Department of Health and Human Services Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research [90RT5007, 90DP0028]	Supported by the U.S. Department of Health and Human Services Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research (grant nos. 90RT5007, 90DP0028).	[Anonymous], 2012, PATIENT REPORTED OUT; Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Brown T., 2015, CONFIRMATORY FACTOR, VSecond; Carle AC, 2015, MED CARE, V53, P894, DOI 10.1097/MLR.0000000000000413; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Clogg C.C., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Revelle W., 2014, PSYCH PROCEDURES PER; Rothrock NE, 2010, J CLIN EPIDEMIOL, V63, P1195, DOI 10.1016/j.jclinepi.2010.04.012; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131	21	11	11	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					62	71		10.1016/j.apmr.2017.04.016			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300007	28527644				2022-02-06	
J	Howell, DR; Brilliant, AN; Meehan, WP				Howell, David R.; Brilliant, Anna N.; Meehan, William P., III			Tandem Gait Test-Retest Reliability Among Healthy Child and Adolescent Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						postural balance; concussions; mild traumatic brain injury; assessment; sports	ERROR SCORING SYSTEM; DUAL-TASK GAIT; SINGLE-TASK; CONCUSSION; BALANCE; PERFORMANCE	Context: The tandem gait test is a method for assessing dynamic postural control and part of the Sport Concussion Assessment Tool, versions 3 and 5. However, its reliability among child and adolescent athletes has yet to be established. Objective: To examine the test-retest reliability of the single-task and dual-task tandem gait test among healthy child and adolescent athletes. Design: Descriptive laboratory study. Setting: Sports injury-prevention center. Patients or Other Participants: Uninjured and healthy athletes between the ages of 9 and 18 years. Intervention(s): Tandem gait measures repeated 3 times across the period of approximately 1 month. Main Outcome Measure(s): Participants completed the tandem gait test under single-task and dual-task (ie, while simultaneously executing a cognitive task) conditions. Our primary outcome measure was completion time during the single-task and dual-task conditions. We also assessed cognitive accuracy and response rate while participants completed the dual-task tandem gait test. Results: Thirty-two child and adolescent athletes completed the study (mean age = 14.3 +/- 2.4 years; females = 16). Single- task tandem gait times were similar across the 3 testing sessions (14.4 +/- 4.8, 13.5 +/- 4.2, and 13.8 +/- 4.8 seconds; P = .45). Dual-task tandem gait times steadily improved across the test timeline (18.6 +/- 6.9, 16.6 +/- 4.5, and 15.8 +/- 4.7 seconds; P = .02). Bivariate correlations indicated moderately high to high agreement from test 1 to test 2 (single-task r= .627; dual-task r= 0.655) and from test 2 to test 3 (single-task r= 0.852; dual-task r = 0.775). Both the single-task (intraclass correlation coefficient; ICC [3,1] = 0.86; 95% confidence interval [CI] = 0.73, 0.93) and dual-task (ICC [3,1] = 0.84; 95% CI = 0.69, 0.92) conditions demonstrated high reliability across testing sessions. Conclusions: Tandem gait outcome measures demonstrated high test-retest reliability in both the single- and dual-task conditions. The overall reliability was within the acceptable range for clinical practice, but improvements across tests suggested a moderate practice effect. Tandem gait represents a reliable, dynamic, postural-control test that requires minimal space, cost, and time.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Brilliant, Anna N.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Brilliant, Anna N.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560-01]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS1009521, 1R41NS103698]; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd (Herzliya, Israel); National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS103698] Funding Source: NIH RePORTER	Dr Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560-01) and the National Institute of Neurological Disorders and Stroke (R01NS1009521 and 1R41NS103698) and from a research contract among Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd (Herzliya, Israel). Dr Meehan receives royalties from (1) ABC-Clio (Santa Barbara, CA) for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents and Concussions; (2) Springer International (New York, NY) for the book Head and Neck Injuries in the Young Athlete, and (3) Wolters Kluwer (Alphen aan den Rijn, The Netherlands) for serving as an author for UpToDate software. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League.	Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lezak Muriel D., 2004, NEUROPSYCHOLOGICAL A, VFOURTH, P35; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Safrit M, 1995, INTRO MEASUREMENT PH, V3rd, P71; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Sullivan SJ, 2012, J CLIN NEUROSCI, V19, P423, DOI 10.1016/j.jocn.2011.09.011; Valovich TC, 2003, J ATHL TRAINING, V38, P51	32	11	11	1	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2019	54	12					1254	1259		10.4085/1062-6050-525-18			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JW6PV	WOS:000503172400005	31657636	gold, Green Published			2022-02-06	
J	Li, XQ; Yu, Q; Fang, B; Zhang, ZL; Ma, H				Li, Xiao-Qian; Yu, Qian; Fang, Bo; Zhang, Zai-Li; Ma, Hong			Knockdown of the AIM2 molecule attenuates ischemia-reperfusion-induced spinal neuronal pyroptosis by inhibiting AIM2 inflammasome activation and subsequent release of cleaved caspase-1 and IL-1 beta	NEUROPHARMACOLOGY			English	Article						Absent in melanoma 2; Inflammasome; Ischemia reperfusion injury; Pyroptosis; Caspase-1; IL-1 beta	CORD ISCHEMIA; BRAIN-INJURY; CELL-DEATH; MELANOMA 2; NLRP3; APOPTOSIS; ABSENT	Ischemia-reperfusion (IR) injury induces activation of several inflammasomes that widely affect neuroinflammation and, subsequently, neuronal viability. The absent in melanoma 2 (AIM2) inflammasome is highly expressed in neurons after traumatic injury. This study was performed to investigate whether the AIM2 molecule acts as an initiator to trigger AIM2 inflammasome activation and regulate neuronal pyroptosis in a mouse IR model. The early motor dysfunction that occurred within the first 8 h post-IR injury was closely associated with a massive increase in dsDNA in serum and cerebrospinal fluid (CSF) at the same observed timepoints. However, the subsequent persistent dysfunction was consistent with the continuously increasing protein levels of apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), cleaved caspase-1 and IL-1 beta with time. Upregulated AIM2 immunoreactivity was primarily visualized in neurons. The si-AIM2 treatment in vivo preserved part of motor function, accompanied by decreased protein levels of AIM2, ASC, cleaved caspase-1 and IL-1 beta. In vitro, the direct interactions between the AIM2 molecule and caspase-1 were demonstrated by immunofluorescence staining and coimmunoprecipitation. In this context, both si-AIM2 and Ac-YVAD-CMK treatments effectively maintained neuronal viability, as demonstrated by the decreased percentage of cells with pyroptosis and release of lactate dehydrogenase (LDH), accompanied by weak immunoreactivity and a decreased number of AIM2-caspase-1 positive neurons. By contrast, poly(dA-dT) treatment exacerbated neuronal pyroptosis by reversing the above-mentioned effects. However, no significant differences were observed after si-Con treatment. These results suggest AIM2 molecule played an important role in initiating AIM2 inflammasome activation through IR-induced release of ectopic dsDNA.	[Li, Xiao-Qian; Fang, Bo; Zhang, Zai-Li; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China; [Yu, Qian] China Med Univ, Affiliated Hosp 4, Dept Thorac Surg, Shenyang 110032, Liaoning, Peoples R China		Ma, H (corresponding author), 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China.	shirley037305@hotmail.com; qianyu_cmu@163.com; drunk0630@126.com; zhangzaili333@sina.com; mahong5466@126.com		Li, Xiao-Qian/0000-0001-6676-735X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601053, 81771342]; Scientific Research Project of Liaoning Province Department of Education [LK201636]; Combined Project of the Liaoning Natural Science Foundation [20180530087]	This work was supported by the National Natural Science Foundation of China (No. 81601053 and 81771342), the Scientific Research Project of Liaoning Province Department of Education (No. LK201636) and the Combined Project of the Liaoning Natural Science Foundation (No. 20180530087).	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Asmussen A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1340-3; Chen J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.490; Coutinho-Budd JC, 2017, GENE DEV, V31, P2023, DOI 10.1101/gad.305888.117; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fu J, 2018, J MED FOOD, V21, P13, DOI 10.1089/jmf.2017.4021; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; He GQ, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0178-y; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ismael S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24350-x; Kim HY, 2015, FEBS J, V282, P259, DOI 10.1111/febs.13123; Kwak SB, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/6054069; Lahmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134476; Li XQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0977-4; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0069-7; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-28; Liu Y, 2018, BIOMED PHARMACOTHER, V98, P856, DOI 10.1016/j.biopha.2017.12.079; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Matsumoto S, 2003, ANESTH ANALG, V96, P1777, DOI 10.1213/01.ANE.0000064204.67561.73; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Nazli Y, 2015, J CARDIOTHOR VASC AN, V29, P351, DOI 10.1053/j.jvca.2014.06.028; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sagulenko V, 2018, J MOL BIOL, V430, P238, DOI 10.1016/j.jmb.2017.10.028; Sun Q, 2017, HEPATOLOGY, V65, P253, DOI 10.1002/hep.28893; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Wang SN, 2019, NEURAL REGEN RES, V14, P542, DOI 10.4103/1673-5374.245481; Wang YC, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009859; Wu Q, 2016, WORLD NEUROSURG, V94, P472, DOI 10.1016/j.wneu.2016.07.039; Zhang BQ, 2017, INT IMMUNOPHARMACOL, V49, P222, DOI 10.1016/j.intimp.2017.05.039	37	11	12	3	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC 1	2019	160								107661	10.1016/j.neuropharm.2019.05.038			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	JO0BG	WOS:000497252100021	31181224				2022-02-06	
J	Sinnott, AM; Elbin, RJ; Collins, MW; Reeves, VL; Holland, CL; Kontos, AP				Sinnott, Aaron M.; Elbin, R. J.; Collins, Michael W.; Reeves, Valerie L.; Holland, Cyndi L.; Kontos, Anthony P.			Persistent vestibular-ocular impairment following concussion in adolescents	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Recovery; Neurocognitive; Vestibular; VOMS; Symptom burden	SPORTS-RELATED CONCUSSION; MOTOR SCREENING VOMS; POSTURAL STABILITY; SYMPTOMS; RELIABILITY; PERFORMANCE; SEVERITY; VALIDITY; DEFICITS; INJURY	Objectives: The current study investigated the role of persistent vestibular-ocular symptoms and impairment following sport-related concussion on recovery time and clinical outcomes among adolescents. Design: Prospective cohort. Methods: 50 (F-22/M-28) adolescents aged 12-20 years completed a vestibular-ocular motor screening, neurocognitive assessment, and the Post-Concussion Symptom Scale (PCSS) at clinical assessments conducted at 0-10 and 11-21 days after concussion. Participants were assigned to: 1) persistent vestibular-ocular (PERSIST), 2) vestibular-ocular improvement (IMPROVE), or 3) no vestibular-ocular impairment (NONE) groups based on vestibular-ocular motor screening conducted during each assessment. A 3 (GROUP) X 2 (TIME) ANOVA was performed on neurocognitive and symptom scores, and a between-subjects ANOVA was performed for recovery time. Results: 49 subjects were identified among the PERSIST (n = 17), IMPROVE (n = 12) and NONE (n= 20) groups. There were no neurocognitive performance differences between groups at 0-10 days post-concussion, but groups differed on PCSS at 11-21 days (p =.001), with the PERSIST (29.0 +/- 24.9) group reporting higher symptoms than the NONE (5.45 +/- 10.0; p = .005) group. The PERSIST group took significantly longer to recover (34.9 +/- 11.6 days) than the NONE (22.9 +/- 14.9 days) group (p =.03). All groups improved on verbal (p < .001) and visual memory (p = .028), visual motor speed (p = .005), and reaction time (p = .004) from 0-10 to 11-20 days following SRC and no significant group by time interactions for cognitive scores identified. Conclusions: Persistent post-concussion vestibular-ocular symptoms and impairment may influence neurocognitive performance and clinical recovery following sport-related concussion. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Sinnott, Aaron M.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Neuromuscular Res Lab, Pittsburgh, PA 15260 USA; [Sinnott, Aaron M.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Sports Med & Nutr, Warrior Human Performance Res Ctr, Pittsburgh, PA 15260 USA; [Elbin, R. J.] Univ Arkansas, Off Sport Concuss Res, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Collins, Michael W.; Reeves, Valerie L.; Holland, Cyndi L.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15260 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15260 USA.	akontos@pitt.edu		Sinnott, Aaron/0000-0002-8887-759X	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1 K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1 K01DC012332-01A1) to Dr Kontos.	Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leung FT, 2019, MUSCULOSKEL SCI PRAC, V39, P144, DOI 10.1016/j.msksp.2018.12.007; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Pardini D., 2004, BR J SPORTS MED, V38, P661; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	29	11	11	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2019	22	12					1292	1297		10.1016/j.jsams.2019.08.004			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JT2OD	WOS:000500834200004	31521485	Green Accepted			2022-02-06	
J	Thomas, CN; Thompson, AM; Ahmed, Z; Blanch, RJ				Thomas, Chloe N.; Thompson, Adam M.; Ahmed, Zubair; Blanch, Richard J.			Retinal Ganglion Cells Die by Necroptotic Mechanisms in a Site-Specific Manner in a Rat Blunt Ocular Injury Model	CELLS			English	Article						necroptosis; retinal ganglion cells; cell death; trauma; traumatic optic neuropathy; commotio retinae; photoreceptors	TRAUMATIC OPTIC NEUROPATHY; PHOTOPIC NEGATIVE RESPONSE; MOUSE MODEL; PROGRAMMED NECROSIS; AXONAL DEGENERATION; NLRP3 INFLAMMASOME; VISUAL OUTCOMES; DEATH; NERVE; INHIBITOR	Closed-globe injury can cause visual loss in military and civilian populations, with retinal cell death, including retinal ganglion cell (RGC) degeneration, leading to irreversible blindness. RGC and optic nerve (ON) degeneration after eye or head injury is termed traumatic optic neuropathy (TON). There are currently no treatments for RGC loss, therefore novel therapeutics to prevent RGC death or promote axonal regeneration are a priority. We investigated necroptotic signaling mechanisms in a rat blunt ocular injury model. After bilateral blunt trauma, protein expression and retinal localization of necroptosis pathway members (receptor interacting protein kinase 1, RIPK1; receptor interacting protein kinase 3, RIPK3; and mixed lineage kinase domain like pseudokinase, MLKL) were assessed by Western blot and immunohistochemistry (IHC), and potent necroptosis inhibitor Necrostatin-1s (Nec-1s) was delivered by intravitreal injection to one eye and vehicle to the contralateral eye. RGC and photoreceptor survival were assessed by cell counting and outer nuclear layer (ONL) thickness measurements on histology. The neuroprotective effects of Nec-1s were assessed in primary retinal culture by beta III-tubulin(+) RGC cell counts. MLKL protein expression were upregulated at 48 h after injury and MLKL immunolocalised to retinal binding protein with multiple splice (RBPMS)(+) RGC, inner nuclear cells and ONL cells, specifically at the retinal injury site. RIPK3 expression did not increase but RIPK3 co-immunolocalised with RBPMS+ RGC in intact and injured retinae. In vitro, a Nec-1s concentration of 0.01 pg/mu L was RGC neuroprotective. In the blunt ocular injury rat model, Nec-1s prevented RGC death at the center of the impact site but did not protect against ONL thinning or provide functional restitution. RGC degeneration in our blunt ocular injury model is site-specific, with necroptosis driving death at the center of the focal impact site.	[Thomas, Chloe N.; Thompson, Adam M.; Ahmed, Zubair; Blanch, Richard J.] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Birmingham B15 2TT, W Midlands, England; [Thomas, Chloe N.] Univ Birmingham, Coll Med & Dent Sci, Sch Biomed Sci, Inst Clin Sci, Birmingham B15 2TT, W Midlands, England; [Blanch, Richard J.] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham B15 2TT, W Midlands, England; [Blanch, Richard J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham B15 2TT, W Midlands, England		Ahmed, Z; Blanch, RJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Birmingham B15 2TT, W Midlands, England.; Blanch, RJ (corresponding author), Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham B15 2TT, W Midlands, England.; Blanch, RJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham B15 2TT, W Midlands, England.	c.thomas.4@bham.ac.uk; a.thompson@exeter.ac.uk; z.ahmed.1@bham.ac.uk; r.j.blanch@bham.ac.uk	Thomas, Chloe N/AAQ-9647-2021; Ahmed, Zubair/AAN-1869-2021	Thomas, Chloe N/0000-0002-6202-1347; 	Fight for Sight, UK [1560/1561]; Ministry of Defence, UK; Drummond Foundation (UK); Sir Ian Fraser Foundation, Blind Veterans UK	This work was supported by (1) a Fight for Sight, UK, PhD Studentship (Grant no. 1560/1561); (2) Ministry of Defence, UK; (3) The Drummond Foundation (UK), and (4) Sir Ian Fraser Foundation, Blind Veterans UK.	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Blanch RJ, 2011, EYE, V25, P218, DOI 10.1038/eye.2010.190; Blanch R J, 2008, J R Army Med Corps, V154, P76; Blanch RJ, 2014, INVEST OPHTH VIS SCI, V55, P6350, DOI 10.1167/iovs.13-13708; Blanch RJ, 2013, OPHTHALMOLOGY, V120, P1588, DOI 10.1016/j.ophtha.2013.01.009; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P7220, DOI 10.1167/iovs.12-9887; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Chaon BC, 2015, CURR OPIN OPHTHALMOL, V26, P445, DOI 10.1097/ICU.0000000000000198; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Cougnoux A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.16; Davies KA, 2018, CELL DEATH DIFFER, V25, P1567, DOI 10.1038/s41418-018-0061-3; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Degterev A, 2019, P NATL ACAD SCI USA, V116, P9714, DOI 10.1073/pnas.1901179116; Do YJ, 2017, EXP CELL RES, V359, P30, DOI 10.1016/j.yexcr.2017.08.012; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Feltham R, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.83; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gizycka A, 2015, POSTEP HIG MED DOSW, V69, P1353; Guy WM, 2014, JAMA OPHTHALMOL, V132, P567, DOI 10.1001/jamaophthalmol.2014.82; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Li B, 2005, DOC OPHTHALMOL, V111, P23, DOI [10.1007/s10633-005-2629-8, 10.1007/S10633-005-2629-8]; Lin CY, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.65; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Mead B, 2016, EXP EYE RES, V151, P96, DOI 10.1016/j.exer.2016.08.006; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110612; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; Morgan-Warren PJ, 2016, INVEST OPHTH VIS SCI, V57, P429, DOI 10.1167/iovs.15-17511; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Murakami Y, 2011, ONCOTARGET, V2, P497; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Notman R, 2006, J AM CHEM SOC, V128, P13982, DOI 10.1021/ja063363t; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Politi K, 2016, CURR BIOL, V26, pR932, DOI 10.1016/j.cub.2016.08.052; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Sanchez-Migallon MC, 2016, INVEST OPHTH VIS SCI, V57, P81, DOI 10.1167/iovs.15-17841; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; SIPPERLEY JO, 1978, ARCH OPHTHALMOL-CHIC, V96, P2267, DOI 10.1001/archopht.1978.03910060563021; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Thomas CN, 2018, INVEST OPHTH VIS SCI, V59, P4453, DOI 10.1167/iovs.18-24045; Thomas CN, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.32; Thompson A, 2019, INVEST OPHTH VIS SCI, V60, P1748, DOI 10.1167/iovs.18-26449; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vigneswara V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057861; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Viringipurampeer IA, 2016, HUM MOL GENET, V25, P1501, DOI 10.1093/hmg/ddw029; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wong TY, 2000, OPHTHALMOLOGY, V107, P2196, DOI 10.1016/S0161-6420(00)00390-0; Yang SH, 2017, EMBO MOL MED, V9, P61, DOI 10.15252/emmm.201606566; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub4; Zamaraev AV, 2018, INT J BIOCHEM CELL B, V102, P101, DOI 10.1016/j.biocel.2018.07.006; Zhang S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.286; Zhang XX, 2016, CELL REP, V16, P3247, DOI 10.1016/j.celrep.2016.06.103; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	77	11	11	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2019	8	12							1517	10.3390/cells8121517			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	KB7AN	WOS:000506643500045	31779177	Green Published, gold			2022-02-06	
J	van Iersel, L; Li, ZH; Srivastava, DK; Brinkman, TM; Bjornard, KL; Wilson, CL; Green, DM; Merchant, TE; Pui, CH; Howell, RM; Smith, SA; Armstrong, GT; Hudson, MM; Robison, LL; Ness, KK; Gajjar, A; Krull, KR; Sklar, CA; van Santen, HM; Chemaitilly, W				van Iersel, Laura; Li, Zhenghong; Srivastava, Deo Kumar; Brinkman, Tara M.; Bjornard, Kari L.; Wilson, Carmen L.; Green, Daniel M.; Merchant, Thomas E.; Pui, Ching-Hon; Howell, Rebecca M.; Smith, Susan A.; Armstrong, Gregory T.; Hudson, Melissa M.; Robison, Leslie L.; Ness, Kirsten K.; Gajjar, Amar; Krull, Kevin R.; Sklar, Charles A.; van Santen, Hanneke M.; Chemaitilly, Wassim			Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; GROWTH-HORMONE; ADULT SURVIVORS; CRANIAL IRRADIATION; COMPUTED-TOMOGRAPHY; HYPOPITUITARISM; DYSFUNCTION; RADIATION; LEUKEMIA	Context: Data on hypothalamic-pituitary (HP) disorders in systematically evaluated childhood cancer survivors are limited. Objective: To describe prevalence, risk factors, and associated adverse health outcomes of deficiencies in GH deficiency (GHD), TSH deficiency (TSHD), LH/FSH deficiency (LH/FSHD), and ACTH deficiency (ACTHD), and central precocious puberty (CPP). Design: Retrospective with cross-sectional health outcomes analysis. Setting: Established cohort; tertiary care center. Patients: Participants (N = 3141; median age, 31.7 years) were followed for a median 24.1 years. Main Outcome Measure: Multivariable logistic regression was used to calculate ORs and 95% CIs for associations among HP disorders, tumor- and treatment-related risk factors, and health outcomes. Results: The estimated prevalence was 40.2% for GHD, 11.1% for TSHD, 10.6% for LH/FSHD, 3.2% for ACTHD, and 0.9% for CPP among participants treated with HP radiotherapy (n = 1089), and 6.2% for GHD, and <1% for other HP disorders without HP radiotherapy. Clinical factors independently associated with HP disorders included HP radiotherapy (at any dose for GHD, TSHD, LH/FSHD, >30 Gy for ACTHD), alkylating agents (GHD, LH/FSHD), intrathecal chemotherapy (GHD), hydrocephalus with shunt placement (GHD, LH/FSHD), seizures (TSHD, ACTHD), and stroke (GHD, TSHD, LH/FSHD, ACTHD). Adverse health outcomes independently associated with HP disorders included short stature (GHD, TSHD), severe bone mineral density deficit (GHD, LH/FSHD), obesity (LH/FSHD), frailty (GHD), impaired physical health-related quality of life (TSHD), sexual dysfunction (LH/FSHD), impaired memory, and processing speed (GHD, TSHD). Conclusion: HP radiotherapy, central nervous system injury, and, to a lesser extent, chemotherapy are associated with HP disorders, which are associated with adverse health outcomes.	[van Iersel, Laura; Chemaitilly, Wassim] St Jude Childrens Res Hosp, Div Endocrinol, Memphis, TN 38105 USA; [van Iersel, Laura; van Santen, Hanneke M.] Wilhelmina Childrens Hosp, Dept Pediat Endocrinol, NL-3508 Utrecht, Netherlands; [Li, Zhenghong; Brinkman, Tara M.; Wilson, Carmen L.; Green, Daniel M.; Armstrong, Gregory T.; Hudson, Melissa M.; Robison, Leslie L.; Ness, Kirsten K.; Krull, Kevin R.; Chemaitilly, Wassim] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Srivastava, Deo Kumar] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Brinkman, Tara M.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38105 USA; [Bjornard, Kari L.; Green, Daniel M.; Pui, Ching-Hon; Hudson, Melissa M.; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Merchant, Thomas E.] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN 38105 USA; [Howell, Rebecca M.; Smith, Susan A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Sklar, Charles A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA		Chemaitilly, W (corresponding author), St Jude Childrens Res Hosp, Div Endocrinol, Dept Pediat Med, MS 737,262 Danny Thomas Pl, Memphis, TN 38105 USA.	wassim.chemaitilly@stjude.org	van Santen, HM/AAL-2404-2021; Krull, Kevin R/N-3882-2018; Ness, Kirsten K/N-2550-2018; Bjornard, Kari/AAC-6674-2019; van Iersel, Laura/AAQ-9267-2020; Chemaitilly, Wassim/AAQ-3397-2021; Armstrong, Gregory/N-8096-2018; Hudson, Melissa M/N-4441-2018	Krull, Kevin R/0000-0002-0476-7001; Ness, Kirsten K/0000-0002-2084-1507; van Iersel, Laura/0000-0002-7626-2336; Hudson, Melissa M/0000-0001-6984-2407; van Santen, Hanneke Margo/0000-0002-6773-6931	American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC); National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01 CA195547, P30 CA021765]; Royal Netherlands Academy of Arts and Sciences (Ter Meulen Grant) [TMB17316]; Stichting Kinderen Kankervrij [282]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA195547] Funding Source: NIH RePORTER	L.L.R. was supported by the American Lebanese Syrian Associated Charities, the National Cancer Institute (Grants U01 CA195547 and P30 CA021765); L.v.I. was supported by the Royal Netherlands Academy of Arts and Sciences (Ter Meulen Grant TMB17316); and H.M.v.S. was supported by Stichting Kinderen Kankervrij (Grant 282).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Bhakta N, 2017, LANCET, V390, P2569, DOI 10.1016/S0140-6736(17)31610-0; Birkebaek NH, 1998, MED PEDIATR ONCOL, V30, P351, DOI 10.1002/(SICI)1096-911X(199806)30:6<351::AID-MPO9>3.0.CO;2-D; CANN CE, 1985, BONE, V6, P1, DOI 10.1016/8756-3282(85)90399-0; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Casano-Sancho P, 2017, ARCH DIS CHILD, V102, P572, DOI 10.1136/archdischild-2016-311609; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chemaitilly W, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.3268; Chemaitilly W, 2017, EUR J ENDOCRINOL, V176, pR183, DOI 10.1530/EJE-17-0054; Chemaitilly W, 2016, CLIN ENDOCRINOL, V84, P361, DOI 10.1111/cen.12964; Chemaitilly W, 2015, J CLIN ONCOL, V33, P492, DOI 10.1200/JCO.2014.56.7933; Cheung YT, 2018, JNCI-J NATL CANCER I, V110, P411, DOI 10.1093/jnci/djx224; Clement SC, 2016, J CLIN ONCOL, V34, P4362, DOI 10.1200/JCO.2016.67.5025; Cohen LE, 2012, PEDIATR BLOOD CANCER, V58, P959, DOI 10.1002/pbc.23300; Conners CK., 2001, CONNERS CONTINUOUS P; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Crowne E, 2015, LANCET DIABETES ENDO, V3, P568, DOI 10.1016/S2213-8587(15)00008-X; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Enright Paul L, 2003, Respir Care, V48, P783; Follin C, 2010, J CLIN ENDOCR METAB, V95, P3726, DOI 10.1210/jc.2010-0117; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gan HW, 2015, J CLIN ENDOCR METAB, V100, P3787, DOI 10.1210/jc.2015-2028; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P3682, DOI 10.1210/jc.2003-030366; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; HASLE H, 1995, EUR J PEDIATR, V154, P24, DOI 10.1007/BF01972968; Hudson MM, 2017, CANCER EPIDEM BIOMAR, V26, P666, DOI 10.1158/1055-9965.EPI-16-0812; Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875; Kelly DM, 2015, OBES REV, V16, P581, DOI 10.1111/obr.12282; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Krull KR, 2019, CANCER-AM CANCER SOC, V125, P1748, DOI 10.1002/cncr.31975; Merchant TE, 2011, J CLIN ONCOL, V29, P4776, DOI 10.1200/JCO.2011.37.9453; Murray RD, 2002, J CLIN ENDOCR METAB, V87, P129, DOI 10.1210/jc.87.1.129; Nyberg F, 2013, NAT REV ENDOCRINOL, V9, P357, DOI 10.1038/nrendo.2013.78; Quigg TC, 2012, PEDIATR BLOOD CANCER, V59, P930, DOI 10.1002/pbc.24058; Rose SR, 2004, J PEDIATR ENDOCR MET, V17, P55; Sklar CA, 2018, J CLIN ENDOCR METAB, V103, P2761, DOI 10.1210/jc.2018-01175; Spoudeas HA, 1996, J ENDOCRINOL, V150, P329, DOI 10.1677/joe.0.1500329; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Syrjala KL, 2000, J SEX RES, V37, P213, DOI 10.1080/00224490009552042; Tamhane S, 2018, J CLIN ENDOCR METAB, V103, P2794, DOI 10.1210/jc.2018-01205; van Iersel L, 2018, JAMA ONCOL, V4, P1613, DOI 10.1001/jamaoncol.2018.4420; VOORHESS ML, 1986, CANCER, V57, P1287, DOI 10.1002/1097-0142(19860401)57:7<1287::AID-CNCR2820570706>3.0.CO;2-O; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Waren JE, 2000, SCORE VERSION 2 SF 3; Wechsler D., 2011, WECHSLER ABBREVIATED	53	11	12	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	DEC	2019	104	12					6101	6115		10.1210/jc.2019-00834			15	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KE0FQ	WOS:000508237600045	31373627	Bronze, Green Published			2022-02-06	
J	Boshra, R; Ruiter, KI; DeMatteo, C; Reilly, JP; Connolly, JF				Boshra, Rober; Ruiter, Kyle I.; DeMatteo, Carol; Reilly, James P.; Connolly, John F.			Neurophysiological Correlates of Concussion: Deep Learning for Clinical Assessment	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; SPORT-RELATED CONCUSSION; LONG-TERM; NEURAL-NETWORKS; EEG; CLASSIFICATION; REDUCTION; COMPONENT; MISMATCH	Concussion has been shown to leave the afflicted with significant cognitive and neurobehavioural deficits. The persistence of these deficits and their link to neurophysiological indices of cognition, as measured by event-related potentials (ERP) using electroencephalography (EEG), remains restricted to population level analyses that limit their utility in the clinical setting. In the present paper, a convolutional neural network is extended to capitalize on characteristics specific to EEG/ERP data in order to assess for post-concussive effects. An aggregated measure of single-trial performance was able to classify accurately (85%) between 26 acutely to post-acutely concussed participants and 28 healthy controls in a stratified 10-fold cross-validation design. Additionally, the model was evaluated in a longitudinal subsample of the concussed group to indicate a dissociation between the progression of EEG/ERP and that of self-reported inventories. Concordant with a number of previous studies, symptomatology was found to be uncorrelated to EEG/ERP results as assessed with the proposed models. Our results form a first-step towards the clinical integration of neurophysiological results in concussion management and motivate a multi-site validation study for a concussion assessment tool in acute and post-acute cases.	[Boshra, Rober; Ruiter, Kyle I.; Reilly, James P.; Connolly, John F.] McMaster Univ, ARiEAL Res Ctr, Hamilton, ON, Canada; [Boshra, Rober; Reilly, James P.; Connolly, John F.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada; [Boshra, Rober; Reilly, James P.; Connolly, John F.] MaRS Ctr, Vector Inst, Toronto, ON, Canada; [Ruiter, Kyle I.; Connolly, John F.] McMaster Univ, Linguist & Languages, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Reilly, James P.] McMaster Univ, Elect & Comp Engn, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Psychol Neurosci & Behav, Hamilton, ON, Canada		Boshra, R; Connolly, JF (corresponding author), McMaster Univ, ARiEAL Res Ctr, Hamilton, ON, Canada.; Boshra, R; Connolly, JF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.; Boshra, R; Connolly, JF (corresponding author), MaRS Ctr, Vector Inst, Toronto, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Linguist & Languages, Hamilton, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Psychol Neurosci & Behav, Hamilton, ON, Canada.	boshrar@mcmaster.ca; jconnol@mcmaster.ca	Boshra, Rober/AAE-6466-2019; Reilly, James/AAT-9223-2021	Boshra, Rober/0000-0003-2925-199X; Connolly, John/0000-0001-8869-5369	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Senator William McMaster Chair in Cognitive Neuroscience of Language; MacDATA fellowship award; Vector Institute postgraduate affiliate award; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario	The authors gratefully acknowledge the participants for their time, Ms. Chia-Yu Lin for coordinating and organizing this study, as well as the entire Back-2-Play team for their support. This work was supported by the Canadian Institutes of Health Research (J.F.C. and C.D.), Canada Foundation for Innovation (J.F.C.), Senator William McMaster Chair in Cognitive Neuroscience of Language (J.F.C.), the MacDATA fellowship award (R.B.), the Vector Institute postgraduate affiliate award (RB), and the Ontario Ministry of Research and Innovation (R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Amenedo E, 1998, EVOKED POTENTIAL, V108, P361, DOI 10.1016/S0168-5597(98)00007-0; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Boshra R., 2019, IEEE T NEURAL SYST R; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Cecotti H, 2011, IEEE T PATTERN ANAL, V33, P433, DOI 10.1109/TPAMI.2010.125; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Connolly JF, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029621; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Johnstone SJ, 1996, INT J PSYCHOPHYSIOL, V24, P223, DOI 10.1016/S0167-8760(96)00065-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawhern VJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8c; LUNDBERG S, 2017, 31 C NEUR INF PROC S, V16, P426, DOI DOI 10.3321/J.ISSN:0529-6579.2007.Z1.029; Lundberg S.M, 2017, EXPLAINABLE MACHINE, DOI [10.1101/206540, DOI 10.1101/206540]; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Opalka S, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103451; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Roy Y, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab260c; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Shrikumar A, 2017, PR MACH LEARN RES, V70; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Sturm I, 2016, J NEUROSCI METH, V274, P141, DOI 10.1016/j.jneumeth.2016.10.008; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264	49	11	11	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 22	2019	9								17341	10.1038/s41598-019-53751-9			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JP1UG	WOS:000498056500017	31758044	Green Published, gold			2022-02-06	
J	Schwab, N; Grenier, K; Hazrati, LN				Schwab, Nicole; Grenier, Karl; Hazrati, Lili-Naz			DNA repair deficiency and senescence in concussed professional athletes involved in contact sports	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Senescence; Neurodegeneration; Ageing; Concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; MILD COGNITIVE IMPAIRMENT; CELLULAR SENESCENCE; LAMIN B1; ALZHEIMERS-DISEASE; BRAIN-INJURY; OXIDATIVE STRESS; DAMAGE RESPONSE; CRITICAL ROLES; GLIAL-CELLS	Mild traumatic brain injury (mTBI) leads to diverse symptoms including mood disorders, cognitive decline, and behavioral changes. In some individuals, these symptoms become chronic and persist in the long-term and can confer an increased risk of neurodegenerative disease and dementia diagnosis later in life. Despite the severity of its consequences, the pathophysiological mechanism of mTBI remains unknown. In this post-mortem case series, we assessed DNA damage-induced cellular senescence pathways in 38 professional athletes with a history of repeated mTBI and ten controls with no mTBI history. We assessed clinical presentation, neuropathological changes, load of DNA damage, morphological markers of cellular senescence, and expression of genes involved in DNA damage signaling, DNA repair, and cellular senescence including the senescence-associated secretory phenotype (SASP). Twenty-eight brains with past history of repeated mTBI history had DNA damage within ependymal cells, astrocytes, and oligodendrocytes. DNA damage burden was increased in brains with proteinopathy compared to those without. Cases also showed hallmark features of cellular senescence in glial cells including astrocytic swelling, beading of glial cell processes, loss of H3K27Me3 (trimethylation at lysine 27 of histone H3) and lamin B1 expression, and increased expression of cellular senescence and SASP pathways. Neurons showed a spectrum of changes including loss of emerin nuclear membrane expression, loss of Brahma-related gene-1 (BRG1 or SMARCA4) expression, loss of myelin basic protein (MBP) axonal expression, and translocation of intranuclear tau to the cytoplasm. Expression of DNA repair proteins was decreased in mTBI brains. mTBI brains showed substantial evidence of DNA damage and cellular senescence. Decreased expression of DNA repair genes suggests inefficient DNA repair pathways in this cohort, conferring susceptibly to cellular senescence and subsequent brain dysfunction after mTBI. We therefore suggest that brains of contact-sports athletes are characterized by deficient DNA repair and DNA damage-induced cellular senescence and propose that this may affect neurons and be the driver of brain dysfunction in mTBI, predisposing the progression to neurodegenerative diseases. This study provides novel targets for diagnostic and prognostic biomarkers, and represents viable targets for future treatments.	[Schwab, Nicole; Grenier, Karl; Hazrati, Lili-Naz] Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada; [Schwab, Nicole; Grenier, Karl; Hazrati, Lili-Naz] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada		Hazrati, LN (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.; Hazrati, LN (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	lili-naz.hazrati@sickkids.ca	hazrati, lili-naz/AAE-7785-2020	hazrati, lili-naz/0000-0003-2715-1485	Canadian Concussion Centre	This research was funded by the Canadian Concussion Centre and Road2Recovery.	Abazov VM, 2009, STROKE, V102, DOI DOI 10.1161/STROKEAHA.115.010835; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Antonius D, 2014, J NEUROPSYCH CLIN N, V26, P313, DOI 10.1176/appi.neuropsych.13090201; Aoyama Y, 2013, BRAIN RES, V1515, P48, DOI 10.1016/j.brainres.2013.03.053; Baker DJ, 2018, J CLIN INVEST, V128, P1208, DOI 10.1172/JCI95145; Becker M, 2009, J IMMUNOL, V182, P6136, DOI 10.4049/jimmunol.0802878; Benhamou Y, 2016, ONCOTARGET, V7, P44236, DOI 10.18632/oncotarget.10005; Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.c100466200; Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y; Camps J, 2015, NUCLEUS-PHILA, V6, P8, DOI 10.1080/19491034.2014.1003510; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Chinta SJ, 2015, EXP GERONTOL, V68, P3, DOI 10.1016/j.exger.2014.09.018; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Cohen J, 2019, AGING CELL, V18, DOI 10.1111/acel.12937; Collin G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0300-z; Conde JR, 2006, NEUROBIOL AGING, V27, P1451, DOI 10.1016/j.neurobiolaging.2005.07.012; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Crowe EP, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00208; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; de Andrade GG, 2018, NEUROIMMUNOMODULAT, V25, P18, DOI 10.1159/000488943; de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deng L, 2015, BRAIN RES, V1622, P186, DOI 10.1016/j.brainres.2015.06.027; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Diniz BS, 2017, AM J GERIAT PSYCHIAT, V25, P64, DOI 10.1016/j.jagp.2016.08.018; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; El Husseini N, 2018, TOXICOL SCI, V162, P439, DOI 10.1093/toxsci/kfx270; Espay AJ, 2019, NEUROLOGY, V92, P329, DOI 10.1212/WNL.0000000000006926; Fakhran S, 2014, PROG NEUROL SURG, V28, P234, DOI 10.1159/000358787; Fielder E, 2017, J ALZHEIMERS DIS, V60, pS107, DOI 10.3233/JAD-161221; Flanary B, 2005, REJUV RES, V8, P82, DOI 10.1089/rej.2005.8.82; Fredebohm J, 2013, J CELL SCI, V126, P3380, DOI 10.1242/jcs.124768; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Frost B, 2016, NUCLEUS-PHILA, V7, P275, DOI 10.1080/19491034.2016.1183859; Frost B, 2016, CURR BIOL, V26, P129, DOI 10.1016/j.cub.2015.11.039; Garwood CJ, 2017, NEUROPATH APPL NEURO, V43, P281, DOI 10.1111/nan.12338; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Gonzalez-Meljem JM, 2018, BRIT J CANCER, V118, P1283, DOI 10.1038/s41416-018-0066-1; Graziano S, 2016, ONCOGENE, V35, P5362, DOI 10.1038/onc.2016.77; Gruosso T, 2016, EMBO MOL MED, V8, P527, DOI 10.15252/emmm.201505891; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haldenwanger A, 2010, J ALZHEIMERS DIS, V22, P971, DOI 10.3233/JAD-2010-101203; Havre PA, 1998, CANCER RES, V58, P4733; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Heng MY, 2013, J CLIN INVEST, V123, P2719, DOI 10.1172/JCI66737; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hestad KA, 2016, NEUROPSYCH DIS TREAT, V12, P817, DOI 10.2147/NDT.S101925; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoare M, 2013, NAT CELL BIOL, V15, P887, DOI 10.1038/ncb2811; Hutchison CJ, 2014, SEMIN CELL DEV BIOL, V29, P158, DOI 10.1016/j.semcdb.2013.12.012; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iacono D, 2014, J NEUROPATH EXP NEUR, V73, P295, DOI 10.1097/NEN.0000000000000052; Iida A, 2015, DEV NEUROBIOL, V75, P947, DOI 10.1002/dneu.22261; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Ito T, 2018, CELL REP, V22, P3480, DOI 10.1016/j.celrep.2018.03.002; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kaminsky N, 2016, GENOM PROTEOM BIOINF, V14, P155, DOI 10.1016/j.gpb.2016.04.003; Kandhaya-Pillai R, 2017, AGING-US, V9, P2411, DOI 10.18632/aging.101328; Kern S, 2014, BRAIN BEHAV IMMUN, V41, P55, DOI 10.1016/j.bbi.2014.05.006; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kim YM, 2013, ENDOCRINOL METAB, V28, P297, DOI 10.3803/EnM.2013.28.4.297; Koch AJ, 2014, SEMIN CELL DEV BIOL, V29, P95, DOI 10.1016/j.semcdb.2013.12.008; Koch G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14204-3; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kritsilis M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102937; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lee SC, 2015, CHINESE MED J-PEKING, V128, P1543, DOI 10.4103/0366-6999.157693; Leffa DD, 2014, ACTA NEUROPSYCHIATR, V26, P161, DOI 10.1017/neu.2013.48; Li ZD, 2016, DNA REPAIR, V38, P94, DOI 10.1016/j.dnarep.2015.11.019; Lillenes MS, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0237-z; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Maina MB, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010009; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Meitzler JL, 2014, ANTIOXID REDOX SIGN, V20, P2873, DOI 10.1089/ars.2013.5603; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mickiewicz E, 2006, EMBO J, V25, P3275, DOI [10.1038/sj.emboj.7601230, DOI 10.1038/SJ.EMBOJ.7601230]; Mohanty K, 2017, OPHTHALMIC GENET, V38, P446, DOI 10.1080/13816810.2016.1261904; Morrel P, 1999, BASIC NEUROCHEMISTRY; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840; Nepal M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081804; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI 10.1016/j.cmet.2018.12.008; Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396; Pang J, 2012, MED SCI MONITOR, V18, pBR281, DOI 10.12659/MSM.883206; Parachikova A, 2007, NEUROBIOL DIS, V28, P143, DOI 10.1016/j.nbd.2007.07.001; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Pettigrew C, 2015, NEUROPSYCHOLOGIA, V78, P63, DOI 10.1016/j.neuropsychologia.2015.09.024; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Popp J, 2017, BRAIN BEHAV IMMUN, V62, P203, DOI 10.1016/j.bbi.2017.01.020; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Savage KI, 2014, CANCER RES, V74, P2773, DOI 10.1158/0008-5472.CAN-13-2611; Schwab N, 2019, LAB INVEST, V99, P1008, DOI 10.1038/s41374-019-0199-8; Schwab N, 2018, J ALZHEIMERS DIS, V64, P1067, DOI 10.3233/JAD-180373; Sepe S, 2016, CELL REP, V15, P1866, DOI 10.1016/j.celrep.2016.04.071; Setayesh T, 2018, MUTAT RES-REV MUTAT, V777, P64, DOI 10.1016/j.mrrev.2018.07.001; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stein D, 2017, NEURAL REGEN RES, V12, P1441, DOI 10.4103/1673-5374.215254; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Swenson B.L., 2019, TRANSL MED AGING, V3, P17, DOI [10.1016/j.tma.2019.01.002, DOI 10.1016/J.TMA.2019.01.002]; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Tibshirani M, 2017, HUM MOL GENET, V26, P4142, DOI 10.1093/hmg/ddx301; Tominaga T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213673; Tse KH, 2017, MECH AGEING DEV, V161, P37, DOI 10.1016/j.mad.2016.05.006; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Violet M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00084; von Bernhardi R, 2016, ADV EXP MED BIOL, V949, P1, DOI 10.1007/978-3-319-40764-7_1; Wa M, 2015, J NEUROTRAUM, V32, P532; Walker C, 2018, BRAIN, V141, P1247, DOI 10.1093/brain/awy076; Wang KC, 2014, ARTERIOSCL THROM VAS, V34, P1437, DOI 10.1161/ATVBAHA.114.303473; Wang ZW, 2012, ONCOTARGET, V3, P1026; Weil MT, 2016, LOSS MYELIN BASIC PR; Weiss RS, 2000, GENE DEV, V14, P1886; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Weyemi U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03948-9; WHITAKER SJ, 1992, EUR J CANCER, V28A, P273, DOI 10.1016/0959-8049(92)90432-2; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045; Zhang Y, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215525; Zhang ZL, 2016, MOL CELL BIOL, V36, P70, DOI 10.1128/MCB.00534-15; Zhou S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0956-3; Zou Y, 2012, BIOCHEM BIOPH RES CO, V426, P100, DOI 10.1016/j.bbrc.2012.08.043	173	11	11	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 14	2019	7	1							182	10.1186/s40478-019-0822-3			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO1ZU	WOS:000497384100005	31727161	gold, Green Published			2022-02-06	
J	Yamagishi, S; Iga, Y; Nakamura, M; Takizawa, C; Fukumoto, D; Kakiuchi, T; Nishiyama, S; Ohba, H; Tsukada, H; Sato, K; Ouchi, Y				Yamagishi, Satoru; Iga, Yurika; Nakamura, Masato; Takizawa, Chika; Fukumoto, Dai; Kakiuchi, Takeharu; Nishiyama, Shingo; Ohba, Hiroyuki; Tsukada, Hideo; Sato, Kohji; Ouchi, Yasuomi			Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglial activation; Senescence-accelerated prone mouse; Cannabinoid receptor type 2; Translocator protein; Positron emission tomography; Immunostaining	TRAUMATIC BRAIN-INJURY; IN-VIVO; CB2 RECEPTOR; MICROGLIAL ACTIVATION; TRANSLOCATOR PROTEIN; EXPRESSION; MOUSE; RATS; MODEL; PET	BackgroundMicroglial cells are activated in response to changes in brain homeostasis during aging, dementia, and stroke. Type 2 endocannabinoid receptors (CB2) and translocator protein 18 kD (TSPO) are considered to reflect distinct aspects of microglia-related neuroinflammatory responses in the brain. CB2 activation is considered to relate to the neuroprotective responses that may occur predominantly in the early stage of brain disorders such as Alzheimer's disease, while an increase in TSPO expression tends to occur later during neuroinflammation, in a proinflammatory fashion. However, this information was deduced from studies with different animal samples under different experimental settings. In this study, we aimed to examine the early microglial status in the inflammation occurring in the brains of senescence-accelerated mouse prone 10 (SAMP10) mice, using positron emission tomography (PET) with CB2 and TSPO tracers, together with immunohistochemistry.MethodsFive- and 15-week-old SAMP10 mice that undergo neurodegeneration after 7months of age were used. The binding levels of the TSPO tracer (R)-[C-11]PK11195 and CB2 tracer [C-11]NE40 were measured using PET in combination with immunohistochemistry for CB2 and TSPO. To our knowledge, this is the first study to report PET data for CB2 and TSPO at the early stage of cognitive impairment in an animal model.ResultsThe standard uptake value ratios (SUVRs) of [C-11]NE40 binding were significantly higher than those of (R)-[C-11]PK11195 binding in the cerebral cortical region at 15weeks of age. At 5weeks of age, the [C-11]NE40 SUVR tended to be higher than the (R)-[C-11]PK11195 SUVR. The (R)-[11C]PK11195 SUVR did not significantly differ between 5- and 15-week-old mice. Consistently, immunostaining analysis confirmed the upregulation of CB2, but not TSPO.ConclusionsThe use of the CB2 tracer [C-11]NE40 and/or an immunohistochemical approach allows evaluation of the role of microglia in acute neuroinflammatory processes in the early stage of neurodegeneration. The present results provide in vivo evidence of different responses of two types of microglia to senescence-accelerated neuroinflammation, implying the perturbation of microglial balance by aging. Specific treatment for CB2-positive microglia might help ameliorate senescence-related neuroinflammation and the following neurodegeneration.	[Yamagishi, Satoru; Iga, Yurika; Nakamura, Masato; Takizawa, Chika; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Organ & Tissue Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Fukumoto, Dai; Kakiuchi, Takeharu; Nishiyama, Shingo; Ohba, Hiroyuki; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Dept Biofunct Imaging, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan		Ouchi, Y (corresponding author), Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Dept Biofunct Imaging, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ouchi@hama-med.ac.jp			JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [17K08512, 17H04247]; AMED [JP19ek0109297, 19lm0203078h0001]; Takeda Science FoundationTakeda Science Foundation (TSF); HUSM;  [JP16H06402]	This work was supported by grants from JSPS KAKENHI (grant numbers 17K08512 and 17H04247), AMED (grant number JP19ek0109297, 19lm0203078h0001), a Grant-in-Aid for Scientific Research on Innovative Areas (grant number JP16H06402), the Takeda Science Foundation, and a HUSM Grant-in-Aid.	Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Betlazar C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092707; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Chida Y, 2006, BRAIN RES, V1067, P201, DOI 10.1016/j.brainres.2005.10.042; Concannon RM, 2015, EXP NEUROL, V269, P133, DOI 10.1016/j.expneurol.2015.04.007; CREMER JE, 1992, NUCL MED BIOL, V19, P159; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Evens N, 2012, NUCL MED BIOL, V39, P389, DOI 10.1016/j.nucmedbio.2011.09.005; Evens N, 2009, NUCL MED BIOL, V36, P455, DOI 10.1016/j.nucmedbio.2009.01.009; Fakhfouri G, 2012, NEUROPHARMACOLOGY, V63, P653, DOI 10.1016/j.neuropharm.2012.05.013; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Fukumoto D, 2011, SYNAPSE, V65, P207, DOI 10.1002/syn.20836; Hardwick M, 1999, CANCER RES, V59, P831; Hasegawa-Ishii S, 2011, NEUROPATHOLOGY, V31, P20, DOI 10.1111/j.1440-1789.2010.01126.x; Hashimoto K, 1989, Ann Nucl Med, V3, P63; Higuchi K, 1997, EXP GERONTOL, V32, P129, DOI 10.1016/S0531-5565(96)00060-5; Hosoya T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0851-4; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Kumagai N, 2007, BRAIN RES, V1185, P75, DOI 10.1016/j.brainres.2007.09.021; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Martin A, 2016, EUR J NUCL MED MOL I, V43, P1124, DOI 10.1007/s00259-015-3275-3; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ni RQ, 2019, ACTA PHARMACOL SIN, V40, P351, DOI 10.1038/s41401-018-0035-5; Notter T, 2018, MOL PSYCHIATR, V23, P36, DOI 10.1038/mp.2017.232; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Ouchi Y, 1998, J NUCL MED, V39, P198; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Postnov A, 2013, J NUCL MED, V54, P2101, DOI 10.2967/jnumed.113.120857; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Savonenko AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129618; Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5; Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x; Shimizu Y, 2014, J NEUROL NEUROPHYSIO, V5; Shukuri M, 2011, J NUCL MED, V52, P1094, DOI 10.2967/jnumed.110.084046; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Venneti S, 2009, J NEUROIMMUNE PHARM, V4, P227, DOI 10.1007/s11481-008-9142-2; Walter HL, 2015, NEUROSCIENCE, V292, P71, DOI 10.1016/j.neuroscience.2015.02.024; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Wu J, 2013, NEUROBIOL AGING, V34, P791, DOI 10.1016/j.neurobiolaging.2012.06.011; Yamagishi S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00146; Yokokura M, 2017, J CEREBR BLOOD F MET, V37, P877, DOI 10.1177/0271678X16646788; Yokokura M, 2011, EUR J NUCL MED MOL I, V38, P343, DOI 10.1007/s00259-010-1612-0; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447	50	11	11	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	NOV 10	2019	16	1							208	10.1186/s12974-019-1604-3			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	JL6NS	WOS:000495647500002	31707986	Green Published, gold			2022-02-06	
J	Ma, ZH; Liu, H; Yue, M				Ma, Zhenhui; Liu, Hu; Yue, Ming			Magnetically recyclable Sm2Co17/Cu catalyst to chemoselectively reduce the 3-nitrostyrene into 3-vinylaniline under room temperature	NANO RESEARCH			English	Article						Sm2Co17/Cu; chemoselective catalysis; 3-nitrostyrene; magnetic recycle	SINGLE-CRYSTAL PARTICLES; PDAG NANOWIRE NETWORKS; FORMIC-ACID; EFFICIENT DEHYDROGENATION; SELECTIVE HYDROGENATION; FACILE SYNTHESIS; NANOPARTICLES; NITROARENE	Using non-noble metal catalysts to chemoselectively reduce the 3-nitrostyrene into 3-vinylaniline is extremely attractive due to the important applications of aromatic amines. However, the separation and recycle of catalytic particles to sustainably catalyze are still challenging on account of their small size. In this communication, we report a novel magnetically recyclable catalyst of Sm2Co17/Cu to chemoselectively reduce 3-nitrostyrene into 3-vinylaniline by activating ammonia borane (AB) to yield hydrogen. The Sm2Co17/Cu, composited of 180 nm Sm2Co17 nanomagnet and 10 nm Cu catalyst nanoparticles, shows a high conversion (98%) and a high selectivity (99%) for 3-nitrostyrene under ultrasonic concussion. More importantly, they are easily collected by self-separation method without any magnetic field. As a consequence, the excellent recyclable feature is acquired even underwent 10 cycles. Our approach provides a green strategy to synthesize magnetically recyclable catalysts.	[Ma, Zhenhui; Yue, Ming] Beijing Univ Technol, Coll Mat Sci & Engn, Minist Educ China, Key Lab Adv Funct Mat, Beijing 100124, Peoples R China; [Liu, Hu] Harbin Inst Technol, MIIT Key Lab Crit Mat Technol New Energy Convers, Sch Chem & Chem Engn, Harbin 150001, Heilongjiang, Peoples R China		Yue, M (corresponding author), Beijing Univ Technol, Coll Mat Sci & Engn, Minist Educ China, Key Lab Adv Funct Mat, Beijing 100124, Peoples R China.	yueming@bjut.edu.cn	Liu, Hu/AAM-8052-2021	LIU, HU/0000-0002-5237-6419	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51701109, 51806115]; Natural Science Foundation of Beijing Municipality, China [2192007]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M641132]; International S&T Cooperation Program of China [2015DFG52020]; Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51331003]; Program of Disciplines Construction in Beijing [PXM2019_014204_500031]	The work was supported by the National Natural Science Foundation of China (Nos. 51701109 and 51806115), Natural Science Foundation of Beijing Municipality, China (No. 2192007), the China Postdoctoral Science Foundation (No. 2018M641132), International S&T Cooperation Program of China (No. 2015DFG52020), Key Program of National Natural Science Foundation of China (51331003), and Program of Disciplines Construction in Beijing (No. PXM2019_014204_500031).	Ai YJ, 2018, NANO RES, V11, P287, DOI 10.1007/s12274-017-1631-2; Assa F, 2016, NANO RES, V9, P2203, DOI 10.1007/s12274-016-1131-9; Camacho-Bunquin J, 2018, J AM CHEM SOC, V140, P3940, DOI 10.1021/jacs.7b11981; Chen GX, 2016, NAT MATER, V15, P564, DOI [10.1038/NMAT4555, 10.1038/nmat4555]; Corma A, 2008, J AM CHEM SOC, V130, P8748, DOI 10.1021/ja800959g; Dhiman M, 2016, J MATER CHEM A, V4, P12416, DOI 10.1039/c6ta04315a; Furukawa S, 2014, ACS CATAL, V4, P1441, DOI 10.1021/cs500082g; Ghimire PP, 2019, J MATER CHEM A, V7, P9618, DOI 10.1039/c9ta02387a; Han AJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11794-6; Jagadeesh RV, 2013, SCIENCE, V342, P1073, DOI 10.1126/science.1242005; Liu H, 2018, J MATER CHEM A, V6, P17323, DOI 10.1039/c8ta06513f; Liu H, 2018, J MATER CHEM A, V6, P4611, DOI 10.1039/c8ta00600h; Liu H, 2018, J MATER CHEM A, V6, P1979, DOI 10.1039/c7ta10963f; Liu H, 2017, NANOSCALE, V9, P9305, DOI 10.1039/c7nr03734a; Ma ZH, 2018, RARE METALS, V37, P1021, DOI 10.1007/s12598-016-0873-6; Ma ZH, 2019, ANGEW CHEM INT EDIT, V58, P14509, DOI 10.1002/anie.201907763; Ma ZH, 2019, NANOSCALE, V11, P12484, DOI 10.1039/c9nr03412a; Ma ZH, 2018, NANOSCALE, V10, P10377, DOI 10.1039/c8nr02893a; Ma ZH, 2016, CHEM ENG J, V304, P993, DOI 10.1016/j.cej.2016.07.024; Ma ZH, 2015, CHEM ENG J, V264, P610, DOI 10.1016/j.cej.2014.11.138; Pingen D, 2010, ANGEW CHEM INT EDIT, V49, P8130, DOI 10.1002/anie.201002583; Qin Z, 2019, RARE METALS, V38, P764, DOI 10.1007/s12598-018-1197-5; Shen MQ, 2018, J AM CHEM SOC, V140, P16460, DOI 10.1021/jacs.8b11303; Song JJ, 2018, APPL CATAL B-ENVIRON, V227, P386, DOI 10.1016/j.apcatb.2018.01.052; Tafesh AM, 1996, CHEM REV, V96, P2035, DOI 10.1021/cr950083f; Tamiolakis I, 2013, J MATER CHEM A, V1, P14311, DOI 10.1039/c3ta13365f; Tan Y, 2017, ANGEW CHEM INT EDIT, V56, P2709, DOI 10.1002/anie.201610736; Wang L, 2016, ACS CATAL, V6, P4110, DOI 10.1021/acscatal.6b00530; Wei HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6634; Westerhaus FA, 2013, NAT CHEM, V5, P537, DOI [10.1038/NCHEM.1645, 10.1038/nchem.1645]; Wienhofer G, 2011, J AM CHEM SOC, V133, P12875, DOI 10.1021/ja2061038; Yang B, 2016, NANO RES, V9, P1879, DOI 10.1007/s12274-016-1080-3; Zhang TL, 2015, J ALLOY COMPD, V637, P253, DOI 10.1016/j.jallcom.2015.03.015	33	11	11	10	66	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	DEC	2019	12	12					3085	3088		10.1007/s12274-019-2555-9		NOV 2019	4	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	JT8FK	WOS:000495070300001					2022-02-06	
J	Gabrys, RL; Dixon, K; Holahan, MR; Anisman, H				Gabrys, Robert L.; Dixon, Kaylyn; Holahan, Matthew R.; Anisman, Hymie			Self-Reported Mild Traumatic Brain Injuries in Relation to Rumination and Depressive Symptoms: Moderating Role of Sex Differences and a Brain-Derived Neurotrophic Factor Gene Polymorphism	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; concussion; cognitive flexibility; rumination; depression; BDNF Val66Met; sex differences	BDNF VAL66MET POLYMORPHISM; NEUROPSYCHOLOGICAL PERFORMANCE; EXECUTIVE FUNCTION; GENDER-DIFFERENCES; CONCUSSION; ATTENTION; STRESS; RISK	Objective: Mild traumatic brain injuries (mTBIs) have frequently been associated with the emergence and persistence of depressive symptoms. However, the factors which contribute to the increased risk for depression after these head injuries remain unclear. Accordingly, we examined the relationship between frequency of self-reported mTBIs and current symptoms of depression and the mediating role of rumination and cognitive flexibility. We also examined whether these relations were moderated by sex differences and the presence of the Val66Met polymorphism in a gene coding for brain-derived neurotrophic factor (BDNF). Design: Retrospective, cross-sectional. Setting: Carleton University. Participants: Two hundred nineteen Carleton University undergraduate students. Main Outcome Measures: Cognitive flexibility as assessed by the Wisconsin Card Sorting Task (WCST); subtypes of rumination (Ruminative Response Scale; Treynor, Gonzalez, and Nolen-Hoeksema, 2003); depressive symptoms (Beck Depression Inventory; Beck, Ward, and Mendelson, 1961). Results: Greater frequency of self-reported mTBIs was associated with more frequent depressive rumination among women, but not men, which was accompanied by elevated current depressive symptoms. In addition, among Met allele carriers of the BDNF polymorphism, but not those who were Val homozygotes, greater frequency of mTBIs was related to higher levels of brooding, which was accompanied by heightened depressive symptoms. Brain-derived neurotrophic factor genotype also moderated the relationship between self-reported mTBIs and cognitive flexibility in that more frequent mTBIs were associated with more perseverative errors on the WCST among Met carriers, but not Val homozygotes. Conclusions: The present findings raise the possibility that the evolution of depression after mTBIs may be dependant on a BDNF polymorphism and sex differences.	[Gabrys, Robert L.; Dixon, Kaylyn; Holahan, Matthew R.; Anisman, Hymie] Carleton Univ, Dept Neurosci, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada		Gabrys, RL (corresponding author), Carleton Univ, Dept Neurosci, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	Robert.Gabrys@carleton.ca			 [341673]	M. R. Holahan holds a Natural Sciences and Engineering Research Council-RGPIN Grant #341673.	Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beevers CG, 2009, EMOTION, V9, P579, DOI 10.1037/a0016189; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bennett RE, 2016, GENETIC INFLUENCES T; Caldwell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065547; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Clasen PC, 2011, GENES BRAIN BEHAV, V10, P740, DOI 10.1111/j.1601-183X.2011.00715.x; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Duman RS, 2002, EUR PSYCHIAT, V17, p306S; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fox CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063885; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Ignacio ZM, 2014, NEUROSCIENCE, V275, P455, DOI 10.1016/j.neuroscience.2014.06.036; Johnson DP, 2013, PERS INDIV DIFFER, V55, P367, DOI 10.1016/j.paid.2013.03.019; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561	42	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2019	29	6					494	499		10.1097/JSM.0000000000000550			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	KG1IB	WOS:000509694100018	31688181				2022-02-06	
J	Greuter, L; Ullmann, M; Mariani, L; Guzman, R; Soleman, J				Greuter, Ladina; Ullmann, Muriel; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda			Effect of preoperative antiplatelet or anticoagulation therapy on hemorrhagic complications in patients with traumatic brain injury undergoing craniotomy or craniectomy	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; antiplatelet therapy; anticoagulation; hemorrhagic complications	CHRONIC SUBDURAL-HEMATOMA; LOW-DOSE ASPIRIN; BURR-HOLE DRAINAGE; THROMBOSIS PROPHYLAXIS; OUTCOMES; EPIDEMIOLOGY; EVACUATION; MANAGEMENT; RECURRENCE; RESUMPTION	OBJECTIVE Traumatic brain injury (TBI) is common among the elderly, often treated with antiplatelet (AP) or anticoagulation (AC) therapy, creating new challenges in neurosurgery. In contrast to elective craniotomy, in which AP/AC therapy is mostly discontinued, in TBI usually no delay in treatment can be afforded. The aim of this study was to analyze the effect of AP/AC therapy on postoperative bleeding after craniotomy/craniectomy in TBI. METHODS Postoperative bleeding rates in patients treated with AP/AC therapy (blood thinner group) and in those without AP/AC therapy (control group) were retrospectively compared. Furthermore, univariate and multivariate analyses were conducted to identify risk factors for postoperative bleeding. Lastly, a proportional Cox regression analysis comparing postoperative bleeding events within 14 days in both groups was performed. RESULTS Of 143 consecutive patients undergoing craniotomy/craniectomy for TBI between 2012 and 2017, 47 (32.9%) were under AP/AC treatment. No significant difference for bleeding events was observed in univariate (40.4% blood thinner group vs 36.5% control group; p = 0.71) or Cox proportional regression analysis (log rank chi(2) = 0.29, p = 0.59). Patients with postoperative bleeding showed a significantly higher mortality rate (p = 0.035). In the univariate analysis, hemispheric lesion, acute subdural hematoma, hematological disease, greater extent of midline shift, and pupillary difference were significantly associated with a higher risk of postoperative bleeding. However, in the multivariate regression analysis none of these factors showed a significant association with postoperative bleeding. CONCLUSIONS Patients treated with AP/AC therapy undergoing craniotomy/craniectomy due to TBI do not appear to have increased rates of postoperative bleeding. Once postoperative bleeding occurs, mortality rates rise significantly.	[Greuter, Ladina; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda] Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland; [Ullmann, Muriel; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda] Univ Basel, Fac Med, Basel, Switzerland		Greuter, L (corresponding author), Univ Hosp Basel, Basel, Switzerland.	ladinaaurca.greuter@gmail.com	Soleman, Jehuda/D-8083-2017	Soleman, Jehuda/0000-0003-1900-9286; Guzman, Raphael/0000-0001-9620-0581			Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Constantini S, 2001, J NEUROSURG, V94, P918, DOI 10.3171/jns.2001.94.6.0918; Copland M, 2001, ARCH INTERN MED, V161, P2125, DOI 10.1001/archinte.161.17.2125; Croci DM, 2017, WORLD NEUROSURG, V105, P841, DOI 10.1016/j.wneu.2017.06.105; Cull JD, 2015, AM SURGEON, V81, P128; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Gressenberger P, 2019, VASA, V48, P389, DOI 10.1024/0301-1526/a000777; Guha D, 2017, NEUROSURG CLIN N AM, V28, P287, DOI 10.1016/j.nec.2016.11.011; Guha D, 2016, J NEUROSURG, V124, P750, DOI 10.3171/2015.2.JNS141889; Han Hokyun, 2016, Korean J Neurotrauma, V12, P61, DOI 10.13004/kjnt.2016.12.2.61; Hanalioglu S, 2020, J NEUROSURG, V132, P1529, DOI 10.3171/2018.12.JNS182483; JIMENEZ AH, 1992, AM J CARDIOL, V69, P258, DOI 10.1016/0002-9149(92)91316-V; Kamenova M, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3064-y; Kamenova M, 2017, WORLD NEUROSURG, V100, P594, DOI 10.1016/j.wneu.2017.01.065; Kamenova M, 2016, NEUROSURGERY, V79, P715, DOI 10.1227/NEU.0000000000001393; Kamenova M, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16173; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Korinth MC, 2006, ACTA NEUROCHIR, V148, P1189, DOI 10.1007/s00701-006-0868-4; Lee AT, 2017, ANESTH ANALG, V125, P514, DOI 10.1213/ANE.0000000000002053; Licci M, 2018, CRIT CARE MED, V46, pE26, DOI 10.1097/CCM.0000000000002804; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nittby HR, 2016, ACTA NEUROCHIR, V158, P837, DOI 10.1007/s00701-016-2778-4; Ogawa Y, 2015, J NEUROSURG, V123, P794, DOI 10.3171/2014.9.JNS141088; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Rahman M, 2015, WORLD NEUROSURG, V84, P41, DOI 10.1016/j.wneu.2015.02.016; Robba C, 2017, CURR OPIN ANESTHESIO, V30, P527, DOI 10.1097/ACO.0000000000000496; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	31	11	11	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E3	10.3171/2019.8.FOCUS19546			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900003	31675713	gold			2022-02-06	
J	Lee, YK; Uchida, H; Smith, H; Ito, A; Sanchez, T				Lee, Yun-Kyoung; Uchida, Hiroki; Smith, Helen; Ito, Akira; Sanchez, Teresa			The isolation and molecular characterization of cerebral microvessels	NATURE PROTOCOLS			English	Article							BLOOD-BRAIN-BARRIER; STROKE; PERMEABILITY; EXPRESSION; MECHANISMS; JUNCTIONS; PTEN; FLOW	The study of cerebral microvessels is becoming increasingly important in a wide variety of conditions, such as stroke, sepsis, traumatic brain injury and neurodegenerative diseases. However, the molecular mechanisms underlying cerebral microvascular dysfunction in these conditions are largely unknown. The molecular characterization of cerebral microvessels in experimental disease models has been hindered by the lack of a standardized method to reproducibly isolate intact cerebral microvessels with consistent cellular compositions and without the use of enzymatic digestion, which causes undesirable molecular and metabolic changes. Herein, we describe an optimized protocol for microvessel isolation from mouse brain cortex that yields microvessel fragments with consistent populations of discrete blood-brain barrier (BBB) components (endothelial cells, pericytes and astrocyte end feet) while retaining high RNA integrity and protein post-translational modifications (e.g., phosphorylation). We demonstrate that this protocol allows the quantification of changes in gene expression in a disease model (stroke) and the activation of signaling pathways in mice subjected to drug administration in vivo. We also describe the isolation of genomic DNA (gDNA) and bisulfite treatment for the assessment of DNA methylation, as well as the optimization of chromatin extraction and shearing from cortical microvessels. This optimized protocol and the described applications should improve the understanding of the molecular mechanisms governing cerebral microvascular dysfunction, which may help in the development of novel therapies for stroke and other neurologic conditions.	[Lee, Yun-Kyoung; Uchida, Hiroki; Smith, Helen; Ito, Akira; Sanchez, Teresa] Weill Cornell Med, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Sanchez, Teresa] Weill Cornell Med, Dept Neurosci, Brain & Mind Res Inst, New York, NY 10065 USA		Sanchez, T (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA.; Sanchez, T (corresponding author), Weill Cornell Med, Dept Neurosci, Brain & Mind Res Inst, New York, NY 10065 USA.	tes2015@med.cornell.edu			American Heart AssociationAmerican Heart Association [12GRNT12050110]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL094465]; Leducq FoundationLeducq Foundation [14CVD02]; Roche Foundation	This work was supported by funds from the American Heart Association (Grant-in-Aid, 12GRNT12050110), the NIH (HL094465) and the Leducq Foundation (14CVD02) to T.S. A.I. was supported by a grant from the Roche Foundation.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Boulay A. C., 2015, JOVE-J VIS EXP, V2015; Bowyer JF, 2012, JOVE-J VIS EXP, DOI 10.3791/4285; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792; Faraci FM, 2003, STROKE, V34, P327, DOI 10.1161/01.STR.0000054052.52510.2C; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Guo SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052665; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jackman K, 2013, J NEUROSCI, V33, P19579, DOI 10.1523/JNEUROSCI.4318-13.2013; Jiang YZ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1656-4; Kim GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8893; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Munikoti VV, 2012, J NEUROSCI METH, V207, P80, DOI 10.1016/j.jneumeth.2012.03.011; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Regan ER, 2012, CIRC RES, V111, P110, DOI 10.1161/CIRCRESAHA.111.261701; Ruck T., 2014, JOVE-J VIS EXP, V2014; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sanchez T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0586-1; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Terasaki Y, 2014, CURR MED CHEM, V21, P2035, DOI 10.2174/0929867321666131228223400; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; Yanagida K, 2017, P NATL ACAD SCI USA, V114, P4531, DOI 10.1073/pnas.1618659114; Yousif S, 2007, BRAIN RES, V1134, P1, DOI 10.1016/j.brainres.2006.11.089; Zaina S, 2014, CIRC-CARDIOVASC GENE, V7, P692, DOI 10.1161/CIRCGENETICS.113.000441; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	49	11	11	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	NOV	2019	14	11					3059	3081		10.1038/s41596-019-0212-0			23	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JI9VM	WOS:000493811300002	31586162				2022-02-06	
J	Watson, A; Mjaanes, JM; LaBella, CR; Brooks, MA; Canty, G; Diamond, AB; Hennrikus, W; Logan, K; Moffatt, K; Nemeth, BA; Pengel, KB; Peterson, AR; Stricker, PR				Watson, Andrew; Mjaanes, Jeffrey M.; LaBella, Cynthia R.; Brooks, M. Alison; Canty, Greg; Diamond, Alex B.; Hennrikus, William; Logan, Kelsey; Moffatt, Kody; Nemeth, Blaise A.; Pengel, K. Brooke; Peterson, Andrew R.; Stricker, Paul R.		Council Sports Med Fitness	Soccer Injuries in Children and Adolescents	PEDIATRICS			English	Article							CRUCIATE LIGAMENT INJURIES; LOWER-EXTREMITY INJURY; US EMERGENCY-DEPARTMENTS; SPORTS-RELATED INJURIES; HIGH-SCHOOL; RISK-FACTORS; FEMALE SOCCER; UNITED-STATES; EYE INJURIES; MUSCULOSKELETAL INJURY	Participation in youth soccer in the United States continues to increase steadily, with a greater percentage of preadolescent participants than perhaps any other youth sport. Despite the wide-ranging health benefits of participation in organized sports, injuries occur and represent a threat to the health and performance of young athletes. Youth soccer has a greater reported injury rate than many other contact sports, and recent studies suggest that injury rates are increasing. Large increases in the incidence of concussions in youth soccer have been reported, and anterior cruciate ligament injuries remain a significant problem in this sport, particularly among female athletes. Considerable new research has identified a number of modifiable risk factors for lower-extremity injuries and concussion, and several prevention programs have been identified to reduce the risk of injury. Rule enforcement and fair play also serve an important role in reducing the risk of injury among youth soccer participants. This report provides an updated review of the relevant literature as well as recommendations to promote the safe participation of children and adolescents in soccer.	[Watson, Andrew] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI 53706 USA; [Mjaanes, Jeffrey M.] Northwestern Univ, Feinberg Sch Med, Dept Orthoped Surg, Chicago, IL 60611 USA		Watson, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI 53706 USA.	watson@ortho.wisc.edu					Alexandre D, 2012, J STRENGTH COND RES, V26, P2890, DOI 10.1519/JSC.0b013e3182429ac7; Ankrah S., 2003, SPORTS ENG, V6.4, P207, DOI [DOI 10.1007/BF02844024, 10.1007/BF02844024]; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Beachy G, 2004, J ATHL TRAINING, V39, P310; Bergeron MF, 2011, PEDIATRICS, V128, pe741; Bernhardt D, 2010, PREPARTICIPATION PHY; Bleyer A, 2017, SPORTS MED, V47, P2437, DOI 10.1007/s40279-017-0735-x; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Boden BP, 2017, SPORTS HEALTH, V9, P444, DOI 10.1177/1941738117712425; Bowen L, 2017, BRIT J SPORT MED, V51, P452, DOI 10.1136/bjsports-2015-095820; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Centers for Disease Control and Prevention, LIGHTN LIGHTN SAF TI; Clausen MB, 2014, AM J SPORT MED, V42, P2487, DOI 10.1177/0363546514541224; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins CL, 2016, DENT TRAUMATOL, V32, P121, DOI 10.1111/edt.12228; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Djaoui L, 2017, PHYSIOL BEHAV, V181, P86, DOI 10.1016/j.physbeh.2017.09.004; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Emery CA, 2006, AM J SPORT MED, V34, P1636, DOI 10.1177/0363546506288018; Esquivel AO, 2015, SPORTS HEALTH, V7, P366, DOI 10.1177/1941738115579854; FIFA, BIG COUNT 2006 STAT; Francisco AC, 2000, AM J SPORT MED, V28, P227, DOI 10.1177/03635465000280021401; Froholdt A, 2009, AM J SPORT MED, V37, P1155, DOI 10.1177/0363546508330132; Frome D, 2019, CLIN J SPORT MED, V29, P368, DOI 10.1097/JSM.0000000000000643; Gabbett TJ, 2014, SPORTS MED, V44, P989, DOI 10.1007/s40279-014-0179-5; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Haring RS, 2016, JAMA OPHTHALMOL, V134, P1382, DOI 10.1001/jamaophthalmol.2016.4253; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Huffman EA, 2008, J ATHL TRAINING, V43, P624, DOI 10.4085/1062-6050-43.6.624; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Inklaar H, 1996, INT J SPORTS MED, V17, P229, DOI 10.1055/s-2007-972837; International Football Association Board, LAWS GAM; Ivarsson A, 2015, J APPL SPORT PSYCHOL, V27, P319, DOI 10.1080/10413200.2015.1008072; JANDA DH, 1995, AM J SPORT MED, V23, P340, DOI 10.1177/036354659502300316; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Kakavelakis KN, 2003, SCAND J MED SCI SPOR, V13, P175, DOI 10.1034/j.1600-0838.2003.00294.x; KERR IL, 1986, SPORTS MED, V3, P415, DOI 10.2165/00007256-198603060-00003; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P19, DOI 10.1186/s40621-017-0116-9; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Krug SE, 2007, PEDIATRICS, V120, P1159, DOI 10.1542/peds.2007-2676; Kucera KL, 2005, BRIT J SPORT MED, V39, P462, DOI 10.1136/bjsm.2004.013672; LaBella CR, 2014, PEDIATRICS, V133, pE1437, DOI 10.1542/peds.2014-0623; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; LaBotz Michele, 2015, Adolesc Med State Art Rev, V26, P18; Lambson RB, 1996, AM J SPORT MED, V24, P155, DOI 10.1177/036354659602400206; Le Gall F, 2008, AM J SPORT MED, V36, P276, DOI 10.1177/0363546507307866; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2017, AM J SPORT MED, V45, P2706, DOI 10.1177/0363546517710213; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Mueller FO, 2001, PHYSICIAN SPORTSMED, V29, P41, DOI 10.3810/psm.2001.07.874; Myer GD, 2008, CLIN SPORT MED, V27, P425, DOI 10.1016/j.csm.2008.02.006; Nagle K, 2017, SPORTS HEALTH, V9, P238, DOI 10.1177/1941738116685704; National Collegiate Athletic Association, SOCC RUL GAM; National Oceanic and Atmospheric Administration, NAT WEATH SERV LIGHT, P13; National Operating Committee on Standards for Athletic Equipment, STAND TEST METH PERF; National Weather Service, LIGHTN SAF TIPS RES; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Nelson NG, 2011, AM J PREV MED, V40, P54, DOI 10.1016/j.amepre.2010.09.031; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Nichols AW, 2014, CURR REV MUSCULOSKE, V7, P355, DOI 10.1007/s12178-014-9240-0; Niedfeldt MW, 2011, CURR SPORT MED REP, V10, P324, DOI 10.1249/JSR.0b013e318237be53; Nilstad A, 2014, SCAND J MED SCI SPOR, V24, P243, DOI 10.1111/j.1600-0838.2012.01471.x; O'Kane JW, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117733963; O'Kane JW, 2016, CLIN J SPORT MED, V26, P245, DOI 10.1097/JSM.0000000000000236; O'Kane JW, 2016, AM J SPORT MED, V44, P318, DOI 10.1177/0363546515613076; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Owoeye OBA, 2014, J SPORT SCI MED, V13, P321; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pettersen JA, 2002, BRIT J SPORT MED, V36, P19, DOI 10.1136/bjsm.36.1.19; Pfirrmann D, 2016, J ATHL TRAINING, V51, P410, DOI 10.4085/1062-6050-51.6.03; Post EG, 2017, SPORTS HEALTH, V9, P518, DOI 10.1177/1941738117714160; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Poulsen T D, 1991, Br J Sports Med, V25, P151; POWELL JW, 1992, AM J SPORT MED, V20, P686, DOI 10.1177/036354659202000609; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Read PJ, 2018, SCAND J MED SCI SPOR, V28, P1244, DOI 10.1111/sms.13013; Read PJ, 2016, SPORTS MED, V46, P1059, DOI 10.1007/s40279-016-0479-z; Rodriguez JO, 2003, AM FAM PHYSICIAN, V67, P1481; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Rossler R, 2019, BRIT J SPORT MED, V53, P309, DOI 10.1136/bjsports-2018-099395; Ryynanen J, 2013, BRIT J SPORT MED, V47, P986, DOI 10.1136/bjsports-2013-092676; Sarofim M.C., 2016, IMPACTS CLIMATE CHAN; Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965; Schwebel DC, 2007, J PEDIATR PSYCHOL, V32, P411, DOI 10.1093/jpepsy/jsl034; Silva DCF, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/1305479; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2009, SCAND J MED SCI SPOR, V19, P442, DOI 10.1111/j.1600-0838.2008.00797.x; Steffen K, 2008, AM J SPORT MED, V36, P700, DOI 10.1177/0363546507311598; Steffen K, 2013, BRIT J SPORT MED, V47, P794, DOI 10.1136/bjsports-2012-091886; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Tatar Y, 2014, J SPORT SCI MED, V13, P120; Thoms AW, 2014, PROCEDIA ENGINEER, V72, P895, DOI 10.1016/j.proeng.2014.06.153; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; US Consumer Product Safety Commission, GUID MOV SOCC GOALS; US Soccer Federation, SOCC HEAD INJ PADD H; US Soccer Federation, LAWS GAM; US Soccer Federation, REC REC US SOCC CONC; US Youth Soccer, MED KIT; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P2059, DOI 10.1111/sms.12855; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; Voskanian N, 2013, CURR REV MUSCULOSKE, V6, P158, DOI 10.1007/s12178-013-9158-y; Walsh KM, 2013, J ATHL TRAINING, V48, P258, DOI 10.4085/1062-6050-48.2.25; Washington RL, 2004, PEDIATRICS, V113, P619; Watson A, 2018, SPORTS HEALTH, V10, P244, DOI 10.1177/1941738118757422; Watson A, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117726976; Watson A, 2017, BRIT J SPORT MED, V51, P194, DOI 10.1136/bjsports-2016-096584; Watterson A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091050; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511	128	11	12	2	20	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2019	144	5							e20192759	10.1542/peds.2019-2759			15	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	JK2MP	WOS:000494681400049	31659001	Bronze			2022-02-06	
J	Wang, WT; Sun, L; Sun, CH				Wang, Wu-Tao; Sun, Li; Sun, Chao-Hui			PDIA3-regulted inflammation and oxidative stress contribute to the traumatic brain injury (TBI) in mice	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury (TBI); PDIA3; Apoptosis; Inflammation; Oxidative stress	SYNAPTIC PROTEINS; RAT MODEL; PDIA3; PATHOPHYSIOLOGY; NEUROPROTECTION; ERP57	Traumatic brain injury (TBI) is a leading cause of death and disability throughout the world. However, the molecular mechanism contributing to TBI still remains unclear. Protein disulfide isomerases (PDI) are a family of redox chaperones, which catalyze formation or isomerization of disulfide bonds in proteins. PDIA3, a critical member of PDI family, is a multi-functional protein, playing critical roles in modulating inflammation, apoptosis and oxidative stress under various kinds of disease conditions. Nevertheless, its regulatory effects on TBI have far from to be known. In the present study, we attempted to explore the modulation of neuroinflammatory responses by PDIA3 and its contribution to oxidative stress and cell death after TBI in the wild type (PDIA(+/+)) and PDIA3 knockout (PDIA3(+/+)) C57BL/6 mice. Results here suggested that PDIA3 expression was markedly up-regulated in the late trauma human brain tissues, which was verified in the PDIA3(+/+) mice at 24 h after TBI. PDIA(-/-) provided significant improvements in cognitive impairments and contusion volume induced by TBI. Apoptosis in brain samples was also alleviated in TBI mice with PDIA3 deficiency. Significantly, PDIA(3-/-) mitigated neuroinflammation after TBI in mice, as evidenced by the reduced expression of pro-inflammatory factors interleukin (IL)-6, tumor necrosis factor-alpha (TNIF-alpha) and IL-1 beta, while the enhanced anti-inflammatory regulator IL-10. These anti-inflammatory activities by PDIA3(-/-) were associated with the decrease in phosphorylated nuclear factor kappa B (NF-kappa B)/p65. PDIA3(-/-) mice following TBI showed attenuated oxidative stress, as proved by the restored superoxide dismutase (SOD) and glutathione (GSH) activities, and the down-regulated malondialdehyde (MDA) levels in brain samples. These effects regulated by PDIA3 were confirmed in OGDR-treated astrocytes. Collectively, these data demonstrated a detrimental role of PDIA3 in regulating TBI, providing an effective therapeutic target for TBI treatment in future. (C) 2019 Published by Elsevier Inc.	[Wang, Wu-Tao] Xian Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Xian 710077, Peoples R China; [Wang, Wu-Tao] Xian Med Univ, Dept Anesthesiol, Sch Gen Med, Xian 710077, Peoples R China; [Sun, Li] Peoples Liberat Army Gen Hosp, Dept Anesthesiol, Med Ctr 7, Beijing 100700, Peoples R China; [Sun, Chao-Hui] Shanxian Cent Hosp, Jining Med Coll, Dept Anesthesiol, Affiliated Huxi Hosp, Shanxian 274300, Shandong, Peoples R China		Sun, CH (corresponding author), Shanxian Cent Hosp, Jining Med Coll, Affiliated Huxi Hosp, 1 Cultural Rd, Shanxian Cty 274300, Shandong, Peoples R China.	2595730386@qq.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Anathy V, 2012, MOL CELL BIOL, V32, P3464, DOI 10.1128/MCB.00125-12; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Antoniou AN, 2007, FEBS LETT, V581, P1988, DOI 10.1016/j.febslet.2007.04.034; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Basu A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146549; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Caorsi C, 2016, TRANSL RES, V171, P17, DOI 10.1016/j.trsl.2015.12.013; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chamberlain N, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101129; Drose S, 2016, BBA-BIOENERGETICS, V1857, P946, DOI 10.1016/j.bbabio.2015.12.013; Hiroaki A., 2017, NEURAL PLAST, V2017, P1; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim-Han JS, 2007, ANTIOXID REDOX SIGN, V9, P2255, DOI 10.1089/ars.2007.1791; Kumar A, 2018, FREE RADICAL BIO MED, V128, pS30, DOI 10.1016/j.freeradbiomed.2018.10.029; Lin SJ, 2018, ACUPUNCT MED, V36, P247, DOI 10.1136/acupmed-2017-011472; Liu SQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20433-x; Mirshekar MA, 2018, IRAN J BASIC MED SCI, V21, P1056, DOI 10.22038/IJBMS.2018.29639.7165; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Ramos FS, 2015, GENET MOL RES, V14, P6960, DOI 10.4238/2015.June.26.4; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24049; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woehlbier U, 2016, EMBO J, V35, P845, DOI 10.15252/embj.201592224; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhang M, 2018, INT IMMUNOPHARMACOL, V65, P64, DOI 10.1016/j.intimp.2018.09.046; Zhao GP, 2015, J BIOL CHEM, V290, P8949, DOI 10.1074/jbc.M114.619353; Zhuang ZM, 2015, INT J CLIN EXP MED, V8, P6866	32	11	11	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 22	2019	518	4					657	663		10.1016/j.bbrc.2019.08.100			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	KB3MD	WOS:000506403000008	31466719				2022-02-06	
J	Clacy, A; Goode, N; Sharman, R; Lovell, GP; Salmon, P				Clacy, Amanda; Goode, Natassia; Sharman, Rachael; Lovell, Geoff P.; Salmon, Paul			A systems approach to understanding the identification and treatment of sport-related concussion in community rugby union	APPLIED ERGONOMICS			English	Article						Systems thinking; Concussion; Injury management; Sport-related injury; Rugby union	RISK-FACTORS; MANAGEMENT; INJURY; IMPLEMENTATION; PREVENTION; STRATEGIES; STATEMENT; PLAYERS; DESIGN; RETURN	Aim: The aim of the present study was to utilise a systems thinking approach to explore the perceived responsibilities for identifying and treating concussion held by different actors across the community rugby system (e.g., players, coaches, parents, medics, referees, and management), as well as their role specific concussion management strategies. Methods: A systems approach was taken to assess what different stakeholders within rugby systems perceive their roles to be regarding concussion identification and treatment. Through an online survey, 118 members of the amateur (community) rugby union system were asked about their role-specific concussion management responsibilities and strategies. Respondents included players, parents, medics, coaches, club managers, administrators, and volunteers. Results: The majority of respondents indicated that they were able to identify the symptoms of rugby related concussion, however, only medics stated their responsibility to use formal concussion assessments (e.g., SCAT2). A smaller number of the respondents indicated that they were involved in treating concussion within their current role/s (majority of which were medics). Conclusions: This study illustrated that the current challenges in the identification and treatment of rugby-related concussion in community sport may be due to role/responsibility confusion and possible overreliance on field-side medics. These findings offer insight into the possible limitations of the current concussion management guidelines and may offer empirically based direction for future revisions. (C) 2017 Elsevier Ltd. All rights reserved.	[Clacy, Amanda; Goode, Natassia; Salmon, Paul] Univ Sunshine Coast, Ctr Human Factors & Sociotech Syst, Sunshine Coast, Australia; [Sharman, Rachael; Lovell, Geoff P.] Univ Sunshine Coast, Fac Arts & Business Psychol, Sunshine Coast, Australia		Clacy, A (corresponding author), Univ Sunshine Coast, Ctr Human Factors & Sociotech Syst, Sunshine Coast, Australia.	aclacy@usc.edu.au		Salmon, Paul/0000-0001-7403-0286			Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Clacy A, 2013, J BIOETHIC INQ, V10, P127, DOI 10.1007/s11673-012-9421-8; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Dallat C, 2015, PROCEDIA MANUF, V3, P1157, DOI 10.1016/j.promfg.2015.07.193; Donaldson A, 2012, BRIT J SPORT MED, V46, P306, DOI 10.1136/bjsports-2011-090461; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Goode N., 2015, P 6 APPL HUM FACT ER; Helps Y, 2008, INJURY RES STAT SERI, V45; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Leveson N, 2004, SAFETY SCI, V42, P237, DOI 10.1016/S0925-7535(03)00047-X; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Marras WS, 2014, APPL ERGON, V45, P55, DOI 10.1016/j.apergo.2013.03.025; McCrory P., 2009, S AFR J SPORTS MED, V21, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Perrow C., 1984, NORMAL ACCIDENTS LIV; Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0; Rasmussen J., 2000, PROACTIVE RISK MANAG; Salmon PM, 2016, APPL ERGON, V53, P312, DOI 10.1016/j.apergo.2015.06.021; Svedung I, 2002, SAFETY SCI, V40, P397, DOI 10.1016/S0925-7535(00)00036-9; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tibbert SJ, 2015, PSYCHOL SPORT EXERC, V17, P68, DOI 10.1016/j.psychsport.2014.10.007; World Rugby, 2015, PLAYER WELF IRB CONC	40	11	11	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0003-6870	1872-9126		APPL ERGON	Appl. Ergon.	OCT	2019	80						256	264		10.1016/j.apergo.2017.06.010			9	Engineering, Industrial; Ergonomics; Psychology, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Psychology	IM0OD	WOS:000477687200030	28687400				2022-02-06	
J	Hirschi, R; Hawryluk, GWJ; Nielson, JL; Huie, JR; Zimmermann, LL; Saigal, R; Ding, Q; Ferguson, AR; Manley, G				Hirschi, Ryan; Hawryluk, Gregory W. J.; Nielson, Jessica L.; Huie, J. Russell; Zimmermann, Lara L.; Saigal, Rajiv; Ding, Quan; Ferguson, Adam R.; Manley, Geoffrey			Analysis of high-frequency PbtO2 measures in traumatic brain injury: insights into the treatment threshold	JOURNAL OF NEUROSURGERY			English	Article						brain tissue oxygenation; PbtO2; outcome; threshold; treatment window; traumatic brain injury; head injury; Licox; trauma	TISSUE OXYGEN; INTRACRANIAL HYPERTENSION; PROGNOSTIC MODELS; HYPOXIA; TENSION; GUIDELINES; MANAGEMENT; PRESSURE	OBJECTIVE Brain tissue hypoxia is common after traumatic brain injury (TBI). Technology now exists that can detect brain hypoxia and guide corrective therapy. Current guidelines for the management of severe TBI recommend maintaining partial pressure of brain tissue oxygen (PbtO2) > 15-20 mm Hg; however, uncertainty persists as to the optimal treatment threshold. The object of this study was to better inform the relationship between PbtO2 values and outcome for patients with TBI. METHODS PbtO2 measurements were prospectively and automatically collected every minute from consecutive patients admitted to the San Francisco General Hospital neurological ICU during a 6-year period. Mean PbtO2 values in TBI patients as well as the proportion of PbtO2 values below each of 75 thresholds between 0 mm Hg and 75 mm Hg over various epochs up to 30 days from the time of admission were analyzed. Patient outcomes were determined using the Glasgow Outcome Scale. The authors explored putative treatment thresholds by generating 675 separate receiver operating characteristic curves and 675 generalized linear models to examine each 1-mm Hg threshold for various epochs. RESULTS A total of 1,380,841 PbtO2 values were recorded in 190 TBI patients. A high proportion of PbtO2 measures were below 20 mm Hg irrespective of the examined epoch. Time below treatment thresholds was more strongly associated with outcome than mean PbtO2. A treatment window was suggested: a threshold of 19 mm Hg most robustly distinguished patients by outcome, especially from days 3-5; however, benefit was suggested from maintaining values at least as high as 33 mm Hg. CONCLUSIONS This analysis of high-frequency physiological data substantially informs the relationship between PbtO2 values and outcome. The results suggest a therapeutic window for PbtO2 in TBI patients along with minimum and preferred PbtO2 treatment thresholds, which may be examined in future studies. Traditional treatment thresholds that have the strongest association with outcome may not be optimal.	[Hirschi, Ryan] Univ Utah, Sch Med, Salt Lake City, UT USA; [Hawryluk, Gregory W. J.] Univ Utah, Dept Neurol Surg, Clin Neurosci Ctr, Salt Lake City, UT USA; [Nielson, Jessica L.] Univ Minnesota, Sch Med, Dept Psychiat, Inst Hlth Informat, Minneapolis, MN 55455 USA; [Huie, J. Russell; Ferguson, Adam R.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Neurosurg, Brain & Spinal Injury Ctr,Weill Inst Neurosci, San Francisco, CA USA; [Zimmermann, Lara L.] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [Saigal, Rajiv] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Ding, Quan] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA; [Manley, Geoffrey] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Hawryluk, GWJ (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	gregory.hawryluk@hsc.utah.edu		Ferguson, Adam/0000-0001-7102-1608	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from National Heart, Lung, and Blood Institute [T35HL007744]	Ryan Hirschi participated in the Medical Student Research Program at the University of Utah School of Medicine. This program is supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (T35HL007744) from National Heart, Lung, and Blood Institute.	Bardt TF, 1998, ACT NEUR S, V71, P153; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Lin CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/529580; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van den Brink WA, 1998, ACT NEUR S, V71, P190; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	36	11	13	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2019	131	4					1216	1226		10.3171/2018.4.JNS172604			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JD8RN	WOS:000490249600027	30497191	Bronze			2022-02-06	
J	Song, YM; Qian, Y; Su, WQ; Liu, XH; Huang, JH; Gong, ZT; Luo, HL; Gao, C; Jiang, RC				Song, Yi-Ming; Qian, Yu; Su, Wan-Qiang; Liu, Xuan-Hui; Huang, Jin-Hao; Gong, Zhi-Tao; Luo, Hong-Liang; Gao, Chuang; Jiang, Rong-Cai			Differences in pathological changes between two rat models of severe traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; severe traumatic brain injury; animal model comparison; free weight drop; controlled cortical impact; neurological impairment; neuroinflammation; blood-brain barrier damage; neuronal apoptosis; diffuse axonal injury; brainstem injury; neural regeneration	CONTROLLED CORTICAL IMPACT; WEIGHT DROP; AXONAL INJURY; DAMAGE; INFLAMMATION; ACCUMULATION; NEUROINFLAMMATION; NEUROPROTECTION; DYSFUNCTION; EVOLUTION	The rat high-impact free weight drop model mimics the diffuse axonal injury caused by severe traumatic brain injury in humans, while severe controlled cortical impact can produce a severe traumatic brain injury model using precise strike parameters. In this study, we compare the pathological mechanisms and pathological changes between two rat severe brain injury models to identify the similarities and differences. The severe controlled cortical impact model was produced by an electronic controlled cortical impact device, while the severe free weight drop model was produced by dropping a 500 g free weight from a height of 1.8 m through a plastic tube. Body temperature and mortality were recorded, and neurological deficits were assessed with the modified neurological severity score. Brain edema and blood-brain barrier damage were evaluated by assessing brain water content and Evans blue extravasation. In addition, a cytokine array kit was used to detect inflammatory cytokines. Neuronal apoptosis in the brain and brainstem was quantified by immunofluorescence staining. Both the severe controlled cortical impact and severe free weight drop models exhibited significant neurological impairments and body temperature fluctuations. More severe motor dysfunction was observed in the severe controlled cortical impact model, while more severe cognitive dysfunction was observed in the severe free weight drop model. Brain edema, inflammatory cytokine changes and cortical neuronal apoptosis were more substantial and blood-brain barrier damage was more focal in the severe controlled cortical impact group compared with the severe free weight drop group. The severe free weight drop model presented with more significant apoptosis in the brainstem and diffused blood-brain barrier damage, with higher mortality and lower repeatability compared with the severe controlled cortical impact group. Severe brainstem damage was not found in the severe controlled cortical impact model. These results indicate that the severe controlled cortical impact model is relatively more stable, more reproducible, and shows obvious cerebral pathological changes at an earlier stage. Therefore, the severe controlled cortical impact model is likely more suitable for studies on severe focal traumatic brain injury, while the severe free weight drop model may be more apt for studies on diffuse axonal injury.	[Song, Yi-Ming; Qian, Yu; Su, Wan-Qiang; Liu, Xuan-Hui; Huang, Jin-Hao; Gong, Zhi-Tao; Luo, Hong-Liang; Gao, Chuang; Jiang, Rong-Cai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Song, Yi-Ming; Qian, Yu; Su, Wan-Qiang; Liu, Xuan-Hui; Huang, Jin-Hao; Gong, Zhi-Tao; Luo, Hong-Liang; Gao, Chuang; Jiang, Rong-Cai] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China		Jiang, RC (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Jiang, RC (corresponding author), Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China.	jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671221]	This study was supported by the National Natural Science Foundation of China, No. 81671221 (to RCJ).; This study was supported by the National Natural Science Foundation of China, No. 81671221 (to RCJ). The funding source had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aldossary NM, 2019, J AFFECT DISORDERS, V243, P1, DOI 10.1016/j.jad.2018.09.001; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bisht A, 2013, NEUROL INDIA, V61, P599, DOI 10.4103/0028-3886.125256; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Chen XR, 2019, J MAGN RESON IMAGING, V49, P1069, DOI 10.1002/jmri.26258; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Dai J, 2018, NEURAL REGEN RES, V13, P2129, DOI 10.4103/1673-5374.241464; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Feltrin FS, 2018, BRAIN INJURY, V32, P1208, DOI 10.1080/02699052.2018.1494852; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; Fu XM, 2015, CELL TRANSPLANT, V24, P1533, DOI 10.3727/096368914X679345; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Guo F, 2017, J PEDIATR SURG, V52, P1496, DOI 10.1016/j.jpedsurg.2017.01.059; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kobuch J, 2015, HAEMATOLOGICA, V100, P1005, DOI 10.3324/haematol.2014.121590; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin HJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1726, DOI 10.1159/000485778; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mateo Z, 2007, NEUROSCIENCE, V146, P1062, DOI 10.1016/j.neuroscience.2007.02.053; McCreedy DA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0101-18.2018; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Povlishock J, 2016, METHODS MOL BIOL, V1462, P3, DOI 10.1007/978-1-4939-3816-2_1; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4	53	11	11	1	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	OCT	2019	14	10					1796	1804	PMID 31169198	10.4103/1673-5374.257534			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	IC3YT	WOS:000470900400027	31169198	Green Published, gold			2022-02-06	
J	Zhang, ZY; Li, J; Ye, Q; Dong, Y; Bao, GM; Shen, YK; Weng, JF; Luo, LF; Cen, M				Zhang, Zu-Yong; Li, Jun; Ye, Qi; Dong, Yong; Bao, Guang-Ming; Shen, You-Kui; Weng, Jian-Feng; Luo, Li-Feng; Cen, Meng			Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Interleukin-33; Prognosis; Severity; Inflammation	IL-33; COAGULOPATHY; PROGRESSION; BIOMARKERS; CONTUSION; OUTCOMES; STROKE; CT	Background: Interleukin-33 is recently identified as a brain injury biomarker. We determined whether serum interlerukin-33 concentrations are associated with inflammation, severity and prognosis after traumatic brain injury (TBI). Methods: We detected serum interlerukin-33 concentrations of 102 healthy controls and 102 severe TBI patients, as well as serum concentrations of 3 inflammatory biomarkers (interleukin-6, tumor necrosis factor-alpha and C-reactive protein) and 7 cell-specific proteins (myelin basic protein, glial fibrillary astrocyte protein, S100B, neuron-specific enolase, phosphorylated axonal neurofilament subunit H, Tau and ubiquitin carboxyl-terminal hydrolase L1) in 102 severe TBI patients. The recorded poor prognosis variables included acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury, posttraumatic cerebral infarction and six-month mortality and poor outcome (Glasgow score of 1-3). Results: Median interlerukin-33 concentration of patients (692 pg/mL) was substantially raised, as compared to controls. Interlerukin-33 concentrations were significantly correlated with Glasgow coma scale (GCS) score and the preceding biomarkers concentrations. Interlerukin-33 concentration > 692 pg/mL emerged as an independent prognostic predictor and its discriminatory capability exceeded those of the above-mentioned inflammatory biomarkers concentrations and was in the range of GCS scores and the aforementioned cell-specific proteins concentrations. Conclusion: Ascending serum interlerukin-33 concentrations could reflect inflammation, severity and worse prognosis following TBI.	[Zhang, Zu-Yong; Li, Jun; Ye, Qi; Dong, Yong; Bao, Guang-Ming; Shen, You-Kui] Zhejiang Chinese Med Univ, Guangxing Hosp, Hangzhou Hosp Tradit Chinese Med, Dept Neurosurg, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China; [Weng, Jian-Feng; Luo, Li-Feng; Cen, Meng] CHC Int Hosp, Dept Neurosurg, 599 Shiji Ave, Cixi 315315, Peoples R China		Ye, Q (corresponding author), Zhejiang Chinese Med Univ, Guangxing Hosp, Hangzhou Hosp Tradit Chinese Med, Dept Neurosurg, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China.	hzzyyzzy@163.com			Hangzhou Medical Research Fund Project [2016Z10]	This study was supported financially by the Hangzhou Medical Research Fund Project (No. 2016Z10).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Belatar B, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.36.10945; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fairlie-Clarke K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02596; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Gong JB, 2018, CLIN CHIM ACTA, V486, P214, DOI 10.1016/j.cca.2018.08.011; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Huang LT, 2015, CELL MOL NEUROBIOL, V35, P493, DOI 10.1007/s10571-014-0143-9; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Korhonen P, 2015, BRAIN BEHAV IMMUN, V49, P322, DOI 10.1016/j.bbi.2015.06.013; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Li Q, 2016, AGING DIS, V7, P614, DOI 10.14336/AD.2016.0207; Liu CL, 2014, CORONARY ARTERY DIS, V25, P498, DOI 10.1097/MCA.0000000000000117; Liu JY, 2014, J CLIN NEUROSCI, V21, P298, DOI 10.1016/j.jocn.2013.04.036; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Luo QP, 2018, NEUROSCIENCE, V385, P75, DOI 10.1016/j.neuroscience.2018.05.047; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Poulsen NN, 2018, RESP MED, V140, P50, DOI 10.1016/j.rmed.2018.05.016; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Saadah OI, 2015, INT J CLIN EXP PATHO, V8, P16000; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Zhang K, 2013, CHINESE MED J-PEKING, V126, P3628, DOI 10.3760/cma.j.issn.0366-6999.20130145; Zhang YJ, 2018, Z RHEUMATOL, V77, P151, DOI 10.1007/s00393-016-0202-3	34	11	11	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	OCT	2019	497						6	12		10.1016/j.cca.2019.07.008			7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IW3KE	WOS:000484878100002	31279693				2022-02-06	
J	Krasil'nikova, I; Surin, A; Sorokina, E; Fisenko, A; Boyarkin, D; Balyasin, M; Demchenko, A; Pomytkin, I; Pinelis, V				Krasil'nikova, Irina; Surin, Alexander; Sorokina, Elena; Fisenko, Andrei; Boyarkin, Dmitry; Balyasin, Maxim; Demchenko, Anna; Pomytkin, Igor; Pinelis, Vsevolod			Insulin Protects Cortical Neurons Against Glutamate Excitotoxicity	FRONTIERS IN NEUROSCIENCE			English	Article						insulin; glutamate excitotoxicity; cortical neuron; delayed calcium deregulation (DCD); mitochondrial depolarization; reactive oxygen species (ROS); BDNF	MITOCHONDRIAL DYSFUNCTION; NMDA RECEPTOR; CALCIUM DEREGULATION; NEUROTROPHIC FACTOR; CALPAIN ACTIVATION; ALZHEIMERS-DISEASE; NEUROPROTECTION; HOMEOSTASIS; MODULATION; DYSREGULATION	Glutamate excitotoxicity is implicated in the pathogenesis of numerous diseases, such as stroke, traumatic brain injury, and Alzheimer's disease, for which insulin resistance is a concomitant condition, and intranasal insulin treatment is believed to be a promising therapy. Excitotoxicity is initiated primarily by the sustained stimulation of ionotropic glutamate receptors and leads to a rise in intracellular Ca2+ ([Ca2+](i)), followed by a cascade of intracellular events, such as delayed calcium deregulation (DCD), mitochondrial depolarization, adenosine triphosphate (ATP) depletion that collectively end in cell death. Therefore, cross-talk between insulin and glutamate signaling in excitotoxicity is of particular interest for research. In the present study, we investigated the effects of short-term insulin exposure on the dynamics of [Ca2+](i) and mitochondrial potential in cultured rat cortical neurons during glutamate excitotoxicity. We found that insulin ameliorated the glutamate-evoked rise of [Ca2+](i) and prevented the onset of DCD, the postulated point-of-no-return in excitotoxicity. Additionally, insulin significantly improved the glutamate-induced drop in mitochondrial potential, ATP depletion, and depletion of brain-derived neurotrophic factor (BDNF), which is a critical neuroprotector in excitotoxicity. Also, insulin improved oxygen consumption rates, maximal respiration, and spare respiratory capacity in neurons exposed to glutamate, as well as the viability of cells in the MTT assay. In conclusion, the short-term insulin exposure in our experiments was evidently a protective treatment against excitotoxicity, in a sharp contrast to chronic insulin exposure causal to neuronal insulin resistance, the adverse factor in excitotoxicity.	[Krasil'nikova, Irina; Surin, Alexander; Sorokina, Elena; Fisenko, Andrei; Boyarkin, Dmitry; Pinelis, Vsevolod] Natl Med Res Ctr Childrens Hlth, Moscow, Russia; [Surin, Alexander] Russian Acad Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Balyasin, Maxim; Demchenko, Anna; Pomytkin, Igor] IM Sechenov First Moscow State Med Univ, Inst Regenerat Med, Dept Adv Cell Technol, Moscow, Russia; [Pomytkin, Igor] Fed Med & Biol Agcy, Sci Ctr Biomed Technol, Moscow, Russia		Krasil'nikova, I; Pinelis, V (corresponding author), Natl Med Res Ctr Childrens Hlth, Moscow, Russia.	irinakrsl81@gmail.com; pinelis@mail.ru	Fisenko, Andrei/AAO-9830-2020; Balyasin, Maxim/B-6324-2017; Krasilnikova, Irina/ABD-3784-2020; Krasilnikova, Irina/AAO-3767-2020; Pinelis, Vsevood/K-5564-2017; Demchenko, Anna/F-8727-2017	Balyasin, Maxim/0000-0002-3097-344X; Krasilnikova, Irina/0000-0001-9453-3040; Pinelis, Vsevood/0000-0001-8579-605X; Demchenko, Anna/0000-0002-4460-7627; Pomytkin, Igor/0000-0002-8426-3371	Russian Science FoundationRussian Science Foundation (RSF) [N 17-15-01487]; Russian Science FoundationRussian Science Foundation (RSF) [17-15-01487] Funding Source: Russian Science Foundation	This work was supported by the grant of Russian Science Foundation N 17-15-01487.	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Bessman SP, 1997, MOL CELL BIOCHEM, V174, P91, DOI 10.1023/A:1006834408181; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Chen SJ, 1996, J NEUROCHEM, V67, P194; Chen W, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00298; Christie JM, 1999, J NEUROCHEM, V72, P1523, DOI 10.1046/j.1471-4159.1999.721523.x; Clerc P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079982; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Datusalia AK, 2018, EUR J PHARMACOL, V833, P524, DOI 10.1016/j.ejphar.2018.07.001; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Fan LW, 2019, NEURAL REGEN RES, V14, P1046, DOI 10.4103/1673-5374.250624; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Hashimoto R, 2002, NEUROPHARMACOLOGY, V43, P1173, DOI 10.1016/S0028-3908(02)00217-4; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Laird MD, 2013, TRANSL STROKE RES, V4, P643, DOI 10.1007/s12975-013-0275-0; Liao GY, 1999, J NEUROCHEM, V73, P1510, DOI 10.1046/j.1471-4159.1999.0731510.x; Lioutas VA, 2016, NEURAL REGEN RES, V11, P400, DOI 10.4103/1673-5374.179040; LIU LF, 1995, NEUROSCI LETT, V192, P5, DOI 10.1016/0304-3940(95)11593-L; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Mota SI, 2014, NEUROPHARMACOLOGY, V76, P16, DOI 10.1016/j.neuropharm.2013.08.013; Nampoothiri M, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/674164; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Persiyantseva Nadezhda A, 2013, J Mol Signal, V8, P11, DOI 10.1186/1750-2187-8-11; Pivovarova NB, 2008, J NEUROCHEM, V104, P1686, DOI 10.1111/j.1471-4159.2007.05080.x; Rueda CB, 2016, BBA-BIOENERGETICS, V1857, P1158, DOI 10.1016/j.bbabio.2016.04.003; Rueda CB, 2015, J NEUROSCI, V35, P3566, DOI 10.1523/JNEUROSCI.2702-14.2015; Rundek T, 2010, ARCH NEUROL-CHICAGO, V67, P1195, DOI 10.1001/archneurol.2010.235; SCHAFER M, 1992, BRAIN RES, V580, P331, DOI 10.1016/0006-8993(92)90962-9; SCHAFER M, 1991, DEV BRAIN RES, V62, P293, DOI 10.1016/0165-3806(91)90179-M; Schinder AF, 1996, J NEUROSCI, V16, P6125; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Song XQ, 2018, NATURE, V556, P515, DOI 10.1038/s41586-018-0039-9; Sorokina E. G, 2018, PATOGENEZ, V16, P168, DOI [10.25557/2310-0435.2018.04.168-173, DOI 10.25557/2310-0435.2018.04.168-173]; Surin AM, 2014, BIOCHEMISTRY-MOSCOW+, V79, P146, DOI 10.1134/S0006297914020084; Surin A.M., 2014, PATOGENEZ RUS, V12, P40; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Virag L, 1999, MOL PHARMACOL, V56, P824; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030	53	11	11	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 24	2019	13								1027	10.3389/fnins.2019.01027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA1XL	WOS:000487611200001	31611766	gold, Green Published			2022-02-06	
J	Eakman, AM; Kinney, AR; Schierl, ML; Henry, KL				Eakman, Aaron M.; Kinney, Adam R.; Schierl, Michelle L.; Henry, Kimberly L.			Academic performance in student service members/veterans: effects of instructor autonomy support, academic self-efficacy and academic problems	EDUCATIONAL PSYCHOLOGY			English	Article						Autonomy support; academic self-efficacy; postsecondary education; veterans; resilience	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; MENTAL-HEALTH PROBLEMS; PSYCHOLOGICAL RESILIENCE; PSYCHOMETRIC PROPERTIES; UNIVERSITY-STUDENTS; DEPRESSION SEVERITY; COLLEGE OUTCOMES; SOCIAL SUPPORT	This study examined relationships between instructor autonomy support, academic self-efficacy, academic problems and academic achievement among student service members/veterans (SSM/V). Participants included veterans, active duty or National Guard/Reservists of the US military (N = 172) enrolled in a postsecondary institution. Online surveys generated responses to indicators of instructor autonomy support, academic self-efficacy, and academic problems. Grade point average (GPA) was obtained from the institution. Multiple regression models found that academic self-efficacy and academic problems independently predicted GPA. Health-related factors (e.g. depression) explained academic self-efficacy, academic problems and academic achievement. Academic self-efficacy and academic problems independently mediated the relationship between instructor autonomy support and GPA. Results indicate that greater academic self-efficacy, fewer academic problems and an autonomy-supportive education environment may promote academic achievement in SSM/V despite the presence of health-related factors such as depression, posttraumatic stress and mild traumatic brain injury. Supported education programs may further academic achievement among SSM/V.	[Eakman, Aaron M.; Kinney, Adam R.] Colorado State Univ, Dept Occupat Therapy, Campus Delivery 1573, Ft Collins, CO 80523 USA; [Schierl, Michelle L.] Washington Cty Sch Dist, St George, UT USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA		Eakman, AM (corresponding author), Colorado State Univ, Dept Occupat Therapy, Campus Delivery 1573, Ft Collins, CO 80523 USA.	aaron.eakman@colostate.edu		Henry, Kimberly/0000-0002-2303-3759			Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Arbuckle, 2014, AMOS VERSION 23 0; Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.2307/1131888; Bandura A., 1997, SELF EFFICACY EXERCI; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Benita M, 2014, J EDUC PSYCHOL, V106, P258, DOI 10.1037/a0034007; Black AE, 2000, SCI EDUC, V84, P740, DOI 10.1002/1098-237X(200011)84:6<740::AID-SCE4>3.0.CO;2-3; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bryan CJ, 2014, J REHABIL RES DEV, V51, P1035, DOI 10.1682/JRRD.2014.01.0012; Cate C.A., 2014, MILLION RECORDS PROJ; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Chemers MM, 2001, J EDUC PSYCHOL, V93, P55, DOI 10.1037//0022-0663.93.1.55; Cleary TJ, 2004, PSYCHOL SCHOOLS, V41, P537, DOI 10.1002/pits.10177; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Durdella NR., 2012, J STUD ED, V2, P109; Eakman AM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016519; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Glynn S. M., 2009, EFFECTIVE TREATMENTS, V2, P388, DOI DOI 10.1002/PON.660; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Hardre PL, 2003, J EDUC PSYCHOL, V95, P347, DOI 10.1037/0022-0663.95.2.347; Hayes, 2018, INTRO MEDIATION MODE; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Jang H, 2012, J EDUC PSYCHOL, V104, P1175, DOI 10.1037/a0028089; Jang H, 2010, J EDUC PSYCHOL, V102, P588, DOI 10.1037/a0019682; Kaplan A, 2002, ADOLESCENCE EDUC, P125; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; King DW, 2006, J APPL SOC PSYCHOL, V36, P2980, DOI 10.1111/j.0021-9029.2006.00138.x; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; Kinney AR, 2017, J POSTSECOND EDUC DI, V30, P345; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Markoulakis R, 2013, REV HIGH EDUC, V37, P77, DOI 10.1353/rhe.2013.0073; Masten A.S, 2014, ORDINARY MAGIC RESIL; Ness BM, 2015, J AM COLL HEALTH, V63, P448, DOI 10.1080/07448481.2014.975719; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Patall EA, 2010, J EDUC PSYCHOL, V102, P896, DOI 10.1037/a0019545; Patrick H, 1997, J EARLY ADOLESCENCE, V17, P109, DOI 10.1177/0272431697017002001; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; Pietrzak RH, 2011, J AFFECT DISORDERS, V133, P560, DOI 10.1016/j.jad.2011.04.028; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Putwain D, 2013, BRIT J EDUC PSYCHOL, V83, P633, DOI 10.1111/j.2044-8279.2012.02084.x; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Rutkowski L, 2010, J EDUC PSYCHOL, V102, P223, DOI 10.1037/a0017287; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Schonfeld L, 2015, J AM COLL HEALTH, V63, P428, DOI 10.1080/07448481.2014.963106; Schunk DH, 1997, EDUC PSYCHOL-US, V32, P195, DOI 10.1207/s15326985ep3204_1; Shen B, 2009, RES Q EXERCISE SPORT, V80, P44, DOI 10.5641/027013609X13087704027553; Simmen-Janevska K, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18560; Smith-Osborne A., 2012, ADV SOCIAL WORK, V31, P34, DOI DOI 10.18060/1870; Smith-Osborne A., 2007, ADV SOCIAL WORK, V8, P152; Smith-Osborne A, 2012, J REHABIL, V78, P4; Smith-Osborne A, 2009, AM J COMMUN PSYCHOL, V44, P327, DOI 10.1007/s10464-009-9278-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tsai J, 2014, J AFFECT DISORDERS, V165, P166, DOI 10.1016/j.jad.2014.04.075; Vansteenkiste M, 2004, J PERS SOC PSYCHOL, V87, P246, DOI 10.1037/0022-3514.87.2.246; Vansteenkiste M, 2013, J PSYCHOTHER INTEGR, V23, P263, DOI 10.1037/a0032359; Vogt D., 2012, MANUAL DEPLOYMENT RI; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wald J, 2009, J TRAUMA STRESS, V22, P312, DOI 10.1002/jts.20430; Weirich C, 1991, LAB LAW, V7, P27; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wright, 2010, HDB ADULT RESILIENCE, P213, DOI DOI 10.1080/17439760.2011.614836.; ZIMMERMAN BJ, 1986, CONTEMP EDUC PSYCHOL, V11, P307, DOI 10.1016/0361-476X(86)90027-5; ZIMMERMAN BJ, 1990, EDUC PSYCHOL, V25, P3, DOI 10.1207/s15326985ep2501_2; ZIMMERMAN BJ, 1989, J EDUC PSYCHOL, V81, P329, DOI 10.1037/0022-0663.81.3.329	87	11	11	3	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0144-3410	1469-5820		EDUC PSYCHOL-UK	Educ. Psychol.	SEP 14	2019	39	8					1005	1026		10.1080/01443410.2019.1605048			22	Education & Educational Research; Psychology, Educational	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology	IO0NS	WOS:000479076200003					2022-02-06	
J	Haider, MN; Johnson, SL; Mannix, R; Macfarlane, AJ; Constantino, D; Johnson, BD; Willer, B; Leddy, J				Haider, Mohammad N.; Johnson, Samantha L.; Mannix, Rebekah; Macfarlane, Alexander J.; Constantino, Dylan; Johnson, Blair D.; Willer, Barry; Leddy, John			The Buffalo Concussion Bike Test for Concussion Assessment in Adolescents	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						sport-related concussion; Buffalo Concussion Treadmill Test; BCTT; Buffalo Concussion Bike Test; BCBT; exercise test	EXERCISE; TREADMILL; BRAIN	Background: The Buffalo Concussion Treadmill Test (BCTT) is a graded exertion test for assessing exercise tolerance after concussion, but its utility is limited for certain populations. Hypothesis: We developed the Buffalo Concussion Bike Test (BCBT) and tested its comparability with the BCTT. We hypothesize that heart rate (HR) at symptom exacerbation on the BCBT will be equivalent to the BCTT. Study Design: Case-control study. Methods: Adolescents with acute concussion (AC) (n = 20; mean age, 15.9 +/- 1.1 years; 60% male) presenting to a concussion clinic within 10 days of injury and age- and sex-matched healthy controls (n = 20; mean age, 15.9 +/- 1.1 years; 60% male) performed the BCTT at first visit and returned within 3 days to perform the BCBT. Test duration, HR, symptom severity (measured using a visual analog scale), and exertion (measured using the Borg Rating of Perceived Exertion) were collected during each test. Results: Adolescents with AC who were exercise intolerant on the BCTT were also intolerant on the BCBT, with symptom exacerbation occurring at a mean 8.1 +/- 2.8 minutes on the BCTT versus 14.6 +/- 6.0 minutes on the BCBT (P < 0.01). Two 1-sided t tests showed that the HR at symptom exacerbation in AC patients on each test were statistically equivalent (137 +/- 28 bpm on BCTT vs 135 +/- 25 bpm on BCBT; 95% CI, <0.01-0.03) and at voluntary exhaustion for controls (175 +/- 13 bpm on BCTT vs 175 +/- 13 bpm on BCBT; 95% CI, 0.03-0.03). Conclusion: The HR at symptom exacerbation on BCBT is equivalent to the BCTT for the assessment of exercise tolerance after concussion in adolescents.	[Haider, Mohammad N.; Johnson, Samantha L.; Leddy, John] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosci, Buffalo, NY 14214 USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Macfarlane, Alexander J.; Constantino, Dylan] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Johnson, Blair D.] SUNY Buffalo, Dept Exercise & Nutr Sci, Ctr Res & Educ Special Environm, Buffalo, NY 14214 USA; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14214 USA		Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	haider@buffalo.edu	Mannix, Rebekah/AAD-8702-2020	Macfarlane, Alexander/0000-0002-8293-7037; Johnson, Blair/0000-0002-1731-4415	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	The authors declared the following potential conflicts of interest: The University at Buffalo received support for this study from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412.	Barth JT, 2001, J ATHL TRAINING, V36, P253; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Borg G., 1998, BORGS PERCEIVED EXER; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; CUMMING GR, 1977, AM HEART J, V93, P261, DOI 10.1016/S0002-8703(77)80321-9; FAIRSHTER RD, 1983, MED SCI SPORT EXER, V15, P549; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Froelicher VF, 2006, MANUAL EXERCISE TEST, V2006, P17; Glass S., 2007, ACSMS METABOLIC CALC; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; HERMANSEN L, 1970, J APPL PHYSIOL, V29, P82, DOI 10.1152/jappl.1970.29.1.82; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Tommasone BA, 2006, J ATHL TRAINING, V41, P470	27	11	11	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2019	11	6					492	497	1941738119870189	10.1177/1941738119870189		SEP 2019	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JI0QB	WOS:000485373300001	31486715	Green Published			2022-02-06	
J	Draxler, DF; Daglas, M; Fernando, A; Hanafi, G; McCutcheon, F; Ho, HD; Galle, A; Gregory, J; Larsson, P; Keragala, C; Wright, DK; Tavancheh, E; Au, AE; Niego, B; Wilson, K; Plebanski, M; Sashindranath, M; Medcalf, RL				Draxler, Dominik F.; Daglas, Maria; Fernando, Anushka; Hanafi, Gryselda; McCutcheon, Fiona; Ho, Heidi; Galle, Adam; Gregory, Julia; Larsson, Pia; Keragala, Charithani; Wright, David K.; Tavancheh, Elnaz; Au, Amanda E.; Niego, Be'eri; Wilson, Kirsty; Plebanski, Magdalena; Sashindranath, Maithili; Medcalf, Robert L.			Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						fibrinolysis; immunosuppression; plasminogen; tranexamic acid; traumatic brain injury	PLASMIN; HEMORRHAGE; CRASH-2; PATHOPHYSIOLOGY; FIBRINOLYSIS; COAGULOPATHY; MECHANISMS	Background Traumatic brain injury (TBI) is known to promote immunosuppression, making patients more susceptible to infection, yet potentially exerting protective effects by inhibiting central nervous system (CNS) reactivity. Plasmin, the effector protease of the fibrinolytic system, is now recognized for its involvement in modulating immune function. Objective To evaluate the effects of plasmin and tranexamic acid (TXA) on the immune response in wild-type and plasminogen-deficient (plg(-/-)) mice subjected to TBI. Methods Leukocyte subsets in lymph nodes and the brain in mice post TBI were evaluated by flow cytometry and in blood with a hemocytometer. Immune responsiveness to CNS antigens was determined by Enzyme-linked Immunosorbent Spot (ELISpot) assay. Fibrinolysis was determined by thromboelastography and measuring D-dimer and plasmin-antiplasmin complex levels. Results Plg(-/-) mice, but not plg(+/+) mice displayed increases in both the number and activation of various antigen-presenting cells and T cells in the cLN 1 week post TBI. Wild-type mice treated with TXA also displayed increased cellularity of the cLN 1 week post TBI together with increases in innate and adaptive immune cells. These changes occurred despite the absence of systemic hyperfibrinolysis or coagulopathy in this model of TBI. Importantly, neither plg deficiency nor TXA treatment enhanced the autoreactivity within the CNS. Conclusion In the absence of systemic hyperfibrinolysis, plasmin deficiency or blockade with TXA increases migration and proliferation of conventional dendritic cells (cDCs) and various antigen-presenting cells and T cells in the draining cervical lymph node (cLN) post TBI. Tranexamic acid might also be clinically beneficial in modulating the inflammatory and immune response after TBI, but without promoting CNS autoreactivity.	[Draxler, Dominik F.; Daglas, Maria; Fernando, Anushka; Hanafi, Gryselda; McCutcheon, Fiona; Ho, Heidi; Galle, Adam; Gregory, Julia; Larsson, Pia; Keragala, Charithani; Tavancheh, Elnaz; Au, Amanda E.; Niego, Be'eri; Sashindranath, Maithili; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia; [Wright, David K.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Wilson, Kirsty; Plebanski, Magdalena] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia; [Plebanski, Magdalena] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia		Sashindranath, M; Medcalf, RL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia.	maithili.sashindranath@monash.edu; robert.medcalf@monash.edu	Gregory, Julia L/K-8726-2012; Niego, Beeri/AAG-5534-2019; Sashindranath, Maithili/AAI-7408-2021; Gregory, Julia/AAW-6017-2020; Plebanski, Magdalena/AAU-3144-2021	Niego, Beeri/0000-0001-6714-9131; Sashindranath, Maithili/0000-0002-9712-4784; Gregory, Julia/0000-0003-2408-677X; Au, Amanda/0000-0003-3656-2673; Daglas, Maria/0000-0002-9356-4061; , Magdalena/0000-0001-6889-3667	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia [APP1045755]; Australian postgraduate scholarshipAustralian Government; Alzheimers Australia Dementia Research Foundation	This project was funded by a grant awarded to Robert L. Medcalf by the National Health and Medical Research Council (NHMRC) of Australia, grant #APP1045755. Dominik F. Draxler is the recipient of an Australian postgraduate scholarship. Maithili Sashindranath is the recipient of an Alzheimers Australia Dementia Research Foundation grant.	Borg RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131216; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Draxler DF, 2017, SEMIN THROMB HEMOST, V43, P143, DOI 10.1055/s-0036-1586227; Draxler DF, 2019, J NEUROTRAUM, V36, P3297, DOI 10.1089/neu.2018.6030; Draxler DF, 2019, BLOOD ADV, V3, P1598, DOI 10.1182/bloodadvances.2019000092; Draxler DF, 2015, TRANSFUS MED REV, V29, P102, DOI 10.1016/j.tmrv.2014.09.006; Frith D, 2012, CURR OPIN CRIT CARE, V18, P631, DOI 10.1097/MCC.0b013e3283599ab9; Gur-Wahnon D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-124; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hultman K, 2014, J THROMB HAEMOST, V12, P701, DOI 10.1111/jth.12553; Jimenez JJ, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-138; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kolev K, 2016, BRIT J HAEMATOL, V175, P12, DOI 10.1111/bjh.14255; Later AFL, 2013, J THORAC CARDIOV SUR, V145, P1611, DOI 10.1016/j.jtcvs.2012.11.042; Li J, 2006, THROMB HAEMOSTASIS, V96, P512, DOI 10.1160/TH06-03-0168; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; McCutcheon M, 1997, J IMMUNOL METHODS, V210, P149, DOI 10.1016/S0022-1759(97)00182-8; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miller I, 2018, CELL REP, V24, P1105, DOI 10.1016/j.celrep.2018.06.110; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Napolitano Lena M, 2017, Trauma Surg Acute Care Open, V2, pe000056, DOI 10.1136/tsaco-2016-000056; Nguyen THO, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.4; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Nishida T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0201-0; Paterson P Y, 1986, Trans Am Clin Climatol Assoc, V97, P149; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Plow EF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/141806; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shaw MA, 2017, J NEUROSCI, V37, P3776, DOI 10.1523/JNEUROSCI.2932-15.2017; Shen Y, 2012, BLOOD, V119, P5879, DOI 10.1182/blood-2012-01-407825; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Tersteeg C, 2017, J THROMB HAEMOST, V15, P2432, DOI 10.1111/jth.13859	49	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	DEC	2019	17	12					2174	2187		10.1111/jth.14603		SEP 2019	14	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	JU0PU	WOS:000484843100001	31393041	Green Published			2022-02-06	
J	Ma, YY; Liu, TY; Fu, JJ; Fu, SL; Hu, C; Sun, B; Fan, XT; Zhu, JC				Ma, Yuanyuan; Liu, Tianyao; Fu, Jingjing; Fu, Shaoli; Hu, Chen; Sun, Bo; Fan, Xiaotang; Zhu, Jingci			Lactobacillus acidophilus Exerts Neuroprotective Effects in Mice with Traumatic Brain Injury	JOURNAL OF NUTRITION			English	Article						traumatic brain injury; neuroprotection; Lactobacillus acidophilus; gut microbiota; intestinal barrier	HEAD-INJURY; MICROBIOTA; SUPPLEMENTATION; INFLAMMATION; RESPONSES; BEHAVIOR; BARRIER; MOUSE; RATS	Background: Traumatic brain injury (TBI) causes dysbiosis and intestinal barrier disruption, which further exacerbate brain damage via an inflammatory pathway. Gut microbiota remodeling by Lactobacillus acidophilus (LA) is a potential intervention. Objective: The aim of this study was to investigate the neuroprotective effects of LA in TBI and elucidated underlying mechanisms. Methods: C57BL/6 male mice (aged 8-9 wk) were subjected to weight-drop impact and gavaged with saline (TBI + vehicle) or LA (1 x 10(10) CFU) (TBI + LA) on the day of injury and each day after for 1, 3, or 7 d. The sham + vehicle mice underwent craniotomy without brain injury and were gavaged with saline. Sensorimotor functions were determined pre-TBI and 1, 3, and 7 d postinjury. Indexes of neuroinflammation, peripheral inflammation, and intestinal barrier function were measured on days 3 and 7. Microbiota composition was measured 3 d postinjury. The data were mainly analyzed by 2-factor ANOVA. Results: Compared with sham + vehiclemice, the TBI + vehiclemice exhibited impairments in the neurological severity score (+ 692%, day 3; + 600%, day 7) and rotarod test (-58%, day 3; -45%, day 7) (P < 0.05), which were rescued by LA. The numbers of microglia (total and activated) and astrocytes and concentrations of TNF-alpha and IL1-beta in the perilesional cortex were elevated in the TBI + vehicle mice on day 3 or 7 compared with sham + vehicle mice (P < 0.05) and were normalized by LA. Comparedwith sham+ vehiclemice, the TBI+ vehiclemice exhibited increased serum concentrations of endotoxin and TNF-alpha, and intestinal barrier permeability (D-lactate) on days 3 and 7 (P < 0.05), and these changeswere alleviated by LA. Three days postinjury, the microbiota composition was disrupted in the TBI + vehicle mice compared with sham + vehicle mice (P < 0.05), which was restored by LA. Conclusion: Our results demonstrate that LA exerts neuroprotective effects that may be associated with gut microbiota remodeling in TBI mice.	[Ma, Yuanyuan; Fu, Jingjing; Fu, Shaoli; Hu, Chen; Sun, Bo; Zhu, Jingci] Third Mil Med Univ, Army Med Univ, Sch Nursing, Dept Basic Nursing, Chongqing, Peoples R China; [Ma, Yuanyuan; Liu, Tianyao; Fan, Xiaotang] Third Mil Med Univ, Army Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing, Peoples R China		Zhu, JC (corresponding author), Third Mil Med Univ, Army Med Univ, Sch Nursing, Dept Basic Nursing, Chongqing, Peoples R China.; Fan, XT (corresponding author), Third Mil Med Univ, Army Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing, Peoples R China.	fanxiaotang2005@163.com; zhujingci2009@163.com		Fu, Jingjing/0000-0003-1811-6637			Abdrabou A. M., 2018, HUMAN MICROBIOME J, V10, P33, DOI [10.1016/j.humic.2018.08.001, DOI 10.1016/J.HUMIC.2018.08.001]; Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Azm SAN, 2018, APPL PHYSIOL NUTR ME, V43, P718, DOI 10.1139/apnm-2017-0648; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bruce-Keller AJ, 2018, BIOL PSYCHIAT, V83, P214, DOI 10.1016/j.biopsych.2017.08.014; Bye N, 2016, EXP NEUROL, V279, P86, DOI 10.1016/j.expneurol.2016.02.012; Cai YL, 2018, P NATL ACAD SCI USA, V115, pE2725, DOI 10.1073/pnas.1800184115; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Corpuz HM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060762; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Erny D, 2017, IMMUNOLOGY, V150, P7, DOI 10.1111/imm.12645; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao Chuang, 2017, Mol Neurobiol, V54, P8348, DOI 10.1007/s12035-016-0318-0; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Hwang YH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020305; Jang SE, 2018, MUCOSAL IMMUNOL, V11, P369, DOI 10.1038/mi.2017.49; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027; Lepine AFP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01439; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Lin RQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00417; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nicholson SE, 2018, SHOCK; O'Hagan C, 2017, NEUROBIOL LEARN MEM, V144, P36, DOI 10.1016/j.nlm.2017.05.015; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Sellmann C, 2017, J NUTR, V147, P2041, DOI 10.3945/jn.117.253815; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Shen NT, 2017, GASTROENTEROLOGY, V152, P1889, DOI 10.1053/j.gastro.2017.02.003; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Stevens BR, 2018, GUT, V67, P1555, DOI 10.1136/gutjnl-2017-314759; Sun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128214; Sun J, 2016, BRAIN RES, V1642, P180, DOI 10.1016/j.brainres.2016.03.042; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Wu DY, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03160; Xia ZN, 2017, SHOCK, V48, P260, DOI 10.1097/SHK.0000000000000826; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang Y, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007626; Yu XY, 2011, NUTRITION, V27, P100, DOI 10.1016/j.nut.2010.01.010; Yu ZY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00324; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	49	11	12	1	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-3166	1541-6100		J NUTR	J. Nutr.	SEP	2019	149	9					1543	1552		10.1093/jn/nxz105			10	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	JB4UE	WOS:000488554700008	31174208	Bronze			2022-02-06	
J	Le Page, LM; Guglielmetti, C; Najac, CF; Tiret, B; Chaumeil, MM				Le Page, Lydia M.; Guglielmetti, Caroline; Najac, Chloe F.; Tiret, Brice; Chaumeil, Myriam M.			Hyperpolarized C-13 magnetic resonance spectroscopy detects toxin-induced neuroinflammation in mice	NMR IN BIOMEDICINE			English	Article						hyperpolarized C-13 MRS; lipopolysaccharide; metabolism; neuroinflammation	IN-VIVO; INFLAMMATORY RESPONSE; MICROGLIAL ACTIVATION; ENERGY-METABOLISM; RODENT MODEL; BRAIN; MR; LIPOPOLYSACCHARIDE; ASTROCYTES; GLUCOSE	Lipopolysaccharide (LPS) is a commonly used agent for induction of neuroinflammation in preclinical studies. Upon injection, LPS causes activation of microglia and astrocytes, whose metabolism alters to favor glycolysis. Assessing in vivo neuroinflammation and its modulation following therapy remains challenging, and new noninvasive methods allowing for longitudinal monitoring would be highly valuable. Hyperpolarized (HP) C-13 magnetic resonance spectroscopy (MRS) is a promising technique for assessing in vivo metabolism. In addition to applications in oncology, the most commonly used probe of [1-C-13] pyruvate has shown potential in assessing neuroinflammation-linked metabolism in mouse models of multiple sclerosis and traumatic brain injury. Here, we aimed to investigate LPS-induced neuroinflammatory changes using HP [1-C-13] pyruvate and HP C-13 urea. 2D chemical shift imaging following simultaneous intravenous injection of HP [1-C-13] pyruvate and HP C-13 urea was performed at baseline (day 0) and at days 3 and 7 post-intracranial injection of LPS (n = 6) or saline (n = 5). Immunofluorescence (IF) analyses were performed for Iba1 (resting and activated microglia/macrophages), GFAP (resting and reactive astrocytes) and CD68 (activated microglia/macrophages). A significant increase in HP [1-C-13] lactate production was observed at days 3 and 7 following injection, in the injected (ipsilateral) side of the LPS-treated mouse brain, but not in either the contralateral side or saline-injected animals. HP C-13 lactate/pyruvate ratio, without and with normalization to urea, was also significantly increased in the ipsilateral LPS-injected brain at 7 days compared with baseline. IF analyses showed a significant increase in CD68 and GFAP staining at 3 days, followed by increased numbers of Iba1 and GFAP positive cells at 7 days post-LPS injection. In conclusion, we can detect LPS-induced changes in the mouse brain using HP C-13 MRS, in alignment with increased numbers of microglia/macrophages and astrocytes. This study demonstrates that HP C-13 spectroscopy has substantial potential for providing noninvasive information on neuroinflammation.	[Le Page, Lydia M.; Guglielmetti, Caroline; Tiret, Brice; Chaumeil, Myriam M.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, 1700 4th St,BH 204,Mission Bay Campus,Box 2530, San Francisco, CA 94143 USA; [Le Page, Lydia M.; Guglielmetti, Caroline; Tiret, Brice; Chaumeil, Myriam M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Najac, Chloe F.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands		Chaumeil, MM (corresponding author), Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, 1700 4th St,BH 204,Mission Bay Campus,Box 2530, San Francisco, CA 94143 USA.	myriam.chaumeil@ucsf.edu		Chaumeil, Myriam/0000-0002-2110-4613; Najac, Chloe/0000-0002-7804-2281; Le Page, Lydia/0000-0002-3807-4772	Conrad N. Hilton Foundation; Dana Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102156]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [FG1507-05297, RG-1701-26630]; NMSSNational Multiple Sclerosis Society [RG-1701-26630, FG-1507-05297]; NIH Hyperpolarized MRI Technology Resource CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB013598]; Hilton Foundation Marilyn Hilton Award for Innovation in MS Research [17319]; CalBRAIN [349087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB013598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102156] Funding Source: NIH RePORTER	Conrad N. Hilton Foundation, Grant/Award Number: Marilyn Hilton Award for Innovation in MS Research; Dana Foundation, Grant/Award Number: The David Mahoney Neuroimaging program; National Institutes of Health, Grant/Award Numbers: Hyperpolarized MRI Technology Resource Center #P41 and R01NS102156; National Multiple Sclerosis Society, Grant/Award Number: Fellowship FG1507-05297 (to C. G.) RG-1701-26630; NMSS, Grant/Award Numbers: FG-1507-05297 and RG-1701-26630; NIH Hyperpolarized MRI Technology Resource Center, Grant/Award Number: #P41EB013598; Hilton Foundation Marilyn Hilton Award for Innovation in MS Research, Grant/Award Number: #17319; CalBRAIN, Grant/Award Number: 349087	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bastiaansen JAM, 2014, METABOLOMICS, V10, P986, DOI 10.1007/s11306-014-0630-5; Bonvento G, 2017, J CEREBR BLOOD F MET, V37, P1927, DOI 10.1177/0271678X17697989; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Chaumeil MM, 2015, METHOD ENZYMOL, V561, P1, DOI 10.1016/bs.mie.2015.04.001; Chaumeil MM, 2012, NEUROIMAGE, V59, P193, DOI 10.1016/j.neuroimage.2011.07.034; Cheshkov S, 2017, MAGN RESON MED, V78, P2065, DOI 10.1002/mrm.26603; Choi YS, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0415-2; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; ENG LF, 1992, PROG BRAIN RES, V94, P353; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Espinosa-Oliva Ana M, 2013, Methods Mol Biol, V1041, P295, DOI 10.1007/978-1-62703-520-0_26; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; Go M, 2016, BIOCHEM BIOPH RES CO, V479, P331, DOI 10.1016/j.bbrc.2016.09.073; Guglielmetti C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17758-4; Guglielmetti C, 2017, P NATL ACAD SCI USA, V114, pE6982, DOI 10.1073/pnas.1613345114; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harris RA, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0389-18.2019; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Herber DL, 2007, J NEUROIMMUNE PHARM, V2, P222, DOI 10.1007/s11481-007-9069-z; Josan S, 2015, NMR BIOMED, V28, P1671, DOI 10.1002/nbm.3431; Klimaszewska-Lata J, 2015, J NEUROCHEM, V133, P284, DOI 10.1111/jnc.12979; Kurhanewicz J, 2019, NEOPLASIA, V21, P1, DOI 10.1016/j.neo.2018.09.006; Lanz B, 2014, J NEUROCHEM, V128, P125, DOI 10.1111/jnc.12479; Lau AZ, 2017, MAGN RESON MED, V77, P151, DOI 10.1002/mrm.26106; Laustsen C, 2014, KIDNEY INT, V86, P67, DOI 10.1038/ki.2013.504; Le Page LM, 2015, DIABETES, V64, P2735, DOI 10.2337/db14-1560; LEO GC, 1993, DEV NEUROSCI-BASEL, V15, P282, DOI 10.1159/000111346; Lewis AJM, 2018, CIRC RES, V122, P1084, DOI 10.1161/CIRCRESAHA.117.312535; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lin AP, 2003, MAGN RESON MATER PHY, V16, P29, DOI 10.1007/s10334-003-0004-x; Lodygensky GA, 2014, PEDIATR RES, V75, P415, DOI 10.1038/pr.2013.242; MacKenzie JD, 2011, RADIOLOGY, V259, P414, DOI 10.1148/radiol.10101921; Marin-Valencia I, 2015, J NEUROCHEM, V132, P99, DOI 10.1111/jnc.12948; Meneses G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201375; Miller JJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33363-5; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; Nordgreen J, 2018, PHYSIOL BEHAV, V195, P98, DOI 10.1016/j.physbeh.2018.07.013; Ohliger MA, 2017, MAGN RESON MED, V77, P2356, DOI 10.1002/mrm.26296; Park I, 2019, MOL IMAGING BIOL, V21, P626, DOI 10.1007/s11307-018-1275-y; Park I, 2014, MAGN RESON MED, V71, P19, DOI 10.1002/mrm.25003; Park JM, 2013, NMR BIOMED, V26, P1197, DOI 10.1002/nbm.2935; Qin H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26296-6; Radoul M, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4044; Sharma A, 2016, CELL MOL NEUROBIOL, V36, P577, DOI 10.1007/s10571-015-0238-y; Spielman DM, 2009, MAGN RESON MED, V62, P307, DOI 10.1002/mrm.21998; Sriram R, 2018, ACS INFECT DIS, V4, P797, DOI 10.1021/acsinfecdis.7b00234; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; von Morze C, 2011, J MAGN RESON IMAGING, V33, P692, DOI 10.1002/jmri.22484; Wilson DM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46014; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	64	11	11	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	NOV	2019	32	11							e4164	10.1002/nbm.4164		AUG 2019	11	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	JH9DS	WOS:000483090400001	31437326	Green Published, Green Accepted			2022-02-06	
J	Morioka, K; Marmor, Y; Sacramento, JA; Lin, A; Shao, T; Miclau, KR; Clark, DR; Beattie, MS; Marcucio, RS; Miclau, T; Ferguson, AR; Bresnaha, JC; Bahney, CS				Morioka, Kazuhito; Marmor, Yotvat; Sacramento, Jeffrey A.; Lin, Amity; Shao, Tiffany; Miclau, Katherine R.; Clark, Daniel R.; Beattie, Michael S.; Marcucio, Ralph S.; Miclau, Theodore, III; Ferguson, Adam R.; Bresnaha, Jacqueline C.; Bahney, Chelsea S.			Differential fracture response to traumatic brain injury suggests dominance of neuroinflammatory response in polytrauma	SCIENTIFIC REPORTS			English	Article							GENE-RELATED PEPTIDE; HEAD-INJURY; HETEROTOPIC OSSIFICATION; ENHANCED OSTEOGENESIS; CALLUS FORMATION; NERVOUS-SYSTEM; BONE-FORMATION; RAT MODEL; CELLS; VASCULATURE	Polytraumatic injuries, specifically long bone fracture and traumatic brain injury (TBI), frequently occur together. Clinical observation has long held that TBI can accelerate fracture healing, yet the complexity and heterogeneity of these injuries has produced conflicting data with limited information on underlying mechanisms. We developed a murine polytrauma model with TBI and fracture to evaluate healing in a controlled system. Fractures were created both contra lateral and ipsilateral to the TBI to test whether differential responses of humoral and/or neuronal systems drove altered healing patterns. Our results show increased bone formation after TBI when injuries occur contralateral to each other, rather than ipsilateral, suggesting a role of the nervous system based on the crossed neuroanatomy of motor and sensory systems. Analysis of the humoral system shows that blood cell counts and inflammatory markers are differentially modulated by polytrauma. A data-driven multivariate analysis integrating all outcome measures showed a distinct pathological state of polytrauma and co-variations between fracture, TBI and systemic markers. Taken together, our results suggest that a contralateral bone fracture and TBI alter the local neuroinflammatory state to accelerate early fracture healing. We believe applying a similar data-driven approach to clinical polytrauma may help to better understand the complicated pathophysiological mechanisms of healing.	[Morioka, Kazuhito; Sacramento, Jeffrey A.; Lin, Amity; Beattie, Michael S.; Ferguson, Adam R.; Bresnaha, Jacqueline C.] UCSF, Dept Neurol Surg, Weill Inst Neurosci Brain & Spinal Injury Ctr BAS, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Morioka, Kazuhito; Sacramento, Jeffrey A.; Lin, Amity; Beattie, Michael S.; Ferguson, Adam R.; Bresnaha, Jacqueline C.] Zuckerberg San Francisco Gen Hosp ZSFG, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Morioka, Kazuhito; Marmor, Yotvat; Shao, Tiffany; Miclau, Katherine R.; Clark, Daniel R.; Marcucio, Ralph S.; Miclau, Theodore, III; Bahney, Chelsea S.] UCSF, Dept Orthopaed Surg, Orthopaed Trauma Inst, 2550 23rd St,Bldg 9,3rd Floor, San Francisco, CA 94110 USA; [Morioka, Kazuhito; Marmor, Yotvat; Shao, Tiffany; Miclau, Katherine R.; Clark, Daniel R.; Marcucio, Ralph S.; Miclau, Theodore, III; Bahney, Chelsea S.] Zuckerberg San Francisco Gen Hosp ZSFG, 2550 23rd St,Bldg 9,3rd Floor, San Francisco, CA 94110 USA; [Ferguson, Adam R.] San Francisco VA Med Ctr, 4150 Clement St,Bldg 13,Room 114M, San Francisco, CA 94121 USA; [Bahney, Chelsea S.] SPRI, 181W Meadows Dr,Suite 1000, Vail, CO 81657 USA		Bresnaha, JC (corresponding author), UCSF, Dept Neurol Surg, Weill Inst Neurosci Brain & Spinal Injury Ctr BAS, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Bresnaha, JC (corresponding author), Zuckerberg San Francisco Gen Hosp ZSFG, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Bahney, CS (corresponding author), UCSF, Dept Orthopaed Surg, Orthopaed Trauma Inst, 2550 23rd St,Bldg 9,3rd Floor, San Francisco, CA 94110 USA.; Bahney, CS (corresponding author), Zuckerberg San Francisco Gen Hosp ZSFG, 2550 23rd St,Bldg 9,3rd Floor, San Francisco, CA 94110 USA.; Bahney, CS (corresponding author), SPRI, 181W Meadows Dr,Suite 1000, Vail, CO 81657 USA.	Jacqueline.Bresnahan@ucsf.edu; cbahney@sprivail.org	Morioka, Kazuhito/AAH-7835-2020	Morioka, Kazuhito/0000-0001-5407-8178; Ferguson, Adam/0000-0001-7102-1608; Clark, Daniel/0000-0003-3453-6498	National Institutes of Health (NIH): National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) [R21-AR066847]; Orthopaedic Trauma Institute; Brain and Spinal Injury Center [UG3NS106899];  [CA082103]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R21AR066847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UG3NS106899] Funding Source: NIH RePORTER	This publication was supported financially by the National Institutes of Health (NIH): National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) under the award number R21-AR066847. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Additional research and analytical support was provided by the Orthopaedic Trauma Institute, and the Brain and Spinal Injury Center supported under UG3NS106899. We thank the Mouse Pathology Core of the UCSF Helen Diller Family Comprehensive Cancer Center supported by CA082103 for working with us to acquire CBC data. We would like to thank Gina Baldoza and Anna-Lissa Wi for administrative and grants support, and Xiaokui Ma for her work processing histology.	Bahney CS, 2019, J ORTHOP RES, V37, P35, DOI 10.1002/jor.24170; Bahney CS, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00004; Bahney CS, 2014, J BONE MINER RES, V29, P1269, DOI 10.1002/jbmr.2148; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Davis EL, 2018, BONE, V109, P22, DOI 10.1016/j.bone.2017.07.016; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Dimitri P, 2017, CALCIFIED TISSUE INT, V100, P476, DOI 10.1007/s00223-016-0179-6; Eid K, 2006, J BONE JOINT SURG BR, V88B, P1394, DOI 10.1302/0301-620X.88B10.17139; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Geusens P, 2013, CURR OPIN RHEUMATOL, V25, P524, DOI 10.1097/BOR.0b013e32836200b8; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Guillory AN, 2018, J SURG RES, V232, P154, DOI 10.1016/j.jss.2018.03.016; Hadjiargyrou M, 2014, J BONE MINER RES, V29, P2307, DOI 10.1002/jbmr.2373; Haefeli J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42474; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Howard CVR, 1998, UNBIASED STEREOLOGY, P246; Hu DN, 2010, J ORTHOP RES, V28, P32, DOI 10.1002/jor.20955; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Irvine KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00116; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]; Kostenuik P, 2017, J ORTHOP RES, V35, P213, DOI 10.1002/jor.23460; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1; Lee JS, 2009, ARCH ORTHOP TRAUM SU, V129, P711, DOI 10.1007/s00402-008-0632-8; Lee S. M., 2014, J NEURTRAUMA; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Machado AG, 2009, BRAIN RES, V1280, P107, DOI 10.1016/j.brainres.2009.05.007; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; Maryanovich M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031344; Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; National Center for Health Statistics (NCHS), 2015, INCR TRAUM DEATHS US; Olmsted-Davis EA, 2017, STEM CELL TRANSL MED, V6, P1109, DOI 10.1002/sctm.16-0347; Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010; Park HJ, 2013, J NEUROSCI METH, V213, P76, DOI 10.1016/j.jneumeth.2012.12.010; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Salisbury EA, 2012, STEM CELL TRANSL MED, V1, P874, DOI 10.5966/sctm.2012-0090; Sciences U. O. A. H., CLIN PATH; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Semple BD., 2012, TRAUMATIC BRAIN SPIN, P155; Shantz JAS, 2014, J ORTHOP TRAUMA, V28, pS10, DOI 10.1097/BOT.0000000000000062; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Xing ZQ, 2010, J ORTHOP RES, V28, P1000, DOI 10.1002/jor.21087; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Zhang DY, 2009, ARTIF CELL BLOOD SUB, V37, P85, DOI 10.1080/10731190902743149; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	72	11	12	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 21	2019	9								12199	10.1038/s41598-019-48126-z			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS2QQ	WOS:000481999500053	31434912	Green Published, gold			2022-02-06	
J	Modi, AC; Mara, CA; Schmidt, M; Smith, AW; Turnier, L; Glaser, N; Wade, SL				Modi, Avani C.; Mara, Constance A.; Schmidt, Matthew; Smith, Aimee W.; Turnier, Luke; Glaser, Noah; Wade, Shari L.			Epilepsy Journey: A proof of concept trial of a Web-based executive functioning intervention for adolescents with epilepsy	EPILEPSIA			English	Article						behavioral regulation; clinical trial; executive dysfunction; metacognition; working memory	PROBLEM-SOLVING INTERVENTION; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; CORTICAL THICKNESS; PEDIATRIC EPILEPSY; CHILDREN; EFFICACY; LIFE; ADHERENCE; YOUTH	Objective To examine the preliminary feasibility and acceptability of a Web-based program, Epilepsy Journey, to improve executive function behaviors in adolescents with epilepsy. Methods We conducted a proof of concept single-arm pilot trial of Epilepsy Journey with 31 adolescents (average age = 15.3 +/- 1.3 years) who had an epilepsy diagnosis and executive function (EF) deficits on the caregiver-report version of the Behavior Rating Inventory of Executive Function (BRIEF). Epilepsy Journey coupled a gamified problem-solving website comprised of 10 learning modules targeting EF deficits (eg, working memory, organization, problem-solving) with Skype sessions with a trained therapist. Outcomes included feasibility (attrition, sessions completed) and acceptability (satisfaction ratings). Exploratory analyses examined changes in caregiver-, self-, and teacher-reported BRIEF scores from baseline to posttreatment and at 2- and 5-month follow-ups. Results Seventy-nine percent of participants completed the program. Satisfaction was high, with 97% of caregivers and adolescents rating the program as helpful and indicating they would recommend it to others. Caregivers and adolescents reported global improvements on the BRIEF, with caregivers reporting significant improvements on all BRIEF subscales. EF symptoms rebounded slightly between the 2- and 5-month follow-ups for some of the self- and caregiver-reported BRIEF scales. Notably, clinically meaningful improvements (eg, clinical/subclinical to normative levels) were reported for several caregiver-reported BRIEF subscales, including the Global Executive Composite (62% to 33-34%) and Metacognitive Index (74% to 41-42%) from baseline to 2- and 5-month follow-up. Significance Findings suggest that a Web-based problem-solving intervention tailored to EF deficits for adolescents with epilepsy is both feasible and acceptable and may contribute to improvements in EF behaviors across domains.	[Modi, Avani C.; Mara, Constance A.; Smith, Aimee W.; Turnier, Luke; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 7039 Adherence Ctr, Cincinnati, OH 45229 USA; [Modi, Avani C.; Mara, Constance A.; Schmidt, Matthew; Glaser, Noah; Wade, Shari L.] Univ Cincinnati, Cincinnati, OH USA		Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 7039 Adherence Ctr, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org		Modi, Avani/0000-0002-7580-3751; Glaser, Noah/0000-0002-1966-2720; Schmidt, Matthew/0000-0002-8110-4367	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD083335]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD083335] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: R21HD083335	Acierno R, 2016, DEPRESS ANXIETY, V33, P415, DOI 10.1002/da.22476; Bagner DM, 2007, CHILD HEALTH CARE, V36, P169, DOI 10.1080/02739610701335001; Baum KT, 2010, EPILEPSY BEHAV, V17, P467, DOI 10.1016/j.yebeh.2010.01.010; Caller TA, 2016, EPILEPSY BEHAV, V57, P111, DOI 10.1016/j.yebeh.2016.01.024; Chacko A, 2013, J CLIN CHILD ADOLESC, V42, P769, DOI 10.1080/15374416.2013.787622; Chavez-Arana C, 2018, J PEDIATR PSYCHOL, V43, P928, DOI 10.1093/jpepsy/jsy013; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Czajkowski SM, 2015, HEALTH PSYCHOL, V34, P971, DOI 10.1037/hea0000161; De Luca CR, 2010, STUD NEUROPSYCHOL NE, P23; DiIorio C, 2009, HEALTH EDUC RES, V24, P185, DOI 10.1093/her/cyn012; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Fuentes A, 2017, EPILEPSY BEHAV, V67, P51, DOI 10.1016/j.yebeh.2016.12.016; Gioia G.A., 2000, BRIEF BEHAV RATING I; Glaser NJ, 2017, J FORMATIVE DES LEAR, V1, P126, DOI 10.1007/s41686-017-0011-3; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; Guy SC, 2004, BRIEF SR BEHAV RATIN; Hoie B, 2008, DEV MED CHILD NEUROL, V50, P530, DOI 10.1111/j.1469-8749.2008.03015.x; Hufford BJ, 1999, REHABIL PSYCHOL, V44, P176, DOI 10.1037/0090-5550.44.2.176; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Kavanaugh BC, 2015, EPILEPSY BEHAV, V42, P22, DOI 10.1016/j.yebeh.2014.11.006; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kerr EN, 2015, EPILEPSIA, V56, P1784, DOI 10.1111/epi.13195; Mahone EM, 2009, J INT NEUROPSYCH SOC, V15, P31, DOI 10.1017/S1355617708090164; McNally K, 2010, DIABETES CARE, V33, P1159, DOI 10.2337/dc09-2116; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Modi AC, 2019, EPILEPSY BEHAV, V90, P112, DOI 10.1016/j.yebeh.2018.11.026; Modi AC, 2018, EPILEPSY BEHAV, V80, P5, DOI 10.1016/j.yebeh.2017.12.021; Modi AC, 2017, EPILEPSY BEHAV, V72, P114, DOI 10.1016/j.yebeh.2017.04.009; Morita DA, 2012, NEUROLOGY, V79, P1252, DOI 10.1212/WNL.0b013e3182635b87; Sherman EMS, 2006, EPILEPSIA, V47, P1936, DOI 10.1111/j.1528-1167.2006.00816.x; StataCorp, 2017, STAT STAT SOFTW BOOK; Thompson NJ, 2010, EPILEPSY BEHAV, V19, P247, DOI 10.1016/j.yebeh.2010.07.031; van den Berg L, 2018, EPILEPSY BEHAV, V87, P117, DOI 10.1016/j.yebeh.2018.07.022; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003	39	11	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2019	60	9					1895	1907		10.1111/epi.16317		AUG 2019	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IW5BS	WOS:000482006700001	31423591	Green Accepted			2022-02-06	
J	Trautz, F; Franke, H; Bohnert, S; Hammer, N; Muller, W; Stassart, R; Tse, R; Zwirner, J; Dressler, J; Ondruschka, B				Trautz, Florian; Franke, Heike; Bohnert, Simone; Hammer, Niels; Mueller, Wolf; Stassart, Ruth; Tse, Rexson; Zwirner, Johann; Dressler, Jan; Ondruschka, Benjamin			Survival-time dependent increase in neuronal IL-6 and astroglial GFAP expression in fatally injured human brain tissue	SCIENTIFIC REPORTS			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-6 MESSENGER-RNA; IN-SITU DETECTION; GENE-EXPRESSION; INFLAMMATORY RESPONSE; CEREBROSPINAL-FLUID; HEAD TRAUMA; ASTROCYTES; RECEPTOR; SERUM	Knowledge on trauma survival time prior to death following a lethal traumatic brain injury (TBI) may be essential for legal purposes. Immunohistochemistry studies might allow to narrow down this survival interval. The biomarkers interleukin-6 (IL-6) and glial fibrillary acidic protein (GFAP) are well known in the clinical setting for their usability in TBI prediction. Here, both proteins were chosen in forensics to determine whether neuronal or glial expression in various brain regions may be associated with the cause of death and the survival time prior to death following TBI. IL-6 positive neurons, glial cells and GFAP positive astrocytes all concordantly increase with longer trauma survival time, with statistically significant changes being evident from three days post-TBI (p < 0.05) in the pericontusional zone, irrespective of its definite cortical localization. IL-6 staining in neurons increases significantly in the cerebellum after trauma, whereas increasing GFAP positivity is also detected in the cortex contralateral to the focal lesion. These systematic chronological changes in biomarkers of pericontusional neurons and glial cells allow for an estimation of trauma survival time. Higher numbers of IL-6 and GFAP-stained cells above threshold values in the pericontusional zone substantiate the existence of fatal traumatic changes in the brain with reasonable certainty.	[Trautz, Florian; Dressler, Jan; Ondruschka, Benjamin] Univ Leipzig, Med Fac, Inst Legal Med, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Med Fac, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Bohnert, Simone] Univ Wurzburg, Inst Forens Med, Wurzburg, Germany; [Hammer, Niels; Zwirner, Johann] Univ Otago, Dept Anat, Dunedin, New Zealand; [Hammer, Niels] Univ Hosp Leipzig, Dept Orthoped & Trauma Surg, Leipzig, Germany; [Hammer, Niels] Fraunhofer IWU, Dresden, Germany; [Mueller, Wolf; Stassart, Ruth] Univ Hosp Leipzig, Dept Neuropathol, Leipzig, Germany; [Tse, Rexson] Auckland City Hosp, Dept Forens Pathol, LabPLUS, Auckland, New Zealand		Ondruschka, B (corresponding author), Univ Leipzig, Med Fac, Inst Legal Med, Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537	University of Leipzig [117-12-23012012]	The authors would like to thank Miss Cornelia Pietschmann (Institute of Legal Medicine, Leipzig), Miss Sarah Richter (Department of Neuropathology, Leipzig) and Miss Katrin Becker (Rudolf Boehm Institute of Pharmacology and Toxicology, Leipzig) for their laudable technical assistances. Further, they want to acknowledge Miss Aqeeda Singh (Department of Anatomy, Dunedin) for proofreading the paper as a native speaker. The investigations were conducted in accordance with the human and ethical principles of the University of Leipzig (No. 117-12-23012012).	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Aniszewska A, 2015, J NEUROIMMUNOL, V284, P1, DOI 10.1016/j.jneuroim.2015.05.001; Bohnert S, 2019, INT J LEGAL MED, V133, P1141, DOI 10.1007/s00414-019-02050-z; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P407, DOI 10.1111/j.1365-2990.1991.tb00740.x; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; Halliday GM, 1996, NEUROSCI LETT, V209, P29, DOI 10.1016/0304-3940(96)12592-1; Hans VHJ, 1999, NEUROREPORT, V10, P409; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 2006, INT J LEGAL MED, V120, P219, DOI 10.1007/s00414-005-0021-6; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KINOSHITA A K Y, 1991, Neurological Research, V13, P184; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Korzhevskii D E, 2006, Neurosci Behav Physiol, V36, P285, DOI 10.1007/s11055-006-0014-z; Kossmann T., 2013, SHOCK, V40, P471; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Li DR, 2009, HISTOL HISTOPATHOL, V24, P1113, DOI 10.14670/HH-24.1113; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Mimasaka S, 2006, INT J LEGAL MED, V120, P265, DOI 10.1007/s00414-006-0081-2; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194442; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Prechel MM, 1996, MECH AGEING DEV, V92, P185, DOI 10.1016/S0047-6374(96)01833-7; Quintana A, 2009, J IMMUNOL, V183, P2079, DOI 10.4049/jimmunol.0900242; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; REMMELE W, 1987, PATHOLOGE, V8, P138; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Sebba A., 2018, AM J HEALTH-SYST PH, V65, P1413; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Tao L, 2000, Fa Yi Xue Za Zhi, V16, P137; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Trautz F, 2018, INT J LEGAL MED, V132, P1103, DOI 10.1007/s00414-017-1767-3; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Wang Q, 2012, FORENSIC SCI INT, V221, P142, DOI 10.1016/j.forsciint.2012.04.025; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2010, DISCOV MED, V10, P434; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Zhang PL, 2007, EXP NEUROL, V208, P285, DOI 10.1016/j.expneurol.2007.08.022; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	88	11	11	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 15	2019	9								11771	10.1038/s41598-019-48145-w			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IQ3VO	WOS:000480679900001	31417126	Green Published, gold			2022-02-06	
J	Alkathiry, AA; Kontos, AP; Furman, JM; Whitney, SL; Anson, ER; Sparto, PJ				Alkathiry, Abdulaziz A.; Kontos, Anthony P.; Furman, Joseph M.; Whitney, Susan L.; Anson, Eric R.; Sparto, Patrick J.			Vestibulo-Ocular Reflex Function in Adolescents With Sport-Related Concussion: Preliminary Results	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						balance; vestibular; oculomotor; concussion; adolescents	VIDEO-HEAD-IMPULSE; POSTURAL STABILITY; POSITION STATEMENT; DIZZINESS; RECOVERY; MANAGEMENT; SYMPTOMS; INJURY	Background: Oculomotor impairments, dizziness, and imbalance are common after sports-related concussion (SRC) in adolescents and suggest a relationship between SRC and vestibular system dysfunction. However, it is not clear if the source of these problems is attributable to the peripheral or central vestibular system. Hypothesis: The video Head Impulse Test (vHIT), which assesses peripheral vestibular function, will show differences in gain between adolescents with and without SRC. Furthermore, there will be an association between vHIT and clinical balance and vestibular/oculomotor testing. Study Design: Cross-sectional study. Level of Evidence: Level 2. Methods: Twenty-five symptomatic adolescents aged between 12 and 19 years with a recent (within 10 days) SRC and 22 healthy controls aged 13 to 20 years were assessed using vHIT, Balance Error Scoring System (BESS), and Vestibular Ocular Motor Screening (VOMS) tool. The vestibulo-ocular reflex (VOR) gain was calculated independently for right and left head impulses. Independent-samples t test or Mann-Whitney U test for nonnormal distributions were used to compare concussed patients and controls on the measures. Spearman rank-order correlations were used to assess the association of vHIT with BESS and VOMS. Results: VOR gain in all adolescents with SRC was greater than 0.8, which is considered within normal limits. VOR gain and BESS scores were not significantly different between groups. Adolescents with SRC had significantly worse VOMS item scores than adolescents without SRC (P < 0.001). There were no significant correlations among vHIT gain and VOMS or BESS. Conclusion: There was no evidence for dysfunction in the peripheral horizontal semicircular canal function at high rotation speeds (ie, vHIT) after SRC, and vHIT was unrelated to balance and vestibular/oculomotor symptoms and dysfunction. However, adolescents with SRC scored worse on vestibular and oculomotor testing than those without SRC. Vestibular dysfunction and symptoms after SRC may be centrally derived. Clinical Relevance: We do not recommend the assessment of head impulse function in adolescents with SRC unless more definitive signs of peripheral vestibular injury are present. We recommend using the VOMS to assess symptoms of suspected SRC injury in adolescents.	[Alkathiry, Abdulaziz A.] Majmaah Univ, Dept Phys Therapy, Riyadh, Saudi Arabia; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Whitney, Susan L.; Sparto, Patrick J.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Anson, Eric R.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA		Alkathiry, AA (corresponding author), Majmaah Univ, Dept Phys Therapy, POB 66, Majmaah 11952, Saudi Arabia.	a.alkathiry@mu.edu.sa	Alkathiry, Abdulaziz A/Z-4078-2019	Alkathiry, Abdulaziz A/0000-0001-7715-6773	Deanship of Scientific Research at Majmaah University [1440-128]	The authors would like to thank the Deanship of Scientific Research at Majmaah University for supporting this work under Project Number No. 1440-128.	Alshehri MM, 2017, J VESTIBUL RES-EQUIL, V26, P439; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mahringer A, 2014, EUR ARCH OTO-RHINO-L, V271, P463, DOI 10.1007/s00405-013-2376-5; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCaslin DL, 2014, EAR HEARING, V35, pE185, DOI 10.1097/AUD.0000000000000047; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Taylor RL, 2015, J NEUROL, V262, P1228, DOI 10.1007/s00415-015-7697-4; TOGLIA JU, 1970, ARCHIV OTOLARYNGOL, V92, P485; van Esch BF, 2016, EUR ARCH OTO-RHINO-L, V273, P1; Zellhuber S, 2014, EUR ARCH OTO-RHINO-L, V271, P2375, DOI 10.1007/s00405-013-2723-6; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	25	11	11	3	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2019	11	6					479	485		10.1177/1941738119865262		AUG 2019	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JI0QB	WOS:000483187200001	31411942	Green Published			2022-02-06	
J	Fadyl, JK; Theadom, A; Channon, A; McPherson, KM				Fadyl, Joanna K.; Theadom, Alice; Channon, Alexis; McPherson, Kathryn M.			Recovery and adaptation after traumatic brain injury in New Zealand: Longitudinal qualitative findings over the first two years*	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Recovery; Adaptation; Rehabilitation; Support; Qualitative; Longitudinal; New Zealand	SELF; NEUROPLASTICITY; RECONSTRUCTION; INDIVIDUALS; COMMUNITY; IDENTITY	Knowledge about the impacts of traumatic brain injury (TBI) and aspects that influence recovery and adaptation are key to understanding how best to provide appropriate services. Whilst injury experiences have been documented, factors that help or hinder recovery and adaptation over time and across injury severities remain unclear. We present overarching findings addressing these matters in a large longitudinal qualitative study of recovery and adaptation following TBI. People experiencing TBI (n = 52) and their significant others (n = 37) were interviewed at 6-, 12- and 24-months post-injury. Data were thematically analysed cross-sectionally and longitudinally. Two overarching themes were captured in the analysis: making room for recovery and cultivating important resources. Themes comprise circumstances and processes that changed and developed over time in different ways for different participants. Key complexities within the overarching themes included the notion of "acceptance" and the role it played in allowing for recovery and adaptation; and the concept of "self" as a resource aiding recovery, but one that is perpetually at risk due to the intersection between the functional and social effects of the injury. Developing concepts of TBI recovery and living with TBI were central processes across diverse participants, but necessarily individualised in how they could be enacted.	[Fadyl, Joanna K.; Theadom, Alice; Channon, Alexis; McPherson, Kathryn M.] Auckland Univ Technol, Ctr Person Ctr Res, Private Bag 92006, Auckland 1142, New Zealand; [Theadom, Alice] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [McPherson, Kathryn M.] Hlth Res Council New Zealand, Auckland, New Zealand		Fadyl, JK (corresponding author), Auckland Univ Technol, Ctr Person Ctr Res, Private Bag 92006, Auckland 1142, New Zealand.	jfadyl@aut.ac.nz		McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [10/471]	This work was supported by the Health Research Council of New Zealand under Grant 10/471.	Bidart C, 2013, TIME SOC, V22, P254, DOI 10.1177/0961463X12447493; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Calman L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-14; Carnicelli S, 2017, DIGITAL LEISURE CULTURES: CRITICAL PERSPECTIVES, P1; Charmaz K., 2014, BROKERAGE CLOSURE IN; Cormack D, 2010, CLASSIFICATION OUTPU; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; Doidge Norman, 2007, BRAIN CHANGES ITSELF; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Fadyl JK, 2017, NURS INQ, V24, DOI 10.1111/nin.12170; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; Nichols JL, 2014, J REHABIL, V80, P21; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Thorne S, 1997, RES NURS HEALTH, V20, P169	34	11	11	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 9	2019	29	7					1095	1112		10.1080/09602011.2017.1364653			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IE0LI	WOS:000472078000006	28829229	hybrid			2022-02-06	
J	Alali, AS; Temkin, N; Barber, J; Pridgeon, J; Chaddock, K; Dikmen, S; Hendrickson, P; Videtta, W; Lujan, S; Petroni, G; Guadagnoli, N; Urbina, Z; Chesnut, RM				Alali, Aziz S.; Temkin, Nancy; Barber, Jason; Pridgeon, Jim; Chaddock, Kelley; Dikmen, Sureyya; Hendrickson, Peter; Videtta, Walter; Lujan, Silvia; Petroni, Gustavo; Guadagnoli, Nahuel; Urbina, Zulma; Chesnut, Randall M.			A clinical decision rule to predict intracranial hypertension in severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial pressure; clinical decision rule; clinical prediction rule; trauma	PRESSURE; TRIAL	OBJECTIVE While existing guidelines support the treatment of intracranial hypertension in severe traumatic brain injury (TBI), it is unclear when to suspect and initiate treatment for high intracranial pressure (ICP). The objective of this study was to derive a clinical decision rule that accurately predicts intracranial hypertension. METHODS Using Delphi methods, the authors identified a set of potential predictors of intracranial hypertension and a clinical decision rule a priori by consensus among a group of 43 neurosurgeons and intensivists who have extensive experience managing severe TBI without ICP monitoring. To validate these predictors, the authors used data from a Latin American trial (n = 150; BEST TRIP). To report on the performance of the rule, they calculated sensitivity, specificity, and positive and negative predictive values with 95% confidence intervals. In a secondary analysis, the rule was validated using data from a North American trial (n = 131; COBRIT). RESULTS The final predictors and the clinical decision rule were approved by 97% of participants in the consensus working group. The predictors are divided into major and minor criteria. High ICP would be considered suspected in the presence of 1 major or >= 2 minor criteria. Major criteria are: compressed cisterns (CT classification of Marshall diffuse injury [DI] III), midline shift > 5 mm (Marshall DI IV), or nonevacuated mass lesion. Minor criteria are: Glasgow Coma Scale (GCS) motor score <= 4, pupillary asymmetry, abnormal pupillary reactivity, or Marshall DI II. The area under the curve for the logistic regression model that contains all the predictors was 0.86. When high ICP was defined as > 22 mm Hg, the decision rule performed with a sensitivity of 93.9% (95% CI 85.0%-98.3%), a specificity of 42.3% (95% CI 31.7%-53.6%), a positive predictive value of 55.5% (95% CI 50.7%-60.2%), and a negative predictive value of 90% (95% CI 77.1%-96.0%). The sensitivity of the clinical decision rule improved with higher ICP cutoffs up to a sensitivity of 100% when intracranial hypertension was defined as ICP > 30 mm Hg. Similar results were found in the North American cohort. CONCLUSIONS A simple clinical decision rule based on a combination of clinical and imaging findings was found to be highly sensitive in distinguishing patients with severe TBI who would suffer intracranial hypertension. It could be used to identify patients who require ICP monitoring in high-resource settings or start ICP-lowering treatment in environments where resource limitations preclude invasive monitoring.	[Alali, Aziz S.; Temkin, Nancy; Barber, Jason; Pridgeon, Jim; Chaddock, Kelley; Dikmen, Sureyya; Hendrickson, Peter; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Chesnut, Randall M.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Lujan, Silvia; Petroni, Gustavo] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Guadagnoli, Nahuel] Hosp Privado Rosario, Hosp Emergencia, Rosario, Santa Fe, Argentina; [Urbina, Zulma] Hosp Erasmo Meoz, Cucuta, Colombia		Alali, AS (corresponding author), Univ Washington, Seattle, WA 98195 USA.	aalali@uw.edu		Chesnut, Randall/0000-0001-6377-3666	National Institutes of Health/the National Institute of Neurological Disorders and Stroke (NIH/NINDS) [1R01NS080648]; Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC); NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS058302]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Integra Endowed Professorship in Neurotrauma; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS080648] Funding Source: NIH RePORTER	The consensus conference was supported by funds from the National Institutes of Health/the National Institute of Neurological Disorders and Stroke (NIH/NINDS) (1R01NS080648) and the Fogarty International Center; ClinicalTrials.gov (NCT02059941). The BEST TRIP trial was funded by the NIH/NINDS (1R01NS058302) and others; ClinicalTrials. gov (NCT01068522). The COBRIT trial was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials. gov (NCT00545662). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; We wish to acknowledge Joanie Howard of Electronic Media Services Inc. for providing and running the automatic response system used in voting and Ezequiel L. Russo, Cristina Gonzalez, and Silvia Calens for serving as multilingual facilitators during the meeting. We would also like to acknowledge the Integra Foundation, as funds from the Integra Endowed Professorship in Neurotrauma (held by R. M. Chesnut at the University of Washington) were used in support of the consensus conference meeting. Finally, we would like to thank those of the BEST TRIP trial investigators and study staff who are not among the authors of the current paper-C. Rondina and N. Carney (investigators) and J. Machamer, J. Celix, M. Cherner, and T. Hendrix (study staff)-as well as those of the COBRIT trial investigators who are not among the authors of the current paper-R. D. Zafonte, DO; E. Bagiella, PhD; B. M. Ansel, PhD; T. A. Novack, PhD; W. T. Friedewald, MD; D. C. Hesdorffer, PhD; S. D. Timmons, MD; J. Jallo, MD, PhD; H. Eisenberg, MD; T. Hart, PhD; J. H. Ricker, PhD; R. Diaz-Arrastia, MD, PhD; R. E. Merchant, PhD; and S. Melton, MD.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein E., 2006, INCIDENCE EC BURDEN; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	21	11	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2019	131	2					612	619		10.3171/2018.4.JNS173166			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IN4JV	WOS:000478642100037	30265194	Bronze, Green Accepted			2022-02-06	
J	Bales, JW; Bonow, RH; Buckley, RT; Barber, J; Temkin, N; Chesnut, RM				Bales, James William; Bonow, Robert H.; Buckley, Robert T.; Barber, Jason; Temkin, Nancy; Chesnut, Randall M.			Primary External Ventricular Drainage Catheter Versus Intraparenchymal ICP Monitoring: Outcome Analysis	NEUROCRITICAL CARE			English	Article						External ventricular drain; Mortality; Outcomes; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; PROPENSITY SCORE; MANAGEMENT; THERAPY; TRIAL	BackgroundIntracranial pressure (ICP) monitoring is central to the care of severe traumatic brain injury (TBI). External ventricular drains (EVD) allow ICP control via cerebrospinal fluid drainage, whereas intraparenchymal monitors (IPM) for ICP do not, but it is unclear whether EVD placement improves outcomes. To evaluate whether there exists a difference in patient outcomes with the use of EVD versus IPM in severe TBI patients, we conducted a retrospective cohort study using data from the Citicoline Brain Injury Treatment trial.MethodsAdults with Glasgow Coma Score <9 who had either an EVD or IPM placed within 6h of study center arrival were included. We compared patients with EVD placement to those without on Glasgow Outcome Scale-Extended (GOS-E) and neuropsychological performance at 180days, mortality, and intensive care unit length of stay. We used regression models with propensity score weighting for probability of EVD placement to test for association between EVD use and outcomes. Of 224 patients included, 45% received an EVD.ResultsEVD patients had lower GOS-E at 180days [3.82.2 vs 4.9 +/- 2.2, p=0.002; weighted difference -0.97, 95% CI (-1.58, -0.37)], higher in-hospital mortality [23% vs 10%, p=0.014; weighted OR 2.46, 95% CI (1.20, 5.05)], and did significantly worse on all 8 neuropsychological measures. Additional sensitivity analysis was performed to minimize confounding effects supported our initial results.Conclusions Our retrospective data analysis suggests that early placement of EVDs in severe TBI is associated with worse functional and neuropsychological outcomes and higher mortality than IPMs and future prospective trials are needed to determine whether these results represent an important consideration for clinicians.	[Bales, James William; Bonow, Robert H.; Buckley, Robert T.; Barber, Jason; Temkin, Nancy; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 Ninth Ave, Seattle, WA 98104 USA		Bales, JW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 Ninth Ave, Seattle, WA 98104 USA.	Balesj@uw.edu		Chesnut, Randall/0000-0001-6377-3666			Agoritsas T, 2017, JAMA-J AM MED ASSOC, V317, P748, DOI 10.1001/jama.2016.20029; Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; HOLM S, 1979, SCAND J STAT, V6, P65; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Khan SH, 1998, ACT NEUR S, V71, P50; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petkus V, 2017, J CRIT CARE, V41, P49, DOI 10.1016/j.jcrc.2017.04.029; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsioutis C, 2017, J CLIN NEUROSCI, V42, P54, DOI 10.1016/j.jocn.2017.03.023; Volovici V, 2019, J NEUROTRAUM, V36, P988, DOI 10.1089/neu.2018.6086; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	30	11	11	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2019	31	1					11	21		10.1007/s12028-019-00712-9			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH0YF	WOS:000474217800003	31037639				2022-02-06	
J	Baniqued, PL; Gallen, CL; Kranz, MB; Kramer, AF; D'Esposito, M				Baniqued, Pauline L.; Gallen, Courtney L.; Kranz, Michael B.; Kramer, Arthur F.; D'Esposito, Mark			Brain network modularity predicts cognitive training-related gains in young adults	NEUROPSYCHOLOGIA			English	Article						Functional connectivity; Brain network modularity; Cognitive training; Working memory; Reasoning	FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; DEFAULT MODE; COMMUNITY STRUCTURE; EXECUTIVE-CONTROL; HEAD MOTION; TASK; INTELLIGENCE; ORGANIZATION; IMPROVEMENTS	The brain operates via networked activity in separable groups of regions called modules. The quantification of modularity compares the number of connections within and between modules, with high modularity indicating greater segregation, or dense connections within sub-networks and sparse connections between sub-networks. Previous work has demonstrated that baseline brain network modularity predicts executive function outcomes in older adults and patients with traumatic brain injury after cognitive and exercise interventions. In healthy young adults, however, the functional significance of brain modularity in predicting training-related cognitive improvements is not fully understood. Here, we quantified brain network modularity in young adults who underwent cognitive training with casual video games that engaged working memory and reasoning processes. Network modularity assessed at baseline was positively correlated with training-related improvements on untrained tasks. The relationship between baseline modularity and training gain was especially evident in initially lower performing individuals and was not present in a group of control participants that did not show training-related gains. These results suggest that a more modular brain network organization may allow for greater training responsiveness. On a broader scale, these findings suggest that, particularly in low-performing individuals, global network properties can capture aspects of brain function that are important in understanding individual differences in learning.	[Baniqued, Pauline L.; Gallen, Courtney L.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Baniqued, Pauline L.; Kranz, Michael B.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Gallen, Courtney L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Gallen, Courtney L.] Univ Calif San Francisco, Neuroscape, San Francisco, CA 94158 USA; [Kramer, Arthur F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA		Baniqued, PL (corresponding author), 132 Barker Hall, Berkeley, CA 94720 USA.	paulineb@berkeley.edu		Kramer, Arthur/0000-0001-5870-2724	Beckman Institute for Advanced Science and Technology; National Science Foundation (IGERT)National Science Foundation (NSF) [0903622]; National Science Foundation (SBE Postdoctoral Research Fellowship Grant) [1808384]; Department of Defense (NDSEG)United States Department of Defense; Office of Naval ResearchOffice of Naval Research [N000140710903]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS079698]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079698] Funding Source: NIH RePORTER	This work was supported by the Beckman Institute for Advanced Science and Technology (Graduate Fellowship to PLB); the National Science Foundation (IGERT Grant 0903622 to PLB and SBE Postdoctoral Research Fellowship Grant 1808384 to CLG); the Department of Defense (NDSEG to CLG); the Office of Naval Research (Grant N000140710903 to AFK); and the National Institutes of Health (Grant NS079698 to MD).	Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Baniqued PL, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00426; Baniqued PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142169; Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Baniqued PL, 2013, ACTA PSYCHOL, V142, P74, DOI 10.1016/j.actpsy.2012.11.009; Basak C, 2011, BRAIN COGNITION, V76, P407, DOI 10.1016/j.bandc.2011.03.017; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bennett G. K., 1997, DIFFERENTIAL APTITUD; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Boot Walter R, 2014, Cerebrum, V2014, P15; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dixon M.L., 2016, BIORXIV, DOI [10.1101/056424, DOI 10.1101/056424]; Doucet GE, 2020, MOL PSYCHIATR, V25, P863, DOI 10.1038/s41380-018-0269-0; Dougherty MR, 2016, PSYCHON B REV, V23, P306, DOI 10.3758/s13423-015-0865-9; Ekstrom R.B., 1976, MANUAL FOR KIT OF FA; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fonov V., 2009, NEUROIMAGE, V47, pS102; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gallen CL, 2019, TRENDS COGN SCI, V23, P293, DOI 10.1016/j.tics.2019.01.014; Gallen CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169015; Garner KG, 2015, P NATL ACAD SCI USA, V112, P14372, DOI 10.1073/pnas.1511423112; Gratton C, 2018, NEURON, V98, P439, DOI 10.1016/j.neuron.2018.03.035; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Green CS, 2019, J COGN ENHANCE, V3, P2, DOI 10.1007/s41465-018-0115-y; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagberg A. A., 2008, PROC 7 PYTHON SCI C, P11; Iordan AD, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00419; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Karbach J, 2014, PSYCHOL SCI, V25, P2027, DOI 10.1177/0956797614548725; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Katz B, 2018, P NATL ACAD SCI USA, V115, P9897, DOI 10.1073/pnas.1617102114; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kranz MB, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00203; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Liang X, 2016, CEREB CORTEX, V26, P1501, DOI 10.1093/cercor/bhu316; Mathewson KE, 2012, PSYCHOPHYSIOLOGY, V49, P1558, DOI 10.1111/j.1469-8986.2012.01474.x; Mattar MG, 2018, NEUROIMAGE, V172, P107, DOI 10.1016/j.neuroimage.2018.01.037; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Melby-Lervag M, 2016, PERSPECT PSYCHOL SCI, V11, P512, DOI 10.1177/1745691616635612; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; NEWMAN MEJ, 2004, PHYS REV E 2, V69, DOI DOI 10.1103/PHYSREVE.69.026113; Nikolaidis A, 2017, CEREB CORTEX, V27, P2607, DOI 10.1093/cercor/bhw070; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ravens J. C., 1962, ADVANCED PROGRESSIVE; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Reggente N, 2018, P NATL ACAD SCI USA, V115, P2222, DOI 10.1073/pnas.1716686115; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Russo R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04312; Sadaghiani S, 2015, P NATL ACAD SCI USA, V112, P8463, DOI 10.1073/pnas.1420687112; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2008, INTELLIGENCE, V36, P464, DOI 10.1016/j.intell.2007.10.003; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schultz DH, 2016, J NEUROSCI, V36, P8551, DOI 10.1523/JNEUROSCI.0358-16.2016; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Sheppard JP, 2012, J COGNITIVE NEUROSCI, V24, P1087, DOI 10.1162/jocn_a_00210; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Stanley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00954; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Strobach T, 2012, ACTA PSYCHOL, V140, P13, DOI 10.1016/j.actpsy.2012.02.001; Tosh CR, 2015, P BIOL SCI, V282, DOI DOI 10.1098/RSPB.2014.2568; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vatansever D, 2015, J NEUROSCI, V35, P15254, DOI 10.1523/JNEUROSCI.2135-15.2015; Verghese A, 2016, J NEUROSCI, V36, P2638, DOI 10.1523/JNEUROSCI.3410-15.2016; Vo LTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016093; Wilcox R.R, 2005, OUTLIER DETECTION, DOI [10.1002/0470013192.bsa742, DOI 10.1002/0470013192.BSA742]; Zachary R., 1986, SHIPLEY INSTITUE OF; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	103	11	12	2	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2019	131						205	215		10.1016/j.neuropsychologia.2019.05.021			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JJ1II	WOS:000493913900020	31132420	Green Accepted			2022-02-06	
J	Chong, CD; Peplinski, J; Berisha, V; Ross, K; Schwedt, TJ				Chong, Catherine D.; Peplinski, Jacob; Berisha, Visar; Ross, Katherine; Schwedt, Todd J.			Differences in fibertract profiles between patients with migraine and those with persistent post-traumatic headache	CEPHALALGIA			English	Article						Persistent post-traumatic headache; magnetic resonance imaging; diffusion tensor imaging; concussion; migraine; mild traumatic brain injury; white matter; fibertracts	TRAUMATIC BRAIN-INJURY; DIFFUSION; MATTER; TRACTOGRAPHY; MICROSTRUCTURE; SEGMENTATION; INDICATORS; ANISOTROPY; INTEGRITY; VETERANS	Objectives Often, persistent post-traumatic headache and migraine are phenotypically similar. However, the similarities and differences in the neuropathological underpinnings of persistent post-traumatic headache and migraine require further understanding. We used diffusion tensor imaging (DTI) and a novel method for detecting subtle changes in fibertract integrity by measuring node-by-node parameters along each tract to compare fibertract profiles between those with migraine and those with persistent post-traumatic headache, and compared both cohorts to a group of controls. Methods Eighteen fibertracts were reconstructed for 131 subjects, including 49 patients with persistent post-traumatic headache attributed to mild traumatic brain injury, 41 with migraine, and 41 controls. Node-by-node diffusion parameters of mean diffusivity and radial diffusivity were calculated along each tract. Mean diffusivity and radial diffusivity measurements were averaged along quartiles of each tract for statistical interpretation and group comparison. Using a post-hoc analysis, correlations between tract quartile measurements and headache frequency were calculated. Results There were significant differences between migraine and persistent post-traumatic headache cohorts for quartile measurements of mean diffusivity or radial diffusivity in the bilateral anterior thalamic radiations, cingulum (angular bundles and cingulate gyri), inferior longitudinal fasciculi, and uncinate fasciculi, the left corticospinal tract, and the right superior longitudinal fasciculi-parietal portion. For migraine patients, there was a significant positive correlation between headache frequency and forceps major mean diffusivity, whereas for persistent post-traumatic headache there was a positive correlation between headache frequency and cingulum angular bundle mean diffusivity and radial diffusivity. Conclusions Quartile measurements of radial diffusivity and mean diffusivity indicate unique differences in fibertract profiles between those with migraine vs. persistent post-traumatic headache. Although for both migraine and persistent post-traumatic headache there was a positive relationship between fibertract alterations and headache frequency, there were disease-specific differences between headache frequency and fibertract injury patterns. These findings might suggest potential differences in the neuropathological mechanisms underlying migraine and persistent post-traumatic headache.	[Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Peplinski, Jacob; Berisha, Visar] Arizona State Univ, Sch Elect Comp & Energy Engn, Phoenix, AZ USA; [Peplinski, Jacob; Berisha, Visar] Arizona State Univ, Dept Speech & Hearing Sci, Phoenix, AZ USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Audiol & Speech Pathol Serv, Phoenix, AZ USA		Chong, CD (corresponding author), Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Chong.Catherine@mayo.edu		Berisha, Visar/0000-0001-8804-8874; chong, catherine/0000-0002-9035-8748	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH K23NS070891]; Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (NIH) grant NIH K23NS070891 and by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	Adnan A, 2016, BRAIN STRUCT FUNCT, V221, P2999, DOI 10.1007/s00429-015-1084-x; Alhilali LM, 2017, AM J NEURORADIOL, V38, P691, DOI 10.3174/ajnr.A5073; Aung Wint Yan, 2013, Imaging Med, V5, P427; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chong CD, 2015, CEPHALALGIA, V35, P1162, DOI 10.1177/0333102415573513; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Coppola G, 2014, EUR J NEUROL, V21, P287, DOI 10.1111/ene.12296; Coppola G, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0825-z; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delic J, 2016, RADIOLOGY, V279, P859, DOI 10.1148/radiol.2015151388; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Heilbronner SR, 2014, J NEUROSCI, V34, P10041, DOI 10.1523/JNEUROSCI.5459-13.2014; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Kara B, 2013, CLIN NEURORADIOL, V23, P31, DOI 10.1007/s00062-012-0165-y; Kim JW, 2015, NEURAL REGEN RES, V10, P1876, DOI 10.4103/1673-5374.170321; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Kreilkamp BAK, 2017, NEUROIMAGE-CLIN, V14, P67, DOI 10.1016/j.nicl.2017.01.003; Lai TH, 2016, CEPHALALGIA, V36, P1324, DOI 10.1177/0333102416630593; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Liu JX, 2013, J PAIN, V14, P1703, DOI 10.1016/j.jpain.2013.08.013; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messina R, 2015, CEPHALALGIA, V35, P1278, DOI 10.1177/0333102415578428; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Rocca MA, 2008, CEPHALALGIA, V28, P1061, DOI 10.1111/j.1468-2982.2008.01655.x; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sarica A, 2014, J NEUROSCI METH, V224, P79, DOI 10.1016/j.jneumeth.2013.12.014; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Wu YP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00084; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yu DH, 2013, NMR BIOMED, V26, P1103, DOI 10.1002/nbm.2924; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476	52	11	11	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	AUG	2019	39	9					1121	1133		10.1177/0333102418815650			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK3UZ	WOS:000476515200005	30913910	Bronze			2022-02-06	
J	Fortina, M; Maniscalco, P; Carulli, C; Meccariello, L; Colasanti, GB; Carta, S				Fortina, Mattia; Maniscalco, Pietro; Carulli, Christian; Meccariello, Luigi; Colasanti, Giovanni Battista; Carta, Serafino			Jockey injuries during the Siena "Palio". A 72-year analysis of the oldest horse race in Italy	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Riding injuries; Prevention; Risk factors; Concussion; Fracture; Trauma	IRELAND; RATES	Introduction: Horse racing is a hazardous sport. We analyzed the incidence and characteristics of jockey injuries in a typical horse race. Methods: We analyzed all injuries sustained by 224 jockeys in the last 72 years. Results: It was found that in 96.1% of the races there was at least one fall and in 28.6% of the races 50% or more of the jockeys fell. In 43.4% of the falls, the jockey was taken to the emergency room. Comparing the Palio with traditional races in other countries, a higher injury incidence rate was observed for every 100 falls (109.884 vs 27-59) and a lower concussion rate/100 falls (0.97 vs 1.8-7.4). Conclusion: The Palio is one of the most threatening races that continues today. Jockeys are at greater risk for a fall than any other race in the world. (C) 2019 Elsevier Ltd. All rights reserved.	[Fortina, Mattia; Colasanti, Giovanni Battista; Carta, Serafino] Univ Hosp Siena, Dept Orthopaed & Traumatol, Vle Bracci 14-16, I-53100 Siena, Italy; [Maniscalco, Pietro] Guglielmo da Saliceto Hosp, Dept Orthopaed & Traumatol, Piacenza, Italy; [Carulli, Christian] Univ Florence, Orthopaed Clin, Florence, Italy; [Meccariello, Luigi] Vito Fazzi Hosp, Dept Orthopaed & Traumatol, Lecce, Italy		Fortina, M (corresponding author), Univ Hosp Siena, Dept Orthopaed & Traumatol, Vle Bracci 14-16, I-53100 Siena, Italy.	mattiafortina@me.com; p.maniscalco@ausl.pc.it; christian.carulli@unifi.it; drlordmec@gmail.com; colasanti.gb@outlook.com; cartaserafino@hotmail.com	Fortina, Mattia/J-5738-2016; carta, serafino/AAK-1710-2020; Meccariello, Luigi/U-2490-2017	Fortina, Mattia/0000-0002-4971-7382; carta, serafino/0000-0003-0378-7710; Maniscalco, Pietro/0000-0002-5637-6774; carulli, christian/0000-0002-0845-7940; COLASANTI, GIOVANNI BATTISTA/0000-0002-5561-8612; Meccariello, Luigi/0000-0002-3669-189X	Club Italiano Osteosintesi	This paper is part of a supplement supported by Club Italiano Osteosintesi.	Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Fortina Mattia, 2009, J Trauma, V67, pE163, DOI 10.1097/TA.0b013e31814b9319; Gibson T., 2007, J BIOMECH, V40, pS133; Griffin R, 1983, Phys Sportsmed, V11, P110, DOI 10.1080/00913847.1983.11708608; Hitchens PL, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113492625; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Jackson KA, 2017, OSTEOPOROSIS INT, V28, P2675, DOI 10.1007/s00198-017-4086-0; Oikawa M., 2004, JPN RACING J, V12, P5; Paix BR, 1999, BRIT J SPORT MED, V33, P46, DOI 10.1136/bjsm.33.1.46; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Siena Pepi G., 1984, AUTONOMOUS CO TOURIS, DOI [10.1177/2325967113492625, DOI 10.1177/2325967113492625]; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; Whitlock M R, 1987, Br J Sports Med, V21, P25	15	11	11	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2019	50			4			S56	S59		10.1016/j.injury.2019.03.015			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	JJ2BW	WOS:000493967200010	30910241				2022-02-06	
J	Lundine, JP; Ciccia, AH; Brown, J				Lundine, Jennifer P.; Ciccia, Angela H.; Brown, Jessica			The Speech-Language Pathologists' Role in Mild Traumatic Brain Injury for Early Childhood-, Preschool-, and Elementary School-Age Children: Viewpoints on Guidelines From the Centers for Disease Control and Prevention	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							POST-CONCUSSIVE SYMPTOMS; UNITED-STATES; EPIDEMIOLOGY; DIAGNOSIS	Purpose: Traumatic brain injury (TBI) impacts millions of children each year, with those between birth and 4 years of age being 1 of the highest incidence groups. To address gaps in service provision specifically for children with mild TBI (mTBI), the Centers for Disease Control and Prevention (CDC) recently released guidelines for providers. Method: The goal of this commentary is to deliver viewpoints on the application of the CDC guidelines directly to speech-language pathology clinical practice, with special attention paid to assessment, symptom monitoring, and intervention using a family-centered approach to care for infants, toddlers, preschoolers, and early elementary students with mTBI. Results: In all pediatric practice settings, speech-language pathologists (SLPs) are a critical component of the care team for children who experience mTBI and should participate in symptom monitoring, assessment, intervention, education, and advocacy for this population. Conclusions: SLPs can use the CDC guidelines to advocate for their role in the care of young children with mTBI. In addition, SLPs can use the guidelines to create a framework for clinical care provision when working with young children with mTBI. Much work is needed to advance evidence-based practices for this population, and dissemination of current clinical practices could help to close this gap.	[Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies & Inpatient Rehabil Program, Columbus, OH USA; [Ciccia, Angela H.] Case Western Reserve Univ, Dept Psychol Sci, Commun Sci Program, Cleveland, OH 44106 USA; [Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA		Brown, J (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875			American Speech -Language -Hearing Association, 2018, ASHA SUMM MEMB AFF C; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baron IS, 2011, CLIN NEUROPSYCHOL, V25, P1075, DOI 10.1080/13854046.2011.594455; Bassan H, 2007, PEDIATRICS, V120, P785, DOI 10.1542/peds.2007-0211; Bayley N., 2006, BAYLEY SCALES INFANT; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2017, RET SCH CONC FACT SH; Engelmann KA, 2012, ARCH NEUROL-CHICAGO, V69, P23, DOI 10.1001/archneurol.2011.1015; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Iversen Maura D, 2003, Pediatr Phys Ther, V15, P23, DOI 10.1097/01.PEP.0000051694.10495.79; Jimerson SR, 2009, SCHOOL PSYCHOL INT, V30, P555, DOI 10.1177/0143034309107077; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mei C, 2018, J HEAD TRAUMA REHAB, V33, P326, DOI 10.1097/HTR.0000000000000366; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Mullen E.M., 1995, MULLEN SCALES EARLY; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Paul D, 2011, LANG SPEECH HEAR SER, V42, P320, DOI 10.1044/0161-1461(2010/09-0079); Sparrow S.S., 2016, VINELAND ADAPTIVE BE, V3rd ed.; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomasello NM, 2010, J FAM SOC WORK, V13, P163, DOI 10.1080/10522150903503010; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	35	11	11	1	4	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	AUG	2019	28	3					1371	1376		10.1044/2019_AJSLP-18-0295			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IQ0BB	WOS:000480413800036	31170348				2022-02-06	
J	Taheri, A; Emami, M; Asadipour, E; Kasirzadeh, S; Rouini, MR; Najafi, A; Heshmat, R; Abdollahi, M; Mojtahedzadeh, M				Taheri, Ali; Emami, Mahdi; Asadipour, Erfan; Kasirzadeh, Sara; Rouini, Mohammad-Reza; Najafi, Atabak; Heshmat, Ramin; Abdollahi, Mohammad; Mojtahedzadeh, Mojtaba			A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury	JOURNAL OF NEUROLOGY			English	Article						Metformin; Traumatic brain injury; Head trauma; Biomarker; S100b; Pharmacokinetics	GASTROINTESTINAL MOTILITY PROBLEMS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; LYMPHOCYTE RATIO; LACTIC-ACIDOSIS; NEUTROPHIL; PROTEIN; S100B; AMPK; GFAP	Objective Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide. Metformin is reported to have pleiotropic neuroprotective effects through anti-inflammatory, antioxidative, and anti-ischemic activity, and improvements in vascular hemodynamics and endothelial function. The aim of this study is to examine the efficacy and safety of metformin therapy in severe TBI patients. Methods This single-blind, parallel-group, randomized controlled trial enrolled adult TBI patients. Of 158 trauma patients assessed, 30 met the eligibility criteria and were randomly allocated in a one-to-one ratio to receive 1 g metformin every 12 h for five consecutive days (intervention group) or to usual management only (control group). For efficacy analysis, temporal profiles of serum levels of S100b, neutrophil to lymphocyte ratio (NLR), and glial fibrillary acidic protein (GFAP) were assessed. For pharmacokinetic analysis, serum concentrations of metformin were evaluated in the intervention group. Results The two study groups were similar in terms of demographics, baseline clinical characteristics, and on-admission biomarkers' serum levels. Longitudinal analysis of S100b and NLR levels showed statistically significant declines in values toward normal levels in the intervention group (p values of < 0.001 and 0.030, respectively), different from the profiles of the control group (p values of 0.074 and 0.645, respectively). Pharmacokinetic analysis demonstrated that metformin absorption is delayed in TBI patients. No events of hypoglycemia and lactic acidosis occurred. Conclusions Metformin could potentially be an effective and safe therapeutic intervention in patients with severe TBI. Large-scale, multicentre studies are needed to confirm our encouraging results.	[Taheri, Ali; Rouini, Mohammad-Reza] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Biopharmaceut & Pharmacokinet Div, Tehran, Iran; [Emami, Mahdi; Asadipour, Erfan; Mojtahedzadeh, Mojtaba] Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran 141556451, Iran; [Kasirzadeh, Sara; Abdollahi, Mohammad] Univ Tehran Med Sci, Fac Pharm, Dept Toxicol & Pharmacol, Tehran, Iran; [Najafi, Atabak] Univ Tehran Med Sci, Sina Hosp, Fac Med, Dept Anesthesiol & Crit Care Med, Tehran, Iran; [Heshmat, Ramin] Univ Tehran Med Sci, Chron Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran		Mojtahedzadeh, M (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran 141556451, Iran.	mojtahed@tums.ac.ir	Abdollahi, Mohammad/B-9232-2008; Heshmat, Ramin/S-7435-2017; Rouini, Mohammadreza/AAT-8557-2021	Abdollahi, Mohammad/0000-0003-0123-1209; Rouini, Mohammadreza/0000-0003-0412-8581; Najafi, Atabak/0000-0002-1663-9533	Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences [1394-031021998]	This work was supported by the Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences [Grant number 1394-031021998].	Abd-Elsameea AA, 2014, EUR REV MED PHARMACO, V18, P2387; Aderinto-Adike AO, 2014, J DIGEST DIS, V15, P335, DOI 10.1111/1751-2980.12147; Anisimov VN, 2010, AGING-US, V2, P760, DOI 10.18632/aging.100230; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chakraborty S, 2018, 2018 FOURTH IEEE INTERNATIONAL CONFERENCE ON RESEARCH IN COMPUTATIONAL INTELLIGENCE AND COMMUNICATION NETWORKS (ICRCICN), P81, DOI 10.1109/ICRCICN.2018.8718736; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Dewan M.C., 2018, J NEUROSURG; Frazer C, 2018, CRIT CARE NURS CLIN, V30, P109, DOI 10.1016/j.cnc.2017.10.010; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Guo ZL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0680-x; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Ibanez L, 2005, J CLIN ENDOCR METAB, V90, P3435, DOI 10.1210/jc.2005-0049; Idkaidek N, 2011, J BIOEQUIV BIOVAILAB, V3, P233, DOI [10.4172/jbb.1000092, DOI 10.4172/jbb.1000092, DOI 10.4172/JBB.1000092]; Jiang T, 2014, BRIT J PHARMACOL, V171, P3146, DOI 10.1111/bph.12655; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lalau JD, 2010, DRUG SAFETY, V33, P727, DOI 10.2165/11536790-000000000-00000; Lin CH, 2017, EXP CELL RES, V359, P367, DOI 10.1016/j.yexcr.2017.08.019; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Mojtahedzadeh M, 2008, ARCH MED SCI, V4, P174; Moyer MT, 2018, TRAUMATIC BRAIN INJU, P165; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Patil SP, 2014, NEUROSCIENCE, V277, P747, DOI 10.1016/j.neuroscience.2014.07.046; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Salani B, 2014, ENDOCR-RELAT CANCER, V21, pR461, DOI 10.1530/ERC-14-0284; Sambe T, 2018, BIOMED PHARMACOTHER, V98, P149, DOI 10.1016/j.biopha.2017.12.023; Soraya H, 2012, IRAN J BASIC MED SCI, V15, P1202; Takata F, 2013, BIOCHEM BIOPH RES CO, V433, P586, DOI 10.1016/j.bbrc.2013.03.036; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Triggle CR, 2017, ACTA PHYSIOL, V219, P138, DOI 10.1111/apha.12644; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang HT, 2015, ARTHRITIS RHEUMATOL, V67, P3190, DOI 10.1002/art.39296	44	11	12	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	AUG	2019	266	8					1988	1997		10.1007/s00415-019-09366-1			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK3RQ	WOS:000476506500019	31093755	Bronze			2022-02-06	
J	Williams, AM; Bhatti, UF; Biesterveld, BE; Graham, NJ; Chtraklin, K; Zhou, J; Dennahy, IS; Kathawate, RG; Vercruysse, CA; Russo, RM; Li, YQ; Alam, HB				Williams, Aaron M.; Bhatti, Umar F.; Biesterveld, Ben E.; Graham, Nathan J.; Chtraklin, Kiril; Zhou, Jing; Dennahy, Isabel S.; Kathawate, Ranganath G.; Vercruysse, Claire A.; Russo, Rachel M.; Li, Yongqing; Alam, Hasan B.			Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Prolonged damage control resuscitation; prolonged field care; valproic acid; prosurvival strategies; hemorrhagic shock	HISTONE DEACETYLASE INHIBITION; TRAUMATIC BRAIN-INJURY; WORK-LOSS COSTS; HEMORRHAGIC-SHOCK; RODENT MODEL; PROSURVIVAL PHENOTYPE; FLUID RESUSCITATION; UNITED-STATES; LESION SIZE; SALINE	BACKGROUND Although damage control resuscitation (DCR) is routinely performed for short durations, prolonged DCR may be required in military conflicts as a component of prolonged field care. Valproic acid (VPA) has been shown to have beneficial properties in lethal hemorrhage/trauma models. We sought to investigate whether the addition of a single dose of VPA to a 72-hour prolonged DCR protocol would improve clinical outcomes. METHODS Fifteen Yorkshire swine (40-45 kg) were subjected to lethal (50% estimated total blood volume) hemorrhagic shock (HS) and randomized to three groups: (1) HS, (2) HS-DCR, (3) HS-DCR-VPA (150 mg/kg over 3 hours) (n = 5/cohort). In groups assigned to receive DCR, Tactical Combat Casualty Care guidelines were applied (1 hour into the shock period), targeting a systolic blood pressure of 80 mm Hg. At 72 hours, surviving animals were given transfusion of packed red blood cells, simulating evacuation to higher echelons of care. Survival rates, physiologic parameters, resuscitative fluid requirements, and laboratory profiles were used to compare the clinical outcomes. RESULTS This model was 100% lethal in the untreated animals. DCR improved survival to 20%, although this was not statistically significant. The addition of VPA to DCR significantly improved survival to 80% (p < 0.01). The VPA-treated animals also had significantly (p < 0.05) higher systolic blood pressures, lower fluid resuscitation requirements, higher hemoglobin levels, and lower creatinine and potassium levels. CONCLUSION VPA administration improves survival, decreases resuscitation requirements, and improves hemodynamic and laboratory parameters when added to prolonged DCR in a lethal hemorrhage model.	[Williams, Aaron M.; Bhatti, Umar F.; Biesterveld, Ben E.; Graham, Nathan J.; Chtraklin, Kiril; Zhou, Jing; Dennahy, Isabel S.; Kathawate, Ranganath G.; Vercruysse, Claire A.; Russo, Rachel M.; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Zhou, Jing] Peking Univ, Peoples Hosp, Dept Orthoped & Traumatol, Ctr Trauma, Beijing, Peoples R China		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Kathawate, Ranganath/AAE-2098-2021; Biesterveld, Ben/AAM-1087-2021	Kathawate, Ranganath/0000-0002-5090-5188	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-16-DMRDP-CCCCRP-PFCRA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010] Funding Source: NIH RePORTER	This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-16-DMRDP-CCCCRP-PFCRA. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. The authors declare no conflicts of interest.	Alam HB, 2011, J TRAUMA, V70, P636, DOI 10.1097/TA.0b013e31820d0dcc; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Baker Benjamin L, 2016, J Spec Oper Med, V16, P112; Baraniuk S, 2014, INJURY, V45, P1287, DOI 10.1016/j.injury.2014.06.001; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Butler FK, 2017, WILD ENVIRON MED, V28, pS74, DOI 10.1016/j.wem.2016.12.007; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chang PP, 2018, J TRAUMA ACUTE CARE, V84, P795, DOI 10.1097/TA.0000000000001824; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; DeSoucy E., J SPEC OPER MED, V17, P121; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; FALK JL, 1984, ACUTE CARE, V10, P59; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1078, DOI 10.15585/mmwr.mm6438a5; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1074, DOI 10.15585/mmwr.mm6438a4; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; HAUPT MT, 1984, CIRC SHOCK, V12, P213; Ho AMH, 2001, J TRAUMA, V51, P173, DOI 10.1097/00005373-200107000-00033; Holcomb JB, 2007, J TRAUMA, V62, pS36, DOI 10.1097/TA.0b013e3180654134; Hu Sen, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P471; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Joint Program Committee 6/Combat Casualty Care Research Program, PROL FIELD CAR RES A; Keenan S, 2017, WILD ENVIRON MED, V28, pS135, DOI 10.1016/j.wem.2017.02.001; Keenan Sean, 2016, J Spec Oper Med, V16, P105; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Montgomery HR, 2017, J SPEC OPER MED, P21; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Powell EK, 2016, J TRAUMA ACUTE CARE, V81, P458, DOI 10.1097/TA.0000000000001078; Rizoli SB, 2003, J TRAUMA, V54, pS82, DOI 10.1097/01.TA.0000064525.03761.0C; Rocha JA, 2010, J TRAUMA, V68, P1335, DOI 10.1097/TA.0b013e3181dbbb36; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; Ross SW, 2018, J AM COLL SURGEONS, V227, P321, DOI 10.1016/j.jamcollsurg.2018.05.005; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Trunkey D D, 1984, Emerg Med Clin North Am, V2, P913; World Health Organization, 2014, INJ VIOL FACTS; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469	44	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2019	87	2					393	401		10.1097/TA.0000000000002281			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	IN3WF	WOS:000478606400018	31206419	Green Accepted			2022-02-06	
J	Borkum, JM				Borkum, Jonathan M.			CGRP and Brain Functioning: Cautions for Migraine Treatment	HEADACHE			English	Article						migraine; calcitonin gene-related peptide; ischemic stroke; traumatic brain injury; multiple sclerosis; oxidative stress	GENE-RELATED PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTOR-LIKE RECEPTOR; NEUROTROPHIC FACTOR; EPISODIC MIGRAINE; OXIDATIVE STRESS; UNITED-STATES; COGNITIVE FUNCTION; SENSORY NEURONS	Background Calcitonin gene-related peptide has emerged as a therapeutic target in migraine. Monoclonal antibodies and small molecule receptor antagonists (gepants) directed against CGRP have been approved or are in Phase II or III clinical trials. For monitoring the long-term safety of these drugs, it is helpful to consider the role of CGRP in brain functioning. Methods Qualitative review of the preclinical literature on CGRP in brain physiology and pathophysiology. Results Within the brain, CGRP is upregulated by stresses such as ischemia, injury, hyperthermia, and seizure, and activates neuroprotective processes. Thus, CGRP buffers intracellular calcium, triggers antiapoptotic signaling, upregulates a number of neurotrophins (including insulin-like growth factor-1/IGF-1, basic fibroblast growth factor/bFGF, and nerve growth factor/NGF), reduces brain edema, and likely increases antioxidant defenses. When released outside the blood-brain barrier, CGRP likely protects the endothelium, upregulates growth factor signaling from the endothelium to the brain parenchyma, strengthens the blood-brain barrier, protects the immune privilege of the brain by inhibiting the movement of neutrophils and monocytes, and facilitates neurogenesis and angiogenesis at stem cell niches. Conclusions CGRP participates in a wide range of neuroprotective processes. In theory, migraineurs with comorbid brain pathology might be at increased risk from CGRP inhibition. However, the extent of compensating processes is unknown and will determine whether these risks materialize in practice.	[Borkum, Jonathan M.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Borkum, Jonathan M.] Hlth Psych Maine, Waterville, ME USA		Borkum, JM (corresponding author), Univ Maine, Dept Psychol, Orono, ME 04469 USA.	jborkum@hpmaine.com		Borkum, Jonathan/0000-0002-5943-3156			Abushik PA, 2017, CEPHALALGIA, V37, P1373, DOI 10.1177/0333102416681588; Amin FM, 2017, EUR J NEUROL, V24, P1116, DOI 10.1111/ene.13341; Amin FM, 2012, CEPHALALGIA, V32, P140, DOI 10.1177/0333102411431333; Argandona EG, 2012, CURR NEUROVASC RES, V9, P72; Ashina M, 2000, PAIN, V86, P133, DOI 10.1016/S0304-3959(00)00232-3; Ashina M, 2017, NEUROLOGY, V89, P1237, DOI 10.1212/WNL.0000000000004391; Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Banki E, 2015, J GERONTOL A-BIOL, V70, P665, DOI 10.1093/gerona/glu116; BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; BANKS WA, 1995, LIFE SCI, V57, P1993, DOI 10.1016/0024-3205(95)02197-Q; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Borkum JM, 2007, CHRONIC HEADACHES BI; Borkum JM, 2018, NEURAL REGEN RES, V13, P609, DOI 10.4103/1673-5374.230275; Borkum JM, 2018, HEADACHE, V58, P118, DOI 10.1111/head.13214; Borkum JM, 2016, HEADACHE, V56, P12, DOI 10.1111/head.12725; Buldyrev I, 2006, J NEUROCHEM, V99, P1338, DOI 10.1111/j.1471-4159.2006.04161.x; Bulloch K, 1996, NEUROREPORT, V7, P1036, DOI 10.1097/00001756-199604100-00016; Bulloch K, 1998, EXP NEUROL, V150, P195, DOI 10.1006/exnr.1997.6765; Bulloch K, 1997, NEUR ABSTR, V23, P716; Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Buse DC, 2013, HEADACHE, V53, P1278, DOI 10.1111/head.12150; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Cai H, 2010, PHARMAZIE, V65, P274, DOI 10.1691/ph.2010.9755; Camporeale A, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1193-2; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carniglia L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5048616; Chan KYY, 2011, PHARMACOL THERAPEUT, V129, P332, DOI 10.1016/j.pharmthera.2010.12.001; Choi JE, 2018, SEMIN IMMUNOPATHOL, V40, P249, DOI 10.1007/s00281-018-0675-z; Chung AM, 2018, REV NEUROSCIENCE, V29, P369, DOI 10.1515/revneuro-2017-0060; Cortelli P, 2009, NEUROL SCI, V30, pS19, DOI 10.1007/s10072-009-0054-6; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Deen M, 2018, CEPHALALGIA, V38, P519, DOI 10.1177/0333102417698708; Deen M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0807-1; Depre C, 2018, HEADACHE, V58, P715, DOI 10.1111/head.13316; Dodick DW, 2018, CEPHALALGIA, V38, P1026, DOI 10.1177/0333102418759786; Dragoni S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051378; Durham PL, 2013, HEADACHE, V53, P67, DOI 10.1111/j.1526-4610.2012.02262.x; Edvinsson L, 2018, NAT REV NEUROL, V14, P338, DOI 10.1038/s41582-018-0003-1; Edvinsson L, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0852-4; Edvinsson L, 2019, CEPHALALGIA, V39, P366, DOI 10.1177/0333102417736900; Edvinsson L, 2010, CEPHALALGIA, V30, P1233, DOI 10.1177/0333102410362122; Evers S, 1999, CEPHALALGIA, V19, P485, DOI 10.1046/j.1468-2982.1999.019005485.x; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Feuilloley MGJ, 2018, SEMIN IMMUNOPATHOL, V40, P281, DOI 10.1007/s00281-018-0671-3; Figueira L, 2017, FOCUS SCI, V3, P1; Filiz A, 2019, CEPHALALGIA, V39, P354, DOI 10.1177/0333102417735845; GALLAI V, 1995, CEPHALALGIA, V15, P384, DOI 10.1046/j.1468-2982.1995.1505384.x; GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017, LANCET, V390, P1211, DOI [10.1016/S0140-6736(17)32154-2, 10.1016/S0140-6736(17)32154]; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gherardini G, 1996, ANN PLAS SURG, V36, P616, DOI 10.1097/00000637-199606000-00009; GOADSBY P, 1995, CEPHALALGIA, V15, P333, DOI 10.1046/j.1468-2982.1995.1505333-2.x; Goadsby PJ, 2012, ANN INDIAN ACAD NEUR, V15, P15, DOI 10.4103/0972-2327.99993; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Gonzalez-Hernadez A, 2016, BIOMED RES INT, V2016, P1; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Guo Z, 2018, EUR J PHARMACOL, V828, P18, DOI 10.1016/j.ejphar.2018.03.031; Hagner S, 2002, CELL TISSUE RES, V310, P41, DOI 10.1007/s00441-002-0616-x; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Harada N, 2009, TRANSL RES, V154, P90, DOI 10.1016/j.trsl.2009.05.001; Hashikawa-Hobara N, 2015, SCI REP-UK, V5, DOI 10.1038/srep12559; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hendrikse ER, 2019, CEPHALALGIA, V39, P403, DOI 10.1177/0333102418765787; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Holland PR, 2018, NEUROTHERAPEUTICS, V15, P304, DOI 10.1007/s13311-018-0617-4; Hou M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0750-1; Hougaard A, 2017, BRAIN, V140, P1633, DOI 10.1093/brain/awx089; Hu DE, 2005, BRIT J PHARMACOL, V146, P576, DOI 10.1038/sj.bjp.0706350; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; Huang J, 2011, BRAIN BEHAV IMMUN, V25, P787, DOI 10.1016/j.bbi.2011.02.007; Jansen-Olesen I, 2003, EUR J PHARMACOL, V481, P207, DOI 10.1016/j.ejphar.2003.09.021; Juhasz G, 2005, CEPHALALGIA, V25, P179, DOI 10.1111/j.1468-2982.2005.00836.x; Jusek G, 2012, IMMUNOBIOLOGY, V217, P761, DOI 10.1016/j.imbio.2012.04.009; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Kaneko Y, 2018, CELL PHYSIOL BIOCHEM, V51, P1982, DOI 10.1159/000495722; Karsan N, 2015, CURR OPIN NEUROL, V28, P250, DOI 10.1097/WCO.0000000000000191; Kastin AJ, 2004, BLOOD SPINAL CORD BR, P57; Kim KJ, 2016, J NEUROSCI, V36, P12624, DOI 10.1523/JNEUROSCI.1300-16.2016; Kimura H, 2003, ACTA BIOCHIM POL, V50, P49; Ladjimi MH, 2019, BEHAV BRAIN RES, V359, P247, DOI 10.1016/j.bbr.2018.10.023; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Leticia F, 2017, BRAIN RES BULL, V128, P83, DOI 10.1016/j.brainresbull.2016.11.012; Li WW, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1145-1; Licht T, 2013, CELL MOL LIFE SCI, V70, P1727, DOI 10.1007/s00018-013-1280-x; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu Z, 2011, REGUL PEPTIDES, V171, P19, DOI 10.1016/j.regpep.2011.05.014; Loder E, 2002, CEPHALALGIA, V22, P624, DOI 10.1046/j.1468-2982.2002.00437.x; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lu CX, 2017, EXP THER MED, V14, P4935, DOI 10.3892/etm.2017.5126; Luo D, 2008, REGUL PEPTIDES, V150, P66, DOI 10.1016/j.regpep.2008.05.007; MaassenVanDenBrink A, 2016, TRENDS PHARMACOL SCI, V37, P779, DOI 10.1016/j.tips.2016.06.002; Maasumi K, 2018, DRUGS, V78, P913, DOI 10.1007/s40265-018-0923-5; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; MANZINI S, 1989, BRIT J PHARMACOL, V97, P303, DOI 10.1111/j.1476-5381.1989.tb11955.x; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Marie C, 2018, J CEREBR BLOOD F MET, V38, P935, DOI 10.1177/0271678X18766772; Mason BN, 2017, J NEUROSCI, V37, P204, DOI 10.1523/JNEUROSCI.2967-16.2016; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Matsumoto Y, 1996, JPN CIRC J, V60, P797, DOI 10.1253/jcj.60.797; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Messali A, 2016, HEADACHE, V56, P306, DOI 10.1111/head.12755; Messlinger K, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0848-0; Meuchel LW, 2011, CARDIOVASC RES, V91, P668, DOI 10.1093/cvr/cvr107; Micheli L, 2018, BRAIN RES BULL, V143, P181, DOI 10.1016/j.brainresbull.2018.09.002; Mishima T, 2011, AM J PHYSIOL-HEART C, V300, pH431, DOI 10.1152/ajpheart.00466.2010; Miyamoto K, 2014, J MOL NEUROSCI, V54, P370, DOI 10.1007/s12031-014-0309-4; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Moreno MJ, 1999, J CEREBR BLOOD F MET, V19, P1270, DOI 10.1097/00004647-199911000-00012; Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280; Nieto FR, 2015, ARTHRITIS RHEUMATOL, V67, P1668, DOI 10.1002/art.39082; Nikulin VV, 2014, NEUROIMAGE, V97, P71, DOI 10.1016/j.neuroimage.2014.04.008; Ohno T, 2008, GASTROENTEROLOGY, V134, P215, DOI 10.1053/j.gastro.2007.10.001; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Okutsu Y, 2017, MOL PAIN, V13, DOI 10.1177/1744806917709201; Oliver KR, 2002, J CEREBR BLOOD F MET, V22, P620, DOI 10.1097/00004647-200205000-00014; Ozge A, 2017, CURR OPIN NEUROL, V30, P287, DOI 10.1097/WCO.0000000000000439; Paemeleire K, 2018, CURR OPIN NEUROL, V31, P274, DOI 10.1097/WCO.0000000000000548; Pakpoor J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045295; Park SH, 2013, PEPTIDES, V44, P158, DOI 10.1016/j.peptides.2013.04.001; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0845-3; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Ringer C, 2017, CELL MOL LIFE SCI, V74, P339, DOI 10.1007/s00018-016-2337-4; Rist PM, 2013, HEADACHE, V53, P589, DOI 10.1111/head.12046; Rist PM, 2011, CEPHALALGIA, V31, P1291, DOI 10.1177/0333102411417466; Rivnyak A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041020; Roach REJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011054.pub2; Rossetti I, 2018, J NEUROIMMUNOL, V323, P94, DOI 10.1016/j.jneuroim.2018.07.005; Rubio-Beltran E, 2016, CEPHALALGIA, V36, P41; Rubio-Beltran E, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0893-8; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Sarchielli P, 2006, CEPHALALGIA, V26, P257, DOI 10.1111/j.1468-2982.2005.01016.x; Sardi C, 2014, J NEUROIMMUNOL, V271, P18, DOI 10.1016/j.jneuroim.2014.03.008; Schebesch KM, 2013, J CLIN NEUROSCI, V20, P584, DOI 10.1016/j.jocn.2012.07.006; Schoknecht K, 2012, EPILEPSIA, V53, P7, DOI 10.1111/j.1528-1167.2012.03697.x; Schorscher-Petcu A, 2009, J MOL NEUROSCI, V39, P125, DOI 10.1007/s12031-009-9201-z; Schou WS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0741-2; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schytz HW, 2009, BRAIN, V132, P16, DOI 10.1093/brain/awn307; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shao B, 2015, PHYSIOL BEHAV, V139, P224, DOI 10.1016/j.physbeh.2014.11.049; Sharma HS, 2000, ACT NEUR S, V76, P541; She Fei, 2003, Shengli Xuebao, V55, P625; Shin HK, 2004, CLIN EXP PHARMACOL P, V31, P1, DOI 10.1111/j.1440-1681.2004.03943.x; Shu YH, 2015, BIOMED PHARMACOTHER, V76, P17, DOI 10.1016/j.biopha.2015.10.010; Silberstein SD, 2019, HEADACHE, V59, P383, DOI 10.1111/head.13446; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Simonetti M, 2008, J BIOL CHEM, V283, P18743, DOI 10.1074/jbc.M800296200; Skljarevski V, 2018, CEPHALALGIA, V38, P1442, DOI 10.1177/0333102418779543; Smillie SJ, 2014, HYPERTENSION, V63, P1056, DOI 10.1161/HYPERTENSIONAHA.113.02517; Subileau EA, 2009, J NEUROPATH EXP NEUR, V68, P227, DOI 10.1097/NEN.0b013e318197eca7; Sun Bao-liang, 2010, Front Biosci (Elite Ed), V2, P1502; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Talme T, 2008, J NEUROIMMUNOL, V196, P60, DOI 10.1016/j.jneuroim.2008.02.007; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Tozzi A, 2012, P NATL ACAD SCI USA, V109, P18985, DOI 10.1073/pnas.1215435109; Tuka B, 2013, CEPHALALGIA, V33, P1085, DOI 10.1177/0333102413483931; Tuo YH, 2013, J RECEPT SIG TRANSD, V33, P114, DOI 10.3109/10799893.2013.770528; van den Brink AM, 2018, HEADACHE, V58, P1257, DOI 10.1111/head.13402; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233; Wang FZ, 1993, ABSTR SOC NEUROSCI, V16, P479; Wang Y, 2016, PHARMACOL REP, V68, P935, DOI 10.1016/j.pharep.2016.05.001; Wilhelm I, 2014, J MOL NEUROSCI, V54, P469, DOI 10.1007/s12031-014-0260-4; Yang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086334; Yang S, 2016, BIOMED REP, V4, P699, DOI 10.3892/br.2016.658; Ye F, 2007, VASC PHARMACOL, V46, P238, DOI 10.1016/j.vph.2006.10.008; Yoon SP, 2018, CELL BIOL TOXICOL, V34, P251, DOI 10.1007/s10565-017-9399-4; Yu Y, 2002, REGUL PEPTIDES, V103, P23, DOI 10.1016/S0167-0115(01)00326-3; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zhai LY, 2018, J HYPERTENS, V36, P876, DOI 10.1097/HJH.0000000000001649; Zhang JY, 2011, EUR J PHARMACOL, V671, P61, DOI 10.1016/j.ejphar.2011.09.170; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27724; Zhang ZH, 2010, BIOMED PHARMACOTHER, V64, P430, DOI 10.1016/j.biopha.2009.06.009; Zhou Z, 2010, ATHEROSCLEROSIS, V213, P92, DOI 10.1016/j.atherosclerosis.2010.08.050	185	11	13	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	SEP	2019	59	8					1339	1357		10.1111/head.13591		JUL 2019	19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IY2MD	WOS:000477529500001	31328279				2022-02-06	
J	Stevens, AR; Su, Z; Toman, E; Belli, A; Davies, D				Stevens, A. R.; Su, Z.; Toman, E.; Belli, A.; Davies, D.			Optical pupillometry in traumatic brain injury: neurological pupil index and its relationship with intracranial pressure through significant event analysis	BRAIN INJURY			English	Article						Head trauma; intracranial pressure; ICP measurements; monitoring	REACTIVITY; LIGHT	Primary Objective: Treatment paradigms for traumatic brain injury (TBI) rely on invasive monitoring of intracranial pressure (ICP) for planning intervention. Optical pupillometry is a non-invasive, objective monitoring method, measuring parameters of pupillary response and displaying a scalar value - a neurological pupil index (NPi). An impaired response on NPi has been tentatively correlated with ICP, through analysis of mean/peak NPi and ICP readings. We sought to evaluate this relationship more closely.Research Design: Prospective observational.Methods and Procedures: We obtained hourly pupillometry readings, alongside ICP values, from 40 patients with TBI requiring invasive ICP monitoring. Significant events were identified for analysis based on the significant aberration of ICP or NPi.Main Outcomes and Results: On average, individuals experienced a few significant events. There was a weak relationship between ICP events and a preceding NPi event. The results show that there is a weak but statistically insignificant relationship between NPi and ICP, where reduced pupil reactivity may indicate a raised ICP. The strength of this trend appears to diminish post-decompressive surgery.Conclusions: Whilst pupillometry may not be a reliable surrogate marker for ICP, NPi may still prove to be a useful tool in a multimodal prognostic assessment of the patient with acute brain injury.	[Stevens, A. R.; Su, Z.; Toman, E.; Belli, A.; Davies, D.] Queen Elizabeth Hosp Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Belli, A.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England		Davies, D (corresponding author), Univ Hosp Birmingham, Inst Translat Med, Birmingham B15 2TH, W Midlands, England.	david.davies@uhb.nhs.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Stevens, Andrew/0000-0002-3222-133X	National Institute for Health Research Surgical Reconstruction Microbiology Research Centre - Department of Health; National Institute for Health Research Surgical Reconstruction Microbiology Research Centre - Ministry of Defence	This work was supported by the National Institute for Health Research Surgical Reconstruction Microbiology Research Centre, which is jointly funded by the Department of Health and the Ministry of Defence.	Bonmati-Carrion MA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01019; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Engwall M, 2015, INTENS CRIT CARE NUR, V31, P325, DOI 10.1016/j.iccn.2015.07.001; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Lobato-Rincon LL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00221; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett M, 2017, J NEUROSCI NURS, V49, P229, DOI 10.1097/JNN.0000000000000290; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Park JG, 2015, J KOREAN NEUROSURG S, V58, P363, DOI 10.3340/jkns.2015.58.4.363; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205	19	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1032	1038		10.1080/02699052.2019.1605621			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000478089800008	31021683				2022-02-06	
J	Aceves, M; Terminel, MN; Okoreeh, A; Aceves, AR; Gong, YM; Polanco, A; Sohrabji, F; Hook, MA				Aceves, Miriam; Terminel, Mabel N.; Okoreeh, Andre; Aceves, Alejandro R.; Gong, Yan Ming; Polanco, Alan; Sohrabji, Farida; Hook, Michelle A.			Morphine increases macrophages at the lesion site following spinal cord injury: Protective effects of minocycline	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Spinal cord injury; Opioids; Morphine; Flow cytometry; Minocyeline; Immune; Microglia; Macrophages; Analgesia	KAPPA-OPIOID RECEPTORS; ATTENUATES MECHANICAL ALLODYNIA; BETA-MEDIATED REGULATION; CENTRAL-NERVOUS-SYSTEM; INDUCED PROLIFERATION; TRAUMATIC INJURY; MESSENGER-RNA; P38 MAPK; DYNORPHIN IMMUNOREACTIVITY; PROINFLAMMATORY CYTOKINES	Opioids are among the most effective and widely prescribed medications for the treatment of pain following spinal cord injury (SCI). Spinally-injured patients receive opioids within hours of arrival at the emergency room, and prolonged opioid regimens are often employed for the management of post-SCI chronic pain. However, previous studies in our laboratory suggest that the effects of opioids such as morphine may be altered in the pathophysiological context of neurotrauma. Specifically, we have shown that morphine administration in a rodent model of SCI increases mortality and tissue loss at the injury site, and decreases recovery of motor and sensory function, and overall health, even weeks after treatment. The literature suggests that opioids may produce these adverse effects by acting as endotoxins and increasing glial activation and inflammation. To better understand the effects of morphine following SCI, in this study we used flow cytometry to assess immune-competent cells at the lesion site. We observed a morphine-induced increase in the overall number of CD11b + cells, with marked effects on microglia, in SCI subjects. Next, to investigate whether this increase in the inflammatory profile is necessary to produce morphine's effects, we challenged morphine treatment with mino-cycline. We found that pre-treatment with minocycline reduced the morphine-induced increase in microglia at the lesion site. More importantly, minocycline also blocked the adverse effects of morphine on recovery of function without disrupting the analgesic efficacy of this opioid. Together, our findings suggest that following SCI, morphine may exacerbate the inflammatory response, increasing cell death at the lesion site and negatively affecting functional recovery.	[Aceves, Miriam; Terminel, Mabel N.; Okoreeh, Andre; Aceves, Alejandro R.; Gong, Yan Ming; Polanco, Alan; Sohrabji, Farida; Hook, Michelle A.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, 8447 Riverside Pkwy 47, Bryan, TX 77807 USA		Aceves, M (corresponding author), Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, 8447 Riverside Pkwy 47, Bryan, TX 77807 USA.	maceves@medicine.tamhsc.edu; terminel@medicine.tamhsc.edu; okoreeh@medicine.tamhsc.edu; aaceves@medicine.tamhsc.edu; sammygong@tamu.edu; alanpolanco@tamu.edu; sohrabji@medicine.tamhsc.edu; hook@medicine.tamhsc.edu		Hook, Michelle/0000-0002-8709-936X; Aceves Rodriguez, Miriam/0000-0002-1778-0213; Sohrabji, Farida/0000-0002-6960-3411	Office of the Assistant Secretary of Defense for Health Affairs, through the Spinal Cord Injury Research Program [W81XWH 17-1-0629]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA31197]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Spinal Cord Injury Research Program under Award No. W81XWH 17-1-0629, and an NIH grant DA31197 to M. A. Hook. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. The NIDA Drug Supply Program generously provided morphine sulfate.	Aceves M, 2016, SPINAL CORD, V54, P767, DOI 10.1038/sc.2016.28; Aceves M, 2017, J NEUROTRAUM, V34, P1164, DOI 10.1089/neu.2016.4601; Adjan VV, 2007, NEUROSCIENCE, V148, P724, DOI 10.1016/j.neuroscience.2007.05.053; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Bao F, 2005, J NEUROCHEM, V94, P1361, DOI 10.1111/j.1471-4159.2005.03280.x; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEATTIE MS, 1992, J NEUROTRAUM, V9, P157, DOI 10.1089/neu.1992.9.157; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Bidlack JM, 2006, J NEUROIMMUNE PHARM, V1, P260, DOI 10.1007/s11481-006-9026-2; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Chao CC, 1997, J PHARMACOL EXP THER, V281, P998; Chao CC, 1996, P NATL ACAD SCI USA, V93, P8051, DOI 10.1073/pnas.93.15.8051; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; CHUANG TK, 1995, BIOCHEM BIOPH RES CO, V216, P922, DOI 10.1006/bbrc.1995.2709; COX BM, 1985, NEUROPEPTIDES, V5, P571, DOI 10.1016/0143-4179(85)90082-4; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; ERIKSSON PS, 1993, NEUROSCIENCE, V54, P401, DOI 10.1016/0306-4522(93)90261-D; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; FORD AL, 1995, J IMMUNOL, V154, P4309; Gessi S, 2016, FEBS LETT, V590, P2813, DOI 10.1002/1873-3468.12313; Grace P. M., 2016, P NATL ACAD SCI USA; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/0897715042664948; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Gurwell JA, 1996, BRAIN RES, V737, P175, DOI 10.1016/0006-8993(96)00728-7; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hauser KF, 1996, BRAIN RES, V720, P191, DOI 10.1016/0006-8993(96)00103-5; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Hook MA, 2007, BEHAV BRAIN RES, V179, P281, DOI 10.1016/j.bbr.2007.02.035; Hook MA, 2017, J NEUROTRAUM, V34, P632, DOI 10.1089/neu.2016.4507; Hook MA, 2011, BRAIN BEHAV IMMUN, V25, P349, DOI 10.1016/j.bbi.2010.10.018; Hook MA, 2009, J NEUROTRAUM, V26, P741, DOI 10.1089/neu.2008.0710; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Hutchinson MR, 2010, NEUROSCIENCE, V167, P880, DOI 10.1016/j.neuroscience.2010.02.011; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Hutchinson MR, 2004, PAIN, V110, P751, DOI 10.1016/j.pain.2004.05.017; Inoue K, 2004, J PHARMACOL SCI, V94, P112, DOI 10.1254/jphs.94.112; Jeffrey S. M., 2001, METHODS PAIN RES; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; Kauppinen T., 2001, J NEUROSCI, V21, P2580; Kawai K, 2005, J ALLERGY CLIN IMMUN, V116, P192, DOI 10.1016/j.jaci.2005.03.021; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Leo Sandra, 2009, J Pain Res, V2, P59; Lewis SS, 2010, NEUROSCIENCE, V165, P569, DOI 10.1016/j.neuroscience.2009.10.011; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Martin E, 2017, JOVE-J VIS EXP, DOI 10.3791/55781; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013; Mika J, 2009, BRAIN BEHAV IMMUN, V23, P75, DOI 10.1016/j.bbi.2008.07.005; Neighbor ML, 2004, ACAD EMERG MED, V11, P1290, DOI 10.1197/j.aem.2004.07.014; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; Ruzicka BB, 1996, J NEUROCHEM, V66, P425; Ruzicka BB, 1997, NEUROSCIENCE, V79, P517, DOI 10.1016/S0306-4522(96)00669-0; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; Schallert T, 2005, BEHAV LAB RAT, P129; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Sedy J, 2008, NEUROSCI BIOBEHAV R, V32, P550, DOI 10.1016/j.neubiorev.2007.10.001; Sharp BM, 2006, BRAIN BEHAV IMMUN, V20, P9, DOI 10.1016/j.bbi.2005.02.002; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stiene-Martin A, 2001, GLIA, V36, P78, DOI 10.1002/glia.1097; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; STIENEMARTIN A, 1991, J NEUROSCI RES, V29, P538, DOI 10.1002/jnr.490290415; STIENEMARTIN A, 1993, DEV BRAIN RES, V76, P189, DOI 10.1016/0165-3806(93)90207-Q; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tsai RY, 2015, J FORMOS MED ASSOC, V114, P446, DOI 10.1016/j.jfma.2014.12.004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vidal EL, 1998, IMMUNOPHARMACOLOGY, V38, P261, DOI 10.1016/S0162-3109(97)00085-4; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Woller SA, 2014, J NEUROTRAUM, V31, P1570, DOI 10.1089/neu.2013.3293; Woller SA, 2012, J NEUROTRAUM, V29, P1650, DOI 10.1089/neu.2011.2100; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	101	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2019	79						125	138		10.1016/j.bbi.2019.01.023			14	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	IH2MH	WOS:000474328400020	30684649				2022-02-06	
J	Bertsimas, D; Dunn, J; Steele, DW; Trikalinos, TA; Wang, YC				Bertsimas, Dimitris; Dunn, Jack; Steele, Dale W.; Trikalinos, Thomas A.; Wang, Yuchen			Comparison of Machine Learning Optimal Classification Trees With the Pediatric Emergency Care Applied Research Network Head Trauma Decision Rules	JAMA PEDIATRICS			English	Article							BRAIN-INJURIES; PREDICTION RULES; COMPUTED-TOMOGRAPHY; CHILDREN; CANCER; CONSCIOUSNESS; ASSOCIATION; VALIDATION; RISKS	IMPORTANCE Computed tomographic (CT) scanning is the standard for the rapid diagnosis of intracranial injury, but it is costly and exposes patients to ionizing radiation. The Pediatric Emergency Care Applied Research Network (PECARN) rules for identifying children with minor head trauma who are at very low risk of clinically important traumatic brain injury (ciTBI) are widely used to triage CT imaging. OBJECTIVE To examine whether optimal classification trees (OCTs), which are novel machine-learning classifiers, improve on PECARN rules' predictive accuracy. DESIGN, SETTING, AND PARTICIPANTS A secondary analysis of prospective, publicly available data on emergency department visits for head trauma used by the PECARN group to develop their tool was conducted to derive OCT-based prediction rules for ciTBI in a development cohort and compare their predictive performance vs the PECARN rules in a validation cohort among children who were younger than 2 years and 2 years or older. Data on 42 412 children with head trauma and without severely altered mental status who were examined between June 1, 2004, and September 30, 2006, were gathered from 25 emergency departments in North America participating in PECARN. Data analysis was conducted from September 15, 2016, to December 18, 2018. MAIN OUTCOMES AND MEASURES The outcome was ciTBI, with predictive performance measured by estimating the sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for the OCT and the PECARN rules. The OCT and PECARN rules' performance was compared by estimating ratios for each measure. RESULTS Of the 42 412 children (15 996 [37.7%] girls) included in the analysis, 10 718 were younger than 2 years (25.3%; mean [SD] age, 11.6 [0.6] months) and 31 694 were 2 years or older (74.7%; age, 9.1 [4.9] years). Compared with PECARN rules, OCTs misclassified 0 vs 1 child with ciTBI in the younger and 10 vs 9 children with ciTBI in the older cohort, and correctly identified more children with very low risk of ciTBI in the younger (7605 vs 5701) and older (20 594 vs 18 134) cohorts. In the validation cohorts, compared with the PECARN rules, the OCTs had statistically significantly better specificity (in the younger cohort: 69.3%; 95% CI, 67.4%-71.2% vs 52.8%; 95% CI, 50.8%-54.9%; in the older cohort: 65.6%; 95% CI, 64.5%-66.8% vs 57.6%; 95% CI, 56.4%-58.8%), positive predictive value (odds ratios, 1.54; 95% CI, 1.36-1.74 and 1.23; 95% CI, 1.17-1.30, in younger and older children, respectively), and positive likelihood ratio (risk ratios, 1.54; 95% CI, 1.36-1.74 and 1.23; 95% CI, 1.17-1.30, in younger and older children, respectively). There were no statistically significant differences in the sensitivity, negative predictive value, and negative likelihood ratio between the 2 sets of rules. CONCLUSIONS AND RELEVANCE If implemented, OCTs may help reduce the number of unnecessary CT scans, without missing more patients with ciTBI than the PECARN rules.	[Bertsimas, Dimitris; Dunn, Jack; Wang, Yuchen] MIT, Ctr Operat Res, Cambridge, MA 02139 USA; [Steele, Dale W.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Steele, Dale W.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Steele, Dale W.; Trikalinos, Thomas A.] Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI 02912 USA		Trikalinos, TA (corresponding author), Brown Univ, Ctr Evidence Synth Hlth, 121 S Main St, Providence, RI 02912 USA.	thomas_trikalinos@brown.edu			University of Utah School of Medicine on behalf of the Pediatric Emergency Care Applied Research Network (PECARN)	We analyzed the Public Use Data Set prepared by the staff at the Data Coordinating Center, University of Utah School of Medicine on behalf of the Pediatric Emergency Care Applied Research Network (PECARN). These data are from the Identification of Children at Very Low Risk of Clinically Important Brain Injuries After Head Trauma: A Prospective Cohort Study (TBI Study). Our analysis and conclusions do not necessarily reflect the opinions or views of the TBI Study investigators or the Health Resources & Services Administration, Maternal Child Health Bureau, or the Emergency Medical Services for Children, which funded the original research.	[Anonymous], 2018, STATA STAT SOFTW REL; Bertsimas D, 2017, MACH LEARN, V106, P1039, DOI 10.1007/s10994-017-5633-9; Bertsimas D, 2017, J MACH LEARN RES, V18; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Breiman L., 1984, CLASSIFICATION REGRE; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Cohen JF, 2017, EUR J CLIN MICROBIOL, V36, P195, DOI 10.1007/s10096-016-2800-z; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Little RJ., 2014, STAT ANAL MISSING DA, V333; Lord SJ, 2009, MED TESTS WHITE PAPE; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Plummer M., 2003, P 3 INT WORKSHOP DIS, V124, P10; R Core Team, 2017, R LANG ENV STAT COMP; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Ukwuoma OI, PEDIAT EMERG CARE; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Zemek R, 2014, GUIDELINES DIAGNOSIN	42	11	11	2	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUL	2019	173	7					648	656		10.1001/jamapediatrics.2019.1068			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IM3MV	WOS:000477898500012	31081856	Green Published, Bronze			2022-02-06	
J	Knollman-Porter, K; Thaxton, S; Hughes, MR; Constantinidou, F				Knollman-Porter, Kelly; Thaxton, Sarah; Hughes, Michael R.; Constantinidou, Fofi			Management and Recovery Patterns Following Sport-Related Mild Traumatic Brain Injury in Male and Female College Athletes	TOPICS IN LANGUAGE DISORDERS			English	Article						gender; mild traumatic brain injury; recovery; sports; symptoms	COMPUTERIZED NEUROCOGNITIVE TEST; SPEECH-LANGUAGE PATHOLOGY; HIGH-SCHOOL; SEX-DIFFERENCES; CONCUSSION MANAGEMENT; UNITED-STATES; SYMPTOMS; TIME; EPIDEMIOLOGY; RELIABILITY	Purpose: We examined patterns in mild traumatic brain injury (mTBI) management and recovery exhibited by male and female athletes over the 19-year history of a Division 1 University Concussion Management Program. Methods: We examined 234 diagnosed mTBIs and compared time required to return to baseline on neurocognitive and self-report symptom measures for male and female athletes. Results: Males and females sustained 63.3% and 36.7% of mTBI, respectively. Athletes required on average 11.89 days to return to baseline on neurocognitive assessments and 11.83 days to report being symptom-free. There was a significant difference in the number of days until genders were symptom-free, with males and females requiring on average 10.11 days and 14.30 days, respectively. Discussion: More collegiate athletes received pre- and post-mTBI management than in the past. There is a continued need to examine patterns of neurocognitive and symptom recovery, which may lead to earlier detection of athletes at risk for persistent post-mTBI symptoms.	[Knollman-Porter, Kelly; Thaxton, Sarah] Miami Univ, Dept Speech Pathol & Audiol, 301 S Patterson Ave,2 Bachelor Hall, Oxford, OH 45056 USA; [Hughes, Michael R.] Miami Univ, Dept Stat, Oxford, OH 45056 USA; [Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus		Knollman-Porter, K (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, 301 S Patterson Ave,2 Bachelor Hall, Oxford, OH 45056 USA.	knollmkk@miamioh.edu					Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; [Anonymous], 1906, JAMA-J AM MED ASSOC, VXLVI, P122; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Benton A., 1978, MULTILINGUAL APHASIA; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Brett BL, 2018, J INT NEUROPSYCH SOC, V24, P476, DOI 10.1017/S1355617717001321; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Causby R, 2014, PERCEPT MOTOR SKILL, V118, P765, DOI 10.2466/25.27.PMS.118k27w2; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Constantinidou F., 2005, ARCHIVES OF PHYSICAL, V86, pe13; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Dick R, 2007, J ATHL TRAINING, V42, P173; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hootman JM, 2007, J ATHL TRAINING, V42, P311; ImPACT Applications Inc, 2016, IMPACT ADM INT MAN; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Klove, 1963, LAF INSTR GROOV PEGB; Knollman-Porter K., 2018, AM C REH MED C; Knollman-Porter K, 2019, SEMIN SPEECH LANG, V40, P3, DOI 10.1055/s-0038-1676363; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Miller JJ, 2011, BIG SCRUM TEDDY ROOS; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; National Collegiate Athletic Association, 2010, NCAA HIST; National Collegiate Athletic Association, 2018, NCAA INJ SURV PROGR; National Collegiate Athletic Association, 2014, ATHL PART RAT CONT R; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Price E. L., 2006, CAN J COUNS PSYCHOT, V40; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; SAS Institute Inc, 2013, SAS STAT 14 2 STAT; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yamamoto Joelle B, 2008, Res Sports Med, V16, P111, DOI 10.1080/15438620802103320; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	80	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2019	39	3			SI		257	275		10.1097/TLD.0000000000000187			19	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	IM3IN	WOS:000477887000004					2022-02-06	
J	Razaghi, R; Biglari, H; Karimi, A				Razaghi, Reza; Biglari, Hasan; Karimi, Alireza			Risk of rupture of the cerebral aneurysm in relation to traumatic brain injury using a patient-specific fluid-structure interaction model	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Cerebral aneurysm; Traumatic brain injury; Fluid-structure interaction; Stress; Deformation	FINITE-ELEMENT SIMULATION; MECHANICAL-PROPERTIES; INTRACRANIAL ANEURYSMS; WALL THICKNESS; HEMODYNAMICS; PATHOPHYSIOLOGY; COMBINATION; COMPUTATION; DYNAMICS; HEALTHY	Background and objective: Cerebral aneurysm, which is defined as one of the weakened area in the wall of an artery in the brain, ruptures when wall tension exceeds its mechanical strength. Traumatic brain injury (TBI) by exerting a sudden impact load to the brain can lead to mechanical failure of the cerebral blood vessels followed by an alteration in not only the structure but also the function of the cerebrovascular. TBI also alters the hemodynamics of the blood flow in the cerebrovascular, while it has been shown that hemodynamics has a key asset in the progression and rupture of the cerebral aneurysms. So far, there is a lack of knowledge on the risk of rupture of the cerebral aneurysm in relation to TBI. Therefore, this study aimed to calculate the mechanical stresses and deformations in the arterial wall as well as the pressure and velocity of the blood using a fluid-structure interaction (FSI) model of the cerebral aneurysm located in the anterior circulation region of the circle of Willis. Method: A patient-specific FSI model of the human skull, brain, and cerebral aneurysm, was established using human computed tomography (CT)/magnetic resonance imaging (MRI) data and subjected to a frontal TBI. Results: The results revealed considerable increasing of similar to 8 kPa (60 mmHg) and 0.40 m/s in the pressure and velocity of the blood in the intraluminal of the cerebral artery after TBI. The von Mises stress, shear stress, and deformation of the cerebral aneurysm wall also showed the increasing of 56.03 kPa, 15.66 Pa, and 0.072 mm after TBI, respectively. Conclusions: Although the injury to the aneurysm wall after TBI is lower than that of the aneurysm wall mechanical strength, it still can alter the stress pattern in the wall and disrupt the hemodynamics of the blood. These results have implications in understanding the rupture risk of the cerebral aneurysm due to TBI, which may contribute in establishing preventive and/or treatment methods. (C) 2019 Elsevier B.V. All rights reserved.	[Razaghi, Reza; Biglari, Hasan] Univ Tabriz, Dept Mech Engn, Tabriz 51666, Iran; [Karimi, Alireza] Kyushu Univ, Dept Mech Engn, Nishi Ku, 744 Motooka, Fukuoka, Fukuoka 8190395, Japan		Biglari, H (corresponding author), Univ Tabriz, Dept Mech Engn, Tabriz 51666, Iran.	rrazaghi@tabrizu.ac.ir; hbiglari@tabrizu.ac.ir; karimi@kyudai.jp	Biglari, Hasan/ABF-6235-2021; Razaghi, Reza/S-7173-2019	Biglari, Hasan/0000-0003-4601-9762; Razaghi, Reza/0000-0002-9563-7535			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alnaes MS, 2007, STROKE, V38, P2500, DOI 10.1161/STROKEAHA.107.482471; Aomura S, 2003, JSME INT J C-MECH SY, V46, P583, DOI 10.1299/jsmec.46.583; Badia S, 2009, COMPUT METHOD APPL M, V198, P2768, DOI 10.1016/j.cma.2009.04.004; Bazilevs Y, 2010, BIOMECH MODEL MECHAN, V9, P481, DOI 10.1007/s10237-010-0189-7; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Castro MA, 2006, AM J NEURORADIOL, V27, P1703; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Cebral JR, 2013, ANN BIOMED ENG, V41, P1366, DOI 10.1007/s10439-012-0723-0; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chua SND, 2003, J MATER PROCESS TECH, V143, P591, DOI 10.1016/S0924-0136(03)00435-7; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DONEA J, 1982, COMPUT METHOD APPL M, V33, P689, DOI 10.1016/0045-7825(82)90128-1; Eken A, 2017, COMPUT FLUIDS, V153, P61, DOI 10.1016/j.compfluid.2017.05.005; Faghihi S, 2014, MAT SCI ENG C-MATER, V38, P299, DOI 10.1016/j.msec.2014.02.015; Faghihi S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864153; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerbeau JF, 2005, COMPUT STRUCT, V83, P155, DOI 10.1016/j.compstruc.2004.03.083; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Jarrahi A, 2016, MATER TECHNOL, V31, P247, DOI 10.1179/1753555715Y.0000000049; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Jou LD, 2005, AM J NEURORADIOL, V26, P2357; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Karimi A, 2014, MATER TECHNOL, V29, P90, DOI 10.1179/1753555713Y.0000000115; Karimi A, 2017, BIOENGINEERED, V8, P154, DOI 10.1080/21655979.2016.1212134; Karimi A, 2016, ARTERY RES, V16, P1, DOI 10.1016/j.artres.2016.08.002; Karimi A, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5686-5; Karimi A, 2015, TISSUE CELL, V47, P152, DOI 10.1016/j.tice.2015.01.004; Karimi A, 2015, COMPUT METHOD BIOMEC, V18, P1418, DOI 10.1080/10255842.2014.910513; Karimi A, 2014, MED BIOL ENG COMPUT, V52, P589, DOI 10.1007/s11517-014-1163-9; Karimi A, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500136; Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779; Lee CH, 2017, CHILD NERV SYST, V33, P125, DOI 10.1007/s00381-016-3252-6; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lin SN, 2011, FERTIL STERIL, V96, pS182, DOI 10.1016/j.fertnstert.2011.07.709; MacDonald DJ, 2000, ANN BIOMED ENG, V28, P533, DOI 10.1114/1.292; Melvin J., 2002, ACCIDENTAL INJURY, P277, DOI [10.1007/978-0-387-21787-1_13, DOI 10.1007/978-0-387-21787-1_13]; Monson K. L. V., 2001, MECH FAILURE PROPERT; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Perdikaris P, 2016, PARALLEL COMPUT, V55, P9, DOI 10.1016/j.parco.2015.10.016; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Razaghi R, 2018, CURR PHARM DESIGN, V24, P4492, DOI 10.2174/1381612825666181204115124; Razaghi R, 2018, INT J IND ERGONOM, V66, P169, DOI 10.1016/j.ergon.2018.03.004; Sadasivan C, 2013, ANN BIOMED ENG, V41, P1347, DOI 10.1007/s10439-013-0800-z; Shamloo A, 2017, J MECH BEHAV BIOMED, V74, P72, DOI 10.1016/j.jmbbm.2017.05.020; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Steiger H J, 1990, Acta Neurochir Suppl (Wien), V48, P1; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sun HT, 2019, ENG APPL COMP FLUID, V13, P229, DOI 10.1080/19942060.2019.1572540; TAKAHASHI A, 1994, ARCH HISTOL CYTOL, V57, P341, DOI 10.1679/aohc.57.341; Tateshima S, 2001, J NEUROSURG, V95, P1020, DOI 10.3171/jns.2001.95.6.1020; Torii R, 2011, INT J NUMER METH FL, V65, P324, DOI 10.1002/fld.2448; Torii R, 2010, INT J NUMER METH BIO, V26, P336, DOI 10.1002/cnm.1289; Torii R, 2009, COMPUT METHOD APPL M, V198, P3613, DOI 10.1016/j.cma.2008.08.020; Valencia A, 2015, J MECH MED BIOL, V15, DOI 10.1142/S021951941550075X; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	64	11	12	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2019	176						9	16		10.1016/j.cmpb.2019.04.015			8	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	IC6QA	WOS:000471095400002	31200915				2022-02-06	
J	Socolovsky, M; Malessy, M; Bonilla, G; Di Masi, G; Conti, ME; Lovaglio, A				Socolovsky, Mariano; Malessy, Martijn; Bonilla, Gonzalo; Di Masi, Gilda; Eugenia Conti, Maria; Lovaglio, Ana			Phrenic to musculocutaneous nerve transfer for traumatic brachial plexus injuries: analyzing respiratory effects on elbow flexion control	JOURNAL OF NEUROSURGERY			English	Article						brachial plexus injury; phrenic nerve transfer; brain plasticity; peripheral nerve		OBJECTIVE In this study, the authors sought to identify the relationship between breathing and elbow flexion in patients with a traumatic brachial plexus injury (TBPI) who undergo a phrenic nerve (PN) transfer to restore biceps flexion. More specifically, the authors studied whether biceps strength and the maximal range of active elbow flexion differ between full inspiration and expiration, and whether electromyography (EMG) activity in the biceps differs between forced maximum breathing during muscular rest, normal breathing during rest, and at maximal biceps contraction. All these variables were studied in a cohort with different intervals of follow-up, as the authors sought to determine if the relationship between breathing movements and elbow flexion changes over time. METHODS The British Medical Research Council muscle-strength grading system and a dynamometer were used to measure biceps strength, which was measured 1) during a maximal inspiratory effort, 2) during respiratory repose, and 3) after a maximal expiratory effort. The maximum range of elbow flexion was measured 1) after maximal inspiration, 2) during normal breathing, and 3) after maximal expiration. Postoperative EMG testing was performed 1) during normal breathing with the arm at rest, 2) during sustained maximal inspiration with the arm at rest, and 3) during maximal voluntary biceps contraction. Within-group (paired) comparisons, and both correlation and regression analyses were performed. RESULTS Twenty-one patients fit the study inclusion criteria. The mean interval from trauma to surgery was 5.5 months, and the mean duration of follow-up 2.6 years (range 10 months to 9.6 years). Mean biceps strength was 0.21 after maximal expiration versus 0.29 after maximal inspiration, a difference of 0.08 (t = 4.97, p < 0.001). Similarly, there was almost a 21 degrees difference in maximum elbow flexion, from 88.8 degrees after expiration to 109.5 degrees during maximal inspiration (t = 5.05, p < 0.001). Involuntary elbow flexion movement during breathing was present in 18/ 21 patients (86%) and averaged almost 20 degrees. Measuring involuntary EMG activity in the biceps during rest and contraction, there were statistically significant direct correlations between readings taken during normal and deep breathing, which were moderate (r = 0.66, p < 0.001) and extremely strong (r = 0.94, p < 0.001), respectively. Involuntary activity also differed significantly between normal and deep breathing (2.14 vs 3.14, t = 4.58, p < 0.001). The degrees of involuntary flexion were significantly greater within the first 2.6 years of follow-up than later. CONCLUSIONS These results suggest that the impact of breathing on elbow function is considerable after PN transfer for elbow function reconstruction following a TBPI, both clinically and electromyographically, but also that there may be some waning of this influence over time, perhaps secondary to brain plasticity. In the study cohort, this waning impacted elbow range of motion more than biceps muscle strength and EMG recordings.	[Socolovsky, Mariano; Bonilla, Gonzalo; Di Masi, Gilda; Lovaglio, Ana] Univ Buenos Aires, Sch Med, Dept Neurosurg, Peripheral Nerve & Brachial Plexus Surg Program, Buenos Aires, DF, Argentina; [Eugenia Conti, Maria] Univ Buenos Aires, Sch Med, Dept Neurol, Unit Neurophysiol, Buenos Aires, DF, Argentina; [Malessy, Martijn] Leiden Univ, Sch Med, Dept Neurosurg, Leiden, Netherlands		Socolovsky, M (corresponding author), Univ Buenos Aires, Sch Med, Buenos Aires, DF, Argentina.	marianosocolovsky@gmail.com	Malessy, Martijn/AAZ-9996-2021	Malessy, Martijn/0000-0003-1936-3664			Anastakis DJ, 2008, HAND CLIN, V24, P425, DOI 10.1016/j.hcl.2008.04.005; Carlstedt Thomas, 2004, Neurosurg Focus, V16, pE7; Dahlin LB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00072; Fraiman D, 2016, NEUROIMAGE-CLIN, V12, P277, DOI 10.1016/j.nicl.2016.07.008; Htut M, 2007, J HAND SURG-BRIT EUR, V32E, P170, DOI 10.1016/j.jhsb.2006.11.011; Lumb AB, 2016, NUNNS APPL RESP PHYS, P73; MALESSY MJA, 1993, CLIN NEUROL NEUROSUR, V95, pS95; Socolovsky M, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16431; Socolovsky M, 2015, ACTA NEUROCHIR, V157, P1077, DOI 10.1007/s00701-015-2387-7; SWIFT TR, 1994, MUSCLE NERVE, V17, P125; Zheng MX, 2010, J HAND SURG-AM, V35A, P1304, DOI 10.1016/j.jhsa.2010.04.006	11	11	11	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2019	131	1					165	174		10.3171/2018.4.JNS173248			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ3XR	WOS:000475838400022	30141757	Bronze			2022-02-06	
J	Ni, HB; Rui, Q; Lin, XL; Li, D; Liu, HX; Chen, G				Ni, Haibo; Rui, Qin; Lin, Xiaolong; Li, Di; Liu, Huixiang; Chen, Gang			2-BFI Provides Neuroprotection Against Inflammation and Necroptosis in a Rat Model of Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						2-BFI; inflammation; necroptosis; neuroprotection; traumatic brain injury	NLRP3 INFLAMMASOME; IMIDAZOLINE I-2; CELL-DEATH; EXPRESSION; NEUROINFLAMMATION; PATHOPHYSIOLOGY; 2-(2-BENZOFURANYL)-2-IMIDAZOLINE; MECHANISMS; NECROSIS; PROTEIN	Inflammation and programmed necrosis (necroptosis) are the two hallmark pathological changes after traumatic brain injury (TBI) that contribute to aggravated brain damage. 2-(2-Benzofuranyl)-2-imidazoline (2-BFI) has been shown to exert both anti-inflammatory and programmed cell death effects. Therefore, the aim of the present study was to evaluate the potential beneficial effects of 2-BFI in a rat model of TBI induced by a weight-drop device. 2-BFI or vehicle was given via intraperitoneal injection starting at 30 min post trauma and then twice daily for three consecutive days. Following a neurofunctional test at 72 h after injury, histological, molecular, and immunohistochemistry analyses were performed on the pericontusional areas of the brain. 2-BFI treatment significantly attenuated neurological deficits, brain edema and blood-brain barrier permeability after TBI. Also, treatment with 2-BFI significantly reduced microglial activation, neutrophil infiltration, and proinflammatory cytokine interleukin (IL)-1 beta secretion, which is related to nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation after TBI. In addition, 2-BFI treatment markedly reduced cortical tissue loss as well as repressed TBI-induced increases in necroptosis and necroptosis-associated proteins, including receptor-interacting protein (RIP1), RIP3, and mixed linkage kinase domain-like (MLKL) in the pericontusional brain tissue. Taken together, these findings indicate that 2-BFI may be an effective neuroprotectant after brain trauma and warrants further study.	[Ni, Haibo; Liu, Huixiang] Zhangriagang First Peoples Hosp, Dept Neurosurg, Suzhou, Peoples R China; [Rui, Qin] Zhangiiagang First Peoples Hosp, Dept Lab, Suzhou, Peoples R China; [Lin, Xiaolong] Zhandiagang First Peoples Hosp, Dept Orthoped, Suzhou, Peoples R China; [Li, Di] Zhangilagang First Peoples Hosp, Dept Translat Med Ctr, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China		Liu, HX (corresponding author), Zhangriagang First Peoples Hosp, Dept Neurosurg, Suzhou, Peoples R China.; Li, D (corresponding author), Zhangilagang First Peoples Hosp, Dept Translat Med Ctr, Suzhou, Peoples R China.	lidilab@sina.com; huixiangliu_zjg@163.com					Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Han Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064894; Han Z, 2012, BIOCHEM BIOPH RES CO, V424, P544, DOI 10.1016/j.bbrc.2012.06.152; Han Z, 2010, BRAIN RES, V1361, P86, DOI 10.1016/j.brainres.2010.09.029; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li F, 2012, BRAIN RES, V1483, P13, DOI 10.1016/j.brainres.2012.09.016; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li JX, 2017, PHARMACOL THERAPEUT, V178, P48, DOI 10.1016/j.pharmthera.2017.03.009; Li JX, 2011, EUR J PHARMACOL, V669, P59, DOI 10.1016/j.ejphar.2011.07.041; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Ni HB, 2018, EXP NEUROL, V304, P102, DOI 10.1016/j.expneurol.2018.03.003; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siemian JN, 2018, BIOCHEM PHARMACOL, V153, P260, DOI 10.1016/j.bcp.2018.01.032; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tian J., 2017, IEEE T CIRCUITS-II, VII, P1, DOI DOI 10.1016/J.NEURES.2017.10.010; Tian JS, 2017, J INTEGR NEUROSCI, V16, P385, DOI 10.3233/JIN-170032; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang P, 2011, BIOCHEM BIOPH RES CO, V406, P152, DOI 10.1016/j.bbrc.2011.02.018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yang JP, 2018, CEREB CORTEX, V28, P2622, DOI 10.1093/cercor/bhy089; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang Z, 2018, NEURAL REGEN RES, V13, P2111, DOI 10.4103/1673-5374.241461; Zhu YB, 2015, NEUROCHEM RES, V40, P572, DOI 10.1007/s11064-014-1502-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	11	11	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 26	2019	13								674	10.3389/fnins.2019.00674			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF6ZH	WOS:000473230800001	31293382	gold, Green Published			2022-02-06	
J	Skandsen, T; Nilsen, TL; Einarsen, C; Normann, I; McDonagh, D; Haberg, AK; Vik, A				Skandsen, Torii; Nilsen, Tom Lund; Einarsen, Cathrine; Normann, Ingunn; McDonagh, David; Haberg, Asta Kristine; Vik, Anne			Incidence of Mild Traumatic Brain Injury: A Prospective Hospital, Emergency Room and General Practitioner-Based Study	FRONTIERS IN NEUROLOGY			English	Article						incidence; concussion; mild traumatic brain injury; epidemiological; glasgow coma scale; Norway; emergency room; primary care	DEPARTMENT VISITS; HEAD-INJURY; EPIDEMIOLOGY; POPULATION; PREVENTION; CONCUSSION; NORWAY	Background: There are no recent estimates of incidence rates of mild traumatic brain injury (MTBI) from Norway. Moreover, reported incidence rates rarely comprise cases of MTBI evaluated in the primary care setting. In this study, we utilized existing data collected as part of the recruitment to a large, follow-up study of patients with MTBI. We estimated the incidence rate of MTBI, including patients who visited outpatient clinics, in the age group 16-59 years in a Norwegian region. Methods: During 81 weeks in 2014 and 2015, all persons aged 16-59 years, presenting with possible MTBI to the emergency department (ED) at St. Olavs Hospital, Trondheim University Hospital or to the general practitioner (GP)-run Trondheim municipal outpatient ED, were evaluated for a diagnosis of MTBI. Patients were identified by computerized tomography (CT) referrals and patient lists. Patients referred to acute CT from their primary GP with suspicion of MTBI were also recorded. This approach identified 732 patients with MTBI. Age-and sex-specific incidence rates of MTBI were calculated using population figures from the regional catchment area. Results: Overall incidence of MTBI in people between 16 and 59 years was 302 per 100,000 person-years (95% confidence interval 281-324). The incidence rate was highest in the age group 16-20 years, where rates were 835 per 100,000 person-years in males and 726 in females. Conclusion: The overall incidence rate of MTBI was lower than expected from existing estimates. Like other reports, the incidence was highest in the late teens.	[Skandsen, Torii; Einarsen, Cathrine; Normann, Ingunn; Haberg, Asta Kristine; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Skandsen, Torii; Einarsen, Cathrine] St Olavs Univ Hosp, Clin Phys Med & Rehabil, Trondheim, Norway; [Nilsen, Tom Lund] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Nilsen, Tom Lund] St Olavs Univ Hosp, Clin Anaesthesia & Intens Care, Trondheim, Norway; [McDonagh, David] St Olavs Univ Hosp, Dept Orthopaed Surg, Trondheim, Norway; [McDonagh, David] Municipal Emergency Dept, Trondheim, Norway; [Haberg, Asta Kristine] St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway		Skandsen, T (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway.; Skandsen, T (corresponding author), St Olavs Univ Hosp, Clin Phys Med & Rehabil, Trondheim, Norway.	toril.skandsen@ntnu.no			Liaison Committee	The study was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology. TS received a separate research grant from the same committee. Helse Midt-Norge is the Norwegian name of the Central Norway Regional Health Authorities.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Co-operation. TNRP, 2012, STAT INCR US COMP TO; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Spinks A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004445.pub2; Strand IH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-62; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Urie Y, 2016, TRAFFIC INJ PREV, V17, P686, DOI 10.1080/15389588.2016.1146823; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	32	11	12	5	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 18	2019	10								638	10.3389/fneur.2019.00638			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID8KW	WOS:000471934000001	31275229	Green Published, gold			2022-02-06	
J	Parivash, SN; Goubran, M; Mills, BD; Rezaii, P; Thaler, C; Wolman, D; Bian, W; Mitchell, LA; Boldt, B; Douglas, D; Wilson, EW; Choi, J; Xie, L; Yushkevich, PA; DiGiacomo, P; Wongsripuemtet, J; Parekh, M; Fiehler, J; Do, H; Lopez, J; Rosenberg, J; Camarillo, D; Grant, G; Wintermark, M; Zeineh, M				Parivash, Sherveen N.; Goubran, Maged; Mills, Brian D.; Rezaii, Paymon; Thaler, Christian; Wolman, Dylan; Bian, Wei; Mitchell, Lex A.; Boldt, Brian; Douglas, David; Wilson, Eugene W.; Choi, Jay; Xie, Long; Yushkevich, Paul A.; DiGiacomo, Phil; Wongsripuemtet, Jitsupa; Parekh, Mansi; Fiehler, Jens; Do, Huy; Lopez, Jaime; Rosenberg, Jarrett; Camarillo, David; Grant, Gerald; Wintermark, Max; Zeineh, Michael			Longitudinal Changes in Hippocampal Subfield Volume Associated with Collegiate Football	JOURNAL OF NEUROTRAUMA			English	Article						cornu ammonis; dentate gyrus; entorhinal cortex; perirhinal cortex	INTRINSIC CONNECTIONS; ENTORHINAL CORTEX; CEREBRAL-CORTEX; DENTATE GYRUS; BRAIN-INJURY; MEMORY; CONCUSSION; MONKEY; RETRIEVAL; MRI	Collegiate football athletes are subject to repeated traumatic brain injuriesthat may cause brain injury. The hippocampus is composed of several distinct subfields with possible differential susceptibility to injury. The aim of this study is to determine whether there are longitudinal changes in hippocampal subfield volume in collegiate football. A prospective cohort study was conducted over a 5-year period tracking 63 football and 34 volleyball male collegiate athletes. Athletes underwent high-resolution structural magnetic resonance imaging, and automated segmentation provided hippocampal subfield volumes. At baseline, football (n = 59) athletes demonstrated a smaller subiculum volume than volleyball (n = 32) athletes (-67.77 mm(3); p = 0.012). A regression analysis performed within football athletes similarly demonstrated a smaller subiculum volume among those at increased concussion risk based on athlete position (p = 0.001). For the longitudinal analysis, a linear mixed-effects model assessed the interaction between sport and time, revealing a significant decrease in cornu ammonis area 1 (CA1) volume in football (n = 36) athletes without an in-study concussion compared to volleyball (n = 23) athletes (volume difference per year = -35.22 mm(3); p = 0.005). This decrease in CA1 volume over time was significant when football athletes were examined in isolation from volleyball athletes (p = 0.011). Thus, this prospective, longitudinal study showed a decrease in CA1 volume over time in football athletes, in addition to baseline differences that were identified in the downstream subiculum. Hippocampal changes may be important to study in high-contact sports.	[Parivash, Sherveen N.; Goubran, Maged; Mills, Brian D.; Wolman, Dylan; Bian, Wei; Douglas, David; Wilson, Eugene W.; Choi, Jay; DiGiacomo, Phil; Wongsripuemtet, Jitsupa; Parekh, Mansi; Do, Huy; Rosenberg, Jarrett; Wintermark, Max; Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Rezaii, Paymon; Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Lopez, Jaime] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Thaler, Christian; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Mitchell, Lex A.; Boldt, Brian] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Boldt, Brian] Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA; [Mitchell, Lex A.] Tripler Army Med Ctr, Dept Radiol, Honolulu, HI 96859 USA; [Xie, Long; Yushkevich, Paul A.] Univ Penn, Dept Radiol, PICSL, Philadelphia, PA 19104 USA		Zeineh, M (corresponding author), Lucas Ctr Imaging, Room P271,1201 Welch Rd, Stanford, CA 94305 USA.	mzeineh@stanford.edu		Goubran, Maged/0000-0001-5880-0818; Rezaii, Paymon/0000-0002-4803-0853	Radiology Society of North America; American Society for Neuroradiology; Center for Biological Imaging at Stanford; General Electric HealthcareGeneral ElectricGE Healthcare; German Research Foundation (DFG)German Research Foundation (DFG) [TH 2235/1-1]; Pac-12 Conference's Student-Athlete Health and Well-Being Initiative	This research was conducted with funding from the Radiology Society of North America and American Society for Neuroradiology, the Center for Biological Imaging at Stanford, and General Electric Healthcare. Christian Thaler received individual research funding by the German Research Foundation (DFG; reference no.: TH 2235/1-1). This publication was also supported, in part, by the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the Pac-12 Conference or its members.	Adamowicz DH, 2017, J NEUROSCI, V37, P1675, DOI 10.1523/JNEUROSCI.3047-16.2016; Aggleton J. P., 1999, BEHAV BRAIN SCI, V22, P444, DOI DOI 10.1017/S0140525X99422034; Ali R, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15326; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Carr VA, 2010, J COGNITIVE NEUROSCI, V22, P2652, DOI 10.1162/jocn.2009.21381; Contijoch F, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0146-9; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goubran M, 2016, HUM BRAIN MAPP, V37, P1103, DOI 10.1002/hbm.23090; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hrybouski S, 2019, NEUROIMAGE, V191, P568, DOI 10.1016/j.neuroimage.2019.01.061; Insausti R, 2012, BT HUMAN NERVOUS SYS, P896, DOI [10.1016/B978-0-12-374236-0.10024-0, DOI 10.1016/B978-0-12-374236-0.10024-0, 10.1016/B978-0-12-374245-2.00020-6]; Kondo H, 2008, J COMP NEUROL, V511, P497, DOI 10.1002/cne.21825; Kondo H, 2009, J COMP NEUROL, V515, P349, DOI 10.1002/cne.22056; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Lim C, 1997, J COMP NEUROL, V385, P352; Lim C, 1997, J COMP NEUROL, V385, P325, DOI 10.1002/(SICI)1096-9861(19970901)385:3<325::AID-CNE1>3.0.CO;2-5; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Parekh MB, 2015, NEUROIMAGE, V112, P1, DOI 10.1016/j.neuroimage.2015.02.029; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rosene D.L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; ROSENE DL, 1977, SCIENCE, V198, P315, DOI 10.1126/science.410102; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Santyr BG, 2017, J MAGN RESON IMAGING, V45, P1359, DOI 10.1002/jmri.25447; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; Saunders RC, 2007, HIPPOCAMPUS, V17, P396, DOI 10.1002/hipo.20276; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stevenson RF, 2018, P NATL ACAD SCI USA, V115, P10148, DOI 10.1073/pnas.1805724115; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsai MH, 2016, EPILEPSIA, V57, P1719, DOI 10.1111/epi.13505; Viskontas IV, 2009, HIPPOCAMPUS, V19, P265, DOI 10.1002/hipo.20503; Wilson DI, 2013, HIPPOCAMPUS, V23, P352, DOI 10.1002/hipo.22095; Wisse LEM, 2017, HIPPOCAMPUS, V27, P3, DOI 10.1002/hipo.22671; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Zeidman P, 2016, NAT REV NEUROSCI, V17, P173, DOI 10.1038/nrn.2015.24; Zeineh MM, 2017, CEREB CORTEX, V27, P1779, DOI 10.1093/cercor/bhw010; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	67	11	11	3	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2762	2773		10.1089/neu.2018.6357		JUN 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000472105100001	31044639	Green Published			2022-02-06	
J	Pandya, JD; Leung, LY; Yang, XF; Flerlage, WJ; Gilsdorf, JS; Deng-Bryant, Y; Shear, DA				Pandya, Jignesh D.; Leung, Lai Yee; Yang, Xiaofang; Flerlage, William J.; Gilsdorf, Janice S.; Deng-Bryant, Ying; Shear, Deborah A.			Comprehensive Profile of Acute Mitochondrial Dysfunction in a Preclinical Model of Severe Penetrating TBI	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury (TBI); penetrating ballistic-like brain injury (PBBI); alternative biofuels; brain energy metabolism; energy crisis; mitochondria preferred substrates; dehydrogenase activities; therapeutics	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; NICOTINAMIDE TREATMENT; CORTICAL CONTUSION; GLUCOSE-METABOLISM; RAT MODEL; PERMEABILITY TRANSITION; ANTIOXIDANT THERAPIES; OXIDATIVE DAMAGE; BIOENERGETICS	Mitochondria constitute a central role in brain energy metabolism, and play a pivotal role in the development of secondary pathophysiology and subsequent neuronal cell death following traumatic brain injury (TBI). Under normal circumstances, the brain consumes glucose as the preferred energy source for adenosine triphosphate (ATP) production over ketones. To understand the comprehensive picture of substrate-specific mitochondrial bioenergetics responses following TBI, adult male rats were subjected to either 10% unilateral penetrating ballistic-like brain injury (PBBI) or sham craniectomy (n = 5 animals per group). At 24 h post-injury, mitochondria were isolated from pooled brain regions (frontal cortex and striatum) of the ipsilateral hemisphere. Mitochondrial bioenergetics parameters were measured ex vivo in the presence of four sets of metabolic substrates: pyruvated-malate (PM), glutamate+malate (GM), succinate (Succ), and beta-hydroxybutyrate+malate (BHBM). Additionally, mitochondrial matrix dehydrogenase activities [i.e., pyruvate dehydrogenase complex (PDHC), alpha-ketoglutarate dehydrogenase complex (alpha-KGDHC), and glutamate dehydrogenase (GDH)] and mitochondrial membrane-bound dehydrogenase activities [i.e., electron transport chain (ETC) Complex I, II, and IV] were compared between PBBI and sham groups. Furthermore, mitochondrial coenzyme contents, including NAD((t)) and FAD((t)), were quantitatively measured in both groups. Collectively, PBBI led to an overall significant decline in the ATP synthesis rates (43-50%; *p < 0.05 vs. sham) when measured using each of the four sets of substrates. The PDHC and GDH activities were significantly reduced in the PBBI group (42-53%; *p < 0.05 vs. sham), whereas no significant differences were noted in alpha-KGDHC activity between groups. Both Complex I and Complex IV activities were significantly reduced following PBBI (47-81%; *p < 0.05 vs. sham), whereas, Complex II activity was comparable between groups. The NAD((t)) and FAD((t)) contents were significantly decreased in the PBBI group (27-35%; *p < 0.05 vs. sham). The decreased ATP synthesis rates may be due to the significant reductions in brain mitochondrial dehydrogenase activities and coenzyme contents observed acutely following PBBI. These results provide a basis for the use of "alternative biofuels" for achieving higher ATP production following severe penetrating brain trauma.	[Pandya, Jignesh D.; Leung, Lai Yee; Yang, Xiaofang; Flerlage, William J.; Gilsdorf, Janice S.; Deng-Bryant, Ying; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Pandya, JD (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA.	jignesh.d.pandya.civ@mail.mil			US Army Combat Casualty Care Research Program [H_026_2014_WRAIR, H_001_2018_WRAIR]	Material has been reviewed by WRAIR. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official, or as reflecting true views of the Department of the Army of the Department of Defense. Support: US Army Combat Casualty Care Research Program H_026_2014_WRAIR and H_001_2018_WRAIR.	Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Aygok GA, 2008, ACTA NEUROCHIR SUPPL, V102, P57, DOI 10.1007/978-3-211-85578-2_12; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Berg J.M, 2002, BIOCHEMISTRY-US; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2016, J NEUROTRAUM, V33, pA54; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1289, DOI 10.1016/j.bbabio.2009.07.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; IOM. (Institute of Medicine), 2011, NUTR TRAUM BRAIN INJ; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Leung LY, 2016, J TRAUMA ACUTE CARE, V81, P860, DOI 10.1097/TA.0000000000001206; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yanagawa T, 2002, COCHRANE DB SYST REV, V3, DOI 10.1002/14651858.CD001530; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	68	11	11	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 11	2019	10								605	10.3389/fneur.2019.00605			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC8TV	WOS:000471255700002	31244764	gold, Green Published			2022-02-06	
J	Baucher, G; Troude, L; Pauly, V; Bernard, F; Zieleskiewicz, L; Roche, PH				Baucher, Guillaume; Troude, Lucas; Pauly, Vanessa; Bernard, Florian; Zieleskiewicz, Laurent; Roche, Pierre-Hugues			Predictive Factors of Poor Prognosis After Surgical Management of Traumatic Acute Subdural Hematomas: A Single-Center Series	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Craniectomy; Polytrauma; Traumatic brain injury	SEVERE HEAD-INJURY; BRAIN-INJURY; ELDERLY-PATIENTS; MIDLINE SHIFT; CT-SCAN; MORTALITY; CRANIOTOMY; CRANIECTOMY; EVACUATION; SURVIVAL	BACKGROUND: Traumatic acute subdural hematomas (ASDHs) showed the highest mortality of intracranial hematomas. The aim of the current study was to identify predictive factors of poor prognosis among patients who were operated on. METHODS: This is a single-center retrospective cohort study of 82 patients who underwent surgical evacuation of a traumatic ASDH between January 2009 and December 2016. The epidemiologic, clinical, radiologic, and surgical features were recorded. Postoperative outcome were assessed by the Glasgow Outcome Scale (GOS) score at 6 months. Univariate and multivariate analysis and a classification and regression tree (CART) were performed. RESULTS: At 6 months, 76% of patients achieved an unfavorable outcome (GOS score 1-3). The context of polytrauma (P = 0.03) and ASDH thickness >= 20 mm (P = 0.02) were significantly associated with poor outcome in the multivariate analysis. The CART algorithm isolated 3 subgroups of patients with an unfavorable prognosis: polytrauma (91%), isolated head injury (HI) featuring an ASDH thickness >= 20 mm (89%), or isolated HI featuring a thickness < 20 mm in a patient older than 54 years (71%). Isolated patients with HI younger than 54 years harboring an ASDH < 20 mm thick had the most promising results, with 53% with a GOS score of 4 or 5. CONCLUSIONS: The context of polytrauma, ASDH thickness, and age were major predictive factors of poor prognosis in patients with surgically evacuated traumatic ASDH. The CART algorithm using these features isolated subgroups with decreasingly unfavorable outcome, providing a relevant statistical tool to apply to future studies of traumatic ASDH.	[Baucher, Guillaume; Troude, Lucas; Roche, Pierre-Hugues] Aix Marseille Univ, Dept Neurosurg, La Timone Med Campus, Marseille, France; [Zieleskiewicz, Laurent] Aix Marseille Univ, Dept Anesthesiol & Crit Care, North Univ Hosp, AP HM, La Timone Med Campus, Marseille, France; [Pauly, Vanessa] Aix Marseille Univ, La Concept Hosp, Dept Publ Hlth, La Timone Med Campus, Marseille, France; [Pauly, Vanessa] Aix Marseille Univ, Qual Life Ctr, CEReSS, La Timone Med Campus, Marseille, France; [Pauly, Vanessa] Aix Marseille Univ, Hlth Serv Res, CEReSS, La Timone Med Campus, Marseille, France; [Bernard, Florian] Univ Angers, Dept Neurosurg, CHU Angers, Angers, France		Baucher, G (corresponding author), Aix Marseille Univ, Dept Neurosurg, La Timone Med Campus, Marseille, France.	guillaume.baucner@ap-hm.fr	Bernard, Florian/AAC-9896-2022	Bernard, Florian/0000-0002-6110-2567; /0000-0003-4023-1463			Arifin MZ, 2013, J NEUROSURG SCI, V57, P277; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bhatia S., 2016, ARCH EMERG MED CRIT, V1, P1010; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2006, NEUROSURGERY, V58, psi; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Evans JA, 2015, INJURY, V46, P76, DOI 10.1016/j.injury.2014.07.009; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hu C, 2018, J BIOPHARM STAT, V28, P333, DOI 10.1080/10543406.2017.1377730; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kakarieka A, 1995, Neurologia, V10, P159; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kato-Negishi M, 2013, PROC IEEE MICR ELECT, P130, DOI 10.1109/MEMSYS.2013.6474194; Kim J, 2013, J CLIN NEUROSCI, V20, P1697, DOI 10.1016/j.jocn.2013.02.021; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Kwon H, 2017, J KOREAN NEUROSURG S, V60, P723, DOI 10.3340/jkns.2017.0506.011; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; LONG DM, 1985, NEUROSURGERY, V17, P348, DOI 10.1227/00006123-198508000-00022; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MAY BR, 1974, BRIT J RADIOL, V47, P742, DOI 10.1259/0007-1285-47-563-742; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moussa WMM, 2018, NEUROSURG REV, V41, P483, DOI 10.1007/s10143-017-0873-5; Okten Ali Ihsan, 2006, Ulus Travma Acil Cerrahi Derg, V12, P107; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Pilitsis J, 2013, CLIN NEUROL NEUROSUR, V115, P1429, DOI 10.1016/j.clineuro.2013.01.017; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111420; REILLY PL, 1975, LANCET, V2, P375; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P43; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Vyas NA, 2007, SURG NEUROL, V67, P314, DOI 10.1016/j.surneu.2006.03.039; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	72	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E944	E952		10.1016/j.wneu.2019.02.194			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400118	30876998				2022-02-06	
J	Dong, HL; Qin, YY; Huang, YY; Ji, DL; Wu, F				Dong, Hongli; Qin, Yuanyuan; Huang, Yuyu; Ji, Dongliang; Wu, Feng			Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease	NEUROCHEMISTRY INTERNATIONAL			English	Article						Poloxamer 188; Parkinson's disease; Ruptured lysosome; Autophagic flux impairment	SURFACTANT POLOXAMER-188; AUTOPHAGY; AGGREGATION; DAMAGE	Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). Rupture of lysosome is a major cellular stress condition leading to cell death in PD. We have previously shown that environmental oxidative toxins could impair autophagic flux and lysosomal functions in PD. Poloxamer 188 (P188) is an amphipathic polymer which has cytoprotective effect in traumatic brain injury and stroke. But whether DyrklA could rescue lysosome malfunction-mediated DA neuron death and alpha-synuclein aggregation in PD is still unknown. In the present study, MPTP mice models and MPP+-treated SH-SY5Y cells were used for study, and we found that P188 rescued MPP4(+)-induced lysosomal dysfunction and impaired autophagy flux in mild MPP+-treated SH-SY5Y cells. P188 administration significantly restored lysosomal membrane integrity and prevented cathepsins leakage from the lysosomes into the cytoplasm, which triggered caspase-dependent apoptotic cell death in sub-acute MPTP mouse model and MPP+-treated SH-SY5Y cells. Furthermore, P188 ameliorated alpha-synuclein accumulation and behavioral impairment in chronic MPTP mouse model with MPTP and probenecid treatment. P188 could alleviate MPTP-induced DA neurons damage by restoring lysosome function.	[Ji, Dongliang; Wu, Feng] Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China; [Dong, Hongli] Nanjing Univ Chinese Med, Hosp Suzhou, Suzhou Hosp Tradit Chinese Med, Encephalopathy Dept, 18 Yangsu Rd, Suzhou 215009, Peoples R China; [Qin, Yuanyuan; Huang, Yuyu] Nanjing Univ Chinese Med, Hosp Suzhou, Suzhou Hosp Tradit Chinese Med, Dept Pharm, 18 Yangsu Rd, Suzhou 215009, Peoples R China		Wu, F (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	wf619@ntu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300893]; Jiangsu Province's Key Provincial Young Talents Program [QNRC2016261]; Research Program of Suzhou [SYS2018095]	This study was supported by funds from the Natural Science Foundation of China (No. 31300893); the Jiangsu Province's Key Provincial Young Talents Program (No. QNRC2016261); the Research Program of Suzhou (No. SYS2018095).	Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Ferguson SA, 2015, BEHAV BRAIN RES, V292, P68, DOI 10.1016/j.bbr.2015.05.057; Fernandez B, 2016, AUTOPHAGY, V12, P1487, DOI 10.1080/15548627.2016.1190072; Gomez-Sintes R, 2016, AGEING RES REV, V32, P150, DOI 10.1016/j.arr.2016.02.009; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; He Q, 2016, MOL NEUROBIOL, V53, P2258, DOI 10.1007/s12035-015-9173-7; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Klaver AC, 2018, BRAIN RES, V1683, P12, DOI 10.1016/j.brainres.2018.01.016; Kotake Y, 2003, CURR MED CHEM, V10, P2507, DOI 10.2174/0929867033456558; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee HJ, 2018, CELL DEATH DIS, V9; Lee YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.260; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Miyara M, 2016, J NEUROCHEM, V139, P294, DOI 10.1111/jnc.13700; Papadopoulos C, 2017, CURR BIOL, V27, pR1330, DOI 10.1016/j.cub.2017.11.012; Pujols J, 2018, P NATL ACAD SCI USA, V115, P10481, DOI 10.1073/pnas.1804198115; Quinn M, 2008, EUR J NEUROSCI, V27, P43, DOI 10.1111/j.1460-9568.2007.05991.x; Radulovic M, 2018, EMBO J, V37, DOI 10.15252/embj.201899753; Ravi PR, 2015, DRUG DELIV, V22, P903, DOI 10.3109/10717544.2013.860501; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Rukmangathen Rajalakshmi, 2019, Current Drug Discovery Technologies, V16, P417, DOI 10.2174/1570163815666180418144019; Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292; Sakamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46668; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; Tanji K, 2015, BIOCHEM BIOPH RES CO, V465, P746, DOI 10.1016/j.bbrc.2015.08.076; Tanji K, 2011, NEUROBIOL DIS, V43, P690, DOI 10.1016/j.nbd.2011.05.022; Wan WB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00001; Wang RX, 2019, J CELL BIOL, V218, P267, DOI 10.1083/jcb.201804165; Wu F, 2015, NEUROSCIENCE, V284, P900, DOI 10.1016/j.neuroscience.2014.11.004; Yildirim T, 2015, INT J NEUROSCI, V125, P941, DOI 10.3109/00207454.2014.979289; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; 2008, INT J TOXICOL SUPPL, V27, P93; 2017, EMBO J, V36, P135; 1997, NEUROSCIENCE, V77, P1037	46	11	12	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2019	126						178	186		10.1016/j.neuint.2019.03.013			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HW6VU	WOS:000466829600018	30904670				2022-02-06	
J	Fucich, EA; Mayeux, JP; McGinn, MA; Gilpin, NW; Edwards, S; Molina, PE				Fucich, Elizabeth A.; Mayeux, Jacques P.; McGinn, M. Adrienne; Gilpin, Nicholas W.; Edwards, Scott; Molina, Patricia E.			A Novel Role for the Endocannabinoid System in Ameliorating Motivation for Alcohol Drinking and Negative Behavioral Affect after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						alcohol motivation; anxiety; central amygdala; glucocorticoid receptor; JZL184	PSYCHIATRIC-DISORDERS; CHRONIC PAIN; AXIS-I; ANXIETY; NEUROINFLAMMATION; AMYGDALA; ACTIVATION; DEPENDENCE; SEEKING; PERFORMANCE	Traumatic brain injury (TBI) is associated with psychiatric dysfunction-including pain, cognitive impairment, anxiety, and increased alcohol use. We previously demonstrated that inhibiting endocannabinoid degradation post-TBI with JZL184 attenuates neuroinflammation and neuronal hyperexcitability at the site of injury and improves neurobehavioral recovery. This study aimed to determine the effect of JZL184 on post-TBI behavioral changes related to psychiatric dysfunction and post-TBI neuroadaptations in brain regions associated with these behaviors. We hypothesized that JZL184 would attenuate post-TBI behavioral and neural changes in alcohol-drinking rats. Adult male Wistar rats were trained to operantly self-administer alcohol before receiving lateral fluid percussion injury. Thirty minutes post-TBI, rats received JZL184 (16 mg/kg, i.p.) or vehicle. Spatial memory (Y-maze), anxiety-like behavior (open field), alcohol motivation (progressive ratio responding), and mechanosensitivity (Von Frey) were measured 3-10 days post-injury, and ventral striatum (VS) and central amygdala (CeA) tissue were collected for western blot analysis of phosphorylated glutamate receptor subunit 1 (GluR1) and glucocorticoid receptor (GR). TBI impaired spatial memory, increased anxiety-like behavior, and increased motivated alcohol drinking. JZL184 prevented these changes. TBI also increased phosphorylated GluR1 and GR in the CeA (but not the VS) compared with sham controls. JZL184 attenuated post-TBI GR phosphorylation in the CeA. These findings suggest that TBI produces comorbid cognitive dysfunction, increased alcohol motivation, and anxiety-like behavior, possibly related to amygdala dysfunction, and these changes are prevented by systemic post-TBI endocannabinoid degradation inhibition. Thus, boosting endocannabinoid tone post-TBI may represent a viable therapeutic strategy for TBI-related psychiatric comorbidities such as alcohol use disorder and anxiety.	[Fucich, Elizabeth A.; Mayeux, Jacques P.; McGinn, M. Adrienne; Gilpin, Nicholas W.; Edwards, Scott; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Fucich, Elizabeth A.; Mayeux, Jacques P.; McGinn, M. Adrienne; Gilpin, Nicholas W.; Edwards, Scott; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, New Orleans, LA 70112 USA		Molina, PE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, 1901 Perdido St,Room 7212, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021; Gilpin, Nicholas/V-1266-2019	Molina, Patricia E./0000-0002-3598-384X; McGinn, M. Adrienne/0000-0002-7728-174X	NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA007577, F31 AA025812-01A1, R00AA020839]; DODUnited States Department of Defense [W81XWH-11-2-0011]; LSUHSC-NO Department of Physiology; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA026779, R01AA025792] Funding Source: NIH RePORTER	Support for this study was provided by NIAAA training grant T32 AA007577, NIAAA fellowship award F31 AA025812-01A1, NIAAA research grant R00AA020839, DODgrantW81XWH-11-2-0011, and funds from the LSUHSC-NO Department of Physiology.	Adamczyk P, 2009, J PHYSIOL PHARMACOL, V60, P119; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DEPOORTERE RY, 1993, PHARMACOL BIOCHEM BE, V45, P539, DOI 10.1016/0091-3057(93)90503-L; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Edwards S, 2012, NEUROPHARMACOLOGY, V62, P1142, DOI 10.1016/j.neuropharm.2011.11.006; Egli M, 2012, NEUROSCI BIOBEHAV R, V36, P2179, DOI 10.1016/j.neubiorev.2012.07.010; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Forget B, 2009, PSYCHOPHARMACOLOGY, V205, P613, DOI 10.1007/s00213-009-1569-5; Fox LC, 2016, BEHAV BRAIN RES, V312, P362, DOI 10.1016/j.bbr.2016.06.048; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hall KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hasanein P, 2007, CLIN EXP PHARMACOL P, V34, P439, DOI 10.1111/j.1440-1681.2007.04592.x; He J, 2009, ALCOHOL CLIN EXP RES, V33, P129, DOI 10.1111/j.1530-0277.2008.00823.x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HOFFMEISTER F, 1979, PSYCHOPHARMACOLOGY, V62, P181, DOI 10.1007/BF00427134; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Kamprath K, 2011, NEUROPSYCHOPHARMACOL, V36, P652, DOI 10.1038/npp.2010.196; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kim CH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4200; Klein RC, 2016, J NEUROSCI RES, V94, P579, DOI 10.1002/jnr.23702; Kodirov SA, 2010, LEARN MEMORY, V17, P832, DOI 10.1101/lm.1663410; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kushner MG, 1999, AM J PSYCHIAT, V156, P723; Lawton J, 2009, PSYCHOL HEALTH MED, V14, P487, DOI 10.1080/13548500902923177; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McGinn MA, 2016, ALCOHOL CLIN EXP RES, V40, P2537, DOI 10.1111/acer.13258; McIntosh TK, 1996, LAB INVEST, V74, P315; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MELLO NK, 1988, DRUG ALCOHOL DEPEN, V21, P81, DOI 10.1016/0376-8716(88)90053-1; Moller C, 1997, ALCOHOL CLIN EXP RES, V21, P656, DOI 10.1111/j.1530-0277.1997.tb03818.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Prendergast MA, 2012, ADDICT BIOL, V17, P209, DOI 10.1111/j.1369-1600.2011.00375.x; Primeaux SD, 2006, ALCOHOL CLIN EXP RES, V30, P791, DOI 10.1111/j.1530-0277.2006.00092.x; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rahimi A, 2015, FUND CLIN PHARMACOL, V29, P185, DOI 10.1111/fcp.12099; Recinto P, 2012, NEUROPSYCHOPHARMACOL, V37, P1275, DOI 10.1038/npp.2011.315; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Ririe DG, 2006, ANESTHESIOLOGY, V104, P344, DOI 10.1097/00000542-200602000-00021; Roltsch EA, 2014, NEUROPHARMACOLOGY, V79, P83, DOI 10.1016/j.neuropharm.2013.11.005; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; Spanagel R, 1995, PSYCHOPHARMACOLOGY, V122, P369, DOI 10.1007/BF02246268; STEWART RB, 1993, ALCOHOL, V10, P1, DOI 10.1016/0741-8329(93)90046-Q; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Vendruscolo LF, 2015, J CLIN INVEST, V125, P3193, DOI 10.1172/JCI79828; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITE N, 1921, ADDICTION, V91, P921; Xu JY, 2015, NEUROSCIENTIST, V21, P152, DOI 10.1177/1073858414524632; Zarrindast MR, 2008, BEHAV PHARMACOL, V19, P716, DOI 10.1097/FBP.0b013e3283123c83	71	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1847	1855		10.1089/neu.2018.5854			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600015	30638118	Green Published			2022-02-06	
J	Harper, MM; Hedberg-Buenz, A; Herlein, J; Abrahamson, EE; Anderson, MG; Kuehn, MH; Kardon, RH; Poolman, P; Ikonomovic, MD				Harper, Matthew M.; Hedberg-Buenz, Adam; Herlein, Judith; Abrahamson, Eric E.; Anderson, Michael G.; Kuehn, Markus H.; Kardon, Randy H.; Poolman, Pieter; Ikonomovic, Milos D.			Blast-Mediated Traumatic Brain Injury Exacerbates Retinal Damage and Amyloidosis in the APPswePSENd19e Mouse Model of Alzheimer's Disease	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						amyloid; chronic; vision; brain injury; transgenic mice	EXPERIMENTAL RODENT MODEL; GANGLION-CELL DAMAGE; PRECURSOR PROTEIN; VISUAL DYSFUNCTION; BETA ACCUMULATION; TRANSGENIC MICE; IN-VIVO; IMPAIRMENT; PATHOLOGY; EXPOSURE	PURPOSE. Traumatic brain injury (TBI) is a risk factor for developing chronic neurodegenerative conditions including Alzheimer's disease (AD). The purpose of this study was to examine chronic effects of blast TBI on retinal ganglion cells (RGC), optic nerve, and brain amyloid load in a mouse model of AD amyloidosis. METHODS. Transgenic (TG) double-mutant APPswePSENd19e (APP/PS1) mice and non-transgenic (Non-TG) littermates were exposed to a single blast TBI (20 psi) at age 2 to 3 months. RGC cell structure and function was evaluated 2 months later (average age at endpoint = 4.5 months) using pattern electroretinogram (PERG), optical coherence tomography (OCT), and the chromatic pupil light reflex (cPLR), followed by histologic analysis of retina, optic nerve, and brain amyloid pathology. RESULTS. APP/PS1 mice exposed to blast TBI (TG-Blast) had significantly lower PERG and cPLR responses 2 months after injury compared to preblast values and compared to sham groups of APP/PS1 (TG-Sham) and nontransgenic (Non-TG-Sham) mice as well as nontransgenic blast-exposed mice (Non-TG-Blast). The TG-Blast group also had significantly thinner RGC complex and more optic nerve damage compared to all groups. No amyloid-beta (A beta) deposits were detected in retinas of APP/PS1 mice; however, increased amyloid precursor protein (APP)/A beta-immunoreactivity was seen in TG-Blast compared to TG-Sham mice, particularly near blood vessels. TG-Blast and TG-Sham groups exhibited high variability in pathology severity, with a strong, but not statistically significant, trend for greater cerebral cortical Ab plaque load in the TG-Blast compared to TG-Sham group. CONCLUSIONS. When combined with a genetic susceptibility for developing amyloidosis of AD, blast TBI exposure leads to earlier RGC and optic nerve damage associated with modest but detectable increase in cerebral cortical Ab pathology. These findings suggest that genetic risk factors for AD may increase the sensitivity of the retina to blast-mediated damage.	[Harper, Matthew M.; Anderson, Michael G.; Kuehn, Markus H.; Kardon, Randy H.; Poolman, Pieter] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Harper, Matthew M.; Hedberg-Buenz, Adam; Herlein, Judith; Anderson, Michael G.; Kuehn, Markus H.; Kardon, Randy H.; Poolman, Pieter] Iowa City VA Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Hedberg-Buenz, Adam; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] Pittsburgh VA Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA		Harper, MM (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, VA Ctr Prevent & Treatment Visual Loss, 601 Highway 6 West, Iowa City, IA 52772 USA.	matthew-harper@uiowa.edu	; Anderson, Michael/B-4580-2009	Harper, Matthew/0000-0003-3395-2406; Kardon, Randy/0000-0002-3173-7123; Anderson, Michael/0000-0001-5730-6105; Kuehn, Markus/0000-0003-3940-198X	Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; Iowa City Center for the Prevention and Treatment of Visual Loss; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583];  [T32DK112751-01]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY029609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK112751] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002860, I01RX001481, I50RX003002] Funding Source: NIH RePORTER	Supported by Department of Veterans Affairs Grant RX000952 (MDI, MMH), Department of Defense Grant W81XWH-14-1-0583 (MMH), a T32 training grant (T32DK112751-01) (AHB), and the Iowa City Center for the Prevention and Treatment of Visual Loss (MMH).	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Buchman AS, 2011, EXPERT REV NEUROTHER, V11, P665, DOI [10.1586/ern.11.57, 10.1586/ERN.11.57]; Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P2469, DOI 10.1167/iovs.14-13943; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cohen AD, 2009, LETT DRUG DES DISCOV, V6, P437, DOI 10.2174/157018009789057526; Criscuolo C, 2018, NEUROBIOL AGING, V67, P181, DOI 10.1016/j.neurobiolaging.2018.03.017; Cunha JP, 2017, GRAEF ARCH CLIN EXP, V255, P1827, DOI 10.1007/s00417-017-3715-9; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; den Haan Jurre, 2018, Alzheimers Dement (Amst), V10, P49, DOI 10.1016/j.dadm.2017.10.005; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fishman CE, 2001, J NEUROSCI METH, V108, P145, DOI 10.1016/S0165-0270(01)00381-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Golzan SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0239-9; Gupta VK, 2016, NEUROSCI LETT, V623, P52, DOI 10.1016/j.neulet.2016.04.059; Harper MM, 2014, INVEST OPHTH VIS SCI, V55, P1350, DOI 10.1167/iovs.13-13692; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ikonomovic MD, 2006, METHOD ENZYMOL, V412, P123, DOI 10.1016/S0076-6879(06)12009-1; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Koronyo Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93621; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Krantic S, 2014, J ALZHEIMERS DIS, V40, P237, DOI 10.3233/JAD-132105; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lad EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192646; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; MENDEZ MF, 1990, NEUROLOGY, V40, P439, DOI 10.1212/WNL.40.3_Part_1.439; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohan K, 2012, VET OPHTHALMOL, V15, P94, DOI 10.1111/j.1463-5224.2012.01034.x; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; O'Bryhim BE, 2018, JAMA OPHTHALMOL, V136, P1242, DOI 10.1001/jamaophthalmol.2018.3556; Olafsdottir Olof Birna, 2018, Alzheimers Dement (Amst), V10, P340, DOI 10.1016/j.dadm.2018.03.002; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Polo V, 2017, EYE, V31, P1034, DOI 10.1038/eye.2017.23; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Risacher SL, 2013, NEUROBIOL AGING, V34, P1133, DOI 10.1016/j.neurobiolaging.2012.08.007; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shariflou S, 2017, CURR ALZHEIMER RES, V14, P1000, DOI 10.2174/1567205014666170329114445; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Shimazawa M, 2008, J NEUROCHEM, V107, P279, DOI 10.1111/j.1471-4159.2008.05606.x; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Verma SK, 2015, NMR BIOMED, V28, P1069, DOI 10.1002/nbm.3351; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016	67	11	11	0	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JUN	2019	60	7					2716	2725		10.1167/iovs.18-26353			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	IH9ZQ	WOS:000474865600007	31247112	Green Published, gold, Green Submitted			2022-02-06	
J	Parkin, GM; Clarke, C; Takagi, M; Hearps, S; Babl, FE; Davis, GA; Anderson, V; Ignjatovic, V				Parkin, Georgia M.; Clarke, Cathriona; Takagi, Michael; Hearps, Stephen; Babl, Franz E.; Davis, Gavin A.; Anderson, Vicki; Ignjatovic, Vera			Plasma Tumor Necrosis Factor Alpha Is a Predictor of Persisting Symptoms Post-Concussion in Children	JOURNAL OF NEUROTRAUMA			English	Article						blood biomarkers; concussion; mild traumatic brain injury; pediatric	TRAUMATIC BRAIN-INJURY; BIOMARKERS; SPORT; INTERLEUKIN-6; PHASE	Mild traumatic brain injury (mTBI)-associated blood proteomics have become an emerging focus in the past decade, with the U.S. Food and Drug Administration recently approving the use of a blood test to determine the necessity of a computed tomography scan after adult mTBI. We now also know that the blood proteome of children is different from that of adults, and new evidence suggests that children may take longer to recover from an mTBI. Despite this, comparatively fewer studies have analyzed changes in blood protein expression after pediatric mTBI. Concussions, an mTBI subset, often go underreported, despite the potential for post-concussive symptoms to last more than one month in up to 30% of children. In the current study, we used a multiplex immunoassay to measure blood protein expression of Apolipoprotein, enolase 2, glial fibrillary acidic protein, interleukin (IL)-1B, IL-6, IL-8, IL-10, S100 calcium-binding protein B, tau and tumor necrosis factor alpha (TNF alpha) at admission, one to four days, two weeks, and three months post-pediatric concussion, comparing patients with normal recovery (n = 9) with those with persisting symptoms (n = 9). We identified significant differences in IL-6 (p < 0.001) and tau (p = 0.048) protein expression across time post-injury irrespective of clinical outcome and in IL-8 protein expression (p = 0.041) across time post-injury specific to children with persisting symptoms. Significantly, we have identified an increase in TNF alpha protein expression at one to four days post-injury (p = 0.031) in children with persisting symptoms compared with normal recovery. To our knowledge, this is the first study to identify TNF alpha as a potential blood biomarker for persisting symptoms post-pediatric concussion.	[Parkin, Georgia M.; Clarke, Cathriona; Takagi, Michael; Hearps, Stephen; Babl, Franz E.; Davis, Gavin A.; Anderson, Vicki; Ignjatovic, Vera] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Takagi, Michael; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Ignjatovic, Vera] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Ignjatovic, Vera/0000-0002-5548-5813; Hearps, Stephen/0000-0003-2984-1172; Takagi, Michael/0000-0003-2903-7598; Parkin, Georgia/0000-0002-0588-2239	Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)Australian GovernmentDepartment of Industry, Innovation and Science; Victorian Government's Operational Infrastructure Support Program	Aspects of this research have been facilitated by access to the Australian Proteome Analysis Facility supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS). This study was supported by the Victorian Government's Operational Infrastructure Support Program.	BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bjelosevic S, 2017, MOL CELL PROTEOMICS, V16, P924, DOI 10.1074/mcp.M116.066720; Breen EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26996; Breen EJ, 2015, CYTOKINE, V71, P188, DOI 10.1016/j.cyto.2014.10.030; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Lugones M, 2018, NEUROSCI BIOBEHAV R, V87, P206, DOI 10.1016/j.neubiorev.2018.02.006; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Takagi M., 2018, BMJ OPEN; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	30	11	11	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1768	1775		10.1089/neu.2018.6042			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600007	30569819				2022-02-06	
J	Garcia, GGP; Lavieri, MS; Jiang, RW; McAllister, TW; McCrea, MA; Broglio, SP				Garcia, Gian-Gabriel P.; Lavieri, Mariel S.; Jiang, Ruiwei; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.		Concussion Assessment Res Educ Con	A Data-Driven Approach to Unlikely, Possible, Probable, and Definite Acute Concussion Assessment	JOURNAL OF NEUROTRAUMA			English	Article						acute concussion assessment; possible; probable; and definite concussion; risk stratification	SPORT-RELATED CONCUSSION; MOTOR SCREENING VOMS; POSTURAL STABILITY; HIGH-SCHOOL; SEX-DIFFERENCES; NEUROCOGNITIVE IMPAIRMENT; SIDELINE CONCUSSION; FOOTBALL PLAYERS; RECOVERY-TIME; RELIABILITY	Kutcher and Giza suggested incorporating levels of certainty in concussion diagnosis decisions. These guidelines were based on clinical experience rather than objective data. Therefore, we combined data-driven optimization with predictive modeling to identify which athletes are unlikely to have concussion and to classify remaining athletes as having possible, probable, or definite concussion with diagnostic certainty. We developed and validated our framework using data from the Concussion Assessment, Research, and Education (CARE) Consortium. Acute concussions had assessments at <6 h (n = 1085) and 24-48 h post-injury (n = 1413). Normal performances consisted of assessments at baseline (n = 1635) and the time of unrestricted return to play (n = 1345). We evaluated the distribution of acute concussions and normal performances across risk categories and identified inter-class and intra-class differences in demographics, time-of-injury characteristics, the Standard Assessment of Concussion (SAC), Sport Concussion Assessment Tool (SCAT) symptom assessments, and Balance Error Scoring System (BESS). Our algorithm accurately classified concussions as probable or definite (sensitivity = 91.07-97.40%). Definite and probable concussions had higher SCAT symptom scores than unlikely and possible concussions (p < 0.05). Definite concussions had lower SAC and higher BESS scores (p < 0.05). Baseline to post-injury change scores for the SAC, SCAT symptoms, and BESS were significantly different between acute possible and probable concussions and normal performances (p < 0.05). There were no consistent patterns in demographics across risk categories, although a greater proportion of concussions classified as unlikely were reported immediately compared with definite concussions (p < 0.05). Although clinical interpretation is still needed, our data-driven approach to concussion risk stratification provides a promising step toward evidence-based concussion assessment.	[Garcia, Gian-Gabriel P.; Lavieri, Mariel S.; Jiang, Ruiwei] Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Garcia, GGP (corresponding author), Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA.	garciagg@umich.edu		Garcia, Gian-Gabriel/0000-0001-9315-0195; Clugston, James/0000-0002-2103-1039	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 1256260]; Grand Alliance CARE Consortium; NCAA; Department of Defense (DoD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Department of Defense (DoD) (Defense Health Program [DHP] funds)	The material is based on work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1256260. This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded, in part, by the NCAA and the Department of Defense (DoD). The United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (DoD) (Defense Health Program [DHP] funds). We thank April Marie (Reed) Hoy, MS, ATC (Azusa Pacific University), Joseph B. Hazzard Jr., EdD, ATC (Bloomsburg University), Louise A. Kelly, PhD (California Lutheran University), Justus D. Ortega, PhD (Humboldt State University), Nicholas Port, PhD (Indiana University), Margot Putukian, MD (Princeton University), Gerald McGinty, DPT and Jonathan C. Jackson, PhD (United States Air Force Academy), Kenneth L. Cameron, PhD, MPC, ATC (United States Military Academy), Christopher Giza, MD (University of California Los Angeles), Holly J. Benjamin, MD (University of Chicago), Thomas Buckley, EdD, ATC and Thomas W. Kaminski, PhD, ATC (University of Delaware), James R. Clugston, MD, MS (University of Florida), Julianne D. Schmidt, PhD, ATC (University of Georgia), Louis A. Feigenbaum, DPT, ATC (University of Miami), James T. Eckner, MD, MS (University of Michigan), Kevin M. Guskiewicz, PhD, ATC and Jason P. Mihalik, PhD, ATC (University of North Carolina), Jessica Dysart Miles, PhD, ATC (University of North Georgia), Scott Anderson, ATC (University of Oklahoma), Christina L. Master, MD (University of Pennsylvania), Anthony P. Kontos, PhD and Micky Collins, PhD (University of Pittsburgh), Sara P.D. Chrisman, MD, MPH (University of Washington), Alison Brooks, MD, MPH (University of Wisconsin), Steven Rowson, PhD (Virginia Tech), Christopher M. Miles, MD and Laura J. Lintner, DO (Wake Forest University), and Brian H. Dykhuizen, MS, ATC, LAT (Wilmington College).	[Anonymous], 2013, Br J Sports Med, V47, P259; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Breiman L., 1984, CLASSIFICATION REGRE; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2004, JAMA-J AM MED ASSOC, V290, P2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meehan SK, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00005; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Royston P, 2004, STATA J, V4, P224; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280	61	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1571	1583		10.1089/neu.2018.6098			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900009	30484375				2022-02-06	
J	Juengst, SB; Terhorst, L; Dicianno, BE; Niemeier, JP; Wagner, AK				Juengst, Shannon B.; Terhorst, Lauren; Dicianno, Brad E.; Niemeier, Janet P.; Wagner, Amy K.			Development and content validity of the behavioral assessment screening tool (BAST(beta))	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; measurement; psychometrics; behavior; emotions	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; CHALLENGING BEHAVIOR; SUICIDAL-BEHAVIOR; CLUSTER-ANALYSIS; SYMPTOMS; DEPRESSION; ADULTS; IMPULSIVITY; VETERANS	Purpose: Develop and establish the content validity of the Behavioral Assessment Screening Tool (BAST(beta)), a self-reported measure of behavioral and emotional symptoms after traumatic brain injury. Methods: This was an assessment development study, including two focus groups of individuals with traumatic brain injury (n = 11) and their family members (n = 10) and an expert panel evaluation of content validity by experts in traumatic brain injury rehabilitation (n = 7). We developed and assessed the Content Validity Index of the BAST(beta). Results: The BAST(beta) initial items (n = 77) corresponded with an established conceptual model of behavioral dysregulation after traumatic brain injury. After expert panel evaluation and focus group feedback, the final BAST(beta) included 66 items (60 primary, 6 branching logic) rated on a three-level ordinal scale (Never, Sometimes, Always) with reference to the past two weeks, and an Environmental Context checklist including recent major life events (n = 23) and four open-ended questions about environmental factors. The BAST(beta) had a high Content Validity Index of 89.3%. Conclusion: The BAST(beta) is a theoretically grounded, multidimensional self-reported assessment of behavioral dysregulation after traumatic brain injury, with good content validity. Future translation into mobile health modalities could improve effectiveness and efficiency of long-term symptom monitoring post-traumatic brain injury. Future work will establish and validate the factor structure, internal consistency reliabilities and other validities of the BAST.	[Juengst, Shannon B.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] Univ Texas Southwestern, Dept Rehabil Counseling, Dallas, TX USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA; [Terhorst, Lauren] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Dicianno, Brad E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Dicianno, Brad E.; Wagner, Amy K.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Niemeier, Janet P.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, SC USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd C56-202, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu	Dicanno, Brad/AAC-5918-2019; Juengst, Shannon B/AAC-5891-2019; Terhorst, Lauren/H-7942-2018	Dicanno, Brad/0000-0003-0738-0192; Juengst, Shannon B/0000-0003-4709-545X; 	University of Pittsburgh Medical Center Rehabilitation Institute Pilot Program(University of Pittsburgh) [01140]; National Institutes of Health Clinical Loan Repayment ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH L30NS089099]; Clinical and Translational Science Institute, University of Pittsburgh(University of Pittsburgh); Clinical and Translational Science Institute, University of Pittsburgh (NIH) [UL1-TR-001857]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001857] Funding Source: NIH RePORTER	This work was supported in part by the University of Pittsburgh Medical Center Rehabilitation Institute Pilot Program(University of Pittsburgh, 10.13039/100007921,#01140), National Institutes of Health Clinical Loan Repayment Program (NIH L30NS089099), and the Clinical and Translational Science Institute, University of Pittsburgh(University of Pittsburgh, 10.13039/100010554, NIH UL1-TR-001857).	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Armistead-Jehle P, 2018, ARCH CLIN NEUROPSYCH, V33, P120, DOI 10.1093/arclin/acx031; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brands IMH, 2014, PSYCHOL ASSESSMENT, V26, P848, DOI 10.1037/a0036275; Brenner LA, 2015, ARCH PHYS MED REHAB, V96, P1411, DOI 10.1016/j.apmr.2015.04.010; Bryan CJ, 2014, JAMA PSYCHIAT, V71, P95, DOI 10.1001/jamapsychiatry.2013.2991; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Monsalve BC, 2014, NEUROREHABILITATION, V35, P67, DOI 10.3233/NRE-141103; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Currier D, 2008, PSYCHIAT CLIN N AM, V31, P247, DOI 10.1016/j.psc.2008.01.005; Davis LL., 1992, APPL NURS RES, V5, P194, DOI DOI 10.1016/S0897-1897(05)80008-4; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Dombrovski AY, 2013, JAMA PSYCHIAT, V70, P1020, DOI 10.1001/jamapsychiatry.2013.75; Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Juengst S, 2014, ARCH PHYS MED REHAB, V95, pE71, DOI [10.1016/j.apmr.2014.07.227, DOI 10.1016/J.APMR.2014.07.227]; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2017, J NEUROPSYCH CLIN N, V29, P260, DOI 10.1176/appi.neuropsych.16100217; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Krueger RA., 2014, FOCUS GROUPS PRACTIC, V5th; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; LYNN MR, 1986, NURS RES, V35, P382; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Pett MA., 2003, MAKING SENSE FACTOR; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	54	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 8	2019	41	10					1200	1206		10.1080/09638288.2017.1423403			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU3XK	WOS:000465208200008	29303003	Green Accepted			2022-02-06	
J	Chen, C; Dong, X; Fang, KH; Yuan, F; Hu, Y; Xu, M; Huang, Y; Zhang, XX; Fang, DJ; Liu, Y				Chen, Cheng; Dong, Xin; Fang, Kai-Heng; Yuan, Fang; Hu, Yao; Xu, Min; Huang, Yu; Zhang, Xixiang; Fang, Danjun; Liu, Yan			Develop a 3D neurological disease model of human cortical glutamatergic neurons using micropillar-based scaffolds	ACTA PHARMACEUTICA SINICA B			English	Article						3D culture; Cortical glutamatergic neurons; Human pluripotent ste cells; Cell differentiation; Disease modeling; Traumatic brain injury; Neural protective drug; Drug screening	PLURIPOTENT STEM-CELLS; INDUCTION	Establishing an effective three-dimensional (3D) in vitro culture system to better model human neurological diseases is desirable, since the human brain is a 3D structure. Here, we demonstrated the development of a polydimethylsiloxane (PDMS) pillar-based 3D scaffold that mimicked the 3D microenvironment of the brain. We utilized this scaffold for the growth of human cortical glutamatergic neurons that were differentiated from human pluripotent stem cells. In comparison with the 2D culture, we demonstrated that the developed 3D culture promoted the maturation of human cortical glutamatergic neurons by showing significantly more MAP2 and less Ki67 expression. Based on this 3D culture system, we further developed an in vitro disease-like model of traumatic brain injury (TBI), which showed a robust increase of glutamate-release from the neurons, in response to mechanical impacts, recapitulating the critical pathology of TBI. The increased glutamate-release from our 3D culture model was attenuated by the treatment of neural protective drugs, memantine or nimodipine. The established 3D in vitro human neural culture system and TBI-like model may be used to facilitate mechanistic studies and drug screening for neurotrauma or other neurological diseases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.	[Chen, Cheng; Dong, Xin; Fang, Kai-Heng; Yuan, Fang; Hu, Yao; Xu, Min; Liu, Yan] Nanjing Med Univ, Inst Stem Cell & Neural Regenerat, Sch Pharm, Nanjing 211166, Jiangsu, Peoples R China; [Chen, Cheng; Dong, Xin; Fang, Kai-Heng; Yuan, Fang; Hu, Yao; Xu, Min; Fang, Danjun; Liu, Yan] Nanjing Med Univ, Key Lab Targeted Intervent Cardiovasc Dis, Sch Pharm, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China; [Chen, Cheng; Huang, Yu] Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA; [Zhang, Xixiang] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div PSE, Thuwal 239556900, Saudi Arabia; [Liu, Yan] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China		Liu, Y (corresponding author), Nanjing Med Univ, Inst Stem Cell & Neural Regenerat, Sch Pharm, Nanjing 211166, Jiangsu, Peoples R China.; Fang, DJ; Liu, Y (corresponding author), Nanjing Med Univ, Key Lab Targeted Intervent Cardiovasc Dis, Sch Pharm, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.	djf@njmu.edu.cn; yanliu@njmu.edu.cn			Strategic Priority Research Program of the Chinese Academy of SciencesChinese Academy of Sciences [XDA16010306]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91849117, 81471301]; Key Research and Development Program of China [2016YFC1306703]; National Jiangsu Outstanding Young Investigator Program (China) [BK20160044]; Jiangsu Province's Innovation Person (China); Natural Science Foundation of the Jiangsu Higher Education Institutions of China Project [17KJB180010]	This study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA16010306), the National Natural Science Foundation of China Grants (91849117 and 81471301), Key Research and Development Program of China (2016YFC1306703), The National Jiangsu Outstanding Young Investigator Program (BK20160044, China), Jiangsu Province's Innovation Person (China), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China Project (Grant No. 17KJB180010).	Anderson SA, 2001, DEVELOPMENT, V128, P353; Bosi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09562; Cao SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03519-w; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Daschil N, 2014, BRAIN RES, V1581, P1, DOI 10.1016/j.brainres.2014.07.014; Frega M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05489; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Jensen G, 2018, ACTA PHARM SIN B, V8, P756, DOI 10.1016/j.apsb.2018.03.006; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lu HF, 2012, BIOMATERIALS, V33, P9179, DOI 10.1016/j.biomaterials.2012.09.006; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Petros TJ, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00030, 10.3389/fnmol.2011.00030]; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Zhang XX, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0187-y	27	11	12	2	11	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES	BEIJING	C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, 100050, PEOPLES R CHINA	2211-3835	2211-3843		ACTA PHARM SIN B	Acta Pharm. Sin. B	MAY	2019	9	3					557	564		10.1016/j.apsb.2019.03.004			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IA2MB	WOS:000469394400010	31193866	gold, Green Published			2022-02-06	
J	Follmer, B; Dellagrana, RA; Zehr, EP				Follmer, Bruno; Dellagrana, Rodolfo Andre; Zehr, E. Paul			Head Trauma Exposure in Mixed Martial Arts Varies According to Sex and Weight Class	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						combat sports; head injuries; brain concussion; traumatic brain injury; chronic traumatic encephalopathy	SYMPTOMS; INJURIES; FOOTBALL; SPORT	Background: Brain injury arising from head trauma is a major concern in mixed martial arts (MMA) because knockout (KO) and technical knockout (TKO) are frequent fight outcomes. Previous studies have shown a high incidence of matches ending due to strikes to the head but did not consider weight categories and female fights. This study aimed at analyzing match stoppages in MMA and the exposure to head trauma distinguished by sex and weight categories. Hypothesis: The heavier the weight class, the greater the risk and incidence of head trauma will be, regardless of sex. Study Design: Descriptive epidemiology study. Methods: Publicly available data of 167 MMA events from 1903 fights between 2014 and 2017 were assessed, comprising 8 male and 2 female weight categories. Results: The combined KO/TKO rates per 100 athlete-exposures in the middleweight (19.53), light heavyweight (20.8), and heavyweight (26.09) divisions were greater than previously reported for MMA. While stoppage via KO/TKO occurred in 7.9% of combats in the female strawweight division, it occurred in 52.1% of the male heavyweight fights. The male middleweight (P = 0.001), light heavyweight (P < 0.001), and heavyweight divisions (P < 0.001) had an increased risk of KO/TKO due to strikes to the head by 80%, 100%, and 206%, respectively. The risk in the flyweight division decreased 62% (P = 0.001). All categories were compared with the lightweight division. The female bantamweight category presented a 221% increased risk in matches ending due to KO/TKO compared with the strawweight division (P = 0.012). Punches to the head were the major technique used to end a combat via KO/TKO, regardless of sex and weight class. Conclusion: Head injury risk and incidence varies considerably according to sex and weight category in MMA.	[Follmer, Bruno; Dellagrana, Rodolfo Andre] Univ Fed Santa Catarina, Ctr Sports, Biomech Lab, Florianopolis, SC, Brazil; [Follmer, Bruno; Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Room 172,McKinnon Bldg,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada; [Follmer, Bruno; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Dellagrana, Rodolfo Andre] Univ Fed Mato Grosso do Sul, Fac Educ, Campo Grande, MS, Brazil; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada		Follmer, B (corresponding author), Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Room 172,McKinnon Bldg,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	brunofollmer@hotmail.com	Dellagrana, Rodolfo/AAZ-4112-2020	Follmer, Bruno/0000-0001-5052-9648			Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Amtmann JA, 2004, J STRENGTH COND RES, V18, P194; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jensen AR, 2017, SPORTS HEALTH, V9, P64, DOI 10.1177/1941738116664860; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Lockwood J, 2018, TRAUMA, V20, P245, DOI 10.1177/1460408617740902; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Miarka B, 2017, INT J PERF ANAL SPOR, V17, P510, DOI 10.1080/24748668.2017.1360103; Miarka B, 2017, HUM MOVEMENT SCI, V55, P73, DOI 10.1016/j.humov.2017.07.009; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P539, DOI 10.1080/24748668.2016.11868907; Miarka B, 2015, INT J PERF ANAL SPOR, V15, P1189, DOI 10.1080/24748668.2015.11868861; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Neselius S, 2015, KNEE SURG SPORT TR A, V23, P2536, DOI 10.1007/s00167-014-3066-6; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Zehr EP, 2016, BRIT J SPORT MED, V50, P1481, DOI 10.1136/bjsports-2016-096792	27	11	11	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY	2019	11	3					280	285		10.1177/1941738119827966			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IA1UM	WOS:000469348000011	30768376	Green Published			2022-02-06	
J	Njoku, I; Radabaugh, HL; Nicholas, MA; Kutash, LA; O'Neil, DA; Marshall, IP; Cheng, JP; Kline, AE; Bondi, CO				Njoku, Ihuoma; Radabaugh, Hannah L.; Nicholas, Melissa A.; Kutash, Lindsay A.; O'Neil, Darik A.; Marshall, Ian P.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.			Chronic treatment with galantamine rescues reversal learning in an attentional set-shifting test after experimental brain trauma	EXPERIMENTAL NEUROLOGY			English	Article						Controlled cortical impact (CCI); Traumatic brain injury; Galantamine; Behavior; Learning and memory; Executive function; Attentional set-shifting; Functional recovery	CONTROLLED CORTICAL IMPACT; NICOTINIC ACETYLCHOLINE-RECEPTOR; CARD SORTING TEST; ENVIRONMENTAL ENRICHMENT; COGNITIVE FLEXIBILITY; FLUID PERCUSSION; INJURY; DONEPEZIL; MEMORY; RATS	Approximately 10 million new cases of traumatic brain injury (TBI) are reported each year worldwide with many of these injuries resulting in higher order cognitive impairments. Galantamine (GAL), an acetylcholine esterase inhibitor (AChEI) and positive allosteric modulator of nicotinic acetylcholine receptors (nAChRs), has been reported to ameliorate cognitive deficits after clinical TBI. Previously, we demonstrated that controlled cortical impact (CCI) injury to rats resulted in significant executive function impairments as measured by the attentional set-shifting test (AST), a complex cognitive task analogous to the Wisconsin Card Sorting Test (WCST). We hypothesized that chronic administration of GAL would normalize performance on the AST post-TBI. Isoflurane-anesthetized adult male rats were subjected to moderate CCI (2.8 mm tissue deformation at 4 m/s) or sham injury. Rata were then randomized into one of three treatment groups (i.e., 1 mg/kg GAL, 2 mg/kg GAL, or 1 mL/kg saline vehicle; VEH) or their respective sham controls. GAL or VEH was administered intraperitoneally daily commencing 24 hours post-surgery and until AST testing at 4 weeks post-injury. The AST data revealed significant impairments in the first reversal stage after TBI, seen as increased trials to reach criterion and elevated total errors (p < 0.05). These behavioral flexibility deficits were equally normalized by the administration of both doses of GAL (p < 0.05). Additionally, the higher dose of GAL (2 mg/kg) also significantly reduced cortical lesion volume compared to TBI VEH controls (p < 0.05). In summary, daily GAL administration provides an efficacious treatment for cognitive deficits and histological recovery after experimental brain trauma. Clinically, these findings are promising considering robust results were attained using a pharmacotherapy already used in the clinic to treat mild dementia.	[Njoku, Ihuoma; Radabaugh, Hannah L.; Nicholas, Melissa A.; Kutash, Lindsay A.; O'Neil, Darik A.; Marshall, Ian P.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Njoku, Ihuoma; Radabaugh, Hannah L.; Nicholas, Melissa A.; Kutash, Lindsay A.; O'Neil, Darik A.; Marshall, Ian P.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA; [Radabaugh, Hannah L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [O'Neil, Darik A.] Columbia Univ, Med Ctr, Dept Neurosci, Grad Program, Studebaker Bldg,MC 8765,615 West 131st St, New York, NY 10027 USA; [Marshall, Ian P.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, 12 Capen Hall, Buffalo, NY 14260 USA		Bondi, CO (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res,Sch Med,John G Rangos Re, Ctr Neurosci Execut Funct & Neuropharmacol,Neurob, Room 6124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	bondico@upmc.edu		O'Neil, Darik/0000-0002-8222-7617; Njoku, Ihuoma/0000-0002-0214-7378; O'Neil, Darik/0000-0002-2475-438X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS095950, NS099683]; IJPP/UPMC Academic Foundation; Univ. Pitt Rehabilitation Institute;  [NS060005];  [HD069620];  [NS084967];  [T32 AG021885]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS094950, R21NS099674, R21NS099683, R01NS084967] Funding Source: NIH RePORTER	Supported in part by NIH Grants NS095950, NS099683, IJPP/UPMC Academic Foundation, Univ. Pitt Rehabilitation Institute (COB), NS060005, HD069620 and NS084967 (AEK), and T32 AG021885 (IN; PI: Dr. Susan Greenspan).	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; ANDERSON NH, 1961, PSYCHOL BULL, V58, P305, DOI 10.1037/h0042576; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Benge JF, 2007, BRAIN INJURY, V21, P395, DOI 10.1080/02699050701311091; BICKEL U, 1991, NEUROPHARMACOLOGY, V30, P447, DOI 10.1016/0028-3908(91)90005-V; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bondi CO, 2018, RESTOR NEUROL NEUROS, V36, P45, DOI 10.3233/RNN-170781; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; Broberg BV, 2009, PSYCHOPHARMACOLOGY, V206, P631, DOI 10.1007/s00213-009-1540-5; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Campbell KA, 2018, BRAIN INJURY, V32, P972, DOI 10.1080/02699052.2018.1468574; Chauhan PS, 2016, PHYSIOL BEHAV, V156, P148, DOI 10.1016/j.physbeh.2016.01.006; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Coyle J, 2001, BIOL PSYCHIAT, V49, P289, DOI 10.1016/S0006-3223(00)01101-X; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fayuk D, 2004, MOL PHARMACOL, V66, P658, DOI 10.1124/mol.104.000042; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Goetghebeur PJD, 2010, PSYCHOPHARMACOLOGY, V212, P635, DOI 10.1007/s00213-010-1990-9; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hernandez CM, 2006, J PHARMACOL EXP THER, V316, P679, DOI 10.1124/jpet.105.093047; Homeman G., 2009, BRAIN INJURY, V23, P907; Hong S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00015; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jett JD, 2015, PSYCHOPHARMACOLOGY, V232, P3123, DOI 10.1007/s00213-015-3957-3; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Koukouli F, 2015, BIOCHEM PHARMACOL, V97, P378, DOI 10.1016/j.bcp.2015.07.018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim Sean Austin O, 2014, Front Synaptic Neurosci, V6, P22, DOI 10.3389/fnsyn.2014.00022; Liu Z, 2007, J NEUROPHYSIOL, V98, P581, DOI 10.1152/jn.00768.2006; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McQuiston A Rory, 2014, Front Synaptic Neurosci, V6, P20, DOI 10.3389/fnsyn.2014.00020; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Naegeli KJ, 2013, EUR J PHARMACOL, V703, P62, DOI 10.1016/j.ejphar.2013.02.006; Nakagawa R, 2017, NEUROPSYCH DIS TREAT, V13, P1115, DOI 10.2147/NDT.S133145; Nikiforuk A, 2016, BEHAV BRAIN RES, V313, P214, DOI 10.1016/j.bbr.2016.07.023; Nikiforuk A, 2016, NEUROPHARMACOLOGY, V101, P389, DOI 10.1016/j.neuropharm.2015.07.034; Nikiforuk A, 2015, EUR NEUROPSYCHOPHARM, V25, P1300, DOI 10.1016/j.euroneuro.2015.04.018; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; O'Neil DA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00579; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Rane P, 2012, NEUROPHARMACOLOGY, V62, P2409, DOI 10.1016/j.neuropharm.2012.01.026; Rattenborg NC, 2011, BIOL REV, V86, P658, DOI 10.1111/j.1469-185X.2010.00165.x; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Tait DS, 2018, NEUROSCI BIOBEHAV R, V89, P72, DOI 10.1016/j.neubiorev.2018.02.013; Tait DS, 2017, NEUROSCIENCE, V345, P287, DOI 10.1016/j.neuroscience.2016.08.008; Tait DS, 2007, ANN NY ACAD SCI, V1121, P407, DOI 10.1196/annals.1401.010; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	70	11	11	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2019	315						32	41		10.1016/j.expneurol.2019.01.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HQ0RG	WOS:000462102100005	30711647	Green Accepted, Bronze			2022-02-06	
J	Roach, J; Gaastra, B; Bulters, D; Shtaya, A				Roach, Joy; Gaastra, Benjamin; Bulters, Diederik; Shtaya, Anan			Safety, Accuracy, and Cost Effectiveness of Bedside Bolt External Ventricular Drains (EVDs) in Comparison with Tunneled EVDs Inserted in Theaters	WORLD NEUROSURGERY			English	Article						Bolt; Cerebrospinal fluid (CSF); External ventricular drain (EVD); Hydrocephalus; Tunneled	OUTCOME ANALYSIS; COMPLICATIONS; PLACEMENT	OBJECTIVES: External ventricular drain (EVD) placement is required frequently in neurosurgical patients to divert cerebrospinal fluid and monitor intracranial pressure. The usual practice is the tunneled EVD technique performed in operating theaters. EVD insertion through a bolt in intensive care also is described. We employ both practices in our institute. Herein, we compare the indications, accuracy, safety, and costs of the 2 techniques. METHODS: This was a retrospective cohort study of a prospectively maintained EVD database of all patients undergoing first frontal EVD placement between January 2010 and December 2015. Those patients with preceding cerebrospinal fluid infection were excluded. We compared bolt EVD with tunneled EVD techniques in terms of accuracy of EVD tip location by analyzing computed tomography scans to grade catheter tip location as optimal (ipsilateral frontal horn) or otherwise suboptimal, and complications that include infection and revision rates. RESULTS: In total, 579 eligible patients aged 3 months to 84 years were identified; 430 had tunneled EVDs and 149 bolt EVDs. The most frequent diagnosis was intracranial hemorrhage (73% bolt vs. 50.4% tunneled group; P < 0.001). Other diagnoses included tumor (4.7% bolt vs. 19.1% tunneled; P < 0.001) and traumatic brain injury (17.5% bolt vs. 17.4% tunneled). In the bolt EVD group 66.4% of EVD tips were optimal, compared with 61.0% in the tunneled group (P = 0.33). Infection was confirmed in 15 (10.0%) bolt EVDs compared with 61 (14.2%) tunneled EVDs (P = 0.2). Each bolt EVD kit costs 260 pound, whereas placing a tunneled one in the theater costs 1316 pound. CONCLUSIONS: Bedside bolt EVD placement is safe, accurate, and cost effective in selective patients with hemorrhage-related hydrocephalus.	[Roach, Joy; Gaastra, Benjamin; Bulters, Diederik; Shtaya, Anan] Univ Hosp Southampton, Wessex Neurol Ctr, Southampton, Hants, England; [Shtaya, Anan] St Georges Univ London, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England; [Shtaya, Anan] St Georges Univ Hosp NHS Trust, London, England		Shtaya, A (corresponding author), Univ Hosp Southampton, Wessex Neurol Ctr, Southampton, Hants, England.; Shtaya, A (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England.; Shtaya, A (corresponding author), St Georges Univ Hosp NHS Trust, London, England.	ashtaya@sgul.ac.uk	Shtaya, Anan/AAX-2494-2020; Bulters, Diederik/ABH-3573-2020	Shtaya, Anan/0000-0001-7459-8437; Bulters, Diederik/0000-0001-9884-9050; Gaastra, Ben/0000-0002-7517-6882			Asaad SK, 2019, ACTA NEUROCHIR, V161, P33, DOI 10.1007/s00701-018-3737-z; Bergdal O, 2013, CLIN NEUROL NEUROSUR, V115, P1972, DOI 10.1016/j.clineuro.2013.05.026; Cinibulak Z, 2016, ACTA NEUROCHIR, V158, P847, DOI 10.1007/s00701-016-2747-y; Fichtner J, 2014, CLIN NEUROL NEUROSUR, V122, P70, DOI 10.1016/j.clineuro.2014.04.018; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; James M, 2015, Open Orthop J, V9, P495, DOI 10.2174/1874325001509010495; Jamjoom AAB, 2018, J NEUROL NEUROSUR PS, V89, P120, DOI 10.1136/jnnp-2017-316415; Jensen TS, 2016, ACTA NEUROCHIR, V158, P1491, DOI 10.1007/s00701-016-2863-8; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Nowacki A, 2018, WORLD NEUROSURG, V114, pE1290, DOI 10.1016/j.wneu.2018.03.199; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; Schodel P, 2012, BRIT J NEUROSURG, V26, P227, DOI 10.3109/02688697.2011.603853; Schodel P, 2012, J CLIN NEUROSCI, V19, P267, DOI 10.1016/j.jocn.2011.04.026; Shtaya A, 2019, J NEUROSURG, V130, P1268, DOI 10.3171/2017.11.JNS171892; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; 2009, NEUROSURGERY, V65, P1197, DOI DOI 10.1227/01.NEU.0000356973.39913.0B; 2012, NEUROSURGERY, V71, P394, DOI DOI 10.1227/NEU.0B013E318257BEBB	17	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E473	E478		10.1016/j.wneu.2019.01.106			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700063	30735879	Green Accepted			2022-02-06	
J	Stromberg, KA; Agyemang, AA; Graham, KM; Walker, WC; Sima, AP; Marwitz, JH; Harrison-Felix, C; Hoffman, JM; Brown, AW; Kreutzer, JS; Merchant, R				Stromberg, Katharine A.; Agyemang, Amma A.; Graham, Kristin M.; Walker, William C.; Sima, Adam P.; Marwitz, Jennifer H.; Harrison-Felix, Cynthia; Hoffman, Jeanne M.; Brown, Allen W.; Kreutzer, Jeffrey S.; Merchant, Randall			Using Decision Tree Methodology to Predict Employment After Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						postinjury employment; posttraumatic amnesia; prognostic model; traumatic brain injury	RACIAL-DIFFERENCES; REGRESSION TREES; UNITED-STATES; HEAD-INJURY; CLASSIFICATION; RETURN; DISABILITY; OUTCOMES; REPRESENTATIVENESS; TRAJECTORIES	Objective: To build decision tree prediction models for long-term employment outcomes of individuals after moderate to severe closed traumatic brain injury (TBI) and assess model accuracy in an independent sample. Setting: TBI Model Systems Centers. Participants: TBI Model Systems National Database participants injured between January 1997 and January 2017 with moderate to severe closed TBI. Sample sizes were 7867 (year 1 postinjury), 6783 (year 2 postinjury), and 4927 (year 5 postinjury). Design: Cross-sectional analyses using flexible classification tree methodology and validation using an independent subset of TBI Model Systems National Database participants. Main Measures: Competitive employment at 1, 2, and 5 years postinjury. Results: In the final employment prediction models, posttraumatic amnesia duration was the most important predictor of employment in each outcome year. Additional variables consistently contributing were age, preinjury education, productivity, and occupational category. Generally, individuals spending fewer days in posttraumatic amnesia, who were competitively employed preinjury, and more highly educated had better outcomes. Predictability in test data sets ranged from a C-statistic of 0.72 (year 5; confidence interval: 0.68-0.76) to 0.77 (year 1; confidence interval: 0.74-0.80). Conclusion: An easy-to-use decision tree tool was created to provide prognostic information on long-term competitive employment outcomes in individuals with moderate to severe closed TBI. Length of posttraumatic amnesia, a clinical marker of injury severity, and preinjury education and employment status were the most important predictors.	[Stromberg, Katharine A.; Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Box 980032, Richmond, VA 23298 USA; [Agyemang, Amma A.; Graham, Kristin M.; Walker, William C.; Marwitz, Jennifer H.; Kreutzer, Jeffrey S.; Merchant, Randall] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Harrison-Felix, Cynthia] Craig Hosp, Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA		Sima, AP (corresponding author), Virginia Commonwealth Univ, Dept Biostat, Box 980032, Richmond, VA 23298 USA.	adam.sima@vcuhealth.org		Sima, Adam/0000-0001-8426-9987	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD089097]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90 DP0013]; NIDILRRUnited States Department of Health & Human Services [90AR5025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089097] Funding Source: NIH RePORTER	This study was supported by National Institute of Health (NIH) no. R21HD089097. The data contents for this manuscript were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90 DP0013). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). Postdoctoral fellows were supported by NIDILRR grant number 90AR5025.	[Anonymous], 2002, DISABILITY EMPLOYMEN; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Breiman L., 1993, CLASSIFICATION REGRE; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Centers for Disease Control and Prevention, 2016, 2016 BEH RISK FACT S; Centers for Disease Control and Prevention, 2013, BRFSS DAT US GUID JU; Conroy L, 1999, SPINAL CORD, V37, P624, DOI 10.1038/sj.sc.3100904; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Fokkema M, 2015, PSYCHOL ASSESSMENT, V27, P636, DOI 10.1037/pas0000072; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hastie T., SPRINGER SERIES STAT; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; Kass GV., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kim H, 2001, J AM STAT ASSOC, V96, P589, DOI 10.1198/016214501753168271; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sobell L., 2004, ALCOHOL CONSUMPTION; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	38	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E64	E74		10.1097/HTR.0000000000000438			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100008	30234849	Green Published, hybrid			2022-02-06	
J	Wood, JN; Henry, MK; Berger, RP; Lindberg, DM; Anderst, JD; Song, LH; Localio, R; Feudtner, C				Wood, Joanne N.; Henry, M. Katherine; Berger, Rachel P.; Lindberg, Daniel M.; Anderst, James D.; Song, Lihai; Localio, Russell; Feudtner, Chris			Use and Utility of Skeletal Surveys to Evaluate for Occult Fractures in Young Injured Children	ACADEMIC PEDIATRICS			English	Article						child abuse; child maltreatment; skeletal survey	SUSPECTED ABUSE; PHYSICAL ABUSE; INFANTS; GUIDELINES; BURNS	OBJECTIVE: To describe the percentage and characteristics of children aged <24 months with non-motor vehicle crash (MVC)-related injuries who undergo a skeletal survey and have occult fractures. METHODS: We performed a retrospective chart review of a stratified, systematic random sample of 1769 children aged <24 months with non-MVC related bruises, burns, fractures, abdominal injuries, and head injuries at 4 children's hospitals between 2008 and 2012. Sampling weights were assigned to each child to allow for representative hospital-level population estimates. Logistic regression models were used to test for associations between patient characteristics with outcomes of skeletal survey completion and occult fracture identification. RESULTS: Skeletal surveys were performed in 46.3% of children aged 0 to 5 months, in 21.1% of those aged 6 to 11 months, in 8.0% of those aged 12 to 17 months, and in 6.2% of those aged 18 to 24 months. Skeletal surveys were performed most frequently in children with traumatic brain injuries (64.7%) and rib fractures (100%) and least frequently in those with burns (2.1%) and minor head injuries (4.4%). In adjusted analyses, older age, private insurance, and reported history of accidental trauma were associated with decreased skeletal survey use (P <= .001 for all). The prevalence of occult fractures on skeletal surveys ranged from 24.6% in children aged 0 to 5 months to 3.6% in those aged 18 to 24 months, and varied within age categories based on the presenting injury (P < .001). CONCLUSIONS: The high rate of occult fractures in infants aged 0 to 5 months underscores the importance of increasing the use of skeletal surveys in this population. Further research is needed to identify the injury characteristics of older infants and toddlers most at risk for occult fractures.	[Wood, Joanne N.; Henry, M. Katherine; Song, Lihai; Feudtner, Chris] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Wood, Joanne N.; Song, Lihai] Childrens Hosp Philadelphia, PolicyLab, Div Gen Pediat, Roberts Ctr Pediat Res, Philadelphia, PA 19104 USA; [Wood, Joanne N.; Henry, M. Katherine; Feudtner, Chris] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Localio, Russell] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Berger, Rachel P.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr,Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Lindberg, Daniel M.] Univ Colorado, Dept Emergency Med, Sch Med, Aurora, CO USA; [Lindberg, Daniel M.] Univ Colorado, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Sch Med, Aurora, CO USA; [Anderst, James D.] Univ Missouri Kansas City, Div Child Abuse & Neglect, Dept Pediat, Sch Med, Kansas City, MO USA; Childrens Mercy Hosp, Kansas City, MO 64108 USA		Wood, JN (corresponding author), Childrens Hosp Philadelphia, Roberts Ctr Pediat Res, 2716 South St, Philadelphia, PA 19146 USA.	woodjo@email.chop.edu	Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434; Wood, Joanne/0000-0001-6431-8024	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD071967]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD071967] Funding Source: NIH RePORTER	This study was funded by Grant 1K23HD071967 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Berger RP, 2016, J PEDIATR-US, V171, P310, DOI 10.1016/j.jpeds.2016.01.017; Bullock DP, 2009, J PEDIATR ORTHOPED, V29, P231, DOI 10.1097/BPO.0b013e31819aad44; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; DeGraw M, 2010, PEDIATRICS, V125, pE295, DOI 10.1542/peds.2009-1478; Deye KP, 2013, J TRAUMA ACUTE CARE, V74, P1553, DOI 10.1097/TA.0b013e31828b7fc4; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Dorfman MV, 2017, ARCH DIS CHILD, P1; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Fisher BT, 2012, PHARMACOEPIDEM DR S, P244, DOI DOI 10.1002/9781119959946.CH16; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Harper NS, 2014, J PEDIATR-US, V165, P383, DOI 10.1016/j.jpeds.2014.04.004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Higginbotham N, 2014, J TRAUMA ACUTE CARE, V76, P871, DOI 10.1097/TA.0000000000000135; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Hooft AM, 2015, ACAD PEDIATR, V15, P444, DOI 10.1016/j.acap.2015.01.008; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Karmazyn B, 2011, AM J ROENTGENOL, V197, pW159, DOI 10.2214/AJR.10.5733; Kish L, 1965, SURVEY SAMPLING; Korn E.L., 1999, ANAL HLTH SURVEYS; Letson MM, 2016, CHILD ABUSE NEGLECT, V60, P36, DOI 10.1016/j.chiabu.2016.09.001; Lindberg DM, 2015, PEDIATRICS, V136, P831, DOI 10.1542/peds.2015-1487; Lindberg DM, 2014, J PEDIATR-US, V164, P1268, DOI 10.1016/j.jpeds.2014.01.068; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; Oral R, 2003, PEDIATR EMERG CARE, V19, P148, DOI 10.1097/01.pec.0000081234.20228.33; Pawlik MC, 2016, CHILD ABUSE NEGLECT, V55, P52, DOI 10.1016/j.chiabu.2016.03.006; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; US Department of Health and Human Services, 2016, CHILD MALTREATMENT; US Department of Health & Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2015, CHILD MALTREATMENT; Wood JN, 2015, PEDIATRICS, V136, P232, DOI 10.1542/peds.2014-3977; Wood JN, 2014, PEDIATRICS, V134, P45, DOI 10.1542/peds.2013-3242; Wood JN, 2012, PEDIATRICS, V130, P853, DOI 10.1542/peds.2012-0244; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Ziegler DS, 2005, J PAEDIATR CHILD H, V41, P251, DOI 10.1111/j.1440-1754.2005.00605.x; 2009, J PEDIATR SURG, V44, P1229, DOI DOI 10.1016/J.JPEDSURG.2009.02.044	39	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	MAY-JUN	2019	19	4					428	437		10.1016/j.acap.2018.08.007			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HY3GM	WOS:000468011300013	30121318	Green Accepted			2022-02-06	
J	Zhong, YH; Wu, HY; He, RH; Zheng, BE; Fan, JZ				Zhong, Yu H.; Wu, Hong Y.; He, Ren H.; Zheng, Bi E.; Fan, Jian Z.			Sex Differences in Sex Hormone Profiles and Prediction of Consciousness Recovery After Severe Traumatic Brain Injury	FRONTIERS IN ENDOCRINOLOGY			English	Article						traumatic brain injury; sex hormones; consciousness; sex; differences	GENDER-DIFFERENCES; PROGESTERONE; TESTOSTERONE; ESTROGEN; NEUROPROTECTION; DYSFUNCTION; SYSTEM; TBI	Objective: The clinical course of unconsciousness after traumatic brain injury (TBI) is commonly unpredictable and it remains a challenge with limited therapeutic options. The aim of this study was to evaluate the early changes in serum sex hormone levels after severe TBI (sTBI) and the use of these hormones to predict recovery from unconsciousness with regard to sex. Methods: We performed a retrospective study including patients with sTBI. A statistical of analysis of serum sex hormone levels and recovery of consciousness at 6 months was made to identify the effective prognostic indicators. Results: Fifty-five male patients gained recovery of consciousness, and 37 did not. Of the female patients, 22 out of 32 patients regained consciousness. Male patients (n = 92) with sTBI, compared with healthy subjects (n = 60), had significantly lower levels of follicular stimulating hormone (FSH), testosterone and progesterone and higher levels of prolactin. Female patients (n = 32) with sTBI, compared with controls (n = 60), had significantly lower levels of estradiol, progesterone, and testosterone and significantly higher levels of FSH and prolactin. Testosterone significantly predicted consciousness recovery in male patients. Normal or elevated testosterone levels in the serum were associated with a reduced risk of the unconscious state in male patients with sTBI. For women patients with sTBI, sex hormone levels did not contribute to the prediction of consciousness recovery. Conclusion: These findings indicate that TBI differentially affects the levels of sex-steroid hormones in men and women patients. Plasma levels of testosterone could be a good candidate blood marker to predict recovery from unconsciousness after sTBI for male patients.	[Zhong, Yu H.; Wu, Hong Y.; He, Ren H.; Zheng, Bi E.; Fan, Jian Z.] Southern Med Univ, Dept Rehabil Med, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China		Fan, JZ (corresponding author), Southern Med Univ, Dept Rehabil Med, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	fjz@smu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802250]; Presidential Foundation of Nanfang Hospital [2017C031]	This study was supported by the National Natural Science Foundation of China (Grant No. 81802250) and the Presidential Foundation of Nanfang Hospital (Grant No. 2017C031).	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Allen KM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0142-x; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Cheng J, 2009, J CEREBR BLOOD F MET, V29, P486, DOI 10.1038/jcbfm.2008.138; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hohl A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00029; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; JONES KJ, 1993, BRAIN RES BULL, V30, P491, DOI 10.1016/0361-9230(93)90283-H; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lin JS, 2011, CELL MOL LIFE SCI, V68, P2499, DOI 10.1007/s00018-011-0631-8; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Ordonez-Rubiano EG, 2017, CUREUS, V9, DOI 10.7759/cureus.1723; Del Rio JP, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00141; Ransome Mark I, 2015, Front Cell Neurosci, V9, P253, DOI 10.3389/fncel.2015.00253; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROSELLI CE, 1991, ENDOCRINOLOGY, V128, P1310, DOI 10.1210/endo-128-3-1310; Scott E, 2012, FRONT NEUROENDOCRIN, V33, P85, DOI 10.1016/j.yfrne.2011.10.001; Son SW, 2016, J NEUROCHEM, V136, P106, DOI 10.1111/jnc.13371; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; 2006, ENDOCRINE, V29, P217, DOI DOI 10.1385/ENDO:29:2:217; 2009, BRAIN 9, V132, P2541, DOI DOI 10.1093/BRAIN/AWP183; 2003, EXP NEUROL, V181, P301, DOI DOI 10.1016/S0014-4886(03)00061-X	49	11	11	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	APR 26	2019	10								261	10.3389/fendo.2019.00261			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	HV6HC	WOS:000466083500002	31080439	Green Published, gold			2022-02-06	
J	Holshouser, B; Pivonka-Jones, J; Nichols, JG; Oyoyo, U; Tong, KR; Ghosh, N; Ashwal, S				Holshouser, Barbara; Pivonka-Jones, Jamie; Nichols, Joy G.; Oyoyo, Udo; Tong, Karen; Ghosh, Nirmalya; Ashwal, Stephen			Longitudinal Metabolite Changes after Traumatic Brain Injury: A Prospective Pediatric Magnetic Resonance Spectroscopic Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						factor analysis; magnetic resonance spectroscopy; outcomes; pediatric; traumatic brain injury	DIFFUSE AXONAL INJURY; DEFAULT MODE NETWORK; MR SPECTROSCOPY; CHILDREN; DISORDERS; THALAMUS; ATROPHY; NUCLEI	The aims of this study were to evaluate longitudinal metabolite changes in traumatic brain injury (TBI) subjects and determine whether early magnetic resonance spectroscopic imaging (MRSI) changes in discrete brain regions predict 1-year neuropsychological outcomes. Three-dimensional (3D) proton MRSI was performed in pediatric subjects with complicated mild (cMild), moderate, and severe injury, acutely (6-17 days) and 1-year post-injury along with neurological and cognitive testing. Longitudinal analysis found that in the cMild/Moderate group, all MRSI ratios from 12 regions returned to control levels at 1 year. In the severe group, only cortical gray matter regions fully recovered to control levels whereas N-acetylaspartate (NAA) ratios from the hemispheric white matter and subcortical regions remained statistically different from controls. A factor analysis reduced the data to two loading factors that significantly differentiated between TBI groups; one included acute regional NAA variables and another consisted of clinically observed variables (e.g., days in coma). Using scores calculated from the two loading factors in a logistic regression model, we found that the percent accuracy for classification of TBI groups was greatest for the dichotomized attention measure (93%), followed by Full Scale Intelligence Quotient at 91%, and the combined memory Z-score measure (90%). Using the acute basal ganglia NAA/creatine (Cr) ratio alone achieved a higher percent accuracy of 94.7% for the attention measure whereas the acute thalamic NAA/Cr ratio alone achieved a higher percent accuracy of 91.9% for the memory measure. These results support the conclusions that reduced NAA is an early indicator of tissue injury and that measurements from subcortical brain regions are more predictive of long-term cognitive outcome.	[Holshouser, Barbara; Oyoyo, Udo; Tong, Karen] Loma Linda Univ, Sch Med, Dept Radiol, Loma Linda, CA USA; [Pivonka-Jones, Jamie; Nichols, Joy G.; Ghosh, Nirmalya; Ashwal, Stephen] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA		Holshouser, B (corresponding author), Loma Linda Univ Hlth, Dept Radiol, CSP Room C1025,11175 Campus St, Loma Linda, CA 92354 USA.	bholshouser@llu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS054001] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Astrakas LG, 2016, PEDIATR RADIOL, V46, P941, DOI 10.1007/s00247-014-3204-9; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ghosh N, 2017, DEV NEUROSCI-BASEL, V39, P413, DOI 10.1159/000475545; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Gratton C, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13032; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Holshouser BA, 2000, J MAGN RESON IMAGING, V11, P9, DOI 10.1002/(SICI)1522-2586(200001)11:1<9::AID-JMRI2>3.3.CO;2-Y; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marmarou A, 2005, ACT NEUR S, V95, P149; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2017, J NEUROIMAGING, V27, P562, DOI 10.1111/jon.12463; Mohamed MA, 2010, RADIOLOGY, V254, P577, DOI 10.1148/radiol.09081867; Mohan Akansha, 2016, Yale Journal of Biology and Medicine, V89, P49; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Penfield W, 1954, EPILEPSY FUNCTIONAL; Posner MI, 2016, CURR OPIN PEDIATR, V28, P720, DOI 10.1097/MOP.0000000000000413; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Sherman SM, 2000, EXPLORING THALAMUS; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	52	11	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1352	1360		10.1089/neu.2018.5919			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000013	30351247	Green Published			2022-02-06	
J	Boone, DR; Weisz, HA; Willey, HE; Torres, KEO; Falduto, MT; Sinha, M; Spratt, H; Bolding, IJ; Johnson, KM; Parsley, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Torres, Karen E. O.; Falduto, Michael T.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Traumatic brain injury induces long-lasting changes in immune and regenerative signaling	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; COMPLEMENT-SYSTEM; TERM POTENTIATION; INFLAMMATION; EXPRESSION; NEUROINFLAMMATION; BIOLOGY; VALIDATION; INDUCTION; BEHAVIOR	There are no existing treatments for the long-term degenerative effects of traumatic brain injury (TBI). This is due, in part, to our limited understanding of chronic TBI and uncertainty about which proposed mechanisms for long-term neurodegeneration are amenable to treatment with existing or novel drugs. Here, we used microarray and pathway analyses to interrogate TBI-induced gene expression in the rat hippocampus and cortex at several acute, subchronic and chronic intervals (24 hours, 2 weeks, 1, 2, 3, 6 and 12 months) after parasagittal fluid percussion injury. We used Ingenuity pathway analysis (IPA) and Gene Ontology enrichment analysis to identify significantly expressed genes and prominent cell signaling pathways that are dysregulated weeks to months after TBI and potentially amenable to therapeutic modulation. We noted long-term, coordinated changes in expression of genes belonging to canonical pathways associated with the innate immune response (i.e., NF-kappa B signaling, NFAT signaling, Complement System, Acute Phase Response, Toll-like receptor signaling, and Neuroinflammatory signaling). Bioinformatic analysis suggested that dysregulation of these immune mediators-many are key hub genes-would compromise multiple cell signaling pathways essential for homeostatic brain function, particularly those involved in cell survival and neuroplasticity. Importantly, the temporal profile of beneficial and maladaptive immunoregulatory genes in the weeks to months after the initial TBI suggests wider therapeutic windows than previously indicated.	[Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Torres, Karen E. O.; Falduto, Michael T.] GenUs Biosyst, Northbrook, IL USA; [Falduto, Michael T.] Paradise Genom Inc, Northbrook, IL USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu		Spratt, Heidi/0000-0002-9420-5028; DeWitt, Douglas/0000-0001-9810-8156	Moody Project for Translational Traumatic Brain Injury Research	This work was funded through a private grant from the Moody Project for Translational Traumatic Brain Injury Research. Recipients are DRB, HAW, HEW, MS, HS, IJB, KMJ, MAP, DSD, DSP, HLH. The funder did not play any role in the study design, data collection and analysis, or in the preparation or decision to publish manuscript. GenUs Biosystems provided support in the form of salaries for authors [MTF, KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Paradise genomics provided support in the form of salaries for [MTF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of MTF is articulated in the 'author contributions' section.	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Adzic M, 2018, CURR NEUROPHARMACOL, V16, P176, DOI 10.2174/1570159X15666170828163048; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Bayram FEO, 2018, CURR TOP MED CHEM, V18, P1416, DOI 10.2174/1568026618666180821144704; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bhandari R, 2018, DRUG TODAY, V54, P349, DOI 10.1358/dot.2018.54.6.2828189; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Dai HW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012018; Dai JX, 2018, ONCOL LETT, V15, P8245, DOI 10.3892/ol.2018.8376; Dolgin E, 2017, NATURE, V551, P427, DOI 10.1038/d41586-017-07291-9; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Jalles A., 2016, MOL SCI, V2, P259; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang S, 2018, BMB REP, V51, P92, DOI 10.5483/BMBRep.2018.51.2.219; Kinch MS, 2015, DRUG DISCOV TODAY, V20, P920, DOI 10.1016/j.drudis.2015.02.006; Kobeissy FH, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00198; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Lai WF, 2018, INFLAMMATION, V41, P449, DOI 10.1007/s10753-017-0701-7; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Li JR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0959-6; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu XY, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0348-1; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maqbool A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-40; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Pettit LK, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-16; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Ruzafa N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700321; Sarnico I, 2009, INT REV NEUROBIOL, V85, P351, DOI 10.1016/S0074-7742(09)85024-1; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Soares HD, 1995, J NEUROSCI, V15, P8223; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Vizuete AFK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1109-5; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang JH, 2011, CHIN OPT LETT, V9, DOI 10.3788/COL201109.090606; Zheng S, 2017, FUTURE ONCOL, V13, P2053, DOI 10.2217/fon-2017-0199	90	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214741	10.1371/journal.pone.0214741			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	WOS:000463194300058	30943276	Green Published, Green Submitted, gold			2022-02-06	
J	Datta, D; Yang, ST; Galvin, VC; Solder, J; Luo, F; Morozov, YM; Arellano, J; Duque, A; Rakic, P; Arnsten, AFT; Wang, M				Datta, Dibyadeep; Yang, Sheng-Tao; Galvin, Veronica C.; Solder, John; Luo, Fei; Morozov, Yury M.; Arellano, Jon; Duque, Alvaro; Rakic, Pasko; Arnsten, Amy F. T.; Wang, Min			Noradrenergic alpha 1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex	JOURNAL OF NEUROSCIENCE			English	Article						alpha-1 receptor; dorsolateral prefrontal cortex; mental disorders; noradrenergic receptor; PTSD; working memory	WORKING-MEMORY PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NOREPINEPHRINE RELEASE; CEREBRAL-CORTEX; RECEPTORS; MODULATION; PRAZOSIN; ACTIVATION; DOPAMINE	Noradrenergic (NE) alpha 1-adrenoceptors (alpha 1-ARs) contribute to arousal mechanisms and play an important role in therapeutic medications such as those for the treatment of posttraumatic stress disorder (PTSD). However, little is known about how alpha 1-AR stimulation influences neuronal firing in the dorsolateral prefrontal cortex (dlPFC), a newly evolved region that is dysfunctional in PTSD and other mental illnesses. The current study examined the effects of alpha 1-AR manipulation on neuronal firing in dlPFC of rhesus monkeys performing a visuospatial working memory task, focusing on the "delay cells" that maintain spatially tuned information across the delay period. Iontophoresis of the alpha 1-AR antagonist HEAT (2-{[beta-(4-hydroxyphenyl)ethyl] aminomethyl}-1-tetralone) had mixed effects, reducing firing in a majority of neurons but having nonsignificant excitatory effects or no effect in remaining delay cells. These data suggest that endogenous NE has excitatory effects in some delay cells under basal conditions. In contrast, the alpha 1-AR agonists phenylephrine and cirazoline suppressed delay cell firing and this was blocked by coadministration of HEAT. These results indicate an inverted-U dose response for alpha 1-AR actions, with mixed excitatory actions under basal conditions and suppressed firing with high levels of alpha 1-AR stimulation such as with stress exposure. Immunoelectron microscopy revealed alpha 1-AR expression presynaptically in axons and axon terminals and postsynaptically in spines, dendrites, and astrocytes. It is possible that alpha 1-AR excitatory effects arise from presynaptic excitation of glutamate release, whereas postsynaptic actions suppress firing through calcium-protein kinase C opening of potassium channels on spines. The latter may predominate under stressful conditions, leading to loss of dlPFC regulation during uncontrollable stress.	[Datta, Dibyadeep; Yang, Sheng-Tao; Galvin, Veronica C.; Solder, John; Morozov, Yury M.; Arellano, Jon; Duque, Alvaro; Rakic, Pasko; Arnsten, Amy F. T.; Wang, Min] Yale Univ, Dept Neurosci, Sch Med, New Haven, CT 06520 USA; [Luo, Fei] Nanchang Univ, Inst Life Sci, Ctr Neuropsychiat Dis, Nanchang 330031, Jiangxi, Peoples R China		Wang, M (corresponding author), Yale Univ, Dept Neurosci, Sch Med, New Haven, CT 06520 USA.	min.wang@yale.edu		Arnsten, Amy/0000-0002-3420-1308; Morozov, Yury/0000-0002-3679-6819; Duque, Alvaro/0000-0002-5086-5438	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1AG047744-01, DA02399, EY002593]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY002593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [DP1AG047744] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Pioneer Award DP1AG047744-01 to A.F.T.A. and Grants DA02399 and EY002593 to P.R.). We thank Lisa Ciavarella, Tracy Sadlon, Sam Johnson, and Michelle Wilson for their technical expertise.	Adetunji Babatunde, 2005, Psychiatry (Edgmont), V2, P43; ARANGO V, 1993, BRAIN RES, V630, P271, DOI 10.1016/0006-8993(93)90666-B; Arnsten AFT, 2000, NEURAL PLAST, V7, P133, DOI 10.1155/NP.2000.133; Arnsten AFT, 1997, PHARMACOL BIOCHEM BE, V58, P55, DOI 10.1016/S0091-3057(96)00477-7; Arnsten AFT, 2015, NAT NEUROSCI, V18, P1376, DOI 10.1038/nn.4087; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; BALDESSARINI RJ, 1992, BRIT J PSYCHIAT, V160, P12, DOI 10.1192/S0007125000296852; Berridge CW, 2012, BIOL PSYCHIAT, V71, P467, DOI 10.1016/j.biopsych.2011.07.022; Berridge CW, 2000, NEUROSCIENCE, V99, P495, DOI 10.1016/S0306-4522(00)00215-3; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; Datta D, 2018, ACS CHEM NEUROSCI, V9, P2127, DOI 10.1021/acschemneuro.7b00505; Ding F, 2013, CELL CALCIUM, V54, P10; Ferry B, 1999, J NEUROSCI, V19, P5119; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; Fitzgerald JM, 2018, HARVARD REV PSYCHIAT, V26, P116, DOI 10.1097/HRP.0000000000000185; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstein LE, 1996, J NEUROSCI, V16, P4787; HORIE K, 1995, BRIT J PHARMACOL, V116, P1611; Hvoslef-Eide M, 2015, PSYCHOPHARMACOLOGY, V232, P4005, DOI 10.1007/s00213-015-4038-3; Keedy SK, 2006, PSYCHIAT RES-NEUROIM, V146, P199, DOI 10.1016/j.pscychresns.2006.01.003; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koola MM, 2014, THER ADV PSYCHOPHARM, V4, P43, DOI 10.1177/2045125313500982; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Luo F, 2014, EUR J NEUROSCI, V39, P1281, DOI 10.1111/ejn.12495; Ma LY, 2015, J NEUROSCI, V35, P11612, DOI 10.1523/JNEUROSCI.1839-15.2015; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Mazure CM, 1995, DOES STRESS CAUSE PS; MCCORMICK DA, 1991, PROG BRAIN RES, V88, P293; MINNEMAN KP, 1994, MOL PHARMACOL, V46, P929; Mitrano DA, 2014, NEUROSCIENCE, V258, P90, DOI 10.1016/j.neuroscience.2013.11.002; Mitrano DA, 2012, NEUROPSYCHOPHARMACOL, V37, P2161, DOI 10.1038/npp.2012.68; Murillo-Rodriguez E, 2018, ACS CHEM NEUROSCI, V9, P151, DOI 10.1021/acschemneuro.7b00374; Nakadate K, 2001, NEUROSCI RES, V40, P155, DOI 10.1016/S0168-0102(01)00224-3; NAKANE H, 1994, AM J PHYSIOL-REG I, V267, pR1559, DOI 10.1152/ajpregu.1994.267.6.R1559; O'Donnell T, 2004, NEUROPSYCHOBIOLOGY, V50, P273, DOI 10.1159/000080952; Oh MM, 2013, J NEUROSCI, V33, P7905, DOI 10.1523/JNEUROSCI.5457-12.2013; Paspalas CD, 2013, CEREB CORTEX, V23, P1643, DOI 10.1093/cercor/bhs152; Peters A., 1991, FINE STRUCTURE NERVO, V3rd ed.; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Puumala T, 1997, PHARMACOL BIOCHEM BE, V56, P705, DOI 10.1016/S0091-3057(96)00408-X; Rajbhandari AK, 2015, J NEUROSCI, V35, P14270, DOI 10.1523/JNEUROSCI.5080-14.2015; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Smith C, 2016, PSYCHIAT ANN, V46, P553, DOI 10.3928/00485713-20160728-01; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; Stein MB, 2002, AM J PSYCHIAT, V159, P1777, DOI 10.1176/appi.ajp.159.10.1777; Taguchi K, 1998, N-S ARCH PHARMACOL, V357, P100, DOI 10.1007/PL00005143; Taylor FB, 2006, BIOL PSYCHIAT, V59, P577, DOI 10.1016/j.biopsych.2005.09.023; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang HX, 2013, NEUROSCIENCE, V246, P312, DOI 10.1016/j.neuroscience.2013.05.009; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; WATERHOUSE BD, 1981, NEUROPHARMACOLOGY, V20, P907, DOI 10.1016/0028-3908(81)90020-4; Wee S, 2008, EUR NEUROPSYCHOPHARM, V18, P303, DOI 10.1016/j.euroneuro.2007.08.003; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Winder-Rhodes SE, 2010, J PSYCHOPHARMACOL, V24, P1649, DOI 10.1177/0269881109105899; Zhang ZH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0065268, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0056344]; Zhou XY, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv060	70	11	11	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 3	2019	39	14					2722	2734		10.1523/JNEUROSCI.2472-18.2019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HR5BH	WOS:000463161100012	30755491	Bronze, Green Published			2022-02-06	
J	Chen, CL; Zhou, FF; Zeng, LW; Jiang, Z; Hu, ZP				Chen, Chunli; Zhou, Fangfang; Zeng, Liuwang; Jiang, Zheng; Hu, Zhiping			Methylene blue offers neuroprotection after intracerebral hemorrhage in rats through the PI3K/Akt/GSK3 signaling pathway	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						apoptosis; GSK3; inflammation; intracerebral hemorrhage (ICH); methylene blue (MB); phosphoinositide 3-kinase (PI3K); Akt	GLYCOGEN-SYNTHASE KINASE-3-BETA; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; GSK-3-BETA INHIBITION; CEREBRAL-ISCHEMIA; MOUSE MODEL; INFLAMMATION; ACTIVATION; MECHANISMS; CELL	Inflammation and apoptosis are two key factors contributing to secondary brain injury after intracerebral hemorrhage (ICH). In the present study, we explored the neuroprotective role of methylene blue (MB) in ICH rats and studied the potential mechanisms involved. Rats were subjected to local injection of collagenase IV in the striatum or sham surgery. We observed that MB treatment could exert a neuroprotective effect on ICH by promoting neurological scores, decreasing the brain water content, alleviating brain-blood barrier disruption, and improving the histological damages in the perihematomal areas. Furthermore, we demonstrated that the various mechanisms underlying MB's neuroprotective effects linked to inhibited apoptosis and inhibited neuroinflammation. In addition, wortmannin, a selective inhibitor of phosphoinositide 3-kinase (PI3K), could reverse the antiapoptotic and anti-inflammatory effects of MB, which suggested that the PI3K-Akt pathway played an important role. In conclusion, these data suggested that MB could inhibit apoptosis and ameliorate neuroinflammation after ICH, and its neuroprotective effects might be exerted via the activation of the PI3K/Akt/GSK3 pathway.	[Chen, Chunli; Zhou, Fangfang; Zeng, Liuwang; Jiang, Zheng; Hu, Zhiping] Cent S Univ, Xiangya Hosp 2, Dept Neurol, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China		Hu, ZP (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Neurol, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China.	zhipinghu@csu.edu.cn		hu, zhiping/0000-0001-5672-9683	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400994]; Hunan Provincial Innovation Foundation for Postgraduate [CX2017B070]	The National Natural Science Foundation of China, Grant/Award Number: 81400994; Hunan Provincial Innovation Foundation for Postgraduate, Grant/Award Number: CX2017B070	Chau M, 2011, ACTA NEUROCHIR SUPPL, V111, P299, DOI 10.1007/978-3-7091-0693-8_50; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen KK, 2014, APOPTOSIS, V19, P946, DOI 10.1007/s10495-014-0977-0; Chen M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0284-x; Chen S, 2015, TRANSL STROKE RES, V6, P4, DOI 10.1007/s12975-014-0384-4; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Di Y, 2015, MOL MED, V21, P420, DOI 10.2119/molmed.2015.00038; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Ginimuge Prashant R, 2010, J Anaesthesiol Clin Pharmacol, V26, P517; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hu X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3215391; Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870; Jiang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131929; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kelly S, 2004, EXP NEUROL, V188, P378, DOI 10.1016/j.expneurol.2004.04.004; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Li WS, 2018, NEUROSCIENCE, V383, P129, DOI 10.1016/j.neuroscience.2018.05.001; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mikulik R, 2015, J INTERN MED, V278, P145, DOI 10.1111/joim.12387; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Murthy SB, 2015, STROKE, V46, P3088, DOI 10.1161/STROKEAHA.115.010054; Pan C, 2018, MOL NEUROBIOL, V55, P1556, DOI 10.1007/s12035-016-0363-8; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46243; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Wei YC, 2017, INFLAMMATION, V40, P1297, DOI 10.1007/s10753-017-0573-x; Wilson D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2484; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xu HZ, 2017, BRAIN BEHAV IMMUN, V65, P125, DOI 10.1016/j.bbi.2017.04.020; Yu AY, 2016, MOL IMMUNOL, V73, P151, DOI 10.1016/j.molimm.2016.04.003; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Yuan BQ, 2015, J NEUROIMMUNOL, V287, P71, DOI 10.1016/j.jneuroim.2015.08.002; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00174; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307; Zhao HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23286; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551; Zhao YY, 2017, CELL TRANSPLANT, V26, P395, DOI 10.3727/096368916X694364; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	52	11	11	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	APR	2019	234	4					5304	5318		10.1002/jcp.27339			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HK0TE	WOS:000457613700179	30216439				2022-02-06	
J	Elkbuli, A; Narvel, RI; Spano, PJ; Polcz, V; Casin, A; Hai, S; Boneva, D; McKenney, M				Elkbuli, Adel; Narvel, Raed Ismail; Spano, Paul J., II; Polcz, Valerie; Casin, Astrid; Hai, Shaikh; Boneva, Dessy; McKenney, Mark			Early versus Late Tracheostomy: Is There an Outcome Difference?	AMERICAN SURGEON			English	Article							MECHANICAL VENTILATION; IMPACT	The effect of timing in patients requiring tracheostomy varies in the literature. The purpose of this study was to evaluate the impact of early tracheostomy on outcomes in trauma patients with and without traumatic brain injury (TBI). This study is a four-year review of trauma patients undergoing tracheostomy. Patients were divided into two groups based on TBI/non-TBI. Each group was divided into three subgroups based on tracheostomy timing: zero to three days, four to seven days, and greater than seven days postadmission. TBI patients were stratified by the Glasgow Coma Scale (GCS), and non-TBI patients were stratified by the Injury Severity Score (ISS). The primary outcome was ventilator-free days (VFDs). Significance was defined as P < 0.05. Two hundred eighty-nine trauma patients met the study criteria: 151 had TBI (55.2%) versus 138 (47.8%) non-TBI. There were no significant differences in demographics within and between groups. In TBI patients, statistically significant increases in VFDs were observed with GCS 13 to 15 for tracheostomies performed in four to seven versus greater than seven days (P = 0.005). For GCS <8 and 8 to 12, there were significant increases in VFDs for tracheostomies performed at days 1 to 3 and 4 to 7 versus greater than seven days (P << 0.05 for both). For non-TBI tracheostomies, only ISS >= 25 with tracheostomies performed at zero to three days versus greater than seven days was associated with improved VFDs. Early tracheostomies in TBI patients were associated with improved VFDs. In trauma patients with no TBI, early tracheostomy was associated with improved VFDs only in patients with ISS >= 25. Future research studies should investigate reasons TBI and non-TBI patients may differ.	[Elkbuli, Adel; Narvel, Raed Ismail; Spano, Paul J., II; Polcz, Valerie; Casin, Astrid; Hai, Shaikh; Boneva, Dessy; McKenney, Mark] Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA; [Boneva, Dessy; McKenney, Mark] Univ S Florida, Tampa, FL USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA.	Adel.Elkbuli@hcahealthcare.com	Elkbuli, Adel/AAK-7374-2021				Bodet-Contentin L, 2018, CRIT CARE MED, V46, P425, DOI 10.1097/CCM.0000000000002890; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Combes A, 2007, CRIT CARE MED, V35, P802, DOI 10.1097/01.CCM.0000256721.60517.B1; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Herritt B, 2018, J CRIT CARE, V44, P285, DOI 10.1016/j.jcrc.2017.11.037; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Lee JC, 2005, CRIT CARE, V9, DOI 10.1186/cc3759; Liu CC, 2016, JAMA OTOLARYNGOL, V142, P981, DOI 10.1001/jamaoto.2016.1829; Correia IAM, 2014, BRAZ J OTORHINOLAR, V80, P428, DOI 10.1016/j.bjorl.2014.07.008; Shibahashi K, 2017, BRIT J NEUROSURG, V31, P564, DOI 10.1080/02688697.2017.1302071; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154; 2005, AM J SURG, V189, P293, DOI DOI 10.1016/J.AMJSURG.2005.01.002	14	11	11	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2019	85	4					370	375					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HW3RX	WOS:000466611500027	31043197				2022-02-06	
J	Fanton, M; Kuo, C; Sganga, J; Hernandez, F; Camarillo, DB				Fanton, Michael; Kuo, Calvin; Sganga, Jake; Hernandez, Fidel; Camarillo, David B.			Dependency of Head Impact Rotation on Head-Neck Positioning and Soft Tissue Forces	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Musculoskeletal biomechanics; concussion; manipulator dynamics; injury biomechanics	SEGMENT DYNAMIC STABILIZATION; CERVICAL-SPINE; PROFESSIONAL FOOTBALL; MUSCLE STRENGTH; BRAIN STRAIN; CONCUSSION; WOODPECKER; STIFFNESS; BIOMECHANICS; ACCELERATIONS	Objective: Humans are susceptible to traumatic brain injuries from rapid head rotations that shear and stretch the brain tissue. Conversely, animals such as woodpeckers intentionally undergo repetitive head impacts without apparent injury. Here, we represent the head as the end effector of a rigid linkage cervical spine model to quantify how head angular accelerations are affected by the linkage positioning (head-neck configuration) and the soft tissue properties (muscles, ligaments, tendons). Methods: We developed a two-pivot manipulator model of the human cervical spine with passive torque elements to represent soft tissue forces. Passive torque parameters were fit against five human subjects undergoing mild laboratory head impacts with tensed and relaxed neck muscle activations. With this representation, we compared the effects of the linkage configuration dependent end-effector inertial properties and the soft tissue resistive forces on head impact rotation. Results: Small changes in cervical spine positioning (<5 degrees) can drastically affect the resulting rotational head accelerations (>100%) following an impact by altering the effective end-effector inertia. Comparatively, adjusting the soft tissue torque elements from relaxed to tensed muscle activations had a smaller (<30%) effect on maximum rotational head accelerations. Extending our analysis to a woodpecker rigid linkage model, we postulate that woodpeckers experience relatively minimal head impact rotation due to the configuration of their skeletal anatomy. Conclusion: Cervical spine positioning dictates the head angular acceleration following an impact, rather than the soft tissue torque elements. Significance: This analysis quantifies the importance of head positioning prior to impact, and may help us to explain why other species are naturally more resilient to head impacts than humans.	[Fanton, Michael; Kuo, Calvin; Hernandez, Fidel] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Sganga, Jake; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Fanton, M (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	mfanton@stanford.edu	Kuo, Calvin/AAH-1933-2019	Kuo, Calvin/0000-0001-8401-9136; fanton, michael/0000-0001-8566-5260	Stanford University Child Health Research Institute; Stanford Bio-X Fellowship Program; Office of Naval Research Young Investigator ProgramOffice of Naval Research [N00014-16-1-2949]; NSF Graduate Research Fellowship ProgramNational Science Foundation (NSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008412] Funding Source: NIH RePORTER	This work was supported in part by the Stanford University Child Health Research Institute, in part by the Stanford Bio-X Fellowship Program, in part by the Office of Naval Research Young Investigator Program (N00014-16-1-2949), and in part by the NSF Graduate Research Fellowship Program.	Alvarez Victor S, 2014, Stapp Car Crash J, V58, P63; Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6; Bosio A. C., 1986, P 30 STAPP CAR CRASH; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; deJager M., 1993, IRCOBI C BIOM IMP, P213; Demircan E, 2016, SPRINGER TRAC ADV RO, V109, P685, DOI 10.1007/978-3-319-23778-7_45; Drake A, 2016, ACTA BIOMATER, V44, P41, DOI 10.1016/j.actbio.2016.08.019; Eckersley C.P., 2017, P IRCOBI C, P674; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2018, CLIN BIOMECH; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Jung JY, 2016, ACTA BIOMATER, V37, P1, DOI 10.1016/j.actbio.2016.03.030; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; Khatib O, 2009, J PHYSIOL-PARIS, V103, P211, DOI 10.1016/j.jphysparis.2009.08.004; KHATIB O, 1995, INT J ROBOT RES, V14, P19, DOI 10.1177/027836499501400103; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knowles BM, 2017, J BIOMECH, V59, P59, DOI 10.1016/j.jbiomech.2017.05.016; Kuo C., 2018, J BIOMECH; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Liu YZ, 2017, INT J IMPACT ENG, V108, P263, DOI 10.1016/j.ijimpeng.2017.05.016; Liu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122677; Mansell J, 2005, J ATHL TRAINING, V40, P310; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; MCGILL SM, 1994, CLIN BIOMECH, V9, P193, DOI 10.1016/0268-0033(94)90021-3; Mertz H. J., 1971, STRENGTH RESPONSE HU, P2903; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Nightingale RW, 2016, J BIOMECH, V49, P558, DOI 10.1016/j.jbiomech.2016.01.006; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Portero R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139333; Portero R, 2013, J BIOMECH, V46, P925, DOI 10.1016/j.jbiomech.2012.12.009; Post A., 2012, P IRCOBI C 2012 DUBL, P419; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; SHEA M, 1991, J BIOMECH, V24, P95, DOI 10.1016/0021-9290(91)90354-P; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Staff D., 2011, PICOIDES ALBOLARVATU; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Vincent IFV, 2007, P I MECH ENG C-J MEC, V221, P1141, DOI 10.1243/09544062JMES574; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Zhu ZD, 2014, SCI CHINA TECHNOL SC, V57, P1269, DOI 10.1007/s11431-014-5582-5	54	11	11	1	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	APR	2019	66	4					988	999		10.1109/TBME.2018.2866147			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HQ4EP	WOS:000462363300009	30130169	Bronze			2022-02-06	
J	Flaherty, E; Legano, L; Idzerda, S; Sirotnak, AP; Budzak, AE; Gavril, AR; Haney, SB; Laskey, A; Legano, LA; Messner, SA; Moles, RL; Palsuci, VJ; Harmon, SL; Fortson, B; MacMillan, H; Stedt, E; Hurley, TP				Flaherty, Emalee; Legano, Lori; Idzerda, Sheila; Sirotnak, Andrew P.; Budzak, Ann E.; Gavril, Amy R.; Haney, Suzanne B.; Laskey, Antoinette Toni; Legano, Lori A.; Messner, Stephen A.; Moles, Rebecca L.; Palsuci, Vincent J.; Harmon, Sara L.; Fortson, Beverly; MacMillan, Harriet; Stedt, Elaine; Hurley, Tammy Piazza		Council Child Abuse Neglect	Ongoing Pediatric Health Care for the Child Who Has Been Maltreated	PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; ABUSIVE HEAD TRAUMA; RISK-FACTORS; HOUSEHOLD DYSFUNCTION; PUBERTAL DEVELOPMENT; MATERNAL DEPRESSION; DATING VIOLENCE; NATIONAL-SURVEY; PHYSICAL ABUSE; UNITED-STATES	Pediatricians provide continuous medical care and anticipatory guidance for children who have been reported to state child protection agencies, including tribal child protection agencies, because of suspected child maltreatment. Because families may continue their relationships with their pediatricians after these reports, these primary care providers are in a unique position to recognize and manage the physical, developmental, academic, and emotional consequences of maltreatment and exposure to childhood adversity. Substantial information is available to optimize follow-up medical care of maltreated children. This new clinical report will provide guidance to pediatricians about how they can best oversee and foster the optimal physical health, growth, and development of children who have been maltreated and remain in the care of their biological family or are returned to their care by Child Protective Services agencies. The report describes the pediatrician's role in helping to strengthen families' and caregivers' capabilities and competencies and in promoting and maximizing high-quality services for their families in their community. Pediatricians should refer to other reports and policies from the American Academy of Pediatrics for more information about the emotional and behavioral consequences of child maltreatment and the treatment of these consequences.	[Flaherty, Emalee] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Legano, Lori] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Idzerda, Sheila] Billings Clin Bozeman Acorn Pediat, Bozeman, MT USA; [Harmon, Sara L.] AAP Sect Pediat Trainees, Itasca, IL USA; [Fortson, Beverly] Ctr Dis Control & Prevent, Atlanta, GA USA; [MacMillan, Harriet] Amer Acad Child & Adolescent Psychiat, Washington, DC USA; [Stedt, Elaine] Adm Children Youth & Families, Off Child Abuse & Neglect, Washington, DC USA		Flaherty, E (corresponding author), Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA.	e-flaherty@northwestern.edu	MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X			Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; [Anonymous], 2015, PEDIATRICS, V136, p4S; [Anonymous], 2015, PEDIATRICS, V136, p4S; [Anonymous], 2005, AMERICAN ACADEMY OF, pA15; Barlow KM, 2005, PEDIATRICS, V116, pe174; Bernard K, 2012, CHILD DEV, V83, P623, DOI 10.1111/j.1467-8624.2011.01712.x; Bonanno GA, 2008, PEDIATRICS, V121, P369, DOI 10.1542/peds.2007-1648; Boynton-Jarrett R, 2013, J ADOLESCENT HEALTH, V52, P241, DOI 10.1016/j.jadohealth.2012.06.006; BRAYDEN RM, 1995, CHILD ABUSE NEGLECT, V19, P1255, DOI 10.1016/0145-2134(95)00078-M; Brown JD, 2008, AMBUL PEDIATR, V8, P368, DOI 10.1016/j.ambp.2008.08.004; Campbell KA, 2017, QUAL HEALTH RES, V27, P155, DOI 10.1177/1049732315625197; Campbell KA, 2010, ARCH PEDIAT ADOL MED, V164, P943, DOI 10.1001/archpediatrics.2010.166; Chaffin M, 1996, CHILD ABUSE NEGLECT, V20, P191, DOI 10.1016/S0145-2134(95)00144-1; CHERNOFF R, 1994, PEDIATRICS, V93, P594; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Christian CW, 2011, PEDIATRICS, V127, P139, DOI 10.1542/peds.2010-2297; Clark CJ, 2014, PEDIATRICS, V134, P678, DOI 10.1542/peds.2014-1179; Connell CM, 2007, CHILD ABUSE NEGLECT, V31, P573, DOI 10.1016/j.chiabu.2006.12.004; Connell CM, 2009, CHILD ABUSE NEGLECT, V33, P218, DOI 10.1016/j.chiabu.2008.07.005; Conron KJ, 2009, ARCH PEDIAT ADOL MED, V163, P922, DOI 10.1001/archpediatrics.2009.176; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crawford-Jakubiak JE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4243; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Dakil SR, 2011, ARCH PEDIAT ADOL MED, V165, P1006, DOI 10.1001/archpediatrics.2011.129; De Sanctis V, 2015, PEDIATR ENDOCR REV P, V13, P458; DePanfilis D, 2002, CHILD ABUSE NEGLECT, V26, P187, DOI 10.1016/S0145-2134(01)00316-7; DePanfilis D., 1998, CHILD MALTREATMENT, V3, P27, DOI DOI 10.1177/1077559598003001003; Diaz A, 2002, ARCH PEDIAT ADOL MED, V156, P811, DOI 10.1001/archpedi.156.8.811; Dubowitz H, 2001, PEDIATRICS, V107, P728, DOI 10.1542/peds.107.4.728; Dubowitz H, 2014, PEDIATR ANN, V43, P444, DOI 10.3928/00904481-20141022-07; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Duffee JH, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2150; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; Eastman AL, 2016, CHILD ABUSE NEGLECT, V55, P22, DOI 10.1016/j.chiabu.2016.03.002; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P479, DOI 10.1016/j.chiabu.2006.03.012; Finkelhor D, 2015, JAMA PEDIATR, V169, P746, DOI 10.1001/jamapediatrics.2015.0676; Fiscella K, 1998, PEDIATRICS, V101, P620, DOI 10.1542/peds.101.4.620; Fisher-Owens SA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1487; Flaherty EG, 2004, CHILD ABUSE NEGLECT, V28, P939, DOI 10.1016/j.chiabu.2004.03.013; Flaherty EG, 2006, CHILD MALTREATMENT, V11, P361, DOI 10.1177/1077559506292287; Fluke JD, 2008, CHILD MALTREATMENT, V13, P76, DOI 10.1177/1077559507311517; Forget-Dubois N, 2009, CHILD DEV, V80, P736, DOI 10.1111/j.1467-8624.2009.01294.x; Gamer AS, 2012, PEDIATRICS, V129, pe224; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Goh PK, 2016, J PEDIATR-US, V177, P121, DOI 10.1016/j.jpeds.2016.06.047; Hagan JF, 2017, BRIGHT FUTURES GUIDE, V4th; Hager ER, 2010, PEDIATRICS, V126, pe26; Heller SS, 1999, CHILD ABUSE NEGLECT, V23, P321; Henrichs KL, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-14; High PE, 2012, PEDIATRICS, V130, P1170, DOI 10.1542/peds.2012-2603; High PC, 2008, PEDIATRICS, V121, pe1008; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Homan GJ, 2016, AM FAM PHYSICIAN, V94, P295; Howell KH, 2014, CHILD ABUSE NEGLECT, V38, P1985, DOI 10.1016/j.chiabu.2014.10.010; Hoyme HE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4256; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Jaffee SR, 2013, DEV PSYCHOPATHOL, V25, P1225, DOI 10.1017/S0954579413000588; Jimenez ME, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1839; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Jonson-Reid M, 2012, PEDIATRICS, V129, P839, DOI 10.1542/peds.2011-2529; Keenan HT, 2007, PEDIATRICS, V119, pe616, DOI 10.1542/peds.2006-2313; Keeshin B, 2019, PEDIATRICS; KELLEHER K, 1994, AM J PUBLIC HEALTH, V84, P1586, DOI 10.2105/AJPH.84.10.1586; Klein S, 2011, CHILD MALTREATMENT, V16, P300, DOI 10.1177/1077559511428801; Klika JB, 2013, TRAUMA VIOLENCE ABUS, V14, P222, DOI 10.1177/1524838013487808; Knight KM, 2010, MED TEACH, V32, P790; Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824; Leake R, 2012, CHILD WELFARE, V91, P47; Li L, 2014, INT J EPIDEMIOL, V43, P1163, DOI 10.1093/ije/dyu071; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; Maclean MJ, 2016, CHILD ABUSE NEGLECT, V51, P120, DOI 10.1016/j.chiabu.2015.10.026; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; MacMillan HL, 2005, LANCET, V365, P1786, DOI 10.1016/S0140-6736(05)66388-X; Masten AS, 2014, CHILD DEV, V85, P6, DOI 10.1111/cdev.12205; MCMAHON P, 1995, J BONE JOINT SURG AM, V77A, P1179, DOI 10.2106/00004623-199508000-00006; McPheeters ML, 2016, SCREENING AUTISM SPE; Mendle J, 2014, J RES ADOLESCENCE, V24, P689, DOI 10.1111/jora.12075; Miller TR, 2014, PEDIATRICS, V134, pe1545; Mills R, 2011, PEDIATRICS, V127, P4, DOI 10.1542/peds.2009-3479; MRAZEK PJ, 1987, CHILD ABUSE NEGLECT, V11, P357, DOI 10.1016/0145-2134(87)90009-3; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Negriff S, 2015, DEV PSYCHOBIOL, V57, P984, DOI 10.1002/dev.21340; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Nuno M, 2015, J NEUROSURG-PEDIATR, V16, P515, DOI 10.3171/2015.3.PEDS14544; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Olds D, 2013, PEDIATRICS, V132, pS110, DOI 10.1542/peds.2013-1021I; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; Olds DL, 2007, PEDIATRICS, V120, pe832; Pau-Charles I, 2012, ACTAS DERMO-SIFILOGR, V103, P94, DOI 10.1016/j.ad.2011.05.004; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Phoenix A, 2016, SOCIAL WORK SOC INT, V14; Pierce MC, 2010, PEDIATRICS, V125, P67, DOI 10.1542/peds.2008-3632; Pierce MC, 2008, PED AC SOC M MAY; Pietrantonio AM, 2013, CHILD ABUSE NEGLECT, V37, P102, DOI 10.1016/j.chiabu.2012.12.007; Power C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119985; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Proctor LJ, 2012, CHILD MALTREATMENT, V17, P207, DOI 10.1177/1077559512448472; Putnam-Hornstein E, 2015, CHILD MALTREATMENT, V20, P92, DOI 10.1177/1077559514558586; Raikes HH, 2013, MONOGR SOC RES CHILD, V78, P1, DOI 10.1111/j.1540-5834.2012.00700.x; Ramchandani PG, 2008, J AM ACAD CHILD PSY, V47, P390, DOI 10.1097/CHI.0b013e31816429c2; Ramchandani PG, 2011, DEPRESS ANXIETY, V28, P471, DOI 10.1002/da.20814; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Risen SR, 2014, J PEDIATR-US, V164, P613, DOI 10.1016/j.jpeds.2013.10.075; Robinson CL, 2017, MMWR-MORBID MORTAL W, V66, P134, DOI 10.15585/mmwr.mm6605e1; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Ryan RM, 2015, J ADOLESCENT HEALTH, V57, P342, DOI 10.1016/j.jadohealth.2015.06.005; Sanders MR, 2007, J ABNORM CHILD PSYCH, V35, P983, DOI 10.1007/s10802-007-9148-x; Sanders MR, 2017, CLIN CHILD FAM PSYCH, V20, P36, DOI 10.1007/s10567-017-0227-4; Sarche MC, 2012, CHILD DEV PERSPECT, V6, P42, DOI 10.1111/j.1750-8606.2011.00218.x; SCOTT D, 1992, CHILD ABUSE NEGLECT, V16, P345, DOI 10.1016/0145-2134(92)90044-R; Sege R, 2011, ACAD PEDIATR, V11, P460, DOI 10.1016/j.acap.2011.08.005; Sege RD, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3112; Sege RD, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0100; Sena AC, 2015, CLIN INFECT DIS, V61, pS856, DOI 10.1093/cid/civ786; Shonkoff JP, 2016, JAMA PEDIATR, V170, P1003, DOI 10.1001/jamapediatrics.2016.1559; Shonkoff JP, 2013, DEV PSYCHOPATHOL, V25, P1635, DOI 10.1017/S0954579413000813; Shonkoff JP, 2012, PEDIATRICS, V129, pe232; Spann MN, 2012, CHILD NEUROPSYCHOL, V18, P182, DOI 10.1080/09297049.2011.595400; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Szilagyi MA, 2015, PEDIATRICS, V136, pe1131; Taussig HN, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e10; Thackeray JD, 2007, PEDIATR EMERG CARE, V23, P735, DOI 10.1097/PEC.0b013e3181568039; Thomas R, 2012, CHILD MALTREATMENT, V17, P253, DOI 10.1177/1077559512459555; Tiet QQ, 1998, J AM ACAD CHILD PSY, V37, P1191, DOI 10.1097/00004583-199811000-00020; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; U. S. Department of Health and Human Services, 2014, CHILD WELF OUTC 2009; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2017, CHILD MALTR 2016; US Department of Health and Human Services, HOM VIS EV EFF; Vadivelu S, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16266; Weiss MJS, 1998, AM J PREV MED, V14, P356; Weitlauf AS, 2015, J DEV BEHAV PEDIATR, V36, P497, DOI 10.1097/DBP.0000000000000194; Westermeyer J, 1977, J Natl Med Assoc, V69, P231; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008; White OG, 2015, MED SCI LAW, V55, P259, DOI 10.1177/0025802414543855; Widom CS, 2012, AM J PUBLIC HEALTH, V102, P1135, DOI 10.2105/AJPH.2011.300636; Wolfe DA, 2001, J AM ACAD CHILD PSY, V40, P282, DOI 10.1097/00004583-200103000-00007; Zabin LS, 2005, J ADOLESCENT HEALTH, V36, P393, DOI 10.1016/j.jadohealth.2004.07.013; Zuckerman B, 2009, PEDIATRICS, V124, P1660, DOI 10.1542/peds.2009-1207	149	11	11	2	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2019	143	4							e20190284	10.1542/peds.2019-0284			16	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HQ9RO	WOS:000462765300032	30886109	Bronze			2022-02-06	
J	Jehan, F; Zeeshan, M; Kulvatunyou, N; Khan, M; O'Keeffe, T; Tang, A; Gries, L; Joseph, B				Jehan, Faisal; Zeeshan, Muhammad; Kulvatunyou, Narong; Khan, Muhammad; O'Keeffe, Terence; Tang, Andrew; Gries, Lynn; Joseph, Bellal			Is There a Need for Platelet Transfusion After Traumatic Brain Injury in Patients on P2Y12 Inhibitors?	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	13th Annual Meeting of the Academic-Surgical-Congress/Society-of-University-Surgeons/Association-for-Academic-Surgery (AAS)	JAN 30-FEB 01, 2018	Jacksonville, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg		Platelet transfusion; Traumatic brain injury; ICH	PREINJURY CLOPIDOGREL; ANTIPLATELET AGENTS; FACTOR VIIA; ASPIRIN; OUTCOMES; MORTALITY; THERAPY	Background: A significant portion of patients sustaining traumatic brain injury (TBI) are on antiplatelet medications. The reversal of P2Y12 agents after intracranial hemorrhage (ICH) remains unclear. The aim of our study is to evaluate outcomes after TBI in patients who are on preinjury P2Y12 inhibitors and received a platelet transfusion. Methods: We analyzed our prospectively maintained TBI database from 2013 to 2016 and included all patients with isolated ICH who were on P2Y12 inhibitors (Clopidogrel, Prasugrel, Ticagrelor). Regression analysis was performed adjusting for demographics and injury parameters. Outcome measures included progression of ICH, adverse discharge disposition (skilled nursing facility), and mortality. Results: A total 243 patients with ICH on preinjury P2Y12 inhibitor met our inclusion criteria and were analyzed. Mean age was 55 +/- 18 y, 58% were males and 60% were white and median injury severity score was 13 [9-18]. 73.6% received platelet transfusion after admission. The median packs of platelet transfusion were 1 [1-2] units. After controlling for confounders, patients who received platelet transfusion had a lower rate of progression (OR: 0.68, P = 0.01) and decreased rate of neurosurgical intervention (OR: 0.80, P = 0.03). Overall mortality was 12.3%. Patients on P2Y12 inhibitors who received platelet transfusion had lower odds of discharge to a skilled nursing facility (OR: 0.75, P = 0.02) and mortality (OR: 0.85, P = 0.04). Conclusions: Platelet transfusion after isolated traumatic ICH in patients on P2Y12 inhibitors is associated with improved outcomes. Platelet transfusion was associated with decreased risk of progression of ICH, neurosurgical intervention, and mortality. Further randomized studies to validate the use of platelet transfusion and define the optimal dose in patients on P2Y12 inhibitors are warranted. (C) 2018 Elsevier Inc. All rights reserved.	[Jehan, Faisal; Zeeshan, Muhammad; Kulvatunyou, Narong; Khan, Muhammad; O'Keeffe, Terence; Tang, Andrew; Gries, Lynn; Joseph, Bellal] Univ Arizona, Dept Surg Crit Care Emergency Surg & Burns, Div Trauma, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma, Crit Care & Emergency Surg, 1501 North Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Altman R, 2006, J THROMB HAEMOST, V4, P2022, DOI 10.1111/j.1538-7836.2006.02088.x; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Downey DM, 2009, AM SURGEON, V75, P1100; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kaufmann JE, 2003, J THROMB HAEMOST, V1, P682, DOI 10.1046/j.1538-7836.2003.00190.x; Kjalke M, 1997, THROMB HAEMOSTASIS, V78, P1202; Langlois JA., 2004, TRAUMATIC BRAIN INJU; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; MILLS DCB, 1992, ARTERIOSCLER THROMB, V12, P430, DOI 10.1161/01.ATV.12.4.430; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Serebruany VL, 2003, AM HEART J, V146, P713, DOI 10.1016/S0002-8703(03)00260-6; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	22	11	11	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2019	236						224	229		10.1016/j.jss.2018.11.050			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	HL1XR	WOS:000458498300030	30694760				2022-02-06	
J	Scarneo, SE; Kerr, ZY; Kroshus, E; Register-Mihalik, JK; Hosokawa, Y; Stearns, RL; DiStefano, LJ; Casa, DJ				Scarneo, Samantha E.; Kerr, Zachary Y.; Kroshus, Emily; Register-Mihalik, Johna K.; Hosokawa, Yuri; Stearns, Rebecca L.; DiStefano, Lindsay J.; Casa, Douglas J.			The Socioecological Framework: A Multifaceted Approach to Preventing Sport-Related Deaths in High School Sports	JOURNAL OF ATHLETIC TRAINING			English	Article						intervention adoption; health behavior; sudden death	SUDDEN CARDIAC-ARREST; ATHLETIC TRAINERS; CONCUSSION; ASSOCIATION; MANAGEMENT; HEALTH; INTERVENTIONS; ADOLESCENTS; OUTCOMES	The socioecological framework is a multilevel conceptualization of health that includes intrapersonal, interpersonal, organizational, environmental, and public policy factors. The socioecological framework emphasizes multiple levels of influence and supports the idea that behaviors both affect and are affected by various contexts. At present, the sports medicine community's understanding and application of the socioecological framework are limited. In this article, we use the socioecological framework to describe potential avenues for interventions to reduce sport-related deaths among adolescent participants.	[Scarneo, Samantha E.; Stearns, Rebecca L.; Casa, Douglas J.] Univ Connecticut, Dept Kinesiol, Korey Stringer Inst, 2095 Hillside Rd,Unit 1110, Storrs, CT 06269 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Hosokawa, Yuri] Ritsumeikan Univ, Coll Sport & Hlth Sci, Shiga, Japan; [DiStefano, Lindsay J.] Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA		Scarneo, SE (corresponding author), Univ Connecticut, Dept Kinesiol, Korey Stringer Inst, 2095 Hillside Rd,Unit 1110, Storrs, CT 06269 USA.	samantha.scarneo@uconn.edu	Hosokawa, Yuri/ABC-8704-2020	Hosokawa, Yuri/0000-0001-9138-5361			Adams WM, 2017, ORTHOP J SPORTS MED, V5, P1; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Cooper ER, 2016, J ATHL TRAINING, V51, P593, DOI 10.4085/1062-6050-51.8.08; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Drezner JA, 2007, PREHOSP EMERG CARE, V11, P253, DOI 10.1080/10903120701204839; Drezner JA, 2013, BRIT J SPORT MED, V47, P1179, DOI 10.1136/bjsports-2013-092786; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Gamst F. C, 1991, ANTHR WORK REV, V12, P19; Heffernan C.J., 1988, BEHAV CHANGE, V5, P37; Kajankova M, 2017, J SCHOOL HEALTH, V87, P409, DOI 10.1111/josh.12508; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Khodaee M, 2015, CURR SPORT MED REP, V14, P435, DOI 10.1249/JSR.0000000000000206; Kirby D., 2007, RES FINDINGS PROGRAM; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lynn J, 2014, J ALLERGY CLIN IMMUN, V134, P1238, DOI 10.1016/j.jaci.2014.09.040; Mazerolle SM, 2010, J ATHL TRAINING, V45, P170, DOI 10.4085/1062-6050-45.2.170; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mueller FO, 2015, CATASTROPHIC SPORTS, V31, P737; National Athletic Trainers' Association, 2013, CONS STAT SICKL CELL; Rav-Acha M, 2004, AM J MED SCI, V328, P84, DOI 10.1097/00000441-200408000-00003; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Rimal RN, 2016, COMMU RES, V32, P389; Sallis JF, 2008, HLTH ED THEORY RES P, P23; Sapien RE, 2001, PEDIATR EMERG CARE, V17, P1; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Smedley BD, 2001, AM J HEALTH PROMOT, V15, P149, DOI 10.4278/0890-1171-15.3.149; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Walsh KM, 2013, J ATHL TRAINING, V48, P258, DOI 10.4085/1062-6050-48.2.25; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; 2012, HEALTH EDUC BEHAV, V39, P229, DOI DOI 10.1177/1090198111415105	35	11	11	3	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2019	54	4					356	360		10.4085/1062-6050-173-18			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HY0LT	WOS:000467804100002	30870600	gold, Green Published			2022-02-06	
J	Swaminathan, A; Basu, M; Bekri, A; Drapeau, P; Kundu, TK				Swaminathan, Amrutha; Basu, Moumita; Bekri, Abdelhamid; Drapeau, Pierre; Kundu, Tapas K.			The Dietary Flavonoid, Luteolin, Negatively Affects Neuronal Differentiation	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						flavonoid; embryonic stem cells; neuronal differentiation; lysine acetyltransferase; p300	REGULATED EXPRESSION; PC12 CELLS; APIGENIN; P300; INHIBITION; DEFECTS; CBP	Luteolin, a polyphenolic plant flavonoid, has been attributed with numerous beneficial properties like anti-cancer, antioxidant, and anti-inflammatory action. Luteolin has been reported earlier to be neuroprotective in models of spinal cord injury and traumatic brain injury and also induces neurite outgrowth in PC12 cells. However, the effect of luteolin on early differentiation, which might be important for its beneficial effects, is unknown. In this report, we show that luteolin negatively affects early differentiation of embryonic stem cells, hampering the formation of embryoid bodies. At later stages of differentiation, luteolin specifically inhibits neuronal differentiation, where the expression of early neuronal markers is suppressed, whereas luteolin treatment does not inhibit expression of meso- and endodermal markers. Further, in a developing zebrafish model, luteolin treatment leads to fewer numbers of mitotic cells in the brain. These specific effects of luteolin on neuronal differentiation could possibly be due to its ability to inhibit the lysine acetyltransferase, p300, since the structurally closely related p300 non-inhibitor flavonoid, apigenin, does not inhibit neuronal differentiation. These results show that luteolin perturbs neuronal differentiation of embryonic stem cells.	[Swaminathan, Amrutha; Basu, Moumita; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bengaluru, India; [Swaminathan, Amrutha; Bekri, Abdelhamid] Univ Montreal, Dept Biochem, Montreal, PQ, Canada; [Bekri, Abdelhamid; Drapeau, Pierre] Univ Montreal, Hosp Res Ctr CRCHUM, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Swaminathan, Amrutha] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel		Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bengaluru, India.	tapas@jncasr.ac.in	Swaminathan, Amrutha/F-8409-2016	Swaminathan, Amrutha/0000-0002-0177-3756; Kundu, Tapas/0000-0001-7790-214X	Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Sir JC Bose Fellowship; Department of Science and Technology (DST), IndiaDepartment of Science & Technology (India) [SR/S2/JCB-28/2010]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Council of Scientific and Industrial Research (CSIR), IndiaCouncil of Scientific & Industrial Research (CSIR) - India	This work was supported by Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Sir JC Bose Fellowship (to TK), Department of Science and Technology (DST), India (Grant No. SR/S2/JCB-28/2010) and a grant from the Canadian Institutes of Health Research (to PD). AS was, and MB is currently supported by Council of Scientific and Industrial Research (CSIR), India.	Barbierato M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16676; Chen ZC, 2018, ONCOL LETT, V15, P1559, DOI 10.3892/ol.2017.7475; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Lee JW, 2009, CYTOTECHNOLOGY, V61, P125, DOI 10.1007/s10616-010-9253-5; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Li X, 2017, NEUROSCIENCE, V364, P45, DOI 10.1016/j.neuroscience.2017.07.064; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Liu L, 2016, CELL BIOL INT, V40, P1094, DOI 10.1002/cbin.10648; Liu L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/534952; Lu XY, 2017, ONCOL LETT, V14, P1993, DOI 10.3892/ol.2017.6380; MOLNAR J, 1981, NEOPLASMA, V28, P11; Partanen M, 1999, INT J DEV BIOL, V43, P487; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Patil SP, 2014, NEUROPHARMACOLOGY, V86, P192, DOI 10.1016/j.neuropharm.2014.07.012; Samet I, 2015, DIFFERENTIATION, V89, P146, DOI 10.1016/j.diff.2015.07.001; Selvi RB, 2015, ONCOTARGET, V6, P43806, DOI 10.18632/oncotarget.6245; Skaper SD, 2018, MOL NEUROBIOL, V55, P103, DOI 10.1007/s12035-017-0722-0; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Tomioka T, 2014, NEUROSCI RES, V88, P39, DOI 10.1016/j.neures.2014.07.009; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xia N, 2016, EXP THER MED, V12, P4049, DOI 10.3892/etm.2016.3854; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	23	11	11	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAR 8	2019	12								41	10.3389/fnmol.2019.00041			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO4MG	WOS:000460896100001	30906251	Green Published, gold			2022-02-06	
J	Alofisan, TO; Algarni, YA; Alharfi, IM; Miller, MR; Stewart, TC; Fraser, DD; Tijssen, JA				Alofisan, Tariq O.; Algarni, Yasser A.; Alharfi, Ibrahim M.; Miller, Michael R.; Stewart, Tanya Charyk; Fraser, Douglas D.; Tijssen, Janice A.			Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury in Children: Prevalence, Risk Factors, and Outcome*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						acquired brain injury; critical care; dysautonomia; pediatric; traumatic brain injury	DYSAUTONOMIA; MANAGEMENT	Objective: To describe paroxysmal sympathetic hyperactivity in pediatric patients with severe traumatic brain injury using the new consensus definition, the risk factors associated with developing paroxysmal sympathetic hyperactivity, and the outcomes associated with paroxysmal sympathetic hyperactivity. Design: Retrospective cohort study. Setting: Academic children's hospital PICU. Patients: All pediatric patients more than 1 month and less than 18 years old with severe traumatic brain injury between 2000 and 2016. We excluded patients if they had a history of five possible confounders for paroxysmal sympathetic hyperactivity diagnosis or if they died within 24 hours of admission for traumatic brain injury. Measurements and Main Results: Our primary outcome was PICU mortality. One hundred seventy-nine patients met inclusion criteria. Thirty-six patients (20%) had at least eight criteria and therefore met classification of "likelihood of paroxysmal sympathetic hyperactivity." Older age was the only factor independently associated with developing paroxysmal sympathetic hyperactivity (odds ratio, 1.08; 95% CI, 1.00-1.16). PICU mortality was significantly lower for those with paroxysmal sympathetic hyperactivity compared with those without paroxysmal sympathetic hyperactivity (odds ratio, 0.08; 95% CI, 0.01-0.52), but PICU length of stay was greater in those with paroxysmal sympathetic hyperactivity (odds ratio, 4.36; 95% CI, 2.94-5.78), and discharge to an acute care or rehabilitation setting versus home was higher in those with paroxysmal sympathetic hyperactivity (odds ratio, 5.59; 95% CI, 1.26-24.84; odds ratio, 5.39; 95% CI, 1.87-15.57, respectively). When paroxysmal sympathetic hyperactivity was diagnosed in the first week of admission, it was not associated with discharge disposition. Conclusions: Our study suggests that the rate of paroxysmal sympathetic hyperactivity in patients with severe traumatic brain injury is higher than previously reported. Older age was associated with an increased risk for developing paroxysmal sympathetic hyperactivity, but severity of the trauma and the brain injury were not. For survivors of severe traumatic brain injury beyond 24 hours who developed paroxysmal sympathetic hyperactivity, there was a lower PICU mortality but also greater PICU length of stay and a lower likelihood of discharge home from the admitting hospital, suggesting that functional outcome in survivors with paroxysmal sympathetic hyperactivity is worse than survivors without paroxysmal sympathetic hyperactivity.	[Alofisan, Tariq O.] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh, Saudi Arabia; [Alofisan, Tariq O.] King Faisal Specialist Hosp & Res Ctr, Pediat Intens Care Unit, Riyadh, Saudi Arabia; [Algarni, Yasser A.] Imam Abdulrahman Bin Faisal Univ Hosp, Dept Pediat & Pediat Crit Care Med, Dammam, Saudi Arabia; [Alharfi, Ibrahim M.] King Fahad Med City, Childrens Hosp, Dept Pediat Crit Care, Riyadh, Saudi Arabia; [Miller, Michael R.; Fraser, Douglas D.; Tijssen, Janice A.] Childrens Hosp, London Hlth Sci Ctr, Dept Paediat, London, ON, Canada; [Miller, Michael R.; Fraser, Douglas D.; Tijssen, Janice A.] Childrens Hlth Res Inst, London, ON, Canada; [Stewart, Tanya Charyk] Western Univ, Dept Surg, London, ON, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada		Tijssen, JA (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Paediat, 800 Commissioners Rd E,POB 5010, London N6A5W9, ON, Canada.	janice.tijssen@lhsc.on.ca					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; American Heart Association The Heart and Stroke Foundation of Canada, 2016, HEART STROK FDN CAN; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Dennis EL, 2014, HUM BRAIN MAPP, V35, P1790, DOI 10.1002/hbm.22292; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; McDougal DH, 2015, COMPR PHYSIOL, V5, P439, DOI 10.1002/cphy.c140014; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Pozzi M, 2017, J HEAD TRAUMA REHAB, V32, P117, DOI 10.1097/HTR.0000000000000255; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Pozzi M, 2014, J NEUROTRAUM, V31, P1897, DOI 10.1089/neu.2014.3540; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Shiozaki T, 2005, CURR HYPERTENS REP, V7, P450, DOI 10.1007/s11906-005-0040-1; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738	32	11	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2019	20	3					252	258		10.1097/PCC.0000000000001811			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	HN4QS	WOS:000460169200013	30489486				2022-02-06	
J	Kelley, ME; Espeland, MA; Flood, WC; Powers, AK; Whitlow, CT; Maldjian, JA; Stitzel, JD; Urban, JE				Kelley, Mireille E.; Espeland, Mark A.; Flood, William C.; Powers, Alexander K.; Whitlow, Christopher T.; Maldjian, Joseph A.; Stitzel, Joel D.; Urban, Jillian E.			Comparison of head impact exposure in practice drills among multiple youth football teams	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						head impacts; biomechanics; pediatrics; head acceleration; football; injury; trauma	HIGH-SCHOOL FOOTBALL; LATER-LIFE; CONCUSSION; INJURIES; PARTICIPATION; ACCELERATION; MAGNITUDE; AGE	OBJECTIVE Limiting contact in football practice can reduce the number of head impacts a player receives, but further research is needed to inform the modification of optimal drills that mitigate head impact exposure (HIE) while the player develops the skills needed to safely play the game. This study aimed to compare HIE in practice drills among 6 youth football teams and to evaluate the effect of a team on HIE. METHODS On-field head impact data were collected from athletes (ages 10-13 years) playing on 6 local youth football teams (teams A-F) during all practices using the Head Impact Telemetry System. Video was recorded and analyzed to verify and assign impacts to a specific drill. Drills were identified as follows: dummy/sled tackling, half install, install, install walk through, multiplayer tackle, Oklahoma, one-on-one, open field tackling, other, passing, position skill work, scrimmage, special teams, tackling drill stations, and technique. HIE was quantified in terms of impacts per player per minute (ppm) and peak linear and rotational head acceleration. Generalized linear models were used to assess differences in head impact magnitude and frequency among drills as well as among teams within the most common drills. RESULTS Among 67 athlete-seasons, a total of 14,718 impacts during contact practices were collected and evaluated in this study. Among all 6 teams, the mean linear (p < 0.0001) and rotational (p < 0.0001) acceleration varied significantly among all drills. Open field tackling had significantly (p < 0.001) higher mean linear acceleration than all other drills. Multiplayer tackle had the highest mean impact rate (0.35 ppm). Significant variations in linear acceleration and impact rate were observed among teams within specific drills. Team A had the highest mean linear acceleration in install, one-on-one, and open field tackling and the highest mean impact rate in Oklahoma and position skill work. Although team A spent the greatest proportion of their practice on minimal- or no-player versus player contact drills (27%) compared to other teams, they had the highest median (20.2g) and 95th percentile (56.4g) linear acceleration in practice. CONCLUSIONS Full-speed tackling and blocking drills resulted in the highest HIE. Reducing time spent on contact drills relative to minimal or no contact drills may not lower overall HIE. Instead, interventions such as reducing the speed of players engaged in contact, correcting tackling technique, and progressing to contact may reduce HIE more effectively.	[Kelley, Mireille E.; Flood, William C.; Whitlow, Christopher T.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA; [Kelley, Mireille E.; Flood, William C.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC USA; [Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA		Urban, JE (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA.	jurban@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033	National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; National Center for Advancing Translational Sciences, NIH [KL2TR001421]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award nos. R01NS094410 and R01NS082453. The National Center for Advancing Translational Sciences, NIH, through grant no. KL2TR001421 supported Dr. Urban. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; We give special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. We also thank the youth football league's coordinators, coaches, parents, athletes, and athletic trainer whose support made this study possible. We also thank Danielle Rocheleau, Joeline Kane, Katie Fabian, Ana Katsafanas, Megan Anderson, Leslie Hoyt, Megan Rosenberg, Kate Middleton, Kat Beck, and Alexander Lord for their valuable assistance in this research.	Aspen Institute, PROJ PLAY SURV PAR Y; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Chao S, 2010, SPORTS MED, V40, P59, DOI 10.2165/11319650-000000000-00000; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Jewett R, 2014, J ADOLESCENT HEALTH, V55, P640, DOI 10.1016/j.jadohealth.2014.04.018; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Lynall RC, 2017, J NEUROTRAUM, V34, P2684, DOI 10.1089/neu.2017.5032; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Trofa DP, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117741647; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z	44	11	11	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2019	23	3					381	389		10.3171/2018.9.PEDS18314			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HO7QV	WOS:000461144200018	30579266	Bronze			2022-02-06	
J	Kirkwood, G; Hughes, TC; Pollock, AM				Kirkwood, Graham; Hughes, Thomas C.; Pollock, Allyson M.			Results on sports-related injuries in children from NHS emergency care dataset Oxfordshire pilot: an ecological study	JOURNAL OF THE ROYAL SOCIETY OF MEDICINE			English	Article						Orthopaedics and sports medicine; injury; epidemiology; emergency medicine	DEPARTMENT VISITS	Objectives To analyse and report on sports-related injuries using enhanced injury data collected by the testbed for the NHS emergency care injury data set and admissions data collected from inpatients. Design Ecological study design. Setting Two Oxfordshire NHS England hospitals. Participants Emergency department attendees and inpatients aged 0-19 years with sports injuries. Main outcome measures Data were analysed from 1 January 2012 to 30 March 2014 by age, gender sport, injury location, injury mechanism and diagnosis including concussion/post-concussion, bone fractures and ligament damage. Admissions data were analysed from 1 January 2012 to 24 January 2015. Results Children and adolescents aged 0-19 years accounted for almost half (47.4%) of sports injury-related emergency department attendances and almost one-quarter (23.5%) of sports injury-related admissions for all ages. The highest rates of attendance occurred at 14 years for boys (68.22 per 1000 person-years) and 12 years for girls (33.72 per 1000 person-years). For male 0-19-year-olds the three main sports were (in order) football (soccer), rugby union and rugby league and for females, trampoline, netball and horse-riding. The largest gender differences were in netball where injuries were predominantly in females and in wheeled motorsports where injuries were predominantly in males. Almost one-quarter of emergency department sports-related injuries recorded were fractures, the highest percentage to the upper limbs. Conclusions Public health departments in local authorities and schools should consider target sports injury prevention at children in the first four years of secondary school. For younger age groups, trampolines in the home warrant improved safety. Rugby and horse-riding should also be a focus for interventions.	[Kirkwood, Graham; Pollock, Allyson M.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Hughes, Thomas C.] Oxford Univ Hosp NHS Fdn Trust, Oxford OX3 9DU, England		Kirkwood, G (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	graham.kirkwood@ncl.ac.uk		Hughes, Thomas/0000-0001-5490-1267			[Anonymous], 2017, EM CAR DAT SET ECDS; Ashby K, 2002, 50 ISSUE HAZARD CELE; Bayt DR, 2016, INJURY PREV, V22, P361, DOI 10.1136/injuryprev-2015-041757; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Buzas David, 2014, ORTHOPEDIC J SPORTS, V2, P1; Cassell E, 2002, PREVENTING INJURY SP; Choyce MQ, 1998, J ACCID EMERG MED, V15, P35; Department for Digital Culture Media & Sport (DCMS), 2017, TAK PART 2016 17 ANN; Department for Trade and Industry (DTI), 2003, 24 DTI; European Commission, 2012, INJ DATABASE PUBL AC; EuroSafe. Injuries in the European Union, 2013, INJ EUR UN REP INJ S; Falvey EC, 2009, EMERG MED J, V26, P590, DOI 10.1136/emj.2008.062315; Hassan I, 2001, EMERG MED J, V18, P167, DOI 10.1136/emj.18.3.167; Information Services Division NHS Scotland, 2018, UN INJ HOSP ADM YEAR; Kirkwood G, 2017, J EPIDEMIOL COMMUN H, V71, P289, DOI 10.1136/jech-2016-207581; Kirkwood G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5337; Meehan WP, 2013, PEDIATR EMERG CARE, V29, P624, DOI 10.1097/PEC.0b013e31828e9cea; NHS Digital, ACC EM ATT ENGL 2014; Routley V, 1991, SPORT RELATED INJURI; Schwebel DC, 2014, J ATHL TRAINING, V49, P780, DOI 10.4085/1062-6050-49.3.41; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; Simon TD, 2004, ACAD EMERG MED, V11, P1042, DOI 10.1197/j.aem.2004.04.013; The Trauma Audit & Research Network (TARN), 2016, INCL CRIT TRAUM AUD; U. S. Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; UK Government, 2017, CHILDH OB PLAN ACT; United States Environmental Protection Agency, 2013, AM CHILDR ENV, V3rd; Vriend I, 2017, SPORTS MED, V47, P2027, DOI 10.1007/s40279-017-0718-y; Wood AM, 2010, INJURY, V41, P834, DOI 10.1016/j.injury.2010.04.008	28	11	11	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0141-0768	1758-1095		J ROY SOC MED	J. R. Soc. Med.	MAR	2019	112	3					109	118		10.1177/0141076818808430			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP0WC	WOS:000461386300006	30384797	Bronze, Green Published			2022-02-06	
J	Marom, BS; Ratzon, NZ; Carel, RS; Sharabi, M				Marom, Batia S.; Ratzon, Navah Z.; Carel, Rafael S.; Sharabi, Moshe			Return-to-Work Barriers Among Manual Workers After Hand Injuries: 1-Year Follow-up Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Hand; Injuries; International Classification of Functioning; Disability and Health; Rehabilitation; Return to work	TRAUMATIC BRAIN-INJURY; EMPLOYMENT OUTCOMES; PAIN; DISABILITY; COMPENSATION; HEALTH; TIME; VALIDATION; SURGERY; IMPACT	Objective: To determine time of return to work (TRTW) in relation to multivariable predictors among male manual workers after hand injury (HI) over a 12-month follow-up. Design: A cohort study with baseline medical information, functional evaluation, and 3-, 6-, 9-, and 12-month follow-up telephone interviews. Setting: Seven physical rehabilitation community occupational therapy clinics. Participants: Participants (N=178) with acute HI aged 22-65. Two participants were lost to follow-up. Intervention: Not applicable. Main Outcome Measure: The dependent variable was TRTW. The independent variables originated from 4 domains: personal factors, environmental factors, body function and structure, and activity limitation and participation restriction. The proportion of return to work (RTW) at each time point was calculated. Multiple Cox regressions established a predictive model for TRTW. Results: At the end of the study, 75.3% participants returned to work. The median TRTW was 94 days. In the final model, only compensation factors and education contributed significantly to overall RTW, but when separate analyses were performed, decreased level of self-efficacy, higher workplace demands, level of pain, level of emotional response to trauma, reduced physical capability of the hand, and higher level of disability were significantly associated with delayed TRTW. Conclusions: TRTW was determined by the physical capability of the hand, pain, and psychosocial factors, but it was also affected by legal factors. Participants who did not return to work during the first 9 months are at risk for long-term disability. Developing treatment programs for those who are at risk for not returning to work, taking into consideration these factors, is recommended. (C) 2018 by the American Congress of Rehabilitation Medicine	[Marom, Batia S.] Univ Haifa, Sch Publ Hlth, Clalit Hlth Serv, Occupat Therapy Unit, Haifa, Israel; [Ratzon, Navah Z.] Tel Aviv Univ, Dept Occupat Therapy, Sackler Fac Med, Tel Aviv, Israel; [Carel, Rafael S.] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Sharabi, Moshe] Max Stern Yezreel Valley Coll, Sociol & Anthropol Dept, Yezreel Valley, Israel		Marom, BS (corresponding author), Clalit Hlth Serv, Occupat Therapy Unit, 1 Hachashmonaim St, IL-1426401 Tiberias, Israel.	batiamarom2@clalit.org.il		Sharabi, Moshe/0000-0001-8570-8769	National Insurance Institute of Israel [12379]	Supported by a grant from the National Insurance Institute of Israel (grant no. 12379).	Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P37, DOI 10.3233/NRE-2009-0452; Arnstein P, 2000, DISABIL REHABIL, V22, P794, DOI 10.1080/09638280050200296; Asher AL, 2017, J NEUROSURG-SPINE, V27, P370, DOI 10.3171/2016.8.SPINE16527; Black RM, 2014, WILLARD SPACKMANS OC, P173; Campbell CM, 2012, PAIN MANAG, V2, P219, DOI 10.2217/PMT.12.7; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Casey PP, 2015, INJURY, V46, P918, DOI 10.1016/j.injury.2015.01.003; Cederlund R, 2010, OCCUP THER INT, V17, P1, DOI 10.1002/oti.287; Chiang M., 2003, BRIT J OCCUP THER, V66, P559, DOI [10.1177/030802260306601204, DOI 10.1177/030802260306601204]; Clarfield AM, 2017, LANCET, V389, P2503, DOI 10.1016/S0140-6736(17)30636-0; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; de Jong JP, 2014, CLIN ORTHOP SURG, V6, P196, DOI 10.4055/cios.2014.6.2.196; Dean SG, 2011, J OCCUP REHABIL, V21, P395, DOI 10.1007/s10926-010-9275-z; Fess EE, 2011, REHABILITATION HAND, P152; Franche RL, 2002, J OCCUP REHABIL, V12, P233, DOI 10.1023/A:1020270407044; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Harris IA, 2008, J ORTHOP TRAUMA, V22, P216, DOI 10.1097/BOT.0b013e31815c11dc; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Karasek R., 1990, HLTH WORK STRESS PRO; Katz J, 1999, SURG CLIN N AM, V79, P231, DOI 10.1016/S0039-6109(05)70381-9; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Kennedy CA, 2011, DISABILITIES ARM SHO, V3rd; Laaksonen M, 2015, J OCCUP REHABIL, V25, P471, DOI 10.1007/s10926-014-9554-1; Labriola Merete, 2007, Work, V29, P233; MacDermid JC, 1999, THESIS; MacDermid JC, 2007, J OCCUP REHABIL, V17, P47, DOI 10.1007/s10926-007-9069-0; Marom BS, 2017, DISABIL REHABIL, V39, P1155, DOI 10.1080/09638288.2016.1189606; NATHAN PA, 1993, J OCCUP ENVIRON MED, V35, P1034; National Insurance Institute of Israel, WORK DIS BEN; National Safety Council, INJ FACTS SOURC INJ; Norrefalk JR, 2006, J REHABIL MED, V38, P87, DOI 10.1080/16501970510044016; Opsteegh L, 2009, J OCCUP REHABIL, V19, P245, DOI 10.1007/s10926-009-9181-4; Poerbodipoero SJ, 2007, HAND THER, V12, P40; Ramel E, 2013, WORK, V44, P459, DOI 10.3233/WOR-2012-1373; Roessler RT, 2002, REHABIL COUNS BULL, V45, P207, DOI 10.1177/00343552020450040301; Rosberg HE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-501; Sahin F, 2013, J HAND SURG-EUR VOL, V38, P673, DOI 10.1177/1753193412469012; SCHWARZWALD J, 1987, J CONSULT CLIN PSYCH, V55, P251, DOI 10.1037/0022-006X.55.2.251; Seftchick JL, 2011, REHABILITATION HAND, V6th, P55; Sharabi M, 2014, COMMIMITY WORK FAM, V17, P219, DOI 10.1080/13668803.2014.889660; Sharon A., 2002, THESIS; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Skirven T.M, 2011, REHABILITATION HAND, V1; Skov O, 1999, J HAND SURG-BRIT EUR, V24B, P187, DOI 10.1054/jhsb.1998.0180; Sorock GS, 2001, SAFETY SCI, V38, P241, DOI 10.1016/S0925-7535(01)00004-2; Urso-Baiarda F, 2008, Int J Surg, V6, P45, DOI 10.1016/j.ijsu.2007.09.001; Ustun T, 2010, MEASURING HLTH DISAB; Whelan LR, 2014, OCCUPATIONAL THERAPY, P144	49	11	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2019	100	3					422	432		10.1016/j.apmr.2018.07.429			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HN5BU	WOS:000460198500004	30130518				2022-02-06	
J	Meyer, EC; Szabo, YZ; Frankfurt, SB; Kimbrel, NA; DeBeer, BB; Morissette, SB				Meyer, Eric C.; Szabo, Yvette Z.; Frankfurt, Sheila B.; Kimbrel, Nathan A.; DeBeer, Bryann B.; Morissette, Sandra B.			Predictors of recovery from post-deployment posttraumatic stress disorder symptoms in war veterans: The contributions of psychological flexibility, mindfulness, and self-compassion	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Posttraumatic stress disorder; Mindfulness; Self-compassion; Psychological flexibility; Recovery; Resilience	ACTION QUESTIONNAIRE-II; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMITMENT THERAPY; PSYCHOMETRIC PROPERTIES; WARZONE EXPERIENCES; GENDER-DIFFERENCES; SUICIDAL IDEATION; SERVICE MEMBERS; US IRAQ	Posttraumatic stress disorder (PTSD) is a major challenge among war veterans. This study assessed the contribution of several interrelated, modifiable psychosocial factors to changes in PTSD symptom severity among combat-deployed post-9/11 Veterans. Data were drawn from a longitudinal study of predictors of mental health and functional outcomes among U.S. Iraq and Afghanistan war Veterans (N = 117). This study assessed the unique contribution of psychological flexibility, mindfulness, and self-compassion to PTSD recovery, after accounting for established predictors of PTSD chronicity, including combat exposure, alcohol use problems, and traumatic brain injury. PTSD symptom severity was assessed using a clinician-administered interview, and PTSD recovery was defined as the change in symptom severity from lifetime worst severity, measured at baseline, to current severity at one-year follow-up. A mindful awareness latent factor comprised of all three variables measured at baseline predicted PTSD recovery beyond the other predictors of PTSD chronicity (f(2) = 0.30, large effect). Each construct predicted PTSD recovery when tested individually. When tested simultaneously, self compassion, but not mindfulness or psychological flexibility, predicted PTSD recovery. These findings suggest that mindful awareness of emotional distress predicts recovery from PTSD symptoms in war veterans, which supports the utility mindfulness-based interventions in promoting post-trauma recovery.	[Meyer, Eric C.; Szabo, Yvette Z.; Frankfurt, Sheila B.; DeBeer, Bryann B.] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [Meyer, Eric C.; Szabo, Yvette Z.; Frankfurt, Sheila B.; DeBeer, Bryann B.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Meyer, Eric C.; Szabo, Yvette Z.; Frankfurt, Sheila B.; DeBeer, Bryann B.] Texas A&M Hlth Sci Ctr, College Stn, TX USA; [Kimbrel, Nathan A.] Durham VA Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA MidAtlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA		Meyer, EC (corresponding author), Cent Texas Vet Hlth Care Syst 151C, VA VISN Ctr Excellence Res Returning War Vet 17, 4800 Mem Dr, Waco, TX 76711 USA.	Eric.Meyer2@va.gov	Szabo, Yvette/ABH-4782-2020	Szabo, Yvette/0000-0002-5436-7081; Frankfurt, Sheila/0000-0002-8156-1488	VISN 17 New Investigator Award from the Rehabilitation Research and Development (RRD) Service of the VA Office of Research and Development (ORD), USA; VA Merit Awards from the Rehabilitation Research and Development (RRD) Service of the VA Office of Research and Development (ORD), USA [I01RX000304-01A1]; VA Advanced Fellowship in Mental Illness Research and Treatment; VA Career Development Award-1 from the RR&D Service of ORD [11K1RX002427-01A2]; Veterans AffairsUS Department of Veterans Affairs [IK1RX002427, I01RX000304] Funding Source: NIH RePORTER	This work was supported by a VISN 17 New Investigator Award to Dr. Meyer, and VA Merit Awards to Dr. Morissette (#I01RX000304-01A1) and Drs. Morissette and Meyer (#I01RX000304-01A4) from the Rehabilitation Research and Development (RRD) Service of the VA Office of Research and Development (ORD), USA. Dr. Szabo's work on this study is supported by the VA Advanced Fellowship in Mental Illness Research and Treatment. Dr. Frankfurt's work on this study was supported by VA Career Development Award-1 #11K1RX002427-01A2 from the RR&D Service of ORD. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arch JJ, 2012, J CONSULT CLIN PSYCH, V80, P750, DOI 10.1037/a0028310; Birnie K, 2010, STRESS HEALTH, V26, P359, DOI 10.1002/smi.1305; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bryan CJ, 2015, J CONTEXT BEHAV SCI, V4, P263, DOI 10.1016/j.jcbs.2015.10.002; Call D, 2015, MINDFULNESS, V6, P1303, DOI 10.1007/s12671-015-0400-0; Crum-Cianflone NF, 2014, EPIDEMIOL REV, V36, P5, DOI 10.1093/epirev/mxt005; Dahm KA, 2015, J TRAUMA STRESS, V28, P460, DOI 10.1002/jts.22045; DeBeer BB, 2014, PSYCHIAT RES, V216, P357, DOI 10.1016/j.psychres.2014.02.010; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Gutner CA, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0734-x; Hayes S. C, 2012, ACCEPTANCE CORRUNIME; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hiraoka R, 2015, J TRAUMA STRESS, V28, P127, DOI 10.1002/jts.21995; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2018, JAMA-J AM MED ASSOC, V319, P343, DOI 10.1001/jama.2017.21880; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kelly A, 2016, J CLIN PSYCHOL, V72, P311, DOI 10.1002/jclp.22273; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Kimbrel NA, 2015, PSYCHIAT RES, V226, P78, DOI 10.1016/j.psychres.2014.12.007; Kimbrel NA, 2014, PSYCHIAT RES, V220, P1118, DOI 10.1016/j.psychres.2014.08.053; King AP, 2013, DEPRESS ANXIETY, V30, P638, DOI 10.1002/da.22104; Kirby JN, 2017, PSYCHOL PSYCHOTHER-T, V90, P432, DOI 10.1111/papt.12104; Linehan M M, 1993, NIDA Res Monogr, V137, P201; Litz B., 2017, SAN ANT COMB PTSD C; MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Meyer EC, 2018, J TRAUMA STRESS, V31, P781, DOI 10.1002/jts.22322; Meyer EC, 2019, PSYCHOL TRAUMA-US, V11, P383, DOI 10.1037/tra0000358; Meyer EC, 2018, J CLIN PSYCHOL, V74, P1272, DOI 10.1002/jclp.22596; Meyer EC, 2018, PSYCHOL SERV, V15, P230, DOI 10.1037/ser0000171; Meyer EC, 2013, PSYCHOL TRAUMA-US, V5, P521, DOI 10.1037/a0030178; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Orcutt HK, 2014, J TRAUMA STRESS, V27, P249, DOI 10.1002/jts.21914; Ostafin B., 2014, HDB MINDFULNESS SELF, P121, DOI DOI 10.1007/978-1-4939-2263-5_10; Owens GP, 2012, PSYCHOL TRAUMA-US, V4, P221, DOI 10.1037/a0024251; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Polusny MA, 2015, JAMA-J AM MED ASSOC, V314, P456, DOI 10.1001/jama.2015.8361; Reijnen A, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.05.003; Schell TL, 2004, J ABNORM PSYCHOL, V113, P189, DOI 10.1037/0021-843X.113.2.189; Schwab KA, 2006, NEUROLOGY, V66, pA235; Simon RI, 1999, HARVARD REV PSYCHIAT, V6, P304, DOI 10.3109/10673229909017208; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Wahbeh Helane, 2011, Mindfulness (N Y), V2, P219; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; Wolgast M, 2014, BEHAV THER, V45, P831, DOI 10.1016/j.beth.2014.07.002; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yadavaia JE, 2014, J CONTEXT BEHAV SCI, V3, P248, DOI 10.1016/j.jcbs.2014.09.002; Zeller M, 2015, J ABNORM CHILD PSYCH, V43, P645, DOI 10.1007/s10802-014-9937-y; Zlotnick C, 1999, J TRAUMA STRESS, V12, P89, DOI 10.1023/A:1024746316245	61	11	12	2	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	MAR	2019	114						7	14		10.1016/j.brat.2019.01.002			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HQ4ZW	WOS:000462420800002	30658166	Green Accepted			2022-02-06	
J	Celikkaya, H; Cosacak, MI; Papadimitriou, C; Popova, S; Bhattarai, P; Biswas, SN; Siddiqui, T; Wistorf, S; Nevado-Alcalde, I; Naumann, L; Mashkaryan, V; Brandt, K; Freudenberg, U; Werner, C; Kizil, C				Celikkaya, Hilal; Cosacak, Mehmet Ilyas; Papadimitriou, Christos; Popova, Stanislava; Bhattarai, Prabesh; Biswas, Srijeeta Nag; Siddiqui, Tohid; Wistorf, Sabrina; Nevado-Alcalde, Isabel; Naumann, Lisa; Mashkaryan, Violeta; Brandt, Kerstin; Freudenberg, Uwe; Werner, Carsten; Kizil, Caghan			GATA3 Promotes the Neural Progenitor State but Not Neurogenesis in 3D Traumatic Injury Model of Primary Human Cortical Astrocytes	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						GATA3; neurogenic potential; neural progenitors; scratch injury; primary human astrocytes; SOX2	STEM-CELL PROLIFERATION; ADULT ZEBRAFISH BRAIN; IN-VIVO; REGENERATIVE NEUROGENESIS; ALZHEIMERS-DISEASE; NEURONAL REGENERATION; SUBVENTRICULAR ZONE; GENE DELIVERY; GLIAL-CELLS; IDENTIFICATION	Astrocytes are abundant cell types in the vertebrate central nervous system and can act as neural stem cells in specialized niches where they constitutively generate new neurons. Outside the stem cell niches, however, these glial cells are not neurogenic. Although injuries in the mammalian central nervous system lead to profound proliferation of astrocytes, which cluster at the lesion site to form a gliotic scar, neurogenesis does not take place. Therefore, a plausible regenerative therapeutic option is to coax the endogenous reactive astrocytes to a pre-neurogenic progenitor state and use them as an endogenous reservoir for repair. However, little is known on the mechanisms that promote the neural progenitor state after injuries in humans. Gata3 was previously found to be a mechanism that zebrafish brain uses to injury-dependent induction of neural progenitors. However, the effects of GATA3 in human astrocytes after injury are not known. Therefore, in this report, we investigated how overexpression of GATA3 in primary human astrocytes would affect the neurogenic potential before and after injury in 2D and 3D cultures. We found that primary human astrocytes are unable to induce GATA3 after injury. Lentivirus-mediated overexpression of GATA3 significantly increased the number of GFAP/SOX2 double positive astrocytes and expression of pro-neural factor ASCL1, but failed to induce neurogenesis, suggesting that GATA3 is required for enhancing the neurogenic potential of primary human astrocytes and is not sufficient to induce neurogenesis alone.	[Celikkaya, Hilal; Cosacak, Mehmet Ilyas; Papadimitriou, Christos; Popova, Stanislava; Bhattarai, Prabesh; Biswas, Srijeeta Nag; Siddiqui, Tohid; Wistorf, Sabrina; Nevado-Alcalde, Isabel; Naumann, Lisa; Mashkaryan, Violeta; Brandt, Kerstin; Kizil, Caghan] Helmholtz Assoc, German Ctr Neurodegenerat Dis, Dresden, Germany; [Celikkaya, Hilal; Popova, Stanislava; Biswas, Srijeeta Nag; Mashkaryan, Violeta; Freudenberg, Uwe; Werner, Carsten; Kizil, Caghan] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Freudenberg, Uwe; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Dresden, Germany; [Wistorf, Sabrina] Inst Bioengn Catalonia, Barcelona, Spain; [Nevado-Alcalde, Isabel] Vivia Biotech, Parque Cient Madrid, Madrid, Spain		Kizil, C (corresponding author), Helmholtz Assoc, German Ctr Neurodegenerat Dis, Dresden, Germany.; Kizil, C (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.	caghan.kizil@dzne.de	Cosacak, Mehmet Ilyas/V-3872-2019; Bhattarai, Prabesh/AAW-1674-2021; Werner, Carsten/F-8127-2010; Werner, Carsten/AAF-1510-2019; Freudenberg, Uwe/C-3009-2019; Kizil, Caghan/J-6923-2015	Cosacak, Mehmet Ilyas/0000-0003-2978-3902; Werner, Carsten/0000-0003-0189-3448; Freudenberg, Uwe/0000-0002-1359-1095; Kizil, Caghan/0000-0002-8164-9762; Papadimitriou, Christos/0000-0002-1752-4711; Siddiqui, Tohid/0000-0003-0625-9710	German Center for Neurodegenerative Diseases (DZNE)Helmholtz Association; Helmholtz Association Young investigator ProgramHelmholtz Association [VH-NG-1021]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [KI1524/6, KI1524/10, KI1524/11]; Graduate Academy scholarship [CRC-TR67, CRC SFB655, FOR/EXC999]; BMBFFederal Ministry of Education & Research (BMBF) [PRECIMATRIX-FKZ-03XP0083-310117]; DZNE I2A award; CRTD; TU DresdenEuropean Commission [FZ-111, 043_261518]	This work was supported by German Center for Neurodegenerative Diseases (DZNE) and Helmholtz Association Young investigator Program (VH-NG-1021 to CK), Deutsche Forschungsgemeinschaft (DFG) (KI1524/6, KI1524/10, and KI1524/11 to CK; DZNE I2A award to CK; CRTD, TU Dresden (FZ-111, 043_261518) to CK; Graduate Academy scholarship to SP; CRC-TR67, CRC SFB655, and FOR/EXC999 to CW) and BMBF (PRECIMATRIX-FKZ-03XP0083-310117 to CW).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bhattarai P, 2017, JOVE-J VIS EXP, DOI 10.3791/56014; Bhattarai P, 2016, CELL REP, V17, P941, DOI 10.1016/j.celrep.2016.09.075; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Brulet R, 2017, STEM CELL REP, V8, P1506, DOI 10.1016/j.stemcr.2017.04.013; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Chen CH, 2019, CEREB CORTEX, V29, P54, DOI 10.1093/cercor/bhx303; Chen G., 2015, ENEURO, V2; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Choi SH, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0139-7; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Cosacak MI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/769763; Costa MR, 2010, BRAIN RES REV, V63, P47, DOI 10.1016/j.brainresrev.2010.01.002; Curto GG, 2014, STEM CELLS DEV, V23, P2813, DOI 10.1089/scd.2014.0058; Deemyad T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06338-3; Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Espuny-Camacho I, 2017, NEURON, V93, P1066, DOI 10.1016/j.neuron.2017.02.001; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gascon S, 2016, CELL STEM CELL, V18, P396, DOI 10.1016/j.stem.2015.12.003; Gould T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0607; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871; Jebelli J, 2015, ANN NY ACAD SCI, V1351, P1, DOI 10.1111/nyas.12711; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones EV, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/321209; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Katz S, 2016, CELL REP, V17, P1383, DOI 10.1016/j.celrep.2016.09.088; Kettenmann H, 2012, NEUROGLIA; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00159; Kizil C, 2018, CURR PATHOBIOL REP, V6, P71, DOI 10.1007/s40139-018-0158-x; Kizil C, 2015, EMBO REP, V16, P416, DOI 10.15252/embr.201439702; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kotterman MA, 2015, DEVELOPMENT, V142, P1885, DOI 10.1242/dev.115253; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Magnusson JP, 2016, DEVELOPMENT, V143, P1075, DOI 10.1242/dev.133975; Masserdotti G, 2015, CELL STEM CELL, V17, P74, DOI 10.1016/j.stem.2015.05.014; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Murphy AR, 2017, ACTA BIOMATER, V54, P1, DOI 10.1016/j.actbio.2017.02.046; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Papadimitriou C., 2017, BIORXIV, DOI [10.1101/227306, DOI 10.1101/227306]; Papadimitriou C., 2017, BIORXIV, DOI [10.1101/225243, DOI 10.1101/225243]; Papadimitriou C, 2018, DEV CELL, V46, P85, DOI 10.1016/j.devcel.2018.06.005; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Phillips W, 2006, STEM CELLS DEV, V15, P359, DOI 10.1089/scd.2006.15.359; Pietschmann T, 1999, J VIROL, V73, P2613, DOI 10.1128/JVI.73.4.2613-2621.1999; Pozniak CD, 2010, P NATL ACAD SCI USA, V107, P21795, DOI 10.1073/pnas.1016485107; Qiu J, 2016, ELIFE, V5, DOI 10.7554/eLife.20337; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Viales RR, 2015, STEM CELLS, V33, P892, DOI 10.1002/stem.1883; Vizuete AFK, 2019, NEUROCHEM RES, V44, P301, DOI 10.1007/s11064-018-2675-8; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	89	11	11	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	FEB 11	2019	13								23	10.3389/fncel.2019.00023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK9DS	WOS:000458290100001	30809125	Green Published, gold			2022-02-06	
J	Ahmed, N; Greenberg, P				Ahmed, N.; Greenberg, P.			Patient mortality following alcohol use and trauma: a propensity-matched analysis	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Injury; Blood alcohol level; Mortality	BRAIN-INJURY; SYSTEMIC INTERLEUKIN-6; INTOXICATION; ETHANOL; TIME; ASSOCIATION; SEVERITY; IMPACT	ObjectiveTo examine the outcomes of trauma patients who tested positive for alcohol at the time of hospital arrival versus those who tested negative.MethodsData were pulled from the National Trauma Data Bank (2007-2010). All injured patients who were 14years of age, sustained a blunt or penetrating injury, had complete systolic blood pressure (SBP) and heart rate (HR) records, were taken to a level 1 or 2 trauma center, and who received a confirmed blood alcohol test were included in the study. Any blood alcohol concentration (BAC) above the legal limit (0.08g/dL) was considered positive for alcohol, and if no alcohol was identified it was considered negative. Patients' demography and clinical information were compared across groups using Chi-square and Wilcoxon rank sum tests. Logistic regression, propensity score matching, and a follow-up paired analysis were also performed.ResultsOf 279,460 total patients, around one-third of the patients (92,960) tested positive for BAC. There were clear demographic differences found between the two groups regarding age, gender, race, and injury type. There was also a significantly higher mortality rate (4.3 vs. 3.1%, P<0.001) and a longer hospital length of stay (4 vs. 3days, P<0.001) found in the alcohol-negative group. Propensity score matching was also performed resulting in 92,959 patients per group. Using the paired data, the overall mortality observed was 3.1 vs. 3.3% (P=0.035) between the alcohol-positive and alcohol-negative groups, respectively. There was no significant difference noted in the total hospital length of stay (median: 3 vs. 4days, P=0.84).ConclusionPatients who tested positive for alcohol following a traumatic injury showed no clinically significant reduction in mortality and no significant difference in total hospital length of stay.	[Ahmed, N.] Jersey Shore Univ Med Ctr, Dept Surg, Neptune, NJ 07753 USA; [Greenberg, P.] Jersey Shore Univ Med Ctr, Off Res Adm, Neptune, NJ USA		Ahmed, N (corresponding author), Jersey Shore Univ Med Ctr, Dept Surg, Neptune, NJ 07753 USA.	Nasim.Ahmed@hackensackmeridian.org					Allison Paul D, 2015, MEASURES FIT L UNPUB; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; BOWERS Jake, 2016, RITOOLS RANDOMIZATIO; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Fulde GWO, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja15.00637; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Hansen BB, 2008, STAT SCI, V23, P219, DOI 10.1214/08-STS254; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Hothorn T., 2015, J STAT SOFTW, V28, P1; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; National Highway Traffic Safety Administration, 2013 MOT VEH CRASH O; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; R Core Team, 2014, R LANG ENV STAT COMP; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Rootman DB, 2007, J TRAUMA, V62, P755, DOI 10.1097/TA.0b013e318031aa7f; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; StataCorp, 2013, STAT STAT SOFTW REL; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Taylor AN, 2015, BRAIN NEUROTRAUMA MO; Therneau T.M., 2000, STAT BIOL HEALTH; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; World Health Organization (WHO), 2014, GLOB STAT REP ALC HL, pXIII; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	34	11	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2019	45	1					151	158		10.1007/s00068-017-0794-6			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HL6QY	WOS:000458861400020	28508098				2022-02-06	
J	Anderson, JR; Nakhate, V; Stephen, CD; Perez, DL				Anderson, Jordan R.; Nakhate, Vihang; Stephen, Christopher D.; Perez, David L.			Functional (Psychogenic) Neurological Disorders: Assessment and Acute Management in the Emergency Department	SEMINARS IN NEUROLOGY			English	Article						conversion disorder; psychogenic nonepileptic seizures; functional movement disorders; functional paralysis	TRAUMATIC BRAIN-INJURY; NONEPILEPTIC SEIZURES; CONVERSION DISORDER; MOVEMENT-DISORDERS; SENSORY SYNDROMES; CLINICAL SIGNS; GAIT DISORDERS; STROKE MIMICS; MOTOR SUBTYPE; DIAGNOSIS	Functional neurological disorders (FND) are complex and prevalent neuropsychiatric conditions. Importantly, some patients with FND develop acute onset symptoms requiring emergency department (ED) evaluations. Historically, FND was a rule-out diagnosis, making assessment and management in the ED difficult. While the rapid triage of potential neurological emergencies remains the initial task, advancements have altered the approach to FND. FND is now a rule-in diagnosis based on validated neurological examination signs and semiological features. In this perspective article, we review signs and semiological features that can help guide the initial assessment of FND in the acute setting. Thereafter, we outline potential approaches to introduce a suspected diagnosis of FND to patients in the ED, while emphasizing the need for a comprehensive neurological evaluation. Physical and occupational therapy may be useful adjunct assessments in some individuals. Notably, clinicians in the ED setting are important members of the interdisciplinary approach to FND.	[Anderson, Jordan R.] Brown Univ, Rhode Isl Hosp, Dept Neurol, Alpert Med Sch, Providence, RI 02903 USA; [Anderson, Jordan R.] Brown Univ, Rhode Isl Hosp, Dept Psychiat, Alpert Med Sch, Providence, RI 02903 USA; [Nakhate, Vihang; Stephen, Christopher D.; Perez, David L.] Harvard Med Sch, Funct Neurol Res Grp, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Perez, David L.] Harvard Med Sch, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA		Anderson, JR (corresponding author), Butler Hosp, Dept Neurol & Psychiat, Providence, RI 02906 USA.	jordan_anderson@brown.edu	Perez, David/AAB-6453-2020; Stephen, Christopher/AAF-4956-2021	Perez, David/0000-0003-2721-583X; 	Sidney R. Baer Jr.; Massachusetts General Hospital Physician-Scientist Career Development Award	D.L.P. was supported by the Sidney R. Baer Jr. Foundation and the Massachusetts General Hospital Physician-Scientist Career Development Award.	Adams Caitlin, 2018, Pract Neurol, V18, P323, DOI 10.1136/practneurol-2017-001835; Asadi-Pooya AA, 2017, J NEUROL SCI, V377, P85, DOI 10.1016/j.jns.2017.03.054; Asmussen SB, 2009, SEIZURE-EUR J EPILEP, V18, P564, DOI 10.1016/j.seizure.2009.05.006; Avbersek A, 2010, J NEUROL NEUROSUR PS, V81, P719, DOI 10.1136/jnnp.2009.197996; Baik JS, 2007, MOVEMENT DISORD, V22, P395, DOI 10.1002/mds.21283; BAKER JHE, 1987, J NEUROL NEUROSUR PS, V50, P375, DOI 10.1136/jnnp.50.4.375; Barbey A, 2017, CURR OPIN NEUROL, V30, P427, DOI 10.1097/WCO.0000000000000464; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Baslet G, 2016, PSYCHOSOMATICS, V57, P1, DOI 10.1016/j.psym.2015.10.004; BASSETTI C, 1993, NEUROLOGY, V43, P1942, DOI 10.1212/WNL.43.10.1942; Beleza P, 2011, J CLIN NEUROSCI, V18, P593, DOI 10.1016/j.jocn.2010.08.018; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Carson A, 2016, HAND CLINIC, V139, P47, DOI 10.1016/B978-0-12-801772-2.00005-9; Carson Alan, 2016, Pract Neurol, V16, P56, DOI 10.1136/practneurol-2015-001242; CHABROL H, 1995, EUR PSYCHIAT, V10, P317, DOI 10.1016/0924-9338(96)80314-2; Chen DK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0781-7; Chernyshev OY, 2010, NEUROLOGY, V74, P1340, DOI 10.1212/WNL.0b013e3181dad5a6; Daum C, 2015, J NEUROL NEUROSUR PS, V86, P425, DOI 10.1136/jnnp-2013-307381; Daum C, 2014, J NEUROL NEUROSUR PS, V85, P180, DOI 10.1136/jnnp-2012-304607; De Paola L, 2016, EPILEPSY BEHAV, V54, P40, DOI 10.1016/j.yebeh.2015.10.025; Direk N, 2012, EPILEPSY BEHAV, V23, P138, DOI 10.1016/j.yebeh.2011.11.013; Dixit R, 2013, EPILEPSY BEHAV, V28, P137, DOI 10.1016/j.yebeh.2013.05.004; Duncan R, 2008, NEUROLOGY, V71, P1000, DOI 10.1212/01.wnl.0000326593.50863.21; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; Dworetzky BA, 2015, CLIN EEG NEUROSCI, V46, P26, DOI 10.1177/1550059414566880; Elwischger K, 2012, NEUROLOGY, V78, P146, DOI 10.1212/WNL.0b013e31823efc82; Erba G, 2017, SEIZURE-EUR J EPILEP, V53, P66, DOI 10.1016/j.seizure.2017.11.001; Espay AJ, 2018, JAMA NEUROL, V75, P1132, DOI 10.1001/jamaneurol.2018.1264; Fasano A, 2012, MOVEMENT DISORD, V27, P1544, DOI 10.1002/mds.25190; Forster A, 2012, J NEUROL, V259, P1347, DOI 10.1007/s00415-011-6354-9; Galli Silvio, 2018, Front Neurol Neurosci, V42, P72, DOI 10.1159/000475699; Gardiner P, 2018, CNS SPECTRUMS, V23, P205, DOI 10.1017/S1092852917000797; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; Hallett M, 2016, PARKINSONISM RELAT D, V22, pS149, DOI 10.1016/j.parkreldis.2015.08.036; Herskovitz M, 2017, EPILEPSY BEHAV, V70, P140, DOI 10.1016/j.yebeh.2017.02.015; Jacob AE, 2018, PM&R, V10, P1164, DOI 10.1016/j.pmrj.2018.05.011; Jin B, 2014, EPILEPSY BEHAV, V41, P197, DOI 10.1016/j.yebeh.2014.09.057; Kenney C, 2007, J NEUROL SCI, V263, P94, DOI 10.1016/j.jns.2007.06.008; Kerr WT, 2018, EPILEPSY BEHAV, V80, P75, DOI 10.1016/j.yebeh.2017.11.035; Kim JS, 1997, STROKE, V28, P1761, DOI 10.1161/01.STR.28.9.1761; KIM JS, 1992, STROKE, V23, P983, DOI 10.1161/01.STR.23.7.983; Kim JS, 1999, EUR NEUROL, V42, P128, DOI 10.1159/000008085; Kranick S, 2011, MOVEMENT DISORD, V26, P1844, DOI 10.1002/mds.23830; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; Ludwig L, 2018, LANCET PSYCHIAT, V5, P307, DOI 10.1016/S2215-0366(18)30051-8; Matin N, 2017, J NEUROPSYCH CLIN N, V29, P375, DOI 10.1176/appi.neuropsych.16110302; McKee K, 2018, PSYCHOSOMATICS, V59, P358, DOI 10.1016/j.psym.2017.12.006; McKenzie PS, 2011, J NEUROL NEUROSUR PS, V82, P967, DOI 10.1136/jnnp.2010.231886; Merkler AE, 2016, J NEUROL NEUROSUR PS, V87, P363, DOI 10.1136/jnnp-2014-310181; Nadarajan V, 2014, Pract Neurol, V14, P23, DOI 10.1136/practneurol-2013-000782; Nielsen G, 2015, J NEUROL NEUROSUR PS, V86, P1113, DOI 10.1136/jnnp-2014-309255; Nielsen G, 2013, J PSYCHOSOM RES, V75, P93, DOI 10.1016/j.jpsychores.2013.05.006; Paciaroni M, 1998, EUR NEUROL, V39, P211, DOI 10.1159/000007936; Parees I, 2014, J NEUROL SCI, V338, P174, DOI 10.1016/j.jns.2013.12.046; Perez DL, 2016, COGN BEHAV NEUROL, V29, P197, DOI 10.1097/WNN.0000000000000106; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Ranford J, 2018, CNS SPECTRUMS, V23, P194, DOI 10.1017/S1092852918000950; Reuber M, 2003, SEIZURE-EUR J EPILEP, V12, P561, DOI 10.1016/S1059-1311(03)00064-5; Reuber M, 2007, PSYCHOSOMATICS, V48, P230, DOI 10.1176/appi.psy.48.3.230; Reuber M, 2017, SEIZURE-EUR J EPILEP, V44, P199, DOI 10.1016/j.seizure.2016.10.029; Roelofs K, 2002, AM J PSYCHIAT, V159, P1908, DOI 10.1176/appi.ajp.159.11.1908; ROLAK LA, 1988, J NERV MENT DIS, V176, P686, DOI 10.1097/00005053-198811000-00007; Roper Louise S, 2013, Pract Neurol, V13, P396, DOI 10.1136/practneurol-2013-000549; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Seneviratne U, 2017, EPILEPSY BEHAV, V66, P127, DOI 10.1016/j.yebeh.2016.10.024; Sheffler LR, 2015, PHYS MED REH CLIN N, V26, P611, DOI 10.1016/j.pmr.2015.06.006; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Stone Jon, 2015, Continuum (Minneap Minn), V21, P818, DOI 10.1212/01.CON.0000466669.02477.45; Stone J, 2011, J PSYCHOSOM RES, V71, P369, DOI 10.1016/j.jpsychores.2011.07.005; Stone J, 2010, AM J PSYCHIAT, V167, P626, DOI 10.1176/appi.ajp.2010.09101440; Stone J, 2010, BRAIN, V133, P1537, DOI 10.1093/brain/awq068; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345; Takahashi K, 2017, J GEN FAM MED, V18, P275, DOI 10.1002/jgf2.54; Thenganatt MA, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8FJ2F0Q; Thomas AA, 2013, EPILEPSY BEHAV, V29, P295, DOI 10.1016/j.yebeh.2013.08.006; Toth C, 2003, J NEUROL NEUROSUR PS, V74, P1113, DOI 10.1136/jnnp.74.8.1113; Wasserman D, 2017, EPILEPSY BEHAV, V73, P42, DOI 10.1016/j.yebeh.2017.04.020; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Wissel BD, 2016, EPILEPSY BEHAV, V61, P180, DOI 10.1016/j.yebeh.2016.05.032	85	11	11	1	6	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2019	39	1					102	114		10.1055/s-0038-1676844			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HL9CY	WOS:000459041400011	30743296	Bronze			2022-02-06	
J	Brickell, TA; Lippa, SM; French, LM; Gartner, RL; Driscoll, AE; Lange, RT				Brickell, Tracey A.; Lippa, Sara M.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.; Lange, Rael T.			Service Needs and Health Outcomes Among Caregivers of Service Members and Veterans Following TBI	REHABILITATION PSYCHOLOGY			English	Article						caregiver; traumatic brain injury; service member veteran; posttraumatic stress; depression	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC STRESS SYMPTOMS; MENTAL-HEALTH; FAMILY NEEDS; BLAST; IRAQ; POSTCONCUSSION; CARE	Purpose/Objective: The purpose of this study was to examine the (a) prevalence of unmet caregiver needs across eight health care and social service needs and the (b) impact of unmet needs on caregiver health and appraisal outcomes. Research Method/Design: Participants were 264 caregivers (95.8% female; 85.2% spouse/partner) providing help to service members and veterans who sustained a mild to severe or penetrating traumatic brain injury. Caregivers were recruited from Walter Reed National Military Medical Center (Maryland) and via community outreach to participate in the congressionally mandated 15-year Longitudinal Traumatic Brain Injury Study (Sec721 NDAA FY2007) supported by the Defense and Veterans Brain Injury Center. Caregivers completed the Caregiver Appraisal Scale, SF-36v2 Health Survey, and caregiver questionnaire. Participants were divided into 3 health care and social service needs groups: no unmet needs, 1-3 unmet needs, and 4-8 unmet needs. Results: Six of the 8 needs were each endorsed by a majority of caregivers (59.1%-70.1%). Each need was reported as unmet by 29.5% to 52.7% of caregivers. A significant linear relation was found between number of needs and poorer outcomes (i.e., 4-8 needs < 1-3 needs < 0 needs). The cumulative number of unmet needs was significantly related to worse outcomes in most areas, while most individual needs were not significantly related to outcomes. One exception was the caregiver's unmet need for medical health, which was significantly related to increased bodily pain. Conclusions/Implications: Continued support from programs and expansion in the breadth and scope of health care and social services for caregivers is required, including identifying the issues that hinder caregivers accessing the services they need. Impact and Implications This study highlights that a large proportion of caregivers report numerous unmet health care and social service needs. Worse caregiver physical health, mental health, and appraisal outcomes were associated with a greater number of unmet needs. While the importance of ongoing care for an injured service member or veteran is routinely acknowledged, it is critical that similar health care and social services are provided to their caregivers, to ensure that burden of care does not exceed the caregiver's physical, emotional, social, or financial capacity, and undermine the care, well-being, or recovery of the service member or veteran. It is necessary that continued support is provided from existing caregiver programs and services. Additionally, there is a demand for expansion in the breadth and scope of existing programs and services to ensure accessibility to all caregivers. Work is required to identify issues that result in problems for caregivers accessing the services they need.	[Brickell, Tracey A.; Lippa, Sara M.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lippa, Sara M.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,Room 1502B,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,8901 Wisconsin Ave, Bethesda, MD 20889 USA.; Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,Room 1502B,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	Gartner, Rachel/0000-0001-8327-9737; french, louis/0000-0002-9451-0604			Baker DG, 2009, MIL MED, V174, P773; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Byrne MB, 2010, CHILD CARE HLTH DEV, V36, P696, DOI 10.1111/j.1365-2214.2009.01047.x; Cairns D, 2014, J APPL RES INTELLECT, V27, P471, DOI 10.1111/jar.12071; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chopin S. M, 2012, ROLE POSITIVE EMOTIO; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Ferrier-Auerbach AG, 2010, J PSYCHIATR RES, V44, P470, DOI 10.1016/j.jpsychires.2009.10.010; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Iverson G., 2011, ENCY CLIN NEUROPSYCH, P2459, DOI DOI 10.1007/978-0-387-79948-3_1254; Iverson G. L., 2012, NEUROPSYCHOLOGICAL A, P9; Iverson G. L, 2013, BRAIN INJURY MED PRI, P333; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Killian JT, 2016, PEDIATR NEUROL, V58, P67, DOI 10.1016/j.pediatrneurol.2015.12.021; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, ENCY CLIN NEUROPSYCH, P2368, DOI DOI 10.1007/978-0-387-79948-3_1249; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Maruish M.E., 2017, ASSESSMENT HLTH STAT; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; National Alliance for Caregiving, 2010, CAR VET SERV HOM; Ramchand R., 2017, HIDDEN HEROES AMERIC, DOI [10.7249/rr499, DOI 10.7249/RR499]; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Tanielian T, 2013, MILITARY CAREGIVERS; Turner-Bowker, 2007, USERS MANUAL SF 36V2; Van Houtven C. H, 2016, 3 CTR HLTH SERV RES; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wadhwa D, 2013, PSYCHO-ONCOLOGY, V22, P403, DOI 10.1002/pon.2104; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	73	11	11	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2019	64	1					72	86		10.1037/rep0000249			15	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	HK5TA	WOS:000458029100007	30247054				2022-02-06	
J	Hoffman, NL; O'Connor, PJ; Schmidt, MD; Lynall, RC; Schmidt, JD				Hoffman, Nicole L.; O'Connor, Patrick J.; Schmidt, Michael D.; Lynall, Robert C.; Schmidt, Julianne D.			Differences in sleep between concussed and nonconcussed college students: a matched case-control study	SLEEP			English	Article						actigraphy; sleep; symptom recovery; concussion	TRAUMATIC BRAIN-INJURY; QUALITY INDEX; ACTIGRAPHY; SYMPTOMS; INSOMNIA; SPORT; VALIDITY; DISORDERS; DISTURBANCES; RELIABILITY	Study Objectives: To describe sleep 2-3 days postconcussion through symptom recovery and make comparison to well-matched nonconcussed controls. Methods: Twenty college students were physician diagnosed with a concussion and compared with 20 nonconcussed controls matched on age, sex, physical activity, and sleep quality. A wrist-worn ActiGraph GT9X Link was provided during initial evaluation (within 72 hr postinjury for concussed) and worn continuously until symptom resolution (duration matched for nonconcussed). All participants completed a sleep symptom severity checklist, the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS). Separate 2(group) x 3(time points) mixed model ANOVAs were conducted to compare actigraphy sleep outcomes (sleep onset latency [SOL], normalized wake after sleep onset [WASO(norm)], total sleep time [TST], sleep efficiency, and number of awakenings) across recovery stages (2-3 days postinjury, mid-point, and end of recovery). Intraindividual coefficient of variation was calculated for each sleep outcome. Mann-Whitney U tests compared PSQI global score, ESS total score, and sleep symptom severity between groups (alpha = 0.05). Results: At 2-3 days postinjury, concussed individuals took longer to fall asleep compared with controls (p = 0.002). Greater intraindividual variability in WASO(norm) (p = 0.017) and TST (p = 0.044) existed in concussed individuals across recovery. Poorer sleep quality (p < 0.001), excessive daytime sleepiness (p = 0.014), and worse sleep symptoms (p < 0.001) existed in concussed compared with controls. Conclusions: Concussed individuals took longer to fall asleep 2-3 days postconcussion, experienced greater variation in sleep fragmentation and sleep time until symptom resolution, and reported worse sleep quality. Our preliminary findings may guide researchers interested in better understanding sleep postconcussion.	[Hoffman, Nicole L.] Illinois State Univ, Sch Kinesiol & Recreat, Campus Box 5120,250 McCormick Hall, Normal, IL 61790 USA; [O'Connor, Patrick J.; Schmidt, Michael D.; Lynall, Robert C.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Lynall, Robert C.; Schmidt, Julianne D.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; Univ Georgia, Athens, GA 30602 USA		Hoffman, NL (corresponding author), Illinois State Univ, Sch Kinesiol & Recreat, Campus Box 5120,250 McCormick Hall, Normal, IL 61790 USA.	nlhoff1@ilstu.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Schmidt, Michael/0000-0002-8062-4491	Louise E. Kindig Research Award through the Department of Kinesiology at the University of Georgia	This study was partially funded by the Louise E. Kindig Research Award through the Department of Kinesiology at the University of Georgia.	Ahrberg K, 2012, J PSYCHIATR RES, V46, P1618, DOI 10.1016/j.jpsychires.2012.09.008; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Augner C, 2011, CENT EUR J PUBL HEAL, V19, P115, DOI 10.21101/cejph.a3647; Berger I, 2017, GLOB PEDIAT HLTH, V4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dietch JR, 2016, J CLIN SLEEP MED, V12, P1121, DOI 10.5664/jcsm.6050; Dinger MK, 2006, AM J HEALTH EDUC, V37, P337, DOI 10.1080/19325037.2006.10598924; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Figueiro MG, 2014, LIGHTING RES TECHNOL, V48, P352; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapella MC, 2017, SLEEP MED, V37, P124, DOI 10.1016/j.sleep.2017.06.012; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Kostyun Regina, 2015, Conn Med, V79, P161; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lemola S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071292, 10.1371/journal.pone.0082059]; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pillai V, 2014, J PSYCHOSOM RES, V77, P70, DOI 10.1016/j.jpsychores.2014.05.004; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Ye LC, 2015, J AM COLL HEALTH, V63, P88, DOI 10.1080/07448481.2014.983926; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	49	11	11	1	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	FEB	2019	42	2							zsy222	10.1093/sleep/zsy222			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM3BE	WOS:000459346600013	30452734	Bronze			2022-02-06	
J	Ibanez, I; Bartolome-Martin, D; Piniella, D; Gimenez, C; Zafra, F				Ibanez, Ignacio; Bartolome-Martin, David; Piniella, Dolores; Gimenez, Cecilio; Zafra, Francisco			Activity dependent internalization of the glutamate transporter GLT-1 requires calcium entry through the NCX sodium/calcium exchanger	NEUROCHEMISTRY INTERNATIONAL			English	Article						Intracellular trafficking; Endocytosis; glutamate; Calcium; Transport	PROTEIN-KINASE; SURFACE-DIFFUSION; NEURONAL-ACTIVITY; CEREBRAL-CORTEX; CA2+ RELEASE; MICE LACKING; ASTROCYTES; BRAIN; LOCALIZATION; STIMULATION	GLT-1 is the main glutamate transporter in the brain and its trafficking controls its availability at the cell surface, thereby shaping glutamatergic neurotransmission under physiological and pathological conditions. Extracellular glutamate is known to trigger ubiquitin-dependent GLT-1 internalization from the surface of the cell to the intracellular compartment, yet here we show that internalization also requires the participation of calcium ions. Consistent with previous studies, the addition of glutamate (1 mM) to mixed primary cultures (containing neurons and astrocytes) promotes GLT-1 internalization, an effect that was suppressed in the absence of extracellular Ca2+. The pathways of Ca2+ mobilization by astrocytes were analyzed in these mixed cultures using the genetically encoded calcium sensor GCaMP6f. A complex pattern of calcium entry was activated by glutamate, with a dramatic and rapid rise in the intracellular Ca2+ concentration partially driven by glutamate transporters, especially in the initial stages after exposure to glutamate. The Na+/Ca2+ exchanger (NCX) plays a dominant role in this Ca2+ mobilization and its blockade suppresses the glutamate induced internalization of GLT-1, both in astrocytes and in a more straightforward experimental system like HEK293 cells transiently transfected with GLT-1. This regulatory mechanism might be relevant to control the amount of GLT-1 transporter at the cell surface in conditions like ischemia or traumatic brain injury, where extracellular concentrations of glutamate are persistently elevated and they promote rapid Ca2+ mobilization.	[Ibanez, Ignacio; Bartolome-Martin, David; Piniella, Dolores; Gimenez, Cecilio; Zafra, Francisco] Univ Autonoma Madrid, CSIC, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ibanez, Ignacio; Bartolome-Martin, David; Piniella, Dolores; Gimenez, Cecilio; Zafra, Francisco] Inst Salud Carlos III, IdiPAZ, Madrid, Spain		Zafra, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fzafra@cbm.csic.es	Martin, David Bartolome/AAX-5855-2020; Gimenez, Cecilio/K-8027-2014; Zafra, Francisco/A-6121-2008	Martin, David Bartolome/0000-0003-0258-7477; Gimenez, Cecilio/0000-0001-6726-8405; Piniella, Dolores/0000-0003-1158-0226; Zafra, Francisco/0000-0003-3801-3109	Spanish MINECOSpanish Government [SAF2014- 55686-R]; Fundacion Ramon Areces	We would like to thank E. Nunez and component of SMOC at CBMSO for expert technical help and to Dr. FJ Diez-Guerra for his advice on calcium measurements. This work was supported by grants from the Spanish MINECO (SAF2014- 55686-R) and the "Fundacion Ramon Areces", the latter also providing an institutional grant to CBMSO.	Al Awabdh S, 2016, GLIA, V64, P1252, DOI 10.1002/glia.22997; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chawla AR, 2017, J NEUROCHEM, V140, P421, DOI 10.1111/jnc.13913; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Garcia-Tardon N, 2012, J BIOL CHEM, V287, P19177, DOI 10.1074/jbc.M112.355909; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Gonzalez MI, 2004, CURR OPIN PHARMACOL, V4, P30, DOI 10.1016/j.coph.2003.09.004; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Ibanez I, 2016, NEUROPHARMACOLOGY, V107, P376, DOI 10.1016/j.neuropharm.2016.03.042; Jackson JG, 2015, J NEUROSCI, V35, P15199, DOI 10.1523/JNEUROSCI.2049-15.2015; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kirischuk S, 2007, PFLUG ARCH EUR J PHY, V454, P245, DOI 10.1007/s00424-007-0207-5; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Loaiza A, 2003, J NEUROSCI, V23, P7337; Magi S, 2013, MOL PHARMACOL, V84, P603, DOI 10.1124/mol.113.087775; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Murphy-Royal C, 2015, NAT NEUROSCI, V18, P219, DOI 10.1038/nn.3901; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Porras OH, 2008, GLIA, V56, P59, DOI 10.1002/glia.20589; Porter JT, 1996, J NEUROSCI, V16, P5073; Pulina MV, 2013, ADV EXP MED BIOL, V961, P365, DOI 10.1007/978-1-4614-4756-6_31; Robinson MB, 2006, HANDB EXP PHARM, V175, P251; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; Rojas H, 2007, J NEUROCHEM, V100, P1188, DOI 10.1111/j.1471-4159.2006.04303.x; Rungta RL, 2016, GLIA, V64, P2093, DOI 10.1002/glia.23042; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shigetomi E, 2016, TRENDS CELL BIOL, V26, P300, DOI 10.1016/j.tcb.2016.01.003; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tsumura M, 2012, CELL CALCIUM, V52, P124, DOI 10.1016/j.ceca.2012.05.002; Underhill SM, 2015, J NEUROSCI, V35, P5260, DOI 10.1523/JNEUROSCI.4365-14.2015; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Zhang YV, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0340-16.2017	49	11	11	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	FEB	2019	123				SI		125	132		10.1016/j.neuint.2018.03.012			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	JR9QX	WOS:000499952000015	29574129				2022-02-06	
J	Shaver, TK; Ozga, JE; Zhu, BX; Anderson, KG; Martens, KM; Vonder Haar, C				Shaver, Trinity K.; Ozga, Jenny E.; Zhu, Binxing; Anderson, Karen G.; Martens, Kris M.; Vonder Haar, Cole			Long-term deficits in risky decision-making after traumatic brain injury on a rat analog of the Iowa gambling task	BRAIN RESEARCH			English	Article						Rodent gambling task; Amphetamine; cFos; Plasticity; Behavior	IMPULSIVE ACTION; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; SEX-DIFFERENCES; UNITED-STATES; DOPAMINE; MOTOR; CONSEQUENCES; SENSITIVITY; PERFORMANCE	Traumatic brain injury (TBI) affects 2.8 million people annually in the United States, with significant populations suffering from ongoing cognitive dysfunction. Impairments in decision-making can have major implications for patients and their caregivers, often enduring for years to decades, yet are rarely explored in experimental TBI. In the current study, the Rodent Gambling Task (RGT), an Iowa Gambling Task analog, was used to assess risk-based decision-making and motor impulsivity after TBI. During testing, rats chose between options associated with different probabilities of reinforcement (sucrose) or punishment (timeout). To determine effects of TBI on learned behaviors versus the learning process, rats were trained either before, or after, a bilateral frontal controlled cortical impact TBI, and then assessed for 12 weeks. To evaluate the degree to which monoamine systems, such as dopamine, were affected by TBI, rats were given an amphetamine challenge, and behavior recorded. Injury immediately and chronically decreased optimal decision-making, and biased rats towards both riskier, and safer (but suboptimal) choices, regardless of prior learning history. TBI also increased motor impulsivity across time, reflecting ongoing neural changes. Despite these similarities in trained and acquisition rats, those that learned the task after injury demonstrated reduced effects of amphetamine on optimal decision-making, suggesting a lesser role of monoamines in post-injury learning. Amphetamine also dose-dependently reduced motor impulsivity in injured rats. This study opens up the investigation of psychiatric-like dysfunction in animal models of TBI and tasks such as the RGT will be useful in identifying therapeutics for the chronic post-injury period.	[Shaver, Trinity K.; Ozga, Jenny E.; Zhu, Binxing; Anderson, Karen G.; Martens, Kris M.; Vonder Haar, Cole] West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wiru.edu		Vonder Haar, Cole/0000-0001-7949-2068	National Center for Responsible Gaming; National Institute of General Medical Sciences (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P20GM109098-04]; West Virginia University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109098] Funding Source: NIH RePORTER	We would like to thank Robelle Dalida, Taylor Scott, Noah Berdar, and Lindsay Veltri for their assistance with behavioral testing. Funding for this project was provided by grants from the National Center for Responsible Gaming, National Institute of General Medical Sciences (NIGMS; 5P20GM109098-04), and West Virginia University.	Adams WK, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0094-17.2017; Baarendse PJJ, 2013, PSYCHOPHARMACOLOGY, V225, P719, DOI 10.1007/s00213-012-2857-z; Bailey MR, 2016, NEUROBIOL LEARN MEM, V133, P233, DOI 10.1016/j.nlm.2016.07.015; Barrus MM, 2016, J NEUROSCI, V36, P785, DOI 10.1523/JNEUROSCI.2225-15.2016; Barrus MM, 2015, J PSYCHIATR NEUROSCI, V40, P108, DOI 10.1503/jpn.140045; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bjork JM, 2016, PSYCHIAT RES, V246, P321, DOI 10.1016/j.psychres.2016.10.008; Brevers D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00665; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Castells X, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007813.pub3; Center for Disease Control, 2017, INJ PREV CONTR TRAUM; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Dixon MR, 2005, BEHAV INTERVENT, V20, P101, DOI 10.1002/bin.173; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gansler DA, 2011, ARCH CLIN NEUROPSYCH, V26, P706, DOI 10.1093/arclin/acr082; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Kraplin A, 2014, PSYCHIAT RES, V215, P675, DOI 10.1016/j.psychres.2013.12.041; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ozga J. E, 2018, BEHAV PHARM; Paine TA, 2013, BEHAV BRAIN RES, V243, P247, DOI 10.1016/j.bbr.2013.01.018; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramic M, 2006, BRAIN RES, V1111, P176, DOI 10.1016/j.brainres.2006.06.063; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Sevy S, 2007, SCHIZOPHR RES, V92, P74, DOI 10.1016/j.schres.2007.01.005; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Silveira MM, 2016, BEHAV PHARMACOL, V27, P350, DOI 10.1097/FBP.0000000000000203; Singh V, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00708; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Visser-Keizer AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166995; Vonder Haar C., 2018, EUR J NEUROSCI; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Weafer J, 2014, ADDICT BEHAV, V39, P1573, DOI 10.1016/j.addbeh.2013.10.033; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeeb FD, 2015, PSYCHOPHARMACOLOGY, V232, P4481, DOI 10.1007/s00213-015-4075-y; Zeeb FD, 2013, J NEUROSCI, V33, P6434, DOI 10.1523/JNEUROSCI.3971-12.2013; Zeeb FD, 2013, PSYCHOPHARMACOLOGY, V225, P381, DOI 10.1007/s00213-012-2822-x; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	63	11	11	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 1	2019	1704						103	113		10.1016/j.brainres.2018.10.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HJ9GY	WOS:000457508100012	30296430	Green Accepted, hybrid			2022-02-06	
J	Tierney, GJ; Denvir, K; Farrell, G; Simms, CK				Tierney, Gregory J.; Denvir, Karl; Farrell, Garreth; Simms, Ciaran K.			Does ball carrier technique influence tackler head injury assessment risk in elite rugby union?	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; Head Impact; Tackling; Injury Prevention	WORLD-CUP; VIDEO ANALYSIS; CONCUSSION; EVENTS; SPORT; PERFORMANCE; MANAGEMENT; AGREEMENT; PLAYERS; TIME	The aim of this study was to use video evidence of tackles in elite level rugby union to identify ball carrier proficiency characteristics, for both lower and upper body tackles, that have a higher propensity to result in Head Injury Assessments(HIA) for the tackler. HIA (n = 74) and non-HIA tackles (n = 233) were categorised as either front-on or side-on upper or lower body tackles and scored for ball carrying proficiency characteristics. Side-on tackles included tackles from behind. A Chi-Square test (p < 0.05) and Cramer's V were calculated to compare proficiency characteristics in HIA and non-HIA cases. For front-on upper body tackles, the ball carrier "fending into contact" (p < 0.01;ES = Moderate) and "explosiveness on contact" (p = 0.04;ES = Moderate) had a higher propensity to result in a HIA for the tackler. Fending into contact was exhibited in 47% of all upper body Tackle front-on HIA cases. The fending arm contacted the tackler's head in 67% of these cases. Fending into contact can potentially be dangerous and therefore emphasis should be placed on safe fending during tackle-based training drills. Referees should also be alert to arm-to-head contact during the fend. Given the low number of ball carrier characteristics identified, focus should be placed on tackler characteristics for HIA prevention strategies.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Denvir, Karl; Farrell, Garreth] Leinster Rugby, Dublin, Ireland		Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.	gtierne@tcd.ie		Tierney, Gregory/0000-0002-4666-4473	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	This work was supported by the Irish Research Council;	Altman D. G., 1990, PRACTICAL STAT MED R, P229; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cohen J., 1988, STAT POWER ANAL BEHA, P7; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gabbett T, 2007, INT J SPORTS SCI COA, V2, P467, DOI [10.1260/174795407783359731, DOI 10.1260/174795407783359731]; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; Hendricks S., 2016, BMJ OPEN SPORT EXERC, V2, P1; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hutchison M. G., 2013, BRIT J SPORT MED, V49, P547; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Montgomery C, 2018, BRIT J SPORT MED, V52, P994, DOI 10.1136/bjsports-2016-096425; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rugby W., 2016, RECKLESS ACCIDENTAL; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Simms C.K., 2015, P INT RES COUNC BIOM, P180, DOI DOI 10.1002/NET.21589; Simms CK., 2016, ISBS C P ARCH, DOI DOI 10.1016/J.PUHE.2015.10.038; Tierney G.J., 2017, IRCOBI C ANTW BELG, P703; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P16, DOI 10.1177/1747954117711866; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Union R. F., 2018, ENGLAND PROFESSIONAL; Wheeler K, 2009, INT J SPORTS SCI COA, V4, P535, DOI 10.1260/174795409790291420	44	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	FEB 1	2019	37	3					262	267		10.1080/02640414.2018.1494952			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HF0FB	WOS:000453833300005	29969061	Green Published, Green Accepted			2022-02-06	
J	Brooks, BL; Low, TA; Plourde, V; Virani, S; Jadavji, Z; MacMaster, FP; Barlow, KM; Lebel, RM; Yeates, KO				Brooks, Brian L.; Low, Trevor A.; Plourde, Vickie; Virani, Shane; Jadavji, Zeanna; MacMaster, Frank P.; Barlow, Karen M.; Lebel, R. Marc; Yeates, Keith Owen			Cerebral blood flow in children and adolescents several years after concussion	BRAIN INJURY			English	Article						Children; closed head injury; concussion; MRI; neuroimaging	TRAUMATIC BRAIN-INJURY; MULTIPLE PAST CONCUSSIONS; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; SYMPTOMS; RECOVERY; OUTCOMES; SPORTS; PERFUSION; HISTORY	Objectives: The long-term effects of concussion in youth remain poorly understood. The objective of this study was to determine the association between history of concussion and cerebral blood flow (CBF) in youth. Methods: A total of 53 children and adolescents with a history of concussion (n = 37) or orthopaedic injury (OI; n = 16) were considered. Measures included pseudo-continuous arterial spin labelling magnetic resonance imaging to quantify CBF, post-concussion symptoms, psychological symptoms, and cognitive testing. Results: Participants (mean age: 14.4 years, 95% CI = 13.8-15.4, range = 8-19) were on average 2.7 years (95% CI = 2.2-3.1) post-injury. Youth with a history of concussion had higher parent-reported physical, cognitive, anxiety, and depression symptoms than children with OI, but the groups did not differ on self-reported symptoms (post-concussive or psychological) or cognitive testing. Global CBF did not differ between groups. Regional CBF analyses suggested that youth with a history of concussion had hypoperfusion in posterior and inferior regions and hyperperfusion in anterior/frontal/temporal regions as compared to those with OI. However, neither global nor regional CBF were significantly associated with demographics, pre-injury functioning, number of concussions, time since injury, post-concussive symptoms, psychological symptoms, or cognitive abilities. Conclusions: Youth with a history of concussion demonstrate differences in regional CBF (not global CBF), but without clear clinical expression.	[Brooks, Brian L.; MacMaster, Frank P.; Yeates, Keith Owen] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.; MacMaster, Frank P.; Lebel, R. Marc; Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada; [Low, Trevor A.; Jadavji, Zeanna] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Virani, Shane] Alberta Childrens Prov Gen Hosp, Res Inst, Vi Riddell Pain & Rehabil Program, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Jadavji, Zeanna] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [MacMaster, Frank P.] Hotchkiss Brain Inst, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada; [MacMaster, Frank P.] Alberta Hlth Serv, Strateg Clin Network Addict & Mental Hlth, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Barlow, Karen M.] Univ Calgary, Dept Paediat, Brisbane, Qld, Australia; [Barlow, Karen M.] Univ Calgary, Dept Clin Neurosci, Brisbane, Qld, Australia; [Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Brisbane, Qld, Australia; [Lebel, R. Marc] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Lebel, R. Marc] Univ Calgary, Dept Biomed Engn, Calgary, AB, Canada; [Lebel, R. Marc] GE Healthcare, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	Brian.Brooks@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Yeates, Keith/AAJ-4223-2020; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Low, Trevor/0000-0002-8564-845X; MacMaster, Frank/0000-0002-7159-7583; Plourde, Vickie/0000-0002-0098-5431; Yeates, Keith/0000-0001-7680-2892	Shaikh Family Research Award; Alberta Children's Hospital Foundation; Alberta Children's Hospital Research Institute; Irene Ward Chair in Pediatric Brain Injury; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (University of Calgary); Integrated Concussion Research Program (University of Calgary); Alberta Innovates-Health Solutions; Ronald and Irene Ward Chair in Pediatric Brain Injury	This study was funded by the Shaikh Family Research Award, an endowment held by the Alberta Children's Hospital Foundation and granted to Brian Brooks by the Alberta Children's Hospital Research Institute. Additional support for the study was provided from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award. Vickie Plourde acknowledges fellowship funding from the Alberta Children's Hospital Research Institute (University of Calgary), the Integrated Concussion Research Program (University of Calgary), and Alberta Innovates-Health Solutions. Trevor Low acknowledges summer studentship funding from the Alberta Children's Hospital Research Institute (University of Calgary), the Integrated Concussion Research Program (University of Calgary), and Alberta Innovates-Health Solutions. Keith Yeates acknowledges funding from the Ronald and Irene Ward Chair in Pediatric Brain Injury.	Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 2010, IBM SPSS STAT WIND V; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; CNS Vital Signs, 2014, CNS VIT SIGNS TEST I; Cohen J., 2013, STAT POWER ANAL BEHA; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hales PW, 2014, J CEREBR BLOOD F MET, V34, P776, DOI 10.1038/jcbfm.2014.17; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012	44	11	11	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					233	241		10.1080/02699052.2018.1540798			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300015	30380944				2022-02-06	
J	Castine, BR; Albein-Urios, N; Lozano-Rojas, O; Martinez-Gonzalez, JM; Hohwy, J; Verdejo-Garcia, A				Castine, Benjamin R.; Albein-Urios, Natalia; Lozano-Rojas, Oscar; Martinez-Gonzalez, Jose M.; Hohwy, Jakob; Verdejo-Garcia, Antonio			Self-awareness deficits associated with lower treatment motivation in cocaine addiction	AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE			English	Article						Self-awareness; insight; substance use disorder; addiction; disinhibition; craving	TRAUMATIC BRAIN-INJURY; SUBSTANCE USE; INTEGRATIVE MODEL; IMPAIRED INSIGHT; ALCOHOL; APATHY; ADULTS; REHABILITATION; INTEROCEPTION; INDIVIDUALS	Background: Individuals with cocaine use disorder (CUD) often display behaviours that are paradoxically misaligned with their situation. Typical examples include poor treatment motivation and inconsistent self-reported craving. These behaviours may reflect impairments in the awareness of one's own behaviour. Objectives: We examined whether impaired self-awareness of addiction-related frontostriatal dysfunction (i.e., symptoms of apathy, disinhibition, and executive dysfunction) was associated with treatment motivation and craving. Methods: Sixty-five outpatients with CUD (57 male) and their informants (those who knew the patient well) completed parallel self and informant versions of the Frontal Systems Behaviour Scale. Self-awareness was indexed through the discrepancy between self and informant scores in the three sub-scales; apathy, disinhibition and executive dysfunction. The University Rhode Island Change Assessment Scale assessed treatment motivation. Self-reported craving was assessed using a visual analogue scale. Multiple linear regression models examined associations between self-awareness and treatment motivation and craving, adjusting for sociodemographic factors and lifetime drug use. Results: We found an inverse relationship between self-awareness of symptoms of disinhibition and treatment motivation maintenance. Although impaired awareness of disinhibition was also correlated with craving, this association was not significant after adjusting for sociodemographic factors and drug use. The apathy and executive dysfunction awareness scores were not associated with treatment motivation or craving. Conclusion: We show that people with lower insight into their disinhibition problems (e.g., impulsivity, mood instability) have more problems maintaining motivation when initiating treatment. Findings suggest that self-awareness interventions could be useful to prevent premature treatment dropout and improve addiction treatment outcomes.	[Castine, Benjamin R.; Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk, Clayton, Vic 3800, Australia; [Albein-Urios, Natalia] Deakin Univ, Sch Psychol, Burwood, Vic, Australia; [Lozano-Rojas, Oscar] Univ Huelva, Dept Psicol Clin Expt & Social, Huelva, Spain; [Martinez-Gonzalez, Jose M.] Diputac Granada, Ctr Prov Drogodependencias, Granada, Spain; [Hohwy, Jakob] Monash Univ, Fac Arts, Dept Philosophy, Clayton, Vic, Australia		Verdejo-Garcia, A (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	Antonio.Verdejo@monash.edu	Albein-Urios, Natalia/A-4514-2016; Lozano, Oscar M./C-6070-2011; Verdejo-Garcia, Antonio/AAV-1147-2021	Albein-Urios, Natalia/0000-0001-7841-018X; Lozano, Oscar M./0000-0003-2722-6563; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Castine, Benjamin/0000-0003-0912-2883; Hohwy, Jakob/0000-0003-3906-3060	Plan Nacional sobre Drogas-Ministerio de Sanidad y Consumo	This study was supported by the Plan Nacional sobre Drogas-Ministerio de Sanidad y Consumo under Grant COPERNICO.	Albein-Urios N, 2013, PSYCHOPHARMACOLOGY, V228, P367, DOI 10.1007/s00213-013-3040-x; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Back SE, 2010, DRUG ALCOHOL DEPEN, V106, P21, DOI 10.1016/j.drugalcdep.2009.07.016; Bordnick PS, 1998, J SUBST ABUSE, V10, P9, DOI 10.1016/S0899-3289(99)80136-9; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Cathomas F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00241; Collins SE, 2012, ADDICT BEHAV, V37, P931, DOI 10.1016/j.addbeh.2012.03.029; DiClemente CC, 2004, AM J ADDICTION, V13, P103, DOI 10.1080/10550490490435777; Elman I, 2001, AM J DRUG ALCOHOL AB, V27, P193, DOI 10.1081/ADA-100103705; Fatseas M, 2015, ADDICTION, V110, P1035, DOI 10.1111/add.12882; Fleming JM, 1996, BRAIN INJURY, V10, P1; Grace J, 2001, FRSBE FRONTAL SYSTEM; Hester R, 2007, NEUROPSYCHOPHARMACOL, V32, P1974, DOI 10.1038/sj.npp.1301326; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Kim KM, 2007, J KOREAN MED SCI, V22, P453, DOI 10.3346/jkms.2007.22.3.453; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Levy R, 2012, REV NEUROL-FRANCE, V168, P585, DOI 10.1016/j.neurol.2012.05.003; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Moeller SJ, 2016, EUR NEUROPSYCHOPHARM, V26, P653, DOI 10.1016/j.euroneuro.2016.02.009; Moeller SJ, 2014, TRENDS COGN SCI, V18, P635, DOI 10.1016/j.tics.2014.09.003; Moeller SJ, 2014, JAMA PSYCHIAT, V71, P61, DOI 10.1001/jamapsychiatry.2013.2833; Moeller SJ, 2012, BRAIN, V135, P3481, DOI 10.1093/brain/aws252; Moeller SJ, 2010, BRAIN, V133, P1484, DOI 10.1093/brain/awq066; Moreno-Lopez L, 2017, ADDICT BIOL, V22, P1438, DOI 10.1111/adb.12422; Moreno-Lopez L, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00052; Myers B, 2016, BMC PSYCHIATRY, V16, P1, DOI [10.1186/s12888-015-0706-4, DOI 10.1186/S12888-015-0706-4]; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Palmer RS, 2009, SUBST USE MISUSE, V44, P1021, DOI 10.1080/10826080802495237; Papachristou H, 2013, PSYCHOPHARMACOLOGY, V228, P641, DOI 10.1007/s00213-013-3063-3; Paulus MP, 2014, NEUROPHARMACOLOGY, V76, P342, DOI 10.1016/j.neuropharm.2013.07.002; Potenza MN, 2012, AM J PSYCHIAT, V169, P406, DOI 10.1176/appi.ajp.2011.11020289; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; Radakovic R, 2018, CURR OPIN BEHAV SCI, V22, P42, DOI 10.1016/j.cobeha.2017.12.022; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Ruiz MA, 2008, J PERS DISORD, V22, P365, DOI 10.1521/pedi.2008.22.4.365; Sayette MA, 2016, ANNU REV CLIN PSYCHO, V12, P407, DOI 10.1146/annurev-clinpsy-021815-093351; Stasiewicz PR, 2012, ADDICT BEHAV, V37, P469, DOI 10.1016/j.addbeh.2011.12.011; Stevens A, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-13; Stevens L, 2015, J SUBST ABUSE TREAT, V49, P58, DOI 10.1016/j.jsat.2014.08.007; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Verdejo-Garcia A, 2013, PRINCIPLES OF ADDICTION: COMPREHENSIVE ADDICTIVE BEHAVIORS AND DISORDERS, VOL 1, P77, DOI 10.1016/B978-0-12-398336-7.00008-5; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001; Verdejo-Garcia A, 2012, NEUROSCI BIOBEHAV R, V36, P1857, DOI 10.1016/j.neubiorev.2012.05.007; Wagner V, 2017, QUAL HEALTH RES, V27, P1614, DOI 10.1177/1049732316679372; Weiss RD, 2003, AM J PSYCHIAT, V160, P1320, DOI 10.1176/appi.ajp.160.7.1320; Witkiewitz K, 2013, PSYCHOL ADDICT BEHAV, V27, P351, DOI 10.1037/a0029258	54	11	11	4	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0095-2990	1097-9891		AM J DRUG ALCOHOL AB	Am. J. Drug Alcohol Abuse	JAN 2	2019	45	1					108	114		10.1080/00952990.2018.1511725			7	Psychology, Clinical; Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Substance Abuse	HM0KW	WOS:000459137500011	30183371				2022-02-06	
J	Douglas, JM; Knox, L; De Maio, C; Bridge, H; Drummond, M; Whiteoak, J				Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen; Drummond, Melanie; Whiteoak, Joanne			Effectiveness of Communication-specific Coping Intervention for adults with traumatic brain injury: preliminary results	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; communication; coping; intervention	SOCIAL INTEGRATION; FACIAL EXPRESSION; FOLLOW-UP; QUESTIONNAIRE; ABILITY; DISCOURSE; VALIDITY; OUTCOMES; SKILLS; PERSPECTIVES	People with traumatic brain injury (TBI) describe everyday interactions as a long-term challenge frequently associated with ongoing stress. Communication-specific Coping Intervention (CommCope-I) is a new treatment developed to target coping in the context of communication breakdown. The intervention incorporates principles of cognitive behavioural therapy, self-coaching and context-sensitive social communication therapy. The purpose of this study was to examine the effectiveness of CommCope-I in a group of adults with severe TBI and ongoing functional communication difficulties. Participants were 13 adults with severe TBI (GCS = 3-8; mean age = 35.2 years; mean time post-injury = 7.6 years). The project involved three phases: (1) Control/pre-intervention wait phase (multiple assessments), (2) Treatment (6 weeks), and (3) Follow-up (12 weeks). Repeated measures ANOVA with planned pairwise comparisons were used to test the significance of change. Intervention elicited statistically significant improvements in communication-specific coping, functional communication and stress that were maintained for three months. Improved use of communication-specific coping strategies was evident in clinician blind ratings. Clients reported significant reduction in stress at the end of treatment and one and three months later. This intervention provides a promising means of improving communication-specific coping and reducing communication dysfunction and its negative consequences for people with TBI.	[Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen; Drummond, Melanie; Whiteoak, Joanne] La Trobe Univ, Sch Allied Hlth, Living Disabil Res Ctr, Bundoora, Vic, Australia; [Douglas, Jacinta M.; Knox, Lucy] Summer Fdn, Box Hill, Vic, Australia; [De Maio, Carren] Scope, Hawthorn, Vic, Australia; [Bridge, Helen] Beachside & South Eastern Suburbs Speech Pathol, Edithvale, Vic, Australia; [Drummond, Melanie] Epworth Monash Rehabil Med Unit, Melbourne, Vic, Australia; [Drummond, Melanie; Whiteoak, Joanne] Epworth HealthCare, Speech Pathol Dept, Epworth Rehabil, Richmond, Vic, Australia; [Whiteoak, Joanne] Caulfield Hosp, Alfred Hlth, Speech Pathol Dept, Caulfield, Australia		Douglas, JM (corresponding author), La Trobe Univ, Sch Allied Hlth, Living Disabil Res Ctr, Bundoora, Vic, Australia.	J.Douglas@latrobe.edu.au	Knox, Lucy/E-8642-2013; Douglas, Jacinta M/C-2380-2009	Knox, Lucy/0000-0001-8331-6032; Douglas, Jacinta/0000-0003-0940-6624	Transport Accident Commission, Victorian Neurotrauma Initiative [DO71]	This work was supported by the Transport Accident Commission, Victorian Neurotrauma Initiative under [grant number DO71].	Access Economics, 2008, EC COST SPIN CORD IN; AIHW, 2007, AIHW B, V55; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Douglas J., 2012, BRAIN IMPAIR, V13, P170; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Friedman A., 2005, BRAIN INJURY S, V19, P50; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Manolov R, 2009, BEHAV RES METHODS, V41, P1262, DOI 10.3758/BRM.41.4.1262; Mellick D., 2000, CRAIG HANDICAP ASSES; Mitchell C., 2011, BRAIN IMPAIRMENT S, V12, P41; Muir A., 2007, BRAIN IMPAIR, V8, P83; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Scruggs TE, 1998, BEHAV MODIF, V22, P221, DOI 10.1177/01454455980223001; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	47	11	11	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2019	29	1					73	91		10.1080/09602011.2016.1259114			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GY1HI	WOS:000448276600004	27911168	hybrid			2022-02-06	
J	Rietdijk, R; Power, E; Brunner, M; Togher, L				Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne			A single case experimental design study on improving social communication skills after traumatic brain injury using communication partner telehealth training	BRAIN INJURY			English	Article						Traumatic brain injury; telemedicine; communication; feasibility studies; videoconferencing	COGNITIVE REHABILITATION; RATING-SCALE; PEOPLE; INTERVENTION; OUTCOMES; PROGRAM; CONVERSATION; INDIVIDUALS; IMPAIRMENTS; RELIABILITY	Primary objective: To investigate use of telehealth to deliver social communication skills training (TBIconneCT) to people with severe traumatic brain injury (TBI) and their communication partners (CPs). Research design: Feasibility study involving single case experimental design with two participants. Methods and procedures: TBI Express is an established program for improving social interactions between people with TBI and their CPs. To improve access to the program, we developed a modified version called TBIconneCT that can be delivered via videoconferencing. Two participants with TBI and their CPs completed TBIconneCT training. Outcome measures included exchange structure analysis of conversation samples, blinded ratings of conversation samples and self-report measures. Main outcomes and results: The study indicated positive change on blinded ratings of conversation and self-reported measures for both participants. Exchange structure analysis conducted on session-by-session data did not demonstrate treatment effects due to variability during baseline. Conclusion: This study indicated potential for using telehealth to provide social communication skills training to people with TBI and their families. The study findings provide a foundation for a phase one clinical trial which will compare in-person with videoconferencing delivery of TBIconneCT.	[Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Power, Emma; Brunner, Melissa] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW, Australia.	rman7827@uni.sydney.edu.au	Rietdijk, Rachael/J-6573-2012; Togher, Leanne/AAC-7083-2019; Brunner, Melissa/AAS-5965-2020; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Togher, Leanne/0000-0002-4518-6748; Brunner, Melissa/0000-0001-6823-5189; Power, Emma/0000-0002-2638-0406			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Babbitt EM, 2011, APHASIOLOGY, V25, P727, DOI 10.1080/02687038.2010.537347; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cahill J, 2012, PSYCHOTHER RES, V22, P241, DOI 10.1080/10503307.2011.643253; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Cherney LR, 2011, TOP STROKE REHABIL, V18, P352, DOI 10.1310/tsr1804-352; Cohn ER, 2011, SIG 18 PERSPECT TELE, V1, P26, DOI DOI 10.1044/tele1.1.26; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Eldridge SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150205; Halliday M., 2004, INTRO FUNCTIONAL GRA; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Lozano BE, 2015, BEHAV TELEHEALTH, P221, DOI 10.1007/978-3-319-08765-8_10; Luxton DD, 2014, PROF PSYCHOL-RES PR, V45, P27, DOI 10.1037/a0034547; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McGrath N, 2008, J HEAD TRAUMA REHAB, V23, P388, DOI 10.1097/01.HTR.0000341434.74875.c8; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Riegler LJ, 2013, MED SCI MONITOR, V19, P269, DOI 10.12659/MSM.883885; Rietdijk R, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000282; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Saldert C, 2018, APHASIOLOGY, V32, P1167, DOI 10.1080/02687038.2018.1470317; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; Tucker JK, 2012, INT J TELEREHABILITA, V4, P61, DOI 10.5195/ijt.2012.6100; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	49	11	11	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		94	104		10.1080/02699052.2018.1531313			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400012	30325220				2022-02-06	
J	Eierued, C; Nathan, DE; Bonavia, GH; Ollinger, J; Riedy, G				Eierued, Cyrus; Nathan, Dominic E.; Bonavia, Grant H.; Ollinger, John; Riedy, Gerard			Cortical thinning in military blast compared to non-blast persistent mild traumatic brain injuries	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; Military; Cortical thickness; Blast; Post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; HUMAN CEREBRAL-CORTEX; CONCUSSION; THICKNESS; MRI; PROBABILITY; SYMPTOMS; SOLDIERS; LESIONS	In the military, explosive blasts are a significant cause of mild traumatic brain injuries (mTBIs). The symptoms associated with blast mTBIs causes significant economic burdens and a diminished quality of life for many service members. At present, the distinction of the injury mechanism (blast versus non-blast) may not influence TBI diagnosis. However, using noninvasive imaging, this study reveals significant distinctions between the blast and non-blast TBI mechanisms. A cortical whole-brain thickness analysis was performed using structural high-resolution T1-weighted MRI to identify the effects of blasts in persistent mTBI (pmTBI) subjects. A total of 41 blast pmTBI subjects were individually age- and gender-matched to 41 non-blast pmTBI subjects. Using FreeSurfer, cortical thickness was quantified for the blast group, relative to the non-blast group. Cortical thinning was identified within the blast mTBI group, in two clusters bilaterally. In the left hemisphere, the cluster overlapped with the lateral orbitofrontal, rostral middle frontal, medial orbitofrontal, superior frontal, rostral anterior cingulate and frontal pole cortices (p < 0.02, two-tailed, size = 1680 mm(2)). In the right hemisphere, the cluster overlapped with the lateral orbitofrontal, rostral middle frontal, medial orbitofrontal, pars orbitalis, pars triangularis and insula cortices (p < 0.002, two-tailed, cluster size = 2453 mm(2)). Self-report assessments suggest significant differences in the Post-Traumatic Stress Disorder Checklist-Civilian Version (p < 0.05, Bonferroni-corrected) and the Neurobehavioral Symptom Inventory (p < 0.01, uncorrected) between the blast and non-blast mTBI groups. These results suggest that blast may cause a unique injury pattern related to a reduction in cortical thickness within specific brain regions which could affect symptoms. No other study has found cortical thickness difference between blast and non-blast mTBI groups and further replication is needed to confirm these initial observations.	[Eierued, Cyrus; Nathan, Dominic E.; Bonavia, Grant H.; Ollinger, John; Riedy, Gerard] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence NICoE, 4860 South Palmer Rd, Bethesda, MD USA; [Eierued, Cyrus; Nathan, Dominic E.] NorthTide Grp LLC, 46020 Manekin Plaza 180, Sterling, VA USA		Riedy, G (corresponding author), Natl Intrepid Ctr Excellence NICoE, Bethesda, MD 20814 USA.	gerard.p.riedy.civ@mail.mil		Eierud, Cyrus/0000-0002-9942-676X	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [DM130132]	This publication would not be possible without valuable help from Julie Kim, Adam Scott, Cheng Koay, Jaquel Barnes, Elyssa Sham, PingHong Yeh, Theresa Teslovich, Siamak Ardekani, Mark Varvaris, Alex Kubli, Christopher Aura, Patrick Regan, Jennifer Mehki, Anmarie Widener and Justin Senseney. Finally, we thank Arnold Fisher and the Intrepid Fallen Heroes Fund for founding the National Intrepid Center of Excellence. This work was supported by the Congressionally Directed Medical Research Programs (grant number DM130132).	Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, J CHILD NEUROL, V31, P1302, DOI 10.1177/0883073816654143; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; GRISSOM RJ, 1994, J APPL PSYCHOL, V79, P314, DOI 10.1037/0021-9010.79.2.314; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Nyein M. K., 2010, SILICO INVESTIGATION, DOI [10.21236/ada533075, DOI 10.21236/ADA533075]; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruscio J, 2008, PSYCHOL METHODS, V13, P19, DOI 10.1037/1082-989X.13.1.19; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1; [No title captured]	59	11	12	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	22								101793	10.1016/j.nicl.2019.101793			7	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IB2UA	WOS:000470123000109	30939340	gold, Green Published			2022-02-06	
J	Ellis, MJ; Boles, S; Derksen, V; Dawyduk, B; Amadu, A; Stelmack, K; Kowalchuk, M; Russell, K				Ellis, Michael J.; Boles, Susan; Derksen, Vickie; Dawyduk, Brenda; Amadu, Adam; Stelmack, Karen; Kowalchuk, Matthew; Russell, Kelly			Evaluation of a pilot paediatric concussion telemedicine programme for northern communities in Manitoba	INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH			English	Article						Concussion; paediatric; telemedicine; multi-disciplinary management	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; AMERICAN; MANAGEMENT; CHILDREN; TELECONCUSSION; TELENEUROLOGY; TELEHEALTH; TELESTROKE; DISORDERS	Pediatric concussion patients living in northern communities in Canada can face unique challenges accessing primary and specialized healthcare. In this study we report the clinical characteristics, healthcare utilization, outcomes and estimated cost avoidance associated with a pilot pediatric concussion telemedicine program established between a multi-disciplinary pediatric concussion program in Winnipeg, Manitoba and a hospital in Thompson, Manitoba. From October 1(st)- July 1(st), 2018, 20 patients were evaluated; mean age 13.1 years, 15 (75%) males and 14 (70%) self-identified as Indigenous. Injury mechanisms included hockey (50%), falls (35%) and assaults (15%). Median time from referral to initial consultation was 2.0 days. After screening by the neurosurgeon, 90% of patients underwent initial consultation via real-time videoconferencing with 80% managed exclusively through telemedicine. At the end of the study, 90% met the criteria for clinical recovery, one remained in treatment and one was discharged to a headache neurologist. Sixty-six telemedicine encounters were completed including 57 videoconferencing appointments and 9 telephone follow-ups representing an estimated cost avoidance of $40,972.94. This study suggests telemedicine may be a useful approach to assist pediatric concussion programs with delivering timely, safe and cost-effective care to patients living in medically underserviced remote and northern communities in Canada.	[Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.; Derksen, Vickie] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Canada North Concuss Network, Winnipeg, MB, Canada; [Boles, Susan; Stelmack, Karen; Kowalchuk, Matthew] Manitoba eHlth, MBTelehlth, Winnipeg, MB, Canada; [Dawyduk, Brenda; Amadu, Adam] Thompson Gen Hosp, Thompson, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB, Canada.	mellis3@panamclinic.com	Hubsher, Marshall/Q-1825-2019	Hubsher, Marshall/0000-0002-9775-0400; Russell, Kelly/0000-0002-9159-9201; Hubsher, Marshall/0000-0002-7315-8947	University of Manitoba Department of Surgery Thorlakson Fund	Financial support for this manuscript was provided by University of Manitoba Department of Surgery Thorlakson Fund [N/A].	Ahmed SN, 2010, CAN J NEUROL SCI, V37, P814, DOI 10.1017/S0317167100051490; [Anonymous], 2017, CANADIAN GUIDELINE C; Arora S, 2013, CLIN INVEST MED, V36, pE57, DOI 10.25011/cim.v36i2.19567; Banerji A, 2012, PAED CHILD HEALT-CAN, V17, P393, DOI 10.1093/pch/17.7.393; Beck CA, 2017, NEUROLOGY, V89, P1152, DOI 10.1212/WNL.0000000000004357; Berryhill MB, 2019, TELEMED E-HEALTH, V25, P435, DOI 10.1089/tmj.2018.0058; Blackmer J, 1999, BRAIN INJURY, V13, P627; Blacquiere D, 2017, INT J STROKE, V12, P886, DOI 10.1177/1747493017706239; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Demaerschalk BM, 2018, J STROKE CEREBROVASC, V27, P2940, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.024; Demaerschalk BM, 2017, TELEMED E-HEALTH, V23, P376, DOI 10.1089/tmj.2017.0006; Dwyer P, 2004, TELEMED J E-HEALTH, V10, P93, DOI 10.1089/153056204773644634; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Flewelling C, 2004, TELEMED J E-HEALTH, V10, P357, DOI 10.1089/tmj.2004.10.357; Haddad N, 2015, EPILEPSY BEHAV, V44, P1, DOI 10.1016/j.yebeh.2014.11.033; Hunt C, 2018, CAN J NEUROL SCI, V45, P283, DOI 10.1017/cjn.2017.299; Kane RL, 2008, J TELEMED TELECARE, V14, P190, DOI [10.1258/jtt.2008.070904, 10.1258/Jtt.2008.070904]; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Loh PK, 2007, J TELEMED TELECARE, V13, P90, DOI 10.1258/135763307780096159; MacDonald Cathy, 2015, INT J REGIONAL LOCAL, V10, P32, DOI DOI 10.1179/2051453015Z.00000000023; Marrone S, 2007, INT J CIRCUMPOL HEAL, V66, P188, DOI 10.3402/ijch.v66i3.18254; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Muller KI, 2017, CEPHALALGIA, V37, P855, DOI 10.1177/0333102416654885; Muttitt Sarah, 2004, Int J Circumpolar Health, V63, P401; Nader F, 2017, J HEALTH CARE POOR U, V28, P1286, DOI 10.1353/hpu.2017.0114; National Collaborating Centre for Aboriginal Health, 2011, ACC HLTH SERV SOC DE; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Gorman LD, 2016, TELEMED E-HEALTH, V22, P473, DOI 10.1089/tmj.2015.0166; Oosterveer TM, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.29576; Pignatiello A, 2011, CHILD ADOL PSYCH CL, V20, P13, DOI 10.1016/j.chc.2010.08.008; Qubty W, 2018, NEUROLOGY, V90, pE1702, DOI 10.1212/WNL.0000000000005482; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reimer K, CLIN J SPORT MED; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Rubin MN, 2013, POSTGRAD MED, V125, P45, DOI 10.3810/pgm.2013.01.2623; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Samii A, 2006, J TELEMED TELECARE, V12, P16, DOI 10.1258/135763306775321371; Schneider RB, 2017, LANCET NEUROL, V16, P541, DOI 10.1016/S1474-4422(17)30167-9; Shah BR, 2003, AM J PUBLIC HEALTH, V93, P798, DOI 10.2105/AJPH.93.5.798; Tenforde AS, 2017, PM&R, V9, pS51, DOI 10.1016/j.pmrj.2017.02.013; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Vargas BB, 2012, TELEMED E-HEALTH, V18, P803, DOI 10.1089/tmj.2012.0118; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vierhile A, 2018, J PEDIATR HEALTH CAR, V32, P500, DOI 10.1016/j.pedhc.2018.02.004; Wechsler LR, 2015, JAMA NEUROL, V72, P349, DOI 10.1001/jamaneurol.2014.3844; Wechsler LR, 2013, NEUROLOGY, V80, P670, DOI 10.1212/WNL.0b013e3182823361; World Health Organization, 1998, HLTH TEL POL SUPP WH; Zeiler KJ, 2017, CAN J NEUROL SCI, V44, P525, DOI 10.1017/cjn.2017.49; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	56	11	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1239-9736	2242-3982		INT J CIRCUMPOL HEAL	Int. J. Circumpolar Health	JAN 1	2019	78	1							1573163	10.1080/22423982.2019.1573163			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HK2IC	WOS:000457732700001	30714513	Green Published, gold			2022-02-06	
J	Johnston, W; O'Reilly, M; Duignan, C; Liston, M; McLoughlin, R; Coughlan, GF; Caulfield, B				Johnston, William; O'Reilly, Martin; Duignan, Ciara; Liston, Mairead; McLoughlin, Rod; Coughlan, Garrett F.; Caulfield, Brian			Association of Dynamic Balance With Sports-Related Concussion: A Prospective Cohort Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; traumatic brain injury; inertial sensor; balance; postural stability; Y balance test; risk factor	TRAUMATIC BRAIN-INJURY; SAMPLE ENTROPY ANALYSIS; MUSCULOSKELETAL INJURY; FOOTBALL PLAYERS; POSTURAL-CONTROL; HEAD-INJURIES; BODY CHECKING; RUGBY UNION; HIGH-SCHOOL; RISK	Background: Concussion is one of the most common sports-related injuries, with little understood about the modifiable and nonmodifiable risk factors. Researchers have yet to evaluate the association between modifiable sensorimotor function variables and concussive injury. Purpose: To investigate the association between dynamic balance performance, a discrete measure of sensorimotor function, and concussive injuries. Study Design: Cohort study (diagnosis); Level of evidence, 3. Methods: A total of 109 elite male rugby union players were baseline tested in dynamic balance performance while wearing an inertial sensor and prospectively followed during the 2016-2017 rugby union season. The sample entropy of the inertial sensor gyroscope magnitude signal was derived to provide a discrete measure of dynamic balance performance. Logistic regression modeling was then used to investigate the association among the novel digital biomarker of balance performance, known risk factors of concussion (concussion history, age, and playing position), and subsequent concussive injury. Results: Participant demographic data (mean +/- SD) were as follows: age, 22.6 +/- 3.6 years; height, 185 +/- 6.5 cm; weight, 98.9 +/- 12.5 kg; body mass index, 28.9 +/- 2.9 kg/m(2); and leg length, 98.8 +/- 5.5 cm. Of the 109 players, 44 (40.3%) had a history of concussion, while 21 (19.3%) sustained a concussion during the follow-up period. The receiver operating characteristic analysis for the anterior sample entropy demonstrated a statistically significant area under the curve (0.64; 95% CI, 0.52-0.76; P < .05), with the cutoff score of anterior sample entropy >= 1.2, which maximized the sensitivity (76.2%) and specificity (53.4%) for identifying individuals who subsequently sustained a concussion. Players with suboptimal balance performance at baseline were at a 2.81-greater odds (95% CI, 1.02-7.74) of sustaining a concussion during the rugby union season than were those with optimal balance performance, even when controlling for concussion history. Conclusion: Rugby union players who possess poorer dynamic balance performance, as measured by a wearable inertial sensor during the Y balance test, have a 3-times-higher relative risk of sustaining a sports-related concussion, even when controlling for history of concussion. These findings have important implications for research and clinical practice, as it identifies a potential modifiable risk factor. Further research is required to investigate this association in a large cohort consisting of males and females across a range of sports.	Univ Coll Dublin, Dublin, Ireland; Irish Rugby Football Union, Dublin, Ireland; [Johnston, William; O'Reilly, Martin; Duignan, Ciara; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Johnston, William; O'Reilly, Martin; Duignan, Ciara; Caulfield, Brian] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Liston, Mairead; McLoughlin, Rod] Irish Rugby Football Union, Med Dept, Dublin, Ireland; [Coughlan, Garrett F.] Connacht Rugby, Med Dept, Galway, Ireland		Johnston, W (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	william.johnston@ucdconnect.ie		O'Reilly, Martin/0000-0003-2425-5393			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Attwood MJ, 2017, BRIT J SPORT MED, V51, P290; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Cancela J, 2011, IEEE ENG MED BIO, P2233, DOI 10.1109/IEMBS.2011.6090423; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giggins Kelly D, 2013, 7 INT C PERV COMP TE; Gribble PA, 2016, AM J SPORT MED, V44, P460, DOI 10.1177/0363546515614585; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Johnston W, 2017, BRIT J SPORT MED, V51, pA54; Johnston William, 2017, Digit Biomark, V1, P106, DOI 10.1159/000485470; Johnston W, 2016, ICSPORTS: PROCEEDINGS OF THE 4TH INTERNATIONAL CONGRESS ON SPORT SCIENCES RESEARCH AND TECHNOLOGY SUPPORT, P15, DOI 10.5220/0006079400150024; Kemp S, 2016, BRIT J SPORT MED, V50, P644, DOI 10.1136/bjsports-2015-095780; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kemp SP, 2016, ENGLAND PROFESSIONAL; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGregor SJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-43; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Palmerini L, 2011, IEEE T INF TECHNOL B, V15, P481, DOI 10.1109/TITB.2011.2107916; Parshad RD, 2012, MATH BIOSCI ENG, V9, P123, DOI 10.3934/mbe.2012.9.123; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rugby Football Union, 2015, ENGL PROF RUGB INJ S; Steffen K, 2013, BRIT J SPORT MED, V47, P794, DOI 10.1136/bjsports-2012-091886; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Whelan D., 2015, P 3 2015 WORKSH ICTS, P144; World Rugby, HEAD INJ ASS HIA PRO; Zhang X, 2012, J ELECTROMYOGR KINES, V22, P901, DOI 10.1016/j.jelekin.2012.06.005	47	11	11	2	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN	2019	47	1					197	205		10.1177/0363546518812820			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HF3PL	WOS:000454146900031	30501391	Bronze, Green Submitted			2022-02-06	
J	Schomer, KJ; Sebat, CM; Adams, JY; Duby, JJ; Shahlaie, K; Louie, EL				Schomer, Kendra J.; Sebat, Christian M.; Adams, Jason Y.; Duby, Jeremiah J.; Shahlaie, Kiarash; Louie, Erin L.			Dexmedetomidine for Refractory Intracranial Hypertension	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						head trauma; intracranial pressure; traumatic brain injury; clinical management of CNS injury; adult brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; CRITICALLY-ILL PATIENTS; HYPEROSMOLAR THERAPY; MICRODIALYSIS	Dexmedetomidine (DEX) is a selective alpha(2) adrenergic agonist that is commonly used for sedation in the intensive care unit (ICU). The role of DEX for adjunctive treatment of refractory intracranial hypertension is poorly defined. The primary objective of this study was to determine the effect of DEX on the need for rescue therapy (ie, hyperosmolar boluses, extraventricular drain [EVD] drainages) for refractory intracranial hypertension. Secondary objectives included the number of intracranial pressure (ICP) excursions, bradycardic, hypotensive, and compromised cerebral perfusion pressure episodes. This retrospective cohort study evaluated patients admitted to the neurosurgical ICU from August 1, 2009, to July 29, 2015, and who received DEX for refractory intracranial hypertension. The objectives were compared between the 2 time periods-before (pre-DEX) and during therapy (DEX). Twenty-three patients with 26 episodes of refractory intracranial hypertension met the inclusion criteria. The number of hyperosmolar boluses was decreased after DEX therapy was initiated. Mannitol boluses required were statistically reduced (1 vs 0.5, P = .03); however, reduction in hypertonic boluses was not statistically significant (1.3 vs 0.9, P = .2). The mean number of EVD drainages per 24 hours was not significantly different between the time periods (15.7 vs 14.0, P = .35). The rate of ICP excursions did not differ between the 2 groups (24.3 vs 22.5, P = .62). When compared to pre-DEX data, there was no difference in the median number of hypotensive (0 vs 0), bradycardic (0 vs 0), or compromised cerebral perfusion pressure episodes (0.5 vs 1.0). Dexmedetomidine may avoid increases in the need for rescue therapy when used as an adjunctive treatment of refractory intracranial hypertension without compromising hemodynamics.	[Schomer, Kendra J.; Duby, Jeremiah J.; Louie, Erin L.] Univ Calif Davis, Med Ctr, Dept Pharm, 2315 Stockton Blvd,Rm 1310, Sacramento, CA 95817 USA; [Sebat, Christian M.; Adams, Jason Y.] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA; [Shahlaie, Kiarash] Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sacramento, CA 95817 USA		Schomer, KJ (corresponding author), Univ Calif Davis, Med Ctr, Dept Pharm, 2315 Stockton Blvd,Rm 1310, Sacramento, CA 95817 USA.	kjschomer@ucdavis.edu					Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chi OZ, 2015, J STROKE CEREBROVASC, V24, P163, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.004; Chi OZ, 2011, ANESTH ANALG, V113, P349, DOI 10.1213/ANE.0b013e31822071db; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Drummond JC, 2010, J NEUROSURG ANESTH, V22, P336, DOI 10.1097/ANA.0b013e3181e4b7e3; Flower O., 2012, EMERG MED INT, V2012, P1; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Karathanou A, 2011, J NEUROSURG SCI, V55, P173; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Shahlaie K, 2011, YOUMANS WINN NEUROLO, P3362; Shehabi Y, 2004, INTENS CARE MED, V30, P2188, DOI 10.1007/s00134-004-2417-z; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130	23	11	12	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2019	34	1					62	66		10.1177/0885066616689555			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HH3CC	WOS:000455595500008	28122469				2022-02-06	
J	Shishido, H; Ueno, M; Sato, K; Matsumura, M; Toyota, Y; Kirino, Y; Tamiya, T; Kawai, N; Kishimoto, Y				Shishido, Hajime; Ueno, Masaki; Sato, Kana; Matsumura, Masahisa; Toyota, Yasunori; Kirino, Yutaka; Tamiya, Takashi; Kawai, Nobuyuki; Kishimoto, Yasushi			Traumatic Brain Injury by Weight-Drop Method Causes Transient Amyloid- Deposition and Acute Cognitive Deficits in Mice	BEHAVIOURAL NEUROLOGY			English	Article							TRANSGENIC MOUSE MODEL; A-BETA DEPOSITION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; HEAD TRAUMA; IMPAIRMENT; ACCUMULATION; EXPRESSION; DEMENTIA; RISK	There has been growing awareness of the correlation between an episode of traumatic brain injury (TBI) and the development of Alzheimer's disease (AD) later in life. It has been reported that TBI accelerated amyloid- (A) pathology and cognitive decline in the several lines of AD model mice. However, the short-term and long-term effects of TBI by the weight-drop method on amyloid- pathology and cognitive performance are unclear in wild-type (WT) mice. Hence, we examined AD-related histopathological changes and cognitive impairment after TBI in wild-type C57BL6J mice. Five- to seven-month-old WT mice were subjected to either TBI by the weight-drop method or a sham treatment. Seven days after TBI, the WT mice exhibited significantly lower spatial learning than the sham-treated WT mice. However, 28 days after TBI, the cognitive impairment in the TBI-treated WT mice recovered. Correspondingly, while significant amyloid- (A) plaques and amyloid precursor protein (APP) accumulation were observed in the TBI-treated mouse hippocampus 7 days after TBI, the A deposition was no longer apparent 28 days after TBI. Thus, TBI induced transient amyloid- deposition and acute cognitive impairments in the WT mice. The present study suggests that the TBI could be a risk factor for acute cognitive impairment even when genetic and hereditary predispositions are not involved. The system might be useful for evaluating and developing a pharmacological treatment for the acute cognitive deficits.	[Shishido, Hajime; Toyota, Yasunori; Tamiya, Takashi] Kagawa Univ, Fac Med, Dept Neurol Surg, Miki, Kagawa 7610793, Japan; [Ueno, Masaki] Kagawa Univ, Dept Inflammat Pathol, Fac Med, Takamatsu, Kagawa 7618057, Japan; [Sato, Kana; Matsumura, Masahisa; Kirino, Yutaka; Kishimoto, Yasushi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Neurobiophys, Sanuki 7692193, Japan; [Kawai, Nobuyuki] Kagawa Gen Rehabil Hosp, Takamatsu, Kagawa 7618057, Japan		Kishimoto, Y (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Neurobiophys, Sanuki 7692193, Japan.	ranran@med.kagawa-u.ac.jp; masaueno@med.kagawa-u.ac.jp; sccully1203@gmail.com; masahisamaru@yahoo.co.jp; toyota@med.kagawa-u.ac.jp; y-kirino@tokushima.bunri-u.ac.jp; tamiya@med.kagawa-u.ac.jp; nobu@kagawa-reha.net; kishimot@kph.bunri-u.ac.jp	Kishimoto, Yasushi/AAH-4923-2021	Kishimoto, Yasushi/0000-0002-4828-1249	Tokushima Bunri University [TBU2012-2-2];  [16K08215];  [24590133];  [15K07910];  [26462161]	We thank Dr. Takashi Kubota, Ms. Ayumi Hamada, and Ms. Mayumi Sawanishi for their technical help. We would like to thank Editage (http://www.editage.jp) for English-language editing. This work was supported by Grants-in-Aid for Scientific Research (c) (grant no. 16K08215 to Yutaka Kirino, grant nos. 24590133 and 15K07910 to Y. Kishimoto, and grant no. 26462161 to N. Kawai) and a grant from Tokushima Bunri University for Educational Reform and Collaborative Research (No. TBU2012-2-2 to Y. Kishimoto).	Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Connor SA, 2017, CELL REP, V21, P3637, DOI 10.1016/j.celrep.2017.11.109; Connor SA, 2016, NEURON, V91, P1052, DOI 10.1016/j.neuron.2016.08.016; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kishimoto Y, 2018, DATA BRIEF, V20, P1877, DOI 10.1016/j.dib.2018.09.044; Kishimoto Y, 2016, DATA BRIEF, V9, P62, DOI 10.1016/j.dib.2016.08.041; Kishimoto Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00134; Kishimoto Y, 2013, BRAIN RES, V1491, P117, DOI 10.1016/j.brainres.2012.10.066; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; Su DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050172; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017	41	11	11	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2019	2019								3248519	10.1155/2019/3248519			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP3SM	WOS:000461597600001	30944661	Green Submitted, Green Published, gold			2022-02-06	
J	Van Pelt, KL; Allred, D; Cameron, KL; Campbell, DE; D'Lauro, CJ; He, XM; Houston, MN; Johnson, BR; Kelly, TF; McGinty, G; Meehan, S; O'Donnell, PG; Peck, KY; Svoboda, SJ; Pasquina, P; McAllister, T; McCrea, M; Broglio, SP				Van Pelt, Kathryn L.; Allred, Dain; Cameron, Kenneth L.; Campbell, Darren E.; D'Lauro, Christopher J.; He, Xuming; Houston, Megan N.; Johnson, Brian R.; Kelly, Tim F.; McGinty, Gerald; Meehan, Sean; O'Donnell, Patrick G.; Peck, Karen Y.; Svoboda, Steven J.; Pasquina, Paul; McAllister, Thomas; McCrea, Michael; Broglio, Steven P.			A cohort study to identify and evaluate concussion risk factors across multiple injury settings: findings from the CARE Consortium	INJURY EPIDEMIOLOGY			English	Article						Traumatic brain injury; Risk; Injury; Epidemiology		BackgroundConcussion, or mild traumatic brain injury, is a major public health concern affecting 42 million individuals globally each year. However, little is known regarding concussion risk factors across all concussion settings as most concussion research has focused on only sport-related or military-related concussive injuries.MethodsThe current study is part of the Concussion, Assessment, Research, and Education (CARE) Consortium, a multi-site investigation on the natural history of concussion. Cadets at three participating service academies completed annual baseline assessments, which included demographics, medical history, and concussion history, along with the Sport Concussion Assessment Tool (SCAT) symptom checklist and Brief Symptom Inventory (BSI-18). Clinical and research staff recorded the date and injury setting at time of concussion. Generalized mixed models estimated concussion risk with service academy as a random effect. Since concussion was a rare event, the odds ratios were assumed to approximate relative risk.ResultsBeginning in 2014, 10,604 (n=2421, 22.83% female) cadets enrolled over 3years. A total of 738 (6.96%) cadets experienced a concussion, 301 (2.84%) concussed cadets were female. Female sex and previous concussion were the most consistent estimators of concussion risk across all concussion settings. Compared to males, females had 2.02 (95% CI: 1.70-2.40) times the risk of a concussion regardless of injury setting, and greater relative risk when the concussion occurred during sport (Odds Ratio (OR): 1.38 95% CI: 1.07-1.78). Previous concussion was associated with 1.98 (95% CI: 1.65-2.37) times increased risk for any incident concussion, and the magnitude was relatively stable across all concussion settings (OR: 1.73 to 2.01). Freshman status was also associated with increased overall concussion risk, but was driven by increased risk for academy training-related concussions (OR: 8.17 95% CI: 5.87-11.37). Medical history of headaches in the past 3months, diagnosed ADD/ADHD, and BSI-18 Somatization symptoms increased overall concussion risk.ConclusionsVarious demographic and medical history factors are associated with increased concussion risk. While certain factors (e.g. sex and previous concussion) are consistently associated with increased concussion risk, regardless of concussion injury setting, other factors significantly influence concussion risk within specific injury settings. Further research is required to determine whether these risk factors may aid in concussion risk reduction or prevention.	[Van Pelt, Kathryn L.; Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA; [Allred, Dain; Campbell, Darren E.; D'Lauro, Christopher J.; Johnson, Brian R.; McGinty, Gerald] US Air Force Acad, 2355 Fac Dr,Suite 1N207, Colorado Springs, CO 80840 USA; [Cameron, Kenneth L.; Houston, Megan N.; Peck, Karen Y.] Keller Army Community Hosp, John A Feagin Jr Sports Med Fellowship, 900 Washington Rd, West Point, NY 10996 USA; [He, Xuming] Univ Michigan, Dept Stat, 1085 South Univ, Ann Arbor, MI 48109 USA; [Kelly, Tim F.] US Mil Acad, Dept Intercollegiate Athlet, 639 Howard Rd, West Point, NY 10996 USA; [Meehan, Sean] Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA; [O'Donnell, Patrick G.] US Coast Guard Acad, 31 Mohegan Ave Pkwy, New London, CT 06320 USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Dept Rehabil Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [McAllister, Thomas] Indiana Univ Sch Med, Goodman Hall,355 W 16th St,Suite 4800, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Svoboda, Steven J.] MedStar, 1120 20th St NW, Washington, DC 20036 USA		Van Pelt, KL (corresponding author), Univ Michigan, NeuroTrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA.	kloconn@umich.edu	Meehan, Sean K/N-6237-2018; D'Lauro, Christopher/X-1518-2019	Meehan, Sean K/0000-0002-9848-8803; D'Lauro, Christopher/0000-0003-0894-6602; Van Pelt, Kathryn/0000-0002-5494-2357; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds.)	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Cohen J, 1998, STAT POWER ANAL BEHA; Covassin T, 2003, J ATHL TRAIN; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; D'Lauro C, 2017, BRIT J SPORT MED, V51, pA64; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Li HM, 2017, AM J SPORT MED, V45, P2148, DOI 10.1177/0363546517702847; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Connor KL, 2018, MIL MED; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rothman MJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000849; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wells T, 2010, HLTH STATUS PERFORMA; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	41	11	11	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.		2019	6	1							1	10.1186/s40621-018-0178-3			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	VK2OW	WOS:000669345000001	30637568	gold, Green Published, Green Submitted			2022-02-06	
J	Yang, ZH; Zhu, T; Mondello, S; Akel, M; Wong, AT; Kothari, IM; Lin, F; Shear, DA; Gilsdorf, JS; Leung, LY; Bramlett, HM; Dixon, CE; Dietrich, WD; Hayes, RL; Povlishock, JT; Tortella, FC; Kochanek, PM; Wang, KK				Yang, Zhihui; Zhu, Tian; Mondello, Stefania; Akel, Miis; Wong, Aaron T.; Kothari, Isha M.; Lin, Fan; Shear, Deborah A.; Gilsdorf, Janice S.; Leung, Lai Yee; Bramlett, Helen M.; Dixon, C. Edward; Dietrich, W. Dalton; Hayes, Ronald L.; Povlishock, John T.; Tortella, Frank C.; Kochanek, Patrick M.; Wang, Kevin K. W.			Serum-Based Phospho-Neurofilament-Heavy Protein as Theranostic Biomarker in Three Models of Traumatic Brain Injury: An Operation Brain Trauma Therapy Study	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; controlled cortical impact; fluid percussion; levetiracetam; nicotinamide; penetrating ballistic-like brain injury; pNF-H	NF-H; SUBUNIT; BLOOD; LIGHT; CSF	Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase (UCH-L1), markers of glial and neuronal cell body injury, respectively, have been previously selected by the Operation Brain Trauma Therapy (OBTT) pre-clinical therapy and biomarker screening consortium as drug development tools. However, traumatic axonal injury (TAI) also represents a major consequence and determinant of adverse outcomes after traumatic brain injury (TBI). Thus, biomarkers capable of assessing TAI are much needed. Neurofilaments (NFs) are found exclusively in axons. Here, we evaluated phospho-neurofilament-H (pNF-H) protein as a possible new TAI marker in serum and cerebrospinal fluid (CSF) across three rat TBI models in studies carried out by the OBTT consortium, namely, controlled cortical impact (CCI), parasagittal fluid percussion (FPI), and penetrating ballistics-like brain injury (PBBI). We indeed found that CSF and serum pNF-H levels are robustly elevated by 24h post-injury in all three models. Further, in previous studies by OBTT, levetiracetam showed the most promising benefits, whereas nicotinamide showed limited benefit only at high dose (500mg/kg). Thus, serum samples from the same repository collected by OBTT were evaluated. Treatment with 54mg/kg intravenously of levetiracetam in the CCI model and 170mg/kg in the PBBI model significantly attenuated pNF-H levels at 24h post-injury as compared to respective vehicle groups. In contrast, nicotinamide (50 or 500mg/kg) showed no reduction of pNF-H levels in CCI or PBBI models. Our current study suggests that pNF-H is a useful theranostic blood-based biomarker for TAI across different rodent TBI models. In addition, our data support levetiracetam as the most promising TBI drug candidate screened by OBTT to date.	[Yang, Zhihui; Zhu, Tian; Akel, Miis; Wong, Aaron T.; Kothari, Isha M.; Lin, Fan; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Mondello, Stefania] Oasi Inst Res Mental Retardat & Brain Aging IRCCS, Dept Neurol, Troina, Italy; [Shear, Deborah A.; Gilsdorf, Janice S.; Leung, Lai Yee; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Neurorestorat, Silver Spring, MD USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15261 USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Neuroprote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wang, KK (corresponding author), Univ Florida, Dept Emergency Med, 1149 Newell Dr,L4-100, Gainesville, FL 32611 USA.	kwang@ufl.edu	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Wang, Kevin/0000-0002-9343-6473	U.S. Department of DefenseUnited States Department of Defense [WH81XWH-10-1-0623, WH81XWH-14-2-0018]	We are grateful to the U.S. Department of Defense grants WH81XWH-10-1-0623 and WH81XWH-14-2-0018 for generous support. We thank Col. Dallas Hack and Col. Todd Rasmussen for support of our program. We also thank Dr. Kenneth Curley and Tammy Crowder, for programmatic support. We thank Dr. Brenda Bart-Knauer for support of our program. We thank Linda Ryan for administrative support with budgetary issues across the consortium, Fran Mistrick for other administrative and coordinating support, and Marci Provins and Natalie Nieman for assistance with manuscript preparation. We thank Rebecca Pedersen, Justin Sun, Ofelia Furones-Alonso, Milton Martinez, Juliana Sanchez-Molano, William Moreno, Ryan Treu, Jessie Truettner, Hong Q. Yan, PhD, Michelle Ma, Jeremy Henchir, and Keri Feldman for superb technical support in the individual TBI models across the consortium.	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; McPherson RC, 2013, J NEUROIMMUNE PHARM, V8, P774, DOI 10.1007/s11481-013-9453-9; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rossi D, 2018, J NEUROL, V265, P510, DOI 10.1007/s00415-017-8730-6; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Singh A., 2018, INT J CRIT ILLN INJ, V7, P212; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	37	11	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					348	359		10.1089/neu.2017.5586			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800017	29987972				2022-02-06	
J	Leung, A; Yang, E; Lim, M; Metzger-Smith, V; Theilmann, R; Song, D; Lin, L; Tsai, A; Lee, R				Leung, Albert; Yang, Eric; Lim, Michael; Metzger-Smith, Valerie; Theilmann, Rebecca; Song, David; Lin, Lisa; Tsai, Alice; Lee, Roland			Pain-related white matter tract abnormalities in mild traumatic brain injury patients with persistent headache	MOLECULAR PAIN			English	Article						Mild traumatic brain injury; traumatic brain injury; diffusion tensor imaging; post-traumatic headache; pain modulation	DIFFUSION; DYSMYELINATION; MICROSTRUCTURE; REORGANIZATION; DEMYELINATION; ACTIVATION; MECHANISMS; CORTEX; BLAST; MRI	Background The occurrence of debilitating chronic persistent (24/7) headache after mild traumatic brain injury represents a central neuropathic pain state. Previous studies suggest that this chronic headache state can be attributed to altered supraspinal modulatory functional connectivity in both resting and evoked pain states. Abnormalities in the myelin sheaths along the supraspinal superior longitudinal fasciculus and anterior thalamic radiation are frequently associated with alteration in pain modulation related to functional connectivity deficit with the prefrontal cortex. This study assessed the correlated axonal injury-related white matter tract abnormality underlying these previously observed prefrontal functional connectivity deficits by comparing the fractional anisotropy, axial diffusivity, and radial diffusivity of brain white matter in patients with mild traumatic brain injury-related headache to healthy controls. Result Diffusion tensor imaging data from patients (N = 12, average age +/- SD = 35.0 +/- 8.0 years old, 10 male) with mild traumatic brain injury-headache were compared with images acquired from healthy controls. The mild traumatic brain injury cohort demonstrated two areas of significant (P < 0.01, F value >16, cluster size >50 voxels) white matter tract abnormalities closely related to pain affective and modulatory functions in (1) the left superior longitudinal fasciculus which connects the prefrontal cortices with the parietal cortices and (2) the right anterior thalamic radiation connecting the prefrontal cortices with the anterior cingulate cortex. In addition, a significant (P < 0.01) decrease in axial diffusivity and increase in radial diffusivity at the superior longitudinal fasciculus cluster were noted in the mild traumatic brain injury cohort. Conclusion The identified white matter tract abnormalities may represent a state of Wallerian degeneration which correlates with the functional connectivity deficit in pain modulation and can contribute to the development of the chronic persistent headache in the patients with mild traumatic brain injury.	[Leung, Albert] Univ Calif San Diego, Dept Anesthesiol, Div Pain Med, San Diego, CA 92103 USA; [Leung, Albert; Metzger-Smith, Valerie; Song, David; Lin, Lisa; Tsai, Alice; Lee, Roland] Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Yang, Eric; Lim, Michael] Univ Calif San Diego, San Diego, CA 92103 USA; [Theilmann, Rebecca; Lee, Roland] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Song, David] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA		Leung, A (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Div Pain Med, San Diego, CA 92103 USA.; Leung, A (corresponding author), Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ayleung@ucsd.edu			VA Rehabilitation and Research Development SPIRE Awards [21RX001359, 21RX002366]; Department of Defense Congressionally Directed Medical Research Program GrantUnited States Department of Defense [W81XWH-16-1-0754]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the funding support from the following agencies: (1) VA Rehabilitation and Research Development SPIRE Awards (21RX001359 and 21RX002366) and (2) Department of Defense Congressionally Directed Medical Research Program Grant (W81XWH-16-1-0754).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; DeSouza DD, 2014, PAIN, V155, P37, DOI 10.1016/j.pain.2013.08.029; Farmer MA, 2015, J UROLOGY, V194, P118, DOI 10.1016/j.juro.2015.02.082; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Huang L, 2016, PAIN, V157, P2782, DOI 10.1097/j.pain.0000000000000703; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Joubert Jacques, 2005, Aust Fam Physician, V34, P621; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P123, DOI 10.1002/cmr.a.20049; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-23; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-18; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25836; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meoded A, 2016, AM J NEURORADIOL, V37, P924, DOI 10.3174/ajnr.A4647; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Oshiro Y, 2007, J NEUROSCI, V27, P3388, DOI 10.1523/JNEUROSCI.5128-06.2007; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Schmidt-Wilcke T, 2014, PAIN MED, V15, P1346, DOI 10.1111/pme.12460; Seifert F, 2010, NEUROSCIENCE, V170, P670, DOI 10.1016/j.neuroscience.2010.07.024; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Suzuki Y, 2003, NMR BIOMED, V16, P257, DOI 10.1002/nbm.848; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tian T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36030; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Tracey Irene, 2007, Curr Opin Support Palliat Care, V1, P109, DOI 10.1097/SPC.0b013e3282efc58b; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3	42	11	12	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		1744-8069		MOL PAIN	Mol. Pain	DEC 28	2018	14								1744806918810297	10.1177/1744806918810297			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HF8MZ	WOS:000454497700001	30324850	Green Published, gold			2022-02-06	
J	Yang, DX; Jing, Y; Liu, YL; Xu, ZM; Yuan, F; Wang, ML; Geng, Z; Tian, HL				Yang, Dian-xu; Jing, Yao; Liu, Ying-liang; Xu, Zhi-ming; Yuan, Fang; Wang, Ming-liang; Geng, Zhi; Tian, Heng-li			Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; blood-brain barrier; capsazepine; transient receptor potential vanilloid 1; traumatic brain injury	INDUCED OXIDATIVE STRESS; INDUCED APOPTOSIS; CYTOCHROME-C; BCL2 FAMILY; TRPV1; ACTIVATION; CELLS; RELEASE; RAT; MITOCHONDRIA	Transient receptor potential vanilloid 1 (TRPV1) is expressed widely in the central nervous system and is activated by various stimuli. Inhibiting TRPV1 has neuroprotective effects in cerebral ischemia. The role of inhibiting TRPV1 to maintain blood-brain barrier (BBB) integrity after traumatic brain injury (TBI) remains unclear, however. Therefore, we investigated the effects of capsazepine-mediated TRPV1 inhibition on the BBB in a mouse model of TBI. Adult male C57BL/6 mice underwent controlled cortical impact injury and received capsazepine (1 mu mol/kg body weight, twice daily, intraperitoneally) until sacrifice. Further, mouse brain microvascular endothelial (bEnd.3) cells were cultured and underwent biaxial stretch injury to investigate the mechanisms underlying the protective effects of capsazepine. The TRPV1 expression was upregulated in the pericontusional area after TBI, peaking at 24 h post-TBI. Capsazepine-treated mice demonstrated decreased brain edema (p = 0.010), Evans Blue extravasation (p = 0.001), tissue hemoglobin levels (p = 0.002), and loss of tight junction proteins (p = 0.016 ZO-1 expression; p = 0.013 occludin expression) after TBI compared with the vehicle-treated group. Capsazepine significantly alleviated early-stage apoptosis by attenuating activation of JNK, P38, and caspase-3, resulting in a protective effect on the level of ZO-1 in bEnd.3 cells after stretch injury. We conclude that the expression of TRPV1 is upregulated after TBI, and inhibition of TRPV1 attenuated disruption of the BBB in a mouse model of TBI, at least partly, through its antiapoptotic effects on brain endothelial cells. Blocking TRPV1 may be a promising pharmacotherapeutic intervention to protect against BBB disruption after TBI.	[Yang, Dian-xu; Jing, Yao; Liu, Ying-liang; Xu, Zhi-ming; Yuan, Fang; Tian, Heng-li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Wang, Ming-liang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Radiol, Shanghai, Peoples R China; [Geng, Zhi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Neurol, 600 Yishan Rd, Shanghai 200233, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Geng, Z (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Neurol, 600 Yishan Rd, Shanghai 200233, Peoples R China.	gengzhi1998@163.com; tianhlsh@126.com			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671207, 81471245, 81701895]	This work was supported by grants from the National Nature and Science Foundation of China (No 81671207, 81471245, and 81701895).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cao JL, 2015, AQUAT TOXICOL, V167, P180, DOI 10.1016/j.aquatox.2015.08.004; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Hakimizadeh E, 2017, FUND CLIN PHARMACOL, V31, P420, DOI 10.1111/fcp.12279; Hu DE, 2005, BRIT J PHARMACOL, V146, P576, DOI 10.1038/sj.bjp.0706350; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang L, 2015, NEUROSCIENCE, V301, P375, DOI 10.1016/j.neuroscience.2015.06.005; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Lam PMW, 2007, J NEUROCHEM, V102, P801, DOI 10.1111/j.1471-4159.2007.04569.x; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Liu T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2831-y; Liu Y.L., 2018, J NEUROTRAUMA; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lv JJ, 2018, PROG NEUROBIOL, V161, P79, DOI 10.1016/j.pneurobio.2017.12.001; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Marrone MC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15292; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Miyanohara J, 2015, BIOCHEM BIOPH RES CO, V467, P478, DOI 10.1016/j.bbrc.2015.10.027; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosas-Hernandez H, 2018, NEUROSCI LETT, V672, P123, DOI 10.1016/j.neulet.2018.02.019; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun ZW, 2014, INT J MOL SCI, V15, P18362, DOI 10.3390/ijms151018362; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Toklu HZ, 2015, OXIDATIVE STRESS BRA; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhao Z, 2017, CELL RES, V27, P849, DOI 10.1038/cr.2017.71	56	11	12	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1279	1290		10.1089/neu.2018.5942		DEC 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000451965900002	30351220				2022-02-06	
J	da Costa, CS; Czosnyka, M; Smielewski, P; Austin, T				da Costa, Cristine Sortica; Czosnyka, Marek; Smielewski, Peter; Austin, Topun			Optimal Mean Arterial Blood Pressure in Extremely Preterm Infants within the First 24 Hours of Life	JOURNAL OF PEDIATRICS			English	Article							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; BIRTH-WEIGHT INFANTS; INTRAVENTRICULAR HEMORRHAGE; PREMATURE-INFANTS; OXYGEN-SATURATION; NEWBORN-INFANTS; FLOW; AUTOREGULATION; CIRCULATION	Objective To define levels of mean arterial blood pressure (MABP) where cerebrovascular reactivity is strongest (MABP(OPT)) during the early transitional circulation in extremely preterm infants and to investigate the association between deviations above and below MABP(OPT) with intraventricular hemorrhage (IVH) and mortality. Study design A total of 44 infants born at a median gestational age 25 (23-27) weeks with indwelling arterial catheter were studied at a median 5.5 (3.1-12.6) hours within the first 24 hours of life. Cerebrovascular reactivity (tissue oxygenation heart rate reactivity index) was estimated by the moving correlation coefficient between heart rate and near-infrared spectroscopy tissue oxygenation index. MABP(OPT) was defined as the MABP where tissue oxygenation heart rate reactivity index reaches minimum value. Deviations below or above MABP(OPT) values were calculated along with MABP(OPT) values during retrospective data analysis. Results MABP(OPT) was detected in all infants. The mean (SD) MABP(OPT) was 31.3 (+/- 4.7) mm Hg. MABP(OPT) increased with increasing gestational age. R = 0.424; P= .004. Deviations below MABP(OPT) were greater in the IVH group (mean 2.7 mm Hg; 95% CI 2.0-3.5) compared with no-IVH (mean 1.7 mm Hg; 1.1-2.2), P= .006. In infants who died, the deviation below MABP(OPT) was greater (mean 3.3; 95% CI 1.9-4.8) compared with those who survived (mean 1.9 mm Hg; 95% CI 1.4-2.3), P= .015. Conclusions Defining optimal MABP based on the strength of cerebrovascular reactivity within the first 24 hours of life is feasible and can provide an individualized approach to the care of extremely preterm infants. Deviations below MABP(OPT) were significantly associated with IVH and death.	[da Costa, Cristine Sortica; Austin, Topun] Cambridge Univ Hosp NHS Fdn Trust, Rosie Hosp, Neonatal Unit, Cambridge, England; [Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Div Neurosurg,Dept Clin Neurosci, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		da Costa, CS (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Neonatal Unit, Neonatal Intens Cam Unit, Rosie Hosp, Box 402,Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0QQ, England.	csortica@cantab.net	Austin, Topun/ABG-1960-2021	Austin, Topun/0000-0002-8428-8624; czosnyka, marek/0000-0003-2446-8006	SPARKS charity [11CUH02]; Cambridge Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Funded by SPARKS charity (11CUH02); Cambridge Trust and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PhD scholarship to C.SdC.).	Alderliesten T, 2016, PEDIATR RES, V79, P55, DOI 10.1038/pr.2015.186; Alderliesten T, 2014, J PEDIATR-US, V164, P986, DOI 10.1016/j.jpeds.2013.12.042; ALTMAN DI, 1988, ANN NEUROL, V24, P218, DOI 10.1002/ana.410240208; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; da Costa CS, 2015, J PEDIATR-US, V167, P86, DOI 10.1016/j.jpeds.2015.03.041; Engle WD, 2012, NEONATOLOGY QUESTION, P49; Evans N, 1996, ARCH DIS CHILD-FETAL, V75, pF183, DOI 10.1136/fn.75.3.F183; GARFUNKEL JM, 1954, J PEDIATR-US, V44, P64, DOI 10.1016/S0022-3476(54)80093-X; GODDARDFINEGOLD J, 1982, J PEDIATR-US, V100, P796, DOI 10.1016/S0022-3476(82)80596-9; Hyttel-Sorensen S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7635; Kaiser JR, 2005, PEDIATR RES, V58, P931, DOI 10.1203/01.pdr.0000182180.80645.0c; Kluckow M, 2005, EARLY HUM DEV, V81, P429, DOI 10.1016/j.earlhumdev.2005.03.006; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF182, DOI 10.1136/fn.82.3.F182; Logan JW, 2011, ARCH DIS CHILD-FETAL, V96, pF321, DOI 10.1136/adc.2010.183335; Meek JH, 1999, ARCH DIS CHILD-FETAL, V81, pF15, DOI 10.1136/fn.81.1.F15; Mitra S, 2014, ACTA PAEDIATR, V103, pE374, DOI 10.1111/apa.12696; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pellicer A, 2009, PEDIATRICS, V123, P1369, DOI 10.1542/peds.2008-0673; PERLMAN JM, 1983, NEW ENGL J MED, V309, P204, DOI 10.1056/NEJM198307283090402; Pichler G, 2016, J PEDIATR-US, V170, P73, DOI 10.1016/j.jpeds.2015.11.053; PRYDS O, 1989, J PEDIATR-US, V115, P638, DOI 10.1016/S0022-3476(89)80301-4; Rhee CJ, 2016, ACTA NEUROCHIR SUPPL, V122, P151, DOI 10.1007/978-3-319-22533-3_31; Smielewski P, 2005, ACT NEUR S, V95, P43; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; VANBEL F, 1987, DEV MED CHILD NEUROL, V29, P601; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	28	11	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2018	203						242	248		10.1016/j.jpeds.2018.07.096			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HA9PI	WOS:000450636400038	30243537				2022-02-06	
J	Dodd, JN; Hall, TA; Guilliams, K; Guerriero, RM; Wagner, A; Malone, S; Williams, CN; Hartman, ME; Piantino, J				Dodd, Jonathan N.; Hall, Trevor A.; Guilliams, Kristin; Guerriero, Rejean M.; Wagner, Amanda; Malone, Sara; Williams, Cydni N.; Hartman, Mary E.; Piantino, Juan			Optimizing Neurocritical Care Follow-Up Through the Integration of Neuropsychology	PEDIATRIC NEUROLOGY			English	Article						Neuropsychology; Neurology; Neurocritical care; Outcome; PICS; Pediatric; Parent satisfaction	TRAUMATIC BRAIN-INJURY; CHILDREN; VALIDATION	BACKGROUND: Pediatric critical care survivors often suffer persisting multisystem health problems and are left with treatment needs that go unmet due to limits in current care models. We proposed that integration of neuropsychology into neurocritical care followup provides incremental benefit to the identification and treatment of persisting complications and reduction in co-morbidities. BASIC PROCEDURES:The aims of this study were three-fold. First, we described pilot programs at two pediatric hospitals as models for implementing systematic follow-up care with interdisciplinary clinic teams consisting of critical care, neurology, and neuropsychology. Second, we described working models specific to neuropsychological service delivery in these programs. Third, we presented preliminary data from the first six months of one of the pilot programs in order to examine incremental benefit of neuropsychology in improving patient care and parent satisfaction. MAIN FINDINGS: A total of 16 patients (age range three to 17 years) were seen by neuropsychology within the first six months of the program. Results showed that integration of neuropsychology into follow-up care resulted in recommendations being made for services or concerns not already addressed in 81% of cases. Parents reported high satisfaction, endorsing the highest possible rating on 96% of all items. Parents reported that neuropsychological consultation improved their understanding and communication with their child, and helped them know what to expect from their child during postacute recovery. CONCLUSIONS: The results of this pilot study suggest that integration of neuropsychology into neurocritical care follow-up programs contributes to parent satisfaction and may provide incremental benefit to patient care. (C) 2018 Elsevier Inc. All rights reserved.	[Dodd, Jonathan N.] Washington Univ, Sch Med, Dept Psychol, St Louis Childrens Hosp, One Childrens Pl, St Louis, MO 63110 USA; [Hall, Trevor A.; Wagner, Amanda] Oregon Hlth & Sci Univ, Dept Pediat, Doernbecher Childrens Hosp, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Guilliams, Kristin; Guerriero, Rejean M.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat & Dev Neurol,Dept Neurol, St Louis, MO 63110 USA; [Guilliams, Kristin; Hartman, Mary E.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Crit Care Med,Dept Pediat, St Louis, MO 63110 USA; [Malone, Sara] Washington Univ, St Louis Childrens Hosp, Sch Med, Sch Social Work, St Louis, MO 63110 USA; [Williams, Cydni N.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Div Pediat Crit Care, Portland, OR 97201 USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Div Child Neurol, Portland, OR 97201 USA		Dodd, JN (corresponding author), Washington Univ, Sch Med, Dept Psychol, St Louis Childrens Hosp, One Childrens Pl, St Louis, MO 63110 USA.	drdodd@gatewayneuro.com	Piantino, Juan/AAI-2184-2019; Guilliams, Kristin/U-7100-2019; Malone, Sara/AAA-6587-2021	Piantino, Juan/0000-0002-8861-5709; Williams, Cydni/0000-0002-2049-7662; Guerriero, Rejean/0000-0001-7788-6661; Guilliams, Kristin/0000-0002-5518-3778; Malone, Sara/0000-0002-0361-8733	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HSO22981]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS099472]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS099472] Funding Source: NIH RePORTER	Dr. Williams is supported by the Agency for Healthcare Research and Quality, grant number K12HS022981. Dr. Piantino is supported by the National Heart, Lung, and Blood Institute, grant number K12HSO22981. Dr. Guilliams is supported by NINDS K23NS099472. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality or National Institutes of Health.	Austin CA, 2016, ASSESSMENT; Baum KT, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26446; Beauchamp MH, 2015, J INT NEUROPSYCH SOC, V21, P596, DOI 10.1017/S1355617715000636; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hardy KK, 2017, J PEDIATR PSYCHOL, V42, P815, DOI 10.1093/jpepsy/jsx060; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Prins A, 2014, ANN M INT SOC TRAUM; Reynolds C.R., 2015, BEHAV ASSESSMENT SYS, V3rd; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Waber DP, 2017, J PEDIATR PSYCHOL, V42, P823, DOI 10.1093/jpepsy/jsx068; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083	20	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	DEC	2018	89						58	62		10.1016/j.pediatrneurol.2018.09.007			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	HH6QP	WOS:000455856400009	30442440	Green Accepted			2022-02-06	
J	Liu, YL; Yuan, F; Yang, DX; Xu, ZM; Jing, Y; Yang, GY; Geng, Z; Xia, WL; Tian, HL				Liu, Ying-liang; Yuan, Fang; Yang, Dian-xu; Xu, Zhi-ming; Jing, Yao; Yang, Guo-yuan; Geng, Zhi; Xia, Wei-liang; Tian, Heng-li			Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adjudin; AQP4; neuroinflammation; NF-kappa B; TBI	NF-KAPPA-B; TRANSCRIPTION FACTOR; BARRIER DISRUPTION; AQUAPORIN-4; EXPRESSION; CNS; NEUROPROTECTION; INFLAMMATION; INHIBITION; ISCHEMIA	Adjudin, a small molecular compound that is used as a male contraceptive, has been reported to play a neuroprotective role in an ischemic stroke injury model. However, its effect on traumatic brain injury (TBI) has not been assessed. Hence, we investigated the effects of adjudin on cerebral edema using a mouse model of TBI and explored the underlying mechanisms. Adult male C57BL/6 mice received controlled cortical impact (CCI) injury, then an injection of adjudin (50 mg/kg). The mice were euthanized 3 days post-CCI injury, and samples were collected for further analysis. Cultured primary mouse astrocytes were used for in vitro experiments. Adjudin treatment significantly attenuated cerebral edema on Day 3 and improved neurobehavioral outcomes on Days 3, 7, and 14 after CCI injury, compared with the vehicle group. Additionally, the evaluation of Evans blue extravasation and expression of tight junction proteins demonstrated remarkable effects of adjudin on blood-brain barrier protection. Further, adjudin treatment significantly decreased the gene and protein expression of aquaporin 4 in post-injury mice and inhibited progression of neuroinflammation in both mice and cultured astrocytes. The Western blot results of the peritraumatic protein samples demonstrated that adjudin significantly blocked the phosphorylation of IKK alpha, I kappa B alpha/beta, and NF-kappa B p65, which resulted in a reduction of NF-kappa B p65 nuclear translocation. In conclusion, adjudin attenuated the development of TBI-induced cerebral edema at least partly via anti-inflammatory effects and inhibition of the NF-kappa B pathway. These findings suggest that adjudin is a potential therapeutic intervention preventing the development of cerebral edema after TBI.	[Liu, Ying-liang; Yuan, Fang; Yang, Dian-xu; Xu, Zhi-ming; Jing, Yao; Tian, Heng-li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 YiShan Rd, Shanghai 200233, Peoples R China; [Geng, Zhi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China; [Yang, Guo-yuan; Xia, Wei-liang] Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200233, Peoples R China; [Yang, Guo-yuan; Xia, Wei-liang] Shanghai Jiao Tong Univ, Med X Res Inst, 1954 Huashan Rd, Shanghai 200233, Peoples R China		Geng, Z; Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 YiShan Rd, Shanghai 200233, Peoples R China.; Xia, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200233, Peoples R China.; Xia, WL (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, 1954 Huashan Rd, Shanghai 200233, Peoples R China.	gengzhi1998@163.com; wlxia@sjtu.edu.cn; tianhlsh@126.com					Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Aoki-Yoshino K, 2005, ACTA NEUROPATHOL, V110, P281, DOI 10.1007/s00401-005-1052-2; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Francesca B, 2010, CURR NEUROPHARMACOL, V8, P92, DOI 10.2174/157015910791233132; Gorelick Daniel A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-14; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jayakumar AR, 2011, NEUROBIOL DIS, V41, P498, DOI 10.1016/j.nbd.2010.10.021; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Kuramatsu JB, 2013, J NEURAL TRANSM, V120, pS35, DOI 10.1007/s00702-013-1040-y; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lee SH, 2017, BIOCHEM PHARMACOL, V146, P1, DOI 10.1016/j.bcp.2017.06.137; Liu TY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-107; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Quan YZ, 2015, ONCOTARGET, V6, P26494, DOI 10.18632/oncotarget.4764; Quan YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08181; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sato S, 2000, ACTA NEUROCHIR SUPPL, V76, P239; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright G, 2014, METAB BRAIN DIS, V29, P965, DOI 10.1007/s11011-014-9553-0; Xia WL, 2016, SEMIN CELL DEV BIOL, V59, P71, DOI 10.1016/j.semcdb.2016.07.020; Xu ZM, 2016, J NEUROTRAUMA; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhu CH, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0252-y	52	11	12	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2850	2860		10.1089/neu.2017.5397			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000450819000011	29860924				2022-02-06	
J	Maissan, IM; Ketelaars, R; Vlottes, B; Hoeks, SE; den Hartog, D; Stolker, RJ				Maissan, Iscander M.; Ketelaars, Rein; Vlottes, Boris; Hoeks, Sanne E.; den Hartog, Dennis; Stolker, Robert J.			Increase in intracranial pressure by application of a rigid cervical collar: a pilot study in healthy volunteers	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						extrication collar; immobilization; intracranial pressure; neurotrauma; optical nerve sheath diameter; rigid cervical collar; traumatic brain injury; ultrasound/sonography	OPTIC-NERVE SHEATH; HEAD-INJURY; ULTRASOUND; DIAMETER	Objectives Rigid cervical collars are known to increase intracranial pressure (ICP) in severe traumatic brain injury (TBI). Cerebral blood flow might decrease according to the Kellie Monroe doctrine. For this reason, the use of the collar in patients with severe TBI has been abandoned from several trauma protocols in the Netherlands. There is no evidence on the effect of a rigid collar on ICP in patients with mild or moderate TBI or indeed patients with no TBI. As a first step we tested the effect in healthy volunteers with normal ICPs and intact autoregulation of the brain. Methods In this prospective blinded cross-over study, we evaluated the effect of application of a rigid cervical collar in 45 healthy volunteers by measuring their optical nerve sheath diameter (ONSD) by transocular sonography. Sonographic measurement of the ONSD behind the eye is an indirect noninvasive method to estimate ICP and pressure changes. Results We included 22 male and 23 female volunteers. In total 360 ONSD measurements were performed in these 45 volunteers. Application of a collar resulted in a significant increase in ONSD in both the left (beta=0.06, 95% confidence interval: 0.05-0.07, P<0.001) and the right eye (beta=0.01, 95% confidence interval: 0.00-0.02, P=0.027) Conclusion Application of a rigid cervical collar significantly increases the ONSD in healthy volunteers with intact cerebral autoregulation. This suggests that ICP may increase after application of a collar. In healthy volunteers, this seems to be of minor importance. On the basis of our findings the effect of a collar on ONSD and ICP in patients with mild and moderate TBI needs to be determined. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Maissan, Iscander M.; Hoeks, Sanne E.; Stolker, Robert J.] Erasmus Univ, Med Ctr Rotterdam, Dept Anesthesiol, Rotterdam, Netherlands; [den Hartog, Dennis] Erasmus Univ, Med Ctr Rotterdam, Trauma Ctr South West Netherlands, Rotterdam, Netherlands; [Vlottes, Boris] Erasmus Univ, Dept Anesthesiol, Erasmus Med Ctr, Rotterdam, Netherlands; [Ketelaars, Rein] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, Nijmegen, Netherlands		Maissan, IM (corresponding author), Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	i.maissan@erasmusmc.nl	R, Ketelaars/D-9762-2016; Hoeks, Sanne/AAM-3313-2020	R, Ketelaars/0000-0002-3548-0417; 			ATLS Subcommittee American College of Surgeons International ATLS working group, 2013, J TRAUMA ACUTE CARE, V5, P148; Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Brain Trauma Foundation, 2016, 4 ED GUID MAN SEV TR; Cowley A, 2016, EUR J EMERG MED, V3, P159; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Ham WHW, 2016, INJURY, V47, P1924, DOI 10.1016/j.injury.2016.03.032; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Holla M, 2012, EMERG MED J, V29, P104, DOI 10.1136/emj.2010.092973; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; National Association of Emergency Medical Technicians, 2016, PHTLS MAN; Oteir AO, 2015, INJURY, V46, P528, DOI 10.1016/j.injury.2014.12.032; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; Tartiere D, 2009, CRIT CARE, V13, DOI 10.1186/cc8200; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Toscano M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1621428; Toth P, 2016, AM J PHYSIOL-HEART C, V1, P311	24	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2018	25	6					E24	E28		10.1097/MEJ.0000000000000490			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GZ7DS	WOS:000449637900002	28727580	Green Submitted			2022-02-06	
J	Mishra, SK; Khushu, S; Singh, AK; Gangenahalli, G				Mishra, Sushanta Kumar; Khushu, Subash; Singh, Ajay K.; Gangenahalli, Gurudutta			Homing and Tracking of Iron Oxide Labelled Mesenchymal Stem Cells After Infusion in Traumatic Brain Injury Mice: a Longitudinal In Vivo MRI Study	STEM CELL REVIEWS AND REPORTS			English	Article						Absolute bias correction; Mesenchymal stem cells; Magnetic resonance imaging; Relaxometry; Stem cell homing; Stem cell tracking; Traumatic brain injury	QUANTITATIVE-EVALUATION; CONTRAST AGENT; CELLULAR MRI; MODEL; STROKE; TRANSPLANTATION; NANOPARTICLES; OPTIMIZATION; RELAXOMETRY; FERUMOXYTOL	Stem cells transplantation has emerged as a promising alternative therapeutic due to its potency at injury site. The need to monitor and non-invasively track the infused stem cells is a significant challenge in the development of regenerative medicine. Thus, in vivo tracking to monitor infused stem cells is especially vital. In this manuscript, we have described an effective in vitro labelling method of MSCs, a serial in vivo tracking of implanted stem cells at traumatic brain injury (TBI) site through 7T magnetic resonance imaging (MRI). Proper homing of infused MSCs was carried out at different time points using histological analysis and Prussian blue staining. Longitudinal in vivo tracking of infused MSCs were performed up to 21days in different groups through MRI using relaxometry technique. Results demonstrated that MSCs incubated with iron oxide-poly-L-lysine complex (IO-PLL) at a ratio of 50:1.5g/ml and a time period of 6h was optimised to increase labelling efficiency. T2*-weighted images and relaxation study demonstrated a significant signal loss and effective decrease in transverse relaxation time on day-3 at injury site after systemic transplantation, revealed maximum number of stem cells homing to the lesion area. MRI results further correlate with histological and Prussian blue staining in different time periods. Decrease in negative signal and increase in relaxation times were observed after day-14, may indicate damage tissue replacement with healthy tissue. MSCs tracking with synthesized negative contrast agent represent a great advantage during both in vitro and in vivo analysis. The proposed absolute bias correction based relaxometry analysis could be extrapolated for stem cell tracking and therapies in various neurodegenerative diseases.	[Mishra, Sushanta Kumar; Khushu, Subash] INMAS, NMR Res Ctr, DRDO, Delhi, India; [Mishra, Sushanta Kumar; Singh, Ajay K.; Gangenahalli, Gurudutta] INMAS, Div Stem Cell & Gene Therapy Res, DRDO, Delhi, India		Khushu, S (corresponding author), INMAS, NMR Res Ctr, DRDO, Delhi, India.; Gangenahalli, G (corresponding author), INMAS, Div Stem Cell & Gene Therapy Res, DRDO, Delhi, India.	skhushu@yahoo.com; gugdutta@rediffmail.com	Singh, Ajay/AAF-4414-2020; Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1/1.6]; Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) [2014-25070]	The S & T project (INM-311, 4.1/1.6) was supported by funding from the Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of India. The authors also wish to express their gratitude to Dr. Anurag Agrawal and Bijay Ranjan Pattnaik (Research Fellow), Translational research in asthma laboratory, IGIB for their unstinted support in the microscopy study. Dr. Sushanta Kumar Mishra sincerely thanks the Indian Council of Medical Research (ICMR, 2014-25070) for providing a research fellowship in support of the project.	Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Betzer O, 2015, SCI REP-UK, V5, DOI 10.1038/srep15400; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Feng SW, 2008, CYTOTHERAPY, V10, P254, DOI 10.1080/14653240802020381; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Geng K, 2015, MOL MED REP, V11, P954, DOI 10.3892/mmr.2014.2805; Gururaj G., 2005, PUBLICATION, V61; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Jacob RE, 2010, J MAGN RESON IMAGING, V31, P1091, DOI 10.1002/jmri.22166; Kumar R, 2011, MAGN RESON IMAGING, V29, P185, DOI 10.1016/j.mri.2010.08.006; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lee NK, 2017, STEM CELL REV REP, V13, P127, DOI 10.1007/s12015-016-9694-0; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Long QF, 2015, NEUROSCI LETT, V606, P30, DOI 10.1016/j.neulet.2015.08.040; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mishra SK, 2018, TOXICOL IN VITRO, V50, P179, DOI 10.1016/j.tiv.2018.03.009; Mishra SK, 2017, EXP CELL RES, V351, P59, DOI 10.1016/j.yexcr.2016.12.025; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Mishra SK, 2016, CONTRAST MEDIA MOL I, V11, P350, DOI 10.1002/cmmi.1698; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Ngen EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13628; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Qin JB, 2012, INT J NANOMED, V7, P5191, DOI 10.2147/IJN.S35647; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Song M, 2009, NEUROSCI RES, V64, P235, DOI 10.1016/j.neures.2009.03.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vande Velde G, 2012, NEUROIMAGE, V62, P367, DOI 10.1016/j.neuroimage.2012.04.040; Vreys R, 2010, NEUROIMAGE, V49, P2094, DOI 10.1016/j.neuroimage.2009.10.034; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Yin Y, 2015, NEURAL REGEN RES, V10, P909, DOI 10.4103/1673-5374.158355; Zhang N, 2009, NMR BIOMED, V22, P391, DOI 10.1002/nbm.1348; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	38	11	11	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2629-3269	2629-3277		STEM CELL REV REP	Stem Cell Rev. Rep.	DEC	2018	14	6					888	900		10.1007/s12015-018-9828-7			13	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	GZ5NX	WOS:000449471900012	29911289				2022-02-06	
J	Williams, CN; Eriksson, C; Piantino, J; Hall, T; Moyer, D; Kirby, A; McEvoy, C				Williams, Cydni N.; Eriksson, Carl; Piantino, Juan; Hall, Trevor; Moyer, Danielle; Kirby, Aileen; McEvoy, Cindy			Long-term Sequelae of Pediatric Neurocritica Care: The Parent Perspective	JOURNAL OF PEDIATRIC INTENSIVE CARE			English	Article						pediatric; critical care; patient outcome assessment	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; FUNCTIONAL OUTCOMES; CRITICAL ILLNESS; COGNITIVE FUNCTION; ORGAN DYSFUNCTION; SYNDROME-FAMILY; YOUNG-CHILDREN; SEVERE SEPSIS	Critical neurologic disease and injury affect thousands of children annually with survivors suffering high rates of chronic morbidities related directly to the illness and to critical care hospitalization. Postintensive care syndrome (PICS) in patients and families encompasses a variety of morbidities including physical, cognitive, emotional, and psychological impairments following critical care. We conducted a focus group study with parents of children surviving pediatric neurocritical care (PNCC) for traumatic brain injury, stroke, meningitis, or encephalitis to determine outcomes important to patients and families, identify barriers to care, and identify potential interventions to improve outcomes. Sixteen parents participated in four groups across Oregon. Three global themes were identified: (1) PNCC is an intense emotional experience for the whole family; (2) PNCC survivorship is a chronic illness; and (3) PNCC has a significant psychological and social impact. Survivors and their families suffer physical, emotional, psychological, cognitive, and social impairments for many years after discharge. Parents in this study highlighted the emotional and psychological distress in survivors and families after PNCC, in contrast to most PNCC research focusing on physical outcomes. Several barriers to care were identified with potential implications on survivor outcomes, including limited pediatric resources in rural settings, perceived lack of awareness of PICS among medical providers, and the substantial financial burden on families. Parents desire improved education surrounding PICS morbidities for families and medical providers, improved communication with primary care providers after discharge, access to educational materials for patients and families, direction to mental health providers, and family support groups to assist them in dealing with morbidities and accessing appropriate resources. Clinicians and researchers should consider the parent perspectives reported here when caring for and evaluating outcomes for children requiring PNCC.	[Williams, Cydni N.; Eriksson, Carl; Kirby, Aileen] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Neurol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Hall, Trevor; Moyer, Danielle] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Psychol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [McEvoy, Cindy] Oregon Hlth & Sci Univ, Dept Pediat, Div Neonatol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA		Williams, CN (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA.	willicyd@ohsu.edu	Piantino, Juan/AAI-2184-2019	Piantino, Juan/0000-0002-8861-5709	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL133115]; National Heart Lung Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL105447]; Office of Dietary SupplementUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01H L129060, UG3OD023288]; THRIVE peer support initiative	Dr. Williams is supported by the Agency for Healthcare Research and Quality (grant number K12HS022981). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Dr. Williams also serves on the Society of Critical Care Medicine's THRIVE task force and received a grant through the THRIVE peer support initiative awarded after completion of this study and submission of the manuscript. Dr. Piantino is supported by the National Heart, Lung and Blood Institute (grant number K12HL133115). Dr. McEvoy is supported by the National Heart Lung Blood Institute, R01 HL105447 with co-funding from the Office of Dietary Supplement R01H L129060 and UG3OD023288.	Alievi PT, 2007, J PEDIAT-BRAZIL, V83, P505, DOI [10.1590/S0021-75572007000800005, 10.2223/JPED.1693]; Ambuehl J, 2007, SWISS MED WKLY, V137, P312; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Araujo GC, 2017, J INT NEUROPSYCH SOC, V23, P529, DOI 10.1017/S1355617717000364; Attride-Stirling J., 2001, QUALITATIVE RES, V1, P385, DOI [10.1177/146879410100100307, DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Banwell BL, 2003, NEUROLOGY, V61, P1779, DOI 10.1212/01.WNL.0000098886.90030.67; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Bronner Madelon B, 2008, Child Adolesc Psychiatry Ment Health, V2, P9, DOI 10.1186/1753-2000-2-9; Bronner MB, 2009, PEDIATR CRIT CARE ME, V10, P636, DOI 10.1097/PCC.0b013e3181ae5c1a; Buysse CMP, 2007, QUAL LIFE RES, V16, P1567, DOI 10.1007/s11136-007-9271-8; Cappell J, 2013, PEDIATR CLIN N AM, V60, P709, DOI 10.1016/j.pcl.2013.02.008; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Choong K, 2015, PEDIATR CRIT CARE ME, V16, P310, DOI 10.1097/PCC.0000000000000362; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Farris RWD, 2013, PEDIATR CRIT CARE ME, V14, P835, DOI 10.1097/PCC.0b013e3182a551c8; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; GEMKE RJBJ, 1995, ARCH DIS CHILD, V73, P196, DOI 10.1136/adc.73.3.196; Hopkins RO, 2015, J PEDIATR INTENSIVE, V4, P204, DOI 10.1055/s-0035-1563547; Huggins EL, 2016, AACN ADV CRIT CARE, V27, P204, DOI 10.4037/aacnacc2016611; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Knoester H, 2008, INTENS CARE MED, V34, P1076, DOI 10.1007/s00134-008-1061-4; Marcin JP, 2016, PEDIATR RES, V79, P169, DOI 10.1038/pr.2015.192; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Polic B, 2013, EUR J PEDIATR, V172, P85, DOI 10.1007/s00431-012-1843-0; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Rees G, 2004, INTENS CARE MED, V30, P1607, DOI 10.1007/s00134-004-2310-9; Rennick JE, 2011, PEDIATR CRIT CARE ME, V12, P635, DOI 10.1097/PCC.0b013e3182191bfa; Rennick JE, 2009, J CHILD HEALTH CARE, V13, P128, DOI 10.1177/1367493509102472; Rennick JE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00002; Skinner AC, 2007, J RURAL HEALTH, V23, P150, DOI 10.1111/j.1748-0361.2007.00082.x; Typpo KV, 2009, PEDIATR CRIT CARE ME, V10, P562, DOI 10.1097/PCC.0b013e3181a64be1; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083; Wintermann GB, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0174-0; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	51	11	11	1	7	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2146-4618	2146-4626		J PEDIATR INTENSIVE	J. Pediatr. Intensive Care	DEC	2018	7	4					173	181		10.1055/s-0038-1637005			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	GZ4YU	WOS:000449419100001		Green Published			2022-02-06	
J	Zhang, M; Huang, LL; Teng, CH; Wu, FF; Ge, LY; Shi, YJ; He, ZL; Liu, L; Jiang, CJ; Hou, RN; Xiao, J; Zhang, HY; Chen, DQ				Zhang, Man; Huang, Li-Li; Teng, Chen-Huai; Wu, Fang-Fang; Ge, Li-yun; Shi, Yu-Juan; He, Zheng-Le; Liu, Lei; Jiang, Cheng-Jie; Hou, Ruo-Nan; Xiao, Jian; Zhang, Hong-Yu; Chen, Da-Qing			Isoliquiritigenin Provides Protection and Attenuates Oxidative Stress-Induced Injuries via the Nrf2-ARE Signaling Pathway After Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						TBI; Nrf2/ARE; Isoliquiritigenin; OGD; Nrf2-/-	TRIPTOLIDE-INDUCED HEPATOTOXICITY; FUNCTIONAL RECOVERY; ACTIVATION; INHIBITION; MECHANISMS; AUTOPHAGY; DISEASE; OXIDASE; ROLES; MODEL	Traumatic brain injury (TBI) is a serious public health and medical problem worldwide. Oxidative stress plays a vital role in the pathogenesis of TBI. Nuclear factor erythroid 2-related factor 2 (Nrf2), an important factor in the cellular defense against oxidative stress, is activated following TBI. In this study, the protective effects of Isoliquiritigenin (ILG), a promising antioxidant stress drug, was evaluated as a protective agent against TBI. In a mouse model of controlled cortical impact Injury, we found that the ILG administration reduced the Garcia neuroscore, injury histopathology, brain water content, cerebral vascular permeability, the expression of cleaved caspase3, aquaporin-4, glial fibrillary acidic protein and the increased the expression of neurofilament light chain protein, indicating the protective effects against TBI in vivo. ILG treatment after TBI also restored the oxidative stress and promoted the Nrf2 protein transfer from the cytoplasm to the nucleus. We then used Nrf2-/- mice to test the protective effect of Nrf2 during ILG treatment of TBI. Our findings indicated that Nrf2-/- mice had greater brain injury and oxidative stress than wild-type (WT) mice and ILG was less effective at inhibiting oxidative stress and repairing the brain injury than in the WT mice. In vitro studies in SY5Y cells under oxygen glucose deprivation/re-oxygenation stimulation yielded results that were consistent with those obtained in vivo showing that ILG promotes Nrf2 protein transfer from the cytoplasm to the nucleus. Taken together, our findings demonstrate that Nrf2 is an important protective factor against TBI-induced injuries, which indicates that the protective effects of ILG are mediated by inhibiting oxidative stress after TBI via a mechanism that involves the promotion of Nrf2 protein transfer from the cytoplasm to the nucleus.	[Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Liu, Lei; Jiang, Cheng-Jie; Hou, Ruo-Nan; Chen, Da-Qing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Liu, Lei; Jiang, Cheng-Jie; Hou, Ruo-Nan; Chen, Da-Qing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Huang, Li-Li; Ge, Li-yun; He, Zheng-Le; Xiao, Jian; Zhang, Hong-Yu] Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Shi, Yu-Juan] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China		Chen, DQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China.; Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou, Zhejiang, Peoples R China.	hyzhang@wmu.edu.cn; cdq1965@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472165, 81772450, 81572237, 81501953]; National Science Fund for Outstanding Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81722028]; Zhejiang Provincial Natural Science Funding [Q18H150013, LY14D060009]	Funding was provided by the National Natural Science Foundation of China (81472165, 81772450, 81572237, 81501953), The National Science Fund for Outstanding Young Scholars (81722028) and Zhejiang Provincial Natural Science Funding (Q18H150013, LY14D060009).	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Borchert, 2018, BIOCHIM BIOPHYS ACTA, V30, P127; Cao LJ, 2016, PHARMAZIE, V71, P394, DOI 10.1691/ph.2016.6535; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011; de la Vega MR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121371; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong XL, 2017, MOL NEUROBIOL, V54, P736, DOI 10.1007/s12035-015-9683-3; Fabrizio FP, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2492063; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Hou ZY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00226; June L, 1973, CANCER RES, V33, P2643; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Lee SH, 2009, INFLAMM RES, V58, P257, DOI 10.1007/s00011-008-8183-6; Liu XN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7161592; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Malavolta M, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4159013; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Ozevren H, 2018, FOLIA MORPHOL, V77, P642, DOI 10.5603/FM.a2018.0029; Pan X, 2000, ACTA PHARMACOL SIN, V21, P949; Park SM, 2016, EUR J NUTR, V55, P2431, DOI 10.1007/s00394-015-1051-6; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Shintani Y, 2015, ALLERGOL INT, V64, pS54, DOI 10.1016/j.alit.2015.06.004; Vomund S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122772; Vona R, 2018, J CELL MOL MED, V22, P3308, DOI 10.1111/jcmm.13630; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yerra VG, 2017, J NUTR BIOCHEM, V47, P41, DOI 10.1016/j.jnutbio.2017.05.001; Yi T, 2018, MED SCI MONITOR, V24, P5973, DOI 10.12659/MSM.908130; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zou P, 2018, INFLAMMOPHARMACOLOGY, V26, P26	37	11	11	2	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2018	43	12					2435	2445		10.1007/s11064-018-2671-z			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HB4MC	WOS:000451026100024	30446968				2022-02-06	
J	Ananthaharan, A; Kravdal, G; Straume-Naesheim, TM				Ananthaharan, Arurann; Kravdal, Gunnhild; Straume-Naesheim, Truls Martin			Utility and effectiveness of the Scandinavian guidelines to exclude computerized tomography scanning in mild traumatic brain injury - a prospective cohort study	BMC EMERGENCY MEDICINE			English	Article						Mild brain injury; Clinical assessment of CNS injury; s100b; Head injury; CT scanning; Head trauma	MINOR HEAD-INJURY; INITIAL MANAGEMENT; S100B; FREQUENCY; RISK	Background: In 2013 the Scandinavian Neurotrauma Committee (SNC) published updated guidelines for the initial management of minimal, mild and moderate traumatic head injuries (MTHI) that included serum analysis of protein S100B as a marker for brain tissue damage. This study reviews the effectiveness of the new guidelines in a clinical setting. Methods: For all patients admitted to Akershus University Hospital (AHUS) from June 30th 2014 to December 15th 2014 with MTHI a separate form was filled in recording the time, indication and result of any S100B sampling and/or head computer tomography (CT) examinations. Data from these forms were compared to information derived from the electronic patient records for patients with MTHI and related diagnoses and data from the laboratory for all patients that had undergone the S100B analysis within the same period. Results: Five hundred seventy-five patients were identified with MTHI, S100B sampling was indicated for 223 (38.8%) patients and carried out for 188 (84.3%) of these patients. 69 (36.7%) of the patients had a negative S100B test, but a head CT scan was still performed in 31 cases despite the negative S100B test. In total the guidelines were followed for 362 of 575 patients (63.0%). 180 (31.3%) of the MTHI cases were discharged without further observation or CT examinations, including 38 (21.1%) as a direct result of S100B testing. No re-admissions or missed initial traumatic brain injuries were observed. Conclusion: The implementation of the updated SNC guidelines resulted in direct discharge of more than one third of the MTHI cases without further observation or CT examinations. One in five of these discharges was a direct result of S100B testing. However, compliance to the guidelines were poor and the guidelines were only followed in 40%. While this study showed benefits of implementing SNC guidelines to reduce the number of CT scans, additional training is needed for optimal use.	[Ananthaharan, Arurann] Akershus Univ Hosp, Lorenskog, Norway; [Ananthaharan, Arurann] St Olavs Hosp, Trondheim, Norway; [Kravdal, Gunnhild] Akershus Univ Hosp, Multidisciplinary Lab Med & Med Biochem, Lorenskog, Norway; [Straume-Naesheim, Truls Martin] Akershus Univ Hosp, Clin Orthoped Surg, Lorenskog, Norway; [Straume-Naesheim, Truls Martin] Univ Oslo, Oslo, Norway		Ananthaharan, A (corresponding author), Akershus Univ Hosp, Lorenskog, Norway.; Ananthaharan, A (corresponding author), St Olavs Hosp, Trondheim, Norway.	arurann@gmail.com					Allouchery G, 2018, CLIN CHEM LAB MED; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Borretzen I, 2007, RADIAT PROT DOSIM, V124, P339, DOI 10.1093/rpd/ncm204; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heskestad B, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-32; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen Tor, 2012, Tidsskr Nor Laegeforen, V132, P1948; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; TheNordicRadiationProtectionCo-operation, 2012, STAT INCR US COMP TO; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	22	11	11	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	NOV 20	2018	18								44	10.1186/s12873-018-0193-2			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HB9FT	WOS:000451397600001	30458714	Green Published, gold			2022-02-06	
J	Crowe, TK; Sanchez, V; Howard, A; Western, B; Barger, S				Crowe, Terry K.; Sanchez, Victoria; Howard, Alyse; Western, Brenna; Barger, Stephanie			Veterans transitioning from isolation to integration: a look at veteran/service dog partnerships	DISABILITY AND REHABILITATION			English	Article						Post-traumatic stress; traumatic brain injury; qualitative methods	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; SERVICE DOGS; PTSD; PREVALENCE; OEF/OIF; PEOPLE; IRAQ	Background: This study explored the dynamics of veteran/service dog partnerships by gathering the perspectives of veterans with a history of post-traumatic stress disorder and/or traumatic brain injury. Methods: Exploratory qualitative methods (focus groups and individual interviews) were used to investigate veteran/service dog relationships related to community involvement, family and friend relationships, self-care, work, and leisure. Nine male veterans, Paws, and Stripes program graduates participated. Data were audio recorded and transcribed by two research team members who used qualitative analytic software to manage and code the data. The full research team discussed themes and reached consensus on the themes that emerged from analysis. Results: Five themes emerged about the perceived benefit of veteran/service dog relationship: Secluded but Seeking Society (moving from isolation to reconnection); Opening Opportunities (navigating daily life); Bridging the Gap (facilitating social opportunities); and Reclaiming Life (transforming sense of worth and purpose). An overarching theme, Calming Catalyst, connected the other four themes. Conclusions: Veterans in this study reported that their goal was to reclaim and develop key aspects of their lives and they perceived service dogs as a support in their transition from isolation to reintegration. This study found that service dogs supported the veterans to meet their goal.	[Crowe, Terry K.] Univ New Mexico, Occupat Therapy Grad Program, Albuquerque, NM 87131 USA; [Sanchez, Victoria] Univ New Mexico, Coll Populat Hlth, MSC 09,50701 Univ New Mexico, Albuquerque, NM 87131 USA; [Howard, Alyse; Western, Brenna] Explorabilities, Albuquerque, NM USA; [Barger, Stephanie] Paws & Stripes, Albuquerque, NM USA		Sanchez, V (corresponding author), Univ New Mexico, Coll Populat Hlth, MSC 09,50701 Univ New Mexico, Albuquerque, NM 87131 USA.	visanchez@salud.unm.edu					Arthur D.C., 2007, ACHIEVABLE VISION RE; Assistance Dogs International Inc, 2015, SERV DOGS; Association A.P., 2013, DIAGN STAT MAN MENT, P271; Bureau of Labor Statistics, 2015, EMPL SIT VET; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Crowe TK, 2014, AM J OCCUP THER, V68, P194, DOI 10.5014/ajot.2014.009324; Cukor J, 2010, ANN NY ACAD SCI, V1208, P82, DOI 10.1111/j.1749-6632.2010.05793.x; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Epidemiology Program; Post Deployment Health Group; Office of Public Health; Veterans Health Administration; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Foa EB, 2000, J TRAUMA STRESS, V13, P539, DOI 10.1023/A:1007802031411; Fry-Johnson YW, 2009, INT J CHILD ADOLESC, V2, P417; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hubert G, 2013, J REHABIL RES DEV, V50, P341, DOI 10.1682/JRRD.2011.07.0124; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Libby DJ, 2012, PSYCHIAT SERV, V63, P1134, DOI 10.1176/appi.ps.201100456; Merriam S.B., 2014, QUALITATIVE RES GUID, V4th ed.; Muramatsu RS, 2013, PSYCHIAT SERV, V66, P87; National Center for Veterans Analysis and Statistics, 2014, PROF VET; Paws and Stripes, 2015, WHO WE AR; Provalis Research, 2014, QDA MIN LITE VERS 1; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Stern SL, 2013, SOC ANIM, V21, P568, DOI 10.1163/15685306-12341286; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Taylor MF, 2013, ANTHROZOOS, V26, P593, DOI 10.2752/175303713X13795775535896; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Veteran's Administration National Center for PTSD, 2017, TRAUM BRAIN INJ PTSD; The Veteran's Administration National Center for PTSD, 2017, TREATM PTSD; VA Office of Research and Development, 2014, POL BLAST REL INJ; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winkle M, 2012, OCCUP THER INT, V19, P54, DOI 10.1002/oti.323; Yeager Arthur F, 2012, US Army Med Dep J, P57; Yount Rick A, 2012, US Army Med Dep J, P63	32	11	11	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 20	2018	40	24					2953	2961		10.1080/09638288.2017.1363301			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HA6OX	WOS:000450400300013	28805082				2022-02-06	
J	Rostowsky, KA; Maher, AS; Irimia, A				Rostowsky, Kenneth A.; Maher, Alexander S.; Irimia, Andrei			Macroscale White Matter Alterations Due to Traumatic Cerebral Microhemorrhages Are Revealed by Diffusion Tensor Imaging	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; cerebral microbleed; diffusion tensor imaging; connectomics; susceptibility weighted imaging	HUMAN CORPUS-CALLOSUM; BRAIN-INJURY; FIBER TRACTS; AMYLOID ANGIOPATHY; SPATIAL STATISTICS; VOXELWISE ANALYSIS; LANGUAGE DISORDER; INHERITED SPEECH; MRI ANALYSIS; MICROBLEEDS	With the advent of susceptibility-weighted imaging (SWI), the ability to identify cerebral microbleeds (CMBs) associated with mild traumatic brain injury (mTBI) has become increasingly commonplace. Nevertheless, the clinical significance of post-traumatic CMBs remains controversial partly because it is unclear whether mTBI-related CMBs entail brain circuitry disruptions which, although structurally subtle, are functionally significant. This study combines magnetic resonance and diffusion tensor imaging (MRI and DTI) to map white matter (WM) circuitry differences across 6 months in 26 healthy control volunteers and in 26 older mTBI victims with acute CMBs of traumatic etiology. Six months post-mTBI, significant changes (p < 0.001) in the mean fractional anisotropy of perilesional WM bundles were identified in 21 volunteers, and an average of 47% (sigma = 21%) of TBI-related CMBs were associated with such changes. These results suggest that CMBs can be associated with lasting changes in perilesional WM properties, even relatively far from CMB locations. Future strategies for mTBI care will likely rely on the ability to assess how subtle circuitry changes impact neural/cognitive function. Thus, assessing CMB effects upon the structural connectome can play a useful role when studying CMB sequelae and their potential impact upon the clinical outcome of individuals with concussion.	[Rostowsky, Kenneth A.; Maher, Alexander S.; Irimia, Andrei] Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA		Irimia, A (corresponding author), Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Maher, Alexander/0000-0003-4140-6085	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100973] Funding Source: NIH RePORTER	The authors wish to thank study volunteers for their participation. This research was supported by the National Institutes of Health, grant R01 NS 100973 to AI.	Aarnink SH, 2014, NEUROIMAGE, V86, P404, DOI 10.1016/j.neuroimage.2013.10.026; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ABOITIZ F, 1992, BRAIN RES, V598, P154, DOI 10.1016/0006-8993(92)90179-D; Batchelor PG, 2006, MAGN RESON MED, V55, P894, DOI 10.1002/mrm.20858; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bian W, 2013, NEUROIMAGE-CLIN, V2, P282, DOI 10.1016/j.nicl.2013.01.012; Corouge I, 2006, MED IMAGE ANAL, V10, P786, DOI 10.1016/j.media.2006.07.003; do Carmo M.P., 1976, DIFFERENTIAL GEOMETR; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Ghafaryasl B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P138, DOI 10.1109/ISBI.2012.6235503; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Iimia A, 2013, NEUROIMAGE, V66, P489, DOI 10.1016/j.neuroimage.2012.10.066; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Leemans A, 2006, MAGN RESON MED, V55, P1414, DOI 10.1002/mrm.20898; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Maddah M, 2006, I S BIOMED IMAGING, P53; Maher AS, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P165, DOI 10.1145/3233547.3233598; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Ni J, 2015, J ALZHEIMERS DIS, V43, P1325, DOI 10.3233/JAD-140864; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Renard D, 2018, EUR J NEUROL, V25, P441, DOI 10.1111/ene.13544; Rencher Alvan C., 2002, METHODS MULTIVARIATE; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Romeny BMT, 2011, BIOL MED PHYS BIOMED, P177, DOI 10.1007/978-3-642-15816-2_7; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tsai HH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44715; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; van Veluw SJ, 2016, BRAIN, V139, P3151, DOI 10.1093/brain/aww229; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Yakushiji Y, 2016, NAT REV NEUROL, V12, P680, DOI 10.1038/nrneurol.2016.179; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013	45	11	11	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 13	2018	9								948	10.3389/fneur.2018.00948			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA2AM	WOS:000450031600001	30483210	Green Published, gold			2022-02-06	
J	Yue, JK; Winkler, EA; Puffer, RC; Deng, H; Phelps, RRL; Wagle, S; Morrissey, MR; Rivera, EJ; Runyon, SJ; Vassar, MJ; Taylor, SR; Cnossen, MC; Lingsma, HF; Yuh, EL; Mukherjee, P; Schnyer, DM; Puccio, AM; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Winkler, Ethan A.; Puffer, Ross C.; Deng, Hansen; Phelps, Ryan R. L.; Wagle, Sagar; Morrissey, Molly Rose; Rivera, Ernesto J.; Runyon, Sarah J.; Vassar, Mary J.; Taylor, Sabrina R.; Cnossen, Maryse C.; Lingsma, Hester F.; Yuh, Esther L.; Mukherjee, Pratik; Schnyer, David M.; Puccio, Ava M.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Temporal lobe contusions on computed tomography are associated with impaired 6-month functional recovery after mild traumatic brain injury: a TRACK-TBI study	NEUROLOGICAL RESEARCH			English	Article							COMMON DATA ELEMENTS; BLUNT HEAD-INJURY; OUTCOME PREDICTION; FOCAL LESIONS; HEMORRHAGIC PROGRESSION; RECOMMENDATIONS; DEFINITION; CT; PATHOPHYSIOLOGY; NEUROPSYCHOLOGY	Introduction: Mild traumatic brain injury (MTBI) can cause persistent functional deficits and healthcare burden. Understanding the association between intracranial contusions and outcome may aid in MTBI treatment and prognosis. Methods: MTBI patients with Glasgow Coma Scale 13-15 and 6-month outcomes [Glasgow Outcome Scale-Extended (GOSE)], without polytrauma from the prospective TRACK-TBI Pilot study were analyzed. Intracranial contusions on computed tomography (CT) were coded by location. Multivariable regression evaluated associations between intracranial injury type (temporal contusion [TC], frontal contusion, extraaxial [epidural/subdural/subarachnoid], other-intraaxial [intracerebral/intraventricular hemorrhage, axonal injury]) and GOSE. Odds ratios (OR) are reported. Results: Overall, 260 MTBI subjects were aged 44.4 +/- 18.1-years; 67.7% were male. Ninety-seven subjects were CT-positive and 46 had contusions (41.3%-frontal, 30.4%-temporal, 21.7%-frontal + temporal, 2.2% each-parietal/occipital/brainstem); 95.7% had concurrent extraaxial hemorrhage. Mortality was 0% at discharge and 2.3% by 6-months. GOSE distribution was 2.3%-death, 1.5%-severe disability, 27.7%-moderate disability, 68.5%-good recovery. Forty-six percent of TC-positive subjects suffered moderate disability or worse (GOSE <= 6) and 41.7% were unable to return to baseline work capacity (RTBWC), compared to 29.1%/20.4% for CT-negative and 26.1%/20.9% for CT-positive subjects without TC. On multivariable regression, TC associated with OR = 3.33 (95% CI [1.16-9.60], p = 0.026) for GOSE <= 6, and OR = 4.48 ([1.49-13.51], p = 0.008) for inability to RTBWC. Conclusions: Parenchymal contusions in MTBI are often accompanied by extraaxial hemorrhage. TCs may be associated with 6-month functional impairment. Their presence on imaging should alert the clinician to the need for heightened surveillance of sequelae complicating RTBWC, with low threshold for referral to services.	[Yue, John K.; Winkler, Ethan A.; Deng, Hansen; Phelps, Ryan R. L.; Morrissey, Molly Rose; Rivera, Ernesto J.; Runyon, Sarah J.; Vassar, Mary J.; Taylor, Sabrina R.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Winkler, Ethan A.; Deng, Hansen; Phelps, Ryan R. L.; Morrissey, Molly Rose; Rivera, Ernesto J.; Runyon, Sarah J.; Vassar, Mary J.; Taylor, Sabrina R.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Puffer, Ross C.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Puffer, Ross C.; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Wagle, Sagar] Mayo Clin, Dept Radiol, Rochester, MN USA; [Cnossen, Maryse C.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA		Yue, JK (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.; Yue, JK (corresponding author), Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA.	yuej@neurosurg.ucsf.edu	Schnyer, David/ABD-6372-2021; Yue, John K/P-1348-2015	Schnyer, David/0000-0002-7472-2853; Yue, John K/0000-0001-9694-7722; Rivera, Ernesto/0000-0002-9001-4515	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS0 86090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	This work was supported by the following grants: NINDS [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS0 86090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DOD [W81XWH-13-1-0441, W81XWH-14-2-0176] (to G. T. M.).	Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Butcher NE, 2014, EUR J TRAUMA EMERG S, V40, P107, DOI 10.1007/s00068-014-0391-x; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dara PK, 2018, J NEUROSCI RURAL PRA, V9, P226, DOI 10.4103/jnrp.jnrp_269_17; Das-Gupta R, 2002, DISABIL REHABIL, V24, P654, DOI 10.1080/09638280110109282; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kim H, 2015, J NEUROTRAUM, V32, P950, DOI 10.1089/neu.2014.3697; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Urgolites ZJ, 2017, P NATL ACAD SCI USA, V114, P8626, DOI 10.1073/pnas.1708963114; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Van Hoesen GW, 1999, ANN NY ACAD SCI, V877, P575; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zare MA, 2013, INT J NEUROSCI, V123, P65, DOI 10.3109/00207454.2012.728653	52	11	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV 2	2018	40	11					972	981		10.1080/01616412.2018.1505416			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW7IM	WOS:000447140600009	30175944	Green Accepted			2022-02-06	
